Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"		NA	NA			"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	15.0	35.1	13.4	22.0	16.6	19.9	16.5	19.2	18.4	17.6	16.4	22.6	20.9	15.4	19.3	26.1	18.2	25.3	19.4	20.7	13.2	11.8	20.4	26.0	13.4	23.4	19.3	10.1	19.7	27.3	33.1	27.3	23.6	15.8	17.3	19.3	21.5	22.8	18.5	19.7	22.2	17.5	21.2	16.4	22.0	19.1	26.6	19.5	39.1	19.5	24.6	24.4	17.2	16.9	15.3	17.2	8.2	14.7	10.0	16.7	10.1	10.3	31.5	24.6	15.1	11.7	14.2	15.8	11.8	12.8	29.8	17.2	21.4	22.0	24.8	20.4	15.0	16.9	15.1	42.9	31.5	17.6	15.7	27.7	20.2	13.9	21.5	11.9	17.8	15.3	13.6	15.9	19.7	19.2	16.2	23.4	21.3	26.7	28.8	14.4	33.5	28.0	18.5	16.9	12.2	22.0	27.5	16.4	27.8	21.1	8.5	13.2	16.9	8.7	19.7	9.1	16.4	25.3	15.6	10.6	14.2	21.5	11.3	12.5	12.9	16.3	22.6	11.4	15.5	16.3	1.2	12.1	8.2	13.7	14.0	16.5	15.2	12.3	12.6	13.7	15.3	16.7	16.2	1.1	10.0	14.7	17.2	12.6	10.1	13.4	16.6	19.2	18.4	13.2	11.8	19.3	10.1	15.8	19.5	11.9	5.6	10.4	16.1	6.5	11.3	5.9	15.3	6.7	7.9	14.0	15.7	53.6	11.6	17.4	11.4	9.1	9.8	23.3	16.1	43.4	12.2	8.6	8.1	11.5	25.1	1.6	8.1	10.4	9.1	18.3	16.4	10.8	10.1	10.8	11.5	17.4	9.4	13.5	12.0	15.4	14.7	19.4	11.3	26.5	45.3	6.5	30.6	10.2	16.2	8.0
ABCA1	"ABC1, HDLDT1, TGD"	ENSG00000165029	"ATP binding cassette subfamily A member 1"	O95477	9	104781002-104928237	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Translocase	"Atherosclerosis, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 98.3;Hepatocytes: 162.2;Kupffer cells: 103.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 11.6;neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 11.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 17.0;U-87 MG: 39.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057283, CAB069889"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"CAB069889: AB_10002789, HPA057283: AB_2683396"	"unprognostic (1.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.22e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.57e-1)"	25.7	38.1	6.3	9.8	13.1	15.8	23.0	2.3	8.5	8.2	14.8	8.0	6.5	4.4	7.8	9.6	7.0	7.9	13.6	10.7	7.5	3.7	7.1	33.3	12.7	29.4	18.9	2.3	8.7	5.4	1.8	3.3	20.1	10.2	9.4	9.4	7.7	6.3	8.7	21.3	12.1	8.1	25.2	16.1	12.8	7.3	8.8	8.0	16.9	5.8	2.2	5.0	16.4	20.0	1.8	0.2	11.6	1.5	0.1	0.6	0.1	0.0	2.7	2.2	0.0	6.5	2.5	2.0	2.8	10.9	0.9	1.0	0.4	0.4	3.8	3.1	2.8	10.7	0.0	1.2	0.1	0.8	0.0	0.0	0.4	0.9	9.5	11.8	0.0	6.7	17.0	0.7	11.1	0.2	10.6	1.0	0.3	0.0	9.8	0.2	0.3	2.3	5.2	3.1	0.5	0.8	0.0	0.0	0.2	1.8	1.8	0.3	0.1	2.9	0.5	0.6	4.5	0.0	1.9	1.0	3.0	0.2	3.9	3.1	3.8	1.8	2.3	39.0	0.0	0.0	2.2	0.8	11.6	0.2	1.0	0.2	1.2	0.3	0.0	0.2	1.8	0.6	0.0	10.6	0.1	1.5	0.1	0.1	0.1	6.3	13.1	2.3	4.0	7.5	3.7	18.9	2.3	10.2	8.0	98.3	9.4	5.1	4.8	26.4	11.9	7.8	12.7	2.7	9.1	10.4	45.2	21.2	0.0	3.8	1.5	9.3	3.2	0.0	1.4	4.6	28.8	3.1	46.1	162.2	63.2	0.0	8.7	25.2	103.3	0.7	28.7	31.4	25.3	2.8	2.4	0.1	4.9	3.5	26.5	17.0	5.5	45.3	16.4	1.2	0.7	16.9	7.4	4.4	2.3	8.9
ABCA10	EST698739	ENSG00000154263	"ATP binding cassette subfamily A member 10"	Q8WWZ4	17	69147214-69244846	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ovary: 11.6"	"Cell type enhanced"	"Detected in many"	24	"Early spermatids: 189.3;Late spermatids: 66.1;Leydig cells: 47.2"	"Low cancer specificity"	"Detected in some"							"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.7;HSkMC: 3.8;HUVEC TERT2: 3.7;RT4: 3.5;U-2197: 5.5"									HPA014535	Uncertain					NA	NA					"HPA014535: AB_1844426"	"unprognostic (1.45e-4)"	"unprognostic (3.17e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.91e-1)"	"unprognostic (2.70e-4)"	"unprognostic (5.23e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.86e-3)"	4.6	0.5	0.0	0.0	0.2	0.0	10.4	5.0	0.4	1.6	1.7			0.6	2.7	2.4	1.1	6.3	3.1	2.7	0.1	0.2	0.5	2.7	2.5	0.1	0.1		11.6	1.3	0.1	1.3	0.0		0.8	3.8		2.6	0.2	3.5	4.1	1.4	1.7	0.2	0.3	1.0	1.6			3.1		0.3	1.3	1.9	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.2	0.0	1.7	0.3	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	1.0	0.0	0.0	3.8	0.5	0.8	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	2.7	0.0	0.4	0.9	7.1	2.4	0.0	4.0	0.0	0.0	23.6	0.0	0.0	0.4	189.3	1.7	2.5	0.0	0.2	0.0	3.8	0.3	0.0	1.0	0.1	0.0	4.7	0.6	0.0	66.1	47.2	0.9	1.7	2.8	2.9	3.1	0.6	0.0	11.0	0.3	7.6	0.0	1.4	7.7	2.8	0.4	0.0	0.0	0.5	0.5
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138428	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 23.1;tongue: 29.3"	"Group enriched"	"Detected in some"	7	"Basal keratinocytes: 11.4;Suprabasal keratinocytes: 33.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 28.7;SK-BR-3: 13.4;T-47d: 7.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"cerebral cortex: 1.6;hippocampal formation: 1.8"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: AB_2732373"	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.1	0.0	0.1	0.1	0.1	0.0	6.9	0.1	0.1	6.2	0.3	0.0	1.4	0.0	0.0	4.4	8.4	0.1	0.0	0.0	0.6	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.1	4.9	0.0	0.1	0.4	0.0	0.3	0.0	0.1	23.1	0.0	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.0	29.3	6.1	0.1	3.7	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	28.7	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	2.0	0.0	13.4	0.0	0.1	7.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	11.4	0.0	0.4	0.0	0.0	3.4	0.0	0.0	0.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.1	0.3	0.4	0.0	0.0	0.3	1.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.5	1.1	0.0	0.7	0.0	0.0	0.0	0.2	0.5	0.2	33.8	2.9	0.0	0.0	2.2
ABCA2	ABC2	ENSG00000107331	"ATP binding cassette subfamily A member 2"	Q9BZC7	9	137007227-137028922	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 84.3"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 35.0;Intestinal endocrine cells: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.7;NK-cells: 1.2;T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 35.2"	"Low region specificity"	"Detected in all"							HPA042886	Approved					NA	NA					"HPA042886: AB_2678213"	"unprognostic (1.01e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.59e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.36e-1)"	7.8	6.1	20.0	3.9	42.4	5.7	2.6	16.7	54.2	4.0	4.5	84.3	0.9	3.2	2.8	4.7	3.5	6.3	5.7	7.1	32.2	17.6	4.8	3.8	4.1	4.1	57.5	21.9	2.5	8.6	8.1	7.8	3.3	31.1	5.2	2.5	3.8	8.0	5.1	5.7	6.3	4.1	2.7	70.5	8.3	6.1	3.0	47.7	0.2	9.5	0.1	2.2	3.3	1.8	0.4	2.7	0.4	0.3	1.2	2.2	1.1	4.4	4.8	2.4	9.7	6.1	6.5	4.2	4.9	2.0	2.2	0.8	1.4	5.4	0.2	14.1	5.3	2.2	7.5	1.5	3.6	0.4	3.3	3.1	0.4	13.9	1.7	3.0	7.0	7.7	2.7	3.3	1.6	0.4	8.3	1.2	1.4	1.1	0.8	2.7	13.3	0.0	15.0	1.2	5.6	4.9	6.8	2.4	6.5	1.5	1.0	9.3	10.7	5.3	10.4	3.8	0.1	35.2	9.1	6.3	6.1	3.3	8.6	2.0	0.1	0.1	0.0	10.3	1.3	3.0	0.0	0.3	0.0	2.2	0.2	1.3	0.4	0.2	0.7	0.3	0.2	0.0	0.9	0.4	1.2	0.0	2.7	1.0	1.1	20.0	42.4	16.7	30.7	32.2	17.6	57.5	21.9	31.1	47.7	0.0	0.0	0.5	1.3	3.0	9.5	4.0	17.8	0.0	0.0	1.8	13.7	1.0	1.7	2.9	0.6	3.4	10.3	0.0	1.3	1.0	4.3	2.6	0.0	6.7	1.2	35.0	33.4	7.4	2.4	1.1	20.4	1.1	5.0	0.0	5.7	10.8	2.3	6.8	22.3	1.1	7.2	0.0	3.8	0.5	4.5	2.4	0.7	14.1	8.9	0.9
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.8;lung: 75.8"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 382.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 15.1;HDLM-2: 15.2;SCLC-21H: 21.2;SH-SY5Y: 15.3;T-47d: 34.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.3	6.2	12.9	3.4	15.3	1.6	7.0	21.9	30.8	3.0	3.8	13.1	1.8	2.7	3.2	4.2	3.6	4.9	3.3	5.6	14.6	13.8	3.9	1.5	75.8	3.9	11.4	13.1	3.2	9.6	14.8	6.0	4.7	18.3	5.3	2.1	4.9	8.5	5.0	5.0	4.2	2.5	5.0	11.3	3.7	3.0	7.2	6.1	5.6	16.2	0.5	6.4	3.0	1.3	0.2	0.5	0.0	0.6	2.0	1.5	0.4	0.3	9.7	1.8	15.1	0.4	0.0	0.1	2.6	0.6	1.0	1.1	1.3	1.5	0.1	3.8	1.2	0.9	0.2	8.7	0.1	0.3	15.2	5.8	1.0	1.1	0.2	1.3	0.1	1.6	0.1	0.2	0.1	0.5	6.2	14.7	0.1	10.4	0.0	0.0	12.9	0.0	1.0	2.0	2.3	4.7	2.4	0.3	1.7	8.7	0.3	21.2	15.3	1.8	10.7	0.2	0.8	34.9	0.9	4.2	0.1	0.5	4.1	4.3	2.8	1.2	0.0	2.1	5.2	0.1	0.0	0.1	0.0	1.5	0.1	0.8	0.2	0.6	1.4	0.5	0.1	0.6	1.5	0.0	2.0	0.6	0.0	0.3	0.4	12.9	15.3	21.9	30.8	14.6	13.8	11.4	13.1	18.3	6.1	65.5	382.0	0.0	0.4	0.6	16.5	5.1	2.5	4.0	17.0	17.4	11.8	0.0	0.0	4.6	7.7	4.2	0.2	0.0	3.3	0.0	1.4	1.9	27.8	0.9	0.9	17.5	5.2	2.5	2.7	2.7	1.7	1.6	1.7	2.8	0.7	6.9	2.4	0.0	3.2	1.5	9.5	6.5	3.1	1.9	14.0	1.4	0.0	2.5	0.6	0.1
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992835-94121132	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 142.7"	"Group enriched"	"Detected in some"	14	"Cone photoreceptor cells: 424.1;Rod photoreceptor cells: 455.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	13	"pons and medulla: 25.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2;SuSa: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064420, HPA078826"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA064420: , HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.72e-4)"	0.7	0.0	0.3	0.2	0.4	0.0	1.1	0.2	0.9	0.7	0.2	3.2	0.2	3.7	0.2	12.9	0.2	0.6	0.2	0.2	2.0	0.2	6.7	1.2	0.4	0.3	0.3	0.2	0.3	0.2	0.0	0.2	0.8	25.5	0.3	0.0	142.7	0.2	2.1	0.2	3.5	4.2	0.2	0.2	0.2	0.1	2.1	0.2	0.2	0.7	0.2	0.2	0.3	0.2	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.3	0.0	0.2	0.1	0.0	0.0	11.2	0.5	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.7	3.5	1.2	0.6	0.0	0.0	0.5	0.0	0.5	0.0	0.2	1.0	0.0	0.0	0.2	0.0	1.4	0.5	0.0	2.0	0.0	0.0	0.2	0.3	0.3	0.5	0.5	0.0	0.0	1.0	4.2	0.2	5.1	0.4	0.0	0.2	0.3	2.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.9	2.0	0.2	0.3	0.2	25.5	0.2	0.0	0.6	0.0	0.2	0.1	14.3	0.8	0.0	2.7	0.0	7.0	424.1	0.1	0.0	0.0	8.5	0.8	0.0	0.0	0.0	1.1	0.2	1.5	0.0	0.0	0.1	9.5	0.0	0.6	0.0	15.5	0.0	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.4	0.0	455.0	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.5
ABCA5	EST90625	ENSG00000154265	"ATP binding cassette subfamily A member 5"	Q8WWZ7	17	69244311-69327244	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 52.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022032, HPA062904"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA022032: AB_1844427, HPA062904: AB_2732692"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.17e-2)"	"unprognostic (8.05e-4)"	"unprognostic (3.05e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.52e-2)"	10.5	8.6	6.7	3.8	9.8	6.0	12.7	35.6	12.4	8.8	9.6	4.3	13.5	9.7	6.0	7.7	8.6	6.6	4.6	5.2	5.3	6.2	7.9	21.7	4.9	3.3	4.1	7.9	6.9	20.3	13.0	35.9	5.3	13.6	7.4	10.6	15.5	8.2	11.4	52.8	24.0	15.5	3.4	7.6	4.3	8.9	9.0	3.9	1.7	7.9	10.3	5.9	5.5	8.1	4.2	3.9	4.5	0.7	3.0	4.2	1.2	4.2	2.0	1.6	2.5	7.9	5.7	0.5	4.5	4.9	4.7	7.0	0.6	1.6	0.0	2.4	3.9	3.7	6.4	1.0	3.7	5.3	0.1	3.0	0.0	4.8	3.0	10.5	0.0	2.7	5.6	4.6	2.0	5.4	1.0	10.2	1.6	0.0	1.7	0.4	3.7	2.6	0.0	1.6	1.6	3.0	0.3	0.1	0.4	0.9	7.2	8.9	1.4	16.1	7.4	4.6	1.5	7.6	2.7	7.4	5.3	1.5	4.9	0.9	9.2	0.2	0.3	2.2	0.0	4.8	0.7	0.7	4.5	3.1	0.2	4.2	2.4	4.0	3.4	0.5	4.2	2.1	3.4	1.9	3.0	0.1	3.9	2.4	1.2	6.7	9.8	35.6	12.4	5.3	6.2	4.1	7.9	13.6	3.9	17.9	16.9	10.2	30.0	58.2	127.4	22.1	28.1	49.5	14.8	36.6	110.0	11.6	5.0	9.2	14.9	17.1	72.6	0.0	8.6	4.9	18.8	32.6	13.9	89.4	6.2	100.1	108.2	18.4	4.8	9.5	59.0	8.9	96.2	47.7	65.8	49.9	12.8	38.6	43.2	10.2	117.6	90.5	24.0	103.0	47.0	46.9	19.8	13.8	26.6	34.4
ABCA6	EST155051	ENSG00000154262	"ATP binding cassette subfamily A member 6"	Q8N139	17	69078702-69141888	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 53.9"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 27.1;Hepatocytes: 95.4;Leydig cells: 47.5"	"Cancer enriched"	"Detected in some"	7	"liver cancer: 4.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 6.6;midbrain: 10.9;pons and medulla: 11.2;thalamus: 9.3"	"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.0;plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 20.7;ASC TERT1: 30.0;HSkMC: 13.1;HUVEC TERT2: 27.9;RT4: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA064878, HPA067180"			Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA064878: AB_2685380, HPA067180: AB_2685797"	"unprognostic (7.76e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.82e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.35e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.96e-4)"	"unprognostic (1.61e-4)"	"unprognostic (2.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.69e-1)"	31.4	4.3	1.4	2.0	6.6	0.4	12.1	0.7	1.9	12.3	9.9	4.7	2.9	1.8	7.9	6.9	10.5	4.9	7.2	13.2	1.5	0.9	3.0	53.9	9.3	3.6	10.9	0.2	22.0	1.9	1.1	6.0	1.8	11.2	8.0	3.4	4.2	7.1	1.9	6.6	5.0	3.9	9.8	21.0	1.8	4.4	5.0	9.3	0.0	6.7	6.6	2.5	16.6	11.7	0.0	1.2	0.0	1.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	20.7	30.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	13.1	0.0	1.6	0.4	0.8	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.0	0.3	1.4	6.6	0.7	1.9	1.5	0.9	10.9	0.2	11.2	9.3	0.0	0.0	2.7	0.9	2.7	13.9	4.8	0.0	0.0	1.2	3.5	5.9	0.0	0.0	0.2	2.9	2.2	0.5	0.0	0.2	0.0	27.1	0.1	0.0	95.4	1.2	0.0	2.4	2.5	1.8	2.2	47.5	2.8	5.0	1.0	0.1	3.9	0.5	0.0	11.3	0.6	13.8	0.0	1.7	0.9	1.0	2.5	0.0	0.0	0.0	0.3
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1040101-1065572	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Phagocytosis, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 35.2"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 68.5;Bipolar cells: 64.0;Cone photoreceptor cells: 164.9;Extravillous trophoblasts: 217.5;Rod photoreceptor cells: 151.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HeLa: 26.7;HMC-1: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Golgi apparatus, Plasma membrane"	"Cell Junctions"	"HPA041564: AB_2677550"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.26e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	6.0	3.5	6.2	20.2	4.8	35.2	7.6	13.6	11.1	5.0	5.8	1.9	4.7	4.9	2.1	3.9	7.5	2.8	5.5	2.3	5.3	6.5	5.3	3.6	9.5	17.7	5.2	5.1	1.0	7.0	5.6	34.5	3.1	7.7	4.9	4.2	34.7	9.9	6.5	5.5	11.1	11.1	1.8	6.7	26.6	7.9	1.6	4.3	19.8	7.0	3.9	14.5	5.1	4.9	1.5	9.9	10.8	2.5	1.9	2.6	1.2	5.7	5.4	1.1	3.4	6.7	3.0	5.6	0.8	0.8	0.3	0.6	4.1	2.2	11.2	3.8	0.8	0.4	5.7	2.3	5.1	0.3	7.4	2.1	8.6	26.7	4.1	2.6	3.2	32.2	2.8	1.8	1.5	2.9	5.5	1.9	6.1	8.7	7.0	1.0	1.4	3.1	2.3	0.6	4.2	2.5	2.9	0.6	8.0	2.8	10.8	0.7	2.2	6.3	1.9	0.6	2.5	3.7	5.2	2.8	0.6	1.4	2.9	0.8	8.1	7.9	6.1	1.4	7.7	1.3	4.3	2.5	7.0	2.6	1.7	1.6	1.0	1.5	1.8	2.8	1.5	1.4	2.1	10.8	1.9	1.6	9.9	0.6	1.2	6.2	4.8	13.6	11.1	5.3	6.5	5.2	5.1	7.7	4.3	68.5	31.1	10.2	0.6	3.0	64.0	5.6	2.5	5.3	9.1	5.2	164.9	2.4	1.7	2.7	6.0	2.9	9.0	0.0	2.1	217.5	2.8	1.4	9.3	3.2	6.9	14.3	3.4	3.1	14.8	2.9	0.0	7.0	0.0	10.0	3.8	13.0	5.9	10.5	0.0	1.3	151.3	0.0	3.1	0.7	1.9	3.0	21.5	10.2	2.9	1.7
ABCA8	KIAA0822	ENSG00000141338	"ATP binding cassette subfamily A member 8"	O94911	17	68867292-68955392	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Leydig cells: 465.4;Muller glia cells: 138.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 16.6;ASC TERT1: 37.0;HSkMC: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044914	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA044914: AB_10964859"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.14e-3)"	29.1	25.2	10.0	3.4	27.2	0.5	15.1	3.2	15.4	7.3	12.8	29.9	3.9	5.4	10.2	13.0	12.4	17.6	14.3	30.0	12.5	5.5	8.1	26.6	15.2	1.3	37.8	9.2	44.7	5.1	4.5	14.8	7.6	22.2	10.3	14.3	16.4	9.8	7.9	8.9	4.9	9.9	7.1	28.2	9.9	11.5	15.8	42.7	0.0	13.0	14.2	2.8	13.6	20.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	16.6	37.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	6.1	0.0	0.0	27.9	0.0	0.4	0.0	0.2	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.0	27.2	3.2	15.4	12.5	5.5	37.8	9.2	22.2	42.7	47.6	0.6	0.0	1.3	5.4	1.4	12.5	0.0	0.0	7.9	0.0	2.0	0.1	0.0	0.0	4.2	4.2	0.0	0.0	0.0	0.1	35.3	0.3	1.1	35.8	0.9	4.8	0.0	7.4	1.9	4.3	465.4	1.8	1.7	0.0	0.0	138.5	0.0	0.0	66.1	0.0	2.1	38.8	6.2	1.1	1.2	4.1	0.2	0.0	0.0	0.2
ABCA9	EST640918	ENSG00000154258	"ATP binding cassette subfamily A member 9"	Q8IUA7	17	68974488-69061064	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 42.5"	"Cell type enhanced"	"Detected in many"	22	"Ito cells: 26.4;Leydig cells: 89.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"ASC diff: 14.5;ASC TERT1: 31.1;HSkMC: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052113, HPA054823"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA052113: AB_2732573, HPA054823: AB_2682615"	"unprognostic (3.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.51e-4)"	"unprognostic (1.83e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.77e-6)"	"unprognostic (5.32e-4)"	"unprognostic (7.22e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-3)"	42.5	4.2	1.2	5.5	2.8	1.7	14.1	2.7	2.6	13.4	17.4	2.6	6.8	1.7	15.5	11.8	25.5	8.8	7.2	15.0	2.1	1.9	2.5	7.6	5.6	2.1	7.8	2.0	25.2	2.3	1.7	2.8	1.1	4.4	13.9	3.8	4.1	5.7	4.7	12.4	5.4	3.7	11.9	3.8	1.6	4.8	10.9	2.1	1.0	7.6	9.9	2.5	20.4	18.7	1.8	0.9	2.9	0.8	1.2	1.3	0.0	0.2	0.4	0.5	0.6	14.5	31.1	0.5	0.3	0.3	0.0	0.2	0.4	0.4	0.4	0.1	0.5	0.3	0.4	0.3	0.5	0.2	0.2	0.4	0.5	1.3	0.4	1.6	0.6	0.9	11.1	0.4	2.3	0.2	0.6	3.1	0.4	0.5	1.1	0.2	0.2	0.2	1.4	0.3	0.1	0.3	1.5	0.1	0.2	0.1	1.3	0.6	0.5	0.4	0.3	0.3	0.4	0.3	0.5	1.3	0.9	0.4	1.7	0.3	1.0	0.3	0.3	0.3	0.3	1.5	1.7	0.8	1.4	1.3	0.6	1.3	1.1	0.8	0.5	0.9	1.8	1.3	1.3	2.9	1.2	0.5	0.7	0.4	0.0	1.2	2.8	2.7	2.6	2.1	1.9	7.8	2.0	4.4	2.1	0.0	1.0	0.0	0.2	1.5	5.4	2.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.4	0.0	0.0	0.0	10.6	0.1	0.0	9.9	0.2	0.0	0.0	26.4	1.8	2.1	89.2	0.6	0.0	0.0	0.0	12.1	0.3	0.0	14.5	0.0	6.1	12.9	1.4	1.2	0.6	1.4	0.0	0.0	0.0	0.1
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503633-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 57.8;intestine: 49.6"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 104.4;Enterocytes: 174.5;Paneth cells: 77.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 19.2"	"Group enriched"	"Detected in many"	8	"NK-cells: 11.4;T-cells: 19.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 30.1;HEK 293: 9.3;HEL: 16.7;Hep G2: 8.2;RPTEC TERT1: 11.5;SH-SY5Y: 36.8"									"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	57.8	9.4	3.2	11.5	1.2	3.4	5.1	10.5	5.5	22.7	3.8	2.0	14.4	9.4	3.5	2.0	3.2	9.0	1.8	9.2	6.6	19.1	15.6	3.8	2.2	9.4	5.7	2.2	1.5	1.7	1.3	3.1	11.1	2.7	10.7	7.6	1.5	2.1	1.1	1.3	49.6	5.7	9.0	2.4	1.7	1.3	8.6	0.1	2.4	1.4	2.2	2.6	5.9	1.9	0.0	0.1	0.0	11.4	19.2	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	9.3	16.7	1.9	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	11.5	0.1	0.4	36.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.4	3.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.8	0.0	19.2	0.4	2.0	4.7	0.0	1.9	1.2	4.8	0.1	11.4	0.0	0.0	0.0	1.5	9.4	11.5	5.1	10.5	9.2	6.6	9.4	5.7	11.1	8.6	0.0	4.8	5.9	0.1	0.7	0.6	2.8	104.4	1.4	1.2	47.1	0.0	5.0	5.0	10.2	21.6	23.1	174.5	23.3	1.6	0.1	0.5	0.1	3.5	32.6	0.4	0.0	0.0	3.7	1.2	2.5	0.9	0.8	0.0	0.0	8.9	0.0	11.4	77.2	0.0	44.0	0.9	0.0	0.8	0.5	0.4	0.5	8.2	27.3	1.7	0.1
ABCB10	"EST20237, M-ABC2, MTABC2"	ENSG00000135776	"ATP binding cassette subfamily B member 10"	Q9NRK6	1	229516582-229558695	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"Erythroid cells: 140.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HL-60: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044063, CAB044065, HPA055175"	Uncertain					NA	NA					"CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: AB_2682727"	"unprognostic (1.00e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.06e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.37e-2)"	13.2	6.4	5.5	6.7	6.0	37.1	14.0	15.1	6.1	7.9	18.8	5.4	3.7	12.6	9.9	6.9	10.7	6.1	11.9	8.3	5.5	5.4	10.9	24.7	9.8	15.5	5.2	3.8	6.3	8.2	9.0	4.2	11.4	4.9	9.9	8.6	5.3	7.1	5.9	13.9	6.0	30.1	14.7	5.0	15.0	7.8	4.0	4.2	9.4	9.6	8.3	12.1	10.0	9.1	2.4	3.2	2.9	2.7	1.3	4.1	1.3	10.4	6.2	5.2	4.2	8.9	7.7	22.7	9.7	7.3	8.8	8.0	6.4	8.0	11.5	8.9	8.8	3.6	9.1	11.1	8.0	8.9	7.8	14.1	12.6	5.6	8.1	6.4	42.4	7.1	5.3	6.9	5.3	6.2	5.3	9.4	20.7	26.9	26.6	9.0	3.3	10.7	24.3	6.9	12.2	5.3	9.8	10.3	12.2	7.1	6.8	3.8	5.8	7.5	8.4	11.8	3.3	6.5	14.8	7.2	9.5	6.0	5.9	13.1	6.5	4.8	10.0	5.0	7.4	6.0	1.7	2.4	2.9	2.8	2.7	3.6	1.8	3.3	4.1	2.8	2.4	3.0	4.0	0.4	1.3	1.9	3.2	2.7	1.3	5.5	6.0	15.1	6.1	5.5	5.4	5.2	3.8	4.9	4.2	8.9	1.3	0.8	2.5	2.9	5.8	11.8	2.5	9.4	5.7	0.0	11.8	5.1	1.7	4.1	0.0	4.5	8.0	140.2	4.5	9.3	4.8	7.1	5.7	15.3	8.1	9.5	9.8	5.5	11.0	0.2	4.6	6.4	8.5	15.4	12.8	2.9	4.3	10.5	4.2	4.5	4.5	6.5	5.2	2.9	2.9	4.4	3.0	3.9	10.5	3.5
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168922938-169031322	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"liver: 47.4"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 38.7;Alveolar cells type 2: 58.1;Club cells: 35.2;granulocytes: 22.1;Hepatocytes: 17.9"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 1.0;NB-4: 1.7;PC-3: 1.0;THP-1: 2.6;TIME: 1.8;U-2197: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.0	0.0	0.4	0.0	0.0	0.0	0.0	1.7	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.7	58.1	0.0	0.0	0.0	0.0	0.3	0.0	16.0	35.2	0.0	0.0	0.0	0.0	0.1	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.1	17.9	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.7
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401697-87480435	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"liver: 93.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 235.3"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"memory B-cell: 4.9;naive B-cell: 11.4"	"Lineage enriched"	"Detected in many"	8	"B-cells: 11.4"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.0;WM-115: 22.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.5	4.1	0.2	4.3	0.2	0.2	0.3	0.1	1.1	0.2	0.6	0.4	0.0	0.0	0.1	0.2	0.6	0.1	0.3	4.0	0.3	0.2	0.4	93.2	0.1	4.1	0.3	0.2	0.3	0.1	0.0	0.5	0.0	0.3	0.3	0.4	0.8	0.4	0.1	2.9	0.6	1.2	1.6	0.5	5.2	0.2	0.5	0.4	0.1	0.4	4.2	3.2	0.6	0.5	11.4	1.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	12.0	0.0	0.6	2.2	0.5	0.2	0.5	0.0	0.2	1.6	0.1	0.0	0.0	0.0	2.8	0.2	0.0	22.9	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.1	1.4	11.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.1	1.1	0.3	0.2	0.3	0.2	0.3	0.4	0.0	0.3	23.1	0.0	0.9	0.0	9.3	0.0	0.0	0.0	1.8	0.0	0.9	0.0	0.1	0.6	0.8	0.1	0.0	0.0	0.2	1.5	0.0	0.0	235.3	0.5	36.5	0.0	5.5	5.4	0.2	0.0	0.0	10.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.0	0.0	0.9	0.5	0.1	0.4	0.1	0.0	0.0	0.0
ABCB5	"ABCB5alpha, ABCB5beta, EST422562"	ENSG00000004846	"ATP binding cassette subfamily B member 5"	Q2M3G0	7	20615207-20777038	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 33.4;retina: 43.3"	"Cell type enhanced"	"Detected in some"	17	"Basal glandular cells: 2.6;Early spermatids: 6.1;Melanocytes: 1.7"	"Cancer enriched"	"Detected in some"	9	"melanoma: 5.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"SK-MEL-30: 32.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.56e-3)"	"unprognostic (9.30e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.70e-2)"	10.6	0.1	0.0	0.4	0.0	0.3	8.6	0.0	0.1	4.4	3.8	0.0	5.3	0.1	1.8	33.4	0.3	0.4	2.8	0.9	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.1	2.9	0.6	43.3	0.3	0.4	1.0	2.1	0.9	1.5	0.3	0.1	0.7	2.6	0.0	0.0	0.1	0.2	0.1	1.8	1.6	0.7	0.5	2.3	0.5	0.5	0.3	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	4.4	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	32.6	0.0	0.0	0.1	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.5	0.4	0.2	0.2	0.1	0.4	0.3	0.2	0.1	0.7	0.2	0.3	0.8	0.5	0.2	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	2.6	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.9	0.7	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.5	0.2	0.5	0.0	0.0	0.0	0.7
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209766-219219017	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 4.0;Club cells: 2.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 27.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"		NA	NA		22000	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.1	8.4	8.2	3.9	13.5	10.2	9.2	7.6	9.1	6.9	7.6	5.4	8.3	8.1	7.1	10.1	9.0	8.4	8.5	9.5	5.6	8.2	6.9	16.2	7.2	4.9	9.8	7.6	13.1	7.1	8.0	6.0	3.7	9.2	9.2	4.2	6.0	5.6	11.3	24.0	5.5	8.0	9.5	9.2	3.2	6.8	19.5	7.7	0.8	9.9	11.3	4.7	14.8	6.0	2.8	5.6	1.3	1.1	1.2	3.2	2.4	0.1	9.9	2.0	12.5	14.0	5.0	12.3	3.7	3.4	4.1	4.1	15.2	2.1	0.1	19.1	3.6	2.2	21.4	0.2	1.5	1.3	6.3	2.2	15.5	10.9	27.9	16.9	0.0	5.2	7.3	1.8	2.7	0.0	6.1	7.1	2.1	13.1	1.9	2.7	5.1	1.0	0.1	3.1	23.0	4.1	5.2	6.3	0.6	2.2	0.2	7.4	7.9	7.7	18.3	8.1	8.0	5.5	0.3	3.2	5.5	0.2	7.4	4.3	5.0	4.0	0.0	6.2	0.1	7.3	1.3	1.1	0.0	1.7	0.9	0.5	2.8	1.3	0.7	0.9	2.3	3.2	2.1	0.0	1.2	0.8	5.6	1.1	2.4	8.2	13.5	7.6	9.1	5.6	8.2	9.8	7.6	9.2	7.7	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	4.0	2.3	0.0	0.0	0.2	0.0	0.6	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.4	0.0	0.7	0.0	0.2	0.9	0.2	0.3	0.2	0.0	0.0	0.0
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051554-75156732	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	15.1	18.0	12.3	14.7	14.3	13.0	14.6	26.0	16.2	11.6	15.2	12.0	13.7	19.0	14.7	13.6	14.7	11.7	10.0	21.4	11.7	7.1	15.6	22.4	12.2	15.9	13.0	8.5	16.4	12.4	14.7	22.6	11.5	14.0	10.6	15.4	9.5	12.9	15.5	34.6	15.3	15.9	14.9	12.2	13.9	14.8	5.4	16.2	19.7	12.4	19.3	16.0	13.9	13.3	19.4	19.3	7.0	18.7	12.2	21.5	12.4	11.6	11.3	11.7	14.7	7.7	19.2	5.6	8.2	9.2	7.5	12.9	14.1	17.2	18.2	15.8	6.7	15.8	12.1	22.4	10.4	12.8	19.6	18.7	12.3	22.8	10.4	6.3	19.8	10.7	13.6	9.9	10.1	13.3	14.9	16.2	16.7	13.3	23.6	8.1	7.0	14.9	14.6	19.8	18.4	15.9	15.2	22.4	21.3	9.7	11.6	13.9	9.3	19.3	17.8	11.0	19.3	8.0	14.0	8.4	7.7	15.0	16.0	7.9	7.7	19.5	16.5	7.5	23.9	8.1	5.9	18.7	7.0	11.5	17.7	12.3	18.1	12.8	12.4	19.3	19.4	21.5	16.0	2.2	12.2	13.4	11.9	17.4	12.4	12.3	14.3	26.0	16.2	11.7	7.1	13.0	8.5	14.0	16.2	8.9	7.2	15.2	12.1	14.1	9.2	43.6	10.2	10.7	7.9	10.4	5.9	19.5	10.0	14.8	0.3	11.1	8.5	0.0	11.6	9.8	12.7	9.0	21.9	11.5	17.9	23.8	13.3	9.8	19.7	0.4	13.6	14.9	10.1	16.2	9.8	12.0	10.6	5.8	12.4	15.9	7.6	32.3	12.4	3.8	9.4	14.1	18.7	13.1	17.8	9.5
ABCB8	"EST328128, M-ABC1, MABC1"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favorable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	12.6	22.8	14.4	13.8	22.0	12.2	8.5	24.9	24.8	16.3	12.3	22.2	10.4	19.3	16.5	14.9	17.6	12.9	11.5	13.0	14.5	12.8	14.5	33.5	11.7	13.3	19.1	17.9	13.3	12.6	15.4	20.1	23.6	15.9	12.3	9.5	12.5	11.1	12.8	11.2	13.7	14.7	12.7	13.3	11.5	13.1	13.6	19.5	14.0	18.4	11.7	10.6	9.6	10.4	4.4	10.4	10.3	6.7	4.0	7.5	3.6	12.5	19.8	5.1	16.1	8.1	4.7	10.2	6.6	6.9	10.6	11.2	7.9	21.1	6.6	8.9	7.0	12.8	13.3	7.4	13.8	4.7	8.2	8.1	5.2	7.9	9.4	5.3	4.0	13.1	8.1	10.5	12.6	5.2	3.9	10.6	14.7	27.4	9.1	7.9	28.1	15.3	7.6	3.4	9.5	22.6	7.3	3.2	23.5	7.1	5.4	4.9	9.9	7.1	20.2	6.4	4.1	8.0	5.3	6.5	9.9	2.6	7.1	9.9	9.2	4.6	4.7	14.0	9.7	10.1	10.3	4.5	3.4	7.5	6.7	5.2	4.4	5.3	6.1	6.3	3.5	4.9	6.9	1.1	4.0	4.7	10.4	5.6	3.6	14.4	22.0	24.9	24.8	14.5	12.8	19.1	17.9	15.9	19.5	11.9	0.6	11.7	5.2	3.3	22.7	6.7	12.7	1.4	1.2	10.4	35.3	32.5	3.3	13.7	1.8	3.4	24.1	0.0	17.6	18.5	6.5	7.1	50.6	21.2	25.1	28.6	0.0	5.5	8.1	1.9	6.1	5.9	8.5	11.8	8.7	11.2	17.7	7.8	11.7	12.8	32.9	25.8	5.9	8.8	15.4	6.5	68.4	7.5	10.6	5.1
ABCB9	EST122234	ENSG00000150967	"ATP binding cassette subfamily B member 9"	Q9NP78	12	122920951-122981649	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 18.3;Muller glia cells: 20.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 6.2"	"Group enriched"	"Detected in many"	5	"B-cells: 6.2;granulocytes: 4.1;T-cells: 1.9"	"Cell line enhanced"	"Detected in many"		"GAMG: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033052, HPA035113, HPA035114"	Approved		Supported	Vesicles		NA	NA			Vesicles		"CAB033052: AB_2273463, HPA035113: AB_2674470, HPA035114: AB_10601329"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.71e-2)"	3.6	4.2	9.5	3.0	13.1	5.3	3.8	19.7	17.0	2.9	4.0	5.8	2.3	5.0	4.2	9.7	4.7	4.7	4.6	4.6	9.0	11.5	3.3	2.7	3.4	3.1	10.8	10.9	4.7	4.3	6.6	9.9	3.5	9.8	3.5	4.1	3.0	7.7	5.6	3.4	6.0	6.1	3.9	7.5	4.0	4.0	21.3	6.4	2.5	3.6	2.0	3.7	2.9	2.7	6.2	0.4	4.1	0.7	0.5	1.9	1.8	3.4	6.4	3.6	3.4	1.5	3.0	1.7	2.2	3.2	3.9	2.5	2.7	3.9	3.9	2.6	2.2	19.9	3.2	2.6	5.4	1.5	0.8	5.2	16.8	5.3	4.3	1.8	0.8	6.8	4.2	2.2	5.7	1.8	9.6	4.3	3.8	3.3	2.9	2.1	7.7	1.2	1.6	1.1	3.7	6.3	4.7	1.0	3.6	1.9	2.3	3.8	1.2	1.1	8.3	8.0	1.4	9.4	1.1	1.9	2.8	9.7	8.7	6.4	9.4	5.2	1.1	4.9	1.9	15.2	4.1	0.7	0.7	0.8	0.4	1.9	6.2	0.8	0.7	0.4	1.2	1.5	1.4	1.7	0.5	0.3	0.3	0.5	1.8	9.5	13.1	19.7	17.0	9.0	11.5	10.8	10.9	9.8	6.4	6.0	5.8	0.0	2.6	2.9	7.9	2.0	0.0	0.0	3.4	3.5	13.7	4.2	0.0	3.3	7.5	2.5	2.1	0.0	1.3	1.5	2.6	1.6	2.3	0.6	0.9	6.4	1.2	1.8	0.0	18.3	2.6	0.9	5.0	0.0	1.6	20.0	1.9	0.0	2.5	0.9	5.2	6.5	3.1	6.5	3.1	2.8	1.1	2.6	2.2	1.4
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949577-16143074	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Translocase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 7.5;eosinophil: 3.1;T-reg: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 7.5;T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 39.0"	"Low region specificity"	"Detected in all"							"HPA002380, HPA076011"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA002380: AB_1844432, HPA076011: "	"unprognostic (9.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.42e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.78e-3)"	"unprognostic (7.19e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.80e-2)"	8.9	8.2	2.4	8.3	3.1	8.4	9.6	4.4	5.0	8.3	10.7	2.6	15.5	3.5	10.5	12.7	14.7	5.6	9.6	8.0	2.1	2.4	4.5	1.6	10.9	12.2	3.0	2.1	6.8	5.8	18.4	4.2	5.2	4.1	9.6	4.1	12.0	16.9	10.9	20.8	6.6	8.2	16.4	4.0	9.2	10.9	15.1	2.3	26.8	15.7	12.6	15.6	15.3	11.8	0.7	0.5	7.5	0.5	0.4	2.1	0.2	2.3	24.7	0.1	6.5	5.7	3.5	1.3	7.3	8.9	6.3	6.6	3.9	17.8	6.7	39.0	14.0	5.9	6.7	2.0	7.1	4.8	11.8	2.3	8.3	14.4	14.3	17.1	3.0	21.5	7.5	4.8	1.8	1.0	5.4	6.9	12.9	8.4	3.4	1.9	4.6	5.3	2.8	3.9	3.3	3.6	18.9	3.7	3.3	2.3	8.3	3.6	5.9	9.2	10.0	2.4	6.6	3.5	1.6	0.7	0.4	1.5	5.2	5.8	6.4	3.2	2.3	3.3	3.1	0.7	7.5	0.1	3.1	0.6	0.4	0.6	0.7	0.5	0.6	0.5	0.3	0.6	0.6	0.0	0.4	0.5	0.3	2.1	0.2	2.4	3.1	4.4	5.0	2.1	2.4	3.0	2.1	4.1	2.3	23.8	6.4	10.4	6.8	7.8	3.1	5.3	5.1	2.7	12.5	5.2	21.6	0.6	3.3	8.7	7.2	6.2	1.1	0.0	5.5	2.2	3.3	13.8	20.9	0.2	7.2	4.8	17.9	8.6	15.5	11.0	6.9	10.2	3.3	6.4	7.2	1.2	8.5	3.5	6.3	1.4	8.3	0.0	3.1	2.4	5.9	4.4	0.5	9.6	3.1	8.4
ABCC10	"EST182763, MRP7, SIMRP7"	ENSG00000124574	"ATP binding cassette subfamily C member 10"	Q5T3U5	6	43427366-43450430	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041607, HPA045464"	Approved					NA	NA					"HPA041607: AB_2677579, HPA045464: AB_2679336"	"unprognostic (2.41e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.80e-2)"	9.2	15.0	13.5	14.4	11.0	11.5	12.6	23.1	15.5	10.3	12.7	12.3	17.1	16.0	15.8	15.1	14.0	12.1	15.6	8.6	12.0	12.8	12.0	11.0	15.9	13.7	10.7	11.7	17.8	30.2	11.0	19.2	15.0	11.2	14.8	13.4	11.6	16.1	14.2	7.8	16.9	17.6	14.9	9.9	13.8	14.3	8.5	9.7	16.2	11.7	6.5	16.7	13.0	11.9	2.1	2.2	7.3	3.5	2.2	6.1	2.8	9.2	4.8	6.3	14.3	13.9	9.0	6.6	9.8	6.9	7.3	6.3	10.5	4.0	1.9	11.6	11.8	5.8	11.7	4.2	7.6	5.3	11.9	8.4	6.7	5.3	20.7	8.6	9.1	10.0	15.5	10.1	9.8	5.4	7.4	9.9	6.4	7.7	10.7	8.6	9.1	5.3	14.1	4.1	22.5	5.8	2.7	1.6	6.7	8.5	15.3	8.8	7.1	5.8	8.3	7.0	5.8	8.1	9.0	10.2	9.1	3.1	8.4	11.6	9.7	4.2	4.8	4.3	6.6	4.2	7.3	3.5	4.2	6.1	1.4	2.6	2.1	4.6	5.4	2.2	1.9	2.7	3.8	1.3	2.2	3.0	1.6	5.2	2.8	13.5	11.0	23.1	15.5	12.0	12.8	10.7	11.7	11.2	9.7	3.0	6.4	0.5	6.4	1.0	8.7	1.9	2.5	10.7	2.3	0.0	9.8	6.1	1.7	3.9	0.7	3.9	4.2	0.0	2.8	4.9	3.9	1.8	5.8	1.5	6.0	11.1	7.5	6.7	3.4	0.4	6.9	4.6	3.3	2.8	4.6	2.8	4.6	4.5	5.6	2.4	4.6	0.0	2.8	1.7	4.4	1.6	3.7	6.9	4.0	2.4
ABCC12	MRP9	ENSG00000140798	"ATP binding cassette subfamily C member 12"	Q96J65	16	48082973-48156018	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 3.5;testis: 13.4"	"Cell type enhanced"	"Detected in some"	20	"Early spermatids: 3.1;Late spermatids: 1.9;Spermatocytes: 1.8"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 3.5;hippocampal formation: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"RPMI-8226: 2.2;T-47d: 4.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			HPA043100	Uncertain					NA	NA					"HPA043100: AB_10794922"	"unprognostic (1.53e-1)"			"unprognostic (6.87e-2)"	"unprognostic (2.37e-2)"			"unprognostic (4.62e-3)"		"unprognostic (1.88e-1)"		"unprognostic (1.59e-2)"		"unprognostic (2.65e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.23e-1)"		0.1	0.0	0.6	0.1	0.1	0.0	1.9	0.3	3.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	2.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	13.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.3	3.5	2.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	0.0	0.0	0.0	0.0	0.0
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782732-99852192	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 28.4;kidney: 25.6;liver: 74.3"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 52.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 24.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 4.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.1"	"Group enriched"	"Detected in some"	5	"A549: 60.2;Hep G2: 60.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA071145	Enhanced					NA	NA					"HPA071145: "	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	0.8	0.3	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.2	13.4	0.1	0.1	16.1	0.3	0.5	0.2	0.4	13.7	0.2	0.1	0.1	25.6	74.3	0.3	0.1	0.1	0.1	0.2	0.6	0.0	0.1	1.2	0.1	0.3	0.0	0.1	0.3	0.1	0.6	0.6	28.4	0.1	0.2	0.8	0.4	0.4	0.1	0.1	0.3	0.4	0.1	0.7	0.3	0.3	0.7	4.1	0.2	0.1	0.5	0.0	0.0	60.2	0.9	3.0	4.6	3.5	1.0	0.1	0.3	0.1	0.2	12.9	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.2	60.0	0.1	0.0	0.2	0.6	4.1	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.1	11.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.9	7.4	0.1	0.0	0.1	0.1	0.1	0.2	0.3	0.1	0.2	0.0	0.0	4.9	1.0	0.3	4.1	0.2	0.3	0.3	0.0	0.4	0.2	0.3	0.1	0.3	0.3	0.3	0.1	1.3	0.1	0.1	0.7	0.5	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.1	0.0	0.2	0.4	2.5	4.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.1	52.9	0.2	0.0	0.0	0.6	1.3	0.2	0.3	0.0	5.0	0.0	0.0	0.2	0.1	0.0	0.0	9.1	1.4	0.0	0.4	0.7	0.3	0.0	1.4	0.0	0.0	0.0
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692252	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 53.5;liver: 66.2"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 262.4;Enterocytes: 161.4;Hepatocytes: 155.5;Paneth cells: 153.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.2;non-classical monocyte: 7.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.6"	"Cell line enhanced"	"Detected in many"		"A549: 31.4;CAPAN-2: 24.0;OE19: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB037136: AB_477165, HPA048483: AB_2680414"	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavorable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.5	36.0	0.4	17.0	0.4	0.5	7.7	0.3	0.4	1.9	23.9	0.8	14.1	10.3	1.6	4.6	5.3	1.0	53.5	0.8	0.4	0.4	13.5	66.2	9.0	10.3	0.6	0.0	1.0	22.2	1.7	0.8	3.5	1.5	5.4	7.7	0.8	4.7	23.6	0.4	4.8	37.0	2.5	4.6	4.9	12.8	1.0	0.0	0.8	4.5	7.0	7.9	7.1	3.5	0.0	1.6	1.3	7.6	0.3	0.5	7.4	2.2	31.4	0.0	0.1	1.8	2.8	0.0	4.2	5.2	0.3	0.3	1.7	24.0	0.0	3.3	8.2	5.9	5.7	0.0	0.4	0.4	0.0	0.0	0.6	13.2	9.5	7.1	0.0	0.0	3.1	2.3	1.2	2.5	3.5	0.5	0.0	0.0	0.0	3.3	7.3	0.0	0.0	0.0	34.9	4.1	0.0	0.0	0.1	13.7	13.6	0.0	0.2	7.6	1.3	0.0	0.0	1.0	0.0	6.9	0.2	1.4	0.1	3.3	0.0	0.0	0.0	3.4	0.0	0.3	0.3	2.8	0.0	0.0	6.2	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	1.3	0.3	7.6	0.2	0.5	7.4	0.4	0.4	0.3	0.4	0.4	0.4	0.6	0.0	1.5	0.0	17.9	5.6	2.4	103.4	8.4	1.2	2.5	262.4	0.0	23.9	14.0	0.0	0.3	5.0	84.3	55.0	1.4	161.4	0.0	92.3	3.0	3.5	62.4	0.0	155.5	27.5	1.6	22.7	4.9	18.2	59.8	8.3	13.8	3.3	4.6	85.5	3.7	82.4	153.0	2.8	7.9	0.1	0.0	5.2	0.7	0.6	9.3	0.8	2.5	66.2	81.6
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019829-95301475	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 35.0"	"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 38.5;granulocytes: 53.1;Proximal tubular cells: 32.7"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"HEL: 61.8;HMC-1: 67.7;RPTEC TERT1: 18.2"	"Low region specificity"	"Detected in all"							HPA002476	Enhanced		Approved	"Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoli, Plasma membrane"	"Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favorable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	3.2	1.7	3.8	11.8	4.7	2.9	6.2	1.0	4.6	4.4	11.6	10.3	3.9	4.1	5.8	16.4	3.0	8.6	10.3	3.5	5.7	3.9	19.6	1.9	13.8	7.4	6.6	2.2	7.2	3.5	7.0	2.8	1.8	7.4	35.0	7.3	6.0	3.3	5.2	7.6	4.5	7.4	11.1	6.5	3.8	8.2	3.8	7.0	3.4	6.6	3.1	5.8	25.6	13.4	3.6	4.1	1.0	4.8	4.1	3.6	3.4	4.5	8.0	1.3	2.4	2.5	3.3	0.3	3.6	3.7	3.3	2.8	11.1	3.4	2.5	2.4	4.9	2.4	6.2	2.0	1.8	4.1	7.5	3.1	61.8	2.5	2.2	5.1	7.0	67.7	2.5	0.8	2.3	4.8	4.7	4.2	2.8	6.4	0.1	4.4	1.4	1.3	1.1	1.5	5.5	1.9	1.9	3.7	6.6	18.2	10.3	3.3	2.4	1.2	0.2	2.5	1.5	0.0	3.8	6.9	3.5	2.2	2.9	4.3	0.0	0.0	1.0	6.6	4.0	1.7	0.6	1.2	0.4	3.2	1.2	2.7	3.6	2.6	3.6	4.1	2.7	1.6	3.5	1.0	4.1	4.8	0.7	3.3	3.4	3.8	4.7	1.0	4.6	5.7	3.9	6.6	2.2	7.4	7.0	8.9	28.3	3.7	6.2	3.8	0.0	3.1	5.1	6.7	11.4	22.7	21.6	0.1	0.0	5.2	3.2	11.3	1.4	0.0	2.6	0.4	3.9	38.5	53.1	0.0	3.8	0.0	0.0	2.5	1.0	1.7	6.4	6.3	1.7	19.0	3.2	0.3	4.1	9.3	1.8	32.7	0.7	0.0	3.9	0.6	9.1	6.6	0.2	2.2	7.8	3.7
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184018015	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 184.6;Rod photoreceptor cells: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 48.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	7.9	11.2	24.7	9.6	26.2	12.0	6.7	42.8	28.6	7.7	11.4	12.0	13.4	6.8	14.1	7.0	17.1	6.1	11.6	16.0	19.1	13.7	12.8	3.6	9.4	7.3	20.5	18.5	11.8	4.9	22.4	20.5	10.8	21.7	10.6	14.4	31.1	7.4	9.3	41.0	14.5	8.5	10.5	12.9	16.3	48.5	9.4	20.9	9.3	5.5	7.3	7.4	18.1	12.7	4.2	3.5	15.8	4.5	5.0	7.0	4.5	7.3	4.1	9.4	11.2	9.4	10.7	14.6	6.0	4.7	5.4	5.9	6.3	5.7	8.0	14.1	5.7	8.2	29.9	11.6	6.6	7.1	8.7	11.2	16.9	10.3	5.7	3.9	5.1	13.2	17.0	6.7	5.8	3.8	11.1	6.3	23.7	15.7	11.1	9.2	19.5	14.1	5.9	9.7	13.4	7.9	9.8	3.1	4.7	19.6	48.0	17.2	10.2	6.1	33.9	10.1	12.7	20.5	1.6	7.2	6.3	6.2	8.0	8.2	4.3	8.3	7.4	4.6	10.3	6.4	10.7	4.5	7.7	7.0	2.1	4.5	3.2	4.0	3.1	3.5	4.2	4.6	6.3	15.8	5.0	3.5	1.3	5.0	4.5	24.7	26.2	42.8	28.6	19.1	13.7	20.5	18.5	21.7	20.9	8.9	4.0	1.9	12.9	7.9	34.3	31.9	2.5	56.2	46.6	41.8	184.6	2.7	6.6	5.0	4.8	6.7	9.5	0.0	4.0	3.9	8.0	10.9	4.7	2.4	39.9	31.8	56.9	5.5	27.9	2.2	7.5	11.2	11.8	6.4	6.3	9.4	6.1	9.3	7.4	2.7	122.3	0.0	8.6	3.1	14.7	10.7	3.8	5.0	7.2	50.3
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16148928-16223522	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 27.4"	"Cell type enhanced"	"Detected in many"	14	"Distal tubular cells: 38.1;Hepatocytes: 56.7;Proximal tubular cells: 117.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 16.7"					"Cell type enriched"	"Detected in some"	5	"classical monocyte: 7.3"	"Lineage enriched"	"Detected in many"	5	"monocytes: 7.3"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 38.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038105			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	2.3	1.4	0.2	0.0	0.2	0.0	1.1	0.0	0.0	0.1	1.5			7.0	0.0	0.0	0.0	0.3	1.2	0.8	0.1	0.1	9.0	27.4	2.8	0.0	0.2		0.1	6.7	0.5	0.1	0.0		0.7	1.2		6.7	0.2	1.7	0.0	3.7	0.0	0.2	0.1	2.2	0.0			2.2		0.0	0.0	0.0	0.2	0.9	1.3	7.3	0.6	0.1	1.2	0.0	0.9	0.4	0.0	0.0	0.5	1.1	0.0	0.2	0.6	0.9	3.8	1.5	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.3	0.0	0.4	1.1	0.1	38.6	0.2	0.0	0.2	1.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.2	0.4	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.6	0.1	0.5	0.1	0.2	4.9	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	7.3	0.3	0.0	1.0	0.0	0.0	0.1	0.0	0.9	0.2	0.1	0.1	1.3	0.6	0.1	0.1	0.0	1.2											26.8	26.9	3.6	0.7	0.1	0.3	2.4	20.4	18.7	9.1	8.7	0.0	0.0	38.1	1.6	0.2	0.6	19.1	0.0	7.1	0.0	1.0	1.6	1.1	56.7	1.1	0.0	2.9	1.8	4.1	0.4	1.4	1.5	1.7	1.0	13.4	1.3	2.9	3.5	5.3	117.8	0.7	0.0	0.5	0.1	0.2	0.6	0.0	0.0	13.3	0.4
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.0;pancreas: 25.5;pituitary gland: 26.6"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 39.2;Intestinal endocrine cells: 21.0"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A549: 4.7;AN3-CA: 3.8;SCLC-21H: 6.7"					"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		No	NA			Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	1.3	6.7	4.4	0.8	6.1	0.9	4.0	28.0	12.3	3.0	1.3	2.6	7.7	1.9	3.1	3.7	0.8	1.2	0.9	2.9	5.1	4.8	1.0	0.8	2.9	0.8	3.6	7.2	0.9	25.5	1.0	26.6	1.6	8.5	2.8	1.3	0.7	0.9	8.5	2.3	1.1	1.5	1.3	4.0	0.9	3.5	1.1	2.3	0.0	6.2	0.0	0.8	0.7	0.8	0.1	0.0	0.5	0.0	0.1	0.2	0.0	0.0	4.7	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.9	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	4.4	6.1	28.0	12.3	5.1	4.8	3.6	7.2	8.5	2.3	0.0	0.0	0.0	0.0	0.0	39.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.0	0.1	0.0	21.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.0	1.2	0.0	1.6	0.0	0.2	0.1	0.0	0.0	0.0	0.1
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797401-21942529	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 47.6;Hepatocytes: 84.7;Sertoli cells: 129.4;Smooth muscle cells: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.6;BJ hTERT+: 10.1;CACO-2: 16.0;HSkMC: 21.0;U-138 MG: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	21.6	4.7	5.5	2.6	5.4	1.2	25.8	1.5	8.6	12.4	6.8	4.8	5.1	3.0	15.3	6.3	9.1	9.5	9.6	26.2	5.7	2.6	5.6	31.1	6.2	2.7	2.9	4.2	11.8	5.8	1.7	2.7	2.8	5.5	7.0	1.6	10.8	4.8	8.4	33.2	3.3	4.1	17.1	4.9	3.5	9.1	3.4	4.2	0.1	6.3	14.5	1.2	9.5	8.4	1.6	0.9	1.8	0.8	0.5	0.9	0.0	0.6	0.1	7.5	0.2	17.6	8.0	0.2	4.1	10.1	4.5	2.3	16.0	0.7	0.3	0.8	0.4	0.5	0.2	0.0	0.0	4.7	0.2	0.1	0.3	0.5	0.2	0.0	0.3	0.4	21.0	0.0	4.5	1.7	0.3	0.0	0.3	0.2	0.9	0.2	0.9	0.2	0.2	1.0	0.8	0.4	0.3	0.2	0.2	0.0	0.8	0.3	1.2	0.2	0.4	0.1	1.2	0.8	0.2	0.2	17.5	1.3	1.5	5.3	0.8	0.8	0.3	4.3	0.2	0.3	0.9	0.5	0.4	0.9	0.4	0.6	0.7	0.7	0.7	0.2	1.6	0.6	0.8	1.8	0.5	0.8	0.9	0.4	0.0	5.5	5.4	1.5	8.6	5.7	2.6	2.9	4.2	5.5	4.2	32.8	47.6	0.0	1.0	3.1	0.4	27.8	0.0	36.1	39.8	0.0	0.0	0.2	0.0	0.0	0.2	4.9	0.0	0.0	0.2	0.1	10.6	0.4	22.1	84.7	0.1	1.6	0.0	11.1	3.3	0.0	0.3	2.1	10.1	0.0	0.0	13.1	0.1	0.0	0.4	0.0	1.1	129.4	47.2	0.5	0.7	1.9	0.2	0.0	0.0	1.4
ABCD1	"adrenoleukodystrophy, ALD, ALDP, AMN"	ENSG00000101986	"ATP binding cassette subfamily D member 1"	P33897	X	153724868-153744762	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 46.2"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 17.9;Syncytiotrophoblasts: 22.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 33.1;PC-3: 23.4;SK-BR-3: 23.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.57e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.23e-2)"	13.8	20.3	2.1	6.0	2.7	5.0	8.9	1.1	2.5	6.2	15.9	2.7	12.7	12.5	21.4	9.7	4.7	6.1	8.8	10.4	2.0	2.0	7.0	14.3	7.5	10.1	3.0	1.9	6.0	11.7	2.2	6.5	23.1	2.0	7.1	2.3	9.3	6.1	7.3	14.7	3.0	46.2	8.3	2.7	9.1	4.6	24.0	1.7	12.1	3.8	6.5	4.9	7.8	9.8	1.9	4.8	4.1	5.4	1.4	7.7	3.4	5.9	1.8	1.2	5.2	3.6	1.5	16.2	2.9	3.2	2.0	3.5	1.2	3.2	1.6	33.1	3.9	5.4	0.8	0.7	0.6	0.2	5.3	1.0	4.7	18.5	15.3	4.7	2.9	10.6	3.0	0.8	2.2	0.2	2.1	3.1	2.2	2.6	5.8	2.7	2.1	2.0	2.7	1.5	1.4	23.4	3.5	2.9	2.5	1.5	0.6	1.3	5.4	7.6	23.1	11.8	1.5	1.7	4.9	3.6	2.6	3.5	6.7	3.2	5.8	2.5	3.8	3.3	9.9	3.6	0.7	4.8	4.1	1.6	5.4	7.7	1.9	1.9	2.3	4.8	1.5	2.1	1.5	3.1	1.4	4.7	3.0	0.6	3.4	2.1	2.7	1.1	2.1	2.0	2.0	3.0	1.9	2.0	1.7	0.0	1.4	0.9	1.5	2.9	2.2	2.0	5.1	0.0	2.3	3.5	2.0	10.8	0.0	3.3	0.5	3.5	13.5	0.0	6.0	14.8	3.3	0.7	0.0	5.5	12.1	7.9	5.8	6.2	17.9	1.9	3.7	7.4	1.7	1.0	4.1	2.6	5.3	2.3	5.3	2.2	0.8	6.5	4.1	2.7	4.8	1.1	22.9	1.5	3.5	1.6
ABCD2	"ALDL1, ALDR, ALDRP"	ENSG00000173208	"ATP binding cassette subfamily D member 2"	Q9UBJ2	12	39550033-39619751	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 24.1;brain: 30.1"	"Cell type enriched"	"Detected in some"	6	"Bipolar cells: 55.5"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"T-cells: 6.5"	"Group enriched"	"Detected in some"	5	"ASC diff: 9.2;HDLM-2: 12.4;Karpas-707: 22.2;SH-SY5Y: 13.4;U-266/70: 7.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.26e-3)"	"unprognostic (4.06e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.31e-5)"	"unprognostic (3.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-4)"	"unprognostic (5.04e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.74e-2)"	24.1	3.6	6.8	3.5	6.8	0.9	5.5	30.1	13.4	10.6	1.7	1.3	0.0	1.4	5.4	1.0	1.3	5.2	1.4	7.4	5.1	4.1	1.4	0.7	1.4	4.8	4.8	8.4	0.7	0.7	0.7	5.1	0.5	11.4	1.2	1.7	2.9	4.6	1.6	0.7	0.7	1.7	5.1	2.1	3.0	1.6	0.9	2.6	0.9	1.0	0.6	3.2	2.8	1.9	0.8	0.8	0.1	0.0	1.4	6.5	1.8	0.0	0.0	0.1	0.0	9.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.4	0.0	0.1	0.0	0.0	0.4	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.5	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	1.9	0.8	4.3	5.7	0.2	0.4	5.0	6.5	0.1	1.4	0.0	0.8	5.1	1.8	6.8	6.8	30.1	13.4	5.1	4.1	4.8	8.4	11.4	2.6	0.0	0.0	0.8	0.0	0.0	55.5	8.9	0.0	4.0	0.0	0.0	5.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	1.7	0.0	0.0	0.7	0.5	1.8	0.0	0.3	0.1	0.0	0.0	0.0	3.5	0.0	0.0
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418455-94518666	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes		NA	NA			Peroxisomes		"CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favorable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	8.9	14.2	13.1	9.5	13.3	10.3	16.8	11.2	12.8	11.8	21.2	14.9	24.9	21.4	9.8	14.6	15.4	10.0	17.3	16.0	12.7	10.3	29.3	60.6	11.2	9.9	13.2	10.4	8.1	16.7	18.3	14.6	11.2	14.3	11.0	20.1	21.4	13.2	24.0	12.9	17.1	21.7	10.8	16.5	7.6	20.8	10.2	12.7	46.5	13.7	10.8	9.9	11.8	11.1	3.1	8.4	3.9	6.2	8.0	7.4	4.2	28.2	13.3	13.7	13.1	10.6	11.7	20.4	14.8	11.5	17.0	19.0	41.4	8.9	17.5	19.2	18.7	18.3	20.8	15.8	19.1	24.0	14.0	13.6	19.9	19.6	35.9	10.3	17.6	6.2	9.8	10.8	19.8	7.6	11.1	10.4	16.7	8.8	10.5	17.6	3.9	29.6	9.3	15.8	21.7	18.9	16.7	28.6	6.8	16.9	43.3	10.4	17.1	25.6	27.2	19.2	10.9	10.0	14.7	10.3	12.7	18.4	22.2	19.6	6.0	5.6	17.1	9.9	9.0	5.9	0.3	5.3	3.9	6.5	6.2	6.1	2.8	5.9	7.4	8.4	3.1	7.1	6.9	1.3	8.0	5.2	2.2	6.5	4.2	13.1	13.3	11.2	12.8	12.7	10.3	13.2	10.4	14.3	12.7	32.8	39.0	10.4	16.3	20.7	25.9	36.4	63.7	30.8	25.0	40.1	21.6	22.7	19.9	19.9	5.4	12.0	62.4	0.0	38.4	9.6	17.3	22.1	27.6	99.9	10.1	31.8	38.2	20.3	21.6	6.2	12.7	12.6	15.1	2.8	38.1	85.8	29.7	28.1	23.0	56.2	22.8	19.4	12.3	10.4	23.7	29.6	12.8	10.5	32.8	20.0
ABCD4	"EST352188, P70R, PMP69, PXMP1L"	ENSG00000119688	"ATP binding cassette subfamily D member 4"	O14678	14	74285423-74303056	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003396	Approved					NA	NA					"HPA003396: AB_1078078"	"unprognostic (3.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-3)"	"unprognostic (7.93e-3)"	17.1	13.0	17.2	13.6	21.9	11.8	15.1	23.4	21.3	13.3	16.7	22.7	15.1	23.4	18.3	17.0	13.6	23.8	21.4	16.6	15.7	15.7	18.6	22.2	16.3	16.4	20.9	11.7	22.2	17.1	12.4	19.7	19.9	17.7	13.4	11.5	15.7	12.7	15.7	11.3	11.7	22.8	14.7	21.7	17.8	13.1	15.7	17.9	13.3	20.0	8.6	13.5	16.4	14.7	3.1	6.7	9.6	2.5	4.0	7.6	2.7	2.7	3.3	8.3	6.4	6.9	4.5	10.1	4.3	5.8	6.0	6.4	6.6	14.1	4.6	7.9	6.2	3.4	9.3	6.2	5.7	3.3	3.9	3.8	2.3	4.4	5.1	2.4	2.8	4.8	11.0	2.5	4.2	2.8	3.4	10.0	6.6	4.3	2.0	4.8	4.7	7.9	5.8	3.0	5.1	6.1	9.7	11.8	6.5	9.3	8.9	3.9	7.7	5.6	5.8	6.0	4.1	12.7	1.8	10.2	3.8	7.7	3.3	2.6	4.7	4.4	3.4	5.5	4.3	4.7	9.6	2.5	2.7	5.0	1.9	3.1	2.9	4.4	5.7	3.9	3.1	2.5	3.5	1.7	4.0	1.5	6.7	7.6	2.7	17.2	21.9	23.4	21.3	15.7	15.7	20.9	11.7	17.7	17.9	26.8	15.2	13.7	13.8	13.9	45.9	7.7	22.9	14.7	17.0	19.2	60.9	44.0	8.3	20.7	9.5	46.4	28.5	0.0	10.0	16.4	24.0	11.2	19.7	19.5	41.8	30.2	11.5	34.4	15.8	5.6	37.4	19.9	20.3	26.2	18.2	43.1	15.4	22.9	23.7	17.7	57.1	32.3	14.6	31.9	22.3	9.4	23.8	29.8	21.1	14.4
ABCG1	ABC8	ENSG00000160179	"ATP binding cassette subfamily G member 1"	P45844	21	42199689-42297244	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cone photoreceptor cells: 47.1;Rod photoreceptor cells: 107.9;Syncytiotrophoblasts: 52.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 19.2;neutrophil: 20.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 13.2;JURKAT: 19.6;MCF7: 16.5;MOLT-4: 15.3;OE19: 27.4;RPMI-8226: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031470, HPA031471"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA031470: AB_10599188, HPA031471: AB_10600201"	"unprognostic (2.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.37e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.42e-2)"	19.9	36.4	14.2	10.0	17.6	6.2	13.3	15.9	15.3	7.7	12.1	17.8	3.8	15.3	5.6	3.8	4.1	6.5	11.9	9.7	12.4	8.0	8.2	5.6	25.2	23.1	20.8	12.2	6.0	4.7	15.4	11.1	12.0	9.6	6.3	13.5	12.1	13.7	6.7	26.8	15.1	18.6	5.8	7.0	29.4	13.7	1.9	19.5	15.4	8.5	5.2	10.4	12.5	12.6	4.8	1.4	20.5	0.9	3.7	4.0	1.0	0.0	3.0	2.4	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.4	0.0	0.3	0.5	0.0	4.4	0.0	4.2	0.2	5.0	10.0	0.0	9.2	0.0	0.2	1.0	13.2	0.0	2.0	0.0	9.3	19.6	0.0	0.0	0.0	16.5	15.3	0.1	0.7	27.4	5.2	0.2	0.0	12.5	0.0	1.4	11.6	3.0	1.8	6.9	0.0	0.2	2.9	0.4	5.9	0.0	2.5	0.0	0.0	6.8	1.9	0.0	0.0	1.6	0.2	0.9	0.9	19.2	1.8	0.3	3.4	3.1	3.7	3.6	0.6	4.8	3.5	2.9	20.5	3.7	0.1	1.4	4.0	1.0	14.2	17.6	15.9	15.3	12.4	8.0	20.8	12.2	9.6	19.5	6.0	8.0	6.7	6.0	7.9	46.2	7.8	2.5	1.4	5.7	24.4	47.1	5.2	3.3	2.2	3.7	31.7	7.8	0.0	1.1	1.0	4.6	3.8	0.0	0.0	15.2	11.1	3.4	39.9	25.5	4.3	0.3	18.8	3.3	5.4	9.1	14.3	1.5	4.8	1.8	0.9	107.9	6.5	5.2	0.6	0.7	5.8	52.7	12.9	0.9	2.6
ABCG4	WHITE2	ENSG00000172350	"ATP binding cassette subfamily G member 4"	Q9H172	11	119149012-119162653	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 20.7;parathyroid gland: 7.4;retina: 7.5;testis: 7.2"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 47.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;HAP1: 2.9;U-2 OS: 2.8"	"Low region specificity"	"Detected in all"							HPA057635	Enhanced					NA	NA					"HPA057635: "	"unprognostic (3.26e-2)"	"unprognostic (4.75e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.15e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (2.65e-3)"	0.7	1.6	3.9	0.7	5.7	0.3	0.4	20.7	12.8	0.8	0.8	0.8	0.0	0.9	1.1	1.3	1.9	0.6	1.2	2.2	4.9	6.6	0.8	0.5	0.5	0.5	4.7	5.2	0.5	1.2	7.4	0.3	0.7	12.7	0.9	0.7	7.5	0.4	2.0	0.4	1.2	0.7	1.4	1.5	0.5	0.5	7.2	0.5	0.6	1.5	0.0	1.5	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	1.2	5.5	0.8	0.0	0.1	0.2	0.1	0.7	1.5	0.0	0.1	0.0	0.6	0.2	2.4	0.5	2.9	0.3	0.7	0.3	1.0	1.0	0.1	0.0	1.9	0.0	1.6	0.5	0.0	1.0	0.0	0.7	1.2	2.8	0.1	0.1	0.9	0.2	0.4	0.0	2.4	0.0	0.6	0.1	0.0	0.1	0.0	0.0	0.5	1.1	1.7	0.2	0.1	0.3	0.4	0.0	0.2	0.4	2.8	0.4	0.2	0.3	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	5.7	20.7	12.8	4.9	6.6	4.7	5.2	12.7	0.5	0.0	0.0	0.0	0.0	0.0	11.4	0.8	0.0	0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.4	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	47.1	0.0	0.1	3.1	0.6	0.0	0.1	0.0	0.0	0.0
ABCG5	STSL	ENSG00000138075	"ATP binding cassette subfamily G member 5"	Q9H222	2	43812472-43838865	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	85	"intestine: 54.3;liver: 40.9"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 47.3"	"Cancer enriched"	"Detected in some"	23	"liver cancer: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	47	"Hep G2: 14.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.71e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.59e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.52e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	19.5	0.0	0.0	27.6	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	40.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	54.3	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.3	5.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882987	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 62.4;liver: 64.4"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 24.1"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	47	"Hep G2: 14.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019556	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.1	0.4	0.1	21.2	0.0	0.0	24.0	0.1	0.1	0.1	0.1	1.7	0.1	0.2	0.3	0.2	64.4	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	62.4	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.6	2.1	0.3	0.5	0.8	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	14.7	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	2.1	0.3	0.4	0.7	0.3	0.5	0.5	0.6	0.5	0.1	0.7	0.8	0.7	1.7	0.5	0.3	0.6	0.3	0.2	0.2	0.3	0.1	0.4	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	1.2	1.8	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ACIN1	"ACINUS, fSAP152, KIAA0670"	ENSG00000100813	"Apoptotic chromatin condensation inducer 1"	Q9UKV3	14	23058564-23095614	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000657	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000657: AB_1078091"	"unprognostic (2.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (1.49e-3)"	"unprognostic (9.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.33e-2)"	32.4	44.4	34.6	46.6	36.2	57.6	32.5	45.7	41.8	36.6	30.1	39.1	35.2	28.5	52.9	32.2	39.3	34.6	33.3	29.7	33.1	28.3	34.9	35.5	28.8	41.1	34.4	27.7	43.9	34.5	51.1	48.3	37.0	33.7	35.4	34.6	31.5	33.0	38.3	43.8	38.1	35.1	40.1	35.0	52.9	34.0	34.5	40.6	44.2	38.5	27.1	45.9	30.5	47.8	6.9	6.8	13.4	4.9	9.7	5.5	2.7	23.7	24.5	38.7	31.3	24.2	19.5	38.9	26.5	18.7	32.1	26.2	32.4	27.9	44.1	15.7	21.9	21.1	26.2	53.4	30.3	33.0	31.0	23.7	38.8	25.9	44.6	13.9	42.0	34.5	22.8	18.7	32.8	27.7	26.3	28.0	32.9	35.7	17.7	24.1	29.7	47.6	41.5	43.5	26.4	23.4	43.2	30.1	23.5	26.6	42.0	25.8	19.0	35.2	23.0	20.9	29.4	18.9	34.0	28.6	22.0	22.0	20.8	24.4	18.8	21.1	45.7	19.5	31.9	23.8	4.1	4.9	5.6	5.5	4.5	4.4	4.4	3.7	4.2	4.1	6.9	5.1	4.6	13.4	9.7	3.7	6.8	3.8	2.7	34.6	36.2	45.7	41.8	33.1	28.3	34.4	27.7	33.7	40.6	65.5	108.5	33.5	28.5	33.2	38.0	57.7	30.6	109.7	78.5	33.2	25.5	48.1	14.9	45.8	27.6	44.3	40.8	46.7	42.7	55.4	35.5	30.5	120.8	24.7	40.9	14.3	55.9	32.5	26.9	5.0	42.6	35.7	25.3	52.3	37.3	25.9	52.1	42.1	36.0	14.1	42.2	6.5	39.6	35.1	34.6	40.7	57.9	36.3	40.7	34.1
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81330005-81394179	"Enzymes, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"liver: 49.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 37.1"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.0;CACO-2: 2.5;Karpas-707: 1.8;SK-MEL-30: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037723, HPA037724"			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA037723: AB_10672606, HPA037724: AB_2675631"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.2	49.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.5	0.1	0.0	0.1	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.3	0.0	0.4	0.0	1.8	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	5.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.1	0.4	0.0	0.0	0.6	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236686454-236764631	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 141.3;skeletal muscle: 320.9;tongue: 75.4"	"Cell type enriched"	"Detected in some"	88	"Cardiomyocytes: 1655.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 3.1;HSkMC: 12.2;hTEC/SVTERT24-B: 7.6;WM-115: 2.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 59.7"	"Low region specificity"	"Detected in many"			"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		NA	NA		69000000	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	3.5	0.6	1.6	0.6	10.7	0.6	0.7	0.3	2.5	0.6	0.6	5.1	0.0	0.6	0.7	4.4	3.7	0.7	0.7	141.3	2.5	1.4	0.6	0.6	0.9	0.6	4.7	1.4	0.7	0.7	0.6	0.1	0.6	2.7	2.8	0.6	0.0	4.9	0.6	320.9	0.6	0.7	1.5	3.9	0.6	0.7	0.9	4.3	0.0	3.5	75.4	4.8	0.9	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.1	3.1	0.0	0.0	0.1	0.0	0.0	0.7	12.2	0.0	7.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.7	0.5	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.6	10.7	0.3	2.5	2.5	1.4	4.7	1.4	2.7	4.3	0.0	1.1	0.0	0.3	0.2	0.7	1655.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.6	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	1.3	0.0	18.7	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.6	1.1	0.0	1.4	1.9	2.0	0.1	0.0	0.0	0.0	0.1
ADAM10	"CD156c, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588807-58749978	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 77.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		8200000	"Plasma membrane"	"Nucleoplasm, Vesicles"	"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	25.9	11.1	15.5	17.1	17.7	15.6	20.0	25.2	17.6	18.6	20.1	15.7	12.7	13.9	19.9	11.8	17.1	13.8	18.0	18.8	17.6	13.7	20.8	14.8	25.0	26.1	23.1	12.4	13.9	13.1	10.9	11.6	36.1	14.5	23.6	16.7	14.6	12.4	19.1	8.9	15.4	15.6	12.8	30.4	40.4	18.4	8.5	18.9	38.5	27.3	9.2	14.9	30.0	19.1	6.2	12.7	26.9	23.7	9.8	12.2	12.8	12.1	27.4	7.5	8.1	9.6	13.9	18.9	10.4	31.0	7.7	10.7	12.6	16.1	5.6	32.2	9.3	13.5	24.8	4.5	11.0	10.2	8.4	5.8	9.6	10.0	11.7	10.7	6.8	27.7	12.1	8.1	5.4	7.9	11.2	14.9	12.2	6.0	15.3	13.5	4.5	22.4	7.7	10.2	4.0	3.9	9.3	24.5	14.4	17.9	32.7	8.1	5.3	11.3	13.2	18.0	17.1	7.8	13.6	10.5	10.1	11.3	77.5	10.0	8.6	18.5	6.1	14.1	13.1	17.6	12.9	18.8	10.4	8.1	21.5	12.2	5.3	8.0	7.1	12.7	6.2	8.4	7.0	26.9	9.8	23.7	5.8	10.3	12.8	15.5	17.7	25.2	16.9	17.6	13.7	23.1	12.4	14.5	18.9	77.4	49.8	30.6	25.8	23.7	20.2	29.7	30.6	30.8	35.2	76.8	25.5	27.4	1.7	45.7	21.6	61.6	39.3	0.0	27.7	46.7	28.8	75.5	27.9	30.4	56.9	42.9	34.7	76.1	87.0	16.2	16.7	64.0	43.9	13.6	45.8	27.0	37.3	43.2	15.9	20.3	32.7	12.9	28.3	13.6	16.2	19.4	22.2	43.6	33.7	59.6
ADAM11	MDC	ENSG00000073670	"ADAM metallopeptidase domain 11"	O75078	17	44759031-44781846	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 42.3;heart muscle: 11.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 6.1;Cardiomyocytes: 10.8;Horizontal cells: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.7"	"Cell line enriched"	"Detected in some"	4	"HEK 293: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074550	Enhanced					NA	NA					"HPA074550: AB_2732259"	"unprognostic (1.79e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.46e-3)"	"unprognostic (7.16e-2)"	"unprognostic (9.99e-16)"	"unprognostic (1.39e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.00e-1)"	1.2	0.5	8.5	0.6	7.5	1.0	0.6	42.3	23.1	0.9	0.8	0.7	0.0	0.8	4.0	1.1	1.1	1.2	1.5	11.2	11.4	4.2	0.7	0.6	0.7	0.7	2.7	9.8	0.9	0.6	0.7	0.6	0.7	5.5	1.6	0.6	0.2	0.5	2.2	0.8	2.5	0.7	2.6	1.5	0.7	0.7	2.3	1.1	0.0	0.6	0.0	0.6	0.7	0.3	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.6	4.9	0.2	0.0	0.3	0.1	0.0	1.4	0.4	0.7	0.2	0.1	0.3	0.0	2.2	0.0	3.6	0.0	0.4	1.4	21.0	0.2	0.4	0.3	0.1	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.4	0.4	0.1	4.2	0.1	2.4	0.9	1.6	1.3	2.9	0.1	0.4	0.0	0.1	3.8	1.9	0.0	0.1	1.1	0.4	1.4	0.7	0.0	0.6	1.7	1.8	0.4	0.7	0.2	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.7	0.0	0.0	8.5	7.5	42.3	21.0	11.4	4.2	2.7	9.8	5.5	1.1	0.0	0.0	0.0	0.2	0.0	6.1	10.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	22.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	1.4	0.0	2.7	0.0	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.0
ADAM12	"MCMPMltna, MLTN"	ENSG00000148848	"ADAM metallopeptidase domain 12"	O43184	10	126012381-126388455	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	50	"placenta: 487.4"	"Cell type enhanced"	"Detected in many"	24	"Cone photoreceptor cells: 96.2;Extravillous trophoblasts: 348.4;Syncytiotrophoblasts: 108.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	5	"MAIT T-cell: 9.8"	"Lineage enriched"	"Detected in single"	98	"T-cells: 9.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 47.3;hTEC/SVTERT24-B: 29.7;U-2197: 29.3;U-251 MG: 26.2;U-87 MG: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA030866, HPA030867, HPA030868"	Enhanced		Supported	"Plasma membrane"	"Secreted in female reproductive system"	NA	NA			"Plasma membrane"		"HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638"	"unprognostic (3.35e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.91e-6)"	"unprognostic (2.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.39e-14)"	"unprognostic (3.11e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-3)"	6.0	0.0	0.6	2.1	2.8	0.0	5.9	0.6	0.6	8.0	0.5	0.5	0.4	0.0	2.6	0.5	0.5	0.1	4.6	0.7	0.6	0.7	1.0	0.4	1.1	1.0	0.8	0.5	8.2	0.6	0.0	1.1	487.4	0.8	0.7	0.1	0.9	1.1	0.4	0.5	0.3	0.4	1.5	0.7	0.5	0.1	0.7	0.6	0.5	0.4	0.5	1.2	4.5	0.8	0.0	0.0	0.0	0.0	0.0	9.8	0.1	5.0	0.7	2.0	0.0	6.0	12.4	0.0	13.2	1.1	4.5	11.3	0.0	0.0	0.0	0.0	47.3	9.5	0.0	0.0	0.4	4.9	0.5	0.1	0.0	8.0	0.0	0.9	0.0	10.5	15.2	0.0	29.7	0.9	8.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.5	1.3	0.1	13.5	0.1	9.0	1.5	0.0	0.2	0.8	0.0	0.0	0.0	16.3	5.4	29.3	26.2	0.0	0.1	0.0	22.5	0.0	10.0	0.0	0.0	0.0	0.5	0.0	9.8	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.6	2.8	0.6	0.6	0.6	0.7	0.8	0.5	0.8	0.6	0.0	3.4	0.0	0.4	1.3	0.8	1.4	0.0	1.4	0.0	0.0	96.2	12.1	0.0	7.6	6.3	1.1	0.4	0.0	1.0	348.4	2.0	0.6	49.5	0.0	14.2	6.4	0.0	2.5	0.3	1.1	15.5	0.7	1.7	15.4	0.2	5.5	1.9	0.0	0.7	0.0	31.5	0.0	1.2	5.1	5.5	0.5	108.0	3.1	0.7	0.5
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9555792	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, HPA051575"	Approved		Supported	Cytosol	"Intracellular and membrane"	NA	NA		27000	Cytosol		"HPA010738: AB_1078100, HPA051575: AB_2681539"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (4.23e-5)"	18.6	11.0	13.6	15.4	13.8	21.9	14.7	20.4	15.5	14.0	11.7	13.8	8.3	8.7	14.2	15.8	18.7	10.7	17.4	13.4	11.2	12.4	12.4	7.8	24.7	15.0	11.6	11.7	18.1	9.6	10.9	11.9	29.0	11.2	8.2	9.4	10.6	12.5	9.8	12.3	16.7	11.1	13.9	14.3	21.4	8.9	17.4	12.3	14.7	12.5	13.9	20.3	12.3	14.4	7.0	7.7	16.0	10.2	6.0	7.9	6.0	7.7	12.7	13.4	13.9	26.4	19.7	24.1	8.1	13.8	9.3	13.9	11.2	18.6	22.0	11.7	10.1	27.3	14.1	9.8	17.2	12.8	8.8	9.8	11.2	9.6	9.9	37.3	11.0	12.6	22.0	17.3	14.9	29.0	20.8	23.4	8.4	15.3	8.5	10.0	7.3	8.2	11.0	11.0	10.8	5.1	9.6	13.1	10.4	12.4	12.8	7.9	19.7	9.0	11.0	19.2	15.1	5.7	14.2	18.7	16.6	8.7	11.6	15.4	11.1	9.9	19.2	13.8	7.1	19.7	16.0	9.8	7.6	6.1	10.2	7.9	7.0	5.0	5.1	7.7	5.1	4.5	4.6	11.8	6.0	9.5	4.3	5.7	6.0	13.6	13.8	20.4	13.1	11.2	12.4	11.6	11.7	11.2	12.3	44.7	76.6	33.0	41.9	115.4	24.9	2.8	12.7	25.4	40.9	29.6	51.1	25.3	5.0	20.9	64.8	44.9	15.5	23.3	16.8	39.0	58.0	41.4	29.0	11.0	32.9	9.5	18.9	42.4	70.5	10.4	17.5	74.4	38.8	26.2	13.4	12.3	18.2	17.3	15.2	7.5	38.2	38.8	26.7	25.4	37.8	135.3	46.8	26.2	12.5	92.9
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294040-24359018	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 133.1"	"Cell type enhanced"	"Detected in many"	15	"B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 24.9;naive B-cell: 32.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 24.8;OE19: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.0	1.7	7.7	17.4	8.8	3.5	2.1	0.9	5.8	6.7	5.8	12.7	2.0	3.7	3.1	133.1	2.7	5.1	16.7	1.1	8.9	5.0	3.1	1.1	3.1	10.1	12.4	3.7	1.8	2.7	1.0	22.5	1.9	10.8	3.3	5.0	1.9	12.6	5.1	0.7	1.8	17.9	1.7	26.0	15.5	38.7	0.9	12.1	0.8	1.8	0.4	19.9	7.4	1.6	32.2	7.5	12.5	0.9	0.9	0.0	0.9	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.0	24.8	0.2	0.8	0.0	0.8	0.1	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.2	0.6	7.6	0.1	0.1	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.1	2.1	0.1	1.9	0.9	0.2	12.5	0.9	6.4	0.0	0.2	0.0	24.9	0.0	0.0	7.5	32.2	0.0	0.0	1.6	0.9	0.0	0.4	0.0	0.9	7.7	8.8	0.9	5.8	8.9	5.0	12.4	3.7	10.8	12.1	3.0	5.9	115.5	2.2	0.8	0.0	0.9	25.5	17.4	62.6	3.5	0.0	0.3	0.0	7.1	0.9	0.7	0.5	0.0	3.1	8.1	1.1	2.0	2.3	0.0	9.0	0.0	0.0	0.0	12.3	1.8	0.6	32.1	5.0	5.4	0.1	0.0	32.8	0.0	0.4	3.6	0.0	6.5	0.3	0.2	0.1	0.5	0.5	6.9	0.9	6.3
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835747-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 112.8"	"Cell type enhanced"	"Detected in many"	9	"Extravillous trophoblasts: 211.3;Sertoli cells: 207.0;Smooth muscle cells: 366.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"gdT-cell: 8.0;NK-cell: 9.0"	"Group enriched"	"Detected in many"	85	"NK-cells: 9.0;T-cells: 8.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 62.1;BJ: 72.4;hTEC/SVTERT24-B: 49.9;hTERT-HME1: 45.5;RPTEC TERT1: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		1900000	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	70.6	13.4	8.2	18.7	14.0	0.7	29.0	6.3	9.2	22.0	18.2	9.5	4.8	3.3	27.7	25.8	30.0	45.8	62.3	40.9	7.6	4.8	15.4	22.8	25.0	10.9	12.7	3.7	112.8	9.3	6.3	7.6	56.8	13.2	23.3	16.5	7.8	5.8	8.1	25.7	6.1	16.2	46.4	10.2	7.2	16.8	12.8	11.4	0.0	14.3	18.1	2.7	32.7	45.3	0.0	0.0	0.0	0.0	9.0	8.0	1.4	0.0	0.0	1.1	0.0	62.1	15.4	3.8	72.4	25.3	12.5	8.3	0.0	0.0	0.0	5.0	22.9	0.3	1.3	0.8	3.7	22.1	0.0	23.0	0.0	7.5	0.0	11.9	2.9	0.0	17.2	0.0	49.9	45.5	3.0	5.1	0.7	1.2	0.0	37.1	0.0	0.3	0.0	4.1	0.0	2.9	0.0	28.6	0.2	42.4	4.0	0.0	5.6	3.4	0.0	0.4	2.7	0.1	0.7	5.2	17.8	0.9	27.8	10.7	0.1	0.0	0.0	14.7	0.0	5.4	0.0	0.0	0.0	8.0	0.0	0.8	0.0	0.3	0.6	0.0	0.0	0.0	1.5	0.0	9.0	0.0	0.0	0.0	1.4	8.2	14.0	6.3	9.2	7.6	4.8	12.7	3.7	13.2	11.4	6.0	31.4	0.0	31.2	107.6	0.5	151.1	7.6	5.3	14.8	54.1	0.0	44.4	1.7	29.9	1.3	165.7	0.0	0.0	18.6	211.3	148.2	23.5	2.3	1.3	14.7	0.0	0.0	124.0	6.0	2.2	100.9	4.8	50.6	1.0	0.0	31.7	24.2	0.0	39.3	2.2	2.2	207.0	366.0	0.5	1.0	36.4	45.9	5.0	0.0	13.3
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184308-161199056	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 58.0"	"Cell type enriched"	"Detected in many"	7	"Smooth muscle cells: 356.4"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basal ganglia: 20.7;cerebral cortex: 10.0;midbrain: 28.6;pons and medulla: 20.5;thalamus: 15.7"	"Cell type enriched"	"Detected in some"	8	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in many"	8	"dendritic cells: 8.0"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 10.9;HUVEC TERT2: 13.2;SH-SY5Y: 7.4;TIME: 11.1;U-138 MG: 6.9;U-251 MG: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA			"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	58.0	9.7	2.6	18.1	20.7	1.8	14.6	1.5	10.7	7.8	6.3	33.4	0.0	1.9	5.8	2.0	7.7	14.2	16.4	19.5	3.4	2.3	3.1	11.0	15.7	2.7	28.6	3.5	35.7	10.6	4.7	4.9	4.4	20.5	5.8	3.4	0.0	1.7	1.7	7.7	1.7	3.0	12.0	15.5	1.9	8.1	1.7	15.7	0.0	7.5	1.2	1.4	8.7	4.0	0.5	8.0	1.0	0.2	0.4	0.6	0.2	0.0	0.0	0.2	0.1	6.1	3.9	0.6	4.9	0.2	0.4	2.8	0.2	0.1	0.2	4.1	1.5	0.0	0.1	0.0	0.0	1.7	0.1	0.3	0.1	0.4	1.2	0.6	0.0	0.1	4.3	0.0	10.9	0.1	0.0	13.2	0.1	0.1	0.3	0.3	0.1	0.0	0.2	4.9	0.0	0.0	0.1	4.8	0.1	0.0	0.1	0.1	7.4	0.0	0.1	0.1	0.3	0.2	0.5	11.1	6.9	0.1	0.3	9.8	0.2	0.1	0.1	2.1	0.1	0.1	0.7	0.2	0.2	0.6	0.1	0.3	0.3	0.3	0.3	0.1	0.5	0.4	0.4	1.0	0.4	0.1	8.0	0.3	0.2	2.6	20.7	1.5	10.0	3.4	2.3	28.6	3.5	20.5	15.7	0.0	5.5	0.0	2.3	27.7	2.2	2.8	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.3	0.0	43.0	0.0	0.0	0.0	0.2	33.3	8.7	0.0	0.8	0.8	3.2	0.0	48.5	1.5	0.0	0.3	6.0	33.7	1.8	0.0	0.3	0.0	0.0	1.1	0.0	1.0	51.8	356.4	2.3	0.6	16.7	0.3	1.5	0.0	4.4
ADCYAP1R1	"PAC1, PAC1R, PACAPR"	ENSG00000078549	"ADCYAP receptor type I"	P41586	7	31052461-31111479	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.2;fallopian tube: 25.1"	"Group enriched"	"Detected in some"	5	"Leydig cells: 10.6;Peritubular cells: 5.3"	"Cancer enriched"	"Detected in some"	11	"glioma: 45.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.6;NTERA-2: 7.3;SCLC-21H: 6.2;SH-SY5Y: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030739, HPA049877"	Enhanced		Enhanced	Vesicles		NA	NA			Vesicles		"HPA030739: AB_2732461, HPA049877: AB_2680928"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.67e-3)"	"unprognostic (6.43e-4)"	"unprognostic (1.09e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-4)"	5.4	10.6	23.6	2.7	24.2	0.9	2.9	13.7	71.2	12.8	2.7	13.4	0.0	1.6	5.4	2.3	3.3	25.1	2.0	2.8	22.1	21.6	1.0	1.1	1.6	1.0	19.0	20.2	1.9	2.2	2.9	4.4	1.0	18.7	2.1	2.0	0.0	2.6	3.7	1.9	1.8	2.0	3.9	6.5	1.3	1.6	2.2	13.3	0.0	2.3	0.9	1.6	1.4	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.5	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	11.1	0.0	0.0	0.0	2.2	0.0	0.0	0.3	0.9	1.3	0.2	0.1	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	23.6	24.2	13.7	17.3	22.1	21.6	19.0	20.2	18.7	13.3	0.0	0.0	0.0	0.0	0.5	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	10.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.0	1.4	0.0	1.5	0.3	0.0	0.0	0.0	0.0
ADGRB2	BAI2	ENSG00000121753	"Adhesion G protein-coupled receptor B2"	O60241	1	31727117-31764893	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 52.0"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 18.3;Horizontal cells: 7.9;Late spermatids: 10.3;Muller glia cells: 10.1"	"Cancer enhanced"	"Detected in many"		"glioma: 20.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.7;SH-SY5Y: 15.2;T-47d: 17.5;U-2 OS: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069175			Supported	"Plasma membrane"		NA	NA		49000	"Plasma membrane"		"HPA069175: "	"prognostic favorable (6.46e-4)"	"unprognostic (1.74e-1)"	"unprognostic (7.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-4)"	"prognostic unfavorable (4.02e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.75e-3)"	"unprognostic (7.98e-2)"	2.2	5.4	15.9	1.3	26.8	1.1	1.4	7.9	52.0	2.4	1.4	7.3	0.0	5.2	2.4	1.2	1.6	2.2	2.1	2.8	18.9	8.0	1.4	0.9	1.3	1.3	7.4	16.5	1.8	1.4	1.3	2.7	3.8	8.4	2.4	1.1	1.3	1.4	3.1	1.1	1.5	5.0	2.4	2.9	1.8	1.8	3.2	6.3	1.5	3.2	0.0	1.1	2.0	0.5	0.4	0.0	0.0	0.0	0.0	0.9	0.3	0.6	4.4	4.2	12.0	1.2	0.7	2.0	2.8	4.5	2.8	4.9	0.2	1.3	0.0	2.8	1.2	4.6	0.4	1.8	0.2	0.4	3.1	1.9	0.0	20.7	0.0	0.1	0.0	1.6	0.7	0.3	3.8	0.0	8.8	0.4	8.8	0.4	0.1	3.1	0.4	7.9	0.1	5.2	0.1	1.3	12.1	0.4	0.4	0.0	5.7	3.2	15.2	6.5	0.4	0.5	1.5	17.5	0.0	0.1	2.1	17.0	0.3	0.7	0.0	0.0	0.4	6.7	0.0	5.1	0.0	0.0	0.0	0.9	0.0	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	15.9	26.8	7.9	37.6	18.9	8.0	7.4	16.5	8.4	6.3	0.0	0.0	0.0	0.5	0.0	18.3	4.1	0.0	0.0	0.0	0.0	5.9	0.7	0.0	0.1	2.9	0.0	0.0	0.0	0.0	1.1	0.4	0.5	0.0	0.0	0.4	7.9	1.2	0.0	0.0	10.3	1.1	0.0	0.0	0.0	0.0	10.1	0.1	0.0	1.8	1.9	4.1	0.0	0.3	0.7	4.5	0.0	0.2	0.0	0.1	0.9
ADGRE1	"EMR1, TM7LN3"	ENSG00000174837	"Adhesion G protein-coupled receptor E1"	Q14246	19	6887566-6940459	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"blood: 64.1;lymphoid tissue: 50.0"	"Cell type enriched"	"Detected in some"	9	"Kupffer cells: 25.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 64.1"	"Group enriched"	"Detected in many"	17	"granulocytes: 64.1;monocytes: 20.2"	"Cell line enhanced"	"Detected in some"		"A549: 5.8;BJ hTERT+: 7.9;GAMG: 8.3;HDLM-2: 19.2;HMC-1: 13.7;Karpas-707: 16.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA052809	Uncertain					NA	NA		9100			"HPA052809: AB_2681959"	"unprognostic (2.06e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.93e-5)"	"unprognostic (6.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-7)"	"unprognostic (6.69e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.35e-1)"	1.8	0.5	0.7	7.2	2.4	5.9	0.5	0.3	1.7	0.5	0.6	0.3	0.0	2.8	0.4	0.9	0.4	0.6	0.7	1.3	1.5	0.7	0.7	4.1	4.6	6.6	1.7	0.0	0.3	0.4	0.0	1.0	1.8	0.9	0.5	0.5	0.5	0.5	0.0	0.4	0.3	2.8	1.7	1.9	50.0	0.7	1.2	1.0	6.9	0.5	0.0	1.7	2.8	0.4	0.0	2.4	64.1	20.2	0.1	2.0	1.9	2.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	19.2	0.0	0.1	0.0	0.0	0.0	0.4	13.7	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	16.8	0.0	0.1	0.5	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.3	0.2	0.3	0.1	0.9	3.0	0.1	3.9	3.7	0.0	27.2	4.3	64.1	0.0	12.0	0.0	0.0	1.5	0.2	2.4	0.0	2.0	0.1	1.6	0.1	20.2	0.1	0.4	1.9	0.7	2.4	0.3	1.7	1.5	0.7	1.7	0.0	0.9	1.0	3.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	1.8	25.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.1	0.0	0.0	0.0
ADGRE5	"CD97, TM7LN1"	ENSG00000123146	"Adhesion G protein-coupled receptor E5"	P48960	19	14380501-14408725	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 95.3"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 102.4;Kupffer cells: 83.8;T-cells: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA013707	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	Yes	10000000	930000	Cytosol		"HPA013707: AB_1846345"	"unprognostic (3.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.51e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.41e-2)"	17.7	8.9	2.5	23.0	4.0	55.3	14.3	1.1	5.2	21.7	15.9	12.9	0.5	12.9	56.9	18.5	11.6	19.1	27.1	16.4	3.0	2.4	10.7	15.5	30.3	41.1	6.3	3.2	10.7	16.2	2.4	3.3	18.2	5.9	11.3	9.0	6.9	17.0	3.6	12.5	6.0	22.2	36.2	4.2	56.9	15.0	6.9	4.9	24.3	8.6	3.7	22.5	34.7	12.4	3.9	13.3	95.3	43.2	22.8	25.8	23.3	30.8	21.9	0.2	21.0	9.3	15.3	3.3	21.4	34.5	15.4	16.9	6.2	31.3	3.5	21.7	27.5	22.0	7.3	5.7	10.4	6.9	19.2	6.4	6.9	32.5	2.7	11.5	14.9	32.3	6.7	0.3	15.7	5.4	5.0	1.5	6.1	9.0	27.7	16.8	6.9	0.9	20.0	0.6	24.5	27.3	2.0	9.2	16.1	5.2	2.7	0.2	0.7	12.2	17.5	15.2	0.5	4.5	13.8	3.7	5.2	8.7	21.7	35.2	0.0	0.1	0.2	18.7	26.7	19.5	42.0	18.6	95.3	25.8	36.7	17.3	3.9	13.1	17.8	13.3	2.6	9.4	12.8	82.7	22.8	43.2	6.4	9.0	23.3	2.5	4.0	1.1	5.2	3.0	2.4	6.3	3.2	5.9	4.9	32.8	102.4	15.9	7.4	0.0	0.2	3.1	12.7	50.9	31.8	0.0	0.0	2.7	0.0	15.1	0.0	4.5	10.2	23.3	19.1	36.8	4.8	9.8	70.9	1.5	47.0	0.0	4.7	26.4	83.8	1.0	6.1	50.6	0.0	2.8	34.7	2.3	17.9	21.0	4.6	0.7	1.2	25.8	17.2	0.5	5.7	0.0	6.6	152.3	31.8	14.1
ADGRL4	"ELTD1, ETL"	ENSG00000162618	"Adhesion G protein-coupled receptor L4"	Q9HBW9	1	78889764-79006718	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 98.9"	"Group enriched"	"Detected in some"	7	"Endothelial cells: 232.9;Ito cells: 348.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 19.6;HUVEC TERT2: 64.3;RPTEC TERT1: 14.0;TIME: 78.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025229	Supported					NA	NA		1800000			"HPA025229: AB_10602493"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.85e-3)"	98.9	4.7	3.6	5.6	5.7	0.0	43.8	3.2	6.1	14.6	7.8	1.5	6.6	2.8	12.9	7.1	12.4	6.8	12.3	12.3	4.3	3.7	11.3	8.8	16.2	8.5	5.4	1.4	9.3	3.0	5.7	7.8	12.8	6.2	12.2	3.6	5.9	4.8	5.7	16.1	5.3	4.8	16.0	4.7	34.8	4.9	6.8	4.3	1.1	13.9	8.0	3.9	16.0	25.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	1.6	5.2	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	3.8	0.0	11.1	0.0	19.6	64.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	78.4	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	5.7	3.2	6.1	4.3	3.7	5.4	1.4	6.2	4.3	0.0	8.9	2.2	0.3	0.0	0.0	4.2	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.8	232.9	0.0	0.0	0.2	0.0	0.3	1.1	0.0	2.0	0.5	1.6	0.0	348.0	29.4	42.9	0.6	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	1.2	1.4	1.1	0.0	0.0	0.0	0.0	0.6
ADGRV1	"DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1"	ENSG00000164199	"Adhesion G protein-coupled receptor V1"	Q8WXG9	5	90529344-91164437	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Hydrolase, Receptor, Transducer"	"Deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 95.3;pituitary gland: 35.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 249.4;Rod photoreceptor cells: 90.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 12.2;HAP1: 18.1;NTERA-2: 9.5;SCLC-21H: 8.8;SuSa: 12.4;U-266/70: 10.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067503	Approved		Approved	"Lipid droplets"		NA	NA			"Lipid droplets"		"HPA067503: AB_2685856"	"unprognostic (1.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.50e-3)"	"unprognostic (9.73e-7)"	"unprognostic (1.87e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.14e-2)"	0.5	95.3	21.9	0.6	19.8	0.8	2.2	13.9	14.7	0.7	1.0	3.1	1.2	0.7	0.6	0.9	1.0	0.6	6.3	0.6	26.5	1.5	10.6	19.4	5.5	0.5	1.1	7.0	0.6	1.3	1.1	35.4	2.4	4.9	1.1	1.0	4.9	0.7	2.4	0.6	1.5	0.7	0.6	0.4	0.7	1.0	1.1	5.3	0.0	4.2	0.0	0.7	5.4	0.4	4.1	2.2	8.4	1.7	1.7	3.4	0.4	0.4	1.6	12.2	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	1.3	0.1	0.2	0.3	0.0	0.3	0.1	18.1	0.1	0.0	0.7	3.4	3.1	1.4	1.0	0.0	0.2	0.1	0.0	3.8	0.0	0.1	0.1	0.0	0.1	7.3	2.0	0.0	1.5	0.1	0.1	9.5	2.2	3.2	0.0	0.3	1.6	0.0	0.4	8.8	2.2	2.6	1.7	0.1	12.4	4.7	0.0	0.6	0.3	1.5	0.4	0.8	10.7	3.0	0.4	0.6	0.1	0.0	4.9	1.7	4.8	2.0	1.3	3.2	2.5	2.2	2.6	0.9	4.1	3.4	1.8	8.4	1.7	1.0	2.2	2.7	0.4	21.9	19.8	13.9	14.7	26.5	1.5	1.1	7.0	4.9	5.3	23.8	17.9	0.0	4.8	0.0	26.4	2.0	5.1	13.4	10.3	5.2	249.4	2.3	1.7	1.4	35.8	0.8	0.0	0.0	3.8	1.5	1.2	2.9	0.0	12.4	0.2	9.5	7.0	0.0	0.3	38.5	0.6	0.0	0.0	1.8	0.0	8.6	2.7	0.0	0.4	12.0	90.0	0.0	0.2	1.9	2.8	0.0	3.4	0.0	0.4	8.6
ADIPOQ	"ACDC, ACRP30, adiponectin, AdipoQ, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842690-186858463	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 176.7;breast: 79.4"	"Cell type enriched"	"Detected in single"	12	"Distal tubular cells: 1.7"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	670	"ASC diff: 86.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	NA	NA	8360000000	1000000000			"CAB046467: AB_1078104, HPA051767: AB_2681598"	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			176.7	1.9	0.0	16.7	0.0	0.1	79.4	0.0	0.1	0.1	23.2	0.0	0.4	0.1	0.1	1.3	0.3	0.1	13.2	5.8	0.0	0.0	0.5	0.1	0.1	6.1	0.0	0.0	0.2	1.3	0.1	0.0	0.1	0.0	0.4	1.4	0.0	14.7	0.6	2.0	1.5	2.1	0.4	0.0	0.1	0.6	0.1	0.0	0.0	0.7	9.5	0.3	1.0	0.9	0.8	0.6	2.4	0.4	0.7	0.5	0.1	0.0	0.0	0.0	0.0	86.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.6	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.8	0.3	0.5	1.9	0.7	0.4	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADIPOR1	"ACDCR1, PAQR1"	ENSG00000159346	"Adiponectin receptor 1"	Q96A54	1	202940823-202958572	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.27e-4)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.63e-2)"	26.8	24.8	20.4	16.4	25.9	65.7	29.6	18.1	29.0	22.2	19.3	33.2	17.1	16.2	18.0	33.7	49.1	24.8	18.5	39.6	19.8	19.5	30.5	56.8	41.5	33.6	20.7	14.3	22.6	66.2	30.4	21.6	63.1	20.2	23.1	21.6	38.3	39.7	17.9	43.5	46.1	24.4	18.2	30.2	36.9	24.8	24.9	18.3	21.9	26.6	28.6	32.1	25.0	29.3	21.6	28.8	112.6	49.9	16.0	23.4	63.8	24.9	23.8	14.6	16.0	30.5	23.5	74.4	28.0	32.7	29.1	27.0	23.7	30.3	16.7	20.8	31.7	23.3	31.0	21.7	38.4	26.4	31.5	24.7	12.8	30.2	18.8	30.1	26.5	19.5	27.8	62.6	31.6	32.3	29.1	28.6	29.5	33.0	35.5	29.3	27.2	21.9	19.5	32.0	22.5	27.3	17.5	35.4	32.3	28.2	30.0	24.0	24.8	29.6	44.2	34.4	40.8	32.1	25.7	25.5	21.5	17.0	10.5	30.8	37.5	50.8	18.9	30.8	15.3	25.1	39.6	49.9	59.9	19.7	33.5	20.4	21.6	21.0	19.3	28.8	21.4	21.0	18.4	112.6	16.0	32.3	19.9	23.4	63.8	20.4	25.9	18.1	29.0	19.8	19.5	20.7	14.3	20.2	18.3	32.8	48.6	40.6	78.1	208.7	24.6	48.9	30.6	50.9	36.4	50.6	27.5	96.5	58.0	65.0	51.8	53.4	41.2	210.2	76.0	142.7	52.5	96.6	35.9	53.5	89.9	11.1	47.2	52.8	115.1	42.9	26.4	67.3	81.0	74.9	43.5	23.3	91.5	45.6	23.0	46.9	35.3	38.8	45.3	11.6	29.6	200.0	169.6	42.7	43.1	136.7
ADORA1	RDC7	ENSG00000163485	"Adenosine A1 receptor"	P30542	1	203090654-203167405	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 38.7"	"Group enriched"	"Detected in some"	4	"granulocytes: 23.0;Muller glia cells: 40.0"	"Cancer enhanced"	"Detected in many"		"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.7;MCF7: 11.9;RH-30: 32.7;RPTEC TERT1: 15.9;SK-BR-3: 17.7;U-138 MG: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044383			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA044383: AB_2678921"	"unprognostic (3.93e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-2)"	"unprognostic (5.76e-4)"	4.5	1.0	19.7	2.6	21.7	0.8	6.1	9.7	38.7	1.1	1.6	27.4	0.0	2.0	2.0	1.6	1.6	2.0	1.8	13.8	19.8	12.1	4.2	1.0	2.8	1.4	22.8	13.4	0.8	15.5	15.5	0.9	8.9	25.0	1.2	1.6	1.8	8.9	1.3	2.0	1.9	1.8	1.3	20.7	7.4	1.6	16.3	15.9	0.0	3.2	0.0	1.4	3.4	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	1.4	0.3	0.1	0.1	0.8	0.1	1.0	1.5	0.4	0.2	19.7	0.3	0.0	4.5	3.6	2.4	0.0	0.3	0.0	0.1	0.0	0.5	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.0	3.2	0.0	3.2	0.0	0.0	3.1	11.9	0.0	0.0	5.1	0.0	0.0	0.0	32.7	1.0	15.9	0.0	0.3	0.4	2.1	17.7	0.2	1.9	1.0	0.4	0.0	10.6	5.4	0.0	5.7	0.0	0.1	0.0	5.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	19.7	21.7	9.7	25.7	19.8	12.1	22.8	13.4	25.0	15.9	0.0	0.0	0.0	0.0	0.0	0.5	2.5	5.1	0.0	0.0	3.5	0.0	0.0	0.0	7.2	0.1	0.0	0.0	0.0	3.0	1.0	0.7	0.0	23.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.4	1.7	0.0	0.0	40.0	0.5	0.0	0.7	1.0	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
ADORA2A	"ADORA2, RDC8"	ENSG00000128271	"Adenosine A2a receptor"	P29274	22	24417879-24442360	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"blood: 22.8;bone marrow: 28.1;brain: 43.9;lymphoid tissue: 59.0"	"Cell type enriched"	"Detected in single"	25	"monocytes: 19.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	8	"basal ganglia: 43.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 15.4;Karpas-707: 21.2;RPMI-8226: 15.0;SK-BR-3: 30.4;U-266/70: 21.2;U-266/84: 27.7;U-698: 21.7"	"Region enriched"	"Detected in some"	10	"basal ganglia: 357.5"	"Region enriched"	"Detected in single"	92	"basal ganglia: 166.0"	"CAB001943, HPA065566, HPA075997"	Enhanced	Supported				NA	NA					"CAB001943: , HPA065566: , HPA075997: AB_2732298"	"unprognostic (7.30e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.87e-3)"	"unprognostic (6.81e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.10e-3)"	1.0	2.4	1.9	10.4	43.9	28.1	1.5	3.4	3.8	0.8	2.0	1.7	0.3	5.4	1.4	1.4	1.0	0.9	2.4	3.5	2.4	1.8	3.5	4.3	5.1	14.8	2.6	1.6	1.2	0.8	0.0	2.1	1.4	2.3	1.6	0.8	3.3	2.7	1.5	1.2	0.9	2.6	0.7	1.3	7.5	2.8	2.0	5.7	59.0	1.3	0.9	8.6	3.8	1.3	17.7	1.1	13.7	9.0	2.2	22.8	11.2	0.2	0.3	0.4	0.1	0.2	0.1	0.4	0.2	9.5	0.5	1.0	1.7	0.1	15.4	1.0	0.3	1.0	0.3	0.9	0.0	0.0	1.8	2.7	0.2	0.0	2.2	0.2	0.3	7.7	0.1	0.0	2.9	0.0	0.2	3.4	2.2	0.1	21.2	0.0	0.2	5.3	1.6	0.6	2.0	0.0	0.2	0.7	15.0	0.0	0.1	1.5	8.9	0.4	30.4	0.1	0.4	0.4	1.5	0.2	0.9	1.5	0.2	0.1	21.2	27.7	21.7	4.8	5.2	0.1	3.0	0.8	4.8	8.6	2.6	20.1	9.6	16.1	16.9	1.1	17.7	22.8	18.3	13.7	2.2	9.0	1.1	21.4	11.2	1.9	43.9	3.4	3.8	2.4	1.8	2.6	1.6	2.3	5.7	0.0	0.3	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADRB1	ADRB1R	ENSG00000043591	"Adrenoceptor beta 1"	P08588	10	114044056-114046908	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 48.0;placenta: 41.7"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 80.0;Cytotrophoblasts: 56.3;Sertoli cells: 51.8;Syncytiotrophoblasts: 32.2"	"Cancer enriched"	"Detected in many"	10	"prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.2;PC-3: 4.0;THP-1: 6.9;TIME: 8.9;U-937: 5.2"	"Group enriched"	"Detected in many"	4	"amygdala: 10.0;basal ganglia: 7.3;cerebral cortex: 17.1;hippocampal formation: 11.3;thalamus: 6.9"	"Low region specificity"	"Detected in many"			HPA067972	Enhanced					NA	NA					"HPA067972: AB_2685936"	"unprognostic (1.45e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.44e-1)"	4.3	1.0	6.9	1.1	14.0	1.3	5.9	1.0	10.7	0.8	3.1	0.8	0.0	1.8	0.9	0.9	1.9	0.8	0.9	48.0	5.6	2.4	1.7	2.5	18.3	0.9	3.5	4.4	0.8	2.4	0.9	1.2	41.7	2.6	6.5	1.6	4.5	10.7	0.8	3.1	0.9	2.3	0.9	1.3	1.7	1.4	1.0	2.5	0.0	1.0	0.0	1.1	1.1	0.4	1.4	1.9	0.1	1.3	0.0	0.5	0.1	2.1	1.3	0.2	1.3	0.0	0.0	0.3	0.1	0.1	0.2	0.2	0.5	1.6	0.3	0.4	0.0	0.6	0.4	0.1	0.1	0.3	10.2	0.6	0.4	0.2	0.2	0.0	0.4	0.7	0.0	1.1	0.0	2.1	0.2	0.3	1.6	0.1	0.1	0.2	1.2	1.6	1.4	0.5	0.3	4.0	0.3	0.4	0.1	0.0	1.7	0.2	0.4	0.0	0.8	0.1	0.5	0.3	6.9	8.9	0.3	0.1	0.2	0.2	0.0	0.1	0.5	0.0	5.2	0.2	0.0	1.3	0.0	0.5	0.9	0.0	0.6	0.1	0.3	1.9	1.4	0.0	0.4	0.1	0.0	0.1	0.2	0.0	0.1	6.9	14.0	1.0	10.7	5.6	2.4	3.5	4.4	2.6	2.5	17.9	8.5	0.0	4.2	0.9	4.7	80.0	5.1	12.0	13.6	0.0	0.0	56.3	1.7	0.0	0.1	0.7	0.0	0.0	0.2	2.1	3.7	7.1	0.0	0.2	3.9	12.7	0.0	0.6	2.4	0.0	0.0	0.6	1.7	0.0	3.1	0.7	0.1	0.3	0.4	0.0	1.2	51.8	0.8	0.5	0.0	0.0	32.2	1.5	0.4	3.1
ADRB2	"ADRB2R, ADRBR, B2AR, BAR"	ENSG00000169252	"Adrenoceptor beta 2"	P07550	5	148825245-148828687	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.6"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 104.2;Basal keratinocytes: 344.2;granulocytes: 116.5;Suprabasal keratinocytes: 214.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 24.5;hTERT-HME1: 25.4;PC-3: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003431, HPA075322"	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"HPA003431: AB_1845333, HPA075322: "	"unprognostic (2.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.15e-9)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	11.7	0.2	0.7	0.9	0.4	4.6	13.8	0.0	0.3	6.1	0.9			0.3	0.9	0.2	6.4	1.4	1.1	2.8	0.7	0.3	0.2	6.0	8.5	1.1	0.9		0.0	0.0	0.5	0.0	4.0		3.8	0.7		3.3	0.1	4.4	15.9	1.3	1.2	1.0	3.7	2.9	0.0			0.5		2.0	2.3	5.4	4.8	6.1	14.0	10.8	7.3	34.6	9.6	7.6	0.0	0.0	0.0	0.3	0.0	0.0	1.5	4.4	2.0	2.3	0.0	3.3	0.0	2.1	0.4	7.4	6.8	0.0	9.2	2.3	0.0	0.2	0.0	1.6	0.0	0.2	0.0	3.8	0.0	24.5	0.6	25.4	1.7	0.9	0.0	0.0	2.9	5.3	0.0	0.0	4.2	0.1	0.0	10.5	2.2	1.4	4.3	1.1	1.9	0.0	0.0	1.8	0.2	0.6	0.9	0.0	2.3	4.1	0.0	1.8	2.5	1.1	0.7	0.0	0.1	0.0	5.0	0.8	3.5	4.7	14.0	34.6	7.8	25.7	4.8	8.2	20.9	5.3	3.0	1.4	12.9	7.6	7.3	10.8	6.1	0.4	9.6											104.2	33.5	11.1	31.2	344.2	0.2	12.4	0.0	8.1	33.0	0.0	0.0	0.3	0.0	1.4	0.2	17.5	0.0	0.0	0.2	0.2	6.1	16.2	116.5	11.9	14.7	0.0	2.9	6.7	12.7	0.4	0.0	16.5	28.7	1.0	1.4	3.5	5.3	0.0	0.0	0.0	4.8	0.0	3.6	0.0	0.0	214.5	0.5	35.5	0.8	48.5
AGTR1	"AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R"	ENSG00000144891	"Angiotensin II receptor type 1"	P30556	3	148697784-148743008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 29.6;placenta: 44.9"	"Group enriched"	"Detected in many"	5	"Leydig cells: 134.3;Sertoli cells: 142.3"	"Group enriched"	"Detected in many"	8	"breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 64.4;ASC TERT1: 9.0;BJ hTERT+ SV40 Large T+: 12.3;HBF TERT88: 19.4;HSkMC: 11.7"					"Low region specificity"	"Detected in many"			HPA003596	Enhanced		Uncertain	Vesicles		NA	NA			Vesicles		"HPA003596: AB_1845163"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.48e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.41e-3)"	18.8	11.6	0.0	0.1	0.0	0.0	10.8	0.0	0.0	0.8	5.5			0.0	0.6	0.5	0.5	2.2	1.6	3.1	0.0	0.1	5.7	29.6	2.6	0.0	0.9		0.8	0.6	0.6	0.8	44.9		1.3	1.0		1.0	1.0	2.9	4.4	0.7	1.1	0.0	2.3	1.7	0.2			4.1		0.0	4.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	64.4	9.0	0.0	0.0	1.3	12.3	7.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	1.1	0.6	0.3	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	1.1	0.0	0.2	3.1	0.0	5.7	5.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	0.2	0.0	0.0	6.6	0.2	13.7	1.2	0.0	26.8	0.6	0.0	22.7	29.4	0.8	0.2	134.3	0.0	1.7	0.0	0.0	4.5	0.8	0.0	7.1	0.0	0.0	142.3	15.5	0.0	0.4	1.5	0.2	0.0	0.0	0.0
AHCTF1	ELYS	ENSG00000153207	"AT-hook containing transcription factor 1"	Q8WYP5	1	246839098-246931978	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 114.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.4"	"Group enriched"	"Detected in many"	5	"B-cells: 5.0;granulocytes: 8.4;T-cells: 2.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031658	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA031658: AB_10601968"	"unprognostic (3.10e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (7.65e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.52e-2)"	20.2	13.7	10.4	11.0	17.4	17.3	14.3	23.3	12.9	12.2	12.6	7.5	10.3	8.3	13.8	8.2	10.7	14.7	8.9	14.9	10.1	6.8	13.4	13.1	9.7	9.5	11.6	8.3	23.3	12.3	19.2	17.6	10.7	10.9	10.1	8.1	7.4	10.7	11.5	15.6	11.3	10.3	10.1	11.4	12.5	12.7	33.9	11.3	17.9	15.3	8.8	9.7	14.5	20.9	5.0	1.1	8.4	0.9	0.7	2.9	0.7	23.9	12.2	10.8	9.5	10.7	10.7	22.9	17.4	8.5	12.7	10.5	11.9	9.1	23.7	19.0	9.0	7.5	20.7	17.2	8.9	21.5	16.8	7.2	15.0	13.3	10.4	8.0	21.7	11.8	10.2	7.9	16.4	16.8	5.9	9.2	8.9	41.6	11.6	12.1	5.5	16.1	9.8	25.1	14.4	13.3	19.8	17.5	18.4	7.8	12.1	13.6	19.8	22.8	8.7	9.3	8.3	11.1	13.5	12.0	13.1	15.1	18.4	32.7	21.1	29.5	26.5	10.6	13.8	12.7	0.7	0.6	1.7	1.7	0.3	1.3	5.0	1.9	1.6	0.8	1.3	2.9	1.5	8.4	0.7	0.9	1.1	2.9	0.7	10.4	17.4	23.3	12.9	10.1	6.8	11.6	8.3	10.9	11.3	32.8	25.4	17.3	13.4	26.7	19.8	17.1	7.6	21.4	27.3	5.2	7.9	12.0	3.3	11.2	54.5	16.3	12.2	0.0	10.5	9.1	14.6	17.6	11.5	12.5	8.0	17.5	20.7	19.0	15.5	17.5	33.4	16.8	3.3	11.8	12.5	8.9	13.9	10.5	36.7	7.6	15.4	32.3	23.7	114.9	37.5	26.8	11.3	13.8	11.2	22.6
AIG1	"AIG-1, dJ95L4.1, FLJ10485"	ENSG00000146416	"Androgen induced 1"	Q9NVV5	6	143060496-143340304	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 115.7"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 202.6;Proximal tubular cells: 212.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060766	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA060766: AB_2684356"	"unprognostic (2.70e-2)"	"prognostic unfavorable (3.26e-6)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.25e-7)"	"unprognostic (1.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.75e-1)"	18.4	14.9	20.1	5.6	18.7	13.0	16.8	15.6	22.3	8.1	15.1	26.6	7.9	22.3	7.7	18.8	14.7	16.7	14.2	21.9	21.7	26.0	51.4	115.7	8.6	5.7	23.3	15.7	17.1	14.2	9.7	19.2	6.3	25.7	12.5	9.7	21.1	11.5	12.8	10.1	8.2	25.6	8.9	28.6	9.4	8.7	10.0	14.7	1.7	23.0	11.2	11.3	14.5	10.5	6.4	19.0	8.2	18.7	6.3	10.0	5.7	9.4	7.1	6.7	18.8	9.6	8.5	2.3	8.2	18.3	8.2	20.1	10.5	27.9	6.3	11.8	18.9	12.1	13.5	8.1	27.1	20.4	18.5	17.9	1.5	11.0	43.5	14.3	13.5	0.9	10.1	27.8	10.4	44.5	29.8	3.2	8.7	1.1	22.2	21.0	12.6	4.1	3.4	12.6	10.7	8.2	6.0	18.2	10.5	32.9	21.6	23.7	13.2	10.7	10.1	4.8	12.0	10.6	31.5	1.0	7.9	8.5	7.8	10.1	29.6	23.5	0.5	19.4	3.2	8.1	5.8	3.9	5.9	4.4	16.8	10.0	6.4	8.2	6.7	19.0	4.2	8.8	6.8	8.2	6.3	18.7	1.9	5.7	5.7	20.1	18.7	15.6	22.3	21.7	26.0	23.3	15.7	25.7	14.7	14.9	23.0	21.7	44.8	22.1	63.0	65.1	76.5	57.6	35.2	48.8	23.6	56.8	44.7	47.3	9.7	28.1	17.9	23.3	27.4	6.9	41.9	39.0	36.8	202.6	29.0	50.9	37.9	31.3	26.1	5.6	29.7	27.8	52.3	23.4	25.0	69.0	25.6	26.6	36.0	212.5	31.0	32.3	36.0	3.6	12.3	40.0	90.4	20.4	28.1	43.8
AKAP5	"AKAP75, AKAP79"	ENSG00000179841	"A-kinase anchoring protein 5"	P24588	14	64465499-64474503	"Plasma proteins, Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 39.1"	"Group enriched"	"Detected in many"	4	"granulocytes: 63.8;Mucus-secreting cells: 24.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"basophil: 5.7"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 5.7"	"Cell line enhanced"	"Detected in many"		"CACO-2: 14.1"					"Group enriched"	"Detected in all"	5	"amygdala: 34.7;basal ganglia: 98.5;cerebral cortex: 52.2;hippocampal formation: 56.3"	"CAB004308, HPA053891"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB004308: AB_626655, HPA053891: AB_2682294"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.44e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.49e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.45e-2)"	0.7	0.8	17.3	2.2	39.1	1.0	1.1	2.9	21.8	0.7	5.9	0.2	0.0	1.1	2.3	0.6	1.0	0.8	1.6	0.6	9.9	1.4	2.4	1.2	3.0	2.9	1.3	9.2	0.7	0.5	1.5	1.3	1.8	0.9	1.0	6.1	0.0	0.7	1.0	0.6	1.0	2.4	2.2	0.7	2.0	1.1	0.7	1.3	0.1	1.1	0.0	2.5	1.4	0.7	0.7	0.4	5.7	0.3	0.9	1.0	0.2	1.7	1.4	1.7	1.0	0.6	0.1	5.7	1.3	0.6	1.6	2.1	14.1	4.4	1.3	2.7	1.0	0.2	0.6	3.7	0.3	1.6	2.6	3.1	4.3	2.6	1.2	0.1	0.5	0.6	0.6	0.1	1.1	0.0	2.9	0.6	3.2	0.5	1.0	1.0	1.0	3.4	0.3	1.3	0.2	0.7	4.2	0.8	0.3	2.6	1.6	4.4	2.0	1.5	0.1	0.4	5.5	1.3	0.3	0.8	1.9	5.8	0.2	2.2	3.0	3.3	3.2	1.3	0.5	0.3	5.7	0.3	0.2	1.0	0.1	0.2	0.5	0.3	0.9	0.2	0.7	0.4	0.5	0.7	0.9	0.1	0.4	0.1	0.2	17.3	39.1	2.9	19.9	9.9	1.4	1.3	9.2	0.9	1.3	6.0	3.7	0.5	1.3	0.8	7.0	0.9	2.5	0.0	0.0	0.0	7.9	0.5	0.0	0.5	1.6	0.8	0.9	0.0	0.2	1.4	1.5	1.0	63.8	0.8	0.4	7.9	0.0	0.6	0.8	0.5	0.0	1.3	1.7	0.0	24.0	0.5	0.6	0.0	0.0	0.7	7.9	0.0	0.4	0.5	4.3	0.6	0.6	10.2	4.6	0.7
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Cell adhesion, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 122.5"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 684.9;Ciliated cells: 364.1;Club cells: 315.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 20.7"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 20.7"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 64.5;U-138 MG: 77.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced				"Intracellular and membrane"	NA	NA		1800000000			"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.15e-4)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (7.76e-2)"	16.6	14.1	23.6	5.2	31.1	4.2	34.2	4.2	25.3	12.9	8.2	25.0	13.9	7.2	7.0	15.4	4.0	20.6	9.9	4.7	23.2	24.3	9.6	19.4	29.6	4.2	45.1	19.7	24.6	15.3	122.5	11.9	5.3	31.5	14.0	6.6	3.0	17.9	17.5	0.9	5.9	7.3	10.8	35.3	3.0	14.2	2.3	43.8	2.2	25.6	2.7	6.2	9.9	5.5	3.5	20.7	3.7	3.2	0.4	1.6	2.0	38.3	14.8	10.6	5.4	16.2	7.1	0.1	31.4	18.4	20.3	28.5	0.1	8.0	2.7	13.1	44.2	11.2	29.8	1.7	25.0	60.1	2.5	2.6	0.3	11.3	0.7	18.2	15.6	0.1	12.6	18.6	25.9	64.5	56.7	22.2	2.8	0.0	4.6	26.6	2.6	2.2	5.7	2.2	12.4	16.8	1.4	0.9	0.1	30.8	4.3	7.7	21.5	3.2	3.1	2.0	4.4	6.0	10.3	46.1	77.7	26.5	3.3	37.2	0.0	0.0	0.2	17.7	3.3	33.2	0.0	3.2	2.4	0.4	1.5	1.4	3.5	1.1	0.7	20.7	2.2	0.2	0.2	3.7	0.4	0.8	7.4	1.6	2.0	23.6	31.1	4.2	24.6	23.2	24.3	45.1	19.7	31.5	43.8	684.9	108.8	7.2	17.0	10.8	3.0	5.6	61.1	364.1	315.1	15.7	2.0	0.6	1.7	16.4	49.7	10.5	7.5	0.0	36.7	0.6	27.3	97.5	10.5	40.4	60.4	1.6	16.1	3.7	38.7	47.9	3.4	105.6	23.6	140.7	15.0	1.3	39.9	5.8	6.0	23.3	0.5	0.0	19.6	2.1	3.4	17.7	0.7	3.2	9.8	69.3
AMIGO1	"AMIGO, KIAA1163"	ENSG00000181754	"Adhesion molecule with Ig like domain 1"	Q86WK6	1	109504175-109509738	"Predicted membrane proteins, Transporters"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.9"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 27.9;Rod photoreceptor cells: 8.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"gdT-cell: 1.5;MAIT T-cell: 1.6;memory CD4 T-cell: 2.2;memory CD8 T-cell: 2.5;naive CD4 T-cell: 5.4;naive CD8 T-cell: 3.9;NK-cell: 1.9;T-reg: 1.5"	"Group enriched"	"Detected in many"	21	"NK-cells: 1.9;T-cells: 5.4"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 9.6;SK-BR-3: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046152	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA046152: AB_2679559"	"unprognostic (1.35e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.16e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	5.3	14.8	11.8	3.7	19.1	1.0	4.7	23.4	33.9	4.8	6.6	4.8	4.0	3.2	5.7	16.4	4.1	4.9	4.3	11.0	12.2	14.3	7.6	3.5	6.4	5.2	9.9	15.0	12.8	9.2	21.1	8.1	3.0	15.6	9.2	3.7	10.3	9.6	11.1	22.4	3.3	4.1	6.5	6.0	4.6	5.0	4.1	5.3	1.7	9.1	1.9	4.6	4.5	3.8	0.1	0.0	0.0	0.1	1.9	5.4	0.9	2.6	1.2	2.7	9.5	3.6	1.5	3.4	4.4	2.2	5.1	2.4	0.5	0.1	0.2	1.2	2.8	1.2	1.4	7.3	0.3	4.3	1.0	0.6	0.0	1.7	0.8	2.9	2.1	5.4	0.7	3.2	1.7	0.0	0.5	1.2	1.5	2.1	0.0	0.1	4.4	0.4	4.4	1.7	2.2	3.0	0.7	0.0	0.4	5.9	1.3	9.6	3.2	1.0	12.6	3.5	1.2	3.6	3.1	1.1	0.2	5.9	3.4	1.8	0.2	0.0	0.0	1.9	0.0	2.7	0.0	0.0	0.0	1.5	0.1	1.6	0.1	2.2	2.5	0.0	0.0	5.4	3.9	0.0	1.9	0.0	0.0	1.5	0.9	11.8	19.1	23.4	33.9	12.2	14.3	9.9	15.0	15.6	5.3	3.0	1.3	0.0	0.4	0.6	27.9	6.7	2.5	0.0	0.0	3.5	3.9	1.0	0.0	1.0	0.0	0.8	1.0	0.0	0.8	0.1	0.6	1.1	0.0	0.8	0.2	4.8	4.6	0.6	0.0	0.0	2.0	0.0	0.0	1.0	0.7	7.1	0.7	0.9	5.3	0.5	8.8	0.0	1.0	0.7	0.9	0.4	0.2	0.0	1.5	0.3
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 166.5;tongue: 58.3"	"Group enriched"	"Detected in many"	10	"Cardiomyocytes: 153.6;Cone photoreceptor cells: 82.5;Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 20.1"	"Group enriched"	"Detected in some"	8	"memory B-cell: 10.6;naive B-cell: 9.1;plasmacytoid DC: 3.5"	"Group enriched"	"Detected in many"	7	"B-cells: 10.6;dendritic cells: 3.5"	"Group enriched"	"Detected in some"	4	"HEL: 38.0;K-562: 39.9;RH-30: 50.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	NA	NA		33000000			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.2	0.3	0.6	0.7	0.6	14.8	0.3	20.1	3.8	0.2	0.2	0.0	0.0	0.4	0.2	2.7	1.8	0.2	0.3	18.0	0.6	1.2	0.3	0.2	0.4	0.9	4.0	0.4	0.2	0.3	4.3	0.3	0.8	8.3	0.9	0.2	0.5	2.9	0.3	166.5	0.2	0.3	0.2	1.0	0.7	1.1	0.3	0.0	0.0	1.0	58.3	3.8	0.3	0.4	10.6	3.5	1.0	0.2	0.1	0.9	0.7	0.0	5.1	0.1	0.0	0.0	0.9	0.0	1.5	10.2	0.5	0.2	0.0	0.0	2.3	0.4	1.0	0.1	0.8	0.2	0.1	0.2	0.9	0.0	38.0	0.2	0.0	0.0	0.1	0.1	1.3	0.2	0.1	0.0	0.2	0.0	0.0	39.9	0.8	0.6	0.1	0.0	0.5	0.5	0.0	0.0	0.3	50.5	0.2	0.2	0.1	0.7	0.4	0.0	0.7	0.0	1.9	0.6	0.9	0.2	0.1	0.2	8.7	0.0	0.0	0.0	1.4	0.9	0.0	0.0	1.0	0.2	0.0	0.1	0.0	0.5	10.6	0.3	0.5	0.1	9.1	0.0	0.0	0.5	0.1	0.0	3.5	0.9	0.7	0.6	0.6	20.1	3.8	0.6	1.2	4.0	0.4	8.3	0.0	0.0	0.0	3.2	1.3	0.6	7.4	153.6	0.0	0.0	0.0	0.0	82.5	0.7	1.7	0.1	6.6	2.1	0.0	210.2	0.0	0.7	0.6	2.2	0.0	0.0	14.9	3.2	1.2	0.0	0.3	2.4	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.4	0.2	4.7	0.0	3.6	0.2	0.7	0.0	0.3	0.0	0.0	1.5
ANK2	LQT4	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818109-113383740	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9"	"Cell type enhanced"	"Detected in many"	21	"Bipolar cells: 313.8;Cone photoreceptor cells: 451.6;Horizontal cells: 1352.3;Rod photoreceptor cells: 483.8"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 16.5;ASC TERT1: 22.9;RH-30: 31.5;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	17.3	8.7	34.0	6.3	42.1	0.8	10.7	43.7	58.5	20.9	9.5	24.5	0.6	4.3	10.5	4.3	8.3	5.8	13.0	56.7	29.4	30.3	59.8	2.0	4.6	5.1	28.7	38.7	19.0	2.4	1.6	8.6	2.0	42.1	5.4	7.2	7.8	2.6	8.7	66.9	3.5	4.7	15.2	19.0	15.1	3.8	5.8	24.2	0.0	5.6	4.4	4.5	4.5	4.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	10.4	4.2	16.5	22.9	0.0	1.1	1.9	0.7	2.1	4.1	0.0	4.3	1.4	3.7	2.5	0.0	7.6	0.4	0.6	1.9	6.3	2.5	0.0	1.7	1.0	1.0	0.7	9.8	1.7	0.9	4.0	2.7	0.0	0.2	0.0	7.0	3.5	0.1	0.2	0.0	5.4	0.0	1.8	0.5	31.5	0.0	0.1	0.0	8.4	15.8	0.1	0.3	5.4	7.4	0.1	0.6	0.0	3.2	1.8	0.2	1.9	4.2	1.2	0.6	12.9	0.4	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.0	42.1	43.7	54.3	29.4	30.3	28.7	38.7	42.1	24.2	0.0	3.8	0.0	0.0	9.3	313.8	152.3	0.0	1.4	2.3	19.2	451.6	0.1	13.3	0.0	92.0	11.6	0.0	0.0	1.5	0.1	44.2	0.4	1.1	0.4	0.8	1352.3	63.4	0.0	0.0	26.4	33.6	1.0	16.9	1.0	0.0	40.0	0.1	0.0	28.3	129.2	483.8	6.5	20.5	1.1	1.5	8.3	0.0	0.0	0.1	0.1
ANKH	"ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1"	ENSG00000154122	"ANKH inorganic pyrophosphate transport regulator"	Q9HCJ1	5	14704800-14871785	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Phosphate transport, Transport"		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 119.8;Hofbauer cells: 162.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068104			Approved	Cytosol		NA	NA			Cytosol		"HPA068104: AB_2685954"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.76e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.46e-2)"	8.5	9.7	15.2	8.0	17.0	5.9	9.2	29.1	25.9	4.4	10.9	19.5	3.4	14.4	6.5	4.7	6.8	7.2	8.4	27.0	15.9	14.9	7.4	18.1	6.3	9.6	19.7	17.1	14.9	13.1	19.6	19.2	7.3	15.4	29.5	10.3	16.1	11.7	8.6	31.0	17.4	14.9	7.6	22.6	6.3	6.5	2.0	15.3	9.3	9.5	12.7	11.8	6.4	6.3	2.5	0.6	0.7	1.4	0.6	7.0	0.7	3.8	2.9	3.8	0.6	7.9	18.8	1.8	3.8	7.6	1.5	1.5	2.3	5.0	9.1	8.9	5.1	3.5	2.5	2.5	4.1	1.7	3.6	6.3	0.2	27.6	6.2	2.6	2.2	0.7	5.9	7.3	4.5	5.2	5.2	3.0	6.8	1.9	19.7	4.8	5.2	3.7	7.1	1.5	5.1	3.3	5.3	1.8	8.2	0.0	1.3	9.3	2.5	18.3	3.0	4.0	3.6	0.1	0.8	3.0	3.9	4.0	6.4	6.8	5.2	4.8	7.1	13.5	8.2	16.1	0.7	0.4	0.1	2.4	0.7	4.0	2.5	5.0	3.9	0.6	2.1	5.7	2.6	0.5	0.6	1.4	0.6	7.0	0.7	15.2	17.0	29.1	25.9	15.9	14.9	19.7	17.1	15.4	15.3	23.8	15.5	11.5	72.4	22.3	53.3	63.0	2.5	9.4	14.8	7.0	119.8	58.3	5.0	1.7	1.1	23.5	47.0	93.5	10.3	3.1	22.5	50.7	17.3	31.4	162.5	19.1	40.1	9.8	59.0	1.4	4.6	30.3	10.1	0.0	31.7	18.8	6.8	28.1	29.7	9.8	47.3	0.0	13.9	2.6	5.9	9.4	35.1	19.1	30.4	13.2
ANKRD50	KIAA1223	ENSG00000151458	"Ankyrin repeat domain 50"	Q9ULJ7	4	124664052-124712732	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.4;monocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 22.2;HUVEC TERT2: 22.1;TIME: 55.6"					"Low region specificity"	"Detected in all"			HPA044008	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA044008: AB_10961996"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.90e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.16e-3)"	10.1	4.8	6.6	8.2	6.8	4.7	7.6	4.0	8.3	17.1	10.0	4.3	8.7	3.7	17.5	7.4	11.4	5.9	10.2	7.3	6.2	6.5	9.8	6.9	13.4	5.4	5.5	6.5	9.0	5.2	12.5	3.9	17.1	6.2	19.1	6.9	6.7	7.7	7.9	3.2	12.9	7.9	14.2	4.8	7.1	8.2	16.8	4.8	15.4	9.2	5.8	4.4	16.5	10.9	0.1	2.4	0.5	3.8	0.4	0.1	0.4	2.3	4.3	12.3	5.7	9.8	6.3	1.2	6.0	5.1	3.1	2.0	1.9	3.0	0.0	1.9	8.5	2.8	2.1	8.1	4.6	5.5	0.0	1.7	1.9	5.6	1.8	7.0	3.2	2.5	6.3	6.3	4.9	22.2	5.9	22.1	2.2	3.5	4.2	5.9	5.3	4.0	1.1	2.5	3.4	6.4	3.3	3.8	0.5	3.9	9.6	3.5	4.4	4.1	2.6	4.8	5.3	2.8	2.7	55.6	6.7	5.2	3.2	5.1	3.1	0.0	0.8	3.0	1.4	7.6	0.0	1.5	0.5	0.0	3.8	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.1	0.0	0.4	2.3	0.9	0.0	0.4	6.6	6.8	4.0	8.3	6.2	6.5	5.5	6.5	6.2	4.8	29.8	18.2	0.5	15.0	35.8	2.8	8.4	15.3	8.1	6.8	5.2	0.0	1.9	0.0	8.8	35.0	14.5	3.8	0.0	17.2	23.7	15.5	12.9	4.7	6.8	4.8	20.6	8.1	31.9	10.0	45.7	6.4	8.7	10.1	2.8	3.1	2.9	13.7	2.9	11.3	3.3	1.0	0.0	18.6	16.8	9.7	26.8	3.4	0.0	4.5	15.8
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 56.2;Hepatocytes: 117.3;Late spermatids: 50.1;Sertoli cells: 45.3;Smooth muscle cells: 42.3;Suprabasal keratinocytes: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A-431: 32.9;CAPAN-2: 50.5;HaCaT: 61.6;OE19: 43.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	6.9	0.4	1.1	2.1	1.1	0.0	17.2	1.6	1.4	9.7	5.3	1.1	142.4	0.2	14.2	38.5	3.6	11.7	10.6	6.9	1.1	0.2	2.6	24.4	4.4	1.5	1.0	1.0	3.9	4.5	0.5	2.0	6.2	1.5	7.2	1.7	1.7	122.9	93.6	3.4	19.1	1.8	5.7	1.0	1.1	9.5	7.6	0.9	1.1	8.9	8.1	3.8	4.5	5.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	32.9	1.3	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	50.5	0.0	0.6	0.0	0.0	61.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.2	43.3	4.8	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	10.5	0.2	0.3	3.9	0.1	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.1	1.6	1.4	1.1	0.2	1.0	1.0	1.5	0.9	0.0	0.0	0.0	18.1	15.8	0.0	2.8	25.5	0.0	1.2	0.0	0.0	1.1	0.0	2.9	56.2	2.2	0.0	0.0	0.0	0.6	3.5	9.1	4.6	117.3	0.2	0.0	0.0	4.9	1.6	50.1	1.7	0.9	5.0	0.0	11.4	1.0	0.6	0.0	1.4	0.4	0.3	45.3	42.3	1.4	1.5	40.8	3.4	0.0	0.2	17.8
ANO10	"FLJ10375, MGC47890, SCAR10, TMEM16K"	ENSG00000160746	"Anoctamin 10"	Q9NW15	3	43354859-43691594	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Distal tubular cells: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 22.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016624, HPA051569"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA016624: , HPA051569: AB_2681537"	"unprognostic (1.51e-3)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.70e-4)"	"prognostic favorable (1.11e-4)"	"unprognostic (4.23e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (7.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.41e-6)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (5.71e-2)"	21.6	12.7	11.8	12.6	13.2	20.6	22.0	18.2	14.1	17.5	27.4	14.3	13.2	42.0	17.9	12.4	19.8	10.4	16.7	10.5	12.3	15.2	22.2	10.5	13.6	10.7	17.3	12.3	12.7	14.4	18.6	14.4	17.5	19.4	10.7	24.4	18.6	23.1	19.5	11.3	24.6	52.9	19.9	23.6	9.4	11.1	9.1	8.8	5.5	17.7	15.8	13.9	13.7	17.0	2.0	8.5	22.4	12.5	6.3	4.6	4.3	9.0	7.2	8.0	8.4	32.6	17.6	9.8	26.5	44.2	13.6	17.3	4.8	8.4	1.0	8.5	34.9	13.4	4.9	6.3	14.5	16.5	10.0	4.5	11.8	9.7	5.2	14.3	2.1	9.6	16.3	11.6	16.7	22.8	24.9	31.7	5.7	8.8	7.7	30.0	6.4	2.3	1.5	9.6	7.0	8.4	1.8	5.7	3.1	26.7	9.5	2.0	5.9	10.5	8.6	6.1	14.8	18.4	4.3	25.8	20.7	7.7	21.7	12.1	5.0	6.5	0.3	18.9	4.5	13.6	4.4	12.5	0.9	4.6	7.1	2.7	1.9	3.2	3.1	8.5	2.0	2.8	4.3	22.4	6.3	7.7	1.5	3.5	4.3	11.8	13.2	18.2	14.1	12.3	15.2	17.3	12.3	19.4	8.8	6.0	2.7	2.2	5.2	4.9	7.1	4.5	10.2	4.0	7.9	14.0	0.0	12.0	104.5	19.0	2.7	14.0	47.9	23.3	15.4	15.5	7.8	5.5	2.3	6.8	10.4	9.5	9.2	19.0	9.2	3.1	5.2	8.2	13.5	1.8	19.1	20.3	11.8	16.5	9.6	14.9	3.6	6.5	12.3	14.7	22.6	5.4	14.3	3.9	24.3	4.6
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"placenta: 46.9;retina: 30.6;testis: 13.4"	"Group enriched"	"Detected in many"	12	"Cone photoreceptor cells: 76.6;Early spermatids: 58.6;Late spermatids: 219.4;Rod photoreceptor cells: 168.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	4	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	51	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 8.6;HUVEC TERT2: 8.5;U-2 OS: 22.5"	"Region enriched"	"Detected in some"	4	"basal ganglia: 20.0"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: AB_2732613"	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	5.8	0.1	1.0	1.3	2.3	0.0	4.3	1.2	1.3	3.3	1.0	1.6	0.9	0.8	1.8	2.1	0.9	1.9	1.5	3.9	1.9	0.9	1.2	0.9	4.7	0.9	1.6	2.0	0.9	0.9	1.4	0.9	46.9	1.2	1.4	0.7	30.6	0.9	1.6	2.3	0.6	0.9	2.1	1.1	1.9	1.0	13.4	0.9	0.9	1.6	1.3	0.9	1.3	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.2	2.2	0.0	4.0	0.0	0.0	0.2	1.9	0.0	8.6	0.4	0.9	0.0	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.1	0.6	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.5	0.0	0.0	1.7	0.0	0.8	0.0	0.0	4.1	2.0	0.0	1.7	0.0	0.9	0.1	0.1	0.0	0.0	2.1	1.4	0.0	3.7	1.2	0.0	0.2	0.0	22.5	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	1.0	2.3	1.2	1.3	1.9	0.9	1.6	2.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	7.4	1.1	0.0	0.0	0.0	0.0	76.6	1.1	0.0	0.0	58.6	3.6	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.2	9.5	0.0	1.8	0.0	219.4	0.3	0.0	0.0	0.0	0.0	10.6	0.0	0.0	1.4	0.0	168.7	0.0	0.4	1.5	1.3	0.1	2.1	0.0	0.0	0.0
ANO3	"C11orf25, DYT23, GENX-3947, TMEM16C"	ENSG00000134343	"Anoctamin 3"	Q9BYT9	11	26309599-26663288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease mutation, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"brain: 83.1;epididymis: 47.3"	"Cell type enhanced"	"Detected in some"	13	"Cone photoreceptor cells: 13.7;Early spermatids: 7.9;Horizontal cells: 7.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"basal ganglia: 83.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;HDLM-2: 10.4;U-2 OS: 2.8;U-2197: 7.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 142.2"	"Region enriched"	"Detected in all"	5	"basal ganglia: 149.8"	HPA041629	Uncertain					NA	NA					"HPA041629: AB_10793969"	"unprognostic (7.01e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-4)"	"unprognostic (9.48e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.01e-1)"	2.8	1.2	6.4	0.5	83.1	0.4	0.6	0.2	13.3	1.1	0.6	0.1	0.0	0.6	0.6	47.3	0.5	0.7	2.0	0.5	7.0	0.6	1.4	1.4	0.8	0.5	1.1	5.4	0.5	0.7	0.5	0.3	0.5	5.9	0.5	0.6	0.0	0.6	0.6	0.4	0.5	0.5	0.7	0.5	0.8	0.5	1.9	9.0	0.0	1.4	0.0	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	2.1	2.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.2	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.6	0.4	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.8	7.6	0.0	0.7	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.4	83.1	0.2	13.3	7.0	0.6	1.1	5.4	5.9	9.0	0.0	1.3	0.0	0.0	0.0	0.7	0.8	0.0	4.0	0.0	0.0	13.7	0.2	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.6	0.0	7.9	0.0	3.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	3.3	2.8	1.1	0.0	0.2	0.0	0.0	0.0
ANO5	"GDD1, LGMD2L, TMEM16E"	ENSG00000171714	"Anoctamin 5"	Q75V66	11	22193176-22283357	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Limb-girdle muscular dystrophy, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.7;parathyroid gland: 26.9;skeletal muscle: 43.7"	"Cell type enriched"	"Detected in many"	11	"Cardiomyocytes: 82.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 6.6;HAP1: 7.2;HEK 293: 9.0;NTERA-2: 5.0;U-266/84: 5.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058857	Uncertain					NA	NA					"HPA058857: AB_2683835"	"unprognostic (5.25e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.55e-2)"	"prognostic favorable (2.50e-7)"	"unprognostic (3.65e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.77e-4)"	"unprognostic (7.94e-2)"	1.0	3.8	3.9	0.9	3.8	0.3	0.9	0.9	7.9	1.7	2.6	1.1	1.0	2.9	1.5	1.6	2.4	1.1	1.6	37.7	4.5	4.2	3.1	2.3	1.4	0.6	3.4	6.3	1.0	3.3	26.9	5.0	0.4	3.5	3.8	2.9	2.7	3.4	3.7	43.7	0.5	3.1	4.1	1.9	1.0	3.0	2.3	1.7	0.0	3.9	14.2	0.6	3.2	1.9	0.0	0.9	0.0	1.5	0.0	0.1	0.1	0.0	6.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	1.7	2.4	4.3	0.0	0.0	0.0	0.0	5.0	3.5	0.0	0.1	0.0	0.0	4.5	0.1	4.0	3.7	0.0	0.0	0.0	3.2	3.3	2.5	0.0	0.0	2.9	0.0	0.0	2.9	5.2	0.0	4.0	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	3.8	0.9	7.9	4.5	4.2	3.4	6.3	3.5	1.7	0.0	5.1	0.5	0.3	0.2	7.2	82.0	0.0	1.4	0.0	1.8	0.0	0.0	1.7	0.9	4.8	2.7	2.6	0.0	2.4	0.0	0.2	1.6	0.0	4.9	0.5	1.6	5.2	3.7	0.8	1.9	0.0	1.3	1.7	0.0	7.5	2.4	1.1	3.5	1.1	2.4	0.4	0.0	0.4	4.1	0.5	0.1	0.0	0.0	3.0	0.1
ANO6	"DKFZp313M0720, TMEM16F"	ENSG00000177119	"Anoctamin 6"	Q4KMQ2	12	45215987-45440404	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038958	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		1500000	"Plasma membrane, Cytosol"		"HPA038958: AB_10672835"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.82e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.28e-1)"	40.7	15.3	6.4	17.3	7.0	3.8	42.8	2.5	7.3	22.2	29.7	6.1	34.8	16.5	33.2	16.0	21.2	18.5	20.2	20.7	6.7	5.4	21.6	25.4	25.6	11.7	7.6	4.2	27.4	12.7	20.1	7.1	23.3	8.8	21.6	6.9	14.2	16.8	39.3	40.3	10.0	41.3	42.8	14.6	12.5	13.5	10.4	5.8	21.6	11.2	14.7	9.6	37.6	38.1	2.1	7.1	4.4	9.3	3.1	4.0	5.0	13.6	15.7	8.8	12.0	40.6	21.1	33.7	19.2	24.2	13.3	12.3	23.6	20.7	7.1	18.0	30.0	11.8	18.1	8.0	10.6	15.5	10.4	5.7	8.2	6.4	19.9	12.9	12.7	6.6	17.6	10.6	11.1	16.4	31.7	17.4	14.9	6.2	11.5	14.1	3.6	13.5	4.1	9.8	0.0	5.9	7.8	11.5	7.8	12.2	21.7	4.0	13.7	20.1	12.5	9.2	23.9	14.7	20.1	23.8	14.2	9.1	14.3	9.7	6.1	7.0	8.6	12.8	40.8	11.3	4.4	7.7	1.9	3.3	9.3	3.4	2.1	3.2	2.8	7.1	1.7	2.9	2.0	0.9	3.1	8.6	3.6	4.0	5.0	6.4	7.0	2.5	7.3	6.7	5.4	7.6	4.2	8.8	5.8	56.6	10.2	3.7	20.1	27.1	0.4	20.3	30.6	6.7	13.6	17.4	0.0	29.4	3.3	35.0	1.0	34.4	4.9	0.0	32.0	21.1	32.3	17.2	12.7	81.6	17.8	0.0	8.1	54.0	49.8	1.3	47.5	21.3	16.9	8.2	11.4	9.8	55.0	10.2	38.2	18.0	0.2	38.8	31.6	2.4	4.2	19.3	20.6	6.4	10.7	25.1
ANO7	"IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G"	ENSG00000146205	"Anoctamin 7"	Q6IWH7	2	241188509-241225377	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.3;prostate: 44.7;stomach 1: 15.1"	"Group enriched"	"Detected in many"	6	"Glandular cells: 15.1;Mucus-secreting cells: 53.7"	"Cancer enriched"	"Detected in many"	19	"prostate cancer: 32.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"BEWO: 5.6;Hep G2: 5.4;OE19: 5.4"	"Low region specificity"	"Detected in single"							HPA078464	Enhanced				"Intracellular and membrane"	NA	NA					"HPA078464: "	"unprognostic (1.93e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.94e-2)"	"unprognostic (4.82e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.53e-2)"	0.2	0.0	0.3	6.5	0.4	1.7	0.2	0.2	0.4	0.3	17.3	0.3	0.2	5.3	0.2	0.2	0.2	0.1	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	44.7	4.9	0.2	2.3	0.2	0.2	0.0	17.3	0.5	0.3	0.2	15.1	0.2	0.2	0.2	0.2	0.7	1.0	0.3	0.2	0.0	0.0	0.0	0.8	2.2	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.0	5.6	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.0	0.2	5.4	0.3	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.1	0.3	0.3	0.3	0.0	1.0	0.0	0.0	1.0	0.5	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.1	0.3	0.4	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.5	0.6	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.1	0.0	1.4	2.4	0.0	3.6	2.8	1.0	15.1	0.0	2.9	1.2	0.0	2.9	4.3	0.3	0.0	3.1	0.9	1.7	0.0	53.7	1.5	6.0	0.0	2.1	1.4	0.5	0.0	0.4	0.0	1.2	0.0	0.6	0.0	2.4	0.7
ANO9	"PIG5, TMEM16J, TP53I5"	ENSG00000185101	"Anoctamin 9"	A1A5B4	11	417933-442011	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 69.4"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 72.1;Mucus-secreting cells: 39.0;Paneth cells: 37.1;Undifferentiated cells: 37.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 26.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	41	"B-cells: 2.2;NK-cells: 3.9;T-cells: 7.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.0;CAPAN-2: 21.2;HaCaT: 12.3;RPMI-8226: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039948, HPA040112"	Approved		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA039948: AB_2676765, HPA040112: "	"unprognostic (3.62e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.98e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (8.81e-4)"	0.7	0.1	0.1	17.4	0.2	0.9	1.4	0.1	0.2	1.4	32.1	0.1	1.3	21.5	0.8	4.7	6.8	1.2	6.2	0.4	0.2	0.1	4.8	0.4	5.8	6.3	0.4	0.1	0.5	5.6	0.0	1.6	0.7	0.3	2.6	5.4	0.6	6.2	0.6	0.1	14.4	69.4	0.5	0.5	4.8	4.4	0.4	0.1	11.3	2.2	6.1	17.2	3.4	2.7	2.2	0.1	0.0	0.0	3.9	7.9	1.5	2.0	0.3	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	1.9	21.2	1.5	1.1	0.0	0.0	12.3	0.0	5.0	0.0	1.7	0.0	0.0	0.3	2.9	0.0	0.3	0.0	0.0	3.4	0.0	0.8	0.0	0.0	3.2	0.1	1.3	0.0	2.4	0.4	0.1	0.0	4.4	0.0	0.1	0.0	14.8	3.2	3.0	0.9	0.1	0.2	5.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	5.6	2.2	6.8	3.2	0.1	1.0	3.9	2.9	0.0	3.9	0.0	0.0	7.9	1.5	0.1	0.2	0.1	0.2	0.2	0.1	0.4	0.1	0.3	0.1	0.0	8.9	12.7	4.0	4.6	0.0	2.2	5.1	0.0	3.4	3.5	0.0	0.1	0.0	9.2	0.5	0.0	72.1	0.0	5.6	2.6	0.5	2.7	0.0	0.0	0.3	0.0	14.9	0.6	0.0	0.0	0.0	0.2	3.3	1.8	39.0	0.0	8.6	37.1	0.0	2.6	0.0	0.0	1.0	0.1	0.0	5.5	0.1	10.1	37.3	3.9
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151757-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 432.6;tongue: 235.4"	"Cell type enhanced"	"Detected in many"	10	"granulocytes: 2387.0;Syncytiotrophoblasts: 5914.0;Urothelial cells: 4139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Enhanced	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	Yes		77000000	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.57e-5)"	"prognostic unfavorable (6.19e-6)"	52.7	3.5	2.7	11.5	3.3	81.4	45.9	0.9	2.5	61.5	8.5	3.6	5.5	2.4	6.9	11.2	432.6	11.9	14.9	8.9	3.2	2.5	9.1	2.1	37.3	7.6	4.3	1.9	11.7	2.4	0.5	6.3	149.5	13.5	12.9	4.4	6.4	93.0	7.2	7.9	11.6	6.4	12.3	6.5	5.9	5.9	5.6	3.1	3.9	21.7	235.4	153.3	18.0	83.1	0.7	98.9	146.2	79.1	27.3	52.5	102.8	66.2	104.7	4.7	4.9	66.8	63.6	0.3	114.8	71.8	47.5	32.2	3.0	59.9	0.1	38.0	100.1	105.0	81.6	10.1	69.5	37.7	37.5	0.7	5.1	31.1	0.1	53.3	11.0	2.5	36.6	57.6	48.0	94.4	44.0	67.3	6.0	21.0	2.8	58.5	0.2	19.5	6.0	5.9	26.5	42.6	0.0	26.7	0.2	106.8	14.0	0.0	0.0	39.5	1.0	26.5	65.5	0.2	1.7	83.1	55.7	35.1	76.5	58.9	0.4	0.1	0.2	128.7	10.3	83.8	146.2	79.1	141.1	52.2	21.5	52.5	0.7	47.0	45.9	98.9	0.2	13.7	25.4	8.6	27.3	19.3	3.5	8.3	102.8	2.7	3.3	0.9	2.5	3.2	2.5	4.3	1.9	13.5	3.1	541.9	512.9	7.3	2232.0	752.1	0.0	11.9	17.8	1060.0	889.5	59.3	0.0	1215.0	0.0	156.6	6.3	398.1	0.8	0.0	20.0	1352.9	735.1	1709.3	2387.0	2.5	570.9	0.0	5.1	113.5	449.6	2.3	206.0	1058.5	291.8	475.3	1.8	0.2	431.7	0.0	8.9	3.1	0.0	64.7	275.6	0.7	2.9	522.6	5914.0	282.4	0.5	4139.3
ANXA11	ANX11	ENSG00000122359	"Annexin A11"	P50995	10	80150889-80205572	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division"		"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004851, HPA027545"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		530000	Nucleoplasm	Cytosol	"CAB004851: AB_626682, HPA027545: AB_1844851"	"unprognostic (1.85e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.06e-2)"	"unprognostic (8.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.69e-8)"	"unprognostic (2.69e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.02e-1)"	44.1	7.3	19.4	27.8	23.8	37.0	61.1	22.8	24.4	26.4	34.4	8.6	18.4	28.6	20.2	36.4	49.5	23.9	47.5	57.1	17.2	8.3	39.1	21.9	35.1	38.1	10.8	14.2	27.3	24.0	26.2	9.7	35.0	7.5	28.9	27.6	16.7	20.2	27.8	39.5	18.6	44.1	28.1	11.2	22.9	29.3	15.1	6.6	45.7	18.9	39.2	31.8	34.9	39.6	12.7	14.4	77.9	12.1	11.6	21.9	13.0	35.1	30.8	1.8	9.2	39.5	39.0	19.7	26.3	67.8	16.4	17.0	27.9	55.0	2.3	19.1	39.3	1.3	46.1	7.9	22.0	10.0	59.8	14.0	14.4	18.3	21.6	23.2	15.8	35.8	41.2	13.3	9.1	7.0	32.5	23.3	19.0	14.1	26.7	12.9	20.9	19.2	34.9	3.3	35.4	65.5	14.7	2.7	53.3	27.7	32.7	0.8	6.4	11.3	45.5	25.7	16.1	13.5	19.4	28.0	11.5	17.3	26.3	13.8	16.3	22.2	15.2	12.0	26.4	7.6	22.6	12.1	77.9	14.5	9.6	15.3	12.7	18.3	20.3	9.1	10.9	17.3	14.9	43.8	11.6	10.7	14.4	21.9	13.0	19.4	23.8	22.8	24.4	17.2	8.3	10.8	14.2	7.5	6.6	89.3	65.4	74.2	217.3	45.4	1.2	269.2	201.2	96.4	109.2	209.3	0.0	234.0	281.8	337.9	2.4	74.8	352.8	0.0	309.2	260.9	113.9	251.0	115.3	34.3	206.7	3.2	74.5	82.9	136.2	4.7	86.0	136.1	86.0	249.7	151.8	36.1	317.7	312.1	87.0	110.5	2.3	90.5	126.4	2.8	34.1	36.8	155.2	122.2	162.8	514.6
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		16000000	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (2.54e-5)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.59e-5)"	91.7	29.8	4.9	23.5	7.1	6.6	50.1	4.5	5.6	65.1	39.1	8.6	38.2	26.4	38.3	40.3	158.8	26.2	54.9	29.9	4.7	5.5	36.7	28.5	62.0	46.6	10.8	5.7	23.3	94.3	29.7	12.8	84.1	25.7	29.5	35.2	31.7	74.7	27.9	22.7	77.3	71.9	37.1	15.1	32.6	25.6	18.7	7.1	14.6	31.0	122.7	81.4	34.0	87.4	35.5	209.6	183.3	138.0	15.2	83.9	150.8	144.7	161.6	8.5	3.8	116.8	187.4	37.1	173.0	111.6	109.9	96.5	76.6	69.9	0.3	142.5	223.8	82.7	154.9	38.0	324.9	120.6	30.8	4.0	2.9	77.8	29.7	70.4	0.1	2.1	91.5	88.7	78.1	168.4	132.2	204.9	2.1	11.5	16.9	234.8	16.8	0.6	8.5	18.5	123.9	125.9	1.7	46.9	8.1	194.9	88.2	11.2	6.3	68.4	15.6	67.9	92.0	33.4	6.0	233.6	93.8	127.8	314.4	169.8	6.3	20.7	2.8	88.3	1.6	186.5	183.3	138.0	17.7	33.4	122.6	36.5	35.5	38.5	38.5	209.6	16.9	4.5	18.1	3.9	15.2	129.1	32.0	83.9	150.8	4.9	7.1	4.5	5.6	4.7	5.5	10.8	5.7	25.7	7.1	1989.1	372.8	135.8	2699.6	2231.6	2.1	19.9	922.3	1675.6	1452.5	532.1	0.0	1604.6	11.6	3597.2	77.7	904.5	724.0	23.3	2130.9	2200.2	1229.1	3363.5	101.8	70.0	1517.4	0.0	99.2	465.3	432.0	90.7	714.0	1131.8	1344.5	1757.5	521.7	18.0	3399.7	582.2	600.4	22.4	6.8	181.1	774.1	7.0	17.7	2032.4	961.8	162.4	580.5	3656.9
ANXA5	"ANX5, ENX2"	ENSG00000164111	"Annexin A5"	P08758	4	121667955-121697113	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 989.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"		NA	NA		6100000	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.70e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.01e-5)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (9.29e-7)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.26e-4)"	130.1	65.6	24.6	43.2	26.1	15.3	151.3	10.0	17.9	85.9	35.6	33.8	45.1	17.5	64.4	45.9	42.8	42.4	54.7	46.8	22.5	25.1	62.2	73.1	68.0	49.3	37.8	16.4	62.6	52.1	25.7	55.3	135.8	40.8	57.1	29.8	56.1	83.7	49.8	23.1	28.0	30.1	68.3	51.5	67.9	39.4	33.3	27.8	15.9	61.8	32.5	31.2	57.3	69.8	13.9	80.0	37.2	87.3	4.8	29.9	64.7	30.9	23.0	31.3	17.3	151.1	115.4	34.2	110.1	98.2	57.1	51.2	16.7	13.5	2.3	19.9	151.0	40.0	11.0	19.9	48.7	53.7	22.1	11.4	6.9	21.7	45.4	86.6	14.9	12.0	66.5	23.7	48.6	48.0	65.3	75.3	1.6	6.8	18.7	144.2	20.5	15.1	5.1	16.1	28.0	48.2	0.5	71.7	4.7	95.9	4.6	8.0	9.7	39.7	15.5	100.2	64.9	13.6	17.9	55.6	91.0	44.5	65.0	32.7	16.8	20.3	5.2	58.2	8.1	106.9	9.2	74.0	37.2	11.9	87.3	15.5	13.9	18.2	14.8	80.0	8.8	6.1	8.8	17.1	4.8	79.7	9.7	29.9	64.7	24.6	26.1	10.0	17.9	22.5	25.1	37.8	16.4	40.8	27.8	226.3	227.0	73.7	202.4	177.1	4.9	75.9	209.0	279.7	232.0	125.6	23.6	989.9	252.0	588.9	12.3	263.9	14.2	0.0	297.2	883.6	492.7	311.2	142.3	46.9	681.5	12.7	46.7	191.5	406.3	27.8	351.8	564.0	334.0	369.7	81.0	152.9	380.8	32.0	344.4	128.7	28.3	291.1	342.1	9.5	14.1	123.1	954.0	91.3	35.2	131.9
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100712-151157882	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"monocytes: 703.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 106.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol		NA	NA		970000	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	78.3	38.2	22.2	44.7	38.3	28.6	109.1	22.0	70.0	37.4	50.2	13.3	34.1	12.5	52.2	34.2	27.0	39.5	39.0	53.0	28.7	37.8	22.1	54.7	33.7	66.7	38.6	30.0	54.9	27.6	8.2	41.4	47.4	62.5	39.3	24.0	36.7	19.7	60.7	85.4	16.6	30.7	82.8	16.8	41.4	31.3	16.8	7.2	44.6	25.5	34.7	50.1	53.0	51.4	36.4	22.4	15.0	15.3	47.0	58.1	50.1	0.3	3.8	24.6	36.3	106.1	48.5	6.7	49.5	58.7	37.2	51.8	13.0	1.9	3.3	17.4	63.0	30.6	0.0	19.0	23.3	37.8	13.3	6.8	1.9	7.8	24.4	35.7	12.0	12.0	60.1	0.1	31.6	5.1	55.8	47.3	23.1	2.6	46.1	87.7	11.8	22.1	18.5	6.9	0.1	11.0	14.5	76.0	3.6	5.5	0.0	1.5	6.4	5.1	35.1	21.3	40.2	60.1	22.7	41.5	35.0	10.6	2.5	12.9	25.8	35.1	0.5	19.0	56.2	5.6	13.8	15.3	15.0	58.1	10.3	38.6	35.0	43.4	52.6	22.4	36.4	30.4	36.9	3.3	47.0	4.6	5.5	34.8	50.1	22.2	38.3	22.0	70.0	28.7	37.8	38.6	30.0	62.5	7.2	14.9	22.4	101.1	11.4	9.7	15.2	49.2	7.6	6.7	0.0	22.7	5.9	54.7	21.6	5.4	35.0	27.8	0.3	23.3	15.2	28.6	64.5	7.2	54.5	119.4	69.2	14.3	20.5	73.6	41.2	35.0	114.2	32.6	52.3	703.3	0.6	42.9	18.1	0.3	198.7	35.6	109.8	226.4	105.6	2.7	1.0	7.0	148.2	109.7	1.9	1.1
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 beta 1 subunit"	Q10567	22	29327680-29423179	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 116.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		1000000	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	22.2	25.8	28.0	32.3	35.2	29.9	17.2	37.3	43.1	17.2	23.9	26.5	23.9	32.1	14.8	18.4	46.4	17.7	22.0	16.6	24.4	30.4	24.2	25.8	21.2	37.2	29.4	24.1	12.7	28.4	48.2	31.1	32.3	31.9	27.3	21.8	24.1	29.5	31.2	31.3	34.0	28.7	19.3	22.4	33.0	24.9	23.4	16.7	25.2	21.6	25.5	37.4	25.6	21.0	12.2	16.9	3.1	17.3	4.0	5.8	11.6	26.4	15.1	15.7	16.7	12.0	8.8	19.6	18.6	20.8	22.9	22.0	23.1	10.9	14.6	12.4	21.1	10.8	23.8	22.5	31.4	14.6	18.8	32.8	24.2	19.6	13.1	13.4	34.5	33.6	12.7	11.7	21.9	17.7	10.6	31.8	5.5	16.5	17.9	15.2	28.9	14.6	11.4	12.2	39.2	17.2	27.9	17.3	38.9	16.2	60.2	24.9	17.6	23.1	27.1	11.6	11.2	22.0	15.8	27.4	26.5	16.4	15.1	19.4	19.5	10.1	26.8	18.8	15.1	15.4	0.0	15.5	3.1	5.8	17.3	5.8	10.1	3.9	4.9	16.9	12.2	3.2	3.2	1.7	4.0	17.3	5.2	5.2	11.6	28.0	35.2	37.3	43.1	24.4	30.4	29.4	24.1	31.9	16.7	11.9	16.0	31.4	7.7	6.4	25.7	14.5	28.1	9.4	11.4	21.0	37.3	42.2	19.9	40.6	6.3	16.7	63.6	23.3	35.1	25.4	7.8	16.3	4.7	29.2	116.9	42.9	20.7	41.7	83.2	10.4	10.9	34.0	11.8	26.2	22.1	26.2	48.1	26.4	11.7	18.8	37.8	6.5	6.9	22.1	13.6	8.0	57.1	15.2	26.2	15.2
AP1G1	"ADTG, CLAPG1"	ENSG00000166747	"Adaptor related protein complex 1 gamma 1 subunit"	O43747	16	71729000-71809201	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 197.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009049, HPA041224"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		150000	Vesicles	Cytosol	"CAB009049: AB_2058329, HPA041224: AB_2677370"	"unprognostic (4.84e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (2.96e-8)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-1)"	23.2	29.8	20.4	19.2	26.3	59.1	22.4	31.8	29.2	19.7	20.4	29.2	19.8	19.2	19.6	23.9	30.1	17.9	18.7	14.5	18.5	17.4	32.8	29.5	23.8	20.0	24.2	20.1	18.3	25.6	53.5	27.4	25.1	27.9	20.8	23.4	20.8	28.2	20.2	30.0	27.7	24.4	16.0	20.3	24.3	24.8	26.5	26.7	30.0	23.1	21.8	28.3	18.1	20.1	7.5	8.5	17.6	8.8	7.6	9.0	4.2	16.5	24.3	18.7	19.0	20.0	19.1	16.2	17.2	16.5	23.1	22.3	23.4	18.4	20.6	16.6	23.4	16.8	21.2	25.2	18.9	31.1	8.3	13.0	13.4	12.7	17.7	11.8	16.1	44.7	15.9	13.5	30.8	19.1	14.6	19.5	14.1	17.8	8.7	22.6	29.5	14.9	13.6	17.0	13.1	10.6	24.0	15.0	22.0	21.6	19.0	17.2	10.3	21.3	13.5	9.5	20.1	23.5	12.8	23.0	19.9	15.5	10.6	12.6	13.8	17.9	42.6	16.0	13.1	16.9	5.8	7.9	10.9	8.3	8.8	8.3	6.3	7.3	9.0	8.5	7.5	5.9	7.2	17.6	7.6	6.8	6.0	7.3	4.2	20.4	26.3	31.8	29.2	18.5	17.4	24.2	20.1	27.9	26.7	29.8	33.2	26.0	27.0	25.5	25.6	10.9	48.4	20.1	19.4	34.9	68.7	10.8	16.6	16.6	197.4	21.8	29.4	0.0	18.7	11.5	18.8	36.6	20.7	51.9	14.6	28.6	22.4	25.2	31.0	105.9	16.4	23.4	21.9	10.8	21.7	16.7	25.1	24.1	18.7	36.0	62.0	19.4	22.8	25.0	34.2	33.8	20.5	22.3	17.8	42.6
AP1M1	"AP47, CLAPM2"	ENSG00000072958	"Adaptor related protein complex 1 mu 1 subunit"	Q9BXS5	19	16197578-16245907	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045256	Uncertain					NA	NA		58000			"HPA045256: AB_10960697"	"unprognostic (5.10e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.02e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.56e-1)"	26.7	24.9	22.8	21.4	27.8	38.1	20.6	20.6	43.5	15.4	17.5	22.8	9.7	23.5	20.2	9.4	17.0	15.6	15.9	25.6	20.0	26.5	23.2	41.0	22.1	24.2	23.8	27.0	21.2	10.8	13.7	13.4	20.1	25.5	15.3	9.7	17.8	12.0	19.8	20.7	15.1	16.2	26.2	19.4	20.7	14.5	40.7	16.6	29.1	12.6	8.6	20.2	20.5	14.9	30.6	37.6	67.2	62.1	36.0	45.5	43.2	18.6	21.1	21.4	20.0	26.1	25.7	12.1	21.0	22.6	30.8	32.2	25.1	14.8	14.4	24.4	23.0	19.9	10.6	16.5	17.2	34.7	25.1	37.1	23.9	19.8	33.8	21.2	26.0	30.1	26.4	12.9	27.5	18.6	20.4	29.2	21.2	11.6	30.1	33.4	22.3	38.1	16.3	17.4	6.6	49.5	26.0	17.4	20.0	17.0	13.6	13.7	30.8	17.2	10.5	19.1	12.0	12.5	21.9	25.0	34.9	14.3	46.7	39.9	32.4	40.1	15.9	39.2	33.4	27.0	23.4	40.7	67.2	32.1	51.2	32.3	30.6	31.9	33.7	34.9	27.9	36.3	45.5	29.1	36.0	62.1	37.6	44.4	43.2	22.8	27.8	20.6	43.5	20.0	26.5	23.8	27.0	25.5	16.6	38.7	31.1	33.3	7.0	4.0	33.5	16.5	12.7	18.7	21.6	12.2	19.6	28.5	13.3	20.0	25.2	19.6	12.0	23.3	15.8	34.2	21.2	5.9	25.5	38.0	37.4	39.7	19.0	23.9	30.0	64.2	21.3	31.1	10.1	27.1	4.9	21.4	22.6	5.8	18.7	19.5	33.7	0.0	15.1	56.7	24.2	6.1	14.6	36.3	6.8	3.7
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 sigma 1 subunit"	P61966	7	101154400-101161596	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.8"	"Cell type enhanced"	"Detected in many"	6	"Distal tubular cells: 291.8;Proximal tubular cells: 208.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	7.6	9.7	30.6	7.9	41.1	3.0	10.8	7.9	45.8	6.8	16.5	6.4	4.6	23.3	6.6	10.6	10.9	8.9	9.3	4.2	22.9	14.6	16.6	15.5	6.7	6.9	12.3	25.3	7.9	8.0	6.3	10.5	10.2	10.1	10.9	14.2	4.6	10.4	6.1	3.5	12.3	18.0	7.9	8.7	7.7	13.2	6.9	9.3	4.7	9.3	7.4	8.5	8.7	6.1	4.4	8.2	2.1	5.5	1.9	5.9	4.2	26.4	21.5	14.5	27.4	10.7	17.6	31.4	17.8	12.1	12.1	12.9	11.5	33.8	5.9	31.1	19.4	23.5	13.2	8.3	27.3	10.8	13.4	13.4	4.0	13.5	14.3	13.2	10.8	20.1	19.7	20.9	11.9	5.2	18.1	17.9	13.4	12.9	24.0	29.9	66.0	9.0	23.4	23.1	39.2	43.4	5.7	6.6	12.4	29.1	22.6	11.4	37.3	10.1	26.8	32.4	24.9	11.8	10.1	18.5	17.5	30.5	6.6	12.2	5.4	11.3	11.4	44.4	12.0	35.1	0.8	5.5	0.5	4.2	4.9	3.7	4.4	5.9	4.7	7.4	3.8	3.5	3.2	2.1	1.9	2.8	8.2	5.5	4.2	30.6	41.1	7.9	35.1	22.9	14.6	12.3	25.3	10.1	9.3	6.0	0.0	18.5	25.1	34.5	26.2	1.1	50.9	0.0	2.3	52.4	7.9	145.9	291.8	115.8	1.0	22.5	124.9	0.0	97.6	75.8	26.7	26.8	5.7	37.6	83.8	28.6	86.6	25.2	24.7	2.0	32.5	23.2	50.6	83.0	83.1	23.6	132.7	74.8	20.5	208.8	16.4	19.4	13.3	10.1	80.0	39.6	50.6	15.2	96.8	26.8
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587825-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 316.6"	"Cell type enriched"	"Detected in some"	8	"Hepatocytes: 3479.3"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HL-60: 3.3;RH-30: 4.3;SiHa: 2.2;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	NA	NA	27700000000	76000000000			"CAB007817: AB_598185, HPA053294: AB_2682104"							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.7	316.6	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	3.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.7	4.3	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.7	0.2	1.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	451.0	0.0	0.0	0.0	0.0	0.0	0.0	77.6	0.0	0.0	0.0	70.0	5.1	0.0	0.0	0.0	0.0	3479.3	0.0	0.0	0.0	63.8	73.6	0.0	0.0	0.0	0.0	5.4	0.0	0.0	16.5	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
APLNR	"AGTRL1, APJ, APJR, FLJ90771"	ENSG00000134817	"Apelin receptor"	P35414	11	57233577-57237314	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 63.8;lymphoid tissue: 44.1;placenta: 40.4"	"Group enriched"	"Detected in some"	5	"Endothelial cells: 24.9;Ito cells: 12.9"	"Cancer enhanced"	"Detected in all"		"glioma: 50.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"AF22: 10.2;HEL: 8.7;K-562: 2.6;NTERA-2: 3.0;SuSa: 4.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			CAB025842	Approved					NA	NA					"CAB025842: "	"unprognostic (5.06e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	8.4	2.1	26.1	3.8	14.2	0.0	3.3	3.8	21.0	1.2	2.3	30.8	0.0	1.8	1.6	0.0	1.8	1.2	5.7	7.2	24.8	9.3	2.5	8.0	3.5	4.0	17.3	10.2	1.2	1.4	1.9	1.5	40.4	32.8	1.2	2.8	0.2	1.7	0.8	5.8	3.0	1.7	4.7	63.8	44.1	1.5	1.2	18.2	0.1	3.1	0.6	1.8	3.8	1.5	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	26.1	14.2	3.8	16.3	24.8	9.3	17.3	10.2	32.8	18.2	0.0	0.0	0.0	0.0	2.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.9	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	12.9	0.6	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.8	0.1	0.0	0.0	0.0
APP	AD1	ENSG00000142192	"Amyloid beta precursor protein"	P05067	21	25880550-26171128	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Alzheimer disease, Amyloidosis, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 24.0"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 24.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000157, HPA001462"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		15000000	"Golgi apparatus"	Vesicles	"CAB000157: AB_323833, HPA001462: AB_1078185"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.79e-6)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.08e-3)"	44.8	92.5	89.9	26.3	109.3	21.2	79.9	64.5	139.1	51.7	63.4	86.9	72.0	39.7	52.2	57.2	33.0	57.6	63.4	69.1	104.6	97.7	102.2	54.5	50.2	12.9	97.4	95.8	58.9	57.1	36.4	34.1	79.7	83.2	49.2	59.6	48.9	47.2	66.6	17.2	38.2	34.9	69.3	109.0	26.3	37.9	32.2	67.5	13.9	85.0	21.5	16.7	52.5	58.4	1.5	24.0	0.9	3.9	0.3	1.5	1.8	31.2	40.4	44.3	36.9	60.4	75.0	47.9	63.4	84.6	32.2	37.9	23.2	76.7	0.0	73.9	49.6	42.0	21.4	27.0	74.5	27.3	1.1	21.8	0.0	24.4	16.3	59.0	29.6	1.6	67.5	82.4	37.7	69.3	133.1	144.0	13.0	0.0	3.2	50.5	35.0	0.5	0.3	34.8	51.2	36.1	19.4	42.7	26.0	109.0	22.0	22.6	33.0	68.0	44.8	31.8	63.1	39.6	32.3	153.9	71.7	30.4	26.1	29.9	19.6	0.2	0.3	58.3	0.1	68.8	0.4	3.9	0.0	0.1	1.2	0.2	0.5	1.4	0.5	3.4	1.5	1.5	0.4	0.9	0.3	0.9	24.0	0.3	1.8	89.9	109.3	64.5	124.6	104.6	97.7	97.4	95.8	83.2	67.5	101.3	43.6	31.5	195.4	161.4	26.5	130.8	282.8	120.5	119.4	476.3	27.5	341.9	48.0	308.0	33.6	371.9	139.3	0.0	158.2	112.6	202.6	156.7	8.1	105.8	67.9	79.4	156.1	527.9	77.8	43.7	224.6	45.9	153.5	92.8	307.0	330.4	178.5	181.4	279.0	124.0	22.1	116.4	133.6	37.0	87.7	92.8	461.7	25.5	256.5	110.0
AQP1	"CHIP28, CO"	ENSG00000240583	"Aquaporin 1 (Colton blood group)"	P29972	7	30911694-30925516	"Blood group antigen proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 156.5"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 218.3;Cholangiocytes: 377.0;Endothelial cells: 221.7;Proximal tubular cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 20.9;HeLa: 7.0;SH-SY5Y: 7.8;U-2 OS: 9.8;WM-115: 37.8"									"CAB001707, HPA019206"	Enhanced		Supported	"Plasma membrane"		NA	NA		250000	"Plasma membrane"		"CAB001707: , HPA019206: AB_1844965"	"unprognostic (4.18e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (6.52e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (1.32e-8)"	"unprognostic (3.43e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.21e-2)"	68.2	8.0	9.9	8.7	17.1	9.4	51.9	10.7	13.0	46.5	18.1	62.1	7.7	10.8	28.0	20.8	58.8	29.0	36.3	46.7	18.1	15.4	156.5	4.2	103.2	9.1	36.9	17.8	16.4	49.9	12.9	4.0	9.1	63.2	32.4	10.6	8.3	19.8	22.7	35.2	24.8	18.2	41.2	56.4	2.9	18.2	15.0	17.8	1.9	21.3	33.5	12.5	36.0	76.7	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.6	0.4	1.8	0.4	1.2	0.4	0.0	0.0	0.2	0.3	0.0	20.9	1.1	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.2	7.0	0.0	0.4	0.1	0.0	3.3	0.0	0.1	0.0	0.0	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	5.2	0.1	0.7	0.0	0.2	7.8	1.2	0.6	0.0	3.9	0.1	0.1	0.0	0.0	9.8	0.8	0.3	0.5	0.3	0.0	0.1	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	9.9	17.1	10.7	13.0	18.1	15.4	36.9	17.8	63.2	17.8	166.7	218.3	2.9	1.1	81.4	1.1	57.7	377.0	6.7	6.8	29.6	7.9	1.9	24.9	35.6	1.9	221.7	4.2	0.0	2.1	3.0	91.5	1.0	1.1	1.3	3.3	0.0	7.0	154.1	1.8	1.6	1.1	9.8	84.4	2.8	18.2	0.3	2.8	19.2	3.2	281.0	0.2	12.9	92.0	0.3	1.3	68.8	6.1	0.0	71.0	1.0
AQP10		ENSG00000143595	"Aquaporin 10"	Q96PS8	1	154321090-154325325	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"intestine: 59.9"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 2.5;granulocytes: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 16.0;HMC-1: 6.7;K-562: 18.3;SH-SY5Y: 4.4"					"Low region specificity"	"Detected in many"			"HPA062621, HPA065947"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA062621: , HPA065947: AB_2685584"	"unprognostic (6.84e-2)"	"unprognostic (4.97e-2)"		"unprognostic (4.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"		"unprognostic (7.64e-3)"	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	36.0	0.0	0.0	37.2	0.2	0.3	0.1	4.3	0.5	0.7	0.4	0.0	0.0	0.1	2.2	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	59.9	0.0	0.0	2.7	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0
AQP11		ENSG00000178301	"Aquaporin 11"	Q8NBQ7	11	77589391-77610355	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 60.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 30.5;Late spermatids: 51.4;Muller glia cells: 29.1;Spermatocytes: 35.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 7.8;GAMG: 12.3;Hep G2: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042879			Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA042879: AB_10794919"	"unprognostic (4.95e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.62e-5)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.66e-3)"	1.0	14.5	4.2	0.8	3.5	0.6	1.1	5.0	4.8	0.6	22.4	2.1	0.7	24.7	0.8	1.2	0.5	0.9	2.4	0.7	2.5	4.5	5.2	13.9	0.6	0.9	3.4	3.4	9.3	3.6	0.9	1.8	3.5	3.4	3.9	2.1	3.8	0.8	0.7	1.0	1.0	60.1	0.6	1.5	1.0	2.3	7.4	1.7	0.0	1.6	0.2	0.4	0.8	0.6	2.0	0.1	0.3	0.1	2.0	2.3	0.8	1.0	3.3	1.4	2.2	3.2	0.8	1.4	1.7	0.8	1.6	0.7	7.8	1.6	1.6	0.8	0.7	12.3	1.0	0.5	0.1	0.8	4.8	1.3	1.3	1.1	13.0	1.0	2.7	1.5	0.8	0.3	0.9	0.2	1.9	0.3	0.4	0.8	1.0	1.8	1.6	1.0	1.8	1.4	7.5	3.0	1.4	3.5	0.6	0.9	1.2	1.4	1.0	2.1	0.4	0.8	1.1	1.6	0.4	0.9	1.3	4.1	2.5	1.1	1.1	0.8	1.3	0.4	0.2	1.8	0.0	0.0	0.3	1.9	0.0	1.3	0.3	0.8	1.5	0.1	2.0	2.3	0.7	0.0	2.0	0.1	0.1	0.1	0.8	4.2	3.5	5.0	4.8	2.5	4.5	3.4	3.4	3.4	1.7	0.0	0.0	0.0	0.7	0.1	7.5	0.4	7.6	0.0	0.0	1.8	0.0	6.6	0.0	1.2	30.5	0.3	15.8	0.0	3.4	10.1	0.9	1.2	4.6	21.5	1.0	0.0	4.1	0.0	0.3	51.4	14.4	0.0	1.7	0.0	3.1	29.1	3.7	3.1	10.6	15.3	5.0	0.0	0.7	35.9	5.8	0.1	13.3	0.0	5.6	0.1
AQP12A	AQP12	ENSG00000184945	"Aquaporin 12A"	Q8IXF9	2	240691845-240698483	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	182	"pancreas: 65.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.8"									HPA042216	Supported					NA	NA					"HPA042216: AB_2677905"			"unprognostic (9.82e-2)"							"unprognostic (1.63e-2)"	"unprognostic (9.48e-2)"			"unprognostic (2.14e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950741-49958881	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Diabetes insipidus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	38	"ductus deferens: 178.6;kidney: 96.5;seminal vesicle: 108.2"	"Cell type enriched"	"Detected in some"	444	"Collecting duct cells: 3930.9"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"intermediate monocyte: 1.4;non-classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	14	"monocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.5;EFO-21: 6.9;HEL: 2.0;HMC-1: 4.2;OE19: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced					NA	NA					"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.1	1.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	178.6	0.0	0.1	3.3	0.1	0.1	0.0	0.6	0.1	0.1	96.5	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.2	108.2	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	7.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3930.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AQP4	MIWC	ENSG00000171885	"Aquaporin 4"	P55087	18	26852038-26865818	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 185.1;lung: 53.5"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 1: 1024.3"	"Cancer enriched"	"Detected in some"	22	"glioma: 223.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;Karpas-707: 2.0;RPTEC TERT1: 3.9;SCLC-21H: 1.3;U-87 MG: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967"	"unprognostic (7.23e-5)"	"unprognostic (1.55e-1)"		"unprognostic (3.19e-8)"	"unprognostic (3.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.10e-2)"		1.7	1.7	60.7	1.6	57.1	1.6	1.8	21.8	185.1	1.9	1.6	41.3	0.0	1.6	1.6	2.0	1.9	2.1	1.6	2.7	64.3	27.1	2.7	2.0	53.5	1.7	39.8	36.4	2.8	1.7	2.9	0.8	1.6	39.1	1.8	1.6	0.0	1.8	1.7	25.4	1.6	1.6	1.6	67.2	1.8	6.1	1.7	42.2	0.0	8.4	0.1	1.6	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.2	0.9	0.0	0.0	0.0	0.0	0.0	3.9	0.0	1.3	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	57.1	21.8	31.7	64.3	27.1	39.8	36.4	39.1	42.2	1024.3	245.1	0.0	0.6	0.0	2.1	8.5	0.0	37.5	138.8	3.5	5.9	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	3.5	0.5	0.0	1.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	224.7	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961870-49965681	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"salivary gland: 217.9;testis: 76.2"	"Group enriched"	"Detected in many"	8	"Early spermatids: 1235.0;Late spermatids: 3096.0"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 70.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065008	Enhanced		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA065008: AB_2685401"	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favorable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	0.2	0.1	0.4	0.2	1.1	0.0	3.8	0.4	0.3	3.0	0.3	0.4	0.3	3.2	0.6	0.8	3.8	0.1	15.6	1.0	0.3	0.3	0.2	0.2	2.3	0.2	0.7	0.2	0.2	0.8	0.1	0.4	0.2	0.3	0.5	0.0	0.4	217.9	0.6	0.9	23.5	0.3	0.6	0.2	0.2	12.0	76.2	0.3	0.2	0.3	2.8	11.5	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	70.7	0.0	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.4	0.3	0.3	0.3	0.7	0.2	0.3	0.3	53.6	1.9	0.0	0.4	1.1	0.5	0.3	0.0	8.1	37.5	7.0	0.0	0.0	0.0	0.0	1235.0	0.0	0.0	0.0	0.2	0.0	0.4	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3096.0	26.4	0.0	280.0	0.0	0.0	45.4	4.3	0.0	18.0	0.0	1.4	19.4	0.3	76.9	15.2	0.6	0.0	0.0	0.0	0.7
AQP6	AQP2L	ENSG00000086159	"Aquaporin 6"	Q13520	12	49967194-49977139	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	25	"kidney: 40.1"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 4.5;Collecting duct cells: 5.2"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 9.1"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 2.0;OE19: 5.1;SH-SY5Y: 2.1"	"Region enriched"	"Detected in some"	7	"cerebellum: 23.5"	"Low region specificity"	"Detected in many"			HPA015278	Enhanced					NA	NA					"HPA015278: AB_10600982"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.77e-1)"	0.1	0.2	0.6	0.1	1.1	0.0	0.1	0.3	1.6	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.7	0.5	40.1	0.2	0.1	0.1	1.2	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.2	0.0	0.1	1.0	0.3	0.1	0.0	0.1	0.1	0.4	0.1	0.2	0.7	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.8	0.5	1.2	0.2	0.2	0.4	0.2	0.3	2.0	0.1	0.3	0.1	0.0	0.0	0.4	0.2	0.0	0.0	1.1	1.2	0.0	0.9	0.0	0.0	0.2	0.3	0.0	0.0	0.2	1.4	0.0	0.1	0.7	0.3	0.0	0.1	0.1	0.0	0.0	0.1	1.1	0.0	0.2	0.4	0.6	0.0	0.9	0.0	0.6	0.4	5.1	1.0	1.0	0.1	0.5	0.9	0.0	0.5	2.1	0.7	0.0	0.7	0.3	0.0	0.1	0.0	0.6	0.9	0.0	0.5	0.2	0.2	0.0	0.2	0.2	0.4	1.2	0.2	0.1	0.4	0.1	0.1	0.3	0.1	0.2	0.5	0.8	0.2	0.3	1.1	0.2	0.2	0.2	0.3	0.2	0.6	1.1	0.3	0.3	0.7	0.5	1.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.7	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
AQP7	"AQP7L, AQP9, AQPap"	ENSG00000165269	"Aquaporin 7"	O14520	9	33383179-33402682	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 72.7;breast: 25.6;heart muscle: 21.5"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 81.4;Early spermatids: 99.6;Enterocytes: 64.2;Proximal tubular cells: 60.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	6	"T-reg: 2.7"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.7"	"Cell line enriched"	"Detected in some"	52	"ASC diff: 79.4"															NA	NA						"unprognostic (3.25e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.25e-5)"	"unprognostic (7.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.56e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	72.7	1.2	0.6	1.3	0.8	0.0	25.6	2.4	0.9	0.6	3.9	0.6	0.6	3.9	0.6	1.1	1.2	1.2	2.3	21.5	0.6	0.0	5.3	5.9	0.6	0.6	0.6	0.6	1.0	3.0	10.2	0.6	0.9	1.2	1.2	0.8	0.8	2.7	0.6	8.8	0.9	5.7	0.6	1.0	0.6	0.3	5.5	0.6	0.8	1.0	3.0	1.6	1.7	0.6	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.0	0.5	0.0	0.0	79.4	1.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	2.7	0.0	0.6	0.8	2.4	0.9	0.6	0.0	0.6	0.6	1.2	0.6	6.0	8.2	0.0	0.2	1.3	0.0	81.4	15.3	4.0	1.2	33.2	0.0	0.0	5.0	1.1	99.6	0.8	64.2	0.0	0.2	0.3	0.2	0.4	0.0	16.8	0.1	0.0	0.0	1.8	0.0	14.4	2.0	0.1	0.0	0.0	3.8	0.0	0.3	28.1	1.8	60.8	0.0	6.5	2.1	1.1	0.7	2.3	0.0	0.0	2.1	1.4
AQP8		ENSG00000103375	"Aquaporin 8"	O94778	16	25215731-25228940	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	29	"intestine: 40.9;pancreas: 163.4"	"Cell type enhanced"	"Detected in some"	20	"Enterocytes: 43.3;Exocrine glandular cells: 9.2;granulocytes: 9.2;Intestinal endocrine cells: 12.6;Paneth cells: 16.9"	"Group enriched"	"Detected in some"	42	"colorectal cancer: 6.4;liver cancer: 3.2;pancreatic cancer: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"Hep G2: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046259	Enhanced					NA	NA					"HPA046259: AB_10960494"	"unprognostic (8.75e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.34e-3)"	"unprognostic (8.47e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.71e-2)"	0.2	0.0	0.2	3.4	0.2	0.0	0.2	0.2	0.2	0.2	40.9	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	163.4	0.0	0.2	0.2	0.2	0.2	19.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.2	0.0	5.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	43.3	0.0	9.2	0.1	0.0	0.1	9.2	0.0	0.1	1.6	12.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.2	0.1	2.5	16.9	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.0	5.4	0.0
AQP9	"HsT17287, SSC1"	ENSG00000103569	"Aquaporin 9"	O43315	15	58138169-58185911	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 127.8;liver: 147.0"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 258.5"	"Cancer enriched"	"Detected in many"	30	"liver cancer: 132.4"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	20	"neutrophil: 127.8"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 127.8"	"Cell line enriched"	"Detected in single"	27	"U-87 MG: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA074762, CAB075684"	Enhanced					NA	NA					"CAB075684: , HPA074762: AB_2732267"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.80e-3)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (5.72e-11)"	"unprognostic (8.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.39e-2)"	7.8	0.3	0.6	12.9	0.7	9.8	0.6	0.7	1.4	0.2	0.3	0.1	1.0	0.0	0.2	7.8	0.7	3.0	0.8	2.0	0.4	0.2	0.8	147.0	8.6	12.0	2.4	0.4	1.2	0.3	2.8	0.4	1.4	0.6	0.4	0.0	0.5	0.4	0.8	0.4	6.9	0.3	1.0	0.5	15.8	0.7	2.5	0.4	0.4	0.5	0.1	0.4	1.3	0.6	0.0	0.2	127.8	6.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	25.9	0.1	0.0	0.0	6.2	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	127.8	0.0	2.3	0.0	0.0	1.7	0.6	0.7	0.7	1.4	0.4	0.2	2.4	0.4	0.6	0.4	0.0	19.3	4.3	0.1	0.3	0.0	1.2	5.1	2.7	5.7	0.0	0.0	0.3	0.0	0.1	1.9	0.1	0.0	0.0	0.2	0.5	0.4	0.0	7.0	258.5	43.2	0.0	0.0	8.0	34.5	0.8	0.3	57.7	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.7	1.3	0.0	0.1
ARL6IP5	"DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b"	ENSG00000144746	"ADP ribosylation factor like GTPase 6 interacting protein 5"	O75915	3	69084944-69106066	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA015540, CAB019321"	Supported		Approved	"Endoplasmic reticulum"		NA	NA		19000000	"Endoplasmic reticulum"		"CAB019321: , HPA015540: AB_1852061"	"unprognostic (8.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.31e-2)"	53.2	53.2	44.0	37.4	48.5	21.3	51.5	32.9	62.1	48.1	31.9	41.5	16.8	21.1	33.8	40.0	38.5	34.5	37.3	76.0	42.9	51.0	43.3	28.4	44.9	43.7	53.1	30.7	28.9	23.3	18.3	36.3	50.6	81.7	49.2	31.8	32.1	54.9	35.6	69.3	18.5	30.3	37.0	51.6	40.7	27.9	21.4	46.1	32.5	39.9	32.7	45.2	46.9	30.2	57.3	40.4	91.5	57.5	41.4	74.8	114.8	15.2	10.6	13.1	9.6	68.3	64.0	16.6	15.8	35.8	12.3	14.5	5.3	37.4	3.0	5.3	27.1	23.1	12.2	10.7	18.2	10.6	59.8	10.0	10.5	18.0	8.1	17.6	8.9	52.1	46.0	32.9	11.3	14.4	43.7	37.6	10.1	4.6	28.7	29.8	8.8	9.7	11.8	3.4	35.6	10.0	8.6	12.0	28.0	60.7	25.7	3.3	8.7	15.7	17.1	20.6	13.5	11.3	14.3	36.7	8.2	6.5	20.7	17.1	25.8	36.1	5.6	27.2	22.4	13.2	81.4	57.5	91.5	52.3	51.4	40.1	57.3	73.9	66.5	40.4	43.9	63.1	66.2	24.0	41.4	43.0	25.6	74.8	114.8	44.0	48.5	32.9	62.1	42.9	51.0	53.1	30.7	81.7	46.1	163.8	103.0	121.2	73.7	64.7	192.5	338.6	84.1	117.8	116.0	89.0	176.7	275.4	21.6	231.6	8.1	130.0	85.8	70.0	188.9	320.0	170.5	132.5	322.8	62.5	267.8	116.0	40.4	118.4	223.5	12.7	191.8	306.3	258.1	527.6	54.0	207.9	194.4	84.2	246.1	66.8	224.8	187.5	100.4	8.1	2.5	64.5	149.2	256.0	66.9	73.3
ARV1		ENSG00000173409	"ARV1 homolog, fatty acid homeostasis modulator"	Q9H2C2	1	230978981-231000595	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 92.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035709	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA035709: AB_2674744"	"unprognostic (2.32e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.95e-2)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.27e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.82e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-3)"	8.2	16.3	22.0	10.1	31.0	10.0	16.1	17.1	24.3	11.0	20.0	16.5	13.9	13.8	8.1	20.6	13.6	12.3	17.0	24.2	23.8	21.8	21.0	20.9	12.5	11.0	22.7	17.7	9.8	14.9	18.4	25.8	9.4	22.0	14.0	21.6	15.4	16.9	13.4	15.7	14.6	15.6	10.7	27.1	10.5	13.7	24.6	18.2	11.0	18.4	16.8	11.9	12.7	9.3	15.3	13.9	7.3	17.7	12.5	14.0	8.3	20.0	21.8	10.9	13.0	15.9	13.9	10.2	9.4	17.5	17.4	20.1	8.0	15.7	5.8	11.8	10.9	10.7	16.5	20.5	12.8	20.7	14.7	28.8	17.9	15.8	10.8	16.2	26.3	14.6	15.0	13.5	9.4	10.9	11.3	11.6	18.0	26.3	15.9	11.4	7.0	10.7	8.0	14.0	21.2	14.8	12.7	16.2	16.4	23.2	16.5	11.4	17.3	11.3	13.4	27.8	2.7	24.0	23.5	6.4	6.9	4.4	12.6	22.6	24.6	21.6	14.4	18.9	23.0	18.8	6.4	7.6	7.3	9.8	10.8	13.3	15.3	11.0	11.7	9.1	10.1	13.8	12.7	1.9	12.5	17.7	13.9	14.0	8.3	22.0	31.0	17.1	24.3	23.8	21.8	22.7	17.7	22.0	18.2	14.9	24.8	20.9	19.1	11.4	19.4	26.9	7.6	17.4	18.2	27.9	2.0	32.5	51.4	20.9	26.0	11.9	11.7	46.7	35.3	12.7	17.5	14.6	16.2	17.9	21.8	36.5	7.5	12.3	11.5	14.7	8.6	14.3	23.6	9.0	15.0	28.4	17.4	10.5	15.6	24.2	13.2	0.0	14.4	92.9	16.8	13.2	13.0	7.9	27.4	16.2
ASIC5	"ACCN5, HINAC, INAC"	ENSG00000256394	"Acid sensing ion channel subunit family member 5"	Q9NY37	4	155829729-155866273	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	13	"intestine: 7.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014903, HPA029444"	Approved					NA	NA					"HPA014903: AB_1844498, HPA029444: AB_10611671"					"unprognostic (8.52e-5)"		"unprognostic (2.52e-1)"	"unprognostic (1.25e-1)"									"unprognostic (4.05e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	7.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.3	0.0	0.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASNA1	"ARSA-I, GET3, TRC40"	ENSG00000198356	"ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		52000	Nucleoli	Nucleoplasm	"HPA045951: AB_2679511, HPA048087: AB_2680258"	"unprognostic (2.87e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavorable (8.47e-4)"	22.3	33.9	32.3	23.1	32.8	35.1	22.2	28.2	51.9	23.5	27.2	26.1	23.6	24.7	24.8	30.3	33.3	30.7	28.9	48.0	30.5	27.9	46.9	28.5	21.2	26.6	29.2	26.5	24.2	30.3	23.8	25.2	32.0	27.3	21.8	18.3	30.9	26.7	21.5	35.7	28.9	24.7	21.3	24.5	26.5	24.2	30.9	18.5	25.8	40.7	28.0	23.5	28.7	20.6	12.5	27.1	16.0	26.9	9.3	20.2	19.4	33.6	27.8	14.9	32.1	29.7	18.3	18.4	17.5	24.2	34.0	26.8	21.7	16.8	15.5	27.4	22.7	39.0	18.1	20.6	23.4	16.3	23.8	32.3	13.4	21.0	24.6	31.8	19.8	26.1	21.1	20.6	27.4	16.3	22.0	24.0	18.4	16.6	21.1	26.5	75.3	26.1	15.9	37.7	21.7	52.4	19.4	23.2	30.3	31.7	28.8	27.7	23.5	23.7	31.9	28.0	13.3	26.3	19.1	20.4	48.1	16.3	53.2	40.6	38.0	63.9	14.3	33.7	32.4	26.4	16.0	26.9	15.0	16.1	20.4	13.7	12.5	14.4	14.2	27.1	10.6	10.4	12.8	9.6	9.3	23.7	17.8	20.2	19.4	32.3	32.8	28.2	51.9	30.5	27.9	29.2	26.5	27.3	18.5	3.0	6.5	44.7	52.5	61.4	33.5	7.4	66.2	9.4	5.7	52.4	15.7	89.1	112.7	135.7	88.0	42.9	87.6	46.7	116.1	66.8	58.1	46.3	34.5	24.5	125.2	27.0	53.9	36.8	50.0	143.9	44.5	54.1	77.6	138.9	56.6	59.9	93.6	94.7	53.0	177.7	23.1	32.3	54.5	52.9	128.0	69.5	92.6	59.8	57.4	54.0
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 462.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 102.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		900000	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	104.6	60.4	27.3	15.0	29.5	4.8	84.3	35.2	31.3	22.3	23.8	10.6	18.3	14.0	16.8	17.8	22.4	16.5	19.1	33.9	26.1	22.4	19.0	23.0	22.5	10.9	21.1	22.2	20.5	13.8	12.5	15.7	14.7	20.5	17.3	26.8	23.6	28.8	23.4	103.1	12.0	13.9	26.1	16.7	12.8	30.5	6.4	19.6	2.9	31.7	36.0	13.7	30.0	25.4	3.3	21.0	15.9	5.2	4.9	3.4	2.3	49.9	72.6	10.2	6.2	45.7	43.5	3.5	89.7	83.3	38.4	40.3	12.4	66.6	3.8	6.2	52.5	30.9	18.7	6.3	31.3	65.7	1.4	6.4	8.9	44.1	33.9	29.3	1.3	1.4	35.7	7.0	21.3	27.3	75.4	16.2	2.0	2.4	3.6	33.8	10.6	0.3	1.8	5.8	48.4	42.8	2.4	11.0	0.8	23.4	41.4	10.6	3.6	27.8	13.1	11.1	5.8	5.3	2.4	50.8	38.9	20.0	35.5	31.6	2.3	2.9	0.1	102.4	0.8	26.0	1.1	5.2	0.1	1.6	1.9	3.1	3.3	2.3	1.6	6.1	3.3	3.4	1.6	15.9	4.9	1.0	21.0	2.3	2.3	27.3	29.5	35.2	31.3	26.1	22.4	21.1	22.2	20.5	19.6	181.7	183.4	8.3	108.3	41.8	126.7	192.2	22.9	57.6	137.6	82.0	276.9	97.4	13.3	97.2	1.6	71.6	39.8	0.0	158.3	85.9	64.5	113.1	8.1	51.6	62.4	120.8	111.8	38.6	25.4	0.5	65.6	43.4	40.5	13.6	178.8	462.0	186.9	24.6	54.1	31.9	150.0	45.3	73.9	2.6	16.8	44.0	40.2	10.0	58.7	212.3
ASTN1	ASTN	ENSG00000152092	"Astrotactin 1"	O14525	1	176857302-177164973	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 19.9;brain: 52.5"	"Cell type enhanced"	"Detected in some"	20	"Horizontal cells: 22.3;Late spermatids: 9.9;Rod photoreceptor cells: 8.8"	"Cancer enriched"	"Detected in some"	14	"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.0;NTERA-2: 4.6;SCLC-21H: 2.8;U-2 OS: 3.7;U-266/84: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074112			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA074112: AB_2686662"	"unprognostic (4.41e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.03e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.16e-1)"	1.4	19.9	21.5	1.6	23.8	1.1	1.7	15.0	52.5	1.3	1.5	7.4	1.9	1.5	2.3	5.4	1.2	3.2	1.9	1.7	17.4	13.7	1.3	1.4	1.4	1.2	8.5	18.8	8.9	1.7	1.2	8.2	1.6	9.8	2.4	1.6	2.2	2.0	3.3	1.3	1.1	1.5	2.2	5.8	3.6	1.2	1.9	7.2	0.0	1.2	0.0	1.5	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.5	23.8	15.0	27.2	17.4	13.7	8.5	18.8	9.8	7.2	0.0	0.0	0.0	0.0	0.1	4.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	22.3	0.0	1.8	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	8.8	0.0	0.1	4.2	0.2	0.0	0.1	0.0	0.0	0.0
ATG101	"C12orf44, FLJ11773"	ENSG00000123395	"Autophagy related 101"	Q9BSB4	12	52069246-52077494	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"plasmacytoid DC: 64.4"	"Lineage enriched"	"Detected in all"	6	"dendritic cells: 64.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039904	Approved					NA	NA					"HPA039904: AB_10673262"	"unprognostic (1.77e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-3)"	"prognostic unfavorable (8.07e-7)"	"unprognostic (9.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.15e-1)"	19.9	23.7	16.9	20.4	22.1	17.1	21.0	16.5	29.0	17.8	20.0	13.0	28.5	16.2	18.4	30.7	22.3	19.0	26.6	21.2	17.3	15.9	21.3	28.9	21.4	17.8	19.3	17.6	19.5	36.3	21.3	21.5	22.2	17.4	20.9	15.1	13.0	49.4	27.6	25.4	28.9	20.2	18.1	12.8	22.0	25.7	33.3	17.3	23.9	30.7	19.6	21.4	22.2	30.9	11.3	64.4	10.9	10.9	5.7	8.7	8.5	16.7	47.4	10.0	13.6	14.9	11.6	14.7	20.7	21.0	19.6	15.4	54.9	19.6	12.6	19.1	24.8	17.2	14.0	12.3	19.0	13.4	14.2	12.9	12.3	34.9	33.6	38.8	10.5	16.8	11.1	21.7	26.2	18.7	15.1	15.1	10.8	11.5	22.7	14.0	64.1	13.7	23.5	19.3	12.5	20.6	9.7	8.3	17.4	13.9	26.5	9.7	13.1	14.1	20.8	27.4	8.0	22.5	12.7	16.9	17.3	15.6	16.2	16.1	14.5	18.1	12.6	17.8	12.3	26.4	2.2	9.4	10.9	7.6	9.0	8.1	10.3	7.4	8.5	12.2	11.3	7.3	8.1	1.8	5.7	10.9	64.4	8.7	8.5	16.9	22.1	16.5	29.0	17.3	15.9	19.3	17.6	17.4	17.3	17.9	21.9	43.6	89.5	0.0	14.8	3.0	40.8	17.4	18.2	27.9	11.8	44.9	59.7	56.6	10.5	24.0	42.0	0.0	57.2	42.6	22.6	88.9	44.9	43.1	40.7	4.8	29.3	43.0	29.5	22.2	25.0	27.1	0.0	72.1	37.0	19.9	51.7	43.2	34.3	47.0	16.0	25.8	1.0	64.4	70.7	0.0	55.0	20.8	34.5	117.8
ATG12	"APG12, APG12L"	ENSG00000145782	"Autophagy related 12"	O94817	5	115828200-115841858	"Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013272	Uncertain					NA	NA					"CAB013272: AB_2533272"	"unprognostic (2.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (5.11e-2)"	20.7	13.4	19.5	12.6	19.0	12.3	15.5	19.6	22.4	16.3	11.5	11.9	18.5	14.1	17.7	14.5	14.3	12.6	14.5	12.7	16.5	19.6	9.7	22.4	14.2	14.9	21.0	13.7	15.8	10.9	7.3	22.5	17.7	18.6	13.8	14.0	8.3	9.5	25.5	17.1	15.9	14.2	15.9	30.3	12.9	10.6	11.3	21.4	11.8	10.7	7.9	13.6	15.5	14.2	13.8	14.8	22.9	17.2	14.9	19.2	11.0	9.4	5.1	12.4	11.2	20.6	27.8	9.5	16.2	17.9	10.7	17.4	7.2	7.6	8.1	7.1	14.8	16.9	5.2	9.5	13.6	17.4	42.5	9.5	5.2	6.7	6.8	16.3	5.8	10.4	20.7	14.8	11.9	14.1	12.4	12.8	8.8	7.4	11.4	20.2	6.0	12.2	9.1	8.4	7.1	11.1	9.0	12.1	11.6	7.3	6.3	12.2	13.2	17.4	6.8	16.2	9.9	9.5	8.9	13.1	19.8	9.1	18.0	16.4	8.8	14.0	13.1	18.0	12.4	18.4	13.9	12.7	19.6	13.9	14.4	19.2	13.7	16.7	13.2	11.1	13.8	17.5	16.4	22.9	14.9	17.2	14.8	13.2	11.0	19.5	19.0	19.6	22.4	16.5	19.6	21.0	13.7	18.6	21.4	41.7	37.1	72.8	53.6	76.2	37.1	37.4	40.8	42.8	37.5	24.4	72.6	56.9	31.5	53.7	13.9	50.9	46.1	0.0	70.7	99.5	62.9	46.1	93.6	50.8	59.8	28.6	40.1	48.5	73.7	10.9	59.2	60.5	50.6	57.7	41.0	32.0	82.0	45.6	50.5	33.7	57.1	25.8	53.3	42.2	41.0	74.0	74.1	74.0	43.1	67.2
ATG13	KIAA0652	ENSG00000175224	"Autophagy related 13"	O75143	11	46617527-46674818	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Autophagy		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039350			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039350: AB_10673142"	"unprognostic (3.66e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.47e-1)"	13.8	15.8	20.2	11.9	27.3	25.8	12.5	32.8	37.0	13.2	12.6	39.5	9.2	14.3	12.9	16.8	14.9	16.6	14.5	17.8	19.5	16.3	14.3	21.1	11.5	13.6	31.8	18.2	15.6	19.7	24.4	23.1	13.5	27.2	12.8	12.0	21.3	17.0	13.5	20.9	16.3	12.4	12.3	15.7	16.2	16.5	60.6	34.9	14.8	18.6	8.8	15.8	12.5	13.0	15.8	20.0	38.9	24.0	17.0	24.7	20.3	13.8	25.5	19.6	11.5	27.3	32.1	19.8	16.2	28.7	20.0	25.7	17.3	13.9	13.0	11.5	24.4	26.0	17.0	18.8	21.9	20.3	24.6	35.9	14.0	17.8	30.4	30.7	18.6	24.3	38.6	26.2	13.8	30.5	28.6	19.7	30.4	24.4	29.8	17.9	20.8	18.5	27.6	24.5	25.5	22.1	17.7	25.4	22.8	13.4	15.3	18.7	18.8	22.4	18.0	23.9	19.7	25.7	38.5	19.4	24.7	15.1	22.7	17.6	27.2	30.1	16.5	30.6	16.9	18.1	21.2	20.7	26.9	21.3	24.0	17.2	15.8	19.2	16.8	20.0	12.7	16.6	18.3	38.9	17.0	18.7	14.9	24.7	20.3	20.2	27.3	32.8	37.0	19.5	16.3	31.8	18.2	27.2	34.9	14.9	15.2	10.4	10.0	8.2	22.0	12.4	5.1	2.7	10.3	12.2	37.3	8.7	6.6	16.3	35.8	11.7	19.0	46.7	28.1	18.9	8.4	17.1	8.1	19.4	13.5	31.8	17.2	12.9	15.2	36.4	10.6	13.5	11.8	22.6	19.5	15.2	26.0	12.2	10.6	11.2	29.7	12.9	13.7	31.1	10.4	10.0	22.1	10.9	10.4	14.3
ATG14	"ATG14L, KIAA0831"	ENSG00000126775	"Autophagy related 14"	Q6ZNE5	14	55366392-55411858	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 56.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037242	Uncertain					NA	NA					"CAB037242: AB_1852353"	"unprognostic (8.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.49e-3)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.30e-1)"	10.8	11.7	8.9	10.0	11.5	38.1	10.7	16.4	12.9	13.4	12.9	19.1	9.3	8.9	20.0	11.1	12.2	10.0	9.8	16.0	10.5	7.6	11.0	8.3	9.0	9.5	9.2	10.7	14.1	8.5	11.4	8.7	12.0	9.4	11.2	6.7	13.6	10.6	13.7	26.6	14.3	9.0	18.0	13.1	9.0	8.8	14.2	9.4	6.6	11.4	9.8	10.4	15.0	15.6	5.2	4.3	4.4	4.6	10.9	5.2	2.8	8.5	6.0	5.0	7.2	9.1	10.8	11.2	7.9	13.8	7.5	9.1	5.3	9.9	3.3	6.8	7.4	3.9	9.2	5.9	3.0	11.0	5.4	3.9	4.9	7.3	6.7	9.0	5.9	6.9	7.2	9.4	6.4	5.9	12.0	7.0	5.8	4.9	7.7	7.1	6.5	4.0	6.5	9.4	3.8	7.8	4.1	13.2	2.4	3.3	5.2	6.2	7.0	11.7	6.7	7.8	6.2	6.8	2.4	8.3	11.9	8.9	6.0	4.0	4.4	4.8	3.6	7.4	3.3	6.3	4.4	4.6	2.0	4.9	3.2	4.4	4.5	4.7	4.5	2.8	5.2	5.0	5.2	2.0	10.9	2.7	4.3	3.5	2.8	8.9	11.5	16.4	12.9	10.5	7.6	9.2	10.7	9.4	9.4	17.9	25.9	11.5	6.6	15.5	14.5	31.9	0.0	9.4	20.5	10.4	7.9	8.7	16.6	9.8	5.9	15.5	10.4	46.7	6.8	6.5	9.7	9.0	24.4	12.1	6.4	3.2	18.9	16.5	11.4	4.3	13.3	10.7	13.5	10.8	9.4	15.7	10.1	9.0	15.6	7.9	20.3	12.9	10.3	15.1	56.3	22.7	12.0	8.7	7.6	7.4
ATG16L1	"APG16L, ATG16A, ATG16L, FLJ10035, WDR30"	ENSG00000085978	"Autophagy related 16 like 1"	Q676U5	2	233210051-233295674	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012577, HPA063900"	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA012577: AB_1845155, HPA063900: AB_2685146"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.93e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.08e-1)"	7.7	8.1	7.8	15.7	16.4	28.2	11.9	25.3	22.7	9.8	12.0	13.5	7.4	11.4	12.3	14.8	11.8	8.4	9.7	11.3	9.6	9.0	10.0	15.0	8.0	11.4	10.9	9.4	9.7	12.8	11.6	6.6	8.6	12.3	13.2	13.8	9.4	11.8	10.7	19.4	16.9	11.5	10.7	9.7	12.1	13.0	16.7	9.2	13.8	12.3	10.2	14.3	11.7	12.5	3.3	2.1	4.4	6.2	6.0	7.3	3.1	10.8	11.5	4.1	6.9	10.7	7.8	13.1	9.9	7.9	8.9	8.4	8.4	7.8	2.8	3.6	8.2	11.6	5.5	9.1	4.8	7.9	5.4	7.8	6.5	7.4	13.3	8.1	5.4	8.3	4.2	8.5	10.4	8.5	5.6	8.6	3.9	6.7	2.8	7.8	8.9	5.6	10.7	17.5	10.6	12.8	4.0	9.5	2.3	7.9	7.1	8.4	5.8	6.8	8.4	5.1	6.9	5.0	5.8	10.1	5.6	4.6	8.9	8.3	6.3	3.3	5.2	9.2	5.5	8.9	0.0	2.5	4.4	7.3	2.0	6.0	3.3	5.0	6.4	2.1	3.2	5.6	5.5	1.7	6.0	6.2	1.1	5.6	3.1	7.8	16.4	25.3	22.7	9.6	9.0	10.9	9.4	12.3	9.2	6.0	8.0	7.4	4.2	8.0	5.7	3.6	2.5	14.7	11.4	5.2	3.9	4.3	5.0	6.1	0.7	5.6	8.1	0.0	6.0	5.1	4.7	5.6	9.2	8.3	4.8	1.6	8.6	7.4	5.7	1.3	3.7	3.9	10.1	6.4	4.6	7.2	12.1	7.0	3.5	4.5	15.7	6.5	6.5	9.7	15.6	11.5	3.1	13.8	7.3	4.5
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814308-72843674	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.9;lymphoid tissue: 52.0"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 45.9;Macrophages: 38.5;Paneth cells: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 28.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045444: AB_2679324, HPA050312: AB_2681082"	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	7.8	6.6	7.1	20.7	8.0	60.9	7.2	7.4	6.2	9.5	9.7	10.5	7.6	5.5	11.9	7.5	10.2	8.3	11.6	5.8	7.4	4.8	7.2	6.5	16.3	16.4	10.7	7.0	10.1	8.0	5.7	11.5	5.2	8.6	7.3	8.9	11.3	10.1	5.5	3.6	35.7	13.1	10.4	7.9	52.0	6.6	2.6	8.3	3.2	6.5	8.0	19.6	8.5	8.5	2.0	4.7	28.5	7.1	2.4	2.6	1.4	1.4	1.3	4.1	3.2	4.9	4.0	2.6	3.2	3.2	1.6	2.5	1.6	3.5	9.6	2.1	4.1	2.9	2.9	0.5	10.8	2.8	7.6	1.6	7.5	6.9	2.7	3.6	9.8	31.3	3.9	1.5	3.6	4.5	17.9	4.9	17.6	1.0	13.2	1.8	4.7	11.3	16.9	0.6	6.4	1.5	5.6	2.9	4.2	5.3	4.9	3.1	2.4	1.3	7.2	3.0	3.4	3.6	13.5	6.8	4.4	1.6	7.9	2.5	6.0	1.5	4.2	1.9	8.8	2.4	2.4	7.1	18.1	1.3	3.9	1.3	1.2	1.9	2.6	4.7	2.0	1.0	1.2	28.5	2.4	4.7	0.8	1.7	1.4	7.1	8.0	7.4	6.2	7.4	4.8	10.7	7.0	8.6	8.3	6.0	18.4	16.7	5.1	14.8	2.6	4.4	5.1	6.7	3.4	5.2	2.0	6.8	0.0	3.7	0.5	7.9	8.0	0.0	0.9	3.1	5.6	2.8	23.0	2.9	15.2	4.8	12.6	12.9	45.9	0.4	9.5	38.5	3.3	16.2	9.0	4.0	2.3	43.6	7.4	1.6	3.7	0.0	6.6	1.6	7.7	15.2	10.3	23.5	10.4	4.2
ATG2A	KIAA0404	ENSG00000110046	"Autophagy related 2A"	Q2TAZ0	11	64894546-64917248	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 16.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 16.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038715	Uncertain		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			Vesicles	Nucleoplasm	"HPA038715: AB_10673474"	"unprognostic (3.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (4.79e-5)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	8.4	8.3	6.0	8.4	10.4	63.7	7.1	12.2	14.3	7.2	9.2	11.6	8.2	10.0	9.5	5.5	6.1	7.7	8.9	6.4	7.0	6.4	9.0	33.2	9.3	7.7	7.5	7.5	11.8	11.7	7.6	8.7	8.9	9.0	8.5	4.3	12.1	9.3	8.4	12.4	15.9	11.4	9.7	6.7	11.1	9.2	8.0	8.2	13.2	8.4	7.8	9.4	7.9	6.2	1.0	2.3	16.5	2.0	1.5	2.6	0.9	9.9	9.7	3.6	9.6	4.7	3.3	9.5	5.5	8.3	7.6	5.6	8.6	7.9	7.2	11.7	4.8	9.8	8.6	3.6	6.6	2.0	6.7	12.4	6.4	14.5	7.7	6.7	5.0	14.9	9.1	5.8	9.6	5.1	4.4	6.3	7.3	12.1	5.9	3.3	16.2	6.0	17.0	4.1	2.8	10.8	6.7	5.6	10.4	4.1	8.6	13.1	5.1	8.1	11.8	10.2	2.8	11.4	6.4	8.0	7.2	7.1	14.2	4.2	11.5	4.0	5.1	10.6	4.0	4.5	2.8	2.0	2.0	2.6	1.9	2.2	0.8	1.7	2.2	1.3	1.0	1.4	2.5	16.5	1.5	1.5	2.3	0.9	0.9	6.0	10.4	12.2	14.3	7.0	6.4	7.5	7.5	9.0	8.2	8.9	14.4	11.8	7.7	25.6	17.0	5.6	2.5	10.7	10.3	8.7	31.4	11.2	1.7	8.3	1.7	9.0	26.4	0.0	8.9	4.7	14.6	10.6	9.2	17.5	9.7	12.7	34.4	8.6	14.6	2.5	11.8	16.9	28.7	10.8	12.8	10.3	12.5	16.1	9.6	5.2	25.4	12.9	10.7	6.2	5.5	33.5	56.0	39.2	15.6	13.5
ATG2B	"C14orf103, FLJ10242"	ENSG00000066739	"Autophagy related 2B"	Q96BY7	14	96279202-96363870	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000880, HPA001427, HPA019665"	Approved		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA000880: AB_1078888, HPA001427: AB_1845551, HPA019665: AB_2274278"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.45e-2)"	"unprognostic (7.60e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.49e-2)"	3.6	3.4	2.6	2.5	4.1	4.4	5.2	9.2	4.5	3.9	3.2			3.1	4.9	4.4	2.9	4.0	3.0	2.7	3.2	3.3	4.5	6.0	3.4	3.1	3.0		5.1	8.1	9.7	4.1	2.7		4.0	3.2		3.1	3.1	5.2	9.3	4.3	3.8	2.7	3.9	3.6	6.5			4.9		3.5	3.3	3.6	1.5	1.6	2.1	1.0	2.5	3.0	0.7	4.1	5.2	6.5	5.1	11.3	10.5	5.2	6.1	8.7	6.7	7.6	2.8	2.8	9.2	5.8	9.9	4.5	5.7	8.8	6.0	10.8	8.5	4.5	4.0	5.7	2.5	7.4	7.3	4.4	8.8	6.1	9.0	7.2	7.1	8.4	7.0	4.6	8.3	5.3	6.6	6.6	6.3	3.1	4.8	5.4	6.1	14.6	6.2	7.5	5.1	6.4	7.2	9.2	3.8	4.4	7.0	6.0	4.2	11.2	3.7	1.7	9.0	3.9	8.4	6.9	8.6	7.6	5.1	3.6	0.6	1.0	1.7	1.6	0.6	3.0	1.5	1.8	1.7	1.3	1.5	1.9	2.0	2.1	2.5	1.0	1.6	2.7	0.7											11.9	10.5	7.5	2.8	12.2	24.5	11.2	7.6	2.7	6.8	8.7	25.5	4.4	3.3	5.2	31.1	9.8	8.2	0.0	5.2	2.7	7.8	11.1	6.9	23.2	3.6	30.2	7.9	13.5	10.5	36.0	11.8	8.9	1.7	3.6	11.8	8.5	4.9	10.5	9.9	6.8	19.0	6.5	8.5	15.6	13.8	24.6	13.2	6.5	8.7	3.1
ATG3	"APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96"	ENSG00000144848	"Autophagy related 3"	Q9NT62	3	112532509-112562046	"Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 501.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037260, HPA040471"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000	"Plasma membrane, Cytosol"		"CAB037260: AB_1078236, HPA040471: AB_2677000"	"unprognostic (2.77e-2)"	"prognostic favorable (6.82e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.35e-6)"	"unprognostic (6.79e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.52e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	24.2	27.7	30.8	30.3	34.2	51.6	23.1	19.5	26.8	20.0	24.3	29.9	16.6	24.5	18.0	17.0	23.6	15.7	17.4	20.9	31.4	27.1	32.2	36.2	23.2	31.0	38.9	17.9	21.1	29.0	24.5	27.7	24.5	33.3	18.5	26.9	13.1	20.3	22.3	18.7	19.6	27.9	19.6	53.3	40.1	23.5	51.7	34.8	33.8	28.2	23.4	28.6	21.6	19.7	12.3	34.5	35.6	61.9	9.7	15.0	24.0	31.2	17.1	16.1	16.4	21.2	17.6	18.1	27.7	20.2	27.4	25.1	23.9	18.7	39.4	21.1	23.8	33.6	22.8	26.3	24.0	38.5	6.7	12.7	24.8	17.0	15.3	33.1	43.3	21.1	16.2	18.4	26.8	41.4	18.0	25.4	25.1	21.2	33.9	28.9	27.4	25.5	20.4	17.6	41.1	34.1	22.4	14.4	33.2	22.7	17.1	27.8	10.9	23.0	22.0	32.3	15.9	24.8	32.5	20.5	29.3	23.9	12.3	24.2	22.1	21.1	61.0	26.8	40.4	21.5	10.8	34.3	23.9	8.6	51.6	10.7	12.3	10.6	10.6	34.5	11.5	10.4	10.2	35.6	9.7	61.9	7.4	15.0	24.0	30.8	34.2	19.5	26.8	31.4	27.1	38.9	17.9	33.3	34.8	44.7	36.6	54.6	35.3	65.8	20.1	77.1	38.2	29.4	29.6	24.4	11.8	64.1	99.5	58.2	501.6	54.0	48.5	93.5	75.2	69.9	44.7	31.1	38.2	35.8	111.6	17.5	30.0	36.2	92.5	97.9	39.4	118.7	65.8	143.3	50.3	40.1	56.9	45.6	40.7	62.4	18.1	58.2	69.0	227.9	110.0	61.7	102.3	47.9	67.3	39.9
ATG4B	"Apg4B, AUTL1, DKFZp586D1822, KIAA0943"	ENSG00000168397	"Autophagy related 4B cysteine peptidase"	Q9Y4P1	2	241637213-241673857	"Enzymes, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037195, HPA069803"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"CAB037195: AB_1078237, HPA069803: AB_2686200"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.60e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (9.64e-4)"	10.9	16.5	19.6	16.6	21.3	31.3	15.1	34.8	25.7	13.5	18.7	21.7	23.2	14.6	33.5	24.0	26.7	17.7	18.8	19.5	20.5	21.5	17.2	15.5	15.8	19.4	29.2	19.7	17.3	19.2	18.7	27.4	15.4	20.3	20.5	18.9	20.8	22.8	14.2	17.2	26.6	21.1	18.9	23.1	18.7	15.5	28.0	21.4	21.2	18.2	7.3	21.9	15.3	14.4	16.5	20.3	18.9	18.6	11.4	19.6	16.8	8.7	13.6	19.5	15.0	19.5	14.2	19.3	12.8	14.0	16.6	13.8	14.9	15.5	6.7	5.8	23.0	13.4	12.9	18.5	24.4	16.1	14.3	18.8	19.8	22.0	32.2	25.4	11.4	11.1	14.1	17.0	18.6	18.0	17.7	17.1	26.1	16.8	10.3	18.8	21.4	20.4	20.1	22.7	15.7	14.5	35.2	17.9	10.1	13.0	28.3	19.5	13.5	10.9	14.5	15.3	16.6	16.0	16.8	18.6	15.8	10.8	10.5	13.8	11.6	12.1	25.7	19.2	14.2	14.8	4.6	18.6	18.9	18.7	15.5	15.5	15.7	15.2	16.5	20.3	16.5	19.6	14.7	14.8	11.4	16.2	16.3	19.3	16.8	19.6	21.3	34.8	25.7	20.5	21.5	29.2	19.7	20.3	21.4	29.8	35.6	22.7	23.7	21.6	21.6	14.1	33.1	10.7	13.6	26.2	31.4	31.0	16.6	32.4	12.9	23.6	57.6	23.3	34.9	23.5	23.5	30.3	18.5	24.9	29.3	39.7	34.4	24.5	27.8	19.8	20.4	31.5	27.0	64.1	34.3	30.2	33.1	28.1	23.3	18.2	25.2	19.4	23.4	44.0	53.5	22.2	45.1	33.0	27.0	27.5
ATG4D	"APG4-D, APG4D, AUTL4"	ENSG00000130734	"Autophagy related 4D cysteine peptidase"	Q86TL0	19	10543895-10553418	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067683	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA067683: AB_2685886"	"unprognostic (2.85e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.73e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.39e-7)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.18e-3)"	6.4	10.8	5.1	9.2	7.8	35.0	6.3	15.6	14.9	6.2	18.4	9.8	8.1	26.0	6.1	7.2	18.4	5.5	7.6	15.4	4.6	4.9	14.5	8.8	7.3	9.8	9.6	6.4	7.0	16.1	8.2	12.1	6.9	7.3	9.7	7.3	7.8	11.5	8.5	31.5	17.7	27.3	4.0	4.5	12.0	10.5	29.0	8.8	19.9	9.8	16.4	10.5	7.5	9.6	2.0	7.6	5.7	1.6	2.2	3.6	1.4	7.0	4.7	6.6	8.9	1.2	1.0	5.1	4.3	4.3	6.2	6.8	7.9	2.3	4.5	8.2	0.5	4.7	11.1	4.1	3.7	0.8	4.4	10.7	12.0	11.5	4.4	4.1	4.8	12.3	1.0	7.7	5.3	1.9	1.6	1.8	9.9	8.9	11.0	1.9	11.3	14.1	29.3	10.0	3.2	12.9	10.4	4.1	8.0	3.5	9.5	24.8	9.6	6.4	12.5	4.9	1.2	7.7	11.8	3.4	9.5	6.0	19.0	9.6	9.8	6.6	5.3	8.1	9.3	10.7	3.0	1.6	5.7	2.1	1.5	3.1	2.0	2.5	2.3	1.1	1.0	2.5	3.4	0.5	2.2	0.7	7.6	3.6	1.4	5.1	7.8	15.6	14.9	4.6	4.9	9.6	6.4	7.3	8.8	8.9	10.0	8.8	18.9	27.1	15.0	0.4	17.8	2.7	1.2	1.8	13.7	23.7	11.6	14.3	51.1	4.1	90.5	23.3	14.4	5.4	10.1	17.3	6.9	9.7	11.7	27.0	21.4	5.5	12.0	6.8	8.1	8.7	11.8	19.0	28.4	10.6	16.6	38.2	4.2	16.8	17.6	12.9	16.0	63.1	19.6	27.4	30.6	21.3	23.3	29.3
ATG5	"APG5, APG5L, ASP, hAPG5"	ENSG00000057663	"Autophagy related 5"	Q9H1Y0	6	106045423-106325791	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Host-virus interaction, Immunity"		"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034432, CAB037309, HPA042973"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA			Centrosome		"CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246"	"unprognostic (1.21e-3)"	"unprognostic (6.53e-3)"	"unprognostic (2.68e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.42e-2)"	18.0	28.5	16.1	15.6	17.2	9.4	21.4	16.0	21.4	23.0	20.9	10.5	14.1	16.9	21.5	23.2	16.7	20.6	12.8	14.0	15.1	15.4	20.5	23.6	15.4	18.1	14.7	15.8	21.0	16.7	12.8	23.3	26.9	17.0	22.9	20.6	11.0	16.5	21.7	20.4	10.9	28.6	19.7	14.9	20.3	16.4	13.0	10.2	23.3	24.9	14.7	18.0	20.7	21.0	7.3	6.8	11.6	10.5	6.5	12.9	4.9	8.2	3.6	6.0	8.1	14.0	15.0	6.3	8.8	14.1	13.0	16.0	3.5	5.0	5.8	7.1	13.4	14.7	5.9	8.7	12.9	23.0	2.5	4.9	6.8	4.5	4.4	14.9	8.0	3.5	11.6	14.4	9.3	11.8	17.6	13.7	5.4	9.8	5.8	14.7	3.8	3.3	9.7	6.9	10.8	4.9	3.4	14.2	4.5	14.1	5.9	4.6	4.3	5.4	10.2	8.0	11.3	5.0	15.5	11.3	5.1	2.9	5.9	15.0	2.4	2.3	5.4	18.9	11.0	9.3	5.1	6.5	11.6	4.8	7.7	12.9	7.3	8.5	6.6	6.8	5.2	9.3	7.9	5.5	6.5	10.5	2.6	9.0	4.9	16.1	17.2	16.0	21.4	15.1	15.4	14.7	15.8	17.0	10.2	20.8	17.6	31.9	25.7	23.4	13.5	16.2	22.9	24.1	34.2	24.4	15.7	40.8	24.9	34.0	26.6	23.2	39.5	0.0	39.3	52.7	23.5	33.0	19.7	18.7	34.1	19.1	18.5	21.5	27.2	9.5	19.0	26.9	21.9	53.3	36.4	17.1	32.5	59.6	17.0	30.7	17.2	25.8	29.7	25.0	38.2	23.7	55.6	34.1	30.0	39.1
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 78.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 13.1;classical monocyte: 39.7;eosinophil: 24.5;intermediate monocyte: 22.9;myeloid DC: 23.8;neutrophil: 31.3;non-classical monocyte: 16.3"	"Group enriched"	"Detected in all"	5	"dendritic cells: 23.8;granulocytes: 31.3;monocytes: 39.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		13000	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	27.0	18.6	14.8	21.1	21.9	37.5	16.6	14.1	29.2	16.4	15.2	26.2	13.4	11.6	28.9	15.9	18.9	17.4	15.1	12.3	14.0	13.1	13.1	11.8	18.4	18.8	14.8	17.1	15.5	13.1	18.7	23.0	18.7	21.6	12.9	17.8	19.3	16.6	11.6	15.8	22.2	16.9	18.3	16.6	19.7	13.1	19.7	13.9	17.7	12.7	12.2	21.6	16.5	15.2	4.0	23.8	31.3	39.7	5.9	4.8	14.2	18.4	14.6	6.5	3.4	11.5	15.2	32.4	17.4	22.7	17.4	20.3	6.2	16.8	8.5	10.6	15.4	18.1	5.7	7.2	24.4	30.0	7.5	9.1	6.1	14.1	7.4	15.2	17.6	20.3	15.6	11.3	33.7	21.2	18.0	24.0	5.4	9.0	7.0	24.1	12.0	5.0	8.2	5.1	8.5	18.9	6.3	7.8	7.5	13.1	13.3	5.8	5.7	12.4	10.5	6.7	8.4	11.4	17.2	16.3	14.3	10.4	9.4	24.3	4.5	11.7	14.3	23.2	16.6	19.3	13.1	39.7	24.5	4.8	22.9	3.7	4.0	4.0	4.5	23.8	3.7	3.5	4.2	31.3	5.9	16.3	4.2	3.4	14.2	14.8	21.9	14.1	29.2	14.0	13.1	14.8	17.1	21.6	13.9	0.0	9.8	6.1	6.1	9.8	11.1	3.9	0.0	12.0	5.7	7.0	17.7	13.7	6.6	10.0	41.0	10.5	6.9	23.3	11.3	14.0	8.9	5.5	14.9	7.8	50.1	19.1	10.9	20.9	20.3	78.6	9.5	19.9	3.3	9.0	7.0	9.3	12.7	7.0	9.2	5.4	12.5	6.5	5.1	19.5	11.5	6.8	16.0	10.0	7.3	7.3
ATG9A	"APG9L1, FLJ22169"	ENSG00000198925	"Autophagy related 9A"	Q7Z3C6	2	219219380-219229717	"Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 59.5;Late spermatids: 76.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059551	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA059551: AB_2684060"	"unprognostic (1.53e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (8.99e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.95e-2)"	13.9	14.3	15.2	9.0	26.1	23.3	13.2	26.7	37.9	12.2	15.0	23.8	10.0	17.1	14.9	9.4	17.6	10.4	13.3	23.4	14.2	13.2	12.6	21.0	13.6	10.2	18.5	14.0	12.9	16.7	27.0	10.8	20.3	20.6	12.8	14.3	12.5	14.0	14.9	61.3	17.5	19.8	18.0	14.3	13.0	13.0	47.0	16.3	7.8	13.1	16.6	12.6	14.7	12.3	5.0	6.6	8.8	16.8	8.4	7.6	8.5	9.6	12.7	9.9	22.9	20.5	21.6	12.8	18.0	21.3	25.3	23.1	19.2	13.5	2.4	14.5	29.5	20.3	21.5	16.2	20.7	19.3	7.8	24.6	19.4	32.8	22.0	20.4	5.2	14.9	21.6	34.4	26.3	24.7	23.1	25.9	6.3	26.4	9.9	17.5	12.6	4.2	10.8	6.9	9.6	10.1	5.7	13.2	9.8	14.8	14.3	15.3	8.9	18.2	16.9	15.9	21.1	6.2	12.5	17.5	25.2	11.7	10.2	16.2	5.3	5.0	4.0	20.5	12.1	13.6	4.8	9.4	4.3	6.2	14.4	6.6	5.0	4.9	7.6	6.6	3.4	4.7	5.5	8.8	8.4	16.8	2.9	5.6	8.5	15.2	26.1	26.7	37.9	14.2	13.2	18.5	14.0	20.6	16.3	0.0	5.0	9.9	6.8	6.9	16.0	30.7	20.4	1.4	3.4	0.0	13.7	21.5	0.0	0.1	59.5	11.7	32.9	23.3	0.4	19.3	9.8	12.3	10.3	30.8	9.9	20.6	13.3	16.0	11.2	76.7	13.0	2.2	10.1	0.0	15.5	20.3	0.2	23.0	8.1	0.1	13.0	12.9	6.6	21.6	12.5	9.7	29.1	10.2	15.3	5.9
ATG9B	"APG9L2, FLJ14885, NOS3AS, SONE"	ENSG00000181652	"Autophagy related 9B"	Q674R7	7	151012209-151024499	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"placenta: 67.1"	"Cell type enhanced"	"Detected in many"	21	"Early spermatids: 27.7;Late spermatids: 21.7;Syncytiotrophoblasts: 96.6"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in many"	4	"memory CD4 T-cell: 6.0;naive CD4 T-cell: 11.0;naive CD8 T-cell: 4.1;T-reg: 5.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 11.0"	"Group enriched"	"Detected in some"	5	"BEWO: 17.0;CAPAN-2: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.59e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.79e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.08e-6)"	"unprognostic (2.82e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.63e-1)"	0.0	0.5	0.0	0.2	8.8	0.1	0.1	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.5	1.2	15.4	1.1	0.1	0.0	0.0		0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	6.1	67.1	0.3	0.0	0.0	0.0	0.4	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	8.8	10.5	0.0	0.1	1.6	0.8	0.2	0.1	0.4	11.0	1.9	0.7	0.0	0.9	0.2	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.1	5.5	0.4	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.7	1.1	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	2.0	0.5	0.7	0.0	1.5	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	1.3	0.0	1.2	1.1	6.0	1.6	0.0	1.6	11.0	4.1	0.0	0.4	0.1	0.8	5.9	1.9											0.0	0.0	3.2	0.2	0.0	1.7	1.1	0.0	16.0	0.0	0.0	0.0	6.6	0.0	0.3	27.7	1.0	0.0	0.0	0.2	2.3	0.0	0.3	14.9	0.0	1.7	0.0	0.0	3.7	0.0	21.7	0.6	0.2	0.0	0.0	0.0	0.5	2.4	0.0	0.7	0.0	0.4	0.0	0.2	16.9	10.4	0.3	96.6	2.2	0.0	1.1
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 202.5;Alveolar cells type 2: 171.3;Cone photoreceptor cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	11.1	11.5	7.2	8.3	16.4	15.7	7.9	5.0	12.5	13.6	5.8	24.4	8.7	9.5	13.7	9.2	8.5	10.8	14.6	19.6	7.2	5.4	12.9	12.3	36.9	7.5	17.7	6.9	8.6	13.2	36.1	17.8	11.2	12.8	5.0	3.6	10.0	12.0	9.0	11.2	11.4	8.7	9.1	12.5	10.2	6.1	9.7	16.2	2.1	16.4	6.4	6.0	5.7	11.3	4.2	1.1	6.4	3.1	0.0	1.0	0.6	14.0	7.2	9.1	10.7	4.6	6.3	16.2	6.7	3.9	5.7	4.7	22.6	16.3	7.1	8.2	5.6	7.4	12.0	8.2	5.5	5.6	7.1	7.7	8.2	6.0	11.7	7.3	15.3	13.4	4.2	4.3	6.9	4.2	4.6	15.0	6.5	5.6	1.2	4.0	5.3	6.9	9.7	3.9	16.1	5.1	6.1	3.7	4.0	31.3	3.3	14.6	4.0	6.5	8.5	5.6	12.4	3.2	20.5	9.8	0.0	12.5	7.4	5.0	3.9	7.5	3.0	2.5	14.5	6.3	0.0	2.3	3.1	1.0	3.1	0.6	1.3	0.6	0.5	1.1	4.2	0.7	0.4	6.4	0.0	2.7	1.1	0.1	0.6	7.2	16.4	5.0	12.5	7.2	5.4	17.7	6.9	12.8	16.2	202.5	171.3	5.6	2.8	9.6	29.4	38.0	35.7	16.0	45.5	15.7	221.9	0.6	5.0	31.2	0.7	19.8	4.2	0.0	10.0	26.5	10.6	5.3	11.5	13.2	17.6	12.7	11.5	24.5	33.5	1.4	10.3	21.3	10.1	7.2	3.3	10.4	18.9	5.8	4.6	15.8	44.2	0.0	5.1	3.9	9.0	8.4	7.2	5.7	5.2	3.7
ATP11B	"ATPIF, ATPIR, KIAA0956"	ENSG00000058063	"ATPase phospholipid transporting 11B (putative)"	Q9Y2G3	3	182793500-182921635	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA036237, HPA036238"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite, Cytosol"		"HPA036237: AB_10673123, HPA036238: AB_10670792"	"unprognostic (4.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.35e-1)"	16.8	7.9	7.7	19.7	9.8	35.4	17.0	18.4	9.4	20.5	21.6	8.9	14.3	13.6	15.0	11.7	37.3	11.8	12.7	21.1	6.9	5.9	13.7	14.3	19.4	20.3	10.3	5.7	15.2	14.6	21.0	26.0	8.0	8.3	16.8	16.9	9.8	19.7	13.8	13.1	21.8	22.8	16.5	11.3	23.4	27.6	22.8	8.9	49.0	10.8	20.4	21.9	22.7	25.5	3.6	4.2	7.5	1.8	3.0	3.4	1.3	22.7	3.3	7.2	10.0	15.3	16.8	6.6	10.5	14.5	8.2	9.6	8.1	11.8	10.6	18.0	15.1	17.1	13.8	8.5	10.8	14.3	23.4	6.8	25.4	4.4	1.7	8.9	20.0	16.3	11.3	12.3	9.2	13.3	12.1	12.8	16.9	9.0	32.9	13.2	7.7	16.6	6.4	5.1	12.9	6.4	6.9	21.0	12.7	9.9	19.1	4.3	7.7	29.3	3.7	12.8	6.8	4.1	14.9	12.6	12.5	13.5	10.7	18.2	45.0	40.2	19.8	8.6	8.6	7.3	7.5	1.7	7.2	3.1	1.8	3.0	3.6	2.7	3.1	1.9	2.4	2.3	3.4	6.8	3.0	1.7	4.2	2.0	1.3	7.7	9.8	18.4	9.4	6.9	5.9	10.3	5.7	8.3	8.9	14.9	10.4	9.7	20.0	30.5	11.4	15.9	17.8	6.7	11.4	19.2	13.7	9.6	0.0	10.9	27.7	14.5	26.1	46.7	14.4	3.2	14.9	34.3	10.5	13.6	9.2	36.5	6.4	14.1	17.8	19.9	17.8	17.7	13.5	5.4	27.5	8.1	20.8	27.1	19.8	6.2	28.3	19.4	16.5	15.4	10.7	39.0	8.0	24.9	20.4	44.2
ATP11C	"ATPIG, ATPIQ"	ENSG00000101974	"ATPase phospholipid transporting 11C"	Q8NB49	X	139726346-139945276	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"monocytes: 47.7;Spermatogonia: 49.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030830	Approved					NA	NA					"HPA030830: AB_10601336"	"unprognostic (8.94e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.18e-2)"	12.8	7.0	4.8	7.6	10.6	4.6	9.6	8.0	5.8	13.1	8.8	5.3	30.2	4.8	12.0	9.5	7.3	9.1	7.4	5.2	6.7	4.5	10.8	41.4	6.7	11.2	9.6	3.2	13.1	4.6	6.8	4.2	4.6	9.5	11.5	6.4	10.7	5.8	21.4	6.6	5.6	7.8	11.3	6.3	14.4	7.1	7.9	9.7	14.9	6.1	4.0	7.4	12.7	12.2	2.8	2.1	5.1	1.7	3.5	2.5	0.5	9.4	4.0	8.4	13.6	12.5	17.0	10.6	11.4	15.3	9.2	12.8	3.6	7.7	13.6	25.7	16.1	6.1	8.0	20.1	5.2	14.5	12.4	11.8	6.9	8.9	7.0	13.9	11.9	4.4	11.2	3.5	10.0	8.6	10.3	15.9	10.6	7.7	10.5	12.1	5.1	10.9	8.1	14.1	0.0	7.7	11.0	9.0	11.3	7.8	15.8	6.5	10.8	4.5	0.5	5.9	8.2	3.4	6.6	17.8	12.6	4.2	15.2	15.4	3.0	2.9	10.8	5.8	15.0	6.3	5.1	1.5	0.4	1.2	1.0	2.5	2.8	1.4	1.1	1.2	2.7	1.4	2.2	2.8	3.5	1.7	2.1	1.0	0.5	4.8	10.6	8.0	5.8	6.7	4.5	9.6	3.2	9.5	9.7	14.9	9.6	13.0	14.5	12.9	1.6	3.9	2.5	5.3	11.4	10.4	0.0	1.7	1.7	4.8	9.9	20.3	4.5	0.0	8.5	10.5	16.6	10.9	9.2	43.9	7.9	0.0	8.7	28.8	29.5	8.5	13.3	8.6	10.1	47.7	6.0	2.8	6.4	5.8	14.5	8.2	3.4	0.0	20.6	23.2	49.4	11.8	5.6	8.7	4.5	13.6
ATP12A	"#945, 2, ATP1AL1, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680411-24712493	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 12.3;lymphoid tissue: 38.4"	"Group enriched"	"Detected in some"	7	"Ciliated cells: 5.3;Club cells: 18.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Cell type enriched"	"Detected in single"	5	"T-reg: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enriched"	"Detected in some"	8	"SuSa: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039526	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.2	1.3	0.4	0.1	0.0	0.0	0.0	0.2	0.2	12.3	0.1	0.0	0.1	0.3	0.2	8.8	0.1	6.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	5.8	0.4	0.3	2.2	0.0	0.4	0.0	0.1	9.8	0.1	0.0	0.1	0.1	0.1	1.0	0.0	1.2	0.2	2.9	38.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.2	1.3	0.3	0.2	0.1	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.3	0.0	5.3	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.2
ATP13A1	"ATP13A, CGI-152, FLJ31858, KIAA1825"	ENSG00000105726	"ATPase 13A1"	Q9HD20	19	19645198-19663693	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031798, HPA049717"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA031798: AB_2674048, HPA049717: AB_2680858"	"unprognostic (2.08e-1)"	"unprognostic (4.92e-2)"	"unprognostic (4.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.40e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.43e-3)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-1)"	13.7	20.8	18.6	22.6	20.4	16.0	15.4	19.9	22.4	16.6	15.3	18.9	11.7	20.5	19.1	13.3	17.5	17.4	15.8	11.4	14.4	11.5	17.6	22.9	15.6	23.9	21.6	14.5	24.6	23.4	38.1	21.0	15.4	15.7	16.8	15.0	18.4	18.9	16.8	13.5	17.0	23.2	13.2	16.1	29.9	18.1	16.7	20.7	24.7	23.1	11.0	22.2	15.4	15.6	3.1	8.1	4.1	10.8	1.8	4.5	2.6	12.3	17.4	9.6	20.7	15.4	10.3	26.1	11.2	15.7	9.7	9.9	16.6	21.1	17.1	19.3	13.2	5.5	6.9	14.5	14.3	5.3	6.2	30.1	9.3	17.4	13.0	15.9	17.6	27.8	14.8	13.5	10.5	12.7	10.8	7.0	12.5	16.0	38.3	9.6	20.4	11.8	12.7	17.5	15.4	21.4	9.4	6.8	38.0	10.3	17.2	13.3	22.5	10.3	16.7	11.6	4.7	10.5	19.3	11.1	20.6	3.1	23.3	13.4	31.2	18.6	10.2	14.4	22.7	15.4	0.0	4.2	4.1	3.9	7.4	4.2	3.1	4.5	4.1	8.1	2.7	3.0	3.7	0.1	1.8	10.8	6.3	3.7	2.6	18.6	20.4	19.9	22.4	14.4	11.5	21.6	14.5	15.7	20.7	8.9	8.0	20.4	6.7	5.3	10.5	4.7	10.2	2.7	3.4	14.0	17.7	16.5	1.7	16.9	8.1	6.8	26.2	0.0	15.7	15.4	8.2	10.0	5.7	12.1	18.3	4.8	17.9	11.1	12.1	3.6	13.0	9.2	6.8	11.8	19.8	12.0	14.5	20.4	9.2	6.2	10.7	6.5	5.4	12.1	14.3	5.4	12.8	7.5	17.7	5.5
ATP13A2	"CLN12, HSA9947, PARK9"	ENSG00000159363	"ATPase 13A2"	Q9NQ11	1	16985958-17011928	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"plasmacytoid DC: 17.9"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 17.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037038, CAB037111, HPA050910, HPA054717"	Enhanced					NA	NA					"CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: AB_2681269, HPA054717: AB_2682583"	"unprognostic (3.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (1.04e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.84e-3)"	9.6	12.3	21.9	16.3	25.8	8.7	6.7	25.5	45.3	6.0	12.5	12.0	4.7	10.4	5.3	6.1	8.9	7.1	7.6	4.5	23.8	34.6	6.5	2.5	9.6	13.2	28.4	20.3	5.3	30.1	7.8	22.2	10.5	52.2	7.2	8.3	9.6	15.6	7.2	7.5	10.0	11.1	7.3	10.9	16.1	10.7	6.2	9.9	5.2	8.6	2.9	8.1	9.2	5.2	2.1	17.9	0.4	2.9	2.2	2.5	1.1	10.2	10.9	6.0	23.1	5.6	4.8	15.8	6.0	5.7	6.6	6.9	19.0	12.0	4.7	25.6	9.9	5.7	16.2	11.9	21.8	2.3	6.2	22.8	15.9	10.2	9.9	7.3	5.8	7.6	3.8	12.1	18.5	13.5	21.4	12.8	12.2	10.2	8.8	26.8	8.4	6.7	3.2	8.8	24.7	7.4	7.4	22.4	18.2	7.4	15.7	16.0	10.3	27.0	35.1	22.7	7.7	11.8	7.1	12.8	7.3	13.8	12.2	12.0	1.8	2.1	4.8	13.8	31.7	11.6	0.0	1.3	0.3	2.4	2.9	2.5	1.2	1.9	2.0	0.4	2.1	1.0	1.4	0.4	2.2	2.7	17.9	1.5	1.1	21.9	25.8	25.5	45.3	23.8	34.6	28.4	20.3	52.2	9.9	0.0	2.1	3.7	6.3	5.8	30.8	3.2	12.7	2.7	1.2	7.0	33.4	5.1	5.0	12.9	0.9	8.4	28.1	0.0	21.6	28.3	4.7	10.7	9.2	3.2	9.2	44.5	7.5	4.3	12.1	0.2	4.9	4.1	5.0	2.8	12.9	37.2	40.5	45.6	6.0	5.7	34.3	0.0	3.8	12.6	14.9	4.5	7.8	8.7	13.3	10.6
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193402077-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 46.4;parathyroid gland: 52.5;thyroid gland: 51.2"	"Cell type enhanced"	"Detected in many"	19	"Alveolar cells type 1: 59.6;Alveolar cells type 2: 19.6;Cholangiocytes: 12.7;Ciliated cells: 13.4;Club cells: 22.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA051932			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.6	0.7	11.2	0.6	11.1	0.6	17.8	2.6	10.1	1.8	2.2	8.4	9.0	0.9	0.6	46.4	11.8	2.7	4.3	0.6	11.1	5.1	0.8	0.7	22.0	0.8	7.5	7.7	0.8	3.9	52.5	3.5	0.6	9.0	0.6	3.2	0.5	4.5	16.7	0.6	11.2	0.6	0.7	6.1	0.7	7.6	0.8	7.5	0.0	51.2	7.8	9.5	0.6	3.7	0.4	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.1	0.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	9.4	0.2	0.1	1.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	1.9	1.0	1.5	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	11.2	11.1	2.6	10.1	11.1	5.1	7.5	7.7	9.0	7.5	59.6	19.6	0.0	0.0	0.1	1.9	0.4	12.7	13.4	22.7	0.0	0.0	0.8	0.0	2.1	0.3	0.0	0.0	0.0	0.2	0.1	0.2	0.0	1.1	0.0	0.2	1.6	0.0	1.8	0.8	0.8	0.0	0.6	1.7	0.0	1.5	0.6	1.2	1.7	0.4	0.2	0.9	0.0	0.0	0.7	1.2	1.4	0.6	0.8	1.7	0.0
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 195.4;parathyroid gland: 194.4"	"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 917.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 254.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced					NA	NA		380000			"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (6.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.98e-8)"	"unprognostic (4.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.01e-4)"	17.4	25.6	22.4	16.2	40.3	10.5	26.9	74.2	67.4	17.8	121.9	14.2	56.1	92.3	13.1	38.3	34.9	17.7	65.8	41.1	26.1	18.7	162.7	34.6	35.1	9.6	19.2	27.6	17.4	78.6	194.4	25.0	19.2	34.1	22.1	65.7	24.1	84.4	53.7	19.0	40.5	195.4	17.7	20.7	13.7	25.0	17.0	13.9	9.1	101.2	13.7	16.2	14.2	23.1	10.3	22.0	6.4	29.7	10.4	30.2	17.2	33.7	12.4	12.9	6.5	26.0	25.3	66.6	20.2	40.3	24.9	35.4	49.8	24.2	26.7	28.6	23.9	25.3	44.1	25.5	42.6	36.3	9.8	28.3	15.5	23.5	42.0	19.9	38.9	21.9	28.1	71.5	29.0	38.3	35.2	30.5	16.3	25.6	25.8	22.0	67.0	15.7	14.1	30.4	53.6	25.0	15.2	30.3	23.6	90.1	34.8	12.7	11.2	31.4	59.6	254.2	33.2	15.7	22.6	26.9	14.2	19.9	36.7	40.9	12.5	9.7	20.5	43.6	22.5	83.4	6.4	13.3	6.1	23.2	20.9	24.8	10.3	26.4	24.9	22.0	5.3	30.2	22.0	1.6	10.4	29.7	11.1	20.3	17.2	22.4	40.3	74.2	67.4	26.1	18.7	19.2	27.6	34.1	13.9	256.1	246.7	58.7	265.3	245.9	76.0	62.7	540.1	113.8	203.6	731.0	375.0	70.1	316.7	432.8	25.0	117.9	917.6	93.5	278.3	130.8	110.9	297.5	43.8	66.4	114.8	96.9	169.4	90.9	77.6	11.5	109.0	130.5	197.4	47.7	304.0	513.0	192.4	264.8	94.7	289.6	141.6	32.3	179.2	17.9	27.5	235.0	56.5	95.6	365.5	236.0
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"brain: 109.8;skeletal muscle: 305.8"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 142.4;Muller glia cells: 63.9;Peritubular cells: 37.1;Sertoli cells: 84.1;Smooth muscle cells: 32.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 32.9;HHSteC: 9.6;RH-30: 10.7;U-87 MG: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022230	Enhanced					NA	NA					"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	12.6	3.9	61.4	2.8	80.1	2.3	6.5	30.4	109.8	4.7	6.6	27.4	2.4	3.7	4.2	7.4	15.3	6.0	5.3	35.4	42.2	27.0	3.3	2.5	3.8	2.4	45.6	37.9	9.9	2.6	2.4	4.6	3.6	58.0	13.8	5.6	12.5	3.1	14.2	305.8	2.8	4.4	5.4	51.5	2.7	2.8	3.9	28.3	0.0	2.6	17.7	2.5	5.5	1.3	0.6	1.4	1.7	0.4	0.6	0.5	0.3	0.0	0.0	32.9	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	2.9	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	1.3	0.4	0.3	0.3	0.3	0.2	0.4	0.3	0.2	0.7	0.6	0.3	0.5	1.7	0.6	0.2	1.4	0.2	0.3	61.4	80.1	30.4	52.0	42.2	27.0	45.6	37.9	58.0	28.3	0.0	0.0	0.0	0.8	0.5	0.7	142.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	26.7	0.0	0.0	0.0	0.0	63.9	0.0	0.0	37.1	0.0	1.9	84.1	32.5	0.3	0.2	0.5	0.1	0.0	0.0	0.5
ATP1A3	DYT12	ENSG00000105409	"ATPase Na+/K+ transporting subunit alpha 3"	P13637	19	41966582-41997497	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Deafness, Disease mutation, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 146.4;heart muscle: 78.3"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 387.3;Cone photoreceptor cells: 161.0;Horizontal cells: 201.8;Late spermatids: 93.3;Rod photoreceptor cells: 178.0"	"Group enriched"	"Detected in many"	6	"glioma: 21.6;testis cancer: 4.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.2;memory CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"Daudi: 20.7;JURKAT: 13.5;Karpas-707: 13.2;REH: 13.0;SCLC-21H: 49.1;SH-SY5Y: 21.1"									"CAB033630, HPA045367, HPA056446"	Enhanced	Approved				NA	NA					"CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136"	"unprognostic (1.90e-1)"	"unprognostic (8.65e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.66e-2)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (3.44e-4)"	"prognostic favorable (6.15e-5)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.27e-1)"	1.9	12.8	34.0	2.5	30.8	2.1	1.8	42.8	146.4	1.8	2.4	4.8	0.0	2.4	1.8	1.8	2.0	1.8	1.9	78.3	48.3	54.6	1.8	1.8	1.9	2.3	39.9	42.6	1.8	2.3	1.8	3.0	1.8	94.4	1.8	2.3	17.3	2.2	1.8	1.8	2.0	2.7	2.2	18.5	2.1	2.0	18.6	6.9	0.0	1.8	0.0	2.1	1.9	0.1	0.3	0.1	0.0	0.0	0.1	2.2	0.3	0.0	0.8	0.3	8.7	0.0	0.0	0.0	0.1	0.0	0.6	0.6	0.3	1.6	20.7	0.9	0.1	2.0	0.2	6.1	0.0	0.2	3.9	1.1	1.8	0.0	0.1	0.0	0.0	6.8	0.0	0.0	0.0	0.1	0.1	0.0	13.5	0.0	13.2	0.1	0.3	3.7	0.0	1.1	2.9	5.3	13.0	7.1	0.6	0.0	0.2	49.1	21.1	0.1	1.6	0.0	0.0	1.3	0.9	0.0	1.1	1.1	0.0	0.4	1.3	0.9	4.7	1.9	7.2	0.2	0.0	0.0	0.0	2.2	0.0	0.2	0.3	0.6	1.7	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.1	0.7	0.3	34.0	30.8	42.8	66.6	48.3	54.6	39.9	42.6	94.4	6.9	0.0	7.9	0.5	0.3	0.2	387.3	15.7	0.0	0.0	0.0	0.0	161.0	0.0	0.0	0.0	33.6	0.3	0.0	0.0	0.0	0.1	0.6	0.2	1.1	0.0	0.2	201.8	0.0	0.0	0.0	93.3	1.7	0.2	0.0	0.0	0.0	25.9	0.0	0.0	0.4	0.0	178.0	0.0	0.0	21.3	3.2	0.3	0.2	1.9	0.0	0.4
ATP1B1	ATP1B	ENSG00000143153	"ATPase Na+/K+ transporting subunit beta 1"	P05026	1	169105697-169132722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 239.7"	"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 1634.8;Proximal tubular cells: 927.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 10.5;gdT-cell: 2.9;intermediate monocyte: 3.0;memory CD4 T-cell: 3.4;myeloid DC: 8.4;NK-cell: 5.6;T-reg: 9.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 127.3;RPTEC TERT1: 68.9;SH-SY5Y: 57.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012911	Enhanced					NA	NA		4100000			"HPA012911: AB_1845173"	"unprognostic (4.20e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (7.08e-7)"	"unprognostic (1.11e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.39e-2)"	3.9	26.3	48.7	8.6	45.1	1.3	14.9	39.4	92.1	8.7	43.8	34.5	11.3	61.3	19.8	11.2	28.7	9.4	50.1	36.0	86.3	68.2	239.7	30.6	16.9	1.9	82.3	52.6	11.5	33.0	130.6	16.7	8.3	111.5	9.8	34.8	15.5	55.7	15.4	55.1	11.2	51.2	17.8	64.0	9.6	69.5	8.4	25.9	0.9	60.1	23.7	13.9	12.3	9.0	1.4	8.4	10.5	3.0	5.6	9.1	1.4	12.3	30.2	9.8	7.5	2.3	0.4	3.4	6.1	5.0	6.4	6.7	36.8	25.0	0.0	23.1	4.8	7.2	14.6	5.4	11.6	6.6	0.1	2.4	0.7	22.8	17.1	3.7	0.5	1.1	1.3	2.9	4.7	6.1	11.2	5.8	0.9	0.1	0.1	7.3	4.7	1.0	1.9	3.9	127.3	6.5	0.1	11.9	2.1	68.9	15.4	7.8	57.2	36.1	36.4	1.6	12.5	7.5	1.2	12.3	4.9	13.2	8.3	21.8	0.7	0.9	0.2	5.9	1.8	6.6	10.5	1.0	0.1	2.9	3.0	1.5	1.4	3.4	1.1	8.4	0.2	1.0	1.1	0.3	5.6	0.9	0.4	9.1	1.4	48.7	45.1	39.4	92.1	86.3	68.2	82.3	52.6	111.5	25.9	223.4	199.8	17.7	144.1	46.6	22.3	136.8	749.1	187.4	257.0	1634.8	13.7	3.9	782.5	509.0	2.8	15.2	580.2	0.0	519.8	7.5	62.9	68.0	22.0	232.9	298.5	548.2	154.6	46.6	63.5	4.1	83.1	111.4	234.5	43.3	240.2	24.3	309.0	614.7	140.0	927.9	48.2	6.5	23.6	8.6	62.0	27.7	8.2	25.4	319.0	251.2
ATP1B3	"CD298, FLJ29027"	ENSG00000069849	"ATPase Na+/K+ transporting subunit beta 3"	P54709	3	141876124-141926514	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 712.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020697, HPA048963"	Enhanced		Supported	"Plasma membrane"		NA	NA		100000	"Plasma membrane"		"CAB020697: , HPA048963: AB_2680574"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (5.19e-5)"	"unprognostic (2.60e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (8.11e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.19e-3)"	"unprognostic (6.15e-2)"	50.5	79.9	12.7	26.3	23.3	17.5	105.9	25.7	35.1	17.7	48.2	9.1	16.8	37.3	17.9	14.6	36.9	20.0	47.8	44.0	16.0	18.9	24.9	7.7	44.9	43.4	21.3	12.8	34.7	11.5	6.3	33.8	32.6	43.3	20.5	58.1	23.9	18.4	24.8	7.4	85.4	57.3	24.3	28.4	16.5	13.5	21.1	13.6	14.5	15.6	41.4	18.4	21.9	31.5	10.4	26.8	13.6	60.9	7.8	20.0	22.5	46.4	28.9	27.2	25.5	73.0	21.3	62.3	54.5	49.6	39.7	45.0	44.9	23.4	37.9	49.3	41.4	57.5	102.0	26.9	26.0	45.2	20.6	34.2	33.1	32.5	29.1	28.9	27.2	26.0	22.5	62.3	31.1	30.1	28.4	42.3	26.6	22.7	33.7	40.6	21.1	27.6	45.6	37.8	64.7	13.9	38.0	20.4	38.6	33.3	35.9	22.4	15.3	71.2	33.1	73.1	49.4	25.2	33.2	29.4	34.9	13.4	52.1	31.7	25.1	32.3	61.1	45.5	29.6	28.6	13.6	27.1	8.9	19.2	44.5	14.1	10.4	15.6	20.0	26.8	7.5	9.2	16.7	1.9	7.8	60.9	16.4	16.9	22.5	12.7	23.3	25.7	35.1	16.0	18.9	21.3	12.8	43.3	13.6	53.6	46.5	109.5	333.7	437.8	35.4	16.7	20.4	10.7	43.3	209.3	23.6	255.9	34.9	71.5	391.5	178.3	384.3	140.2	52.8	199.5	109.5	121.1	129.2	6.0	276.1	23.8	53.9	79.8	137.2	712.2	78.6	209.3	210.9	518.4	67.0	42.5	54.6	123.0	64.3	29.8	25.4	122.9	189.2	42.4	191.3	362.3	327.4	66.0	109.6	362.4
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 188.3;skeletal muscle: 319.7"	"Cell type enriched"	"Detected in all"	12	"Cardiomyocytes: 1592.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					NA	NA		38000000			"HPA062605: AB_2684805"	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	8.4	8.8	7.3	8.5	14.5	5.7	7.5	7.4	20.8	8.2	9.6	8.0	8.3	7.3	9.4	10.3	24.1	9.4	9.3	188.3	10.1	5.0	6.7	11.8	8.9	5.6	5.6	13.1	8.5	7.6	8.7	6.1	8.1	10.2	13.0	11.2	22.3	18.3	9.6	319.7	9.3	9.3	14.3	7.4	5.4	7.9	11.9	7.1	3.1	12.6	51.3	12.7	13.4	11.4	0.8	2.2	0.2	4.4	1.7	1.7	0.7	35.5	70.9	35.9	28.8	23.9	30.6	51.8	44.3	55.8	45.0	30.3	51.2	37.9	43.9	37.5	42.1	34.0	52.0	59.4	70.0	51.2	36.3	29.7	38.3	28.4	29.9	40.6	43.7	37.1	32.1	49.4	57.1	55.4	43.3	34.7	23.0	44.6	21.5	36.6	34.1	23.6	27.1	40.9	36.5	35.9	24.9	32.3	36.2	22.2	73.4	38.0	28.5	55.8	45.8	25.9	34.2	61.6	23.6	37.2	41.7	22.4	27.7	33.8	44.2	53.8	49.2	38.0	18.9	47.2	0.0	1.9	0.0	1.7	4.4	0.9	0.7	1.3	1.1	1.9	0.8	1.3	1.2	0.2	1.7	2.3	2.2	1.2	0.7	7.3	14.5	7.4	20.8	10.1	5.0	5.6	13.1	10.2	7.1	41.7	53.9	23.1	78.3	101.7	60.4	1592.4	45.9	96.4	83.0	48.8	60.9	28.0	1.7	40.8	10.7	37.6	123.8	23.3	60.6	31.5	51.2	89.3	43.9	110.5	56.0	79.4	131.8	41.1	50.1	9.0	28.1	40.7	64.1	19.0	80.6	24.0	82.4	70.2	78.1	23.9	39.0	51.8	126.0	61.6	55.1	95.2	25.6	17.0	66.5	93.6
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 55.1;liver: 15.2;salivary gland: 28.6;skeletal muscle: 30.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 85.3;Hepatocytes: 27.0;Horizontal cells: 98.5"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 5.4;RPMI-8226: 15.3;SCLC-21H: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced					NA	NA					"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	1.0	1.5	7.6	1.0	23.0	0.9	1.0	39.9	55.1	3.0	1.0	2.4	0.0	1.0	3.2	1.1	1.1	4.3	1.0	1.0	10.0	6.2	1.1	15.2	1.0	1.0	7.9	14.7	1.0	1.1	0.9	1.7	0.9	15.5	1.0	1.0	0.7	28.6	0.9	30.3	1.3	1.0	2.3	2.5	1.0	1.0	1.5	4.2	0.0	0.9	0.0	1.0	0.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	15.3	0.0	0.0	5.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	7.6	23.0	39.9	55.1	10.0	6.2	7.9	14.7	15.5	4.2	0.0	0.0	0.0	0.0	0.5	85.3	7.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	27.0	0.0	98.5	0.0	0.6	1.0	5.7	0.0	0.0	3.3	0.0	0.0	14.5	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0
ATP2B4	"ATP2B2, MXRA1, PMCA4"	ENSG00000058668	"ATPase plasma membrane Ca2+ transporting 4"	P23634	1	203626561-203744081	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Muller glia cells: 153.7;Suprabasal keratinocytes: 132.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 59.5;fHDF/TERT166: 45.1;SuSa: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016118, HPA040431"	Enhanced		Supported	"Plasma membrane"		NA	NA		21000	"Plasma membrane"		"CAB016118: AB_2061729, HPA040431: AB_2676980"	"unprognostic (7.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.81e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.52e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-3)"	23.0	14.0	24.8	10.8	14.2	5.9	11.6	9.4	23.6	32.6	44.2	7.5	12.9	5.3	69.6	13.1	20.4	27.0	13.9	24.0	13.1	8.7	5.0	14.2	16.1	5.3	6.4	19.2	21.9	6.4	8.0	4.8	16.2	9.3	17.0	13.4	11.6	7.5	31.5	5.4	22.0	13.2	74.2	5.7	4.8	16.4	13.1	7.5	9.0	8.3	8.4	7.7	32.8	14.2	1.0	4.2	4.5	2.2	4.2	10.4	2.6	9.2	1.7	3.4	3.2	26.0	38.8	18.0	41.8	59.5	7.1	6.1	0.8	4.7	2.1	6.1	45.1	9.5	9.0	4.9	5.8	7.5	26.5	1.7	6.2	8.3	0.5	9.3	8.8	11.0	28.1	5.7	22.8	3.5	17.3	13.5	12.3	2.7	4.2	5.2	0.5	8.9	2.9	2.0	1.7	5.2	4.7	2.5	3.3	2.4	0.8	1.0	1.4	14.7	2.2	6.6	49.6	1.9	4.3	11.8	17.3	2.5	29.0	10.0	2.8	4.2	1.1	17.3	6.4	5.1	3.0	2.2	0.0	10.4	1.5	7.9	1.0	6.6	8.3	2.4	0.3	1.6	4.2	4.5	4.2	2.2	4.2	6.3	2.6	24.8	14.2	9.4	23.6	13.1	8.7	6.4	19.2	9.3	7.5	83.4	62.7	10.4	15.6	86.3	2.8	64.1	7.6	34.8	40.9	17.4	2.0	22.3	0.0	31.1	4.3	39.1	3.9	23.3	13.2	13.3	48.3	9.5	9.3	15.7	31.0	111.2	23.0	54.6	14.6	1.3	40.6	13.2	25.3	7.2	1.9	153.7	25.2	11.9	35.7	5.0	6.9	19.4	82.4	22.3	2.1	132.0	21.7	45.7	2.6	43.3
ATP2C1	"ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1"	ENSG00000017260	"ATPase secretory pathway Ca2+ transporting 1"	P98194	3	130850595-131016712	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010207, HPA035116, HPA069684"	Supported		Supported	"Golgi apparatus"		NA	NA		28000	"Golgi apparatus"		"CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.06e-6)"	"unprognostic (7.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-1)"	18.6	22.9	29.6	14.5	29.4	20.4	36.8	24.5	34.6	22.2	21.6	23.0	14.3	14.4	19.3	18.0	16.9	23.4	16.8	19.2	31.6	32.3	28.0	17.1	30.7	16.0	31.8	25.4	18.5	14.6	47.6	31.0	19.6	26.7	54.0	22.4	18.1	20.3	16.6	16.1	21.3	16.0	19.2	44.6	11.1	18.7	16.0	25.6	20.5	21.7	15.5	15.4	19.3	29.6	4.7	7.6	21.6	7.0	8.7	7.2	4.9	36.6	14.4	14.5	13.9	40.6	32.9	15.6	40.1	53.5	20.2	25.5	23.4	30.3	13.3	27.9	37.9	28.1	43.7	27.2	22.1	29.6	28.7	9.8	35.4	15.3	10.8	25.9	14.1	43.2	25.8	22.3	21.2	24.1	36.9	21.3	16.9	10.2	24.3	24.8	16.3	13.8	11.3	16.4	20.0	15.7	10.0	14.4	20.9	37.2	24.7	22.4	13.4	34.5	10.8	20.2	21.6	16.0	11.6	29.1	21.5	12.0	27.6	18.4	15.7	19.0	19.7	22.2	10.6	17.9	21.6	7.0	12.1	6.3	6.0	5.9	4.7	6.2	5.6	7.6	2.9	4.3	4.3	3.5	8.7	7.0	6.6	7.2	4.9	29.6	29.4	24.5	34.6	31.6	32.3	31.8	25.4	26.7	25.6	35.7	45.2	11.3	32.9	34.9	26.4	27.0	40.8	24.1	23.9	43.6	19.6	13.5	5.0	32.7	12.6	25.1	15.9	0.0	33.1	24.1	29.4	68.4	27.7	24.6	26.6	77.9	34.2	22.7	18.3	14.0	15.0	28.6	20.3	19.8	31.3	22.6	44.4	25.9	13.8	18.6	33.2	6.5	24.2	15.2	14.9	46.2	14.8	13.8	29.3	33.5
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.0;salivary gland: 35.8"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 2: 42.2;Ciliated cells: 72.3;Mucus-secreting cells: 62.9;Undifferentiated cells: 69.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"MCF7: 14.5;OE19: 26.0;RT4: 11.4;SK-BR-3: 20.2;T-47d: 6.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.3	0.0	2.1	8.0	1.5	6.1	2.5	0.2	2.0	3.5	23.0	0.5	1.9	16.3	1.8	1.9	2.7	4.0	18.8	0.4	1.8	1.9	2.6	0.2	21.9	0.2	1.3	0.7	1.3	0.5	0.0	2.9	4.8	0.7	7.9	21.9	1.0	35.8	0.2	0.9	15.2	14.5	0.5	0.6	0.2	3.4	0.4	0.4	0.3	8.2	2.2	8.1	4.8	7.8	0.0	0.0	2.7	0.0	0.0	0.1	0.0	3.6	0.2	0.4	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	3.4	3.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	26.0	0.1	0.0	0.0	0.1	0.0	11.4	2.9	0.0	0.0	20.2	0.1	0.5	6.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.2	2.0	1.8	1.9	1.3	0.7	0.7	0.4	29.8	42.2	0.0	12.3	0.6	1.4	0.6	2.5	72.3	29.6	0.0	0.0	1.9	0.0	7.2	3.0	0.6	15.4	0.0	2.3	2.2	0.3	21.6	9.2	0.0	0.2	0.0	32.8	0.0	0.0	1.1	0.0	0.7	1.7	0.0	62.9	1.3	3.1	17.3	0.0	1.9	5.6	0.0	0.5	0.7	0.6	1.0	20.1	0.0	69.5	9.5
ATP4A	ATP6A	ENSG00000105675	"ATPase H+/K+ transporting alpha subunit"	P20648	19	35550043-35563658	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 120.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 7.3;Late spermatids: 15.2"	"Cancer enriched"	"Detected in single"	21	"stomach cancer: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.2;U-138 MG: 1.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA039154, HPA076684"	Enhanced					NA	NA		790000			"HPA039154: AB_10672772, HPA076684: "	"unprognostic (3.54e-2)"	"unprognostic (6.98e-3)"		"unprognostic (2.77e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-3)"		"unprognostic (4.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	0.1	0.2	0.1	0.1	0.6	0.0	0.1	0.1	0.6	0.1	0.1	3.4	0.1	0.0	0.1	0.1	4.9	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	120.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	1.5	0.3	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.6	0.0	0.0	1.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.6	0.0	0.0	0.0	0.0	0.0
ATP4B	ATP6B	ENSG00000186009	"ATPase H+/K+ transporting beta subunit"	P51164	13	113648804-113658186	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"stomach 1: 156.3"	"Cell type enriched"	"Detected in single"	6	"Distal tubular cells: 1.7"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 8.9"	"Region enriched"	"Detected in single"	9	"cerebral cortex: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 3.9;RPMI-8226: 1.6;SCLC-21H: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045400, HPA052649"	Enhanced					NA	NA					"HPA045400: AB_2679314, HPA052649: AB_2681900"	"unprognostic (9.92e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.66e-1)"	"unprognostic (4.86e-1)"			"unprognostic (6.43e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.78e-2)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	1.0	0.1	0.1	2.0	0.1	0.0	0.1	0.1	1.5	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	6.5	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	156.3	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	3.9	0.0	1.6	0.0	0.0	2.6	0.9	0.2	0.7	0.0	0.0	0.1	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP6AP2	"APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR"	ENSG00000182220	"ATPase H+ transporting accessory protein 2"	O75787	X	40579372-40606848	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease mutation, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 176.7"	"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 584.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003156	Approved					NA	NA					"HPA003156: AB_1078245"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.01e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.86e-2)"	25.0	23.8	33.8	17.4	39.3	30.6	31.7	31.5	76.0	35.0	24.0	22.1	13.0	10.0	30.8	25.5	21.4	22.7	23.9	19.3	35.5	36.7	48.7	30.0	30.2	37.9	32.1	34.7	22.3	16.3	176.7	16.1	30.2	37.8	26.4	25.0	21.0	16.8	31.8	8.7	24.0	16.8	35.7	27.8	22.6	15.8	11.9	17.2	16.2	56.1	12.6	19.1	25.7	20.0	16.1	53.2	60.8	78.0	20.0	29.6	85.8	14.7	19.4	14.2	19.1	94.0	59.9	8.8	33.3	51.7	24.6	28.8	11.2	24.3	8.5	16.6	48.6	25.0	15.2	21.8	25.9	33.7	16.6	17.1	10.6	18.9	10.7	34.6	18.9	19.9	51.8	34.7	30.2	24.3	34.7	32.8	8.0	10.7	23.1	37.2	18.6	8.1	16.4	13.1	23.6	21.9	7.7	24.9	28.6	31.8	16.6	10.2	9.5	32.4	20.2	20.3	51.1	26.2	17.4	32.2	31.0	17.0	37.0	11.2	7.2	12.3	8.4	25.6	16.0	24.1	34.4	78.0	60.8	25.9	55.1	27.0	16.1	26.4	26.6	53.2	15.7	29.6	27.0	39.5	20.0	54.1	19.3	24.7	85.8	33.8	39.3	31.5	76.0	35.5	36.7	32.1	34.7	37.8	17.2	53.6	61.1	73.9	115.8	86.4	152.6	26.9	84.1	85.6	72.8	130.9	51.1	152.0	53.0	120.3	3.0	89.3	48.4	70.0	52.6	93.0	160.2	97.5	86.5	55.7	584.5	178.0	54.9	90.9	237.6	4.3	108.7	238.9	141.7	110.0	52.9	170.2	52.8	49.1	142.1	86.4	64.1	103.5	143.2	80.8	23.0	87.3	145.9	82.0	61.8	109.5
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 66.2;parathyroid gland: 65.6"	"Cell type enhanced"	"Detected in all"	8	"Cone photoreceptor cells: 276.9;Rod photoreceptor cells: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		NA	NA		21000	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (6.90e-4)"	9.4	15.6	19.3	9.3	46.1	9.9	9.1	55.8	66.2	8.0	11.6	25.8	5.1	17.9	11.4	11.1	9.6	9.7	12.2	9.9	23.8	32.8	20.3	11.3	12.7	6.6	23.6	24.8	11.4	9.3	65.6	23.6	11.2	43.3	9.9	11.3	19.7	8.2	10.7	28.9	14.7	12.4	11.7	23.7	11.1	8.8	9.8	13.1	5.2	16.3	6.7	7.8	6.7	6.9	6.3	9.1	14.2	10.5	0.1	2.8	4.2	6.6	13.8	8.5	15.2	14.2	12.4	4.9	4.7	8.8	10.1	13.3	8.8	15.0	1.2	8.7	9.7	13.9	14.5	13.0	8.0	11.8	10.3	13.6	10.7	10.4	6.9	8.8	4.6	19.6	9.1	11.6	16.2	6.9	12.6	7.1	5.0	38.9	42.3	15.0	5.7	1.8	4.1	5.4	8.8	0.1	0.1	8.8	18.6	11.7	5.3	23.4	12.4	7.3	6.7	14.0	11.5	16.3	7.0	4.2	8.6	0.3	12.6	5.6	17.2	23.4	2.5	11.5	0.1	10.0	12.1	10.5	8.0	0.8	3.4	1.2	3.5	0.6	0.1	9.1	6.3	1.0	0.8	14.2	0.1	2.4	4.7	2.8	4.2	19.3	46.1	55.8	65.9	23.8	32.8	23.6	24.8	43.3	13.1	17.9	46.6	27.3	45.1	17.5	158.7	19.5	30.6	6.7	14.8	14.0	276.9	26.4	10.0	14.7	2.4	19.2	44.6	46.7	15.8	13.4	33.9	38.7	23.1	33.6	46.0	90.6	81.5	19.6	33.1	3.1	16.1	25.8	38.8	3.6	23.1	51.9	17.6	38.6	22.3	28.4	349.7	6.5	48.9	38.7	18.5	17.7	83.5	4.4	19.5	10.7
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 40.6;salivary gland: 55.4"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 15.7;Cytotrophoblasts: 11.7;Distal tubular cells: 26.6;Melanocytes: 6.8"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 35.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA018029, HPA064555"	Enhanced		Uncertain	Cytosol		NA	NA			Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.1	0.0	0.5	0.0	0.3	0.0	2.2	0.1	0.4	1.7	0.0	0.3	3.1	0.0	0.3	0.5	2.7	0.0	0.0	0.0	0.4	0.3	40.6	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.6	0.2	1.0	0.2	0.5	0.0	0.3	55.4	1.2	0.0	6.5	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.1	0.0	1.8	7.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.4	1.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	3.1	1.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	3.0	0.1	0.0	0.0	0.0	35.9	1.2	2.0	0.1	0.0	0.1	0.4	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.1	0.4	0.4	0.3	0.3	0.0	0.2	0.1	0.0	0.6	0.0	0.8	0.0	0.0	0.3	0.0	1.4	1.2	15.7	2.0	11.7	26.6	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.3	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.1	4.2	0.0	0.0	1.1
ATP6V0D1	"ATP6D, ATP6DV, P39, VATX, Vma6, VPATPD"	ENSG00000159720	"ATPase H+ transporting V0 subunit d1"	P61421	16	67438014-67481237	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hofbauer cells: 351.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016938	Uncertain					NA	NA					"HPA016938: AB_1845191"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.79e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (5.72e-3)"	"prognostic favorable (1.76e-8)"	"unprognostic (2.72e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.33e-3)"	24.2	41.4	32.0	28.2	58.8	31.0	19.8	41.1	89.9	27.9	36.7	35.3	17.1	30.5	26.8	27.4	33.0	26.3	24.7	27.0	40.4	48.5	34.3	30.6	34.5	29.7	39.6	39.1	17.9	25.7	42.5	40.7	30.1	66.6	23.8	33.0	26.6	23.7	26.3	42.5	30.1	29.6	36.0	24.8	37.0	26.9	40.6	18.9	27.6	35.2	21.3	27.4	26.9	22.0	21.1	53.8	106.5	79.7	16.8	16.0	66.3	18.1	25.9	16.0	20.7	40.9	22.2	15.4	21.7	35.7	44.9	54.1	26.8	19.6	7.6	18.3	31.3	30.2	21.8	23.6	27.2	27.0	9.2	21.7	14.0	15.1	22.3	38.7	13.9	59.0	34.4	27.1	45.3	10.8	16.2	27.9	9.1	15.8	10.1	36.2	43.5	10.3	31.7	15.6	15.9	18.6	18.5	18.8	21.1	27.2	30.4	31.4	14.7	56.7	15.5	23.4	13.5	25.1	21.4	26.8	22.6	9.3	27.7	11.4	17.1	24.1	22.2	31.8	14.9	13.3	29.6	79.7	58.7	16.0	56.9	11.0	21.1	12.0	14.7	53.8	18.9	9.3	11.5	106.5	16.8	51.1	19.3	14.4	66.3	32.0	58.8	41.1	89.9	40.4	48.5	39.6	39.1	66.6	18.9	14.9	47.6	54.7	53.3	65.6	70.5	33.2	56.0	33.5	19.4	64.6	68.7	97.4	154.2	105.3	59.6	41.4	193.6	46.7	97.5	61.6	79.6	47.2	49.6	45.1	351.8	77.9	116.9	45.4	155.0	38.2	54.4	136.8	118.1	170.5	128.1	66.4	83.9	175.4	49.8	124.5	50.6	116.4	56.6	90.0	61.9	76.5	237.2	54.3	73.1	55.8
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747019-113812056	"Disease related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 467.9;Late spermatids: 569.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.6"	"Group enriched"	"Detected in all"	6	"dendritic cells: 16.4;granulocytes: 33.6;monocytes: 15.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		2700000	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	12.8	19.8	24.1	10.4	33.2	7.4	12.7	34.8	52.8	14.0	11.1	10.3	5.6	9.3	7.5	8.2	13.2	10.0	10.8	4.7	26.2	38.2	47.9	18.2	12.3	11.4	25.4	25.0	6.2	10.5	39.3	13.5	12.3	52.0	11.2	11.8	14.7	18.0	8.4	4.5	12.6	7.9	8.2	13.6	13.7	10.9	8.9	8.3	9.6	21.0	5.7	13.6	10.2	8.2	3.8	16.4	33.6	15.4	3.8	3.4	6.0	25.4	11.6	14.6	12.7	30.9	13.8	15.6	13.8	21.1	14.5	20.1	21.8	20.5	20.9	32.9	20.1	16.1	16.6	33.0	18.2	19.1	9.5	9.1	18.5	18.0	16.8	25.5	13.6	21.7	18.6	12.6	18.8	13.2	22.6	23.6	10.6	21.1	15.8	21.5	16.7	9.9	6.1	18.3	17.8	14.6	8.6	10.6	23.7	39.8	24.3	28.3	10.4	24.2	16.5	18.1	21.0	25.0	11.0	21.7	13.6	10.1	9.3	8.2	16.6	17.8	19.3	26.6	17.2	15.0	9.2	15.4	5.2	2.8	11.7	2.6	3.8	2.6	2.7	16.4	2.9	2.5	2.9	33.6	3.8	9.5	4.6	3.4	6.0	24.1	33.2	34.8	52.8	26.2	38.2	25.4	25.0	52.0	8.3	26.8	28.3	28.9	13.2	27.0	92.7	7.9	33.1	14.7	19.4	94.2	39.3	18.1	69.6	25.2	467.9	26.0	24.0	0.0	23.9	18.8	17.8	28.2	10.4	64.4	67.8	95.3	53.6	36.2	95.4	569.6	16.7	67.0	43.9	49.5	25.8	42.1	22.3	24.6	21.5	62.8	37.3	6.5	14.6	25.3	14.3	41.9	36.7	17.1	21.3	21.1
ATP6V1B2	"ATP6B2, HO57, VATB, Vma2, VPP3"	ENSG00000147416	"ATPase H+ transporting V1 subunit B2"	P21281	8	20197367-20226819	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 116.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 69.7;eosinophil: 47.6;intermediate monocyte: 62.5;myeloid DC: 34.5;neutrophil: 116.0;non-classical monocyte: 54.1"	"Group enriched"	"Detected in all"	10	"dendritic cells: 34.5;granulocytes: 116.0;monocytes: 69.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008147	Enhanced		Supported	Vesicles		NA	NA		240000	Vesicles		"HPA008147: AB_1845195"	"unprognostic (1.90e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.25e-2)"	17.1	29.9	31.7	25.8	45.0	14.4	13.2	39.2	72.9	12.2	13.9	15.9	5.5	16.2	10.6	12.2	15.3	10.3	14.8	13.9	33.8	47.8	53.9	18.0	22.8	17.5	46.9	47.1	10.9	12.2	18.8	23.6	18.5	64.2	11.0	16.5	17.3	12.8	10.9	18.2	18.2	21.1	15.0	19.2	20.9	10.7	24.0	12.7	10.3	12.7	9.3	17.5	14.3	12.4	4.9	34.5	116.0	69.7	4.8	7.1	51.1	10.8	18.2	22.7	7.4	31.0	19.2	20.4	24.5	15.7	31.6	32.7	20.5	6.4	19.3	10.0	23.3	32.2	9.3	17.9	16.3	33.7	8.1	12.0	13.4	8.2	15.7	36.4	9.5	28.0	17.1	14.9	19.6	18.1	34.9	19.7	25.8	19.9	18.7	33.7	6.1	27.8	11.3	16.8	16.0	8.0	11.5	29.2	10.0	29.2	17.2	17.6	25.4	11.8	16.0	77.9	19.6	20.9	17.5	20.8	15.9	12.2	26.2	19.5	7.6	10.2	22.7	22.0	22.8	40.3	15.9	69.7	47.6	5.7	62.5	6.2	4.9	5.9	6.1	34.5	4.3	6.1	6.0	116.0	4.8	54.1	8.4	7.1	51.1	31.7	45.0	39.2	69.0	33.8	47.8	46.9	47.1	64.2	12.7	23.8	20.2	30.3	24.8	51.5	100.1	14.0	12.7	12.0	11.4	27.9	96.2	100.2	68.0	38.5	22.5	24.8	23.6	46.7	33.2	46.1	30.0	15.5	21.9	30.6	167.3	179.6	71.4	28.3	171.7	15.9	18.1	165.7	99.5	87.4	19.6	39.2	37.2	20.4	26.5	193.9	117.5	12.9	37.6	83.9	46.7	62.6	104.2	27.7	20.0	18.2
ATP6V1C1	"ATP6C, ATP6D, VATC, Vma5"	ENSG00000155097	"ATPase H+ transporting V1 subunit C1"	P21283	8	103021063-103073051	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023943, HPA057297"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA023943: AB_1845197, HPA057297: AB_2683402"	"unprognostic (5.73e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (3.29e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.83e-1)"	17.1	23.1	25.1	16.8	36.7	6.5	15.7	26.2	58.8	13.6	11.1	11.4	7.6	12.1	14.1	10.9	10.6	12.2	13.7	19.0	28.5	28.0	35.0	18.1	12.9	15.9	23.2	33.3	14.4	12.9	21.3	29.2	20.2	45.1	13.2	13.7	11.5	10.4	12.2	11.7	8.5	12.8	14.5	15.0	14.3	12.1	13.0	12.5	10.7	26.9	8.4	15.6	15.5	10.7	10.6	16.3	27.9	24.3	10.0	12.5	10.8	29.1	17.5	9.3	6.9	24.4	15.8	11.5	21.9	21.8	24.6	29.1	12.9	29.6	18.8	25.1	17.4	39.3	11.8	18.3	17.0	35.2	12.3	14.1	18.3	13.3	15.3	26.0	9.8	22.1	15.1	22.2	33.0	15.9	14.8	18.5	12.2	23.3	15.4	27.3	13.2	18.3	7.2	8.1	26.5	17.0	10.6	16.4	14.2	27.5	21.0	11.9	10.2	12.3	11.7	38.3	17.3	24.5	11.6	22.0	14.3	14.5	31.7	15.3	20.2	7.3	17.9	27.7	20.4	13.8	8.4	17.4	20.6	9.1	24.3	10.2	10.6	7.7	8.9	16.3	10.2	9.0	9.7	27.9	10.0	22.1	8.8	12.5	10.8	25.1	36.7	26.2	58.8	28.5	28.0	23.2	33.3	45.1	12.5	29.8	23.7	18.1	27.2	31.0	29.7	39.1	12.7	41.5	18.2	29.6	15.7	32.6	54.7	34.3	128.0	23.1	13.6	23.3	27.3	30.1	23.0	29.4	23.1	15.3	87.3	35.0	15.0	18.4	45.4	117.5	22.5	45.4	18.6	26.2	12.6	31.4	26.9	14.4	17.3	112.2	20.4	19.4	32.5	10.5	20.2	28.7	62.6	17.5	13.4	25.0
ATP6V1C2	"ATP6C2, VMA5"	ENSG00000143882	"ATPase H+ transporting V1 subunit C2"	Q8NEY4	2	10721649-10785110	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.3;placenta: 39.0;retina: 54.4;salivary gland: 41.8"	"Cell type enhanced"	"Detected in some"	19	"Cytotrophoblasts: 101.4;Distal tubular cells: 38.1;Intestinal endocrine cells: 39.9;Syncytiotrophoblasts: 141.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"BEWO: 40.6;SK-BR-3: 14.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA034734, HPA067305"	Approved		Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA034734: AB_2674305, HPA067305: AB_2732763"	"unprognostic (2.29e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.12e-11)"	"unprognostic (6.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.27e-2)"	1.4	0.9	0.4	0.4	0.5	1.1	2.4	0.5	0.8	21.2	0.8	0.6	49.3	0.1	2.1	30.5	6.9	0.8	0.8	0.7	0.8	0.3	13.2	2.0	0.8	0.5	0.4	0.4	0.9	1.1	0.1	8.9	39.0	0.5	1.8	0.7	54.4	41.8	15.1	0.4	36.7	0.7	0.4	0.6	1.3	0.6	0.8	0.4	0.9	1.4	6.0	3.5	0.5	7.2	1.1	0.8	0.6	1.7	0.9	2.2	1.1	0.3	0.4	1.3	1.5	0.0	0.0	40.6	0.6	0.0	0.0	0.0	0.8	1.0	1.0	0.8	0.0	0.6	0.6	0.6	0.0	0.0	0.5	1.5	0.5	0.6	1.4	0.0	0.9	0.6	0.0	0.1	0.0	0.0	1.0	0.0	0.3	0.4	2.0	0.0	1.2	0.3	1.5	1.0	0.6	0.4	0.8	0.7	3.3	0.0	0.9	1.1	1.3	0.3	14.5	0.4	5.5	1.4	2.1	0.2	0.5	1.0	0.6	0.5	3.5	1.0	0.6	0.6	0.8	0.4	0.3	0.8	0.6	2.2	1.7	1.3	1.1	1.0	1.7	0.5	0.9	1.0	0.5	0.0	0.9	0.8	0.8	0.9	1.1	0.4	0.5	0.5	0.8	0.8	0.3	0.4	0.4	0.5	0.4	0.0	1.6	0.0	4.2	0.3	0.0	1.0	0.0	2.7	2.3	7.0	0.0	101.4	38.1	0.0	0.6	0.1	0.0	0.0	0.2	23.0	0.5	0.6	2.3	0.0	12.0	0.0	39.9	0.0	0.3	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.4	2.0	141.4	0.0	0.6	0.3
ATP6V1E1	"ATP6E, ATP6E2, ATP6V1E, P31, Vma4"	ENSG00000131100	"ATPase H+ transporting V1 subunit E1"	P36543	22	17592136-17628818	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 391.3;Syncytiotrophoblasts: 400.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009528, CAB018699, HPA029196"	Enhanced		Approved	Nucleoplasm		NA	NA		61000	Nucleoplasm		"CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944"	"unprognostic (1.53e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (4.18e-4)"	"prognostic favorable (7.66e-8)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.75e-1)"	32.8	45.9	59.5	20.4	69.0	24.9	31.5	48.9	90.3	30.2	26.7	34.5	25.2	17.6	27.7	44.4	37.5	26.7	26.7	67.4	58.9	55.4	71.7	26.1	31.7	24.5	54.5	52.3	27.0	15.8	48.3	29.6	46.2	69.8	31.1	32.0	24.1	21.5	42.1	48.5	26.9	19.1	38.1	53.7	23.9	23.8	20.2	32.4	17.5	31.9	26.1	32.5	32.1	22.0	24.2	26.3	55.3	34.8	22.6	29.4	30.1	21.7	19.8	18.0	17.4	59.9	32.4	19.7	29.1	38.8	37.0	43.0	24.6	18.0	13.6	25.0	38.8	47.5	34.5	28.0	25.5	33.1	26.1	31.7	24.5	19.8	32.9	87.7	28.2	42.5	40.6	50.1	35.7	26.1	41.6	31.2	17.4	30.6	28.0	63.0	22.6	24.4	20.5	13.1	48.7	28.0	14.3	26.2	8.1	61.4	34.5	13.2	23.0	26.6	18.9	62.6	36.7	18.3	32.7	26.6	26.1	13.8	32.5	21.5	27.4	48.1	17.3	42.0	13.8	35.0	45.2	32.9	55.3	21.4	30.8	20.8	24.2	21.9	20.5	26.3	19.0	20.8	21.5	44.3	22.6	34.8	25.4	29.4	30.1	59.5	69.0	48.9	90.3	58.9	55.4	54.5	52.3	69.8	32.4	71.5	74.4	66.3	65.8	37.3	53.1	103.3	86.6	80.3	53.4	130.9	25.5	202.2	391.3	124.1	6.9	68.0	66.0	23.3	104.7	118.4	63.5	55.0	86.8	40.9	161.1	50.9	40.3	70.0	71.1	12.5	87.2	106.2	75.9	170.5	45.1	93.9	121.5	73.7	91.9	264.4	32.5	58.2	83.4	71.0	67.3	45.0	400.7	65.0	28.6	80.6
ATP6V1F	"ATP6S14, VATF, Vma7"	ENSG00000128524	"ATPase H+ transporting V1 subunit F"	Q16864	7	128862826-128865844	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hofbauer cells: 1024.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009529, HPA048700, HPA062011"	Supported					NA	NA					"CAB009529: AB_2290237, HPA048700: AB_2680498, HPA062011: AB_2684656"	"unprognostic (1.70e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.28e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.33e-2)"	42.2	44.3	72.8	35.3	66.6	62.7	30.4	49.2	82.8	31.5	26.8	29.2	30.3	26.0	22.6	22.8	62.7	35.7	36.0	38.3	63.0	63.9	65.6	26.0	38.9	42.3	60.7	56.9	27.0	37.2	21.1	33.3	49.6	43.5	27.8	20.3	30.1	44.8	31.3	53.1	44.0	25.3	25.0	43.3	36.8	29.5	41.9	29.8	32.5	31.5	39.2	35.0	39.1	31.3	47.7	73.5	67.4	101.2	32.3	43.9	105.3	44.0	51.0	22.9	48.4	46.0	36.6	13.1	22.5	30.0	37.3	40.6	37.5	26.7	41.8	23.9	25.7	56.3	24.4	33.4	37.2	14.0	45.2	54.4	32.0	33.3	36.5	53.3	32.6	61.0	42.8	51.0	43.0	25.0	28.9	35.4	38.7	75.9	44.7	41.2	58.2	54.4	71.4	30.4	27.9	41.9	24.4	16.6	67.7	46.5	35.0	43.4	29.9	31.8	119.8	52.9	24.9	27.6	41.7	37.4	46.4	10.0	61.9	34.4	50.8	45.4	52.9	91.7	46.0	39.3	44.8	101.2	67.4	37.8	66.4	36.2	47.7	38.4	36.3	73.5	47.0	37.2	37.4	29.7	32.3	44.0	41.6	43.9	105.3	72.8	66.6	49.2	82.8	63.0	63.9	60.7	56.9	43.5	29.8	26.8	64.5	166.3	164.2	211.0	100.0	143.6	150.3	76.3	53.4	314.0	35.3	152.3	893.6	205.5	442.7	189.8	97.4	0.0	194.5	171.0	184.8	188.9	270.0	99.0	1024.3	514.9	108.7	105.0	280.3	674.3	152.1	338.9	241.3	249.7	87.7	129.3	222.3	82.7	120.2	704.9	64.1	84.1	184.9	202.1	98.8	285.6	335.7	137.1	88.4	298.2
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587746-114598373	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		150000	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	34.8	66.4	41.5	36.7	38.0	56.6	56.6	37.5	49.4	45.2	34.2	23.4	42.3	26.7	43.7	91.0	57.5	32.3	39.2	45.4	40.8	52.5	84.9	65.9	45.3	50.0	52.2	39.5	49.2	55.9	39.5	79.4	77.8	44.7	65.3	33.2	49.2	63.2	45.1	54.9	40.8	33.2	31.7	35.6	66.5	52.7	58.3	25.6	51.7	65.2	53.5	53.4	45.8	40.1	99.9	81.6	96.6	67.9	50.0	85.1	121.6	18.2	17.6	36.2	8.8	30.1	21.8	33.6	28.5	22.6	23.6	17.0	23.6	22.0	17.7	24.9	20.3	44.1	41.4	27.0	21.5	19.9	14.0	18.6	17.0	22.3	34.2	42.1	37.8	31.5	27.9	57.9	18.9	23.6	24.8	22.3	28.7	32.5	37.6	32.2	39.6	36.4	23.9	42.8	52.2	33.2	35.4	23.2	28.3	48.4	31.4	27.3	34.9	38.4	67.2	101.2	36.5	54.4	44.9	29.7	19.3	15.3	30.0	31.9	50.7	99.4	30.9	24.8	22.7	26.4	78.3	67.9	96.6	46.7	63.9	57.9	99.9	65.6	56.0	50.9	94.2	85.1	67.1	87.3	50.0	65.8	81.6	76.5	121.6	41.5	38.0	37.5	49.4	40.8	52.5	52.2	39.5	44.7	25.6	148.9	142.4	298.6	409.4	461.0	169.7	124.8	155.4	207.5	149.0	314.0	39.3	304.8	822.3	322.2	78.2	218.7	155.2	93.5	229.3	273.5	294.0	644.3	261.0	292.4	487.8	155.7	346.4	198.9	353.7	42.3	283.3	376.1	469.0	820.6	271.3	242.1	355.1	164.9	235.8	828.3	125.3	232.8	269.9	334.2	301.9	504.0	633.4	276.3	162.4	656.9
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"ductus deferens: 16.9;kidney: 33.4"	"Cell type enriched"	"Detected in some"	43	"Distal tubular cells: 376.4"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.9;BJ hTERT+: 1.8;fHDF/TERT166: 6.8;hTERT-RPE1: 2.2;TIME: 1.5;U-2197: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA028701	Enhanced					NA	NA					"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	1.8	1.3	0.4	0.0	0.0	0.0	0.6	6.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.5	0.1	1.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	376.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ATP6V1H	"CGI-11, SFD, SFDalpha, SFDbeta, VMA13"	ENSG00000047249	"ATPase H+ transporting V1 subunit H"	Q9UI12	8	53715557-53843558	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009532, HPA023421"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		48000	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB009532: AB_667834, HPA023421: AB_1845202"	"unprognostic (1.67e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.95e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.30e-2)"	"prognostic favorable (1.46e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	14.1	25.1	42.2	9.7	41.5	14.0	15.8	22.5	46.2	14.6	12.1	12.0	10.5	8.3	13.7	19.3	18.1	13.1	11.6	17.2	39.0	25.5	36.6	11.3	13.8	11.1	21.4	30.0	15.0	11.7	27.0	20.0	14.0	30.0	19.6	12.0	12.7	16.4	18.2	17.3	14.4	8.3	14.6	14.7	10.2	13.3	10.8	11.3	15.3	30.0	11.5	12.3	15.3	11.0	12.0	16.3	30.6	17.0	18.8	17.7	9.3	19.2	13.5	12.3	13.3	21.9	14.0	10.5	21.4	19.2	24.6	24.8	12.5	22.3	12.2	20.1	17.2	33.6	30.2	20.3	26.5	21.7	19.1	16.5	13.4	14.1	15.2	31.8	8.6	15.0	20.9	32.9	16.8	26.3	23.1	16.4	14.0	16.9	6.0	31.2	13.4	13.5	13.6	12.1	15.8	8.0	11.7	5.0	7.7	34.8	25.8	9.9	16.4	12.3	22.1	33.3	14.4	28.1	7.3	19.1	10.9	10.0	26.0	11.6	12.8	12.8	14.2	26.3	11.7	11.8	19.0	11.5	30.6	11.5	13.0	13.1	12.0	14.2	13.7	16.3	10.8	13.8	14.3	13.8	18.8	17.0	13.4	17.7	9.3	42.2	41.5	22.5	46.2	39.0	25.5	21.4	30.0	30.0	11.3	35.7	20.6	45.5	34.9	26.3	65.4	25.0	28.1	28.1	37.5	55.8	106.0	58.8	89.5	44.6	6.6	20.4	29.0	0.0	27.2	36.4	26.2	27.6	15.1	20.3	58.3	58.8	33.9	30.7	34.6	6.2	40.0	49.3	28.7	37.9	16.0	52.6	36.9	27.5	45.3	44.2	68.3	19.4	20.3	15.0	47.2	27.5	83.6	39.2	19.6	31.1
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Sertoli cells: 32.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA012887: AB_1845205, HPA048107: AB_2680266"	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	9.8	7.4	2.6	8.6	4.6	6.4	8.5	2.3	2.9	8.2	7.7	5.9	9.6	4.8	9.5	7.6	10.0	5.7	4.5	5.1	2.9	2.8	9.0	3.3	9.3	9.3	4.1	1.7	7.3	6.3	13.2	15.9	5.0	4.3	8.2	4.4	5.2	12.3	10.3	6.1	15.9	8.5	7.8	6.3	10.8	7.0	2.7	6.0	15.6	6.0	7.1	11.7	11.8	7.0	2.3	1.4	10.7	2.4	1.7	3.0	1.2	2.6	6.8	4.5	4.6	4.3	4.6	0.8	4.0	5.5	2.3	4.8	0.9	3.0	3.8	5.9	3.9	2.9	3.2	5.9	3.2	4.4	5.6	4.0	1.9	6.6	0.7	5.5	3.3	3.6	4.8	1.3	5.0	1.5	5.5	6.2	3.9	15.5	14.7	4.3	2.2	3.6	1.1	1.3	9.1	1.5	3.0	7.6	12.8	3.9	7.3	1.4	17.4	9.8	2.4	5.0	3.0	1.8	1.1	7.8	3.1	3.2	4.4	1.5	4.8	8.4	4.4	5.2	2.0	4.8	8.3	2.0	5.5	2.4	1.9	1.2	2.0	1.7	1.7	1.3	2.3	2.1	3.0	10.7	1.7	2.4	1.4	0.6	1.2	2.6	4.6	2.3	2.9	2.9	2.8	4.1	1.7	4.3	6.0	0.0	5.9	2.0	4.6	6.5	6.1	4.5	0.0	9.4	3.4	8.7	3.9	1.8	1.7	4.3	0.4	7.1	2.8	0.0	12.0	1.9	5.4	5.7	9.2	2.4	12.0	1.6	4.6	9.2	9.9	1.1	6.6	5.4	18.6	1.8	6.2	3.8	6.0	2.9	9.2	5.4	3.6	32.3	4.2	0.9	5.4	14.4	1.8	5.0	4.1	5.5
ATP7B	WND	ENSG00000123191	"ATPase copper transporting beta"	P35670	13	51930436-52012125	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 18.5;liver: 13.5"	"Cell type enhanced"	"Detected in many"	13	"Cone photoreceptor cells: 21.6;Early spermatids: 29.4;Late spermatids: 57.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.3;CACO-2: 11.1;HEL: 29.3;Hep G2: 10.1;RPTEC TERT1: 17.1"	"Low region specificity"	"Detected in many"							"HPA009137, HPA013187"	Supported		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA009137: AB_2668214, HPA013187: AB_1845206"	"unprognostic (1.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (3.49e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.40e-1)"	3.4	0.7	1.8	2.4	2.9	1.8	1.6	7.0	2.8	1.4	6.8	1.1	1.1	10.5	1.6	1.9	1.1	1.9	18.5	1.8	2.1	2.1	2.1	13.5	1.2	1.1	1.6	1.1	2.0	1.7	7.7	1.2	7.1	3.5	1.9	2.6	1.4	3.0	1.1	1.1	0.7	9.6	1.5	1.1	1.6	4.5	7.1	1.6	1.1	1.1	1.1	1.1	2.1	1.1	0.0	0.0	1.0	0.3	0.0	0.5	0.1	0.4	1.6	3.0	2.7	0.6	0.5	19.3	0.8	0.2	0.9	0.7	11.1	0.1	0.0	0.3	1.4	2.1	0.2	2.1	2.4	0.6	0.2	4.1	29.3	0.3	10.1	0.9	0.3	6.9	1.2	2.9	0.1	1.1	1.3	2.1	2.1	7.8	0.0	0.9	0.5	0.1	0.7	1.0	3.7	1.0	1.1	0.8	0.0	17.1	1.9	2.2	1.3	1.1	1.6	1.1	3.4	4.6	0.2	1.1	0.1	1.0	1.6	0.3	0.3	0.4	0.1	0.0	0.1	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	1.8	2.9	7.0	2.8	2.1	2.1	1.6	1.1	3.5	1.6	6.0	0.0	1.7	0.7	0.3	3.0	1.8	0.0	5.3	3.4	1.8	21.6	10.2	0.0	1.5	29.4	1.1	6.1	0.0	0.8	4.4	0.6	1.3	0.0	16.3	2.0	0.0	2.4	3.7	1.0	57.4	2.0	0.0	1.7	0.0	4.0	0.5	1.7	2.9	0.7	1.3	6.7	6.5	0.9	1.1	1.9	0.4	3.8	0.0	4.7	1.1
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 38.9"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 61.4;Cone photoreceptor cells: 76.6;Horizontal cells: 58.8;Intestinal endocrine cells: 81.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.2;Daudi: 28.1;HEL: 9.9;REH: 9.7;SH-SY5Y: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA		20000	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	5.3	8.6	14.2	8.0	29.6	18.5	4.8	7.2	32.0	3.1	11.3	27.3	8.4	4.2	3.4	11.6	2.9	3.5	2.8	8.0	13.7	8.8	4.0	2.1	10.6	12.5	18.0	17.4	15.1	10.0	38.9	6.9	2.6	15.3	7.9	10.7	3.9	4.4	15.2	16.9	3.2	8.1	3.1	23.1	7.8	10.5	2.8	24.9	8.9	34.9	1.9	10.3	4.5	4.0	4.4	3.8	0.9	3.3	3.2	7.3	0.9	0.0	0.1	0.3	17.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.2	28.1	8.0	0.1	0.0	1.4	4.0	0.0	0.0	4.4	2.8	9.9	1.0	0.4	0.0	2.4	0.2	0.3	0.0	0.0	0.0	0.3	0.1	6.3	0.0	3.2	0.0	1.2	3.5	0.8	1.3	1.1	0.3	9.7	0.0	3.1	6.1	0.3	3.1	9.3	0.2	5.9	0.0	0.7	1.9	0.0	0.2	0.0	1.3	0.3	0.0	1.1	0.0	5.7	0.4	3.4	0.1	0.0	1.0	0.9	6.0	0.4	3.2	2.6	1.9	6.5	0.9	4.4	2.9	7.3	0.9	3.2	3.3	3.8	1.4	0.9	14.2	29.6	7.2	22.1	13.7	8.8	18.0	17.4	15.3	24.9	26.8	61.4	5.1	1.7	1.3	17.7	12.8	0.0	0.0	9.1	5.2	76.6	0.0	3.3	0.0	3.0	9.3	46.1	0.0	2.2	0.1	2.2	16.2	8.1	1.1	1.5	58.8	81.2	17.8	7.5	2.3	3.1	3.8	3.3	1.8	23.3	1.0	0.8	7.0	1.8	1.4	41.3	0.0	0.3	1.1	4.1	1.3	0.0	21.8	23.1	2.4
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803101	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 198.4;Mucus-secreting cells: 179.9;Undifferentiated cells: 138.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.5;HBF TERT88: 24.7;RT4: 58.5"	"Low region specificity"	"Detected in many"							"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	3.8	2.3	0.0	1.8	0.0	0.0	3.4	0.0	0.3	4.5	21.3			8.9	2.4	0.8	6.7	2.6	4.8	1.8	0.2	0.0	2.1	3.0	3.6	0.0	0.1		0.7	10.7	2.7	1.1	1.3		6.0	19.3		5.8	2.8	0.4	3.6	11.1	2.0	0.2	1.2	13.3	0.0			5.7		0.2	12.8	5.4	6.0	2.0	4.7	2.1	0.7	1.3	0.3	10.2	3.5	0.1	0.1	3.6	6.6	5.0	19.9	19.4	21.0	13.1	2.6	8.9	0.7	6.0	27.5	8.3	15.2	0.1	4.2	24.7	0.2	0.4	0.1	0.9	0.9	1.1	0.2	0.1	1.0	3.8	6.3	11.1	15.5	11.0	0.2	0.1	0.4	12.1	4.9	0.2	0.2	0.2	11.0	1.0	0.1	0.1	0.2	2.9	58.5	0.4	0.3	0.4	12.3	0.1	0.5	3.8	0.6	12.6	17.1	0.6	2.7	4.6	0.2	0.1	0.2	0.4	0.2	0.9	0.8	2.1	0.5	1.3	0.9	1.0	2.7	1.0	0.7	0.5	6.0	0.9	1.0	4.7	0.7	1.2	2.0	0.4	0.3											17.9	18.2	4.5	44.8	6.9	0.7	4.0	33.1	40.2	48.9	38.4	0.0	17.1	0.0	20.8	2.0	26.8	198.4	0.0	45.9	1.9	5.1	74.4	4.6	16.8	2.3	6.4	65.7	30.1	3.8	0.0	0.3	1.3	6.8	1.0	179.9	0.2	33.7	74.8	0.0	0.1	1.1	12.9	17.6	0.3	1.2	14.3	9.2	1.5	138.5	100.6
ATP9A	"ATPIIA, KIAA0611"	ENSG00000054793	"ATPase phospholipid transporting 9A (putative)"	O75110	20	51596514-51768634	"Enzymes, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 64.7"	"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 6.3;NK-cell: 2.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 6.3;NK-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 29.3;SK-BR-3: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020699, HPA035630"	Enhanced					NA	NA					"CAB020699: , HPA035630: AB_10669526"	"unprognostic (5.19e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.67e-5)"	"unprognostic (5.82e-2)"	"unprognostic (5.81e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	18.5	8.2	23.7	3.9	31.8	2.0	11.2	29.8	64.7	5.6	12.2	19.9	8.2	9.1	8.6	13.1	8.8	16.9	8.2	7.7	24.3	26.8	6.8	5.4	6.7	2.6	21.1	23.9	13.2	10.0	22.7	8.3	3.6	22.5	14.3	11.3	4.1	14.9	11.3	9.2	4.1	11.5	8.7	18.9	2.2	14.0	12.4	15.8	0.8	18.7	2.9	2.4	7.4	5.6	0.0	0.0	6.3	0.2	2.2	0.8	1.8	9.7	8.3	6.9	15.4	20.3	15.1	0.1	3.5	6.7	2.3	0.7	19.1	20.3	0.0	29.3	14.5	11.7	7.8	9.0	5.1	2.3	7.5	2.7	0.0	9.2	7.7	2.8	0.0	0.0	5.0	10.4	0.5	1.4	5.4	12.5	1.8	0.0	0.0	2.6	13.6	0.7	0.0	1.2	9.9	10.6	1.5	0.0	0.0	4.7	13.7	13.0	9.3	14.0	28.1	5.1	2.5	5.3	0.2	8.1	19.3	5.2	7.5	1.5	0.0	0.1	0.3	5.1	0.0	1.7	6.3	0.0	0.0	0.8	0.2	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.4	2.2	0.1	0.0	0.0	1.8	23.7	31.8	29.8	34.9	24.3	26.8	21.1	23.9	22.5	15.8	14.9	12.8	0.0	10.2	2.6	32.1	11.5	30.6	17.4	14.8	17.4	3.9	0.3	1.7	18.0	0.6	5.4	32.5	0.0	14.8	0.2	7.1	27.0	1.1	10.0	4.5	41.3	53.0	11.1	2.7	1.7	12.4	1.6	3.3	0.0	36.1	4.5	21.7	24.6	21.9	1.2	6.4	6.5	7.1	0.9	1.5	3.6	0.2	0.5	19.7	25.5
AVPR1B	AVPR3	ENSG00000198049	"Arginine vasopressin receptor 1B"	P47901	1	206109692-206117699	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"pituitary gland: 52.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;NTERA-2: 1.0;PC-3: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075404	Enhanced					NA	NA					"HPA075404: AB_2732291"		"unprognostic (4.87e-2)"		"unprognostic (1.44e-1)"	"unprognostic (4.82e-1)"			"unprognostic (2.82e-1)"		"unprognostic (2.87e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.66e-3)"	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.6	0.5	0.1	1.3	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	52.8	0.1	0.1	0.2	0.8	0.0	0.0	0.4	0.0	0.0	1.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	1.0	0.0	3.6	0.0	0.0	0.2	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AVPR2	"DIR, DIR3, V2R"	ENSG00000126895	"Arginine vasopressin receptor 2"	P30518	X	153902531-153907166	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes insipidus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 8.9"	"Cell type enriched"	"Detected in some"	8	"Collecting duct cells: 47.1"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	26	"intermediate monocyte: 6.2;non-classical monocyte: 5.3"	"Lineage enriched"	"Detected in single"	28	"monocytes: 6.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.7;SCLC-21H: 6.6;U-266/84: 6.0;U-698: 6.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"cerebellum: 7.9"							NA	NA						"unprognostic (3.05e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.50e-4)"	"unprognostic (2.76e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.38e-1)"	"unprognostic (9.83e-2)"	8.9	0.1	0.0	0.1	0.0	0.9	7.1	1.2	0.0	2.1	1.5			0.7	2.7	0.0	0.8	2.6	1.4	6.3	0.0	0.0	4.7	0.0	1.9	1.1	0.0		0.1	0.6	0.2	0.0	0.1		1.1	0.0		1.2	0.8	4.3	2.2	1.3	1.0	0.0	0.0	1.2	0.0			1.9		0.2	1.8	2.1	0.0	0.2	0.0	6.2	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.4	2.8	5.7	0.0	0.9	0.0	0.0	0.0	0.0	1.9	0.2	2.2	0.9	0.0	0.1	2.8	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	2.7	0.0	0.1	1.4	1.6	0.2	0.0	0.1	2.5	1.1	2.5	0.1	0.0	6.6	1.2	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.2	1.1	6.0	6.3	0.0	1.6	0.1	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.2											3.0	2.2	0.0	0.0	0.9	0.0	1.4	0.0	1.4	0.0	47.1	0.0	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.1
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	8	"brain: 53.0;pancreas: 161.1"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 111.9;Early spermatids: 89.1;Late spermatids: 222.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.76e-4)"	6.5	7.1	12.1	3.8	18.8	2.2	5.5	9.6	22.4	9.8	4.6	42.5	2.7	3.4	9.3	5.6	7.6	8.6	9.1	5.9	16.9	12.4	6.8	12.1	7.3	2.8	28.8	15.0	11.4	161.1	12.8	4.2	6.3	26.4	6.5	4.7	6.9	5.3	9.9	6.2	7.2	3.6	11.7	53.0	5.7	4.9	4.1	21.4	0.0	6.3	2.3	2.8	6.7	5.5	4.0	2.2	0.7	3.2	2.2	6.7	1.1	3.9	4.7	9.7	14.8	32.2	34.7	0.4	21.3	18.6	10.4	8.5	3.6	6.3	0.8	5.2	38.6	7.8	6.9	10.3	6.1	8.5	2.3	5.5	2.4	7.9	4.3	15.9	0.8	0.5	30.0	9.6	13.2	12.9	25.7	8.9	1.4	0.8	0.4	19.0	14.3	0.6	1.9	6.3	4.1	10.4	1.8	4.4	0.8	4.4	2.2	12.6	14.1	7.9	1.0	2.3	8.9	10.2	2.7	12.2	18.7	2.0	19.5	6.8	0.3	0.3	0.4	8.8	1.2	13.0	0.6	2.0	0.7	2.0	3.2	5.2	4.0	6.7	5.3	2.2	1.8	3.1	2.7	0.0	2.2	1.3	1.3	6.3	1.1	12.1	18.8	9.6	21.7	16.9	12.4	28.8	15.0	26.4	21.4	17.9	8.5	0.0	3.8	4.1	53.4	8.1	17.8	4.0	20.5	5.2	111.9	0.8	5.0	4.7	89.1	5.2	1.5	0.0	17.3	0.9	11.5	2.8	2.3	31.6	7.9	54.0	20.8	6.7	12.6	222.6	17.8	5.8	3.3	1.8	2.4	16.6	5.8	4.0	20.8	5.4	48.1	6.5	6.6	3.2	1.7	3.0	0.7	1.0	2.7	2.5
BACE2	"AEPLC, ALP56, CEAP1, DRAP"	ENSG00000182240	"Beta-site APP-cleaving enzyme 2"	Q9Y5Z0	21	41167801-41282518	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Glandular cells: 265.1;Syncytiotrophoblasts: 430.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 4.8;eosinophil: 8.4"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"OE19: 42.8;SK-BR-3: 24.4;SK-MEL-30: 18.9;WM-115: 17.3"	"Low region specificity"	"Detected in all"							HPA035416	Approved				"Intracellular and membrane"	NA	NA					"HPA035416: AB_2732467"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.23e-2)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.64e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.83e-2)"	16.1	2.5	1.4	5.9	1.6	0.9	13.8	0.9	2.0	9.0	11.0	3.4	5.6	5.1	10.3	10.7	13.0	6.8	38.9	7.2	1.7	1.6	11.4	4.4	4.9	21.6	2.7	0.5	8.4	29.0	3.3	2.2	17.2	4.4	22.7	7.4	8.7	28.3	4.4	10.6	5.5	5.4	7.8	5.9	7.0	31.6	5.1	1.4	1.3	9.9	7.6	14.3	11.8	33.6	1.0	0.0	8.4	0.0	0.3	0.0	0.0	14.4	1.3	4.8	0.0	1.3	1.3	0.0	3.6	0.0	2.5	2.1	0.0	5.6	0.0	6.8	4.5	3.9	4.5	0.0	8.5	0.8	0.0	7.2	2.8	1.6	0.0	0.6	0.0	6.8	3.5	1.6	0.3	1.8	11.1	7.2	3.3	0.0	0.0	3.4	2.7	1.6	0.0	3.8	42.8	7.4	0.5	0.0	5.4	4.4	0.9	0.2	0.0	0.2	24.4	18.9	0.6	6.8	0.0	7.1	4.0	2.9	3.3	5.1	0.0	0.0	0.0	8.3	0.0	17.3	4.8	0.0	8.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	1.6	0.9	2.0	1.7	1.6	2.7	0.5	4.4	1.4	11.9	15.7	28.2	70.7	16.5	0.3	6.1	124.9	96.4	81.9	19.2	2.0	98.7	79.6	150.6	17.8	58.1	13.6	0.0	91.4	48.8	34.0	265.1	88.9	0.5	22.6	0.0	17.7	36.8	13.4	7.9	13.3	4.8	170.4	4.6	61.8	2.5	75.6	17.3	17.7	1.1	0.2	0.0	30.1	0.5	0.4	10.3	430.4	2.2	37.1	109.5
BAK1	"BAK, BCL2L7, CDN1"	ENSG00000030110	"BCL2 antagonist/killer 1"	Q16611	6	33572547-33580293	"Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005029	Enhanced					NA	NA					"CAB005029: AB_562051"	"unprognostic (3.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.67e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (4.52e-4)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (6.07e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	8.9	19.8	6.5	14.5	9.3	15.6	5.2	6.7	10.4	7.0	21.2	8.7	6.2	30.9	7.6	7.1	22.1	6.1	14.0	13.8	6.0	5.0	12.7	8.2	9.6	13.0	6.0	7.2	7.1	9.6	6.2	8.7	9.8	7.7	7.9	16.9	8.1	13.1	6.4	10.9	12.6	29.1	8.9	6.2	21.8	14.0	6.0	7.0	15.4	6.8	9.6	18.2	12.2	7.9	12.1	18.8	35.6	27.9	9.2	24.4	20.3	14.7	8.2	8.7	13.1	5.9	5.9	11.1	7.7	6.2	22.1	17.4	16.8	11.6	12.9	13.5	11.2	10.2	15.5	16.6	31.2	9.8	14.7	17.7	8.1	7.7	13.5	15.4	17.4	13.3	9.6	25.0	18.5	21.8	6.4	12.0	11.6	7.3	11.7	8.1	21.6	15.0	11.6	9.7	10.4	20.3	14.6	8.4	23.6	18.7	12.2	10.8	8.1	9.8	31.7	14.6	11.5	10.4	29.6	11.3	11.8	12.5	7.6	9.8	31.1	38.3	10.9	4.0	20.9	12.9	23.8	19.8	35.6	16.3	27.9	18.6	12.1	15.3	16.3	18.8	8.4	8.6	11.2	13.7	9.2	23.4	6.5	24.4	20.3	6.5	9.3	6.7	10.4	6.0	5.0	6.0	7.2	7.7	7.0	3.0	4.3	29.8	10.0	24.2	6.7	5.5	7.6	1.4	2.3	3.5	7.9	12.3	11.6	18.4	4.0	8.4	69.5	0.0	16.4	29.8	11.0	6.4	11.5	2.9	28.0	4.8	21.2	11.6	19.1	1.3	7.2	17.0	20.3	33.3	25.6	5.5	23.0	49.1	11.0	7.6	5.9	12.9	12.2	0.3	0.9	18.9	8.2	27.4	31.9	13.3
BASP1	"CAP-23, CAP23, NAP-22, NAP22"	ENSG00000176788	"Brain abundant membrane attached signal protein 1"	P80723	5	17065598-17276843	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 107.3;epididymis: 126.9"	"Cell type enhanced"	"Detected in many"	10	"monocytes: 416.6;Muller glia cells: 714.2;Syncytiotrophoblasts: 617.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 42.4"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 42.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 63.6;HeLa: 111.9;SiHa: 107.5"	"Low region specificity"	"Detected in many"							"HPA045218, HPA050333"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		85000000	"Plasma membrane"		"HPA045218: AB_2679263, HPA050333: AB_2681090"	"unprognostic (3.35e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.25e-11)"	"unprognostic (1.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.70e-1)"	9.2	6.7	64.3	28.4	37.4	31.1	4.8	37.2	107.3	16.2	5.2	4.0	15.1	3.8	15.5	126.9	4.0	3.6	12.7	4.4	65.0	55.8	4.2	7.7	9.1	30.2	30.1	56.6	11.7	2.5	3.6	6.4	36.4	21.9	32.2	5.5	7.9	3.8	11.5	1.6	6.0	5.7	14.2	11.0	21.9	9.2	2.2	4.3	3.7	3.6	1.3	35.4	17.6	13.0	2.5	1.6	42.4	1.1	0.6	0.1	0.2	0.0	16.7	20.9	0.0	10.0	10.7	29.9	20.9	6.9	17.6	18.7	0.8	0.0	6.5	2.9	14.9	63.6	1.3	13.3	14.6	22.9	2.6	7.5	0.0	111.9	0.0	22.4	12.9	0.1	18.4	18.2	19.9	16.8	22.6	19.0	0.0	0.0	0.0	18.7	24.0	0.0	11.8	15.4	0.0	5.1	0.0	0.0	3.6	6.3	4.1	13.4	2.8	107.5	9.9	0.0	48.5	0.0	13.4	24.2	23.3	0.0	1.9	3.3	0.2	0.0	3.5	23.5	16.0	3.0	6.2	1.1	7.8	0.0	0.4	0.0	1.8	0.0	0.0	1.6	2.5	0.0	0.0	42.4	0.6	0.6	0.1	0.1	0.2	64.3	37.4	37.2	107.3	65.0	55.8	30.1	56.6	21.9	4.3	8.9	7.4	119.4	82.9	191.9	32.5	1.2	0.0	54.9	18.2	8.7	11.8	112.9	0.0	0.6	0.4	8.9	0.0	23.3	3.0	281.6	123.4	116.0	26.5	0.9	53.1	230.4	0.0	41.7	176.3	0.0	0.6	106.8	27.0	416.6	0.3	714.2	1.2	0.0	0.0	0.0	54.1	0.0	24.5	0.0	1.5	51.4	617.6	1.0	0.6	11.2
BAX	BCL2L4	ENSG00000087088	"BCL2 associated X, apoptosis regulator"	Q07812	19	48954815-48961798	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"monocytes: 382.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004206, HPA027878"	Approved					NA	NA		1300000			"CAB004206: AB_626729, HPA027878: AB_10601687"	"unprognostic (4.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (4.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.22e-2)"	15.2	20.0	12.3	26.0	13.2	25.3	20.2	7.6	13.6	14.9	33.3	15.1	13.5	30.7	19.3	11.2	21.4	15.5	40.4	14.9	11.3	10.2	19.5	26.1	26.6	25.9	18.7	12.5	16.4	16.2	8.8	10.0	21.5	14.9	16.6	27.8	10.3	16.5	13.3	11.6	17.1	28.7	16.3	15.1	37.8	19.6	10.7	13.2	37.8	17.7	16.3	26.5	19.1	19.5	6.6	10.6	11.1	16.5	9.1	6.4	6.6	34.3	57.2	34.6	30.3	34.6	33.9	57.1	23.5	47.2	31.0	43.4	15.1	33.7	42.1	11.0	35.9	28.9	18.7	15.7	45.8	25.8	32.4	36.2	17.9	11.6	56.0	55.6	18.6	57.5	46.4	32.9	25.7	15.5	37.7	71.3	16.7	17.5	17.3	53.1	24.3	30.1	29.2	26.8	33.6	16.4	21.2	23.0	16.1	32.5	33.5	19.9	23.5	19.8	14.1	10.8	51.5	11.3	33.6	41.7	40.0	43.4	24.4	32.2	20.0	25.4	27.3	24.2	25.3	55.2	4.3	10.4	10.5	6.0	15.3	4.3	6.6	3.4	6.4	10.4	5.8	2.3	5.3	11.1	9.1	16.5	10.6	6.3	6.6	12.3	13.2	7.6	13.6	11.3	10.2	18.7	12.5	14.9	13.2	3.0	4.5	117.5	48.9	48.7	17.5	7.3	79.0	5.3	3.4	57.6	9.8	113.9	63.0	111.1	0.9	69.9	164.3	0.0	84.3	129.6	73.3	76.7	44.8	26.7	232.2	28.6	109.5	54.0	114.6	1.6	44.5	121.4	79.2	382.3	86.5	32.3	116.8	161.4	36.0	172.3	13.7	45.3	56.6	12.6	35.8	49.3	85.2	119.3	131.1	73.4
BCAP29	"BAP29, DKFZp686M2086"	ENSG00000075790	"B cell receptor associated protein 29"	Q9UHQ4	7	107579977-107629170	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029215, HPA049694"	Enhanced		Approved	Cytosol		NA	NA			Cytosol		"HPA029215: AB_10602331, HPA049694: AB_2680854"	"unprognostic (3.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.42e-3)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.43e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.81e-1)"	25.6	16.0	17.6	13.7	21.3	11.0	24.0	15.9	33.8	30.5	18.9	10.3	13.6	10.4	27.4	12.3	23.3	13.5	14.7	34.0	18.9	17.0	16.7	24.4	17.3	10.6	20.3	28.7	14.6	12.3	20.8	14.8	23.6	25.7	18.5	19.3	10.0	12.1	17.0	22.9	13.6	13.6	24.0	28.1	12.8	14.6	40.0	13.7	6.3	51.4	13.8	9.8	20.5	20.8	6.6	6.3	20.0	12.4	5.1	6.5	4.3	18.9	5.0	7.9	4.1	17.0	20.2	6.4	21.4	18.6	10.5	11.6	5.5	20.3	3.7	15.2	16.0	18.5	9.5	4.8	10.1	14.6	12.5	5.2	9.1	7.8	5.3	16.8	10.4	12.6	13.0	7.4	13.4	11.0	24.7	28.4	6.8	15.3	10.7	20.7	12.9	6.6	8.8	4.7	6.9	7.8	6.0	10.7	11.7	15.8	9.9	3.4	11.0	20.7	17.9	15.8	10.5	6.8	10.2	30.3	31.0	14.3	27.2	29.6	8.2	21.1	8.8	23.2	9.6	22.6	20.0	6.4	13.0	5.4	7.4	5.5	6.6	4.5	5.7	6.3	5.2	2.7	5.1	2.2	5.1	12.4	6.1	6.5	4.3	17.6	21.3	15.9	33.8	18.9	17.0	20.3	28.7	25.7	13.7	62.5	45.7	19.1	44.3	34.2	31.4	99.3	15.3	32.1	34.2	22.7	9.8	28.2	13.3	40.3	198.1	89.9	22.6	46.7	64.6	44.0	48.3	97.8	56.6	39.4	46.1	7.9	21.5	62.6	29.8	66.5	56.7	40.5	35.4	39.7	32.4	30.9	57.9	31.6	83.8	17.0	22.5	77.6	55.3	226.6	29.8	33.9	59.2	24.5	45.9	62.9
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724746	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		NA	NA		6800000	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	60.7	43.4	38.3	20.3	38.8	27.4	71.3	22.2	48.1	28.7	31.8	27.1	27.5	28.8	30.2	48.6	42.4	31.0	26.8	26.7	34.1	36.5	41.6	52.4	42.2	50.0	38.1	26.0	29.1	67.6	36.0	27.4	43.6	44.5	34.3	36.6	30.7	44.5	37.7	15.6	37.3	37.8	32.4	33.6	36.7	24.8	31.6	21.1	25.4	53.1	27.2	37.1	38.1	30.8	72.7	109.7	104.4	97.5	68.2	89.8	150.4	55.1	52.0	14.4	72.3	64.2	19.5	33.5	26.8	30.8	31.9	41.1	41.9	40.5	32.3	122.4	43.4	42.5	55.9	36.0	56.3	26.7	15.9	53.7	20.4	41.2	36.0	31.5	33.1	44.2	26.0	48.9	31.1	36.6	33.6	39.0	19.1	27.6	58.9	35.7	57.7	21.2	45.1	16.5	74.8	53.8	23.2	16.1	72.4	50.0	60.5	18.9	26.8	12.0	59.6	40.2	23.7	21.8	37.4	40.7	28.1	27.7	38.0	53.7	60.5	116.6	42.9	54.8	44.9	24.6	80.3	80.6	77.5	89.0	86.1	79.5	71.2	89.8	88.1	69.9	72.7	79.4	86.4	104.4	68.2	97.5	109.7	72.4	150.4	38.3	38.8	22.2	48.1	34.1	36.5	38.1	26.0	44.5	21.1	104.2	111.8	94.7	188.6	125.9	40.7	56.9	135.0	112.4	95.5	122.1	43.2	414.9	31.5	221.9	4.3	139.7	190.7	23.3	182.9	352.4	105.7	160.9	92.5	177.7	341.5	30.2	99.2	204.4	127.2	16.4	97.5	153.8	151.8	150.5	117.5	122.3	207.2	171.9	93.0	136.1	33.7	155.2	85.4	143.9	179.9	114.0	450.0	97.8	147.8	228.6
BCL2L1	"Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52"	ENSG00000171552	"BCL2 like 1"	Q07817	20	31664452-31723989	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Endocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035734, CAB072801"	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"CAB072801: , HPA035734: AB_2674757"	"unprognostic (2.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.82e-3)"	"prognostic favorable (9.57e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.89e-5)"	"unprognostic (9.67e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.32e-2)"	30.8	21.4	25.1	16.4	34.3	57.0	40.7	27.7	40.7	28.2	22.6	37.0	13.0	31.3	18.7	12.2	36.9	31.5	35.9	26.9	27.0	23.7	42.6	39.3	40.6	17.8	43.4	24.3	11.5	28.5	17.5	22.8	29.0	33.4	24.8	21.4	31.5	33.8	21.5	21.9	26.1	30.4	19.2	28.8	26.6	28.0	30.2	38.4	56.4	25.8	15.4	20.7	24.5	22.4	3.9	7.8	17.0	8.9	12.5	27.2	16.5	64.0	38.2	7.1	6.8	38.0	27.5	22.6	15.3	25.1	16.1	15.4	90.1	31.1	10.5	39.2	22.1	31.2	21.7	9.4	43.4	11.4	11.0	2.4	48.0	8.2	44.8	28.5	4.8	28.5	19.7	18.1	20.3	44.2	21.8	23.0	18.4	29.7	8.0	54.3	18.3	14.1	4.6	9.7	31.8	34.1	8.9	21.3	33.3	65.8	17.9	18.3	8.6	18.8	18.6	8.8	13.5	36.9	5.5	31.8	20.3	23.5	8.1	27.5	5.3	29.7	8.7	29.9	21.1	12.8	17.0	8.1	15.4	27.2	8.2	21.0	3.9	12.4	18.1	7.8	3.7	5.7	13.0	9.8	12.5	8.9	4.7	13.8	16.5	25.1	34.3	27.7	40.7	27.0	23.7	43.4	24.3	33.4	38.4	14.9	11.6	8.2	49.1	16.4	21.1	9.0	101.9	21.4	5.7	36.6	43.2	22.9	72.9	88.0	6.3	31.5	38.7	93.5	56.7	9.6	15.0	56.5	12.7	32.5	33.2	27.0	23.7	20.9	17.2	4.2	17.5	12.2	16.9	127.2	22.5	15.8	125.9	17.5	40.3	57.4	27.1	45.3	20.2	26.5	12.6	8.5	15.8	30.5	18.5	125.1
BCL2L11	"BIM, BimEL, BimL, BimS, BOD"	ENSG00000153094	"BCL2 like 11"	O43521	2	111119378-111168447	"Predicted intracellular proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 85.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026332, CAB079899"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"CAB026332: AB_566386, CAB079899: AB_10981505"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-3)"	"unprognostic (8.15e-3)"	"unprognostic (7.86e-2)"	10.0	7.9	4.9	18.9	5.6	24.8	17.9	1.6	4.7	6.9	15.7	5.1	17.7	5.3	7.9	6.6	10.8	7.8	10.3	7.0	3.8	3.0	14.6	16.3	9.7	46.7	5.5	4.1	12.2	15.1	12.2	21.3	13.3	4.6	8.6	8.8	7.8	11.4	21.8	13.9	6.2	13.7	3.8	4.2	31.5	7.2	19.1	5.5	40.4	32.3	8.6	16.0	10.3	11.8	4.9	3.4	8.3	8.2	2.4	9.5	2.2	3.5	1.4	5.1	4.6	4.0	2.1	13.7	0.6	1.0	1.4	1.4	3.7	11.0	13.8	3.4	0.5	8.9	4.1	4.3	1.6	1.0	10.6	8.7	16.6	3.5	4.5	2.1	6.1	4.3	2.1	4.6	1.9	1.7	3.3	2.0	6.7	8.7	21.2	0.3	2.8	7.3	6.2	5.9	3.3	3.5	8.7	4.5	18.2	1.9	6.0	4.7	11.8	4.9	6.3	3.8	3.3	2.7	13.7	0.9	0.9	6.0	1.8	1.8	41.9	8.1	19.6	1.3	4.4	0.7	6.1	5.6	3.3	2.6	3.8	3.0	4.9	3.9	3.1	3.4	3.2	2.7	2.1	8.3	2.4	8.2	0.7	9.5	2.2	4.9	5.6	1.6	4.7	3.8	3.0	5.5	4.1	4.6	5.5	3.0	6.9	40.9	14.7	15.5	4.7	16.1	7.6	14.7	6.8	8.7	9.8	3.6	11.6	9.8	85.7	10.8	16.8	46.7	5.8	6.7	8.7	12.8	10.5	10.5	9.4	0.0	20.6	12.3	29.4	27.6	5.5	17.5	21.9	36.9	17.7	15.1	7.7	14.4	3.5	4.6	20.2	0.0	11.3	5.7	17.0	9.5	4.8	23.5	9.8	13.6
BCL2L2	"BCL-W, KIAA0271, PPP1R51"	ENSG00000129473	"BCL2 like 2"	Q92843	14	23298790-23311759	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB040539, HPA048740"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"CAB040539: , HPA048740: "	"unprognostic (8.23e-3)"	"unprognostic (9.85e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.99e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.60e-2)"	"unprognostic (5.38e-2)"	29.9	22.8	38.2	15.6	33.6	7.4	25.1	27.3	44.8	13.7	32.3	27.4	21.9	19.4	19.0	20.6	32.8	16.6	17.6	23.8	36.2	32.9	22.3	9.0	18.6	8.6	43.3	39.5	17.5	30.6	34.1	16.5	15.1	32.8	31.8	20.4	15.0	36.5	31.9	10.6	29.2	19.0	34.8	40.9	11.3	22.3	14.9	28.1	1.2	25.6	11.8	10.1	23.0	23.2	1.3	1.8	0.6	1.8	0.1	0.3	1.3	11.8	12.8	11.6	8.5	22.4	19.6	10.6	21.5	13.2	10.7	11.8	7.8	18.9	7.7	7.7	11.8	13.6	22.1	7.2	13.5	13.5	3.9	6.8	8.5	17.1	15.4	14.0	9.2	15.1	15.1	26.6	8.0	13.0	13.7	9.0	1.4	8.3	7.6	12.7	8.9	0.7	6.2	4.5	16.4	25.0	5.5	14.3	3.5	9.4	20.3	15.4	9.2	9.7	15.5	17.5	7.5	9.8	7.4	17.5	19.1	12.0	12.9	11.0	9.8	5.8	1.1	12.1	7.6	21.6	0.0	1.8	0.4	0.3	1.8	0.2	1.3	0.0	0.2	1.8	1.0	0.3	0.0	0.6	0.1	1.0	0.9	0.1	1.3	38.2	33.6	27.3	44.8	36.2	32.9	43.3	39.5	32.8	28.1	8.9	13.3	0.5	6.8	7.7	17.1	25.0	2.5	9.4	12.5	5.2	23.6	4.4	11.6	7.4	17.7	9.0	10.1	0.0	15.7	3.4	6.7	14.5	5.7	6.4	4.9	19.1	17.9	9.8	7.3	3.3	10.3	4.0	6.8	4.6	15.5	6.8	18.7	10.5	20.1	7.5	12.0	6.5	16.0	0.0	0.2	9.7	4.7	1.8	9.7	15.2
BCL2L2-PABPN1		ENSG00000258643	"BCL2L2-PABPN1 readthrough"	Q92843	14	23306835-23325369	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 3.8;Ciliated cells: 8.1;Club cells: 2.3;granulocytes: 2.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 21.5;BJ hTERT+ SV40 Large T+ RasG12V: 23.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000637, HPA048740"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"		NA	NA			Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553, HPA048740: "	"unprognostic (1.32e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-3)"	"unprognostic (9.82e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.05e-6)"	"unprognostic (4.39e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.84e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.72e-7)"	"unprognostic (3.13e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.95e-2)"	11.4	5.3	14.2	5.8	17.7	12.0	17.7	16.4	24.2	17.9	21.0	14.4	11.4	4.5	13.7	6.9	14.4	16.1	16.0	11.2	17.8	9.5	7.1	6.9	10.3	6.4	13.1	21.2	8.0	21.4	29.1	11.4	18.0	17.5	16.3	5.6	7.5	22.1	37.7	7.0	14.5	7.7	18.6	20.2	9.7	13.0	15.0	14.8	0.0	14.4	5.7	5.4	16.6	12.1	1.9	1.1	2.1	4.4	3.5	0.3	1.1	5.1	6.6	4.2	3.4	0.3	9.6	3.3	1.4	13.8	21.5	23.4	5.4	16.8	1.7	1.2	7.2	5.2	7.3	4.8	6.6	5.6	3.5	5.3	0.4	0.9	8.7	2.9	1.8	10.4	8.7	12.2	7.9	1.5	1.7	5.1	0.1	1.6	5.1	6.5	7.9	0.2	1.1	5.3	1.0	4.2	3.2	0.1	1.1	3.7	2.1	7.0	2.8	2.1	7.1	1.9	0.7	3.8	2.8	1.9	5.6	4.4	5.5	3.6	2.8	2.6	0.5	2.3	3.8	8.6	2.1	4.4	0.3	0.2	1.6	0.2	1.4	0.0	0.0	0.6	1.9	0.3	0.1	0.8	3.5	2.6	1.1	0.0	1.1	14.2	17.7	16.4	24.2	17.8	9.5	13.1	21.2	17.5	14.8	3.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	8.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
BCS1L	"BCS, BJS, h-BCS, Hs.6719"	ENSG00000074582	"BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone"	Q9Y276	2	218658764-218663443	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Deafness, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037700, HPA037701"	Supported					NA	NA					"HPA037700: AB_10794619, HPA037701: AB_10805235"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.28e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.31e-4)"	13.4	19.5	16.4	12.6	19.8	10.5	16.2	15.6	23.4	14.1	15.8	18.3	15.8	15.2	22.0	15.1	18.1	19.7	15.2	26.8	14.3	13.5	18.8	29.1	10.7	13.2	19.5	18.5	21.2	26.6	18.9	18.4	11.4	21.9	17.2	16.6	14.8	17.2	18.3	23.4	18.1	13.0	16.7	14.2	15.9	15.5	7.3	18.9	7.2	16.2	15.8	13.2	14.5	14.9	10.9	19.7	11.5	9.8	5.2	10.2	7.9	6.8	14.2	8.1	11.3	18.6	12.5	12.2	11.8	6.5	19.2	14.0	37.7	11.6	10.3	17.2	11.8	12.9	19.1	26.3	30.4	10.9	15.1	28.7	16.6	18.3	30.9	21.3	14.4	10.2	15.9	23.3	26.0	34.0	7.8	19.1	14.7	23.3	15.0	17.0	23.3	10.7	19.3	10.0	16.3	18.2	15.5	10.1	16.2	16.0	13.1	17.5	7.6	8.3	20.3	14.8	13.5	10.5	14.4	11.1	14.4	11.9	9.3	16.1	11.7	9.0	17.2	9.0	22.1	13.4	11.5	9.8	7.9	8.7	5.8	10.0	10.9	7.0	8.2	19.7	10.1	8.5	10.2	1.2	5.2	0.8	11.1	9.9	7.9	16.4	19.8	15.6	23.4	14.3	13.5	19.5	18.5	21.9	18.9	8.9	6.9	4.5	12.9	9.4	11.6	29.4	12.7	8.1	10.3	5.2	5.9	25.5	18.3	16.4	1.3	12.0	9.3	0.0	8.7	13.3	14.6	10.5	11.5	10.9	15.3	6.4	5.8	9.2	8.7	1.7	8.3	6.3	13.5	13.6	8.6	9.2	10.2	14.0	14.5	17.1	15.4	6.5	22.1	4.1	10.2	8.7	12.1	7.0	14.9	11.1
BEST1	"BEST, BMD, RP50, VMD2"	ENSG00000167995	"Bestrophin 1"	O76090	11	61949821-61965515	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 218.0"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 70.9;Macrophages: 85.3"	"Group enriched"	"Detected in some"	6	"glioma: 2.0;melanoma: 6.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 23.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 23.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 9.4;SK-MEL-30: 33.5;U-266/70: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057464	Enhanced					NA	NA					"HPA057464: AB_2683444"	"unprognostic (2.41e-3)"	"unprognostic (3.67e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-10)"	"unprognostic (1.38e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.72e-3)"	5.2	2.9	7.4	9.5	11.8	26.4	2.3	1.6	12.6	2.0	1.4	16.0	0.7	2.1	2.6	9.6	3.0	2.6	6.2	2.5	9.2	5.3	1.4	1.1	4.7	2.5	14.8	6.0	3.7	2.2	0.5	1.4	2.8	9.4	1.6	1.3	218.0	1.2	1.9	0.7	3.0	2.0	2.1	16.9	5.4	1.3	3.9	13.3	0.3	2.3	0.4	0.6	3.9	2.3	0.3	1.6	23.3	2.8	0.1	0.1	0.9	0.5	0.5	0.2	0.4	9.4	2.0	0.9	0.7	1.2	0.2	0.8	0.3	0.3	0.1	1.3	0.6	1.3	0.7	0.0	0.0	0.1	0.1	0.1	0.0	3.6	0.6	2.9	0.1	0.3	2.7	1.1	1.2	2.6	1.2	0.0	0.5	0.5	5.3	1.2	0.3	0.1	0.4	0.0	0.5	1.3	0.0	0.1	0.2	0.0	1.3	0.7	0.5	1.0	0.1	33.5	0.5	0.5	1.3	0.1	0.6	0.4	0.5	0.2	9.0	0.5	0.5	3.4	0.4	1.0	1.5	2.3	2.1	0.1	2.7	0.1	0.3	0.1	0.1	1.6	0.1	0.1	0.0	23.3	0.1	2.8	0.3	0.1	0.9	7.4	11.8	1.6	5.9	9.2	5.3	14.8	6.0	9.4	13.3	23.8	66.0	6.0	5.8	32.3	1.8	3.2	12.7	37.5	62.6	1.8	0.0	12.7	0.0	2.4	6.6	8.3	19.1	0.0	2.9	18.2	15.0	9.1	70.9	4.7	33.7	0.0	9.9	22.7	60.1	1.8	14.1	85.3	52.3	4.6	10.3	6.0	3.0	14.4	6.3	4.8	9.0	6.5	8.3	1.6	2.8	28.5	17.0	10.2	10.9	5.4
BEST2	"FLJ20132, VMD2L1"	ENSG00000039987	"Bestrophin 2"	Q8NFU1	19	12751702-12758458	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 25.2;retina: 28.7;skin 1: 11.7"	"Cell type enriched"	"Detected in some"	62	"Mucus-secreting cells: 105.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 3.5"	HPA046229	Approved					NA	NA					"HPA046229: AB_10966140"	"unprognostic (3.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.02e-3)"		"unprognostic (2.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.18e-6)"	"unprognostic (3.45e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-5)"	0.2	0.1	0.2	4.1	0.2	1.8	0.3	0.2	1.3	0.4	25.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.2	2.2	0.2	0.2	0.4	0.2	0.4	0.2	0.2	0.2	0.2	12.8	28.7	0.6	0.2	0.2	11.7	11.5	0.5	0.2	0.2	0.1	0.3	0.2	0.2	0.4	1.5	5.2	0.2	1.0	3.1	2.7	2.2	0.8	1.7	2.1	1.2	0.9	0.7	2.3	3.5	0.0	0.4	1.6	1.0	0.0	0.5	0.7	2.6	3.6	2.9	0.9	1.2	0.7	1.8	0.0	0.5	0.6	3.3	1.6	2.4	3.3	0.9	0.4	1.2	5.2	0.5	0.3	0.4	0.3	1.4	0.3	0.6	0.6	1.5	0.5	3.0	0.8	1.9	3.0	0.2	2.6	0.4	1.3	0.5	1.0	1.2	1.9	1.9	1.5	0.7	0.6	2.7	1.8	0.9	2.6	0.9	1.0	1.6	2.1	0.9	1.3	1.1	1.3	2.7	1.9	1.7	0.5	0.4	1.4	0.8	1.1	2.2	1.0	0.8	0.2	3.1	2.1	2.1	2.2	1.7	0.5	2.7	0.7	1.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	105.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	1.6	0.1
BNIP3	Nip3	ENSG00000176171	"BCL2 interacting protein 3"	Q12983	10	131966455-131982013	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 122.7"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 391.8;Proximal tubular cells: 579.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 72.0;hTERT-RPE1: 56.2;U-87 MG: 68.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003015, CAB011676"	Supported		Uncertain	Cytosol		NA	NA			Cytosol		"CAB011676: , HPA003015: AB_1078290"	"unprognostic (1.01e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-3)"	"unprognostic (6.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.98e-1)"	19.3	12.0	18.3	4.0	18.6	3.0	8.7	13.5	28.3	7.7	4.6	13.0	5.1	4.0	6.0	11.4	8.1	6.0	7.9	43.3	16.9	14.6	27.6	53.4	6.7	4.6	16.5	14.2	19.3	122.7	6.0	7.3	13.0	22.6	18.2	2.9	5.2	19.2	6.6	48.0	9.0	4.5	6.0	13.3	4.9	6.4	6.0	11.1	3.3	10.8	6.2	4.0	9.2	7.3	6.1	3.0	5.1	3.5	2.2	23.4	8.9	72.0	5.8	4.2	11.7	11.2	11.9	21.6	17.6	16.3	13.3	38.0	1.2	1.6	0.1	28.6	10.1	15.5	4.4	8.8	25.0	50.1	3.8	6.7	2.5	3.7	16.7	15.0	3.3	2.0	8.2	6.3	12.9	13.1	56.2	9.2	4.5	6.6	0.2	21.7	5.7	1.6	18.4	3.5	0.5	17.5	4.0	2.1	6.1	14.5	1.2	5.5	12.9	3.6	7.4	10.0	18.6	4.5	4.6	10.5	18.8	6.3	7.0	13.9	12.3	10.5	10.0	68.2	0.1	3.2	2.2	3.5	5.1	9.8	2.3	10.4	5.7	13.9	10.3	3.0	6.1	23.4	15.4	0.9	2.2	3.1	2.3	13.2	8.9	18.3	18.6	13.5	28.3	16.9	14.6	16.5	14.2	22.6	11.1	44.7	40.9	23.1	75.3	26.6	87.6	141.4	101.9	89.7	48.9	80.3	37.3	149.9	255.4	174.2	61.9	44.2	3.5	0.0	75.7	295.7	56.6	118.1	0.0	391.8	65.8	314.6	77.8	54.6	21.8	85.4	65.0	16.1	32.1	39.7	6.7	125.3	189.3	1.9	97.2	579.1	50.2	38.8	23.8	33.5	100.7	11.4	206.9	25.4	4.8	42.9
BNIP3L	"BNIP3a, Nix"	ENSG00000104765	"BCL2 interacting protein 3 like"	O60238	8	26382898-26505636	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Erythroid cells: 467.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015652, CAB025371"	Enhanced		Supported	"Nuclear speckles,Mitochondria"		NA	NA			Mitochondria	"Nuclear speckles"	"CAB025371: , HPA015652: AB_1845406"	"unprognostic (1.02e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.36e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (8.72e-3)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (7.59e-3)"	61.7	27.8	32.7	18.2	39.1	79.4	40.1	26.1	39.0	35.0	19.9	32.3	30.7	11.5	27.3	34.0	26.7	26.4	28.0	36.0	36.0	27.4	39.9	22.9	31.3	20.7	43.1	31.9	63.4	10.4	26.8	16.0	51.2	41.0	23.7	14.9	20.9	22.1	39.2	21.0	38.1	14.5	26.5	47.9	19.5	16.7	33.0	43.9	17.8	21.5	12.4	25.2	48.3	30.8	14.2	30.4	68.7	53.9	7.8	17.6	36.3	17.9	6.9	16.4	11.1	45.7	28.8	13.9	18.2	53.5	17.1	37.9	3.1	8.7	5.5	17.2	34.2	23.9	9.2	8.1	23.4	57.0	3.6	4.5	22.9	7.1	5.4	25.5	2.0	39.8	34.6	18.4	19.3	11.6	56.7	21.8	13.7	10.3	13.4	35.8	7.8	14.2	7.6	5.3	11.3	7.5	7.6	20.8	10.9	17.7	11.7	17.5	15.6	8.8	1.7	13.8	18.8	9.0	4.3	28.6	32.1	13.9	20.0	4.1	19.7	8.9	7.4	48.9	4.1	7.2	49.9	53.9	32.1	7.6	27.8	6.7	12.4	11.4	8.3	30.4	14.2	17.6	12.8	68.7	7.8	17.4	6.9	15.0	36.3	32.7	39.1	26.1	39.0	36.0	27.4	43.1	31.9	41.0	43.9	80.4	113.7	54.1	47.2	87.7	108.8	31.1	30.6	89.7	69.4	97.7	31.4	24.2	41.4	101.3	153.2	88.4	28.4	467.2	33.9	141.0	136.5	90.8	116.8	23.2	118.2	77.9	115.7	155.9	197.5	155.5	296.6	132.1	101.3	70.3	45.5	412.0	125.0	28.8	326.7	215.8	62.1	142.3	150.4	113.3	98.5	110.7	135.9	55.4	28.1	62.0
BPI	BPIFD1	ENSG00000101425	"Bactericidal/permeability-increasing protein"	P17213	20	38304123-38337505	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"bone marrow: 197.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 167.9;Late spermatids: 173.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"classical monocyte: 13.6;neutrophil: 6.4"	"Group enriched"	"Detected in many"	18	"granulocytes: 6.4;monocytes: 13.6"	"Cell line enhanced"	"Detected in some"		"BJ: 1.3;BJ hTERT+: 2.1;HL-60: 5.2;RPMI-8226: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061284	Enhanced				"Secreted to blood"	NA	NA	7290000				"HPA061284: AB_2684465"	"unprognostic (9.30e-4)"	"unprognostic (5.49e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.83e-6)"	"unprognostic (2.66e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (9.47e-3)"	0.2	0.1	0.0	0.1	0.1	197.4	0.2	0.1	0.8	1.8	0.1	0.3	0.0	0.1	0.6	0.5	0.1	0.2	0.2	15.3	0.0	0.0	0.6	0.5	6.0	0.1	0.0	0.0	1.7	0.1	0.1	0.5	2.8	0.3	0.2	0.1	0.2	0.3	0.4	0.6	0.3	0.1	0.1	0.1	10.5	0.1	41.7	0.1	5.3	1.3	0.0	0.1	0.1	0.7	0.0	0.5	6.4	13.6	0.0	0.0	6.7	0.0	0.0	0.6	0.0	0.2	0.3	0.0	1.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	13.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.5	0.0	0.0	6.7	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.3	0.1	0.0	2.2	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	3.5	0.0	0.0	8.3	0.0	167.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.1	0.0	0.0	1.3	0.0	173.1	16.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	17.3	27.0	0.0	0.0	0.0	1.8	1.1	0.1	0.0	0.0	0.0	0.0
BPIFB2	"BPIL1, C20orf184, dJ726C3.2, LPLUNC2"	ENSG00000078898	"BPI fold containing family B member 2"	Q8N4F0	20	33007600-33023709	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"lymphoid tissue: 218.0;salivary gland: 191.2"	"Cell type enhanced"	"Detected in some"	19	"Early spermatids: 2.8;Glandular cells: 6.1;Hepatocytes: 1.5;Late spermatids: 7.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	552	"Hep G2: 69.5"	"Region enhanced"	"Detected in single"		"olfactory region: 0.5"	"Not detected"	"Not detected"			"HPA049491, HPA060121"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA		68000	Vesicles		"HPA049491: AB_2680792, HPA060121: AB_2684207"	"unprognostic (1.94e-1)"			"prognostic favorable (1.97e-5)"	"unprognostic (2.24e-4)"	"unprognostic (9.48e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.02e-3)"		"unprognostic (1.72e-2)"		"unprognostic (2.71e-1)"		"unprognostic (9.28e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.19e-2)"		0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	191.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.6	218.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3
BRI3BP	"BNAS1, HCCR-2, HCCRBP-3, KG19"	ENSG00000184992	"BRI3 binding protein"	Q8WY22	12	124993700-125031231	"Predicted membrane proteins, Transporters"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 128.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.1;U-698: 46.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014957	Approved		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Nucleoplasm, Mitochondria"		"HPA014957: AB_1845447"	"unprognostic (1.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.44e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.55e-1)"	3.8	3.2	10.8	12.6	13.7	4.7	6.8	13.4	16.0	3.8	16.8	8.8	2.4	22.5	2.9	3.0	10.7	5.0	9.8	3.0	11.0	10.8	8.3	7.5	3.4	14.2	10.9	10.3	2.2	11.2	9.8	4.0	2.6	10.5	3.8	17.8	4.7	4.1	3.1	2.0	8.0	21.8	3.3	12.6	7.3	9.0	2.6	7.7	11.1	5.4	4.5	17.8	3.6	4.3	2.4	5.7	9.5	2.5	1.5	1.2	0.7	9.4	12.5	4.6	4.3	4.0	2.1	5.0	6.7	1.5	4.0	1.9	7.9	6.5	38.1	7.9	1.7	2.8	11.7	10.8	6.0	3.9	7.0	5.9	17.5	5.6	7.1	0.7	25.4	22.0	0.9	3.5	4.7	2.6	1.9	1.7	13.9	6.0	2.2	4.2	10.1	13.0	11.4	2.5	10.3	4.9	8.3	7.7	8.3	6.2	14.5	6.2	4.0	8.2	9.0	3.0	1.6	16.0	21.0	2.0	3.6	3.8	3.8	6.7	7.4	13.3	46.8	3.8	9.5	9.8	4.5	2.5	9.5	1.2	1.7	1.1	1.8	0.9	0.9	2.4	2.4	0.8	1.2	3.8	1.5	1.6	5.7	0.8	0.7	10.8	13.7	13.4	16.0	11.0	10.8	10.9	10.3	10.5	7.7	8.9	7.2	26.7	7.9	10.9	35.5	6.3	45.9	8.1	5.7	8.7	13.7	8.8	3.3	9.0	23.9	3.0	55.2	0.0	9.2	18.3	5.5	8.0	18.4	25.2	17.3	23.8	7.5	3.7	28.3	128.6	1.1	15.5	10.1	3.6	39.6	13.2	14.1	35.1	3.9	10.9	25.6	0.0	5.9	0.9	8.1	15.9	4.3	8.7	67.9	7.8
BRINP1	"DBC1, DBCCR1, FAM5A"	ENSG00000078725	"BMP/retinoic acid inducible neural specific 1"	O60477	9	119153458-119369467	"Predicted intracellular proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.0"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 7.5;Cone photoreceptor cells: 23.6;Ito cells: 4.9;Proximal tubular cells: 8.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 9.2;NTERA-2: 17.6;SCLC-21H: 7.8;SH-SY5Y: 3.4;SuSa: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038828	Approved		Uncertain	Microtubules	"Intracellular and membrane"	NA	NA			Microtubules		"HPA038828: AB_10670909"	"unprognostic (8.60e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-4)"	"unprognostic (1.51e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	1.0	5.6	17.7	1.0	16.5	0.9	3.8	19.7	47.0	1.4	1.1	5.1	0.0	1.1	1.2	7.2	1.2	1.0	2.7	2.8	16.0	12.4	3.0	1.7	1.1	0.9	7.4	10.7	1.0	0.9	1.0	1.0	0.9	5.8	2.9	1.0	0.2	1.7	7.6	1.2	0.9	1.7	1.0	9.7	1.3	1.0	1.5	5.1	0.0	1.3	0.0	0.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	17.6	0.0	0.0	0.0	1.8	0.0	0.1	0.0	7.8	3.4	0.0	0.0	0.0	6.5	0.7	0.0	0.0	1.2	1.9	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	16.5	19.7	32.2	16.0	12.4	7.4	10.7	5.8	5.1	0.0	0.0	0.0	0.4	0.0	7.5	0.6	0.0	0.0	0.0	0.0	23.6	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	2.4	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.4	8.8	2.3	0.0	0.3	0.7	0.7	0.0	0.0	0.0	0.0	0.1
BRINP2	"DBCCR1L2, FAM5B"	ENSG00000198797	"BMP/retinoic acid inducible neural specific 2"	Q9C0B6	1	177171497-177282422	"Predicted secreted proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"adrenal gland: 11.5;brain: 27.9"	"Cell type enriched"	"Detected in some"	9	"Horizontal cells: 14.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 11.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 10.7;PC-3: 2.6;REH: 3.0;SCLC-21H: 9.7;SH-SY5Y: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050681	Uncertain				"Secreted in other tissues"	NA	NA					"HPA050681: "	"unprognostic (7.78e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.20e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.82e-3)"	0.4	11.5	12.2	0.3	8.2	0.3	1.9	0.4	27.9	0.3	0.4	0.6	0.0	0.3	0.5	0.9	0.3	0.6	0.4	0.4	7.0	6.0	0.3	0.4	0.3	0.3	4.5	3.6	0.3	0.3	0.3	2.0	1.0	0.8	0.4	0.3	0.0	0.3	0.4	0.3	0.3	0.3	0.4	1.5	0.5	0.3	1.8	0.3	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	2.6	3.0	0.0	0.0	0.0	0.0	9.7	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	8.2	0.4	15.9	7.0	6.0	4.5	3.6	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.3	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.8	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0
BSG	"CD147, EMMPRIN, OK"	ENSG00000172270	"Basigin (Ok blood group)"	P35613	19	571277-583493	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cytotrophoblasts: 1238.9;Syncytiotrophoblasts: 1384.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB002427, HPA036048, HPA074870"	Enhanced		Approved	Vesicles		NA	NA		3400000	Vesicles		"CAB002427: AB_563501, HPA036048: AB_2674917, HPA074870: AB_2686719"	"unprognostic (1.88e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.53e-3)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.34e-1)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (5.48e-6)"	"unprognostic (1.54e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.61e-2)"	"prognostic favorable (1.95e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-1)"	53.0	74.8	60.0	33.3	73.0	86.3	42.3	36.2	103.0	41.7	93.4	57.8	37.3	50.1	56.0	62.2	35.1	48.8	52.0	205.8	58.5	45.9	78.5	39.1	36.1	22.6	57.6	44.0	51.3	64.2	28.2	48.2	96.2	57.9	49.5	39.6	109.4	44.0	48.4	97.4	38.1	45.5	52.9	34.9	28.3	63.9	76.8	30.4	31.8	61.9	45.9	31.2	48.5	31.5	22.0	43.8	89.4	58.7	30.9	44.5	65.5	63.3	85.6	40.8	91.7	121.6	52.3	86.8	52.8	66.0	63.7	55.5	68.2	68.7	22.7	61.3	47.7	17.4	103.5	41.4	64.1	22.1	47.7	88.7	15.6	72.4	92.2	76.9	37.7	73.6	54.4	65.1	36.6	40.9	76.8	45.7	21.3	73.5	107.6	37.4	113.8	27.4	72.3	95.8	41.1	43.8	55.2	33.4	74.9	75.3	47.6	63.4	57.6	109.6	44.2	78.3	38.1	46.4	116.6	50.2	61.2	38.9	101.3	79.6	69.4	69.8	21.6	116.0	52.3	75.7	32.0	58.7	62.0	44.5	45.2	39.5	22.0	30.2	42.6	39.9	18.3	23.1	29.1	89.4	30.9	48.3	43.8	35.1	65.5	60.0	73.0	36.2	103.0	58.5	45.9	57.6	44.0	57.9	30.4	20.8	26.9	96.8	148.3	185.3	141.6	73.6	104.4	61.6	43.3	272.2	192.4	1238.9	124.3	507.3	196.9	200.0	714.8	607.3	327.4	909.7	249.5	169.5	116.3	84.7	379.2	131.9	245.0	132.0	136.1	473.6	278.2	146.3	480.8	346.3	224.4	452.0	369.5	480.7	316.4	241.2	167.7	200.5	269.3	259.3	553.8	137.0	1384.0	132.0	328.6	155.8
BSND	"BART, DFNB73"	ENSG00000162399	"Barttin CLCNK type accessory beta subunit"	Q8WZ55	1	54998193-55011784	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Bartter syndrome, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 3.9;kidney: 12.3;salivary gland: 4.2"	"Group enriched"	"Detected in some"	37	"Collecting duct cells: 8.7;Distal tubular cells: 21.6"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.5"					"Group enriched"	"Detected in some"	5	"basophil: 1.3;neutrophil: 3.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.9"	"Cell line enriched"	"Detected in single"	20	"RPMI-8226: 13.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053836, HPA060617"	Enhanced					NA	NA					"HPA053836: AB_2682277, HPA060617: AB_2732651"	"unprognostic (3.38e-2)"	"unprognostic (9.17e-2)"		"unprognostic (2.27e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.35e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.51e-1)"		"unprognostic (1.78e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.57e-1)"			0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.0			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.3	0.0		0.0	0.0		4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2			0.0		0.0	0.0	0.0	0.4	0.2	3.9	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.5	0.3	0.2	0.5	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.2	3.9	0.1	0.4	0.2	0.1	0.1											0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	8.7	0.0	0.0	21.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA		930000	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	24.1	51.6	34.0	51.0	31.4	36.3	42.3	25.8	46.2	22.0	48.8	21.1	22.5	33.9	25.8	25.7	51.1	27.1	33.0	47.1	34.8	35.4	48.4	69.0	26.6	81.1	35.4	25.1	25.2	51.9	32.7	31.2	26.7	36.6	23.8	52.2	24.9	25.1	28.0	55.0	27.3	30.0	29.2	27.8	43.8	26.4	21.3	17.2	55.4	28.1	71.9	46.0	25.5	25.4	59.5	68.1	9.9	35.8	39.0	55.6	65.7	49.5	77.1	27.3	44.0	20.4	25.2	36.9	38.0	31.1	88.6	54.6	73.7	16.6	106.5	37.7	28.7	32.0	44.4	87.6	51.6	82.0	24.3	150.8	49.0	40.0	85.6	32.5	59.7	39.0	27.7	47.5	48.7	70.4	21.4	45.1	63.3	58.2	27.3	34.4	34.6	84.7	43.2	61.5	56.3	46.1	67.6	38.6	58.1	51.1	37.6	21.9	41.1	31.2	40.2	53.0	28.6	25.4	30.3	26.5	28.5	26.0	32.3	82.6	14.3	21.8	46.8	27.2	57.5	43.6	9.9	34.7	8.3	40.1	35.8	52.5	59.5	45.0	39.9	68.1	49.4	55.6	46.3	2.8	39.0	26.9	56.9	34.3	65.7	34.0	31.4	25.8	46.2	34.8	35.4	35.4	25.1	36.6	17.2	26.8	23.3	138.5	155.3	215.9	60.0	72.6	68.8	16.0	27.3	78.5	25.5	269.8	265.2	184.9	64.3	105.7	64.2	23.3	178.3	380.4	101.4	99.0	62.2	125.2	179.0	57.2	76.1	74.3	73.1	64.4	110.7	119.7	148.5	174.1	146.5	91.7	174.3	77.2	92.6	338.8	60.8	84.1	121.5	45.2	160.8	223.2	149.7	85.6	301.5	214.0
C1QTNF9	"AQL1, C1QTNF9A, CTRP9, MGC48915"	ENSG00000240654	"C1q and TNF related 9"	P0C862	13	24307166-24322535	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 15.2;skeletal muscle: 14.1"	"Cell type enhanced"	"Detected in some"	10	"Cardiomyocytes: 1.2;Collecting duct cells: 1.8;Early spermatids: 1.5;Endothelial cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 1.9;OE19: 1.8"									HPA056632	Uncertain				"Secreted to blood"	NA	NA	210000000				"HPA056632: AB_2683197"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.14e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	5.6	0.3	0.2	2.4	0.9	0.3	4.9	0.1	0.2	0.7	2.8	0.1	0.1	1.1	1.6	1.6	4.8	0.3	1.9	15.2	0.9	0.3	0.3	0.8	0.4	0.4	0.2	0.1	0.4	1.2	0.5	0.2	4.8	0.1	2.6	0.7	0.1	0.9	1.0	14.1	0.6	1.2	1.8	0.2	0.6	1.1	1.6	0.1	0.3	0.5	5.2	0.9	1.0	7.1	0.5	0.7	0.7	0.3	0.0	0.2	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.1	0.5	0.1	0.9	0.0	1.3	0.7	0.5	0.3	0.0	0.0	0.2	0.1	0.0	0.5	0.4	0.7	0.0	0.4	0.0	0.0	0.1	0.5	0.3	0.1	0.0	0.5	0.0	0.0	0.5	0.3	1.7	0.0	1.9	0.7	1.2	0.2	1.8	1.3	0.2	0.2	0.0	0.5	0.5	0.1	0.2	0.5	0.0	0.2	0.3	0.4	0.2	0.0	0.4	0.6	1.1	0.4	0.8	0.3	0.5	0.7	0.7	1.1	0.1	0.1	0.0	0.2	0.1	0.0	0.5	0.1	0.2	0.0	0.5	0.0	0.2	0.7	0.0	0.3	0.7	0.0	0.0	0.2	0.9	0.1	0.1	0.9	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0
C2CD2L	"KIAA0285, TMEM24"	ENSG00000172375	"C2CD2 like"	O14523	11	119102198-119118544	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.1"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 29.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011044	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nucleoli,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Nuclear membrane, Cytosol"	"HPA011044: AB_2668414"	"unprognostic (3.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.99e-3)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.02e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	5.2	7.0	15.9	7.3	33.1	14.7	4.8	18.2	31.2	5.8	10.3	7.5	8.3	18.7	4.1	6.1	9.4	10.9	6.3	7.9	15.8	13.6	6.3	7.3	8.3	8.5	9.1	12.6	3.9	7.5	7.8	14.2	4.8	11.7	4.8	8.8	5.6	8.7	7.0	8.3	12.5	19.4	6.1	7.3	9.2	5.5	2.6	9.1	7.0	5.5	6.7	6.6	6.6	5.3	0.4	1.1	5.7	4.2	1.7	1.6	1.1	3.4	2.5	3.5	7.2	4.6	1.9	2.2	5.2	4.6	5.2	4.4	4.1	3.6	5.2	13.7	3.6	5.3	7.7	4.4	2.2	2.1	8.1	3.7	20.4	3.3	2.9	6.1	5.8	29.8	2.3	4.6	9.7	3.6	5.7	3.2	7.8	8.4	9.3	4.8	9.1	6.5	14.1	1.3	8.4	6.9	4.1	3.2	5.9	5.1	2.2	11.0	6.2	2.2	11.7	3.3	1.4	20.6	7.8	3.9	4.8	1.6	5.7	9.1	4.1	2.4	2.0	3.0	10.1	5.3	1.1	3.0	5.7	0.6	3.2	1.0	0.4	1.4	1.4	1.1	0.1	1.6	0.8	1.0	1.7	4.2	0.7	1.6	1.1	15.9	33.1	18.2	31.2	15.8	13.6	9.1	12.6	11.7	9.1	6.0	6.2	2.2	1.4	9.5	14.6	2.0	2.5	13.4	4.5	1.8	35.3	0.8	3.3	2.8	2.6	5.0	25.7	0.0	2.4	1.2	2.0	2.9	2.3	4.3	7.9	20.6	1.2	15.4	12.9	1.5	2.0	9.7	6.8	7.2	5.5	4.8	4.2	10.1	1.4	3.3	29.7	6.5	3.1	2.3	1.9	9.5	0.9	8.7	4.5	1.6
C4orf3	HCVFTP1	ENSG00000164096	"Chromosome 4 open reading frame 3"	Q8WVX3	4	119296419-119304445	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Proximal tubular cells: 865.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA026907	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA026907: AB_10600760"	"unprognostic (2.97e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.85e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.04e-1)"	"unprognostic (8.85e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (8.32e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.59e-1)"	51.6	41.9	46.2	39.1	47.2	19.0	31.7	18.2	41.1	46.1	33.5	41.1	25.6	41.3	39.4	49.0	101.3	33.8	37.0	43.4	46.5	45.4	55.8	63.4	33.6	32.2	61.2	31.6	45.1	32.7	19.6	34.7	36.6	47.3	38.7	20.3	33.4	42.6	34.1	70.5	37.7	45.0	41.5	68.7	38.0	26.9	19.4	35.8	30.3	44.2	42.3	39.3	50.0	59.8	60.4	66.8	112.7	53.3	38.0	48.6	65.5	69.1	8.0	23.3	19.3	32.7	24.9	19.0	30.6	8.3	9.0	16.7	8.5	23.1	47.6	23.7	29.2	16.8	13.6	10.3	25.3	14.1	31.9	10.2	19.7	18.5	29.9	9.8	32.3	21.6	26.0	21.2	12.9	5.6	42.0	15.0	13.7	17.5	19.9	33.0	19.9	20.9	30.2	11.8	26.9	8.2	15.0	31.2	12.1	17.0	15.8	14.7	23.8	23.2	30.8	15.9	23.9	16.5	16.9	29.5	33.3	19.8	20.1	12.4	33.6	34.4	22.1	62.6	13.4	18.8	69.3	50.7	60.4	40.1	53.3	38.7	60.4	47.8	45.0	42.7	46.4	48.4	46.9	112.7	38.0	49.0	66.8	48.6	65.5	46.2	47.2	18.2	41.1	46.5	45.4	61.2	31.6	47.3	35.8	145.9	143.1	236.2	239.8	280.2	80.9	421.0	165.6	215.5	144.5	211.1	23.6	289.6	325.0	242.8	18.7	229.5	160.4	23.3	156.7	297.9	248.2	254.6	179.3	378.8	279.6	144.6	65.7	200.7	283.9	15.8	155.1	255.4	189.0	413.8	155.2	139.4	215.9	181.4	202.6	865.1	58.0	194.1	282.9	205.3	54.1	303.0	372.8	183.3	101.9	339.6
C6		ENSG00000039537	"Complement C6"	P13671	5	41142234-41261438	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"liver: 176.1"	"Group enriched"	"Detected in some"	7	"Cholangiocytes: 132.5;Ciliated cells: 99.0;Hepatocytes: 342.0;Leydig cells: 111.4"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 5.2;ASC TERT1: 7.3;HSkMC: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	NA	NA		7600000000			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	2.3	0.1	0.2	0.1	0.2	0.0	1.0	0.1	0.2	0.3	0.5	0.5	0.1	0.1	0.2	2.7	0.3	8.8	2.4	24.1	0.2	0.0	5.2	176.1	0.9	0.8	0.1	0.1	3.2	10.1	0.0	0.4	0.4	0.6	0.2	0.0	0.2	0.1	0.1	0.2	0.0	0.8	0.1	0.2	0.1	0.4	1.7	0.1	0.1	0.4	0.7	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	7.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.1	0.6	0.1	0.0	0.0	3.9	0.0	0.0	0.0	16.8	132.5	99.0	13.6	0.0	0.0	0.0	0.0	4.4	8.1	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	342.0	0.0	0.0	0.0	3.7	8.6	25.4	111.4	0.1	0.0	0.0	0.0	0.0	0.9	0.2	0.4	0.8	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854806-56918221	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	305	"liver: 210.3"	"Cell type enriched"	"Detected in some"	11	"Hepatocytes: 254.8"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Hep G2: 5.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		3400000000										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	210.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	23.3	4.3	0.0	0.0	0.0	0.0	254.8	0.0	0.0	0.0	6.2	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACFD1	"C9orf7, D9S2135, flower"	ENSG00000160325	"Calcium channel flower domain containing 1"	Q9UGQ2	9	133459965-133470848	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 7.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"T-47d: 15.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015280			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015280: AB_1845833"	"unprognostic (3.15e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.83e-8)"	"unprognostic (5.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.99e-3)"	2.8	7.0	7.2	7.4	6.9	3.5	11.4	8.5	9.4	5.7	14.0	9.4	5.9	18.9	6.7	16.9	8.4	7.3	15.8	9.1	6.5	5.5	19.1	33.7	9.8	8.6	12.3	6.7	7.7	16.6	10.6	12.6	5.3	8.4	8.3	8.3	6.9	9.9	10.3	5.2	3.3	17.9	6.3	8.7	5.0	22.1	13.7	8.6	4.4	13.7	3.7	3.8	8.7	12.6	4.2	1.3	7.6	1.4	2.7	1.0	1.1	0.8	3.7	8.1	5.0	1.7	0.8	5.1	2.5	3.4	2.3	0.8	8.1	6.7	1.0	8.1	3.4	3.9	1.6	2.5	2.0	0.1	1.4	3.0	0.6	5.3	5.6	4.3	0.0	1.0	1.8	5.5	1.8	1.3	6.6	3.0	1.9	1.4	2.7	2.6	9.4	1.0	1.4	4.9	8.2	3.1	2.1	2.1	7.1	4.7	3.6	10.2	11.4	3.2	13.8	2.0	3.3	15.9	1.8	1.4	5.5	5.2	1.5	0.3	4.6	5.5	3.0	2.1	0.6	1.9	3.7	1.4	7.6	0.8	1.1	0.6	3.5	0.7	1.0	1.3	4.2	0.4	0.7	0.2	2.7	0.9	0.5	0.5	1.1	7.2	6.9	8.5	9.4	6.5	5.5	12.3	6.7	8.4	8.6	17.9	15.8	1.4	4.6	2.5	4.4	7.0	28.1	1.4	6.8	19.2	11.8	1.9	3.3	17.8	10.8	2.3	46.4	0.0	28.6	3.0	5.1	9.4	4.6	38.0	2.9	3.2	27.9	6.2	5.6	6.2	7.5	1.8	5.0	4.6	36.5	6.0	22.8	42.1	7.1	14.4	9.7	0.0	4.2	12.5	6.5	1.4	2.4	1.8	12.8	5.5
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"brain: 77.9"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 68.3;Horizontal cells: 235.2;Intestinal endocrine cells: 205.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	4	"cerebellum: 77.9"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 31.2;U-87 MG: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	2.2	5.3	7.6	1.0	12.2	0.7	0.9	77.9	19.7	0.8	1.5	1.8	0.0	3.9	1.2	2.8	0.7	2.2	0.8	1.1	5.7	5.1	0.7	0.5	0.7	1.3	3.9	7.3	1.1	3.0	0.7	1.5	0.6	7.2	0.8	1.7	1.2	0.9	0.8	1.3	0.7	2.8	0.9	3.3	1.3	7.7	1.9	2.8	0.0	0.7	0.0	1.0	0.8	0.3	2.8	0.8	1.9	1.1	0.8	0.8	0.4	0.0	0.1	0.0	3.9	0.1	0.3	0.0	1.6	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	3.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	2.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.1	0.9	0.0	0.2	0.4	0.0	0.1	0.0	0.1	31.2	0.0	0.0	0.0	0.2	0.1	0.0	1.2	0.1	0.1	0.7	0.1	0.0	0.0	0.0	0.0	17.6	0.0	0.4	1.9	0.4	0.7	0.5	0.5	0.8	2.8	0.5	0.3	0.4	1.7	0.6	0.7	1.6	0.8	1.1	0.8	0.6	0.4	7.6	12.2	77.9	17.4	5.7	5.1	3.9	7.3	7.2	2.8	6.0	2.7	1.3	1.4	0.6	68.3	2.2	0.0	6.7	2.3	1.8	15.7	0.0	0.0	0.6	22.1	4.2	0.0	0.0	0.3	0.1	2.1	0.8	1.1	0.0	0.5	235.2	205.4	1.8	1.3	17.9	1.1	2.1	0.0	1.0	1.1	2.9	1.9	0.0	0.4	2.0	6.2	0.0	4.2	4.1	5.1	0.1	0.2	4.3	0.8	0.9
CACNA1C	"CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS"	ENSG00000151067	"Calcium voltage-gated channel subunit alpha1 C"	Q13936	12	1970786-2697950	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Host-virus interaction, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Brugada syndrome, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 32.5"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 284.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 4.2"	"Group enriched"	"Detected in many"	19	"NK-cells: 4.2;T-cells: 1.2"	"Cell line enriched"	"Detected in some"	17	"HDLM-2: 47.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039796, CAB079031"	Enhanced	Approved				NA	NA					"CAB079031: , HPA039796: AB_10673019"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-7)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.39e-2)"	3.8	2.5	8.6	6.0	7.7	1.4	2.4	7.1	11.7	11.2	26.5	1.3	7.4	2.4	29.7	4.5	5.2	4.3	7.1	32.5	5.5	4.0	2.7	1.4	4.7	2.0	2.4	6.6	2.7	3.2	1.5	8.1	5.1	3.9	7.9	3.8	6.5	2.4	8.1	2.3	1.7	5.2	28.8	1.9	3.5	7.2	11.3	1.7	0.0	2.0	1.1	1.7	12.6	5.4	0.0	0.1	0.0	0.1	4.2	1.2	0.2	0.0	0.0	0.0	0.0	1.6	1.1	0.1	1.7	2.0	1.1	0.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	47.6	0.4	0.6	0.0	0.0	1.2	0.0	0.0	2.7	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.7	0.3	2.6	0.0	0.0	0.0	0.0	2.2	0.1	0.6	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.5	0.7	0.0	0.0	0.9	0.7	0.0	4.2	0.1	0.1	0.4	0.2	8.6	7.7	7.1	11.7	5.5	4.0	2.4	6.6	3.9	1.7	0.0	0.0	0.0	1.2	0.6	15.3	42.8	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	27.5	2.9	0.0	0.0	0.0	0.2	2.5	1.4	0.0	0.0	0.2	284.4	35.2	2.5	0.0	64.7	0.9	0.0	0.0	0.0	0.6	6.1	0.3	0.2	3.9	0.0	1.2	12.9	17.5	2.6	5.8	0.1	0.1	0.0	0.4	2.4
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 2: 45.9;Cone photoreceptor cells: 33.4;Intestinal endocrine cells: 57.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"basophil: 7.2"	"Lineage enriched"	"Detected in single"	20	"granulocytes: 7.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 14.4;RPMI-8226: 33.6;SK-BR-3: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (5.85e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.34e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.09e-3)"	"unprognostic (6.70e-3)"	0.6	13.4	10.0	0.8	12.6	1.4	3.6	12.2	16.5	11.2	2.8	3.7	0.1	3.3	6.8	13.2	1.2	14.9	6.2	1.8	5.3	3.5	4.2	3.0	9.0	0.5	2.5	9.6	1.2	5.3	3.0	13.6	1.4	8.7	5.7	3.1	10.1	1.1	3.5	0.6	1.5	4.2	1.7	2.2	4.4	1.8	3.0	1.6	0.0	5.2	0.0	0.6	2.3	0.6	0.1	0.3	7.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.5	0.0	0.0	0.1	33.6	0.3	2.2	3.1	1.3	0.2	6.3	0.7	0.0	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	7.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.0	12.6	12.2	16.5	5.3	3.5	2.5	9.6	8.7	1.6	3.0	45.9	0.0	0.6	0.8	23.0	1.2	12.7	14.7	14.8	1.8	33.4	0.6	0.0	5.5	3.6	0.5	3.3	0.0	2.0	0.1	1.0	2.6	11.6	2.4	0.2	7.9	57.1	0.0	1.0	4.9	4.0	0.3	5.0	0.0	2.7	2.5	2.6	3.5	25.5	1.6	13.0	0.0	2.8	1.1	2.5	0.9	0.2	1.3	4.5	0.6
CACNA1F	"AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2"	ENSG00000102001	"Calcium voltage-gated channel subunit alpha1 F"	O60840	X	49205063-49233371	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Transport, Vision"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"retina: 55.8"	"Group enriched"	"Detected in some"	15	"Bipolar cells: 66.5;Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 91.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.8;U-266/70: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA068379	Enhanced					NA	NA					"HPA068379: AB_2732782"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.04e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-7)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.77e-3)"	0.7	0.8	1.8	0.7	1.5	4.0	1.8	5.3	2.0	0.7	1.0	0.7	0.7	1.9	0.7	2.7	0.7	1.0	0.7	0.7	0.8	0.6	0.7	0.7	1.4	2.7	0.7	0.7	0.7	1.4	0.0	0.7	0.7	0.7	0.7	1.5	55.8	1.2	0.9	0.7	2.4	3.7	0.7	0.7	1.8	1.0	0.7	0.7	0.7	1.2	0.7	0.9	0.7	0.7	1.4	4.6	2.0	0.9	0.5	1.0	0.2	0.2	2.5	0.2	0.0	0.6	0.0	2.5	0.4	0.2	0.0	0.0	0.1	0.9	1.4	0.5	0.5	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.7	0.0	0.5	0.6	0.1	0.8	0.6	0.0	0.4	0.0	0.2	0.8	0.8	1.0	0.3	0.0	2.8	1.3	1.5	1.1	1.9	0.0	0.1	0.0	0.5	0.4	1.5	0.6	0.0	0.0	0.1	0.0	0.9	0.9	1.5	1.0	0.2	0.3	0.3	0.1	4.6	1.6	0.1	0.8	0.4	0.0	0.9	0.7	0.6	0.6	0.5	0.5	0.7	0.8	0.4	0.8	1.4	0.5	1.0	2.0	0.5	0.9	4.6	0.7	0.2	1.8	1.5	5.3	2.0	0.8	0.6	0.7	0.7	0.7	0.7	0.0	0.3	0.0	0.1	0.0	66.5	1.2	0.0	0.0	0.0	1.8	125.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	6.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.3	5.5	0.0	0.0	0.4	0.0	91.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153121-1221772	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 49.5"	"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 16.2;Late spermatids: 13.2;Peritubular cells: 24.4;Sertoli cells: 25.8;Smooth muscle cells: 16.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 10.9;AN3-CA: 15.7;MCF7: 28.9;OE19: 9.6;T-47d: 8.6"	"Low region specificity"	"Detected in many"							HPA039125	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA039125: AB_10795578"	"unprognostic (1.66e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (1.93e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.55e-2)"	5.0	6.8	5.1	4.2	12.0	0.3	3.3	0.3	4.3	17.5	28.1	1.6	10.2	5.4	25.7	5.9	16.3	11.7	26.0	2.2	2.5	2.1	4.7	5.5	3.5	0.7	1.0	2.8	31.8	2.1	6.6	14.8	1.9	2.0	21.0	2.2	4.2	1.7	24.9	2.9	4.8	8.5	49.5	1.1	0.5	9.7	11.7	2.1	0.0	5.2	1.4	0.5	34.6	20.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	10.9	1.9	15.7	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.4	0.0	0.0	6.5	1.9	0.0	2.8	0.2	0.0	0.0	0.0	0.0	0.0	1.9	2.9	0.0	0.0	28.9	0.0	0.0	5.9	9.6	2.2	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	0.0	0.5	0.7	8.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	12.0	0.3	4.3	2.5	2.1	1.0	2.8	2.0	2.1	0.0	0.0	0.0	0.0	1.3	16.2	1.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.0	1.2	0.0	0.0	0.0	0.0	0.2	3.3	4.6	8.1	0.1	0.0	10.4	0.6	0.0	13.2	7.8	0.0	0.0	0.0	0.3	0.8	0.7	0.0	24.4	0.8	1.0	25.8	16.5	1.8	4.5	3.0	0.0	0.0	0.0	0.5
CACNA1S	"CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5"	ENSG00000081248	"Calcium voltage-gated channel subunit alpha1 S"	Q13698	1	201039512-201112566	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 83.1"	"Cell type enhanced"	"Detected in some"	21	"Cardiomyocytes: 1.4;Cone photoreceptor cells: 5.9;Early spermatids: 1.4;Late spermatids: 3.3;Rod photoreceptor cells: 1.2"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"BEWO: 5.5;HSkMC: 7.1"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	13	"olfactory region: 5.3"	"CAB009507, HPA048892, HPA056815"	Enhanced					NA	NA					"CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242"	"unprognostic (2.14e-2)"		"unprognostic (1.38e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.52e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.84e-1)"		"unprognostic (2.23e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-1)"	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.0	83.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	10.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
CACNA2D1	"CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3"	ENSG00000153956	"Calcium voltage-gated channel auxiliary subunit alpha2delta 1"	P54289	7	81946444-82443798	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 59.0"	"Cell type enhanced"	"Detected in many"	11	"Cardiomyocytes: 89.3;Early spermatids: 53.8;Intestinal endocrine cells: 37.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 49.0;HUVEC TERT2: 20.6;SH-SY5Y: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008213, HPA008621"	Enhanced				"Intracellular and membrane"	NA	NA		310000000			"HPA008213: AB_1233654, HPA008621: AB_1845863"	"unprognostic (5.07e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (4.28e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.03e-4)"	9.9	13.4	15.7	4.2	18.1	0.7	4.3	8.8	20.8	5.7	11.3	7.3	1.0	5.0	7.1	2.9	5.4	4.1	6.3	25.8	12.7	14.9	8.0	1.8	3.6	2.2	6.3	15.6	7.8	2.0	1.9	8.3	4.2	8.6	12.8	5.3	1.9	3.3	6.6	59.0	4.7	3.5	13.0	5.6	4.3	5.5	3.7	8.0	0.0	16.9	14.6	3.3	6.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	4.0	0.0	7.1	9.0	0.0	8.7	5.6	4.3	4.3	0.0	1.3	0.0	0.0	7.5	5.4	0.0	4.2	0.0	5.7	0.0	5.6	0.2	5.6	0.0	4.6	1.9	0.0	5.3	0.0	15.1	0.0	49.0	20.6	0.0	0.0	0.0	9.7	0.0	0.0	0.0	4.7	0.0	1.8	0.8	0.8	0.0	0.3	0.3	8.0	23.9	1.7	0.0	0.0	4.4	0.0	0.0	14.7	7.7	5.8	7.6	0.0	0.0	0.0	0.0	6.5	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	18.1	8.8	20.8	12.7	14.9	6.3	15.6	8.6	8.0	0.0	1.7	0.0	4.0	5.0	30.7	89.3	0.0	1.4	2.3	7.0	17.7	0.0	0.0	0.0	53.8	9.0	0.0	0.0	0.0	0.0	11.0	11.4	24.3	0.0	0.2	23.8	37.2	1.3	0.0	25.0	9.5	0.4	1.7	1.0	0.2	5.8	0.6	0.0	5.6	9.9	6.0	6.5	17.6	1.0	2.3	5.6	0.1	0.0	0.0	1.4
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362799-50504244	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"lung: 86.1"	"Group enriched"	"Detected in many"	6	"Alveolar cells type 1: 71.5;Alveolar cells type 2: 145.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 66.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		NA	NA		1000000	Vesicles		"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	1.0	0.9	1.6	1.3	11.1	1.1	1.4	14.9	6.5	1.1	1.7	0.9	0.6	1.4	1.7	1.2	0.9	1.1	0.9	7.6	1.7	9.1	1.6	0.5	86.1	1.3	3.9	3.2	2.2	4.0	3.8	6.0	1.9	6.1	3.0	2.0	6.1	1.5	1.4	1.7	2.6	1.7	1.4	1.4	1.5	4.1	5.8	2.5	0.2	2.3	0.1	0.7	0.7	0.7	1.8	0.3	0.7	0.1	2.3	3.6	1.1	0.0	0.0	1.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	8.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	6.4	66.5	0.2	0.1	0.0	2.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	2.2	0.0	2.7	1.8	2.6	2.0	0.0	1.3	3.6	2.2	0.0	2.3	0.1	0.3	3.2	1.1	1.6	11.1	14.9	6.5	1.7	9.1	3.9	3.2	6.1	2.5	71.5	145.9	0.0	0.3	1.3	7.2	3.0	0.0	4.0	4.5	1.8	19.6	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.1	0.7	19.7	0.0	0.1	0.0	1.2	0.6	0.0	2.3	0.3	0.0	0.0	0.0	3.5	4.0	0.6	0.0	1.8	0.4	10.0	12.9	0.8	1.6	11.1	0.5	0.2	1.0	0.4	0.3
CACNA2D3	HSA272268	ENSG00000157445	"Calcium voltage-gated channel auxiliary subunit alpha2delta 3"	Q8IZS8	3	54122547-55074557	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.2;skeletal muscle: 19.5"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 28.9;Early spermatids: 77.9;Late spermatids: 41.2;Syncytiotrophoblasts: 56.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.2;HAP1: 2.8;HeLa: 14.0"					"Low region specificity"	"Detected in all"			HPA030849			Uncertain	Nucleoplasm		NA	NA		49000	Nucleoplasm		"HPA030849: "	"unprognostic (6.92e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-5)"	"unprognostic (5.53e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.84e-3)"	"unprognostic (7.22e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.95e-2)"	1.5	10.3	6.4	1.3	21.9	1.0	1.5	2.4	23.2	1.5	2.0	1.4	0.2	1.4	1.4	4.0	2.1	2.1	1.6	5.1	8.9	8.0	3.8	1.1	2.2	2.2	4.8	12.8	6.7	1.2	1.1	2.4	2.1	9.0	3.4	1.7	2.4	1.9	4.4	19.5	1.2	1.7	2.4	1.7	1.6	1.9	3.9	4.2	0.0	2.1	3.6	2.1	1.0	2.1	0.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	1.7	0.2	14.0	0.0	0.8	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	6.4	21.9	2.4	16.1	8.9	8.0	4.8	12.8	9.0	4.2	0.0	0.0	0.0	0.3	0.2	9.8	28.9	0.0	1.4	1.2	0.0	7.9	8.4	6.6	0.0	77.9	0.1	0.0	0.0	0.6	2.3	2.4	0.2	0.0	0.0	5.4	0.0	0.0	0.6	7.9	41.2	2.6	10.3	0.0	0.0	0.0	4.3	0.8	0.0	1.4	0.1	1.3	6.5	1.9	5.0	2.2	0.1	56.9	0.0	0.0	0.4
CACNB2	"CACNLB2, MYSB"	ENSG00000165995	"Calcium voltage-gated channel auxiliary subunit beta 2"	Q08289	10	18140677-18543557	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Brugada syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 30.8;Cone photoreceptor cells: 102.1;Intestinal endocrine cells: 35.6;Rod photoreceptor cells: 76.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 10.7;HSkMC: 13.5;SCLC-21H: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035326	Enhanced					NA	NA					"HPA035326: AB_10669903"	"unprognostic (3.03e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.67e-4)"	"unprognostic (8.03e-2)"	"unprognostic (3.76e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.16e-2)"	2.7	15.6	10.5	4.2	16.4	2.1	2.8	27.0	25.8	7.0	11.6	1.9	7.4	3.4	9.6	5.8	9.7	7.8	4.6	15.8	8.8	9.7	4.6	4.0	2.7	1.8	4.3	11.8	18.1	8.6	2.7	16.9	1.3	9.2	9.7	8.7	10.0	7.1	18.0	2.1	5.6	9.4	31.1	2.4	1.7	6.5	2.0	3.2	0.1	2.5	0.0	1.0	13.4	12.8	1.9	0.8	4.0	0.7	1.0	3.7	0.2	0.2	1.4	1.0	0.7	0.7	0.5	0.6	0.4	0.0	0.1	0.4	0.6	0.6	1.1	0.3	0.3	0.5	0.9	10.7	0.0	0.0	0.4	3.3	1.0	1.8	2.0	2.8	0.8	1.9	13.5	0.0	0.0	0.0	0.4	0.0	1.8	1.1	2.2	0.0	0.8	1.1	1.3	3.8	0.0	0.1	0.9	1.0	1.0	0.0	1.1	5.4	1.6	0.1	0.1	0.5	1.2	0.2	1.1	0.2	0.8	2.4	0.4	0.7	2.5	2.4	2.2	0.3	1.5	0.5	4.0	0.5	0.6	1.0	0.7	1.4	1.3	1.1	0.5	0.1	1.9	1.8	2.6	0.7	1.0	0.7	0.8	3.7	0.2	10.5	16.4	27.0	18.3	8.8	9.7	4.3	11.8	9.2	3.2	0.0	1.1	0.0	1.1	3.0	30.8	16.2	0.0	0.0	0.0	0.0	102.1	0.2	1.7	0.3	0.7	0.3	3.8	0.0	0.2	0.0	1.3	2.0	0.0	0.9	0.1	7.9	35.6	0.0	0.0	0.6	0.9	0.5	1.7	0.0	6.9	14.8	0.3	3.1	4.2	0.0	76.6	6.5	9.2	0.1	0.0	3.6	0.2	0.0	5.2	0.7
CACNB3	CACNLB3	ENSG00000167535	"Calcium voltage-gated channel auxiliary subunit beta 3"	P54284	12	48813794-48828941	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.7"	"Lineage enriched"	"Detected in single"	9	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"U-937: 44.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059515			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA059515: AB_2684047"	"unprognostic (1.77e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (2.12e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	3.8	3.7	27.4	2.9	22.4	1.2	4.2	18.5	42.9	11.9	9.1	1.5	3.0	3.8	22.6	8.1	11.6	16.1	6.7	2.6	16.4	12.2	3.9	1.3	6.1	1.7	10.0	14.5	24.1	2.1	2.8	4.2	5.3	4.4	5.7	7.8	3.4	4.5	9.1	2.1	7.8	5.8	20.4	2.4	2.2	4.7	4.7	2.3	4.6	6.1	3.4	3.6	7.5	6.9	0.2	0.5	0.0	0.3	0.0	4.7	0.5	6.6	5.3	8.9	18.2	10.9	7.7	5.4	6.8	14.5	10.2	6.0	1.7	5.5	0.8	9.0	11.5	1.7	7.1	8.1	7.5	3.8	7.8	2.4	3.5	4.3	0.2	4.3	0.6	3.9	4.9	4.5	4.2	2.1	28.4	11.6	7.4	0.4	2.8	6.5	16.6	8.3	0.9	5.5	6.9	4.5	9.5	2.0	2.6	7.4	12.6	12.7	12.5	2.1	15.2	5.0	7.5	10.4	2.9	11.0	6.5	9.2	3.1	3.7	3.3	1.3	0.2	5.4	44.2	2.0	0.0	0.3	0.0	0.9	0.1	0.4	0.2	1.8	1.8	0.5	0.0	0.4	0.2	0.0	0.0	0.0	0.4	4.7	0.5	27.4	22.4	18.5	42.9	16.4	12.2	10.0	14.5	4.4	2.3	3.0	7.0	0.0	3.1	2.6	1.0	2.4	0.0	2.7	2.3	1.8	3.9	0.5	1.7	8.6	0.7	3.1	8.4	0.0	3.7	9.3	6.6	2.8	1.1	0.0	1.5	0.0	9.8	3.1	0.6	1.8	12.4	2.3	1.7	5.4	9.1	0.9	8.5	5.8	10.3	0.6	1.0	0.0	10.8	0.5	5.9	4.4	0.9	4.4	11.7	1.4
CACNB4	EJM4	ENSG00000182389	"Calcium voltage-gated channel auxiliary subunit beta 4"	O00305	2	151832768-152099475	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.7"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 38.2;Glandular cells: 25.1;Horizontal cells: 19.1"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in all"	4	"basal ganglia: 28.0;cerebellum: 35.7;cerebral cortex: 21.7;olfactory region: 10.9;pons and medulla: 9.8"	"Cell type enriched"	"Detected in some"	5	"neutrophil: 7.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.0"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 21.2"									HPA015601	Approved					NA	NA					"HPA015601: AB_1845873"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.42e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.45e-1)"	1.6	1.7	5.2	1.3	28.0	1.7	3.2	35.7	28.0	1.4	1.2	2.6	0.0	1.2	1.4	1.7	3.1	1.1	2.1	1.1	4.5	4.4	2.8	0.9	3.9	1.1	4.3	10.9	1.3	1.2	1.0	3.8	2.1	9.8	3.9	1.4	0.9	2.1	3.9	0.8	11.7	1.1	4.2	3.0	1.2	1.6	4.1	3.4	0.0	3.1	0.0	2.2	3.5	0.8	0.4	1.3	7.0	0.6	0.2	0.1	0.1	0.0	0.0	0.7	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.9	0.0	2.0	0.0	0.1	0.3	3.3	0.0	0.2	4.1	0.0	0.2	21.2	0.2	0.1	0.4	0.0	1.6	0.0	0.8	0.0	0.5	0.2	0.0	0.2	0.3	0.5	0.1	0.6	1.8	0.2	0.6	1.2	0.6	1.4	0.8	0.0	0.0	0.0	0.1	3.4	0.9	0.0	1.9	2.2	0.7	0.4	0.4	0.0	0.0	0.5	4.9	0.1	1.2	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.4	0.1	0.1	7.0	0.2	0.0	1.3	0.0	0.1	5.2	28.0	35.7	21.7	4.5	4.4	4.3	10.9	9.8	3.4	11.9	38.2	0.8	10.5	11.0	3.1	0.9	0.0	1.4	5.7	3.5	3.9	0.1	3.3	0.3	0.8	0.6	0.0	0.0	1.3	0.0	3.9	25.1	0.0	0.0	2.6	19.1	0.0	0.6	0.8	1.7	3.1	2.4	1.7	0.0	0.0	1.9	1.2	0.0	4.2	0.6	3.3	0.0	0.7	0.5	0.0	7.2	0.0	0.7	0.0	12.2
CACNG1	CACNLG	ENSG00000108878	"Calcium voltage-gated channel auxiliary subunit gamma 1"	Q06432	17	67044590-67056797	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skeletal muscle: 126.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HSkMC: 8.3;SH-SY5Y: 2.6"	"Region enriched"	"Detected in single"	6	"basal ganglia: 3.0"	"Not detected"	"Not detected"									NA	NA						"unprognostic (1.76e-1)"	"unprognostic (9.83e-3)"		"unprognostic (1.75e-5)"	"unprognostic (2.60e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-2)"		"unprognostic (4.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.94e-1)"	5.7	0.4	0.3	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	1.6	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	126.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.7	25.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	2.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG2	"MGC138502, MGC138504, stargazin"	ENSG00000166862	"Calcium voltage-gated channel auxiliary subunit gamma 2"	Q9Y698	22	36563921-36703558	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 30.7"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 10.8;Horizontal cells: 25.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 7.8;SH-SY5Y: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA										"unprognostic (7.54e-2)"					"unprognostic (3.06e-1)"	"unprognostic (8.80e-3)"			"unprognostic (2.34e-2)"	"unprognostic (3.07e-2)"			0.7	2.7	5.6	0.8	6.4	0.9	0.7	30.7	21.9	0.6	0.7	0.3	0.0	0.8	0.6	0.6	0.7	0.6	0.6	0.6	3.8	4.7	0.7	0.7	0.7	0.7	2.9	7.8	0.6	1.1	0.6	2.7	0.7	6.9	0.7	0.7	0.1	0.6	0.6	1.0	0.8	0.8	0.7	1.7	0.7	0.7	1.0	0.8	0.0	0.7	0.0	0.6	0.7	0.1	0.3	1.0	1.0	0.3	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	7.8	3.5	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.2	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.4	0.4	0.3	0.1	0.3	0.3	0.2	0.0	0.3	0.4	0.4	1.0	0.3	0.2	1.0	0.2	0.1	5.6	6.4	30.7	12.3	3.8	4.7	2.9	7.8	6.9	0.8	0.0	0.0	0.0	0.1	0.0	10.8	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG3		ENSG00000006116	"Calcium voltage-gated channel auxiliary subunit gamma 3"	O60359	16	24255553-24362801	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"brain: 32.2"	"Cell type enriched"	"Detected in some"	46	"Horizontal cells: 166.8"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.7"	"Group enriched"	"Detected in many"	6	"amygdala: 12.8;basal ganglia: 13.1;cerebral cortex: 20.0;hippocampal formation: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.3;Karpas-707: 1.0;U-266/70: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077238	Enhanced					NA	NA					"HPA077238: "					"unprognostic (5.61e-2)"						"unprognostic (3.09e-1)"			"unprognostic (2.12e-1)"	"unprognostic (1.17e-1)"			0.4	1.8	12.8	0.4	13.1	0.5	0.3	0.2	32.2	0.3	0.4	0.1	0.0	0.3	0.3	0.4	0.3	0.4	0.3	0.3	12.7	2.2	0.3	0.4	0.3	0.4	1.8	2.3	0.4	0.3	0.3	0.0	0.4	0.3	0.4	0.4	0.1	0.3	0.4	0.3	0.4	0.3	0.4	0.3	0.4	0.4	0.6	0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.2	0.9	0.2	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	12.8	13.1	0.2	20.0	12.7	2.2	1.8	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	166.8	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964910-67033398	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.8;prostate: 16.5"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Glandular cells: 3.0;Intestinal endocrine cells: 7.5;Muller glia cells: 3.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SH-SY5Y: 97.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"basal ganglia: 159.8"	"HPA005803, HPA065370"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA005803: AB_2667439, HPA065370: AB_2685480"	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.7	1.8	16.0	0.8	32.3	0.7	8.1	3.5	37.8	1.2	0.9	11.4	0.2	1.0	1.2	0.8	0.8	6.2	1.2	0.7	9.6	12.9	0.8	0.7	8.0	0.7	7.5	7.1	0.7	1.2	4.9	0.1	1.6	6.8	16.5	0.8	0.1	0.9	2.4	0.8	0.9	0.9	2.0	4.2	0.7	1.7	0.9	10.3	0.0	0.7	0.0	0.7	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	3.9	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	10.3	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	3.9	1.7	0.0	0.0	0.1	2.1	0.0	2.7	3.9	97.2	0.9	2.5	0.0	10.0	9.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	32.3	3.5	13.0	9.6	12.9	7.5	7.1	6.8	10.3	3.0	2.2	0.0	1.1	0.0	0.0	1.1	0.0	1.4	2.3	0.0	0.0	0.1	0.0	0.1	2.1	0.0	0.0	0.0	0.2	0.1	0.2	3.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.5
CACNG6		ENSG00000130433	"Calcium voltage-gated channel auxiliary subunit gamma 6"	Q9BXT2	19	53992288-54012669	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"blood: 11.4;skeletal muscle: 45.4"	"Cell type enhanced"	"Detected in some"	28	"Ciliated cells: 5.3;Horizontal cells: 1.6;Spermatogonia: 1.1"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	96	"basophil: 11.4;eosinophil: 7.8"	"Lineage enriched"	"Detected in single"	114	"granulocytes: 11.4"	"Cell line enhanced"	"Detected in some"		"A549: 12.7;EFO-21: 22.3;HHSteC: 5.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056615			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Nucleoli fibrillar center"	Cytosol	"HPA056615: AB_2683192"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"		"unprognostic (7.07e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.89e-2)"		"unprognostic (2.27e-1)"		"unprognostic (7.69e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.07e-8)"	"unprognostic (9.79e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0			0.0	0.0	0.0	0.1	5.9	0.0	0.0	0.2	0.2	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	0.9	0.0		0.1	0.0		0.4	0.0	45.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0			0.0		0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	12.7	0.3	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.1	1.1	0.0	22.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	5.8	0.0	0.1	0.1	0.0	0.0	0.0	2.1	3.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.2	1.5	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	2.9	0.0	2.6	0.0	0.0	0.0	3.1	0.1	0.2	0.0	0.0	11.4	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0
CACNG7		ENSG00000105605	"Calcium voltage-gated channel auxiliary subunit gamma 7"	P62955	19	53909335-53943941	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"brain: 54.4"	"Cell type enriched"	"Detected in some"	17	"Horizontal cells: 127.1"	"Cancer enriched"	"Detected in some"	16	"glioma: 29.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 26.8;GAMG: 7.5;HMC-1: 20.9;hTERT-RPE1: 26.3;SH-SY5Y: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA									"unprognostic (3.11e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.24e-2)"				"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.01e-5)"	"unprognostic (1.51e-1)"	"unprognostic (7.36e-2)"			1.2	1.8	22.2	1.3	15.6	1.2	1.2	22.7	54.4	1.2	1.3	8.3	0.0	1.2	1.2	1.2	1.2	1.2	1.2	1.2	21.4	13.7	1.2	1.2	1.3	1.2	16.5	10.3	1.2	1.3	1.2	1.8	1.2	9.9	1.2	1.2	0.3	1.2	1.3	1.2	1.2	1.4	1.3	13.5	1.2	1.3	1.5	4.5	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	26.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.5	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	20.9	0.2	0.0	0.0	0.0	26.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	5.7	0.0	0.0	0.0	1.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.2	15.6	22.7	25.9	21.4	13.7	16.5	10.3	9.9	4.5	0.0	0.0	0.0	0.0	0.0	7.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0
CACNG8		ENSG00000142408	"Calcium voltage-gated channel auxiliary subunit gamma 8"	Q8WXS5	19	53963040-53990215	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"blood: 7.9;brain: 22.8"	"Cell type enriched"	"Detected in many"	7	"Horizontal cells: 47.7"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.6"	"Group enriched"	"Detected in many"	5	"amygdala: 9.4;basal ganglia: 9.1;cerebral cortex: 13.6;hippocampal formation: 20.3;hypothalamus: 5.4"	"Cell type enriched"	"Detected in some"	7	"basophil: 7.9"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 7.9"	"Group enriched"	"Detected in some"	5	"AF22: 6.4;HMC-1: 21.3;hTERT-RPE1: 7.6;TIME: 13.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA041351	Enhanced					NA	NA					"HPA041351: AB_10796666"	"unprognostic (7.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.29e-4)"	"unprognostic (9.66e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.40e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.82e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	0.4	0.4	9.4	0.4	9.1	0.6	0.4	0.7	22.8	0.3	0.3	2.1	0.0	0.4	0.5	0.4	0.3	0.4	0.4	0.3	20.3	5.4	0.3	0.3	0.4	0.4	2.3	2.0	0.4	0.3	0.5	0.0	0.3	1.5	0.4	0.4	0.0	0.4	0.3	0.9	0.7	0.4	0.4	0.9	0.4	0.6	1.5	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.4	0.3	7.9	0.2	0.3	0.3	0.1	0.0	2.1	6.4	0.2	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.4	0.3	0.0	0.2	0.0	0.3	0.2	0.1	0.1	0.0	0.0	0.9	2.4	0.5	0.0	1.0	0.0	21.3	0.3	0.0	0.0	0.2	7.6	2.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	1.3	0.2	2.6	0.0	0.0	0.0	0.0	0.1	0.1	1.4	0.1	0.1	0.0	0.2	0.2	0.0	13.0	0.1	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.1	7.9	0.2	1.1	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.3	0.2	0.5	0.3	0.1	0.3	0.1	0.1	9.4	9.1	0.7	13.6	20.3	5.4	2.3	2.0	1.5	0.0	0.0	0.0	0.0	1.0	1.4	0.9	2.8	0.0	4.0	1.2	1.8	0.0	0.0	0.0	1.4	0.4	1.9	0.0	0.0	0.0	0.0	0.5	1.3	0.0	0.0	0.1	47.7	0.0	3.1	1.5	1.1	0.0	0.0	0.0	0.0	0.4	1.0	0.1	0.0	0.4	0.0	1.5	0.0	0.8	5.0	6.4	1.0	0.1	0.0	0.5	1.0
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390438	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 50.6;brain: 118.9"	"Group enriched"	"Detected in many"	6	"Exocrine glandular cells: 89.2;granulocytes: 237.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"cerebellum: 31.2;hypothalamus: 74.2;pons and medulla: 118.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.2;HEL: 24.0;HMC-1: 52.2;U-2 OS: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		6400	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	50.6	11.6	10.1	5.1	7.5	0.9	18.2	31.2	9.9	1.7	8.9	1.7	0.0	1.7	1.4	3.0	3.0	2.4	2.0	2.2	5.9	74.2	0.9	0.9	2.1	0.9	17.7	7.5	5.6	1.4	0.9	3.0	0.9	118.9	1.1	6.0	4.9	2.1	1.3	1.0	1.0	2.7	2.7	7.5	0.9	1.2	14.6	1.5	0.0	0.8	0.2	1.8	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.7	6.6	0.0	0.2	0.0	1.3	0.2	0.1	0.2	0.0	0.0	8.2	0.0	0.1	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.2	0.0	0.0	52.2	0.0	0.0	0.5	0.1	0.1	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	14.9	0.1	1.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	7.5	31.2	9.9	5.9	74.2	17.7	7.5	118.9	1.5	8.9	11.1	0.0	0.0	0.2	3.5	0.3	0.0	2.7	0.0	0.0	5.9	0.0	0.0	1.7	2.1	0.1	0.0	0.0	89.2	0.1	0.4	0.1	237.6	0.0	0.1	28.6	0.0	0.0	0.0	2.3	5.8	0.0	5.0	0.0	0.0	2.5	10.4	0.0	0.0	0.0	6.7	0.0	0.3	0.3	3.6	0.0	0.1	0.0	0.0	0.1
CALCA	CALC1	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972354	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"parathyroid gland: 122.2;thyroid gland: 55.3"	"Cell type enriched"	"Detected in some"	5	"Collecting duct cells: 34.9"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enriched"	"Detected in single"	48	"pons and medulla: 19.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.9;hTERT-HME1: 1.8;Karpas-707: 1.8;SCLC-21H: 3.5"	"Region enriched"	"Detected in many"	5	"pons and medulla: 60.6"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	NA	NA	51500				"HPA059886: , HPA064453: "			"unprognostic (1.97e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.2	0.0	0.1	0.3	0.4	0.0	0.8	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	6.2	16.8	0.6	0.0	0.1	0.0	0.0	0.1	122.2	0.2	0.0	19.8	1.2	0.0	0.3	0.4	0.0	0.3	0.0	0.0	0.3	1.5	4.6	0.0	0.0	0.0	0.6	55.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.4	0.1	0.2	0.0	0.2	0.1	0.0	19.8	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.0	0.0	0.0	34.9	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	6.5	0.0	3.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.5	0.0	0.0	0.0	1.3
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187343129-187448460	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.0"	"Group enriched"	"Detected in many"	9	"Endothelial cells: 183.3;Ito cells: 192.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.3;myeloid DC: 11.2;plasmacytoid DC: 3.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.2;monocytes: 3.3"	"Cell line enriched"	"Detected in some"	4	"HUVEC TERT2: 62.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA008070: AB_1845912, HPA046515: AB_2679681"	"unprognostic (7.06e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.60e-3)"	"unprognostic (9.25e-3)"	"unprognostic (4.14e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	42.4	5.2	4.9	6.4	3.8	0.2	19.6	7.3	9.4	21.2	12.6	2.6	4.0	3.1	17.9	6.8	16.3	6.5	13.4	15.1	4.5	3.8	16.5	12.5	91.0	16.9	4.7	3.5	15.2	3.7	8.2	5.3	6.4	7.5	10.7	5.3	7.5	8.4	4.4	5.0	4.2	5.6	14.5	18.1	9.1	5.0	7.9	2.8	2.3	16.9	11.8	4.7	10.6	14.0	0.2	11.2	0.1	3.3	1.2	1.1	1.1	0.0	0.0	3.2	0.0	2.3	0.6	0.0	0.2	0.4	0.0	0.4	0.0	0.3	0.0	0.8	0.2	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.5	0.0	0.0	1.8	0.0	0.0	1.6	0.1	0.1	0.7	0.2	62.5	0.0	0.0	0.8	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.1	0.1	14.7	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.0	0.2	0.0	0.0	0.1	2.3	0.0	0.2	0.1	0.0	0.0	0.0	3.3	0.0	0.0	0.6	0.0	0.2	0.0	0.0	11.2	0.0	1.1	0.2	0.1	1.2	1.2	3.3	0.0	1.1	4.9	3.8	7.3	3.7	4.5	3.8	4.7	3.5	7.5	2.8	0.0	14.0	0.8	2.3	8.2	0.1	7.0	2.5	2.7	4.5	0.0	0.0	0.3	3.3	0.1	0.5	183.3	0.0	0.0	0.4	0.1	5.4	1.7	4.7	2.1	0.9	0.0	0.0	192.8	14.2	0.4	7.2	7.7	10.1	20.8	0.0	0.0	0.1	0.0	2.5	12.3	0.0	6.5	6.6	1.2	0.4	5.9	0.2	0.0	0.0	1.2
CALHM1	FAM26C	ENSG00000185933	"Calcium homeostasis modulator 1"	Q8IU99	10	103453387-103458888	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sensory transduction, Taste, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 5.7;kidney: 2.4;lymphoid tissue: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 4.2;U-266/70: 4.4;U-266/84: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA061816	Enhanced					NA	NA					"HPA061816: "	"unprognostic (2.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.65e-3)"	"unprognostic (3.44e-2)"		"unprognostic (2.86e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.21e-8)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-2)"	0.0	0.0	1.1	0.5	0.3	0.8	0.0	3.4	5.7	0.0	0.0			0.5	0.1	0.3	0.0	0.0	0.4	0.1	1.2	2.5	2.4	0.0	0.0	0.4	1.3		0.1	0.4	0.0	0.2	0.0		0.0	0.1		0.1	0.0	0.0	0.3	0.2	0.0	0.2	0.3	0.1	0.2			0.0		2.0	0.2	0.0	1.0	1.6	0.8	1.6	1.3	1.0	0.2	0.4	0.3	0.3	0.4	0.1	0.0	0.5	0.4	0.1	0.1	0.2	0.0	0.2	0.3	0.2	0.0	0.3	0.4	0.1	0.3	0.3	0.4	0.7	0.3	0.9	0.2	0.0	0.0	0.4	0.2	0.2	0.1	0.4	0.5	0.0	0.3	0.2	1.1	0.3	0.5	0.0	0.8	0.4	0.0	0.5	0.4	0.3	4.2	0.3	0.5	0.6	0.3	0.2	1.0	0.1	0.5	0.0	0.0	1.0	0.4	0.3	0.2	0.4	4.4	5.0	0.6	0.5	1.1	0.1	0.6	0.6	0.4	1.0	1.6	0.2	0.5	0.4	1.0	1.6	1.0	0.4	0.9	0.8	1.3	1.4	0.3	0.3	0.2											0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CALHM2	FAM26B	ENSG00000138172	"Calcium homeostasis modulator family member 2"	Q9HA72	10	103446786-103452402	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Extravillous trophoblasts: 63.7;Hofbauer cells: 47.4;Leydig cells: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.8;BJ: 18.8;BJ hTERT+: 19.1;fHDF/TERT166: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014706	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Nucleoplasm, Mitochondria"	Cytosol	"HPA014706: AB_2243916"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (8.59e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.74e-1)"	24.2	10.5	3.7	10.2	3.8	1.8	28.7	1.9	7.1	34.1	9.2	3.9	8.0	5.6	36.0	18.4	13.4	19.7	18.2	17.0	3.9	2.2	5.7	3.7	11.1	15.9	4.8	5.4	32.5	4.5	1.9	4.0	23.6	4.8	18.2	4.0	10.7	7.6	10.0	8.9	8.9	9.0	19.8	5.5	24.4	7.2	14.1	3.1	3.0	11.0	9.2	10.8	19.9	24.1	7.1	36.6	11.2	47.9	14.0	21.5	17.1	5.3	3.8	0.9	1.2	14.3	23.8	4.6	18.8	19.1	5.8	8.2	1.6	2.6	1.6	2.1	21.5	0.3	2.5	1.9	0.0	1.1	0.2	10.8	3.8	1.1	0.3	6.5	0.6	0.3	8.1	0.0	1.7	0.0	10.8	6.8	4.1	0.8	10.0	3.7	12.3	1.4	1.7	2.4	1.1	3.4	4.5	1.5	3.6	0.5	0.4	2.7	1.2	0.7	3.1	1.0	0.4	0.6	1.2	12.1	1.8	2.3	6.4	1.3	1.5	3.5	1.9	15.9	11.8	0.3	11.2	22.7	0.4	21.5	42.2	17.5	7.1	14.8	17.6	36.6	1.5	2.9	11.2	0.9	14.0	47.9	4.2	18.9	17.1	3.7	3.8	1.9	7.1	3.9	2.2	4.8	5.4	4.8	3.1	3.0	1.1	3.4	2.8	4.7	0.0	2.8	2.5	0.0	0.0	3.5	0.0	2.0	0.0	3.1	0.8	20.4	0.0	0.0	0.2	63.7	23.4	0.8	8.1	0.0	47.4	0.0	1.2	28.3	27.5	0.8	42.3	14.7	8.5	1.8	0.0	0.3	0.2	0.0	15.2	0.3	0.0	19.4	29.8	0.7	0.2	3.3	16.0	17.3	0.0	1.0
CALHM3	"bA225H22.7, FAM26A"	ENSG00000183128	"Calcium homeostasis modulator 3"	Q86XJ0	10	103472804-103479240	"Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Taste, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.8;pancreas: 2.8;testis: 2.0"	"Cell type enhanced"	"Detected in some"	23	"Cardiomyocytes: 1.1;Early spermatids: 2.2;Extravillous trophoblasts: 5.4;Late spermatids: 1.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.5"					"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.8;myeloid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"U-266/84: 17.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018205	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018205: AB_2069267"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.06e-1)"		"unprognostic (1.25e-2)"		"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.44e-1)"		"unprognostic (4.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.53e-1)"	0.2	0.1	0.5	0.0	0.6	0.0	0.0	0.2	0.7	0.3	0.1			0.8	0.3	0.9	0.0	0.3	0.0	0.0	0.2	0.9	0.0	0.0	0.1	0.0	0.0		0.4	2.8	0.0	0.2	0.7		0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	2.0			0.0		0.0	0.2	0.4	0.0	1.5	0.0	1.8	0.0	0.7	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.3	3.3	0.4	1.8	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	17.4	0.2	0.2	0.0	0.0	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4											0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.0	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0
CALHM4	"C6orf78, FAM26D, FLJ32239"	ENSG00000164451	"Calcium homeostasis modulator family member 4"	Q5JW98	6	116529013-116558868	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"placenta: 29.7;skin 1: 9.1"	"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 45.7"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 2.8;SuSa: 6.2"														"Intracellular and membrane"	NA	NA															"unprognostic (7.95e-2)"			"unprognostic (3.44e-4)"		"unprognostic (1.99e-1)"	"unprognostic (1.44e-2)"		0.5	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	29.7	1.4	0.0	0.0	0.2	0.0	0.0	0.5	9.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.3	0.1	0.0	2.8	0.0	0.3	0.2	0.2	0.3	0.0	0.3	0.6	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	6.2	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.2	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0
CALHM6	"C6orf187, dJ93H18.5, FAM26F, INAM, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5"	ENSG00000188820	"Calcium homeostasis modulator family member 6"	Q5R3K3	6	116461370-116463779	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 95.3;lymphoid tissue: 58.7"	"Cell type enriched"	"Detected in some"	7	"Hofbauer cells: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 83.9;non-classical monocyte: 95.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 10.0;Karpas-707: 16.7;RPMI-8226: 56.6;U-937: 21.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.14e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.46e-3)"	"unprognostic (7.15e-3)"	"unprognostic (9.53e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (9.31e-10)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.25e-3)"	3.0	2.7	2.8	19.6	5.2	12.9	3.1	1.1	2.1	1.5	3.4	1.5	1.7	3.9	1.1	1.3	2.0	1.5	3.9	4.3	3.1	3.2	2.9	8.1	4.2	30.6	2.6	1.8	2.8	1.0	0.4	2.5	4.6	3.4	3.1	2.2	2.7	4.2	0.7	1.0	0.9	8.1	3.7	5.1	58.7	2.2	3.3	1.7	7.3	2.1	1.9	7.5	3.5	1.4	39.6	23.3	13.8	95.3	3.1	3.8	17.8	2.3	0.0	0.2	0.1	0.2	0.7	4.3	0.0	0.4	0.7	0.5	0.0	0.3	0.0	1.3	0.5	0.0	0.0	0.1	0.0	1.6	0.2	0.1	10.0	0.0	0.0	1.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	16.7	2.0	0.0	0.9	1.7	1.3	0.0	0.0	0.8	0.0	56.6	0.8	0.1	1.0	0.0	5.4	0.0	4.0	0.6	0.1	2.6	0.0	0.0	0.0	0.0	0.3	4.3	0.0	0.0	0.1	21.5	1.4	1.8	24.7	5.5	2.1	83.9	2.1	27.0	2.9	1.9	23.3	39.6	3.8	1.9	13.8	3.1	95.3	10.2	0.3	17.8	2.8	5.2	1.1	2.1	3.1	3.2	2.6	1.8	3.4	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.0	9.1	4.9	0.0	0.0	0.0	0.0	118.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	18.0	0.0	0.0	2.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0
CAMLG	"CAML, GET2"	ENSG00000164615	"Calcium modulating ligand"	P49069	5	134738501-134752160	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 658.5;Late spermatids: 1206.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052636, HPA056472"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			Vesicles	"Nucleoplasm, Nucleoli"	"HPA052636: AB_2681893, HPA056472: AB_2683143"	"unprognostic (9.23e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.58e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.16e-1)"	24.2	29.0	37.6	14.3	32.4	22.7	29.3	28.2	39.3	33.3	32.7	15.5	20.2	26.1	31.7	45.2	21.4	23.0	21.8	22.3	32.4	38.3	20.1	19.7	18.9	18.4	36.2	22.7	53.0	25.7	14.8	21.9	14.0	22.4	27.5	14.3	21.7	15.9	26.2	32.5	19.7	22.2	30.4	26.0	15.1	17.7	36.6	14.0	21.1	21.6	18.5	19.3	40.3	20.0	25.0	16.1	32.1	23.3	16.6	28.6	17.4	9.6	7.5	12.8	23.8	28.5	44.2	5.8	13.7	19.9	10.2	19.4	13.7	14.7	39.3	20.1	9.5	15.9	12.5	10.5	16.7	14.6	18.3	19.5	10.4	13.6	11.1	21.0	5.5	33.0	35.8	18.2	12.6	21.7	33.9	19.3	17.4	6.6	18.3	15.2	10.7	14.5	23.3	6.6	12.0	7.6	16.4	17.0	15.1	17.5	9.4	19.0	13.3	9.8	6.3	32.7	17.2	17.3	11.5	18.4	10.0	6.2	15.2	12.4	17.2	18.6	15.0	16.8	17.4	5.4	32.1	15.2	32.1	18.3	17.3	24.6	25.0	26.4	22.9	16.1	22.4	27.8	26.8	27.6	16.6	23.3	14.7	28.6	17.4	37.6	32.4	28.2	39.3	32.4	38.3	36.2	22.7	22.4	14.0	35.7	31.3	84.3	104.0	148.5	76.2	38.6	76.5	32.1	48.9	40.1	23.6	43.8	77.9	53.1	658.5	74.5	44.2	0.0	78.9	53.3	107.2	105.7	119.1	66.0	62.6	52.4	60.0	81.6	102.8	1206.3	155.6	92.2	91.1	124.4	64.9	79.0	61.6	59.6	124.5	149.1	63.7	97.0	161.7	114.4	74.5	176.2	61.2	108.0	83.2	90.1
CASC3	"BTZ, MLN51"	ENSG00000108349	"Cancer susceptibility 3"	O15234	17	40140318-40172183	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Stress response, Translation regulation, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024592, HPA050262"	Approved		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA024592: AB_1846034, HPA050262: AB_2681067"	"unprognostic (3.76e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.40e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.48e-2)"	27.4	21.0	37.8	20.4	34.8	22.6	26.8	30.0	36.5	30.1	27.3	40.7	19.3	16.4	35.9	26.8	22.2	35.1	21.7	17.8	36.6	32.7	21.6	14.7	23.2	21.8	39.9	27.7	42.1	22.7	31.8	32.6	21.4	29.4	27.4	23.4	25.7	22.5	36.6	50.9	23.0	19.6	35.0	40.7	23.2	22.7	59.7	31.0	19.6	29.4	18.1	25.5	34.1	29.7	6.5	7.2	26.1	11.5	6.8	9.2	5.6	13.5	13.9	17.9	20.1	14.5	15.3	11.5	13.8	12.3	19.0	16.5	15.1	11.8	25.4	22.1	17.3	15.6	24.4	21.8	14.6	26.0	17.3	19.3	18.3	17.3	15.1	13.2	22.3	12.4	15.8	13.5	18.5	29.1	14.7	23.5	14.0	19.6	19.0	15.5	7.8	32.7	12.6	14.1	11.9	8.5	20.5	23.9	26.0	9.8	11.9	28.1	16.1	20.5	74.3	18.1	29.6	24.4	17.6	15.6	16.6	17.3	15.6	21.7	18.2	16.8	25.7	15.8	12.2	17.9	5.8	5.9	8.6	9.2	8.0	8.3	6.5	6.9	8.3	7.2	6.5	7.9	7.4	26.1	6.8	11.5	3.9	6.4	5.6	37.8	34.8	30.0	36.5	36.6	32.7	39.9	27.7	29.4	31.0	17.9	30.8	20.6	20.1	17.5	38.5	23.6	17.8	29.4	45.5	22.7	21.6	17.0	18.3	15.8	11.3	31.6	14.4	0.0	20.7	17.2	23.3	22.2	15.1	19.7	14.8	28.6	30.0	17.2	20.4	18.4	33.4	25.7	33.7	16.2	19.3	20.8	18.6	14.4	28.0	14.3	40.4	12.9	35.0	52.8	63.8	17.3	22.7	21.7	18.8	22.6
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190556-160201886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 320.9;tongue: 83.5"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 16.7;Rod photoreceptor cells: 13.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 10.6;HDLM-2: 20.2;RT4: 36.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	6.1	0.1	0.5	0.0	0.3	0.1	0.2	0.3	2.0	0.1	0.1	0.0	0.1	0.0	0.1	11.9	3.9	0.2	0.1	4.0	0.4	0.3	0.1	0.1	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.5	0.0	1.3	0.0	0.2	4.5	0.4	320.9	0.1	0.1	0.6	0.2	0.1	0.1	0.3	0.0	0.0	0.9	83.5	4.7	0.4	0.1	0.9	0.0	0.9	0.7	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	10.6	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	20.2	0.2	0.0	0.0	0.0	0.1	0.3	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.1	0.0	36.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.4	0.4	0.1	0.2	0.0	0.0	0.9	0.7	0.2	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.9	0.1	0.1	0.9	0.2	0.1	0.0	0.3	0.0	0.5	0.3	0.3	2.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.6	16.7	0.0	1.4	0.0	0.0	2.0	1.6	0.0	0.0	1.5	0.0	0.0	0.0	0.0	3.6	0.0	0.1	3.5	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.4	0.0	13.0	0.0	0.8	1.4	1.0	0.0	3.8	0.0	0.0	0.3
CASR	"FHH, GPRC2A, HHC, HHC1, NSHPT"	ENSG00000036828	"Calcium sensing receptor"	P41180	3	122183683-122291629	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"parathyroid gland: 155.3"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 13.2;Cholangiocytes: 33.1;Ciliated cells: 28.1;Club cells: 10.3;Distal tubular cells: 11.6;Intestinal endocrine cells: 11.1"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 5.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 4.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA039686, HPA050335"	Enhanced					NA	NA					"HPA039686: AB_10673536, HPA050335: AB_2681092"		"unprognostic (1.97e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.32e-2)"		"unprognostic (7.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-5)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.24e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	0.4	0.0	0.1	0.0	0.0	0.0	0.0	21.0	0.0	0.1	0.2	18.1	0.5	0.0	0.0	0.1	0.0	0.6	12.1	155.3	0.6	0.0	0.2	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.6	0.3	0.2	0.2	0.5	0.3	0.0	0.1	1.6	0.0	0.1	0.7	0.0	1.4	0.5	1.1	0.3	0.8	1.1	0.2	0.6	1.3	0.7	1.1	0.3	0.3	0.7	0.7	0.0	0.0	0.1	0.6	0.9	1.1	0.9	0.4	0.8	0.5	0.2	0.2	0.3	0.8	0.1	1.4	1.1	1.1	0.0	0.7	0.8	0.4	0.4	0.5	0.2	0.5	0.2	1.1	0.6	2.0	0.3	0.7	0.5	0.9	1.4	0.8	0.7	0.6	0.5	0.6	4.0	1.5	0.6	0.8	0.9	0.5	0.3	1.7	1.0	0.3	1.3	1.0	1.9	1.0	0.3	1.7	1.1	0.5	0.7	0.6	1.0	1.0	0.3	0.1	0.9	0.2	0.9	0.7	0.9	0.9	0.1	1.4	0.7	0.6	1.1	0.8	0.2	0.5	1.1	0.2	0.0	0.0	0.0	0.6	0.1	0.2	0.1	0.0	0.2	0.0	23.8	13.2	0.0	0.0	0.0	0.0	0.8	33.1	28.1	10.3	3.5	0.0	0.0	11.6	3.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	11.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.2	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
CATSPER3	CACRC	ENSG00000152705	"Cation channel sperm associated 3"	Q86XQ3	5	134967906-135011707	"Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 31.9"	"Group enriched"	"Detected in some"	39	"Early spermatids: 152.2;Late spermatids: 43.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 7.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.59e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.58e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.96e-3)"	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.4	0.5	0.4	0.5	0.4	0.8	0.4	0.4	0.4	0.4	0.6	1.0	0.4	0.4	0.4	0.4	0.6	0.8	0.2	0.4	0.4	0.4	0.4	0.4	0.4	0.6	0.4	2.7	0.3	0.4	0.4	0.4	0.4	0.3	31.9	0.4	0.4	0.4	0.4	0.4	0.4	0.4	3.3	1.4	0.4	0.6	3.2	1.8	0.4	0.4	3.6	1.4	1.6	1.1	0.4	0.8	0.6	0.3	7.2	0.6	2.0	3.1	1.4	1.8	0.3	0.7	1.1	2.3	1.2	0.7	1.9	2.7	0.3	2.0	1.2	0.7	0.9	0.8	0.4	1.8	0.6	2.8	0.7	0.0	0.9	1.5	2.6	0.5	1.6	1.5	2.3	0.4	2.7	1.9	1.9	0.6	0.8	3.1	0.5	1.1	1.1	1.3	1.0	1.1	1.2	1.4	2.2	1.0	0.1	1.3	0.3	1.6	1.2	1.0	0.4	0.7	2.3	0.5	0.0	0.6	0.0	0.4	0.1	0.0	0.8	0.7	0.7	1.4	3.3	1.8	0.7	0.4	3.2	0.1	0.7	0.0	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.5	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	152.2	0.1	0.0	0.0	1.0	0.2	0.0	0.4	0.0	0.5	0.3	0.0	0.0	0.0	0.3	43.8	1.4	0.0	0.0	1.0	0.0	0.4	0.3	0.0	0.7	1.0	2.5	0.0	0.3	2.1	1.1	0.3	0.1	0.0	0.1	0.0
CATSPER4		ENSG00000188782	"Cation channel sperm associated 4"	Q7RTX7	1	26190561-26202968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"testis: 13.5"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 36.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.1;hTCEpi: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045257	Enhanced					NA	NA					"HPA045257: AB_10968995"	"unprognostic (7.20e-2)"	"unprognostic (2.06e-2)"		"unprognostic (4.56e-2)"		"unprognostic (2.69e-2)"		"unprognostic (3.49e-1)"		"unprognostic (3.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.16e-1)"		"unprognostic (3.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.67e-5)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.5	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0
CATSPERB	"C14orf161, FLJ14298"	ENSG00000133962	"Cation channel sperm associated auxiliary subunit beta"	Q9H7T0	14	91580696-91780707	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 15.1"	"Cell type enhanced"	"Detected in some"	11	"Early spermatids: 11.1;Exocrine glandular cells: 9.3;Pancreatic endocrine cells: 11.1"	"Low cancer specificity"	"Detected in some"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.8;OE19: 4.0;U-937: 3.7"					"Not detected"	"Not detected"			HPA035134	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA035134: AB_10671510"	"unprognostic (2.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.04e-3)"	"unprognostic (2.72e-5)"	"unprognostic (1.81e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.85e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.71e-3)"	0.6	0.1	0.0	0.6	0.0	0.0	1.4	0.0	0.2	0.4	0.9			0.3	0.4	0.4	0.6	0.7	1.2	0.6	0.0	0.0	0.3	0.2	0.9	1.1	0.0		0.2	15.1	1.0	0.3	0.0		0.9	0.7		3.7	0.0	1.7	4.2	1.2	0.1	0.0	0.8	2.0	2.0			0.9		0.6	0.5	0.3	0.4	0.2	1.1	0.2	0.7	1.6	0.4	0.6	0.0	0.7	1.6	0.0	0.0	1.8	0.2	0.3	0.0	0.0	2.3	3.8	1.1	0.9	0.0	0.1	0.6	0.0	0.5	0.7	1.4	2.0	0.4	1.2	2.2	0.0	1.6	0.8	0.6	0.7	0.4	0.5	1.5	0.0	1.0	0.5	0.2	0.4	2.2	0.6	0.7	0.2	4.0	0.5	0.3	0.0	0.0	0.4	0.9	1.6	0.1	0.0	0.8	1.5	1.7	0.4	2.1	0.9	0.2	0.2	0.0	0.3	0.9	0.8	0.3	0.2	3.7	1.0	1.1	0.2	0.6	1.1	0.0	1.5	0.4	1.6	1.0	0.0	0.2	1.1	1.4	0.4	0.7	0.2	0.2	0.0	0.4											3.0	1.0	0.0	0.2	0.1	0.0	0.1	0.0	1.4	2.3	0.0	0.0	0.0	0.0	1.6	11.1	0.0	0.3	0.0	9.3	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	1.0	2.1	0.0	11.1	0.9	0.0	0.5	0.0	0.0	0.0	0.9	0.2	0.0	0.2	0.0	0.4	0.3
CATSPERD	"MGC39581, TMEM146"	ENSG00000174898	"Cation channel sperm associated auxiliary subunit delta"	Q86XM0	19	5720677-5778734	"Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"testis: 32.8"	"Group enriched"	"Detected in some"	13	"Ciliated cells: 194.1;Early spermatids: 109.5;Late spermatids: 120.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	60	"HEL: 13.2"					"Not detected"	"Not detected"			HPA024056	Enhanced					NA	NA					"HPA024056: AB_1858093"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"		"unprognostic (3.77e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.74e-2)"		"unprognostic (6.85e-2)"	"unprognostic (2.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.95e-8)"	"unprognostic (2.54e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.74e-2)"	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	32.8	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.5	0.6	0.0	0.1	0.1	0.1	0.1	0.0	2.1	0.0	0.1	0.3	0.0	0.4	0.0	194.1	6.8	0.0	0.0	0.0	0.0	0.0	109.5	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	120.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	11.1	1.1	1.3	0.2	0.0	0.0	0.0
CATSPERG	"C19orf15, DKFZp434A1022, FLJ46353"	ENSG00000099338	"Cation channel sperm associated auxiliary subunit gamma"	Q6ZRH7	19	38335775-38370943	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.7"	"Group enriched"	"Detected in many"	7	"Early spermatids: 23.9;Enterocytes: 14.0;Late spermatids: 27.8;Spermatocytes: 31.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 4.8;monocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;HMC-1: 5.3;MCF7: 4.3"					"Low region specificity"	"Detected in all"			HPA052777			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in male reproductive system"	NA	NA			Nucleoli	"Nucleoplasm, Cytosol"	"HPA052777: "	"unprognostic (8.50e-5)"	"unprognostic (5.12e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.37e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.07e-3)"	0.9	0.8	2.9	0.8	7.7	1.1	1.3	4.3	5.8	1.2	1.1	6.5	1.9	1.2	1.2	1.8	0.9	1.4	0.9	0.8	3.9	1.0	1.0	1.0	1.1	1.0	7.4	2.2	1.3	1.0	1.0	1.2	0.8	5.2	1.3	1.0	0.4	2.0	1.1	1.0	2.0	1.1	0.9	3.2	0.9	1.0	35.7	6.5	2.2	1.3	0.0	1.0	0.9	3.3	0.1	0.6	4.8	1.8	0.2	0.5	0.2	0.2	0.5	0.2	1.8	0.8	0.0	4.2	0.2	0.0	0.0	0.0	1.3	0.8	0.3	0.0	0.0	0.7	0.6	0.5	0.1	0.0	0.9	0.2	0.1	0.2	0.0	0.1	0.3	5.3	0.0	0.8	0.0	0.5	0.5	0.1	0.8	0.0	1.4	0.0	4.3	0.0	0.0	0.0	1.1	0.8	0.1	0.0	0.8	2.0	0.1	0.4	0.6	0.4	0.9	0.2	0.7	0.4	0.0	0.3	0.0	1.0	0.7	0.0	0.8	0.9	0.0	0.2	0.2	0.0	0.3	0.8	1.8	0.4	0.9	0.2	0.0	0.1	0.2	0.6	0.1	0.5	0.2	4.8	0.2	1.8	0.4	0.3	0.2	2.9	7.7	4.3	5.8	3.9	1.0	7.4	2.2	5.2	6.5	0.0	2.4	1.7	1.9	2.3	1.1	2.4	2.5	0.0	0.0	1.8	0.0	1.0	0.0	0.8	23.9	1.5	14.0	0.0	0.6	0.2	1.5	1.8	1.1	0.5	2.8	1.6	1.7	1.8	0.8	27.8	1.7	2.6	0.0	1.8	1.5	1.9	0.5	3.5	2.1	1.1	1.1	0.0	1.0	31.9	2.7	1.6	1.1	2.5	2.0	1.4
CAV1	CAV	ENSG00000105974	"Caveolin 1"	Q03135	7	116524785-116561184	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 1: 3305.3;Basal keratinocytes: 1221.7;Endothelial cells: 1019.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 10.6;memory B-cell: 6.0"	"Group enriched"	"Detected in many"	37	"B-cells: 6.0;granulocytes: 10.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 145.0;BJ hTERT+: 152.8;HBEC3-KT: 148.8;LHCN-M2: 155.1;U-138 MG: 123.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003791, HPA049326"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB003791: AB_562068, HPA049326: AB_2680714"	"unprognostic (5.98e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.35e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.35e-3)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.65e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.14e-3)"	143.9	2.3	2.4	27.5	5.9	0.0	70.5	1.0	3.8	73.8	57.4	2.6	32.3	4.3	84.6	40.9	51.1	31.4	42.0	60.2	2.7	2.3	5.7	4.2	132.7	8.6	7.9	4.5	26.6	3.8	2.0	1.9	92.0	4.2	42.3	13.7	13.6	12.8	26.5	33.3	21.7	18.6	104.0	5.5	28.6	30.1	21.5	5.2	2.8	92.1	34.7	6.6	85.9	33.7	6.0	0.1	10.6	0.0	0.0	0.2	1.1	27.9	22.9	0.6	0.2	94.7	145.0	1.3	66.8	152.8	36.9	38.9	0.1	41.7	0.0	23.6	78.5	32.5	52.9	0.1	148.8	56.2	1.8	1.2	0.0	9.0	0.0	13.1	0.0	0.1	49.4	31.6	53.9	35.7	35.6	111.1	0.0	0.0	1.5	155.1	2.9	0.0	0.0	2.1	0.0	11.0	0.3	1.5	15.9	20.9	0.1	0.0	0.0	20.5	1.3	3.2	9.6	0.1	0.2	85.3	123.8	14.2	47.2	18.4	6.3	0.9	0.1	49.9	0.0	44.7	10.6	0.0	0.0	0.0	0.0	0.0	6.0	0.2	0.1	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.1	2.4	5.9	1.0	3.8	2.7	2.3	7.9	4.5	4.2	5.2	3305.3	101.8	0.8	331.2	1221.7	5.1	274.0	73.9	30.8	542.6	7.0	2.0	44.7	5.0	68.5	1.7	1019.9	0.4	23.3	0.6	374.1	329.7	54.2	12.8	3.4	12.7	0.0	1.7	373.8	14.3	5.0	349.2	22.2	416.7	6.4	0.1	209.8	27.0	0.0	531.4	0.0	4.5	549.7	544.6	1.9	4.9	534.0	97.8	6.4	0.4	74.0
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733800-8841808	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"skeletal muscle: 65.8;tongue: 44.6"	"Cell type enhanced"	"Detected in some"	28	"Cardiomyocytes: 18.9;Early spermatids: 4.4;Sertoli cells: 6.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 46.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	6.3	2.3	0.0	0.3	10.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.7	1.3	0.1	65.8	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	44.6	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	18.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	1.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167010-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 71.4"	"Cell type enriched"	"Detected in many"	9	"Extravillous trophoblasts: 610.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol		Yes	Yes			Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522"	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.54e-7)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	3.2	4.6	2.7	23.9	4.8	20.5	4.6	6.5	5.6	4.4	9.9	1.6	1.6	9.3	3.5	2.8	28.8	3.3	3.5	1.9	3.5	4.2	4.6	2.9	3.4	23.6	4.0	4.2	3.7	4.0	1.6	2.6	12.1	11.5	2.6	14.2	1.7	5.3	1.7	2.0	6.4	8.7	6.4	2.5	9.1	7.1	21.7	1.3	71.4	6.3	23.3	30.1	5.3	7.5	13.2	5.1	2.4	4.1	6.5	14.7	5.5	58.6	40.6	55.8	49.6	2.9	5.0	131.7	26.0	19.5	68.6	58.1	60.0	55.4	36.1	31.7	23.9	78.7	37.0	56.1	56.8	77.0	35.4	27.7	22.9	33.9	41.4	0.9	19.9	26.2	2.2	3.6	39.3	27.4	6.3	36.6	35.4	27.6	28.7	55.8	55.9	27.2	23.7	31.0	19.5	25.8	28.7	40.2	37.0	25.1	21.7	28.4	17.9	44.7	21.1	19.2	32.8	40.3	20.9	15.3	15.3	49.7	27.6	64.9	14.4	26.6	50.4	21.2	34.9	47.0	2.4	1.8	1.2	2.8	4.1	4.0	13.2	7.6	6.7	5.1	8.6	2.5	2.4	1.0	6.5	1.9	4.2	14.7	5.5	2.7	4.8	6.5	5.6	3.5	4.2	4.0	4.2	11.5	1.3	0.0	0.3	5.2	4.8	10.2	4.2	1.5	2.5	13.4	4.5	5.2	2.0	53.5	1.7	5.3	63.8	1.8	2.9	46.7	1.2	610.8	11.3	3.6	2.3	3.0	50.4	0.0	1.2	6.2	6.0	9.4	2.8	4.4	3.3	3.6	4.6	2.8	2.5	0.0	2.5	4.3	2.9	6.5	3.1	28.8	70.2	6.4	34.7	4.4	11.5	2.7
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105078-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 70.2;testis: 73.9"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 102.4;Erythroid cells: 163.5;Extravillous trophoblasts: 106.5;Spermatocytes: 88.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	4	"T-reg: 17.8"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.8"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	2.0	1.1	0.4	21.0	0.4	24.7	2.5	0.3	0.6	1.8	5.5	0.5	0.2	5.2	1.0	1.5	11.3	0.5	1.6	1.2	0.4	0.4	1.0	1.0	1.9	12.0	0.4	0.3	0.8	0.7	0.0	0.4	6.7	0.4	1.1	6.3	0.4	2.1	0.6	0.4	3.6	5.1	2.0	1.3	5.2	3.0	73.9	0.2	70.2	0.8	10.3	16.0	1.8	3.4	1.8	2.3	0.7	0.1	3.0	17.8	1.8	28.7	25.3	41.6	10.3	1.9	3.8	22.1	23.8	15.3	36.9	30.4	40.9	17.7	26.7	17.3	15.4	21.6	35.5	39.3	20.2	34.9	27.7	21.1	34.6	29.6	23.2	0.5	25.7	22.3	1.4	2.7	15.9	20.3	7.2	25.0	33.0	34.9	42.9	27.8	20.9	29.3	37.5	30.7	12.4	15.0	34.3	58.9	27.1	11.6	20.3	25.9	17.5	32.6	17.7	21.5	34.0	30.7	25.7	13.0	18.4	31.2	20.2	45.3	19.1	28.7	47.5	12.0	58.9	25.9	0.0	0.1	0.6	0.1	0.0	0.2	1.8	3.9	4.1	2.3	0.9	0.0	0.1	0.7	3.0	0.0	0.1	17.8	1.8	0.4	0.4	0.3	0.6	0.4	0.4	0.4	0.3	0.4	0.2	0.0	1.1	7.8	1.0	4.2	0.0	0.3	0.0	1.4	2.3	0.0	0.0	26.7	0.0	0.4	102.4	0.4	1.7	163.5	0.2	106.5	1.1	1.7	0.0	0.8	25.3	0.0	2.9	3.1	10.7	30.4	4.0	4.2	0.0	3.6	5.5	0.0	0.5	1.7	1.8	0.0	0.2	0.0	0.0	88.2	36.6	5.4	13.6	3.2	12.4	2.0
CD151	"PETA-3, RAPH, SFA-1, TSPAN24"	ENSG00000177697	"CD151 molecule (Raph blood group)"	P48509	11	832843-839831	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Blood group antigen"	"Deafness, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 112.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002428, HPA011906"	Supported					NA	NA		680000			"CAB002428: AB_564129, HPA011906: AB_1846245"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.45e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (5.58e-4)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.24e-1)"	"prognostic favorable (6.92e-4)"	"unprognostic (7.83e-2)"	63.1	28.1	7.4	19.1	8.1	3.4	133.2	7.9	11.3	39.8	36.0	9.5	37.8	23.2	55.7	45.3	43.1	29.3	63.0	85.2	7.3	7.9	52.8	47.2	45.8	16.3	7.5	10.3	29.8	82.7	27.8	14.1	58.6	10.7	52.0	16.5	31.2	62.9	41.1	19.2	17.1	46.0	62.4	6.7	15.8	31.7	20.8	5.5	2.4	43.2	27.1	16.1	35.9	34.9	2.1	8.1	14.9	14.3	5.2	4.8	6.5	38.1	52.9	7.6	22.8	109.5	45.6	11.9	59.8	40.9	30.2	25.6	27.5	54.6	0.0	24.0	89.4	40.3	34.9	6.7	52.8	7.6	14.3	26.0	10.5	16.3	21.0	41.7	8.5	14.7	44.0	35.3	17.7	31.2	112.1	35.6	1.7	12.9	5.0	45.0	21.4	0.2	10.1	5.0	21.6	63.5	1.9	15.8	8.2	67.2	11.1	10.5	11.8	55.4	30.9	10.4	7.9	12.4	10.3	60.9	41.1	20.4	13.2	33.1	6.6	6.8	0.4	40.5	8.9	22.7	14.9	12.0	9.6	4.2	12.6	4.8	2.1	3.5	3.6	8.1	1.5	1.5	2.2	5.7	5.2	14.3	1.3	2.1	6.5	7.4	8.1	7.9	11.3	7.3	7.9	7.5	10.3	10.7	5.5	193.5	73.9	15.2	121.9	62.7	15.1	156.1	160.5	32.1	73.9	235.5	3.9	213.2	16.6	600.9	2.2	178.4	409.1	0.0	557.1	348.4	135.3	228.7	81.7	50.8	127.0	35.0	122.5	247.9	64.9	8.8	114.5	96.8	121.4	92.8	320.3	85.6	610.0	308.6	266.2	116.1	12.3	207.0	270.6	1.4	13.0	47.6	155.3	44.9	214.1	153.3
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 464.3;breast: 156.1"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 491.8;Hofbauer cells: 1111.0;Ito cells: 465.9;Sertoli cells: 685.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 104.4;intermediate monocyte: 30.4;myeloid DC: 56.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 56.9;monocytes: 104.4"	"Group enriched"	"Detected in some"	5	"ASC diff: 82.7;HEL: 39.3"	"Low region specificity"	"Detected in many"							"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		92000000	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	464.3	3.6	1.2	8.9	1.3	10.9	156.1	0.5	0.5	1.8	31.8	0.6	3.3	9.8	1.8	7.5	7.5	3.3	7.2	76.8	1.8	1.9	2.2	13.3	11.5	4.8	0.6	0.3	2.5	3.9	3.1	0.8	37.9	2.9	9.2	3.5	0.8	4.6	2.3	23.6	5.4	23.4	4.7	0.8	42.8	5.0	6.0	0.5	2.7	13.6	15.3	1.4	9.4	19.2	0.3	56.9	1.8	104.4	0.7	0.2	60.2	0.0	0.0	0.2	0.1	82.7	0.8	0.1	0.2	2.8	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.0	0.1	0.0	0.1	0.1	39.3	0.1	6.3	0.0	0.0	0.0	8.0	3.1	0.0	0.0	1.9	0.2	0.0	1.4	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.0	0.7	2.7	4.5	0.0	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.0	13.5	10.4	0.9	104.4	0.3	0.2	30.4	0.2	0.3	0.0	0.0	56.9	0.0	0.1	0.0	1.8	0.7	7.5	14.3	0.1	60.2	1.2	1.3	0.5	0.5	1.8	1.9	0.6	0.3	2.9	0.5	6.0	69.8	5.2	0.1	6.5	0.0	491.8	7.6	0.0	5.7	7.0	0.0	8.5	0.0	0.0	9.2	46.6	0.0	163.5	0.0	9.4	14.4	0.7	14.0	12.1	1111.0	0.0	0.0	465.9	196.7	2.3	0.6	68.0	15.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.3	685.6	31.5	4.7	0.7	4.1	15.3	1.3	0.0	0.1
CD47	"IAP, MER6, OA3"	ENSG00000196776	"CD47 molecule"	Q08722	3	108043094-108091862	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016055, HPA044659"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		2000000	"Plasma membrane"	Vesicles	"CAB016055: AB_627086, HPA044659: AB_2679040"	"unprognostic (3.54e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.05e-3)"	"unprognostic (8.77e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (7.37e-2)"	"unprognostic (3.78e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (1.83e-1)"	16.2	24.3	23.0	28.8	46.5	58.0	29.0	44.0	55.5	20.5	25.7	42.5	13.4	19.8	16.2	30.4	46.7	31.7	26.0	26.7	24.1	24.4	19.1	22.1	49.6	35.1	27.4	28.8	16.2	25.7	11.5	34.8	23.3	43.6	40.2	29.0	15.7	43.8	18.9	18.1	19.3	21.2	21.0	37.7	29.0	33.4	20.6	25.0	34.4	30.1	22.0	42.5	25.1	29.1	40.1	35.6	44.1	64.4	45.1	65.3	51.7	45.7	8.2	16.6	9.4	23.8	25.6	21.9	17.3	27.1	13.5	23.1	0.4	25.9	21.0	28.1	16.6	31.0	31.4	9.2	17.5	17.6	12.4	6.3	53.5	7.7	0.7	13.8	38.1	72.3	16.4	10.7	12.9	10.4	21.0	13.3	21.8	12.6	50.0	20.0	23.5	46.3	14.3	6.9	42.7	21.0	24.6	12.2	29.7	34.2	18.3	12.6	7.8	10.3	20.5	17.5	8.8	37.1	12.5	12.8	35.0	6.4	19.6	11.7	19.4	13.1	29.5	25.5	19.1	9.6	31.7	24.7	44.1	40.2	48.1	35.0	40.1	47.0	42.0	35.6	39.2	35.4	38.3	30.1	45.1	64.4	27.7	65.3	51.7	23.0	46.5	44.0	55.5	24.1	24.4	27.4	28.8	43.6	25.0	342.4	135.6	141.2	259.6	146.8	90.6	37.8	109.5	58.9	102.4	89.0	90.3	137.8	13.3	418.5	33.5	71.3	35.8	23.3	357.7	75.9	79.2	245.6	56.6	30.2	163.7	116.0	61.4	82.9	78.2	40.6	31.7	105.3	111.3	90.2	60.0	47.2	337.0	107.2	45.6	11.9	214.8	64.7	72.9	25.2	13.2	122.5	101.4	137.1	79.7	264.1
CD53	"MOX44, TSPAN25"	ENSG00000143119	"CD53 molecule"	P19397	1	110873154-110899928	"CD markers, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 146.7;lymphoid tissue: 103.0"	"Group enriched"	"Detected in many"	7	"B-cells: 233.1;granulocytes: 158.2;Hofbauer cells: 322.4;Kupffer cells: 293.3;Macrophages: 340.3;T-cells: 289.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 87.2;HDLM-2: 37.5;HMC-1: 54.9;Karpas-707: 34.2;U-266/70: 47.3;U-698: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047216	Enhanced					NA	NA					"HPA047216: AB_2679986"	"unprognostic (2.93e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.72e-2)"	29.7	8.1	6.1	50.6	10.3	20.4	6.6	1.6	5.8	4.5	9.6	7.6	1.2	6.7	4.3	6.0	5.5	9.9	11.0	6.4	6.4	5.9	9.6	8.8	28.9	93.8	13.3	2.7	4.7	3.8	0.8	3.1	10.6	8.5	5.2	10.5	4.5	10.1	2.3	2.3	2.2	35.2	10.0	14.9	103.0	7.5	4.8	10.0	37.2	4.6	4.1	82.1	15.2	4.0	97.5	74.6	138.0	97.0	59.2	91.8	146.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	37.5	0.0	4.6	0.0	0.0	0.0	10.4	54.9	0.0	0.0	0.0	0.0	0.0	0.0	25.0	1.9	34.2	0.0	0.0	17.7	12.4	0.0	0.0	0.0	17.2	0.1	18.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	15.7	3.1	0.0	0.0	0.0	0.1	47.3	21.4	27.0	0.2	12.1	0.6	138.0	87.0	54.1	91.8	93.3	82.8	97.5	67.5	80.8	74.6	83.3	49.2	70.8	136.2	59.2	97.0	61.4	85.0	146.7	6.1	10.3	1.6	5.8	6.4	5.9	13.3	2.7	8.5	10.0	14.9	35.6	233.1	0.4	6.3	0.0	0.8	5.1	8.1	15.9	1.8	0.0	1.7	0.0	0.0	0.2	7.2	0.0	23.3	0.2	4.2	5.0	0.3	158.2	1.7	322.4	0.0	0.0	15.4	293.3	0.9	2.0	340.3	37.1	39.7	0.0	0.0	0.2	0.0	0.4	1.1	0.6	6.5	0.7	0.1	0.7	4.8	3.4	289.1	0.0	0.3
CD63	"ME491, MLA1, TSPAN30"	ENSG00000135404	"CD63 molecule"	P08962	12	55725323-55729707	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 276.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010088, CAB026356, HPA073506"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: "	"unprognostic (8.76e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.66e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.02e-2)"	115.3	88.2	42.5	44.9	37.2	67.4	106.3	13.7	33.1	80.6	84.7	34.4	71.5	39.9	99.7	177.9	70.9	60.4	102.7	154.4	36.9	39.0	106.6	92.5	109.6	113.8	49.8	27.2	93.8	187.1	33.3	49.3	176.9	50.8	82.9	81.8	102.1	105.0	83.7	92.7	38.5	72.4	88.2	43.6	107.7	74.8	52.1	30.5	17.6	108.1	50.7	47.4	96.3	82.2	9.6	40.3	147.4	50.8	58.4	29.8	56.6	22.2	38.8	21.3	20.7	276.2	173.2	28.1	90.7	166.3	53.7	58.5	43.3	44.9	6.4	28.9	134.9	38.3	20.7	15.4	37.5	69.1	18.1	14.5	35.0	30.3	23.9	109.9	15.5	83.4	127.4	37.4	59.6	54.7	111.7	59.1	3.2	19.7	44.8	170.8	35.6	3.1	21.1	19.4	49.2	45.2	7.0	46.8	16.0	90.8	75.9	8.3	21.3	24.8	18.8	162.9	32.5	26.5	51.9	43.9	34.8	25.4	47.9	30.3	18.4	11.3	4.4	99.6	10.0	63.4	89.6	50.8	147.4	29.8	38.5	21.8	9.6	11.9	23.7	40.3	6.5	5.3	18.1	55.7	58.4	26.1	27.0	10.0	56.6	42.5	37.2	13.7	33.1	36.9	39.0	49.8	27.2	50.8	30.5	476.4	590.3	176.4	1219.6	503.8	174.4	555.7	917.2	377.4	564.1	830.5	143.3	558.0	197.3	2170.1	13.3	768.7	766.8	0.0	3001.1	2390.1	1497.1	1539.2	986.0	374.3	3024.5	31.8	557.9	750.1	794.3	26.6	1599.3	1215.7	1891.2	756.6	1108.9	851.5	2709.4	1083.7	1087.6	631.9	181.5	1235.3	1556.4	33.0	71.8	350.0	2264.8	339.0	575.6	1313.8
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397419	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Muller glia cells: 752.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 41.4;naive B-cell: 37.6"	"Lineage enriched"	"Detected in all"	4	"B-cells: 41.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 236.1;ASC TERT1: 134.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane"		NA	NA		1900000	"Plasma membrane"		"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	102.5	43.7	52.8	40.1	57.0	9.6	79.3	31.7	63.2	124.7	88.9	75.8	261.4	21.1	143.5	141.5	56.8	123.1	86.8	101.2	46.6	52.8	65.5	123.9	107.4	82.4	70.4	51.3	77.9	62.4	41.4	42.9	61.2	63.0	89.3	34.0	46.6	59.7	263.3	22.6	59.6	39.7	138.9	59.3	64.5	52.1	57.6	53.3	25.3	66.3	38.5	37.9	93.5	80.2	41.4	2.1	5.7	1.8	3.5	9.9	2.7	25.0	26.1	20.9	31.9	236.1	134.3	17.5	47.4	105.1	38.4	38.8	24.4	0.1	21.4	17.1	132.9	24.5	33.0	12.9	33.7	15.8	10.1	39.7	3.2	9.9	0.0	78.1	13.9	28.2	97.5	48.3	15.6	23.8	59.6	36.7	15.6	14.6	37.6	53.6	19.2	11.7	17.7	25.1	22.9	21.1	24.2	10.5	13.6	41.2	16.9	22.6	25.0	15.1	39.8	28.6	17.5	13.2	25.4	48.8	19.6	14.4	36.6	16.2	27.9	6.3	39.1	28.4	8.3	33.4	0.2	0.9	5.7	6.0	1.4	9.9	41.4	4.3	9.4	0.6	37.6	2.6	5.0	0.3	3.5	1.8	2.1	3.0	2.7	52.8	57.0	31.7	63.2	46.6	52.8	70.4	51.3	63.0	53.3	226.3	220.8	55.9	245.9	159.7	80.4	246.3	147.7	72.3	130.8	197.1	25.5	19.0	29.9	103.9	13.1	213.4	6.4	46.7	46.5	23.9	217.2	129.6	79.7	450.6	229.2	139.8	69.1	262.8	169.7	26.3	360.5	166.2	143.4	23.4	40.0	752.2	58.2	11.5	236.2	26.2	63.6	116.4	236.9	12.0	13.4	144.2	16.8	56.5	36.6	204.6
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Urothelial cells: 2399.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	21	"basophil: 137.8;eosinophil: 98.3"	"Lineage enriched"	"Detected in many"	24	"granulocytes: 137.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 129.4;RT4: 95.9;TIME: 191.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"		NA	NA		68000000	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (1.38e-1)"	"unprognostic (6.36e-3)"	"unprognostic (8.27e-3)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (6.10e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.26e-2)"	38.1	44.5	20.0	24.1	36.2	3.1	48.2	6.8	29.6	55.0	68.3	63.1	151.6	19.5	36.2	43.4	139.8	38.4	23.2	39.2	30.3	15.6	39.9	12.2	61.1	8.2	43.3	23.3	14.1	23.3	89.5	15.2	13.0	28.7	77.9	73.5	25.5	91.6	180.4	11.3	60.1	29.6	62.2	48.9	12.2	27.7	10.4	47.7	6.0	63.6	112.3	85.8	54.5	76.0	1.9	0.9	137.8	5.6	0.2	1.1	5.6	34.3	15.1	0.3	9.3	14.8	15.3	13.1	20.4	40.7	7.0	10.7	11.1	129.4	0.1	5.1	4.3	20.8	75.4	7.9	40.7	5.4	1.7	5.5	0.1	11.5	2.4	6.4	0.1	43.3	0.0	30.3	12.8	11.0	19.7	83.6	2.5	1.6	0.1	4.4	49.2	0.1	3.7	11.7	41.8	15.2	0.3	24.9	43.8	68.4	95.9	0.0	2.9	20.3	16.8	17.5	71.5	7.8	3.5	191.3	0.7	19.1	0.7	2.4	0.1	0.1	5.2	11.9	0.0	18.8	137.8	5.6	98.3	0.1	1.8	0.2	0.5	0.1	0.1	0.9	1.9	0.4	1.1	2.6	0.2	0.0	0.3	0.0	5.6	20.0	36.2	6.8	29.6	30.3	15.6	43.3	23.3	28.7	47.7	738.4	321.6	28.1	1345.7	921.9	3.7	14.2	76.5	519.3	651.7	1020.6	0.0	8.4	116.0	478.4	2.3	477.7	411.2	0.0	155.9	225.1	473.0	1465.7	638.5	36.4	653.0	0.0	166.1	406.4	33.8	7.3	29.7	438.3	892.5	256.1	636.4	386.7	257.1	669.9	66.4	14.0	13.1	653.2	455.3	7.0	76.5	1118.7	45.2	23.0	620.5	2399.6
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 88.4"	"Cell type enhanced"	"Detected in many"	18	"Erythroid cells: 280.4;Extravillous trophoblasts: 116.8;Spermatocytes: 104.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 6.1;T-reg: 5.7"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;NK-cells: 6.1;T-cells: 5.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"							"HPA003387, CAB003799"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes			Cytosol	Nucleoplasm	"CAB003799: AB_344898, HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	4.1	2.2	0.8	17.8	2.4	17.8	4.4	0.7	1.6	4.2	6.5	1.1	3.4	6.1	2.9	4.8	19.0	1.5	2.4	2.3	0.9	0.7	3.1	1.7	5.7	15.1	1.7	0.6	2.2	1.0	0.5	4.4	13.3	1.2	1.5	8.3	1.0	3.8	2.9	1.0	4.9	8.3	2.7	2.5	8.3	5.0	13.8	1.2	88.4	1.8	16.7	20.1	3.2	6.9	0.9	1.7	0.0	0.2	6.1	5.7	1.8	48.9	18.6	49.6	19.6	3.2	5.0	20.4	37.0	27.0	45.2	43.6	43.6	43.3	44.9	14.4	10.1	16.6	30.5	33.7	21.5	47.1	31.9	24.6	23.5	18.4	25.3	0.6	36.0	24.3	0.9	2.1	29.2	28.5	10.3	27.1	29.6	35.9	55.3	50.2	13.0	45.3	25.9	21.8	29.6	39.3	39.4	46.2	22.0	17.2	16.3	23.3	20.4	24.9	37.8	19.2	28.1	40.8	22.1	11.1	19.3	41.2	20.3	50.6	21.7	34.8	40.5	16.6	40.4	23.9	0.0	0.0	0.0	0.5	0.2	0.5	0.9	1.5	2.7	0.5	0.5	0.5	1.5	0.0	6.1	0.2	1.7	5.7	1.8	0.8	2.4	0.7	1.6	0.9	0.7	1.7	0.6	1.2	1.2	0.0	2.7	2.2	3.6	35.3	1.0	0.5	0.0	14.7	7.9	17.4	0.0	11.0	3.3	0.7	8.8	4.5	1.7	280.4	0.0	116.8	5.1	1.0	0.0	0.8	46.3	0.0	2.9	9.8	15.3	6.3	2.0	8.8	1.7	1.8	4.0	1.0	0.3	0.0	0.7	2.1	0.5	0.0	1.4	104.2	29.6	16.3	18.4	7.0	5.6	6.0
CELSR1	"ADGRC1, CDHF9, FMI2, HFMI2, ME2"	ENSG00000075275	"Cadherin EGF LAG seven-pass G-type receptor 1"	Q9NYQ6	22	46360834-46537170	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 38.7;Ciliated cells: 33.5;Club cells: 27.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"memory B-cell: 3.0;naive B-cell: 3.0"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.0"	"Cell line enhanced"	"Detected in many"		"A549: 24.1;HaCaT: 15.2;T-47d: 17.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052976, HPA060521"			Enhanced	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA052976: AB_2682004, HPA060521: AB_2684303"	"unprognostic (5.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	3.4	0.5	0.6	5.0	1.4	0.3	4.1	0.4	0.3	8.7	1.3	0.9	3.6	0.3	5.7	7.5	14.2	11.1	5.3	4.6	0.7	0.7	16.2	0.8	19.3	4.2	0.4	0.0	6.0	2.6	7.5	3.8	3.4	2.2	7.2	0.4	3.8	22.6	3.0	0.3	13.9	2.3	3.1	0.4	1.8	3.6	2.8	0.0	1.8	5.7	12.7	12.8	3.1	5.0	3.0	0.2	0.0	0.0	0.7	0.1	0.0	8.7	24.1	4.6	3.9	0.0	0.0	2.2	0.7	1.5	1.4	0.3	5.7	6.8	0.0	11.9	0.1	9.3	15.2	3.8	11.5	0.5	0.0	4.6	0.0	9.7	0.2	0.2	1.5	0.6	0.0	10.8	0.0	9.6	9.1	0.0	0.6	0.0	0.0	0.0	10.9	0.0	1.7	1.7	2.8	3.8	0.0	0.0	2.8	6.4	5.4	0.2	0.3	7.5	6.0	1.2	1.9	17.3	5.1	0.3	0.0	0.1	0.0	0.1	4.6	0.2	2.4	6.0	0.0	5.2	0.0	0.0	0.0	0.1	0.0	0.0	3.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.6	1.4	0.4	0.3	0.7	0.7	0.4	0.0	2.2	0.0	38.7	16.8	1.3	3.3	15.1	0.0	10.2	0.0	33.5	27.3	5.2	0.0	1.0	0.0	1.4	1.2	5.5	0.0	0.0	0.6	1.7	1.7	3.6	0.0	1.6	2.4	0.0	1.2	1.3	0.0	5.0	0.0	1.3	5.0	1.8	2.0	1.3	2.6	0.0	0.0	11.0	0.3	0.0	1.0	0.2	0.2	13.7	0.7	0.0	1.5	4.7
CEPT1		ENSG00000134255	"Choline/ethanolamine phosphotransferase 1"	Q9Y6K0	1	111139627-111185102	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.20e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.27e-2)"	22.4	22.9	16.0	22.2	19.5	5.6	20.1	20.7	19.8	14.9	13.7	22.2	17.5	19.0	18.3	19.1	21.3	16.6	15.3	12.2	17.9	16.0	22.6	39.4	16.5	31.7	22.9	15.1	22.9	17.8	19.6	25.5	22.5	18.2	13.9	18.1	16.9	19.2	12.0	11.2	17.8	20.2	16.3	23.3	34.5	17.5	12.5	21.3	22.3	19.4	11.5	24.7	19.5	17.8	14.6	9.0	4.2	19.1	5.3	9.0	5.5	14.0	5.3	6.3	6.1	25.0	12.3	15.3	15.6	8.9	7.3	8.8	4.6	16.0	16.8	17.3	8.0	9.3	17.4	9.1	12.2	10.5	12.4	14.1	7.3	9.5	10.2	16.7	17.1	10.5	10.0	23.5	5.3	25.5	13.9	9.6	17.5	15.7	11.0	9.5	10.2	17.5	16.9	9.7	22.6	10.9	9.5	20.0	13.6	11.9	8.9	8.3	4.4	14.4	22.0	16.6	12.8	11.7	18.7	8.4	11.9	7.5	25.7	10.4	10.1	10.9	13.1	16.0	15.4	22.5	3.2	7.6	4.2	6.4	13.6	8.4	14.5	7.2	6.7	9.0	14.6	8.4	9.0	1.9	5.3	19.1	7.0	6.2	5.5	16.0	19.5	20.7	19.8	17.9	16.0	22.9	15.1	18.2	21.3	32.8	12.2	37.9	14.6	11.6	26.0	3.6	20.4	21.4	14.8	34.9	33.4	24.6	5.0	11.7	1.7	9.7	16.0	0.0	7.1	16.3	11.4	13.2	18.5	29.7	25.2	27.0	9.8	22.7	40.9	2.2	13.6	19.4	15.1	9.0	13.6	9.4	8.5	14.7	15.9	12.0	20.7	12.9	7.2	12.0	13.2	13.4	15.9	20.0	13.3	12.4
CETP	BPIFF	ENSG00000087237	"Cholesteryl ester transfer protein"	P11597	16	56961850-56983845	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Atherosclerosis, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.5;lymphoid tissue: 54.5"	"Group enriched"	"Detected in some"	27	"Ito cells: 70.6;Kupffer cells: 86.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 5.1;plasmacytoid DC: 5.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 5.2;HUVEC TERT2: 8.8;TIME: 5.1"														"Secreted to blood"	NA	NA	2470000000	380000000				"unprognostic (6.52e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-3)"	"unprognostic (4.92e-3)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.97e-2)"	16.0	1.9	0.6	4.8	1.0	2.0	4.8	0.3	0.7	0.3	0.9	0.3	0.2	0.3	0.3	0.7	1.3	0.3	1.8	3.1	0.7	0.5	4.1	23.5	2.9	54.5	0.7	0.7	0.6	0.6	0.3	3.0	17.7	0.9	0.7	0.1	9.7	7.7	0.5	0.4	0.5	1.7	0.2	0.7	36.7	0.5	0.4	0.0	3.7	4.6	0.1	3.4	0.7	0.3	1.7	5.8	0.3	5.1	4.2	0.2	2.3	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.9	1.1	1.7	0.0	0.1	0.0	0.1	0.0	0.0	0.4	8.8	0.5	0.0	0.8	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.8	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.1	0.4	0.0	0.6	0.0	0.4	0.1	0.8	0.2	0.0	0.0	0.0	0.9	0.0	0.2	1.2	0.0	1.7	0.0	0.0	0.7	0.3	0.1	0.0	0.3	4.2	5.1	5.8	0.1	2.3	0.6	1.0	0.3	0.7	0.7	0.5	0.7	0.7	0.9	0.0	0.0	2.6	2.7	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.8	0.4	0.0	0.0	0.0	1.0	2.4	0.0	0.0	70.6	86.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0
CFTR	"ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR"	ENSG00000001626	"Cystic fibrosis transmembrane conductance regulator"	P13569	7	117465784-117715971	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Isomerase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 103.0"	"Cell type enriched"	"Detected in many"	5	"Ductal cells: 325.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.9;pancreatic cancer: 28.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"CACO-2: 12.8;MOLT-4: 48.1;U-266/70: 26.3"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"olfactory region: 6.3"	"CAB001951, HPA021939, HPA079652"	Enhanced					NA	NA					"CAB001951: , HPA021939: AB_1846578, HPA079652: "	"unprognostic (6.38e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.64e-2)"	0.4	0.2	0.4	10.5	0.4	0.0	0.3	0.3	0.3	2.5	19.8	0.1	0.8	10.5	0.6	2.1	0.4	0.4	15.8	0.3	0.4	0.3	1.1	1.4	5.7	0.1	0.5	0.1	0.3	103.0	0.0	0.3	0.1	0.1	1.5	12.5	0.1	22.4	0.1	0.3	1.1	24.2	0.3	0.7	0.3	0.6	0.9	0.1	0.1	0.3	0.2	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.1	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.3	0.4	0.3	0.5	0.1	0.1	0.1	6.0	48.7	0.0	1.7	0.0	0.4	1.2	43.3	9.4	23.9	0.0	0.0	0.0	0.0	325.5	2.9	0.0	19.4	0.0	3.7	0.0	0.1	3.6	1.1	0.2	0.0	0.0	6.9	0.0	0.0	1.6	0.3	0.0	0.0	11.8	11.5	0.6	21.5	37.7	0.0	0.0	0.0	0.0	0.3	1.8	0.4	0.0	0.0	0.0	64.4	3.9
CHP1	"CHP, p22, p24, Sid470p, SLC9A1BP"	ENSG00000187446	"Calcineurin like EF-hand protein 1"	Q99653	15	41230839-41281890	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Protein kinase inhibitor"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Distal tubular cells: 330.0;Enterocytes: 365.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006616	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA006616: AB_1857461"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.63e-4)"	"unprognostic (7.29e-2)"	"unprognostic (3.74e-1)"	"prognostic favorable (4.07e-6)"	"unprognostic (2.20e-1)"	"unprognostic (7.46e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.79e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.04e-1)"	39.4	32.5	21.2	17.0	21.5	25.7	32.3	13.5	34.1	17.0	51.0	19.0	18.9	41.0	13.4	16.4	39.1	11.2	38.8	27.3	22.7	23.8	35.6	82.3	31.6	14.4	22.4	15.6	13.6	31.1	27.1	13.9	12.2	32.1	16.8	37.6	15.2	28.7	23.1	42.2	24.2	55.6	15.8	19.0	12.6	52.5	7.5	11.3	10.3	23.6	34.2	24.7	21.7	22.5	8.6	30.5	52.5	47.4	11.0	11.8	19.4	21.7	21.3	8.2	31.5	34.9	33.2	12.8	16.9	21.3	13.3	14.3	18.8	42.0	3.7	19.0	22.2	14.1	26.7	15.9	25.7	14.7	15.3	6.0	14.6	17.6	29.1	27.3	19.2	23.1	34.0	28.0	15.2	15.3	19.4	23.8	11.5	23.6	24.0	14.6	12.0	8.0	19.7	8.9	32.5	11.4	11.5	13.4	10.5	26.0	39.8	5.6	13.9	28.8	53.1	14.0	14.8	31.4	18.2	34.1	15.0	16.2	23.5	11.0	14.1	37.3	17.8	26.8	11.8	13.5	42.9	47.4	52.5	10.7	40.0	11.0	8.6	10.1	10.7	30.5	6.8	6.5	9.3	35.6	11.0	38.5	19.2	11.8	19.4	21.2	21.5	13.5	34.1	22.7	23.8	22.4	15.6	32.1	11.3	41.7	95.4	37.9	53.7	64.2	9.4	73.8	193.6	22.7	38.7	97.7	9.8	29.7	330.0	84.2	45.0	25.3	365.9	23.3	131.3	51.6	41.6	79.7	36.9	304.1	61.4	11.1	53.4	75.5	170.6	81.7	27.3	82.7	123.2	54.1	120.3	19.0	140.2	153.1	27.6	162.5	9.3	25.8	42.4	12.5	19.0	94.9	56.0	55.4	104.3	95.4
CHRNA1	CHRNA	ENSG00000138435	"Cholinergic receptor nicotinic alpha 1 subunit"	P02708	2	174747592-174787935	"Disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 96.7"	"Cell type enhanced"	"Detected in some"	11	"Early spermatids: 1.6;Melanocytes: 1.7;T-cells: 1.8"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 2.0"	"Cell type enriched"	"Detected in single"	27	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	27	"dendritic cells: 2.6"	"Group enriched"	"Detected in some"	18	"LHCN-M2: 89.4;RH-30: 73.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA071554	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA071554: AB_2686416"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.34e-2)"	"unprognostic (5.29e-3)"	"unprognostic (9.59e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.66e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-2)"	4.5	0.0	0.5	0.5	0.1	0.0	0.6	0.0	0.4	0.7	1.7	0.0	0.1	0.2	0.0	4.6	1.2	0.0	0.0	0.3	2.0	0.1	0.0	0.2	0.7	0.9	0.1	0.0	0.0	0.0	0.0	12.1	0.2	0.0	2.4	1.0	0.0	1.5	0.0	96.7	0.0	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.5	0.0	4.5	1.3	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	89.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.1	0.0	0.4	2.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0
CHRNA4	"BFNC, EBN, EBN1"	ENSG00000101204	"Cholinergic receptor nicotinic alpha 4 subunit"	P43681	20	63343223-63378401	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 16.4;liver: 38.8;parathyroid gland: 21.6"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 131.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-2 OS: 7.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"midbrain: 22.6;pons and medulla: 19.3;thalamus: 29.6"	CAB034064	Uncertain					NA	NA					"CAB034064: AB_2080535"	"unprognostic (3.40e-1)"	"unprognostic (1.71e-1)"		"unprognostic (2.87e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.10e-3)"	"unprognostic (5.72e-4)"	"unprognostic (9.02e-3)"	"unprognostic (9.79e-4)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.81e-2)"		0.6	0.8	5.2	0.6	8.7	0.6	0.6	3.1	14.5	0.6	0.6	11.0	0.0	0.6	0.6	0.6	0.6	2.0	0.6	0.6	5.1	6.8	2.1	38.8	0.7	0.6	11.3	8.2	0.7	0.6	21.6	1.0	0.6	16.4	1.3	0.6	5.7	0.6	0.6	0.6	0.6	0.6	0.6	3.9	4.8	0.6	1.9	3.9	0.0	1.2	0.0	0.6	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	8.7	3.1	14.5	5.1	6.8	11.3	8.2	16.4	3.9	0.0	0.0	0.0	0.0	0.0	20.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.0	131.9	0.0	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.8	2.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0
CHRNA7		ENSG00000175344	"Cholinergic receptor nicotinic alpha 7 subunit"	P36544	15	31923438-32173018	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 27.2"	"Cell type enhanced"	"Detected in some"	14	"Cholangiocytes: 5.1;Enterocytes: 7.1;Horizontal cells: 15.9;Spermatogonia: 7.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.3;RT4: 12.2;SH-SY5Y: 6.9;SK-BR-3: 13.5;U-2 OS: 11.1"	"Low region specificity"	"Detected in all"							"HPA029422, CAB033624"	Enhanced					NA	NA					"CAB033624: AB_784835, HPA029422: AB_10600863"	"unprognostic (3.43e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.61e-4)"	"unprognostic (6.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.36e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.43e-1)"	0.8	12.9	4.4	1.5	3.4	2.3	2.0	0.9	8.4	1.1	12.2	1.0	1.1	7.9	1.4	0.8	0.8	0.7	4.6	1.2	2.5	5.6	0.9	0.4	1.2	2.0	3.8	2.7	2.9	4.9	1.8	2.0	0.4	11.8	2.2	4.0	11.7	2.1	1.2	0.8	0.7	27.2	0.9	3.1	5.2	11.2	5.1	0.6	0.1	4.3	0.9	1.4	3.1	2.0	0.3	1.2	3.1	1.1	1.8	0.7	0.4	0.0	1.4	2.3	6.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.0	2.9	0.0	0.0	0.0	1.8	0.4	0.0	1.9	0.0	0.3	0.6	0.0	0.0	0.1	0.0	0.1	0.1	2.5	0.0	0.2	0.0	0.2	0.0	0.2	1.1	3.5	0.0	0.0	3.8	0.2	0.2	12.2	0.5	6.9	0.2	13.5	0.0	0.7	0.0	0.0	0.7	0.0	11.1	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.5	1.1	3.1	0.7	0.4	0.2	0.3	0.4	0.1	1.2	0.2	0.2	0.3	0.7	1.8	0.6	0.7	0.5	0.4	4.4	3.4	0.9	8.4	2.5	5.6	3.8	2.7	11.8	0.6	0.0	0.0	0.0	2.2	0.2	1.7	1.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	7.1	0.0	2.2	0.0	0.0	0.5	1.1	0.0	0.1	15.9	2.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	0.0	1.5	1.1	0.0	0.0	0.0	0.0	0.4	0.2	7.9	0.0	0.0	0.0	1.5	0.9
CHRNB1	CHRNB	ENSG00000170175	"Cholinergic receptor nicotinic beta 1 subunit"	P11230	17	7445061-7457707	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.6;tongue: 33.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 18.4;RH-30: 38.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005822, CAB011200"	Approved					NA	NA					"CAB011200: AB_262151, HPA005822: AB_1079484"	"unprognostic (2.89e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	4.5	11.5	5.7	1.9	5.1	6.1	3.7	2.3	4.4	3.4	2.0	4.5	3.7	2.3	2.4	5.5	3.6	2.9	1.6	5.0	4.8	3.9	3.9	5.5	2.4	2.6	6.0	3.5	2.9	18.2	8.3	2.5	5.8	4.0	2.6	2.1	4.5	4.5	2.6	81.6	4.0	2.2	2.6	5.1	3.1	2.0	1.2	4.4	4.5	6.0	33.9	3.2	2.4	2.5	7.8	8.2	15.2	11.1	12.3	11.7	7.1	0.8	1.2	2.0	2.5	3.3	2.2	4.6	0.6	2.0	3.0	2.5	0.8	1.1	3.2	2.2	1.3	1.1	7.3	0.7	13.3	1.1	3.9	2.5	1.8	1.2	4.2	1.4	1.1	4.7	4.9	3.7	1.8	6.0	5.1	2.0	6.4	2.3	1.8	18.4	0.5	3.4	2.1	1.5	0.8	0.6	2.2	38.4	8.1	8.3	0.7	0.3	6.0	1.3	2.2	2.5	3.3	2.1	1.6	1.9	1.3	3.5	0.9	2.6	4.4	4.8	0.9	1.1	2.5	1.1	10.6	6.6	15.2	9.9	7.2	7.7	7.8	11.0	10.0	8.2	7.6	9.0	11.7	2.2	12.3	11.1	6.3	8.9	7.1	5.7	5.1	2.3	4.1	4.8	3.9	6.0	3.5	4.0	4.4	0.0	3.7	9.9	2.9	5.7	3.9	7.5	2.5	9.4	5.7	8.7	2.0	34.2	19.9	14.8	1.2	10.3	6.8	0.0	11.8	7.3	8.0	3.5	12.7	8.3	11.1	14.3	2.4	8.0	6.5	1.5	20.1	8.4	11.8	19.8	4.8	11.2	14.5	6.5	15.9	11.9	7.2	0.0	10.3	2.8	2.1	5.6	25.4	14.6	4.8	3.1
CHRNB2		ENSG00000160716	"Cholinergic receptor nicotinic beta 2 subunit"	P17787	1	154567781-154580026	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 28.4"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 12.2;Cone photoreceptor cells: 13.7;Horizontal cells: 39.7;Late spermatids: 8.0;Rod photoreceptor cells: 7.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.2"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 20.7;SH-SY5Y: 20.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.13e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.84e-1)"	0.9	3.2	7.8	1.2	16.4	1.0	1.8	8.1	28.4	0.9	1.1	1.6	0.0	1.4	1.0	0.9	1.1	1.0	0.9	0.9	9.4	8.9	0.9	0.9	0.9	0.9	7.9	9.8	1.0	2.1	0.9	3.3	0.9	15.4	0.9	1.2	3.1	1.0	0.9	0.9	1.3	1.2	1.1	1.4	0.9	1.6	2.0	1.7	0.0	0.9	0.0	0.9	0.9	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.5	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	20.7	20.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	7.8	16.4	8.1	22.1	9.4	8.9	7.9	9.8	15.4	1.7	0.0	0.0	0.0	0.0	0.1	12.2	1.6	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	39.7	3.5	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	7.6	0.0	0.0	0.9	0.3	0.3	0.0	0.0	0.0	0.0
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 49.1"	"Cell type enriched"	"Detected in single"	11	"Muller glia cells: 4.3"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	72	"RH-30: 43.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"olfactory region: 1.4"	"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA056404: AB_2732603, HPA065404: AB_2732734"				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	49.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHRNE	ACHRE	ENSG00000108556	"Cholinergic receptor nicotinic epsilon subunit"	Q04844	17	4897774-4903074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"heart muscle: 53.3;pituitary gland: 19.0"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 132.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 5.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"HEL: 6.0;HMC-1: 15.1"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in single"	13	"basal ganglia: 5.7"							NA	NA						"unprognostic (2.00e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.35e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.80e-4)"	"unprognostic (7.75e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.70e-2)"	0.3	0.1	0.1	0.4	0.1	0.4	0.1	0.3	0.4	0.1	0.2	0.1	0.1	0.3	0.4	0.8	0.2	0.1	0.4	53.3	0.1	0.0	0.1	1.3	0.3	0.2	0.3	0.1	0.3	0.6	0.3	19.0	0.4	0.2	0.1	0.0	0.5	0.5	0.1	1.0	0.8	0.1	0.2	0.1	0.7	0.1	0.2	0.1	0.1	0.1	1.4	0.2	0.1	0.1	1.0	0.3	1.0	0.4	1.6	5.9	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	6.0	0.0	0.7	0.5	0.0	15.1	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.0	5.9	0.2	0.0	0.0	0.0	2.1	0.2	1.0	0.1	1.6	0.2	1.6	0.4	0.3	0.0	1.5	0.1	0.1	0.3	0.4	0.1	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	1.1	1.4	0.8	6.3	2.5	0.0	0.0	1.8	3.9	0.4	1.7	0.1	27.7	1.4	0.0	0.0	0.8	6.2	2.6	0.9	8.1	5.9	3.1	3.2	0.0	3.7	1.8	132.7	0.9	5.7	0.0	8.2	0.0	1.2	0.8	0.0	0.4	1.1	10.0	0.0	0.5	4.3	3.0	1.0	9.3	3.2	0.1	0.6
CHRNG	ACHRG	ENSG00000196811	"Cholinergic receptor nicotinic gamma subunit"	P07510	2	232539727-232546403	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"epididymis: 16.7;skeletal muscle: 40.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	18	"HSkMC: 5.1;RH-30: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.26e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.38e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.19e-6)"	"unprognostic (6.13e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.24e-2)"	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	16.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.6	0.0	40.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.1	0.0	0.6	0.3	0.5	0.5	1.1	0.8	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.5	0.1	0.2	0.1	0.0	0.1	0.1	14.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.5	0.2	0.2	0.2	0.7	0.2	0.4	0.5	0.2	0.6	0.8	0.8	0.2	1.1	0.2	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLCA1	"CaCC, CLCRG1"	ENSG00000016490	"Chloride channel accessory 1"	A8K7I4	1	86468368-86500289	"Predicted secreted proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 242.9"	"Cell type enriched"	"Detected in some"	56	"Mucus-secreting cells: 1736.8"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 86.8;pancreatic cancer: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.6;K-562: 1.7;NB-4: 5.3;RPMI-8226: 5.7;SH-SY5Y: 4.1;U-2197: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052787, HPA059301"	Enhanced				"Secreted to digestive system"	NA	NA		70000			"HPA052787: AB_2681947, HPA059301: AB_2683971"			"prognostic favorable (2.98e-4)"								"unprognostic (3.42e-1)"			"unprognostic (8.61e-2)"	"unprognostic (1.06e-1)"			0.2	0.2	0.2	41.7	0.2	0.0	0.2	0.2	0.2	0.2	100.0	0.1	0.1	80.7	0.2	0.1	0.2	0.3	4.4	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.2	98.0	0.2	0.2	0.1	0.2	0.2	242.9	1.1	0.2	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.6	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1736.8	0.0	0.0	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	30.9	0.0
CLCC1	MCLC	ENSG00000121940	"Chloride channel CLIC like 1"	Q96S66	1	108929508-108963457	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009087, HPA013210"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA009087: AB_1078532, HPA013210: AB_1846895"	"unprognostic (2.95e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.68e-3)"	"unprognostic (9.65e-2)"	17.4	19.5	17.5	13.2	24.8	7.1	19.1	22.8	26.1	19.0	16.4	28.4	22.9	15.6	22.1	31.2	12.2	16.9	15.8	20.2	19.5	15.2	12.2	23.5	15.1	10.9	24.4	16.3	23.3	28.5	26.6	24.4	20.0	20.5	23.1	15.3	17.7	21.8	24.1	29.3	16.1	14.8	19.3	21.5	13.7	17.9	8.3	24.3	5.1	21.7	10.4	12.9	17.1	16.0	7.7	9.5	9.0	15.4	7.1	9.4	5.5	23.8	10.4	13.5	23.3	18.8	17.1	17.5	19.9	16.4	14.1	15.3	11.2	10.0	5.7	21.4	15.7	9.2	9.2	12.2	7.5	18.1	18.1	10.9	14.1	13.0	10.3	15.1	13.9	15.6	12.5	11.3	16.3	13.4	14.5	12.9	6.7	17.0	23.3	10.3	9.5	1.3	5.5	10.2	8.4	9.4	12.9	6.9	13.6	11.8	14.2	8.1	12.4	23.3	25.2	18.0	10.8	7.9	9.5	13.9	18.9	15.1	18.0	19.5	17.0	13.9	8.8	23.0	11.3	40.6	4.1	9.2	9.0	9.1	11.1	9.4	7.7	7.7	7.2	8.0	5.9	8.7	7.9	1.6	7.1	15.4	9.5	9.2	5.5	17.5	24.8	22.8	26.1	19.5	15.2	24.4	16.3	20.5	24.3	23.8	18.1	4.5	11.7	3.3	13.1	4.5	15.3	18.7	19.4	10.4	27.5	24.4	0.0	15.5	6.1	7.1	5.7	0.0	18.3	10.5	14.6	15.9	11.5	19.2	11.6	20.6	3.5	10.4	4.3	2.1	18.4	5.7	8.5	11.8	8.8	14.5	17.7	0.0	17.7	5.6	15.6	19.4	8.0	4.2	4.6	5.5	15.4	6.4	10.1	8.9
CLCN1	"ClC-1, CLC1"	ENSG00000188037	"Chloride voltage-gated channel 1"	P35523	7	143316126-143352083	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"skeletal muscle: 38.9;tongue: 21.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 20.5;Late spermatids: 67.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.4;intermediate monocyte: 2.6;myeloid DC: 1.8;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.8;monocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.5;HSkMC: 5.5;NTERA-2: 1.2;PC-3: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (5.16e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.12e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.55e-3)"	"unprognostic (3.57e-2)"	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	38.9	0.0	0.8	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.7	21.1	0.9	0.1	0.0	0.0	1.8	0.5	3.8	0.0	0.2	0.9	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.2	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.2	2.6	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	3.8	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	2.1
CLCN2	"ClC-2, CLC2, EJM6"	ENSG00000114859	"Chloride voltage-gated channel 2"	P51788	3	184346185-184361651	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 21.0;intestine: 20.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 10.2;Enterocytes: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009397, HPA014545, HPA024108"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883"	"unprognostic (1.13e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (4.67e-8)"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.35e-1)"	1.6	5.4	4.9	2.6	8.3	1.3	1.6	8.8	6.3	2.8	20.2	16.9	5.1	11.6	4.5	5.0	1.7	2.8	21.0	1.5	6.3	3.1	3.7	1.8	1.3	1.0	15.3	4.1	6.1	5.9	4.4	4.0	1.5	8.9	2.6	14.0	15.6	3.7	9.0	1.2	2.2	11.8	2.4	10.8	1.6	2.7	11.9	9.8	0.1	3.2	1.3	1.3	2.2	2.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	8.0	2.8	2.3	6.2	2.1	1.8	5.4	2.9	1.6	2.9	1.8	15.1	2.7	2.8	8.0	1.4	7.5	14.0	3.3	3.1	0.9	2.5	4.0	2.5	5.8	6.4	1.3	1.0	2.5	3.4	2.5	2.5	2.9	1.3	2.7	3.0	1.0	1.4	1.0	4.4	0.8	1.3	3.5	6.7	4.4	5.0	2.2	9.6	3.5	6.1	3.9	2.3	3.0	10.5	4.7	1.6	8.5	1.1	1.3	1.5	4.4	7.1	7.0	3.8	4.8	1.7	2.6	4.8	6.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	8.3	8.8	6.3	6.3	3.1	15.3	4.1	8.9	9.8	3.0	2.6	0.0	0.7	0.9	2.2	1.1	10.2	4.0	1.2	0.0	0.0	0.9	0.0	3.5	2.4	0.5	30.8	0.0	1.8	0.4	1.0	0.6	1.1	0.4	0.5	1.6	2.9	1.8	0.0	1.3	4.9	0.4	0.0	1.0	3.6	1.8	1.8	7.8	4.6	2.2	2.6	0.0	0.8	3.3	1.6	0.4	1.3	0.0	6.5	0.3
CLCN4	"ClC-4, CLC4"	ENSG00000073464	"Chloride voltage-gated channel 4"	P51793	X	10156945-10237660	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;epididymis: 22.8;skeletal muscle: 34.6"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 75.3;Cone photoreceptor cells: 96.2;Horizontal cells: 49.3;Rod photoreceptor cells: 37.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.3;memory B-cell: 1.7;naive B-cell: 6.8;neutrophil: 4.4"	"Group enriched"	"Detected in many"	9	"B-cells: 6.8;granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"GAMG: 17.5;HEL: 16.2;SCLC-21H: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031313, HPA063637"	Enhanced	Approved	Approved	Vesicles		NA	NA			Vesicles		"HPA031313: AB_10601358, HPA063637: AB_2685069"	"unprognostic (1.01e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.96e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.99e-2)"	"prognostic favorable (9.55e-4)"	"unprognostic (9.70e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	3.1	3.4	9.7	2.0	21.3	2.1	1.6	18.6	29.1	2.0	1.4	15.7	0.0	1.2	1.3	22.8	2.3	3.0	2.8	11.4	13.0	10.5	3.4	3.5	3.4	2.9	23.5	10.4	2.2	2.4	8.9	3.9	1.7	18.2	2.1	1.1	6.0	2.3	1.7	34.6	1.2	1.2	1.4	15.2	3.2	2.1	2.2	17.9	0.0	6.8	2.0	2.2	2.3	0.8	6.8	0.6	4.4	0.5	0.0	0.0	0.6	4.8	3.0	2.2	0.0	1.1	2.0	0.0	0.1	0.0	0.0	0.0	5.9	3.3	3.6	8.7	0.9	17.5	1.0	1.4	3.2	0.1	0.0	3.4	16.2	1.6	2.4	5.4	0.0	0.0	9.7	2.6	4.2	1.0	3.4	6.2	0.0	1.2	0.0	2.2	0.5	0.0	0.1	2.8	5.2	10.5	0.0	3.6	0.0	1.5	0.5	16.8	6.3	6.9	0.7	0.0	2.0	1.8	2.0	6.1	2.6	4.4	11.4	0.4	0.4	8.1	1.3	8.3	0.0	3.3	2.3	0.5	0.0	0.0	0.4	0.0	1.7	0.0	0.0	0.6	6.8	0.0	0.0	4.4	0.0	0.1	0.0	0.0	0.6	9.7	21.3	18.6	26.7	13.0	10.5	23.5	10.4	18.2	17.9	8.9	1.9	3.7	0.7	0.5	75.3	26.7	12.7	5.3	1.2	7.0	96.2	0.1	0.0	2.2	0.0	1.4	0.0	0.0	3.1	0.2	1.0	0.7	1.1	4.2	2.5	49.3	14.5	17.2	4.7	0.0	0.9	0.5	0.0	0.0	0.0	12.8	2.9	0.0	3.5	2.6	37.1	0.0	0.8	0.0	0.2	0.1	0.2	0.0	0.0	0.8
CLCN7	"CLC-7, CLC7, OPTA2, PPP1R63"	ENSG00000103249	"Chloride voltage-gated channel 7"	P51798	16	1444934-1475580	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease mutation, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043019, HPA043586"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043019: AB_10964727, HPA043586: AB_10965322"	"unprognostic (2.69e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.49e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.54e-1)"	19.5	34.7	23.2	18.7	23.0	35.0	19.4	22.9	26.8	16.7	15.5	29.3	15.4	18.3	18.8	16.8	12.5	15.8	17.0	15.0	21.9	17.5	19.5	22.7	17.7	19.6	30.3	18.5	14.2	24.1	30.9	19.5	15.5	22.2	14.6	9.4	34.4	17.5	17.5	22.5	21.7	18.9	17.3	18.0	24.8	18.1	17.6	29.5	16.4	21.8	10.9	14.9	17.2	10.2	2.5	2.3	2.0	6.4	0.5	1.6	1.5	5.0	14.1	8.0	12.6	18.2	9.3	12.6	6.9	15.9	15.1	18.8	11.0	18.9	5.8	14.2	9.3	29.2	10.7	7.2	8.9	4.6	9.2	11.3	4.1	13.2	10.9	31.7	10.6	17.0	18.3	12.3	13.6	11.7	9.3	9.6	14.1	16.7	11.3	7.6	10.1	7.4	18.2	8.0	3.4	8.1	34.8	5.4	16.1	7.5	7.3	9.0	9.2	11.1	14.0	44.3	4.7	12.3	28.4	9.5	13.3	6.1	14.6	6.5	17.2	11.2	6.0	11.1	20.2	8.3	0.0	3.0	2.0	1.6	5.4	0.7	2.2	0.9	0.7	2.3	2.5	0.4	0.6	0.6	0.5	6.4	2.3	0.3	1.5	23.2	23.0	22.9	26.8	21.9	17.5	30.3	18.5	22.2	29.5	0.0	6.9	7.8	4.9	6.5	40.9	2.8	5.1	2.7	5.7	19.2	33.4	8.6	1.7	14.1	8.1	5.7	15.8	0.0	15.2	7.9	8.7	7.7	5.8	13.9	31.5	69.9	11.5	20.3	25.7	7.2	10.6	15.2	37.1	15.4	11.7	24.7	17.3	8.0	7.8	12.3	25.3	0.0	6.9	10.2	9.8	5.9	12.9	9.5	10.0	4.3
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305701-190322475	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 134.3;skin 1: 73.9"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 390.9;Suprabasal keratinocytes: 730.8;Urothelial cells: 538.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"EFO-21: 107.5;HaCaT: 37.6;hTCEpi: 46.9;RPTEC TERT1: 67.3;RT4: 42.1"	"Low region specificity"	"Detected in many"							"CAB002602, HPA048319"	Enhanced					NA	NA					"CAB002602: , HPA048319: AB_2680355"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (7.92e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.22e-1)"	11.4	14.7	1.0	4.9	0.5	0.0	5.8	0.2	0.7	10.1	7.2	1.2	11.4	0.1	46.5	18.8	13.8	18.8	9.2	3.2	0.7	0.6	7.2	134.3	5.5	0.0	1.0	0.4	13.3	18.0	0.0	1.3	30.5	2.0	13.0	0.3	0.5	10.6	18.2	0.6	73.9	0.4	31.1	1.3	1.2	0.4	7.1	0.1	6.7	8.5	12.2	19.8	9.7	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	4.7	0.0	0.0	0.0	0.0	0.0	0.4	8.4	0.1	0.3	2.7	11.0	0.0	107.5	0.0	9.5	37.6	0.2	12.3	1.0	0.1	0.2	0.0	1.6	6.4	8.2	0.0	0.0	0.0	46.9	0.9	14.2	0.4	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.3	0.8	0.0	0.1	0.0	67.3	42.1	0.0	0.0	4.9	0.9	2.8	0.6	8.6	0.0	2.0	0.1	1.6	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.2	0.7	0.7	0.6	1.0	0.4	2.0	0.1	11.9	29.6	0.0	214.2	390.9	0.0	0.4	173.3	195.4	155.8	29.6	0.0	1.3	0.0	178.6	0.0	0.8	0.0	0.0	49.1	0.2	10.7	75.9	1.1	165.2	1.0	0.0	1.7	1.8	2.7	0.9	14.4	13.7	30.4	10.0	0.2	0.0	113.1	0.0	33.2	1.9	0.0	0.0	9.2	0.2	0.3	730.8	28.3	0.5	0.0	538.7
CLDN15		ENSG00000106404	"Claudin 15"	P56746	7	101232092-101238820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"intestine: 194.8"	"Cell type enhanced"	"Detected in many"	6	"Undifferentiated cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.85e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (5.31e-5)"	"unprognostic (9.98e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (3.30e-4)"	15.4	0.7	1.0	5.2	1.0	3.9	12.5	1.3	1.1	2.5	172.9	1.1	1.2	76.6	2.4	4.4	1.8	3.2	7.2	2.1	1.7	0.8	3.7	7.0	2.2	2.9	1.7	0.8	4.4	1.3	1.1	1.3	2.0	1.7	2.2	2.4	0.8	1.4	1.2	1.1	2.1	194.8	1.6	2.3	5.7	1.7	2.4	1.4	1.0	1.8	1.3	2.3	2.7	3.0	1.0	1.8	1.7	1.2	0.8	1.9	1.4	2.2	6.9	3.7	5.8	5.8	4.7	2.5	2.2	2.8	2.7	4.0	4.6	2.6	7.4	3.9	1.4	4.5	4.2	6.1	1.3	2.7	9.2	12.9	3.4	3.9	5.9	5.1	3.8	7.5	4.5	6.1	3.6	4.7	5.9	2.2	7.5	16.0	12.1	2.1	7.7	6.0	21.9	2.9	3.3	4.8	8.2	3.2	6.1	1.6	2.8	3.6	12.7	2.0	3.8	10.6	5.3	3.5	7.7	3.2	9.0	7.8	13.6	2.6	12.8	16.0	7.9	2.5	10.0	5.2	0.2	1.2	0.1	1.9	0.7	0.6	0.4	1.9	0.2	0.8	1.0	1.3	1.4	1.7	0.8	0.9	1.8	0.8	1.4	1.0	1.0	1.3	1.0	1.7	0.8	1.7	0.8	1.7	1.4	3.0	1.4	5.2	5.3	6.1	17.9	0.8	12.7	5.3	7.9	21.0	29.5	4.1	11.6	4.4	13.8	6.7	24.5	0.0	5.8	3.2	6.0	5.3	0.0	8.1	2.4	14.3	11.6	4.9	1.9	3.0	14.1	2.9	6.8	3.6	27.6	4.1	4.8	25.4	2.1	2.2	21.1	6.5	2.5	6.0	6.3	4.5	4.2	8.2	51.4	2.7
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412143	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"kidney: 55.9"	"Cell type enriched"	"Detected in many"	7	"Distal tubular cells: 159.2"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	131	"EFO-21: 101.3;RPTEC TERT1: 35.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced					NA	NA					"HPA056020: AB_2683011"	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.2	0.8	0.4	0.2	0.3	0.0	0.2	0.2	0.5	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.6	0.2	0.2	0.3	0.4	55.9	1.2	0.2	0.7	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.6	0.5	0.2	1.8	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.4	3.4	0.2	0.4	0.3	0.2	0.5	0.4	1.4	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	101.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	1.4	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.1	0.0	0.5	0.3	0.2	1.2	0.3	0.2	0.4	0.1	0.0	0.4	0.3	0.2	0.5	0.3	0.4	0.3	0.2	0.2	0.2	0.0	0.0	0.0	4.8	6.3	0.2	0.3	5.1	22.7	1.2	8.7	0.0	0.2	159.2	2.2	0.6	0.0	0.0	0.0	0.3	0.1	0.3	1.2	1.1	1.5	0.1	3.2	0.0	0.0	0.3	0.0	0.0	1.0	5.0	0.0	0.0	0.0	0.4	0.0	0.4	0.6	0.1	0.0	0.0	0.1	0.1	11.0	5.1	0.0	0.0	3.1
CLDN17	"MGC126552, MGC126554"	ENSG00000156282	"Claudin 17"	P56750	21	30165564-30166756	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"esophagus: 12.8;salivary gland: 6.7;tongue: 24.4;vagina: 9.0"	"Cell type enriched"	"Detected in single"	6	"Early spermatids: 3.5"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"HaCaT: 2.2;hTCEpi: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045903	Enhanced					NA	NA					"HPA045903: AB_2679491"						"unprognostic (2.41e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	24.4	2.8	0.0	9.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 13.8;kidney: 22.5;placenta: 20.9;retina: 37.0"	"Cell type enriched"	"Detected in some"	7	"Extravillous trophoblasts: 192.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Group enriched"	"Detected in some"	54	"midbrain: 13.8;pons and medulla: 9.5"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"CACO-2: 5.1;Hep G2: 10.6;SuSa: 6.4"	"Region enhanced"	"Detected in some"		"olfactory region: 6.7"	"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	1.0	0.2	0.1	0.1	0.2	0.2	1.6	0.2	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.9	0.6	0.3	0.1	0.4	0.2	0.1	22.5	0.2	0.2	0.1	13.8	0.0	0.2	0.2	0.1	0.2	20.9	9.5	0.4	0.1	37.0	1.2	2.7	0.4	0.8	0.3	1.0	6.2	0.1	0.5	0.2	0.0	1.3	0.1	2.6	0.1	0.8	1.0	0.5	0.4	1.4	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.3	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.5	0.5	0.5	1.4	0.2	0.2	0.4	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	13.8	0.0	9.5	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	1.2	12.2	0.0	9.1	28.2	0.0	0.0	0.0	0.0	0.0	0.0	192.3	0.2	0.1	0.0	0.0	4.4	0.0	0.0	0.6	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	0.1	0.0	10.4	0.0	0.0	0.0
CLDN22	CLDN21	ENSG00000177300	"Claudin 22"	Q8N7P3	4	183318194-183320774	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"fallopian tube: 4.2;salivary gland: 7.2"	"Group enriched"	"Detected in some"	18	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0;Club cells: 3.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.0;MCF7: 1.0;RT4: 1.3;SCLC-21H: 1.5;THP-1: 1.1"															NA	NA																							0.0	0.4	0.2	0.0	0.4	0.2	0.0	0.3	0.5	0.1	0.1			0.0	1.0	0.0	0.9	4.2	0.0	0.0	0.5	0.2	1.1	1.3	0.1	0.0	0.1		0.0	0.2	0.1	0.4	0.0		0.4	0.0		7.2	0.1	0.5	0.4	0.0	0.1	0.2	0.2	0.0	0.1			0.5		0.2	0.0	0.0	0.0	0.3	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.3	0.3	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0											3.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLDN23	CLDNL	ENSG00000253958	"Claudin 23"	Q96B33	8	8701938-8704106	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Enterocytes: 128.5;Paneth cells: 76.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.4;plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 9.8;Daudi: 7.8;RT4: 8.3;SK-BR-3: 8.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070578			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA070578: "	"unprognostic (1.86e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.97e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-2)"	"unprognostic (8.25e-3)"	"prognostic favorable (9.65e-8)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.33e-3)"	9.1	1.0	0.3	7.1	1.4	0.3	6.1	0.4	0.6	2.6	14.8	0.5	3.8	5.5	1.0	6.3	2.8	1.4	10.6	1.4	0.9	0.2	6.5	13.3	8.7	3.1	1.1	0.3	2.6	3.2	1.5	0.7	15.7	1.7	3.3	8.8	2.8	6.0	2.5	0.9	10.0	20.0	0.5	0.3	2.4	18.0	1.5	0.5	0.4	8.8	4.3	3.0	6.0	5.3	0.5	3.9	0.8	2.4	0.0	0.0	0.6	0.2	3.2	0.0	0.2	1.0	0.1	9.8	2.4	1.9	2.6	4.0	1.9	5.2	7.8	0.0	0.1	1.0	3.1	0.0	0.1	0.2	1.5	0.0	0.0	1.0	0.1	4.6	0.0	0.1	1.3	1.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.3	4.0	0.1	0.2	2.5	0.4	1.6	0.0	0.0	0.0	1.2	8.3	0.4	1.2	3.2	8.5	0.1	1.0	1.2	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.8	0.0	2.4	0.0	0.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.6	0.3	1.4	0.4	0.6	0.9	0.2	1.1	0.3	1.7	0.5	8.9	1.9	1.3	6.7	0.1	0.0	0.5	20.4	6.7	1.2	1.8	0.0	15.9	6.6	19.6	0.0	1.0	128.5	0.0	9.5	15.2	3.5	2.8	4.6	6.8	15.3	0.0	7.5	8.0	1.9	0.0	0.3	2.9	3.3	1.0	23.5	0.2	20.1	76.4	0.4	3.8	1.1	6.5	2.1	0.0	0.0	0.5	7.9	0.0	18.9	10.5
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.4;thyroid gland: 91.6"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 2133.6;Mucus-secreting cells: 1109.4;Paneth cells: 1932.3;Undifferentiated cells: 955.0"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.1;pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.6;MCF7: 66.5;PC-3: 14.2;RPMI-8226: 11.4;SCLC-21H: 17.6;T-47d: 31.6"	"Not detected"	"Not detected"							HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA		15000	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.3	0.1	0.1	11.5	0.1	0.2	7.1	3.1	0.2	3.8	77.9	1.6	21.8	24.3	2.8	8.8	0.3	9.4	11.3	0.1	0.2	0.4	20.7	16.0	6.0	0.2	0.0	0.0	4.3	38.0	0.2	7.4	3.1	3.0	14.6	8.0	1.9	31.1	32.1	0.1	2.1	100.4	0.5	0.0	0.1	0.7	1.2	0.0	2.2	91.6	0.9	3.6	0.8	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.5	0.7	1.0	0.0	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	1.2	10.6	0.0	3.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.1	0.3	0.6	2.6	14.2	0.0	0.0	11.4	0.6	0.0	17.6	0.2	0.0	10.1	0.0	0.0	31.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	3.1	0.2	0.2	0.4	0.0	0.0	3.0	0.0	35.7	34.4	4.2	34.2	0.1	0.7	0.5	206.4	104.4	48.9	120.4	3.9	47.1	8.3	212.5	0.0	0.0	2133.6	23.3	15.9	8.6	0.5	498.9	28.7	32.7	4.3	0.0	581.8	0.0	0.0	0.0	2.3	0.9	10.1	3.6	1109.4	10.8	59.3	1932.3	0.0	42.3	8.5	0.0	0.4	0.0	0.0	0.0	60.5	2.9	955.0	455.4
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832693	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 141.0"	"Cell type enhanced"	"Detected in many"	17	"Basal glandular cells: 2545.0;Glandular cells: 2415.4;Urothelial cells: 7943.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 43.3;BEWO: 51.0;CAPAN-2: 95.4;MCF7: 48.6;OE19: 49.3;PC-3: 62.1;RT4: 42.0;SK-BR-3: 80.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB002610	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favorable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	0.7	0.2	0.4	17.1	0.4	0.0	17.1	0.4	0.5	17.5	53.7	0.7	23.2	25.0	5.1	15.9	62.3	15.4	15.4	0.5	0.4	0.3	30.2	2.0	28.8	0.4	0.4	0.4	5.5	32.4	2.7	3.5	78.1	1.3	31.8	24.7	0.7	52.0	25.7	0.6	35.3	93.3	2.7	0.4	0.4	2.7	2.5	0.4	3.8	141.0	60.9	55.7	38.5	21.0	0.1	0.1	0.2	0.1	0.1	0.6	0.0	43.3	0.5	0.0	0.2	0.0	0.0	51.0	0.4	0.0	0.0	0.0	22.7	95.4	0.0	3.5	0.0	0.3	24.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	15.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	48.6	0.0	0.2	0.0	49.3	62.1	0.0	0.8	1.0	11.6	42.0	10.1	0.2	0.0	80.9	0.1	2.9	31.6	0.1	0.0	0.1	1.8	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.3	0.4	0.4	1.3	0.4	256.1	182.2	2.2	2545.0	14.3	0.2	0.6	242.0	323.9	224.1	207.6	0.0	586.9	11.6	821.2	0.0	2.9	1686.2	0.0	388.8	629.5	21.8	2415.4	27.6	0.8	67.0	0.0	648.6	0.0	0.3	0.0	2.3	10.6	13.5	27.1	955.9	0.9	781.5	1557.1	0.0	10.2	0.0	0.0	2.1	0.0	0.2	47.2	799.6	1.7	627.6	7943.2
CLDN5	"AWAL, BEC1, CPETRL1, TMVCF"	ENSG00000184113	"Claudin 5"	O00501	22	19523024-19527545	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 101.1"	"Group enriched"	"Detected in many"	22	"Endothelial cells: 667.5;Ito cells: 611.4"	"Cancer enhanced"	"Detected in all"		"glioma: 32.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"basophil: 7.4;naive CD4 T-cell: 3.4;neutrophil: 4.1"	"Group enriched"	"Detected in many"	20	"granulocytes: 7.4;T-cells: 3.4"	"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 41.0;SCLC-21H: 25.8"	"Low region specificity"	"Detected in all"							CAB002607	Approved					NA	NA		730000			"CAB002607: "	"unprognostic (1.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.96e-2)"	101.1	4.9	13.9	6.8	17.9	1.9	45.5	7.1	20.0	10.6	19.4	10.2	3.0	9.9	10.2	5.1	7.8	9.5	11.7	14.1	16.9	15.0	7.6	6.0	43.6	9.2	19.8	4.5	8.6	5.5	2.4	1.5	13.1	20.0	8.2	5.0	5.4	4.1	5.1	26.2	10.2	10.3	7.6	18.9	13.5	8.8	6.5	11.9	0.3	20.1	7.3	3.7	7.6	34.7	0.1	0.2	7.4	0.2	0.0	3.4	20.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	41.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.4	0.3	0.0	0.0	0.0	25.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	3.4	0.1	4.1	0.0	0.0	0.1	0.0	20.9	13.9	17.9	7.1	15.8	16.9	15.0	19.8	4.5	20.0	11.9	3.0	10.6	2.2	1.1	28.7	0.6	15.4	2.5	0.0	1.2	7.0	0.0	0.2	0.0	0.0	3.6	667.5	0.0	0.0	0.7	0.2	7.1	3.4	1.1	1.0	0.7	0.0	2.4	611.4	25.1	2.3	4.9	2.8	13.5	0.0	0.0	2.5	0.0	0.0	0.7	0.0	4.4	0.0	16.5	0.7	0.9	26.7	0.0	5.7	0.0	6.3
CLDN7	"CEPTRL2, CPETRL2, Hs.84359"	ENSG00000181885	"Claudin 7"	O95471	17	7259903-7263983	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 166.7"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 1175.0;Paneth cells: 985.5;Urothelial cells: 711.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 26.8;CACO-2: 27.9;CAPAN-2: 54.3;HaCaT: 114.0;MCF7: 39.7;OE19: 42.8;SK-BR-3: 47.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013063, HPA014703, HPA073662"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			Vesicles	"Cell Junctions"	"CAB013063: , HPA014703: AB_1846873, HPA073662: "	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.96e-11)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (1.62e-1)"	1.6	2.0	0.4	28.0	0.4	0.0	9.5	0.4	0.4	9.9	71.4	0.4	47.6	47.2	2.4	49.3	73.4	13.4	47.2	0.7	0.4	0.3	30.0	12.1	32.3	0.8	0.4	0.4	3.4	70.9	12.3	7.3	25.0	0.4	9.8	42.5	0.7	40.9	42.2	0.9	2.9	166.7	1.8	0.5	1.4	1.2	1.8	0.4	1.5	40.5	28.3	45.6	12.2	19.3	3.8	1.6	0.0	3.0	2.2	6.7	2.3	3.2	0.3	0.0	0.0	0.0	0.2	26.8	0.0	0.1	0.0	0.0	27.9	54.3	0.0	1.0	0.1	0.1	114.0	0.0	3.5	0.0	0.0	0.6	0.0	0.7	0.0	2.1	0.0	0.2	0.5	5.4	0.0	0.2	0.0	2.5	0.0	0.3	0.1	0.0	39.7	0.0	0.3	0.2	42.8	1.0	0.0	0.0	0.7	0.0	0.0	6.5	0.1	0.3	47.5	0.0	2.2	17.3	0.4	5.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	2.2	3.0	4.8	0.5	1.5	3.3	1.6	3.8	3.7	6.7	0.0	2.2	0.1	0.2	0.9	2.3	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.4	104.2	43.9	5.4	188.2	1.8	0.8	0.5	226.7	123.1	91.0	305.4	7.9	231.4	33.2	701.7	0.0	3.8	1175.0	0.0	684.7	284.5	5.1	310.2	5.7	34.7	29.8	0.0	313.6	3.7	3.1	0.0	1.1	9.1	23.6	18.0	591.9	0.4	632.6	985.5	0.0	47.8	6.8	0.0	2.1	0.2	3.0	2.3	492.5	5.9	501.5	711.9
CLDN8		ENSG00000156284	"Claudin 8"	P56748	21	30214006-30216073	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 26.2;kidney: 48.4"	"Cell type enriched"	"Detected in some"	8	"Collecting duct cells: 212.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"HaCaT: 27.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060605	Supported					NA	NA					"HPA060605: AB_2684331"	"unprognostic (3.74e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-1)"		"unprognostic (3.04e-2)"		"unprognostic (1.17e-1)"		"unprognostic (1.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.32e-4)"			"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	0.6	0.6	0.6	0.1	0.6	0.0	26.2	0.7	0.6	2.5	10.0	0.0	6.9	0.0	0.7	14.0	4.2	0.8	0.0	0.7	0.6	0.6	48.4	0.9	1.7	0.0	0.6	0.0	0.6	1.5	0.0	1.3	5.9	0.0	4.6	19.5	0.0	14.2	8.7	0.6	2.2	0.8	0.0	0.6	0.6	0.7	1.0	0.0	0.0	12.2	1.2	1.8	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.7	0.6	0.6	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.9	0.0	0.0	0.0	26.8	4.5	212.9	0.0	0.0	10.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	13.5	0.0	0.0	17.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	6.6	18.2
CLDND1	"C3orf4, Z38"	ENSG00000080822	"Claudin domain containing 1"	Q9NY35	3	98497912-98523066	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 75.9;brain: 227.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029841	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			Nucleoplasm	"Nucleoli, Cytosol"	"HPA029841: AB_10600658"	"unprognostic (1.64e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.08e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.84e-6)"	"unprognostic (5.73e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.51e-1)"	14.7	12.4	61.6	10.7	76.1	11.7	14.1	11.9	77.1	14.1	10.4	100.5	3.3	10.0	16.9	12.6	22.6	10.9	14.3	15.9	85.4	52.3	11.0	14.0	12.2	13.6	133.4	28.9	19.1	5.8	7.0	6.7	20.5	72.7	14.6	13.6	4.9	6.8	15.7	9.7	17.6	9.4	18.5	227.4	11.5	7.5	28.5	95.4	4.3	11.5	4.7	14.8	14.7	11.1	19.9	19.7	28.1	18.6	49.5	75.9	28.6	17.9	7.3	22.9	14.0	27.7	21.6	12.5	14.2	19.6	20.0	27.7	14.8	18.3	9.0	19.2	13.6	38.0	24.3	17.6	10.8	35.1	21.2	7.5	18.7	5.2	13.2	22.2	16.8	18.7	25.2	58.3	15.6	16.8	21.5	21.7	17.9	9.3	27.7	28.1	9.4	12.3	11.1	19.9	7.8	15.6	8.3	30.8	11.4	18.7	8.1	8.3	22.8	19.6	6.6	28.1	32.1	6.6	14.3	20.1	26.1	24.1	17.7	18.4	36.7	15.7	14.5	43.6	16.2	33.3	28.1	18.6	19.8	21.7	10.7	40.8	19.9	40.9	39.8	19.7	16.4	16.6	16.9	13.8	49.5	10.5	12.7	75.9	28.6	61.6	76.1	11.9	38.8	85.4	52.3	133.4	28.9	72.7	95.4	32.8	39.6	30.5	103.2	128.0	19.7	48.0	12.7	16.0	23.9	26.2	23.6	44.0	24.9	18.4	58.8	63.1	19.7	46.7	14.2	132.7	70.7	85.5	35.8	18.7	31.6	14.3	27.5	54.0	25.9	62.2	47.8	38.0	108.0	43.3	18.8	28.6	24.0	11.5	43.9	18.2	31.4	51.8	126.4	168.0	50.6	171.8	80.1	103.6	17.1	110.7
CLIC1	"G6, NCC27, p64CLCP"	ENSG00000213719	"Chloride intracellular channel 1"	O00299	6	31730581-31739763	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB020825, CAB040557"	Enhanced		Supported	Cytosol		NA	NA		78000000	Cytosol		"CAB020825: , CAB040557: "	"unprognostic (7.26e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (2.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.31e-2)"	64.5	22.9	7.4	33.7	11.3	35.3	41.1	2.5	8.3	38.7	50.3	9.0	27.1	24.5	30.0	29.2	59.0	26.3	60.8	35.5	7.9	7.7	70.8	28.3	58.6	59.6	13.9	3.7	34.8	30.3	11.1	17.0	72.3	12.1	42.2	43.5	20.0	37.7	33.6	18.3	45.0	54.9	31.5	13.6	79.9	34.8	16.7	9.2	52.9	46.1	37.4	58.5	49.2	40.0	39.0	30.5	70.9	39.4	33.5	37.2	67.9	27.2	12.6	20.8	10.8	13.8	29.2	10.3	12.1	24.9	22.2	18.7	29.0	20.5	11.2	17.7	43.2	28.1	16.4	15.5	36.3	30.1	8.9	8.1	21.3	10.8	25.0	17.9	37.2	30.2	18.1	19.2	37.5	35.9	24.5	37.2	10.5	24.6	35.5	42.7	18.1	17.3	48.5	1.8	29.7	18.5	3.0	11.3	26.3	50.0	17.0	3.9	4.6	10.0	11.6	16.9	15.1	8.0	52.7	24.6	31.0	21.9	9.6	38.3	11.6	21.7	15.0	15.0	28.1	31.9	45.8	36.5	48.1	37.2	39.4	30.3	39.0	22.5	34.5	30.5	30.4	7.0	21.9	70.9	33.5	33.8	17.2	31.0	67.9	7.4	11.3	2.5	8.3	7.9	7.7	13.9	3.7	12.1	9.2	65.5	61.3	354.7	452.1	853.4	0.0	16.5	257.4	207.5	94.4	225.1	0.0	468.2	510.6	945.1	18.6	330.4	596.8	70.0	880.9	648.8	394.1	631.9	536.3	52.1	938.8	0.0	366.1	247.4	525.8	10.3	216.6	766.3	497.7	307.4	477.4	70.1	1089.0	792.5	176.8	468.7	6.7	200.5	405.4	19.4	13.4	811.1	479.0	498.6	571.6	861.7
CLIC2	XAP121	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 62.3;vagina: 66.1"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 83.4;Alveolar cells type 2: 48.6;Endothelial cells: 49.6;Kupffer cells: 47.8;monocytes: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 9.5;myeloid DC: 24.5;non-classical monocyte: 6.5"	"Group enriched"	"Detected in many"	14	"dendritic cells: 24.5;monocytes: 9.5"	"Group enriched"	"Detected in some"	5	"HDLM-2: 37.3;K-562: 20.2;Karpas-707: 18.6;RPMI-8226: 31.8"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		290000	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	26.5	3.7	3.8	7.5	6.1	3.4	24.1	2.6	4.8	15.5	6.8	0.6	3.3	4.0	11.3	10.5	10.4	6.5	9.8	9.4	3.7	3.4	5.4	6.3	31.0	15.6	7.5	1.4	12.5	2.6	2.0	7.8	4.5	6.8	9.1	6.9	3.0	5.4	3.2	10.3	5.2	7.3	10.2	5.2	32.1	4.7	5.6	4.3	6.9	62.3	8.7	12.4	14.0	66.1	0.0	24.5	0.6	9.5	1.1	0.1	1.0	0.2	0.0	0.4	0.3	0.3	2.1	0.0	0.1	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	37.3	0.2	5.2	0.1	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.2	20.2	18.6	0.1	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	31.8	0.1	0.0	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.4	0.0	1.7	0.6	0.7	0.3	1.2	1.6	0.0	0.9	1.1	0.6	0.0	1.8	0.1	0.0	9.5	0.1	0.0	0.0	0.1	24.5	0.0	0.0	0.0	0.6	1.1	6.5	2.5	0.0	1.0	3.8	6.1	2.6	4.8	3.7	3.4	7.5	1.4	6.8	4.3	83.4	48.6	0.8	0.7	11.7	1.1	2.8	0.0	2.7	10.3	0.0	0.0	0.0	0.0	0.0	0.1	49.6	0.0	23.3	0.2	0.1	22.3	0.4	3.5	1.0	4.8	0.0	1.2	19.0	47.8	0.4	12.7	29.8	16.9	118.2	0.0	0.0	0.1	0.0	8.9	0.2	0.3	6.5	4.8	0.0	0.0	12.0	0.0	2.2	0.0	1.4
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994635-136996803	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 163.5;esophagus: 74.1;placenta: 103.5"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 778.7;Extravillous trophoblasts: 921.9;Syncytiotrophoblasts: 1705.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	10	"plasmacytoid DC: 163.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 163.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 68.1;MCF7: 31.0;SK-BR-3: 13.0;T-47d: 29.6;TIME: 23.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA005963	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.74e-4)"	1.9	0.2	0.1	1.6	0.2	1.2	1.1	0.0	0.5	17.6	0.5	0.1	0.0	0.2	1.3	6.8	74.1	0.6	0.8	1.8	0.2	0.1	0.4	0.2	27.3	1.4	0.2	0.2	0.4	0.2	0.1	0.5	103.5	0.8	1.0	0.1	1.3	8.2	0.6	0.2	25.0	0.8	0.3	0.6	2.2	2.9	0.6	0.0	15.7	55.5	53.4	43.1	0.8	28.1	0.2	163.5	0.6	0.1	17.1	15.8	10.2	5.5	0.0	0.0	0.0	0.1	0.3	68.1	0.5	0.2	0.1	0.0	0.3	2.7	0.0	4.5	4.8	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.7	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	11.7	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	9.3	13.0	0.0	0.0	29.6	0.0	23.5	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	15.8	0.1	6.9	0.1	2.2	9.6	0.6	0.2	0.5	8.6	0.6	17.1	0.1	163.5	0.7	10.2	0.1	0.2	0.0	0.5	0.2	0.1	0.2	0.2	0.8	0.0	199.5	37.7	10.4	3.5	3.4	0.0	1.6	0.0	1.4	30.7	1.8	0.0	778.7	8.3	2.3	0.7	5.8	6.5	0.0	5.8	921.9	16.8	2.3	1.1	0.8	81.9	0.0	4.7	4.3	1.0	5.3	116.2	0.2	10.1	3.6	3.8	0.0	49.2	9.9	39.3	0.3	0.0	0.0	1.7	0.0	0.2	16.9	1705.4	70.8	2.9	18.2
CLIC4	"CLIC4L, DKFZP566G223, H1, huH1, P64H1"	ENSG00000169504	"Chloride intracellular channel 4"	Q9Y696	1	24745357-24844324	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Proximal tubular cells: 262.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 13.0;naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008019, HPA060804"	Enhanced		Supported	Cytosol		NA	NA		20000000	Cytosol		"HPA008019: AB_1846946, HPA060804: AB_2684370"	"unprognostic (7.35e-3)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.54e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.01e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.82e-3)"	45.3	16.9	20.6	26.3	26.7	7.6	35.4	4.5	20.0	52.1	46.4	41.6	23.2	8.9	68.0	27.4	42.0	34.7	29.7	77.4	23.5	16.5	71.2	19.9	40.8	12.9	28.2	13.0	37.6	13.5	10.8	6.1	53.7	22.3	51.9	19.1	29.1	18.2	45.2	20.9	12.6	19.3	87.2	33.6	15.1	33.4	20.9	26.4	7.1	17.7	11.2	15.0	106.7	42.3	13.0	5.3	2.2	5.1	0.0	0.3	3.3	26.4	3.0	26.7	21.2	36.4	79.4	15.4	71.8	67.3	30.4	36.9	5.9	13.9	17.3	41.8	92.7	9.1	9.6	18.2	17.7	76.7	4.3	8.6	6.6	8.2	10.1	51.0	2.2	0.8	36.6	30.7	43.4	44.0	50.2	50.3	9.4	5.1	16.8	87.1	4.4	4.1	3.3	26.1	5.7	13.7	10.4	31.5	6.3	31.1	6.8	5.0	12.8	18.9	8.1	52.4	28.5	7.2	13.4	78.4	56.0	21.4	24.7	27.4	10.2	14.0	14.1	41.2	18.6	16.9	0.7	5.1	2.2	0.3	4.1	0.0	13.0	0.3	0.2	5.3	11.9	0.2	0.2	1.1	0.0	3.3	1.6	0.0	3.3	20.6	26.7	4.5	15.8	23.5	16.5	28.2	13.0	22.3	26.4	14.9	26.2	47.7	48.0	54.7	3.4	162.6	25.5	2.7	13.6	14.0	9.8	55.0	34.9	32.8	34.8	119.6	4.5	0.0	36.5	153.1	125.4	76.4	39.3	31.1	35.9	1.6	9.2	88.4	26.6	20.0	26.4	47.9	123.2	68.5	15.5	9.3	48.8	8.0	82.4	262.2	21.6	45.3	178.4	35.6	29.6	45.5	148.1	6.9	2.9	26.7
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9"	"Cell type enhanced"	"Detected in many"	20	"Alveolar cells type 1: 473.4;Cardiomyocytes: 276.0;Enterocytes: 100.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.8"	"Lineage enriched"	"Detected in single"	23	"T-cells: 8.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.6;EFO-21: 9.6;HDLM-2: 5.0;REH: 11.7;U-266/70: 12.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		1000000	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	7.4	0.6	0.8	3.2	1.5	0.0	2.3	0.6	1.1	6.0	10.2	0.3	0.4	5.6	0.8	2.5	2.2	1.2	2.1	65.6	0.9	1.2	17.5	0.5	32.8	0.4	1.1	1.4	0.7	0.7	0.4	1.3	22.0	0.8	0.9	7.5	7.8	2.0	0.4	99.9	0.7	46.2	1.4	0.9	16.1	0.9	1.0	0.0	0.2	4.8	18.8	1.5	1.0	4.3	0.3	0.0	0.0	0.0	0.3	8.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.6	0.0	9.6	0.0	0.0	0.3	0.0	0.1	0.0	5.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.3	1.5	0.0	11.7	0.3	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	8.8	0.3	3.6	2.2	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	1.6	0.8	0.8	1.5	0.6	1.1	0.9	1.2	1.1	1.4	0.8	0.0	473.4	23.0	0.5	0.0	0.1	0.1	276.0	0.0	20.1	48.9	14.0	0.0	0.1	0.0	1.4	38.1	3.8	100.0	0.0	0.2	0.0	0.2	1.5	1.1	0.0	0.0	0.0	12.5	0.6	0.0	75.0	0.9	0.0	0.0	1.0	16.3	47.6	1.9	24.6	0.7	2.1	1.1	0.0	2.1	0.6	0.1	0.1	1.8	2.9	9.8	0.8
CLIC6	"CLIC1L, CLIC5"	ENSG00000159212	"Chloride intracellular channel 6"	Q96NY7	21	34669389-34718227	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 63.3;retina: 85.1;stomach 1: 45.1"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 30.6;Ciliated cells: 72.3;Club cells: 52.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"pons and medulla: 63.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 4.4;NTERA-2: 5.9;T-47d: 12.0;THP-1: 5.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065285	Enhanced					NA	NA					"HPA065285: AB_2685454"	"prognostic favorable (6.11e-5)"	"unprognostic (2.17e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (3.15e-5)"	"unprognostic (4.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.43e-3)"	7.7	0.0	0.8	3.0	1.7	0.0	5.7	0.6	2.3	8.7	1.8	12.4	0.6	0.9	1.0	5.2	1.2	6.1	4.5	6.3	5.4	1.0	0.9	0.6	6.4	0.4	0.4	0.5	2.3	1.2	0.0	1.3	0.6	63.3	4.0	1.3	85.1	10.9	3.8	1.9	2.3	1.1	1.9	0.6	0.7	45.1	1.1	0.6	2.4	8.2	0.9	1.8	7.5	2.0	0.3	0.1	0.4	0.0	0.2	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	1.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.0	4.4	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.4	1.7	12.0	5.3	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.1	0.8	1.7	0.6	2.3	5.4	1.0	0.4	0.5	63.3	0.6	6.0	20.2	0.0	4.6	0.6	0.0	5.3	30.6	72.3	52.4	8.7	0.0	0.0	1.7	6.3	0.0	0.0	0.2	0.0	0.8	0.0	3.8	9.0	1.1	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.3	0.0	6.8	1.0	1.0	0.0	15.9	0.0	2.8	0.0	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	3.3	13.7
CLN3	"BTN1, BTS, JNCL"	ENSG00000188603	"CLN3, battenin"	Q13286	16	28474111-28495575	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 278.0;Syncytiotrophoblasts: 377.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 53.8;SK-BR-3: 52.9"									HPA063280	Uncertain					NA	NA					"HPA063280: AB_2684975"	"unprognostic (2.38e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.06e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.38e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.27e-2)"	"unprognostic (5.26e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.05e-2)"	14.0	23.8	10.6	15.7	11.8	9.0	15.8	14.5	10.3	12.5	27.1	14.6	61.5	14.8	11.7	23.0	15.2	10.6	10.1	9.2	10.8	7.1	18.2	22.3	20.6	15.3	14.4	8.0	14.6	18.4	22.2	6.7	26.0	11.4	13.3	20.4	11.9	22.6	45.3	9.3	16.9	17.4	9.6	13.1	15.8	18.6	7.5	16.5	8.9	19.1	9.4	10.0	15.4	14.8	11.6	28.2	39.6	25.0	15.3	24.1	17.6	6.3	10.9	4.5	10.8	12.2	6.0	53.8	4.0	12.4	9.1	11.0	5.4	15.8	4.7	13.5	7.3	16.4	6.8	7.7	7.4	3.9	11.6	10.4	4.5	7.4	16.0	18.7	6.8	19.6	8.1	17.9	7.0	4.5	7.7	10.0	7.5	7.9	14.4	9.1	15.2	6.0	11.1	6.9	9.6	7.1	10.4	4.4	14.7	8.7	14.3	6.1	6.3	1.9	52.9	5.1	4.4	17.0	9.2	5.5	5.4	3.1	7.4	6.7	16.3	18.3	4.5	8.7	14.0	3.8	18.1	25.0	39.6	24.1	19.5	18.0	9.6	19.4	23.3	27.2	11.6	16.1	18.2	9.4	15.3	14.3	28.2	19.7	17.6	10.6	11.8	14.5	10.3	10.8	7.1	14.4	8.0	11.4	16.5	20.8	15.7	9.0	13.8	0.1	9.9	0.0	33.1	2.7	11.4	1.8	11.8	278.0	0.0	1.5	0.9	5.8	37.7	0.0	0.5	81.9	4.1	11.7	2.3	32.7	61.9	12.7	16.4	18.4	38.9	0.5	17.5	7.9	0.0	1.0	51.1	26.6	1.3	59.6	11.7	0.7	10.6	12.9	0.0	2.3	6.8	0.1	377.5	17.3	69.6	13.6
CLNS1A	"CLCI, ICln"	ENSG00000074201	"Chloride nucleotide-sensitive channel 1A"	P54105	11	77514936-77637805	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017840, HPA031707, HPA031708, HPA032045"	Approved		Supported	Nucleoplasm,Microtubules,Cytosol		No	No			Cytosol	"Nucleoplasm, Microtubules"	"CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123"	"unprognostic (1.30e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.12e-3)"	"unprognostic (5.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	22.6	44.7	43.0	31.3	37.3	27.8	36.4	24.5	45.6	30.0	31.9	41.8	26.2	22.1	29.3	47.4	41.5	34.5	29.9	33.2	37.2	39.5	26.8	90.9	20.8	41.2	45.3	31.2	49.2	44.9	26.5	28.9	29.0	38.5	28.7	35.7	29.6	28.2	27.4	43.1	24.4	26.3	26.1	48.5	32.5	28.5	21.7	31.7	47.0	40.5	36.8	45.1	31.9	28.8	33.4	45.9	12.8	34.1	31.8	32.7	30.6	24.2	23.8	39.8	29.6	29.8	42.9	16.1	21.4	33.0	34.9	31.5	58.2	34.7	54.7	35.6	25.9	27.4	29.5	48.1	44.4	42.8	30.6	29.3	53.6	30.0	33.5	25.1	79.3	24.9	34.4	51.9	30.7	58.4	34.6	39.6	33.7	70.3	16.9	34.2	36.0	52.0	64.7	37.6	81.2	44.8	28.1	77.5	58.6	25.2	34.0	40.6	46.2	28.8	32.7	19.8	30.1	44.4	34.7	25.9	26.1	31.9	50.8	20.6	34.0	47.3	58.6	10.3	29.8	20.9	12.8	33.1	12.2	21.0	34.1	24.0	32.1	26.8	23.1	45.9	33.4	32.7	27.5	2.3	31.8	28.7	28.2	23.0	30.6	43.0	37.3	24.5	45.6	37.2	39.5	45.3	31.2	38.5	31.7	14.9	16.9	79.3	88.6	73.5	68.6	66.7	50.9	33.5	48.9	55.8	47.1	114.2	71.3	64.7	13.3	56.2	37.1	0.0	75.8	112.7	69.2	58.1	76.2	62.5	82.7	55.6	30.5	48.5	94.8	10.9	81.1	78.8	72.6	146.9	56.2	179.4	61.9	45.6	64.3	70.3	55.1	51.8	46.4	90.1	100.9	75.3	67.4	77.1	110.2	89.9
CLRN1	"RP61, USH3, USH3A"	ENSG00000163646	"Clarin 1"	P58418	3	150926163-150972999	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Sensory transduction, Vision"		"Deafness, Disease mutation, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"adrenal gland: 11.2;retina: 16.2"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 150.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	32	"NTERA-2: 8.9"															NA	NA						"unprognostic (1.00e-3)"				"unprognostic (1.26e-1)"					"unprognostic (5.54e-1)"					"unprognostic (9.68e-2)"			0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.1	0.0	1.6	0.0	2.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.8	0.7	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	8.9	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	150.4	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLRN2		ENSG00000249581	"Clarin 2"	A0PK11	4	17515165-17527104	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"kidney: 1.2;salivary gland: 1.1;testis: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			HPA042407	Uncertain					NA	NA					"HPA042407: AB_10806237"																		0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.6	0.3	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	1.2	0.1	0.4	0.0	0.4		0.0	0.0	0.0	0.2	0.0		0.1	0.0		1.1	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.7			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLRN3	"MGC32871, TMEM12, USH3AL1"	ENSG00000180745	"Clarin 3"	Q8NCR9	10	127877841-127892947	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 69.3;kidney: 14.7;liver: 25.6"	"Group enriched"	"Detected in some"	5	"Enterocytes: 118.1;Hepatocytes: 34.8;Intestinal endocrine cells: 39.9;Mucus-secreting cells: 70.4;Paneth cells: 98.2;Proximal tubular cells: 59.1;Undifferentiated cells: 39.3"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 45.3;liver cancer: 9.4;pancreatic cancer: 10.7;renal cancer: 30.0;stomach cancer: 16.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	40	"OE19: 46.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014482	Approved					NA	NA					"HPA014482: AB_2082885"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.22e-2)"		"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"		"unprognostic (2.62e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.67e-1)"	"unprognostic (8.86e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.00e-2)"	0.4	0.2	0.3	3.1	0.2	0.0	0.2	0.2	0.3	0.2	27.5	0.3	0.2	23.7	0.2	1.3	0.2	0.1	9.5	0.2	0.3	0.2	14.7	25.6	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	23.5	0.2	0.2	0.2	0.2	0.1	69.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	1.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.0	0.1	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	118.1	0.0	0.5	0.0	0.0	0.0	0.0	34.8	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.4	0.0	0.2	98.2	0.0	59.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.3	0.0
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15665031	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 204.4"	"Cell type enriched"	"Detected in some"	15	"Proximal tubular cells: 679.1"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Region enriched"	"Detected in single"	9	"pons and medulla: 5.0"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 10.6;hTERT-HME1: 6.1;RPTEC TERT1: 9.8;SuSa: 6.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.1	0.2	0.3	0.1	0.4	0.0	0.3	0.1	0.2	0.2	0.2	0.5	0.1	0.1	0.2	1.6	0.2	0.4	0.6	0.2	0.5	0.4	204.4	11.5	0.6	0.1	0.3	0.1	0.8	1.2	4.0	0.2	0.7	5.0	0.3	0.0	11.3	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.1	2.4	0.3	0.1	0.2	0.7	0.1	0.1	0.4	0.2	0.9	0.6	0.0	0.5	0.0	3.0	0.4	3.0	2.1	1.5	0.6	0.8	1.2	1.0	0.1	0.0	0.1	0.1	0.2	0.5	0.3	2.1	0.1	0.2	10.6	0.9	2.5	0.0	0.4	1.4	0.3	0.0	1.0	1.6	0.0	0.0	0.2	2.4	0.4	6.1	0.7	0.0	2.4	0.7	0.6	0.3	3.5	0.2	0.4	3.5	0.9	3.1	0.3	0.5	1.3	9.8	0.2	1.4	1.3	0.8	0.2	2.0	6.5	1.0	0.3	0.1	0.2	0.5	0.4	0.0	0.5	0.3	0.4	0.9	0.1	0.1	0.0	0.5	0.0	0.6	0.2	1.3	0.4	0.8	0.5	0.6	0.9	3.0	0.9	0.0	0.0	0.0	0.0	0.8	0.4	0.3	0.4	0.1	0.2	0.5	0.4	0.3	0.1	5.0	0.1	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	3.4	26.2	0.0	1.9	46.4	19.8	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	679.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0
CMKLR1	RVER1	ENSG00000174600	"Chemerin chemokine-like receptor 1"	Q99788	12	108288044-108339341	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 42.6"	"Cell type enhanced"	"Detected in some"	20	"Hofbauer cells: 25.9;Kupffer cells: 51.2;Macrophages: 10.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 11.9;plasmacytoid DC: 15.2"	"Group enriched"	"Detected in many"	31	"dendritic cells: 15.2;monocytes: 11.9;T-cells: 6.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.9;ASC TERT1: 33.3;BJ hTERT+: 23.7;hTERT-RPE1: 8.0;LHCN-M2: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047865	Uncertain					NA	NA					"HPA047865: AB_2680191"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.14e-1)"	11.3	6.3	2.5	8.5	3.5	0.3	5.1	0.9	3.6	6.7	5.2	5.1	1.7	3.1	9.6	12.0	4.1	5.4	6.4	9.3	2.9	2.3	4.3	7.1	10.5	17.2	5.6	1.5	3.9	3.2	1.6	4.1	18.9	4.0	5.3	6.5	10.7	5.6	3.7	2.9	4.6	5.4	12.1	5.1	42.6	3.4	4.6	4.8	3.2	9.9	5.9	5.8	6.9	3.2	0.0	15.2	0.2	11.9	0.3	6.3	3.1	0.0	0.0	0.1	0.0	7.9	33.3	0.1	0.0	23.7	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	8.0	0.4	0.0	0.0	0.0	7.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	3.2	0.0	6.3	11.9	0.0	0.0	1.0	4.2	0.8	0.0	0.4	3.4	0.2	0.3	2.0	15.2	0.3	3.1	2.5	3.5	0.9	2.6	2.9	2.3	5.6	1.5	4.0	4.8	0.0	0.0	0.9	0.0	0.8	0.0	1.2	0.0	1.4	1.2	0.0	0.0	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	6.2	0.0	0.0	0.0	25.9	0.0	0.0	5.5	51.2	0.0	0.3	10.6	3.3	1.8	0.0	0.0	0.0	0.0	4.9	0.0	0.0	6.5	5.3	0.0	0.0	0.5	0.5	0.0	0.0	0.0
CMTM1	"CKLFH, CKLFH1a, CKLFSF1"	ENSG00000089505	"CKLF like MARVEL transmembrane domain containing 1"	Q8IZ96	16	66566393-66579137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 80.7"	"Group enriched"	"Detected in some"	13	"Early spermatids: 60.6;Late spermatids: 113.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Lineage enriched"	"Detected in many"	4	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"REH: 16.8"									"HPA013801, HPA017136"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA013801: AB_1846990, HPA017136: AB_1846992"	"unprognostic (2.37e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (2.47e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-1)"	0.9	0.8	0.8	1.9	1.2	0.0	0.5	2.2	1.3	0.7	0.9	0.5	0.5	1.7	1.3	1.1	0.6	0.8	1.5	0.7	0.8	1.1	0.8	0.5	0.9	1.2	0.8	0.6	1.7	0.5	0.3	1.1	0.9	0.7	0.7	0.2	0.5	0.6	0.5	0.6	0.6	1.2	0.5	0.9	2.8	0.9	80.7	0.7	0.8	0.7	0.5	0.6	0.9	0.6	0.3	1.9	8.7	2.1	1.3	1.9	1.1	4.2	6.7	1.2	5.6	2.4	2.3	1.2	5.6	2.7	4.5	4.7	1.4	2.9	2.0	3.0	1.6	1.4	3.4	1.9	0.3	2.4	7.4	1.3	0.7	3.0	1.4	1.1	3.9	4.9	1.9	0.5	4.0	0.5	6.9	2.3	4.0	3.5	2.8	1.9	1.6	7.4	3.8	1.0	0.6	2.5	16.8	14.4	4.6	4.0	2.0	3.2	4.3	7.8	0.6	2.0	0.2	2.0	2.8	5.7	8.0	12.7	4.8	2.4	2.8	6.7	7.3	3.8	5.3	9.3	8.7	2.1	7.1	1.9	0.6	1.6	0.2	0.6	0.9	1.9	0.3	0.5	0.6	8.4	1.3	1.2	0.5	0.6	1.1	0.8	1.2	2.2	1.0	0.8	1.1	0.8	0.6	0.7	0.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.3	0.0	0.0	0.0	0.0	113.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	6.5	0.0	4.8	0.4	0.3	0.1	0.0	0.0	0.0
CMTM7	"CKLFSF7, FLJ30992"	ENSG00000153551	"CKLF like MARVEL transmembrane domain containing 7"	Q96FZ5	3	32391671-32483067	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 104.7;Kupffer cells: 102.2;Macrophages: 86.9;monocytes: 120.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 39.8;hTERT-RPE1: 41.0"	"Low region specificity"	"Detected in all"							HPA077409			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA077409: AB_2686838"	"unprognostic (2.27e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.03e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.00e-6)"	"unprognostic (5.86e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	14.5	6.5	3.3	18.9	5.7	23.8	43.1	4.5	2.2	10.0	6.2	4.3	11.0	3.1	7.7	12.3	4.8	24.5	14.6	8.3	2.8	2.8	14.8	5.9	25.1	47.5	5.9	1.0	9.3	27.6	0.9	2.8	11.4	4.7	12.8	5.9	6.1	8.7	17.6	4.0	6.4	10.9	7.0	10.3	32.4	8.2	5.8	4.6	45.9	24.5	3.3	23.1	16.5	12.4	10.0	24.8	24.4	47.0	4.9	36.2	22.1	0.1	4.5	9.8	11.9	9.2	9.1	27.9	4.4	5.3	8.0	7.4	5.0	39.8	0.0	13.8	5.3	9.9	5.0	12.1	20.5	7.1	0.0	9.6	5.3	0.0	11.6	37.6	1.3	8.5	9.6	2.7	8.2	13.1	41.0	18.0	0.0	4.4	12.0	5.9	0.1	0.0	12.3	11.8	2.0	20.9	25.6	3.7	24.4	11.3	8.8	0.5	10.2	0.6	0.7	22.8	4.4	6.2	13.8	10.3	7.6	7.6	8.3	15.4	3.4	1.2	0.0	2.7	16.7	15.9	5.5	47.0	24.4	5.3	44.1	3.2	10.0	17.9	10.9	24.8	7.0	19.5	13.5	18.0	4.9	37.2	10.5	36.2	22.1	3.3	5.7	4.5	2.2	2.8	2.8	5.9	1.0	4.7	4.6	23.8	14.7	40.7	17.6	8.8	0.2	1.5	15.3	14.7	23.9	17.4	0.0	19.8	0.0	83.6	0.1	15.7	1.3	23.3	13.6	6.7	16.0	11.2	28.9	1.0	104.7	1.6	16.6	18.4	102.2	1.0	1.4	86.9	23.6	120.0	3.4	1.3	59.3	8.6	1.1	24.0	0.2	6.5	14.5	1.2	7.2	4.8	5.7	43.6	3.0	10.2
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel alpha 1"	P29973	4	47935977-48016672	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.7"	"Cell type enriched"	"Detected in many"	9	"Rod photoreceptor cells: 880.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.4;RT4: 10.7;U-2 OS: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: AB_2686781"	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	4.9	1.1	0.6	2.7	1.0	0.1	2.9	0.3	0.5	5.7	6.1	0.2	1.6	2.1	0.6	12.1	13.7	3.9	1.5	1.0	0.6	0.6	4.9	23.7	0.5	0.0	1.3	0.0	1.6	2.1	5.2	4.2	21.3	0.4	6.2	2.3	14.7	4.9	1.7	4.2	5.3	12.7	0.5	0.9	8.2	2.5	1.4	0.2	0.1	2.2	3.6	2.7	8.2	8.8	0.7	2.7	1.2	0.4	1.9	1.6	0.1	3.2	1.2	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.2	2.9	13.4	0.1	0.7	0.0	3.6	2.1	0.3	0.4	0.1	0.0	0.9	0.0	0.3	1.0	0.0	0.1	0.3	0.1	0.6	0.0	0.1	1.6	0.0	1.1	0.9	0.7	0.2	1.3	0.1	0.2	0.6	2.0	3.1	0.1	0.0	0.1	0.6	10.7	0.3	0.1	0.2	0.6	0.2	0.3	1.2	0.0	0.6	0.3	4.2	0.1	0.1	0.9	1.0	0.1	0.1	0.1	2.4	0.2	0.4	0.0	0.5	0.4	0.1	0.3	0.2	1.6	0.3	0.7	0.3	0.6	1.2	1.9	0.2	2.7	0.1	0.1	0.6	1.0	0.3	0.5	0.6	0.6	1.3	0.0	0.4	0.2	0.0	0.0	0.0	1.4	0.1	78.5	0.4	2.5	0.0	0.0	59.3	86.4	0.0	0.0	7.8	0.4	0.1	8.4	0.0	5.9	0.0	0.2	4.0	0.0	30.0	1.3	42.9	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.0	3.2	100.9	1.6	10.5	0.0	0.3	880.8	0.0	3.1	0.3	1.3	2.4	0.2	0.0	2.9	15.6
CNGA3	"ACHM2, CCNC1, CCNCa, CNCG3, CNG3"	ENSG00000144191	"Cyclic nucleotide gated channel alpha 3"	Q16281	2	98346155-98398601	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pituitary gland: 32.0"	"Cell type enriched"	"Detected in some"	39	"Cone photoreceptor cells: 41.2"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"U-87 MG: 12.8"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.9;hypothalamus: 2.2"	"Not detected"	"Not detected"			"HPA049378, CAB079025"	Approved	Approved				NA	NA					"CAB079025: , HPA049378: AB_2732551"	"unprognostic (2.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.18e-1)"		"unprognostic (4.17e-4)"		"unprognostic (4.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.88e-1)"		"unprognostic (3.85e-3)"	"unprognostic (8.98e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.71e-2)"	0.1	0.0	0.3	1.4	0.7	0.0	0.7	0.1	2.9	0.1	6.1	2.4	0.1	2.8	0.1	0.1	4.6	0.8	0.4	0.1	1.2	4.0	0.1	0.1	0.2	0.1	0.8	0.4	0.1	1.5	0.0	32.0	0.1	4.9	0.1	3.2	1.2	0.2	0.5	0.1	0.0	4.0	2.2	4.3	0.1	3.0	1.1	0.3	0.1	0.1	0.1	0.1	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	1.5	1.2	4.0	0.8	0.4	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel beta 1"	Q14028	16	57882340-57971116	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"retina: 79.8"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 312.2;Rod photoreceptor cells: 1014.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.0;RPMI-8226: 3.4;SCLC-21H: 9.6;SiHa: 5.6;SK-BR-3: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039159, HPA060355"			Approved	Vesicles,Cytosol		No	NA			Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.2	7.2	13.1	3.0	3.0	0.7	0.2	0.2	6.3	0.2	1.7	0.0	0.0	0.5	0.2	0.5	0.2	0.4	0.8	0.2	7.1	11.0	0.2	0.2	0.4	0.7	1.3	4.0	0.1	1.5	0.0	0.5	1.2	4.2	0.2	1.2	79.8	0.3	0.4	0.1	0.5	1.8	0.2	0.7	0.2	0.2	1.3	0.0	0.0	0.2	0.0	0.4	0.3	0.2	0.4	0.3	2.6	0.3	0.3	0.4	0.0	0.6	1.2	0.0	0.2	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	3.0	0.0	1.0	0.0	0.0	2.5	0.0	0.2	0.0	0.6	1.8	1.0	0.0	0.0	0.2	0.0	0.1	0.0	1.7	0.2	0.0	0.1	0.0	0.4	0.0	0.1	0.6	0.1	0.2	0.0	0.2	0.1	0.0	3.4	0.0	1.2	9.6	0.1	5.6	2.8	0.0	0.2	0.1	0.1	0.7	0.3	0.5	0.4	0.1	0.2	0.6	0.1	0.1	0.3	0.1	0.6	0.3	0.2	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.4	0.4	0.2	2.6	0.3	0.3	0.3	0.0	0.0	13.1	3.0	0.2	6.3	7.1	11.0	1.3	4.0	4.2	0.0	0.0	0.0	0.0	0.5	0.0	44.0	0.8	0.0	0.0	0.0	0.0	312.2	4.7	0.0	0.2	1.5	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.4	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.7	0.3	0.0	0.0	0.0	1014.1	0.0	0.0	0.4	0.6	0.0	1.1	0.0	0.0	0.1
CNIH1	"CNIH, CNIL, TGAM77"	ENSG00000100528	"Cornichon family AMPA receptor auxiliary protein 1"	O95406	14	54423560-54441431	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002544	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA002544: AB_2081856"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.09e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.71e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (8.95e-4)"	32.2	32.3	24.3	19.9	24.9	11.7	27.7	20.6	28.0	23.5	31.0	18.9	22.5	35.8	25.4	20.3	28.7	25.2	27.5	31.0	21.6	22.9	29.4	83.6	26.1	36.2	23.5	18.9	22.0	26.3	12.3	31.2	21.0	20.5	26.9	35.8	23.2	20.5	23.2	25.1	14.3	32.1	46.2	25.5	17.1	20.7	16.7	16.2	26.3	24.1	27.3	27.8	40.6	20.0	23.6	31.7	7.6	31.2	15.6	30.7	31.6	41.6	25.5	21.5	24.1	58.1	74.4	20.0	50.7	65.1	44.0	50.5	15.1	58.8	52.6	33.8	38.4	26.9	41.8	38.8	36.9	55.0	20.1	22.7	20.1	16.4	27.4	58.4	24.3	17.0	60.5	46.1	40.9	58.0	45.2	41.2	21.8	19.6	17.9	48.9	23.0	26.9	18.5	15.8	48.4	51.8	20.7	36.1	17.5	49.7	31.2	18.0	20.0	29.6	23.8	56.1	20.8	36.6	26.5	26.4	37.0	36.9	31.0	30.5	11.2	24.2	25.5	44.9	20.9	32.7	1.9	31.2	3.8	12.9	23.7	21.5	23.6	22.8	18.4	31.7	18.9	30.7	20.5	7.6	15.6	18.2	17.8	23.2	31.6	24.3	24.9	20.6	28.0	21.6	22.9	23.5	18.9	20.5	16.2	32.8	55.8	74.2	72.9	93.9	41.9	74.4	43.3	65.6	43.3	43.6	19.6	81.2	76.3	83.7	21.1	62.1	85.5	46.7	54.2	106.7	92.0	77.1	194.9	125.6	106.1	63.5	100.2	65.1	100.9	13.8	55.5	72.8	79.2	77.5	75.5	42.1	62.6	89.2	61.9	125.2	36.3	45.3	68.4	49.2	77.8	96.1	59.3	59.7	96.4	71.6
CNIH2	"CNIH-2, Cnil, MGC50896"	ENSG00000174871	"Cornichon family AMPA receptor auxiliary protein 2"	Q6PI25	11	66278190-66285301	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"brain: 74.5"	"Group enriched"	"Detected in some"	9	"Early spermatids: 56.3;Horizontal cells: 15.9;Intestinal endocrine cells: 47.6;Late spermatids: 18.6"	"Cancer enhanced"	"Detected in many"		"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.1;AN3-CA: 7.8;MCF7: 7.7;NTERA-2: 8.5;SCLC-21H: 35.5;SH-SY5Y: 16.4;T-47d: 7.7"	"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.84e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.25e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.95e-8)"	"unprognostic (3.53e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.55e-2)"	1.5	6.5	33.9	1.5	37.6	3.2	1.4	8.4	49.5	1.2	1.4	6.2	0.0	2.1	1.5	1.3	1.3	2.0	1.5	1.2	74.5	17.3	1.2	1.2	1.4	1.4	9.6	15.5	1.2	4.2	1.6	8.8	2.0	4.6	1.4	1.6	0.0	1.3	1.2	1.2	3.1	1.6	1.6	2.4	1.6	2.8	2.6	4.7	0.5	1.3	0.0	1.3	1.3	0.0	0.8	0.3	0.0	0.0	0.0	0.8	0.0	0.2	0.4	9.1	7.8	0.1	0.2	1.1	0.5	0.6	1.1	0.1	0.2	0.0	0.0	0.1	0.1	0.5	0.1	2.0	0.0	0.1	0.8	0.7	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.9	0.1	1.2	0.5	7.7	1.2	0.1	8.5	0.0	0.6	3.7	0.0	0.0	0.1	0.4	35.5	16.4	0.0	4.4	0.3	0.4	7.7	0.1	0.0	1.0	0.4	0.3	0.3	0.2	0.2	0.3	2.4	0.2	5.9	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.1	0.8	0.2	0.8	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	33.9	37.6	8.4	36.5	74.5	17.3	9.6	15.5	4.6	4.7	0.0	0.3	0.0	0.2	0.6	1.7	0.8	2.5	4.0	0.0	0.0	0.0	0.6	0.0	0.0	56.3	0.3	0.0	0.0	0.2	1.7	0.2	0.2	0.0	0.0	0.2	15.9	47.6	0.6	0.0	18.6	0.6	0.0	0.0	0.0	1.2	0.5	0.7	0.0	0.4	0.0	2.8	0.0	0.0	0.5	0.7	0.4	1.0	0.8	0.3	0.3
CNNM3	ACDP3	ENSG00000168763	"Cyclin and CBS domain divalent metal cation transport mediator 3"	Q8NE01	2	96816245-96833911	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016711	Supported		Approved	Cytosol		NA	NA			Cytosol		"HPA016711: AB_1847394"	"unprognostic (1.50e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.32e-3)"	"unprognostic (3.64e-1)"	"unprognostic (5.31e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.48e-2)"	8.1	10.7	8.6	6.4	11.5	5.2	8.6	25.0	11.2	8.9	13.3	16.9	7.4	17.4	10.7	5.3	7.5	12.0	15.0	5.9	10.0	5.2	8.6	20.7	8.8	7.2	14.5	9.7	11.6	27.9	28.9	15.7	10.3	11.4	8.9	8.3	13.1	11.4	9.9	9.9	7.7	15.1	10.7	7.0	9.5	12.3	11.4	15.9	13.8	10.0	2.4	10.2	9.9	8.2	3.0	1.8	5.5	3.3	2.1	5.4	1.3	6.9	7.3	6.0	9.8	7.5	3.6	18.3	4.9	4.2	4.7	4.7	18.8	11.7	7.8	17.0	3.8	5.3	8.1	9.1	6.4	3.0	7.7	22.0	10.6	9.2	19.0	6.6	9.1	7.8	3.6	7.8	6.3	5.6	5.7	5.7	6.4	9.6	12.5	1.8	9.2	8.5	8.9	8.3	10.2	8.5	10.5	8.4	9.7	7.6	9.5	19.3	11.7	6.3	9.6	5.3	8.6	9.7	6.7	2.7	4.2	11.9	6.1	6.8	12.5	12.1	5.7	2.4	8.7	4.2	2.7	1.4	5.5	5.4	0.6	2.9	3.0	2.8	4.4	0.4	2.8	2.5	2.7	3.0	2.1	3.3	1.8	4.6	1.3	8.6	11.5	25.0	11.2	10.0	5.2	14.5	9.7	11.4	15.9	8.9	3.7	4.2	2.8	1.1	17.9	14.3	10.2	4.0	3.4	0.0	7.9	4.3	0.0	3.6	6.3	2.3	4.9	0.0	3.6	2.0	2.4	5.7	0.0	12.9	2.2	31.8	4.1	4.3	2.6	1.1	2.3	0.8	3.3	1.0	6.4	8.9	2.9	0.0	3.9	1.6	12.9	12.9	3.3	3.4	7.5	1.4	1.4	2.5	6.9	2.2
CNNM4	"ACDP4, KIAA1592"	ENSG00000158158	"Cyclin and CBS domain divalent metal cation transport mediator 4"	Q6P4Q7	2	96760902-96811891	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Biomineralization, Ion transport, Sensory transduction, Transport, Vision"		"Amelogenesis imperfecta, Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Cone photoreceptor cells: 106.0;Enterocytes: 53.8;Rod photoreceptor cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 29.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA017732	Enhanced		Uncertain	"Plasma membrane,Actin filaments"		NA	NA			"Actin filaments"	"Plasma membrane"	"HPA017732: AB_1847395"	"unprognostic (1.98e-3)"	"unprognostic (8.95e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (3.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.72e-1)"	"unprognostic (8.14e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	3.7	4.0	4.8	17.0	9.6	4.5	7.4	24.1	11.1	6.8	31.2	11.3	8.3	6.3	10.4	5.2	7.7	10.8	7.3	11.5	5.4	5.0	5.9	4.9	8.1	4.3	6.0	6.6	6.1	11.4	9.0	10.6	17.1	5.5	7.4	33.5	13.9	10.8	11.3	21.3	7.4	11.1	5.7	5.2	6.1	12.6	11.8	6.1	4.6	9.7	6.1	9.3	6.5	7.4	3.7	2.2	2.8	2.3	0.8	3.2	1.1	6.9	4.6	3.7	6.8	3.9	2.6	10.2	3.0	4.3	4.5	6.1	8.3	7.5	5.0	8.8	3.1	6.2	9.0	9.5	5.2	4.2	10.1	7.5	4.0	3.1	4.5	5.4	1.9	4.0	2.5	6.5	7.2	4.4	3.0	2.4	5.1	2.0	14.4	2.3	9.8	4.0	2.8	4.9	12.9	6.3	6.0	1.7	5.8	4.5	5.4	17.4	5.2	5.8	29.6	4.3	10.8	14.4	3.3	2.2	2.6	5.9	5.7	3.4	5.0	4.0	2.6	3.8	3.8	4.6	2.8	1.6	0.5	3.2	1.8	1.1	3.7	1.7	1.7	2.2	2.1	1.1	2.1	0.7	0.8	2.3	1.7	0.8	1.1	4.8	9.6	24.1	11.1	5.4	5.0	6.0	6.6	5.5	6.1	35.7	7.7	4.7	3.8	5.0	38.8	11.8	7.6	5.3	14.8	7.0	106.0	4.7	0.0	2.6	4.1	2.9	53.8	0.0	3.6	1.4	2.8	3.4	1.1	3.0	3.0	31.8	9.7	3.1	5.4	1.0	0.9	2.4	0.0	0.0	26.3	7.7	3.8	20.9	1.1	1.2	46.8	0.0	4.7	5.5	2.0	3.6	5.6	2.9	21.7	4.9
CNR1	"CANN6, CB-R, CB1, CB1A, CB1K5, CNR"	ENSG00000118432	"Cannabinoid receptor 1"	P21554	6	88139864-88166359	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Cell type enriched"	"Detected in some"	14	"Sertoli cells: 97.0"	"Cancer enriched"	"Detected in many"	13	"glioma: 12.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.9;naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.9"	"Group enriched"	"Detected in some"	7	"ASC diff: 40.3;HSkMC: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042256, HPA069945"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane"	"Actin filaments"	"HPA042256: AB_2677917, HPA069945: "	"unprognostic (1.28e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.00e-2)"	19.4	6.4	18.0	5.2	15.8	1.5	14.9	13.8	30.5	3.9	5.5	0.8	0.8	2.3	3.1	4.7	3.7	5.5	3.6	1.4	17.6	7.7	0.9	0.7	6.4	6.5	2.3	14.7	4.1	1.8	1.3	18.3	5.2	4.2	1.5	5.1	0.0	4.3	4.0	1.7	2.4	4.2	5.8	3.2	2.3	2.3	2.7	2.8	0.0	2.6	0.0	9.9	2.7	3.1	2.9	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	40.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.9	1.4	0.0	2.6	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.7	3.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	18.0	15.8	13.8	21.4	17.6	7.7	2.3	14.7	4.2	2.8	0.0	7.2	2.7	0.4	0.6	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	97.0	2.3	0.0	0.1	0.1	0.1	0.0	0.0	0.7
CNR2	CB2	ENSG00000188822	"Cannabinoid receptor 2"	P34972	1	23870526-23913362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 19.2;lymphoid tissue: 31.1"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 2: 4.6;B-cells: 16.4;T-cells: 5.7"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 19.2;eosinophil: 16.2;memory B-cell: 14.9;naive B-cell: 15.1;NK-cell: 8.7"	"Group enriched"	"Detected in many"	7	"B-cells: 15.1;granulocytes: 19.2;NK-cells: 8.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.0;HEL: 4.2;HMC-1: 19.4;U-698: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB009719	Uncertain					NA	NA					"CAB009719: AB_2082784"	"unprognostic (9.45e-4)"	"unprognostic (5.40e-3)"	"unprognostic (8.50e-3)"	"unprognostic (8.19e-3)"	"unprognostic (3.55e-3)"	"unprognostic (9.34e-6)"	"unprognostic (5.58e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.91e-2)"	0.3	0.2	0.2	18.5	0.2	1.8	0.2	0.2	0.2	0.2	0.4	0.0	0.0	0.1	0.2	0.1	1.8	0.2	0.3	0.3	0.2	0.2	0.4	0.3	0.6	27.7	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.4	0.3	0.3	3.1	0.0	1.8	0.2	5.5	0.0	0.2	29.7	0.4	0.4	0.0	3.0	0.6	0.6	31.1	1.5	0.3	15.1	0.8	19.2	0.1	8.7	2.0	0.9	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.2	0.1	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	13.0	0.0	0.1	0.0	19.2	0.1	16.2	1.7	0.0	2.0	14.9	0.1	1.5	0.2	15.1	0.1	0.9	0.6	8.7	0.1	0.8	0.1	0.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	3.0	4.6	16.4	0.7	0.6	0.7	0.3	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.3	3.5	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	2.5	0.0	0.0	0.8	0.0	0.3	0.3	0.2	0.3	0.2	5.7	0.0	0.6
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078284	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 78.5"	"Group enriched"	"Detected in some"	4	"Early spermatids: 10.8;Late spermatids: 18.2"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 5.7;SCLC-21H: 14.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"	NA	NA		13000			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	2.0	2.4	15.6	2.1	52.5	1.6	1.6	11.0	68.8	1.8	2.3	78.5	0.0	1.7	1.6	1.7	1.9	1.7	1.8	1.7	27.4	15.9	1.6	1.6	1.6	1.7	59.8	22.0	1.6	1.6	1.6	2.7	1.6	41.9	1.8	2.3	0.0	2.2	2.4	1.6	2.3	2.2	1.8	55.4	1.7	1.7	9.1	48.3	0.0	1.6	0.0	2.0	1.6	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	15.6	52.5	11.0	28.4	27.4	15.9	59.8	22.0	41.9	48.3	0.0	1.1	0.0	0.0	0.0	0.2	3.4	0.0	2.7	1.2	1.8	0.0	0.0	0.0	0.4	10.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	18.2	0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.5	0.0	0.0	0.0	0.0	0.1
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 63.0;pancreas: 136.8"	"Cell type enhanced"	"Detected in many"	12	"Exocrine glandular cells: 52.5;Horizontal cells: 79.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	8	"basal ganglia: 63.0"	"Group enriched"	"Detected in some"	13	"memory B-cell: 24.0;naive B-cell: 7.7"	"Lineage enriched"	"Detected in many"	20	"B-cells: 24.0"	"Cell line enhanced"	"Detected in many"		"HEK 293: 30.6;Hep G2: 20.0;K-562: 39.4;NB-4: 32.7;SCLC-21H: 36.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 25.4;basal ganglia: 40.0;cerebral cortex: 16.6;hippocampal formation: 15.6"	HPA065086			Supported	Vesicles	"Secreted to extracellular matrix"	NA	NA		88000	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	1.1	1.4	2.1	1.1	63.0	1.3	0.9	1.1	2.3	4.0	0.8	1.4	1.6	0.6	0.6	1.0	0.6	2.2	1.2	0.9	1.2	2.9	1.8	0.5	0.5	3.1	0.8	1.9	0.6	136.8	0.4	3.3	0.9	2.1	14.7	1.0	0.8	1.8	21.8	0.6	4.6	0.7	0.7	1.4	0.8	0.8	1.8	7.9	0.0	0.6	0.7	2.4	1.1	7.8	24.0	0.0	0.1	0.3	0.0	1.1	0.6	0.0	11.2	1.0	0.0	0.2	0.0	7.0	0.0	0.0	2.1	5.6	6.6	0.4	0.1	0.5	0.0	0.4	0.0	7.1	0.0	3.5	0.0	30.6	5.6	2.6	20.0	0.0	0.5	2.3	0.4	0.0	0.2	0.0	0.0	0.1	12.7	39.4	1.6	0.5	0.2	2.8	32.7	3.8	0.0	1.2	8.3	0.0	0.2	0.3	1.0	36.3	9.8	0.8	0.1	0.0	4.1	0.0	15.3	0.2	0.0	0.0	0.1	0.0	1.8	4.8	3.5	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	24.0	0.2	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.6	2.1	63.0	1.1	2.3	1.2	2.9	0.8	1.9	2.1	7.9	0.0	0.3	11.3	1.6	16.9	1.9	0.4	2.5	0.0	1.2	0.0	3.9	3.9	1.7	0.4	1.3	2.1	0.2	0.0	52.5	9.8	3.8	3.0	1.1	3.9	3.1	79.4	16.4	4.3	8.6	1.3	1.4	1.5	18.6	4.6	0.0	14.5	5.7	0.0	5.6	7.9	3.9	0.0	15.6	3.9	6.6	11.8	5.5	2.9	0.4	1.0
COX18	FLJ38991	ENSG00000163626	"COX18, cytochrome c oxidase assembly factor"	Q8N8Q8	4	73052362-73069755	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046772, HPA049489"	Approved					NA	NA					"HPA046772: AB_2679799, HPA049489: AB_2680791"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (9.01e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.22e-7)"	"unprognostic (1.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.22e-3)"	8.5	20.4	8.9	6.8	11.6	4.4	8.3	8.5	11.7	8.2	10.4	12.3	11.2	9.8	11.0	9.5	7.9	7.3	9.6	16.3	8.2	9.1	14.7	18.9	7.2	12.6	9.1	9.5	8.4	15.9	6.8	9.2	8.2	9.6	9.3	10.2	10.4	16.5	8.4	10.4	7.4	8.4	5.5	10.6	9.8	9.7	15.6	7.8	10.9	10.1	9.0	9.9	8.4	6.1	4.2	6.7	2.1	6.0	2.6	5.4	3.0	4.3	9.4	4.1	7.0	4.8	6.1	6.0	6.2	4.3	2.5	3.0	6.7	7.1	9.2	5.4	4.7	4.5	3.0	7.5	5.2	3.1	8.6	3.7	5.0	5.7	8.3	4.8	8.3	7.3	7.3	4.0	2.8	7.3	4.5	5.8	8.1	8.6	7.0	5.6	6.2	9.9	4.0	6.4	5.5	10.0	6.2	8.0	10.2	4.9	6.1	8.1	5.3	4.9	8.1	3.2	4.1	5.7	3.4	6.8	5.2	2.5	9.2	3.8	16.4	7.8	6.5	6.4	6.3	5.7	2.1	5.9	1.8	3.4	5.6	4.9	3.8	3.5	3.8	4.6	4.2	5.4	5.3	1.5	2.6	6.0	6.7	2.9	3.0	8.9	11.6	8.5	11.7	8.2	9.1	9.1	9.5	9.6	7.8	3.0	4.6	10.0	3.1	2.3	11.3	11.5	5.1	8.1	6.8	8.7	21.6	6.6	11.6	5.6	3.3	5.9	5.3	23.3	6.8	7.2	3.5	5.3	0.0	15.8	7.7	19.1	5.2	14.1	8.3	1.5	8.3	6.9	5.0	8.2	8.5	8.8	7.3	2.9	8.9	11.2	14.8	12.9	5.2	7.7	7.0	1.3	2.5	9.6	9.0	3.0
COX4I1	"COX4, COX4-1"	ENSG00000131143	"Cytochrome c oxidase subunit 4I1"	P13073	16	85798633-85807044	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002485, CAB004080"	Supported		Supported	Mitochondria		NA	NA		970000	Mitochondria		"CAB004080: AB_2085427, HPA002485: AB_1078559"	"unprognostic (4.73e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.56e-8)"	"unprognostic (4.23e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-2)"	41.6	38.6	101.1	54.0	100.2	66.5	60.6	51.6	86.9	38.1	87.1	38.9	43.9	77.6	33.9	69.3	54.7	50.4	59.8	218.6	82.3	73.0	59.7	69.5	29.6	49.1	100.1	65.9	45.4	71.2	55.7	36.3	36.8	57.0	37.6	98.4	40.6	65.9	53.1	172.3	48.0	76.5	51.2	58.4	40.1	56.5	21.8	38.7	46.6	49.1	112.6	70.2	47.1	52.4	123.0	144.1	74.8	130.8	74.7	121.9	222.6	44.7	73.0	49.7	66.3	92.0	86.3	85.7	40.9	83.7	77.5	38.8	123.5	67.9	73.5	50.3	65.1	42.4	90.2	70.6	82.2	69.1	24.9	73.0	41.0	61.8	119.9	83.0	37.2	30.6	100.0	127.6	63.4	86.6	81.2	80.9	60.5	68.9	30.2	65.7	161.5	74.4	115.3	66.6	99.8	86.1	84.6	31.2	64.3	114.9	88.9	59.1	48.0	86.6	55.1	66.2	55.7	80.8	103.9	56.8	38.9	45.1	35.7	43.7	60.9	57.8	168.9	59.4	73.8	43.6	50.9	130.8	74.8	72.5	112.8	88.4	123.0	96.3	85.0	144.1	116.1	121.9	100.0	50.7	74.7	98.6	107.7	102.7	222.6	101.1	100.2	51.6	86.9	82.3	73.0	100.1	65.9	57.0	38.7	256.1	363.9	981.6	971.7	1003.2	230.7	3140.6	1197.4	362.7	382.2	600.2	123.7	1081.3	2332.7	965.7	464.1	701.9	2320.1	280.4	1145.7	924.4	671.8	956.9	507.1	1060.0	1395.9	200.2	970.5	596.0	1378.7	820.3	462.0	1118.7	1086.5	1424.7	1513.6	283.9	1228.5	1740.3	336.3	1959.5	260.3	349.3	760.4	345.7	304.0	1190.3	1239.3	852.8	1984.7	1551.2
COX4I2	"COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2"	ENSG00000131055	"Cytochrome c oxidase subunit 4I2"	Q96KJ9	20	31637888-31645006	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 60.7"	"Group enriched"	"Detected in some"	34	"Sertoli cells: 407.4;Smooth muscle cells: 177.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	11	"naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	11	"B-cells: 2.6"	"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.64e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.51e-2)"	"prognostic favorable (6.04e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.59e-2)"	9.9	0.7	1.6	1.7	1.9	0.1	7.9	0.7	2.5	4.7	2.2	1.5	0.9	1.1	5.9	3.5	7.1	2.6	5.4	15.5	1.7	1.4	2.0	0.5	24.6	4.9	2.4	1.0	1.9	1.9	2.1	1.1	60.7	2.7	5.2	1.6	4.1	2.4	2.8	12.8	2.5	2.7	3.9	1.2	0.8	2.0	1.5	2.1	0.5	8.0	7.5	2.3	3.7	3.7	2.6	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	6.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	1.9	0.7	2.5	1.7	1.4	2.4	1.0	2.7	2.1	0.0	0.0	0.0	0.2	5.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	5.7	0.0	0.0	0.0	0.2	4.3	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	3.4	1.1	8.5	0.0	0.0	1.1	0.1	0.0	0.7	0.0	0.4	407.4	177.5	0.0	0.1	5.8	2.1	0.0	0.0	0.3
COX5A		ENSG00000178741	"Cytochrome c oxidase subunit 5A"	P20674	15	74919791-74938168	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 209.7;skeletal muscle: 222.8"	"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 1647.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027526	Supported					NA	NA		5400000			"HPA027526: AB_10602802"	"unprognostic (7.32e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (9.78e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-3)"	22.4	20.1	30.4	25.9	29.1	20.6	36.1	22.4	57.9	15.0	70.8	12.1	21.6	51.5	11.6	19.3	31.6	14.6	22.7	209.7	26.7	25.4	42.6	49.4	17.7	29.0	32.7	27.3	8.7	41.1	27.7	16.4	15.0	26.7	15.6	65.7	13.7	32.2	23.1	222.8	17.2	49.4	15.9	20.9	17.3	31.7	26.2	12.2	21.9	19.9	86.5	30.6	17.9	15.1	52.2	81.2	47.3	80.6	58.8	64.1	65.7	35.1	39.1	48.5	42.3	29.9	34.6	53.4	32.0	28.3	41.1	38.4	43.6	44.6	80.7	39.5	27.6	50.0	69.6	114.5	46.5	34.4	45.6	106.8	66.9	40.8	54.0	37.5	76.4	42.1	35.0	50.6	25.6	58.1	28.2	48.0	55.9	61.4	54.9	41.0	27.7	63.7	58.8	51.5	71.5	58.0	59.4	46.5	93.7	60.0	59.5	71.1	30.5	48.5	72.9	100.2	55.3	36.5	62.4	32.4	31.1	29.4	38.8	50.8	62.9	115.4	89.4	33.4	101.4	28.3	47.3	65.5	36.1	37.6	80.6	44.9	52.2	46.7	44.2	81.2	37.8	33.2	38.5	15.8	58.8	72.1	64.7	64.1	65.7	30.4	29.1	22.4	57.9	26.7	25.4	32.7	27.3	26.7	12.2	92.3	98.3	157.9	175.6	140.6	98.6	1647.0	242.0	117.8	108.1	162.3	37.3	430.9	1250.1	355.7	826.5	138.1	1074.0	93.5	379.0	409.1	121.0	226.5	102.6	381.0	504.7	87.4	443.2	110.5	242.1	581.7	92.9	227.7	237.8	426.6	815.4	91.5	365.2	768.6	80.6	703.8	110.5	90.5	143.5	367.8	236.9	139.0	427.4	165.8	1016.3	341.5
COX5B		ENSG00000135940	"Cytochrome c oxidase subunit 5B"	P10606	2	97646040-97648383	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 336.2"	"Cell type enhanced"	"Detected in all"	5	"Cardiomyocytes: 3263.7;Distal tubular cells: 3068.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA034517	Supported		Enhanced	Mitochondria		NA	NA		2200000	Mitochondria		"HPA034517: AB_10603561"	"unprognostic (4.61e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.73e-4)"	39.8	25.3	54.5	20.8	46.1	27.6	23.9	22.6	46.4	19.5	58.6	16.0	27.6	44.5	13.1	22.3	31.9	19.4	24.0	160.6	39.9	36.0	44.8	52.5	13.8	16.1	48.1	32.5	17.7	24.6	19.9	17.5	18.1	39.0	21.5	31.5	14.3	36.5	29.2	336.2	18.9	38.6	19.9	30.8	17.9	40.4	13.4	23.0	14.2	25.8	65.4	15.3	19.4	16.7	85.1	111.2	115.8	122.5	48.1	83.6	145.2	19.9	23.3	14.4	23.9	17.0	15.5	62.3	25.7	14.4	17.1	19.1	64.4	20.9	33.7	55.3	16.4	27.0	30.5	16.6	25.8	7.8	26.2	70.6	45.4	25.8	76.9	32.7	43.0	33.3	28.7	22.9	16.4	12.8	17.5	14.6	27.0	33.3	14.9	13.2	49.4	27.1	62.4	28.4	34.1	122.6	26.7	24.8	50.4	23.0	30.7	28.6	30.6	25.0	30.2	48.2	20.0	16.1	45.1	26.5	15.6	26.6	25.0	16.5	38.9	36.8	25.7	28.3	37.0	16.1	96.9	122.5	99.8	54.7	114.1	52.6	85.1	66.3	57.1	111.2	68.8	64.5	57.5	115.8	48.1	95.9	75.8	83.6	145.2	54.5	46.1	22.6	46.4	39.9	36.0	48.1	32.5	39.0	23.0	205.4	224.6	375.1	495.2	343.3	204.5	3263.7	647.1	369.4	268.4	759.0	214.0	640.2	3068.8	479.5	156.4	370.1	2132.4	140.2	527.3	778.4	340.5	424.2	320.2	1125.6	767.8	133.5	711.5	338.8	489.5	270.1	325.7	488.5	865.4	798.1	1204.0	259.4	460.5	1508.0	286.4	1849.4	303.9	439.8	473.4	213.2	290.0	419.6	512.8	265.9	1320.1	744.1
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428428	"Predicted intracellular proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	28	"heart muscle: 398.6;skeletal muscle: 421.1;tongue: 230.8"	"Cell type enriched"	"Detected in some"	64	"Cardiomyocytes: 3924.5"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	125	"NK-cell: 12.5"	"Lineage enriched"	"Detected in single"	125	"NK-cells: 12.5"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			3.0	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	9.3	5.6	0.1	0.1	398.6	0.1	0.3	0.2	0.9	0.1	0.1	0.2	0.0	0.1	0.2	0.2	0.8	0.1	0.0	2.3	0.1	0.9	8.4	0.1	421.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	5.5	230.8	11.4	0.1	0.1	0.0	0.0	0.0	0.0	12.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3924.5	0.0	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	61.4	2.1	3.2	0.0	0.6	2.1	0.8	0.3	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.7	20.3	3.9	19.4	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354814	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	12	"testis: 66.5"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 23.6;Late spermatids: 19.1;Spermatocytes: 77.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 22.6;SCLC-21H: 9.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.3	0.0	0.4	0.6	0.6	0.7	0.5	0.3	0.6	0.2	3.3	0.2	0.2	0.0	0.2	0.8	0.5	0.4	0.2	0.2	0.2	0.5	0.5	0.2	0.2	0.6	0.4	0.2	0.4	0.2	0.0	0.4	0.2	0.6	0.2	3.5	0.7	0.6	0.2	0.2	1.8	0.2	0.2	0.7	0.2	0.0	66.5	0.3	0.2	0.2	0.2	1.2	0.2	0.4	1.3	1.4	5.7	1.0	1.6	0.9	0.8	2.7	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.1	22.6	0.1	0.2	0.2	0.3	1.8	0.7	0.2	0.2	0.8	0.7	0.0	1.7	0.1	0.3	0.2	1.8	0.2	2.5	0.4	0.5	1.7	0.0	0.1	0.4	0.2	0.0	0.5	0.1	0.2	0.6	2.3	0.5	0.1	0.0	0.2	0.0	0.4	9.7	0.3	0.3	0.1	0.0	0.6	0.4	0.0	0.4	0.3	0.5	0.1	0.2	1.5	1.2	0.1	0.1	0.3	0.2	1.9	1.0	1.0	0.8	0.5	0.5	0.7	0.7	0.6	0.3	1.3	0.7	0.9	5.7	1.6	0.7	1.4	0.6	0.8	0.4	0.6	0.3	0.6	0.2	0.5	0.4	0.2	0.6	0.3	0.0	0.3	0.0	0.6	0.5	2.1	0.4	0.0	0.0	0.0	0.0	3.9	0.5	0.0	0.6	23.6	0.0	3.2	0.0	0.6	0.2	0.4	0.2	0.0	0.0	0.1	3.2	1.2	0.0	0.0	19.1	0.6	0.0	0.0	0.0	1.3	0.9	5.6	3.5	0.0	0.0	4.1	0.0	0.0	77.8	1.3	0.4	0.3	0.0	4.4	2.5
COX7A1	"COX7A, COX7AH"	ENSG00000161281	"Cytochrome c oxidase subunit 7A1"	P24310	19	36150922-36152869	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 114.9;skeletal muscle: 404.3"	"Cell type enriched"	"Detected in many"	28	"Cardiomyocytes: 19391.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 1.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.3;granulocytes: 1.4;monocytes: 1.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 24.5;ASC TERT1: 18.0;BJ: 16.5;BJ hTERT+: 13.7;fHDF/TERT166: 25.1;HHSteC: 16.3;HSkMC: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.27e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.54e-2)"	15.7	8.1	5.3	2.5	3.6	1.2	8.8	2.1	13.1	4.1	8.0	0.8	2.6	2.0	3.9	6.1	6.6	3.1	5.0	114.9	3.3	2.4	5.0	1.6	4.0	2.7	2.6	4.6	4.2	3.5	6.0	7.9	2.6	1.7	5.9	2.3	5.9	6.2	7.1	404.3	2.0	2.2	12.3	1.4	3.1	3.6	1.6	1.5	1.6	5.1	59.7	2.6	7.0	4.7	0.0	1.3	1.4	1.9	0.0	0.1	0.3	0.1	2.6	0.2	0.0	24.5	18.0	0.1	16.5	13.7	0.5	0.0	0.0	0.8	0.6	6.9	25.1	0.0	0.3	0.0	0.0	0.1	0.1	0.9	0.1	0.9	0.1	16.3	0.0	0.2	16.9	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.2	0.0	0.3	0.0	0.1	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	3.7	0.0	0.6	0.2	0.1	0.4	0.4	0.3	0.1	0.3	0.5	0.0	1.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	1.4	0.0	0.5	0.4	0.1	0.3	5.3	3.6	2.1	13.1	3.3	2.4	2.6	4.6	1.7	1.5	0.0	9.0	5.9	1.3	23.5	71.7	19391.7	25.5	1.4	3.4	21.0	43.2	1.0	693.0	10.8	13.4	160.8	0.0	0.0	12.2	0.9	86.2	2.4	43.9	4.4	18.4	63.5	0.0	239.4	11.6	76.0	207.9	6.0	269.9	0.0	0.0	16.2	9.2	0.0	264.5	128.7	56.3	181.1	233.8	1.5	3.2	16.7	1.6	2.5	0.0	0.6
COX7B2		ENSG00000170516	"Cytochrome c oxidase subunit 7B2"	Q8TF08	4	46734827-46909235	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	13	"testis: 43.9"	"Group enriched"	"Detected in some"	7	"Early spermatids: 328.3;Late spermatids: 134.7;Spermatocytes: 292.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Cell line enriched"	"Detected in some"	15	"Karpas-707: 28.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA												"unprognostic (2.82e-1)"								"unprognostic (2.42e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	3.4	0.2	0.6	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	28.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.2	0.4	0.1	0.1	0.0	0.4	0.1	0.0	3.4	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	328.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.7	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	292.2	34.5	0.0	0.0	0.0	0.0	0.0
COX7C		ENSG00000127184	"Cytochrome c oxidase subunit 7C"	P15954	5	86617904-86620962	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 298.4"	"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 4397.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA046647	Approved					NA	NA					"HPA046647: AB_2679736"	"unprognostic (1.45e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.70e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.23e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.46e-2)"	43.3	60.4	76.4	35.7	68.1	36.8	49.6	41.1	65.0	35.0	74.8	22.7	44.0	76.0	50.7	55.5	53.7	32.6	44.4	150.2	61.8	57.6	91.6	83.1	36.0	66.1	72.0	44.2	51.9	88.8	39.3	47.3	26.5	51.5	42.7	53.9	36.2	127.6	46.1	298.4	28.0	73.3	71.5	39.7	35.5	54.2	31.2	32.1	39.7	56.3	84.9	40.1	53.9	58.0	92.8	91.6	54.1	73.4	51.2	96.5	113.9	55.5	64.2	57.7	107.6	53.9	54.3	64.7	43.2	34.7	28.7	40.6	74.5	101.3	75.7	47.3	31.9	78.1	60.6	51.0	82.1	47.1	56.1	78.3	60.5	99.2	76.9	45.1	71.9	72.2	63.5	70.8	36.5	50.2	82.4	45.8	66.0	36.6	89.1	41.9	110.9	74.5	90.7	61.3	55.5	185.9	72.5	67.3	139.2	85.7	106.5	72.0	52.6	41.5	97.8	91.1	65.6	99.3	98.1	45.3	26.7	49.0	45.7	82.5	86.4	99.9	87.4	68.5	84.2	50.4	38.0	72.1	54.1	58.1	73.4	72.5	92.8	91.1	71.8	91.6	79.4	96.5	84.2	7.3	51.2	68.2	85.2	80.2	113.9	76.4	68.1	41.1	65.0	61.8	57.6	72.0	44.2	51.5	32.1	476.4	561.1	1097.3	719.7	642.7	245.3	4397.0	1722.3	686.6	645.0	1151.5	147.3	1042.4	4003.9	1050.4	765.0	580.9	1905.7	373.8	1318.7	727.2	613.8	874.5	590.4	2267.2	1206.0	217.7	881.2	710.8	1215.4	325.7	912.7	888.1	1057.8	1208.3	1577.3	394.4	1159.8	1813.1	677.5	3328.8	216.7	588.6	707.6	958.9	346.1	817.7	1104.6	792.5	1997.9	1118.8
COX8A	"COX, COX8, COX8-2, COX8L, VIII, VIII-L"	ENSG00000176340	"Cytochrome c oxidase subunit 8A"	P10176	11	63974607-63976543	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 275.5"	"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 1984.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA055942	Supported					NA	NA					"HPA055942: AB_2682979"	"unprognostic (6.93e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.70e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.51e-6)"	"unprognostic (2.70e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.44e-2)"	41.4	42.8	54.0	32.8	53.4	50.4	47.4	40.9	60.3	30.2	76.6	18.2	35.5	69.0	23.3	31.2	63.3	35.9	43.9	154.9	41.5	41.0	78.8	61.1	38.1	50.8	54.5	34.0	24.7	43.0	38.7	37.6	32.2	35.7	37.9	51.6	35.9	54.4	50.2	275.5	31.2	66.7	29.9	37.0	31.0	50.8	18.7	24.3	44.6	42.4	121.7	34.8	38.8	29.8	52.7	114.8	87.8	108.6	51.0	75.7	80.3	60.3	80.6	52.0	51.6	22.3	27.3	37.7	32.0	35.9	63.6	49.5	53.8	49.6	28.8	70.9	44.5	60.2	60.3	40.0	55.1	21.8	42.3	69.5	41.9	65.4	63.1	35.8	42.2	54.6	35.2	41.9	50.9	41.1	28.4	39.4	68.6	48.7	62.8	39.9	157.1	59.7	143.7	47.3	72.0	141.6	46.8	41.8	121.1	51.4	51.0	47.2	66.8	38.1	55.4	78.5	23.2	81.4	45.9	24.2	37.0	50.2	79.2	37.3	78.9	61.8	44.4	48.1	41.7	44.3	78.3	101.8	87.8	57.5	108.6	42.4	52.7	63.2	56.4	114.8	46.4	49.0	53.4	71.3	51.0	97.9	113.0	75.7	80.3	54.0	53.4	40.9	60.3	41.5	41.0	54.5	34.0	35.7	24.3	208.4	199.1	288.8	299.8	261.7	169.3	1162.0	458.6	376.1	244.5	415.2	68.7	392.2	1984.5	389.4	7.0	198.9	1123.7	140.2	421.4	448.5	223.4	381.0	221.4	677.3	801.9	101.7	693.6	209.3	461.0	13.2	221.8	429.5	595.5	445.4	846.8	231.3	439.3	874.7	207.9	1094.8	128.1	155.2	347.5	51.9	59.0	324.2	306.9	320.7	910.0	526.5
COX8C	COX8-3	ENSG00000187581	"Cytochrome c oxidase subunit 8C"	Q7Z4L0	14	93347191-93348356	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	72	"testis: 72.8"	"Group enriched"	"Detected in some"	11	"Early spermatids: 811.2;Late spermatids: 1407.4;Spermatocytes: 393.6"	"Group enriched"	"Detected in some"	8	"ovarian cancer: 2.9;testis cancer: 6.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	9	"U-937: 18.0"					"Not detected"	"Not detected"			HPA003127	Approved					NA	NA					"HPA003127: AB_1078560"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"		"unprognostic (1.47e-1)"	"unprognostic (3.76e-3)"			"unprognostic (2.11e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.15e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.1	0.0	0.0	72.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	811.2	0.0	0.0	0.0	0.0	10.6	0.2	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1407.4	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.2	0.0	19.4	0.0	393.6	80.8	0.1	2.9	0.0	0.0	0.1
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria		NA	NA		790000	Mitochondria		"HPA008835: AB_1078563"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (2.67e-7)"	"unprognostic (9.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	18.0	18.3	9.9	9.9	12.1	15.8	24.4	7.0	10.3	12.8	31.9	8.2	14.1	33.7	17.0	7.2	11.2	12.8	14.7	14.6	12.0	6.6	30.6	62.0	13.1	10.1	10.5	8.6	17.0	24.4	16.9	13.8	8.7	10.8	15.6	22.0	19.7	12.9	11.4	6.9	10.3	33.4	16.9	8.7	18.9	16.8	10.4	9.0	17.9	13.2	7.5	7.6	11.3	30.2	2.5	11.9	10.6	8.6	5.7	8.8	2.5	8.1	14.5	2.1	14.2	9.3	8.4	0.6	6.5	5.4	5.2	1.0	0.5	27.6	0.0	24.2	17.2	18.2	26.9	18.4	3.9	1.5	13.0	1.8	20.1	15.8	6.7	13.9	11.6	24.3	8.7	1.9	10.4	6.3	7.1	18.3	8.1	2.1	16.5	4.7	23.4	9.4	20.6	0.2	42.2	15.4	26.5	0.3	35.6	12.2	20.4	0.2	9.3	18.0	34.9	5.7	1.4	31.1	11.3	18.4	11.3	0.2	22.6	9.4	12.9	16.4	8.3	11.9	8.6	12.3	9.2	7.8	10.6	8.8	8.6	5.1	2.3	5.5	5.3	5.0	2.5	3.4	7.0	3.8	5.7	7.2	11.9	2.9	2.5	9.9	12.1	7.0	10.3	12.0	6.6	10.5	8.6	10.8	9.0	35.7	36.9	11.5	7.7	8.4	4.9	22.1	28.1	32.1	22.7	22.7	60.9	12.9	16.6	11.2	9.2	25.4	82.1	0.0	8.1	4.1	13.9	7.4	27.8	79.0	14.6	1.6	15.5	37.4	42.3	15.7	8.9	13.5	0.0	11.8	44.9	12.9	9.7	40.3	30.1	9.4	41.0	38.8	16.0	12.1	8.8	6.8	6.5	16.6	59.0	6.4
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094810-129111189	"Enzymes, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 98.6;testis: 71.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 149.6;Late spermatids: 410.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		13000	"Nucleoplasm, Nuclear membrane"		"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	11.6	13.4	8.4	4.6	9.2	5.9	10.7	7.5	15.9	8.3	15.4	8.6	6.2	24.3	6.5	9.5	9.4	5.4	10.0	17.3	7.7	7.9	12.9	50.0	4.2	3.1	8.3	9.1	7.3	33.1	16.8	3.2	7.9	9.3	10.5	4.4	8.1	14.7	7.9	98.6	7.0	22.8	8.3	5.2	4.6	8.1	71.7	4.4	2.4	8.0	20.2	4.4	9.3	6.8	2.6	11.3	6.0	11.3	6.0	10.0	8.1	0.1	18.3	6.4	13.1	12.0	16.1	9.3	7.8	8.7	9.5	6.0	3.8	7.4	0.7	4.7	13.1	12.7	3.3	1.7	2.8	3.4	11.8	0.4	3.6	9.2	14.7	17.1	0.1	14.0	14.7	0.0	8.0	0.2	12.1	12.4	3.5	1.6	3.8	9.7	3.6	0.3	8.1	1.5	19.8	8.2	9.1	12.3	6.0	9.2	0.3	2.1	6.6	0.0	4.1	2.7	2.1	26.6	4.0	11.1	14.3	1.0	17.9	7.7	13.0	11.0	0.0	16.9	2.2	9.1	2.5	11.3	6.0	5.0	7.4	10.0	2.4	6.9	6.6	11.3	2.6	4.3	4.7	2.9	6.0	7.3	5.3	6.4	8.1	8.4	9.2	7.5	15.9	7.7	7.9	8.3	9.1	9.3	4.4	6.0	3.0	5.4	4.5	2.9	1.4	52.0	20.4	1.4	3.4	3.5	2.0	38.4	14.9	16.6	149.6	12.6	94.4	0.0	19.6	46.4	21.8	14.9	6.9	58.6	18.0	1.6	14.9	14.1	8.1	410.0	20.4	8.8	5.0	9.0	16.9	13.4	12.1	38.6	23.0	41.0	1.4	6.5	14.6	94.3	6.9	4.0	42.1	10.7	22.1	9.9
CRHR1	"CRF-R, CRF1, CRHR"	ENSG00000120088	"Corticotropin releasing hormone receptor 1"	P34998	17	45784280-45835828	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	7	"brain: 23.2;pituitary gland: 16.5"	"Group enriched"	"Detected in some"	13	"Early spermatids: 37.9;Late spermatids: 37.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RT4: 8.1;SH-SY5Y: 5.0"									CAB025251	Enhanced				"Intracellular and membrane"	NA	NA					"CAB025251: "	"unprognostic (4.59e-2)"	"unprognostic (1.43e-2)"		"unprognostic (2.59e-7)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.55e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-4)"	"unprognostic (2.07e-5)"	"unprognostic (3.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	0.8	0.6	14.7	0.5	5.1	0.5	1.5	23.2	11.5	1.4	0.6	1.1	0.0	0.8	2.7	1.1	0.5	1.6	0.7	0.5	3.2	2.2	0.6	0.5	0.6	0.5	1.8	5.2	0.6	0.5	0.6	16.5	0.6	2.9	1.3	0.6	1.9	1.2	2.5	0.6	1.4	1.0	1.2	1.0	0.5	0.5	1.0	2.8	0.0	0.9	0.0	0.5	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	1.6	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	5.1	23.2	11.5	3.2	2.2	1.8	5.2	2.9	2.8	0.0	0.0	0.0	1.1	1.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.5	0.0	0.1	2.3	1.5	2.9	0.0	0.0	0.0	0.5
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345681-87399795	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 116.1;Rod photoreceptor cells: 76.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 35.3;RT4: 34.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favorable (4.02e-4)"	4.6	10.1	9.3	5.1	9.6	1.6	10.5	7.4	8.4	9.0	9.4	5.5	24.1	19.6	10.0	12.6	17.0	6.8	8.7	5.9	5.2	5.4	12.3	21.5	4.2	3.4	5.4	6.6	7.2	4.6	15.5	9.1	13.7	5.8	14.8	7.0	9.8	8.3	32.3	7.2	15.0	19.1	8.8	6.8	4.8	4.9	3.8	4.7	7.4	27.1	8.4	8.0	22.4	15.3	2.2	2.3	3.4	5.5	13.0	9.5	3.0	7.2	5.4	6.6	2.3	6.3	5.8	4.9	7.7	7.2	4.7	5.1	2.8	3.8	3.0	6.8	6.5	9.4	9.1	1.1	10.2	6.7	4.3	4.6	6.6	3.8	3.6	4.1	4.1	4.1	4.7	35.3	3.8	3.0	6.0	6.6	5.0	0.3	4.4	12.3	7.1	5.1	4.1	1.4	2.6	8.0	2.3	9.1	0.5	6.0	34.6	1.1	5.2	9.4	10.9	4.9	4.7	6.9	1.5	3.5	10.9	4.7	14.7	7.2	6.7	9.6	4.2	7.3	0.0	6.4	2.0	1.4	3.4	7.4	1.7	9.5	2.2	7.5	6.0	2.0	2.2	6.1	6.6	0.9	13.0	5.5	2.3	6.3	3.0	9.3	9.6	7.4	8.4	5.2	5.4	5.4	6.6	5.8	4.7	20.8	7.7	4.4	49.0	14.9	16.1	13.2	7.6	32.1	36.4	50.6	43.2	116.1	8.3	6.6	18.7	6.5	24.7	0.0	7.6	5.2	7.3	20.4	7.0	28.8	12.0	14.3	7.0	5.5	7.5	33.1	14.7	7.4	18.6	6.4	13.1	24.1	8.0	7.4	13.1	15.3	76.5	6.5	8.3	2.5	3.6	13.4	41.0	7.0	10.9	43.1
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 153.6;Spermatogonia: 127.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol		No	No		64000	Nucleoplasm	Cytosol	"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavorable (6.91e-4)"	15.7	18.9	19.5	18.7	23.7	13.7	21.2	24.9	31.3	17.5	14.2	13.4	14.0	12.0	19.5	15.5	25.5	17.3	11.8	17.8	20.0	17.7	18.8	18.7	12.8	24.0	27.3	19.4	18.7	17.3	23.2	16.8	23.1	24.2	16.7	18.4	8.4	15.5	17.0	34.3	20.9	12.4	21.7	31.3	12.6	17.1	50.9	21.0	27.0	14.7	28.1	25.3	18.3	17.5	12.8	14.8	9.4	15.9	16.8	18.0	12.8	36.2	25.2	30.9	23.7	12.0	15.5	33.4	28.6	15.2	90.0	38.2	82.4	29.3	37.1	38.4	18.1	36.5	42.0	45.3	53.7	86.0	6.0	22.0	25.7	29.7	39.9	7.3	28.3	14.2	8.6	20.2	44.0	25.5	12.4	29.7	20.7	36.3	14.7	33.7	12.4	34.1	14.6	25.9	30.3	37.6	21.7	50.8	28.9	19.8	25.3	27.2	15.8	45.7	49.5	16.2	24.5	41.3	18.5	19.1	48.0	40.3	28.2	40.5	8.6	20.8	34.8	28.6	22.9	25.5	9.4	11.8	2.7	11.0	15.2	16.5	12.8	16.8	13.4	14.8	10.4	18.0	15.3	3.3	16.8	15.9	6.6	14.4	12.8	19.5	23.7	24.9	31.3	20.0	17.7	27.3	19.4	24.2	21.0	6.0	23.2	18.2	20.7	26.9	14.3	23.5	35.7	21.4	18.2	26.2	9.8	56.3	11.6	28.2	61.2	21.5	7.8	0.0	23.0	50.5	21.6	15.7	4.6	23.2	26.0	14.3	5.2	20.9	15.1	39.7	23.6	19.3	25.3	29.7	9.1	21.8	23.6	10.5	29.7	17.0	11.9	38.8	19.1	153.6	127.3	30.2	60.8	16.6	18.2	20.0
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776445	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 365.3;lymphoid tissue: 130.6;tongue: 138.8"	"Cell type enhanced"	"Detected in all"	7	"Hofbauer cells: 2667.6;Urothelial cells: 2153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 68.7;RT4: 87.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA		6100000	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755"	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	21.1	7.5	5.6	6.1	5.9	3.2	13.6	3.0	5.3	57.8	8.8	4.4	3.9	5.6	6.1	6.4	365.3	6.0	7.2	6.5	4.6	5.0	9.6	17.3	17.2	11.2	5.3	4.9	7.8	5.0	3.2	7.6	5.2	5.8	7.1	7.2	7.8	65.2	6.2	4.8	9.4	7.5	6.3	5.1	7.4	10.4	4.1	4.1	8.6	11.6	138.8	130.6	14.0	81.5	11.4	43.2	25.4	69.1	7.7	22.3	21.3	55.9	16.9	5.6	7.1	29.8	24.5	13.9	12.1	14.1	7.7	7.6	13.0	31.4	4.5	9.4	18.8	68.7	10.0	12.9	13.5	4.8	18.8	15.3	12.6	13.0	15.0	26.7	3.1	10.6	26.0	14.1	21.0	10.5	14.4	10.6	4.3	9.3	25.0	11.2	14.1	3.9	9.7	13.5	37.6	29.2	6.5	3.1	51.3	22.0	87.3	5.3	4.8	15.9	8.5	34.0	2.8	7.9	7.8	16.3	12.7	6.6	11.9	7.6	6.1	10.8	8.4	55.4	14.7	8.9	16.8	28.2	16.9	14.5	45.9	13.3	11.4	18.6	15.0	43.2	9.7	13.2	13.0	25.4	7.7	69.1	5.3	22.3	21.3	5.6	5.9	3.0	5.3	4.6	5.0	5.3	4.9	5.8	4.1	163.8	245.7	187.7	333.5	342.3	67.2	88.0	305.8	447.0	218.4	394.3	33.4	255.6	455.9	484.2	8.1	312.8	471.8	23.3	431.0	773.3	255.1	459.8	223.9	313.1	2667.6	63.5	229.7	229.6	443.8	23.5	353.0	857.1	447.1	1223.7	177.1	98.3	684.5	378.7	310.4	313.1	54.5	116.4	179.2	37.0	105.4	520.9	336.5	191.8	261.7	2153.8
CTIF	KIAA0427	ENSG00000134030	"Cap binding complex dependent translation initiation factor"	O43310	18	48539046-48863217	"Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 32.8;Bipolar cells: 29.8;Peritubular cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016865, HPA024801"	Uncertain		Supported	Cytosol		NA	NA			Cytosol		"HPA016865: AB_1852311, HPA024801: AB_1852312"	"unprognostic (5.84e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.33e-3)"	40.7	15.7	17.3	8.0	21.9	5.2	18.2	28.8	34.5	10.3	12.8	12.4	6.2	6.6	12.3	7.2	19.2	8.5	16.7	18.1	17.2	23.4	9.1	12.7	12.8	4.1	19.7	24.5	29.8	9.2	9.6	12.1	10.1	22.7	9.5	5.0	10.0	11.9	13.4	16.0	7.2	7.5	15.6	23.1	7.1	11.0	8.0	16.3	0.9	9.9	4.7	3.7	12.7	13.0	0.1	0.8	0.8	0.7	0.0	1.4	0.1	2.3	2.5	3.4	4.4	8.8	4.7	1.9	11.9	10.0	9.5	8.6	2.6	1.4	0.0	2.7	16.3	3.9	5.0	2.5	6.7	4.1	0.0	2.0	1.0	5.6	6.1	16.8	1.8	3.4	6.5	11.1	5.9	10.6	6.8	6.7	3.0	2.8	7.4	6.0	1.2	0.6	1.4	1.7	2.5	2.1	1.2	3.9	3.0	2.8	3.2	7.3	7.4	4.2	4.5	3.4	3.0	2.8	2.3	13.4	8.8	8.2	2.6	2.1	2.5	2.9	0.0	7.7	1.2	3.8	0.8	0.7	0.7	1.4	0.4	0.3	0.1	0.1	0.1	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.1	17.3	21.9	28.8	34.5	17.2	23.4	19.7	24.5	22.7	16.3	32.8	3.0	2.9	1.8	3.0	29.8	14.1	5.1	4.0	5.7	7.0	15.7	1.2	6.6	4.8	10.1	6.2	4.6	0.0	4.2	2.0	8.0	2.3	4.6	17.3	3.8	11.1	3.4	6.7	6.2	13.8	23.3	3.3	3.3	1.0	2.6	3.3	5.9	3.5	47.7	5.4	6.5	6.5	6.4	1.8	1.0	1.9	1.0	0.0	2.9	2.8
CTNS	"CTNS-LSB, PQLC4"	ENSG00000040531	"Cystinosin, lysosomal cystine transporter"	O60931	17	3636468-3661542	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 33.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 46.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046947			Supported	"Vesicles,Intermediate filaments"		NA	NA			"Vesicles, Intermediate filaments"		"HPA046947: AB_2679872"	"unprognostic (1.64e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.28e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.62e-3)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	9.6	19.0	8.5	8.2	11.9	8.3	12.1	5.0	9.9	18.8	8.2	16.1	34.8	10.8	10.3	7.2	7.3	8.3	10.6	9.3	7.7	5.9	23.9	16.4	11.4	9.1	12.1	5.6	12.6	32.7	11.3	14.5	13.2	8.5	10.2	6.4	11.4	10.5	46.2	22.6	18.0	9.2	7.9	10.2	12.2	12.9	27.0	13.0	11.7	9.0	6.5	9.0	10.1	9.1	3.5	19.6	13.7	5.6	2.5	3.3	3.7	6.2	14.0	8.2	7.0	13.3	6.8	5.1	6.0	10.2	7.0	8.8	7.8	6.1	3.7	6.4	4.1	19.2	16.0	7.2	4.1	5.4	46.5	12.7	4.2	10.5	6.3	18.0	2.8	29.1	8.4	5.3	7.3	6.0	10.9	7.7	6.0	4.3	5.9	6.5	5.7	2.8	2.7	3.6	4.3	6.1	6.2	3.3	8.8	6.2	6.3	1.6	6.0	7.1	9.5	7.1	7.3	6.7	2.8	9.0	6.9	4.3	15.5	4.9	4.7	6.1	1.8	10.6	3.1	4.7	13.7	5.6	12.1	1.9	3.7	2.7	3.5	2.3	3.3	5.4	3.1	2.9	3.1	2.0	2.5	3.8	19.6	2.6	3.7	8.5	11.9	5.0	9.9	7.7	5.9	12.1	5.6	8.5	13.0	3.0	2.1	0.0	3.2	1.4	1.4	3.6	7.6	2.7	1.2	12.2	9.8	5.1	0.0	5.4	33.5	6.0	2.8	0.0	5.5	5.9	4.8	5.5	8.1	5.8	20.7	4.8	2.4	13.5	7.1	23.4	8.9	8.3	5.0	12.6	2.5	6.6	5.8	2.0	12.0	7.9	3.6	6.5	2.8	11.4	8.5	2.0	7.1	4.3	1.8	2.6
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 122.1"	"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 105.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	11.6	4.9	5.7	9.8	8.7	7.9	9.8	3.5	6.5	5.3	5.9	7.2	3.5	4.4	4.9	8.0	6.2	5.1	5.8	13.2	5.9	4.7	5.3	11.0	5.1	7.9	8.6	6.6	4.6	4.5	3.5	3.6	4.5	5.5	6.0	6.4	6.9	5.7	5.4	122.1	5.8	6.2	11.6	7.4	9.2	6.0	14.1	8.3	9.2	4.3	25.1	7.3	13.5	11.4	32.8	24.2	47.1	19.4	25.5	36.3	19.3	9.5	20.5	7.2	21.9	26.8	12.3	3.9	7.8	10.1	7.9	8.9	9.4	7.3	34.7	7.0	13.3	3.9	8.2	14.7	13.0	8.8	10.2	14.0	11.5	9.2	14.8	12.4	21.3	5.6	12.7	8.1	12.6	26.2	9.8	13.5	20.2	10.1	7.7	5.9	6.6	19.1	22.0	7.2	9.7	7.7	13.0	8.5	13.3	8.3	3.9	2.4	5.4	3.6	5.7	9.8	10.4	9.1	12.2	7.5	3.3	4.4	3.6	10.3	12.7	16.5	24.3	10.8	45.8	2.9	26.5	19.4	47.1	27.2	15.2	28.3	32.8	25.9	25.9	21.0	29.0	36.3	27.8	30.8	25.5	18.5	24.2	24.7	19.3	5.7	8.7	3.5	6.5	5.9	4.7	8.6	6.6	5.5	8.3	8.9	12.2	21.9	13.0	10.8	16.5	35.8	10.2	20.1	10.3	5.2	7.9	15.9	18.3	14.6	8.1	21.5	4.9	0.0	15.0	10.7	15.3	11.4	30.0	20.2	18.3	11.1	11.6	22.7	17.8	6.8	12.0	15.9	28.7	27.9	7.8	17.8	10.1	10.1	15.2	24.5	27.1	19.4	15.6	105.8	35.1	9.5	11.3	20.1	9.7	10.7
CXCL16	"CXCLG16, SR-PSOX, SRPSOX"	ENSG00000161921	"C-X-C motif chemokine ligand 16"	Q9H2A7	17	4733526-4739922	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	22	"Early spermatids: 715.4;Late spermatids: 3190.9;monocytes: 938.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 18.3;intermediate monocyte: 29.3;myeloid DC: 10.7;neutrophil: 25.9;non-classical monocyte: 37.7"	"Group enriched"	"Detected in many"	7	"dendritic cells: 10.7;granulocytes: 25.9;monocytes: 37.7"	"Cell line enhanced"	"Detected in many"		"A-431: 35.0;CACO-2: 24.1;CAPAN-2: 19.0;HaCaT: 39.2;T-47d: 18.9"									"HPA053253, HPA066315"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1100000	4000000	"Golgi apparatus"	Vesicles	"HPA053253: AB_2682091, HPA066315: AB_2685657"	"unprognostic (4.64e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-1)"	32.5	9.5	8.2	18.7	9.7	16.3	9.7	2.0	6.6	8.0	17.2	15.8	3.4	19.1	4.8	10.5	13.1	9.5	23.0	5.2	9.9	6.9	12.5	34.8	41.9	28.8	13.3	5.1	10.6	11.0	34.6	8.6	9.7	10.0	9.8	8.3	12.7	26.6	5.9	3.3	11.3	29.5	5.2	16.5	34.1	18.7	51.9	10.0	4.5	8.1	8.5	10.1	9.7	7.4	3.4	10.7	25.9	37.7	0.0	0.3	6.9	35.0	4.8	0.0	11.3	0.1	0.9	4.5	0.4	3.4	3.4	4.6	24.1	19.0	0.0	4.2	0.2	2.1	39.2	5.6	4.0	1.2	3.6	6.4	0.0	0.5	10.6	2.4	0.0	5.2	0.2	6.7	1.8	0.2	1.3	0.9	0.1	0.0	0.2	0.3	7.4	0.1	0.6	0.0	10.1	3.0	0.4	0.0	5.2	7.2	5.8	0.0	0.4	7.1	2.9	1.8	0.4	18.9	0.4	0.1	0.5	2.5	0.8	2.0	1.2	1.6	0.0	0.1	0.1	0.9	0.0	18.3	4.0	0.1	29.3	0.1	2.9	0.3	0.2	10.7	3.4	0.1	0.3	25.9	0.0	37.7	4.6	0.0	6.9	8.2	9.7	2.0	6.6	9.9	6.9	13.3	5.1	10.0	10.0	68.5	50.1	21.2	107.8	62.3	2.0	0.7	40.8	14.7	37.5	38.4	2.0	2.4	3.3	146.2	715.4	13.4	32.3	0.0	129.6	1.8	13.6	179.9	71.7	5.9	190.7	3.2	29.6	160.8	160.8	3190.9	22.7	246.0	25.3	938.6	23.4	6.8	134.1	45.6	28.3	6.8	0.8	19.4	18.9	20.7	11.8	66.9	2.4	10.0	19.3	257.2
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136118165	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 149.9;lymphoid tissue: 186.3"	"Cell type enhanced"	"Detected in many"	14	"B-cells: 772.9;Macrophages: 299.5;monocytes: 255.1;T-cells: 588.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 76.4;JURKAT: 43.5;Karpas-707: 41.0;MOLT-4: 69.2;REH: 36.7;U-266/70: 88.9;U-698: 89.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.19e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.99e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.41e-7)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.33e-2)"	15.4	26.5	3.0	39.1	3.4	149.9	9.7	0.8	2.1	7.7	8.7	6.8	1.5	1.6	8.3	3.8	16.4	9.1	12.0	5.4	4.1	4.7	8.2	7.1	29.3	94.5	6.5	1.3	6.3	3.1	0.7	8.1	7.8	6.1	6.8	7.0	10.0	10.6	2.2	3.2	2.3	57.8	3.8	22.9	82.4	8.0	7.2	3.4	186.3	9.2	4.6	97.5	50.0	6.6	47.3	16.8	37.8	7.2	4.0	32.0	11.9	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	76.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.9	4.6	12.1	0.0	0.0	10.5	8.3	0.0	0.0	0.0	0.0	0.0	7.3	43.5	0.1	41.0	0.0	0.2	69.2	9.4	1.2	5.9	0.4	36.7	8.5	13.3	0.6	0.0	4.2	3.5	0.0	0.2	0.0	0.4	0.0	20.7	1.0	0.0	0.2	0.0	0.0	88.9	15.0	89.4	0.0	17.4	0.0	17.9	7.2	29.6	22.9	3.8	18.7	30.1	21.1	21.7	6.6	47.3	32.0	30.1	37.8	4.0	2.1	16.8	18.9	11.9	3.0	3.4	0.8	2.1	4.1	4.7	6.5	1.3	6.1	3.4	14.9	64.2	772.9	4.0	36.5	4.4	3.6	2.5	4.0	6.8	3.5	0.0	1.4	11.6	3.6	0.9	19.0	0.0	46.7	0.8	2.2	30.2	4.8	11.6	5.5	168.4	0.0	1.7	22.7	175.5	1.7	1.4	299.5	108.0	255.1	0.1	1.0	1.6	0.0	2.5	2.1	0.6	45.3	16.3	0.5	5.5	31.1	5.3	588.4	0.4	3.2
CYB561	"CYB561A1, FRRS2"	ENSG00000008283	"Cytochrome b561"	P49447	17	63432304-63446378	"Predicted membrane proteins, Transporters"	"Electron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 86.9"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 90.7;SK-BR-3: 43.4;T-47d: 35.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014753	Enhanced					NA	NA					"HPA014753: AB_1847364"	"prognostic unfavorable (8.89e-5)"	"unprognostic (2.90e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-5)"	"unprognostic (1.81e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.89e-1)"	4.7	46.3	7.0	5.6	12.4	1.0	16.6	2.4	12.3	16.6	11.8	3.7	43.7	12.4	5.2	20.9	16.8	19.8	13.2	9.9	7.1	14.5	10.1	12.0	14.6	9.1	4.7	7.8	8.8	86.9	21.8	26.3	12.2	9.9	22.8	7.3	6.2	26.0	32.0	2.7	11.9	13.7	3.4	3.7	2.8	16.9	4.7	1.8	1.2	17.1	8.3	8.3	5.3	8.6	0.4	1.2	3.4	4.4	12.6	16.2	3.1	19.6	6.7	0.5	4.2	2.4	11.3	8.9	1.9	2.4	2.5	1.0	6.0	19.9	0.0	4.6	15.3	0.7	17.2	4.2	1.6	1.0	5.0	1.6	2.5	4.2	0.4	4.6	0.2	0.8	1.8	17.4	2.3	0.3	3.7	4.9	0.0	7.7	3.7	0.8	28.1	0.0	0.9	4.1	16.2	9.9	0.0	0.0	6.2	8.2	10.1	15.4	90.7	5.1	43.4	2.0	1.6	35.0	1.2	0.7	5.5	6.0	12.8	0.6	0.0	0.1	0.0	4.8	1.0	2.9	0.1	1.1	0.1	12.6	3.4	16.2	0.4	9.6	8.5	1.2	0.4	0.8	2.8	3.4	12.6	4.4	0.0	0.0	3.1	7.0	12.4	2.4	12.3	7.1	14.5	4.7	7.8	9.9	1.8	26.8	31.5	1.9	20.2	14.5	3.6	9.6	22.9	60.2	43.3	22.7	0.0	20.6	3.3	36.2	4.3	10.0	21.5	0.0	44.2	24.7	8.9	51.0	16.1	9.6	4.4	0.0	20.7	8.0	4.0	4.1	3.4	4.5	3.3	6.4	26.8	5.6	29.3	5.8	3.2	10.5	26.5	6.5	4.1	8.4	5.8	24.3	20.7	11.7	23.3	15.7
CYBA	p22-PHOX	ENSG00000051523	"Cytochrome b-245 alpha chain"	P13498	16	88643283-88651152	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	Oxidoreductase	"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 116.7;lymphoid tissue: 129.2"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 1995.7;Kupffer cells: 1785.0;Macrophages: 1690.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 94.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 141.2;THP-1: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009492	Enhanced					NA	NA					"CAB009492: AB_2090309"	"prognostic favorable (8.19e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (4.75e-5)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.63e-2)"	31.4	12.6	9.7	60.1	14.9	116.7	16.5	2.0	8.6	16.1	40.5	11.5	25.8	35.7	11.4	20.0	19.6	19.2	43.6	18.0	7.8	8.0	49.3	19.8	46.7	120.1	15.7	3.4	14.8	37.4	0.9	8.2	19.3	11.8	14.7	15.2	15.1	21.7	22.5	6.7	7.1	41.0	9.0	16.7	129.2	41.1	7.4	12.7	31.0	25.6	14.0	60.4	27.0	13.6	15.3	28.4	94.1	20.7	5.2	11.9	5.7	0.2	55.2	0.2	0.1	0.1	0.0	29.8	13.5	7.4	3.9	2.2	36.8	78.7	42.3	40.1	5.6	0.0	23.0	2.1	0.0	0.5	13.4	45.6	8.3	20.7	58.7	7.4	14.0	37.5	7.8	0.0	0.1	0.0	0.1	2.1	9.6	23.7	57.8	0.3	85.6	13.6	66.7	10.1	23.9	0.1	39.7	0.1	141.2	32.1	46.3	7.9	7.0	40.4	7.9	12.7	6.4	0.1	117.9	11.2	0.1	0.5	0.1	0.2	34.5	41.4	46.5	19.2	40.2	5.1	15.9	14.7	94.1	11.9	20.7	8.7	14.5	5.8	11.0	15.7	15.3	4.6	5.7	28.5	5.2	19.3	28.4	5.8	5.7	9.7	14.9	2.0	8.6	7.8	8.0	15.7	3.4	11.8	12.7	14.9	14.3	1206.4	193.9	106.1	0.0	11.3	382.1	38.8	34.2	270.4	2.0	56.0	107.8	589.8	3.5	108.2	700.4	256.9	138.1	250.5	228.6	131.9	281.8	17.4	1995.7	0.0	221.3	360.3	1785.0	7.4	46.3	1690.4	1093.2	1012.7	382.5	1.5	573.4	1045.1	20.1	714.0	2.1	58.2	83.9	0.6	17.7	74.9	98.9	597.7	722.2	321.4
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780011-37813461	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"	"Chronic granulomatous disease, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.3;lung: 49.4;lymphoid tissue: 74.5"	"Group enriched"	"Detected in many"	6	"Hofbauer cells: 133.2;Kupffer cells: 479.9;Macrophages: 227.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 50.3"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Daudi: 16.5;NB-4: 19.8;REH: 16.9;RPMI-8226: 65.1"	"Not detected"	"Not detected"							HPA051227	Enhanced					NA	NA		640000			"HPA051227: AB_2681395"	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	16.4	11.0	9.7	44.2	13.2	42.6	8.1	2.5	6.7	3.7	6.0	10.4	0.2	5.2	3.4	6.3	3.2	6.0	7.5	10.1	6.8	6.5	6.2	11.8	49.4	74.5	12.6	2.9	5.3	4.5	1.4	4.9	16.1	10.3	4.8	8.9	4.5	6.0	2.7	2.5	2.2	16.1	15.3	20.3	49.9	4.9	2.3	10.3	5.4	3.4	3.5	20.2	13.9	3.1	8.1	17.5	20.0	50.3	0.1	0.1	22.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	16.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.1	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	19.8	0.0	0.0	0.1	16.9	0.0	65.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.0	0.0	2.8	0.0	0.3	45.5	20.0	0.0	50.3	0.1	8.1	0.0	0.0	12.1	7.2	0.0	0.0	3.7	0.1	42.7	17.5	0.1	22.0	9.7	13.2	2.5	6.7	6.8	6.5	12.6	2.9	10.3	10.3	23.8	33.4	47.7	0.1	0.9	0.0	9.6	2.5	13.4	23.9	1.8	0.0	0.9	0.0	0.0	0.1	1.6	0.9	0.0	0.3	0.9	4.3	0.0	7.0	2.1	133.2	1.6	0.0	7.4	479.9	0.4	0.6	227.9	1.7	3.6	0.7	0.1	0.2	0.0	0.0	0.5	0.5	12.9	0.9	0.0	0.3	1.1	1.5	2.5	1.2	0.0
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Leydig cells: 88.6;Melanocytes: 74.2;Sertoli cells: 90.5;Smooth muscle cells: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 4.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 25.0;Hep G2: 19.1;HHSteC: 38.0;HSkMC: 31.0;SH-SY5Y: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: AB_2684573"	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favorable (2.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	48.1	16.1	6.2	9.5	8.3	1.1	34.4	10.9	11.6	13.3	19.0	1.5	8.4	15.2	8.8	8.4	12.5	8.8	24.1	43.4	4.2	11.2	6.9	13.6	17.8	9.5	6.3	5.5	11.2	7.6	8.5	5.0	10.0	17.7	22.8	7.0	23.7	10.4	9.4	17.1	8.2	17.8	17.6	3.5	8.0	13.1	9.3	2.2	1.1	22.0	11.4	3.4	35.1	41.5	4.4	0.4	2.4	0.3	2.5	1.3	0.5	0.0	0.3	0.6	0.1	25.0	7.4	8.4	0.2	0.6	0.1	0.3	0.0	0.1	0.0	8.1	0.7	0.1	0.2	0.0	10.7	0.0	0.0	0.0	0.1	0.1	19.1	38.0	0.0	0.0	31.0	2.3	0.8	0.8	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.2	41.5	0.0	0.0	0.8	1.9	0.0	0.2	0.0	1.0	0.5	0.1	0.0	0.4	0.0	0.1	0.0	0.1	3.2	0.0	0.3	0.4	0.5	0.2	0.3	3.4	0.4	0.2	0.4	4.4	0.7	1.3	2.4	2.5	0.2	0.0	0.5	0.5	6.2	8.3	10.9	11.6	4.2	11.2	6.3	5.5	17.7	2.2	3.0	1.3	0.0	1.2	9.6	24.0	3.4	0.0	25.4	10.3	0.0	0.0	0.9	0.0	0.8	0.7	16.2	0.0	0.0	0.2	0.5	13.7	0.7	0.0	0.9	0.4	7.9	0.0	3.7	0.0	1.1	88.6	3.5	74.2	0.0	0.0	17.5	0.2	0.0	21.9	0.0	10.0	90.5	44.5	1.0	1.2	5.8	2.4	0.5	0.0	0.6
CYSLTR1	"CysLT(1), CysLT1, CYSLT1R"	ENSG00000173198	"Cysteinyl leukotriene receptor 1"	Q9Y271	X	78271464-78327691	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.9;esophagus: 24.6"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 62.5;Alveolar cells type 2: 54.8;Ciliated cells: 65.6;Club cells: 67.1;granulocytes: 76.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 33.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;Karpas-707: 7.5;NB-4: 16.2;RPMI-8226: 24.7;THP-1: 15.2;U-937: 16.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA010546	Approved					NA	NA					"HPA010546: AB_1078268"	"unprognostic (9.48e-2)"	"unprognostic (6.01e-5)"	"unprognostic (4.72e-3)"	"unprognostic (3.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.52e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.41e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.56e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.94e-2)"	7.3	2.0	1.7	7.8	1.7	2.8	5.4	0.8	2.2	3.0	3.3	1.7	2.9	2.2	2.3	4.4	24.6	2.3	5.6	3.1	2.3	1.9	4.8	2.7	6.9	19.5	3.8	0.8	1.7	2.0	1.7	1.5	3.3	2.9	3.7	4.8	3.1	5.4	0.8	1.7	3.1	7.1	4.2	5.1	22.8	5.2	2.3	4.0	4.7	4.5	4.8	11.3	9.8	3.5	8.1	7.4	33.9	11.9	4.1	3.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	11.6	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	16.2	0.0	0.0	0.0	3.3	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	16.8	0.0	5.8	6.3	33.9	0.0	10.9	0.0	8.1	2.4	0.1	4.8	5.8	3.7	0.0	18.4	4.1	11.9	7.4	0.5	2.8	1.7	1.7	0.8	2.2	2.3	1.9	3.8	0.8	2.9	4.0	62.5	54.8	40.4	3.9	3.3	2.9	0.6	0.0	65.6	67.1	0.0	5.9	0.3	0.0	0.1	0.0	9.0	0.0	0.0	0.2	0.2	1.4	1.2	76.2	0.0	23.3	0.0	0.0	3.7	30.2	0.0	0.6	32.2	6.8	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.2	3.1	0.7	17.5	0.5	1.4
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease mutation, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 62.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353, HPA070563"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		70000000	"Vesicles, Plasma membrane"	Nucleoplasm	"CAB001960: , CAB016353: AB_627292, HPA070563: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	19.2	17.4	16.5	10.1	21.1	2.8	16.2	17.3	27.1	17.3	23.9	24.1	13.1	14.1	23.4	14.3	19.1	19.6	19.7	40.9	19.9	10.3	22.7	31.7	18.9	6.3	16.7	15.7	22.6	35.0	32.7	15.8	45.6	18.1	18.6	18.9	22.2	19.9	24.3	57.3	18.7	17.5	27.9	14.0	7.3	22.2	29.4	16.3	6.0	15.3	24.0	14.3	20.4	15.0	3.2	3.6	1.8	6.1	1.9	3.7	3.3	19.5	19.5	13.6	33.6	18.2	8.9	62.0	13.8	20.5	23.7	15.3	16.0	20.8	2.7	14.1	22.5	20.1	36.7	11.8	17.9	14.7	2.6	3.9	1.8	19.6	18.2	8.1	2.4	3.9	7.8	16.2	22.5	7.5	21.7	21.2	3.3	2.8	2.1	6.4	15.7	2.0	1.6	14.6	24.1	6.5	1.2	13.2	4.6	18.6	27.5	4.8	9.9	16.6	45.8	22.4	41.3	38.6	4.8	11.1	9.0	14.3	16.7	19.7	2.4	4.9	1.7	10.9	2.6	54.3	1.8	2.8	1.1	3.3	3.5	3.7	3.2	2.8	2.5	1.8	2.6	3.0	2.4	0.6	1.9	6.1	3.6	1.9	3.3	16.5	21.1	17.3	27.1	19.9	10.3	16.7	15.7	18.1	16.3	50.6	13.6	9.0	8.0	12.7	7.8	50.0	30.6	10.7	11.4	33.2	3.9	95.1	1.7	26.2	25.8	16.8	20.6	0.0	69.3	96.3	24.2	13.2	6.9	48.8	18.3	3.2	31.7	17.8	7.2	13.6	19.8	4.0	32.1	5.4	27.5	30.3	50.2	25.1	34.6	6.8	8.7	45.3	23.7	7.0	18.6	14.9	80.2	5.0	26.4	9.0
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644591-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"breast: 84.3;skin 1: 197.7"	"Cell type enriched"	"Detected in some"	386	"Melanocytes: 7747.1"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 3.9"									HPA063967	Enhanced				"Secreted in other tissues"	NA	NA		370000000			"HPA063967: AB_2685163"	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				7.3	0.0	0.1	0.1	0.1	0.2	84.3	0.1	0.1	0.1	0.1	0.1	4.4	0.0	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	4.6	0.1	2.7	197.7	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	1.8	1.8	5.2	2.2	3.2	2.5	0.8	0.7	0.9	1.6	1.4	0.8	1.2	1.7	1.9	0.3	0.0	1.1	0.0	1.8	0.7	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.6	2.4	2.1	0.8	0.5	0.0	0.4	1.4	0.7	0.4	0.0	0.0	0.2	0.4	0.2	1.1	3.9	0.0	0.0	0.0	1.5	0.6	0.0	0.7	1.0	0.7	0.3	0.0	0.8	1.6	1.1	0.0	1.4	0.4	1.3	0.5	0.6	0.0	1.1	0.9	0.9	0.1	0.0	0.6	0.3	0.3	1.0	0.2	5.2	1.6	2.0	1.4	1.2	2.5	1.8	1.7	1.4	1.0	1.7	2.1	2.3	3.6	3.2	2.2	1.8	1.9	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7747.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	20.1	0.0	0.0	0.0	0.0
DCP1A	"HSA275986, SMAD4IP1, SMIF"	ENSG00000272886	"Decapping mRNA 1A"	Q9NPI6	3	53283428-53347610	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 30.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013202	Approved		Supported	"Cytoplasmic bodies"		NA	NA			"Cytoplasmic bodies"		"HPA013202: AB_1857287"	"unprognostic (2.10e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (9.01e-4)"	"unprognostic (9.79e-3)"	"unprognostic (7.68e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.33e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.95e-1)"	8.0	5.7	4.8	5.4	6.9	18.5	6.1	11.1	8.8	7.2	4.7	6.8	2.1	3.9	8.4	5.8	5.5	6.5	5.5	5.4	4.3		4.6	4.9	5.1	6.3	5.1	3.7	11.2	6.9	8.5	10.0	9.9	5.8	5.8	5.8	7.0	3.8	5.0	5.0	4.9	6.4	7.6	5.8	6.5	4.1	4.9	6.0	11.4	6.1	4.0	10.0	8.2	5.8	26.7	17.4	23.6	25.8	29.4	30.3	19.0	5.8	6.1	14.4	11.6	9.9	10.4	19.3	6.9	9.2	15.4	14.5	17.9	10.7	13.6	2.8	8.7	9.0	5.0	18.7	7.1	13.4	12.1	8.3	13.3	8.4	9.2	8.7	15.7	18.2	8.1	6.9	13.8	11.3	9.4	11.1	9.6	11.1	14.8	7.4	3.6	21.6	7.9	9.1	6.1	8.9	10.0	9.7	9.4	6.4	13.3	7.6	12.3	12.0	7.9	10.3	11.2	5.1	12.2	11.9	7.4	10.6	7.5	10.3	9.3	8.0	15.7	9.0	9.1	13.1	23.6	13.6	22.4	24.3	14.4	30.1	21.7	24.8	28.1	15.0	26.7	30.3	28.1	13.9	29.4	25.8	17.4	16.9	19.0											26.8	30.7	38.9	43.4	51.1	29.0	23.8	15.3	8.1	19.4	7.0	45.2	35.0	3.3	24.3	8.2	29.2	20.6	0.0	30.3	45.7	31.6	39.2	36.8	11.0	17.6	27.0	49.6	26.4	22.2	19.1	23.0	23.0	10.1	34.3	24.7	17.5	34.8	14.0	24.4	13.1	28.3	12.9	30.9	12.2	16.6	36.0	53.5	27.4	26.1	50.6
DCSTAMP	"DC-STAMP, FIND, TM7SF4"	ENSG00000164935	"Dendrocyte expressed seven transmembrane protein"	Q9H295	8	104339087-104356689	"Predicted membrane proteins, Transporters"	"Differentiation, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"adipose tissue: 28.8;lung: 18.2"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 7.5;Macrophages: 2.5"	"Cancer enriched"	"Detected in some"	46	"thyroid cancer: 45.3"	"Region enriched"	"Detected in single"	4	"amygdala: 3.5"	"Cell type enriched"	"Detected in single"	8	"non-classical monocyte: 1.5"	"Lineage enriched"	"Detected in single"	16	"monocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.1;RPMI-8226: 1.2;SuSa: 1.4;U-87 MG: 4.5;U-937: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.61e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.34e-3)"	28.8	0.1	3.5	0.3	0.2	0.4	1.2	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.3	0.3	0.0	0.8	0.2	0.1	1.0	18.2	0.8	0.2	0.0	0.8	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.5	1.6	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.9	3.5	0.2	0.0	0.6	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	7.5	0.0	0.0	0.0	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDX19A	"DDX19L, FLJ11126"	ENSG00000168872	"DEAD-box helicase 19A"	Q9NUU7	16	70346829-70373383	"Enzymes, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045252, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045252: AB_10961128, HPA066668: "	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.38e-4)"	"prognostic unfavorable (8.05e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.68e-3)"	18.4	20.6	14.5	15.5	19.7	9.8	18.1	16.6	19.6	16.9	19.2	19.2	17.8	9.3	22.0	14.2	19.2	17.1	16.1	22.1	18.6	13.5	16.6	24.8	14.4	18.0	17.1	15.5	21.6	22.5	31.7	17.4	21.8	15.1	15.4	14.4	14.2	14.4	21.1	51.5	15.8	13.5	25.9	15.4	14.1	17.2	9.7	13.7	17.1	19.7	14.4	18.4	19.5	15.5	8.1	14.2	7.9	11.4	8.2	10.3	8.8	13.2	15.0	15.8	16.0	23.8	16.2	15.1	16.9	17.4	26.8	20.9	22.5	9.9	22.2	16.1	17.8	12.7	15.2	28.3	16.8	22.2	7.4	15.4	11.6	12.3	27.6	21.5	20.2	9.7	19.9	12.1	24.4	19.2	13.2	17.0	16.2	27.9	5.8	16.0	19.0	22.4	16.8	25.5	15.8	9.2	27.8	10.6	30.4	16.2	8.2	13.0	17.5	43.3	9.5	12.7	17.1	17.4	12.9	11.5	18.7	14.8	11.8	16.0	16.4	24.6	48.9	12.6	18.5	18.3	7.9	11.4	5.8	10.2	10.7	9.4	7.7	8.9	10.0	14.2	8.1	9.9	10.3	0.7	8.2	9.6	7.3	7.5	8.8	14.5	19.7	16.6	19.6	18.6	13.5	17.1	15.5	15.1	13.7	14.9	20.2	21.7	15.7	8.9	31.9	16.2	28.1	13.4	22.7	10.4	31.4	18.9	8.3	11.1	1.4	13.8	6.6	23.3	12.1	13.1	12.8	16.7	17.3	15.3	12.3	22.3	13.8	14.7	14.5	1.3	24.2	11.8	10.1	17.2	8.8	18.0	11.6	8.6	11.7	10.6	31.0	25.8	15.5	12.2	16.4	8.9	14.4	12.9	11.3	15.9
DDX19B	"DBP5, DDX19"	ENSG00000157349	"DEAD-box helicase 19B"	Q9UMR2	16	70289663-70335283	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 170.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037229, CAB037284, HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: "	"unprognostic (2.91e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.32e-2)"	22.2	18.6	8.8	16.6	12.7	19.4	20.1	30.4	16.3	13.1	16.7	14.6	13.8	14.4	15.0	13.9	16.0	13.2	15.2	15.0	8.3	8.3	15.9	33.9	16.6	15.3	10.5	10.7	14.6	21.6	20.3	17.9	12.0	13.2	13.8	18.2	19.3	16.8	15.2	24.8	26.9	16.6	15.7	10.1	17.8	18.5	64.3	12.3	17.4	18.0	16.9	20.8	16.2	13.9	21.1	21.1	27.0	28.6	22.1	35.4	22.5	2.0	12.4	17.7	16.0	9.8	13.1	15.3	10.0	14.2	22.0	23.0	26.4	15.3	16.2	9.5	12.6	8.9	12.2	0.1	5.7	22.8	6.7	11.3	9.6	8.1	21.6	21.1	20.5	9.3	16.1	11.3	16.7	12.7	9.1	16.8	5.0	9.7	7.0	13.4	14.2	0.0	29.7	11.1	7.7	5.2	28.4	9.6	23.4	13.1	11.5	11.6	15.3	23.6	5.4	12.7	8.1	12.1	18.2	10.2	10.4	9.3	8.6	9.2	15.1	7.8	37.7	3.4	16.8	13.4	27.0	22.1	19.0	23.2	28.6	22.3	21.1	20.9	25.3	21.1	19.0	19.0	18.0	4.1	22.1	17.7	6.5	35.4	22.5	8.8	12.7	30.4	16.3	8.3	8.3	10.5	10.7	13.2	12.3	11.9	17.9	27.3	15.3	8.4	17.8	6.6	12.7	29.4	20.5	10.4	11.8	16.5	26.6	35.6	170.5	17.5	27.5	0.0	57.8	18.6	16.1	14.9	10.5	12.4	25.9	9.5	21.1	11.6	14.6	32.4	19.2	19.7	3.3	43.3	14.6	16.0	37.9	34.5	14.9	17.4	15.7	12.9	12.3	78.8	7.4	9.2	26.4	25.5	20.3	15.7
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 40.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		120000	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	27.1	31.0	16.1	33.3	20.6	11.3	29.1	37.3	22.7	34.9	35.4	31.8	25.6	8.2	53.4	75.4	40.2	43.5	23.8	28.3	16.3	12.8	25.3	28.6	29.1	26.5	19.2	15.6	49.8	36.8	17.6	50.6	25.9	19.7	35.3	19.3	35.3	26.4	34.4	39.0	24.7	33.2	25.8	30.8	39.9	27.7	21.3	17.8	45.5	31.2	30.5	37.1	32.9	27.7	5.1	8.5	3.8	6.2	3.4	7.4	5.5	3.0	16.3	13.5	6.6	13.7	11.8	7.8	3.5	3.9	10.1	9.1	4.1	4.0	3.1	11.8	16.9	14.1	5.6	15.3	26.0	9.6	2.7	40.9	5.5	4.8	9.7	4.5	7.5	6.1	18.2	15.6	10.2	32.1	18.0	6.3	18.0	24.1	2.5	8.4	2.1	6.6	27.4	5.7	6.0	2.9	5.6	6.0	3.7	20.4	4.0	6.2	17.2	6.9	3.1	4.0	13.2	2.3	6.5	3.5	1.3	4.9	1.3	9.0	10.3	12.8	25.3	0.8	10.5	5.4	3.5	6.1	3.8	5.4	6.2	6.7	4.5	6.8	6.5	8.5	5.1	7.4	6.8	3.4	3.4	5.6	6.5	7.3	5.5	16.1	20.6	37.3	22.7	16.3	12.8	19.2	15.6	19.7	17.8	20.8	37.5	38.9	22.5	12.8	19.8	3.5	7.6	48.2	27.3	3.5	21.6	11.5	5.0	7.9	0.9	17.1	14.7	0.0	7.0	10.1	12.1	18.4	34.8	5.8	8.7	14.3	16.6	10.4	8.9	2.2	15.0	21.5	8.5	8.2	7.4	10.4	7.8	9.3	11.0	4.1	27.3	25.8	12.7	6.0	5.9	11.8	14.2	27.4	8.6	20.7
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3, X-linked"	O00571	X	41333284-41364472	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 631.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		110000	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	80.9	49.3	26.1	40.0	34.5	49.3	46.5	31.1	36.2	52.4	43.3	35.1	21.3	29.5	56.4	25.9	53.5	56.3	42.6	47.6	30.8	24.5	55.6	77.9	45.3	40.4	41.4	29.0	60.1	30.9	68.7	60.2	79.9	37.9	30.0	29.2	30.8	37.4	26.5	63.4	42.2	54.0	57.2	53.9	46.1	43.0	27.0	39.0	49.2	45.6	44.0	42.6	55.8	50.2	13.1	20.5	32.0	21.6	17.3	21.5	17.9	45.8	51.1	47.7	26.2	56.2	47.7	29.1	33.5	47.1	34.4	27.6	52.5	30.9	0.5	23.9	37.4	41.4	31.0	58.3	47.1	57.3	27.2	45.4	29.2	50.8	31.5	29.2	54.7	52.5	34.5	33.4	57.9	56.0	38.5	53.9	25.7	53.6	28.9	31.9	34.7	34.4	17.1	45.9	24.4	20.6	40.4	50.8	37.4	32.4	61.9	32.6	49.4	75.8	38.9	40.1	50.2	35.0	37.2	48.6	35.5	37.9	37.9	39.7	33.7	40.0	45.3	35.7	33.2	33.6	22.5	20.2	17.5	14.8	21.1	21.5	13.1	14.5	16.3	20.5	9.0	16.3	15.1	32.0	17.3	21.6	6.9	14.3	17.9	26.1	34.5	31.1	36.2	30.8	24.5	41.4	29.0	37.9	39.0	80.4	161.8	98.4	138.2	234.8	74.1	130.3	81.5	65.6	85.3	55.8	123.7	79.4	36.5	59.8	317.8	170.8	178.1	116.8	73.8	80.3	155.2	122.4	162.7	142.1	107.7	57.2	176.3	120.3	200.6	631.6	61.5	160.4	121.4	72.1	136.1	88.8	86.2	143.8	59.1	71.7	117.4	71.1	155.5	15.7	55.7	291.5	144.6	132.3	100.9	182.7
DEFA1	"DEF1, DEFA2, HNP-1, MRS"	ENSG00000206047	"Defensin alpha 1"	P59665	8	6977649-6980080	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"bone marrow: 825.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	17	"NB-4: 6.8"									"CAB032548, HPA052517"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB032548: AB_2277258, HPA052517: AB_2681860"																		1.3	0.1	0.2	0.1	0.6	825.5	0.6	0.0	0.4	0.1	0.1			0.1	0.4	0.1	0.1	0.1	0.1	2.3	0.2	0.2	0.2	6.0	41.9	0.3	0.3		0.1	0.1	0.1	1.0	0.6		0.1	0.1		0.6	0.1	0.5	1.8	0.1	0.1	0.0	115.5	0.1	0.1			0.6		0.1	0.1	0.0	0.1	0.3	0.5	0.7	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.3	0.1	0.0	0.2	0.0	0.3	0.7	0.0	0.3	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFA1B		ENSG00000240247	"Defensin alpha 1B"	P59665	8	6996766-6999195	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"bone marrow: 734.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory B-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											HPA052517	Supported				"Intracellular and membrane"	NA	NA					"HPA052517: AB_2681860"																		0.4	0.0	0.0	0.0	0.0	734.0	0.1	0.0	0.2	0.0	0.0			0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	16.0	0.0	0.0		0.0	0.0	0.0	0.3	0.5		0.0	0.0		1.8	0.0	0.0	0.5	0.0	0.0	0.0	49.1	0.0	0.0			0.2		0.0	0.0	0.0	1.8	1.2	0.8	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	1.8	0.5	1.1	1.2	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB1	"BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822"	ENSG00000164825	"Defensin beta 1"	P60022	8	6870575-6878022	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 121.1;pancreas: 219.9;salivary gland: 173.0"	"Cell type enriched"	"Detected in many"	5	"Distal tubular cells: 11270.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 522.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"classical monocyte: 1.4;intermediate monocyte: 1.6"	"Lineage enriched"	"Detected in single"	9	"monocytes: 1.6"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 27.8"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA						"unprognostic (2.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (5.94e-4)"	"unprognostic (3.24e-1)"	"prognostic favorable (1.90e-5)"	"unprognostic (9.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.16e-1)"	1.1	0.0	0.2	0.5	0.3	0.5	10.5	0.6	0.3	38.7	2.3	0.3	1.6	0.6	2.6	3.1	14.9	2.7	6.5	0.7	0.3	0.0	121.1	22.3	0.7	0.2	0.4	0.3	0.8	219.9	0.0	1.6	4.3	0.8	3.8	1.5	0.5	173.0	3.2	0.8	14.6	0.7	0.5	0.7	0.3	4.0	0.7	0.3	0.3	0.8	10.4	8.8	1.8	10.6	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.3	0.0	1.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.2	0.0	0.1	0.2	0.0	1.3	0.6	27.8	0.2	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.3	0.3	0.0	0.4	0.3	0.8	0.3	3.0	5.0	2.9	372.3	80.0	0.3	0.0	2435.7	5.3	4.5	931.7	0.0	6.7	11270.5	1231.2	0.0	0.6	52.3	0.0	250.8	0.3	5.0	291.3	0.0	169.8	3.4	0.0	15.1	4.9	6.0	0.0	16.1	5.3	6.8	26.2	10.3	0.5	226.2	20.7	0.0	94.9	0.6	0.0	4.1	0.0	0.0	470.0	3.1	3.8	11.3	236.2
DEFB103A	"DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3"	ENSG00000176797	"Defensin beta 103A"	P81534	8	7881204-7882664	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.6;tongue: 16.7;vagina: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 5.6;LHCN-M2: 1.2;U-2197: 2.2"														"Secreted in other tissues"	NA	NA																							0.3	0.0	0.1	0.1	0.1	0.0	1.0	0.1	0.1	2.2	0.1	0.1	0.1	0.0	0.1	0.5	3.3	0.0	0.1	0.1	0.1	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	3.5	0.1	0.1	1.9	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	16.7	6.6	0.1	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB103B		ENSG00000177243	"Defensin beta 103B"	P81534	8	7428888-7430348	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 4.1;lymphoid tissue: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 5.6;LHCN-M2: 1.2;U-2197: 2.2"														"Secreted in other tissues"	NA	NA																							0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	4.1	0.0			0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		1.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0			0.0		6.3	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB4A	"DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1"	ENSG00000171711	"Defensin beta 4A"	O15263	8	7894629-7896711	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 44.1;lymphoid tissue: 15.7;tongue: 50.4"	"Group enriched"	"Detected in some"	32	"Exocrine glandular cells: 31.8;Pancreatic endocrine cells: 27.9"	"Group enriched"	"Detected in many"	6	"head and neck cancer: 32.2;melanoma: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"EFO-21: 6.9;NTERA-2: 2.6"														"Secreted in other tissues"	NA	NA							"unprognostic (6.96e-2)"		"unprognostic (1.17e-2)"		"unprognostic (2.72e-2)"		"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"				"unprognostic (2.75e-1)"				0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.0	0.2	0.2	0.2	0.0	0.3	0.2	44.1	0.0	8.6	0.2	0.2	0.0	0.2	0.2	2.9	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	7.3	0.2	0.2	1.3	0.2	0.2	0.2	0.2	2.9	0.2	0.2	0.2	0.2	50.4	15.7	0.2	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	31.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DEFB4B	DEFB4P	ENSG00000177257	"Defensin beta 4B"	O15263	8	7414860-7416863	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 14.3;lymphoid tissue: 8.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CAPAN-2: 1.4;JURKAT: 1.2"														"Secreted in other tissues"	NA	NA											"unprognostic (1.35e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0			0.0		8.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DERL1	"DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577"	ENSG00000136986	"Derlin 1"	Q9BUN8	8	123013164-123042423	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 135.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016562, CAB037269"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB037269: AB_609868, HPA016562: AB_1847611"	"prognostic unfavorable (2.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	31.2	34.3	12.7	24.5	14.6	43.4	31.6	18.6	19.5	17.3	23.9	16.6	21.4	22.9	21.3	17.0	23.4	17.5	20.2	23.8	11.7	12.4	25.4	73.3	23.4	42.3	14.1	11.5	23.5	33.6	11.7	23.0	25.0	14.9	16.4	21.5	17.9	21.9	24.4	48.0	16.3	32.6	16.9	14.4	35.3	18.1	22.4	13.0	17.9	25.2	20.9	31.2	23.3	18.3	34.0	26.6	32.8	35.1	34.6	47.3	35.1	20.5	15.3	9.2	11.9	16.6	12.6	7.6	17.3	11.8	11.6	14.3	9.7	20.7	23.8	21.7	14.2	13.5	17.3	8.6	11.2	16.4	27.6	9.6	24.8	10.7	8.1	15.2	9.6	18.6	11.3	14.7	12.6	15.2	10.5	10.2	9.8	14.8	31.8	12.9	41.0	10.5	6.0	6.9	26.6	13.7	10.9	7.6	39.9	29.3	14.8	10.0	14.7	17.5	135.8	11.0	10.4	16.0	8.7	11.8	13.8	26.0	12.1	16.2	40.1	67.1	21.4	22.7	12.1	12.9	27.3	28.8	32.8	45.1	35.1	47.3	34.0	30.6	37.1	23.4	26.2	21.6	33.3	19.8	34.6	34.2	26.6	36.6	35.1	12.7	14.6	18.6	19.5	11.7	12.4	14.1	11.5	14.9	13.0	29.8	23.4	47.9	34.8	37.5	21.5	25.5	12.7	10.7	21.6	27.9	19.6	36.4	8.3	77.0	57.1	33.4	43.9	46.7	65.5	54.9	36.5	51.0	42.6	68.3	62.7	17.5	29.2	42.4	44.8	14.7	22.7	41.9	57.3	51.3	45.8	25.2	57.9	42.1	24.1	23.1	22.1	45.3	37.1	43.5	36.8	44.4	65.2	61.8	30.5	53.3
DIRC2	"FLJ14784, RCC4"	ENSG00000138463	"Disrupted in renal carcinoma 2"	Q96SL1	3	122794795-122881139	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	14	"Syncytiotrophoblasts: 189.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 4.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 4.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072579			Supported	Vesicles		NA	NA			Vesicles		"HPA072579: AB_2686536"	"unprognostic (1.40e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.87e-1)"	"prognostic favorable (8.81e-11)"	"unprognostic (2.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.13e-2)"	7.6	7.8	6.5	4.0	7.7	7.9	6.8	5.2	8.8	5.0	6.2	10.0	4.4	3.0	4.2	6.1	8.8	5.0	5.9	9.9	6.4	6.3	7.5	9.2	8.0	6.9	7.5	4.5	4.9	12.9	18.4	7.6	34.8	6.7	7.8	6.9	11.9	7.7	6.0	27.0	9.7	6.1	6.7	7.8	5.8	5.9	4.2	3.8	3.1	8.0	11.2	7.4	7.4	5.4	0.6	0.3	4.2	0.8	0.0	0.5	0.1	5.6	4.7	4.7	2.6	6.1	5.0	15.7	2.4	5.3	3.9	4.0	11.1	6.4	0.8	3.1	2.7	8.8	8.3	3.4	4.4	3.8	1.2	2.5	0.9	2.6	4.7	4.5	0.5	0.6	4.1	12.0	2.8	4.8	6.1	4.4	1.6	0.5	1.0	5.0	2.5	0.7	0.6	4.2	1.9	7.8	1.5	10.6	1.2	5.6	6.6	4.9	3.8	7.1	3.3	6.3	3.1	3.8	1.2	6.2	6.1	2.3	3.7	2.0	1.1	0.9	0.3	3.1	1.0	3.3	0.0	0.7	0.1	0.5	0.8	0.0	0.1	0.0	0.0	0.3	0.6	0.5	0.3	4.2	0.0	0.7	0.0	0.1	0.1	6.5	7.7	5.2	8.8	6.4	6.3	7.5	4.5	6.7	3.8	11.9	5.9	2.7	17.9	9.4	4.8	11.8	7.6	6.7	7.9	14.0	3.9	38.7	1.7	19.4	2.9	3.9	4.4	0.0	22.2	50.7	5.1	13.3	2.3	3.9	11.3	1.6	14.3	4.3	12.7	1.0	3.1	12.2	8.5	21.6	5.6	20.3	18.6	6.8	4.2	5.7	5.4	6.5	3.8	4.7	4.1	10.2	189.5	1.8	4.7	14.5
DLG1	"dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97"	ENSG00000075711	"Discs large MAGUK scaffold protein 1"	Q12959	3	197042560-197299300	"Predicted intracellular proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016307, HPA069593"	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"CAB016307: AB_2092015, HPA069593: "	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.56e-3)"	"unprognostic (3.54e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-1)"	12.3	12.6	30.0	10.2	34.5	9.6	14.2	42.1	37.7	19.9	17.8	32.3	17.0	16.1	15.4	8.8	30.2	12.7	12.9	13.8	26.9	19.2	21.0	18.6	12.9	10.6	32.9	27.3	18.7	11.9	28.2	19.8	15.1	29.1	12.1	20.2	10.4	16.5	14.7	18.7	13.7	18.4	15.3	32.2	8.8	16.7	11.1	39.4	14.7	34.6	13.9	14.8	13.8	15.7	3.7	2.9	2.9	1.0	1.4	3.9	1.5	45.1	7.1	14.2	25.8	11.7	11.0	14.5	16.1	14.8	16.2	19.1	20.9	19.5	13.1	46.3	16.0	32.9	29.7	13.0	25.1	31.3	3.5	8.6	11.5	11.0	15.2	11.7	11.4	11.5	9.9	13.7	14.9	32.7	54.8	20.3	10.9	9.3	16.1	39.0	17.5	17.0	4.4	11.1	25.5	13.8	9.1	17.2	9.5	16.9	19.1	7.0	11.8	25.3	16.8	18.4	16.5	38.4	8.8	19.3	44.0	11.6	12.1	27.2	25.4	18.3	17.1	16.2	17.5	13.8	0.0	0.9	2.9	1.5	1.0	3.9	3.7	2.9	2.7	2.2	2.0	3.0	3.1	1.1	1.4	0.4	2.9	2.9	1.5	30.0	34.5	42.1	37.7	26.9	19.2	32.9	27.3	29.1	39.4	23.8	18.8	19.3	47.6	47.4	27.5	25.2	22.9	28.1	18.2	47.1	90.3	41.8	5.0	19.0	10.7	25.6	44.1	0.0	17.6	17.3	28.1	48.9	11.5	47.8	12.9	35.0	27.7	28.3	20.6	14.9	26.4	15.8	35.4	9.0	32.3	90.6	23.3	43.2	24.1	15.4	91.0	12.9	20.8	28.6	35.1	61.9	20.9	24.5	33.3	110.2
DLG4	"PSD-95, PSD95, SAP-90, SAP90"	ENSG00000132535	"Discs large MAGUK scaffold protein 4"	P78352	17	7189890-7219702	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 83.2"	"Cell type enhanced"	"Detected in many"	15	"Bipolar cells: 35.6;Cone photoreceptor cells: 96.2;Rod photoreceptor cells: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.6;plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HMC-1: 30.9;hTERT-RPE1: 28.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001999, CAB002000, HPA010122"	Enhanced				"Intracellular and membrane"	NA	NA					"CAB001999: , CAB002000: , HPA010122: AB_1855169"	"unprognostic (7.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (8.82e-6)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.77e-3)"	5.5	16.0	58.3	7.5	73.3	4.1	4.5	47.4	83.2	9.7	4.1	5.4	4.3	4.7	13.8	5.0	5.0	9.2	10.7	8.9	58.7	24.2	3.3	3.1	6.0	4.2	14.4	53.9	12.8	4.6	11.5	15.1	8.7	14.8	7.3	3.8	3.1	6.3	12.5	3.6	4.0	4.4	10.7	11.3	7.8	5.7	10.1	17.0	1.7	5.8	0.0	3.5	7.0	4.2	0.0	1.6	0.0	0.9	0.0	1.6	0.6	0.2	7.4	18.5	6.2	7.1	10.5	0.5	9.7	8.5	7.3	7.0	0.3	3.0	1.3	4.3	8.4	0.9	0.7	1.0	3.9	3.6	9.6	1.9	5.5	13.3	0.9	6.0	0.1	30.9	11.6	0.4	6.2	6.3	28.1	8.6	7.7	2.2	4.9	10.9	0.2	4.2	3.3	2.6	0.2	0.5	7.6	0.7	0.7	5.3	0.2	7.6	6.0	0.2	0.4	1.1	3.3	4.4	3.5	10.5	17.6	8.5	3.5	5.1	0.8	0.5	0.7	13.2	3.5	5.4	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.1	1.6	0.0	0.6	58.3	73.3	47.4	71.2	58.7	24.2	14.4	53.9	14.8	17.0	0.0	1.0	3.7	1.7	2.4	35.6	3.1	2.5	1.4	2.3	3.5	96.2	0.4	0.0	0.7	1.5	5.0	0.3	0.0	0.2	0.4	6.2	1.4	6.9	1.5	3.3	19.1	14.5	5.5	10.2	0.9	6.6	5.5	3.3	1.8	0.7	6.0	0.3	0.0	9.6	0.0	58.6	0.0	2.3	6.5	1.9	1.6	0.5	0.5	0.6	0.7
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339441	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 380.8;Cone photoreceptor cells: 290.6;Rod photoreceptor cells: 392.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 2.6;naive B-cell: 4.9;plasmacytoid DC: 1.6"	"Group enriched"	"Detected in many"	18	"B-cells: 4.9;dendritic cells: 1.6"	"Cell line enhanced"	"Detected in many"		"AF22: 15.7;Hep G2: 14.3;RH-30: 19.8;SuSa: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced					NA	NA					"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	19.8	11.8	12.5	11.6	11.1	0.7	11.8	15.6	11.6	18.9	25.6	6.8	30.3	4.5	22.2	10.0	13.1	12.5	22.3	27.5	10.0	7.6	4.4	36.2	5.9	3.7	8.5	9.8	11.7	34.5	4.9	4.1	10.3	7.8	14.5	6.8	10.7	19.7	31.6	57.7	8.5	7.4	48.2	6.1	1.9	11.9	4.6	7.4	0.0	6.2	34.5	4.7	32.6	7.9	4.9	1.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	15.7	0.0	0.1	0.1	4.7	3.1	0.3	1.7	1.9	7.8	0.0	0.2	0.0	8.6	0.6	5.2	6.2	8.0	2.6	4.6	5.0	0.2	7.1	14.3	9.1	0.0	1.5	2.1	5.8	2.9	11.0	9.3	4.2	1.5	0.6	0.1	4.5	0.3	2.4	0.0	7.9	0.0	7.2	0.1	19.8	0.0	0.1	1.3	0.3	4.4	0.0	1.1	2.2	17.7	1.0	0.0	0.5	0.1	0.0	0.2	3.2	0.1	6.5	0.3	0.4	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.1	0.0	0.7	4.9	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	12.5	11.1	15.6	11.6	10.0	7.6	8.5	9.8	7.8	7.4	26.8	19.3	2.2	5.4	17.9	21.6	380.8	2.5	84.3	17.0	3.5	290.6	22.8	3.3	2.7	17.9	3.6	1.3	0.0	10.7	8.0	14.5	2.7	1.1	44.8	3.5	11.1	8.1	9.8	3.9	16.7	82.6	2.2	18.6	11.8	0.7	46.5	6.0	0.0	111.7	1.7	392.7	116.4	36.0	3.8	6.1	10.0	4.2	0.0	3.7	3.4
DNAJB12	"DJ10, FLJ20027"	ENSG00000148719	"DnaJ heat shock protein family (Hsp40) member B12"	Q9NXW2	10	72332830-72355230	"Predicted membrane proteins, Transporters"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 160.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010642, HPA072702"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nuclear membrane"	"HPA010642: AB_1078692, HPA072702: "	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.73e-2)"	"unprognostic (5.60e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.87e-1)"	24.9	31.7	18.6	20.1	20.6	27.2	32.6	24.0	28.3	24.1	21.8	29.9	26.4	25.0	26.8	31.0	23.8	21.1	28.7	25.3	18.0	17.3	25.6	34.3	26.8	27.5	19.9	19.4	25.4	33.1	38.4	26.2	36.0	20.2	24.5	17.5	27.5	32.4	44.8	40.3	28.6	27.4	22.8	22.3	26.9	24.3	29.2	18.2	20.8	25.5	25.8	23.5	21.1	21.2	7.6	15.5	23.3	19.8	8.3	8.7	9.9	15.6	16.3	10.3	17.2	13.5	13.8	13.0	15.8	27.4	21.8	20.3	19.1	27.4	11.6	12.8	19.0	13.6	26.4	9.5	14.2	11.5	12.6	13.0	6.2	9.7	12.3	29.8	12.6	23.8	17.7	29.5	19.2	24.4	19.7	15.1	11.2	9.7	17.5	18.0	15.2	10.7	10.7	4.8	12.0	4.8	9.9	7.8	8.0	16.0	9.2	7.1	10.2	8.6	32.0	15.4	5.8	12.2	14.4	16.9	10.9	15.0	12.2	19.8	14.8	11.0	6.8	18.0	13.9	7.4	9.1	18.1	11.0	8.7	19.8	7.8	7.6	8.6	6.5	15.5	7.3	7.2	7.1	23.3	8.3	16.8	10.5	8.7	9.9	18.6	20.6	24.0	28.3	18.0	17.3	19.9	19.4	20.2	18.2	26.8	27.7	36.1	25.5	11.8	32.1	20.2	53.5	20.1	22.7	22.7	21.6	34.5	10.0	30.2	95.9	21.5	37.6	46.7	56.5	35.4	21.6	25.1	39.3	26.0	34.3	28.6	28.3	17.8	36.2	160.7	33.6	33.3	10.1	33.3	24.0	31.9	29.4	31.7	32.9	30.0	34.0	51.8	25.0	20.2	9.0	13.6	56.9	20.3	21.7	29.8
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		500000	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	23.8	32.6	18.5	29.3	31.2	53.4	20.4	25.7	29.7	20.1	51.4	57.5	46.0	32.1	20.4	16.8	29.9	19.7	27.0	35.0	20.8	18.0	38.5	25.1	39.2	28.2	48.3	18.0	17.9	32.2	19.5	20.0	32.3	32.2	24.0	42.5	24.5	24.7	37.7	46.6	40.6	50.8	18.6	43.1	37.6	48.2	23.3	36.4	39.1	23.5	21.1	41.5	35.7	31.5	3.4	11.1	8.6	9.8	10.1	5.8	4.6	35.0	29.0	21.3	16.9	22.0	21.5	27.3	23.5	22.3	34.8	29.6	28.9	23.2	25.5	42.3	25.3	16.6	30.8	29.0	25.5	29.2	31.2	23.0	48.9	25.9	32.3	27.1	26.8	46.4	22.1	19.7	26.6	25.1	21.2	33.8	26.3	39.3	43.9	21.4	42.5	37.3	25.6	24.2	41.6	35.2	37.9	23.1	28.7	22.9	52.9	30.7	20.1	26.8	23.0	16.8	24.8	18.4	32.0	30.6	38.3	13.0	53.7	31.0	36.4	37.1	23.5	28.6	41.1	18.9	3.0	4.5	8.6	5.6	8.2	5.1	3.4	4.2	5.8	5.3	3.1	2.4	4.1	8.5	10.1	9.8	11.1	4.8	4.6	18.5	31.2	25.7	29.7	20.8	18.0	48.3	18.0	32.2	36.4	29.8	21.1	33.5	15.2	20.6	26.5	23.8	15.3	5.3	18.2	48.8	21.6	21.9	43.1	30.7	37.5	27.5	130.4	0.0	27.6	96.1	18.2	17.4	18.5	18.7	42.3	41.3	20.7	20.3	22.9	75.8	15.5	40.5	18.6	50.5	92.3	16.0	35.8	87.7	26.2	31.5	27.7	25.8	19.8	8.0	13.3	27.6	26.5	39.9	56.9	19.7
DPP10	"DPL2, DPPY, DPRP3"	ENSG00000175497	"Dipeptidyl peptidase like 10"	Q8N608	2	114442299-115845752	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 15.6;brain: 30.3;pancreas: 23.4"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 5.1;Early spermatids: 10.4;Extravillous trophoblasts: 7.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 5.1;HAP1: 7.6;HMC-1: 5.4;JURKAT: 4.1;NTERA-2: 4.6;RT4: 8.1;SCLC-21H: 12.0;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048767	Uncertain					NA	NA					"HPA048767: AB_2680515"	"unprognostic (1.19e-1)"		"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"		"unprognostic (2.03e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.33e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.22e-2)"	0.7	15.6	13.4	1.1	15.9	0.9	0.9	1.9	30.3	1.3	3.6	7.9	0.0	2.4	1.4	0.8	0.8	0.9	1.9	0.8	17.5	9.9	1.1	0.9	1.0	0.7	7.1	21.3	0.9	23.4	0.7	1.5	1.8	10.8	0.8	4.6	0.0	1.0	0.8	0.7	0.9	2.4	1.9	12.7	0.7	1.5	2.1	10.3	0.0	1.6	0.0	0.8	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	8.1	12.0	4.8	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	15.9	1.9	30.3	17.5	9.9	7.1	21.3	10.8	10.3	0.0	0.0	0.0	0.0	0.0	2.7	1.4	5.1	0.0	1.2	0.0	0.0	1.1	0.0	0.0	10.4	0.0	0.4	0.0	2.3	7.3	0.2	0.0	0.0	0.0	0.3	4.8	4.1	0.6	0.0	4.3	0.3	0.0	1.7	0.0	1.3	1.4	1.2	0.0	0.0	0.0	0.5	0.0	0.0	1.7	1.1	0.0	3.7	0.0	2.9	0.0
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.7;endometrium 1: 24.5;thyroid gland: 24.1"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 13.3;Horizontal cells: 30.2;Late spermatids: 16.0;Melanocytes: 15.1;Muller glia cells: 18.7"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported				NA	NA					"HPA050509: AB_2681150"	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	1.6	7.2	15.4	1.4	32.5	1.3	1.5	26.6	45.7	2.3	6.8	8.7	0.0	1.6	24.5	3.1	1.5	4.6	1.3	1.4	26.6	15.2	3.6	1.2	2.2	1.3	14.0	22.7	1.3	4.0	1.2	4.9	1.3	18.8	1.5	2.4	0.4	1.3	8.1	4.6	3.7	2.0	15.8	7.2	4.2	3.5	7.9	10.0	0.0	24.1	0.0	1.2	1.3	0.4	0.6	0.6	1.9	0.9	0.9	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	1.2	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.9	0.4	0.7	0.4	0.6	0.7	0.6	0.6	0.4	0.4	0.6	0.7	0.7	1.6	0.9	0.9	0.6	0.5	0.3	15.4	32.5	26.6	32.4	26.6	15.2	14.0	22.7	18.8	10.0	0.0	0.0	0.0	0.4	3.0	9.3	5.9	0.0	1.4	2.3	0.0	0.0	0.0	0.0	0.1	13.3	0.0	0.0	0.0	3.6	0.0	0.3	0.1	0.0	0.0	0.2	30.2	9.9	0.0	0.0	16.0	1.1	0.0	15.1	0.0	0.2	18.7	0.5	0.0	3.5	0.3	6.0	0.0	0.3	0.9	1.7	1.4	0.0	0.0	0.0	0.1
DRD2		ENSG00000149295	"Dopamine receptor D2"	P14416	11	113409615-113475691	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	8	"adrenal gland: 17.3;brain: 52.0;pituitary gland: 51.6"	"Cell type enriched"	"Detected in some"	12	"Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"basal ganglia: 52.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 45.2"	"Region enriched"	"Detected in many"	10	"basal ganglia: 183.8"	"Group enriched"	"Detected in many"	8	"basal ganglia: 126.7;midbrain: 41.7"	"HPA015139, HPA015691"	Supported	Supported				NA	NA					"HPA015139: , HPA015691: AB_1847834"	"unprognostic (8.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"		"unprognostic (1.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.49e-3)"	0.6	17.3	0.9	0.5	52.0	0.2	2.1	0.2	3.3	1.3	0.6	1.5	0.0	0.3	2.3	0.4	0.9	2.1	0.6	0.5	0.3	4.1	0.3	0.2	0.6	0.2	9.9	0.2	0.3	0.4	0.3	51.6	0.2	2.4	1.5	0.9	3.9	5.1	1.7	1.7	0.3	0.5	3.2	0.2	0.2	0.5	1.6	9.5	0.0	0.2	0.0	0.3	0.3	0.3	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	45.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.9	52.0	0.2	3.3	0.3	4.1	9.9	0.2	2.4	9.5	0.0	0.0	0.0	0.0	0.0	4.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRD3		ENSG00000151577	"Dopamine receptor D3"	P35462	3	114128652-114199407	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 2.0;brain: 8.3;testis: 4.2"	"Group enriched"	"Detected in some"	39	"Early spermatids: 5.5;Late spermatids: 12.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.0;T-reg: 1.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.0"	"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Region enriched"	"Detected in some"	5	"basal ganglia: 7.5"	"Region enriched"	"Detected in many"	12	"basal ganglia: 25.2"							NA	NA										"unprognostic (2.32e-1)"													0.0	0.0	0.0	0.1	8.3	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2			0.0		0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	2.0	0.6	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	1.4	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
DUOX1	"LNOX1, NOXEF1, THOX1"	ENSG00000137857	"Dual oxidase 1"	Q9NRD9	15	45129933-45165576	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 48.7"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 1: 77.4;Alveolar cells type 2: 116.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.4"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HaCaT: 34.6;hTCEpi: 16.8;RT4: 19.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 17.5"	HPA023544	Approved					NA	NA					"HPA023544: AB_1847878"	"unprognostic (2.85e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (2.49e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.02e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.03e-1)"	0.4	5.2	0.5	0.4	0.8	0.0	2.0	1.2	0.9	18.9	0.6	2.4	43.3	0.1	2.2	37.8	38.3	6.0	6.2	1.1	0.6	0.1	0.2	0.1	48.7	0.1	1.0	0.5	1.2	0.1	1.8	0.9	2.5	0.9	4.8	0.0	4.3	9.8	19.2	0.8	34.2	0.3	1.6	0.5	0.1	18.0	1.0	1.1	0.7	31.9	35.9	31.9	6.2	13.1	0.2	1.5	0.5	0.5	0.1	0.4	0.0	4.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	34.6	0.0	3.2	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	16.8	0.0	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.0	19.3	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.4	0.5	0.0	0.1	0.3	0.0	1.1	0.2	0.2	0.0	0.0	0.1	0.1	1.5	0.2	0.0	0.5	0.8	1.2	0.9	0.6	0.1	1.0	0.5	0.9	1.1	77.4	116.2	6.7	13.0	9.8	20.8	2.0	10.2	38.8	34.2	3.5	7.9	3.8	0.0	3.4	0.5	2.9	2.7	0.0	4.8	0.6	5.2	5.8	8.1	1.7	1.1	6.4	20.8	8.6	5.1	0.0	3.1	5.8	15.1	1.8	3.4	4.1	3.3	4.2	3.5	0.3	2.6	0.0	2.7	2.8	2.3	15.7	3.1	10.1	2.3	23.7
DUOX2	"LNOX2, P138-TOX, P138(TOX), THOX2"	ENSG00000140279	"Dual oxidase 2"	Q9NRD8	15	45092650-45114344	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 151.5;gallbladder: 80.4"	"Cell type enhanced"	"Detected in many"	18	"Ductal cells: 151.4;Exocrine glandular cells: 106.5;Pancreatic endocrine cells: 346.5;Urothelial cells: 98.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 60.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"basophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	8	"HaCaT: 11.8"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.3"	"Not detected"	"Not detected"									NA	NA						"unprognostic (3.19e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.63e-2)"	0.1	0.6	0.1	8.4	0.3	0.0	0.1	0.1	0.2	5.1	3.2	0.2	151.5	0.3	0.4	0.8	10.9	0.0	80.4	0.3	0.1	0.0	0.3	0.8	1.2	0.1	0.1	0.1	0.2	0.8	0.0	0.1	0.2	0.2	3.4	1.4	0.4	7.3	1.2	0.6	2.1	3.5	0.6	0.1	0.1	14.9	0.5	0.1	0.1	29.0	6.1	6.6	20.4	9.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.6	0.0	0.0	11.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.3	0.2	0.4	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.1	44.7	41.2	0.0	1.9	1.6	0.4	1.6	68.8	21.4	37.5	0.0	0.0	0.0	0.0	151.4	0.5	0.0	4.3	0.0	106.5	0.0	0.5	3.8	30.2	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.3	0.9	0.0	9.0	4.1	0.1	346.5	4.2	0.0	0.0	0.3	0.0	3.1	0.7	0.3	1.6	0.0	0.0	2.1	98.5
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"testis: 3.4"	"Group enriched"	"Detected in some"	21	"Early spermatids: 4.1;Late spermatids: 4.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.5;U-2 OS: 3.7;U-266/70: 8.0;U-266/84: 10.4;U-698: 2.4"									HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: AB_2683722"																		0.0	0.4		0.0		0.0	0.0		0.5	0.0	0.0			1.0	0.1	0.0	0.0	0.9	0.0	0.0			0.0	0.0	0.5	0.1			0.1	0.5	0.3		0.0		1.1	0.0		0.5	0.1	0.0	0.3	0.0	0.0		0.0	0.3	3.4			0.0		0.0	0.0		0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	2.5	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.7	0.0	8.0	10.4	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 39.9;skeletal muscle: 53.3"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 20.1;Endothelial cells: 22.1;Ito cells: 34.4;Kupffer cells: 20.6;Syncytiotrophoblasts: 55.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 19.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 19.9"	"Group enriched"	"Detected in some"	5	"hTERT-RPE1: 12.8;HUVEC TERT2: 32.9;LHCN-M2: 29.9;RH-30: 31.6;TIME: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		Yes	No			"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	6.6	2.1	1.1	7.2	1.3	18.6	7.9	1.2	2.0	1.9	6.4	0.0	3.9	1.6	4.2	4.9	5.1	3.6	3.3	20.8	1.2	2.0	4.7	13.4	9.1	17.8	2.1	0.7	4.1	1.4	2.0	2.1	39.9	7.0	4.8	1.9	3.3	1.9	3.6	53.3	1.7	3.3	12.1	1.4	26.5	3.2	1.5	0.3	0.8	4.9	8.3	1.0	8.7	11.9	0.0	0.0	19.9	2.6	0.3	0.3	0.7	0.4	0.0	1.3	1.1	0.0	0.0	2.4	0.0	0.3	0.9	0.6	0.1	0.3	0.0	4.9	0.0	1.3	1.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.9	4.2	12.8	32.9	0.0	3.1	0.0	29.9	0.0	0.0	2.2	3.2	0.0	0.3	0.0	31.6	0.0	1.0	0.0	0.0	0.0	1.5	0.2	0.0	3.3	0.1	0.3	21.5	0.1	1.5	0.1	0.4	0.0	0.0	0.0	0.0	5.2	0.0	0.0	2.6	0.0	0.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	19.9	0.3	0.1	0.0	0.0	0.7	1.1	1.3	1.2	2.0	1.2	2.0	2.1	0.7	7.0	0.3	3.0	13.8	0.5	0.0	2.2	0.8	20.1	0.0	1.4	2.3	0.0	0.0	5.4	0.0	0.4	4.4	22.1	0.0	0.0	0.2	2.8	1.4	0.2	2.3	9.9	11.0	0.0	0.0	34.4	20.6	4.1	0.6	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	1.7	0.1	6.5	3.1	0.5	0.0	1.4	55.4	0.9	0.0	0.0
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24, autophagy associated transmembrane protein"	O14681	11	125569216-125584687	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 164.6"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 494.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 117.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	13.4	10.2	13.3	8.9	16.2	4.6	16.7	11.2	22.1	12.7	17.0	14.4	13.8	11.3	13.6	12.9	22.7	12.1	15.8	16.4	10.6	10.7	14.6	55.5	12.1	11.2	12.0	11.1	13.1	34.2	164.6	9.2	11.9	11.0	13.7	18.9	13.2	20.9	14.3	26.5	17.2	16.1	15.9	9.2	10.5	17.7	10.4	10.5	9.9	12.0	14.2	13.0	16.2	12.9	8.5	15.5	5.4	7.3	6.5	10.0	4.9	24.5	18.7	21.4	25.8	35.2	26.8	26.8	25.2	19.1	17.4	15.7	28.4	49.7	24.7	42.9	23.7	18.5	28.4	32.5	53.0	22.6	6.5	20.6	117.9	13.4	26.6	26.2	26.6	12.8	25.0	48.6	26.1	38.7	17.2	36.7	13.5	53.5	10.1	24.4	17.3	12.1	13.6	28.2	63.6	20.5	17.8	25.3	21.0	29.0	44.0	20.0	19.2	29.5	35.2	9.5	37.0	71.9	26.5	30.5	22.4	15.2	15.7	20.4	6.3	12.7	32.2	9.8	40.8	29.8	4.1	7.3	5.4	8.2	7.0	8.1	8.5	6.5	10.0	11.6	7.3	9.4	7.6	0.9	6.5	5.1	15.5	9.0	4.9	13.3	16.2	11.2	22.1	10.6	10.7	12.0	11.1	11.0	10.5	29.8	34.7	29.8	114.2	107.2	57.4	55.7	129.9	9.4	27.3	104.7	35.3	140.6	122.7	154.4	19.7	84.2	53.8	0.0	158.4	174.0	83.1	141.9	27.6	494.9	92.4	77.9	94.5	65.1	44.4	33.9	66.2	50.8	86.0	34.3	100.9	68.5	153.1	52.6	67.8	102.8	30.5	45.3	89.6	92.8	109.0	158.6	117.2	35.1	116.3	136.4
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80135214-80147183	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		73000	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	27.3	37.0	19.6	23.6	21.5	71.7	22.0	20.3	19.8	24.2	23.8	16.9	19.2	16.2	24.9	18.0	41.5	29.4	17.1	24.2	17.8	12.3	24.5	20.3	21.6	25.4	16.8	19.7	37.5	16.8	17.1	21.9	38.3	13.1	24.7	20.9	14.7	22.1	31.2	19.8	31.2	18.6	18.5	13.7	25.5	20.4	35.1	19.3	30.7	26.9	26.4	30.6	28.9	25.8	38.7	80.4	33.1	41.9	30.2	38.9	48.3	48.1	43.2	28.6	21.1	22.0	13.4	25.0	25.6	18.2	36.3	29.2	46.0	22.5	44.1	17.2	22.3	26.0	32.1	39.1	27.3	40.4	16.2	41.0	27.6	34.2	49.6	21.7	49.7	29.0	20.5	14.0	30.4	24.7	14.7	29.6	25.8	36.7	28.6	21.4	36.8	44.8	25.3	30.7	44.4	40.0	37.1	57.9	34.8	17.7	41.2	39.8	21.7	35.2	68.9	29.5	28.1	45.0	33.5	20.3	22.5	28.9	33.1	40.3	25.1	21.6	81.4	18.2	31.4	23.0	25.7	41.1	33.1	26.7	41.9	34.5	38.7	34.5	30.8	50.3	31.6	32.0	30.7	24.4	30.2	32.9	80.4	38.9	48.3	19.6	21.5	20.3	19.8	17.8	12.3	16.8	19.7	13.1	19.3	38.7	49.5	57.4	240.8	251.5	20.3	50.7	30.6	36.1	62.6	27.9	15.7	121.7	54.7	70.9	25.8	58.9	51.0	23.3	101.3	178.8	96.2	78.8	91.1	26.0	94.7	6.4	57.8	30.7	62.3	10.0	62.2	81.9	97.8	83.8	45.6	43.1	73.7	52.7	46.7	47.7	27.1	84.1	170.0	87.7	109.4	261.3	219.0	53.3	56.0	264.3
EIF5A	"EIF-5A, EIF5A1, MGC104255, MGC99547"	ENSG00000132507	"Eukaryotic translation initiation factor 5A"	P63241	17	7306999-7312463	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB005042, HPA061298"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"CAB005042: AB_562281, HPA061298: AB_2684472"	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (4.10e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (3.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.01e-2)"	"unprognostic (7.65e-2)"	69.0	55.6	37.9	57.0	40.4	83.1	44.5	35.0	59.8	44.6	54.8	37.5	39.8	47.4	47.2	45.5	107.0	38.1	52.9	55.8	35.6	33.6	58.5	192.9	46.6	67.2	34.3	35.9	50.3	126.0	26.0	34.1	73.9	34.0	38.0	57.2	40.7	87.7	40.7	100.6	71.1	49.0	45.4	29.5	65.5	42.9	56.8	24.2	77.9	57.9	105.4	79.0	48.6	50.7	64.7	87.7	44.4	75.7	75.2	79.3	64.3	132.8	165.9	51.2	102.4	39.5	51.0	71.9	100.3	66.2	135.7	94.9	99.2	56.8	128.8	65.0	77.1	55.6	90.9	111.1	129.3	123.5	71.6	161.3	77.5	137.4	127.0	70.1	58.8	80.2	54.0	67.9	100.2	136.1	45.9	87.1	38.7	106.5	36.0	91.8	82.4	69.1	85.1	97.1	77.7	81.9	68.4	62.2	118.7	81.9	73.9	59.5	77.4	64.3	78.4	62.1	40.8	62.0	45.4	81.5	95.7	68.9	63.5	158.5	30.3	41.4	83.3	90.4	88.6	108.9	44.4	56.0	38.9	65.1	75.7	79.3	64.7	67.1	57.7	85.8	62.6	62.3	62.6	25.1	75.2	68.6	87.7	58.9	64.3	37.9	40.4	35.0	59.8	35.6	33.6	34.3	35.9	34.0	24.2	50.6	35.2	135.1	56.5	310.0	85.2	62.9	114.7	41.5	36.4	59.3	13.7	296.4	63.0	289.3	125.7	155.1	221.7	163.5	206.2	541.5	192.2	120.0	138.2	197.7	267.8	47.7	144.4	98.8	106.6	60.7	93.2	101.1	249.7	306.6	167.0	82.0	274.1	169.5	76.4	70.8	45.7	90.5	172.0	216.9	81.3	274.3	358.2	71.9	197.1	61.2
EIF5A2		ENSG00000163577	"Eukaryotic translation initiation factor 5A2"	Q9GZV4	3	170888415-170908693	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 31.2"	"Group enriched"	"Detected in many"	11	"Early spermatids: 309.4;Late spermatids: 705.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029090	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA029090: AB_10671359"	"unprognostic (2.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.05e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (1.11e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.29e-3)"	5.6	3.9	3.6	4.1	8.4	4.9	4.2	1.9	14.4	4.4	4.6	4.3	2.0	2.5	6.2	2.0	4.1	3.6	4.9	5.4	4.3	5.8	6.8	3.4	3.2	3.6	6.7	6.2	6.4	4.5	2.2	5.2	2.5	21.6	4.8	3.8	3.4	2.7	4.2	1.9	3.0	2.6	9.6	5.1	3.0	11.0	31.2	2.5	6.1	3.1	2.6	4.2	6.3	6.2	2.6	0.9	10.2	1.3	6.9	11.2	4.3	11.6	6.1	2.2	3.1	12.0	7.9	5.3	8.8	11.5	9.4	13.2	12.4	7.7	7.4	16.6	12.3	21.1	3.9	7.1	3.2	12.0	8.1	3.1	3.4	2.5	3.9	8.1	9.1	10.7	8.6	4.7	14.1	11.7	13.1	4.6	1.9	2.8	0.0	15.3	3.7	4.1	4.1	4.2	9.1	3.9	0.0	6.5	0.0	3.9	2.1	1.8	3.4	9.4	2.4	7.4	3.7	5.4	6.2	6.4	11.6	8.2	23.8	20.2	11.6	0.1	16.8	3.9	3.2	8.2	10.2	1.2	1.2	11.2	1.3	7.7	2.0	7.7	10.6	0.9	2.6	4.6	7.6	0.6	6.9	1.2	0.8	9.2	4.3	3.6	8.4	1.9	14.4	4.3	5.8	6.7	6.2	21.6	2.5	0.0	0.3	3.2	5.2	15.1	2.8	8.1	0.0	4.0	1.2	1.8	0.0	0.8	1.7	6.4	309.4	7.1	1.0	0.0	6.6	1.7	11.3	4.4	2.3	2.4	7.4	0.0	4.7	2.5	4.1	705.4	11.8	4.9	10.1	11.8	1.1	7.5	12.5	4.2	10.6	18.0	2.6	45.3	14.5	25.1	9.3	18.9	0.6	16.6	1.6	5.0
EIF5AL1	"bA342M3.3, EIF5AP1"	ENSG00000253626	"Eukaryotic translation initiation factor 5A-like 1"	Q6IS14	10	79512601-79516440	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"testis: 19.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 5.7"															NA	NA						"unprognostic (2.16e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.55e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.81e-1)"	0.8	1.0	0.6	0.8	1.0	0.7	0.7	0.6	1.0	1.2	1.1	0.5	1.6	0.7	0.6	0.7	2.5	0.5	0.8	2.5	0.5	0.5	1.0	8.4	1.0	1.0	0.5	0.0	0.7	3.7	1.4	0.9	0.5	0.8	1.5	0.8	0.0	1.7	0.5	2.6	1.4	2.7	0.4	0.3	1.6	0.8	19.5	0.4	3.3	1.1	2.8	1.1	1.6	0.7	3.9	6.5	2.3	4.9	4.0	3.7	1.3	1.2	2.1	0.9	4.7	0.1	0.6	0.9	0.7	0.5	0.8	0.5	1.6	0.9	2.3	0.8	0.2	0.5	1.4	0.5	0.1	0.5	0.7	1.8	0.6	2.8	0.9	0.5	0.7	1.8	0.1	0.1	0.3	0.4	0.1	0.6	0.2	0.5	0.9	0.3	1.6	2.5	2.3	3.4	0.3	0.3	0.8	2.1	1.5	1.4	2.2	0.6	1.4	1.4	1.3	1.5	0.3	2.2	1.9	0.7	1.3	2.8	3.1	5.7	1.2	1.3	2.1	2.1	0.6	1.8	2.3	2.1	1.5	3.3	4.9	3.7	3.6	3.1	3.7	3.8	3.9	2.4	3.5	2.0	4.0	2.9	6.5	2.5	1.3	0.6	1.0	0.6	1.0	0.5	0.5	0.5	0.0	0.8	0.4	14.9	35.4	7.2	2.5	30.0	0.6	38.6	2.5	9.4	25.0	0.0	0.0	18.6	10.0	58.5	11.5	13.8	60.4	0.0	41.0	29.8	19.2	2.9	47.3	4.9	15.9	1.6	57.6	2.5	8.1	4.4	4.6	16.8	18.6	64.1	60.4	1.3	56.7	66.6	2.8	3.6	0.5	0.0	27.6	84.1	3.8	30.2	23.1	7.5	80.1	2.7
EMB	MGC71745	ENSG00000170571	Embigin	Q6PCB8	5	50396192-50443248	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;intestine: 42.2;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 62.5;Cone photoreceptor cells: 102.1;T-cells: 112.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 70.3;U-937: 30.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.01e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.86e-3)"	15.0	16.4	1.7	21.7	2.0	43.3	8.4	1.1	2.9	2.7	18.9	1.4	0.5	21.7	1.6	5.6	6.5	4.7	6.1	16.7	2.2	4.7	4.2	1.9	10.6	44.1	3.8	1.4	2.7	1.8	15.2	8.0	6.6	4.5	9.5	3.6	4.0	7.4	6.9	2.7	15.9	42.2	2.5	3.3	20.6	3.7	10.5	1.8	15.9	13.7	3.6	17.0	5.3	2.9	9.9	11.4	16.4	14.7	16.4	26.1	16.1	8.6	0.7	1.7	0.0	0.7	2.3	0.1	0.4	0.0	0.7	0.0	0.0	22.7	17.3	0.4	0.8	0.0	13.1	3.9	11.1	0.1	5.3	8.8	8.2	2.8	0.0	0.1	16.4	0.0	0.1	6.1	1.8	7.5	11.8	0.0	6.9	0.0	23.1	13.5	10.0	10.1	9.7	6.6	0.0	4.4	16.1	0.0	22.6	0.0	7.7	5.2	4.7	0.0	2.6	0.2	3.6	1.0	70.3	0.0	0.0	8.3	0.0	0.0	0.2	0.0	14.3	0.0	30.5	2.1	3.7	14.7	16.4	21.5	1.9	26.1	9.9	19.4	19.3	9.7	6.5	11.5	15.5	13.7	16.4	0.6	11.4	23.4	16.1	1.7	2.0	1.1	2.9	2.2	4.7	3.8	1.4	4.5	1.8	62.5	15.9	38.9	1.7	16.3	3.3	1.5	2.5	32.1	40.9	0.0	102.1	10.9	0.0	0.8	0.4	3.6	2.6	46.7	0.8	7.9	5.8	13.2	18.5	1.3	19.1	1.6	7.0	24.5	40.6	0.5	2.6	44.9	10.1	18.0	6.4	0.9	9.3	2.9	6.3	0.2	9.0	0.0	5.9	0.9	1.9	11.0	7.1	112.1	9.7	1.6
EMC1	KIAA0090	ENSG00000127463	"ER membrane protein complex subunit 1"	Q8N766	1	19215664-19251552	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048904	Approved					NA	NA		5600			"HPA048904: AB_2680552"	"unprognostic (9.46e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (5.98e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (1.43e-4)"	18.9	15.2	13.5	12.8	28.3	9.3	14.4	19.7	37.5	15.7	14.6	21.8	9.7	10.0	19.6	16.1	16.1	14.6	13.5	18.2	12.6	15.5	13.5	20.5	14.6	10.1	13.6	15.7	19.0	13.1	24.4	20.0	31.4	22.8	16.1	16.9	14.8	18.7	13.8	27.0	13.5	12.0	22.0	12.4	12.2	13.5	15.2	12.7	12.1	16.6	10.5	13.9	13.4	14.4	5.7	10.9	3.2	10.8	18.3	8.3	7.2	13.8	12.5	14.2	36.8	22.9	17.9	27.6	22.5	21.1	31.2	31.0	13.0	32.1	12.4	29.8	34.4	20.2	15.7	19.7	25.2	36.5	10.4	10.3	14.9	17.0	15.4	16.7	19.0	17.9	19.0	16.4	36.8	30.7	29.2	26.3	10.8	18.3	18.8	24.0	7.9	7.7	9.3	8.5	16.0	11.8	11.6	17.5	21.5	12.7	6.4	17.5	12.0	24.7	12.9	18.6	17.5	14.1	12.0	23.1	28.3	18.6	21.5	25.5	10.5	22.0	16.1	26.9	25.1	37.7	3.2	10.8	2.6	7.5	8.1	8.3	5.6	7.4	8.3	10.9	5.7	7.5	7.5	0.4	18.3	10.0	5.2	5.1	7.2	13.5	28.3	19.7	37.5	12.6	15.5	13.6	15.7	22.8	12.7	14.9	13.4	11.7	9.3	10.3	18.1	14.9	12.7	8.1	5.7	21.0	9.8	32.2	0.0	12.8	0.9	13.4	5.4	0.0	7.4	34.7	11.3	8.0	8.1	23.8	17.2	14.3	18.9	14.7	12.3	1.9	13.8	11.5	10.1	7.2	11.6	20.7	10.2	10.5	13.4	8.1	60.3	6.5	8.6	10.1	21.3	8.2	30.1	7.5	11.5	6.2
EMC10	"C19orf63, HSM1, HSS1, INM02"	ENSG00000161671	"ER membrane protein complex subunit 10"	Q5UCC4	19	50476400-50490870	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 147.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 52.1;PC-3: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053905	Uncertain				"Secreted to blood"	NA	NA					"HPA053905: AB_2682303"	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.38e-3)"	"unprognostic (3.23e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (4.39e-4)"	"unprognostic (5.01e-2)"	"prognostic favorable (6.64e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	17.8	24.4	21.9	12.4	21.2	17.2	11.1	10.8	32.1	14.5	22.4	41.1	23.1	23.4	17.4	24.9	14.4	22.7	24.9	21.9	21.8	19.2	33.8	43.2	15.3	19.8	23.0	20.0	22.4	25.6	32.5	48.2	21.1	22.2	20.5	8.7	29.8	29.4	19.0	147.8	13.9	28.7	8.5	31.4	14.6	33.1	24.3	19.1	15.4	34.0	13.7	16.4	12.6	11.7	12.2	10.8	11.2	10.5	4.7	10.3	6.8	17.2	21.4	0.8	8.3	2.4	3.0	0.2	16.8	3.1	1.5	1.6	0.2	11.9	5.7	0.2	3.0	2.7	14.5	1.0	2.7	0.5	22.0	52.1	1.2	9.5	0.0	4.1	4.9	33.5	3.7	3.1	1.5	1.2	1.4	3.6	5.0	11.0	12.2	3.0	12.1	7.8	0.1	0.0	6.8	37.2	13.5	2.6	18.4	6.8	15.8	13.3	29.6	24.8	8.0	8.8	1.0	8.4	9.1	6.9	1.0	23.0	6.3	9.1	13.6	33.8	4.7	6.8	3.5	8.3	7.8	10.5	11.2	8.1	8.0	6.9	9.4	8.6	8.6	7.7	12.2	10.3	10.0	4.5	4.7	5.9	10.8	6.8	6.8	21.9	21.2	10.8	32.1	21.8	19.2	23.0	20.0	22.2	19.1	59.6	135.5	78.7	47.6	26.4	78.3	8.1	86.6	29.4	64.8	66.3	76.6	114.1	19.9	150.7	157.7	33.8	118.0	0.0	98.3	126.3	46.9	69.4	51.9	61.8	121.6	35.0	203.6	53.4	97.1	29.5	63.9	74.5	79.2	85.6	93.3	93.2	107.1	129.8	108.2	56.1	61.3	6.5	41.2	14.0	52.6	27.4	126.3	73.4	108.6	54.5
EMC2	"KIAA0103, TTC35"	ENSG00000104412	"ER membrane protein complex subunit 2"	Q15006	8	108443601-108486918	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022838	Approved					NA	NA					"HPA022838: AB_2670967"	"prognostic unfavorable (2.64e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.15e-3)"	25.4	28.1	34.9	16.7	43.6	5.4	23.9	29.0	39.2	20.2	21.8	33.5	24.8	19.7	19.9	26.3	23.6	20.9	19.4	33.9	39.3	28.8	34.4	29.7	23.9	15.4	49.8	35.5	21.6	24.5	31.8	27.8	29.6	48.8	22.1	23.4	13.9	23.6	23.4	29.6	17.2	20.1	21.0	91.2	17.9	20.1	33.2	51.5	9.5	27.9	20.3	18.4	24.2	18.7	11.5	15.6	31.6	11.3	11.7	16.0	7.6	28.4	12.5	14.2	12.8	24.1	26.9	12.0	14.8	16.5	15.7	15.8	10.2	20.6	11.4	24.5	15.5	16.6	14.9	21.2	21.9	20.5	27.6	15.0	16.3	13.1	16.6	33.5	8.9	11.3	26.3	26.5	15.7	26.9	27.5	22.1	14.5	14.9	18.4	22.9	28.7	12.3	10.2	10.2	44.3	23.0	9.2	13.8	15.9	32.7	14.5	12.7	8.8	12.6	4.4	24.4	21.3	24.1	12.8	18.6	13.8	13.4	26.4	13.6	18.5	19.9	14.0	27.0	20.1	16.6	31.6	10.6	14.5	13.7	11.0	15.5	11.5	14.1	14.9	11.0	10.9	15.1	16.0	16.1	11.7	11.3	15.6	14.1	7.6	34.9	43.6	29.0	39.2	39.3	28.8	49.8	35.5	48.8	51.5	29.8	37.2	23.9	43.3	24.5	17.3	61.0	33.1	66.9	43.3	34.9	13.7	49.8	72.9	42.6	24.5	34.2	20.3	0.0	41.1	38.8	41.8	28.5	34.6	21.7	42.1	17.5	20.3	33.7	18.7	17.5	33.9	25.4	30.4	50.5	19.8	45.8	32.4	24.9	35.0	78.0	27.9	64.7	39.6	131.8	74.6	23.8	61.4	23.5	19.1	40.9
EMC3	TMEM111	ENSG00000125037	"ER membrane protein complex subunit 3"	Q9P0I2	3	9962537-10011116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 287.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042372	Approved		Approved	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA042372: AB_10795609"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.81e-6)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.58e-2)"	41.8	31.5	19.8	17.2	27.1	35.4	24.7	17.2	28.0	17.6	25.0	18.6	23.5	23.2	19.4	19.6	31.3	18.8	17.7	28.3	18.6	21.5	33.0	47.2	22.3	12.7	23.6	20.6	16.3	27.2	25.5	15.9	19.6	27.9	20.8	23.2	16.3	26.0	21.9	54.7	25.4	24.8	20.2	21.9	17.1	23.1	52.6	19.2	15.0	37.7	22.4	20.3	27.3	25.4	25.0	35.1	41.6	46.1	28.1	40.2	51.4	13.5	28.8	10.8	6.5	69.2	27.2	36.4	27.9	24.2	17.5	19.0	19.7	21.7	10.8	20.4	31.6	33.7	19.1	18.4	16.5	18.1	29.3	18.5	17.7	21.9	12.8	29.9	19.9	20.0	31.9	29.8	30.5	17.6	22.4	21.7	11.9	22.5	31.7	25.8	33.4	10.5	9.9	12.0	28.9	19.7	13.7	15.2	32.1	21.2	24.6	7.7	15.5	19.9	29.9	17.9	11.9	25.3	16.3	24.8	17.5	14.7	18.9	28.3	17.1	44.3	21.9	37.0	14.7	21.9	38.4	46.1	41.3	27.4	36.2	28.3	24.9	27.2	31.2	35.1	25.0	19.9	26.8	41.6	28.1	34.7	31.5	40.2	51.4	19.8	27.1	17.2	27.9	18.6	21.5	23.6	20.6	27.9	19.2	50.6	63.5	44.0	48.5	45.0	39.0	97.2	56.0	62.9	61.4	43.6	37.3	43.1	39.7	83.4	287.9	55.4	60.4	256.9	103.9	42.9	46.8	56.5	32.4	82.2	88.7	22.3	20.3	42.4	51.0	67.2	46.6	55.9	55.6	120.8	32.8	60.4	90.0	70.2	35.3	57.8	53.0	58.2	48.9	135.1	54.3	53.1	71.7	50.4	50.0	70.1
EMC4	"FLJ90746, MGC24415, PIG17, TMEM85"	ENSG00000128463	"ER membrane protein complex subunit 4"	Q5J8M3	15	34224999-34230156	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026868, HPA053440"	Approved		Supported	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA026868: AB_2672032, HPA053440: AB_2682151"	"unprognostic (8.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.97e-2)"	36.3	34.3	43.5	23.4	48.3	25.4	35.2	34.9	54.3	33.5	32.2	31.0	25.7	27.5	33.5	54.3	36.2	35.4	28.4	38.5	39.4	40.6	39.1	47.5	27.1	24.5	41.7	42.8	35.3	45.2	29.1	29.5	41.5	48.6	32.5	30.1	32.8	38.9	34.7	95.1	29.6	27.9	30.1	36.7	27.2	31.2	26.4	32.0	26.9	34.6	41.2	29.0	28.9	32.6	71.6	53.3	65.7	59.4	60.3	65.9	78.0	31.9	67.2	28.3	36.6	36.9	33.6	26.0	36.7	42.2	45.4	39.5	43.7	28.5	12.7	48.6	42.4	39.9	61.6	28.7	36.0	32.6	38.7	27.8	24.0	62.0	40.1	44.7	36.3	24.1	33.7	34.4	33.0	37.2	32.4	37.5	38.9	29.9	50.6	39.5	36.4	28.8	38.9	31.7	43.2	44.1	26.7	25.8	35.9	43.2	50.4	37.3	45.6	27.3	40.1	19.4	21.5	26.8	43.2	28.5	41.7	28.6	35.8	37.3	44.9	63.5	32.4	50.8	43.4	35.2	65.7	52.3	54.5	53.0	54.0	57.9	71.6	59.5	63.4	52.2	54.6	60.8	59.8	29.1	60.3	59.4	53.3	65.9	78.0	43.5	48.3	34.9	54.3	39.4	40.6	41.7	42.8	48.6	32.0	50.6	63.2	53.6	84.9	81.4	33.7	52.6	50.9	116.4	81.9	62.8	17.7	127.8	106.1	146.0	74.2	81.8	39.4	0.0	149.7	140.0	89.5	80.2	84.5	75.5	101.4	17.5	50.0	54.0	38.3	16.6	93.2	68.5	96.2	106.4	60.1	89.7	146.5	66.8	85.2	85.7	30.5	84.1	115.4	137.4	96.5	96.1	118.5	65.3	63.0	96.2
EMC6	"MGC2963, TMEM93"	ENSG00000127774	"ER membrane protein complex subunit 6"	Q9BV81	17	3668815-3669668	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062681	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			Centrosome	Nucleoplasm	"HPA062681: AB_2684831"	"unprognostic (2.21e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.32e-2)"	14.6	18.5	15.5	12.2	15.5	21.4	12.5	9.9	21.2	8.9	15.9	14.9	10.0	16.9	9.8	10.8	15.6	9.5	12.1	26.2	14.5	12.3	19.8	42.1	10.2	10.7	14.2	11.0	8.7	24.5	7.6	9.3	16.6	12.2	12.9	9.7	14.6	17.8	10.5	100.1	10.6	16.8	10.1	13.6	12.5	18.8	27.4	11.1	14.3	14.9	31.5	14.3	9.7	9.1	34.5	56.1	40.7	42.0	25.2	43.4	38.5	31.2	30.8	13.5	14.1	9.7	7.8	26.0	22.5	11.0	18.5	17.1	18.6	11.8	19.7	32.8	10.5	16.3	30.2	15.6	15.8	13.4	19.0	58.3	14.3	21.6	25.8	14.1	9.9	14.7	9.8	18.0	17.0	11.9	14.6	14.0	23.7	17.9	14.3	13.5	19.0	20.2	29.2	19.4	19.1	34.8	18.9	12.6	18.6	25.9	8.9	11.1	20.2	18.4	14.5	23.9	14.1	16.9	10.7	15.3	15.5	19.2	23.3	32.8	14.0	15.4	12.9	24.3	13.0	18.6	34.5	42.0	40.7	34.9	39.7	32.0	34.5	39.0	38.3	35.8	32.3	40.6	36.7	31.6	25.2	27.9	56.1	43.4	38.5	15.5	15.5	9.9	21.2	14.5	12.3	14.2	11.0	12.2	11.1	14.9	23.4	62.6	99.3	79.0	40.5	0.3	94.3	53.5	23.9	55.8	33.4	102.2	140.9	117.4	202.1	52.2	55.0	23.3	123.7	126.4	43.1	113.2	54.3	108.8	90.3	31.8	49.3	39.3	53.3	121.5	35.6	54.6	64.1	101.0	61.0	85.4	129.4	63.1	32.2	149.9	38.8	38.8	51.5	146.4	87.0	89.1	107.9	52.2	68.0	156.9
EMC7	"C11orf3, C15orf24"	ENSG00000134153	"ER membrane protein complex subunit 7"	Q9NPA0	15	34084017-34101948	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010029, HPA047572"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA010029: AB_1078335, HPA047572: AB_2680090"	"unprognostic (2.16e-1)"	"unprognostic (8.16e-3)"	"unprognostic (5.28e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (9.25e-5)"	"unprognostic (1.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.47e-3)"	31.2	45.1	36.8	22.4	41.6	31.8	29.7	22.5	36.8	25.1	30.1	30.9	38.2	25.1	27.1	53.1	25.0	23.0	24.5	36.5	34.0	45.3	52.5	62.3	26.5	24.4	44.0	38.7	24.1	46.7	35.5	33.5	57.6	35.2	31.8	32.3	29.8	29.6	46.0	44.8	28.2	28.1	29.0	42.2	28.5	28.5	39.3	30.8	18.8	35.3	26.7	21.8	26.3	26.2	37.8	68.8	66.6	54.7	32.6	53.7	49.1	14.3	39.6	14.4	18.3	56.4	32.3	15.1	41.2	43.0	38.6	40.1	36.0	17.3	8.5	42.8	40.2	40.1	28.0	20.9	20.7	28.9	20.9	20.7	21.1	59.2	30.7	51.6	21.1	30.1	35.7	39.5	27.6	40.1	26.3	24.2	16.4	20.5	57.0	37.2	16.6	11.7	24.1	12.8	33.8	26.3	14.8	16.7	29.4	40.6	25.5	23.6	17.5	24.5	33.2	20.4	17.9	24.0	34.2	20.3	41.4	16.0	27.3	30.7	38.6	46.6	19.0	41.8	32.4	33.5	66.6	47.3	49.0	42.7	51.0	41.6	37.8	42.9	43.4	43.1	28.9	31.6	39.0	41.3	32.6	54.7	68.8	53.7	49.1	36.8	41.6	22.5	36.8	34.0	45.3	44.0	38.7	35.2	30.8	26.8	26.0	38.7	50.2	77.2	49.7	83.2	45.9	48.2	40.9	97.7	43.2	105.5	33.2	106.2	83.3	62.5	52.0	0.0	149.7	127.4	78.3	46.4	44.9	78.4	102.1	28.6	43.8	56.4	57.1	65.1	83.4	60.8	97.8	64.1	51.6	111.7	112.9	52.6	97.9	61.9	46.3	116.4	76.2	178.6	21.7	75.5	133.9	64.0	55.9	50.3
EMC8	"C16orf2, C16orf4, COX4NB, FAM158B, NOC4"	ENSG00000131148	"ER membrane protein complex subunit 8"	O43402	16	85771758-85799608	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 178.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049476	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA049476: AB_2680784"	"unprognostic (2.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	16.8	17.4	18.8	17.1	19.8	26.9	39.3	12.4	21.0	14.5	16.6	16.3	14.1	18.9	18.2	14.4	17.3	14.0	16.8	23.0	17.7	15.5	19.1	22.5	14.2	16.2	18.0	12.4	16.2	16.2	20.5	14.6	20.9	14.0	14.5	16.2	13.4	16.6	17.0	25.6	13.3	16.3	17.0	17.3	17.9	15.5	15.5	13.3	24.3	19.5	18.2	16.5	14.8	12.3	12.8	20.9	21.2	15.8	16.3	13.9	9.5	13.0	15.2	9.7	8.8	10.6	10.2	19.0	12.9	12.8	21.6	9.6	24.2	15.1	11.3	15.0	12.9	9.7	14.9	14.5	13.5	19.3	4.7	20.6	9.2	8.4	22.0	16.1	9.4	6.3	11.1	9.2	16.3	19.2	9.3	12.2	13.9	21.0	4.3	13.2	22.1	14.8	26.8	19.4	12.1	19.6	21.9	7.9	9.6	13.6	9.2	16.5	9.8	23.7	7.8	14.3	9.1	15.4	16.8	10.6	13.0	13.2	11.4	16.4	12.2	11.7	45.1	11.1	18.2	13.6	12.5	15.2	21.2	9.9	15.8	11.7	9.6	11.0	13.5	20.9	12.8	13.9	13.2	6.6	16.3	15.7	15.5	10.2	9.5	18.8	19.8	12.4	21.0	17.7	15.5	18.0	12.4	14.0	13.3	6.0	7.5	21.6	23.5	54.5	20.7	18.1	12.7	9.4	9.1	24.4	11.8	43.2	51.4	39.7	178.6	25.3	21.3	23.3	36.8	53.9	27.0	29.2	9.2	19.2	40.7	14.3	44.7	28.3	24.3	39.4	23.0	25.5	27.0	39.7	22.0	22.1	39.4	21.0	29.7	34.3	14.9	25.8	23.5	45.4	53.2	47.7	42.7	17.8	30.2	39.3
EMC9	"C14orf122, CGI-112, FAM158A"	ENSG00000100908	"ER membrane protein complex subunit 9"	Q9Y3B6	14	24138959-24141588	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Late spermatids: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054715, HPA078254"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA054715: AB_2682582, HPA078254: "	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.99e-1)"	5.0	15.4	10.6	5.2	11.7	10.0	8.5	18.4	16.0	6.1	11.4	5.7	13.1	17.8	5.9	9.8	7.9	6.7	7.3	9.6	9.9	11.1	9.9	17.1	5.1	7.4	8.6	9.7	6.8	15.1	8.8	17.0	6.1	12.8	9.8	6.9	16.8	15.5	12.7	35.6	9.0	11.4	6.3	5.2	8.4	6.5	10.3	4.2	11.8	10.1	12.9	9.3	7.5	5.5	5.3	12.3	4.0	5.2	3.8	8.9	4.3	7.6	18.1	5.1	14.2	2.7	1.4	4.7	4.9	4.0	7.1	7.2	7.8	5.9	6.4	4.3	3.9	5.5	7.0	4.2	7.7	4.2	5.0	10.1	1.5	7.0	34.4	3.4	5.5	3.3	2.0	3.2	3.8	6.8	5.8	8.0	9.2	1.4	8.4	5.6	18.0	5.5	4.8	5.9	7.8	13.4	3.5	12.7	6.6	5.5	9.2	9.0	7.2	9.1	16.4	4.2	2.6	9.1	2.9	4.0	3.1	8.8	4.6	8.0	10.7	9.3	7.2	4.8	2.4	4.9	1.0	5.2	4.0	5.0	2.6	5.5	5.3	6.8	6.5	5.3	4.9	3.4	4.5	0.5	3.8	2.5	12.3	8.9	4.3	10.6	11.7	18.4	16.0	9.9	11.1	8.6	9.7	12.8	4.2	0.0	6.5	18.6	8.4	16.1	47.5	16.3	22.9	10.7	10.3	22.7	17.7	24.4	48.0	15.0	62.5	9.3	25.7	23.3	10.3	21.5	21.2	14.4	4.7	22.2	25.9	11.1	20.2	6.7	12.7	115.8	10.6	13.2	15.1	19.0	14.6	13.8	10.4	10.5	20.5	44.8	44.0	12.9	21.2	9.7	5.5	20.8	20.5	17.0	26.2	7.2
ENY2	"DC6, FLJ20480, Sus1"	ENSG00000120533	"ENY2, transcription and export complex 2 subunit"	Q9NPA8	8	109334324-109345953	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024648	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA024648: AB_2100208"	"unprognostic (2.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (7.17e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.66e-1)"	31.9	35.0	28.7	28.1	34.3	44.4	34.8	20.6	31.4	28.2	34.5	18.7	28.3	31.8	24.6	33.8	30.1	22.9	19.1	34.0	31.8	26.2	44.1	58.8	24.7	26.6	27.6	28.3	19.6	27.8	16.5	35.8	30.6	29.1	24.0	33.7	19.9	27.2	25.9	66.7	20.3	31.6	28.4	31.9	30.6	29.0	21.3	24.3	26.1	24.3	29.5	30.3	29.6	23.3	14.0	32.1	30.3	38.9	13.0	14.6	22.6	42.3	35.5	52.8	23.7	20.1	25.8	15.2	33.9	21.9	34.8	44.0	26.2	26.4	27.6	31.9	26.3	15.8	21.7	23.6	24.0	42.5	43.7	27.9	53.0	26.7	53.9	21.5	18.2	33.0	19.5	16.4	22.9	21.7	25.5	52.3	27.3	50.4	15.6	39.5	69.1	55.0	41.4	38.3	49.6	34.6	35.1	23.0	34.2	47.0	32.6	31.9	34.4	21.2	26.7	28.9	30.4	33.9	31.6	35.5	23.4	39.5	24.2	34.3	26.7	28.5	52.2	23.6	30.8	27.2	16.3	35.6	30.3	10.7	37.1	13.2	14.0	14.6	13.0	32.1	9.6	12.1	13.3	19.4	13.0	38.9	26.5	14.2	22.6	28.7	34.3	20.6	31.4	31.8	26.2	27.6	28.3	29.1	24.3	65.5	81.6	148.3	163.4	164.9	66.1	154.2	137.6	89.7	112.6	137.9	115.8	224.8	323.3	190.8	103.7	229.2	183.6	46.7	173.6	235.2	173.8	163.6	89.0	317.8	241.4	42.9	147.9	137.5	200.9	78.7	137.2	217.4	150.1	225.4	166.7	92.6	220.3	192.9	105.7	416.4	119.0	77.6	185.8	187.5	108.4	152.6	139.9	126.9	175.3	175.2
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.7"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 129.6;Erythroid cells: 116.8;Rod photoreceptor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 59.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 39.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	11	"cerebellum: 375.3"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		3400000	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	9.2	9.6	3.3	19.4	10.2	28.0	9.6	59.7	11.6	8.2	12.4	2.0	9.8	9.3	10.5	5.7	10.8	5.5	7.9	7.5	3.3	4.8	10.0	13.2	11.0	25.4	3.9	3.0	12.3	10.4	9.1	9.0	8.7	10.3	8.3	12.5	14.6	10.1	10.8	15.0	8.9	14.6	9.2	5.8	13.5	14.0	7.9	6.9	42.2	8.1	8.8	19.8	11.3	12.4	9.9	3.0	30.1	2.1	5.7	15.9	7.7	7.4	1.8	18.6	8.8	1.5	0.2	6.2	1.9	2.8	2.3	2.9	4.9	9.0	13.8	5.0	2.5	3.8	3.4	23.2	1.8	2.5	24.8	7.1	39.5	5.6	8.0	2.9	13.4	26.4	0.5	5.4	2.2	4.0	5.7	4.1	22.1	37.2	11.0	0.0	2.5	21.7	8.8	19.5	12.3	2.9	33.4	8.2	19.8	2.2	9.5	25.1	18.6	5.8	5.5	12.6	6.6	4.2	5.2	0.4	0.1	3.9	3.6	3.8	16.5	21.4	24.7	3.5	13.8	2.1	17.2	2.1	12.6	8.5	0.7	9.6	9.9	12.4	9.3	2.4	9.3	14.8	8.9	30.1	5.7	0.8	3.0	15.9	7.7	3.3	10.2	59.7	11.6	3.3	4.8	3.9	3.0	10.3	6.9	17.9	64.9	30.6	6.3	9.3	105.3	20.1	30.6	22.7	21.6	15.7	129.6	2.3	14.9	15.8	13.9	14.5	25.2	116.8	16.1	3.2	3.3	11.2	23.1	28.8	6.5	20.6	40.0	20.3	22.1	13.3	2.0	11.5	0.0	11.8	25.9	13.2	25.6	22.4	2.1	10.5	166.4	12.9	4.7	8.6	53.0	14.6	3.4	42.8	28.3	11.5
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.5"	"Cell type enhanced"	"Detected in many"	10	"Bipolar cells: 11.2;Cardiomyocytes: 15.3;Ciliated cells: 26.8;Club cells: 17.0;Collecting duct cells: 12.2;Muller glia cells: 12.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 4.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.6;EFO-21: 7.2;HEK 293: 5.3;RPTEC TERT1: 7.8;SCLC-21H: 4.4;T-47d: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		140000			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	1.6	1.9	15.1	1.2	15.0	1.0	13.4	18.6	14.1	7.8	1.1	7.6	8.8	1.1	1.5	1.2	1.3	24.5	1.2	7.0	14.3	6.5	11.9	1.1	2.9	1.2	7.8	10.7	1.3	2.4	10.8	5.1	1.3	8.8	1.7	1.1	2.0	9.7	18.1	3.8	1.8	1.2	1.1	7.3	1.2	1.5	7.6	12.0	0.0	4.5	1.1	1.2	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	9.6	0.2	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.0	0.0	0.0	7.2	1.0	0.0	0.4	0.2	0.0	0.0	0.1	5.3	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.8	0.0	0.0	0.5	0.0	7.8	0.4	4.4	0.2	0.0	0.1	0.1	0.1	7.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	15.0	18.6	14.1	14.3	6.5	7.8	10.7	8.8	12.0	0.0	9.3	0.0	0.8	0.6	11.2	15.3	0.0	26.8	17.0	12.2	0.0	0.0	5.0	0.4	4.1	0.1	0.0	0.0	0.4	0.1	0.2	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	1.7	0.0	3.3	0.0	0.0	12.4	0.0	0.0	0.4	0.0	1.4	6.5	3.1	1.9	1.5	1.1	0.0	0.0	0.0	1.0
ERLEC1	"C2orf30, CL25084, ERLECTIN, XTP3-B, XTP3TPB"	ENSG00000068912	"Endoplasmic reticulum lectin 1"	Q96DZ1	2	53787044-53818819	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031501, HPA031502, HPA031503"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA031501: AB_10600104, HPA031502: AB_10602174, HPA031503: AB_10670425"	"unprognostic (1.27e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.92e-2)"	21.4	30.0	20.8	15.3	27.7	14.9	26.2	16.7	40.0	38.2	23.6	18.2	48.2	19.4	26.0	52.2	16.9	21.5	21.9	28.9	22.9	30.7	20.7	40.0	24.7	22.2	23.4	26.9	23.2	69.0	26.3	48.8	42.9	29.3	40.5	27.1	19.3	31.0	53.8	20.2	14.4	19.3	20.5	24.3	21.8	28.3	21.0	15.5	17.9	39.0	13.2	20.7	26.5	19.8	21.1	22.5	32.0	17.3	24.3	27.1	21.0	12.2	13.7	13.6	8.3	38.8	35.3	19.9	30.2	33.1	15.1	16.0	9.0	16.8	8.6	28.9	31.8	26.6	8.9	8.8	12.7	19.4	19.2	11.1	10.6	9.4	27.4	26.6	17.5	19.6	22.1	21.3	15.9	26.0	30.8	17.6	8.5	11.2	35.4	22.4	10.1	7.9	14.0	10.4	19.8	8.8	7.2	16.3	23.9	17.9	11.7	8.1	14.1	10.9	24.2	18.6	16.2	11.5	13.5	18.8	16.7	14.6	13.4	17.8	52.1	34.0	4.8	27.4	10.6	19.5	32.0	14.3	16.6	24.9	15.0	27.1	21.1	21.9	23.5	15.5	16.0	20.8	23.8	5.6	24.3	17.3	22.5	19.9	21.0	20.8	27.7	16.7	40.0	22.9	30.7	23.4	26.9	29.3	15.5	83.4	94.3	32.0	36.7	22.2	76.4	75.4	61.1	111.1	68.2	62.8	29.5	89.5	28.2	65.2	121.9	56.4	29.2	23.3	101.3	87.9	88.5	101.8	71.7	82.5	53.0	90.6	52.9	71.8	37.2	85.0	81.7	39.0	75.9	68.5	97.0	72.1	77.7	45.6	79.2	35.3	50.5	51.8	53.6	120.2	65.3	29.2	153.6	48.1	48.8	43.9
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100188334	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 81.4"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 68.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	12.9	8.0	5.4	6.9	10.1	23.2	13.9	6.7	6.1	11.3	18.6	5.7	7.0	13.8	11.9	6.6	17.9	11.2	6.8	6.8	6.2	3.7	12.3	81.4	8.7	10.1	7.3	3.8	13.9	17.7	5.9	8.8	24.2	4.7	9.2	13.5	8.2	9.8	5.7	5.5	10.8	18.9	7.7	4.1	9.7	12.7	17.4	5.4	8.6	11.8	10.3	14.3	14.7	14.6	6.2	12.6	18.2	16.0	7.5	9.0	7.0	23.5	23.4	12.0	21.8	28.9	28.4	24.5	37.5	34.8	31.0	35.8	15.7	27.5	10.5	15.2	34.7	25.4	24.6	10.7	22.1	43.0	6.3	9.5	9.0	10.5	19.8	12.0	31.5	10.0	16.1	13.4	27.1	32.9	29.2	22.4	10.8	8.9	6.4	32.6	9.5	8.1	11.5	8.5	15.8	9.8	6.9	19.7	7.6	13.3	9.4	4.9	7.9	21.3	6.0	13.2	14.4	15.0	26.1	25.3	31.1	23.9	18.5	39.4	5.0	8.4	14.3	27.3	49.9	15.3	4.3	16.0	18.2	8.5	11.7	7.6	6.2	6.6	7.0	12.6	5.5	6.8	9.0	11.6	7.5	8.6	2.9	3.8	7.0	5.4	10.1	6.7	6.1	6.2	3.7	7.3	3.8	4.7	5.4	0.0	8.6	8.0	9.7	14.1	4.7	3.7	2.5	34.8	12.5	14.0	5.9	17.0	0.0	8.5	15.7	14.3	24.4	23.3	9.6	54.3	14.0	10.1	8.1	68.9	12.5	3.2	12.7	11.1	15.9	10.0	14.1	7.2	10.1	10.0	23.4	5.6	8.4	17.5	7.4	10.3	5.3	0.0	6.6	35.7	16.8	17.8	20.7	5.0	23.6	11.9
ERLIN2	"C8orf2, Erlin-2, NET32, SPFH2, SPG18"	ENSG00000147475	"ER lipid raft associated 2"	O94905	8	37736599-37759101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002025, CAB014894"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB014894: , HPA002025: AB_1080077"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (6.67e-6)"	"unprognostic (4.78e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.33e-1)"	14.5	17.7	15.6	9.5	17.6	8.9	17.5	11.0	13.8	16.6	16.2	21.4	26.9	11.8	18.1	23.1	19.5	21.8	20.6	11.9	13.1	11.3	28.5	31.1	12.0	16.5	13.2	16.0	22.3	45.7	34.2	12.9	26.8	15.2	21.2	17.9	23.3	23.2	18.9	13.0	12.4	19.1	22.8	15.3	12.0	16.6	15.9	12.5	13.8	32.4	14.8	14.0	20.5	13.5	4.9	8.7	14.8	9.8	2.8	5.8	3.5	16.3	17.1	18.7	12.5	20.9	15.6	19.6	24.5	23.3	13.8	15.0	8.6	20.7	8.0	41.4	27.0	13.5	17.0	14.1	21.2	22.9	4.5	10.5	11.4	10.9	9.5	13.9	7.3	16.4	19.1	21.3	20.6	21.7	17.9	14.4	7.7	21.2	7.6	20.9	8.1	10.5	5.8	18.9	22.0	7.2	7.4	13.2	5.8	16.7	17.8	3.5	9.1	15.9	4.8	14.5	23.7	26.7	11.0	12.9	13.2	11.8	24.6	13.1	10.2	16.6	10.0	23.7	11.9	18.0	1.7	7.5	14.8	5.2	7.5	4.3	4.9	3.5	4.2	6.0	2.8	5.4	4.8	9.6	2.8	9.8	8.7	5.8	3.5	15.6	17.6	11.0	13.8	13.1	11.3	13.2	16.0	15.2	12.5	11.9	14.7	6.5	9.1	8.7	24.5	28.3	33.1	52.2	20.5	31.4	19.6	15.2	8.3	18.0	17.6	10.5	17.4	0.0	19.3	19.3	14.4	18.4	3.5	34.7	17.8	15.9	10.9	15.4	21.0	11.9	10.9	14.6	13.5	7.2	23.9	21.9	17.5	17.3	16.6	17.4	17.9	19.4	8.5	42.7	17.2	6.5	13.2	7.0	25.9	10.5
ERVFRD-1	"envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2"	ENSG00000244476	"Endogenous retrovirus group FRD member 1, envelope"	P60508	6	11102489-11111732	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"placenta: 66.9"	"Cell type enriched"	"Detected in some"	52	"Syncytiotrophoblasts: 481.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	4	"SuSa: 30.4"															NA	NA						"unprognostic (1.99e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.80e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	1.4	2.0	0.1	0.1	0.1	0.1	0.8	0.2	0.2	0.5	0.8	0.1	0.1	0.3	1.3	0.8	0.7	0.2	0.5	0.5	0.1	0.0	1.5	0.7	1.5	1.0	0.1	0.1	0.1	0.1	15.8	0.1	66.9	0.1	1.2	0.2	0.7	0.9	0.5	0.1	0.9	1.9	0.8	0.1	0.1	1.0	0.3	0.1	0.6	0.2	0.9	0.3	1.5	2.2	0.5	0.0	0.3	0.1	2.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.7	0.4	0.3	2.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	2.6	0.0	0.0	0.0	0.9	0.4	0.0	0.0	1.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	9.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	481.3	0.0	0.0	0.0
ERVW-1	"envW, ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW"	ENSG00000242950	"Endogenous retrovirus group W member 1, envelope"	Q9UQF0	7	92468380-92477986	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 83.4"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 179.3;Syncytiotrophoblasts: 714.1"	"Cancer enriched"	"Detected in single"	143	"testis cancer: 31.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	34	"BEWO: 43.6;SuSa: 13.9"															NA	NA						"unprognostic (2.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.48e-4)"	"unprognostic (4.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-2)"	"unprognostic (8.02e-2)"	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.0	0.2	2.0	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	83.4	0.2	0.2	0.1	0.2	0.4	0.2	0.4	0.4	0.2	0.2	0.3	0.3	0.5	10.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.0	2.2	0.8	0.1	0.2	0.0	0.1	0.2	0.3	0.2	0.0	0.3	43.6	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.6	0.3	0.2	0.1	0.1	0.1	0.2	0.2	0.5	0.1	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.7	0.0	0.2	0.2	0.3	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.0	0.6	0.0	13.9	0.1	0.2	0.1	0.0	0.8	0.2	0.1	0.7	0.3	0.1	0.1	0.2	0.0	0.0	0.4	2.2	0.2	0.8	0.1	0.5	0.1	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.6	0.0	0.1	0.0	0.2	0.2	0.4	0.2	0.3	0.2	0.2	0.2	0.2	0.2	3.0	1.9	0.0	0.5	0.7	2.2	0.2	0.0	9.4	2.3	0.0	0.0	179.3	0.0	0.0	28.9	0.1	0.0	0.0	0.0	79.7	2.8	0.2	2.3	0.0	23.6	0.0	0.0	0.0	1.0	5.3	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	1.4	0.0	0.0	0.5	0.4	1.8	714.1	0.0	0.0	0.5
ESYT1	"FAM62A, KIAA0747, MBC2"	ENSG00000139641	"Extended synaptotagmin 1"	Q9BSJ8	12	56118250-56144671	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016858, HPA076926"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		2600000	"Endoplasmic reticulum"		"HPA016858: AB_1848404, HPA076926: AB_2686819"	"unprognostic (5.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.04e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.98e-2)"	49.8	25.9	10.8	17.6	11.5	7.8	40.3	14.3	16.5	22.8	25.1	15.9	13.7	8.3	33.7	16.4	21.7	24.4	21.1	15.2	10.1	11.3	17.8	27.6	21.8	20.2	11.3	10.8	28.9	25.8	24.7	8.6	19.1	28.1	25.4	18.4	15.9	18.4	24.7	23.4	15.7	18.5	36.6	9.2	23.6	19.1	19.7	12.7	24.3	17.9	18.1	23.5	27.1	22.0	11.7	15.2	70.9	13.4	13.6	29.2	26.3	22.7	16.8	13.8	34.8	20.4	15.3	11.8	25.8	28.3	30.2	21.1	15.4	25.0	8.7	20.6	43.2	11.2	25.9	16.1	25.9	27.1	12.4	11.8	52.7	13.1	12.2	28.3	41.1	83.5	17.3	27.4	32.5	18.2	32.3	25.5	8.4	32.3	58.2	26.9	16.9	14.6	24.0	17.4	9.3	22.4	22.5	19.0	22.6	25.1	19.3	11.6	12.1	38.3	11.5	17.2	16.4	24.5	27.0	33.9	23.5	21.6	13.2	18.3	13.9	20.7	12.7	21.9	17.1	24.5	63.2	6.2	70.9	23.4	12.0	29.2	11.7	24.2	23.7	15.2	9.5	19.5	22.5	1.7	13.6	13.4	5.1	23.9	26.3	10.8	11.5	14.3	16.5	10.1	11.3	11.3	10.8	28.1	12.7	8.9	9.4	28.3	15.0	14.4	4.9	7.2	10.2	2.7	10.3	29.6	9.8	25.2	0.0	30.2	1.6	24.5	2.3	0.0	22.8	13.7	14.6	18.2	61.2	28.0	40.0	0.0	24.2	27.0	18.1	1.9	16.1	21.3	33.7	60.5	11.2	5.8	24.0	0.0	23.7	4.2	5.8	51.8	24.5	3.7	2.6	10.5	31.7	34.6	9.2	13.7
ESYT2	"CHR2SYT, FAM62B, KIAA1228"	ENSG00000117868	"Extended synaptotagmin 2"	A0FGR8	7	158730995-158830253	"Plasma proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002132	Approved		Uncertain	Cytosol		NA	NA		130000	Cytosol		"HPA002132: AB_1078807"	"unprognostic (2.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.13e-1)"	"unprognostic (7.54e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (2.81e-5)"	33.3	25.6	15.3	16.2	23.5	19.6	27.3	21.7	26.3	26.7	27.9	17.8	21.6	15.8	31.2	31.0	32.5	28.3	31.1	28.4	16.1	17.5	20.6	16.7	26.1	18.0	15.6	16.7	41.6	23.2	29.7	22.0	35.2	20.6	21.1	22.6	23.4	26.7	31.4	34.5	24.5	22.5	37.8	14.9	13.2	19.4	13.3	12.1	29.0	30.5	24.3	23.2	30.5	27.6	1.4	3.6	2.0	2.3	6.6	8.5	2.9	29.6	17.8	5.7	6.0	19.2	22.3	19.0	14.0	14.3	11.2	12.6	9.9	39.0	9.1	16.2	25.1	23.1	14.8	8.2	14.7	10.8	9.4	8.4	7.5	14.2	10.5	19.6	26.9	17.2	16.1	18.3	12.6	16.9	22.5	13.2	24.8	16.1	30.8	18.2	24.9	27.9	19.5	9.1	20.0	17.2	23.8	11.0	11.2	19.0	12.7	16.7	9.2	44.6	36.1	20.3	13.9	13.1	29.5	20.4	12.4	6.5	54.7	17.8	21.1	5.4	8.9	30.7	28.0	36.5	2.0	1.9	1.5	8.5	2.3	4.7	1.4	7.1	6.0	3.6	1.0	6.7	7.9	1.2	6.6	1.5	2.4	5.8	2.9	15.3	23.5	21.7	26.3	16.1	17.5	15.6	16.7	20.6	12.1	35.7	32.5	9.0	10.9	41.0	15.1	25.8	22.9	36.1	33.0	45.4	15.7	24.1	3.3	13.5	11.2	41.4	27.1	23.3	17.1	22.4	41.1	18.3	11.6	17.4	18.3	12.7	20.3	25.2	23.8	3.0	32.5	22.6	49.0	10.8	29.5	15.2	24.1	5.8	51.2	8.2	10.6	32.3	52.8	10.9	10.0	45.2	34.1	25.9	22.5	21.4
ESYT3	"CHR3SYT, FAM62C"	ENSG00000158220	"Extended synaptotagmin 3"	A0FGR9	3	138434586-138481686	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;skin 1: 13.7"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 35.7;Alveolar cells type 2: 30.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Region enriched"	"Detected in all"	5	"cerebellum: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.3;NTERA-2: 7.5;SCLC-21H: 8.1;SiHa: 3.3;SK-MEL-30: 4.0;SuSa: 3.7"	"Region enhanced"	"Detected in many"		"hypothalamus: 8.5"	"Low region specificity"	"Detected in all"			HPA039200	Approved					NA	NA					"HPA039200: AB_10805356"	"unprognostic (4.48e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-4)"	"unprognostic (2.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.55e-3)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.38e-1)"	"unprognostic (5.57e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.16e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.43e-2)"	0.6	0.8	5.7	0.6	5.8	0.5	2.6	28.5	5.9	1.3	4.9	0.6	0.2	0.7	5.3	0.8	0.9	1.0	2.8	1.1	5.3	3.0	1.8	0.5	12.4	0.5	1.9	4.0	0.9	2.0	3.5	3.0	1.5	4.2	1.0	1.1	0.7	0.8	0.7	0.8	13.7	0.7	4.8	1.2	0.5	2.7	1.4	1.2	0.0	11.5	1.8	1.6	2.5	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.2	0.4	0.0	2.0	1.8	0.2	0.6	3.0	0.2	0.0	0.5	0.1	0.2	1.0	1.1	0.3	0.1	0.3	0.1	1.3	0.1	0.1	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.2	0.7	7.5	0.0	0.5	0.0	0.1	0.0	0.8	0.2	8.1	0.0	3.3	0.4	4.0	3.7	0.8	0.3	0.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.7	5.8	28.5	5.9	5.3	3.0	1.9	4.0	4.2	1.2	35.7	30.7	0.0	0.7	0.7	1.8	2.0	2.5	1.4	7.9	1.8	3.9	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.8	0.4	1.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.2	0.5	0.0	0.0	0.2	2.3	0.0	0.5	2.1	0.5	1.4	0.6	0.0	0.1	0.0
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 69.4;pancreas: 32.3"	"Cell type enhanced"	"Detected in many"	9	"Hepatocytes: 71.0;Proximal tubular cells: 53.7;Syncytiotrophoblasts: 104.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.2;U-138 MG: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	0.6	0.3	0.3	0.7	0.5	0.0	1.2	0.3	0.2	3.7	0.6	0.1	11.4	0.5	1.6	5.1	0.5	1.3	0.4	0.6	0.3	0.3	23.6	69.4	15.2	0.1	0.8	0.0	0.8	32.3	0.8	0.8	26.6	0.5	0.6	0.2	5.7	14.3	13.5	0.9	1.5	1.1	0.7	0.4	5.9	0.4	2.2	0.3	3.3	1.2	0.8	0.8	0.3	0.6	0.8	0.0	0.0	0.0	0.0	1.1	0.7	0.3	4.6	0.5	0.1	1.0	7.1	0.5	21.7	14.6	19.4	9.9	0.1	0.4	0.0	2.0	27.2	17.8	3.0	0.5	4.6	12.2	0.0	0.3	0.0	0.8	14.4	0.7	0.0	0.0	5.0	2.7	23.9	11.0	19.5	12.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	1.0	0.0	7.5	2.4	0.0	0.0	10.7	0.1	0.3	0.5	2.0	0.1	16.6	0.7	0.0	0.1	9.8	36.5	15.3	0.6	22.6	0.2	0.0	0.0	20.7	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.5	0.3	0.2	0.3	0.3	0.8	0.0	0.5	0.3	38.7	30.7	2.7	9.2	2.5	0.8	0.2	0.0	1.4	36.4	10.4	0.0	33.7	23.2	27.0	11.0	1.3	0.0	0.0	14.2	17.5	2.1	5.2	0.0	71.0	3.2	0.0	1.7	3.7	0.6	8.2	0.3	0.8	27.0	0.0	0.0	0.0	15.1	0.0	0.7	53.7	0.0	0.0	1.0	1.7	0.4	0.6	104.4	0.0	0.0	10.0
EXOC1	"BM-102, FLJ10893, SEC3, SEC3L1, Sec3p"	ENSG00000090989	"Exocyst complex component 1"	Q9NV70	4	55853616-55905034	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037706, HPA044873"	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Plasma membrane"	"Microtubules, Cytosol"	"HPA037706: AB_10670525, HPA044873: AB_2679125"	"unprognostic (7.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (8.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (2.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (5.50e-5)"	21.2	19.7	20.7	21.0	24.0	12.9	25.3	22.8	40.7	18.4	20.2	18.2	14.6	18.9	20.8	24.6	32.7	18.3	17.9	19.8	26.9	23.6	18.7	11.4	26.2	29.2	24.7	22.8	18.2	14.9	29.7	20.0	23.4	30.7	16.8	22.4	12.9	20.3	19.2	14.6	31.6	20.5	18.4	29.1	23.7	17.5	18.5	21.5	19.1	19.0	15.8	21.9	18.8	21.4	7.3	11.7	16.4	18.1	10.1	9.2	6.3	11.5	6.7	12.1	13.9	20.9	26.2	8.1	16.3	16.5	13.4	14.1	4.6	20.2	11.2	11.5	17.5	16.2	13.9	9.8	13.0	19.3	5.9	6.8	10.3	8.4	5.4	19.7	11.2	14.7	21.1	17.8	13.9	15.4	17.4	21.8	8.7	14.8	11.0	29.0	7.3	8.1	11.4	7.6	16.6	12.8	9.5	9.0	9.0	14.9	12.7	9.0	16.0	9.8	16.1	13.5	10.8	10.2	12.1	26.2	16.6	13.6	14.2	14.0	13.3	6.6	9.9	21.6	12.5	15.7	15.2	12.1	10.4	5.8	15.7	7.5	7.3	8.2	8.2	11.7	6.7	7.4	5.4	16.4	10.1	18.1	5.3	9.2	6.3	20.7	24.0	22.8	40.7	26.9	23.6	24.7	22.8	30.7	21.5	38.7	29.4	13.7	12.5	30.9	45.5	26.4	20.4	44.2	26.1	21.0	29.5	53.7	16.6	18.4	31.3	32.2	30.4	0.0	17.4	27.7	28.1	16.9	34.8	9.7	35.9	27.0	21.4	41.7	40.5	10.6	19.8	36.1	38.8	19.8	26.7	45.2	26.5	28.1	22.3	14.0	30.3	32.3	21.4	27.7	34.1	34.9	42.8	18.8	25.1	19.6
EXOC2	"FLJ11026, SEC5L1, Sec5p"	ENSG00000112685	"Exocyst complex component 2"	Q96KP1	6	485133-693111	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032093			Approved	Vesicles		NA	NA		5300	Vesicles		"HPA032093: AB_10611964"	"unprognostic (1.61e-1)"	"unprognostic (4.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.20e-1)"	15.9	13.8	16.6	18.2	19.9	8.8	16.7	17.0	20.8	16.4	13.5	22.2	9.3	12.8	14.3	12.5	18.7	10.5	13.6	16.7	17.0	19.0	14.5	15.3	16.8	18.2	19.7	11.6	12.6	11.0	22.8	22.0	26.4	22.4	12.5	15.5	24.4	13.4	12.9	15.7	17.5	14.5	14.1	22.2	18.4	13.4	25.7	17.1	24.8	21.5	12.2	20.2	16.5	14.5	12.5	12.1	8.9	13.6	12.2	18.8	11.4	10.3	8.0	13.4	14.6	12.3	11.1	8.2	9.4	11.0	11.3	13.5	10.2	5.6	7.7	23.2	11.2	17.0	9.1	15.0	16.4	13.5	24.1	16.0	9.8	9.7	10.1	15.4	10.4	9.9	9.6	13.4	8.0	9.4	11.2	18.9	15.3	19.2	5.7	14.0	9.0	13.9	10.2	13.6	9.3	7.7	13.2	11.6	15.5	10.1	11.3	13.2	7.7	7.5	4.6	14.8	26.3	11.9	6.4	27.4	10.2	7.6	12.7	8.7	14.1	28.1	8.2	10.4	8.7	31.3	8.9	7.8	8.6	15.7	9.5	18.8	12.5	15.9	16.4	12.1	12.0	15.2	14.5	2.5	12.2	13.6	9.9	17.2	11.4	16.6	19.9	17.0	20.8	17.0	19.0	19.7	11.6	22.4	17.1	3.0	16.4	4.4	3.0	4.2	8.1	7.6	0.0	6.7	5.7	5.2	7.9	11.8	6.6	5.8	8.8	8.4	4.0	0.0	4.4	5.8	4.5	4.9	4.7	8.3	8.7	7.9	2.4	9.8	9.8	2.7	6.4	5.6	5.0	8.2	5.9	4.8	6.2	4.9	8.5	6.9	9.0	0.0	6.2	17.2	17.9	6.8	10.8	15.2	5.1	6.0
EXOC3	"SEC6L1, Sec6p"	ENSG00000180104	"Exocyst complex component 3"	O60645	5	443158-471937	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 31.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037880			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA037880: AB_2675716"	"unprognostic (2.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (4.82e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.70e-1)"	18.7	15.6	22.0	20.7	22.4	19.1	16.5	20.1	28.6	18.1	22.4	22.5	22.3	18.3	22.2	14.9	26.3	19.0	20.9	20.8	22.5	17.3	15.9	14.1	15.6	18.8	23.3	29.5	21.6	23.5	20.8	18.0	17.9	22.7	17.6	13.3	14.5	23.9	20.2	47.5	24.9	17.1	26.7	16.2	18.2	20.8	40.7	21.0	13.3	19.8	20.7	17.4	20.8	17.6	3.6	3.5	31.0	6.2	9.8	6.4	4.4	12.7	21.5	7.3	16.2	12.5	10.8	18.1	11.3	11.8	11.5	13.9	10.8	18.9	10.9	17.7	14.2	14.1	14.6	5.8	9.8	8.4	40.0	10.1	11.7	45.1	8.1	11.7	17.5	29.6	11.0	7.3	12.8	11.3	12.1	12.8	7.2	8.9	7.1	8.9	15.1	12.5	20.8	6.0	7.8	12.9	10.3	8.3	13.9	9.7	16.1	7.3	9.3	28.3	16.1	11.0	7.4	21.7	20.2	9.5	11.4	14.1	8.7	9.1	12.1	8.7	7.7	12.0	21.2	10.3	5.4	5.7	31.0	6.4	6.2	5.4	3.3	5.0	5.1	3.5	3.6	6.4	5.9	7.9	9.8	4.4	2.6	6.4	4.4	22.0	22.4	20.1	28.6	22.5	17.3	23.3	29.5	22.7	21.0	20.8	26.1	14.5	14.7	38.0	13.8	26.6	12.7	33.5	20.5	14.0	33.4	20.2	23.2	23.4	22.8	15.3	23.8	0.0	25.9	19.0	15.8	14.7	23.0	15.7	20.9	60.4	5.2	13.5	24.4	44.8	18.7	21.7	25.3	21.6	18.6	16.9	24.4	20.1	15.9	20.3	19.2	19.4	22.3	30.9	16.2	47.0	28.5	19.1	20.7	20.4
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Rod photoreceptor cells: 229.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: AB_2673886"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favorable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	21.2	23.7	18.5	17.7	22.3	10.5	19.4	25.7	24.4	20.8	17.0	19.7	22.2	11.2	25.8	20.6	21.5	24.2	16.8	16.5	14.7	15.4	15.6	15.2	16.5	12.6	14.2	19.3	27.7	26.5	28.5	31.2	16.4	22.0	16.9	18.8	19.3	20.5	18.8	50.7	24.4	13.7	20.8	18.7	17.9	16.3	17.2	17.3	34.7	22.9	18.3	22.1	26.3	20.6	8.3	16.3	8.1	12.7	18.4	12.4	10.4	17.8	14.7	20.4	20.1	23.9	25.0	7.1	13.1	21.9	11.9	15.7	8.5	25.2	13.4	9.5	24.6	17.5	11.4	10.9	17.9	19.8	20.4	13.1	10.8	15.5	8.9	26.3	14.2	11.8	24.3	22.4	17.0	31.5	26.4	20.3	17.8	15.5	13.4	22.1	11.7	25.8	15.7	15.3	21.5	13.8	11.5	18.1	24.1	19.2	16.0	15.9	25.1	19.7	18.2	21.1	24.0	12.0	13.4	22.0	13.3	7.0	14.0	14.3	21.3	13.0	13.0	39.3	16.7	20.2	8.1	12.0	6.9	11.8	12.7	10.5	8.3	12.3	12.4	16.3	8.0	10.1	10.4	4.0	18.4	10.5	7.3	12.4	10.4	18.5	22.3	25.7	24.4	14.7	15.4	14.2	19.3	22.0	17.3	20.8	21.1	11.9	14.2	16.8	35.3	24.9	7.6	18.7	15.9	14.0	88.4	13.6	3.3	12.9	23.1	21.5	15.8	0.0	15.7	13.8	11.9	17.0	8.1	14.4	15.6	47.7	16.7	24.5	30.4	20.6	16.1	18.0	13.5	12.6	21.4	20.6	13.9	17.5	17.7	13.3	229.7	12.9	10.8	18.1	12.6	14.9	9.4	20.8	18.4	16.9
EXOC5	"SEC10, SEC10L1, SEC10P"	ENSG00000070367	"Exocyst complex component 5"	O00471	14	57200507-57269008	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 123.9;Spermatocytes: 114.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060837	Approved					NA	NA					"HPA060837: AB_2684375"	"unprognostic (2.95e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.47e-3)"	"unprognostic (2.82e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.98e-2)"	17.2	13.4	15.5	13.6	16.3	9.0	22.4	10.8	16.6	10.9	11.6	7.8	7.9	11.3	11.9	10.6	15.2	9.6	9.9	12.8	14.8	15.1	15.8	16.9	13.2	14.2	16.5	9.6	12.2	10.7	15.0	18.8	15.3	16.7	12.0	9.5	5.1	11.4	10.6	16.4	11.3	11.5	15.8	22.1	14.9	11.2	34.5	13.5	20.5	15.4	10.6	13.0	17.0	26.0	10.9	11.7	11.1	10.1	11.0	11.6	11.9	13.2	8.3	16.8	8.5	11.4	11.2	12.8	20.7	9.9	7.9	9.2	7.8	8.4	19.6	12.6	11.1	8.0	10.8	10.3	8.4	12.4	23.0	6.0	12.5	6.4	5.9	10.5	15.2	16.4	6.7	9.0	7.7	8.7	10.4	14.2	14.0	11.9	14.9	15.8	6.0	20.6	3.4	9.0	7.6	15.0	14.6	24.7	7.1	9.8	11.0	13.1	11.2	16.7	6.8	10.2	14.8	12.5	7.5	15.5	17.3	19.4	10.9	10.1	7.7	9.5	16.8	15.8	8.7	11.0	10.3	9.5	11.1	9.8	10.1	11.6	10.9	10.0	10.2	11.7	10.9	11.1	9.5	5.4	11.0	9.0	5.9	11.2	11.9	15.5	16.3	10.8	15.4	14.8	15.1	16.5	9.6	16.7	13.5	23.8	15.2	22.0	14.3	20.0	32.1	21.3	22.9	24.1	26.1	14.0	27.5	14.7	14.9	16.0	123.9	26.3	9.5	23.3	14.7	16.7	19.1	25.2	34.6	34.5	19.1	60.4	33.3	46.6	32.4	76.1	21.9	27.6	20.3	21.6	18.4	25.5	20.9	7.0	33.6	35.3	29.3	19.4	25.8	114.5	30.8	26.2	15.7	22.5	13.3	15.3
EXOC6	"DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p"	ENSG00000138190	"Exocyst complex component 6"	Q8TAG9	10	92834713-93059493	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Rod photoreceptor cells: 133.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 21.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 46.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036285, HPA059111"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA036285: AB_10673617, HPA059111: AB_2683907"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.13e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.41e-2)"	9.7	19.4	15.3	8.5	16.9	11.6	9.4	18.9	16.2	7.4	9.6	4.5	5.1	8.3	7.3	7.5	4.9	6.3	10.3	7.0	15.5	8.6	7.0	10.8	12.0	16.7	6.1	12.8	5.4	12.5	8.2	17.8	34.6	8.1	9.4	10.8	3.5	7.2	5.0	29.3	6.2	9.8	12.8	6.7	12.6	7.6	10.0	8.1	13.5	29.1	10.2	8.2	9.5	8.2	4.9	7.6	21.2	3.4	1.8	2.5	1.7	8.5	10.7	11.4	7.5	0.6	0.7	4.1	3.9	10.9	3.6	4.4	4.0	7.3	9.7	8.3	1.9	2.9	5.4	9.2	2.5	4.6	8.6	9.3	14.1	3.8	5.0	4.4	15.2	12.6	1.0	1.3	3.2	2.2	6.6	46.7	6.4	11.9	6.5	1.7	4.6	6.4	9.9	1.5	17.4	3.1	9.7	4.9	5.0	7.8	5.8	3.8	5.4	4.1	4.1	5.1	3.0	8.1	8.0	9.5	0.2	3.7	3.4	6.4	4.9	5.2	7.9	1.2	17.2	4.0	3.7	3.4	10.1	2.2	2.7	2.2	4.7	2.5	2.1	3.4	4.9	2.1	2.4	21.2	1.8	2.6	7.6	2.3	1.7	15.3	16.9	18.9	16.2	15.5	8.6	6.1	12.8	8.1	8.1	14.9	14.7	15.9	8.5	3.0	36.3	10.8	22.9	12.0	13.6	15.7	37.3	18.0	5.0	22.6	4.1	34.6	10.2	70.0	13.2	6.2	3.6	13.6	10.4	13.4	17.9	22.3	24.5	55.9	20.6	10.9	4.0	14.9	5.0	4.6	14.7	20.2	13.2	8.5	13.8	7.1	133.9	12.9	3.3	15.7	22.4	4.3	17.2	12.8	10.0	15.7
EXOC7	"BLOM4, EXO70, Exo70p, KIAA1067, YJL085W"	ENSG00000182473	"Exocyst complex component 7"	Q9UPT5	17	76081017-76121576	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022840, HPA022842"	Supported		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Vesicles, Plasma membrane"	"HPA022840: AB_1848316, HPA022842: AB_1848317"	"unprognostic (5.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-1)"	23.2	22.2	30.5	18.2	37.1	27.5	20.4	27.8	46.2	23.8	24.4	33.0	20.8	19.1	28.7	20.8	31.8	32.6	21.3	27.5	29.2	23.5	21.0	22.6	21.2	17.6	20.9	28.2	31.5	24.1	40.5	29.3	24.0	34.6	30.0	17.0	27.0	29.2	27.9	24.0	21.8	21.6	31.1	21.7	21.4	19.6	14.5	23.0	23.7	29.5	14.1	26.4	30.2	20.5	12.8	13.7	29.6	34.4	15.5	17.9	19.0	21.6	27.0	24.9	20.2	23.7	16.8	25.9	19.9	26.7	36.2	26.2	22.7	14.7	11.3	14.7	34.8	22.9	17.9	15.0	19.4	24.3	9.7	20.3	18.6	21.2	23.9	16.5	20.7	19.4	23.5	15.4	28.0	13.7	25.7	40.0	20.5	12.4	11.5	22.5	20.0	33.3	9.2	13.1	16.3	28.8	18.0	42.7	11.4	20.8	45.1	13.6	31.8	22.6	16.8	15.5	25.0	27.5	17.1	26.1	38.8	23.4	25.6	21.9	15.9	5.8	10.4	23.2	9.4	20.0	21.1	19.2	29.6	17.9	26.6	12.3	12.4	13.7	15.3	13.7	12.8	14.5	12.2	22.2	15.5	34.4	5.9	14.8	19.0	30.5	37.1	27.8	46.2	29.2	23.5	20.9	28.2	34.6	23.0	17.9	34.9	47.7	30.5	17.5	78.7	6.4	35.7	32.1	27.3	38.4	135.5	45.1	28.2	34.4	17.9	25.1	47.9	23.3	32.5	23.9	29.3	37.9	39.4	22.8	32.8	63.5	46.8	27.6	25.9	31.6	34.5	25.7	23.6	33.3	34.6	62.0	34.4	38.6	36.0	28.6	102.9	45.3	31.0	26.8	16.6	17.3	59.5	38.9	27.8	37.5
EXOC8	"EXO84, Exo84p, SEC84"	ENSG00000116903	"Exocyst complex component 8"	Q8IYI6	1	231332753-231337852	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027438	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA027438: AB_1848318"	"unprognostic (3.85e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	12.1	9.3	10.4	11.2	9.6	22.1	10.3	14.8	12.8	8.6	8.6	9.9	9.5	8.8	9.3	7.6	11.1	8.5	7.7	9.0	9.2	10.3	9.2	11.2	9.5	12.6	9.1	9.9	11.2	11.2	17.1	11.9	14.4	11.9	8.7	7.3	6.7	9.5	9.9	26.7	12.2	11.4	6.8	9.0	13.0	10.1	6.7	9.3	16.9	12.9	9.2	13.3	7.7	9.9	1.8	2.1	6.0	3.8	2.0	3.5	1.2	7.4	8.2	5.0	5.1	13.1	10.7	12.2	9.1	7.7	6.9	6.5	7.7	7.5	8.4	8.1	9.0	6.2	12.2	7.2	9.8	7.6	10.9	17.6	5.1	10.4	4.9	7.4	8.9	14.2	10.7	10.8	10.1	9.7	8.1	8.4	8.8	9.3	20.2	10.9	3.8	8.3	5.5	7.6	9.3	7.0	5.5	7.8	10.8	8.6	8.6	6.7	7.2	9.2	12.1	8.9	4.1	11.6	13.0	11.4	9.3	6.6	12.4	15.9	15.2	8.7	9.2	10.7	8.1	11.7	4.5	1.8	3.3	1.3	2.3	1.6	1.2	1.7	1.5	1.3	1.8	2.0	3.5	6.0	2.0	3.8	2.1	1.5	1.2	10.4	9.6	14.8	12.8	9.2	10.3	9.1	9.9	11.9	9.3	8.9	9.8	9.0	4.6	16.5	3.9	6.7	12.7	2.7	9.1	8.7	5.9	3.6	1.7	2.9	0.8	9.2	6.3	23.3	3.1	2.5	5.3	4.9	2.3	8.2	4.8	3.2	4.6	8.6	12.3	0.4	3.7	6.4	3.3	2.8	4.5	5.7	4.0	0.0	5.3	4.1	11.6	0.0	3.8	4.9	4.7	12.9	7.8	7.7	3.8	6.5
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.1"	"Cell type enhanced"	"Detected in many"	9	"Basal keratinocytes: 97.5;Enterocytes: 75.9;Suprabasal keratinocytes: 147.0;Urothelial cells: 93.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 7.8"	"Cell type enriched"	"Detected in many"	4	"neutrophil: 24.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 24.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 34.7;RPTEC TERT1: 57.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"		NA	Yes			"Plasma membrane"		"CAB012989: AB_2533199, HPA014091: AB_2668939"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	0.6	1.1	1.0	7.2	1.4	0.1	2.9	0.4	0.8	2.4	34.0	1.1	25.3	17.4	1.0	2.2	6.4	2.9	13.6	3.6	1.1	0.9	28.9	7.4	2.8	3.7	0.8	0.4	1.2	16.6	1.3	3.2	2.8	7.8	6.0	21.4	1.1	7.1	23.7	0.3	24.8	64.1	0.7	1.5	3.5	16.8	0.8	0.5	0.6	9.6	5.8	3.1	5.3	3.9	0.3	2.7	24.9	5.7	0.3	2.3	2.0	8.7	14.4	1.2	0.0	0.4	1.1	9.3	0.4	4.8	0.2	0.7	12.4	22.6	0.0	19.5	1.0	22.3	15.0	7.6	6.7	0.4	0.0	7.1	0.2	0.3	8.8	3.1	0.0	0.0	1.6	19.2	2.2	14.4	2.3	23.9	2.2	0.1	0.0	0.0	4.7	1.0	0.0	1.6	4.9	34.7	0.0	0.0	0.2	57.6	16.2	0.6	0.1	3.4	3.5	0.0	14.5	1.5	0.0	15.7	0.0	9.1	0.0	0.0	1.3	0.2	0.0	5.1	0.0	0.4	4.6	5.7	1.0	0.3	1.9	1.2	0.3	2.3	1.2	2.7	0.1	2.2	1.3	24.9	0.3	0.3	0.3	0.6	2.0	1.0	1.4	0.4	0.8	1.1	0.9	0.8	0.4	7.8	0.5	8.9	3.0	2.0	18.2	97.5	0.0	0.3	35.7	18.7	11.4	29.6	0.0	4.8	1.7	20.1	0.0	0.6	75.9	0.0	13.1	6.2	3.7	19.6	2.3	8.5	0.7	0.0	12.6	1.8	2.4	0.0	0.0	1.1	1.7	0.0	43.8	0.0	29.3	35.1	0.0	20.2	1.6	0.0	1.0	0.0	1.4	147.0	1.7	0.0	39.6	93.4
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280363-81284777	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 237.0;tongue: 204.1;vagina: 141.9"	"Cell type enhanced"	"Detected in many"	11	"Alveolar cells type 2: 1256.0;Hofbauer cells: 2357.3;monocytes: 1172.2"	"Cancer enhanced"	"Detected in all"		"cervical cancer: 268.3;head and neck cancer: 288.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 93.8;MOLT-4: 91.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		28000000	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	41.4	1.5	8.5	11.8	13.2	8.5	37.3	5.5	8.9	78.7	20.6	7.9	2.2	8.0	5.7	3.1	237.0	2.1	8.5	27.1	8.5	9.8	1.6	2.7	24.8	15.1	7.6	5.0	2.0	8.7	0.7	1.9	30.0	19.1	4.4	18.2	4.2	32.9	1.6	9.4	42.9	9.7	4.5	23.0	14.9	15.6	3.8	10.6	6.6	4.4	204.1	25.7	19.5	141.9	6.8	20.3	2.5	5.9	8.2	5.2	4.3	5.8	16.7	10.2	0.0	48.8	4.6	0.0	11.9	0.6	9.3	11.8	0.2	8.0	93.8	6.8	2.9	0.1	5.4	24.8	19.1	8.0	47.6	53.9	33.8	11.9	25.2	4.3	32.3	8.8	3.5	39.3	11.5	23.7	9.4	53.4	24.9	9.7	10.2	5.6	5.6	91.6	16.5	13.5	57.9	64.9	40.9	0.0	9.9	15.0	72.5	42.4	16.1	5.8	1.9	4.4	18.5	0.1	16.6	7.6	0.0	26.5	0.1	0.1	12.6	4.9	66.8	4.3	31.0	14.9	2.5	5.0	0.3	2.3	5.9	3.7	6.8	2.7	5.2	20.3	3.3	1.3	4.5	2.0	8.2	2.0	20.1	3.5	4.3	8.5	13.2	5.5	8.9	8.5	9.8	7.6	5.0	19.1	10.6	268.0	1256.0	87.2	58.7	107.4	21.2	2.8	2.5	100.4	708.6	21.0	43.2	16.9	3.3	27.1	23.0	313.1	94.4	0.0	20.3	209.8	84.3	44.5	54.3	0.8	2357.3	20.6	189.4	31.9	161.8	37.2	5.8	624.3	195.7	1172.2	116.5	252.2	31.0	459.1	4.9	0.8	41.8	355.7	66.0	131.8	169.3	147.4	22.5	71.0	321.9	172.7
FAM189A1	"KIAA0574, TMEM228"	ENSG00000104059	"Family with sequence similarity 189 member A1"	O60320	15	29120254-29570723	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.3;parathyroid gland: 6.5"	"Cell type enhanced"	"Detected in some"	7	"Cardiomyocytes: 3.1;Ductal cells: 3.7;Enterocytes: 2.3;Intestinal endocrine cells: 2.9;Paneth cells: 3.5;Undifferentiated cells: 2.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.4;HDLM-2: 15.6;Karpas-707: 2.0;REH: 3.7"	"Low region specificity"	"Detected in many"							"HPA009410, HPA010637"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA009410: AB_1852332, HPA010637: AB_1852333"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.12e-1)"	0.8	1.5	12.8	0.6	7.9	0.4	0.6	4.2	9.5	0.4	4.0	1.5	0.0	1.0	1.1	0.8	0.6	1.5	0.5	0.7	15.3	4.7	1.7	0.5	1.5	0.5	3.5	3.4	0.4	3.3	6.5	0.0	0.7	4.0	0.8	3.0	0.0	1.1	0.5	0.4	0.8	3.2	1.0	0.7	1.3	0.6	2.3	0.3	0.0	1.9	0.0	1.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.3	0.0	0.0	0.0	0.2	15.6	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	2.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	12.8	7.9	4.2	9.5	15.3	4.7	3.5	3.4	4.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.7	0.0	2.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.5	0.9	0.0	0.0	0.0	1.7	0.1	0.2	3.5	1.4	0.8	0.3	0.0	0.2	0.5	1.2	0.0	0.0	0.0	2.9	0.5
FAM8A1	AHCP	ENSG00000137414	"Family with sequence similarity 8 member A1"	Q9UBU6	6	17600355-17611719	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Early spermatids: 685.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044698, HPA073675"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA044698: AB_2679051, HPA073675: AB_2732236"	"unprognostic (4.06e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.11e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.17e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (4.44e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.98e-1)"	14.7	13.0	19.8	8.3	21.1	21.1	15.2	23.7	22.6	17.2	16.2	10.8	23.8	12.9	21.4	15.4	11.1	16.7	16.4	11.8	17.7	17.8	18.8	58.7	14.5	14.6	17.3	16.5	22.6	17.8	19.0	16.2	11.5	17.5	16.9	18.1	8.7	16.3	31.4	17.5	13.1	15.9	19.7	17.9	10.5	12.0	28.4	16.4	15.1	18.3	10.5	6.4	15.0	16.2	0.2	0.4	9.0	0.6	2.6	2.0	0.5	4.8	1.9	7.2	17.1	25.0	23.6	5.9	7.9	10.8	4.0	7.1	11.1	1.6	4.2	19.0	13.3	4.4	4.0	10.8	6.8	5.4	3.5	15.4	5.0	6.8	23.7	11.1	3.1	5.2	12.4	11.1	4.6	3.3	13.1	9.0	4.7	10.1	8.6	6.4	5.9	2.3	9.8	3.0	6.0	3.0	6.2	7.0	12.6	13.8	3.9	2.2	11.5	6.1	13.3	12.0	13.0	15.4	4.9	6.9	5.2	1.8	8.0	2.8	7.2	6.0	4.1	4.7	3.7	7.1	4.2	0.5	1.5	1.9	0.6	2.0	0.0	0.9	1.6	0.3	0.2	1.2	1.9	9.0	2.6	0.4	0.4	0.6	0.5	19.8	21.1	23.7	22.6	17.7	17.8	17.3	16.5	17.5	16.4	17.9	19.0	3.0	8.6	11.8	26.8	12.2	15.3	12.0	14.8	27.9	13.7	8.4	5.0	7.4	685.5	9.3	26.4	0.0	6.8	10.4	12.6	10.7	1.1	67.4	5.4	14.3	11.5	23.9	20.0	149.2	33.9	6.5	5.0	1.0	11.3	17.4	7.3	17.5	29.0	11.4	15.3	32.3	17.5	30.6	16.8	13.9	10.2	10.2	13.4	7.0
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Fibroblasts: 12.4;Smooth muscle cells: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 57.4;BJ hTERT+: 33.7;fHDF/TERT166: 62.3;hTERT-HME1: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	NA	NA	92500		"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	28.1	3.8	19.4	6.9	21.3	0.7	12.1	6.5	15.3	10.2	14.2	10.3	1.9	2.6	17.9	6.3	6.4	10.1	9.4	5.6	17.1	11.0	5.5	2.9	8.3	2.5	9.9	10.7	16.8	2.4	10.1	4.0	8.1	18.6	10.3	5.6	7.5	4.6	11.9	2.0	2.3	4.1	16.2	17.3	1.9	7.6	3.0	12.3	0.0	3.1	3.8	2.7	7.5	14.5	0.8	0.8	0.5	0.5	0.3	1.0	0.0	1.2	3.1	1.8	6.9	4.4	7.4	0.0	57.4	33.7	24.1	14.0	0.0	0.1	0.0	6.7	62.3	19.0	0.2	1.8	0.1	24.3	4.5	0.8	0.0	6.5	0.0	13.0	0.3	0.0	3.9	0.4	23.8	34.4	12.1	2.6	0.0	1.7	1.9	6.2	0.0	0.0	0.0	5.2	0.0	1.4	0.0	0.9	0.0	7.6	0.0	1.0	0.9	11.1	0.0	0.4	10.8	0.0	0.1	2.4	20.0	3.9	7.4	4.9	3.4	3.6	0.0	5.7	0.0	2.1	0.5	0.5	0.4	0.3	0.4	0.2	0.4	0.5	0.4	0.2	0.8	0.7	1.0	0.4	0.3	0.4	0.8	0.7	0.0	19.4	21.3	6.5	15.3	17.1	11.0	9.9	10.7	18.6	12.3	6.0	0.0	0.0	1.5	1.4	3.5	3.9	0.0	0.0	2.3	7.0	0.0	1.8	3.3	6.9	8.7	5.8	0.0	0.0	0.8	0.0	12.4	5.2	0.0	0.4	0.4	0.0	1.7	7.4	0.0	2.5	9.2	0.9	5.0	1.0	0.0	8.4	6.7	0.0	7.8	0.4	1.8	0.0	15.5	3.1	0.2	1.1	4.0	0.0	0.0	0.3
FGF23		ENSG00000118972	"Fibroblast growth factor 23"	Q9GZV9	12	4368227-4379728	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	Differentiation	"Growth factor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 11.1;heart muscle: 9.1;liver: 10.1;urinary bladder: 6.7"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 9.8;Early spermatids: 3.8;Ito cells: 14.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 5.5;HBEC3-KT: 4.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	56800								"unprognostic (1.31e-1)"						"unprognostic (2.18e-2)"				"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"			0.3	0.4	0.2	0.2	0.2	0.8	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.4	0.5	3.5	1.2	0.5	0.2	9.1	0.2	0.2	0.3	10.1	0.3	2.6	0.2	0.2	0.3	0.2	0.1	0.4	0.3	0.2	0.2	1.4	0.2	1.0	0.2	2.5	0.4	0.3	0.7	0.2	1.1	0.2	0.9	0.2	0.6	0.3	0.2	1.3	6.7	0.2	3.1	2.9	11.1	3.6	3.4	3.1	1.7	0.2	0.0	5.5	1.8	2.9	0.6	0.8	0.1	0.1	0.0	0.2	1.0	2.0	0.3	0.2	0.9	0.3	1.2	0.8	4.0	0.2	0.2	0.6	0.2	0.7	0.6	1.6	1.2	0.5	1.6	0.2	2.5	3.3	0.3	0.4	0.2	0.5	2.3	0.1	0.0	0.7	1.4	1.4	0.3	0.2	0.9	0.1	0.9	0.7	1.1	1.2	1.1	0.0	1.8	0.2	1.0	1.3	0.8	0.0	2.0	0.5	1.4	0.3	0.1	0.2	0.3	1.2	0.4	1.3	11.1	2.3	2.9	2.6	2.4	3.1	2.9	2.5	2.0	1.8	3.1	2.8	2.9	7.2	3.4	3.6	2.9	2.3	1.7	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.8	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.2	1.6	0.0	14.1	1.2	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.1
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	"Fibroblast growth factor receptor 1"	P11362	8	38411138-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease mutation, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Leydig cells: 177.8;Muller glia cells: 106.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 111.2;BJ hTERT+: 50.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033614, HPA056402"	Approved					NA	NA		120000000			"CAB033614: AB_783377, HPA056402: AB_2683118"	"unprognostic (9.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.02e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.97e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.87e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.05e-3)"	41.1	8.6	12.5	14.5	12.2	7.2	39.5	45.0	10.5	36.0	31.5	10.1	11.6	5.5	29.3	20.6	22.9	29.4	32.4	31.7	12.8	10.1	11.8	5.4	18.6	9.7	11.4	14.3	42.0	51.2	11.5	22.3	28.4	20.0	28.2	10.8	35.8	14.0	31.6	12.0	12.9	14.4	52.4	15.6	4.5	16.4	16.4	8.5	11.3	12.6	13.0	9.8	39.6	41.2	1.6	0.7	1.8	1.1	0.8	5.7	0.7	2.4	9.4	41.1	111.2	25.5	18.2	27.1	25.3	50.7	17.6	18.4	6.1	1.4	0.3	7.0	24.2	22.6	0.0	19.4	1.2	20.4	6.6	4.3	0.0	1.6	6.0	14.4	5.9	0.1	16.5	0.1	14.3	2.9	9.5	16.9	1.4	2.3	0.1	8.3	2.9	17.4	2.0	28.9	0.3	3.9	16.0	4.3	0.0	8.5	0.0	1.6	3.6	4.5	0.2	1.0	21.5	2.3	1.1	10.6	11.5	6.4	31.8	6.0	0.4	0.8	0.0	13.6	0.3	6.0	1.4	1.1	0.4	5.7	0.3	3.9	0.7	2.7	3.7	0.1	1.6	1.5	4.1	1.8	0.8	0.5	0.7	2.2	0.7	12.5	12.2	45.0	10.5	12.8	10.1	11.4	14.3	20.0	8.5	3.0	12.0	0.0	68.4	27.9	1.3	48.2	17.8	1.4	9.1	8.7	3.9	6.5	0.0	23.4	14.2	57.3	0.0	0.0	56.3	69.1	85.6	80.3	8.1	0.9	19.7	20.6	24.0	47.3	3.2	9.3	177.8	7.5	32.1	2.8	0.0	106.2	29.8	0.0	93.7	8.0	2.4	12.9	68.0	1.4	11.3	17.2	8.7	6.4	0.4	8.4
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086886-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 33.6;kidney: 37.7;liver: 45.3"	"Cell type enhanced"	"Detected in many"	11	"Cholangiocytes: 50.9;Hepatocytes: 23.7;Proximal tubular cells: 19.5;Sertoli cells: 19.4;Undifferentiated cells: 33.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CACO-2: 43.0;Hep G2: 43.0;RH-30: 69.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	NA	NA		4300000			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	0.5	5.7	0.7	14.3	0.6	0.1	1.6	2.6	0.5	2.8	10.4	0.9	0.7	13.5	0.9	4.8	1.6	1.7	33.6	0.7	0.8	0.3	37.7	45.3	25.3	2.5	0.7	1.0	13.6	26.0	0.0	0.7	1.3	0.8	4.0	3.7	2.0	1.6	0.3	4.3	0.5	17.3	1.6	0.8	11.2	5.4	2.9	0.4	0.3	0.8	2.3	0.7	1.9	3.6	1.1	0.9	3.0	1.1	0.4	0.4	0.0	0.7	12.1	0.2	2.9	0.0	0.0	5.9	0.0	0.0	0.0	0.0	43.0	1.6	1.3	5.6	0.0	0.6	0.6	2.4	0.4	0.0	0.7	2.8	0.1	0.6	43.0	1.3	0.1	1.0	0.2	0.0	2.1	0.0	0.0	0.0	0.8	4.0	0.1	0.9	9.8	0.0	0.8	7.3	7.6	1.0	1.9	69.1	7.2	5.8	0.1	0.4	0.7	0.4	3.1	1.4	1.6	2.9	0.6	0.2	0.0	5.8	0.0	0.1	0.4	0.4	0.7	0.0	0.2	0.5	1.5	1.1	0.4	0.4	0.3	0.3	1.1	0.4	0.0	0.1	0.6	0.4	0.4	3.0	0.4	0.3	0.9	0.2	0.0	0.7	0.6	2.6	0.5	0.8	0.3	0.7	1.0	0.8	0.4	0.0	0.0	0.8	0.6	0.6	0.4	0.8	50.9	0.0	0.0	3.5	0.0	1.1	3.3	8.4	0.1	0.1	10.6	0.0	4.4	3.2	1.7	0.3	0.0	23.7	0.3	0.0	4.1	2.5	0.8	0.0	0.6	0.0	0.0	1.0	5.2	0.9	3.6	2.9	1.4	19.5	0.1	19.4	0.5	1.6	12.8	0.4	7.3	0.0	33.6	0.6
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026897	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 51.1"	"Cell type enhanced"	"Detected in many"	14	"Hepatocytes: 29.6;Muller glia cells: 87.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.5;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;monocytes: 3.6;T-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"U-251 MG: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB026019, HPA068828"	Approved		Supported	Vesicles		No	No			Vesicles		"CAB026019: , HPA068828: AB_2686043"	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	21.8	22.9	16.0	6.1	20.5	5.8	21.5	13.8	20.6	8.1	6.6	9.1	5.3	6.6	6.6	5.0	4.7	19.7	9.8	12.2	16.6	3.6	11.5	25.1	6.4	4.0	8.8	8.4	14.0	51.1	12.6	9.0	3.1	17.0	7.6	4.8	12.7	29.3	3.1	9.6	3.7	6.0	4.1	14.0	5.3	15.0	3.2	11.1	1.0	33.8	3.9	3.6	6.2	11.5	0.4	0.3	1.2	3.6	0.1	1.2	0.4	8.5	11.6	4.2	12.8	4.5	4.7	1.1	15.2	2.3	4.9	3.2	8.4	17.7	0.9	19.8	23.2	22.0	2.2	8.1	5.1	4.5	3.2	7.9	0.1	15.2	22.1	9.2	4.9	2.1	9.9	4.4	8.4	3.6	18.3	4.6	3.4	9.3	3.3	2.9	11.1	5.7	13.5	5.3	14.4	31.6	9.4	6.2	6.0	8.5	1.3	0.4	0.8	14.1	0.3	5.6	5.3	8.4	4.3	9.9	26.2	10.7	13.2	36.8	3.6	4.8	1.3	6.9	5.7	8.4	1.2	0.1	0.0	0.7	3.5	0.1	0.4	1.2	0.2	0.3	0.1	0.2	0.5	0.0	0.1	3.6	0.3	0.1	0.4	16.0	20.5	13.8	20.6	16.6	3.6	8.8	8.4	17.0	11.1	3.0	5.5	0.5	2.9	5.8	4.7	7.5	7.6	9.4	4.5	7.0	0.0	1.2	0.0	8.0	0.2	2.2	3.2	0.0	8.9	16.2	4.6	8.6	1.1	29.6	2.6	0.0	1.7	4.9	2.1	1.0	4.0	2.9	6.8	1.0	8.1	87.5	15.6	3.5	3.2	6.2	5.1	0.0	4.2	0.2	2.2	4.1	1.3	2.5	3.2	5.1
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FK506 binding protein 1A"	P62942	20	1368978-1393172	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 63.6;granulocytes: 88.4;monocytes: 94.3"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 152.2;TIME: 176.4"									"CAB004639, HPA051798"	Uncertain					NA	NA		16000000			"CAB004639: AB_425434, HPA051798: AB_2681615"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	106.0	42.4	67.3	55.0	114.8	44.4	63.5	15.8	55.8	33.2	39.7	22.1	33.8	32.7	45.5	45.9	42.7	33.8	32.0	36.4	51.7	30.6	41.9	41.7	59.2	84.1	26.0	36.5	41.7	57.7	20.6	21.7	65.0	22.5	34.4	49.4	21.4	30.8	40.6	38.9	31.5	37.1	56.0	23.3	68.0	33.0	21.1	28.4	47.4	62.2	39.7	48.3	48.1	37.0	13.3	63.6	88.4	94.3	14.5	18.6	84.3	71.4	19.8	15.8	22.8	53.5	67.2	20.8	45.4	30.8	36.4	33.8	19.8	27.8	29.3	14.6	42.3	52.9	32.9	20.4	83.1	47.9	8.4	22.1	30.0	9.3	37.6	32.9	34.8	16.7	39.0	26.5	33.7	34.8	42.5	152.2	33.0	27.4	15.1	42.8	8.9	34.0	48.0	33.9	25.3	38.8	29.2	27.6	35.4	47.0	18.1	26.3	19.9	22.4	45.3	75.2	22.1	17.7	29.7	176.4	135.4	22.7	28.8	33.5	7.5	16.3	30.6	23.3	35.4	29.9	23.9	79.4	88.4	11.5	94.3	10.2	12.8	13.9	13.2	63.6	13.3	14.8	14.2	77.9	14.5	90.3	31.6	18.6	84.3	67.3	114.8	15.8	55.8	51.7	30.6	26.0	36.5	22.5	28.4	80.4	70.6	192.2	178.9	233.8	16.6	52.9	173.3	66.9	58.0	164.0	0.0	249.8	202.2	393.2	31.1	486.6	196.8	23.3	297.3	496.2	197.8	189.6	142.9	99.4	651.5	33.4	317.5	445.0	487.0	41.0	185.2	363.6	229.5	390.5	244.5	40.1	382.3	768.7	153.1	245.7	11.0	135.8	189.1	153.9	133.6	261.7	193.6	124.6	263.1	202.2
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374638	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 396.7;urinary bladder: 276.1"	"Cell type enhanced"	"Detected in many"	6	"Peritubular cells: 470.6;Sertoli cells: 413.9;Smooth muscle cells: 354.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		2900000000	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.88e-4)"	42.8	8.8	2.9	46.4	3.9	22.9	30.7	2.0	5.2	106.5	204.2	6.3	86.0	13.1	158.9	54.4	140.2	79.9	121.0	18.8	3.2	2.2	17.2	5.5	29.1	21.1	3.4	5.9	77.4	7.3	1.6	4.8	20.0	9.4	129.3	13.4	19.0	12.6	98.8	13.7	15.0	50.2	396.7	3.6	25.5	82.7	29.9	2.9	12.1	11.7	16.3	15.1	276.1	64.5	6.3	13.1	7.1	19.7	5.9	22.6	24.1	87.1	67.8	23.9	30.8	20.9	27.7	39.3	58.4	65.1	53.6	47.7	43.9	16.2	7.5	151.5	90.7	94.6	50.1	21.5	51.2	15.1	30.8	7.5	24.2	88.6	15.2	38.5	28.6	31.7	26.4	12.4	79.8	31.9	52.5	39.8	9.2	6.8	52.3	38.3	20.0	13.6	9.9	25.2	9.1	45.1	13.7	21.7	6.7	20.8	18.1	5.3	12.1	48.8	7.9	39.3	19.2	7.6	9.0	95.2	61.2	59.0	61.9	107.5	32.8	19.2	15.2	56.8	19.2	61.2	4.1	11.5	7.1	22.6	15.2	14.3	6.3	10.5	18.7	13.1	3.0	4.0	9.1	2.6	5.9	19.7	1.7	12.8	24.1	2.9	3.9	2.0	5.2	3.2	2.2	3.4	5.9	9.4	2.9	53.6	43.8	55.7	72.4	110.4	2.7	24.1	43.3	4.0	20.5	33.2	0.0	18.9	1.7	255.8	1.7	80.7	1.4	0.0	117.7	74.6	126.9	16.4	25.4	2.1	124.7	11.1	1.7	85.3	148.7	6.8	113.4	134.1	84.4	135.3	1.3	35.9	247.2	0.8	470.6	0.9	2.8	413.9	354.2	2.3	8.3	64.4	16.7	76.7	3.1	31.4
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 215.6;Extravillous trophoblasts: 184.6;Pancreatic endocrine cells: 247.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 15.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 71.8;TIME: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		NA	NA		37000000	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	24.7	17.8	7.8	25.3	10.6	2.2	30.0	12.6	7.4	21.3	33.5	17.2	49.6	19.4	36.1	47.4	18.6	17.3	16.0	7.7	10.6	8.5	20.6	29.2	14.1	9.4	16.1	5.3	22.9	22.4	25.6	7.8	36.0	13.2	35.8	28.5	20.1	25.5	44.0	7.7	28.9	50.2	39.7	24.3	12.1	21.2	11.7	13.5	49.3	28.2	12.0	13.0	32.8	34.7	3.8	15.9	7.4	1.2	5.9	4.9	1.2	20.2	34.7	3.5	5.1	2.4	4.1	61.2	7.5	6.1	16.9	17.3	34.7	34.8	3.3	2.8	26.6	27.5	33.4	6.5	48.2	16.5	18.3	3.2	2.8	29.5	16.8	17.5	2.4	10.0	6.5	20.9	23.4	71.8	20.0	57.0	14.8	4.6	1.0	10.5	4.4	7.3	5.8	5.4	22.4	30.1	3.2	0.9	2.8	22.5	34.6	3.9	3.6	38.3	21.0	4.2	26.8	17.3	6.7	80.8	4.4	13.8	52.7	26.9	0.7	0.2	2.6	16.4	4.4	4.6	7.4	0.3	4.2	0.5	0.8	2.6	3.8	1.6	0.7	1.2	1.6	4.9	3.5	0.1	5.9	1.2	15.9	1.7	1.2	7.8	10.6	12.6	7.4	10.6	8.5	16.1	5.3	13.2	13.5	47.6	33.3	5.1	35.9	45.0	2.7	10.5	58.6	54.9	44.3	45.4	37.3	23.5	0.0	81.2	15.8	61.2	215.6	0.0	57.7	184.6	26.7	99.5	24.3	46.4	13.6	1.6	47.3	130.8	11.4	17.1	15.0	10.9	5.0	17.2	70.6	10.0	247.2	108.7	26.2	6.8	10.9	0.0	12.0	1.9	5.1	45.2	41.6	7.5	60.6	62.1
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830377-128859274	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease mutation, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"skeletal muscle: 546.8"	"Cell type enriched"	"Detected in many"	40	"Cardiomyocytes: 1815.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 80.1;fHDF/TERT166: 36.4;hTEC/SVTERT24-B: 39.6;U-2 OS: 34.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		54000000	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	2.6	0.8	0.5	7.1	0.7	0.2	0.7	0.3	1.0	5.2	24.4	1.4	18.4	1.9	14.0	10.1	16.0	4.8	13.3	70.0	0.8	0.5	0.4	0.3	1.4	0.3	1.4	0.5	3.1	0.6	1.0	0.3	0.6	1.9	11.9	2.1	1.7	3.1	20.2	546.8	1.0	5.2	69.0	4.7	0.3	10.0	1.3	0.6	0.0	4.7	40.0	2.2	39.6	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	7.3	8.8	0.8	80.1	15.2	22.8	11.0	24.9	0.2	0.0	13.5	36.4	9.3	0.0	4.8	0.1	13.6	0.0	2.7	0.0	4.1	0.0	9.2	0.0	0.0	16.6	0.0	39.6	0.0	9.3	14.2	0.0	9.6	0.0	15.5	0.0	0.0	0.3	13.3	0.0	4.6	0.0	26.5	0.2	0.0	0.0	0.4	1.4	0.1	0.0	0.0	19.2	0.1	0.3	29.3	8.0	34.2	2.0	0.0	0.0	0.0	0.0	27.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.3	0.6	0.8	0.5	1.4	0.5	1.9	0.6	3.0	0.3	0.0	0.1	3.3	0.4	1815.4	0.0	0.0	3.4	1.8	0.0	0.3	0.0	0.6	0.2	6.2	0.0	0.0	0.2	0.7	11.9	1.4	0.0	0.0	0.8	0.0	0.0	1.8	0.0	0.0	4.9	0.8	5.0	0.0	0.0	0.1	1.8	0.0	9.9	1.0	0.1	0.0	45.3	0.2	0.4	4.0	1.6	0.0	0.0	0.4
FLVCR1	"AXPC1, FLVCR, MFSD7B, PCA"	ENSG00000162769	"Feline leukemia virus subgroup C cellular receptor 1"	Q9Y5Y0	1	212858255-212899363	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Erythrocyte maturation, Transport"	Receptor	"Disease mutation, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 33.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046646	Approved		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA046646: AB_2679735"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.88e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-2)"	"unprognostic (7.29e-3)"	3.2	3.8	4.6	4.5	7.2	7.8	4.8	11.3	5.9	4.4	12.9	4.7	3.3	13.5	4.0	7.5	3.2	3.6	3.6	2.5	5.0	7.5	3.5	3.1	3.7	4.1	5.3	5.9	4.0	5.1	7.0	16.8	3.5	7.2	5.3	4.4	4.0	2.9	4.3	1.6	4.3	40.6	3.8	4.8	4.2	7.1	4.0	5.5	5.4	3.6	2.1	3.3	4.0	5.0	1.2	1.6	4.7	0.8	0.7	1.4	0.2	4.8	6.4	10.0	3.0	1.7	2.1	18.9	1.4	1.1	2.9	1.8	9.4	9.0	5.3	2.7	1.0	6.2	7.4	10.8	3.2	2.9	3.1	4.7	3.1	6.3	8.5	2.0	8.3	5.1	1.6	2.1	3.1	4.0	1.5	2.2	3.7	8.3	4.4	1.9	1.8	2.3	4.1	33.1	6.4	4.6	5.2	9.2	6.1	3.6	4.7	10.9	7.7	6.6	6.6	6.0	8.7	10.8	3.9	1.3	1.4	3.4	4.6	6.5	2.7	5.5	6.3	2.1	4.8	1.7	1.6	0.8	4.7	0.8	0.6	0.9	0.9	1.2	1.0	0.5	1.2	1.2	1.1	2.6	0.7	0.8	1.6	1.4	0.2	4.6	7.2	11.3	5.9	5.0	7.5	5.3	5.9	7.2	5.5	11.9	13.6	12.6	8.8	12.7	22.7	3.3	7.6	9.4	15.9	19.2	33.4	3.0	1.7	3.8	3.2	7.7	17.9	0.0	11.7	5.3	7.8	10.1	6.9	4.9	5.5	15.9	31.2	10.4	10.3	5.3	5.8	9.0	5.0	8.2	8.6	6.3	7.3	10.5	2.5	4.1	31.2	6.5	7.2	10.1	5.9	8.2	2.1	8.9	6.5	3.7
FLVCR2	"C14orf58, FLJ20371, MFSD7C"	ENSG00000119686	"Feline leukemia virus subgroup C cellular receptor family member 2"	Q9UPI3	14	75578617-75663214	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 45.7"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 60.5;Late spermatids: 110.7;Syncytiotrophoblasts: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 11.3;intermediate monocyte: 12.1;myeloid DC: 6.2;non-classical monocyte: 8.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 6.2;monocytes: 12.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 27.1;ASC TERT1: 11.8;BEWO: 36.2;MCF7: 12.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA037984	Enhanced					NA	NA					"HPA037984: AB_10672733"	"unprognostic (2.42e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.44e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.80e-2)"	"prognostic favorable (2.53e-5)"	"unprognostic (6.69e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.16e-1)"	5.6	11.6	1.4	6.5	2.6	3.0	2.4	0.7	2.4	2.5	24.1	1.9	0.9	12.5	1.4	2.9	2.4	2.0	2.6	3.0	1.7	1.0	8.3	19.0	11.5	7.7	4.8	0.7	2.4	0.8	0.8	4.1	25.6	5.0	2.3	5.2	30.9	8.7	2.5	7.6	5.1	45.7	2.8	6.0	17.5	1.1	15.6	2.6	1.1	3.2	5.6	3.3	2.2	4.2	0.1	6.2	0.5	12.1	0.3	1.3	3.0	1.7	1.3	0.4	1.9	27.1	11.8	36.2	0.3	1.5	1.6	1.3	3.0	0.2	0.0	0.1	0.1	2.7	0.2	4.7	0.1	0.6	9.1	0.3	0.0	1.3	6.3	2.2	0.0	0.3	5.5	3.7	1.9	1.1	0.0	0.4	0.1	0.1	0.2	4.9	12.5	0.0	0.9	0.8	0.5	2.1	0.0	1.2	0.0	1.7	2.4	0.0	0.0	0.9	3.9	0.7	2.4	2.2	4.8	4.2	2.0	0.7	1.0	0.0	0.3	0.5	0.0	5.7	1.2	0.3	0.0	11.3	0.5	0.3	12.1	1.0	0.0	0.9	0.3	6.2	0.1	0.7	0.1	0.3	0.3	8.9	0.1	1.3	3.0	1.4	2.6	0.7	2.1	1.7	1.0	4.8	0.7	5.0	2.6	6.0	5.4	0.8	0.2	0.6	0.0	0.5	0.0	0.0	5.7	3.5	0.0	20.2	0.0	0.1	60.5	1.9	16.9	0.0	0.2	26.2	2.2	1.1	1.1	16.1	15.9	0.0	0.0	2.5	32.4	110.7	3.1	17.3	0.0	1.8	0.9	1.3	0.1	1.9	1.8	5.9	0.1	0.0	0.0	1.2	1.2	0.6	45.5	0.0	2.1	0.1
FOLR1	FOLR	ENSG00000110195	"Folate receptor 1"	P15328	11	72189558-72196323	"Disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 157.6;salivary gland: 101.2"	"Cell type enhanced"	"Detected in many"	9	"Alveolar cells type 1: 461.6;Club cells: 316.2;Collecting duct cells: 301.8;Cytotrophoblasts: 307.8;Proximal tubular cells: 286.0;Syncytiotrophoblasts: 216.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Region enriched"	"Detected in many"	20	"pons and medulla: 157.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 83.6;RPTEC TERT1: 88.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 23.1;hippocampal formation: 49.6;pons and medulla: 45.9;thalamus: 34.0"	"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA		81000	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.0	0.7	1.3	0.2	1.7	0.0	6.6	0.6	3.5	31.4	0.1	21.4	2.8	0.0	1.0	3.5	1.6	46.7	1.0	0.2	7.9	1.8	38.8	0.2	47.0	0.0	0.8	0.4	8.9	1.8	0.4	3.5	24.5	157.6	1.5	0.0	17.0	101.2	4.0	0.1	0.9	0.1	0.0	0.7	0.0	7.4	0.4	0.2	0.0	12.7	2.6	3.5	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	7.8	7.9	0.0	8.1	0.1	0.0	0.1	0.4	0.3	0.0	0.0	0.2	0.1	83.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	2.7	0.0	88.8	0.0	0.0	0.5	0.2	1.2	0.0	7.3	11.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.3	1.7	0.6	3.5	7.9	1.8	0.8	0.4	157.6	0.2	461.6	156.4	0.0	7.8	0.8	0.0	0.3	35.7	178.0	316.2	301.8	0.0	307.8	112.7	15.6	0.0	0.0	0.0	0.0	1.2	101.0	3.8	4.7	4.7	0.0	26.1	0.0	1.7	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	1.4	4.1	0.0	0.0	286.0	0.0	0.0	0.1	0.0	0.1	0.1	216.6	0.0	0.0	8.6
FSHR	"FSHRO, LGR1, ODG1"	ENSG00000170820	"Follicle stimulating hormone receptor"	P23945	2	48962157-49154537	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 5.3;ovary: 6.5;testis: 16.3"	"Group enriched"	"Detected in some"	24	"Early spermatids: 1.6;Late spermatids: 4.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"basal ganglia: 1.5;cerebral cortex: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	11	"SuSa: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Intracellular and membrane"	NA	NA															"unprognostic (5.94e-2)"			"unprognostic (4.06e-3)"		"unprognostic (5.78e-2)"			0.1	0.1	0.1	0.0	1.5	0.1	0.1	0.1	2.9	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.3	5.3	1.0	0.1	0.4	0.3	0.1	0.1	0.0	0.1	0.1	6.5	0.1	0.0	0.1	0.0	0.5	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	16.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.3	0.0	3.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.5	0.1	2.9	0.1	0.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035259-69120427	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"CAB022164: , HPA068304: AB_2685970"	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	8.7	19.9	10.8	9.1	9.8	21.9	11.8	13.9	11.0	8.3	9.3	12.3	11.6	6.6	12.4	11.7	9.2	9.6	7.2	20.2	8.7	10.1	10.2	40.2	9.5	12.8	11.7	8.5	16.8	25.9	18.8	8.6	8.4	10.5	9.9	11.6	12.1	11.9	13.6	25.1	5.2	7.2	16.6	8.9	12.9	9.2	13.3	9.7	3.7	11.1	9.5	9.6	10.5	7.9	15.8	17.7	2.0	18.5	24.2	28.3	19.1	11.3	9.6	15.8	7.6	7.2	10.7	15.3	8.2	7.3	12.6	9.7	5.1	7.4	20.4	6.4	8.5	13.0	12.4	18.6	18.8	15.9	23.8	21.3	28.6	6.3	37.8	12.4	20.9	12.5	11.9	15.2	12.6	13.7	4.5	16.8	12.6	21.5	20.0	11.6	11.1	5.9	9.2	21.3	23.1	19.2	14.1	10.8	13.9	14.5	9.4	12.2	5.5	8.4	5.5	8.6	11.6	6.2	6.5	10.0	8.3	14.4	10.8	11.9	5.6	4.8	12.1	3.9	17.3	8.2	2.0	16.7	0.1	21.5	18.5	16.3	15.8	22.0	21.2	17.7	10.3	28.3	27.1	0.8	24.2	14.1	15.0	17.0	19.1	10.8	9.8	13.9	11.0	8.7	10.1	11.7	8.5	10.5	9.7	3.0	11.5	20.6	17.3	8.7	6.2	39.9	7.6	5.3	3.4	14.0	3.9	35.6	18.3	16.1	2.0	11.7	3.1	0.0	12.7	16.7	14.6	12.0	6.9	60.1	30.0	0.0	6.9	8.0	14.6	4.6	14.7	15.5	16.9	14.4	11.5	8.3	15.0	0.0	12.4	20.7	1.0	12.9	17.6	3.8	31.7	7.0	12.2	13.1	15.6	11.9
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease mutation, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 258.1;pancreas: 68.9;salivary gland: 91.7"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 1434.4;Distal tubular cells: 2501.8;Proximal tubular cells: 3101.2"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"memory CD8 T-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	25	"MOLT-4: 141.0;RPTEC TERT1: 323.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA064218, HPA068838"	Supported		Approved	Mitochondria		NA	NA		26000	Mitochondria		"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	0.3	0.2	0.2	0.2	0.1	0.0	0.7	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.3	2.8	0.3	0.3	54.7	0.2	0.1	0.2	258.1	2.2	0.2	0.6	0.1	0.0	0.4	68.9	0.0	0.3	0.6	0.1	0.3	0.0	0.1	91.7	0.1	0.1	0.2	0.3	0.1	0.1	0.4	0.2	0.2	0.0	9.5	0.2	0.3	0.4	0.2	0.6	0.4	3.2	0.0	1.1	8.4	14.1	2.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.2	0.0	0.0	0.0	0.0	141.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	323.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	1.1	0.2	1.8	14.1	0.2	0.4	5.1	4.1	0.0	8.4	0.0	3.2	1.6	2.0	0.2	0.1	0.2	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.1	0.8	1434.4	0.0	0.0	413.5	0.0	0.1	2501.8	465.3	14.4	1.3	0.0	0.0	8.3	0.1	1.1	0.1	0.0	2.4	2.9	0.0	14.6	5.5	4.3	15.4	8.6	2.6	0.0	14.4	0.0	0.5	33.3	0.0	7.1	3101.2	3.5	6.5	3.9	0.4	0.2	0.6	0.2	0.0	0.0	0.0
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 160.2;salivary gland: 141.7"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 1850.8;Mucus-secreting cells: 1977.6;Paneth cells: 3546.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 70.3;hTCEpi: 128.0;OE19: 239.6;RT4: 66.8;SK-BR-3: 65.8;WM-115: 47.1"									HPA010856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	0.4	0.1	1.6	29.5	2.3	0.0	20.4	1.7	2.1	30.0	133.2	1.1	2.3	8.6	3.9	2.9	82.1	9.0	56.6	0.8	1.4	0.3	2.1	0.5	35.8	0.3	2.1	0.8	1.9	28.9	0.0	3.7	41.9	2.2	58.4	160.2	15.8	141.7	3.5	0.5	64.2	36.4	7.5	1.8	0.4	50.6	0.7	1.0	2.5	0.5	93.2	49.8	48.7	42.5	0.3	3.2	0.6	0.1	0.0	0.2	0.5	12.6	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.4	18.5	0.0	0.0	0.0	0.1	70.3	0.0	26.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	128.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.2	0.0	0.1	0.0	239.6	0.1	0.0	0.0	0.0	0.0	66.8	15.7	0.1	0.0	65.8	4.8	0.1	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.6	0.0	0.0	3.2	0.0	0.5	1.6	2.3	1.7	2.1	1.4	0.3	2.1	0.8	2.2	1.0	708.7	211.8	0.0	720.0	512.4	2.3	1.3	239.5	860.6	417.5	127.4	0.0	696.6	1.7	18.8	0.1	3.8	1850.8	0.0	640.2	148.4	41.3	1079.2	23.0	0.6	70.8	1.6	937.0	0.0	0.0	0.0	0.0	12.2	391.4	2.8	1977.6	233.2	377.2	3546.9	0.0	0.6	8.5	0.0	25.8	0.2	0.2	756.6	1264.5	0.7	1253.7	1183.0
FXYD5	OIT2	ENSG00000089327	"FXYD domain containing ion transport regulator 5"	Q96DB9	19	35154730-35169883	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 407.2;Kupffer cells: 403.3;Macrophages: 433.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA010817	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA010817: AB_1849214"	"unprognostic (3.97e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.66e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.71e-9)"	"unprognostic (6.07e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"	58.8	10.6	6.0	47.4	9.0	72.4	66.9	2.7	7.1	44.3	15.6	14.4	10.4	8.8	33.6	25.9	31.3	26.0	28.6	29.1	7.0	7.9	13.7	13.2	39.5	110.7	12.0	7.6	18.9	8.0	3.4	11.7	56.9	11.8	27.3	14.0	19.8	19.7	16.7	17.0	22.7	27.0	18.7	18.2	80.3	20.8	10.8	9.3	33.9	16.0	26.9	97.4	36.6	59.8	73.3	91.4	66.5	76.9	99.6	109.0	94.6	98.9	23.7	0.0	0.1	35.4	44.9	23.8	56.9	75.9	40.7	30.4	6.7	29.1	22.8	15.6	68.7	14.6	23.3	14.6	35.1	26.3	28.1	9.6	42.6	13.1	0.0	27.9	24.2	42.5	26.6	15.7	29.5	51.1	24.0	38.3	6.3	39.9	110.3	25.3	0.1	2.8	10.1	7.3	92.0	13.8	13.6	5.0	28.8	14.9	0.5	4.3	0.0	31.4	16.5	33.2	13.5	8.6	19.5	54.0	50.3	19.1	54.5	4.3	0.1	1.6	5.8	76.6	56.4	76.7	66.5	73.5	13.4	60.3	76.9	56.8	73.3	102.5	62.8	91.4	66.7	68.0	55.0	18.1	99.6	74.5	41.9	109.0	94.6	6.0	9.0	2.7	7.1	7.0	7.9	12.0	7.6	11.8	9.3	3.0	14.9	263.7	53.6	95.1	0.3	2.4	22.9	1.4	7.9	94.2	0.0	9.5	0.0	153.7	1.1	336.6	0.8	0.0	176.3	377.4	156.4	26.1	356.4	4.3	407.2	0.0	10.3	249.2	403.3	2.7	6.1	433.0	199.1	27.9	5.1	0.0	365.9	7.0	0.7	2.5	0.2	64.7	75.9	1.1	7.0	60.5	42.6	318.2	5.2	88.0
FXYD6		ENSG00000137726	"FXYD domain containing ion transport regulator 6"	Q9H0Q3	11	117836976-117877486	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 142.8"	"Group enriched"	"Detected in many"	4	"Ito cells: 132.6;Leydig cells: 220.4;Peritubular cells: 341.9;Sertoli cells: 349.3"	"Cancer enriched"	"Detected in all"	6	"glioma: 71.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"classical monocyte: 21.9"	"Lineage enriched"	"Detected in many"	6	"monocytes: 21.9"	"Cell line enhanced"	"Detected in some"		"AF22: 37.9;HAP1: 25.0;RH-30: 15.7;SCLC-21H: 57.4;SH-SY5Y: 32.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041334, HPA042284"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA041334: AB_10970752, HPA042284: AB_2677931"	"unprognostic (2.18e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.31e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (3.44e-2)"	"prognostic favorable (4.38e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.60e-4)"	12.9	38.7	41.2	9.5	46.2	3.1	8.1	49.1	142.8	24.3	52.0	30.2	9.2	7.6	54.8	19.0	9.8	26.7	29.0	25.6	35.4	51.6	12.3	10.4	21.5	8.5	18.4	59.5	82.8	9.5	3.5	28.5	5.6	20.2	35.6	11.7	11.9	9.8	22.9	11.0	3.9	16.3	58.5	12.8	42.8	17.6	23.2	18.5	2.9	15.9	6.4	5.9	38.1	13.9	0.0	3.6	0.5	21.9	0.0	0.3	5.1	0.0	0.2	37.9	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	1.4	0.1	25.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.4	1.6	0.1	7.6	0.0	0.0	0.0	15.7	0.2	0.9	0.0	57.4	32.7	0.0	0.1	1.3	10.9	0.6	0.6	0.0	0.0	9.1	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	21.9	0.0	0.0	5.3	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	5.1	41.2	46.2	49.1	78.8	35.4	51.6	18.4	59.5	20.2	18.5	6.0	2.1	0.0	2.7	6.0	2.1	4.8	2.5	2.7	1.2	0.0	2.0	0.8	1.7	5.2	2.2	57.8	0.0	0.0	0.3	1.1	30.7	2.3	0.0	0.4	57.8	1.6	12.0	132.6	22.4	8.6	220.4	9.7	15.1	3.6	0.0	51.6	0.6	0.0	341.9	0.0	3.0	349.3	63.8	1.4	3.2	3.3	1.1	0.0	0.0	1.4
FZD1	DKFZp564G072	ENSG00000157240	"Frizzled class receptor 1"	Q9UP38	7	91264364-91271326	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 61.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 61.1;Horizontal cells: 133.5;Peritubular cells: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2;non-classical monocyte: 5.4"	"Lineage enriched"	"Detected in many"	4	"monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"AF22: 16.6;HSkMC: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013008	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB013008: "	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.39e-3)"	"prognostic favorable (8.87e-7)"	"unprognostic (1.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.13e-2)"	5.8	4.6	2.6	4.9	3.5	0.9	10.7	8.2	2.8	17.6	8.5	4.1	9.3	4.9	10.1	9.9	7.8	6.1	11.0	12.3	6.1	1.8	15.3	3.9	10.5	1.4	2.0	3.2	15.0	7.9	2.5	4.6	10.0	5.7	12.3	3.7	11.1	9.2	17.5	3.1	10.7	8.3	7.2	4.6	3.4	4.5	4.4	3.5	1.4	61.2	6.5	2.9	10.4	13.9	0.1	1.3	0.2	5.4	0.0	0.0	0.4	0.5	1.6	16.6	1.7	13.5	11.7	3.0	6.0	3.8	2.2	1.6	0.7	2.8	0.0	1.5	3.8	2.8	3.0	2.5	1.3	1.5	0.0	3.2	0.1	3.2	0.8	1.0	2.7	0.7	22.1	2.4	5.1	1.6	8.5	0.5	1.8	0.9	2.4	6.4	3.9	0.5	0.7	4.2	0.8	2.8	3.3	10.2	0.3	3.5	7.7	2.3	4.3	4.5	3.7	0.9	4.0	1.9	2.4	2.5	9.4	7.1	10.0	2.4	2.2	1.5	0.2	10.1	2.3	10.9	0.0	1.4	0.0	0.0	4.2	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	5.4	0.1	0.0	0.4	2.6	3.5	8.2	2.8	6.1	1.8	2.0	3.2	5.7	3.5	3.0	1.0	1.3	30.9	3.8	0.8	12.1	61.1	0.0	4.5	12.2	2.0	3.0	0.0	4.5	0.2	3.6	4.6	0.0	1.8	1.6	12.0	11.7	12.7	0.5	3.6	133.5	3.4	10.4	14.3	0.4	30.8	11.2	16.9	0.0	3.2	3.7	2.1	3.4	42.5	10.8	3.1	0.0	9.4	0.4	2.0	4.4	1.7	0.5	3.5	5.9
GABARAP	"ATG8A, MM46"	ENSG00000170296	"GABA type A receptor-associated protein"	O95166	17	7240014-7242770	"Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Intestinal endocrine cells: 381.1;monocytes: 547.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065883			Approved	Vesicles		NA	NA			Vesicles		"HPA065883: AB_2685574"	"unprognostic (2.58e-1)"	"unprognostic (4.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (9.52e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.58e-1)"	104.5	120.3	103.9	69.9	94.9	90.9	108.6	54.9	127.8	105.0	89.0	125.1	77.0	63.3	84.0	136.8	103.0	94.1	86.2	94.1	91.8	97.8	113.0	191.6	99.8	87.9	112.1	68.9	139.6	109.2	82.0	118.8	112.4	85.7	108.8	86.6	98.2	126.9	96.9	152.5	85.6	114.5	80.8	119.8	116.5	83.7	142.8	61.4	109.4	148.8	100.7	90.7	98.9	88.7	54.9	138.6	314.7	174.9	30.4	47.9	162.9	25.1	39.7	67.6	46.0	109.6	126.8	26.7	41.3	79.8	41.4	62.0	16.4	22.7	26.5	26.4	77.4	49.3	22.9	49.2	38.4	54.9	46.3	53.6	20.2	36.0	41.4	104.1	12.8	41.7	125.0	54.1	49.4	45.2	107.4	75.0	39.3	15.7	29.3	70.4	18.1	30.5	29.6	26.9	47.0	37.6	42.4	31.6	35.2	79.7	26.9	30.3	80.0	32.2	29.7	42.3	53.4	38.2	25.4	63.1	42.6	24.2	41.0	34.3	31.4	30.4	16.5	67.9	33.4	43.6	107.9	174.9	157.5	35.9	155.4	37.2	54.9	42.8	37.6	138.6	50.7	38.9	36.5	314.7	30.4	130.2	105.9	47.9	162.9	103.9	94.9	54.9	127.8	91.8	97.8	112.1	68.9	85.7	61.4	83.4	111.1	36.6	3.4	18.4	2.4	0.3	43.3	279.7	127.4	26.2	0.0	20.6	36.5	370.8	18.5	15.3	263.7	0.0	269.7	25.6	28.6	6.9	143.5	38.2	69.9	1.6	381.1	46.1	163.5	56.9	19.5	71.9	32.1	547.4	268.5	7.7	357.3	340.1	13.1	66.3	2.5	6.5	18.4	18.5	5.3	20.3	44.3	34.6	223.3	2.3
GABBR2	"GABABR2, GPR51, GPRC3B, HG20"	ENSG00000136928	"Gamma-aminobutyric acid type B receptor subunit 2"	O75899	9	98288082-98709197	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 52.7"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 87.5;Early spermatids: 83.9;Late spermatids: 26.5"	"Group enriched"	"Detected in many"	10	"glioma: 7.2;thyroid cancer: 11.6;urothelial cancer: 3.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 11.1;fHDF/TERT166: 5.5;HUVEC TERT2: 23.0;U-138 MG: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013820, HPA031684, CAB079065"	Enhanced	Approved				NA	NA					"CAB079065: , HPA013820: AB_1849364, HPA031684: AB_2673993"	"unprognostic (2.00e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.09e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	0.9	4.4	13.6	1.0	14.6	0.8	0.9	19.7	52.7	0.8	0.9	2.1	0.0	0.8	1.1	1.1	0.9	0.8	0.9	0.9	14.6	11.1	0.9	0.9	1.0	0.9	7.6	17.6	0.8	0.8	0.9	0.3	0.9	10.3	0.9	0.8	0.6	0.9	0.9	3.2	0.9	0.8	1.0	2.2	0.9	1.0	1.3	0.2	0.0	2.3	0.0	1.1	1.5	0.1	0.7	0.7	1.7	1.1	1.7	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	1.0	11.1	2.2	2.4	4.3	0.0	0.1	0.0	0.7	5.5	0.5	0.0	0.1	0.2	0.8	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.8	0.2	0.0	23.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.6	3.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	1.0	9.0	0.6	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	1.7	0.4	0.8	0.6	0.7	1.0	0.7	0.7	0.7	0.4	0.6	0.8	0.9	1.2	1.7	1.1	0.7	1.0	0.4	13.6	14.6	19.7	35.0	14.6	11.1	7.6	17.6	10.3	0.2	0.0	0.0	0.0	0.0	0.1	87.5	1.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	83.9	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	26.5	0.3	0.0	1.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.8	0.0	0.5	0.6	0.7	0.1	0.3	0.0	0.0	0.0
GABRA1	EJM5	ENSG00000022355	"Gamma-aminobutyric acid type A receptor alpha1 subunit"	P14867	5	161847063-161899981	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"brain: 58.6"	"Cell type enriched"	"Detected in some"	24	"Bipolar cells: 209.5"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 3.7;SCLC-21H: 1.1;U-2 OS: 1.6;U-87 MG: 2.3;WM-115: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022502, HPA029363, HPA055746"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"CAB022502: , HPA029363: , HPA055746: AB_2682904"					"unprognostic (2.58e-2)"						"unprognostic (4.78e-3)"	"unprognostic (1.84e-1)"		"unprognostic (3.31e-1)"		"unprognostic (2.43e-1)"		1.0	2.6	8.5	1.0	21.9	1.0	1.0	35.2	58.6	1.0	1.0	1.8	0.0	1.1	1.0	1.0	1.0	1.0	1.0	1.0	10.5	8.8	1.0	1.0	1.0	1.0	6.7	22.0	1.0	1.0	1.0	0.1	1.0	7.4	1.2	1.0	0.2	1.0	1.1	1.0	1.0	1.0	1.0	1.3	1.1	1.5	1.1	0.0	0.0	1.0	0.0	1.3	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.0	0.0	2.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	21.9	35.2	49.8	10.5	8.8	6.7	22.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	209.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRA2		ENSG00000151834	"Gamma-aminobutyric acid type A receptor alpha2 subunit"	P47869	4	46248427-46475230	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 52.6"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 38.4;Enterocytes: 16.9;Intestinal endocrine cells: 30.6"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 9.6;U-87 MG: 4.5;WM-115: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029363, CAB079061"		Supported	Uncertain	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	Nucleoplasm	"CAB079061: , HPA029363: "	"unprognostic (2.03e-2)"		"unprognostic (2.77e-1)"	"unprognostic (2.45e-4)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	2.2	1.3	38.5	1.4	34.4	1.2	1.9	10.4	52.6	1.7	4.5	4.9	0.0	2.0	1.4	11.7	1.7	1.0	1.6	1.0	38.9	7.7	8.8	1.4	1.0	1.4	3.7	31.0	1.9	1.0	0.9	0.6	1.5	10.5	1.0	3.5	0.0	1.2	1.9	1.0	1.3	7.7	1.3	6.9	2.3	1.6	1.5	7.1	0.0	1.1	0.0	1.4	1.2	0.8	0.2	0.3	1.0	0.1	0.1	0.1	0.0	0.5	0.5	0.1	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	2.1	0.6	0.2	0.5	0.0	0.1	0.8	0.0	0.0	0.2	0.5	0.5	0.1	0.7	0.3	0.8	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.2	0.8	0.2	0.0	0.4	0.0	0.3	0.9	1.8	0.1	0.0	0.6	0.4	0.1	0.6	0.2	0.0	0.1	0.3	0.0	0.6	0.4	0.4	0.1	0.5	9.6	0.5	0.1	0.8	1.2	0.2	4.5	0.4	5.1	1.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.1	0.3	0.0	0.0	38.5	34.4	10.4	31.4	38.9	7.7	3.7	31.0	10.5	7.1	0.0	0.0	0.0	0.0	0.1	1.5	0.4	0.0	0.0	0.0	38.4	3.9	0.0	3.3	0.0	6.4	0.2	16.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	30.6	0.0	0.0	6.9	0.6	0.0	1.7	0.0	1.9	0.3	0.0	0.9	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.0
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor alpha3 subunit"	P34903	X	152166234-152451358	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 30.1"	"Cell type enriched"	"Detected in some"	4	"Hofbauer cells: 12.1"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 16.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"basophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.1;HMC-1: 7.7;Karpas-707: 13.0;PC-3: 7.6;U-266/70: 7.0;U-266/84: 11.6;U-87 MG: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000839, HPA029363"	Approved	Supported	Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA000839: AB_1078929, HPA029363: "	"unprognostic (9.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.07e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.34e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.29e-6)"	"unprognostic (7.42e-3)"	"unprognostic (6.20e-2)"		"unprognostic (8.13e-2)"	0.7	0.7	7.7	0.6	15.2	0.7	0.7	1.3	30.1	2.2	0.8	3.3	0.0	0.8	1.2	0.8	1.3	0.7	0.7	0.7	10.9	15.9	0.7	0.7	0.7	0.7	4.7	10.5	0.6	0.7	0.6	0.9	5.2	6.2	0.8	0.8	0.4	0.7	1.8	0.8	1.1	0.9	0.8	2.1	0.7	0.7	1.8	1.1	0.0	0.7	0.0	0.9	1.8	0.4	0.0	0.1	1.5	0.3	0.3	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	13.0	0.0	0.0	0.0	0.0	2.4	5.5	7.6	0.0	0.0	0.0	0.0	0.0	0.2	4.7	0.0	4.8	0.4	0.3	0.1	1.2	0.0	4.9	6.5	0.3	1.4	7.0	11.6	0.0	7.7	0.0	4.9	1.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.3	0.1	0.2	0.0	7.7	15.2	1.3	28.4	10.9	15.9	4.7	10.5	6.2	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.9	0.0	1.6	0.0	0.0	0.3
GABRB2		ENSG00000145864	"Gamma-aminobutyric acid type A receptor beta2 subunit"	P47870	5	161288429-161549044	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 48.7"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 17.4;Cone photoreceptor cells: 25.5;Rod photoreceptor cells: 9.0"	"Cancer enriched"	"Detected in some"	20	"thyroid cancer: 10.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001964, HPA067632"	Enhanced					NA	NA					"CAB001964: , HPA067632: AB_2685874"	"unprognostic (5.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.26e-6)"	"unprognostic (2.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.04e-2)"	1.2	3.6	7.7	0.8	19.2	0.7	0.9	48.7	45.4	1.3	1.5	0.9	0.0	2.0	0.9	5.8	0.8	1.2	0.8	0.9	8.1	4.6	2.8	0.7	1.8	0.8	3.7	16.3	0.9	0.9	0.8	0.5	1.0	4.3	0.9	2.2	0.1	1.3	1.5	0.8	0.8	1.4	0.9	1.1	3.4	1.2	1.5	1.8	0.0	1.3	0.0	0.8	0.8	0.3	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	23.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	7.7	19.2	48.7	34.1	8.1	4.6	3.7	16.3	4.3	1.8	0.0	0.0	0.0	0.0	0.2	17.4	1.6	0.0	0.0	0.0	0.0	25.5	0.0	5.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.0	0.4	2.6	9.0	0.0	0.4	2.7	1.5	0.4	0.0	0.0	3.0	0.0
GABRB3		ENSG00000166206	"Gamma-aminobutyric acid type A receptor beta3 subunit"	P28472	15	26543546-26939539	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.6"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 136.2;Cone photoreceptor cells: 37.3;Horizontal cells: 71.5;Rod photoreceptor cells: 48.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 32.3;HAP1: 13.3;NTERA-2: 23.2;OE19: 10.0;SCLC-21H: 21.5;U-2 OS: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.72e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.05e-1)"	1.2	6.2	16.8	1.1	22.6	0.7	1.5	12.7	48.6	3.0	1.8	1.6	0.1	1.4	2.4	1.6	1.9	3.0	13.9	7.4	14.3	11.7	7.8	1.5	1.5	0.7	4.6	13.7	2.5	5.2	1.2	12.2	0.7	3.7	5.7	1.6	3.2	1.2	1.9	0.7	1.3	1.2	2.0	2.5	1.2	6.0	4.4	3.4	0.0	9.1	0.0	0.9	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	32.3	5.1	0.0	0.0	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	2.6	1.6	0.0	0.0	0.0	0.0	0.0	7.0	0.9	0.0	0.0	0.0	2.2	0.0	23.2	10.0	1.6	0.0	0.0	0.0	2.3	0.0	21.5	8.1	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	16.8	22.6	12.7	25.7	14.3	11.7	4.6	13.7	3.7	3.4	11.9	2.2	0.0	1.0	0.0	136.2	8.9	17.8	18.7	2.3	5.2	37.3	0.4	0.0	3.3	9.0	1.3	0.5	0.0	0.4	0.0	0.2	3.6	0.0	0.5	0.0	71.5	9.9	1.3	0.0	4.9	1.7	0.0	0.0	0.0	1.8	6.7	1.4	0.0	3.2	6.3	48.7	0.0	0.9	5.1	15.1	0.1	0.2	0.0	0.4	0.3
GABRG2		ENSG00000113327	"Gamma-aminobutyric acid type A receptor gamma2 subunit"	P18507	5	162000057-162162977	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 47.1"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 81.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.3"	"Group enriched"	"Detected in many"	5	"B-cells: 2.9;granulocytes: 7.3;T-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.6;RPMI-8226: 10.2;SuSa: 11.4;U-266/70: 17.8;U-266/84: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB079060		Supported				NA	NA					"CAB079060: "					"unprognostic (2.88e-2)"			"unprognostic (1.56e-2)"			"unprognostic (6.31e-3)"			"unprognostic (3.07e-3)"	"unprognostic (1.52e-1)"			1.1	5.7	9.7	1.2	28.8	3.3	0.9	21.7	47.1	0.7	1.5	1.1	0.0	2.2	1.2	1.3	1.3	1.3	3.8	1.6	10.6	19.6	1.0	1.2	1.9	1.2	7.5	19.1	1.5	1.0	0.8	5.3	2.9	17.6	1.0	1.3	0.6	1.3	0.8	1.2	3.3	1.9	1.6	2.6	1.2	3.3	1.7	1.8	0.0	1.8	0.0	1.3	1.5	0.3	2.9	0.7	7.3	0.3	0.9	3.2	0.2	3.6	1.7	1.9	0.3	0.0	0.0	2.0	0.6	0.0	0.0	0.0	10.6	4.7	0.7	5.2	0.0	0.4	1.6	1.2	0.0	0.0	0.8	1.1	0.0	2.1	1.3	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.5	0.0	1.0	1.8	8.5	0.0	2.5	0.4	0.1	6.1	3.4	2.9	0.4	0.1	10.2	0.0	3.4	0.9	0.8	0.3	0.6	3.4	11.4	5.6	5.7	0.2	0.3	4.5	0.3	0.5	17.8	14.1	0.5	0.2	0.4	0.4	7.3	0.3	0.6	0.4	0.3	2.7	2.9	0.7	0.6	0.0	2.5	3.2	0.7	1.6	0.9	0.2	0.7	0.6	0.2	9.7	28.8	21.7	38.1	10.6	19.6	7.5	19.1	17.6	1.8	17.9	19.7	0.0	0.0	0.0	81.7	0.2	0.0	12.0	19.4	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.1	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0
GABRR1		ENSG00000146276	"Gamma-aminobutyric acid type A receptor rho1 subunit"	P24046	6	89177501-89231278	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"retina: 12.3;testis: 4.6"	"Cell type enriched"	"Detected in some"	11	"Bipolar cells: 53.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"amygdala: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 3.3;OE19: 6.7;SuSa: 4.6"	"Not detected"	"Not detected"													NA	NA						"unprognostic (5.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.90e-2)"		"unprognostic (8.32e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	0.4	0.0	2.2	0.1	0.1	0.0	0.2	0.3	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.2	1.0	0.1	0.1	0.1	0.1	0.2	0.4	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.2	1.0	0.3	0.2	0.1	12.3	0.2	0.1	0.7	0.6	0.7	0.1	0.1	0.1	0.0	4.6	0.1	0.1	0.1	0.1	0.2	0.6	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.3	6.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	4.6	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	53.4	0.3	0.0	0.0	0.0	0.0	3.9	0.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	3.8	0.0	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1
GAP43	"B-50, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623324-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	25	"brain: 132.7"	"Cell type enhanced"	"Detected in some"	8	"Bipolar cells: 2.4;Cone photoreceptor cells: 2.0;Fibroblasts: 1.7;Melanocytes: 1.7;Rod photoreceptor cells: 3.1;Smooth muscle cells: 1.9"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"naive CD8 T-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"AF22: 16.7;NTERA-2: 35.6;SCLC-21H: 22.9;SH-SY5Y: 17.2;U-87 MG: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	1.8	5.0	48.8	5.2	38.3	1.4	1.9	31.2	132.7	1.6	4.1	4.3	0.0	2.7	1.5	1.5	1.9	1.5	3.8	3.6	29.0	56.6	1.4	1.4	1.5	1.5	30.6	42.2	1.4	1.8	1.4	1.5	2.2	25.7	1.7	4.0	0.8	2.2	1.5	1.4	1.4	4.3	3.6	6.1	1.4	1.5	1.6	5.7	0.0	1.5	0.0	1.6	1.7	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.2	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	17.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	48.8	38.3	31.2	75.7	29.0	56.6	30.6	42.2	25.7	5.7	0.0	0.0	0.0	0.0	0.2	2.4	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.7	0.0	0.0	0.8	1.2	0.0	0.0	0.0	3.1	0.0	1.9	0.7	1.5	0.1	0.0	0.0	0.0	0.0
GHRHR		ENSG00000106128	"Growth hormone releasing hormone receptor"	Q02643	7	30938669-30993254	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	36	"pituitary gland: 108.9"	"Cell type enhanced"	"Detected in single"	31	"Spermatogonia: 2.4"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (8.32e-2)"		"unprognostic (1.45e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.39e-1)"		"unprognostic (7.23e-2)"	"unprognostic (4.15e-1)"		"unprognostic (2.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.87e-3)"		0.4	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	108.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.0
GHSR		ENSG00000121853	"Growth hormone secretagogue receptor"	Q92847	3	172445133-172448456	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.4;blood: 2.4;pituitary gland: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	25	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	25	"NK-cells: 2.4"	"Cell line enriched"	"Detected in single"	4	"HMC-1: 1.8"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.8"	"Low region specificity"	"Detected in all"									NA	NA																"unprognostic (1.27e-1)"			"unprognostic (3.31e-2)"				0.0	2.4	0.0	0.8	0.5	0.7	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.8	0.0	0.0	0.6	0.0	0.0		0.0	0.1	0.0	7.4	0.0		0.0	0.1		0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GIPR		ENSG00000010310	"Gastric inhibitory polypeptide receptor"	P48546	19	45668244-45683724	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 21.3;stomach 1: 26.1"	"Cell type enhanced"	"Detected in many"	10	"Ciliated cells: 33.5;Club cells: 13.6;Intestinal endocrine cells: 28.7;Rod photoreceptor cells: 18.6"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 4.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 8.1;HMC-1: 18.4;SCLC-21H: 12.2;U-266/70: 15.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			CAB022710	Uncertain					NA	NA					"CAB022710: "	"unprognostic (2.40e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-4)"	"unprognostic (1.82e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.59e-2)"	8.0	0.4	2.3	4.5	8.4	2.4	6.6	1.8	10.5	2.9	4.5	9.4	0.1	4.3	0.7	1.5	1.8	10.0	1.8	12.3	3.7	2.6	1.7	0.5	4.8	3.6	21.3	1.4	1.0	8.5	9.0	2.0	0.4	6.3	5.3	5.8	2.6	5.8	0.6	0.4	3.3	3.6	0.5	4.6	4.1	26.1	0.4	16.2	0.2	1.8	0.8	4.4	3.0	3.3	2.3	1.2	2.5	0.8	4.1	2.3	0.7	0.7	0.4	1.2	0.7	0.5	0.0	0.2	0.9	0.7	0.1	0.7	0.4	3.4	1.6	0.5	0.6	0.6	1.8	0.3	0.1	0.1	8.1	0.3	1.4	0.8	0.3	0.1	0.5	18.4	0.0	0.3	0.2	0.2	1.6	0.1	1.8	3.7	1.9	0.0	0.2	0.2	1.2	0.1	2.4	0.9	0.5	0.3	3.6	0.4	0.9	12.2	1.2	0.1	0.8	0.1	0.5	1.7	2.6	0.3	0.0	0.6	0.3	0.3	15.0	0.2	0.3	0.5	1.4	0.3	2.5	0.7	2.0	2.3	0.8	0.8	0.9	0.9	1.6	0.9	2.3	1.1	1.8	2.2	4.1	0.5	1.2	1.8	0.7	2.3	8.4	1.8	10.5	3.7	2.6	21.3	1.4	6.3	16.2	3.0	4.6	0.5	3.1	0.8	0.4	3.6	5.1	33.5	13.6	5.2	0.0	0.0	0.0	1.6	0.3	0.3	2.6	0.0	3.1	0.1	0.2	1.1	1.1	0.0	0.1	0.0	28.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	4.4	0.5	3.6	7.0	0.0	0.0	18.6	12.9	0.5	0.0	0.2	0.4	0.1	0.7	1.2	2.0
GJA3	"CX46, CZP3"	ENSG00000121743	"Gap junction protein alpha 3"	Q9Y6H8	13	20138255-20161049	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.1;parathyroid gland: 6.2"	"Cell type enriched"	"Detected in some"	10	"Cardiomyocytes: 12.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 5.6;CAPAN-2: 10.2;HL-60: 8.4;U-266/84: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014821	Supported					NA	NA					"HPA014821: AB_2669097"	"unprognostic (2.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.65e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-2)"	"unprognostic (8.04e-3)"	0.2	0.0	0.1	0.1	0.9	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.3	0.1	0.8	0.1	0.5	23.1	0.1	0.0	1.2	0.1	0.2	0.1	0.1	0.1	0.1	0.3	6.2	0.1	3.9	0.2	0.4	0.0	0.2	0.1	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.0	4.2	0.1	0.2	0.1	1.0	1.6	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.4	0.0	5.6	0.3	0.0	5.0	0.2	1.5	0.0	0.7	4.7	0.8	1.0	0.5	10.2	0.0	0.2	1.7	1.7	0.1	3.3	2.8	0.7	0.2	2.6	2.4	0.0	0.0	0.1	8.4	0.0	0.3	1.6	0.2	0.5	0.0	0.0	3.8	0.6	0.0	0.2	0.0	0.0	0.0	0.7	0.1	2.0	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	5.0	0.2	1.1	1.9	0.0	0.0	0.0	2.0	0.3	2.3	5.9	0.0	0.0	0.1	4.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0
GJA4	CX37	ENSG00000187513	"Gap junction protein alpha 4"	P35212	1	34792998-34795747	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Ito cells: 227.8;Sertoli cells: 653.2;Smooth muscle cells: 352.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047981	Approved					NA	NA					"HPA047981: AB_2680228"	"unprognostic (2.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.48e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (3.28e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.17e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.82e-3)"	"unprognostic (7.96e-3)"	36.1	7.9	2.9	6.7	6.8	0.6	35.9	2.4	3.6	16.2	8.1	2.8	2.0	2.4	18.8	9.7	13.8	23.1	12.7	33.6	4.2	2.8	10.9	17.4	15.3	15.9	4.9	1.8	17.0	3.0	5.7	2.7	45.6	6.3	10.8	3.2	13.3	6.5	9.0	19.4	5.7	5.2	12.0	3.0	7.3	5.3	10.3	3.2	1.5	16.5	10.8	5.8	13.5	13.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.9	6.8	2.4	3.6	4.2	2.8	4.9	1.8	6.3	3.2	0.0	0.0	0.0	1.4	8.7	0.0	2.0	0.0	1.4	1.2	3.5	0.0	0.1	0.0	5.8	0.0	63.9	0.0	0.0	0.0	0.1	5.9	2.3	0.0	0.8	0.2	0.0	15.0	227.8	7.5	0.4	0.9	4.7	18.6	1.0	0.0	0.0	1.6	0.0	12.0	0.0	0.6	653.2	352.3	0.2	0.7	7.5	0.0	0.0	0.0	2.6
GJA8	"CAE, CAE1, CX50, CZP1"	ENSG00000121634	"Gap junction protein alpha 8"	P48165	1	147907956-147909257	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	76	"testis: 18.0"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 1.8;Early spermatids: 6.8;Late spermatids: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"RPTEC TERT1: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014715, HPA062940"	Enhanced					NA	NA					"HPA014715: AB_2732411, HPA062940: AB_2732693"										"unprognostic (3.73e-2)"					"unprognostic (2.35e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71215194-71225516	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.4;liver: 114.4;pancreas: 37.1"	"Cell type enhanced"	"Detected in many"	15	"Cholangiocytes: 112.1;Enterocytes: 72.8;Hepatocytes: 237.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 46.8;SK-MEL-30: 51.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain					NA	NA					"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.4	0.4	7.2	2.5	9.3	0.3	2.6	1.9	14.4	3.3	12.0	46.3	2.5	14.6	0.9	8.1	0.5	9.5	19.8	0.4	13.4	8.0	14.8	114.4	1.2	0.4	22.4	5.6	0.4	37.1	0.3	0.4	0.4	23.0	4.3	8.3	0.5	19.6	8.7	0.4	0.6	11.7	1.0	52.4	0.4	5.7	3.1	12.1	0.0	0.4	0.0	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	9.3	1.9	14.4	13.4	8.0	22.4	5.6	23.0	12.1	0.0	3.7	3.4	0.5	0.6	0.0	0.0	112.1	0.0	2.3	8.7	0.0	0.0	8.3	19.1	0.1	0.0	72.8	0.0	50.9	0.0	0.0	3.9	4.6	237.9	0.0	0.0	9.2	3.1	3.7	0.0	0.3	0.0	21.9	1.0	23.0	0.0	47.9	51.0	0.4	59.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	56.4	2.4
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20193010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease mutation, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"cervix, uterine: 52.8;esophagus: 128.1;lymphoid tissue: 71.1;tongue: 129.0;vagina: 64.9"	"Cell type enhanced"	"Detected in many"	12	"Basal keratinocytes: 62.0;Hepatocytes: 24.2;Suprabasal keratinocytes: 25.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Region enhanced"	"Detected in some"		"pons and medulla: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 43.7;hTCEpi: 32.6;OE19: 22.7;RT4: 50.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	0.2	0.0	0.2	1.5	0.3	0.5	0.7	1.0	0.5	52.8	3.9	0.4	0.4	2.4	4.2	0.6	128.1	0.1	2.7	0.1	0.5	0.1	3.5	9.1	0.1	0.0	1.3	0.7	0.1	0.1	0.0	0.5	0.2	4.5	0.3	3.4	0.3	19.7	0.2	0.2	10.3	1.9	0.4	3.7	0.0	1.5	0.2	0.2	3.2	0.2	129.0	71.1	2.3	64.9	0.0	0.0	0.4	0.6	0.0	0.0	0.0	2.5	0.2	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.4	43.7	0.0	0.2	0.0	0.3	8.7	1.6	4.3	0.0	3.6	0.5	0.0	0.0	0.1	0.0	0.0	1.5	0.7	32.6	0.5	6.0	0.0	0.0	0.6	0.0	3.2	0.0	0.4	0.3	0.0	0.1	22.7	4.3	0.0	0.0	2.4	0.0	50.8	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.0	0.0	0.7	6.5	2.6	2.7	0.0	5.3	0.0	0.6	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.5	0.5	0.1	1.3	0.7	4.5	0.2	3.0	0.0	0.8	8.0	62.0	0.0	0.4	5.1	0.0	3.4	1.8	0.0	0.0	0.0	3.5	0.7	0.2	19.0	0.0	8.8	0.2	1.6	7.8	0.0	24.2	0.7	0.0	4.1	0.0	0.8	0.9	0.0	1.2	1.7	8.2	3.9	0.0	8.1	15.0	0.0	14.7	0.0	0.0	2.0	0.2	0.4	25.1	0.1	0.0	19.7	15.6
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781189-34786369	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.1;lymphoid tissue: 25.0;skin 1: 49.3;tongue: 32.1"	"Group enriched"	"Detected in many"	7	"Basal glandular cells: 49.4;Basal keratinocytes: 123.0;Pancreatic endocrine cells: 70.6;Suprabasal keratinocytes: 149.2;Urothelial cells: 169.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 26.3;CAPAN-2: 37.4;HaCaT: 30.4;HBEC3-KT: 26.0;hTCEpi: 42.7;OE19: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.1	0.1	1.0	2.4	0.4	0.0	3.4	1.4	1.2	6.3	2.2	0.0	0.6	0.0	0.7	3.0	40.1	0.5	4.1	0.1	0.2	0.1	0.5	0.8	0.6	0.4	0.1	0.1	0.2	0.2	0.0	0.1	11.3	0.0	3.7	2.8	0.0	3.7	0.9	0.2	49.3	0.6	0.2	0.1	0.1	3.2	0.5	0.0	0.7	0.2	32.1	25.0	4.7	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	3.6	0.0	0.0	30.4	0.0	26.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	42.7	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	16.3	6.8	0.0	0.0	0.0	12.7	10.0	0.0	0.0	4.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	1.4	1.2	0.2	0.1	0.1	0.1	0.0	0.0	3.0	0.0	0.0	49.4	123.0	0.0	0.3	2.5	1.4	2.3	5.2	0.0	0.0	0.0	15.7	0.0	0.1	3.1	0.0	6.3	0.1	3.1	16.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	13.5	0.0	1.9	0.0	70.6	7.0	0.0	0.0	0.0	0.0	3.1	0.0	0.2	149.2	0.1	0.0	16.1	169.4
GJC1	"CX45, GJA7"	ENSG00000182963	"Gap junction protein gamma 1"	P36383	17	44798448-44830816	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	23	"Sertoli cells: 155.2;Smooth muscle cells: 65.3;Spermatogonia: 32.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA071788			Uncertain	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			Nucleoli	"Cell Junctions, Cytosol"	"HPA071788: "	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.55e-8)"	"unprognostic (5.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (7.83e-4)"	7.3	0.8	2.2	4.1	3.4	1.0	4.7	8.2	4.2	14.8	23.0	2.8	7.0	1.6	24.2	3.1	3.2	5.0	5.4	10.0	3.3	1.8	1.5	0.9	6.5	2.3	2.5	4.0	2.2	1.3	2.6	0.7	28.5	3.4	8.2	2.8	3.7	1.7	17.0	5.4	1.9	4.8	27.5	2.2	0.9	7.8	8.0	2.9	1.4	5.3	2.9	1.7	12.6	10.4	1.2	1.0	4.7	1.0	1.9	1.0	0.4	17.4	9.0	22.7	7.8	3.0	4.7	8.9	19.4	15.3	20.9	22.5	5.2	9.7	0.1	1.0	18.1	28.6	4.5	11.8	6.0	29.4	0.1	8.8	0.1	4.8	0.5	1.8	0.1	0.7	3.2	0.6	15.9	5.3	7.8	7.1	3.9	0.8	0.2	12.1	0.1	2.8	1.7	10.2	0.0	7.7	16.5	28.8	0.1	5.0	7.3	4.3	9.9	2.2	0.1	6.5	15.3	4.7	2.7	5.9	18.5	17.9	8.4	16.5	0.1	4.5	12.9	6.4	0.1	17.3	4.7	1.0	1.1	0.9	0.6	0.8	0.9	0.7	0.6	0.3	1.2	0.9	1.0	3.9	1.9	0.7	1.0	0.6	0.4	2.2	3.4	8.2	4.2	3.3	1.8	2.5	4.0	3.4	2.9	0.0	0.0	0.0	1.6	1.8	1.0	18.1	0.0	0.0	0.0	1.8	2.0	0.3	0.0	1.3	1.3	11.7	0.0	0.0	0.0	2.1	5.7	1.2	0.0	0.0	1.2	12.7	0.0	6.2	0.8	0.0	1.4	0.0	3.3	1.0	0.0	0.4	0.6	0.0	2.1	0.3	1.0	155.2	65.3	10.2	32.0	2.6	0.5	0.0	0.0	1.4
GJC3	"CX30.2, GJE1"	ENSG00000176402	"Gap junction protein gamma 3"	Q8NFK1	7	99923269-99929620	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 9.1;pancreas: 12.1;salivary gland: 9.0"	"Cell type enhanced"	"Detected in many"	11	"Exocrine glandular cells: 20.9;Glandular cells: 18.1;Pancreatic endocrine cells: 8.3;Proximal tubular cells: 8.2;Urothelial cells: 9.7"	"Group enriched"	"Detected in many"	5	"breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6"					"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.5;T-reg: 2.1"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Cell line enhanced"	"Detected in some"		"OE19: 3.3;SK-MEL-30: 5.7;U-2197: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015024	Uncertain					NA	NA					"HPA015024: AB_1847132"	"unprognostic (9.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.81e-3)"	1.0	0.5	0.1	0.0	0.3	0.0	9.1	0.0	0.5	0.0	0.1			0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	1.1	2.8	0.1	0.1	0.6		0.3	12.1	0.0	0.1	1.2		4.3	0.0		9.0	0.0	0.0	2.0	0.0	0.1	0.7	0.0	0.8	1.6			0.2		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.4	0.6	0.8	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.4	1.2	2.6	0.0	0.0	1.0	0.5	0.5	0.0	0.0	0.2	0.3	0.9	0.2	2.3	0.0	0.4	0.3	0.4	0.0	0.1	0.6	0.2	1.1	1.8	1.4	1.7	0.3	1.3	0.5	1.2	3.0	3.3	0.2	0.0	1.2	0.8	0.0	1.1	0.5	0.6	0.3	1.0	5.7	1.5	1.8	0.2	0.8	0.2	1.0	4.8	0.3	0.4	1.4	0.1	0.6	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.0	2.1	0.4											3.0	3.0	0.0	4.8	0.2	0.0	0.0	2.5	0.0	1.2	1.8	0.0	0.0	1.7	0.3	0.2	0.6	0.0	0.0	20.9	0.0	0.0	18.1	4.6	3.9	0.1	0.0	1.2	0.0	0.0	0.5	0.3	0.0	0.0	1.0	0.0	3.7	8.3	0.0	0.0	8.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	9.7
GJD2	"CX36, GJA9"	ENSG00000159248	"Gap junction protein delta 2"	Q9UKL4	15	34751032-34754965	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 13.8;pancreas: 8.7;pituitary gland: 23.9;retina: 9.1"	"Cell type enhanced"	"Detected in some"	27	"Bipolar cells: 11.5;Cone photoreceptor cells: 37.3;Horizontal cells: 6.4;Rod photoreceptor cells: 12.7"	"Cancer enriched"	"Detected in single"	32	"pancreatic cancer: 4.2"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"SuSa: 7.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (4.30e-2)"						"unprognostic (2.87e-2)"			"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"			0.3	13.8	1.3	0.3	2.1	0.3	0.2	1.4	4.5	0.4	0.3	0.1	0.0	0.2	0.4	0.2	0.2	0.2	0.3	7.0	1.1	1.6	0.9	0.2	0.3	0.2	0.8	2.8	0.2	8.7	0.2	23.9	0.3	3.4	0.2	0.3	9.1	0.2	0.2	0.3	0.3	0.3	0.3	0.2	0.3	0.4	0.4	0.0	0.0	0.3	0.0	0.3	0.3	0.0	0.5	0.6	2.1	1.1	1.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	7.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.4	0.8	0.5	0.6	0.7	0.5	0.5	0.3	0.5	0.5	0.6	0.6	2.1	1.0	1.1	0.6	0.5	0.4	1.3	2.1	1.4	4.5	1.1	1.6	0.8	2.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.7	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJD4	"CX40.1, FLJ90023"	ENSG00000177291	"Gap junction protein delta 4"	Q96KN9	10	35605410-35608935	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 5.4;brain: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"RH-30: 5.9"	"Not detected"	"Not detected"							HPA038266	Uncertain					NA	NA					"HPA038266: AB_10672741"	"unprognostic (2.05e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.74e-6)"	"unprognostic (2.00e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.92e-2)"		"unprognostic (8.49e-2)"		"unprognostic (7.70e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.19e-10)"	"unprognostic (3.06e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-1)"	0.2	0.2	0.7	0.2	1.0	2.5	0.2	0.2	3.5	0.5	0.2	0.2	0.2	1.0	0.7	0.2	0.3	0.2	1.3	0.3	0.6	1.3	0.2	0.3	0.2	0.4	0.8	0.2	0.2	0.4	0.3	0.5	0.4	0.2	0.3	0.3	0.2	0.8	0.2	1.5	2.6	0.8	0.2	0.3	0.4	0.8	0.9	0.2	0.2	0.9	0.2	0.2	0.4	0.2	0.7	0.9	5.4	0.6	0.6	0.8	0.2	0.9	0.9	0.5	1.5	0.2	0.0	1.4	0.2	0.0	0.0	0.3	0.7	1.4	1.0	0.6	0.1	0.6	1.5	0.1	0.3	0.3	1.1	0.8	0.9	0.4	0.6	0.0	0.2	0.9	0.3	0.3	0.4	0.1	1.2	0.2	0.9	1.8	2.0	0.2	1.3	1.4	1.0	0.9	0.6	2.4	0.8	5.9	0.4	0.1	1.6	1.2	0.8	0.8	0.6	1.3	0.7	1.0	1.4	1.4	1.1	2.0	0.8	0.6	1.0	0.6	0.3	0.9	0.8	1.0	1.8	0.6	0.7	0.5	0.2	0.4	0.6	0.5	0.4	0.4	0.7	0.8	0.7	5.4	0.6	0.2	0.9	0.2	0.2	0.7	1.0	0.2	3.3	0.6	1.3	0.8	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1, RNA export mediator"	Q53GS7	9	128504700-128542288	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 55.3;Late spermatids: 44.8;Spermatocytes: 45.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	12.5	17.0	11.1	13.5	13.2	12.2	14.7	22.1	13.8	13.1	15.7	16.5	17.6	14.6	13.8	11.4	18.5	13.5	12.6	13.2	10.5	8.9	13.1	20.4	11.3	23.0	11.2	9.9	15.7	21.1	20.8	16.3	16.4	10.6	13.4	17.2	13.1	13.6	16.7	23.3	18.3	14.9	12.0	9.8	17.5	12.1	42.8	11.8	27.2	12.4	14.6	20.0	14.3	13.5	16.0	19.2	26.2	22.5	22.6	20.5	15.8	10.8	20.4	10.0	17.1	9.9	10.1	13.3	11.0	9.4	15.5	11.0	13.7	7.6	22.0	8.9	12.3	14.9	38.3	17.3	15.7	13.4	20.9	11.3	11.3	22.5	12.7	11.2	18.2	14.9	7.1	15.3	17.5	18.8	8.6	8.7	20.7	16.1	19.5	17.7	25.2	17.9	12.9	8.5	29.2	17.7	18.3	24.6	29.1	10.4	9.7	11.9	8.9	26.8	16.3	9.6	8.5	30.0	12.9	6.3	16.5	11.0	19.2	15.2	19.6	47.1	17.2	15.4	13.9	17.7	26.2	18.1	20.3	20.5	22.5	16.7	12.0	16.0	18.1	19.2	16.0	14.4	16.6	15.4	22.6	22.0	11.4	18.3	15.8	11.1	13.2	22.1	13.8	10.5	8.9	11.2	9.9	10.6	11.8	8.9	7.0	10.2	6.2	5.8	6.6	10.9	0.0	9.4	4.5	7.0	7.9	14.2	5.0	9.6	55.3	3.1	11.4	0.0	5.4	9.5	5.1	4.8	9.2	10.5	13.4	9.5	5.2	3.7	12.6	44.8	9.5	9.9	3.3	20.8	13.4	8.4	7.6	5.8	6.0	11.1	8.2	12.9	5.1	45.3	28.1	5.9	11.1	11.5	13.9	4.3
GLP1R	GLP-1R	ENSG00000112164	"Glucagon like peptide 1 receptor"	P43220	6	39048798-39087743	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 19.0"	"Cell type enhanced"	"Detected in single"	37	"Cardiomyocytes: 2.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.6;HAP1: 1.3;HMC-1: 1.5;NTERA-2: 3.3;SCLC-21H: 8.1;SH-SY5Y: 1.8"	"Group enriched"	"Detected in some"	5	"basal ganglia: 16.1;hypothalamus: 4.8"	"Low region specificity"	"Detected in some"									NA	NA						"unprognostic (4.06e-3)"			"unprognostic (5.38e-6)"	"unprognostic (1.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.42e-2)"	0.2	0.1	0.1	0.0	1.8	0.0	0.9	0.1	2.2	0.1	0.1	0.8	0.0	2.4	0.1	0.6	0.1	0.0	3.5	4.8	1.4	1.4	0.1	0.0	0.5	1.0	0.1	2.3	0.0	19.0	0.0	0.1	0.0	2.0	0.1	0.0	0.0	4.1	0.0	0.4	0.3	0.1	0.0	1.4	0.1	1.8	0.4	0.0	0.4	0.8	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.1	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	1.8	0.1	0.7	1.4	1.4	0.1	2.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLRA1	STHE	ENSG00000145888	"Glycine receptor alpha 1"	P23415	5	151822513-151924842	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	10	"brain: 31.7"	"Cell type enhanced"	"Detected in some"	26	"Basal glandular cells: 1.1;Bipolar cells: 4.9;Horizontal cells: 1.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	10	"pons and medulla: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.4"	"Group enriched"	"Detected in many"	4	"hypothalamus: 11.0;midbrain: 18.1;pons and medulla: 27.6"	"Region enhanced"	"Detected in all"		"pons and medulla: 54.9"	CAB079042		Supported				NA	NA					"CAB079042: "					"unprognostic (3.17e-1)"						"unprognostic (2.47e-1)"		"unprognostic (3.85e-7)"	"unprognostic (8.24e-2)"		"unprognostic (9.45e-3)"		0.3	3.2	1.2	0.1	0.7	0.2	0.1	3.2	0.9	0.1	0.2	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.7	0.2	0.1	0.1	0.1	2.7	0.0	0.1	2.2	0.1	0.1	0.2	31.7	0.1	0.1	1.6	0.1	0.1	0.6	0.1	0.1	0.1	12.6	0.1	0.1	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	3.2	0.9	0.1	2.7	2.7	0.0	31.7	0.0	0.0	0.0	0.0	1.1	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6
GLRA2	GLR	ENSG00000101958	"Glycine receptor alpha 2"	P23416	X	14529298-14731812	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	14	"brain: 21.0;intestine: 11.1"	"Cell type enhanced"	"Detected in some"	16	"Cardiomyocytes: 1.2;Horizontal cells: 1.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	33	"AN3-CA: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070422	Approved					NA	NA					"CAB070422: AB_11153055"	"unprognostic (2.52e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.74e-2)"			"unprognostic (1.81e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.95e-3)"		"unprognostic (1.13e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.69e-2)"			0.4	0.5	14.5	0.7	13.2	0.7	0.5	21.0	10.8	0.4	4.1	0.1	0.0	0.7	0.5	0.5	0.4	0.8	0.7	0.4	3.6	13.9	0.5	0.5	0.4	0.5	1.6	8.4	0.9	0.5	0.4	0.5	0.8	10.1	0.4	11.1	1.1	0.8	0.5	0.5	0.8	0.9	0.7	6.5	0.5	0.5	0.9	0.8	0.0	0.5	0.0	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	20.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	13.2	21.0	10.4	3.6	13.9	1.6	8.4	10.1	0.8	0.0	0.0	0.0	0.0	0.1	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0
GLRA3		ENSG00000145451	"Glycine receptor alpha 3"	O75311	4	174636914-174829314	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"brain: 15.2;breast: 6.1;pituitary gland: 12.5"	"Group enriched"	"Detected in some"	9	"Early spermatids: 18.4;Late spermatids: 13.2"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.2"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"HEL: 2.7;Karpas-707: 6.3;U-698: 2.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.75e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"		"unprognostic (1.36e-1)"	"unprognostic (9.02e-2)"		"unprognostic (3.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.64e-5)"	"unprognostic (4.61e-4)"	"unprognostic (2.24e-1)"		"unprognostic (1.15e-2)"	0.5	2.6	13.3	0.6	7.3	0.6	6.1	0.7	15.2	0.5	0.5	0.3	0.0	0.5	0.7	0.5	0.5	0.4	0.6	0.4	2.7	7.4	0.5	0.4	0.5	0.9	4.6	8.7	0.4	1.4	0.5	12.5	0.5	4.4	0.5	0.5	0.0	0.5	0.5	0.4	0.7	0.5	0.8	2.1	0.6	0.5	1.7	0.0	0.0	0.5	0.0	0.9	0.4	0.2	2.7	0.1	1.1	0.0	0.3	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.0	0.6	0.0	0.7	0.6	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	2.3	0.1	0.1	0.1	0.6	0.0	0.4	0.1	0.0	0.5	2.7	0.2	0.1	0.0	0.5	0.2	0.2	1.1	0.3	0.0	0.1	0.1	0.0	13.3	7.3	0.7	14.5	2.7	7.4	4.6	8.7	4.4	0.0	0.0	1.1	0.0	1.0	0.0	0.7	1.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.6	0.0	0.4	0.2	1.5	0.1	0.0	0.0	0.0	0.3
GLRB		ENSG00000109738	"Glycine receptor beta"	P48167	4	157076057-157172090	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 43.1;parathyroid gland: 37.0"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 12.6;Cholangiocytes: 7.6;Ciliated cells: 8.1;Muller glia cells: 11.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	18	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 17.5;hTERT-RPE1: 23.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052363	Approved					NA	NA					"HPA052363: AB_2681800"	"unprognostic (7.36e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.89e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.66e-2)"	4.5	7.2	12.6	1.5	20.9	0.7	10.3	15.9	43.1	9.4	2.3	2.8	0.1	1.1	3.3	5.4	1.5	7.4	3.5	9.9	18.3	17.3	4.1	1.6	3.4	0.8	11.1	21.3	1.8	14.2	37.0	6.7	2.9	16.5	6.5	1.4	0.7	16.7	5.2	3.3	1.5	1.2	4.0	6.1	0.6	2.2	1.9	4.5	0.0	1.5	0.5	0.7	1.9	1.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	4.8	2.0	5.8	17.5	11.3	4.6	0.0	9.6	6.2	4.7	8.9	0.0	14.8	0.0	2.3	9.7	5.8	0.0	4.4	1.5	8.9	0.0	5.8	2.9	2.2	0.2	5.2	3.7	0.0	4.1	1.3	8.2	1.2	23.3	4.2	3.1	0.0	0.0	8.5	0.0	0.4	0.0	0.3	0.0	1.3	0.0	7.9	0.0	12.7	0.8	6.3	3.8	0.0	4.5	0.7	0.9	4.1	0.9	6.2	2.8	8.3	4.7	9.3	0.0	0.0	0.0	6.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	12.6	20.9	15.9	43.1	18.3	17.3	11.1	21.3	16.5	4.5	0.0	0.6	0.0	0.7	1.0	6.9	12.6	7.6	8.1	3.4	0.0	2.0	0.3	0.0	6.9	0.2	1.0	0.0	0.0	1.5	0.0	2.6	0.6	1.1	0.0	0.1	1.6	0.0	1.8	0.0	0.0	0.3	0.0	3.3	1.0	0.0	11.6	1.9	0.0	3.2	0.4	1.6	0.0	1.1	1.1	3.0	0.3	0.1	0.0	0.0	0.1
GML	LY6DL	ENSG00000104499	"Glycosylphosphatidylinositol anchored molecule like"	Q99445	8	142834247-142916506	"Predicted intracellular proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"adrenal gland: 68.3"	"Cell type enhanced"	"Detected in some"	28	"granulocytes: 4.6;Sertoli cells: 6.5;Spermatocytes: 24.7;Spermatogonia: 7.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.2"	"Group enriched"	"Detected in some"	19	"HMC-1: 1.2;JURKAT: 2.1;SK-MEL-30: 1.6;U-937: 2.5"														"Intracellular and membrane"	NA	NA																							0.0	68.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.4	0.0	2.2	0.0	0.8	1.4	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	6.5	0.0	24.7	7.2	0.0	0.0	0.0	0.0	0.0
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease mutation, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 303.3;thyroid gland: 304.5"	"Cell type enhanced"	"Detected in all"	5	"Horizontal cells: 1781.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	56.2	79.0	84.2	34.4	44.5	42.1	87.4	86.0	107.4	43.2	42.3	25.4	27.0	33.2	37.2	44.7	41.0	43.6	34.4	106.0	71.0	144.0	39.6	35.3	46.6	44.6	75.8	64.7	43.6	118.1	120.9	303.3	49.8	85.6	36.3	31.5	42.7	171.6	31.1	172.9	26.3	34.9	40.5	61.4	36.9	42.4	18.2	27.4	56.0	304.5	80.6	41.0	37.3	44.6	27.3	41.5	29.9	36.2	25.3	24.2	24.6	9.7	32.8	55.4	25.8	94.2	43.0	49.8	56.4	51.6	64.5	46.3	95.8	50.6	32.0	87.9	73.2	46.2	42.3	50.8	75.1	43.7	21.1	30.6	35.6	49.9	62.7	43.5	20.7	22.4	51.3	38.2	31.3	42.2	51.2	48.9	39.5	31.2	43.7	42.5	133.6	105.4	50.6	17.6	6.4	34.7	64.9	48.5	56.5	51.7	38.7	68.7	157.4	78.4	77.9	62.9	50.7	59.5	56.7	53.7	85.7	77.0	30.8	53.1	76.8	49.5	67.6	37.6	10.1	43.7	29.9	24.8	29.5	20.7	35.7	22.1	26.7	22.0	22.2	37.8	27.3	21.3	24.2	29.1	25.3	36.2	41.5	23.3	24.6	84.2	44.5	86.0	107.4	71.0	144.0	75.8	64.7	85.6	27.4	205.4	224.1	189.5	151.9	115.9	363.0	884.0	242.0	250.3	255.9	247.7	53.0	672.6	376.4	220.5	577.5	343.9	323.7	303.7	196.1	292.5	221.9	260.9	133.0	165.2	333.8	1781.3	444.7	335.7	327.9	1338.6	245.7	276.8	210.9	147.9	250.3	861.2	313.5	239.3	185.3	130.9	175.1	207.0	226.4	48.2	25.4	103.0	1013.3	142.4	268.2	212.5
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 1104.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		60000000	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	55.2	42.1	84.7	55.1	82.3	41.7	37.8	78.8	112.5	44.0	52.1	46.4	26.0	55.4	44.3	31.2	41.7	38.8	36.6	39.6	74.7	65.7	43.9	38.7	47.1	47.1	68.5	52.1	45.0	33.9	48.9	36.9	45.3	56.6	40.1	41.0	70.7	37.6	41.7	19.7	35.5	65.3	51.2	61.0	51.0	40.8	31.4	39.2	44.5	37.6	19.5	45.6	42.2	54.1	7.7	18.8	18.4	13.2	10.6	9.9	6.0	54.7	51.8	61.6	42.9	35.2	38.8	23.8	77.8	51.9	70.7	55.6	42.3	54.9	57.2	57.4	78.5	40.1	28.9	61.7	56.4	64.7	87.8	30.3	55.5	49.2	48.0	44.4	33.3	61.0	34.3	39.8	67.5	62.9	47.8	57.3	45.4	34.3	51.8	67.3	34.1	73.0	26.3	35.4	28.2	42.0	71.3	47.6	45.2	48.4	34.1	75.8	86.4	72.1	47.0	63.1	44.3	32.9	45.8	87.3	62.3	41.8	48.4	56.4	35.1	61.2	131.0	53.3	70.4	35.0	7.4	11.1	17.1	8.7	13.2	8.0	7.4	8.7	9.7	10.9	7.7	5.9	6.5	18.4	10.6	13.2	18.8	9.9	6.0	84.7	82.3	78.8	112.5	74.7	65.7	68.5	52.1	56.6	39.2	65.5	41.8	61.1	42.7	76.6	128.2	51.2	58.6	30.8	35.2	71.5	164.9	36.8	39.7	78.1	24.7	107.9	139.4	0.0	86.3	77.4	70.2	78.2	52.0	51.3	89.1	170.0	118.1	93.9	126.8	25.1	70.5	95.3	50.6	74.9	88.7	159.0	130.7	84.2	82.7	56.2	1104.1	77.6	76.5	56.5	67.9	89.0	30.4	48.0	64.7	70.1
GNGT2	GNG9	ENSG00000167083	"G protein subunit gamma transducin 2"	O14610	17	49202791-49210574	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	5	"blood: 29.1;lymphoid tissue: 21.1;retina: 46.7"	"Cell type enhanced"	"Detected in many"	18	"Cone photoreceptor cells: 68.7;Kupffer cells: 22.4;Macrophages: 17.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 29.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 36.4;HDLM-2: 31.2;HUVEC TERT2: 9.4;RH-30: 11.6;TIME: 9.1;U-698: 11.2"	"Low region specificity"	"Detected in some"							HPA043381	Enhanced					NA	NA					"HPA043381: AB_2678455"	"unprognostic (9.11e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.99e-2)"	"unprognostic (4.62e-5)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.23e-1)"	2.7	2.1	2.7	9.4	3.7	1.3	1.8	0.7	2.2	2.1	2.3	2.0	0.4	2.6	1.6	1.2	1.8	1.7	3.3	2.4	2.5	1.9	3.0	2.6	6.2	12.2	3.2	0.4	1.7	1.2	0.1	1.4	1.9	2.2	2.2	3.3	46.7	1.6	1.1	0.6	0.6	4.9	2.9	4.5	21.1	1.7	0.8	2.5	6.0	2.5	1.4	16.6	3.6	5.1	2.0	9.7	0.9	29.1	10.6	14.4	5.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.7	0.5	0.0	0.0	36.4	0.3	0.1	0.0	0.0	0.0	0.0	2.1	31.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	9.4	4.5	0.0	0.2	0.8	0.0	2.7	2.2	0.3	0.0	0.0	7.0	11.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	9.1	0.0	5.8	0.0	0.0	0.1	1.6	11.2	0.1	0.1	0.0	0.0	4.3	0.4	14.4	21.5	12.6	1.9	2.4	10.2	9.7	2.0	1.5	5.9	0.9	10.6	29.1	0.8	1.8	5.4	2.7	3.7	0.7	2.2	2.5	1.9	3.2	0.4	2.2	2.5	0.0	1.4	5.6	0.0	0.3	2.3	0.6	0.0	0.0	1.2	0.0	68.7	0.0	3.3	0.0	0.6	4.7	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	11.1	0.0	0.0	2.5	22.4	6.5	0.6	17.7	0.0	7.2	0.0	3.3	0.0	0.0	0.0	0.0	12.3	6.5	0.0	0.0	0.0	0.1	0.2	14.0	0.0	0.0
GNLY	"D2S69E, LAG-2, LAG2, NKG5, TLA519"	ENSG00000115523	Granulysin	P22749	2	85685175-85698854	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 444.6"	"Cell type enhanced"	"Detected in many"	26	"Alveolar cells type 2: 120.7;Melanocytes: 75.9;T-cells: 467.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 226.1;NK-cell: 444.6"	"Group enriched"	"Detected in many"	55	"NK-cells: 444.6;T-cells: 226.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;JURKAT: 1.5;NB-4: 3.4;SuSa: 1.4;U-2197: 2.0;U-87 MG: 2.5"									"CAB025186, HPA058021"	Enhanced				"Secreted to blood"	NA	NA	2920000				"CAB025186: , HPA058021: AB_2683581"	"unprognostic (5.80e-2)"	"unprognostic (5.64e-3)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.48e-5)"	"unprognostic (4.34e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.79e-2)"	"prognostic favorable (6.60e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.46e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (8.07e-4)"	7.1	1.0	2.1	3.5	2.3	72.0	3.3	1.2	2.0	1.7	2.4	5.8	0.0	1.2	31.5	2.2	4.4	2.0	2.1	4.0	2.3	3.2	1.8	5.7	20.8	10.7	3.8	0.8	1.0	0.6	0.1	1.4	45.2	3.6	3.2	2.1	4.9	2.6	1.9	5.7	0.8	12.4	1.4	4.2	34.3	1.5	0.7	1.8	2.0	2.4	3.9	5.9	2.3	1.6	0.8	1.5	6.1	0.8	444.6	226.1	175.3	0.0	0.0	0.0	0.0	0.7	0.0	1.4	0.0	0.6	0.3	0.0	0.0	0.0	0.5	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.5	0.7	0.0	1.5	0.3	0.8	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	1.2	0.0	0.0	0.0	2.0	0.0	0.3	0.1	0.0	2.5	0.6	0.0	4.0	0.7	0.4	226.1	0.6	61.2	0.8	26.0	96.4	0.6	0.5	7.4	89.8	6.1	444.6	0.8	1.5	1.0	175.3	2.1	2.3	1.2	2.0	2.3	3.2	3.8	0.8	3.6	1.8	11.9	120.7	9.9	0.3	6.3	0.0	1.6	0.0	6.7	11.4	0.0	2.0	1.0	1.7	0.0	0.0	9.8	1.3	70.0	0.0	1.3	3.2	0.1	48.8	1.5	5.5	0.0	1.7	14.7	5.7	0.0	0.3	5.7	75.9	0.0	0.3	0.0	0.0	0.0	0.0	7.2	0.1	0.0	3.1	0.2	0.2	6.8	0.9	467.7	0.2	0.5
GNRHR	"GRHR, LHRHR"	ENSG00000109163	"Gonadotropin releasing hormone receptor"	P30968	4	67739328-67754360	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	14	"pituitary gland: 56.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"K-562: 3.0"	"Not detected"	"Not detected"							HPA013424	Enhanced					NA	NA					"HPA013424: AB_2668840"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.99e-2)"	0.1	3.9	0.1	0.4	0.2	0.2	0.1	0.3	1.7	0.3	0.1	0.1	0.1	0.7	0.1	0.1	1.6	0.0	0.2	0.2	0.2	0.2	0.1	0.1	0.1	1.1	0.1	0.1	0.2	0.3	0.0	56.6	0.1	0.5	0.2	0.0	0.1	0.3	0.1	0.2	0.9	0.1	0.1	0.1	0.2	0.3	0.3	0.1	0.2	1.0	0.1	0.4	0.1	0.5	1.3	0.2	0.0	0.0	0.4	0.3	0.0	0.2	1.5	1.5	1.6	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.5	1.7	1.3	0.2	0.0	0.6	0.5	0.0	0.0	0.0	0.3	0.5	0.3	0.3	0.7	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	1.2	3.0	0.0	0.0	0.8	0.6	0.4	1.0	0.5	0.0	0.6	1.3	0.6	0.0	0.0	0.9	2.1	0.0	0.3	0.0	0.3	0.3	0.2	1.0	0.1	0.2	0.6	0.2	1.2	0.3	0.6	1.4	0.8	0.9	0.0	0.0	0.0	0.2	0.0	0.2	0.5	0.1	0.0	0.0	1.3	0.1	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.3	0.3	0.2	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GOLGA7	"GCP16, GOLGA3AP1, GOLGA7A, HSPC041"	ENSG00000147533	"Golgin A7"	Q7Z5G4	8	41490396-41510980	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046878	Uncertain					NA	NA					"HPA046878: AB_2679854"	"unprognostic (2.93e-1)"	"unprognostic (9.56e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.88e-1)"	24.2	20.5	55.0	16.8	52.1	23.0	21.8	23.1	38.7	20.6	17.2	50.9	12.9	19.3	22.2	18.3	22.1	15.0	21.2	17.0	54.8	36.9	27.1	29.2	18.7	20.5	56.6	33.0	20.6	20.2	16.5	10.7	30.1	31.0	20.0	16.6	16.7	23.3	17.8	14.0	29.7	19.5	20.5	62.8	21.2	17.3	26.6	38.8	18.7	18.1	14.9	19.2	21.0	19.4	10.9	18.9	49.8	25.1	23.9	29.4	38.4	23.6	27.1	20.7	23.8	26.2	22.9	15.8	20.8	19.9	24.6	27.3	48.1	22.5	11.5	27.8	19.5	23.5	16.7	20.4	16.2	27.6	16.0	18.0	23.3	16.1	19.7	28.8	10.6	19.5	20.0	30.6	15.7	23.5	20.0	23.9	20.8	27.5	23.0	19.8	17.5	33.6	29.0	23.1	21.9	13.1	20.7	37.2	12.5	28.5	22.2	37.1	23.9	18.7	14.7	37.2	18.1	30.0	20.6	24.6	20.9	20.3	26.5	18.2	17.4	27.3	16.6	22.2	18.4	28.7	49.8	25.1	24.2	28.5	21.5	28.0	10.9	27.5	26.0	18.9	10.7	23.2	23.0	44.3	23.9	20.1	13.1	29.4	38.4	55.0	52.1	23.1	32.2	54.8	36.9	56.6	33.0	31.0	38.8	6.0	19.3	34.0	49.7	98.0	24.7	25.2	30.6	24.1	20.5	27.9	3.9	53.1	81.2	55.4	17.5	58.1	33.9	23.3	41.8	59.0	78.9	63.7	17.3	44.2	57.0	17.5	40.8	39.3	64.2	18.0	41.7	55.4	57.3	53.3	28.1	67.9	46.4	17.3	58.4	96.0	22.5	58.2	61.7	94.6	126.9	94.9	71.9	72.1	29.8	42.1
GOT2	"KAT4, KATIV, KYAT4, mitAAT"	ENSG00000125166	"Glutamic-oxaloacetic transaminase 2"	P00505	16	58707131-58734357	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Lipid transport, Transport"	"Aminotransferase, Transferase"	"Cancer-related genes, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 167.8"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 269.3;Hepatocytes: 145.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018139	Enhanced				"Intracellular and membrane"	NA	NA		7000000			"HPA018139: AB_1849903"	"unprognostic (1.50e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (1.61e-4)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (2.90e-9)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.22e-1)"	6.1	21.0	12.7	8.0	19.1	5.5	10.7	19.4	35.7	10.6	15.9	16.0	33.3	10.6	10.4	19.5	17.7	13.5	8.9	78.1	15.8	16.7	24.6	85.5	7.1	11.1	16.2	17.8	8.7	8.8	27.0	13.0	7.3	27.7	17.2	18.8	23.4	13.0	20.5	167.8	10.4	9.4	13.5	12.3	8.0	13.6	10.8	9.9	10.7	12.3	53.9	15.0	15.5	11.2	14.3	17.6	3.5	9.9	14.5	24.5	14.3	27.6	37.6	19.8	24.1	14.4	13.0	26.0	21.3	22.7	42.0	23.1	32.5	25.0	61.9	25.3	23.5	18.4	40.9	42.4	41.3	53.6	17.0	38.9	16.6	20.5	36.3	18.3	26.7	15.4	12.6	23.5	26.4	23.1	24.0	42.1	30.0	33.4	6.4	21.3	24.7	33.2	25.8	26.9	18.5	73.0	36.5	30.2	59.4	39.6	40.7	31.7	23.0	40.7	43.9	15.3	18.7	22.1	8.7	16.9	15.3	28.0	11.9	27.0	14.9	13.8	50.7	16.3	26.8	15.4	2.3	9.9	3.5	15.2	8.6	23.5	14.3	18.0	18.4	17.6	10.6	16.7	15.3	0.9	14.5	8.5	15.5	24.5	14.3	12.7	19.1	19.4	35.7	15.8	16.7	16.2	17.8	27.7	9.9	8.9	12.0	18.2	27.1	28.4	31.7	269.3	33.1	13.4	14.8	34.9	72.6	40.0	48.0	48.1	3.5	16.6	29.5	23.3	36.8	30.5	15.1	29.5	13.9	145.0	34.4	19.1	19.8	25.8	17.4	5.6	16.7	14.4	23.6	9.0	29.0	15.2	34.5	5.8	21.2	51.6	42.1	0.0	14.7	11.2	14.7	26.2	19.8	14.4	49.8	58.8
GPBAR1	"BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5"	ENSG00000179921	"G protein-coupled bile acid receptor 1"	Q8TDU6	2	218259496-218263859	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 85.6;gallbladder: 73.8"	"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 14.0;Intestinal endocrine cells: 44.2;Kupffer cells: 42.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 3.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 85.6;non-classical monocyte: 78.5"	"Lineage enriched"	"Detected in many"	5	"monocytes: 85.6"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.1;HHSteC: 5.1;SCLC-21H: 2.6;U-937: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062890	Enhanced					NA	NA					"HPA062890: AB_2684896"	"unprognostic (8.47e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.76e-3)"	"unprognostic (4.32e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.40e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.29e-1)"	19.9	1.1	0.3	2.6	0.4	1.8	11.4	0.2	0.4	0.7	2.7	0.5	0.8	1.0	1.1	1.4	1.3	0.9	73.8	3.8	0.2	0.0	3.2	1.7	2.2	3.8	0.4	0.2	1.4	1.5	0.0	0.7	8.9	0.4	2.0	0.5	0.9	0.5	0.9	0.8	0.8	3.2	10.3	0.2	6.5	5.5	1.5	0.2	1.0	1.5	1.8	0.6	3.2	0.7	0.0	17.4	0.8	85.6	0.0	0.1	15.8	0.2	0.1	0.4	0.0	3.1	0.1	0.9	0.0	0.4	0.0	0.1	0.8	0.4	0.2	0.3	0.3	0.2	0.1	0.1	0.3	0.0	0.0	0.8	0.3	0.5	0.4	5.1	0.4	1.4	0.0	2.5	0.0	0.0	0.2	0.2	0.4	0.3	0.5	0.6	0.3	0.2	0.7	0.2	0.0	0.0	0.2	0.0	0.2	1.6	1.1	2.6	2.3	0.3	0.7	0.4	0.2	0.0	0.8	0.0	0.1	0.3	0.3	0.2	0.3	0.7	0.1	0.3	5.1	0.3	0.0	36.4	0.0	0.1	85.6	0.1	0.0	0.0	0.1	17.4	0.0	0.0	0.0	0.8	0.0	78.5	0.7	0.1	15.8	0.3	0.4	0.2	0.4	0.2	0.0	0.4	0.2	0.4	0.2	0.0	4.3	0.9	0.1	0.2	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.4	10.0	0.0	2.6	0.5	0.0	0.0	0.4	2.8	1.9	0.1	1.1	0.0	14.0	0.0	44.2	3.1	42.9	1.6	3.1	6.8	0.0	1.0	0.3	0.0	0.4	0.8	2.5	0.0	0.0	0.0	0.8	0.0	0.0	0.4	1.4	0.0	0.1	0.2
GPER1	"CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR"	ENSG00000164850	"G protein-coupled estrogen receptor 1"	Q99527	7	1082208-1093815	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 22.2;Kupffer cells: 13.5;Paneth cells: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.3;intermediate monocyte: 4.2;myeloid DC: 8.4"	"Group enriched"	"Detected in many"	18	"dendritic cells: 8.4;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 10.1;Daudi: 10.6;Hep G2: 19.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA016718, HPA027052"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			Nucleoli	"Nucleoplasm, Vesicles, Cytosol"	"HPA016718: , HPA027052: AB_10612112"	"unprognostic (4.74e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.78e-2)"	14.2	10.9	12.1	3.6	13.2	1.2	11.5	5.1	11.1	6.4	7.1	5.6	3.5	2.0	5.4	1.8	5.5	4.8	3.2	6.0	8.3	6.2	7.4	19.5	25.6	6.4	8.6	8.7	3.3	4.0	1.8	4.7	13.3	6.1	6.8	3.7	5.2	4.2	11.8	8.6	2.8	2.6	5.5	4.1	6.5	23.9	2.2	8.6	1.3	16.5	2.3	2.8	6.4	7.2	0.3	8.4	0.0	4.3	0.0	0.0	1.6	0.9	0.4	0.2	10.1	2.5	2.4	1.0	5.8	3.9	1.8	3.3	0.2	0.2	10.6	1.0	7.3	0.1	0.5	0.1	0.0	0.2	2.2	1.8	0.0	1.3	19.4	0.3	0.1	0.7	1.3	0.0	1.1	0.0	1.4	0.5	0.2	0.1	0.1	0.4	0.7	0.0	0.3	1.9	2.0	6.9	0.9	0.0	0.0	0.2	0.0	0.1	4.0	0.0	0.4	2.1	0.8	0.2	0.1	1.4	0.4	2.6	6.1	1.8	0.0	0.0	3.6	3.4	0.2	0.2	0.0	4.3	0.0	0.0	4.2	0.0	0.3	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	1.6	12.1	13.2	5.1	11.1	8.3	6.2	8.6	8.7	6.1	8.6	0.0	0.0	0.0	0.0	0.5	0.0	2.5	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	2.2	1.3	0.0	2.8	0.5	1.4	0.7	0.0	22.2	0.5	0.0	1.2	0.6	13.5	0.6	2.6	1.7	0.0	0.0	2.5	4.3	0.8	8.2	1.1	3.0	0.4	0.0	4.1	0.3	3.1	0.3	0.0	0.0	1.5	0.0
GPR137B	TM7SF1	ENSG00000077585	"G protein-coupled receptor 137B"	O60478	1	236142505-236221865	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"monocytes: 130.8;Muller glia cells: 234.3;Rod photoreceptor cells: 135.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 11.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.3;SK-MEL-30: 67.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026422	Approved					NA	NA					"HPA026422: AB_1849338"	"unprognostic (1.59e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (6.49e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	12.6	6.0	26.3	11.6	32.0	4.5	11.3	12.1	23.2	16.3	7.8	18.4	5.6	7.6	14.9	31.8	7.5	5.1	15.8	19.7	24.1	16.3	51.2	16.7	12.7	18.8	23.4	16.7	10.2	3.3	2.0	3.1	22.4	18.9	8.7	8.8	31.1	5.5	12.2	1.7	13.2	6.8	12.7	26.5	16.2	8.4	3.1	20.0	3.8	11.9	1.7	12.7	19.0	10.4	0.5	1.2	11.7	6.8	0.1	2.7	0.4	1.7	2.4	2.0	1.8	27.3	15.5	0.6	3.9	8.7	2.4	3.3	0.5	2.1	0.2	6.3	4.1	5.4	1.4	2.6	2.4	2.3	1.7	5.1	1.0	0.3	0.4	3.8	1.3	9.7	10.0	8.2	1.8	0.9	7.6	3.8	2.4	0.1	0.0	4.0	2.0	1.1	0.5	1.0	0.7	0.9	1.9	3.2	0.7	3.5	6.3	1.5	3.0	1.4	5.4	67.0	1.6	7.0	2.3	3.3	3.6	2.5	8.5	3.8	0.3	2.1	0.2	2.2	0.9	5.5	11.7	0.9	9.2	0.9	4.0	0.5	0.5	0.7	2.7	1.2	0.3	0.4	0.9	0.2	0.1	6.8	0.3	1.8	0.4	26.3	32.0	12.1	17.6	24.1	16.3	23.4	16.7	18.9	20.0	0.0	1.7	13.7	19.2	22.9	31.8	21.6	5.1	0.0	0.0	12.2	33.4	32.4	14.9	10.9	0.0	5.1	0.8	0.0	9.1	8.0	22.8	18.1	20.7	3.9	78.6	49.3	8.2	13.5	52.0	0.0	8.3	34.3	65.8	130.8	3.6	234.3	10.4	2.9	5.6	77.4	135.9	0.0	10.3	0.1	0.2	17.3	34.1	17.5	2.3	23.0
GPR143	OA1	ENSG00000101850	"G protein-coupled receptor 143"	P51810	X	9725346-9786297	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"retina: 51.5"	"Group enriched"	"Detected in many"	9	"Cytotrophoblasts: 34.8;Melanocytes: 119.8"	"Cancer enriched"	"Detected in all"	9	"melanoma: 84.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	6	"basophil: 5.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 5.0"	"Cell line enriched"	"Detected in some"	6	"SK-MEL-30: 58.4"	"Not detected"	"Not detected"							HPA003648	Enhanced					NA	NA					"HPA003648: AB_2667028"	"unprognostic (4.60e-2)"	"prognostic favorable (8.73e-4)"	"unprognostic (7.43e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.45e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.59e-2)"	0.8	1.3	4.2	0.0	7.6	0.0	2.1	1.5	4.5	2.0	1.6	3.0	3.6	0.6	3.9	7.0	2.8	3.7	1.1	0.4	3.4	3.7	6.6	2.0	1.2	0.4	5.7	3.1	4.5	2.1	3.0	2.0	7.9	6.3	3.4	1.8	51.5	4.1	6.3	0.2	11.5	0.5	1.2	4.3	0.2	0.9	1.0	2.2	1.0	4.2	1.0	1.8	1.8	1.1	0.5	0.1	5.0	0.3	0.1	0.3	0.0	0.7	0.1	1.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.9	0.0	1.3	0.0	0.6	0.0	0.0	9.5	2.5	0.0	0.0	0.0	0.0	4.4	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	8.4	1.2	0.3	0.0	0.1	0.0	58.4	4.3	0.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.0	0.3	0.2	0.3	0.1	0.1	0.4	0.1	0.1	0.1	0.5	0.1	0.2	0.8	0.1	0.1	0.0	0.0	0.0	4.2	7.6	1.5	4.5	3.4	3.7	5.7	3.1	6.3	2.2	0.0	0.0	0.0	1.0	4.8	0.4	0.6	0.0	4.0	5.7	7.0	0.0	34.8	1.7	4.6	0.2	0.7	0.2	0.0	0.6	1.3	1.0	1.5	0.0	0.0	4.0	0.0	0.0	3.7	0.0	1.3	1.7	0.0	119.8	0.0	0.4	1.4	1.3	0.0	6.0	3.9	0.0	0.0	0.3	0.2	1.2	0.5	8.5	0.0	1.9	1.4
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037929-170085403	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"parathyroid gland: 71.0"	"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 186.9;Rod photoreceptor cells: 156.5;Undifferentiated cells: 149.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 31.0;SK-BR-3: 24.8;THP-1: 48.9;U-266/70: 54.0;U-266/84: 31.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA006970	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.61e-4)"	7.0	1.4	3.1	21.7	2.5	23.6	8.2	0.9	1.8	2.6	31.2	1.5	7.9	18.0	1.9	21.5	2.6	1.8	16.2	3.0	1.9	1.7	27.4	2.1	23.2	25.6	2.7	0.4	1.6	14.7	71.0	3.5	2.9	1.8	10.7	18.1	11.8	14.2	4.7	2.0	1.8	43.2	0.9	4.7	17.9	18.0	2.9	2.4	6.6	3.8	1.0	10.7	9.1	6.9	11.2	2.9	10.1	1.1	0.3	3.0	1.2	15.9	0.3	0.0	0.1	0.1	0.1	4.0	0.1	0.1	0.1	0.5	2.9	2.0	7.4	3.4	0.1	1.0	0.1	2.2	0.1	0.2	11.3	4.4	4.8	0.2	6.0	0.0	9.4	6.5	0.0	0.2	0.5	0.6	0.7	0.3	3.5	1.5	19.2	0.1	10.2	0.7	2.0	2.6	9.8	0.6	1.3	0.3	31.0	8.4	22.1	1.6	0.4	0.2	24.8	1.1	2.2	14.5	48.9	0.5	0.0	0.1	1.8	1.2	54.0	31.0	12.9	0.2	10.2	0.7	1.5	1.1	8.1	0.5	0.4	0.9	6.8	0.9	0.4	2.2	11.2	3.0	1.1	10.1	0.3	0.1	2.9	0.3	1.2	3.1	2.5	0.9	1.8	1.9	1.7	2.7	0.4	1.8	2.4	8.9	39.0	27.8	3.1	0.3	7.9	1.0	25.5	18.7	18.2	59.3	37.3	2.6	46.4	10.6	24.4	4.5	103.3	0.0	63.8	15.0	0.4	47.4	1.1	0.5	7.0	14.3	186.9	16.0	9.2	32.2	0.6	10.0	27.0	97.4	129.6	7.7	48.2	137.8	0.4	121.7	156.5	0.0	0.3	6.4	11.9	0.6	22.8	2.5	149.6	25.7
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 27.1;smooth muscle: 21.0"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 149.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 24.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Approved	Nucleoplasm,Nucleoli		Yes	No			Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	2.4	0.9	2.1	3.6	1.7	0.0	1.9	1.2	4.0	7.3	4.9	3.1	8.5	0.8	27.1	8.2	7.4	7.7	5.6	2.4	2.8	1.5	1.1	0.4	2.8	0.4	3.0	1.2	7.6	11.0	4.9	1.3	1.3	3.0	8.2	2.3	3.4	2.3	9.4	0.8	1.5	2.1	21.0	3.0	1.2	2.2	3.0	0.8	1.4	1.2	1.7	0.7	2.8	6.8	0.3	1.2	1.5	0.5	0.2	0.3	0.2	6.1	3.8	15.5	9.9	3.7	6.6	0.0	5.9	6.5	5.1	5.4	24.0	1.0	0.0	3.3	8.9	9.6	18.4	3.7	5.8	3.0	2.3	4.8	2.2	3.0	0.1	1.6	0.6	1.5	2.3	3.8	4.4	7.1	11.9	10.2	1.9	2.0	0.1	7.7	0.5	0.7	0.1	6.3	10.3	6.0	1.8	6.7	0.0	2.7	1.7	3.1	13.7	6.5	0.2	17.8	6.1	3.4	0.7	13.7	10.5	5.5	14.1	6.7	0.0	0.0	0.0	2.8	0.0	2.7	1.5	0.3	0.2	0.1	0.3	0.1	0.1	0.1	0.0	1.2	0.3	0.1	0.3	1.3	0.2	0.5	0.3	0.0	0.2	2.1	1.7	1.2	4.0	2.8	1.5	3.0	1.2	3.0	0.8	3.0	0.6	0.0	5.0	1.9	1.7	2.0	0.0	1.4	1.2	0.0	0.0	0.4	0.0	3.6	0.4	6.3	0.0	0.0	7.2	0.2	6.3	4.6	0.0	0.0	0.7	149.4	0.0	4.3	1.8	0.6	6.9	1.3	1.7	1.8	1.7	2.7	2.9	0.0	15.9	0.0	1.5	19.4	12.2	0.0	0.7	1.3	0.3	0.0	2.3	2.3
GPR35		ENSG00000178623	"G protein-coupled receptor 35"	Q9HC97	2	240605431-240631259	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 109.6"	"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 80.6;granulocytes: 38.0;Mucus-secreting cells: 25.1;Paneth cells: 24.6;Undifferentiated cells: 21.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"classical monocyte: 16.4;eosinophil: 16.8;intermediate monocyte: 22.7;myeloid DC: 14.5;non-classical monocyte: 6.1"	"Group enriched"	"Detected in many"	14	"dendritic cells: 14.5;granulocytes: 16.8;monocytes: 22.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 10.8;CAPAN-2: 27.2;HDLM-2: 9.0;Hep G2: 17.3;HMC-1: 17.1;OE19: 20.1;U-937: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.05e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (7.03e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-3)"	0.8	0.2	1.5	7.0	1.8	2.4	1.4	2.4	2.2	1.6	50.4	1.0	0.5	27.2	1.7	1.8	1.1	3.4	24.1	0.8	1.5	1.5	2.2	0.7	3.1	6.6	1.6	0.8	2.5	0.5	0.3	3.2	0.7	1.8	1.8	11.2	0.6	0.8	0.7	3.9	1.2	109.6	1.3	1.4	8.9	10.8	2.0	1.6	1.9	1.2	0.9	2.4	1.0	1.0	0.0	14.5	16.8	22.7	0.3	1.3	5.5	0.0	0.2	0.1	0.5	0.5	0.0	0.2	0.0	0.1	0.0	0.1	10.8	27.2	0.1	0.1	0.1	0.4	0.2	0.0	0.0	0.0	9.0	0.3	4.5	0.2	17.3	0.2	0.2	17.1	0.1	0.0	0.3	0.1	0.2	0.0	0.7	0.2	1.5	0.0	0.3	0.2	8.4	0.4	20.1	0.1	1.0	0.0	0.2	0.1	0.1	1.0	0.4	0.0	0.1	0.2	0.3	0.1	3.0	0.4	0.1	0.1	0.7	0.0	1.9	0.8	0.1	0.0	9.5	0.2	0.0	16.4	16.8	0.7	22.7	1.3	0.0	0.4	0.4	14.5	0.0	0.2	0.5	0.2	0.3	6.1	0.3	0.1	5.5	1.5	1.8	2.4	2.2	1.5	1.5	1.6	0.8	1.8	1.6	0.0	7.9	0.0	0.0	1.8	1.3	0.8	2.5	0.0	0.0	1.8	0.0	0.1	0.0	1.2	0.0	0.2	80.6	0.0	2.9	0.0	0.4	0.1	38.0	0.0	11.0	1.6	6.4	0.0	5.1	0.0	0.3	8.8	0.0	2.8	25.1	0.2	8.3	24.6	1.1	2.1	2.4	0.0	0.5	1.1	0.7	1.0	0.2	2.5	21.8	0.1
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124745997-124765627	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 62.4"	"Cell type enriched"	"Detected in many"	36	"Muller glia cells: 779.4"	"Cancer enhanced"	"Detected in many"		"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.4;fHDF/TERT166: 22.0;hTCEpi: 9.8;SK-BR-3: 8.5;SuSa: 10.6;TIME: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"		No	No		48000	"Nuclear membrane, Cytosol"		"HPA042903: AB_2678219, HPA068009: AB_2685940"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	1.6	1.0	14.5	1.1	19.6	0.9	1.7	2.3	52.6	1.5	1.4	62.4	0.0	1.0	2.1	1.4	7.8	2.1	1.4	0.9	23.9	11.3	1.2	8.8	1.3	1.1	33.5	12.3	1.0	3.0	0.8	0.3	10.0	23.3	1.8	1.5	3.5	1.6	1.8	1.1	4.1	1.3	3.0	49.4	4.3	1.2	15.5	26.5	0.0	0.9	0.0	0.9	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	9.4	0.0	0.0	0.0	2.7	0.5	2.5	2.4	0.6	0.4	0.8	0.0	0.0	22.0	0.3	0.2	2.8	0.0	0.5	0.4	1.2	0.1	5.9	0.0	2.8	0.0	0.4	0.0	9.8	0.0	0.1	0.0	4.5	0.0	0.0	4.3	0.0	0.5	0.0	0.0	1.4	0.0	4.5	0.0	0.0	0.0	0.0	0.1	2.2	3.3	0.0	8.5	3.2	10.6	2.2	0.0	15.3	2.0	0.7	0.0	0.0	1.3	0.0	0.0	1.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	19.6	2.3	19.6	23.9	11.3	33.5	12.3	23.3	26.5	0.0	0.0	0.0	0.3	4.0	21.7	0.4	2.5	0.0	0.0	1.8	5.9	7.1	0.0	4.3	0.2	0.5	0.0	0.0	0.5	15.1	2.7	2.1	0.0	21.5	1.0	17.5	0.0	0.0	0.3	0.9	2.6	0.0	3.3	1.0	0.4	779.4	0.4	0.0	0.7	0.0	12.5	0.0	0.9	0.6	0.7	8.9	2.5	0.0	0.0	0.1
GPRC5C	RAIG-3	ENSG00000170412	"G protein-coupled receptor class C group 5 member C"	Q9NQ84	17	74424851-74451653	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 76.2"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 193.6;Hepatocytes: 148.3;Paneth cells: 149.7;Sertoli cells: 142.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.1"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 10.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 10.2;monocytes: 4.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 24.0;HMC-1: 42.2;RPTEC TERT1: 56.9;RT4: 26.3;T-47d: 32.0"	"Region enriched"	"Detected in many"	9	"cerebellum: 47.7"	"Low region specificity"	"Detected in all"			HPA029776	Enhanced		Uncertain	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA029776: AB_10602324"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.58e-5)"	"unprognostic (7.58e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.54e-3)"	4.3	4.1	5.2	2.2	5.3	0.0	7.7	31.1	5.7	19.7	15.4	4.4	17.0	10.0	5.8	9.9	5.3	12.5	17.6	7.7	5.3	2.6	43.8	46.1	11.5	2.8	4.8	4.9	12.3	76.2	12.0	3.4	4.5	6.1	15.1	6.2	18.0	16.8	11.7	25.4	9.2	15.2	3.9	4.6	5.1	44.7	4.4	4.1	1.9	42.2	10.2	3.5	12.6	8.0	0.7	10.2	0.1	4.7	0.0	0.1	0.3	4.6	16.7	1.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	21.4	0.0	13.3	0.1	5.4	14.7	2.2	0.3	0.0	0.0	2.7	0.0	1.2	24.0	4.9	0.0	42.2	0.4	7.6	0.0	0.0	22.7	0.0	0.0	1.2	0.3	0.0	5.2	0.1	4.5	2.7	23.1	19.4	0.0	0.0	1.1	56.9	26.3	8.1	0.7	0.8	1.8	0.0	10.9	32.0	1.2	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.1	0.6	0.1	0.0	1.7	0.1	0.0	3.4	0.0	0.7	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	4.7	10.2	0.0	0.3	5.2	5.3	31.1	5.7	5.3	2.6	4.8	4.9	6.1	4.1	3.0	48.9	1.5	39.6	12.0	0.8	193.6	68.8	22.7	18.2	129.1	0.0	0.7	24.9	53.1	0.1	8.7	61.7	0.0	58.9	7.1	19.9	46.9	10.3	148.3	9.6	4.8	43.7	25.8	8.5	0.5	16.7	4.2	3.3	5.4	47.3	18.8	37.9	149.7	20.8	51.6	0.8	142.3	56.7	0.4	3.0	9.8	21.2	1.5	44.1	40.9
GPRC6A	bA86F4.3	ENSG00000173612	"G protein-coupled receptor class C group 6 member A"	Q5T6X5	6	116792085-116829037	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	21	"adrenal gland: 1.1;kidney: 3.2;prostate: 1.4;salivary gland: 3.6"	"Cell type enhanced"	"Detected in single"	35	"Intestinal endocrine cells: 1.7"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"U-266/70: 6.0;U-266/84: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA								"unprognostic (9.16e-2)"									"unprognostic (2.48e-1)"			"unprognostic (4.38e-3)"			0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		1.4	0.1		3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRAMD1B	"KIAA1201, LINC01059"	ENSG00000023171	"GRAM domain containing 1B"	Q3KR37	11	123358428-123627774	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.7;brain: 55.2;intestine: 21.7"	"Cell type enhanced"	"Detected in many"	14	"Bipolar cells: 41.9;Cone photoreceptor cells: 108.0;Horizontal cells: 42.9;Rod photoreceptor cells: 85.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 11.5"	"Group enriched"	"Detected in many"	4	"A549: 22.2;HDLM-2: 58.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008557, HPA075204"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"		NA	NA			"Endoplasmic reticulum, Plasma membrane"	Vesicles	"HPA008557: AB_1079197, HPA075204: "	"unprognostic (1.86e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (4.30e-7)"	"unprognostic (1.39e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	1.4	67.7	15.5	3.1	16.0	11.8	1.1	55.2	25.0	1.2	3.1	5.1	5.9	21.7	1.2	6.6	0.9	2.9	8.1	4.3	13.6	7.5	10.4	1.3	1.9	3.6	6.8	15.1	7.6	2.0	0.6	6.7	5.0	14.4	1.1	1.2	11.9	1.3	2.5	1.8	0.8	15.6	1.3	4.1	2.7	7.8	10.6	5.1	3.4	3.7	0.0	2.7	1.5	0.8	0.1	11.5	0.6	2.0	2.6	2.7	0.7	0.0	22.2	1.2	0.0	0.1	0.2	3.6	7.4	5.3	1.6	0.6	0.9	0.1	1.3	3.9	3.7	2.5	0.0	2.3	0.0	1.7	58.9	2.0	0.0	10.0	0.2	0.0	7.6	0.0	0.4	0.0	2.8	0.0	1.9	0.7	0.6	0.0	0.0	1.4	0.1	1.3	2.6	2.8	9.9	8.4	4.0	3.6	2.4	0.1	0.0	7.4	6.0	1.7	0.1	0.0	3.4	0.2	4.3	4.4	8.9	1.4	1.5	0.3	0.0	0.0	0.0	1.8	8.0	0.4	0.0	2.0	0.6	0.7	1.0	0.4	0.0	2.7	2.1	3.0	0.1	0.3	0.3	0.2	2.6	1.0	11.5	1.1	0.7	15.5	16.0	55.2	25.0	13.6	7.5	6.8	15.1	14.4	5.1	0.0	0.3	0.0	0.0	0.0	41.9	5.5	25.5	0.0	0.0	5.2	108.0	4.5	3.3	0.5	5.2	0.7	0.3	0.0	0.4	3.0	1.1	0.1	0.0	0.0	2.3	42.9	0.0	0.6	3.5	2.3	0.6	2.8	0.0	1.0	0.8	21.5	2.3	0.2	0.7	5.5	85.7	0.0	0.8	1.0	1.5	0.4	2.1	1.0	0.4	0.0
GRIA2	"GluA2, GLUR2, GLURB"	ENSG00000120251	"Glutamate ionotropic receptor AMPA type subunit 2"	P42262	4	157204182-157366075	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 95.9"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 242.0;Horizontal cells: 130.3"	"Group enriched"	"Detected in some"	10	"breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008441	Enhanced					NA	NA					"HPA008441: AB_1078983"	"unprognostic (1.36e-1)"	"unprognostic (9.60e-3)"		"unprognostic (4.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"		"unprognostic (8.70e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.91e-5)"	"unprognostic (2.42e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.55e-2)"	1.2	6.5	36.9	1.3	39.1	1.1	2.0	22.1	95.9	8.2	1.3	5.6	0.0	1.2	13.5	9.8	1.2	9.6	1.2	1.2	30.1	15.7	1.5	1.1	1.4	1.2	10.0	30.6	1.7	2.2	1.2	10.5	1.2	7.1	1.8	1.2	0.1	2.1	3.0	1.2	1.1	1.2	6.1	6.9	1.3	1.5	2.1	8.8	0.0	1.2	0.0	1.2	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	19.9	2.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	0.2	0.0	0.0	0.6	0.0	0.0	0.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.9	39.1	22.1	41.2	30.1	15.7	10.0	30.6	7.1	8.8	0.0	0.0	0.0	0.0	0.0	242.0	2.2	0.0	0.0	0.0	0.0	41.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	130.3	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	3.1	0.0	0.0	0.4	0.0	14.0	0.0	0.7	3.9	1.5	0.0	0.0	0.0	0.0	0.0
GRIA3	"GluA3, GLUR3, GLURC, MRX94"	ENSG00000125675	"Glutamate ionotropic receptor AMPA type subunit 3"	P42263	X	123184153-123490915	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.8"	"Cell type enriched"	"Detected in some"	22	"Horizontal cells: 187.5"	"Cancer enriched"	"Detected in some"	11	"glioma: 10.2"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"BJ: 14.4;BJ hTERT+: 20.9;fHDF/TERT166: 27.5;U-2197: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058659, HPA073344"	Enhanced				"Intracellular and membrane"	NA	NA					"HPA058659: AB_2683791, HPA073344: "	"unprognostic (2.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.29e-4)"	"unprognostic (2.42e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	1.5	10.7	31.4	1.0	27.4	0.7	2.3	3.5	40.8	9.1	1.3	3.7	0.1	0.9	3.0	4.9	1.1	2.0	1.9	2.7	26.1	8.1	3.4	9.3	1.0	1.1	10.2	21.2	5.6	2.6	0.6	0.6	1.1	4.9	2.1	1.5	0.7	0.9	3.0	0.9	1.2	1.0	2.9	8.4	0.7	3.0	1.4	7.8	0.0	0.8	0.0	1.5	1.3	1.8	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	14.4	20.9	0.2	0.5	0.0	0.0	0.0	0.0	27.5	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.1	0.0	9.2	0.1	0.0	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	27.4	3.5	27.5	26.1	8.1	10.2	21.2	4.9	7.8	0.0	0.0	0.0	0.0	0.2	4.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.1	0.5	0.0	4.7	0.1	187.5	0.0	0.6	0.0	0.0	8.6	0.0	1.7	0.0	0.0	1.5	0.5	0.0	3.9	6.0	3.1	0.0	0.5	0.0	0.0	0.9	0.1	0.0	0.0	0.0
GRIK4	"GluK4, GRIK, KA1"	ENSG00000149403	"Glutamate ionotropic receptor kainate type subunit 4"	Q16099	11	120511700-120988904	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 19.3;ovary: 8.5"	"Cell type enriched"	"Detected in some"	8	"Cone photoreceptor cells: 33.4"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.4;HEL: 19.7;T-47d: 5.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA074453	Enhanced					NA	NA					"HPA074453: AB_2732255"	"unprognostic (9.63e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.64e-4)"	"unprognostic (1.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.84e-11)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.58e-2)"	1.0	5.4	11.3	1.0	9.0	0.8	1.3	3.9	19.3	1.2	1.1	9.4	0.0	1.2	1.1	0.9	1.2	1.7	1.1	1.6	13.9	7.2	1.0	0.8	3.1	1.0	8.7	11.0	8.5	0.8	0.8	2.6	1.5	12.3	1.5	1.1	0.0	1.1	1.0	1.0	1.3	1.2	1.0	6.3	1.4	0.9	2.0	8.2	0.0	6.3	0.0	1.0	1.2	0.4	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	6.4	0.6	19.7	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.6	5.1	0.0	0.2	0.0	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	11.3	9.0	3.9	14.0	13.9	7.2	8.7	11.0	12.3	8.2	0.0	1.1	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.0	0.0	33.4	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.3	4.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.7	0.0	0.1	0.0	0.0	0.4
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137138390-137168762	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	38	"brain: 97.5"	"Cell type enhanced"	"Detected in some"	10	"Bipolar cells: 5.6;Cardiomyocytes: 2.4;monocytes: 3.6;Rod photoreceptor cells: 5.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.6;REH: 3.1;RPMI-8226: 4.3;SCLC-21H: 10.0;SH-SY5Y: 6.9;T-47d: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced					NA	NA					"HPA067773: "	"unprognostic (3.58e-2)"	"unprognostic (4.51e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.48e-4)"	"unprognostic (5.20e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.72e-2)"	1.7	2.0	23.6	2.0	47.5	1.7	1.8	28.1	97.5	1.8	2.0	3.2	0.0	2.2	1.7	1.8	1.7	1.7	1.7	1.7	29.1	26.4	1.8	1.7	1.8	1.8	15.4	37.9	1.7	1.8	1.8	0.0	1.7	22.0	2.2	1.8	0.7	2.5	1.8	1.7	1.8	2.2	1.8	4.7	1.8	1.8	1.9	6.3	0.0	1.7	0.0	1.8	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.4	1.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	1.5	0.1	0.0	0.2	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	0.0	0.1	2.6	0.0	3.1	0.0	4.3	0.0	0.0	10.0	6.9	0.1	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	23.6	47.5	28.1	87.9	29.1	26.4	15.4	37.9	22.0	6.3	0.0	0.0	0.0	0.4	0.0	5.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.1	1.6	1.7	0.0	0.0	0.4	0.0	0.0	0.0	3.6	1.7	1.6	0.3	0.0	0.0	0.0	5.7	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.3
GRIN2A	"GluN2A, NMDAR2A"	ENSG00000183454	"Glutamate ionotropic receptor NMDA type subunit 2A"	Q12879	16	9753404-10182754	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.2"	"Cell type enhanced"	"Detected in some"	9	"Cardiomyocytes: 14.9;Early spermatids: 13.4;Late spermatids: 13.0;Muller glia cells: 17.7;Rod photoreceptor cells: 12.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 7.8;hTERT-RPE1: 3.4;RPMI-8226: 2.9;U-138 MG: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB022725	Enhanced					NA	NA					"CAB022725: "	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.33e-2)"	0.9	1.0	5.4	0.5	5.9	0.4	0.6	8.5	25.2	0.6	0.7	1.5	0.0	0.9	0.8	4.5	2.1	4.1	0.5	4.0	8.0	1.9	0.9	0.4	1.0	0.5	1.7	10.3	0.5	0.6	0.4	0.3	0.4	1.4	0.5	0.7	1.4	0.7	1.0	0.5	1.2	0.7	0.9	1.2	0.4	1.1	5.2	0.8	0.0	0.8	0.0	0.7	0.6	0.5	0.6	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	1.9	0.6	1.4	0.0	0.1	0.0	0.0	7.8	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	8.5	0.8	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	5.4	5.9	8.5	17.9	8.0	1.9	1.7	10.3	1.4	0.8	0.0	0.0	0.0	1.9	1.6	3.6	14.9	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	13.4	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.1	1.6	0.0	0.0	0.0	13.0	0.9	0.0	0.0	0.0	0.0	17.7	1.2	0.0	0.0	0.0	12.1	0.0	4.2	3.2	3.8	0.4	0.0	0.0	0.0	0.3
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 43.6;heart muscle: 13.2;salivary gland: 14.2;thyroid gland: 12.4"	"Cell type enhanced"	"Detected in some"	13	"Cardiomyocytes: 15.9;Hofbauer cells: 9.4;Muller glia cells: 18.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Region enriched"	"Detected in many"	5	"cerebellum: 43.6"	"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 11.3;RPMI-8226: 4.0;SCLC-21H: 5.2"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in some"	13	"cerebellum: 65.6"							NA	NA						"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	1.0	1.4	7.8	0.5	9.1	1.0	0.5	43.6	8.9	0.5	0.5	2.4	0.0	0.5	0.5	0.5	0.4	0.6	0.6	13.2	4.5	1.4	0.3	0.2	0.3	0.3	3.2	4.5	0.4	0.2	0.5	0.0	2.7	4.2	0.3	0.4	0.3	14.2	0.5	0.6	0.4	0.6	0.5	1.0	0.4	0.3	2.7	0.9	0.0	12.4	0.0	0.3	0.4	0.0	0.2	1.3	0.3	0.1	0.2	0.7	0.0	0.0	0.4	0.4	0.1	0.1	0.0	11.3	0.0	0.0	0.0	0.0	1.4	0.2	0.5	0.1	0.0	0.1	0.4	0.1	0.0	0.0	1.0	0.3	0.2	0.3	0.3	0.0	0.8	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.3	0.0	1.7	0.1	0.1	0.1	0.1	0.1	0.3	0.9	4.0	0.0	0.3	5.2	0.4	2.2	0.2	0.8	0.8	0.7	0.1	0.2	0.4	2.0	0.5	0.2	1.1	0.1	0.2	0.5	0.7	0.2	0.1	0.1	0.3	0.7	0.1	0.1	0.0	0.1	0.3	0.1	0.2	0.3	0.2	0.3	0.2	0.0	1.3	0.2	0.0	7.8	9.1	43.6	6.3	4.5	1.4	3.2	4.5	4.2	0.9	0.0	0.0	0.0	0.0	0.1	2.5	15.9	2.5	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.8	0.3	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	9.4	1.6	0.0	1.3	0.3	4.3	0.0	0.0	1.7	0.0	0.0	18.3	0.0	0.0	0.4	0.0	2.4	0.0	1.0	3.0	2.5	0.0	0.6	0.0	0.0	0.0
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437598	"Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.9"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 113.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 39.9"	"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.1"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.1"	"Cell line enhanced"	"Detected in some"		"AF22: 1.4;GAMG: 2.5;HeLa: 1.2;hTERT-RPE1: 1.5;Karpas-707: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015701	Approved	Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.5	0.5	6.6	0.4	6.0	0.4	0.5	39.9	13.0	0.5	0.5	0.9	0.0	0.4	0.5	0.7	0.5	0.7	0.5	7.7	6.0	2.7	2.7	0.5	0.6	0.5	2.6	4.1	0.5	0.5	0.4	0.2	0.5	3.6	0.5	0.4	2.6	0.5	0.8	0.4	0.5	0.5	0.5	1.0	0.6	0.5	1.3	0.9	0.0	0.8	0.0	0.4	0.5	0.1	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.1	1.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.1	2.5	0.0	0.0	0.0	0.1	0.1	0.0	0.3	1.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.5	0.6	0.0	0.0	1.2	0.1	0.0	0.0	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.9	0.5	0.1	0.1	0.4	0.1	0.0	0.4	0.1	0.0	0.1	0.6	0.2	0.2	0.0	0.1	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	6.6	6.0	39.9	10.5	6.0	2.7	2.6	4.1	3.6	0.9	0.0	0.0	0.0	0.0	0.0	13.4	3.9	0.0	0.0	0.0	1.8	15.7	0.0	1.7	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	113.7	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0
GSDMA	"FLJ39120, GSDM, GSDM1"	ENSG00000167914	"Gasdermin A"	Q96QA5	17	39953263-39977766	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skin 1: 35.7;tongue: 19.4"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 3.5;Hofbauer cells: 4.9;Kupffer cells: 6.0;Suprabasal keratinocytes: 2.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;T-cells: 5.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 7.3;hTCEpi: 5.0;hTERT-HME1: 9.8"					"Not detected"	"Not detected"			"HPA023313, HPA064826"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		7100	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA023313: AB_1850378, HPA064826: AB_2685361"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.79e-2)"	2.1	0.4	0.2	0.4	0.1	0.0	2.2	0.1	0.1	1.1	0.6	0.0	0.0	0.1	0.4	8.6	1.9	0.3	0.3	2.0	0.2	0.2	0.4	0.2	0.7	8.5	0.2	0.7	0.2	0.2	1.0	0.9	0.9	0.1	0.2	0.6	0.0	0.6	0.0	0.9	35.7	0.3	0.5	0.2	0.3	0.2	0.9	0.0	0.8	0.2	19.4	7.8	0.8	1.1	0.6	0.5	1.9	0.4	0.6	5.6	1.0	0.4	0.1	0.0	0.3	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	7.3	0.0	0.2	0.5	0.9	0.6	0.5	0.0	0.3	1.6	0.0	5.0	0.9	9.8	0.1	0.0	0.1	0.2	2.4	0.0	1.0	0.0	0.2	0.1	0.5	0.1	0.6	0.0	0.9	0.2	0.7	0.0	0.2	0.2	0.3	0.0	0.1	0.6	0.1	0.1	0.3	0.7	0.1	0.1	0.3	0.1	0.6	0.4	0.1	0.0	1.7	0.4	0.4	4.8	0.2	5.6	0.3	3.1	1.8	0.2	0.6	1.6	2.5	1.9	0.6	0.3	0.5	1.1	1.0	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	1.3	6.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.4	0.0	0.0	0.0	0.0
GSDMB	"GSDML, PRO2521"	ENSG00000073605	"Gasdermin B"	Q8TAX9	17	39904595-39919854	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 71.3"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 65.9;Mucus-secreting cells: 26.1;Paneth cells: 57.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"SK-BR-3: 103.0"									"CAB013681, HPA023925, HPA052407"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819"	"unprognostic (5.78e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (5.13e-11)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.91e-2)"	"prognostic favorable (5.91e-9)"	4.0	0.0	1.3	13.3	2.0	1.3	2.8	4.8	1.7	2.1	33.1	1.4	2.0	25.2	1.3	1.7	1.3	1.3	14.4	1.3	1.3	0.6	2.2	17.1	2.4	3.5	1.3	1.3	2.0	2.8	0.0	1.3	1.8	1.3	3.5	22.4	1.3	1.3	2.7	1.3	2.8	71.3	3.9	1.3	4.7	18.1	1.4	1.5	1.6	2.9	1.3	2.8	4.1	4.5	0.8	0.0	1.8	0.0	0.1	2.8	0.4	0.4	0.3	0.6	0.1	1.5	1.0	0.6	0.4	0.2	0.1	0.4	0.3	12.2	0.6	0.5	0.3	0.2	1.6	0.3	0.3	0.9	2.5	0.4	0.2	0.1	0.1	0.4	0.0	0.1	0.6	2.0	0.5	0.7	1.0	0.2	2.0	0.2	0.7	0.1	0.1	0.6	1.3	0.1	3.9	0.4	0.6	0.2	0.9	0.0	0.4	0.2	0.3	0.1	103.0	0.3	3.1	0.5	0.4	0.3	0.4	0.7	1.1	0.2	2.2	1.9	0.6	0.1	0.4	0.0	0.0	0.0	1.8	1.1	0.0	0.0	0.8	2.8	1.4	0.0	0.0	2.6	0.6	0.7	0.1	0.0	0.0	0.4	0.4	1.3	2.0	4.8	1.7	1.3	0.6	1.3	1.3	1.3	1.5	3.0	11.8	4.2	1.2	1.6	2.1	2.4	12.7	2.7	4.5	5.2	3.9	1.2	0.0	1.6	4.4	1.4	65.9	0.0	7.0	0.6	1.4	1.5	1.1	8.1	0.3	1.6	5.8	0.0	1.9	3.3	1.1	1.1	3.3	1.8	26.1	2.0	7.3	57.5	1.8	0.0	2.3	0.0	2.1	0.5	1.1	3.0	0.2	2.5	15.0	5.0
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786888	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 25.9;lymphoid tissue: 25.0;skin 1: 14.1;tongue: 19.2"	"Group enriched"	"Detected in some"	6	"Basal keratinocytes: 41.3;Suprabasal keratinocytes: 46.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 11.8;head and neck cancer: 19.0;lung cancer: 5.3;urothelial cancer: 4.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 8.3;HaCaT: 5.9;hTCEpi: 3.1;HUVEC TERT2: 3.3;TIME: 8.7"									"HPA023670, HPA024767, HPA026317"	Supported		Approved	Mitochondria		NA	NA			Mitochondria		"HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.5	0.2	25.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.1	0.0	3.4	0.0	0.0	14.1	0.0	0.0	0.2	25.0	0.0	0.0	0.0	0.1	0.1	19.2	17.5	1.4	5.9	0.3	0.3	1.2	0.1	0.4	0.3	0.0	8.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	5.9	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.1	0.0	0.3	0.0	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.2	0.9	0.4	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.7	41.3	0.0	2.4	0.0	0.0	3.4	0.0	0.0	0.0	1.7	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	46.4	0.0	0.0	0.0	2.3
GSDMD	"DF5L, FLJ12150, GSDMDC1"	ENSG00000104518	"Gasdermin D"	P57764	8	143553207-143563062	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity, Necrosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 225.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004656, HPA044487"	Uncertain		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			Nucleoplasm		"CAB004656: AB_426076, HPA044487: AB_2678957"	"unprognostic (1.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (8.51e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.77e-3)"	15.1	13.3	4.8	19.7	5.9	18.6	19.2	2.2	4.6	12.1	25.4	3.9	17.2	23.3	13.9	15.6	14.5	13.7	22.4	11.6	5.1	2.6	21.7	64.6	19.0	28.1	6.8	2.8	14.8	18.3	6.9	6.9	17.0	6.8	13.6	7.2	10.9	17.9	15.0	8.7	5.8	31.7	13.0	5.3	42.9	13.2	4.1	5.0	17.2	20.0	9.8	15.9	11.5	13.1	19.6	22.9	20.8	32.3	19.6	30.4	21.6	11.5	6.7	0.1	0.0	4.2	4.7	8.7	5.4	11.3	14.4	13.8	3.4	15.4	5.3	9.4	5.6	6.5	4.6	0.2	8.8	4.4	15.3	1.0	11.0	2.2	6.5	5.1	3.1	0.5	9.9	0.8	5.2	3.1	5.7	11.6	11.2	0.5	13.8	0.6	0.4	23.5	3.9	0.1	8.2	20.9	10.6	1.3	14.1	6.2	15.1	0.2	0.2	17.3	10.7	11.5	2.6	19.8	7.0	5.4	0.1	17.9	1.2	6.9	4.6	7.0	0.1	8.5	7.1	5.9	20.8	21.9	20.0	26.5	32.3	22.8	19.6	24.5	26.5	22.9	17.2	18.9	20.9	18.9	19.6	26.7	13.2	30.4	21.6	4.8	5.9	2.2	4.6	5.1	2.6	6.8	2.8	6.8	5.0	11.9	26.1	49.1	34.0	9.6	0.2	9.7	45.9	20.1	18.2	29.6	0.0	56.0	51.4	54.3	1.8	43.6	225.0	0.0	80.6	77.0	30.7	33.5	27.6	63.6	55.5	0.0	38.1	73.1	50.7	3.2	21.9	36.3	16.9	82.0	83.9	26.1	56.4	154.3	21.2	93.5	1.1	58.2	23.5	0.9	6.6	7.9	34.9	68.6	85.6	32.7
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698351-24758113	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	21	"Cytotrophoblasts: 151.1;Distal tubular cells: 34.9;Hofbauer cells: 35.4;Syncytiotrophoblasts: 87.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 8.7;myeloid DC: 6.9;naive B-cell: 8.7"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	8.1	6.5	7.7	2.2	10.3	0.5	6.1	5.9	12.1	12.0	14.5	7.8	0.5	6.1	18.4	12.8	4.2	9.9	6.7	7.4	7.5	8.8	10.7	3.6	4.0	4.0	9.3	4.5	14.1	2.3	2.2	4.5	27.1	10.1	5.9	2.1	9.0	2.0	17.7	5.1	1.8	31.3	12.2	25.4	1.5	2.7	9.9	5.0	0.8	11.7	4.0	2.9	9.5	7.0	8.7	6.9	0.0	2.1	0.0	0.1	0.7	9.7	7.2	3.1	13.3	17.0	9.6	5.3	7.6	20.4	8.0	11.3	7.4	0.3	0.1	6.8	21.0	26.7	6.6	1.8	33.5	14.0	0.0	0.7	0.2	12.6	15.0	14.3	0.0	0.5	10.5	24.5	14.1	33.8	23.9	13.5	4.4	0.9	1.6	17.8	0.1	0.6	0.2	3.3	0.0	5.1	0.0	10.9	0.0	24.1	6.9	0.1	19.6	12.0	0.2	13.3	8.3	0.7	0.8	9.1	7.6	13.3	10.2	9.1	0.8	0.2	4.7	22.9	0.0	1.9	0.0	2.1	0.0	0.0	0.2	0.0	8.7	0.1	0.0	6.9	8.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.7	7.7	10.3	5.9	9.5	7.5	8.8	9.3	4.5	10.1	5.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.2	5.2	0.0	151.1	34.9	1.5	0.0	0.0	0.0	0.0	0.8	19.3	0.0	0.0	0.0	0.0	35.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	14.4	0.0	0.0	1.3	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0
GSG1	MGC3146	ENSG00000111305	"Germ cell associated 1"	Q2KHT4	12	13083560-13103683	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	60	"testis: 156.4"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 9027.4"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 9.6;LHCN-M2: 11.0;RPTEC TERT1: 13.7;U-2 OS: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (1.50e-1)"	"unprognostic (2.21e-2)"		"unprognostic (6.33e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.85e-2)"	"unprognostic (8.23e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.32e-3)"	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.0	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.2	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	156.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.7	2.6	0.7	0.5	1.2	0.1	0.1	0.5	0.3	0.1	2.3	1.4	0.5	0.2	0.4	0.4	0.5	0.2	0.1	0.2	0.2	9.6	0.8	0.1	0.2	0.0	0.9	0.2	0.0	0.2	0.6	0.3	0.0	0.2	0.1	0.9	0.0	1.8	0.1	0.1	0.0	0.1	0.1	1.8	11.0	0.3	0.1	1.1	2.3	0.1	0.2	0.1	4.0	0.2	13.7	0.2	0.6	0.3	0.2	0.0	0.1	0.3	0.1	1.6	0.1	0.6	6.9	0.3	0.3	0.6	0.4	0.1	3.0	0.3	0.2	1.3	0.5	0.9	1.2	0.4	0.6	0.8	0.6	1.0	0.4	1.3	0.8	0.9	2.6	0.5	0.7	0.7	0.5	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.2	0.0	3.0	1.4	0.0	0.1	0.1	9.4	0.4	0.0	0.0	0.0	0.0	5.9	0.1	1.7	0.4	1969.0	0.0	0.0	23.3	0.0	0.1	0.0	0.1	0.0	0.0	0.7	1.6	26.4	2.5	0.0	9027.4	49.5	0.0	0.0	0.0	0.0	5.7	0.0	0.0	37.4	0.0	14.7	6.5	0.0	51.2	19.7	0.0	0.0	0.0	0.0	0.0
GSG1L	"KTSR5831, MGC18079, PRO19651"	ENSG00000169181	"GSG1 like"	Q6UXU4	16	27787535-28063509	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 14.6;heart muscle: 19.3"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 1.4;Cardiomyocytes: 4.1;Club cells: 1.2;Early spermatids: 2.5;Horizontal cells: 1.6;Late spermatids: 1.8;Rod photoreceptor cells: 1.4;Spermatogonia: 1.2"	"Cancer enriched"	"Detected in some"	7	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 1.7"	"Group enriched"	"Detected in some"	7	"HMC-1: 13.6;THP-1: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014479	Enhanced					NA	NA					"HPA014479: AB_2247974"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.06e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.35e-2)"	"unprognostic (9.77e-2)"	0.7	0.8	8.7	0.6	14.6	0.7	0.6	1.8	13.3	0.8	1.1	2.7	0.0	1.1	1.1	1.0	0.6	3.4	0.5	19.3	6.0	6.8	1.1	1.1	0.9	0.6	10.0	3.3	0.4	0.7	0.4	0.2	2.0	6.5	0.8	0.7	1.2	0.8	0.6	1.0	1.8	1.2	0.5	3.5	0.9	2.5	2.2	3.3	0.0	1.0	0.0	0.5	0.5	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.3	0.0	0.3	0.2	0.2	0.2	0.3	0.3	0.1	0.0	0.0	13.6	0.0	0.0	0.0	0.2	0.4	0.4	0.1	0.2	0.2	0.5	0.9	0.1	0.3	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.1	0.7	0.4	0.1	5.0	1.3	0.0	0.9	0.0	0.2	1.0	0.4	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	8.7	14.6	1.8	10.7	6.0	6.8	10.0	3.3	6.5	3.3	0.0	0.0	0.0	0.0	0.1	1.4	4.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696585	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"intestine: 85.1"	"Cell type enhanced"	"Detected in some"	21	"Enterocytes: 37.2;Intestinal endocrine cells: 169.6;Mucus-secreting cells: 61.9;Paneth cells: 99.3;Undifferentiated cells: 41.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.2;CAPAN-2: 4.6;SiHa: 4.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles		NA	NA			Vesicles		"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.2	0.1	0.2	3.4	0.2	0.0	0.2	0.2	0.2	0.2	38.8	0.2	0.2	28.0	0.3	0.2	0.4	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.2	17.5	0.2	0.5	0.2	0.2	1.0	85.1	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	4.3	0.7	2.7	1.7	0.0	0.0	0.6	1.1	0.1	0.0	3.7	0.0	0.0	2.2	0.2	0.0	0.0	0.0	3.2	4.6	0.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.6	4.2	0.3	0.0	1.1	0.4	0.1	0.0	0.0	0.0	0.9	0.1	1.3	0.8	1.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.5	0.0	4.3	0.0	0.0	0.7	2.3	0.0	0.0	2.7	0.0	0.0	0.7	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	1.5	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	169.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	61.9	0.0	0.3	99.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	41.2	0.0
GUCY2D	"CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1"	ENSG00000132518	"Guanylate cyclase 2D, retinal"	Q02846	17	8002594-8020339	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase	"Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 10.6;retina: 33.3"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 58.9;Rod photoreceptor cells: 55.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	31	"plasmacytoid DC: 10.6"	"Lineage enriched"	"Detected in single"	53	"dendritic cells: 10.6"	"Cell line enriched"	"Detected in some"	4	"JURKAT: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (3.57e-4)"	"unprognostic (5.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.75e-5)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.07e-1)"	0.1	0.0	0.1	0.3	0.1	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	1.3	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.4	0.0	33.3	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.6	0.1	5.0	0.1	0.2	0.1	0.1	0.9	0.1	0.2	0.0	10.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.1	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.3	0.1	0.1	0.1	0.0	0.0	0.0	1.2	0.3	2.4	1.6	0.0	0.0	0.0	0.0	58.9	1.2	1.7	0.1	6.8	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.0	0.8	1.1	0.0	0.0	0.0	0.3	11.0	0.0	0.0	0.0	1.0	0.0	2.5	0.2	0.0	0.4	0.5	55.6	0.0	0.0	0.2	0.0	0.3	1.8	0.0	0.0	0.4
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hormone"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 716.5"	"Cell type enriched"	"Detected in many"	8	"Hepatocytes: 1549.8"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"myeloid DC: 2.5;plasmacytoid DC: 7.6"	"Lineage enriched"	"Detected in single"	13	"dendritic cells: 7.6"	"Cell line enriched"	"Detected in single"	229	"Hep G2: 69.9"					"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	1900000	3900000				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	0.4	0.5	1.8	0.6	10.8	1.2	0.7	0.2	4.4	0.6	0.3	0.2	0.0	0.5	0.4	0.4	0.4	0.9	0.4	45.1	10.0	1.8	0.3	716.5	0.4	1.0	4.2	0.0	1.1	8.7	0.4	0.5	0.7	6.7	0.6	0.3	0.0	0.4	0.6	0.5	0.4	0.3	0.4	13.9	0.3	0.4	0.5	4.0	0.0	0.3	0.0	1.0	0.4	0.0	0.5	7.6	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	69.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	2.5	0.5	0.0	0.0	0.0	0.5	0.0	7.6	0.0	0.0	1.8	10.8	0.2	4.4	10.0	1.8	4.2	0.0	6.7	4.0	0.0	0.0	9.3	0.9	0.5	0.0	1.1	30.6	0.0	1.2	0.0	0.0	0.6	0.0	0.4	0.0	0.6	0.0	23.3	82.0	0.9	0.5	5.2	69.8	1549.8	198.8	0.0	0.0	28.3	41.3	0.0	0.0	3.4	0.0	0.0	1.0	0.5	36.6	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	16.3	0.6	1.5	0.2	1.7
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723994	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6"	"Cell type enhanced"	"Detected in some"	13	"Basal keratinocytes: 23.7;Fibroblasts: 9.0;Melanocytes: 8.5;Smooth muscle cells: 24.7;Suprabasal keratinocytes: 15.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"eosinophil: 5.9;neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 5.9"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 51.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	23.7	0.5	0.6	13.7	1.3	2.8	1.0	1.5	1.9	0.6	1.2	0.4	1.1	0.1	0.8	2.5	1.3	5.8	5.5	5.9	1.4	2.0	0.3	0.6	4.5	0.3	0.6	0.3	23.6	2.2	0.0	0.3	0.3	0.6	0.4	0.5	1.0	0.3	1.2	2.1	2.7	4.0	3.6	0.9	0.7	0.7	0.9	0.3	0.3	0.3	0.8	0.3	1.8	0.3	0.1	0.1	5.9	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	51.0	0.0	0.1	0.0	0.1	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.6	1.3	1.5	1.7	1.4	2.0	0.6	0.3	0.6	0.3	0.0	2.6	0.0	0.1	23.7	4.2	0.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.1	2.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.3	8.5	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.6	0.0	24.7	0.0	0.1	15.6	0.1	0.0	0.0	0.1
HBA1	HBA-T3	ENSG00000206172	"Hemoglobin subunit alpha 1"	P69905	16	176680-177522	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"bone marrow: 1020.7"	"Cell type enriched"	"Detected in many"	24	"Erythroid cells: 99681.0"	"Cancer enhanced"	"Detected in many"		"glioma: 6.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 11.7;plasmacytoid DC: 7.4"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.4;granulocytes: 11.7"	"Group enriched"	"Detected in some"	37	"HEL: 248.9;K-562: 175.4"									"CAB032534, HPA043780"	Enhanced					NA	NA		17000000000			"CAB032534: AB_2294993, HPA043780: AB_2678667"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.87e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.56e-2)"	12.6	8.8	7.1	5.0	6.6	1020.7	5.0	7.9	10.0	2.2	3.2	3.0	2.2	1.3	2.2	4.1	2.8	4.8	4.0	16.9	5.2	5.1	20.6	15.7	30.3	8.1	10.1	5.8	4.9	2.2	0.9	7.5	104.1	3.3	4.8	1.4	4.5	6.7	3.3	9.4	1.9	2.2	5.1	7.9	101.4	1.6	6.7	2.2	2.2	9.3	2.2	2.2	3.4	9.4	0.6	7.4	11.7	0.5	0.9	2.1	186.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	248.9	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	175.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	3.3	1.9	0.0	0.0	0.6	0.2	0.7	0.7	0.4	0.7	2.1	11.7	0.9	0.0	7.4	0.0	186.1	7.1	6.6	7.9	10.0	5.2	5.1	10.1	5.8	3.3	2.2	0.0	0.0	18.2	0.0	9.4	0.2	0.8	2.5	0.0	0.0	0.0	0.0	0.0	6.6	0.0	4.6	0.5	0.7	99681.0	0.0	0.0	0.0	0.1	0.0	30.9	0.0	0.0	1.2	17.2	53.0	11.2	0.0	0.0	4114.8	0.0	0.9	0.3	0.1	1.7	0.4	3.7	14.8	0.0	179.2	0.1	5.1	11.5	0.0	21.3	1.4	0.0
HBA2	HBA-T2	ENSG00000188536	"Hemoglobin subunit alpha 2"	P69905	16	172876-173710	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 427.1;bone marrow: 1094.2"	"Cell type enriched"	"Detected in many"	20	"Erythroid cells: 168432.0"	"Cancer enhanced"	"Detected in all"		"glioma: 59.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"eosinophil: 9.8;neutrophil: 33.6;plasmacytoid DC: 15.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 15.7;granulocytes: 33.6"	"Group enriched"	"Detected in some"	18	"HEL: 161.2;K-562: 43.2"									"CAB038417, HPA043780"	Enhanced					NA	NA		17000000000			"CAB038417: , HPA043780: AB_2678667"	"unprognostic (1.57e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.92e-2)"	15.4	11.8	7.2	6.9	7.3	1094.2	7.6	4.1	4.1	4.1	4.1	4.1	4.1	1.1	4.1	4.1	4.1	7.7	5.8	19.5	5.8	6.2	24.3	17.7	38.4	4.1	11.2	4.1	4.1	4.1	0.5	8.9	128.7	4.1	4.1	1.3	4.1	9.2	5.6	17.7	0.9	4.1	4.1	9.3	98.3	1.9	4.1	4.1	4.1	12.5	4.1	4.1	4.1	20.1	1.4	15.7	33.6	0.9	1.5	3.0	427.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.1	1.6	1.3	0.1	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.9	9.8	3.0	0.0	0.1	1.4	0.3	0.2	1.4	0.8	0.8	2.6	33.6	1.5	0.0	15.7	0.0	427.1	7.2	7.3	4.1	4.1	5.8	6.2	11.2	4.1	4.1	4.1	3.0	1.0	72.9	0.1	39.4	1.2	4.0	12.7	4.0	1.2	0.0	0.0	0.0	46.4	0.0	2.6	9.0	1.0	168432.0	0.0	0.0	2.1	0.2	1.1	54.4	0.0	0.0	2.9	39.9	114.1	9.4	0.0	1.1	8337.5	0.0	1.3	1.3	0.0	3.7	0.0	12.3	41.0	0.0	364.9	0.2	6.6	39.0	0.0	20.8	0.7	0.0
HBB	"beta-globin, CD113t-C"	ENSG00000244734	"Hemoglobin subunit beta"	P68871	11	5225464-5229395	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Hypotensive agent, Vasoactive"	"Congenital dyserythropoietic anemia, Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"bone marrow: 3646.7"	"Cell type enriched"	"Detected in many"	16	"Erythroid cells: 407904.6"	"Cancer enhanced"	"Detected in all"		"glioma: 244.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"neutrophil: 19.3;plasmacytoid DC: 9.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 9.9;granulocytes: 19.3"	"Cell line enhanced"	"Detected in some"		"HEL: 5.5;SCLC-21H: 4.8;SH-SY5Y: 6.1;U-266/70: 22.3;U-266/84: 3.7"									"CAB009526, HPA043234"	Enhanced					NA	NA		15000000000			"CAB009526: AB_2143058, HPA043234: AB_2678378"	"unprognostic (2.41e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.87e-3)"	"unprognostic (6.41e-2)"	32.7	20.0	20.9	10.1	21.0	3646.7	43.4	6.5	10.7	9.2	11.3	7.2	3.4	3.2	7.3	11.1	36.6	28.4	30.4	38.9	17.9	17.4	45.0	37.6	305.8	7.0	31.6	10.8	82.6	28.4	2.9	18.6	236.8	23.7	23.1	7.5	32.0	17.4	12.8	29.5	3.8	3.9	12.0	26.5	216.8	4.0	9.3	3.8	5.6	46.4	20.2	7.6	124.5	256.7	0.6	9.9	19.3	0.6	1.2	1.1	523.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.1	0.0	0.0	0.0	0.8	0.2	0.4	0.0	0.0	0.4	0.3	0.0	0.0	4.8	6.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	22.3	3.7	0.0	0.0	0.0	0.0	2.2	0.6	1.9	0.9	0.0	0.1	0.6	0.2	0.0	0.9	0.4	0.4	1.1	19.3	1.2	0.1	9.9	0.0	523.2	20.9	21.0	6.5	10.7	17.9	17.4	31.6	10.8	23.7	3.8	3.0	5.9	120.0	0.0	139.4	3.4	2.0	28.1	49.5	2.3	7.0	3.9	1.1	43.1	0.0	0.0	20.2	1.0	407904.6	0.0	2.3	16.4	0.0	0.0	226.1	6.6	3.2	3.5	92.1	289.2	0.0	0.0	2.3	25972.5	0.0	3.8	6.2	0.1	2.9	0.0	79.6	86.7	0.0	737.5	0.0	0.0	220.7	1.8	46.8	0.6	0.0
HCAR1	"FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR"	ENSG00000196917	"Hydroxycarboxylic acid receptor 1"	Q9BXC0	12	122726076-122730843	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"breast: 13.9;parathyroid gland: 41.4"	"Group enriched"	"Detected in some"	4	"Club cells: 5.7;Early spermatids: 8.6;Extravillous trophoblasts: 2.5;Late spermatids: 4.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.6;MCF7: 6.2;RT4: 27.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA						"prognostic unfavorable (3.61e-5)"	"unprognostic (8.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.80e-4)"	"unprognostic (5.43e-4)"	"unprognostic (1.41e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-2)"	7.1	0.4	0.4	0.0	0.4	0.4	13.9	0.4	0.4	0.5	0.5	0.2	12.2	0.1	0.4	2.8	0.9	0.9	0.7	2.1	0.4	0.4	1.2	0.4	0.6	0.6	0.4	0.2	0.5	0.4	41.4	0.5	1.0	0.5	1.8	0.0	2.4	8.0	3.2	0.4	0.9	0.5	0.6	2.2	5.2	0.7	1.4	0.0	0.0	2.0	0.0	0.5	1.0	1.8	1.5	1.2	4.4	0.9	1.4	0.9	0.3	0.1	0.2	0.2	0.3	0.0	0.1	1.6	0.1	0.0	0.0	0.1	1.9	9.6	0.2	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.1	0.5	1.4	0.2	0.2	0.2	0.6	0.0	0.5	0.0	0.1	0.1	0.2	0.2	0.5	0.1	6.2	0.2	0.3	0.3	2.3	0.6	0.2	0.2	0.2	0.1	27.4	2.1	0.2	0.1	3.3	0.0	0.3	2.8	0.1	0.3	0.3	0.2	0.2	0.1	0.4	0.1	0.3	0.2	0.2	0.3	4.4	0.9	0.8	0.9	0.5	0.7	0.8	0.8	0.6	0.3	1.5	0.8	0.8	4.0	1.4	0.5	1.2	0.5	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.2	0.5	0.0	0.0	0.3	0.0	1.2	0.1	0.4	0.3	0.0	0.0	5.7	0.0	0.0	0.2	0.0	0.0	8.6	0.0	0.0	0.0	0.0	2.5	0.2	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.7	0.3	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.9
HCN2	"BCNG-2, BCNG2, HAC-1"	ENSG00000099822	"Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2"	Q9UL51	19	589893-617159	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 38.1;heart muscle: 16.8"	"Cell type enhanced"	"Detected in some"	23	"Bipolar cells: 58.4;Horizontal cells: 38.1;Rod photoreceptor cells: 14.2"	"Group enriched"	"Detected in many"	6	"glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 18.0;HeLa: 9.6;MCF7: 16.7;U-138 MG: 12.6;U-87 MG: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.69e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.31e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.19e-3)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.53e-4)"	"unprognostic (9.72e-3)"	1.1	4.8	12.0	1.4	29.1	1.5	1.0	8.5	38.1	1.1	1.2	8.2	0.0	1.2	1.0	1.3	2.2	1.0	1.1	16.8	18.3	11.7	1.5	1.1	1.1	1.5	22.0	6.6	1.0	1.5	1.2	3.0	1.1	11.4	1.2	1.1	0.6	1.4	1.2	1.1	1.7	1.2	1.2	24.5	1.3	1.3	3.7	7.3	0.0	1.1	0.0	1.4	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	18.0	0.2	0.6	1.9	1.3	0.6	1.2	1.5	0.5	0.1	2.5	0.1	0.0	4.0	1.7	1.3	0.1	0.4	0.1	0.0	3.0	7.6	0.0	9.6	0.2	1.4	0.2	3.4	3.5	0.3	0.1	0.0	0.5	0.1	0.4	1.0	0.1	1.3	16.7	0.0	0.0	0.9	0.4	0.5	0.1	0.1	0.4	0.3	0.5	7.0	3.6	4.4	0.0	1.3	0.3	3.6	0.6	1.7	12.6	1.9	0.2	4.9	0.3	0.2	0.1	25.9	0.8	3.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	12.0	29.1	8.5	19.6	18.3	11.7	22.0	6.6	11.4	7.3	0.0	0.0	0.0	0.0	0.6	58.4	3.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	38.1	1.2	1.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.7	0.0	14.2	0.0	0.8	0.1	0.9	0.5	0.2	0.0	0.0	0.0
HCN4		ENSG00000138622	"Hyperpolarization activated cyclic nucleotide gated potassium channel 4"	Q9Y3Q4	15	73319859-73369264	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Brugada syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 4.3;heart muscle: 12.5;testis: 9.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 28.7;Late spermatids: 33.9"	"Group enriched"	"Detected in some"	8	"testis cancer: 3.1;thyroid cancer: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.6;CACO-2: 3.2;HDLM-2: 2.1;NTERA-2: 9.5;SuSa: 2.5;U-2 OS: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA073174	Approved					NA	NA					"HPA073174: "	"unprognostic (2.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.05e-5)"	"unprognostic (5.56e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.95e-2)"	0.2	1.3	4.3	0.2	1.1	0.1	0.1	0.9	3.4	0.2	0.4	2.1	0.0	1.2	0.1	0.2	0.1	0.3	0.2	12.5	0.6	2.0	0.4	0.1	0.3	0.1	1.8	0.9	0.1	0.2	0.1	2.1	0.1	3.9	0.6	0.3	0.2	0.1	1.0	0.1	0.2	0.4	0.2	0.7	0.1	0.6	9.6	1.9	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.2	0.0	1.5	0.0	0.6	0.2	0.0	0.0	0.1	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.1	0.9	3.4	0.6	2.0	1.8	0.9	3.9	1.9	0.0	0.0	0.0	0.0	0.0	0.5	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	28.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	33.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	1.2	0.0	0.1	0.6	1.3	0.0	0.0	0.0	0.0	0.0
HEPACAM	"FLJ25530, GLIALCAM, hepaCAM"	ENSG00000165478	"Hepatic and glial cell adhesion molecule"	Q14CZ8	11	124919193-124936412	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell cycle, Growth arrest, Growth regulation"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adipose tissue: 17.3;brain: 64.7;liver: 19.6"	"Group enriched"	"Detected in some"	7	"Hepatocytes: 9.3;Muller glia cells: 13.0"	"Cancer enriched"	"Detected in some"	12	"glioma: 29.2"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in single"	31	"Hep G2: 24.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017613, CAB025486"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"CAB025486: , HPA017613: AB_1850595"	"unprognostic (3.22e-3)"	"unprognostic (1.06e-2)"		"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"		"unprognostic (1.47e-1)"		"unprognostic (9.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.06e-6)"	"unprognostic (2.62e-1)"	"unprognostic (3.21e-1)"			17.3	1.8	25.6	1.7	25.7	1.5	2.6	8.5	64.7	1.6	1.8	55.4	0.0	1.6	1.6	1.7	1.6	1.6	1.6	1.7	31.0	10.8	1.6	19.6	1.6	1.7	30.3	22.4	1.5	1.6	1.5	0.6	1.5	27.9	1.6	1.8	0.0	1.7	2.1	1.6	1.6	1.6	1.6	21.5	1.5	1.6	1.7	35.5	0.0	1.6	0.0	2.3	1.5	0.3	1.5	1.2	3.0	1.4	2.0	1.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.0	1.1	1.2	1.1	1.2	1.5	1.5	1.4	1.0	1.2	1.3	1.7	1.5	1.3	2.0	1.4	1.0	1.1	1.5	25.6	25.7	8.5	29.7	31.0	10.8	30.3	22.4	27.9	35.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0
HGSNAT	"FLJ32731, HGNAT, TMEM76"	ENSG00000165102	"Heparan-alpha-glucosaminide N-acetyltransferase"	Q68CP4	8	43140455-43202855	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mucopolysaccharidosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA029578	Approved					NA	NA					"HPA029578: AB_10602423"	"unprognostic (5.35e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (3.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-3)"	"unprognostic (5.02e-2)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.55e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.45e-2)"	24.8	16.9	21.4	16.0	18.8	16.0	29.6	18.5	20.6	28.5	17.8	20.3	24.5	15.4	27.5	29.7	20.4	24.0	22.1	18.7	18.0	16.5	16.9	19.9	21.8	14.9	12.9	19.8	31.1	28.8	26.5	24.8	25.6	15.7	21.6	14.7	20.9	20.7	20.7	11.9	29.5	18.1	25.3	18.2	14.9	18.6	8.5	11.7	9.1	21.9	18.4	18.2	21.1	23.2	2.3	14.5	8.3	8.0	8.2	3.1	4.0	11.7	15.9	4.0	8.0	32.8	24.8	6.0	13.4	16.0	9.8	8.7	2.2	17.3	7.1	9.3	18.6	7.0	6.8	1.7	8.1	5.7	2.8	3.2	7.0	10.1	3.9	10.5	1.5	1.1	16.6	11.7	5.4	11.2	15.7	17.3	3.1	3.2	10.0	17.8	5.3	6.3	3.1	3.8	7.0	2.4	0.7	7.3	3.5	16.1	9.9	2.1	6.3	17.5	5.6	7.7	8.9	19.4	9.0	20.2	15.1	2.5	9.3	5.5	8.1	7.6	2.6	12.1	2.8	9.2	0.2	8.0	8.3	2.8	5.0	3.1	1.8	2.3	2.8	14.5	2.3	1.7	1.9	3.0	8.2	7.2	1.9	1.5	4.0	21.4	18.8	18.5	20.6	18.0	16.5	12.9	19.8	15.7	11.7	14.9	32.2	9.1	18.6	16.0	43.5	9.6	22.9	14.7	6.8	48.8	47.1	30.0	3.3	25.0	0.4	30.9	25.7	0.0	24.4	35.2	27.7	19.3	8.1	19.2	26.1	23.8	23.2	42.4	29.7	1.4	32.5	31.5	18.6	19.0	24.3	19.7	25.8	17.5	29.7	9.7	37.8	25.8	22.6	1.2	1.9	18.4	25.2	15.2	18.7	14.3
HMGCR		ENSG00000113161	"3-hydroxy-3-methylglutaryl-CoA reductase"	P04035	5	75336329-75362104	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Suprabasal keratinocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008338, CAB016797"	Approved					NA	NA					"CAB016797: , HPA008338: AB_10960401"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.42e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.37e-2)"	5.6	28.9	12.4	8.7	31.1	12.1	16.4	14.4	36.3	13.9	23.0	10.9	7.1	18.9	9.0	14.4	35.0	6.5	8.2	4.0	21.8	16.5	12.1	53.5	12.1	7.0	9.8	19.4	15.2	8.4	16.2	11.4	9.2	29.6	12.4	19.7	7.8	12.4	4.5	3.4	36.1	19.0	6.8	17.0	7.9	14.6	14.0	8.8	13.9	12.5	23.2	12.4	6.2	18.1	4.3	12.5	23.2	11.0	9.5	6.5	5.1	15.3	6.0	61.4	21.1	13.0	25.2	15.4	4.4	12.4	9.0	20.1	22.6	37.8	13.7	16.1	7.1	58.9	19.4	31.9	51.8	9.6	4.6	11.7	10.5	9.1	17.5	19.2	8.7	7.7	16.3	30.5	31.5	15.6	4.5	7.2	19.7	11.2	21.0	14.2	10.0	16.0	8.8	26.2	3.9	4.5	11.3	18.4	19.6	37.1	35.8	21.3	9.7	9.7	10.1	8.8	22.1	10.0	22.9	8.4	4.9	7.3	5.2	7.5	6.7	8.5	18.9	7.1	17.1	10.1	6.7	11.0	6.3	6.1	6.9	5.1	4.3	4.6	6.4	12.5	4.2	4.5	6.2	23.2	9.5	7.4	3.9	6.5	5.1	12.4	31.1	14.4	36.3	21.8	16.5	9.8	19.4	29.6	8.8	17.9	33.4	7.5	8.5	36.9	20.9	5.7	12.7	32.1	22.7	26.2	17.7	16.3	3.3	12.1	38.1	7.6	33.8	0.0	18.8	21.6	10.5	13.9	24.2	22.5	11.5	38.1	41.2	9.8	19.3	19.5	8.6	12.3	15.1	2.8	50.6	10.3	11.9	20.1	5.6	6.3	13.1	12.9	8.2	21.0	14.0	80.0	39.0	8.7	20.2	17.3
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241330	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Basal glandular cells: 1106.3;Syncytiotrophoblasts: 1110.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 200.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		1000000000	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	44.2	40.3	26.3	40.8	38.4	125.0	58.8	19.5	26.9	37.7	29.3	19.8	47.0	25.5	31.6	75.3	34.1	31.1	25.5	72.7	23.3	28.6	60.4	147.6	43.6	32.7	34.3	14.3	36.2	110.3	41.1	47.6	62.6	43.5	34.3	33.0	16.5	84.9	40.7	23.9	32.3	38.3	33.8	28.2	33.8	35.1	33.0	41.5	23.2	219.3	21.7	29.8	50.4	75.1	33.3	53.8	57.4	55.3	51.9	63.0	90.0	35.5	24.0	31.7	41.8	37.9	43.9	74.7	64.1	50.9	47.7	56.0	37.2	71.1	41.1	40.0	46.7	103.4	45.5	28.3	57.2	51.3	23.8	14.3	24.6	30.1	67.1	200.5	33.5	46.6	27.0	112.4	38.2	167.8	50.6	74.0	8.7	18.2	57.5	34.6	26.3	14.7	23.7	35.8	87.0	24.2	14.0	32.3	66.6	46.2	23.5	16.4	29.2	40.7	43.7	65.3	51.1	45.0	24.5	49.6	29.1	28.3	29.7	29.7	60.2	57.4	34.8	70.6	28.3	43.8	57.4	55.3	44.3	61.9	54.8	63.0	33.3	45.7	57.7	48.6	24.9	37.6	46.6	44.3	51.9	35.5	53.8	31.2	90.0	26.3	38.4	19.5	26.9	23.3	28.6	34.3	14.3	43.5	41.5	172.7	228.8	134.1	1106.3	260.1	93.3	493.6	73.9	190.1	253.6	106.4	331.8	423.2	38.1	330.8	34.2	189.6	316.5	46.7	227.7	576.5	389.6	402.8	329.8	324.2	392.1	60.4	487.5	159.0	114.8	42.9	162.3	280.8	172.1	141.5	125.9	124.7	293.4	101.7	164.1	109.1	122.6	116.4	222.8	360.8	228.7	206.6	1110.2	140.9	109.4	772.3
HTN3	HIS2	ENSG00000205649	"Histatin 3"	P15516	4	70028413-70036538	"Predicted secreted proteins, Transporters"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	535	"salivary gland: 3346.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 4.5;HL-60: 4.9"									CAB073541	Enhanced				"Secreted to digestive system"	NA	NA					"CAB073541: "																		0.1	0.4	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.2	1.4	0.0	6.2	0.0	0.0	0.2	0.0	0.0	3346.6	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	3.3	0.3	0.1	0.1	1.2	0.6	2.2	1.2	0.5	1.0	0.4	1.1	1.4	0.5	0.5	0.0	0.3	0.4	0.2	0.0	0.6	0.6	0.2	1.6	1.7	0.8	0.2	2.0	0.9	0.0	0.3	0.1	4.5	0.7	0.3	0.9	0.6	0.0	4.9	3.5	0.4	0.8	0.1	0.0	0.5	0.7	0.8	0.6	3.0	0.5	0.6	1.3	2.4	1.2	0.6	1.4	3.0	0.8	0.6	0.3	0.6	2.0	1.2	1.1	0.8	0.9	1.0	2.2	1.3	0.0	1.2	1.8	1.2	0.9	2.0	2.3	0.7	1.1	1.5	2.5	2.2	0.7	0.5	0.5	1.1	0.3	1.0	0.8	0.4	0.4	1.2	1.0	0.6	2.0	0.5	1.2	0.6	0.5	0.4	0.1	0.2	0.2	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77461753-77463773	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 11.8;placenta: 14.2;stomach 1: 10.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 11.8"	"Cell type enriched"	"Detected in single"	17	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	17	"granulocytes: 1.6"	"Group enriched"	"Detected in some"	15	"HUVEC TERT2: 41.8;TIME: 18.4"	"Region enriched"	"Detected in many"	4	"basal ganglia: 34.5"					HPA028808	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA028808: AB_2672782"	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	2.2	1.5	1.3	1.1	11.8	0.3	2.4	0.4	3.7	2.9	0.6	0.1	0.0	0.6	1.1	1.0	1.4	0.8	2.8	0.4	1.0	2.1	0.9	0.3	1.1	0.3	1.2	0.9	1.1	0.5	0.3	0.5	14.2	3.0	1.6	0.4	0.3	1.3	1.2	0.9	0.5	0.4	4.1	0.6	0.4	10.2	1.5	0.6	0.0	0.5	0.0	0.3	2.6	1.4	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.4	1.1	0.8	41.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	11.8	0.4	3.7	1.0	2.1	1.2	0.9	3.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR2B	"5-HT(2B), 5-HT2B"	ENSG00000135914	"5-hydroxytryptamine receptor 2B"	P41595	2	231108230-231125118	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"placenta: 26.0"	"Cell type enhanced"	"Detected in some"	14	"Cone photoreceptor cells: 3.9;Ito cells: 5.5;monocytes: 10.8;Peritubular cells: 4.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"basophil: 3.8;T-reg: 2.9"	"Group enriched"	"Detected in many"	29	"granulocytes: 3.8;T-cells: 2.9"	"Group enriched"	"Detected in some"	4	"HHSteC: 7.0;HSkMC: 13.3;SK-MEL-30: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012867, HPA063658"	Enhanced		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA012867: AB_1856710, HPA063658: AB_2685079"	"unprognostic (1.86e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.42e-3)"	"unprognostic (7.44e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	2.3	17.9	0.2	5.8	0.3	0.7	4.1	0.3	0.6	17.8	7.3	0.2	1.7	1.0	14.9	9.5	5.7	1.9	0.8	4.6	0.3	0.3	5.6	2.5	1.8	0.5	0.3	0.4	4.3	0.3	0.3	0.4	26.0	0.9	2.6	1.5	1.8	0.5	1.0	0.2	0.2	6.3	12.8	0.3	0.4	5.2	3.3	0.3	2.4	6.8	1.0	0.4	4.9	0.8	0.0	0.1	3.8	0.0	0.0	2.9	0.0	0.1	0.2	0.0	0.1	0.4	3.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.1	0.3	13.3	0.0	0.0	0.0	0.0	2.5	1.1	0.1	0.0	0.0	0.1	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	24.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	2.9	0.0	0.2	0.3	0.3	0.6	0.3	0.3	0.3	0.4	0.9	0.3	0.0	0.0	0.0	0.0	0.1	0.5	0.3	0.0	2.7	0.0	0.0	3.9	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.9	2.6	1.6	0.0	5.5	1.2	0.0	0.6	0.0	0.0	10.8	0.0	0.0	0.1	0.0	4.9	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1
HTR3A	"5-HT3A, 5-HT3R, HTR3"	ENSG00000166736	"5-hydroxytryptamine receptor 3A"	P46098	11	113974881-113990313	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 11.1;lymphoid tissue: 12.0;salivary gland: 8.6"	"Group enriched"	"Detected in some"	11	"Ductal cells: 14.6;Exocrine glandular cells: 44.3;Pancreatic endocrine cells: 54.7"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 15.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"memory B-cell: 4.1;naive B-cell: 9.7;plasmacytoid DC: 11.1"	"Group enriched"	"Detected in many"	104	"B-cells: 9.7;dendritic cells: 11.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.3;Daudi: 6.0;NTERA-2: 3.8;SCLC-21H: 20.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	15	"amygdala: 3.3;cerebral cortex: 4.0;hippocampal formation: 4.2"	HPA069442	Supported					NA	NA					"HPA069442: AB_2732132"	"unprognostic (6.46e-3)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (3.36e-3)"	"unprognostic (8.36e-3)"	"unprognostic (1.65e-5)"	"unprognostic (1.46e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.40e-2)"	0.3	0.5	2.2	4.4	3.9	0.0	0.3	0.3	0.9	0.3	2.5	0.3	0.3	1.0	0.3	0.3	0.8	0.0	0.3	0.3	2.1	0.0	0.3	0.3	0.3	9.7	0.3	0.3	0.3	3.7	0.0	0.3	0.3	0.3	0.3	0.6	0.3	8.6	0.3	0.3	0.6	2.0	1.0	0.3	3.0	0.9	0.3	0.3	0.7	0.3	0.3	12.0	0.3	0.3	9.7	11.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	6.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	20.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.6	9.7	0.0	0.0	0.0	0.0	0.0	11.1	0.0	0.2	2.2	3.9	0.3	0.9	2.1	0.0	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	44.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	54.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR3D		ENSG00000186090	"5-hydroxytryptamine receptor 3D"	Q70Z44	3	184031544-184039369	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.8"					"Low region specificity"	"Detected in many"									NA	NA															"unprognostic (3.08e-1)"								0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1		0.0	0.0	0.0	0.2	0.0		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8			0.3		0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HVCN1	"Hv1, MGC15619, VSOP"	ENSG00000122986	"Hydrogen voltage gated channel 1"	Q96D96	12	110627841-110704950	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 99.8;lymphoid tissue: 40.6"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 65.1;Early spermatids: 69.1;Hofbauer cells: 51.3;Late spermatids: 55.1;Macrophages: 42.5;Spermatocytes: 72.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 99.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"NB-4: 78.2;U-698: 24.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039329	Enhanced					NA	NA					"HPA039329: AB_10674284"	"unprognostic (3.43e-2)"	"unprognostic (6.32e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.85e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-1)"	4.8	3.3	7.6	17.6	12.2	3.8	3.3	4.7	7.4	5.6	3.9	20.4	3.2	3.0	6.4	7.0	2.9	5.8	5.0	13.8	9.7	11.3	2.6	2.6	8.0	34.6	26.9	5.0	8.6	1.5	1.5	2.0	4.8	36.7	5.9	4.1	14.2	2.6	5.5	4.6	1.9	10.8	6.1	9.4	25.6	4.3	24.5	8.2	5.0	2.5	2.8	40.6	7.5	5.3	99.8	15.4	75.6	24.2	19.8	3.3	18.8	0.0	0.2	0.8	0.0	1.3	1.3	0.4	0.2	0.3	0.7	0.4	0.1	0.0	0.7	0.7	1.4	0.0	0.1	0.9	0.0	1.0	0.0	0.2	0.0	0.0	0.2	1.1	11.9	0.8	1.8	0.1	0.6	0.0	0.1	1.8	3.8	0.5	0.7	1.3	0.0	1.7	78.2	0.9	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	11.9	0.5	0.0	0.0	0.1	0.0	7.7	0.9	24.4	0.0	0.6	0.0	39.8	24.2	75.6	1.7	23.0	0.9	63.0	1.6	2.8	10.4	99.8	3.2	2.1	38.4	19.8	19.9	15.4	3.3	18.8	7.6	12.2	4.7	7.4	9.7	11.3	26.9	5.0	36.7	8.2	3.0	7.7	65.1	2.0	0.7	0.4	6.3	0.0	2.7	3.4	1.8	0.0	0.3	0.0	0.4	69.1	10.6	0.0	0.0	0.2	1.2	3.5	0.5	8.1	0.2	51.3	0.0	0.0	9.8	31.3	55.1	12.4	42.5	11.8	1.8	0.1	16.0	0.2	0.0	13.1	0.4	1.5	12.9	9.8	72.9	2.5	0.4	1.0	4.9	0.0	1.0
IFITM1	"9-27, CD225, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	313506-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Club cells: 187.7;Leydig cells: 278.5;Sertoli cells: 271.7;T-cells: 358.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"eosinophil: 56.6;gdT-cell: 120.0;MAIT T-cell: 80.7;memory CD4 T-cell: 128.1;memory CD8 T-cell: 121.4;naive CD4 T-cell: 123.5;naive CD8 T-cell: 123.4;neutrophil: 106.8;NK-cell: 164.4;T-reg: 70.4"	"Group enriched"	"Detected in all"	7	"granulocytes: 106.8;NK-cells: 164.4;T-cells: 128.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 122.7;BJ hTERT+ SV40 Large T+ RasG12V: 219.9;HMC-1: 67.9"									"HPA004810, CAB017615"	Enhanced		Uncertain	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	81.1	14.2	17.4	36.7	24.5	41.2	57.0	11.9	23.1	71.0	28.2	12.9	20.6	17.2	48.3	152.4	44.4	67.2	31.2	62.6	19.8	13.9	59.8	34.5	44.1	159.7	34.8	14.7	100.2	16.3	22.3	23.3	36.3	27.3	38.7	22.1	49.5	27.4	41.6	38.7	23.6	33.0	46.0	37.9	112.9	20.5	29.4	20.1	42.7	48.3	28.0	50.3	39.3	52.8	13.0	4.3	106.8	18.6	164.4	128.1	147.7	6.4	0.1	53.3	4.3	3.9	13.7	0.3	11.3	53.0	122.7	219.9	0.1	44.5	0.1	8.5	11.9	1.2	15.1	1.7	1.1	2.4	13.5	2.8	6.5	4.1	0.4	35.3	9.5	67.9	25.6	0.0	1.3	0.1	1.3	0.2	2.1	23.2	53.9	0.0	0.9	4.7	18.3	15.2	0.0	1.6	1.2	0.1	1.2	32.8	0.0	0.0	0.0	5.9	0.6	10.9	7.6	2.2	0.8	0.3	0.1	0.1	0.0	0.0	3.8	2.0	0.3	0.1	14.3	0.1	15.6	2.3	56.6	120.0	10.9	80.7	13.0	128.1	121.4	4.3	11.3	123.5	123.4	106.8	164.4	18.6	1.2	70.4	147.7	17.4	24.5	11.9	23.1	19.8	13.9	34.8	14.7	27.3	20.1	32.8	96.7	12.5	9.5	24.7	0.0	4.8	0.0	36.1	187.7	31.4	0.0	1.2	5.0	0.9	1.2	146.9	12.4	0.0	1.2	25.0	131.5	1.8	17.4	17.9	9.3	0.0	1.2	130.1	11.0	0.0	278.5	21.9	74.2	0.0	14.4	0.0	0.9	10.1	117.0	0.3	0.0	271.7	95.7	0.3	1.0	12.5	3.3	358.0	24.3	4.4
IFITM2	1-8D	ENSG00000185201	"Interferon induced transmembrane protein 2"	Q01629	11	307631-315272	"Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 875.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 875.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 875.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 99.8;HMC-1: 113.9;HSkMC: 123.4;U-937: 88.6"									HPA004337	Uncertain					NA	NA					"HPA004337: AB_1851427"	"unprognostic (2.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.37e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	101.0	25.2	14.3	95.5	20.9	56.3	143.6	8.2	16.6	70.8	40.2	10.9	14.3	9.5	63.6	46.1	56.0	70.8	28.5	91.1	13.3	10.8	83.0	326.2	141.9	255.5	29.3	3.3	106.5	31.1	68.6	18.9	48.0	21.1	54.3	17.7	39.1	20.1	37.7	72.7	20.1	24.0	63.2	21.7	233.4	28.4	38.5	15.6	12.5	83.4	26.2	35.4	98.0	119.7	27.5	21.6	875.3	74.9	52.8	33.3	47.1	4.2	13.0	36.0	0.2	23.4	68.0	0.1	13.2	25.6	7.6	17.5	0.4	38.8	0.0	32.2	67.4	0.0	8.7	0.1	2.3	3.2	0.0	5.4	13.0	14.8	14.4	99.8	20.8	113.9	123.4	0.4	2.1	1.1	16.9	24.7	4.1	0.5	42.8	5.4	29.0	0.1	76.2	4.4	0.7	30.4	14.3	3.7	0.2	69.8	0.0	0.1	0.8	9.8	11.3	3.9	1.1	16.4	7.4	64.8	1.2	4.1	5.9	0.2	0.1	0.6	0.6	2.1	88.6	4.0	77.9	19.8	138.8	33.3	53.2	24.6	27.5	30.0	29.4	21.6	24.5	26.0	28.1	875.3	52.8	74.9	9.1	15.8	47.1	14.3	20.9	8.2	16.6	13.3	10.8	29.3	3.3	21.1	15.6	285.9	694.3	247.8	177.4	92.7	0.2	31.1	163.1	124.5	320.8	235.5	0.0	7.0	412.8	337.7	5.7	710.3	6.8	46.7	224.8	10.2	373.5	99.0	503.9	361.8	178.2	0.0	9.2	617.5	355.0	16.0	470.0	230.3	199.1	21.6	27.9	38.6	121.6	101.8	210.4	27.2	0.9	310.4	755.0	7.7	7.8	72.5	19.6	655.6	24.8	92.5
IFITM3	1-8U	ENSG00000142089	"Interferon induced transmembrane protein 3"	Q01628	11	319669-327537	"Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 148.9;non-classical monocyte: 150.9"	"Group enriched"	"Detected in all"	6	"granulocytes: 148.9;monocytes: 150.9;NK-cells: 44.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 144.3;BJ hTERT+ SV40 Large T+ RasG12V: 184.0;HHSteC: 168.6;HSkMC: 160.3"									HPA004337	Uncertain					NA	NA					"HPA004337: AB_1851427"	"unprognostic (4.17e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (5.78e-7)"	"unprognostic (7.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.19e-1)"	109.8	46.1	34.2	64.5	39.8	21.2	197.5	15.1	36.3	135.2	70.4	28.3	45.8	25.3	98.7	143.6	50.9	118.2	68.7	162.1	31.6	24.8	94.3	157.0	161.7	135.3	36.2	15.3	148.4	47.5	99.8	33.7	92.5	39.6	78.2	25.4	81.0	52.8	70.8	62.0	31.1	50.0	111.5	43.8	153.4	51.3	54.3	30.4	6.8	115.9	60.7	27.8	89.2	75.9	3.0	20.1	148.9	150.9	44.7	4.9	34.0	24.8	2.2	94.9	24.7	43.5	70.6	2.0	38.6	72.1	144.3	184.0	3.0	83.9	0.0	41.4	56.1	39.6	40.6	0.0	27.3	9.0	0.9	2.7	0.3	33.9	30.9	168.6	0.2	0.3	160.3	6.1	11.6	26.6	20.6	26.4	0.2	0.1	0.3	13.2	52.4	0.1	1.1	11.3	0.1	19.2	3.3	8.7	0.4	83.5	2.8	0.0	0.1	46.3	7.8	39.3	14.8	1.9	2.1	51.6	9.5	6.4	8.4	1.5	0.1	0.1	0.3	4.3	0.4	14.5	21.0	33.1	21.2	4.9	132.0	2.8	3.0	2.9	4.5	20.1	2.4	3.0	4.3	148.9	44.7	150.9	1.5	1.6	34.0	34.2	39.8	15.1	36.3	31.6	24.8	36.2	15.3	39.6	30.4	494.3	647.7	89.1	597.6	281.8	1.2	92.7	535.0	289.1	593.8	500.7	2.0	85.1	474.2	1655.3	22.9	1810.3	50.2	0.0	1623.3	537.2	1132.6	295.6	229.5	1626.8	441.7	0.0	52.0	1856.2	459.6	48.4	1723.9	440.5	342.5	95.6	185.7	87.0	1285.6	219.8	997.1	331.8	3.9	944.3	1633.2	7.5	11.0	182.8	105.2	139.6	190.0	209.0
IFNAR1	"IFNAR, IFRC"	ENSG00000142166	"Interferon alpha and beta receptor subunit 1"	P17181	21	33324477-33359862	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 50.8"					"Low region specificity"	"Detected in all"			HPA029226	Approved					NA	NA		100000			"HPA029226: AB_2672954"	"unprognostic (2.42e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.38e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.06e-2)"	27.2	16.4	18.5	16.8	18.7	14.8	15.9	18.1	22.9	14.2	16.8	15.1	10.0	12.3	15.7	10.9	15.8	13.5	16.2	14.5	16.9	15.8	17.5	56.4	16.6	15.0	19.7	13.8	16.6	18.3	30.6	17.9	23.2	18.3	14.7	12.2	12.1	17.6	12.6	17.3	10.6	15.8	13.7	22.2	29.8	18.8	10.3	16.7	26.9	21.4	9.1	13.1	18.7	18.1	20.5	17.8	64.5	23.1	7.3	12.1	10.7	13.3	12.2	5.2	5.9	17.2	17.5	6.0	14.4	15.5	6.7	6.8	13.1	15.3	10.3	11.7	9.9	8.4	8.0	4.9	8.5	7.1	11.7	9.8	15.4	11.8	7.7	7.3	11.3	11.0	14.5	7.5	11.0	6.6	8.8	12.7	11.8	17.6	50.8	10.9	11.1	8.4	4.6	5.6	8.9	7.8	8.3	18.3	17.6	7.3	17.6	6.2	5.6	14.5	10.3	9.2	3.6	15.9	8.3	20.2	13.4	7.3	17.6	8.0	33.9	46.6	11.9	18.0	16.0	14.3	18.9	16.8	9.7	8.0	19.7	7.5	18.5	10.6	9.0	11.3	20.5	12.1	9.4	64.5	7.3	23.1	17.8	12.0	10.7	18.5	18.7	18.1	22.9	16.9	15.8	19.7	13.8	18.3	16.7	101.3	37.9	45.4	49.1	40.6	49.3	32.2	25.5	61.6	71.7	41.8	27.5	23.5	18.3	64.6	10.8	66.9	25.8	23.3	78.0	78.5	32.8	57.7	37.1	71.7	60.0	55.6	25.8	50.3	69.5	7.7	30.2	70.9	35.4	83.0	28.9	32.2	57.6	24.6	29.0	21.4	25.6	19.4	33.4	26.3	12.1	39.3	16.8	29.3	26.0	69.1
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969099-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 13.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		150000000	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.08e-4)"	28.0	22.2	6.8	13.5	8.1	16.7	39.4	6.4	8.2	14.9	17.3	9.5	13.0	9.4	19.6	16.0	16.7	13.1	17.9	27.9	6.7	6.2	20.6	26.6	32.6	44.7	12.3	3.6	18.0	19.6	23.5	13.6	15.5	10.0	14.1	13.3	13.9	18.2	13.5	62.0	15.9	15.4	16.5	7.6	30.2	14.4	13.8	9.0	37.9	18.5	17.3	14.1	16.3	26.9	0.4	2.9	13.3	2.0	1.0	3.6	0.9	7.7	7.0	12.4	17.4	45.2	25.0	16.8	12.2	26.3	10.1	17.4	10.6	12.2	3.2	13.7	13.4	40.7	10.4	9.3	59.5	17.0	16.8	6.6	1.4	12.2	19.1	26.7	7.4	12.1	19.8	19.1	21.0	60.6	24.4	6.5	13.9	13.8	17.4	15.8	5.7	3.4	7.4	5.5	7.1	7.5	8.0	8.5	16.3	14.2	7.8	4.1	9.1	16.5	14.8	16.5	17.8	6.2	21.0	9.8	9.8	10.3	21.0	22.3	10.3	14.4	3.3	18.9	10.1	15.1	0.1	2.0	1.1	3.6	0.8	1.4	0.3	1.2	1.7	0.3	0.4	1.0	2.4	13.3	1.0	1.4	2.9	0.7	0.9	6.8	8.1	6.4	8.2	6.7	6.2	12.3	3.6	10.0	9.0	44.7	38.9	12.8	8.9	19.7	14.1	33.2	33.1	6.7	19.4	15.7	19.6	6.2	0.0	29.2	5.3	22.4	21.3	0.0	16.6	11.0	16.7	15.0	3.5	54.4	22.3	14.3	21.5	30.7	48.2	3.6	44.0	26.4	11.8	8.2	20.6	13.6	37.4	14.4	36.0	21.7	13.9	64.7	17.0	6.5	9.6	17.2	7.8	21.8	20.1	15.6
IL1A	"IL-1A, IL1, IL1-ALPHA, IL1F1"	ENSG00000115008	"Interleukin 1 alpha"	P01583	2	112773915-112784590	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 17.6;lymphoid tissue: 22.2;tongue: 17.9"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 6.0;Early spermatids: 6.2;Late spermatids: 3.2;Macrophages: 4.8;Pancreatic endocrine cells: 2.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.3;urothelial cancer: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 86.6;hTCEpi: 42.9;hTERT-HME1: 56.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	10800					"unprognostic (3.41e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.99e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.62e-2)"	0.7	0.3	0.7	1.2	1.4	0.8	0.3	0.2	1.2	5.8	0.3	2.3	0.5	0.0	2.6	0.7	17.6	0.3	2.4	0.3	3.1	0.8	0.2	0.2	3.7	0.2	1.2	0.1	0.3	0.2	0.3	0.4	3.1	2.1	0.3	0.1	0.0	1.9	1.2	0.2	1.2	0.3	0.0	1.8	0.5	0.2	10.9	1.2	0.0	0.2	17.9	22.2	5.4	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.1	0.0	10.4	0.0	13.1	0.7	0.0	86.6	0.3	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	42.9	0.7	56.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.2	0.9	3.1	0.8	1.2	0.1	2.1	1.2	6.0	1.4	0.0	0.7	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.6	6.2	0.0	0.0	0.0	0.7	0.1	0.0	0.2	1.1	0.0	0.3	0.0	0.0	0.0	0.0	3.2	0.0	4.8	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.3
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836903	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 62.3;lymphoid tissue: 35.4"	"Cell type enriched"	"Detected in many"	7	"Macrophages: 764.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 34.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 34.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 93.2;HBEC3-KT: 42.4;HMC-1: 34.6;hTEC/SVTERT24-B: 46.6;hTERT-RPE1: 40.3;U-87 MG: 85.2"	"Low region specificity"	"Detected in some"												"Secreted to blood"	NA	NA	2330					"unprognostic (1.55e-3)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (1.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.01e-2)"	19.6	3.3	4.2	20.4	15.3	62.3	0.8	1.1	10.8	1.6	3.2	12.7	0.2	1.2	3.0	1.5	3.5	3.4	7.5	3.7	19.0	3.6	1.7	4.0	17.3	5.0	5.9	0.3	3.4	2.4	2.4	3.0	10.3	24.9	2.6	2.6	1.0	2.2	0.8	0.4	0.9	3.7	3.5	29.7	35.4	20.9	1.6	5.8	0.8	1.1	13.5	14.0	10.4	1.2	0.0	6.9	34.4	7.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	93.2	0.4	1.0	0.0	0.0	0.0	2.6	0.0	1.6	2.1	0.0	42.4	5.8	0.0	0.0	4.1	0.0	0.0	0.3	0.0	34.6	0.1	1.3	46.6	15.7	40.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	3.5	0.1	0.0	0.0	0.0	5.6	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.4	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	85.2	1.9	3.2	0.5	4.2	1.5	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	34.4	0.0	2.7	0.0	0.0	1.0	4.2	15.3	1.1	10.8	19.0	3.6	5.9	0.3	24.9	5.8	8.9	45.3	1.4	4.6	27.4	0.0	4.3	0.0	13.4	7.9	1.8	0.0	1.2	0.0	12.2	0.1	2.2	0.3	0.0	0.5	2.1	9.9	2.3	39.4	0.0	109.6	0.0	0.0	1.3	54.0	0.0	0.0	764.6	21.9	0.0	2.2	0.0	3.6	6.2	0.0	0.5	0.2	0.0	4.3	0.0	0.2	17.8	3.7	2.2	0.0	4.6
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Club cells: 93.3;Ito cells: 139.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 95.6;ASC TERT1: 42.7;HHSteC: 30.0;HSkMC: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1000000	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	48.6	25.2	2.6	18.2	5.2	4.0	92.4	2.4	3.9	47.8	21.0	2.5	34.3	5.2	15.2	30.2	18.2	17.1	25.8	27.0	4.2	2.5	23.7	74.8	40.5	28.0	5.6	1.1	25.1	17.1	16.9	7.3	66.2	10.9	26.0	8.4	8.6	12.7	36.4	15.5	13.5	13.0	15.1	10.0	19.2	15.6	13.4	2.8	3.5	33.6	9.0	9.6	32.0	36.4	0.1	0.1	4.0	0.5	0.8	1.8	0.2	0.2	1.8	0.0	1.5	95.6	42.7	0.6	4.0	18.2	2.8	4.3	0.8	0.5	0.0	2.9	8.0	5.0	0.8	0.0	0.3	2.4	7.9	0.0	0.1	0.4	4.4	30.0	0.0	0.0	117.7	0.3	3.2	0.7	1.2	1.2	0.0	0.5	0.1	4.1	0.8	0.0	0.1	0.1	0.8	0.1	0.0	0.3	0.0	2.7	1.9	0.0	0.0	1.8	1.1	0.0	0.5	1.6	0.1	0.0	8.2	0.5	13.7	0.3	0.0	0.0	0.0	3.2	0.0	0.5	0.6	0.5	0.1	0.0	0.0	0.7	0.1	1.1	0.0	0.1	0.1	0.0	0.1	4.0	0.8	0.0	0.1	1.8	0.2	2.6	5.2	2.4	3.9	4.2	2.5	5.6	1.1	10.9	2.8	23.8	55.6	3.7	27.6	27.6	0.0	3.9	28.1	40.2	93.3	5.2	0.0	5.3	3.3	21.6	6.4	58.3	0.0	0.0	18.7	76.6	77.2	84.5	1.1	43.2	5.1	0.0	1.2	139.3	12.4	9.4	25.9	21.6	18.6	9.0	0.7	7.3	15.4	0.0	1.4	6.2	1.0	6.5	23.1	0.7	0.9	33.8	20.0	2.6	0.9	19.6
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37125838-37175054	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.6;lymphoid tissue: 35.0;placenta: 58.5"	"Group enriched"	"Detected in many"	8	"Extravillous trophoblasts: 80.1;T-cells: 97.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdT-cell: 14.7;NK-cell: 51.6"	"Group enriched"	"Detected in many"	32	"NK-cells: 51.6;T-cells: 14.7"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 106.6"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Low region specificity"	"Detected in single"			HPA062657	Enhanced					NA	NA					"HPA062657: AB_2684822"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (6.76e-4)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.44e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (4.63e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.46e-2)"	2.2	1.0	0.8	20.5	0.8	12.3	1.6	0.6	0.7	1.3	5.5	0.6	1.4	1.8	4.3	2.8	2.6	1.8	5.8	3.7	0.7	0.8	1.9	6.0	7.4	20.8	0.8	0.2	1.5	1.0	0.0	1.1	58.5	0.7	3.5	1.8	2.9	3.7	2.1	0.9	4.0	7.3	0.6	1.1	35.0	2.3	1.1	0.2	21.0	2.1	1.8	28.7	4.0	1.5	0.3	0.0	1.0	0.1	51.6	14.7	7.9	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	106.6	0.1	0.2	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.0	0.0	2.8	0.0	0.1	7.7	13.2	0.0	0.1	0.0	0.1	1.0	0.0	0.1	14.7	0.1	8.1	0.1	3.3	8.2	0.0	0.3	1.1	4.3	0.3	51.6	0.1	0.0	6.8	7.9	0.8	0.8	0.6	0.7	0.7	0.8	0.8	0.2	0.7	0.2	3.0	11.6	1.5	0.8	2.9	0.0	1.1	0.0	1.4	1.2	1.8	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.2	80.1	1.1	0.1	9.3	1.0	2.1	0.0	0.0	8.6	1.6	0.9	0.3	0.5	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.0	97.0	0.0	0.0
IMMT	"HMP, Mic60, MINOS2, P87, P89"	ENSG00000132305	"Inner membrane mitochondrial protein"	Q16891	2	86143932-86195770	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Cardiomyocytes: 201.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022439, HPA036164, HPA036165"	Supported		Enhanced	Mitochondria		NA	NA		240000	Mitochondria		"CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980"	"unprognostic (3.83e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (5.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.51e-6)"	"unprognostic (2.06e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	20.0	36.9	15.6	17.0	23.5	15.3	15.4	17.5	27.1	13.6	24.8	16.0	15.4	25.1	16.5	13.6	19.1	13.9	12.3	67.3	15.1	18.0	37.5	35.1	14.3	17.7	18.4	18.8	13.3	23.1	31.4	17.6	21.6	32.2	12.8	26.3	17.3	16.7	21.2	78.6	15.4	25.6	17.9	12.1	20.0	22.0	28.3	15.0	29.1	16.2	38.3	19.9	18.0	14.1	10.9	21.5	7.6	21.6	13.2	16.1	14.4	33.9	33.5	30.4	13.9	29.6	27.3	31.1	24.4	25.6	33.0	30.1	48.1	27.0	52.0	24.5	25.8	27.2	25.3	38.9	35.2	40.5	21.0	31.7	41.1	21.2	56.9	30.1	39.6	28.2	31.2	25.7	31.1	37.2	20.8	37.2	30.1	40.0	29.6	31.9	29.2	39.4	41.4	36.2	52.1	26.7	26.3	65.1	46.8	37.7	38.5	37.0	27.5	25.0	38.1	37.2	25.1	21.6	28.1	27.9	23.7	26.2	34.3	30.2	23.6	29.8	35.7	27.0	47.3	28.7	7.5	18.6	7.6	16.1	21.6	14.6	10.9	14.4	13.3	21.5	8.8	13.1	15.5	2.5	13.2	19.9	11.1	14.9	14.4	15.6	23.5	17.5	27.1	15.1	18.0	18.4	18.8	32.2	15.0	50.6	42.2	33.5	27.5	20.7	39.1	201.3	17.8	52.2	63.7	38.4	31.4	84.0	112.7	49.3	128.3	35.3	53.1	23.3	46.0	62.7	35.8	15.4	45.2	57.1	62.8	22.3	53.9	35.6	49.3	95.4	25.6	41.4	16.9	81.2	42.6	25.5	37.2	31.7	34.6	68.6	39.4	6.5	37.2	87.7	51.5	21.8	82.4	36.6	63.4	30.8
IPO11	RanBP11	ENSG00000086200	"Importin 11"	Q9UI26	5	62403972-62628582	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 35.3;Ito cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 51.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065346, HPA067097"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA065346: , HPA067097: AB_2685776"	"unprognostic (9.29e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (4.26e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.24e-2)"	25.5	15.3	13.6	14.2	17.1	8.8	22.2	18.4	18.3	19.5	13.7	14.2	17.4	10.4	19.9	13.9	18.6	16.1	16.4	20.0	15.2	13.4	18.5	16.9	12.8	14.2	14.9	13.7	18.6	14.4	23.9	20.9	24.4	17.1	15.9	13.7	13.2	14.8	16.6	19.0	14.0	12.3	17.0	14.4	26.3	13.7	30.9	13.3	18.8	21.7	15.7	15.0	19.8	24.4	4.2	3.6	12.2	5.6	18.0	5.3	3.2	11.9	11.3	10.5	16.1	8.5	11.6	14.2	12.9	9.9	13.6	15.2	12.6	9.4	20.5	10.3	13.1	17.0	9.9	21.6	15.0	21.4	7.7	11.4	9.5	11.6	11.3	6.2	10.8	5.5	8.2	8.7	16.2	17.5	6.8	51.2	10.2	17.9	6.7	13.5	11.3	11.4	14.0	13.4	7.0	6.9	13.9	15.5	18.6	8.4	11.8	11.1	6.5	11.3	8.9	9.2	11.0	11.5	7.5	23.0	8.2	9.0	9.0	11.7	5.3	8.6	14.2	10.1	15.1	9.7	12.2	2.1	1.8	3.5	3.4	4.2	3.1	3.7	3.6	3.6	4.2	5.3	3.8	2.1	18.0	5.6	2.3	2.3	3.2	13.6	17.1	18.4	18.3	15.2	13.4	14.9	13.7	17.1	13.3	8.9	3.0	6.0	3.7	7.6	3.6	10.7	0.0	30.8	4.5	7.0	2.0	6.2	3.3	3.3	35.3	30.0	1.7	23.3	4.6	5.4	5.8	4.2	12.7	5.8	4.4	4.8	2.9	41.7	6.5	18.8	5.2	4.5	3.3	1.8	5.5	3.3	2.5	0.0	3.9	3.4	4.8	6.5	6.6	12.9	16.3	7.8	4.2	4.9	4.6	4.0
IPO13	"IMP13, KIAA0724, RANBP13"	ENSG00000117408	"Importin 13"	O94829	1	43946939-43968022	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 80.5"	"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 39.4;Late spermatids: 63.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070425	Uncertain					NA	NA					"CAB070425: AB_11157631"	"unprognostic (7.15e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (1.21e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.93e-3)"	8.1	10.7	21.8	7.3	28.5	6.7	6.8	17.6	27.6	8.4	7.4	42.1	4.5	7.2	8.5	11.1	12.2	10.7	7.4	17.4	27.6	16.6	16.0	9.2	7.2	7.0	27.8	18.4	7.6	8.0	21.6	10.8	8.0	18.4	10.4	8.2	7.4	10.5	13.1	80.5	11.1	6.1	12.1	35.8	7.7	7.3	25.1	27.6	6.3	13.8	13.0	7.9	8.1	5.8	2.8	5.5	2.6	3.7	4.5	4.9	2.2	13.6	11.1	11.2	17.7	30.6	15.9	9.4	13.1	12.2	19.7	15.1	8.5	6.9	14.3	13.6	17.1	12.5	15.3	20.1	23.1	13.1	14.5	17.2	14.9	20.1	11.6	21.6	9.9	13.9	16.2	23.6	25.5	16.0	14.8	13.0	11.2	14.9	13.2	15.6	9.5	10.0	13.1	10.3	11.7	18.7	13.9	14.1	15.0	14.5	13.2	18.0	8.3	12.3	20.8	17.0	15.4	13.0	13.8	10.6	19.7	11.9	17.1	14.7	14.8	18.1	6.9	12.6	21.5	17.1	0.0	3.3	2.6	4.9	3.7	4.4	2.8	3.2	4.9	5.5	2.2	2.9	3.6	1.1	4.5	3.7	5.3	3.8	2.2	21.8	28.5	17.6	27.6	27.6	16.6	27.8	18.4	18.4	27.6	0.0	1.3	6.5	2.5	3.0	14.7	21.7	10.2	5.3	3.4	10.4	7.9	5.2	1.7	5.8	39.4	5.2	7.5	0.0	3.7	3.3	4.2	3.3	0.0	10.2	14.0	27.0	2.9	4.9	9.1	63.2	7.8	2.8	8.5	8.2	4.6	11.2	5.2	0.0	14.9	14.7	7.3	0.0	4.7	19.1	11.9	3.8	3.4	5.0	4.7	3.4
IPO4	"FLJ23338, Imp4"	ENSG00000196497	"Importin 4"	Q8TEX9	14	24180219-24188964	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 49.5"	"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 59.5;Late spermatids: 85.2;Spermatocytes: 44.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039043, HPA064572"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA039043: AB_10673233, HPA064572: AB_2685291"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (9.45e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (3.20e-4)"	"unprognostic (8.59e-4)"	"unprognostic (5.45e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.15e-2)"	5.3	8.1	1.2	5.2	2.2	6.9	6.1	1.7	3.3	6.5	5.8	2.8	5.5	7.5	5.4	6.5	8.8	6.3	4.4	3.6	2.2	1.6	18.0	29.0	4.4	10.8	1.8	1.2	9.8	27.0	2.2	6.4	4.4	4.1	5.0	2.3	3.0	8.7	7.9	17.2	8.5	4.7	5.3	2.4	8.8	6.9	49.5	1.4	8.8	6.5	11.0	7.4	5.7	4.0	3.5	5.3	0.3	3.0	3.6	5.4	2.2	7.8	10.4	0.9	6.2	0.8	1.2	10.7	4.8	0.2	2.3	0.7	8.9	3.9	11.3	7.8	1.7	2.7	8.8	3.7	6.9	0.3	5.4	15.6	7.0	3.3	20.1	0.8	8.5	5.1	1.6	2.2	2.1	0.7	0.5	2.3	6.2	13.1	0.9	2.4	17.4	5.5	7.6	9.5	5.4	22.9	7.5	4.4	6.1	2.2	5.5	8.1	8.7	8.0	3.8	4.1	0.6	6.9	2.0	4.0	4.8	11.6	5.2	7.0	8.0	12.0	10.0	3.2	4.6	7.9	0.0	1.9	0.3	4.8	2.6	5.4	2.8	4.6	4.4	3.1	3.5	3.6	5.0	0.0	3.6	3.0	5.3	2.2	2.2	1.2	2.2	1.7	2.8	2.2	1.6	1.8	1.2	4.1	1.4	0.0	6.4	4.7	3.4	5.3	0.6	1.8	10.2	9.4	11.4	5.2	3.9	10.1	0.0	11.4	59.5	3.5	0.7	0.0	9.4	8.5	4.2	2.5	0.0	5.1	7.2	1.6	4.1	1.3	1.9	85.2	4.6	1.4	0.0	1.0	5.6	1.3	7.2	0.0	5.3	9.8	2.7	6.5	4.4	44.5	17.3	5.5	4.9	1.3	8.3	2.6
IPO5	"IMB3, KPNB3, MGC2068, Pse1, RANBP5"	ENSG00000065150	"Importin 5"	O00410	13	97953658-98024297	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Early spermatids: 1043.3;Late spermatids: 1438.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009110, HPA040983, HPA056548"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		92000	"Nucleoplasm, Cytosol"		"CAB009110: AB_2264985, HPA040983: AB_2677236, HPA056548: AB_2683169"	"unprognostic (5.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.73e-1)"	26.3	13.8	16.5	14.5	18.3	13.0	23.5	16.3	20.2	20.2	19.7	15.9	13.5	9.6	21.1	13.4	19.4	18.9	12.4	23.9	15.7	12.7	18.9	23.2	14.1	16.0	20.8	15.9	33.5	60.7	12.5	13.0	14.3	15.3	19.1	16.6	11.0	13.9	20.2	65.0	13.5	11.3	25.5	24.3	14.9	18.9	79.5	19.4	23.3	23.0	24.1	21.1	21.8	23.9	8.0	11.0	1.1	7.3	10.3	12.3	6.1	28.6	19.3	36.3	33.2	24.7	62.9	22.3	42.2	33.3	59.5	42.3	39.6	22.1	82.8	14.8	50.7	13.4	25.0	75.4	28.9	82.3	20.9	23.7	45.1	36.7	31.0	17.7	48.6	16.1	35.3	19.0	48.2	40.6	25.4	33.8	25.6	31.1	11.2	50.7	7.8	36.7	13.2	36.4	43.3	23.2	47.2	41.3	24.5	14.3	18.8	26.9	22.0	21.6	25.3	15.8	46.0	19.2	26.9	23.7	40.2	20.2	20.0	38.3	15.0	18.4	25.8	41.5	30.9	27.5	0.5	4.4	1.1	7.1	7.3	12.3	8.0	8.3	8.8	11.0	7.6	11.6	9.6	0.6	10.3	5.1	5.4	8.5	6.1	16.5	18.3	16.3	20.2	15.7	12.7	20.8	15.9	15.3	19.4	17.9	23.8	15.7	33.9	36.9	31.1	68.2	35.7	18.7	22.7	21.0	5.9	28.6	23.2	26.7	1043.3	35.1	7.8	0.0	36.0	38.4	34.0	35.8	13.9	40.9	21.3	60.4	33.9	28.3	24.1	1438.4	48.9	18.7	25.3	14.4	20.2	40.9	32.7	3.5	41.4	35.7	20.2	25.8	49.1	109.7	53.2	32.2	27.0	19.2	36.5	33.9
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384622-9448126	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA		26000	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: AB_2683180"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	23.9	20.6	21.8	18.6	24.4	12.3	36.0	24.1	30.6	24.3	27.4	14.4	19.3	17.0	25.7	19.3	29.0	20.3	20.3	37.7	22.8	23.4	26.5	24.7	22.0	23.2	23.3	17.4	23.4	25.9	33.1	19.1	26.5	24.8	24.4	22.1	12.0	21.4	22.4	88.2	17.1	16.1	53.4	25.7	16.6	21.5	9.7	16.8	20.8	34.3	28.5	20.9	43.7	33.9	3.8	5.8	1.3	6.3	6.9	5.4	1.6	37.7	29.5	34.8	27.6	35.3	45.6	27.9	46.0	29.6	34.0	36.8	25.5	34.8	35.4	16.8	35.3	30.9	29.7	49.3	35.7	56.9	16.8	40.7	29.3	33.5	25.6	22.1	44.7	22.3	29.1	38.7	22.4	52.7	34.8	40.1	12.2	43.9	21.3	44.3	15.3	26.9	21.9	34.2	35.0	34.3	28.4	54.8	16.0	28.1	35.7	13.8	27.2	20.5	40.7	33.1	28.9	18.7	22.5	31.5	41.9	28.9	43.1	49.1	6.2	23.6	24.5	27.5	24.2	22.7	0.1	2.5	0.6	2.7	4.8	5.4	3.8	3.1	3.9	5.8	3.1	3.9	3.2	1.3	6.9	6.3	2.7	2.8	1.6	21.8	24.4	24.1	30.6	22.8	23.4	23.3	17.4	24.8	16.8	62.5	53.8	24.3	76.2	128.0	37.1	127.5	30.6	49.5	67.1	33.2	55.0	44.9	28.2	32.5	3.3	40.5	18.6	0.0	35.7	54.7	55.8	105.1	35.9	39.4	31.6	33.4	29.9	25.2	47.7	3.6	25.9	41.8	37.1	26.2	36.8	30.1	37.3	28.8	33.6	35.8	38.8	12.9	55.6	15.4	22.6	129.4	30.7	22.3	45.0	129.0
IPO8	"IMP8, RANBP8"	ENSG00000133704	"Importin 8"	O15397	12	30628988-30695986	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018439, HPA023765"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018439: AB_1851771, HPA023765: AB_1851773"	"unprognostic (1.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (2.66e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (8.62e-5)"	"unprognostic (9.75e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.24e-1)"	15.7	20.9	21.2	17.3	22.5	10.0	15.4	19.8	22.6	17.4	25.2	12.3	15.9	17.9	22.4	16.0	22.9	17.2	18.3	18.9	17.9	14.5	22.5	23.3	15.6	17.5	14.8	20.3	21.1	23.9	54.4	27.8	17.2	19.0	18.4	22.6	11.9	16.7	18.5	19.8	16.6	22.6	21.3	15.9	20.4	17.8	27.5	14.6	24.8	22.1	13.1	18.0	21.6	20.4	8.0	3.6	7.3	6.0	6.0	7.5	2.8	16.9	19.9	19.1	14.0	18.0	20.7	26.8	18.8	18.1	15.0	17.7	13.6	17.7	21.9	16.5	23.0	15.9	11.0	21.1	20.3	21.9	25.5	14.9	17.9	23.9	12.4	11.8	25.9	14.1	16.7	12.8	23.9	20.4	27.1	24.7	15.4	15.9	16.5	21.2	8.6	19.5	16.0	37.2	23.4	7.6	16.0	40.1	17.7	18.9	23.5	11.8	14.5	19.7	14.4	10.4	35.5	23.0	9.4	22.0	14.4	12.7	31.0	16.3	16.3	22.1	33.2	17.6	15.6	24.9	7.2	4.5	5.4	4.8	6.0	7.1	5.6	5.4	5.2	3.3	8.0	5.9	7.5	7.3	6.0	5.5	3.6	6.1	2.8	21.2	22.5	19.8	22.6	17.9	14.5	14.8	20.3	19.0	14.6	8.9	18.9	11.0	5.4	8.5	11.5	16.9	10.2	8.1	21.6	10.4	11.8	9.8	3.3	8.6	29.2	13.9	11.7	23.3	11.9	6.0	9.1	6.7	11.5	22.4	13.9	7.9	6.4	24.5	22.2	6.4	8.1	12.1	8.5	3.6	13.0	12.1	11.0	5.8	12.4	12.9	14.6	12.9	11.2	9.1	3.2	8.2	15.0	7.7	13.0	7.5
IPO9	"FLJ10402, Imp9"	ENSG00000198700	"Importin 9"	Q96P70	1	201829141-201884294	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059540			Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		30000	Cytosol	Vesicles	"HPA059540: "	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (8.92e-3)"	"unprognostic (2.23e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.78e-4)"	16.8	18.0	27.1	14.2	26.5	11.0	15.2	29.1	27.8	14.2	14.3	18.7	11.0	11.5	19.7	24.2	15.2	17.4	12.2	12.0	22.3	17.9	14.9	23.1	16.5	15.7	17.7	22.8	20.9	16.5	24.9	26.0	18.1	21.2	16.3	18.1	24.7	11.2	14.7	15.4	21.9	13.3	21.5	15.0	18.3	13.4	12.8	17.2	21.1	18.4	8.4	20.3	14.4	13.7	10.9	14.6	10.7	15.3	11.0	13.3	8.3	17.8	19.0	26.0	21.1	15.1	10.2	19.5	13.8	14.0	23.1	22.5	30.3	15.6	10.6	7.9	13.2	20.3	16.6	17.5	19.1	20.0	9.7	15.5	7.9	30.8	22.6	11.5	10.3	13.1	11.3	8.8	24.8	20.3	15.5	23.1	14.6	15.7	10.1	16.5	17.9	11.9	13.5	26.1	16.1	6.2	12.7	27.1	10.5	12.5	28.5	22.1	25.2	15.2	24.1	12.2	41.9	17.6	13.1	12.5	21.8	19.5	12.2	25.2	7.5	4.5	12.3	10.8	12.2	16.2	10.7	11.7	9.7	12.2	15.3	10.6	10.9	11.9	13.3	14.6	10.3	9.7	10.4	2.9	11.0	14.9	7.7	10.7	8.3	27.1	26.5	29.1	27.8	22.3	17.9	17.7	22.8	21.2	17.2	20.8	42.9	23.1	13.3	14.1	57.4	22.8	7.6	8.1	26.1	7.0	56.9	22.0	1.7	15.1	6.0	18.8	6.3	23.3	16.1	16.8	22.1	10.7	10.5	17.1	16.6	71.5	10.9	21.5	17.0	6.3	18.7	16.7	13.5	10.0	12.7	40.4	15.2	10.5	26.5	7.9	54.1	38.8	21.7	24.9	32.2	12.4	18.9	13.8	15.0	10.8
ITGA1	"CD49a, VLA1"	ENSG00000213949	"Integrin subunit alpha 1"	P56199	5	52787896-52959210	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 50.6;Alveolar cells type 2: 39.3;Endothelial cells: 75.2;Fibroblasts: 29.3;Hepatocytes: 101.1;Ito cells: 98.2;Sertoli cells: 97.0;Smooth muscle cells: 74.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 1.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.2;T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 21.4;HHSteC: 26.3;WM-115: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042555	Uncertain					NA	NA		2300000			"HPA042555: AB_10794281"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (3.13e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.62e-2)"	22.6	20.2	2.3	12.7	2.7	0.0	12.4	1.2	2.9	10.9	28.2	1.5	13.6	5.3	15.9	12.5	22.3	9.2	13.9	11.1	2.5	2.2	17.9	40.4	28.8	10.2	3.1	1.4	9.6	3.3	11.5	3.0	24.8	3.3	26.1	8.2	5.9	2.9	18.2	9.7	2.4	13.5	52.8	2.7	66.0	16.8	4.1	1.6	0.6	10.7	3.5	2.2	42.7	17.8	0.0	0.1	1.2	0.3	0.0	1.8	0.1	0.0	0.0	2.0	0.0	5.9	1.7	1.2	2.8	7.3	1.6	4.9	3.8	0.3	0.0	0.9	21.4	4.8	1.4	0.4	2.4	1.5	0.0	1.5	0.0	3.5	2.7	26.3	0.0	0.0	4.0	0.2	2.0	0.7	4.5	0.3	0.1	0.0	0.0	2.5	0.0	0.8	0.0	1.2	0.1	0.7	0.0	2.0	0.0	3.1	0.0	0.1	9.2	2.8	0.7	0.6	6.0	0.0	0.0	2.2	4.5	0.4	0.1	1.4	0.0	0.0	0.0	2.9	0.0	19.5	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.6	1.8	0.1	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.1	0.1	2.3	2.7	1.2	2.9	2.5	2.2	3.1	1.4	3.3	1.6	50.6	39.3	2.2	3.3	2.9	1.7	10.4	2.5	10.7	14.8	5.2	2.0	1.2	1.7	2.6	16.7	75.2	5.2	0.0	4.8	12.0	29.3	1.3	9.3	101.1	2.0	0.0	15.7	98.2	9.7	4.1	8.6	3.9	6.8	14.4	11.8	0.2	12.6	7.0	7.8	15.3	1.6	97.0	74.8	0.9	0.7	2.8	2.9	15.2	9.9	1.7
ITGA6	CD49f	ENSG00000091409	"Integrin subunit alpha 6"	P23229	2	172427354-172506282	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 170.5;Basal keratinocytes: 217.4;Urothelial cells: 209.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.2"	"Group enriched"	"Detected in many"	34	"granulocytes: 16.2;NK-cells: 5.5;T-cells: 10.0"	"Cell line enhanced"	"Detected in many"		"BJ: 51.0;HaCaT: 56.1;HBEC3-KT: 110.4;hTCEpi: 48.1;hTERT-HME1: 48.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009009, HPA012696, HPA027582"	Enhanced					NA	NA		45000000			"CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-3)"	"unprognostic (9.34e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.35e-11)"	"unprognostic (3.35e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.21e-3)"	28.0	3.1	9.8	19.1	10.5	1.6	30.1	3.0	8.4	27.0	34.9	9.4	42.3	28.5	28.2	11.3	17.0	11.1	23.8	21.7	9.7	8.2	22.0	4.9	29.0	14.9	9.8	5.1	7.6	31.3	7.4	4.9	38.7	12.6	14.3	25.2	17.6	37.1	32.4	13.5	17.5	44.2	15.2	9.6	14.9	25.0	12.4	6.9	15.1	11.5	35.2	13.2	24.1	17.3	0.3	0.1	16.2	0.2	5.5	10.0	3.3	11.6	10.0	4.4	7.8	0.2	0.1	24.0	51.0	5.5	5.2	3.2	5.6	22.3	0.1	14.4	13.5	11.9	56.1	2.9	110.4	9.5	0.1	2.6	0.2	10.7	9.3	0.7	3.2	0.3	1.0	48.1	0.3	48.9	5.3	33.4	6.3	0.0	0.8	6.6	0.5	0.9	2.8	7.9	33.2	8.6	0.1	13.1	0.2	7.9	16.4	0.1	0.5	9.4	0.0	10.9	4.8	2.1	0.2	15.0	7.3	6.6	13.5	8.8	0.7	0.5	0.3	0.2	1.1	29.4	2.6	0.2	16.2	4.2	0.0	8.5	0.2	5.4	5.0	0.1	0.3	10.0	4.6	0.5	5.5	0.0	0.0	5.7	3.3	9.8	10.5	3.0	8.4	9.7	8.2	9.8	5.1	12.6	6.9	8.9	15.0	7.5	170.5	217.4	1.2	28.0	28.1	4.0	5.7	26.2	53.0	80.2	5.0	26.3	28.6	129.7	78.8	0.0	53.3	26.5	14.5	163.8	8.1	17.0	24.0	1.6	55.0	14.1	1.6	33.8	3.7	9.2	49.0	0.0	103.3	1.5	85.9	64.5	2.5	49.4	12.5	0.0	12.7	3.3	25.5	73.4	18.7	14.9	95.0	209.9
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590065-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 7.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 7.7;monocytes: 2.3"	"Cell line enhanced"	"Detected in many"		"RT4: 71.7;SuSa: 62.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"		NA	NA		750000	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (4.03e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.61e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.07e-2)"	23.2	22.1	17.9	18.3	21.8	3.1	25.8	16.7	23.1	22.9	13.6	23.4	11.6	8.4	26.0	11.4	14.2	14.5	25.2	40.7	16.8	12.3	51.5	9.5	20.6	7.6	24.2	11.6	35.4	18.7	65.0	11.0	29.6	22.1	16.5	11.9	83.4	17.9	15.9	13.1	21.5	10.1	29.6	33.0	12.1	17.3	11.2	17.0	7.8	33.1	10.9	11.1	17.6	17.9	0.3	0.9	7.7	2.3	0.4	1.1	0.5	9.3	11.1	7.4	23.7	27.3	18.5	28.3	18.3	14.8	6.5	6.5	9.7	32.2	0.0	36.1	20.6	22.7	11.7	3.8	17.2	9.4	1.8	3.4	2.2	14.6	13.3	10.8	1.5	1.4	13.4	8.2	14.4	12.3	39.0	15.4	1.1	2.1	4.7	17.2	3.7	0.9	1.3	5.6	5.6	5.6	0.0	15.2	1.2	16.8	71.7	1.5	4.6	21.1	6.5	7.7	62.1	5.1	4.3	46.8	40.2	12.6	8.2	15.4	1.1	1.9	1.0	16.2	0.6	19.8	7.7	1.1	1.6	1.0	2.3	0.7	0.3	0.5	0.8	0.9	0.1	0.5	0.5	0.5	0.4	1.2	0.4	1.1	0.5	17.9	21.8	16.7	17.3	16.8	12.3	24.2	11.6	22.1	17.0	26.8	18.5	2.4	54.8	114.0	118.2	124.7	73.9	12.0	20.5	73.3	72.6	46.9	1.7	78.4	0.5	50.4	13.2	0.0	89.0	21.8	61.3	83.9	49.5	15.8	26.1	14.3	7.0	34.4	33.9	1.6	17.8	18.2	43.9	20.8	18.9	82.5	120.4	18.2	24.4	16.5	54.8	32.3	47.2	0.7	1.4	90.7	33.2	6.9	11.4	48.6
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32900319-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Ductal cells: 1163.1;Pancreatic endocrine cells: 917.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 196.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		540000000	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	95.2	30.6	13.7	32.1	19.7	9.7	107.7	6.5	14.8	55.1	61.3	17.0	80.2	20.2	84.2	56.2	59.9	45.0	49.8	68.7	15.0	14.4	47.3	85.8	55.4	34.5	23.0	11.1	47.4	37.4	17.6	35.2	83.3	19.5	53.1	32.2	18.6	30.3	76.2	58.0	19.5	42.3	109.3	30.1	59.8	45.4	26.9	18.8	12.7	36.8	27.6	19.4	92.7	47.4	31.3	9.1	4.3	27.1	21.9	68.4	26.2	45.6	67.0	36.2	40.1	87.3	75.2	31.6	153.5	89.0	73.1	66.9	15.0	106.9	12.3	27.8	128.7	48.0	31.9	10.9	87.3	81.6	12.1	8.8	14.8	31.9	17.5	61.5	3.3	14.7	76.2	47.8	76.9	31.3	196.1	89.8	6.1	10.2	5.4	120.5	7.5	5.7	3.3	8.0	13.9	34.0	3.7	26.8	2.2	104.2	13.2	8.6	21.4	47.8	8.1	34.4	61.5	10.9	11.9	100.4	94.2	54.7	66.9	51.1	5.0	1.1	6.9	69.4	14.1	36.9	1.6	9.8	4.3	25.5	17.8	6.0	31.3	54.6	37.5	9.1	8.6	7.1	19.1	2.3	21.9	27.1	3.7	68.4	26.2	13.7	19.7	6.5	14.8	15.0	14.4	23.0	11.1	19.5	18.8	318.6	128.6	76.4	295.7	485.6	32.6	175.3	242.0	164.6	252.5	214.6	29.5	156.7	11.6	1163.1	4.3	314.7	83.6	70.0	355.7	460.3	265.1	177.2	86.6	221.3	161.3	36.5	185.6	387.9	152.7	9.7	235.6	174.3	325.6	83.0	81.4	76.8	917.0	113.2	565.7	64.3	45.2	627.3	497.4	10.0	63.7	149.1	183.8	106.6	98.8	257.2
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493348-4847840	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 46.6"	"Cell type enhanced"	"Detected in many"	5	"Peritubular cells: 49.5;Sertoli cells: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 35.0;HeLa: 25.5;HMC-1: 16.9;U-87 MG: 20.8"	"Region enhanced"	"Detected in all"		"cerebellum: 782.1"	"Low region specificity"	"Detected in all"			"HPA014765, HPA016487"	Approved		Approved	Vesicles		NA	NA		37000	Vesicles		"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.40e-1)"	4.8	8.2	6.1	7.4	18.6	3.2	11.9	39.5	30.2	10.2	7.4	1.7	21.5	2.4	18.4	13.2	7.8	10.1	11.8	5.3	8.7	5.1	8.7	2.5	6.4	7.1	4.8	10.4	14.2	2.7	46.6	7.3	4.6	3.8	15.0	3.7	12.5	9.6	27.4	3.2	3.2	5.0	17.4	3.7	6.0	5.5	3.0	4.3	7.0	19.3	0.6	8.6	14.1	10.6	8.9	3.6	5.4	1.6	1.2	2.2	1.2	0.0	1.3	0.2	0.6	10.0	0.4	3.2	0.2	0.2	0.3	0.3	0.3	0.3	4.4	0.4	0.4	1.8	0.0	0.9	1.1	0.5	35.0	1.4	12.7	25.5	1.6	13.8	5.4	16.9	2.6	0.7	1.7	0.5	3.6	1.4	3.4	1.4	5.1	1.3	0.5	2.4	1.8	0.9	0.2	3.9	1.4	0.2	0.3	1.1	1.1	0.1	8.5	2.3	1.4	2.3	0.3	0.9	7.7	1.7	0.8	1.4	1.1	1.0	7.8	3.7	2.9	20.8	5.8	1.8	5.4	1.6	1.9	1.5	1.0	1.9	6.6	1.7	1.5	2.1	8.9	2.2	1.9	0.8	1.2	0.7	3.6	1.3	1.2	6.1	18.6	39.5	30.2	8.7	5.1	4.8	10.4	3.8	4.3	0.0	31.8	25.3	4.8	3.4	1.6	4.8	5.1	21.4	14.8	8.7	0.0	0.5	3.3	1.5	4.4	22.4	0.0	0.0	4.5	0.4	13.0	6.1	24.4	1.8	4.7	1.6	3.4	22.1	13.3	5.7	27.9	15.3	6.8	6.4	0.8	3.9	1.5	0.3	49.5	3.5	1.0	38.8	26.4	1.4	2.6	2.8	0.8	19.5	0.6	3.1
IZUMO1	"IZUMO, MGC34799, OBF"	ENSG00000182264	"Izumo sperm-egg fusion 1"	Q8IYV9	19	48740852-48746909	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 17.2"	"Group enriched"	"Detected in some"	21	"Early spermatids: 134.8;Late spermatids: 82.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;CAPAN-2: 2.7;HaCaT: 1.8;hTCEpi: 4.4;K-562: 2.1;RT4: 2.8;U-266/84: 1.5"					"Low region specificity"	"Detected in many"			HPA038104	Enhanced					NA	NA					"HPA038104: AB_10670655"	"unprognostic (2.03e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.53e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.31e-3)"	"unprognostic (6.92e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0			0.7	0.0	0.6	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0		0.0	1.2	0.0	0.0	0.3		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	17.2			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	2.7	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.3	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.1	0.1	0.0	0.8	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	134.8	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	3.1	0.0	82.3	1.1	0.0	1.7	0.0	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.1
IZUMO1R	"Folbp3, FOLR4, JUNO"	ENSG00000183560	"IZUMO1 receptor, JUNO"	A6ND01	11	94305592-94307721	"Predicted intracellular proteins, Transporters"	Fertilization	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 3.0;lymphoid tissue: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 1.0;CACO-2: 2.1;HBEC3-KT: 2.3;U-266/84: 3.1;WM-115: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.56e-3)"									"unprognostic (1.37e-1)"	"unprognostic (7.22e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.08e-2)"	"unprognostic (8.61e-2)"		0.2	3.0	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.9	0.1			0.1	0.3	0.0	0.0	0.4	0.5	1.2	0.0	0.0	1.3	0.2	0.0	2.4	0.0		1.3	0.0	0.0	0.6	0.0		0.3	1.1		0.3	0.0	0.0	0.0	0.3	0.3	0.1	0.6	0.0	0.4			0.9		1.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IZUMO2	"C19orf41, MGC33947, SCRL"	ENSG00000161652	"IZUMO family member 2"	Q6UXV1	19	50152548-50163195	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"testis: 33.0"	"Group enriched"	"Detected in some"	30	"Early spermatids: 576.2;Late spermatids: 208.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.6;RH-30: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042143	Uncertain					NA	NA					"HPA042143: AB_10794078"			"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.31e-2)"			"unprognostic (1.81e-1)"		"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.75e-2)"		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	33.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	1.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	1.0	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.1	0.8	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.7	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	576.2	0.0	0.0	0.0	0.0	0.0	0.2	0.7	1.1	0.0	0.1	0.0	3.5	0.6	0.0	208.4	4.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	3.2	0.0	0.1	12.9	0.4	4.1	4.5	0.4	0.0	0.0	0.0	1.6
IZUMO3	"bA20A20.1, C9orf134"	ENSG00000205442	"IZUMO family member 3"	Q5VZ72	9	24542952-24545946	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	169	"testis: 16.9"	"Group enriched"	"Detected in some"	89	"Early spermatids: 185.3;Late spermatids: 58.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	62	"SCLC-21H: 8.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0
IZUMO4	C19orf36	ENSG00000099840	"IZUMO family member 4"	Q1ZYL8	19	2096429-2099593	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 108.2"	"Group enriched"	"Detected in many"	5	"Early spermatids: 1393.1;Late spermatids: 1780.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 11.1;RPMI-8226: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048496	Enhanced				"Secreted in male reproductive system"	NA	NA					"HPA048496: AB_2680419"	"unprognostic (2.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-5)"	"unprognostic (2.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (2.12e-1)"	"unprognostic (6.58e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.68e-1)"	"unprognostic (7.51e-3)"	1.6	1.1	4.4	0.9	5.6	0.6	0.9	1.3	4.4	1.0	0.8	2.9	1.2	0.6	0.9	1.6	1.0	1.4	1.3	1.6	4.4	2.1	1.1	2.0	0.9	1.1	10.5	3.3	3.0	8.3	0.8	2.7	0.6	4.2	1.9	0.8	0.6	1.4	1.6	0.9	1.4	0.7	0.7	3.6	0.8	1.0	108.2	6.6	0.4	1.3	0.8	1.4	0.9	0.6	5.3	2.8	3.4	3.1	1.0	5.1	2.6	0.8	0.7	0.4	3.4	1.5	1.6	0.5	0.5	0.8	0.6	0.1	0.3	0.7	0.6	0.8	0.8	0.0	0.7	0.1	3.8	0.2	1.6	0.3	0.0	1.3	1.0	4.3	0.0	0.6	0.6	1.4	1.0	1.1	1.2	0.0	2.0	0.0	11.1	1.4	0.2	1.0	0.3	0.3	1.4	0.9	0.8	0.0	13.4	1.7	0.4	0.6	0.9	0.5	1.2	0.5	0.2	0.6	1.3	0.5	0.5	0.2	0.1	0.3	1.2	1.4	1.0	1.8	1.2	0.3	0.0	1.6	1.4	1.6	2.2	3.5	5.3	5.1	3.7	2.2	1.8	4.1	1.7	3.4	1.0	3.1	2.8	4.7	2.6	4.4	5.6	1.3	4.4	4.4	2.1	10.5	3.3	4.2	6.6	0.0	0.0	0.9	3.8	2.2	3.7	1.2	2.5	0.0	0.0	8.7	7.9	0.4	5.0	2.0	1393.1	0.6	1.6	0.0	5.1	3.3	0.9	6.1	0.0	8.9	0.8	0.0	7.5	0.6	2.1	1780.5	26.4	1.6	11.8	16.2	1.9	6.0	2.5	0.0	18.7	7.2	8.7	6.5	1.3	339.6	12.2	1.5	1.4	5.1	2.6	3.7
KCNA2	"HK4, Kv1.2"	ENSG00000177301	"Potassium voltage-gated channel subfamily A member 2"	P16389	1	110519837-110631474	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 28.0"	"Cell type enriched"	"Detected in some"	5	"Muller glia cells: 24.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.1"	"Lineage enriched"	"Detected in single"	8	"T-cells: 4.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 10.9;SCLC-21H: 2.8;U-2 OS: 2.4;U-266/70: 3.6;U-266/84: 5.4;WM-115: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001976	Enhanced					NA	NA					"CAB001976: "	"unprognostic (1.84e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.17e-3)"	"unprognostic (6.68e-3)"		"unprognostic (5.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.93e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.83e-1)"	3.2	1.4	7.1	2.2	13.1	0.8	1.2	17.2	28.0	1.2	1.6	3.1	0.0	1.4	1.0	1.3	1.7	1.1	1.6	1.6	7.2	6.1	0.9	0.9	1.0	1.9	7.2	14.5	1.1	1.9	0.8	1.4	0.7	21.1	1.8	2.0	1.4	1.8	2.4	2.1	1.6	1.6	1.6	2.8	1.3	1.3	2.5	3.8	0.3	5.3	0.0	3.5	1.4	0.5	0.5	0.0	0.0	0.0	0.0	4.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	10.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.0	1.4	0.0	0.0	2.8	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.1	2.4	0.0	0.0	3.6	5.4	0.2	0.1	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.3	0.5	1.8	1.3	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	4.1	0.1	7.1	13.1	17.2	26.3	7.2	6.1	7.2	14.5	21.1	3.8	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	24.2	0.0	0.0	4.9	0.0	2.9	0.0	0.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110672465-110675033	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 59.4"	"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 2: 3.4;Melanocytes: 3.3;Sertoli cells: 6.5;T-cells: 8.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 3.3;T-cells: 11.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 12.7;Karpas-707: 26.1;U-266/70: 18.9;U-266/84: 16.9"	"Low region specificity"	"Detected in all"							HPA016625	Approved					NA	NA					"HPA016625: AB_2669407"	"unprognostic (2.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-5)"	"unprognostic (1.70e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	1.9	1.3	4.0	7.8	5.7	5.6	1.3	5.0	5.6	1.7	3.1	0.5	0.0	3.2	1.1	0.4	1.1	1.3	2.3	1.4	3.5	4.3	1.5	1.3	7.8	14.5	1.5	3.1	1.3	0.9	0.4	1.8	0.9	3.1	1.1	2.6	0.5	3.7	0.3	0.5	0.8	5.9	0.7	1.9	7.7	5.3	1.4	1.5	59.4	2.1	0.3	10.9	5.8	1.3	3.3	1.0	0.0	0.7	0.9	11.5	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	26.1	0.0	0.0	5.4	0.0	0.5	0.0	0.0	0.0	0.0	5.2	0.0	0.0	3.6	0.3	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.4	0.0	0.0	18.9	16.9	6.5	0.0	1.5	0.0	0.0	0.7	0.0	7.2	0.0	8.2	2.3	10.8	11.5	1.0	3.3	8.5	6.4	0.0	0.9	0.1	0.5	9.5	2.9	4.0	5.7	5.0	5.6	3.5	4.3	1.5	3.1	3.1	1.5	0.0	3.4	2.2	0.0	0.3	1.3	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	2.5	0.6	0.0	0.0	1.6	3.3	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	6.5	0.0	0.9	0.2	0.5	0.0	8.7	0.0	0.0
KCNA5	"HK2, HPCN1, Kv1.5"	ENSG00000130037	"Potassium voltage-gated channel subfamily A member 5"	P22460	12	5043989-5046788	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 33.0"	"Cell type enriched"	"Detected in some"	8	"Bipolar cells: 153.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	134	"plasmacytoid DC: 13.3"	"Lineage enriched"	"Detected in single"	134	"dendritic cells: 13.3"	"Cell line enriched"	"Detected in single"	12	"NTERA-2: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA021516, CAB022562"	Approved					NA	NA					"CAB022562: , HPA021516: AB_2670732"	"unprognostic (3.87e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.08e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.92e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.08e-2)"	3.4	1.4	1.9	0.9	8.6	0.7	1.2	0.4	2.3	1.6	3.3	7.2	0.0	1.1	1.7	2.6	7.6	2.1	2.3	33.0	3.5	5.8	1.9	0.8	2.3	0.9	2.3	2.2	3.2	2.4	0.6	7.5	3.4	8.8	3.7	1.3	7.2	0.9	2.0	5.3	0.6	1.1	3.0	3.9	1.2	3.3	0.8	4.9	0.0	1.1	3.4	1.2	4.5	3.4	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	1.9	8.6	0.4	2.3	3.5	5.8	2.3	2.2	8.8	4.9	0.0	0.0	0.0	0.0	0.8	153.4	8.6	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.4	0.0	3.4	12.9	19.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.1;thyroid gland: 25.7"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 54.8;Cone photoreceptor cells: 29.5;Sertoli cells: 77.6;Smooth muscle cells: 66.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 5.9;hTEC/SVTERT24-B: 9.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 300.5"	"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Nucleoplasm, Plasma membrane"	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	12.6	5.9	7.5	1.1	41.1	1.4	3.5	10.7	16.4	5.7	2.9	4.6	2.5	1.6	3.4	11.9	2.1	2.7	2.7	4.8	12.3	4.3	1.8	2.3	3.1	0.9	3.7	10.3	2.8	3.7	1.8	1.2	1.3	3.0	21.1	1.8	7.2	3.4	17.9	1.7	1.3	1.9	2.6	2.6	4.3	1.3	2.7	12.3	0.0	25.7	1.0	0.5	2.0	3.0	1.0	4.3	2.4	1.2	0.9	2.7	0.4	0.9	0.8	1.3	0.3	0.1	0.0	2.5	2.2	0.0	0.0	0.2	1.7	0.2	0.6	1.2	0.0	0.5	0.6	0.0	0.0	0.0	0.7	1.7	5.9	1.1	2.7	0.0	1.7	0.5	0.0	0.0	9.2	0.0	2.1	3.7	0.9	0.2	0.5	0.4	0.2	0.5	1.0	1.9	2.6	0.5	0.9	1.3	4.7	0.0	0.4	1.4	1.4	0.5	1.1	1.2	0.9	1.5	0.9	3.8	1.5	0.9	2.5	2.0	3.2	0.7	0.7	4.5	1.9	1.7	2.4	0.6	0.2	1.5	0.7	2.7	0.9	1.4	1.3	0.9	1.0	1.2	1.3	0.1	0.9	1.2	4.3	1.7	0.4	7.5	41.1	10.7	16.4	12.3	4.3	3.7	10.3	3.0	12.3	0.0	0.0	0.5	0.1	0.7	54.8	4.1	0.0	0.0	1.2	0.0	29.5	0.1	0.0	0.4	11.9	1.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	3.6	0.0	0.0	1.3	9.3	4.7	0.0	1.1	1.7	0.0	0.0	1.6	0.0	0.0	2.5	0.0	6.1	77.6	66.2	0.1	0.9	0.6	0.1	0.0	0.0	0.1
KCNB1	Kv2.1	ENSG00000158445	"Potassium voltage-gated channel subfamily B member 1"	Q14721	20	49293394-49484297	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Exocytosis, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;retina: 22.4"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 119.5;Cone photoreceptor cells: 200.3;Rod photoreceptor cells: 366.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.6;CACO-2: 5.1;hTCEpi: 3.2;U-2 OS: 4.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB001979, HPA042434"	Enhanced					NA	NA					"CAB001979: , HPA042434: AB_2677996"	"unprognostic (4.51e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.17e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.25e-4)"	16.9	3.6	11.4	1.3	14.6	0.8	2.4	8.1	25.9	2.3	5.1	1.8	0.7	1.2	6.8	2.3	3.9	9.0	1.9	1.9	6.6	5.3	1.3	3.5	1.2	0.8	3.3	12.5	1.2	1.2	0.9	2.5	1.0	2.5	4.8	1.9	22.4	1.7	6.5	6.2	1.1	1.8	9.6	1.2	1.2	3.9	1.5	2.4	0.0	1.0	0.1	0.8	4.0	0.9	0.4	0.3	1.2	0.2	0.3	0.7	0.0	0.0	0.1	0.8	0.0	3.6	0.3	0.1	0.0	0.4	0.4	0.0	5.1	0.0	0.0	0.0	0.1	1.3	0.1	0.0	0.1	0.3	0.1	0.2	0.0	0.1	0.0	0.0	2.6	0.0	0.6	3.2	0.0	0.1	0.2	0.0	0.0	0.0	1.9	1.2	0.3	0.0	2.4	0.1	0.0	0.9	0.0	1.0	0.0	0.0	0.0	2.3	1.9	1.6	2.3	0.0	0.0	1.7	0.0	0.0	2.2	4.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.0	0.1	0.1	0.3	0.2	0.0	0.4	0.7	0.2	1.2	0.3	0.1	0.3	0.1	0.0	11.4	14.6	8.1	25.9	6.6	5.3	3.3	12.5	2.5	2.4	0.0	2.1	0.0	0.1	0.7	119.5	1.2	2.5	5.3	1.2	0.0	200.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.5	4.7	0.1	17.5	0.0	0.0	0.0	0.4	4.0	0.1	0.0	0.0	0.0	26.9	0.1	0.0	32.5	0.0	366.4	0.0	3.4	0.2	0.3	0.3	0.1	0.0	0.0	0.0
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537391-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;lymphoid tissue: 8.6;pituitary gland: 9.2"	"Cell type enriched"	"Detected in some"	15	"Cone photoreceptor cells: 249.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 3.2;HDLM-2: 3.1;HEK 293: 7.6;SCLC-21H: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"		Yes	NA			"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: AB_2685591"	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.8	1.9	3.8	0.6	5.3	0.4	0.7	0.3	9.7	0.5	0.7	0.0	0.0	1.2	0.4	0.4	1.1	2.1	0.5	0.4	7.1	3.1	0.5	0.4	0.6	0.5	0.9	7.8	0.4	2.4	0.4	9.2	0.5	3.2	0.7	0.7	4.2	0.5	0.5	0.4	0.4	1.6	0.5	1.6	8.6	2.4	1.7	0.4	0.9	0.4	0.0	0.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.1	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	5.3	0.3	9.7	7.1	3.1	0.9	7.8	3.2	0.4	0.0	0.0	0.0	0.0	0.0	12.9	0.2	0.0	0.0	0.0	1.8	249.4	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	17.1	0.0	0.0	5.0	1.1	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.4	0.0	2.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 67.5"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 36.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Region enhanced"	"Detected in all"		"cerebellum: 67.5"	"Cell type enhanced"	"Detected in some"		"basophil: 5.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.7	2.3	8.2	1.0	10.0	2.9	0.9	67.5	33.3	3.0	1.0	1.0	0.0	1.4	1.5	0.6	1.1	0.9	1.3	0.6	5.6	4.9	0.9	1.1	1.0	1.2	3.3	12.6	1.1	0.9	0.6	1.4	0.7	19.5	1.2	0.8	0.7	1.2	0.7	1.7	1.8	1.2	0.8	1.9	1.0	1.3	2.9	2.0	0.0	1.5	0.0	0.8	2.4	0.5	1.7	0.8	5.8	0.8	0.7	1.1	0.3	0.4	0.1	3.1	1.2	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.2	0.0	0.9	1.1	1.8	0.0	0.3	0.3	2.1	0.6	3.0	0.2	0.4	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	1.4	0.0	0.5	0.5	1.2	1.5	0.0	0.0	0.8	7.5	0.9	0.0	0.4	7.1	4.4	0.4	0.5	0.0	0.4	0.6	0.5	0.1	0.2	2.3	0.3	0.3	0.5	0.6	1.0	0.5	0.3	1.0	5.8	0.7	1.1	1.1	0.7	0.7	0.7	0.9	0.5	0.2	1.7	0.7	0.8	3.8	0.7	0.8	0.8	0.4	0.3	8.2	10.0	67.5	33.3	5.6	4.9	3.3	12.6	19.5	2.0	0.0	0.0	0.0	0.0	0.0	36.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	7.5	0.0	0.0	8.4	0.3	0.0	0.0	1.0	0.0	1.5	0.2	0.0	0.0	0.1	7.4	0.0	0.4	5.4	4.5	0.0	0.0	0.0	0.0	0.0
KCNC3	"Kv3.3, SCA13"	ENSG00000131398	"Potassium voltage-gated channel subfamily C member 3"	Q14003	19	50311937-50333515	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 32.1;parathyroid gland: 31.1;thyroid gland: 23.9"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 9.8;Collecting duct cells: 19.2;Cone photoreceptor cells: 7.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 8.9;CAPAN-2: 7.8;HDLM-2: 8.0;HMC-1: 21.4;K-562: 7.9;SK-BR-3: 14.5;T-47d: 13.8;U-2 OS: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018041	Approved					NA	NA					"HPA018041: AB_1855579"	"unprognostic (8.05e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.01e-4)"	"unprognostic (4.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.10e-5)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.19e-1)"	1.4	2.2	7.2	5.4	9.4	1.4	2.3	32.1	31.2	3.1	1.1	3.4	3.0	1.8	4.5	5.8	1.1	12.8	1.4	1.7	6.9	4.2	10.6	2.5	4.5	4.7	4.0	6.6	0.6	3.7	31.1	9.7	2.4	15.6	2.4	1.4	3.0	2.3	15.1	1.2	2.1	1.8	1.7	3.8	6.5	2.1	2.4	2.9	1.1	23.9	0.0	3.4	1.8	1.0	0.4	1.1	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.0	4.2	0.0	0.0	0.0	0.0	8.9	7.8	0.7	1.0	0.0	0.5	1.2	0.2	0.0	0.0	8.0	1.8	0.0	0.0	1.7	0.0	0.0	21.4	0.1	0.0	0.0	0.0	0.0	0.1	0.3	7.9	0.0	0.0	2.8	0.1	0.0	1.1	0.9	3.3	0.0	0.1	0.0	0.5	0.2	0.0	1.4	1.7	14.5	0.0	0.2	13.8	2.2	0.2	0.0	9.5	0.0	0.0	0.1	0.1	0.5	0.3	1.8	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	7.2	9.4	32.1	31.2	6.9	4.2	4.0	6.6	15.6	2.9	0.0	0.3	0.0	0.8	0.7	9.8	2.6	0.0	1.4	1.2	19.2	7.9	1.9	0.0	1.2	0.3	0.0	0.0	0.0	1.2	0.7	0.2	1.1	0.0	1.5	2.8	1.6	4.1	0.6	5.3	0.0	0.6	2.3	0.0	2.8	0.0	0.7	0.2	0.0	0.0	2.3	6.3	0.0	1.0	0.9	1.1	0.5	1.9	0.0	0.0	0.9
KCND1	Kv4.1	ENSG00000102057	"Potassium voltage-gated channel subfamily D member 1"	Q9NSA2	X	48961378-48971569	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.8"	"Cell type enhanced"	"Detected in some"	8	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Intestinal endocrine cells: 3.4;Leydig cells: 1.7;Peritubular cells: 3.5;Rod photoreceptor cells: 2.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HSkMC: 13.2;NB-4: 10.5;SuSa: 10.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000524, HPA001066"	Supported		Uncertain	Nucleoplasm		Yes	No			Nucleoplasm		"HPA000524: AB_2666013, HPA001066: AB_1079662"	"unprognostic (6.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.19e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.41e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.30e-11)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.22e-3)"	4.9	2.4	4.2	3.4	4.7	6.0	2.2	16.8	7.8	5.1	2.2	6.3	1.9	2.0	5.0	3.8	1.4	7.4	6.3	2.9	6.9	2.5	2.5	1.8	3.0	3.1	3.1	3.5	4.6	1.4	1.8	3.0	2.5	10.4	3.3	2.1	2.6	1.2	6.0	0.7	1.6	2.6	6.6	6.5	4.2	2.5	3.0	2.7	1.1	2.3	0.5	3.6	3.0	3.0	0.6	1.3	1.4	0.1	0.0	0.8	0.1	0.4	1.9	0.8	4.7	6.4	5.1	1.6	1.0	4.0	2.8	1.9	1.2	0.6	1.6	3.4	3.1	0.8	0.6	0.8	0.4	2.7	2.6	3.1	1.4	1.9	0.1	2.4	0.4	2.9	13.2	1.8	5.2	0.6	4.7	0.9	2.2	1.1	3.6	2.0	3.5	0.4	10.5	2.5	0.3	0.7	1.3	0.9	1.5	3.1	1.5	0.5	2.1	0.9	0.0	2.1	10.2	2.0	1.5	2.4	0.6	2.6	0.6	0.2	2.9	3.8	3.8	1.7	3.7	2.1	0.0	0.1	0.0	0.5	0.0	0.3	0.6	0.2	0.8	0.0	0.1	0.2	0.0	1.4	0.0	0.0	1.3	0.0	0.1	4.2	4.7	16.8	7.8	6.9	2.5	3.1	3.5	10.4	2.7	0.0	1.4	0.0	0.0	0.7	0.2	0.4	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	3.4	0.6	0.8	0.0	1.7	0.0	0.0	0.0	0.2	0.3	0.1	0.0	3.5	0.0	2.8	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.1
KCND2	"KIAA1044, Kv4.2, RK5"	ENSG00000184408	"Potassium voltage-gated channel subfamily D member 2"	Q9NZV8	7	120273668-120750331	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 41.1"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 2.9;Cholangiocytes: 5.1;Ductal cells: 2.5;Leydig cells: 3.4;Spermatocytes: 4.2;Spermatogonia: 3.3"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Region enhanced"	"Detected in all"		"cerebellum: 41.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.5;HSkMC: 4.1;NTERA-2: 3.2;RT4: 3.3;SCLC-21H: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029068	Enhanced					NA	NA					"HPA029068: AB_10601436"	"unprognostic (4.22e-1)"	"unprognostic (2.79e-4)"	"unprognostic (3.79e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-3)"	"unprognostic (9.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.77e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.51e-4)"	"unprognostic (4.07e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.83e-3)"	2.9	1.0	3.9	1.0	6.7	0.3	1.9	41.1	20.6	2.4	0.7	1.5	0.0	0.7	5.6	0.5	0.5	1.7	7.0	0.5	3.7	5.4	0.3	0.4	0.6	0.5	4.2	3.6	5.9	0.6	2.5	6.6	0.8	12.1	0.5	0.6	0.0	0.7	1.7	0.5	0.3	0.5	3.7	3.7	0.3	0.5	2.9	4.5	0.0	0.8	1.1	0.3	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.0	0.0	0.0	3.3	16.6	0.0	0.0	0.0	0.0	0.2	0.2	0.8	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	6.7	41.1	5.3	3.7	5.4	4.2	3.6	12.1	4.5	0.0	0.0	0.0	0.0	0.0	2.9	1.2	5.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.3	0.1	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.5	0.0	0.4	4.2	3.3	0.1	0.0	0.0	0.0	0.1
KCND3	"KSHIVB, Kv4.3, SCA19, SCA22"	ENSG00000171385	"Potassium voltage-gated channel subfamily D member 3"	Q9UK17	1	111770662-111989155	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 38.5;Cardiomyocytes: 34.4;Early spermatids: 29.0;Horizontal cells: 28.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"OE19: 6.6;SCLC-21H: 15.9;U-2 OS: 2.4;WM-115: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029452	Approved					NA	NA					"HPA029452: AB_10602239"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-3)"	"unprognostic (6.64e-3)"	3.3	0.8	6.8	3.1	6.9	0.0	2.1	25.9	11.9	1.3	2.5	1.3	1.3	0.3	4.1	9.6	3.2	3.4	4.2	5.5	5.6	5.6	1.3	11.6	1.3	1.3	8.9	5.7	1.3	2.2	4.1	1.5	1.3	1.6	9.2	1.6	1.9	1.3	10.0	2.8	5.1	1.3	7.7	1.3	2.0	1.7	1.3	1.3	1.3	1.3	2.3	1.3	3.7	1.3	0.5	0.4	1.2	0.3	0.9	0.3	0.7	0.0	0.0	0.3	0.0	0.5	0.1	0.1	0.4	0.0	0.0	0.0	0.8	0.1	0.0	1.6	0.6	0.0	0.5	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.2	0.3	6.6	0.0	0.0	0.1	0.0	0.0	0.3	15.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.5	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.3	0.4	0.5	0.3	0.2	1.2	0.9	0.3	0.3	0.1	0.7	6.8	6.9	25.9	9.3	5.6	5.6	8.9	5.7	1.6	1.3	0.0	9.4	0.0	10.7	6.6	38.5	34.4	0.0	0.0	1.2	0.0	3.9	0.1	0.0	0.7	29.0	1.8	0.0	0.0	21.1	0.1	1.4	14.3	0.0	23.7	0.2	28.6	0.0	1.8	0.6	20.3	16.7	0.0	3.3	0.0	0.2	6.1	4.4	0.3	1.8	0.2	4.2	0.0	3.1	1.1	0.7	5.8	0.0	0.0	0.0	12.3
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911937-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	17	"brain: 36.9"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 10.2;Syncytiotrophoblasts: 6.4"	"Cancer enriched"	"Detected in many"	7	"glioma: 27.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 16.9;MCF7: 6.0;T-47d: 7.3"	"Group enriched"	"Detected in many"	4	"amygdala: 70.7;basal ganglia: 55.9;cerebral cortex: 78.2;hippocampal formation: 69.5;olfactory region: 141.1"	"Low region specificity"	"Detected in all"			"HPA014738, HPA062278"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA014738: AB_1852114, HPA062278: AB_2732679"	"unprognostic (2.54e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.41e-4)"	"unprognostic (1.54e-3)"	"unprognostic (4.83e-5)"	"unprognostic (1.57e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.10e-4)"	"unprognostic (2.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.08e-2)"	0.9	0.9	11.5	1.0	25.5	0.8	1.2	0.8	36.9	0.9	1.2	2.4	0.0	1.2	1.9	0.8	1.6	1.1	1.0	1.1	13.1	4.7	1.1	0.9	1.0	1.0	3.1	10.5	0.9	2.2	0.8	0.2	0.9	3.6	1.0	1.2	0.0	0.8	1.4	0.8	0.8	1.1	1.0	1.0	1.5	1.1	1.0	3.1	0.5	0.8	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	16.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.0	0.0	2.6	0.1	1.8	0.0	0.1	0.0	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.2	7.3	0.8	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	11.5	25.5	0.8	28.5	13.1	4.7	3.1	10.5	3.6	3.1	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0
KCNG1	"K13, KCNG, kH2, Kv6.1"	ENSG00000026559	"Potassium voltage-gated channel modifier subfamily G member 1"	Q9UIX4	20	51003656-51023129	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 25.8;endometrium 1: 48.3"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 45.1;Syncytiotrophoblasts: 81.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	27	"naive B-cell: 10.8"	"Lineage enriched"	"Detected in single"	87	"B-cells: 10.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 26.7;U-138 MG: 20.3;WM-115: 17.0"	"Group enriched"	"Detected in many"	5	"amygdala: 21.4;basal ganglia: 17.0;cerebral cortex: 15.2;hippocampal formation: 19.7"	"Group enriched"	"Detected in all"	4	"amygdala: 16.3;basal ganglia: 12.0;cerebral cortex: 22.5;hippocampal formation: 21.1"	"HPA039530, HPA040024"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA039530: AB_10795144, HPA040024: AB_10796338"	"unprognostic (1.19e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.05e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.83e-9)"	"unprognostic (1.52e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-2)"	0.5	4.5	13.3	2.9	7.0	0.3	0.7	2.3	11.9	9.6	2.4	1.6	25.8	0.6	48.3	2.8	3.7	11.9	1.9	1.0	7.9	2.9	0.5	0.4	0.5	3.0	2.0	9.5	0.9	3.7	1.3	0.8	9.3	6.7	5.6	1.3	0.7	1.4	18.3	0.3	0.5	7.2	5.8	1.0	3.5	0.8	5.4	2.6	0.0	0.5	0.0	1.4	2.8	3.4	10.8	0.0	0.0	0.1	0.0	0.0	0.1	0.4	1.7	1.3	6.5	0.7	1.7	0.1	5.7	0.0	3.4	2.6	0.1	0.1	0.0	3.5	1.7	9.4	1.6	0.8	1.7	3.4	0.2	2.2	0.0	6.3	0.0	11.9	0.0	0.2	3.4	26.7	12.8	13.1	0.6	0.9	0.0	0.1	0.0	0.3	6.3	0.0	0.1	6.8	0.0	11.8	0.0	0.0	0.0	0.0	2.0	2.0	7.4	12.4	14.5	9.3	2.2	1.0	0.9	0.3	20.3	12.0	0.1	1.6	0.0	0.0	0.0	6.0	0.4	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	13.3	7.0	2.3	11.9	7.9	2.9	2.0	9.5	6.7	2.6	3.0	1.4	1.5	9.3	1.0	0.3	0.8	0.0	1.4	1.2	0.0	0.0	45.1	0.0	2.9	14.5	0.3	3.5	0.0	0.0	2.4	1.0	5.6	0.0	0.0	2.9	1.6	0.0	0.0	0.0	14.4	1.4	0.0	0.0	0.0	0.2	0.2	0.3	3.5	3.9	0.0	0.1	0.0	1.0	1.2	0.9	0.3	81.1	0.0	0.3	7.9
KCNG4	Kv6.4	ENSG00000168418	"Potassium voltage-gated channel modifier subfamily G member 4"	Q8TDN1	16	84218667-84239750	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"retina: 8.8"	"Cell type enriched"	"Detected in some"	18	"Bipolar cells: 29.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.2"	"Region enhanced"	"Detected in many"		"cerebellum: 101.5"	"Low region specificity"	"Detected in many"									NA	NA										"unprognostic (3.54e-1)"									"unprognostic (6.67e-2)"				0.7	2.8	2.6	0.2	1.8	1.8	0.1	0.7	3.5	0.0	0.1	1.6	0.0	0.1	0.3	0.8	0.4	0.2	0.3	0.1	2.8	2.0	0.2	0.1	0.1	0.5	2.8	0.0	0.6	0.3	0.0	1.1	0.2	2.3	0.4	0.2	8.8	0.4	0.1	1.0	2.1	0.4	0.1	1.3	0.4	0.4	0.7	1.0	0.0	0.4	0.0	0.1	0.4	0.0	0.9	0.8	2.4	0.6	1.3	0.6	0.2	0.3	0.3	0.9	3.2	0.3	0.3	0.9	0.6	0.0	0.0	0.0	0.6	0.7	0.5	0.4	0.2	0.1	0.4	0.0	0.0	0.2	0.2	0.7	0.5	1.1	1.0	0.2	0.1	0.3	0.1	0.0	0.1	0.3	0.6	0.1	0.5	0.6	1.4	0.0	0.8	0.3	1.0	0.8	0.0	0.8	0.4	0.9	0.1	0.0	0.8	0.8	0.7	0.7	0.4	1.8	0.3	0.6	0.3	0.5	0.5	0.4	0.9	0.4	0.6	0.3	0.4	0.7	0.5	0.6	2.4	0.6	0.6	0.4	0.3	0.3	0.4	0.4	0.3	0.2	0.9	0.4	0.6	2.1	1.3	0.3	0.8	0.4	0.2	2.6	1.8	0.7	3.5	2.8	2.0	2.8	0.0	2.3	1.0	0.0	0.0	0.0	0.0	0.0	29.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNH1	"eag, eag1, h-eag, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134180	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 20.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 9.0;Late spermatids: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 4.3;RH-30: 7.2;RPTEC TERT1: 4.2;SH-SY5Y: 9.2;SK-MEL-30: 8.6;T-47d: 6.5"	"Low region specificity"	"Detected in all"							"HPA014551, HPA019445, HPA076421"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: "	"unprognostic (9.12e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.70e-2)"	0.9	2.3	6.3	1.3	13.3	0.7	0.6	19.1	20.2	1.0	1.3	3.3	0.2	1.2	1.5	1.0	0.9	1.2	1.0	0.7	3.8	1.7	1.0	0.7	0.7	0.7	1.1	7.5	0.8	0.9	0.9	0.8	1.1	1.7	1.3	1.3	0.0	0.8	0.9	0.7	0.9	1.0	1.0	2.1	0.6	1.5	2.4	1.5	0.0	0.8	0.0	0.7	0.9	0.7	0.1	0.7	0.7	0.1	0.1	0.3	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.1	0.7	0.1	1.5	1.7	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	4.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	7.2	0.0	4.2	0.0	0.3	9.2	1.6	0.1	8.6	1.2	6.5	0.0	0.0	1.1	0.1	1.4	0.8	0.0	0.0	0.0	0.2	0.0	0.6	0.7	0.1	0.1	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.7	0.1	0.0	6.3	13.3	19.1	20.2	3.8	1.7	1.1	7.5	1.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0
KCNH2	"erg1, HERG, Kv11.1, LQT2"	ENSG00000055118	"Potassium voltage-gated channel subfamily H member 2"	Q12809	7	150944961-150978315	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 37.9"	"Group enriched"	"Detected in many"	5	"Bipolar cells: 199.1;Cardiomyocytes: 76.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.0"	"Group enriched"	"Detected in some"	7	"K-562: 59.8;NB-4: 29.8;SH-SY5Y: 25.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (9.79e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.52e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (6.08e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.02e-2)"	1.1	4.9	5.0	3.2	8.3	37.9	0.7	19.3	8.0	4.3	17.3	2.8	3.1	3.5	9.3	4.6	3.4	4.1	28.5	24.9	4.8	9.3	0.8	0.7	1.7	0.9	4.7	3.9	6.6	5.1	10.5	23.8	2.2	14.1	6.8	1.8	8.0	1.8	10.2	0.8	0.7	6.9	9.4	2.2	1.6	6.8	18.0	1.6	0.1	0.7	0.0	0.7	7.5	2.4	0.1	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.5	0.9	0.0	0.0	0.0	1.1	0.0	0.0	0.2	0.1	5.7	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	59.8	0.0	0.0	0.3	0.5	29.8	0.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	1.2	25.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.5	0.0	0.0	1.7	0.0	0.6	0.0	3.7	0.0	0.8	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	8.3	19.3	8.0	4.8	9.3	4.7	3.9	14.1	1.6	0.0	0.0	0.0	0.1	0.0	199.1	76.1	0.0	0.0	0.0	0.0	3.9	0.1	0.0	1.8	0.8	0.0	0.0	23.3	0.2	1.0	0.9	0.1	26.4	0.0	0.3	15.9	15.6	2.5	0.0	2.5	2.3	0.0	0.0	0.0	0.7	2.7	0.5	0.0	12.4	0.0	9.6	0.0	1.9	0.7	2.6	0.0	0.2	0.0	0.2	0.3
KCNH3	"BEC1, elk2, Kv12.2"	ENSG00000135519	"Potassium voltage-gated channel subfamily H member 3"	Q9ULD8	12	49539157-49558308	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 30.7"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 9.4;Early spermatids: 4.1;Late spermatids: 3.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.8"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 3.6"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.6"	"Cell line enhanced"	"Detected in some"		"A549: 9.6;AN3-CA: 4.5;HMC-1: 4.6;RPTEC TERT1: 11.8;U-2 OS: 12.5"	"Group enriched"	"Detected in many"	11	"amygdala: 60.0;basal ganglia: 42.5;cerebral cortex: 73.6;hippocampal formation: 46.6;olfactory region: 50.0"	"Low region specificity"	"Detected in many"			HPA051088			Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA051088: AB_2681340"	"unprognostic (5.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-4)"	"unprognostic (8.24e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.91e-3)"	"unprognostic (5.28e-2)"	"unprognostic (6.39e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.07e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	0.9	3.8	24.3	1.5	18.5	1.4	1.0	5.8	30.7	0.9	0.8	0.5	0.0	0.9	1.3	0.9	0.7	8.7	1.7	1.2	22.0	3.0	1.6	0.7	1.2	1.9	1.9	13.0	0.8	1.4	6.3	9.3	0.8	0.0	1.2	0.7	0.0	1.1	1.6	0.8	1.1	1.0	1.0	0.6	1.4	1.4	2.6	2.1	0.0	1.7	0.0	1.4	0.9	0.0	0.0	0.1	0.6	0.8	0.4	3.6	0.5	1.0	9.6	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.6	0.0	0.3	2.3	0.7	0.2	0.0	0.1	0.4	0.0	0.5	0.1	0.1	0.0	4.6	0.0	0.0	0.1	0.0	1.8	0.0	0.2	0.0	0.3	0.0	1.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.6	11.8	0.0	1.8	0.3	0.3	0.0	0.3	0.0	1.1	0.2	0.1	0.0	12.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.7	0.0	3.6	0.0	0.3	1.1	0.1	0.0	1.1	2.6	0.6	0.4	0.1	0.0	0.4	0.5	24.3	18.5	5.8	30.7	22.0	3.0	1.9	13.0	0.0	2.1	0.0	0.3	0.0	0.2	0.1	0.0	0.6	2.5	9.4	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.6	2.4	1.3	0.8	3.6	0.3	0.0	0.0	0.0	0.0	0.4	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.9	2.5	0.3	0.0	1.0	0.0	0.0
KCNIP1	KCHIP1	ENSG00000182132	"Potassium voltage-gated channel interacting protein 1"	Q9NZI2	5	170353487-170736632	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.2;epididymis: 27.8"	"Cell type enriched"	"Detected in some"	4	"Horizontal cells: 47.7"	"Cancer enriched"	"Detected in some"	18	"glioma: 22.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"RPTEC TERT1: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022864, HPA066717"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA022864: AB_1858712, HPA066717: "	"unprognostic (7.75e-5)"	"unprognostic (2.66e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.22e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.46e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-2)"	1.1	5.9	20.6	1.2	27.9	0.6	1.9	6.4	31.2	4.0	1.0	6.0	5.2	0.9	2.7	27.8	1.0	2.8	2.9	1.2	11.7	20.5	4.9	0.8	1.9	1.2	12.9	7.3	0.9	2.4	5.1	0.7	2.1	11.1	2.3	1.3	0.8	1.3	7.9	0.8	0.7	1.1	2.1	6.9	2.2	1.1	5.2	5.3	0.0	1.2	0.0	1.2	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	36.8	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	27.9	6.4	14.6	11.7	20.5	12.9	7.3	11.1	5.3	0.0	0.0	0.0	0.1	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	47.7	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNIP2	KCHIP2	ENSG00000120049	"Potassium voltage-gated channel interacting protein 2"	Q9NS61	10	101825974-101843920	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adipose tissue: 86.5;brain: 54.5;heart muscle: 74.8"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 37.5;Cardiomyocytes: 109.6;Cone photoreceptor cells: 23.6;Horizontal cells: 46.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.9;intermediate monocyte: 1.2;memory B-cell: 2.9;naive B-cell: 4.6"	"Group enriched"	"Detected in many"	5	"B-cells: 4.6;granulocytes: 1.9;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"HEL: 20.1;HMC-1: 12.5"	"Group enriched"	"Detected in many"	5	"amygdala: 96.2;basal ganglia: 204.2;cerebral cortex: 97.2;hippocampal formation: 151.4;olfactory region: 172.7"	"Low region specificity"	"Detected in all"			HPA066717			Approved	Vesicles		NA	NA			Vesicles		"HPA066717: "	"unprognostic (5.92e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.77e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.80e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.49e-9)"	"unprognostic (9.85e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.37e-4)"	86.5	3.5	15.5	2.0	54.5	0.9	10.4	8.3	26.1	1.8	2.4	2.6	0.0	1.4	2.3	2.4	1.2	2.2	1.9	74.8	19.6	5.0	1.0	1.0	1.4	3.7	4.2	11.3	5.7	1.6	1.2	3.3	1.8	4.3	1.6	2.7	1.7	4.6	2.1	3.8	3.0	1.6	1.8	2.1	2.8	1.6	4.1	9.8	0.0	1.3	0.8	3.9	1.6	0.7	4.6	0.5	1.9	1.2	0.0	0.4	0.4	1.6	2.5	2.5	3.1	1.0	1.1	0.6	1.1	1.0	0.6	0.9	3.6	3.2	1.6	1.0	0.7	0.6	1.7	0.8	0.4	0.6	2.2	1.9	20.1	2.4	1.9	0.9	1.3	12.5	2.6	1.7	1.0	1.3	3.6	1.0	4.5	5.8	1.8	1.0	1.1	0.7	3.9	0.8	0.7	0.6	0.9	0.2	1.2	1.0	1.0	7.3	1.2	0.8	0.5	2.4	1.6	2.1	0.8	2.2	1.4	2.1	0.6	1.1	1.7	1.7	1.7	1.5	5.1	0.2	0.0	0.1	1.9	0.1	1.2	0.4	2.9	0.3	0.0	0.4	4.6	0.0	0.1	0.0	0.0	0.5	0.5	0.3	0.4	15.5	54.5	8.3	26.1	19.6	5.0	4.2	11.3	4.3	9.8	0.0	0.0	1.3	0.1	0.3	37.5	109.6	0.0	0.0	0.0	1.8	23.6	0.2	0.0	0.1	5.6	0.0	0.4	0.0	0.0	0.1	0.2	0.2	0.0	0.0	1.8	46.1	0.0	0.6	0.6	5.3	1.7	0.3	0.0	0.0	0.1	6.3	0.2	0.0	0.7	0.0	4.8	0.0	0.4	1.4	5.3	0.0	0.2	0.0	0.3	0.0
KCNIP3	"CSEN, DREAM, KCHIP3"	ENSG00000115041	"Potassium voltage-gated channel interacting protein 3"	Q9Y2W7	2	95297304-95386083	"Predicted intracellular proteins, Transporters"	"Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport"	"Ion channel, Potassium channel, Repressor, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 39.8;parathyroid gland: 32.5"	"Group enriched"	"Detected in some"	5	"Leydig cells: 23.6;Peritubular cells: 40.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.1;hTERT-RPE1: 15.9;RPTEC TERT1: 23.8;U-138 MG: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066717, HPA069797"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA			Vesicles		"HPA066717: , HPA069797: AB_2686199"	"unprognostic (1.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.33e-3)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.44e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-1)"	4.2	1.8	19.8	1.5	20.1	0.7	2.8	3.7	39.8	6.0	4.6	12.9	0.6	2.1	5.8	4.9	3.5	5.3	2.4	3.4	16.7	7.8	4.6	1.2	1.5	1.1	9.1	19.5	8.8	2.5	32.5	5.6	6.5	8.2	5.7	1.8	1.4	6.9	18.6	2.2	3.9	1.9	6.4	6.3	2.2	2.9	9.2	15.9	5.4	19.5	0.0	1.3	4.5	5.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.9	0.0	0.5	4.1	3.6	2.9	0.0	4.2	12.1	6.9	6.4	0.0	0.0	0.0	0.4	5.5	3.7	0.1	2.7	0.7	2.9	0.0	0.9	0.0	1.1	0.0	1.5	0.0	0.0	2.0	2.4	1.5	6.8	15.9	0.0	0.7	0.0	0.0	0.5	5.2	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	23.8	0.0	0.4	0.1	0.2	0.2	4.6	0.0	0.2	0.0	0.2	11.2	2.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.8	20.1	3.7	39.8	16.7	7.8	9.1	19.5	8.2	15.9	0.0	0.6	0.0	0.7	0.3	0.6	0.9	0.0	0.0	0.0	1.8	0.0	0.0	6.6	0.3	0.3	0.6	0.2	0.0	0.0	0.0	3.3	0.4	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.0	23.6	0.0	6.8	1.0	0.0	0.7	0.3	0.0	40.3	0.6	0.0	0.0	2.3	0.0	0.9	0.6	0.0	0.0	0.1	0.0
KCNIP4	"CALP, KCHIP4, MGC44947"	ENSG00000185774	"Potassium voltage-gated channel interacting protein 4"	Q6PIL6	4	20728616-21948799	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 38.9"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 32.3;Distal tubular cells: 53.0;Muller glia cells: 43.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 10.1;SCLC-21H: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022862, HPA066717"		Supported	Approved	Vesicles		NA	NA			Vesicles		"HPA022862: AB_1852654, HPA066717: "	"unprognostic (8.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.10e-2)"	1.1	3.6	15.8	2.2	28.3	1.0	0.9	22.4	38.9	15.0	4.2	1.8	0.0	2.4	9.6	1.1	5.6	3.9	2.6	1.8	11.9	16.2	7.8	0.7	1.1	1.1	11.6	19.3	1.9	1.0	0.5	5.1	1.8	16.9	1.0	5.2	3.5	1.4	0.8	1.3	2.3	5.5	7.8	3.9	1.1	1.3	1.3	3.5	0.0	8.9	0.0	0.5	2.7	1.1	0.3	0.7	0.0	0.7	0.8	0.7	0.3	1.7	1.5	2.2	2.2	0.0	0.0	1.1	1.3	0.0	0.0	0.0	1.9	1.7	3.4	1.4	0.5	1.7	0.9	0.0	0.1	0.0	0.4	2.3	1.2	2.5	1.2	0.0	3.2	0.5	0.0	0.8	0.0	1.4	2.9	0.6	1.3	2.0	1.1	0.0	0.6	2.8	1.9	2.8	1.3	1.4	0.8	4.2	1.3	10.1	1.0	7.9	4.7	1.4	1.7	2.2	2.7	0.9	1.2	2.2	1.1	1.5	2.4	3.2	1.0	0.1	1.2	3.7	2.7	1.7	0.0	0.3	0.0	0.2	0.7	0.7	0.2	0.1	0.2	0.7	0.3	0.5	0.5	0.0	0.8	0.5	0.3	0.2	0.3	15.8	28.3	22.4	33.0	11.9	16.2	11.6	19.3	16.9	3.5	0.0	0.0	0.0	0.0	0.0	32.3	0.4	0.0	0.0	0.0	14.0	0.0	0.0	53.0	0.0	6.9	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	3.2	0.0	0.0	3.3	1.0	0.0	43.9	0.0	7.0	0.0	4.7	11.8	0.0	0.0	0.1	0.7	0.1	0.1	0.0	0.3	0.0
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium voltage-gated channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"kidney: 123.2"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 165.8"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.4"	"Region enriched"	"Detected in single"	4	"basal ganglia: 2.3"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	40	"RPTEC TERT1: 51.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced					NA	NA					"HPA026962: AB_10601934"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.81e-3)"	0.1	0.0	0.5	0.2	2.3	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.0	123.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.3	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.9	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	2.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	36.6	0.0	0.0	165.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium voltage-gated channel subfamily J member 10"	P78508	1	159998651-160070483	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 74.1;kidney: 28.1"	"Cell type enriched"	"Detected in some"	8	"Muller glia cells: 83.5"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.5"	"Group enriched"	"Detected in many"	6	"NK-cells: 1.7;T-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"Hep G2: 11.7;SK-MEL-30: 3.7;U-266/70: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced					NA	NA					"HPA078302: AB_2732378"	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	1.4	1.5	23.6	3.0	28.1	1.3	1.3	10.5	74.1	1.4	1.7	37.9	0.0	1.5	1.3	1.3	1.4	1.3	1.3	1.3	21.8	13.2	28.1	3.1	1.3	7.1	28.1	15.1	1.3	1.3	1.3	0.3	1.3	25.5	1.3	1.5	0.5	1.5	1.5	1.2	1.6	1.7	1.3	42.9	10.3	2.0	1.8	25.5	0.0	1.5	0.0	2.9	1.5	0.1	0.0	0.0	0.0	0.3	1.7	2.5	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.3	0.0	0.2	1.7	0.2	0.0	1.1	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.1	11.7	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.6	0.0	2.2	0.1	0.0	0.0	0.2	0.4	0.0	0.3	3.7	1.0	0.1	0.5	0.1	0.1	0.3	0.9	0.0	3.8	1.7	0.0	0.2	0.2	1.8	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	1.7	0.3	0.0	2.5	0.2	23.6	28.1	10.5	22.2	21.8	13.2	28.1	15.1	25.5	25.5	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	3.5	3.9	0.0	10.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.4	1.0	0.0	0.0	0.0	0.0	0.0	83.5	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium voltage-gated channel subfamily J member 11"	Q14654	11	17385859-17389331	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Diabetes mellitus, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"skeletal muscle: 63.1"	"Cell type enhanced"	"Detected in some"	17	"Cardiomyocytes: 11.3;Collecting duct cells: 5.2;Intestinal endocrine cells: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;HEK 293: 13.5;MCF7: 10.8;SCLC-21H: 9.2"	"Low region specificity"	"Detected in all"							HPA048891	Approved					NA	NA					"HPA048891: AB_2680547"	"unprognostic (1.95e-2)"	"unprognostic (6.18e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-5)"	"unprognostic (1.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.72e-3)"	"unprognostic (9.23e-3)"	"prognostic favorable (1.56e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-2)"	2.5	1.1	2.9	1.0	7.8	0.8	2.7	13.6	7.8	1.0	1.1	0.7	4.9	1.4	1.1	2.1	1.7	1.1	1.1	6.2	3.5	2.4	1.3	0.9	1.3	1.2	2.7	5.2	0.8	8.7	2.7	3.3	0.7	3.5	2.5	1.0	0.1	1.2	7.6	63.1	1.0	1.1	0.8	1.7	1.0	4.6	0.8	1.9	0.0	4.1	4.5	1.0	0.9	1.1	0.8	0.4	1.4	0.3	0.8	0.4	0.4	1.5	2.4	0.3	4.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	2.5	0.2	7.1	0.2	0.0	0.3	0.3	4.8	0.1	0.3	1.7	13.5	3.7	0.9	0.8	0.1	0.4	0.3	0.1	0.3	0.0	0.1	0.1	0.0	6.1	3.8	3.8	0.0	10.8	0.7	0.1	1.0	4.2	0.3	1.4	1.7	2.1	0.4	0.9	9.2	0.8	0.0	3.6	0.0	0.0	4.7	0.2	0.0	0.0	1.2	0.0	0.1	0.2	6.0	0.9	0.0	1.0	0.0	1.4	0.3	0.2	0.4	0.3	0.3	0.7	0.4	0.4	0.1	0.8	0.4	0.4	1.3	0.8	0.1	0.4	0.3	0.4	2.9	7.8	13.6	7.8	3.5	2.4	2.7	5.2	3.5	1.9	0.0	2.4	0.0	0.1	0.0	2.4	11.3	0.0	0.0	1.2	5.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	1.0	0.1	0.0	4.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.1
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium voltage-gated channel subfamily J member 13"	O60928	2	232766464-232776568	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease mutation, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 22.9;intestine: 49.5;retina: 70.3"	"Group enriched"	"Detected in some"	14	"Melanocytes: 20.3;Muller glia cells: 44.0"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Region enriched"	"Detected in some"	7	"pons and medulla: 22.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;CACO-2: 2.6;SuSa: 3.1;U-2197: 4.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051609			Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA051609: "	"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.2	0.2	0.5	0.0	0.7	0.1	0.3	0.4	0.9	0.2	10.1	7.0	1.3	4.3	0.2	0.3	0.2	0.1	1.6	0.2	3.2	0.5	1.9	0.3	0.2	0.0	0.4	0.4	0.3	0.4	8.5	0.3	0.0	22.9	0.3	0.0	70.3	0.3	1.6	0.2	1.8	49.5	0.0	0.6	0.2	1.1	0.5	0.1	0.0	3.8	0.0	0.0	0.3	0.3	1.1	0.8	5.4	1.1	1.1	2.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.7	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.0	0.0	0.5	0.0	0.3	0.2	0.0	0.9	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.3	1.0	3.1	0.2	0.3	0.0	0.1	0.0	4.6	0.3	1.3	0.1	0.8	0.8	0.4	0.0	5.4	1.1	0.9	1.0	0.2	1.2	0.8	1.8	0.7	0.4	1.1	2.1	1.1	0.8	1.1	1.0	0.8	2.7	0.1	0.5	0.7	0.4	0.9	3.2	0.5	0.4	0.4	22.9	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.0	2.4	0.0	1.0	0.0	1.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	44.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium voltage-gated channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 96.5;parathyroid gland: 59.4;thyroid gland: 60.4"	"Cell type enhanced"	"Detected in some"	27	"Cholangiocytes: 43.3;Collecting duct cells: 232.1;Distal tubular cells: 34.9;Proximal tubular cells: 89.7"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 5.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.1"	"Cell line enriched"	"Detected in some"	23	"RPTEC TERT1: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles		NA	NA			Vesicles		"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.58e-4)"	"unprognostic (3.88e-1)"	0.4	0.3	4.1	0.3	4.4	0.4	1.5	22.6	6.1	0.3	0.4	1.7	12.6	0.4	0.4	6.4	0.3	2.0	6.5	0.4	6.0	7.2	96.5	0.9	0.5	0.4	8.3	3.4	0.4	15.8	59.4	0.8	0.5	25.5	1.0	0.3	0.0	4.1	14.3	0.4	0.5	1.2	0.2	7.5	1.1	7.4	0.8	5.3	0.0	60.4	0.0	0.2	0.3	0.3	1.1	0.5	5.1	0.2	0.9	1.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.5	0.0	0.0	80.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.6	0.9	0.1	1.2	1.0	1.0	0.5	0.1	1.1	0.7	0.6	5.1	0.9	0.1	0.5	1.1	0.3	4.1	4.4	22.6	6.1	6.0	7.2	8.3	3.4	25.5	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	43.3	17.4	4.5	232.1	0.0	0.0	34.9	6.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	89.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium voltage-gated channel subfamily J member 2"	P63252	17	70168673-70180048	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease mutation, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.7;parathyroid gland: 34.8"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 227.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 20.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 20.8"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 7.5;HUVEC TERT2: 5.2;REH: 6.0;RH-30: 24.5;U-138 MG: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029109	Approved					NA	NA					"HPA029109: AB_10602913"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.49e-3)"	3.0	1.5	6.2	6.3	17.9	2.5	6.6	1.3	12.8	1.8	5.0	23.7	5.1	1.6	1.5	1.2	4.7	8.4	2.2	11.4	6.4	4.4	1.7	1.9	3.9	4.4	22.4	8.5	1.4	1.0	34.8	1.6	9.0	11.7	2.6	4.3	3.1	2.7	2.9	10.3	6.0	2.1	1.6	14.9	10.4	2.0	0.9	18.2	0.5	1.9	6.0	2.2	2.6	3.3	0.1	0.7	20.8	4.7	0.0	0.0	0.4	0.0	0.7	1.5	0.0	1.6	0.4	0.0	0.5	3.7	0.0	0.1	0.0	0.0	0.0	0.3	0.4	1.0	0.4	0.1	0.2	0.1	0.0	0.2	0.0	0.5	0.0	4.7	0.0	0.0	1.7	0.1	2.3	0.2	7.5	5.2	0.0	0.0	0.0	1.6	0.0	0.5	0.0	0.1	0.6	0.1	6.0	24.5	0.0	0.6	0.0	0.3	0.7	0.4	0.1	0.0	3.1	0.2	0.4	0.1	9.0	0.1	0.0	2.0	0.0	0.0	0.1	1.9	0.0	1.2	1.8	2.5	3.6	0.0	4.7	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	20.8	0.0	4.6	0.1	0.0	0.4	6.2	17.9	1.3	12.8	6.4	4.4	22.4	8.5	11.7	18.2	0.0	2.7	0.8	5.2	7.2	6.6	14.2	0.0	5.3	1.2	1.8	0.0	0.5	0.0	0.0	0.2	8.7	2.6	0.0	0.0	0.1	0.8	1.7	0.0	0.0	5.7	227.2	10.3	3.7	28.3	0.0	1.4	5.2	3.3	1.0	2.8	5.0	0.0	11.2	1.1	0.0	4.6	0.0	2.2	0.0	0.4	2.9	1.1	0.0	6.6	0.1
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium voltage-gated channel subfamily J member 3"	P48549	2	154698299-154858352	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;parathyroid gland: 22.1"	"Cell type enhanced"	"Detected in many"	21	"Cardiomyocytes: 43.7;Horizontal cells: 117.6;Intestinal endocrine cells: 29.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Region enhanced"	"Detected in many"		"cerebellum: 33.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ: 5.4;SCLC-21H: 1.7;SH-SY5Y: 3.3"	"Low region specificity"	"Detected in all"							HPA024231	Uncertain					NA	NA					"HPA024231: AB_1855558"	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.3	1.0	4.5	0.0	3.4	0.0	0.2	33.8	13.6	1.3	1.5	1.4	0.3	7.9	0.2	0.9	0.1	0.4	0.9	10.8	8.4	4.0	8.0	2.3	0.2	0.4	1.8	4.9	0.2	1.5	22.1	9.0	0.0	3.0	5.1	0.6	1.0	0.1	9.2	3.5	0.2	6.7	0.1	1.5	0.4	0.5	0.2	0.9	0.0	0.2	0.0	0.0	0.5	0.6	1.2	0.9	3.3	1.1	1.8	1.0	0.4	0.2	0.3	0.0	0.1	0.2	0.1	0.4	5.4	0.2	0.0	0.2	0.1	0.3	0.3	0.2	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.2	0.4	0.4	0.1	0.1	0.0	0.2	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.8	0.0	0.7	0.5	0.1	0.5	0.1	0.0	0.4	0.2	0.4	1.7	3.3	0.1	0.6	0.2	0.1	0.4	0.1	0.0	0.3	0.4	0.4	0.3	0.3	0.2	0.1	1.2	0.2	0.5	3.3	0.7	0.9	0.7	0.8	0.9	1.0	0.9	0.6	0.6	1.2	1.0	0.9	1.9	1.8	1.1	0.9	0.7	0.4	4.5	3.4	33.8	12.0	8.4	4.0	1.8	4.9	3.0	0.9	0.0	0.0	0.0	4.4	0.7	4.8	43.7	5.1	0.0	0.0	19.2	13.7	0.0	5.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.6	5.1	0.0	0.9	0.1	117.6	29.9	0.0	0.0	0.0	5.8	0.4	1.7	0.0	0.1	0.7	0.0	0.0	3.9	6.8	3.6	0.0	2.1	0.5	0.1	1.6	0.0	0.0	0.2	4.7
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium voltage-gated channel subfamily J member 5"	P48544	11	128891356-128921035	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cancer-related genes, Disease mutation, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 40.7;ductus deferens: 54.6;pituitary gland: 23.4"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 10.6;Hofbauer cells: 37.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 17.5"	"Group enriched"	"Detected in many"	6	"basal ganglia: 3.1;hypothalamus: 8.0;midbrain: 2.2;thalamus: 4.0"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Approved					NA	NA					"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.8	40.7	0.8	0.3	1.9	0.2	0.9	0.3	1.2	0.8	0.8	1.9	54.6	0.4	0.3	1.1	0.6	0.6	1.3	8.7	1.6	2.5	2.0	0.3	3.4	0.8	3.7	0.8	0.8	16.6	0.7	23.4	4.3	3.4	0.8	0.4	3.3	0.9	21.7	0.3	0.4	0.5	0.7	4.5	7.7	1.5	0.7	0.9	2.3	0.7	0.4	0.3	1.1	0.5	0.9	0.4	2.9	0.7	0.6	0.4	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.3	0.1	0.4	17.5	0.0	0.2	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.4	0.3	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.5	0.2	0.1	0.1	1.3	0.0	2.2	0.7	0.6	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.9	0.3	0.4	2.9	0.6	0.4	0.4	0.2	0.4	0.8	1.9	0.3	1.2	1.6	2.5	3.7	0.8	3.4	0.9	0.0	10.6	0.0	2.3	1.3	1.7	5.8	0.0	0.0	0.0	1.8	0.0	0.7	0.0	0.0	2.1	0.6	0.0	0.0	3.2	0.6	2.1	0.4	0.0	0.0	37.1	1.6	0.0	0.6	1.8	4.5	0.9	1.9	3.3	1.8	0.0	0.3	1.3	0.0	0.7	0.0	1.4	0.0	0.1	0.2	0.7	1.5	1.0	0.0	0.0	0.5
KCNJ6	"BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2"	ENSG00000157542	"Potassium voltage-gated channel subfamily J member 6"	P48051	21	37607376-38121345	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Congenital generalized lipodystrophy, Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0;pituitary gland: 12.2"	"Cell type enriched"	"Detected in some"	6	"Horizontal cells: 232.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basophil: 4.2;eosinophil: 3.6;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 4.2"	"Cell line enriched"	"Detected in some"	7	"LHCN-M2: 25.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.43e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.75e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.96e-10)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.21e-1)"	2.0	1.2	7.7	0.9	8.4	1.0	1.1	24.0	15.6	0.9	1.4	0.8	0.0	1.1	1.4	0.6	0.7	0.7	0.8	1.2	14.6	1.1	1.2	0.9	1.0	1.4	1.3	10.8	0.8	2.7	0.7	12.2	7.4	13.5	1.5	0.9	0.0	0.8	0.6	2.2	1.1	1.1	0.5	1.5	1.6	2.7	2.0	0.4	0.0	0.8	0.0	0.6	0.8	0.8	0.3	0.3	4.2	0.3	0.3	0.2	0.0	0.0	0.0	0.6	0.3	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.8	1.4	0.0	0.0	0.0	2.9	0.1	25.6	0.1	0.0	0.0	0.3	0.0	2.5	0.0	0.1	0.8	3.6	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.8	0.3	0.0	0.1	0.2	3.8	1.0	0.0	0.0	0.0	0.0	4.2	0.3	3.6	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	2.0	0.3	0.2	0.3	0.1	0.0	7.7	8.4	24.0	15.6	14.6	1.1	1.3	10.8	13.5	0.4	0.0	0.6	0.0	0.4	0.1	31.8	21.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.0	0.0	0.0	232.0	39.7	0.0	0.0	0.0	0.6	0.0	3.3	0.0	0.0	0.9	1.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.1	0.1	0.2	0.0	0.1	0.3
KCNJ8	Kir6.1	ENSG00000121361	"Potassium voltage-gated channel subfamily J member 8"	Q15842	12	21764955-21775581	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 60.1;pancreas: 47.6"	"Group enriched"	"Detected in many"	5	"Sertoli cells: 194.1;Smooth muscle cells: 65.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"eosinophil: 4.5"	"Lineage enriched"	"Detected in single"	45	"granulocytes: 4.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 42.5;HSkMC: 8.6;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031066	Uncertain					NA	NA					"HPA031066: AB_10602240"	"unprognostic (8.12e-3)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.81e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (4.70e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.54e-3)"	14.6	12.9	3.2	2.7	3.4	0.0	14.7	1.7	5.1	7.7	6.6	2.3	3.6	2.0	10.6	4.5	6.7	5.9	6.3	60.1	2.2	1.7	6.4	29.7	12.4	3.5	2.9	3.0	12.4	47.6	1.7	3.8	4.9	3.7	10.6	1.6	8.8	2.9	15.7	15.0	2.4	3.8	13.2	2.6	3.8	6.5	3.4	2.8	0.9	8.4	7.0	1.2	11.4	5.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	5.2	3.4	0.0	5.7	4.6	6.6	3.4	42.5	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.0	1.9	0.0	2.1	1.3	0.0	0.0	0.2	0.0	0.0	8.6	0.0	2.5	0.0	0.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	4.2	0.0	0.0	0.0	4.2	1.9	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.4	1.7	5.1	2.2	1.7	2.9	3.0	3.7	2.8	3.0	19.8	0.0	0.4	1.1	0.0	24.3	0.0	0.0	1.2	1.8	0.0	0.1	0.0	0.0	0.0	2.4	0.0	0.0	1.1	0.0	6.6	0.3	0.0	22.1	0.2	0.0	1.2	1.8	1.5	0.0	0.3	0.0	1.7	0.0	0.0	12.2	2.0	0.0	0.7	0.0	1.1	194.1	65.3	0.0	0.4	0.6	0.2	0.0	0.0	0.1
KCNK15	"dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5"	ENSG00000124249	"Potassium two pore domain channel subfamily K member 15"	Q9H427	20	44745780-44752313	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 24.2"	"Cell type enhanced"	"Detected in some"	9	"Cholangiocytes: 5.1;Collecting duct cells: 8.7;Exocrine glandular cells: 6.4;Leydig cells: 6.1;Urothelial cells: 7.0"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 47.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"MCF7: 32.2"	"Region enriched"	"Detected in single"	18	"olfactory region: 8.4"	"Region enriched"	"Detected in many"	8	"olfactory region: 9.3"	HPA064861	Uncertain					NA	NA					"HPA064861: AB_2685373"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.38e-4)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.11e-1)"	6.0	4.5	0.4	1.3	3.4	0.5	5.9	0.0	1.2	6.2	2.3	0.0	24.2	1.1	4.3	10.6	3.2	15.1	10.7	3.8	0.6	0.4	3.5	7.0	3.0	2.2	0.6	0.0	12.6	7.4	0.6	4.2	1.1	1.1	2.7	0.8	2.1	3.4	9.6	2.6	2.0	0.9	3.8	0.3	0.6	4.1	10.6	0.0	0.0	6.5	0.5	0.9	2.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.3	0.0	0.9	0.4	3.1	0.0	0.3	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.4	0.0	1.2	0.6	0.4	0.6	0.0	1.1	0.0	0.0	0.0	0.0	1.7	0.5	0.0	0.6	5.1	0.0	0.0	8.7	0.0	0.0	0.0	3.2	0.2	0.7	0.0	0.0	6.4	0.0	1.3	2.3	0.0	0.0	0.1	0.0	1.2	0.6	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	1.8	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.4	0.6	0.0	0.0	0.8	7.0
KCNK16	"K2p16.1, TALK-1, TALK1"	ENSG00000095981	"Potassium two pore domain channel subfamily K member 16"	Q96T55	6	39314698-39322968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"pancreas: 22.4;stomach 1: 11.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	17	"pancreatic cancer: 13.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"basophil: 4.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 4.6"	"Cell line enriched"	"Detected in single"	406	"SCLC-21H: 55.9"					"Low region specificity"	"Detected in all"									NA	NA																"unprognostic (3.29e-2)"					"unprognostic (3.48e-1)"		0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.2	0.1	0.1	3.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	22.4	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.1	11.3	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.4	4.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314553	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 29.1;retina: 20.0"	"Group enriched"	"Detected in some"	4	"Exocrine glandular cells: 7.3;granulocytes: 5.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	34	"plasmacytoid DC: 29.1"	"Lineage enriched"	"Detected in single"	34	"dendritic cells: 29.1"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 42.5"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.7	0.4	0.3	0.6	1.1	1.4	3.3	0.3	0.8	0.7	1.3	0.8	1.9	3.0	1.9	0.5	1.0	1.3	6.5	7.9	0.6	0.6	0.3	4.6	10.4	0.9	2.6	0.8	0.4	6.1	0.4	2.7	6.3	1.9	1.1	0.6	20.0	2.9	1.0	0.2	0.1	1.7	1.5	0.6	1.1	5.4	0.6	0.1	3.4	9.3	2.6	2.4	0.9	0.5	0.0	29.1	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	42.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	29.1	0.0	0.1	0.3	1.1	0.3	0.8	0.6	0.6	2.6	0.8	1.9	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	5.8	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNK3	"K2p3.1, TASK, TASK-1"	ENSG00000171303	"Potassium two pore domain channel subfamily K member 3"	O14649	2	26692690-26733420	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 69.2"	"Cell type enhanced"	"Detected in many"	17	"Collecting duct cells: 97.7;Exocrine glandular cells: 82.2;Pancreatic endocrine cells: 31.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 4.0;cerebellum: 4.7;cerebral cortex: 6.2;hypothalamus: 4.0;pons and medulla: 13.4"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.7;EFO-21: 10.0;HeLa: 3.4;SCLC-21H: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.16e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (3.09e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.24e-3)"	2.4	69.2	1.3	1.9	4.0	0.6	8.3	4.7	6.2	3.5	4.0	0.8	5.7	1.3	2.4	5.6	1.9	2.0	2.3	10.3	1.0	4.0	1.8	0.7	10.0	0.6	1.5	1.5	4.6	24.7	0.7	3.6	16.6	13.4	8.2	1.1	1.9	0.6	7.7	0.6	0.6	2.6	4.7	1.1	0.9	2.2	0.9	0.0	0.0	2.1	0.0	0.5	3.2	2.3	0.7	0.5	2.5	0.4	1.2	0.4	0.0	0.0	0.6	0.2	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	10.0	0.0	1.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	1.3	0.0	23.5	2.1	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.4	0.3	0.4	0.2	0.4	0.3	0.3	0.3	0.2	0.7	0.4	0.4	2.5	1.2	0.2	0.5	0.2	0.0	1.3	4.0	4.7	6.2	1.0	4.0	1.5	1.5	13.4	0.0	0.0	3.2	0.0	0.2	0.0	11.5	10.0	0.0	0.0	0.0	97.7	0.0	0.2	0.0	0.8	0.4	1.0	0.0	0.0	82.2	0.2	1.9	1.6	0.0	0.0	0.3	1.6	22.5	0.6	0.0	1.3	0.9	0.0	0.0	1.0	0.4	1.2	31.4	0.0	0.0	0.0	3.9	6.5	3.1	0.0	1.3	0.1	0.5	0.0	0.0	0.3
KCNK5	"K2p5.1, TASK-2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188973-39229450	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.4;intestine: 74.2;kidney: 46.3"	"Cell type enhanced"	"Detected in many"	8	"Cholangiocytes: 43.3;Enterocytes: 50.9;Proximal tubular cells: 29.1;Syncytiotrophoblasts: 38.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 18.0;OE19: 14.7;T-47d: 14.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059148	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (4.45e-4)"	2.2	1.3	0.3	4.5	0.4	4.5	3.9	0.4	0.5	4.3	25.5	0.8	2.6	16.1	5.6	4.0	4.3	1.4	48.4	1.5	0.3	0.0	46.3	12.6	3.6	1.1	0.8	0.4	4.0	15.3	1.2	1.0	15.2	0.8	2.3	4.7	3.6	16.0	1.6	0.5	15.8	74.2	1.3	0.6	1.2	9.4	0.9	0.3	2.0	9.0	2.2	4.1	2.2	3.8	0.0	0.9	0.2	0.1	0.0	1.4	0.5	3.4	3.2	4.3	1.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	18.8	7.8	0.0	5.7	0.0	0.4	7.2	3.3	0.1	0.0	0.0	2.4	19.3	1.5	0.1	0.0	3.9	17.8	0.0	0.0	0.1	0.0	0.0	0.0	4.3	18.0	0.0	0.0	6.1	8.7	4.3	7.9	14.7	0.0	0.0	0.8	7.3	3.0	2.9	1.0	0.8	3.1	4.0	0.0	1.7	14.3	6.5	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.3	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.9	1.4	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.9	0.2	0.5	0.3	0.4	0.4	0.5	0.3	0.0	0.8	0.4	0.8	0.3	0.0	19.2	0.0	1.8	3.3	0.0	0.4	43.3	0.0	6.8	1.8	0.0	22.6	5.0	13.0	0.0	0.2	50.9	0.0	10.8	3.9	1.9	1.8	0.0	23.1	1.8	0.0	0.0	0.0	0.3	0.0	0.6	0.7	1.7	1.0	10.8	0.0	7.5	10.5	0.0	29.1	0.0	0.0	0.4	0.0	0.7	2.4	38.1	1.0	6.4	10.7
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319844-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ito cells: 179.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 16.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 8.9;granulocytes: 16.2;monocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HEL: 21.9;HMC-1: 24.6;T-47d: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: AB_2676876"	"unprognostic (7.98e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.45e-6)"	"unprognostic (3.76e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.91e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.59e-3)"	3.0	2.0	2.1	7.4	2.5	2.8	4.9	0.8	2.0	25.3	9.2	1.7	10.6	3.8	20.1	5.2	21.7	8.6	13.1	4.3	2.1	1.0	2.8	2.7	7.1	8.9	2.0	1.3	8.0	21.3	0.2	1.7	11.6	2.3	7.3	8.3	2.3	29.0	13.5	0.9	15.1	10.1	13.4	3.7	12.7	7.0	2.0	2.2	4.2	1.7	17.5	18.8	14.3	12.5	1.2	8.9	16.2	5.4	0.6	1.9	1.5	5.3	2.0	0.3	0.3	3.2	2.1	0.4	4.6	2.3	1.2	1.6	1.5	5.9	0.4	2.2	6.6	1.3	7.0	2.5	10.5	0.8	0.2	0.2	21.9	1.0	0.2	2.9	1.6	24.6	0.5	9.5	1.5	2.9	6.4	3.2	3.6	0.3	1.7	3.4	11.7	1.5	1.4	0.3	11.3	1.3	2.3	0.4	1.6	4.3	0.5	0.3	0.5	0.5	0.5	0.2	1.1	13.8	6.2	3.5	0.4	2.8	2.5	0.2	0.6	0.1	0.6	0.4	7.9	0.2	16.2	5.4	11.7	1.3	4.8	1.1	1.2	1.7	1.6	8.9	1.1	1.5	1.1	4.2	0.6	5.1	2.5	1.9	1.5	2.1	2.5	0.8	2.0	2.1	1.0	2.0	1.3	2.3	2.2	0.0	14.6	13.7	23.5	38.2	2.8	10.2	22.9	6.7	9.1	7.0	5.9	1.3	0.0	19.0	1.1	17.5	33.5	70.0	41.6	3.3	11.7	39.3	21.9	1.0	34.5	0.0	12.1	179.2	66.5	0.5	23.9	52.6	5.0	14.4	56.7	0.9	47.3	39.3	19.1	0.3	5.0	25.8	6.9	9.3	2.7	58.7	2.1	10.1	24.1	88.8
KCNK9	"K2p9.1, TASK-3, TASK3"	ENSG00000169427	"Potassium two pore domain channel subfamily K member 9"	Q9NPC2	8	139600838-139703056	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adrenal gland: 9.4;brain: 15.4"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 1.8;Distal tubular cells: 1.7;Exocrine glandular cells: 2.2;Late spermatids: 4.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 15.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"PC-3: 6.6;SCLC-21H: 2.9;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075842			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA075842: "	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.96e-8)"	"unprognostic (1.91e-1)"	"unprognostic (8.17e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.12e-6)"	"unprognostic (2.94e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.76e-1)"	0.2	9.4	0.5	0.5	1.0	0.1	0.1	15.4	7.7	1.3	0.5	0.0	0.0	0.1	0.3	0.1	0.2	0.3	0.1	0.2	1.6	1.4	0.1	0.1	0.1	0.1	0.7	1.7	0.1	0.1	0.1	1.1	0.2	6.6	0.1	0.2	0.2	0.1	0.1	1.4	0.1	0.1	0.6	0.6	0.1	0.3	0.5	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.0	0.0	2.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.0	15.4	3.7	1.6	1.4	0.7	1.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.0	0.0	1.7	0.2	1.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
KCNMB1	hslo-beta	ENSG00000145936	"Potassium calcium-activated channel subfamily M regulatory beta subunit 1"	Q16558	5	170374671-170389677	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 55.5"	"Cell type enriched"	"Detected in many"	6	"Peritubular cells: 333.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 7.0;monocytes: 7.1"	"Cell line enhanced"	"Detected in some"		"REH: 13.0;SK-BR-3: 3.2;U-937: 5.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (2.06e-2)"	"unprognostic (2.70e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.04e-2)"	3.2	1.0	0.6	7.7	0.5	0.7	4.2	0.4	0.6	26.8	34.7	0.8	12.6	2.2	31.3	10.6	29.8	10.9	32.4	2.6	0.6	0.7	1.9	0.4	2.2	1.3	1.1	0.9	8.7	0.5	0.1	0.5	0.9	2.2	29.4	5.0	5.6	5.3	29.3	0.9	1.6	11.4	55.5	1.5	1.1	13.4	8.0	0.6	0.3	1.0	1.5	1.6	43.4	6.4	0.5	7.0	1.4	7.1	0.6	0.3	1.0	0.1	0.2	2.3	0.6	0.2	0.0	0.4	0.3	0.1	0.1	0.1	0.5	0.4	0.2	1.6	0.1	0.6	0.2	0.1	0.1	0.1	0.5	0.1	1.5	0.8	0.3	0.0	0.6	0.4	0.4	0.0	0.2	0.4	0.2	0.2	0.7	0.5	1.1	0.1	1.0	0.0	1.4	0.4	0.1	0.2	13.0	0.1	0.3	0.1	0.4	0.5	0.3	0.1	3.2	0.0	1.1	0.2	1.4	0.8	0.3	0.5	0.5	0.1	0.8	0.3	0.2	0.2	5.4	0.2	1.3	4.3	0.4	0.2	7.1	0.1	0.2	0.3	0.2	7.0	0.5	0.2	0.2	1.4	0.6	6.0	2.6	0.2	1.0	0.6	0.5	0.4	0.5	0.6	0.7	1.1	0.9	2.2	0.6	0.0	7.5	1.3	1.0	1.8	1.5	2.6	2.5	8.1	7.9	1.8	5.9	0.5	0.0	0.1	0.5	2.7	0.0	0.0	0.4	0.6	14.4	1.0	19.6	0.0	7.7	1.6	0.0	1.8	9.1	1.6	35.6	21.4	3.3	29.7	0.0	1.1	0.0	0.0	333.0	0.0	1.8	45.3	59.8	0.7	0.9	1.5	0.5	0.0	0.0	0.5
KCNMB2		ENSG00000197584	"Potassium calcium-activated channel subfamily M regulatory beta subunit 2"	Q9Y691	3	178272932-178844429	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"epididymis: 36.8"	"Group enriched"	"Detected in some"	4	"Ciliated cells: 14.7;Intestinal endocrine cells: 13.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 6.5;fHDF/TERT166: 2.6;RPMI-8226: 1.8;SCLC-21H: 8.5"									CAB022649	Uncertain					NA	NA					"CAB022649: "	"unprognostic (9.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.85e-2)"	0.7	6.3	7.8	0.5	6.2	0.4	1.3	1.8	11.2	2.5	1.9	2.2	4.4	1.0	7.2	36.8	0.9	14.3	0.9	7.4	13.2	4.5	4.1	0.6	1.6	0.4	4.7	4.9	16.3	4.5	0.4	10.2	0.5	6.2	1.1	0.9	0.5	0.6	1.9	0.6	0.7	0.9	3.0	3.2	1.9	3.6	0.6	3.2	0.0	1.1	0.0	0.4	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	6.5	0.0	0.0	0.4	0.0	0.0	1.4	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	1.8	0.0	1.0	8.5	0.0	0.0	0.5	0.0	0.6	1.4	0.0	0.3	0.0	0.1	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	6.2	1.8	11.2	13.2	4.5	4.7	4.9	6.2	3.2	0.0	0.0	0.0	0.0	0.0	0.4	2.8	0.0	14.7	1.2	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	13.3	2.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNMB3	"KCNMB2, KCNMBL"	ENSG00000171121	"Potassium calcium-activated channel subfamily M regulatory beta subunit 3"	Q9NPA1	3	179236691-179267002	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 13.7;Late spermatids: 10.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 11.2;NB-4: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015665, HPA019185"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA015665: AB_1852142, HPA019185: AB_1852144"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.76e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.95e-5)"	"unprognostic (5.93e-10)"	"unprognostic (7.22e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.49e-2)"	3.0	2.0	0.7	2.9	0.7	1.2	3.3	0.2	0.6	1.8	2.0			1.9	2.0	2.3	0.7	1.0	2.4	1.8	1.0	0.9	2.2	4.0	1.2	2.9	1.1		1.6	5.3	3.7	2.1	6.6		2.9	2.2		2.7	1.4	0.5	0.6	2.2	1.9	1.5	5.9	2.6	4.5			2.4		2.6	1.9	1.5	3.5	0.3	2.3	0.4	3.6	1.0	0.0	3.0	0.7	1.2	0.0	1.4	1.1	1.9	0.8	0.5	1.3	0.6	6.5	2.6	0.1	3.0	0.6	2.7	1.1	0.0	0.2	1.5	3.8	0.4	11.2	2.9	2.5	1.2	0.2	3.7	1.9	0.6	0.9	0.0	1.0	1.1	0.1	0.4	0.1	1.5	1.8	0.1	7.6	0.0	1.2	2.3	3.3	0.0	0.1	1.0	2.1	1.5	0.4	1.0	1.2	0.7	1.1	3.1	6.1	0.7	0.6	1.1	0.3	0.9	1.0	0.4	3.6	0.6	4.3	0.8	2.3	0.4	0.5	1.0	0.3	0.6	3.5	0.6	0.8	0.1	2.1	0.4	0.7	1.9	3.6	0.1	0.3	0.9	0.0											0.0	2.2	0.8	1.8	0.2	2.3	0.6	2.5	1.4	2.3	0.0	13.7	1.0	0.0	4.3	8.0	2.7	1.5	0.0	3.1	1.0	1.2	1.6	2.3	1.5	1.0	0.0	4.7	1.8	1.6	10.9	2.6	0.8	0.0	1.0	1.3	1.9	2.7	0.0	2.8	0.0	5.3	6.5	1.4	1.6	1.4	0.1	1.0	0.0	1.1	0.7
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114360945-114496500	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 25.3;brain: 23.1;liver: 33.2"	"Cell type enhanced"	"Detected in some"	12	"Cardiomyocytes: 10.8;Hepatocytes: 14.7;Melanocytes: 20.3;Rod photoreceptor cells: 7.2"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 15.0;NTERA-2: 5.7;SK-MEL-30: 10.6;THP-1: 18.7;U-937: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA038221: AB_10673044"	"unprognostic (9.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.25e-1)"	0.8	25.3	12.6	0.8	7.3	0.6	1.1	21.7	15.0	1.7	1.2	9.5	0.0	0.9	3.9	0.9	0.8	1.0	1.0	7.7	23.1	3.6	4.8	33.2	2.5	0.9	4.5	16.9	1.4	3.8	1.0	16.0	0.6	9.1	11.7	1.3	4.2	1.1	5.4	9.9	2.1	0.9	2.8	8.4	1.1	1.1	3.8	6.5	0.0	0.9	0.0	0.8	2.4	1.1	0.3	0.3	0.8	0.3	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	15.0	2.3	0.3	0.1	0.0	0.2	0.0	0.5	0.0	2.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.1	0.0	0.2	0.0	1.2	5.7	0.0	0.0	0.1	0.0	0.7	0.3	0.1	1.8	0.0	0.0	0.2	10.6	0.3	0.2	18.7	0.2	0.0	0.4	1.7	0.0	0.1	0.0	0.1	1.8	6.7	0.5	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.3	0.1	0.3	0.8	0.1	0.3	0.3	0.1	0.0	12.6	7.3	21.7	15.0	23.1	3.6	4.5	16.9	9.1	6.5	0.0	0.6	0.0	0.1	0.2	6.8	10.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.7	5.2	0.0	0.0	0.8	0.0	0.9	4.5	0.0	14.7	0.0	0.0	0.0	6.2	1.0	0.0	0.0	0.0	20.3	0.0	0.5	0.3	1.4	0.0	0.0	0.5	7.2	0.0	0.5	0.5	3.2	0.3	0.0	0.0	0.4	0.1
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43781257	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 45.7;salivary gland: 82.3"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 196.8;Syncytiotrophoblasts: 638.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 27.8;hTERT-RPE1: 24.5;SK-BR-3: 27.5;WM-115: 70.6"	"Region enhanced"	"Detected in single"		"olfactory region: 2.3"	"Not detected"	"Not detected"			"HPA053841, HPA059622"	Approved					NA	NA					"HPA053841: AB_2682278, HPA059622: AB_2684085"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (9.96e-3)"	"prognostic unfavorable (1.05e-14)"	"unprognostic (3.70e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.75e-4)"	3.0	0.1	0.5	12.2	2.5	6.5	5.6	0.4	0.5	8.0	5.7	0.7	6.4	2.0	0.9	2.9	2.6	2.6	8.8	0.6	1.4	0.5	0.8	0.3	2.6	5.7	1.7	0.6	1.3	0.3	0.0	0.3	45.7	1.5	11.0	3.8	0.8	82.3	6.8	0.7	10.8	10.0	2.0	1.1	8.4	13.6	0.9	1.0	9.1	0.7	3.6	17.3	10.3	2.4	18.7	14.4	1.9	15.8	0.0	6.9	5.2	5.1	9.6	0.0	0.0	0.0	0.8	13.5	0.2	0.7	0.5	0.1	0.1	27.8	1.5	2.2	0.2	3.2	4.1	0.0	9.8	1.4	9.3	0.0	6.8	12.5	0.2	0.0	0.0	0.1	0.0	1.2	0.6	4.4	24.5	0.0	0.0	1.5	0.8	0.1	5.0	1.5	5.2	0.0	21.9	10.3	4.6	0.1	5.1	8.5	14.4	0.0	0.0	13.8	27.5	8.1	0.6	0.0	5.5	0.3	3.8	19.7	0.1	11.1	0.0	0.3	0.6	13.1	1.2	70.6	1.9	10.2	0.0	0.3	15.8	0.4	18.7	5.1	2.6	14.4	9.4	3.4	3.2	0.5	0.0	8.6	0.4	6.9	5.2	0.5	2.5	0.4	0.5	1.4	0.5	1.7	0.6	1.5	1.0	0.0	3.4	27.2	43.3	2.5	0.1	0.4	7.6	0.0	6.8	1.8	3.9	196.8	0.0	3.0	0.7	2.8	4.2	23.3	3.5	6.8	2.8	66.7	0.0	0.0	43.0	0.0	0.0	0.0	7.5	0.0	0.0	28.3	20.3	0.0	5.9	0.0	37.2	16.9	0.0	0.0	0.3	0.0	1.0	0.0	1.3	1.9	638.3	6.5	43.7	53.5
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849110	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease mutation, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 78.2;ductus deferens: 88.1;seminal vesicle: 83.6"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 32.7;Undifferentiated cells: 44.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 19.9;OE19: 24.0;RPMI-8226: 13.4;U-266/70: 7.9;U-937: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB018656, HPA048553"	Enhanced					NA	NA					"CAB018656: AB_2131551, HPA048553: AB_2680438"	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favorable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	3.0	78.2	1.0	5.1	1.0	3.4	3.1	0.6	1.2	5.0	13.7	4.1	88.1	14.2	1.9	15.9	1.5	2.1	12.2	10.7	1.5	1.0	13.8	1.0	11.4	5.8	1.2	0.8	1.6	25.6	5.6	2.7	1.8	1.8	7.5	4.6	2.5	9.5	83.6	0.8	1.0	18.4	1.5	1.4	5.5	31.2	3.6	1.5	1.6	36.2	0.9	4.8	5.5	3.6	1.2	5.6	5.3	4.7	0.0	1.7	1.4	0.0	0.1	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.4	0.9	3.3	0.0	0.2	0.1	0.4	0.0	0.0	0.2	0.9	0.0	2.4	0.2	0.2	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.7	24.0	0.1	0.1	0.0	13.4	5.0	1.6	0.4	3.7	0.4	0.0	0.0	0.3	0.1	5.1	0.0	0.0	0.1	0.1	0.0	7.9	0.0	0.0	0.0	7.8	0.0	1.6	4.7	4.7	0.0	2.6	0.1	1.2	0.6	0.1	5.6	0.6	1.7	1.7	5.3	0.0	3.7	1.9	0.5	1.4	1.0	1.0	0.6	1.2	1.5	1.0	1.2	0.8	1.8	1.5	3.0	11.7	6.7	6.7	0.6	0.0	15.9	17.8	2.7	5.7	27.9	0.0	1.0	13.3	16.6	1.1	2.9	32.7	0.0	18.8	1.1	1.0	6.2	19.6	0.2	13.9	0.0	6.3	9.2	24.1	0.6	0.3	10.1	1.7	1.8	21.3	0.6	17.8	17.5	0.0	1.6	0.2	6.5	1.0	0.2	0.1	0.9	1.7	1.3	44.9	14.7
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400210-63472677	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 10.8;Horizontal cells: 12.7;Late spermatids: 5.7;Spermatocytes: 6.6;Spermatogonia: 17.0"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.2;T-reg: 1.5"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Cell line enhanced"	"Detected in some"		"AF22: 8.5;AN3-CA: 14.0;NTERA-2: 7.8;SCLC-21H: 27.5;SH-SY5Y: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: AB_2683339"	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	1.2	10.0	18.7	1.3	21.4	1.2	1.2	24.1	50.8	1.2	1.3	2.4	0.0	1.3	1.2	1.3	1.2	1.7	1.7	1.2	15.4	10.0	1.2	1.2	1.2	1.2	8.4	14.1	1.2	1.9	1.2	9.2	1.2	8.9	2.8	1.2	0.0	1.2	1.2	1.2	1.2	1.3	1.2	2.6	1.2	1.3	6.9	4.2	0.0	1.2	0.0	1.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	8.5	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	27.5	48.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.9	0.0	0.0	0.0	0.0	1.5	0.0	18.7	21.4	24.1	31.2	15.4	10.0	8.4	14.1	8.9	4.2	0.0	0.0	0.0	0.0	0.1	1.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	12.7	0.0	0.0	0.0	5.7	0.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	2.1	0.0	0.0	6.6	17.0	0.0	0.0	0.0	0.0	0.0
KCNQ3	"EBN2, Kv7.3"	ENSG00000184156	"Potassium voltage-gated channel subfamily Q member 3"	O43525	8	132120858-132481019	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 29.5"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 2: 9.4;Bipolar cells: 5.7;Cardiomyocytes: 4.5;Exocrine glandular cells: 5.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.1;JURKAT: 5.6;RPMI-8226: 4.1;U-2 OS: 6.6;U-87 MG: 5.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.90e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.65e-5)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.57e-6)"	"unprognostic (5.82e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.71e-4)"	"unprognostic (1.14e-3)"	"unprognostic (3.52e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.50e-2)"	1.8	3.3	10.6	1.5	13.1	0.7	1.4	0.9	29.5	1.4	1.0	1.7	0.0	1.0	1.0	0.9	0.8	1.2	1.3	1.8	8.0	7.3	1.8	0.7	2.0	0.9	7.4	11.5	0.8	1.2	1.2	1.4	1.0	6.5	1.4	1.0	0.0	1.0	1.8	0.7	1.3	1.7	1.6	2.1	1.3	0.9	1.0	4.7	0.0	1.2	0.0	1.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.5	1.6	0.0	0.5	1.6	0.0	0.0	0.0	1.5	0.0	1.8	2.3	3.8	0.0	0.0	3.7	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	2.6	10.1	0.1	0.0	5.6	0.0	0.2	1.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	4.1	2.4	0.0	1.9	1.7	0.7	0.0	0.0	0.3	0.0	1.4	0.0	0.0	6.6	0.2	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	13.1	0.9	13.3	8.0	7.3	7.4	11.5	6.5	4.7	0.0	9.4	0.0	0.0	0.2	5.7	4.5	0.0	1.4	2.3	0.0	0.0	0.0	0.0	2.9	1.5	0.6	0.0	0.0	5.1	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.0	1.2	0.0	1.0	0.0	0.2	2.8	0.0	0.0	0.4	0.4	0.0	1.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783814-40840452	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Hearing, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 40.1;retina: 23.0"	"Cell type enhanced"	"Detected in some"	12	"Muller glia cells: 4.1;Sertoli cells: 6.5;Smooth muscle cells: 2.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 4.0;HEK 293: 5.9;K-562: 5.9;MCF7: 3.5;REH: 3.1;THP-1: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain					NA	NA					"HPA018305: AB_1855556"	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	2.5	0.9	1.1	1.5	2.9	0.4	1.3	3.8	3.6	2.5	9.1	0.9	1.5	1.5	5.8	0.9	3.5	4.6	2.8	2.1	1.6	0.7	0.4	0.4	1.4	0.4	1.4	2.1	1.6	40.1	0.5	0.6	2.1	1.3	3.3	1.7	23.0	5.4	5.3	5.9	1.1	2.3	7.5	2.0	0.4	2.9	1.2	1.4	0.5	0.6	0.9	0.4	5.3	2.5	0.0	0.5	0.0	0.0	0.0	0.4	0.4	0.1	0.2	0.3	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.3	1.6	0.4	0.6	0.0	0.0	0.0	4.0	0.0	0.0	0.1	5.9	2.0	0.3	0.0	0.4	0.4	0.2	0.5	0.0	0.0	0.0	0.1	0.0	0.9	5.9	0.1	0.0	3.5	0.7	0.0	0.4	0.0	0.1	3.1	0.0	0.0	0.7	0.0	2.6	0.5	0.0	1.5	0.6	0.4	0.3	3.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.4	1.1	2.9	3.8	3.6	1.6	0.7	1.4	2.1	1.3	1.4	0.0	0.0	0.0	0.0	0.1	0.3	1.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	1.2	0.2	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	1.6	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	4.1	0.3	0.0	0.7	0.0	0.3	6.5	2.7	0.2	0.5	0.4	0.0	0.0	0.4	0.1
KCNS1	Kv9.1	ENSG00000124134	"Potassium voltage-gated channel modifier subfamily S member 1"	Q96KK3	20	45092310-45101112	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 27.0"	"Cell type enriched"	"Detected in some"	6	"Cholangiocytes: 10.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 6.1"	"Region enhanced"	"Detected in many"		"cerebral cortex: 27.0"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 3.2;HHSteC: 4.9;hTEC/SVTERT24-B: 2.7;THP-1: 4.1;U-87 MG: 7.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.46e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.11e-4)"	"unprognostic (8.91e-3)"	"unprognostic (6.01e-3)"	"unprognostic (7.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.65e-2)"	"unprognostic (6.35e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.39e-1)"	0.3	0.8	1.4	0.2	4.6	0.4	0.7	0.4	27.0	0.6	0.3	0.0	5.9	0.2	0.2	0.2	0.4	0.3	5.2	0.4	2.1	1.1	0.5	0.3	0.7	0.3	1.0	7.2	0.2	0.3	0.1	0.4	0.3	0.0	0.9	0.2	0.0	3.4	7.0	0.2	2.6	0.3	0.2	0.4	0.3	0.3	2.0	0.0	0.0	0.3	0.0	0.5	0.4	0.6	0.6	0.2	2.5	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.1	0.5	0.0	0.3	0.3	1.0	0.9	0.1	0.4	1.4	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.2	0.9	0.0	2.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.3	1.8	0.0	2.1	0.5	0.0	4.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.2	0.6	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.4	4.6	0.4	27.0	2.1	1.1	1.0	7.2	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.9	10.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.1
KCNS2	Kv9.2	ENSG00000156486	"Potassium voltage-gated channel modifier subfamily S member 2"	Q9ULS6	8	98427022-98432848	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 20.9"	"Cell type enhanced"	"Detected in single"	20	"Leydig cells: 1.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 20.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 4.0;SCLC-21H: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051417	Uncertain					NA	NA					"HPA051417: AB_2681478"	"unprognostic (7.83e-2)"	"unprognostic (9.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-5)"	"unprognostic (2.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-3)"	1.6	1.4	2.9	0.6	6.6	0.3	0.7	0.7	20.9	2.0	1.0	0.1	0.5	0.4	1.3	1.7	0.9	1.0	1.5	0.4	1.9	2.8	0.7	0.3	0.7	0.4	0.8	6.4	1.9	0.8	0.8	1.2	4.4	3.4	0.9	0.9	0.1	0.3	3.3	0.2	0.3	0.7	0.6	0.9	0.3	1.5	1.0	0.4	0.0	0.5	0.0	0.3	2.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.4	1.3	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	11.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	6.6	0.7	20.9	1.9	2.8	0.8	6.4	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 54.4"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 26.8;Intestinal endocrine cells: 31.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 33.8;RPMI-8226: 13.6;RT4: 23.0;U-266/84: 15.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Golgi apparatus, Plasma membrane"	"HPA014864: AB_1852155"	"unprognostic (5.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.47e-3)"	"unprognostic (9.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	2.2	1.1	2.7	5.6	3.2	0.4	14.8	0.5	5.1	6.8	7.9	4.8	1.3	3.1	4.5	2.4	7.2	3.3	5.3	4.6	3.9	3.4	4.2	2.6	17.6	1.2	6.8	1.4	1.1	7.7	1.9	0.8	8.3	15.2	4.4	4.1	9.9	7.6	2.8	54.4	3.7	4.3	9.7	4.7	1.1	7.0	3.9	1.4	0.2	2.4	19.0	3.6	5.0	4.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.7	0.3	0.0	0.8	0.4	1.8	1.3	4.1	0.8	1.0	0.0	8.3	0.0	0.4	1.4	0.9	1.2	10.0	0.0	0.9	0.0	2.6	0.0	0.1	0.0	4.0	0.1	0.3	0.3	6.3	0.0	0.6	7.7	0.2	1.8	0.2	0.0	0.5	1.0	0.0	0.0	5.0	5.4	0.1	1.1	33.8	13.6	0.8	23.0	10.0	0.3	0.0	2.6	2.7	2.4	1.3	0.0	0.1	1.3	0.0	0.1	10.1	0.0	15.7	0.0	7.5	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.2	0.5	5.1	3.9	3.4	6.8	1.4	15.2	1.4	26.8	5.1	0.0	10.1	12.4	0.0	0.4	20.4	0.0	4.5	10.4	0.0	0.5	0.0	16.1	0.2	6.0	3.2	0.0	0.3	2.9	16.6	8.1	1.1	3.2	0.4	0.0	31.2	3.1	0.0	0.2	1.4	0.6	20.3	1.0	3.0	0.1	3.7	3.5	3.5	2.6	0.1	6.5	9.5	0.2	3.1	5.1	0.7	0.0	9.9	5.4
KCNT1	"KCa4.1, KIAA1422, SLACK, Slo2.2"	ENSG00000107147	"Potassium sodium-activated channel subfamily T member 1"	Q5JUK3	9	135702185-135795508	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.7;skeletal muscle: 19.5"	"Cell type enriched"	"Detected in single"	5	"Cardiomyocytes: 4.5"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 5.6;RH-30: 1.9;RPMI-8226: 4.2;SCLC-21H: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059880	Uncertain					NA	NA					"HPA059880: AB_2684149"	"unprognostic (1.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.98e-13)"	"unprognostic (9.26e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.89e-7)"	"unprognostic (9.15e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	1.4	0.8	7.3	1.0	12.4	1.0	0.7	29.7	29.3	0.7	0.9	0.2	0.0	1.0	0.8	0.9	1.2	0.9	1.1	1.8	5.3	4.2	0.7	0.7	0.9	0.8	1.8	12.0	7.3	0.8	0.7	4.7	1.2	6.1	0.8	0.8	0.0	0.7	0.8	19.5	0.8	0.8	0.8	2.1	9.6	1.4	1.9	3.1	0.0	0.8	0.0	0.7	1.1	0.1	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	5.6	0.0	0.0	1.9	4.2	0.0	0.0	6.3	1.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	7.3	12.4	29.7	29.3	5.3	4.2	1.8	12.0	6.1	3.1	0.0	0.0	0.0	0.0	0.0	0.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.7	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0
KCNT2	"KCa4.2, SLICK, SLO2.1"	ENSG00000162687	"Potassium sodium-activated channel subfamily T member 2"	Q6UVM3	1	196225779-196609225	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 38.7;Early spermatids: 12.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 4.3;hTERT-RPE1: 12.4;SCLC-21H: 9.3;SH-SY5Y: 8.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051218	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA051218: AB_2681392"	"unprognostic (5.06e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.10e-6)"	"unprognostic (1.22e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.18e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (3.30e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.72e-3)"	3.9	2.8	4.8	1.3	5.5	0.6	2.2	1.4	8.3	1.8	2.3	0.6	0.0	2.1	2.2	1.7	4.0	2.7	5.9	6.8	9.4	3.1	1.8	10.5	5.5	1.3	1.8	5.2	14.9	1.1	0.9	14.1	1.8	3.7	4.2	2.5	2.9	2.6	2.5	1.2	1.9	2.1	2.6	5.2	1.4	2.6	3.3	1.0	0.0	4.5	3.4	1.2	3.3	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.0	0.1	0.3	0.0	0.0	1.3	0.3	2.7	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.3	0.0	1.6	0.0	4.3	0.0	0.0	1.0	0.0	0.4	0.1	12.4	0.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	3.3	0.0	0.2	0.0	0.3	0.0	0.0	0.7	9.3	8.4	0.0	0.0	0.2	3.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.5	1.4	8.3	9.4	3.1	1.8	5.2	3.7	1.0	38.7	0.6	0.0	0.3	0.3	0.0	1.2	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	5.9	0.0	0.0	0.0	2.5	0.0	2.3	6.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1
KCNV2	Kv8.2	ENSG00000168263	"Potassium voltage-gated channel modifier subfamily V member 2"	Q8TDN2	9	2717502-2730037	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cone-rod dystrophy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 82.3"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 485.0;Rod photoreceptor cells: 393.2"	"Cancer enriched"	"Detected in single"	78	"testis cancer: 6.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.6;HDLM-2: 2.9;HEK 293: 1.4;HeLa: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031131	Enhanced					NA	NA					"HPA031131: AB_10609996"	"unprognostic (5.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-8)"	"unprognostic (3.01e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-2)"	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	82.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.6	0.0	0.2	0.7	0.2	0.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.9	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.9	1.4	0.8	2.3	0.3	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.5	0.7	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.4	0.3	0.0	0.1	0.2	0.1	0.1	0.6	0.0	0.0	0.7	0.4	0.6	0.3	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	0.2	0.0	0.0	0.0	0.0	485.0	0.0	0.0	0.0	85.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	19.8	0.6	0.0	0.0	0.0	0.0	36.6	0.0	0.0	1.1	0.0	393.2	12.9	0.0	5.9	11.4	0.0	0.0	0.0	0.0	0.0
KDELR1	"ERD2, ERD2.1, HDEL"	ENSG00000105438	"KDEL endoplasmic reticulum protein retention receptor 1"	P24390	19	48382570-48391553	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Extravillous trophoblasts: 488.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017455	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus"	"Vesicles, Cytosol"	"CAB017455: AB_10615208"	"unprognostic (3.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.49e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.35e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-2)"	46.9	49.3	22.6	23.4	21.5	14.5	60.6	16.1	28.8	51.8	43.3	24.4	64.8	47.7	44.0	45.2	41.3	40.3	56.5	42.8	20.9	20.4	57.3	81.3	38.0	44.6	18.6	20.4	68.9	61.0	63.5	45.7	81.4	20.9	44.8	47.7	39.7	65.8	69.9	31.8	37.4	59.9	39.6	26.0	33.7	42.5	33.2	18.6	26.2	75.5	32.9	42.3	53.2	54.4	10.6	26.5	6.8	23.3	11.6	12.8	9.3	30.2	43.8	25.4	26.9	57.2	67.0	18.6	29.9	52.9	36.5	41.9	28.8	34.6	12.6	19.6	65.3	22.8	27.2	30.6	32.0	34.9	10.2	32.6	10.5	15.6	53.7	49.8	11.7	19.7	63.2	39.5	24.7	26.5	57.6	33.9	10.9	18.2	23.5	48.4	24.4	11.0	120.4	18.4	60.6	17.8	15.8	15.2	19.7	46.3	25.2	25.5	19.9	26.2	23.5	15.6	30.4	18.5	14.5	26.2	25.8	21.4	21.3	25.4	66.6	52.1	8.5	16.4	15.9	26.3	5.9	23.3	6.8	11.2	19.8	12.8	10.6	11.0	12.1	17.7	9.6	9.2	9.9	5.9	11.6	16.5	26.5	11.7	9.3	22.6	21.5	16.1	28.8	20.9	20.4	18.6	20.4	20.9	18.6	32.8	44.6	55.9	109.7	66.9	36.0	25.0	94.3	48.2	69.4	89.0	5.9	200.0	48.0	191.8	3.8	91.1	175.8	46.7	148.2	488.3	138.8	143.5	61.2	66.0	162.8	38.1	139.2	77.3	97.8	10.5	151.3	75.4	87.7	106.4	269.4	89.6	162.2	178.9	124.1	122.0	21.4	84.1	77.3	41.2	38.1	61.4	324.3	45.4	168.0	114.5
KISS1R	"AXOR12, GPR54, HOT7T175"	ENSG00000116014	"KISS1 receptor"	Q969F8	19	917287-921015	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;lymphoid tissue: 12.4"	"Cell type enriched"	"Detected in some"	18	"Extravillous trophoblasts: 31.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.0;neutrophil: 1.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 10.8;RPMI-8226: 26.3;SCLC-21H: 5.5;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007156, HPA071913"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA007156: , HPA071913: AB_2686471"	"unprognostic (1.54e-1)"	"unprognostic (3.01e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.46e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.17e-2)"	"prognostic unfavorable (3.33e-6)"	"unprognostic (1.87e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-2)"	0.2	0.2	2.1	2.1	4.1	0.2	0.3	0.1	4.7	0.1	0.3	0.1	0.1	0.4	0.2	0.1	0.1	0.2	0.1	0.1	1.0	6.8	1.4	0.1	0.3	12.4	1.1	0.1	0.4	3.6	0.1	2.0	1.0	0.8	0.2	0.2	0.3	0.3	0.1	0.1	0.1	0.7	0.5	1.0	2.4	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.5	0.1	0.6	0.0	1.8	0.0	0.0	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	2.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.8	0.0	0.0	0.2	0.1	0.0	0.4	0.8	0.3	0.7	0.0	26.3	0.0	0.0	5.5	14.7	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.7	0.0	0.0	0.1	2.0	0.6	1.8	0.0	0.0	0.0	0.1	0.0	2.1	4.1	0.1	1.5	1.0	6.8	1.1	0.1	0.8	0.1	0.0	0.0	1.4	0.1	0.1	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.2	31.2	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.4	0.3	1.4	0.0	0.0	0.0
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016433-33066145	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 64.3;parathyroid gland: 76.9;placenta: 25.5"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 99.7"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Region enhanced"	"Detected in some"		"pons and medulla: 11.6"	"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"HMC-1: 5.1;SK-BR-3: 9.6"	"Low region specificity"	"Detected in many"												"Secreted to blood"	NA	NA	510000					"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	4.8	0.6	0.8	0.9	4.3	0.1	7.4	0.0	0.8	0.7	2.1	3.3	0.2	1.0	1.0	3.2	0.8	0.7	0.9	0.9	2.4	0.8	64.3	0.2	10.4	0.9	0.5	0.3	0.4	1.6	76.9	0.3	25.5	11.6	3.3	0.4	0.3	0.7	1.0	0.9	0.4	3.2	0.7	0.4	3.1	1.9	0.6	0.3	0.0	1.4	1.3	0.3	1.5	1.1	0.0	0.0	0.0	1.0	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.8	4.3	0.0	0.8	2.4	0.8	0.5	0.3	11.6	0.3	0.0	0.3	0.0	0.1	0.1	0.0	0.8	0.0	1.4	1.2	12.2	0.0	0.1	5.0	0.0	1.7	1.8	0.9	0.0	0.0	0.1	0.7	4.4	0.0	0.0	2.1	0.0	15.6	0.0	0.8	0.0	0.3	0.7	0.0	1.0	0.0	0.0	0.0	0.0	0.4	99.7	0.0	0.0	0.3	0.5	0.2	0.1	0.1	0.0	0.6	0.1
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406853-39451536	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adipose tissue: 17.3;liver: 49.2;pancreas: 21.4"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 2: 12.1;Hepatocytes: 28.7;Intestinal endocrine cells: 16.7;Spermatocytes: 11.1"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	23	"ASC diff: 6.5;Hep G2: 23.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021136	Uncertain					NA	NA		290000			"HPA021136: AB_1852616"	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	17.3	0.0	0.2	1.9	1.0	0.2	3.9	0.4	0.2	0.0	1.6	0.0	0.0	0.2	0.1	0.5	0.3	0.1	1.3	0.5	1.0	0.2	0.1	49.2	1.4	0.5	0.1	0.0	0.2	21.4	0.2	0.2	0.0	0.4	0.0	0.4	0.0	0.3	0.0	0.4	0.5	0.6	0.3	0.0	0.0	1.5	2.5	0.2	0.0	0.1	0.4	0.0	0.3	0.2	0.5	2.5	2.3	0.7	0.4	0.4	0.2	0.0	0.2	0.0	0.0	6.5	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	23.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.7	0.2	0.3	0.4	0.2	0.4	0.2	0.2	0.1	0.5	0.2	0.4	2.3	0.4	0.5	2.5	0.1	0.2	0.2	1.0	0.4	0.2	1.0	0.2	0.1	0.0	0.4	0.2	3.0	12.1	0.0	0.9	0.5	2.1	0.9	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.9	5.9	0.3	1.4	0.0	3.7	1.1	0.4	1.0	0.0	28.7	0.2	1.6	16.7	0.0	0.3	1.1	1.4	0.2	1.7	0.0	6.7	0.3	1.4	3.5	0.7	0.8	1.6	0.0	0.0	11.1	0.7	0.6	1.1	0.0	0.6	0.7
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.8;lymphoid tissue: 30.7"	"Cell type enriched"	"Detected in some"	9	"T-cells: 20.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	39	"gdT-cell: 49.4;MAIT T-cell: 18.5;memory CD8 T-cell: 44.0;naive CD8 T-cell: 44.3;NK-cell: 50.8"	"Group enriched"	"Detected in many"	47	"NK-cells: 50.8;T-cells: 49.4"	"Cell line enriched"	"Detected in some"	8	"U-698: 36.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"		NA	NA		33000	"Plasma membrane"		"CAB021896: , HPA068877: AB_2686052"	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"	4.1	0.9	1.3	18.3	1.1	10.6	2.1	0.4	0.8	2.8	4.5	1.2	0.6	2.0	2.4	2.7	3.1	2.0	7.7	1.3	1.3	1.1	2.4	3.6	13.6	22.2	2.1	0.1	1.5	3.3	0.0	1.2	1.6	1.2	2.2	2.1	2.4	7.0	0.6	0.5	1.1	13.1	1.3	2.1	30.7	3.3	1.9	0.6	6.0	2.9	2.8	11.4	11.3	2.5	1.0	0.2	0.8	0.1	50.8	49.4	16.7	0.2	0.0	0.4	1.9	0.1	4.7	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.1	0.1	0.0	0.4	0.7	0.0	0.2	0.0	0.2	0.1	0.4	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	36.9	0.1	0.0	0.2	0.0	0.0	0.0	49.4	0.1	18.5	0.8	0.3	44.0	0.1	1.0	0.4	44.3	0.8	50.8	0.1	0.2	0.1	16.7	1.3	1.1	0.4	0.8	1.3	1.1	2.1	0.1	1.2	0.6	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	20.3	0.0	0.0
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421949-122514945	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.4"	"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 145.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA053627: AB_2682211, HPA063426: AB_2685013"	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	15.4	16.9	15.1	14.4	15.5	7.6	17.8	14.6	19.3	11.8	13.6	12.0	9.0	9.9	14.4	12.3	17.2	10.8	9.6	18.7	13.9	11.6	13.1	24.6	12.5	11.2	14.4	16.8	10.8	14.5	19.6	13.8	13.6	16.5	12.3	12.3	8.6	13.2	15.1	89.4	13.1	11.3	17.7	15.8	10.9	12.3	15.2	13.5	12.4	14.1	10.9	15.3	14.5	13.6	11.4	17.3	29.3	18.2	13.5	13.9	10.9	29.9	17.8	30.7	15.5	20.0	22.1	9.7	23.2	19.7	25.5	23.1	21.4	14.7	21.9	21.4	25.5	20.2	15.8	24.0	19.8	37.7	5.9	9.1	26.9	16.0	11.9	11.7	23.8	12.4	15.3	25.8	18.3	25.8	12.5	27.8	11.9	18.8	12.7	23.1	14.0	17.2	5.7	13.3	21.2	19.2	17.7	25.5	14.0	11.1	21.1	21.2	12.8	24.9	13.6	20.2	25.1	18.0	14.1	23.7	16.0	17.6	7.8	17.9	12.2	12.3	40.7	22.4	16.7	16.2	15.7	13.1	12.5	12.6	13.4	13.5	11.4	11.2	13.9	17.3	8.8	11.6	11.8	29.3	13.5	18.2	5.5	11.8	10.9	15.1	15.5	14.6	16.7	13.9	11.6	14.4	16.8	16.5	13.5	14.9	28.5	15.2	21.0	36.9	27.4	26.5	25.5	46.8	42.1	14.0	29.5	18.8	11.6	21.1	89.9	29.2	15.5	46.7	28.8	20.9	21.6	27.0	38.1	43.9	20.5	19.1	15.6	26.4	29.7	145.2	20.8	25.2	16.9	25.2	17.0	23.9	27.4	17.5	23.3	16.7	47.9	12.9	33.5	30.1	16.6	39.6	20.8	27.3	10.7	24.2
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035519-68046842	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.9"	"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 663.6;Spermatocytes: 296.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		38000	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	10.6	8.3	10.2	19.5	12.0	38.6	11.9	6.1	13.2	7.4	11.5	6.6	4.3	10.1	8.3	10.4	21.1	6.3	7.9	8.9	11.6	13.2	10.9	11.8	9.1	25.5	10.3	10.3	5.3	4.7	4.5	8.4	16.4	11.4	4.6	14.5	4.0	8.2	4.7	7.2	8.7	10.2	13.2	8.5	14.8	9.7	103.9	9.0	56.6	5.9	20.3	36.8	10.0	8.3	24.6	28.1	16.4	22.6	20.3	17.7	15.0	62.2	81.9	78.2	31.3	11.6	11.3	49.7	55.0	42.7	88.9	69.4	56.3	29.2	58.5	17.4	31.7	44.3	34.5	86.4	42.9	102.4	23.5	50.9	51.8	39.6	53.7	12.2	44.5	35.7	7.0	8.1	51.1	31.5	12.5	85.5	25.0	41.1	42.3	78.8	58.1	55.5	28.7	52.8	50.8	42.5	30.7	71.4	32.0	35.0	29.2	31.1	34.6	30.9	99.8	32.3	74.7	58.1	22.4	33.3	49.3	61.0	34.7	73.9	35.1	50.2	58.4	24.0	38.3	52.9	16.4	16.1	6.6	14.1	22.6	10.9	24.6	10.3	14.4	28.1	19.7	7.9	12.3	1.2	20.3	18.9	21.4	17.7	15.0	10.2	12.0	6.1	13.2	11.6	13.2	10.3	10.3	11.4	9.0	11.9	32.3	47.6	33.0	97.4	19.1	12.6	7.6	8.1	18.2	17.4	7.9	59.0	13.3	31.3	663.6	49.2	9.8	70.0	22.3	244.0	94.4	18.1	43.8	15.3	104.7	30.2	41.1	16.0	36.5	186.9	17.8	52.4	50.6	104.6	9.7	29.4	18.3	10.5	13.8	26.9	17.8	32.3	72.6	296.7	211.0	77.3	99.4	34.5	15.8	20.4
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699307-49792921	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 71.8"	"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 254.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046852, HPA077643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA046852: AB_2679840, HPA077643: "	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	12.4	8.0	15.2	9.1	11.8	14.1	12.4	10.9	14.4	8.5	11.4	7.5	8.1	7.0	9.5	6.8	14.5	7.3	8.4	17.2	12.3	11.4	8.0	13.6	9.6	9.4	11.1	11.4	8.1	6.3	9.1	8.1	8.3	13.0	9.4	9.7	5.9	8.3	11.4	71.8	9.0	8.5	14.3	13.2	8.1	8.3	15.1	11.8	11.4	10.9	14.6	10.8	15.0	16.3	6.0	5.0	7.6	6.8	8.1	12.1	4.1	14.1	9.8	18.9	15.8	19.4	21.3	9.5	25.8	21.4	22.7	16.6	29.8	13.2	30.6	5.3	30.0	15.3	16.7	22.5	20.7	38.0	18.3	15.8	22.4	9.7	34.6	18.9	33.4	14.6	15.6	15.1	19.0	25.1	15.0	28.0	12.9	12.3	8.3	31.2	6.5	17.9	18.2	21.8	19.8	6.9	23.5	18.6	9.3	13.9	11.8	7.9	12.6	9.4	11.8	10.2	16.4	7.0	13.5	25.4	16.8	13.7	15.3	17.1	6.7	9.4	27.0	10.2	15.5	16.6	7.6	4.6	4.3	8.6	5.5	12.1	6.0	8.8	8.4	5.0	4.0	8.8	7.9	2.8	8.1	6.8	2.9	10.1	4.1	15.2	11.8	10.9	14.4	12.3	11.4	11.1	11.4	13.0	11.8	62.5	29.8	19.7	23.8	38.2	22.9	70.2	10.2	37.5	25.0	12.2	31.4	13.2	14.9	42.7	254.1	35.9	17.7	23.3	46.6	15.0	28.3	24.7	32.3	33.4	29.7	49.3	29.2	35.0	34.0	136.0	20.4	32.3	18.6	37.9	17.6	46.9	45.4	10.5	47.0	20.9	62.4	25.8	29.3	52.1	29.9	43.5	8.8	27.7	20.2	28.7
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160494995-160565588	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 66.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm		NA	NA		250000	Nucleoplasm		"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	18.0	9.4	12.6	12.9	12.7	15.2	25.1	13.1	14.1	14.8	14.4	8.6	11.1	7.3	13.1	10.8	22.1	8.9	13.9	45.0	12.0	12.1	11.0	12.6	11.4	12.4	11.6	10.8	15.0	10.7	12.5	6.9	17.5	11.1	11.0	9.7	7.1	10.9	13.1	66.1	10.6	9.5	20.4	10.4	12.1	10.8	13.5	6.3	13.8	11.4	22.2	10.2	21.8	25.2	2.9	2.9	6.8	11.5	8.3	5.6	3.2	33.8	12.0	12.4	16.7	14.3	13.2	16.3	21.1	15.1	15.5	13.2	15.3	17.8	18.0	25.3	21.6	23.2	15.8	13.9	13.6	23.4	22.3	7.8	15.2	10.7	9.1	18.6	21.2	13.7	13.5	14.4	15.0	30.6	12.5	20.4	8.9	11.4	14.6	22.0	9.5	19.1	8.8	25.2	15.3	11.2	12.8	18.5	18.2	12.5	13.0	10.1	9.8	20.4	20.5	29.3	14.4	17.8	11.6	22.7	17.8	15.3	17.7	33.9	26.8	17.7	41.3	16.2	22.2	15.7	6.8	3.6	6.0	3.1	6.7	5.6	2.9	4.5	4.5	2.7	2.5	3.6	4.7	5.4	8.3	11.5	2.9	4.2	3.2	12.6	12.7	13.1	13.3	12.0	12.1	11.6	10.8	11.1	6.3	35.7	24.3	27.5	63.0	109.9	56.4	153.2	20.4	40.2	43.3	10.4	74.6	22.7	29.9	33.3	19.9	45.0	51.2	0.0	32.4	20.6	50.3	69.0	30.1	26.1	35.0	50.9	27.5	29.4	41.9	14.3	31.4	45.8	42.2	26.2	29.9	52.1	57.1	33.4	32.5	31.4	60.8	32.3	42.2	40.3	21.8	110.2	34.0	29.9	30.5	94.6
KPNA5	"IPOA6, SRP6"	ENSG00000196911	"Karyopherin subunit alpha 5"	O15131	6	116681187-116741866	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 46.6"	"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 211.4;Alveolar cells type 2: 181.5;Ciliated cells: 240.9;Club cells: 211.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB026464, HPA054037"	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"CAB026464: , HPA054037: AB_2682351"	"unprognostic (9.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.56e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.98e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.43e-1)"	5.7	6.5	11.9	5.9	12.8	7.5	7.6	24.1	21.2	8.6	6.0	4.3	3.4	4.0	11.2	5.3	6.1	9.8	6.5	5.8	11.0	8.1	6.6	3.6	7.2	10.7	9.0	13.5	22.3	4.4	9.5	19.7	5.6	14.1	8.4	4.5	5.7	4.7	7.1	14.0	4.7	5.6	8.5	12.0	7.4	4.8	46.6	8.2	10.9	12.2	3.9	7.3	6.4	7.4	18.0	10.5	11.9	4.0	6.3	16.6	2.9	2.5	1.5	11.0	6.8	4.2	7.9	4.5	3.8	10.6	6.7	9.5	7.1	2.6	9.2	5.0	4.1	7.6	4.2	5.8	3.4	8.7	5.8	15.8	8.8	4.6	4.0	5.2	6.8	5.5	7.0	2.1	8.2	4.8	7.9	7.6	9.3	12.9	4.0	7.4	3.4	10.5	4.7	4.9	1.7	4.1	8.7	3.6	2.6	5.1	5.0	11.5	11.0	2.9	2.3	3.6	7.5	4.6	6.7	6.0	2.8	5.7	2.9	6.6	10.4	11.3	10.7	3.1	4.8	5.8	11.9	3.1	3.7	8.8	3.2	10.9	14.9	10.0	10.3	1.6	18.0	16.6	12.1	0.8	6.3	4.0	10.5	7.3	2.9	11.9	12.8	24.1	21.2	11.0	8.1	9.0	13.5	14.1	8.2	211.4	181.5	19.3	7.0	12.0	45.3	13.6	10.2	240.9	211.5	8.7	27.5	3.3	8.3	5.3	34.2	15.8	1.4	0.0	4.7	1.5	10.8	7.1	119.7	4.2	3.8	44.5	32.4	16.0	5.4	5.9	16.4	10.4	10.1	4.6	6.8	34.6	4.2	0.0	15.6	4.2	36.7	12.9	7.2	60.3	9.8	7.9	2.7	12.5	3.5	2.6
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108038-32176568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 204.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA		11000	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	16.1	18.7	24.6	14.6	19.0	22.9	18.1	23.9	25.2	16.3	18.8	15.7	23.0	11.5	21.3	17.5	21.4	15.9	12.1	23.4	22.7	18.2	18.3	18.0	17.3	13.2	15.4	19.8	16.9	17.1	40.9	18.0	23.5	29.7	17.6	17.3	14.1	16.2	19.8	54.0	20.5	14.2	23.1	29.2	14.8	17.4	22.2	17.6	12.6	17.8	14.5	18.3	17.9	17.8	9.1	9.3	9.5	12.5	5.0	11.2	6.4	17.0	13.5	12.1	15.5	18.6	16.4	14.2	13.8	16.3	20.2	19.6	15.0	18.7	14.3	16.4	24.8	12.2	14.8	18.5	21.1	25.9	14.4	10.2	14.7	20.8	12.1	16.5	16.1	12.1	16.5	20.1	25.0	24.0	17.1	21.0	11.3	14.2	13.2	19.1	9.4	13.0	9.2	28.1	11.1	10.1	13.1	17.4	11.7	17.6	15.7	11.6	9.8	25.1	15.1	13.4	30.9	10.6	8.6	24.4	18.8	13.0	24.4	19.8	9.5	10.8	11.3	20.5	15.1	17.9	4.0	10.2	9.5	11.2	12.5	11.0	7.8	9.7	8.7	8.3	9.1	11.2	10.8	6.0	5.0	12.5	9.3	9.6	6.4	24.6	19.0	23.9	25.2	22.7	18.2	15.4	19.8	29.7	17.6	38.7	37.4	43.4	31.3	56.4	47.6	28.5	33.1	40.2	21.6	27.9	55.0	38.1	14.9	32.5	204.0	37.9	20.6	0.0	27.4	36.4	38.2	41.3	12.8	56.3	26.8	49.3	44.3	35.6	32.3	48.0	31.7	26.8	23.6	28.9	37.1	29.8	38.9	17.5	38.2	28.3	40.5	32.3	29.9	55.9	52.6	74.4	113.5	32.6	29.2	51.1
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 28.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 28.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No		5500000	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavorable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	38.0	42.1	31.9	46.1	30.7	22.1	33.3	32.9	33.5	37.6	37.9	29.7	39.9	24.5	39.3	35.4	51.2	33.1	35.0	43.5	28.1	30.5	33.8	48.8	35.8	50.5	31.6	35.3	47.2	32.3	42.3	29.4	34.6	34.9	36.1	39.3	23.7	35.2	45.9	74.6	31.7	32.1	40.7	36.6	50.3	35.7	62.4	34.8	47.6	37.0	34.3	62.8	50.8	47.5	5.4	4.0	28.2	3.9	3.7	6.3	2.8	43.7	74.6	47.5	43.1	23.0	40.0	47.7	52.2	46.8	68.5	53.9	130.2	26.1	56.5	35.7	48.7	48.3	31.0	85.7	48.1	104.1	34.7	52.3	62.4	60.2	40.7	23.7	70.6	41.1	32.4	21.2	78.6	77.1	29.2	45.1	31.5	70.5	38.7	52.9	47.6	65.4	21.2	45.2	29.9	47.2	40.6	84.0	32.9	28.1	62.7	41.8	38.8	35.7	19.2	30.2	59.2	41.5	27.3	37.5	74.9	46.5	38.9	63.2	47.4	54.7	81.0	31.9	34.2	54.9	4.3	3.5	7.1	4.9	3.6	6.3	5.4	5.5	5.5	2.1	5.1	5.2	4.9	28.2	3.7	3.9	4.0	4.0	2.8	31.9	30.7	32.9	33.3	28.1	30.5	31.6	35.3	34.9	34.8	119.1	66.6	108.8	81.6	111.6	93.4	119.7	66.2	52.2	73.9	41.8	64.8	98.4	34.9	106.8	32.0	100.4	53.1	46.7	102.8	118.0	87.0	86.2	75.0	80.5	109.7	76.3	118.8	122.8	99.2	31.1	89.8	89.3	57.3	151.5	71.7	76.6	115.8	60.4	114.2	42.9	82.7	97.0	78.3	276.1	166.5	125.5	132.3	92.4	98.1	114.9
LAMP1	CD107a	ENSG00000185896	"Lysosomal associated membrane protein 1"	P11279	13	113297241-113323672	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Late spermatids: 526.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004260, HPA014750"	Supported					NA	NA		460000000			"CAB004260: AB_626851, HPA014750: AB_1846219"	"unprognostic (3.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (4.15e-5)"	"unprognostic (2.06e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.54e-1)"	61.3	41.9	34.6	36.7	44.7	28.5	70.7	17.6	50.6	50.4	39.0	77.9	46.7	49.9	55.7	73.4	50.6	38.1	60.8	45.0	38.0	30.7	61.2	83.3	74.6	78.1	64.3	42.3	44.4	79.5	38.2	43.7	68.6	42.1	47.0	31.3	30.1	60.6	47.8	26.6	72.0	46.7	43.3	67.6	46.2	43.6	41.6	57.3	34.9	59.5	43.1	37.0	47.6	48.1	3.1	7.6	12.2	7.0	5.4	6.5	2.7	43.5	15.1	15.8	43.1	88.8	33.5	29.8	51.5	54.3	32.1	43.0	29.6	81.5	10.3	23.6	52.2	55.1	56.0	15.4	32.7	22.0	21.5	25.5	17.0	30.1	27.8	46.0	51.9	39.9	40.8	44.7	29.7	19.5	52.4	38.7	10.1	14.1	15.2	39.4	17.5	10.4	25.4	11.9	42.0	16.6	15.5	13.7	15.5	29.1	32.9	14.5	15.2	30.2	45.0	29.7	15.9	43.4	37.0	58.4	33.0	35.8	43.5	22.9	28.6	28.2	11.0	55.1	51.9	38.1	3.8	7.0	12.2	5.9	5.3	5.0	3.1	4.6	6.5	3.5	3.0	5.2	4.3	9.2	5.4	5.8	7.6	4.6	2.7	34.6	44.7	17.6	50.6	38.0	30.7	64.3	42.3	42.1	57.3	80.4	59.2	63.9	130.8	125.1	41.6	48.2	104.4	22.7	31.8	174.5	72.6	154.6	34.9	98.2	251.4	94.3	194.6	46.7	53.5	180.7	117.2	107.4	70.3	264.0	253.3	28.6	114.5	160.2	161.9	526.2	151.6	139.9	94.5	36.1	89.0	55.4	78.3	154.3	160.1	159.6	73.1	116.4	98.8	100.7	113.1	172.6	261.2	98.0	112.3	103.9
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120427827-120469365	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease mutation, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 336.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 112.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 112.9"	"Cell line enhanced"	"Detected in all"		"ASC diff: 112.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100, HPA029101"	Supported		Supported	"Vesicles,Plasma membrane"		NA	NA		820000000	"Vesicles, Plasma membrane"		"CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: "	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	21.8	33.6	39.9	16.1	87.9	22.6	27.1	16.2	55.5	33.0	18.3	88.7	27.9	25.1	20.8	37.5	34.6	22.4	43.3	20.9	52.5	30.3	55.0	83.7	25.3	14.3	131.0	36.9	22.7	27.4	28.8	20.2	35.4	58.6	37.3	19.7	17.2	47.8	32.9	32.4	26.9	20.5	21.1	84.3	17.9	23.6	11.9	116.9	21.2	33.7	14.3	15.4	21.1	27.0	3.7	11.6	112.9	21.7	5.4	5.8	10.5	11.7	11.6	8.6	10.9	112.3	38.3	23.6	20.3	35.4	19.7	37.0	9.6	21.0	8.3	17.9	35.2	63.0	19.7	12.4	15.3	32.2	9.3	8.8	6.5	12.9	12.9	37.4	28.7	18.2	41.5	30.9	26.3	17.4	52.1	26.9	5.9	7.5	29.7	31.9	21.6	8.0	14.7	6.6	16.8	10.2	6.2	14.5	14.8	28.9	8.7	2.9	4.5	21.7	22.1	43.3	15.8	13.1	32.1	27.8	28.4	13.8	36.5	54.7	14.9	14.2	5.4	27.1	34.7	67.9	4.9	21.7	41.3	5.0	18.7	4.0	3.1	4.8	4.7	11.6	3.7	4.3	4.1	112.9	5.4	17.3	6.3	5.8	10.5	39.9	87.9	16.2	55.5	52.5	30.3	131.0	36.9	58.6	116.9	68.5	48.0	23.8	73.6	89.6	15.0	29.0	186.0	44.2	52.4	62.8	13.7	140.2	33.2	170.8	2.3	65.2	53.1	0.0	62.0	111.7	86.5	124.2	16.3	167.8	191.1	17.5	35.2	100.7	120.2	4.2	105.3	97.6	124.9	124.4	31.2	128.8	66.8	43.5	103.3	128.2	9.3	38.8	61.8	5.6	13.2	119.1	336.5	30.5	31.0	76.1
LAPTM4B	LC27	ENSG00000104341	"Lysosomal protein transmembrane 4 beta"	Q86VI4	8	97775057-97853013	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Rod photoreceptor cells: 397.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 5.0"	"Group enriched"	"Detected in many"	4	"granulocytes: 5.0;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"HEL: 86.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020782, HPA068830"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB020782: , HPA068830: AB_2686044"	"prognostic unfavorable (5.63e-4)"	"unprognostic (1.91e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (9.25e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	12.3	19.7	12.2	6.1	14.2	1.6	14.9	5.9	27.3	19.7	14.4	21.0	4.0	26.8	24.8	11.5	13.2	24.2	25.8	75.1	10.3	13.7	33.9	12.5	14.8	9.4	15.3	8.4	25.8	28.1	16.1	9.8	9.6	21.9	14.7	11.4	56.1	29.8	16.1	50.6	14.8	41.9	17.0	16.2	20.4	14.4	32.2	9.0	2.6	18.1	27.1	8.9	17.9	13.4	1.0	0.5	5.0	0.2	0.9	3.5	0.6	34.7	30.2	24.0	48.1	12.3	8.6	17.3	16.3	7.4	31.5	27.0	15.5	23.3	0.1	70.3	12.0	11.3	37.9	35.2	15.8	36.2	0.2	52.9	86.2	25.2	21.8	9.7	0.0	16.8	12.9	10.0	22.5	11.5	10.6	4.7	10.9	62.8	0.1	12.5	22.3	8.1	4.4	46.0	15.2	19.0	0.0	12.2	0.0	74.0	17.0	25.8	43.7	18.7	8.6	21.0	28.0	22.1	10.9	1.3	8.3	16.3	14.7	10.7	3.9	11.9	0.2	9.3	0.0	20.5	5.0	0.2	0.0	1.4	0.0	3.5	1.0	1.3	1.1	0.5	0.3	2.3	2.5	0.4	0.9	0.1	0.3	0.7	0.6	12.2	14.2	5.9	27.3	10.3	13.7	15.3	8.4	21.9	9.0	95.3	44.3	3.6	46.8	49.0	192.0	174.6	91.7	6.7	19.4	101.2	210.1	23.4	33.2	202.9	6.3	36.0	24.5	0.0	110.3	32.0	43.2	49.2	12.7	30.4	6.9	127.1	34.0	98.8	3.2	7.0	22.2	7.7	40.5	4.6	24.5	101.1	68.4	34.3	29.0	46.1	397.0	58.2	31.9	7.6	39.3	38.8	11.8	7.5	49.0	77.9
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757820	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 166.6;bone marrow: 157.5;lymphoid tissue: 144.5"	"Group enriched"	"Detected in many"	5	"B-cells: 749.7;granulocytes: 621.6;Hofbauer cells: 1099.3;Kupffer cells: 831.6;Macrophages: 787.9;T-cells: 409.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 47.1;HEL: 89.3;HL-60: 56.6;HMC-1: 211.5;REH: 66.3;U-698: 76.8;U-937: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	56.0	15.5	11.5	59.1	17.8	157.5	15.0	2.2	10.4	8.2	11.2	20.7	1.8	9.5	7.5	6.8	8.3	13.7	19.9	9.2	11.2	12.7	14.0	18.2	60.8	144.5	19.0	3.3	7.7	6.3	2.0	6.8	20.1	14.6	8.2	13.2	7.4	11.7	4.7	4.0	5.5	37.1	12.9	33.8	130.9	9.5	6.7	15.8	75.2	10.1	5.2	91.2	21.4	6.4	98.2	69.1	145.1	109.3	26.0	55.4	166.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	47.1	4.9	0.1	0.1	0.1	0.0	0.0	0.0	5.2	0.0	89.3	0.0	0.1	0.0	56.6	211.5	0.0	0.1	0.0	0.3	0.0	10.8	6.1	1.1	2.9	0.7	0.0	9.7	11.9	0.0	0.0	0.0	66.3	8.7	32.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	36.0	12.5	0.0	0.2	0.0	0.2	0.2	0.0	76.8	0.2	46.2	0.1	73.5	109.3	115.3	47.7	87.9	55.4	70.2	43.7	44.6	69.1	98.2	44.2	43.1	145.1	26.0	83.9	33.2	53.7	166.6	11.5	17.8	2.2	10.1	11.2	12.7	19.0	3.3	14.6	15.8	23.8	148.6	749.7	1.1	21.2	0.0	5.6	10.2	18.7	25.0	3.5	0.0	5.6	0.0	0.4	1.5	31.3	0.7	0.0	0.6	5.1	16.6	0.8	621.6	4.2	1099.3	0.0	1.2	36.2	831.6	1.7	1.4	787.9	47.2	70.3	0.6	0.2	0.9	0.0	0.4	2.2	1.3	0.0	6.8	0.3	0.3	17.6	7.4	409.7	0.3	1.6
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346356-38377023	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"liver: 429.7"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 356.7"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"ASC diff: 12.4;HSkMC: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	NA	NA	25000000000	910000000			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.62e-12)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	12.8	0.0	0.1	4.7	0.1	0.0	0.7	0.1	0.1	0.6	0.4	0.1	0.1	0.0	0.4	0.2	0.1	0.0	0.1	0.4	0.1	0.0	3.1	429.7	0.1	0.5	0.1	0.1	0.2	0.2	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	4.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	1.4	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	12.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.7	0.0	0.0	0.0	0.0	0.1	6.6	0.3	0.6	0.0	0.0	23.3	9.1	0.1	0.0	0.0	0.0	356.7	0.3	0.0	0.0	11.1	8.6	0.0	0.6	0.0	0.0	1.0	0.0	0.0	8.2	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
LETM1	SLC55A1	ENSG00000168924	"Leucine zipper and EF-hand containing transmembrane protein 1"	O95202	4	1811479-1856247	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011029, HPA011100"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA011029: AB_1852804, HPA011100: AB_1852802"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.48e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic favorable (8.90e-4)"	"unprognostic (8.06e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.42e-1)"	16.9	15.3	11.9	11.2	13.1	9.9	16.8	17.3	19.9	6.7	23.7	10.0	7.5	20.3	8.5	6.9	22.0	8.1	15.0	18.9	10.2	10.2	16.2	20.4	9.4	10.7	10.6	10.5	9.5	19.7	13.0	8.7	7.6	10.7	8.2	16.3	9.2	9.7	7.2	17.2	18.5	19.4	8.0	7.7	10.6	15.6	12.6	9.0	50.7	10.9	19.9	16.6	8.0	9.7	5.0	14.7	3.8	5.6	6.7	7.1	2.1	12.0	20.6	6.4	19.8	9.9	6.9	11.5	12.0	5.9	12.1	9.5	19.0	13.5	20.0	8.6	12.5	18.9	12.3	16.3	16.9	7.4	13.2	17.0	20.4	16.7	13.6	12.8	20.7	16.8	11.3	12.2	13.8	12.2	5.6	10.4	12.3	26.8	12.6	8.3	13.3	29.9	23.7	16.8	13.2	23.7	17.2	9.0	11.7	9.4	16.9	16.4	14.4	13.7	17.3	7.1	5.8	16.3	10.8	15.6	13.9	8.3	11.7	19.9	11.0	16.8	15.9	12.3	18.1	11.1	3.8	4.5	2.1	7.1	5.6	7.0	5.0	6.0	6.1	4.7	4.6	4.0	5.9	0.7	6.7	5.3	14.7	4.6	2.1	11.9	13.1	17.3	19.9	10.2	10.2	10.6	10.5	10.7	9.0	14.9	7.8	27.6	25.3	35.5	17.1	18.2	7.6	1.4	9.1	26.2	31.4	14.6	26.6	22.9	25.3	14.3	78.7	23.3	27.0	18.4	16.4	20.8	10.3	24.1	19.6	14.3	15.0	16.5	15.3	31.9	18.7	15.0	18.6	10.0	27.0	11.6	31.9	43.2	15.6	38.2	26.2	12.9	19.8	34.8	40.1	44.7	12.7	20.2	29.9	41.9
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35805293-35833874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"bone marrow: 7.4;brain: 6.7;epididymis: 12.0;pancreas: 12.3"	"Cell type enriched"	"Detected in single"	16	"Cardiomyocytes: 13.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055110	Uncertain					NA	NA					"HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.5	0.5	3.9	1.2	4.1	7.4	0.5	0.4	5.8	0.4	0.4	0.2	0.0	0.9	0.9	12.0	0.3	0.3	0.7	0.3	3.5	2.8	0.4	0.4	0.3	1.5	1.2	6.7	0.6	12.3	0.0	2.2	0.6	2.0	0.6	0.3	0.2	1.1	0.1	0.6	2.3	0.8	0.1	0.6	1.0	0.5	0.8	0.0	0.0	0.8	0.0	0.4	0.3	0.4	1.0	0.3	1.0	0.8	0.5	0.9	0.0	1.5	1.9	3.6	2.2	0.6	1.7	3.2	2.5	0.9	0.4	1.1	2.1	2.2	3.6	1.9	1.3	2.3	2.0	0.6	1.4	0.9	1.8	2.9	3.8	5.6	1.9	0.1	1.7	2.6	1.4	0.7	0.7	1.0	3.1	0.5	3.4	2.0	7.2	2.0	1.2	2.3	1.8	2.4	0.9	1.5	2.0	1.6	1.0	1.2	3.3	3.3	2.2	1.6	1.9	1.1	2.5	3.0	1.3	3.6	2.4	2.1	3.3	1.0	4.1	3.4	2.8	1.1	2.4	1.5	1.0	0.3	0.2	0.9	0.6	0.5	0.5	0.5	0.3	0.0	1.0	0.6	0.8	0.9	0.5	0.8	0.3	0.4	0.0	3.9	4.1	0.4	5.8	3.5	2.8	1.2	6.7	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39342892-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"Extravillous trophoblasts: 146.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 9.4;plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 9.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 66.1;HSkMC: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA058975: AB_2683866"	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (2.30e-4)"	57.2	26.8	12.5	14.8	17.7	0.9	45.7	40.8	19.0	20.3	16.4	12.3	8.5	5.3	28.6	23.7	17.9	27.0	34.9	49.4	12.7	12.9	12.8	6.9	27.0	27.4	19.3	12.6	25.7	8.3	7.1	14.3	62.0	16.8	21.4	8.4	19.8	11.4	18.8	13.6	13.1	9.6	33.1	18.5	18.5	10.2	16.2	11.9	1.3	22.7	22.1	8.3	20.1	25.8	0.2	9.4	0.1	0.6	0.0	0.0	0.4	2.7	1.0	30.0	1.3	66.1	30.0	13.1	15.3	22.1	7.8	5.9	0.1	2.9	4.2	0.3	21.3	10.2	4.3	3.7	8.9	6.5	4.1	4.4	11.5	0.9	0.0	6.9	0.2	0.3	48.3	1.2	7.0	11.7	7.0	7.2	0.2	0.0	0.0	15.0	2.4	0.0	3.5	2.2	0.0	4.0	1.8	13.0	0.0	5.2	3.7	0.1	0.9	1.4	1.8	4.1	17.9	1.7	0.0	13.5	19.9	2.9	6.1	8.3	0.2	0.0	12.0	8.3	0.0	14.3	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	9.4	0.2	0.0	0.0	0.1	0.0	0.1	3.2	0.0	0.4	12.5	17.7	40.8	19.0	12.7	12.9	19.3	12.6	16.8	11.9	3.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	18.2	0.0	0.0	3.1	1.7	0.6	0.0	0.0	0.0	0.0	0.6	146.6	0.0	0.0	2.3	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69675802-69797111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016491, HPA019547"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA016491: , HPA019547: AB_2281256"	"unprognostic (1.44e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-2)"	21.3	44.1	34.1	14.2	32.5	5.4	29.1	32.9	34.1	23.7	20.9	38.1	20.0	23.1	18.4	32.1	20.6	25.5	23.9	19.8	35.8	32.7	53.1	38.9	24.7	21.9	37.9	22.8	29.0	36.8	58.9	23.6	25.0	32.5	19.0	21.8	26.5	22.4	24.6	17.9	18.6	30.2	17.2	57.8	19.9	19.9	11.9	30.6	17.8	41.8	13.2	18.7	22.7	19.4	24.4	9.9	37.8	18.5	7.8	14.4	11.5	6.7	3.2	7.6	10.3	22.9	24.5	11.4	5.4	19.8	4.5	9.5	5.3	14.0	9.0	15.4	14.2	7.0	10.8	8.4	8.0	8.1	17.6	10.8	8.7	6.3	7.7	14.0	5.3	11.8	17.3	17.0	5.2	7.3	21.7	8.0	7.3	15.9	13.5	14.4	4.6	3.6	5.6	3.9	12.7	3.4	4.1	18.7	25.3	31.0	11.2	4.9	8.1	6.8	9.3	9.9	6.1	9.9	19.0	12.2	6.3	4.0	5.9	5.4	8.1	7.0	3.4	7.8	8.6	11.9	25.2	10.6	19.0	8.4	13.2	8.6	24.4	11.2	9.5	9.9	21.7	12.8	9.0	37.8	7.8	18.5	9.6	14.4	11.5	34.1	32.5	32.9	34.1	35.8	32.7	37.9	22.8	32.5	30.6	59.6	34.7	34.6	36.9	25.8	68.6	35.2	45.9	52.2	50.0	55.8	104.1	65.0	16.6	37.2	15.4	36.2	60.6	23.3	43.3	52.5	48.2	25.5	39.3	51.4	37.9	52.4	18.0	36.8	63.3	3.2	32.8	46.1	30.4	39.7	38.1	48.7	36.8	42.1	31.8	49.4	81.3	25.8	22.8	17.0	15.9	33.2	64.8	31.0	27.5	33.1
LPAR2	"EDG-4, EDG4, LPA2"	ENSG00000064547	"Lysophosphatidic acid receptor 2"	Q9HBW0	19	19623668-19628930	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 43.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 32.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA019616	Approved					NA	NA					"HPA019616: AB_1847988"	"unprognostic (1.60e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.61e-7)"	"prognostic favorable (1.43e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.29e-2)"	3.4	1.2	2.2	12.6	1.9	26.1	4.6	1.3	2.4	6.5	7.9	1.4	13.8	5.1	2.4	3.9	10.5	4.4	17.9	1.9	2.2	4.0	7.0	2.4	11.0	17.7	2.4	1.1	6.1	27.3	7.4	4.0	4.2	2.7	8.2	4.3	7.4	12.3	12.3	1.6	7.2	16.4	1.1	2.8	31.4	19.2	43.7	1.1	18.5	23.2	10.0	21.1	4.9	4.1	3.8	1.1	6.7	1.0	1.7	15.9	4.1	12.8	1.4	15.3	3.4	4.0	2.0	13.2	0.8	1.2	0.6	1.1	9.2	12.4	8.3	8.6	1.2	0.8	13.6	2.3	4.6	0.6	3.5	3.9	1.9	2.6	0.7	0.5	3.1	32.0	2.1	11.6	0.6	0.9	2.1	0.3	4.1	1.8	3.3	0.5	21.0	1.8	5.1	15.2	17.4	5.9	8.2	1.2	3.7	9.4	19.0	5.4	10.2	3.4	2.8	2.0	8.8	7.2	19.6	3.8	3.0	2.5	5.3	1.2	1.5	4.3	2.8	0.6	22.4	1.4	0.1	0.6	2.2	6.1	0.7	11.2	3.8	14.0	8.0	0.4	2.0	12.8	9.2	6.7	1.7	1.0	1.1	15.9	4.1	2.2	1.9	1.3	2.4	2.2	4.0	2.4	1.1	2.7	1.1	3.0	11.1	4.2	8.9	5.6	0.4	1.2	7.6	4.0	5.7	7.0	2.0	0.7	3.3	12.1	0.3	0.7	9.3	0.0	17.2	5.0	1.3	10.5	3.5	0.4	2.3	1.6	2.4	1.8	5.4	1.3	0.6	4.7	0.0	6.4	10.0	5.8	13.8	6.8	0.4	0.6	1.3	0.0	0.9	1.1	3.7	4.4	0.1	13.8	7.8	9.5
LPAR4	"GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9"	ENSG00000147145	"Lysophosphatidic acid receptor 4"	Q99677	X	78747709-78757094	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 15.8;ovary: 10.0"	"Cell type enriched"	"Detected in some"	7	"Leydig cells: 18.7"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	12	"basophil: 7.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.4"	"Cell line enhanced"	"Detected in some"		"AF22: 10.3;NTERA-2: 16.7;RH-30: 7.0;SuSa: 4.0;U-937: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA046563, HPA054951, HPA055571"	Uncertain		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853"	"unprognostic (1.62e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.81e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.86e-4)"	"unprognostic (2.99e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.03e-3)"	1.5	0.2	6.0	1.0	2.1	0.6	2.0	4.9	3.7	1.8	0.9	7.4	0.7	0.2	2.9	0.8	1.8	1.1	2.1	1.9	15.8	1.4	0.3	0.3	0.3	0.2	2.4	4.0	10.0	0.7	0.1	0.7	0.2	3.6	0.6	1.2	0.5	1.0	1.6	0.2	1.6	0.9	1.3	3.8	0.4	1.5	0.8	5.6	0.0	0.6	0.8	1.2	1.4	0.9	0.0	0.5	7.4	0.0	0.0	0.0	0.1	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.6	1.1	1.4	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.7	0.0	1.3	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.1	2.3	0.0	0.5	1.8	16.7	0.0	0.2	0.9	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	2.7	0.0	0.0	0.2	0.0	0.7	1.4	0.0	0.7	0.7	4.0	1.6	7.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	6.0	2.1	4.9	3.5	15.8	1.4	2.4	4.0	3.6	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.7	0.0	1.7	1.0	0.0	0.5	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.1
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362685	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 61.7;parathyroid gland: 61.4"	"Cell type enhanced"	"Detected in many"	23	"Cone photoreceptor cells: 82.5;Cytotrophoblasts: 52.4;Proximal tubular cells: 250.3"	"Group enriched"	"Detected in many"	6	"breast cancer: 8.1;renal cancer: 29.9;thyroid cancer: 7.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"AF22: 21.9;CACO-2: 36.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria		No	NA			"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.7	0.4	2.7	0.4	12.9	0.5	7.4	0.7	5.7	0.6	0.4	18.5	0.0	0.4	0.5	4.8	0.4	0.4	0.6	0.5	6.2	3.4	61.7	0.6	1.8	0.4	20.7	1.9	0.4	0.4	61.4	0.4	10.5	8.5	0.5	0.4	7.9	1.1	0.5	0.5	0.5	0.4	0.4	17.2	0.4	0.5	0.6	17.0	0.0	18.2	0.0	0.4	0.4	0.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	2.7	12.9	0.7	5.7	6.2	3.4	20.7	1.9	8.5	17.0	6.0	39.5	0.0	0.1	0.2	1.9	1.7	2.5	4.0	4.5	3.5	82.5	52.4	14.9	0.0	1.4	0.0	0.0	0.0	0.0	1.9	0.8	0.0	2.3	0.0	4.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	31.9	0.0	0.0	0.0	250.3	18.0	0.0	0.0	0.0	0.5	0.0	19.3	0.0	0.0	0.1
LRRC55	FLJ45686	ENSG00000183908	"Leucine rich repeat containing 55"	Q6ZSA7	11	57181747-57191717	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 9.2;lymphoid tissue: 24.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"glioma: 9.0;ovarian cancer: 2.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"	"Cell line enriched"	"Detected in some"	4	"AF22: 21.0"	"Low region specificity"	"Detected in many"							HPA014053	Uncertain					NA	NA					"HPA014053: AB_2137630"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.17e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.79e-2)"	0.8	1.0	2.2	3.4	2.3	0.0	0.1	0.8	9.2	0.1	0.9	0.4	0.1	0.6	3.1	0.1	1.2	0.7	0.6	0.5	2.7	7.3	0.6	2.5	1.5	24.4	6.9	0.5	0.6	0.4	0.0	0.1	2.9	1.7	0.1	1.0	0.1	3.4	0.1	0.6	0.1	0.9	2.2	7.3	2.6	0.1	0.2	0.1	2.2	0.2	2.1	1.0	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.2	2.3	0.8	3.7	2.7	7.3	6.9	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC8A	"FLJ10337, KIAA1437, LRRC8, SWELL1"	ENSG00000136802	"Leucine rich repeat containing 8 VRAC subunit A"	Q8IWT6	9	128882112-128918039	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Basal glandular cells: 147.0;Glandular cells: 170.8;Urothelial cells: 292.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 50.6"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (3.53e-1)"	"prognostic favorable (5.27e-5)"	"unprognostic (3.69e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.02e-2)"	25.8	10.6	24.3	14.2	26.8	13.4	17.8	28.5	50.4	13.8	14.0	18.5	10.9	9.0	18.8	7.4	37.9	12.4	21.1	14.5	22.6	21.0	11.6	16.4	20.3	7.7	27.2	19.5	11.4	19.0	21.3	7.4	21.8	21.1	18.4	8.2	12.1	16.2	24.8	8.0	16.0	9.5	25.8	13.0	10.5	16.7	9.2	22.6	8.4	13.5	12.0	14.3	20.9	18.7	2.5	2.8	3.2	1.9	6.1	7.4	1.7	10.5	16.6	10.1	8.6	23.7	9.2	12.7	12.2	8.1	7.6	5.4	7.3	22.7	3.8	13.8	13.2	9.5	50.6	6.2	27.0	3.6	3.9	5.0	3.4	10.7	8.8	16.1	4.1	6.4	7.1	19.2	13.4	16.1	15.4	26.2	5.4	7.6	3.9	9.9	9.1	4.6	3.9	30.0	17.7	18.1	6.4	11.6	6.2	11.9	5.3	6.0	12.6	13.6	8.5	4.8	7.9	6.2	3.1	45.8	22.3	9.6	9.4	17.7	4.5	10.6	4.7	12.3	3.1	12.8	1.2	1.4	3.2	7.4	1.9	3.4	2.5	3.7	4.7	1.8	2.0	3.7	3.6	2.6	6.1	0.5	2.8	6.1	1.7	24.3	26.8	28.5	32.6	22.6	21.0	27.2	19.5	21.1	22.6	14.9	14.1	6.0	147.0	93.9	11.9	28.4	15.3	9.4	34.2	7.0	5.9	10.4	0.0	22.5	5.2	46.3	20.4	46.7	18.3	15.3	18.4	170.8	5.8	12.4	5.3	23.8	15.4	51.0	7.6	2.2	21.3	7.4	25.3	2.8	15.4	42.9	51.7	13.9	41.8	7.3	9.7	64.7	30.8	3.3	5.1	126.8	17.4	10.9	8.8	292.5
LRRC8B	"KIAA0231, TA-LRRP"	ENSG00000197147	"Leucine rich repeat containing 8 VRAC subunit B"	Q6P9F7	1	89524836-89597864	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8"	"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 81.5;Late spermatids: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HAP1: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017950	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA017950: AB_1853346"	"unprognostic (2.50e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.15e-4)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	8.1	18.0	13.0	4.4	19.3	3.0	6.6	2.5	27.8	3.8	5.6	15.4	0.5	7.4	2.6	6.9	5.0	4.3	6.2	3.3	15.3	6.5	4.9	4.8	5.8	4.9	8.8	17.1	2.6	8.5	12.4	5.1	2.4	8.3	5.6	6.8	4.4	5.0	1.6	5.9	6.9	4.9	3.6	16.2	4.3	6.4	17.4	8.2	3.1	6.1	2.7	5.9	3.3	3.3	3.0	2.4	1.5	2.2	0.9	3.7	1.6	8.5	3.3	2.4	8.4	12.2	7.3	9.7	0.2	2.5	1.1	1.6	5.2	5.2	0.7	3.5	1.2	3.3	4.5	22.3	1.9	1.4	4.1	4.5	16.6	2.2	4.5	1.2	7.9	11.8	4.0	7.1	0.9	3.7	0.4	11.9	6.7	18.5	5.7	1.3	4.6	3.9	3.8	13.8	3.5	4.8	8.8	1.1	3.0	2.7	10.7	7.0	11.2	4.7	11.4	8.1	3.0	6.9	3.8	3.9	1.0	5.7	2.6	2.7	4.2	3.4	4.2	1.4	2.0	2.0	1.4	2.2	1.5	1.1	1.1	1.7	3.0	2.1	1.7	2.4	2.3	3.7	2.9	0.7	0.9	1.2	2.1	3.4	1.6	13.0	19.3	2.5	27.5	15.3	6.5	8.8	17.1	8.3	8.2	14.9	11.5	5.6	11.4	29.3	34.9	3.4	12.7	20.1	14.8	7.0	45.2	2.6	1.7	12.0	81.5	8.4	5.1	0.0	16.2	9.6	1.5	17.3	2.3	6.7	6.1	0.0	25.8	19.6	13.2	55.3	2.3	7.7	1.7	3.6	13.0	5.5	12.8	3.5	2.5	4.5	21.5	6.5	14.7	6.9	4.1	24.1	2.1	2.5	11.0	8.9
LRRC8C	AD158	ENSG00000171488	"Leucine rich repeat containing 8 VRAC subunit C"	Q8TDW0	1	89633072-89769903	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 40.3;Endothelial cells: 39.4;Suprabasal keratinocytes: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 9.1;monocytes: 6.1;T-cells: 11.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029347	Uncertain		Approved	"Golgi apparatus"		No	No			"Golgi apparatus"		"HPA029347: AB_10601544"	"unprognostic (2.61e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.76e-3)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (2.78e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.38e-2)"	19.8	12.6	8.3	11.7	11.4	9.2	27.8	2.0	11.0	6.6	4.8	12.9	1.4	4.5	11.9	7.3	4.4	6.0	9.2	8.2	7.8	7.4	4.5	4.8	10.4	14.8	13.0	7.6	7.8	3.0	5.8	6.9	9.0	9.0	4.5	5.5	6.4	5.0	3.2	5.9	8.3	7.7	21.3	10.8	12.1	4.5	6.4	10.2	3.4	7.6	6.1	10.3	7.5	7.5	0.8	9.1	0.9	6.1	1.9	11.3	3.3	0.1	2.0	1.7	1.5	5.1	5.8	0.8	10.6	11.9	4.8	4.5	0.0	0.7	3.2	3.0	4.6	8.3	7.2	5.5	15.8	11.8	7.9	3.3	3.1	1.7	0.1	4.2	14.1	1.0	2.5	3.2	10.5	5.6	3.2	19.5	5.1	2.0	4.4	4.1	0.3	2.0	13.9	1.8	0.0	4.3	14.1	0.8	1.1	1.0	1.7	1.3	6.0	3.9	0.3	8.8	2.7	0.1	22.2	16.3	8.6	4.1	2.9	8.0	1.6	1.3	1.7	2.7	10.6	1.4	0.4	6.1	0.0	4.2	5.5	3.7	0.8	6.7	5.5	9.1	0.5	5.4	5.0	0.9	1.9	6.1	0.7	11.3	3.3	8.3	11.4	2.0	11.0	7.8	7.4	13.0	7.6	9.0	10.2	3.0	5.1	4.7	3.0	40.3	2.5	5.2	5.1	4.0	3.4	0.0	0.0	0.1	0.0	1.5	29.1	39.4	0.0	0.0	2.2	0.4	4.0	0.9	0.0	0.0	12.1	1.6	1.2	31.3	28.6	17.3	0.0	24.5	25.3	16.2	0.2	0.4	7.7	1.9	0.7	0.6	1.3	0.0	16.5	1.4	1.7	39.3	0.2	17.5	0.2	1.7
LRRC8D	"FLJ10470, LRRC5"	ENSG00000171492	"Leucine rich repeat containing 8 VRAC subunit D"	Q7L1W4	1	89821014-89936611	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 46.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	No						"unprognostic (2.92e-3)"	"unprognostic (9.50e-2)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (4.98e-2)"	"unprognostic (7.03e-2)"	"unprognostic (7.71e-3)"	"unprognostic (7.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.91e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.61e-2)"	4.4	26.3	15.7	11.0	24.0	9.6	9.7	8.8	21.3	9.7	13.1	46.2	4.3	14.1	7.7	8.1	6.7	5.9	6.0	5.5	24.5	16.9	19.8	17.6	7.1	17.0	34.7	20.3	4.6	9.6	6.8	16.2	7.5	24.5	4.3	14.0	7.5	17.8	4.6	7.8	5.0	13.6	8.6	38.5	16.8	8.3	7.5	31.6	11.8	12.1	4.3	14.8	8.9	3.4	5.8	7.8	3.0	8.8	10.5	14.3	8.4	24.7	16.2	6.6	15.6	11.9	10.1	22.5	17.0	25.7	9.7	12.2	6.9	6.3	19.6	19.4	28.2	11.0	32.7	15.2	20.4	12.3	15.3	8.4	23.0	14.7	14.6	23.3	26.2	7.3	6.3	17.0	8.2	18.0	13.4	16.4	11.4	12.5	6.2	10.5	7.4	10.8	17.0	11.5	5.6	14.9	14.7	9.6	14.0	24.4	8.8	12.4	8.7	21.1	21.9	47.0	12.0	5.2	26.1	7.2	10.4	3.5	21.1	12.8	7.6	12.9	11.8	4.0	33.1	9.1	0.0	7.1	1.2	6.2	8.8	10.3	5.8	14.3	7.4	6.8	5.3	13.8	10.2	3.0	10.5	6.6	7.8	13.8	8.4	15.7	24.0	8.8	21.3	24.5	16.9	34.7	20.3	24.5	31.6	3.0	1.7	6.5	1.5	5.4	6.1	2.1	10.2	6.7	4.5	12.2	2.0	3.5	6.6	5.0	0.6	5.8	17.1	23.3	7.4	7.9	1.8	2.0	5.7	26.3	10.8	3.2	7.5	9.2	20.6	0.0	1.1	16.3	10.1	20.8	11.2	6.5	5.7	10.5	3.5	9.7	7.1	6.5	1.4	0.1	0.6	1.0	1.5	8.7	9.8	1.4
LRRC8E	FLJ23420	ENSG00000171017	"Leucine rich repeat containing 8 VRAC subunit E"	Q6NSJ5	19	7888505-7902021	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Basal keratinocytes: 8.5;Ciliated cells: 8.1;Club cells: 6.8;Suprabasal keratinocytes: 9.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 22.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA020466	Uncertain					NA	NA					"HPA020466: AB_1853352"	"unprognostic (3.79e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (7.64e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.98e-6)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.07e-1)"	2.2	7.6	0.6	0.9	0.6	1.5	4.4	0.3	0.5	4.3	1.1	0.3	15.3	0.4	2.2	6.3	8.3	1.7	3.8	0.9	0.3	0.3	3.1	10.4	5.1	0.3	0.6	0.3	1.0	7.7	2.4	1.3	14.2	0.5	4.1	0.7	1.7	19.6	7.4	2.9	13.4	1.0	0.9	0.6	0.3	3.3	1.3	0.3	0.3	4.2	7.4	7.8	3.3	5.6	3.0	1.6	5.0	1.4	3.2	2.1	0.4	13.9	3.6	0.1	0.4	0.7	3.6	2.2	6.1	5.3	9.9	7.7	4.9	3.2	0.5	4.7	5.9	14.1	11.1	4.7	6.0	9.4	0.2	5.5	0.2	1.7	4.8	2.6	0.3	0.4	5.8	8.6	6.5	4.9	13.3	1.2	2.5	3.9	0.5	1.1	7.1	0.1	0.4	1.1	2.6	13.3	0.8	0.1	0.4	7.5	12.9	0.4	0.2	4.7	6.5	0.2	1.1	7.9	0.3	1.9	3.1	5.6	8.3	3.6	0.9	1.8	0.3	22.8	0.4	1.0	3.9	1.4	1.4	1.6	1.2	2.0	1.9	1.3	1.2	0.5	3.0	1.6	2.1	5.0	3.2	1.3	1.6	1.2	0.4	0.6	0.6	0.3	0.5	0.3	0.3	0.6	0.3	0.5	0.3	3.0	5.6	0.0	4.4	8.5	0.0	0.1	0.0	8.1	6.8	1.8	0.0	0.6	0.0	5.9	0.0	0.1	0.0	0.0	5.2	0.8	0.7	5.0	1.1	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.1	0.0	5.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	9.8	1.6	0.0	1.1	5.2
LTB4R	"BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7"	ENSG00000213903	"Leukotriene B4 receptor"	Q15722	14	24311450-24318036	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 36.8;skin 1: 47.0"	"Cell type enhanced"	"Detected in many"	8	"Basal keratinocytes: 21.3;Kupffer cells: 41.4;Macrophages: 20.5;Suprabasal keratinocytes: 41.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"classical monocyte: 13.8;eosinophil: 13.9;neutrophil: 36.8"	"Group enriched"	"Detected in many"	6	"granulocytes: 36.8;monocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"HaCaT: 17.6;Karpas-707: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003873	Approved					NA	NA					"HPA003873: AB_1078288"	"unprognostic (4.07e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (2.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.45e-2)"	7.8	2.7	0.4	3.5	1.7	9.8	2.9	1.7	2.2	8.4	2.8	0.9	0.4	3.0	2.4	4.0	27.0	2.5	2.6	6.5	1.0	0.2	3.1	10.8	9.2	27.7	1.4	0.4	3.6	3.5	0.6	2.5	2.3	1.2	3.9	1.3	2.9	5.9	2.0	2.6	47.0	2.6	1.3	2.1	23.9	1.6	1.7	1.0	2.4	2.3	14.3	7.2	2.5	11.6	0.1	4.0	36.8	13.8	0.7	1.2	4.3	2.1	4.9	1.7	1.4	1.1	1.1	7.4	1.0	0.7	1.1	1.3	3.6	2.6	3.6	1.6	0.9	1.9	17.6	1.5	2.8	1.5	9.4	5.5	3.8	5.9	2.3	0.6	5.1	5.0	0.6	5.0	2.2	2.6	1.5	2.0	6.0	3.0	14.9	0.5	4.8	2.1	8.7	1.3	0.2	3.8	7.7	1.6	6.1	0.6	3.5	3.9	1.4	5.2	2.5	2.3	3.2	4.1	5.2	1.1	3.6	3.6	3.7	1.3	8.4	1.9	5.8	0.7	13.6	2.4	4.9	13.8	13.9	1.2	1.7	0.9	0.0	0.9	1.0	4.0	0.1	0.4	0.3	36.8	0.7	0.3	0.4	0.2	4.3	0.4	1.7	1.7	2.2	1.0	0.2	1.4	0.4	1.2	1.0	0.0	1.1	0.9	8.4	21.3	3.0	1.2	5.1	2.7	3.4	0.0	5.9	0.7	0.0	2.1	0.2	3.6	2.6	0.0	5.5	0.6	2.6	2.1	1.1	3.6	12.9	0.0	0.0	8.0	41.4	0.4	3.1	20.5	3.3	0.0	2.3	0.6	3.6	2.9	1.4	0.5	11.0	6.5	1.7	1.2	1.3	41.0	0.7	10.1	2.6	2.4
LYPD6B	"CT116, LYPD7"	ENSG00000150556	"LY6/PLAUR domain containing 6B"	Q8NI32	2	149038107-149215262	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 38.9"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 202.8;Late spermatids: 80.2;Suprabasal keratinocytes: 60.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"basophil: 14.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.0"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 26.0;LHCN-M2: 41.7;NB-4: 13.6;RT4: 22.0;SK-BR-3: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA049239	Uncertain				"Intracellular and membrane"	NA	NA					"HPA049239: AB_2680688"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.59e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-3)"	0.2	0.2	1.4	0.1	1.5	0.0	8.9	0.7	2.4	1.4	2.3	0.6	21.8	1.1	1.1	0.5	2.1	12.2	27.3	0.1	5.0	2.4	4.0	0.4	2.7	2.4	0.7	0.6	1.7	13.2	9.8	0.6	0.6	0.9	5.0	1.5	2.5	11.9	26.6	0.1	38.9	2.9	1.8	0.6	1.3	20.3	16.9	0.7	0.2	0.2	0.6	2.3	9.1	3.7	2.8	0.0	14.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.6	0.0	0.0	0.0	3.2	0.6	2.7	1.0	0.3	0.0	0.0	0.0	26.0	0.0	5.6	0.6	0.6	8.6	0.0	3.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	9.4	0.0	13.6	0.8	5.8	0.1	0.0	0.1	1.7	1.3	22.0	1.5	0.0	0.1	13.2	0.0	2.7	1.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	14.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	1.5	0.7	2.4	5.0	2.4	0.7	0.6	0.9	0.7	0.0	1.3	2.0	20.2	26.6	0.0	1.1	50.9	22.7	6.8	43.6	0.0	0.0	6.6	10.6	202.8	0.8	3.6	0.0	16.3	0.5	0.8	26.4	0.0	0.0	0.1	0.0	2.4	0.0	0.0	80.2	2.0	1.1	5.0	1.0	3.1	0.0	23.2	6.5	0.0	0.0	0.0	0.0	0.9	1.5	1.5	60.3	0.2	0.0	2.5	35.1
M6PR	"CD-M6PR, CD-MPR"	ENSG00000003056	"Mannose-6-phosphate receptor, cation dependent"	P20645	12	8940363-8949955	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Hofbauer cells: 214.9;monocytes: 227.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 127.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034464, HPA040445"	Approved					NA	NA		280000			"CAB034464: AB_2139108, HPA040445: AB_2676989"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.44e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.98e-1)"	37.9	40.5	24.7	40.7	27.6	34.8	32.3	21.8	39.6	25.6	28.3	26.3	27.9	20.8	37.4	26.2	30.0	29.2	28.0	36.5	23.3	22.8	37.2	50.6	42.8	46.8	27.4	23.0	30.1	40.0	31.3	24.8	34.0	24.2	27.8	35.2	26.1	37.0	29.4	32.3	27.7	36.9	31.7	26.5	56.1	31.6	33.9	25.2	43.1	46.9	24.4	44.8	34.3	27.2	17.6	47.4	75.4	74.6	22.1	30.4	57.5	14.7	23.0	15.4	17.3	27.2	13.1	46.4	19.4	22.6	26.7	29.4	24.5	36.0	25.8	7.1	20.4	58.1	22.3	21.8	19.4	30.9	127.9	12.0	45.0	19.3	18.3	32.3	48.9	85.5	19.7	23.0	28.6	36.3	26.5	14.5	18.9	12.7	17.1	23.1	14.4	17.5	16.3	53.7	26.7	9.8	16.9	33.9	14.2	20.6	37.4	3.5	15.8	21.4	20.4	25.6	57.2	5.1	31.3	14.6	22.1	26.4	26.6	28.5	21.6	37.7	29.4	25.6	29.8	16.2	75.4	40.3	42.9	26.9	64.5	29.7	17.6	30.4	28.0	47.4	14.5	22.5	25.4	5.9	22.1	74.6	28.2	23.9	57.5	24.7	27.6	21.8	39.6	23.3	22.8	27.4	23.0	24.2	25.2	53.6	53.6	73.6	61.1	39.2	43.5	8.7	17.8	60.2	69.4	29.6	21.6	56.3	16.6	78.0	6.0	32.2	18.8	23.3	58.0	58.9	32.0	49.1	127.2	22.7	214.9	52.4	36.8	31.9	110.8	5.2	32.5	120.2	64.1	227.2	29.6	31.8	48.3	24.6	30.1	33.8	31.4	25.8	44.8	102.2	45.3	35.4	44.4	78.7	41.7	55.7
MACO1	"FLJ10747, TMEM57"	ENSG00000204178	"Macoilin 1"	Q8N5G2	1	25430858-25500209	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ciliated cells: 25.4;Ductal cells: 30.7;Exocrine glandular cells: 53.7;Pancreatic endocrine cells: 38.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019680			Approved	Cytosol		NA	NA			Cytosol		"HPA019680: AB_1858125"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (7.13e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.35e-3)"	9.8	16.5	12.1	6.9	11.3	26.5	8.9	27.8	13.2	9.2	8.9	11.3	12.7	9.5	9.7	11.9	17.2	7.9	8.8	8.8	8.7	9.4	11.9	33.0	9.4	7.8	12.9	11.5	17.2	28.1	11.4	12.8	8.1	11.3	12.9	9.2	10.4	20.7	13.5	31.2	10.7	9.7	8.5	10.1	9.6	11.5	15.6	13.8	17.9	13.2	12.5	11.1	10.5	10.2	2.6	4.0	6.8	2.5	1.5	3.0	0.7	10.2	3.4	10.5	18.9	12.7	9.7	5.6	11.0	11.5	9.9	10.9	3.1	13.7	20.7	12.8	12.1	6.3	10.6	8.9	10.4	10.4	10.7	8.7	25.7	5.8	8.5	9.0	9.1	18.9	9.6	12.8	14.5	9.7	8.9	11.2	12.7	16.9	7.5	9.7	6.2	22.0	11.8	12.4	9.4	5.6	13.5	11.1	16.3	10.9	5.2	17.8	19.3	8.3	21.1	13.2	9.3	7.7	11.2	13.1	11.8	7.6	14.7	7.1	13.4	8.7	12.0	12.9	12.6	9.2	6.8	1.1	6.2	2.1	0.9	3.0	1.6	2.4	2.7	1.4	2.6	2.5	3.0	0.5	1.5	2.5	4.0	1.4	0.7	12.1	11.3	27.8	13.2	8.7	9.4	12.9	11.5	11.3	13.8	17.9	20.5	0.0	0.0	0.0	0.0	0.0	0.0	25.4	20.5	7.0	0.0	11.1	5.0	30.7	0.0	0.0	0.0	0.0	53.7	16.7	0.0	0.0	9.3	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	12.6	0.0	0.0	38.1	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0
MAGI2	"ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2"	ENSG00000187391	"Membrane associated guanylate kinase, WW and PDZ domain containing 2"	Q86UL8	7	78017057-79453574	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.7;parathyroid gland: 31.8"	"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 30.1;Horizontal cells: 44.5;Muller glia cells: 24.9"	"Cancer enhanced"	"Detected in many"		"glioma: 7.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"Karpas-707: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013650	Approved					NA	NA					"HPA013650: AB_1853501"	"unprognostic (4.32e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (4.34e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	5.4	8.3	21.0	2.2	20.5	1.8	3.9	43.7	36.8	5.5	3.2	17.7	2.5	3.1	5.6	5.6	3.6	4.8	4.6	3.9	21.8	12.7	7.6	2.5	4.4	1.6	13.6	19.5	11.5	5.1	31.8	7.7	2.3	16.5	11.9	3.0	3.5	2.8	11.6	2.9	2.3	3.2	4.1	15.1	3.1	2.9	5.1	24.4	0.0	9.0	0.0	1.4	4.1	2.9	2.0	1.4	3.8	0.9	1.0	0.9	0.2	0.0	0.3	10.3	0.2	2.1	3.4	0.1	1.8	3.4	0.4	0.5	0.0	0.1	0.0	0.0	1.1	1.4	0.1	0.6	0.0	0.5	0.5	0.4	0.1	0.2	0.6	3.2	0.2	0.5	2.5	0.1	0.2	0.1	1.9	0.4	0.3	0.3	43.1	0.9	0.4	0.1	0.2	2.3	0.3	0.1	0.1	0.1	0.7	0.1	0.1	1.6	2.6	0.4	0.1	1.0	1.6	0.2	0.3	0.6	1.5	0.5	4.2	0.2	0.2	0.0	0.1	0.9	0.1	0.6	2.7	0.7	0.8	0.9	0.6	0.6	1.1	0.6	0.5	0.4	2.0	0.6	0.8	3.8	1.0	0.9	1.4	0.6	0.2	21.0	20.5	43.7	34.5	21.8	12.7	13.6	19.5	16.5	24.4	8.9	8.4	0.0	1.1	0.9	30.1	5.2	5.1	2.7	5.7	1.8	19.6	0.3	5.0	0.4	21.7	2.0	0.9	0.0	0.8	0.1	4.4	3.0	0.0	1.6	0.2	44.5	2.4	3.1	0.0	22.8	6.1	0.1	1.7	0.0	1.1	24.9	0.3	1.1	18.7	1.4	21.2	12.9	4.7	2.4	1.2	0.9	0.3	0.0	1.2	0.7
MAGOH	"MAGOH1, MAGOHA"	ENSG00000162385	"Mago homolog, exon junction complex core component"	P61326	1	53226892-53238610	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB015425, HPA043036, HPA047754"	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB015425: AB_629914, HPA043036: AB_2678279, HPA047754: AB_2680148"	"prognostic favorable (1.85e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (2.01e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.75e-3)"	31.5	31.3	25.7	32.9	28.9	70.7	33.8	23.0	36.8	26.9	33.9	17.4	33.5	30.2	37.5	33.7	37.5	31.4	25.6	27.6	30.3	25.6	35.9	42.5	33.2	43.2	23.5	28.8	36.7	35.6	18.9	46.6	43.4	31.4	24.6	31.9	22.8	31.2	31.1	40.9	30.7	35.7	35.3	32.6	36.9	28.5	28.1	24.3	50.3	37.4	37.2	46.0	28.0	30.0	29.8	35.2	31.3	30.9	29.8	33.0	18.2	33.1	16.0	28.2	24.5	14.6	9.4	32.6	24.9	14.6	32.9	33.4	36.5	15.9	47.4	29.1	14.5	41.7	20.5	36.8	21.8	39.3	31.4	40.9	43.2	20.9	39.4	23.4	74.9	24.2	10.1	15.7	29.9	24.6	12.9	21.7	43.8	43.3	10.9	17.8	25.8	61.4	52.0	52.1	27.3	35.2	42.0	53.9	25.1	17.5	33.2	24.2	19.6	33.3	27.1	39.0	35.3	14.0	53.9	19.9	20.5	28.1	28.9	56.9	16.0	28.6	74.0	18.6	47.7	20.9	17.0	21.6	31.3	32.3	30.9	31.1	29.8	31.2	33.0	30.5	29.0	28.8	29.5	26.0	29.8	28.1	35.2	32.3	18.2	25.7	28.9	23.0	36.8	30.3	25.6	23.5	28.8	31.4	24.3	47.6	37.5	73.4	102.0	128.2	31.7	45.8	56.0	76.3	62.6	54.1	13.7	170.1	150.9	70.5	11.4	70.8	46.6	0.0	74.0	157.5	82.2	60.3	80.9	46.1	101.6	22.3	52.2	54.6	49.1	8.4	69.9	77.4	77.6	102.8	70.6	51.5	72.6	70.2	64.0	112.9	28.8	58.2	90.6	80.9	69.2	105.6	202.3	78.8	80.9	86.6
MAGT1	"DKFZp564K142, IAP, MRX95, OST3B"	ENSG00000102158	"Magnesium transporter 1"	Q9H0U3	X	77826364-77895593	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049851	Approved				"Intracellular and membrane"	NA	NA		14000			"HPA049851: AB_2680913"	"prognostic unfavorable (1.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.66e-1)"	17.3	17.1	11.3	11.7	15.4	9.2	18.3	4.7	10.1	21.4	15.5	25.9	17.5	12.7	17.5	28.1	18.4	14.2	13.1	22.3	11.5	9.5	29.0	69.5	20.4	20.3	19.3	8.2	19.8	49.8	20.0	21.3	28.6	14.0	17.3	13.8	13.6	28.9	17.6	13.7	14.1	22.4	13.4	22.6	21.0	14.5	11.1	18.2	19.8	45.3	11.0	17.6	18.2	15.4	14.3	23.6	13.2	21.3	18.5	20.8	17.3	23.1	13.6	16.4	18.4	28.1	19.5	25.2	25.1	25.0	19.7	21.6	17.0	38.5	16.6	34.5	27.1	20.7	21.7	34.3	18.4	31.2	12.3	20.8	11.2	20.3	15.1	25.0	23.2	12.5	17.0	15.9	26.1	21.8	20.3	27.9	11.8	13.4	48.7	23.4	14.8	13.6	8.3	21.1	22.8	15.3	16.7	27.3	31.1	22.7	17.1	5.4	9.9	34.5	23.6	20.7	16.9	16.9	12.5	28.4	18.0	20.5	27.8	12.5	17.1	38.0	21.7	19.8	21.7	23.3	12.8	14.2	13.2	20.6	21.1	20.8	14.3	17.9	18.9	12.4	12.3	17.8	20.7	11.9	18.5	21.3	23.6	13.0	17.3	11.3	15.4	4.7	10.1	11.5	9.5	19.3	8.2	14.0	18.2	38.7	53.0	20.1	43.3	29.3	5.4	40.3	58.6	13.4	38.7	38.4	3.9	29.0	3.3	29.8	1.6	35.9	32.9	46.7	30.6	45.3	37.3	74.8	29.0	127.0	37.8	1.6	21.8	43.6	35.8	1.1	28.4	35.6	32.1	21.6	34.3	15.8	34.2	30.0	25.5	25.2	4.6	19.4	26.7	3.2	16.9	39.9	68.0	29.9	24.1	56.7
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 18.4;CAPAN-2: 15.9;HaCaT: 12.3;hTCEpi: 10.3;RT4: 14.2;SCLC-21H: 16.7;T-47d: 12.4"	"Region enriched"	"Detected in single"	8	"cerebellum: 8.8"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA018119: AB_2669771, HPA061726: AB_2684595"	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.6	0.7	1.1	2.3	1.4	0.2	4.5	0.7	1.3	2.6	13.2	1.6	9.5	9.4	1.6	6.4	9.1	4.4	9.2	0.9	1.4	1.2	12.2	24.2	11.2	0.4	1.7	0.8	1.0	18.9	3.9	8.0	9.9	2.1	5.0	7.3	5.2	10.9	7.4	0.4	5.4	21.8	1.4	1.3	0.6	8.9	2.7	0.7	1.1	25.7	6.4	7.3	4.7	4.1	1.4	0.4	1.5	0.8	1.1	2.3	1.0	6.6	2.5	0.0	0.0	0.0	0.0	18.4	0.1	0.0	0.1	0.4	8.6	15.9	0.0	1.8	1.1	0.0	12.3	0.0	9.2	0.3	0.1	3.5	0.0	0.8	4.6	1.1	0.0	0.0	0.3	10.3	0.1	1.4	0.4	0.7	0.1	0.0	0.1	0.0	6.6	0.0	0.0	1.3	3.9	0.2	0.0	0.0	0.4	6.9	14.2	16.7	0.0	1.7	1.7	0.2	3.2	12.4	0.0	1.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.1	0.0	1.5	0.8	0.2	0.4	0.2	1.1	1.2	2.3	0.2	0.3	1.4	0.7	0.5	0.9	1.1	0.1	0.4	0.1	1.0	1.1	1.4	0.7	1.3	1.4	1.2	1.7	0.8	2.1	0.7	20.8	21.6	0.8	16.8	4.4	0.1	2.5	25.5	30.8	20.5	15.7	2.0	19.2	14.9	19.8	4.6	3.1	25.7	0.0	22.9	7.1	0.8	23.1	1.1	33.9	1.6	0.0	16.1	3.7	0.6	1.6	0.0	0.8	1.7	13.6	23.4	0.8	23.3	31.9	0.0	5.3	0.2	0.0	1.0	3.8	1.9	5.6	10.1	0.0	24.5	33.8
MARVELD3	MRVLDC3	ENSG00000140832	"MARVEL domain containing 3"	Q96A59	16	71626161-71642114	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.9;pancreas: 34.5"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 154.2;Paneth cells: 84.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 11.7;BEWO: 17.6;CACO-2: 13.0;CAPAN-2: 12.6;HaCaT: 11.9;MCF7: 22.2;RT4: 10.4;SK-BR-3: 10.5;T-47d: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043514, HPA045471"			Approved	"Vesicles,Intermediate filaments"		No	NA			Vesicles	"Intermediate filaments"	"HPA043514: AB_10959475, HPA045471: "	"unprognostic (1.18e-1)"	"unprognostic (3.92e-1)"	"unprognostic (9.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.16e-2)"	"prognostic favorable (6.80e-10)"	"unprognostic (2.63e-3)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.43e-1)"	0.4	0.3	0.4	12.5	0.3	0.0	5.0	0.7	1.2	2.0	35.7	0.3	5.2	17.3	1.3	8.6	4.1	2.1	15.4	0.5	0.5	0.4	14.2	4.3	3.3	0.5	0.3	0.1	1.0	34.5	5.4	1.2	5.3	2.4	6.5	10.5	2.4	10.4	4.3	0.3	3.0	52.9	0.7	0.4	0.4	2.1	1.2	0.1	1.3	8.3	2.3	4.6	3.0	3.4	1.5	1.4	4.1	0.8	1.5	0.8	0.2	11.7	0.4	0.2	0.5	0.0	0.1	17.6	0.0	0.0	0.0	0.0	13.0	12.6	0.1	1.3	0.0	0.0	11.9	1.1	5.7	0.0	0.0	6.8	0.0	0.1	3.4	0.0	0.1	0.1	0.5	7.1	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	22.2	0.1	0.2	2.0	7.4	0.1	0.0	0.0	4.7	0.2	10.4	2.1	0.1	0.2	10.5	0.0	1.5	14.9	0.2	0.0	0.0	0.2	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	4.1	0.8	0.8	0.7	0.5	0.4	0.8	0.8	0.6	0.3	1.5	0.7	0.7	4.0	1.5	0.5	1.4	0.7	0.2	0.4	0.3	0.7	0.5	0.5	0.4	0.3	0.1	2.4	0.1	8.9	5.9	0.0	25.0	7.0	5.9	0.4	38.2	20.1	12.5	8.7	0.0	31.8	1.7	23.0	4.2	0.0	154.2	0.0	29.6	0.7	1.0	32.3	0.0	5.0	2.5	0.0	59.0	0.6	1.2	2.2	0.3	1.0	0.0	1.0	62.0	0.8	24.0	84.2	0.7	20.2	19.7	0.0	1.0	7.7	4.3	3.1	4.0	1.3	44.3	38.8
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Muscle protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	26	"heart muscle: 366.6;skeletal muscle: 871.2;tongue: 310.7"	"Cell type enriched"	"Detected in many"	38	"Cardiomyocytes: 4117.3"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"NK-cell: 4.4"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 4.4"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 62.9"	"Not detected"	"Not detected"							"CAB000060, HPA003123"	Enhanced					NA	NA	13500000	190000000			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	3.6	0.1	0.2	0.1	0.2	0.0	1.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	13.0	19.6	0.4	0.0	366.6	0.2	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.1	0.7	0.0	0.3	0.1	0.0	5.0	0.3	0.0	13.0	0.0	871.2	0.3	0.3	0.0	0.2	0.1	0.1	0.1	0.0	0.0	4.6	310.7	14.4	0.3	0.1	0.1	0.4	0.1	0.0	4.4	0.7	0.0	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.2	0.0	0.1	0.3	0.3	0.0	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	6.4	0.0	0.2	0.0	0.6	0.9	0.3	0.2	2.7	0.0	2.2	0.5	0.0	6.7	62.9	0.0	0.1	14.0	0.0	0.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.4	0.0	0.0	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.2	0.0	4117.3	0.0	20.1	3.4	0.0	0.0	0.0	0.0	3.6	20.4	0.0	1.6	0.0	0.2	0.0	0.0	28.6	0.0	0.0	0.0	0.0	11.1	0.0	0.0	52.6	0.0	0.0	11.8	0.0	109.2	0.0	0.4	2.9	0.7	0.0	0.0	0.0	1.9	0.4	0.6	0.1	0.2	0.0	2.6	8.4
MC2R	ACTHR	ENSG00000185231	"Melanocortin 2 receptor"	Q01718	18	13882044-13915707	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adrenal gland: 31.7;pituitary gland: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;MCF7: 3.6;SuSa: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079148	Enhanced					NA	NA					"HPA079148: "											"unprognostic (2.09e-1)"			"unprognostic (3.63e-2)"	"unprognostic (1.85e-2)"			0.0	31.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	14.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.1	0.1	1.3	0.3	0.1	0.1	0.0	0.2	0.0	0.1	0.3	0.1	0.3	1.1	0.2	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.4	0.1	0.3	0.1	0.9	0.1	0.0	0.5	0.0	1.7	0.2	0.0	0.2	0.0	0.0	0.9	0.0	0.6	0.2	0.0	0.2	0.1	0.4	0.0	3.6	0.0	0.0	0.6	0.0	0.1	0.2	0.5	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	1.8	0.1	0.3	0.0	0.2	0.3	0.5	0.0	0.2	0.2	0.0	0.1	0.4	0.0	1.3	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.5	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MC4R		ENSG00000166603	"Melanocortin 4 receptor"	P32245	18	60371110-60372775	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 9.8;fallopian tube: 10.3"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 1.1;Rod photoreceptor cells: 1.1"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	69	"fHDF/TERT166: 47.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA016719	Uncertain					NA	NA					"HPA016719: AB_1853617"	"unprognostic (2.29e-1)"			"unprognostic (5.31e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.41e-1)"		"unprognostic (1.35e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"			"unprognostic (2.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.59e-1)"		0.4	1.1	4.0	0.3	9.8	0.2	0.9	0.7	6.4	0.5	0.5	0.3	0.0	0.6	0.4	1.3	0.4	10.3	0.4	0.4	3.0	7.8	0.4	0.2	0.3	0.4	1.1	7.6	0.6	0.2	0.2	0.3	0.2	3.3	0.4	0.5	0.1	2.5	0.5	0.2	0.3	0.4	0.2	0.8	0.8	0.6	0.6	5.1	0.0	0.2	0.0	1.4	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	47.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	9.8	0.7	6.4	3.0	7.8	1.1	7.6	3.3	5.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MCHR1	"GPR24, MCH1R, SLC1"	ENSG00000128285	"Melanin concentrating hormone receptor 1"	Q99705	22	40678750-40682814	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.4"	"Group enriched"	"Detected in some"	5	"Leydig cells: 2.6;Melanocytes: 8.5"	"Group enriched"	"Detected in some"	7	"glioma: 4.9;liver cancer: 1.5;melanoma: 3.1;renal cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 2.5;RH-30: 3.4;SuSa: 10.1;T-47d: 2.8;U-87 MG: 3.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.84e-3)"	"unprognostic (4.92e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (1.49e-6)"	"unprognostic (3.07e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.91e-2)"	0.7	0.8	3.4	1.1	4.7	0.4	0.4	1.0	14.4	1.2	0.5	0.2	0.0	0.7	4.8	1.5	0.4	1.2	0.4	3.1	4.6	7.3	0.4	2.6	0.5	0.8	3.4	4.9	5.1	0.5	0.3	2.8	0.6	2.5	0.4	0.5	0.8	0.4	0.5	0.5	1.7	0.5	2.4	1.2	0.4	0.5	0.6	0.1	0.0	0.3	0.0	0.7	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	2.5	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.1	2.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.1	0.0	0.7	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	4.7	1.0	11.6	4.6	7.3	3.4	4.9	2.5	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.6	0.0	0.0	2.6	0.0	8.5	0.0	0.0	1.2	0.2	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235126-46286297	"Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: AB_2674152"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	19.4	16.7	14.2	21.5	25.3	19.5	19.0	26.6	29.2	18.3	17.2	27.7	19.3	15.4	24.8	18.0	18.1	21.1	16.3	17.9	14.4	13.2	15.5	13.3	18.2	21.9	16.5	14.6	23.7	17.5	25.7	20.6	18.2	18.2	17.7	17.6	21.3	22.1	21.4	52.9	18.2	19.9	19.5	15.1	20.7	18.7	15.7	15.7	31.8	19.6	15.7	26.0	21.1	16.4	4.8	4.8	3.8	4.9	3.0	6.9	4.1	16.0	15.8	18.6	20.0	15.2	19.0	16.9	17.7	21.7	16.8	13.7	14.4	9.6	22.9	14.6	18.7	18.1	9.6	24.5	14.9	14.8	23.5	22.2	37.5	15.1	11.2	13.7	17.0	21.2	14.8	13.0	22.9	15.9	11.5	17.8	13.9	44.7	17.5	19.3	9.2	18.2	11.5	31.9	17.5	13.2	23.8	11.7	20.7	8.2	14.9	15.7	16.7	22.6	15.0	17.3	14.7	20.4	17.8	22.5	17.6	13.4	14.6	13.2	31.9	35.3	14.2	15.9	16.5	22.8	1.5	4.7	3.8	6.1	4.9	6.5	2.9	3.7	6.9	4.8	4.8	3.3	3.4	2.9	3.0	2.7	4.2	4.4	4.1	14.2	25.3	26.6	29.2	14.4	13.2	16.5	14.6	18.2	15.7	8.9	17.6	16.7	6.1	6.3	21.7	3.6	15.3	10.7	12.5	10.4	19.6	9.8	1.7	9.7	2.5	7.8	12.3	0.0	12.4	9.8	8.9	11.6	8.1	15.3	13.5	15.9	11.5	13.5	20.6	3.6	17.0	12.4	10.1	21.6	18.4	8.9	12.8	7.0	13.4	5.2	21.0	19.4	6.6	18.9	13.4	9.2	7.8	8.5	14.5	5.5
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522626-7534009	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 91.8;Kupffer cells: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 30.9;monocytes: 28.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	18.9	27.5	10.1	10.3	11.9	10.0	10.3	8.2	19.7	7.7	9.6	11.2	7.2	9.6	8.8	9.5	11.2	8.4	11.7	11.7	9.0	9.2	11.5	20.6	17.9	20.6	10.6	10.0	7.8	10.5	9.8	26.0	17.9	13.6	8.8	6.9	9.7	9.2	8.0	14.2	13.9	8.0	9.5	10.4	38.3	8.9	6.5	9.4	7.0	6.2	7.6	5.1	12.5	8.7	1.3	6.2	30.9	28.9	2.8	2.7	4.4	6.4	6.6	3.2	11.0	18.9	6.1	9.3	12.0	9.7	14.6	12.6	5.0	5.7	3.6	14.8	8.1	12.9	3.0	5.4	4.1	4.3	7.0	12.0	3.2	6.5	4.0	16.6	3.6	14.2	8.6	9.7	13.9	2.4	4.6	6.1	8.1	5.9	16.1	8.4	2.1	4.9	3.6	7.2	3.4	14.2	6.9	5.4	7.7	5.5	5.6	8.4	10.3	5.1	9.1	15.2	3.7	5.5	6.4	7.6	7.0	4.0	28.1	8.9	12.4	19.0	2.5	11.2	5.1	10.4	30.9	13.7	29.7	2.3	27.5	2.0	1.1	2.0	1.9	5.6	1.3	1.9	2.0	12.2	2.8	28.9	6.2	2.7	4.4	10.1	11.9	8.2	19.7	9.0	9.2	10.6	10.0	13.6	9.4	3.0	1.6	10.4	6.1	11.8	26.9	2.0	17.8	4.0	1.2	29.6	21.6	10.4	1.7	20.9	4.9	11.9	19.5	46.7	19.9	15.2	17.9	4.5	1.1	12.4	91.8	55.6	16.1	11.1	81.2	10.8	15.3	42.0	20.3	5.4	8.6	23.6	17.7	20.1	14.9	9.2	37.0	6.5	9.2	10.2	11.9	15.2	24.7	10.2	8.6	4.1
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 34.6;Macrophages: 15.1;monocytes: 53.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 18.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;HAP1: 10.1;HDLM-2: 16.8;THP-1: 20.1;U-698: 12.5"	"Region enriched"	"Detected in single"	5	"amygdala: 0.4"	"Low region specificity"	"Detected in all"			HPA019114	Uncertain					NA	NA					"HPA019114: AB_1853645"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	1.3	12.5	0.4	31.9	0.4	2.2	1.1	0.2	0.4	1.7	8.5	0.5	1.6	1.2	1.4	18.4	1.3	2.9	3.8	2.0	0.6	0.4	1.4	0.6	7.5	18.4	0.6	0.0	1.0	1.8	0.0	1.2	2.1	1.5	1.5	14.0	1.6	3.2	0.9	0.6	1.8	7.5	0.5	1.7	9.7	1.7	2.7	0.4	4.1	1.0	2.8	27.5	2.3	1.3	6.6	18.9	0.2	0.8	0.4	5.9	1.4	1.0	1.1	0.1	3.0	0.6	0.2	0.4	0.7	3.8	0.9	1.2	0.0	0.1	14.1	0.4	0.0	1.8	0.1	10.1	1.2	1.1	16.8	7.5	1.4	0.4	0.0	0.8	0.3	1.3	0.2	0.0	0.9	0.8	0.1	0.1	3.7	0.0	0.3	0.2	0.4	0.2	0.1	1.1	0.0	1.9	0.1	2.3	0.0	0.1	0.3	0.7	0.0	0.1	0.2	6.2	0.2	1.8	20.1	0.1	1.0	1.6	0.1	2.6	0.1	0.0	12.5	0.9	0.1	2.4	0.1	0.2	0.0	4.1	0.8	1.3	6.6	3.3	5.9	4.5	1.9	0.5	3.4	0.2	0.4	0.1	18.9	0.2	1.4	0.4	0.4	0.2	0.4	0.6	0.4	0.6	0.0	1.5	0.4	0.0	1.1	9.8	0.5	3.9	0.0	0.5	0.0	2.7	2.3	1.8	0.0	0.1	0.0	0.0	34.6	0.1	6.0	0.0	1.2	0.1	2.1	0.7	0.0	0.0	0.7	0.0	2.4	1.3	0.6	14.2	0.0	15.1	8.5	53.3	4.1	0.0	0.4	5.8	0.0	0.3	0.0	0.0	0.1	0.2	3.7	2.9	0.2	8.2	2.3	0.1
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048499	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.2;pituitary gland: 38.3"	"Group enriched"	"Detected in many"	8	"Intestinal endocrine cells: 109.0;Melanocytes: 143.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 10.1;HAP1: 10.0;RH-30: 12.2;SK-MEL-30: 21.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 1.7"	"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA018106: AB_1853647, HPA062137: AB_2684695"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	4.7	29.2	1.5	0.8	0.8	0.0	3.0	0.2	0.4	6.1	2.8	0.9	2.1	3.2	5.4	15.6	0.8	1.1	0.6	5.1	3.4	0.3	4.5	0.2	4.1	0.0	0.5	0.0	2.2	6.5	17.9	38.3	1.8	2.7	0.5	0.5	4.5	8.1	0.4	1.9	2.5	1.9	1.1	0.3	0.9	1.6	0.4	0.3	2.6	1.5	0.9	0.4	0.7	2.8	0.0	0.0	0.0	0.0	0.0	2.9	0.7	6.5	1.5	0.0	0.0	5.3	4.8	1.7	0.1	10.1	2.5	7.0	0.5	1.2	0.0	0.7	0.1	2.3	0.0	10.0	3.2	1.6	2.6	5.9	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.2	2.1	1.2	2.6	0.0	0.0	0.0	0.0	4.9	0.6	0.0	0.0	0.7	0.0	0.6	0.0	12.2	0.0	0.3	0.0	0.4	0.0	0.3	0.0	21.6	0.8	4.1	5.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.8	0.2	0.4	3.4	0.3	0.5	0.0	2.7	0.3	14.9	1.7	0.0	3.6	7.7	0.0	6.9	10.2	0.0	1.2	3.5	0.0	6.4	0.0	1.9	0.3	0.5	1.3	0.0	8.4	0.1	5.1	1.1	0.0	0.0	3.4	0.0	109.0	0.0	0.0	0.0	1.7	0.8	143.4	2.8	0.6	0.0	4.9	7.8	0.0	2.2	0.0	6.5	1.2	0.9	1.6	3.0	2.2	0.0	0.6	0.3
MCUB	"CCDC109B, FLJ20647"	ENSG00000005059	"Mitochondrial calcium uniporter dominant negative beta subunit"	Q9NWR8	4	109560205-109688726	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 39.3;lymphoid tissue: 45.3"	"Cell type enhanced"	"Detected in some"	9	"Cytotrophoblasts: 107.3;Exocrine glandular cells: 99.3;Extravillous trophoblasts: 82.0;Hofbauer cells: 95.7;Pancreatic endocrine cells: 50.6;Syncytiotrophoblasts: 61.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 36.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048776	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Nucleoplasm, Vesicles, Mitochondria"		"HPA048776: AB_2680518"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.35e-6)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	11.6	2.2	4.1	21.0	3.2	8.3	16.6	0.4	3.7	8.2	4.9	4.6	1.4	3.5	12.3	5.5	9.2	6.3	7.3	14.9	4.5	4.7	3.9	2.1	7.8	44.2	3.5	2.6	7.5	2.1	2.3	5.1	9.9	6.5	5.4	6.1	4.1	6.5	2.2	4.3	7.6	8.8	8.4	8.5	13.8	4.2	3.6	1.9	45.3	4.7	9.5	24.8	7.3	9.0	14.0	15.7	1.1	16.0	20.0	39.3	25.7	10.4	4.5	2.5	12.8	2.8	7.4	9.7	9.0	5.5	9.9	8.9	0.2	8.5	36.7	1.9	7.7	5.5	3.0	9.4	5.5	8.8	23.3	7.4	4.4	5.0	0.6	4.9	8.9	0.1	4.7	1.5	6.0	5.1	7.0	13.2	13.6	1.3	23.4	7.5	12.8	20.4	0.1	11.6	1.8	6.5	7.8	19.4	4.1	11.6	4.6	10.3	4.5	9.7	28.9	3.0	2.1	3.6	0.4	9.4	3.9	5.1	20.6	15.6	9.1	6.3	8.9	12.0	1.9	2.7	0.0	16.0	0.2	6.3	9.7	9.0	13.5	26.7	19.0	15.7	14.0	39.3	22.2	1.1	20.0	7.2	11.0	22.4	25.7	4.1	3.2	0.4	3.7	4.5	4.7	3.5	2.6	6.5	1.9	8.9	6.9	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.5	5.2	0.0	107.3	0.0	22.4	0.0	0.0	0.0	0.0	99.3	82.0	0.0	0.0	1.1	0.0	95.7	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	25.2	0.0	0.0	50.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	61.4	0.0	0.0	0.0
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"intestine: 241.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 2.1;Enterocytes: 6.3"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 3.0;stomach cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 10.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029119	Enhanced				"Secreted to digestive system"	NA	NA		120000			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.1	0.1	78.8	0.0	0.0	54.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	241.5	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	0.4	0.3	0.3	0.0	1.4	0.5	0.2	0.0	0.0	0.5	0.6	0.0	2.1	1.0	0.3	0.3	0.1	0.6	1.4	1.7	0.5	0.0	0.8	0.2	0.0	0.0	0.0	0.8	1.0	1.1	0.7	0.6	0.4	1.3	0.3	0.0	0.7	0.0	0.1	0.7	0.5	1.6	1.1	0.2	0.0	1.9	1.3	4.1	1.3	0.5	0.0	1.8	1.8	2.9	0.0	0.7	10.6	2.4	0.8	0.2	0.3	0.3	0.4	3.1	0.9	1.4	0.8	3.4	0.0	0.6	2.3	0.5	2.6	0.0	0.5	0.0	0.3	0.3	1.0	0.1	1.3	1.1	0.7	1.4	0.4	0.1	1.2	0.3	0.2	0.0	0.1	0.2	0.5	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	6.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12013514	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"	Hydrolase	"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 100.9;skeletal muscle: 111.1"	"Cell type enriched"	"Detected in all"	8	"Cardiomyocytes: 308.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030554, CAB079902"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"CAB079902: AB_2724683, HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	12.8	10.1	16.4	8.9	20.3	17.2	10.1	15.9	32.1	8.7	17.0	17.0	11.2	16.5	12.1	8.7	20.1	9.0	9.0	100.9	17.9	16.0	14.8	20.4	10.6	8.0	18.8	19.3	10.2	9.0	22.0	9.3	12.9	20.8	14.1	13.2	16.5	10.7	23.7	111.1	18.8	25.7	22.9	15.7	10.2	14.0	11.3	10.9	7.3	18.7	28.5	12.1	16.3	10.6	7.3	8.9	18.5	16.9	5.8	10.2	13.4	26.0	15.9	18.1	23.8	18.3	13.8	21.0	20.6	19.1	28.3	22.1	26.3	17.4	19.1	22.4	24.9	18.6	27.9	29.9	47.8	25.4	69.2	22.7	27.3	25.6	20.4	19.0	27.7	17.2	17.4	36.9	39.8	36.9	12.2	19.9	10.3	28.2	16.8	20.9	13.1	16.8	12.7	12.5	17.5	23.5	19.7	26.4	17.8	17.0	17.4	21.1	13.8	24.2	25.8	23.9	14.2	13.9	16.7	19.9	19.0	19.0	28.8	21.5	20.1	21.1	31.3	22.5	31.2	20.5	8.5	10.3	7.1	9.6	13.5	10.2	7.3	7.2	8.6	8.9	6.6	6.3	8.0	18.5	5.8	16.9	4.6	8.0	13.4	16.4	20.3	15.9	32.1	17.9	16.0	18.8	19.3	20.8	10.9	20.8	18.6	11.5	8.2	20.3	24.8	308.6	12.7	12.0	14.8	14.0	11.8	12.2	18.3	12.7	3.6	12.0	31.1	23.3	17.3	13.2	9.3	12.5	10.4	39.2	14.2	28.6	17.3	13.5	18.1	4.4	6.6	11.8	16.9	10.0	20.9	11.6	13.9	14.0	14.2	13.3	18.6	12.9	14.4	27.7	16.8	26.3	21.1	9.6	22.1	12.9
MFSD13A	"bA18I14.8, C10orf77, FLJ22529, TMEM180"	ENSG00000138111	"Major facilitator superfamily domain containing 13A"	Q14CX5	10	102461395-102477045	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 17.9;Horizontal cells: 20.6;Syncytiotrophoblasts: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018031	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA018031: AB_2204891"	"unprognostic (2.24e-2)"	"prognostic favorable (8.29e-4)"	"unprognostic (7.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.16e-3)"	"unprognostic (4.70e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.02e-2)"	3.8	3.3	8.8	5.9	15.7	9.0	2.6	18.0	18.7	2.4	7.0	8.5	0.4	10.2	4.3	1.8	3.0	2.4	4.7	5.2	9.0	6.5	3.3	5.7	14.1	5.6	7.9	8.7	2.3	5.1	2.8	4.4	7.2	8.2	3.1	6.4	3.9	3.0	2.3	3.9	17.4	7.5	4.9	5.2	6.9	7.1	5.8	8.6	2.3	5.7	1.8	6.7	3.1	2.5	5.0	7.5	5.5	7.2	2.2	5.8	3.4	9.3	4.3	3.3	7.9	0.3	0.3	5.1	1.9	4.9	3.7	8.7	8.5	12.9	8.4	9.8	0.7	3.6	11.7	6.2	5.0	1.4	10.6	5.5	10.3	6.1	4.4	8.5	5.2	10.1	4.3	2.1	2.1	3.8	3.1	4.3	11.4	2.3	4.6	0.3	1.9	8.7	3.4	5.6	8.2	4.2	10.6	0.5	1.4	1.7	2.5	8.2	7.8	1.8	1.0	4.2	1.2	4.8	3.5	1.3	1.7	2.1	2.1	2.6	1.6	4.1	10.9	9.6	8.6	2.4	0.7	7.2	5.5	5.2	5.3	5.2	5.0	5.0	4.1	7.5	2.8	5.2	5.8	4.4	2.2	3.0	0.8	1.4	3.4	8.8	15.7	18.0	18.7	9.0	6.5	7.9	8.7	8.2	8.6	17.9	9.6	0.0	1.2	0.0	6.8	0.0	2.5	1.4	1.2	1.8	3.9	1.5	0.0	2.4	1.1	2.3	2.9	0.0	3.2	2.5	0.7	1.4	1.1	4.9	15.8	20.6	2.4	4.9	3.5	0.4	0.9	7.8	0.0	4.6	3.9	3.0	2.8	5.7	2.1	1.2	13.5	0.0	0.0	3.4	2.9	0.0	23.8	1.5	6.0	0.9
MFSD14A	"DKFZP564L0864, HIAT1"	ENSG00000156875	"Major facilitator superfamily domain containing 14A"	Q96MC6	1	100038097-100083377	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 248.4;Late spermatids: 274.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA073127, HPA073681"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA073127: , HPA073681: AB_2686625"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.15e-2)"	24.3	23.7	21.8	23.9	23.5	55.7	34.7	16.3	28.3	22.0	23.5	30.2	21.2	14.7	29.4	20.6	24.5	22.9	19.3	17.0	19.9	20.8	22.7	21.7	27.1	24.1	24.5	16.8	27.0	29.2	92.6	19.4	25.0	23.6	26.0	17.1	20.5	23.0	32.0	18.8	22.4	18.5	29.3	33.9	20.6	21.7	28.3	22.3	24.4	21.3	15.9	21.0	23.0	22.9	24.1	27.0	47.1	28.1	26.9	29.8	30.8	23.5	9.8	22.2	11.4	26.0	24.7	18.7	17.3	29.6	23.5	27.5	8.3	16.5	17.7	28.3	22.4	15.5	22.7	19.7	19.0	22.6	15.4	15.6	17.4	15.0	12.4	23.0	28.0	22.9	20.1	29.2	20.7	26.6	20.8	18.0	20.1	21.3	34.8	21.6	6.9	21.0	16.5	25.5	11.5	14.5	14.8	27.1	17.3	25.1	20.7	23.1	20.6	19.5	28.5	28.5	14.7	11.0	28.6	19.7	19.4	13.7	20.3	17.8	33.2	34.9	24.7	21.1	20.5	8.3	32.8	28.1	26.1	25.9	25.2	29.2	24.1	26.5	28.3	27.0	19.4	29.8	27.6	47.1	26.9	20.7	12.6	28.6	30.8	21.8	23.5	16.3	28.3	19.9	20.8	24.5	16.8	23.6	22.3	6.0	8.6	16.2	37.8	0.0	16.3	0.0	25.5	10.7	6.8	3.5	9.8	31.3	1.7	8.7	248.4	19.6	4.3	46.7	6.2	26.8	8.2	35.5	2.3	14.3	20.0	12.7	12.9	17.2	28.9	274.7	21.0	4.2	0.0	7.2	13.2	20.5	5.7	19.3	28.7	0.6	10.5	12.9	0.0	16.3	20.7	0.0	48.7	13.8	13.6	47.7
MFSD14B	"FLJ14753, HIATL1"	ENSG00000148110	"Major facilitator superfamily domain containing 14B"	Q5SR56	9	94374551-94461042	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 86.0"	"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017978			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA017978: AB_2116836"	"unprognostic (3.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.96e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.01e-2)"	15.1	18.9	13.3	14.3	14.7	9.0	20.2	11.6	12.8	14.9	14.2	19.7	15.5	9.9	18.6	16.1	28.1	14.4	12.5	13.4	13.3	12.4	14.7	9.0	25.7	21.5	14.6	7.8	15.9	21.5	86.0	9.2	24.2	28.3	14.5	15.4	21.6	15.9	14.2	7.3	21.8	16.0	12.8	19.1	19.3	13.0	9.2	13.2	24.0	16.7	14.2	23.9	14.1	18.8	4.6	7.8	10.4	11.4	3.6	7.1	3.6	25.9	16.7	13.1	10.2	28.8	20.7	20.9	25.3	22.0	22.5	22.1	8.4	31.1	31.3	15.1	21.7	26.1	57.4	15.6	16.1	22.0	22.3	8.4	10.7	16.1	12.6	20.5	33.8	20.0	18.9	24.4	23.8	18.3	12.6	19.2	17.2	20.3	18.6	29.9	19.7	24.7	19.4	19.2	38.0	13.5	12.4	30.1	10.1	24.0	20.0	12.6	16.6	21.5	25.5	26.7	16.4	11.6	20.0	20.6	23.6	16.7	36.2	23.3	20.6	25.5	8.6	21.0	16.6	21.1	0.6	7.9	5.9	5.6	11.4	5.1	4.6	5.1	5.6	7.8	2.9	5.1	7.1	10.4	3.6	7.7	7.7	5.1	3.6	13.3	14.7	11.6	12.8	13.3	12.4	14.6	7.8	28.3	13.2	6.0	21.9	13.7	20.2	0.0	11.2	0.0	17.8	13.4	12.5	41.8	3.9	12.4	6.6	15.2	2.6	11.3	7.1	0.0	16.4	22.4	13.2	30.5	3.5	10.4	25.8	4.8	7.0	27.0	63.5	2.1	15.5	18.5	0.0	10.8	26.6	18.1	22.0	15.8	15.2	5.7	9.1	12.9	0.0	10.4	17.5	0.0	16.0	13.8	14.9	41.4
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 96.9;liver: 87.9;placenta: 111.3;seminal vesicle: 121.2"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 2: 112.2;Enterocytes: 112.9;Hepatocytes: 268.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.3;intermediate monocyte: 4.6;myeloid DC: 10.3;plasmacytoid DC: 16.7"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.7;monocytes: 9.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 18.9;THP-1: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.33e-4)"	2.0	0.9	6.0	1.6	7.2	3.3	6.2	2.4	6.5	1.6	5.6	4.3	96.9	6.4	4.3	45.0	5.0	1.5	1.2	0.7	7.6	6.1	7.2	87.9	15.8	1.1	7.5	2.6	0.8	0.5	0.3	3.0	111.3	7.8	1.0	2.5	2.0	1.7	121.2	0.3	27.0	20.4	1.8	7.3	0.8	1.0	17.7	2.3	0.2	2.9	4.7	1.7	2.6	4.6	1.1	16.7	0.9	9.3	0.1	0.1	2.3	2.1	0.9	4.5	6.8	3.2	0.6	0.0	2.0	4.0	4.6	5.5	0.2	1.2	13.3	1.2	1.0	3.2	5.3	4.4	7.7	3.6	1.7	2.1	1.6	0.0	0.0	10.7	2.3	7.9	3.6	4.8	18.9	7.8	0.8	1.1	4.1	0.0	3.4	2.0	0.2	3.6	3.6	3.6	7.4	1.6	2.5	6.6	3.0	0.7	6.3	1.6	2.4	1.6	11.4	1.1	0.4	0.5	59.5	0.7	1.0	2.0	3.4	8.7	0.6	1.2	2.9	10.6	9.0	3.3	0.0	9.3	0.9	0.1	4.6	0.1	1.1	0.0	0.1	10.3	0.2	0.0	0.0	0.5	0.1	0.8	16.7	0.0	2.3	6.0	7.2	2.4	6.5	7.6	6.1	7.5	2.6	7.8	2.3	17.9	112.2	11.5	13.4	46.9	1.9	0.6	12.7	12.0	31.8	15.7	0.0	0.3	0.0	3.2	0.6	6.7	112.9	0.0	22.5	6.5	9.7	5.7	17.3	268.3	6.4	0.0	1.2	10.4	12.4	0.9	0.6	11.4	0.0	2.8	16.4	41.8	16.3	3.5	0.4	3.7	1.8	0.0	3.4	1.1	1.0	47.9	43.9	2.2	10.0	23.0
MFSD4A	"DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064"	ENSG00000174514	"Major facilitator superfamily domain containing 4A"	Q8N468	1	205568885-205602918	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.9;kidney: 37.6;stomach 1: 60.0"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 1: 6.0;Ciliated cells: 5.3;Club cells: 11.4;Collecting duct cells: 8.7;Distal tubular cells: 11.6;Exocrine glandular cells: 5.6;Proximal tubular cells: 6.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.1;HAP1: 2.7;HMC-1: 4.6;SCLC-21H: 5.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 17.1;cerebellum: 24.8;cerebral cortex: 56.2;hippocampal formation: 32.0"							NA	NA						"unprognostic (7.15e-4)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (2.27e-13)"	"unprognostic (1.58e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.75e-3)"	"unprognostic (8.78e-2)"	1.7	0.6	17.3	0.8	10.6	0.3	2.1	18.8	24.9	4.9	7.3	1.3	0.0	1.2	0.8	5.2	1.0	1.6	11.1	0.8	11.9	4.3	37.6	0.5	3.8	0.5	3.6	13.3	0.6	1.0	0.4	3.2	3.5	8.4	1.1	9.5	2.4	8.6	0.6	0.6	3.3	1.1	0.7	2.8	0.6	60.0	0.5	0.2	0.0	0.7	0.8	2.8	0.9	0.8	1.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.2	0.8	0.1	0.8	0.0	0.1	2.1	2.7	0.0	0.0	0.0	1.1	0.0	0.0	0.9	0.0	0.0	4.6	0.2	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.2	0.5	5.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.3	0.3	0.1	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	17.3	10.6	18.8	24.9	11.9	4.3	3.6	13.3	8.4	0.2	6.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	5.3	11.4	8.7	0.0	0.5	11.6	1.2	0.0	0.0	0.0	0.0	5.6	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
MFSD6L	FLJ35773	ENSG00000185156	"Major facilitator superfamily domain containing 6 like"	Q8IWD5	17	8797162-8799349	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 8.5;testis: 20.1"	"Group enriched"	"Detected in some"	6	"Early spermatids: 104.1;Late spermatids: 27.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.4"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 14.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA023164	Uncertain					NA	NA					"HPA023164: AB_2142777"	"prognostic favorable (1.84e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.07e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.25e-1)"	0.5	0.0	0.5	3.2	0.5	0.0	0.5	0.5	0.5	1.4	2.1	0.5	0.5	1.8	0.5	0.9	0.5	1.6	0.5	0.5	0.5	0.0	1.1	0.5	2.2	0.5	0.5	0.5	0.5	8.5	4.8	4.3	0.5	0.5	0.5	2.6	0.5	5.5	1.8	0.5	0.2	1.0	0.5	0.5	0.5	3.4	20.1	0.5	0.5	3.1	0.5	0.5	0.7	0.5	0.0	0.3	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.1	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.0	0.5	0.5	0.5	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	2.3	0.0	6.0	104.1	0.0	0.0	0.0	6.7	0.1	0.0	0.6	0.0	0.0	0.6	0.0	1.2	0.0	0.8	27.4	0.9	0.0	0.0	0.0	5.8	0.0	3.0	0.0	1.1	0.0	0.0	0.0	0.1	10.7	0.2	0.0	1.3	0.0	3.7	0.6
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917732-127966034	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	8.9	9.6	9.1	11.7	15.4	5.3	13.0	19.6	15.4	12.2	12.1	14.6	9.4	17.1	19.0	11.9	10.3	9.8	9.2	7.5	8.9	10.1	12.6	19.1	9.1	9.7	9.3	11.8	13.2	14.5	16.7	21.5	18.0	15.8	10.2	15.6	14.8	10.9	9.7	7.2	11.0	15.0	12.4	11.8	13.5	12.0	9.4	10.2	12.9	13.6	7.1	15.0	9.9	10.5	7.0	5.8	7.1	8.2	5.4	8.3	4.1	8.3	6.9	7.2	4.0	6.4	5.7	6.2	6.2	8.1	8.2	8.2	4.3	11.9	3.9	12.2	11.2	13.2	6.9	8.4	6.3	11.8	9.1	6.7	4.8	7.8	6.6	7.2	5.0	5.9	6.2	2.1	7.7	5.8	4.1	8.7	6.1	8.1	5.3	11.6	7.7	4.3	1.7	1.4	8.6	4.6	4.6	0.5	4.5	5.8	11.9	7.3	2.6	7.8	8.0	3.3	5.7	4.7	3.4	4.5	2.7	2.8	10.1	5.9	11.5	18.9	8.8	8.7	4.3	7.3	4.6	5.6	7.1	7.1	6.2	6.2	7.0	7.9	6.6	4.5	3.6	8.3	8.3	6.3	5.4	8.2	5.8	8.0	4.1	9.1	15.4	19.6	15.4	8.9	10.1	9.3	11.8	15.8	10.2	11.9	13.1	8.1	4.7	2.9	16.3	2.8	2.5	10.7	13.6	15.7	19.6	9.8	1.7	7.4	9.5	5.6	7.0	0.0	6.1	6.5	5.6	4.3	12.7	9.4	6.6	11.1	4.1	8.0	7.5	10.7	8.6	6.0	3.3	6.4	6.8	11.0	6.3	9.7	8.9	5.7	21.2	6.5	3.8	11.4	4.3	5.0	18.4	14.4	6.8	3.5
MFSD9	MGC11332	ENSG00000135953	"Major facilitator superfamily domain containing 9"	Q8NBP5	2	102715840-102736888	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055293, HPA061859"	Approved		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Nucleoli, Nucleoli rim"		"HPA055293: AB_2682775, HPA061859: AB_2684627"	"unprognostic (1.27e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.38e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.28e-2)"	4.3	4.1	3.0	3.5	3.1	6.2	6.2	12.9	5.2	4.6	8.4	2.4	11.0	11.6	2.8	3.8	7.2	2.7	4.1	3.8	2.3	2.8	7.2	16.2	3.0	4.5	2.3	1.5	3.3	16.8	6.3	10.7	3.4	4.8	3.4	7.9	5.1	9.0	6.8	2.2	4.4	16.0	4.0	2.7	4.8	6.7	2.7	1.7	10.0	5.0	3.9	6.3	5.5	3.5	3.0	4.4	6.4	3.2	4.1	4.3	3.0	3.9	3.3	3.6	6.3	4.2	1.8	8.7	2.6	2.4	3.9	3.9	10.0	6.0	3.2	4.2	1.8	6.4	6.2	4.9	2.6	2.7	13.0	5.0	5.8	3.6	13.1	3.6	4.5	7.7	2.1	6.5	2.7	1.4	3.4	2.6	9.2	3.5	2.0	1.8	3.8	4.3	7.0	3.4	7.8	3.7	3.5	5.6	3.3	6.7	13.5	6.9	5.1	2.6	7.8	7.7	3.9	3.3	6.5	1.9	3.1	5.7	4.2	3.4	4.7	3.7	2.4	2.8	9.7	3.6	3.7	1.2	6.4	4.3	3.2	3.3	3.0	3.4	3.1	2.6	2.7	3.7	3.8	5.0	4.1	1.9	4.4	2.2	3.0	3.0	3.1	12.9	5.2	2.3	2.8	2.3	1.5	4.8	1.7	0.0	1.0	4.4	2.9	3.0	1.5	2.2	2.5	2.7	4.5	7.0	3.9	7.3	0.0	5.3	13.0	1.2	8.4	0.0	7.4	7.2	2.1	3.9	3.5	7.8	4.1	0.0	2.9	0.6	1.2	3.0	0.9	2.1	0.0	4.6	7.9	1.7	8.5	8.6	1.1	2.9	2.6	6.5	1.2	0.9	4.9	3.9	9.6	5.2	6.3	8.0
MIA3	"FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077"	ENSG00000154305	"MIA family member 3, ER export factor"	Q5JRA6	1	222618086-222668012	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA055922, HPA056816"	Supported		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA		750000	Vesicles		"HPA055922: AB_2682971, HPA056816: AB_2683243"	"unprognostic (1.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.62e-3)"	"unprognostic (3.26e-1)"	20.5	24.1	21.4	17.4	23.7	25.8	25.0	32.8	25.0	23.3	19.3	10.0	26.2	18.7	23.5	24.4	15.7	18.1	18.5	19.5	18.4	17.4	19.5	63.7	18.4	19.0	17.0	18.8	23.4	34.1	30.2	34.7	22.7	25.6	30.1	23.1	9.9	32.8	31.7	25.5	16.5	23.2	21.3	22.9	23.0	36.6	29.3	19.6	19.5	25.6	19.5	19.3	26.8	19.8	18.6	14.9	29.4	20.1	22.0	18.3	11.1	11.7	8.9	13.9	21.1	44.1	22.2	23.3	16.9	25.3	18.7	22.3	9.2	12.2	9.7	16.1	19.1	11.3	20.1	14.8	15.6	19.2	16.6	9.2	13.3	9.2	14.4	40.5	22.8	16.1	20.3	15.0	17.9	31.7	21.9	19.6	14.6	17.0	23.7	14.1	7.1	17.8	14.7	15.3	36.8	12.8	12.1	37.7	23.3	9.6	11.7	15.0	15.8	17.4	15.8	14.0	20.4	16.9	15.0	14.2	12.7	9.8	21.4	17.9	27.1	17.2	12.1	15.9	11.0	16.6	23.6	14.6	29.4	17.4	19.5	18.3	18.3	15.0	17.0	10.4	18.6	17.8	17.4	24.8	22.0	20.1	14.9	16.0	11.1	21.4	23.7	32.8	25.0	18.4	17.4	17.0	18.8	25.6	19.6	65.5	44.7	27.0	22.7	16.7	55.5	55.8	28.1	60.2	58.0	5.2	29.5	23.4	0.0	21.4	25.4	21.9	30.2	23.3	30.0	14.2	25.4	40.1	16.3	52.3	18.5	42.9	58.0	17.8	17.4	18.1	34.2	23.7	18.6	13.6	83.2	42.1	26.6	22.0	46.0	21.6	37.6	19.4	25.6	49.2	40.6	14.1	30.0	34.1	22.9	26.0
MICU1	"CALC, CBARA1, EFHA3, FLJ12684"	ENSG00000107745	"Mitochondrial calcium uptake 1"	Q9BPX6	10	72367327-72626191	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"		Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037479, HPA037480"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA037479: AB_2675495, HPA037480: AB_10696934"	"unprognostic (8.18e-2)"	"unprognostic (6.98e-3)"	"unprognostic (6.71e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.38e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.23e-2)"	"prognostic favorable (4.66e-7)"	"unprognostic (1.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.70e-2)"	16.8	36.4	22.9	14.4	25.3	17.0	15.4	56.3	30.7	18.2	16.9	18.9	11.6	20.9	29.7	14.3	13.3	20.5	18.6	24.0	23.3	21.7	58.9	64.7	16.7	11.2	20.9	22.7	25.0	11.6	21.1	23.4	16.3	25.2	14.9	19.2	15.1	15.5	13.8	36.9	16.3	21.5	22.2	17.5	18.1	24.1	11.8	15.0	15.1	13.8	14.6	11.9	20.0	15.2	6.5	9.5	39.0	21.7	5.6	6.5	11.5	15.8	28.1	17.9	21.0	29.0	27.3	8.1	17.5	39.9	26.3	36.3	16.5	30.2	21.5	14.9	24.6	21.5	19.1	22.5	15.8	31.1	19.2	18.4	14.5	15.7	23.8	23.0	19.9	16.1	27.2	14.4	28.8	26.9	36.2	22.6	20.8	22.4	25.5	30.5	14.5	17.5	18.9	7.5	17.2	6.9	19.2	24.1	14.2	32.2	11.9	13.8	19.9	20.8	26.0	16.1	18.8	15.5	19.4	13.9	13.1	20.3	25.8	14.5	13.5	22.5	15.1	26.1	26.7	8.8	7.3	21.7	39.0	6.5	18.3	5.7	5.8	5.8	6.0	9.5	6.5	5.7	4.8	18.3	5.6	18.4	6.1	5.5	11.5	22.9	25.3	56.3	30.7	23.3	21.7	20.9	22.7	25.2	15.0	50.6	25.2	26.6	13.0	8.9	30.3	31.7	30.6	44.2	53.4	33.2	19.6	16.4	68.0	29.8	7.7	21.6	24.5	0.0	23.4	16.0	19.5	12.8	17.4	51.2	30.8	15.9	13.8	19.0	33.9	7.9	24.7	24.0	11.8	20.8	23.9	57.0	39.7	23.0	24.4	60.0	30.6	6.5	15.5	61.4	40.5	12.4	18.0	14.9	22.1	12.3
MICU2	EFHA1	ENSG00000165487	"Mitochondrial calcium uptake 2"	Q8IYU8	13	21492691-21604214	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045511, HPA058790"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			Nucleoplasm	Mitochondria	"HPA045511: AB_10959894, HPA058790: AB_2683821"	"unprognostic (4.32e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.40e-7)"	"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.50e-1)"	14.8	32.4	23.9	23.5	23.2	20.9	22.9	28.6	25.4	19.5	25.4	17.3	16.1	18.0	16.7	21.1	19.9	17.8	16.3	41.7	22.9	24.1	52.8	24.5	15.6	16.8	23.4	25.6	17.0	16.9	19.5	30.3	31.2	20.6	20.3	23.9	14.5	16.9	23.6	39.6	15.5	21.0	14.7	28.1	19.4	20.1	17.5	22.6	25.2	26.3	25.6	19.4	15.6	15.4	33.2	21.8	26.5	23.5	22.8	30.7	17.2	11.8	6.8	16.2	10.3	14.5	19.5	14.0	20.1	16.5	21.5	15.0	9.9	19.2	18.5	13.1	19.1	11.1	15.9	15.9	16.9	29.7	18.7	16.5	31.9	7.4	11.4	17.5	23.9	18.6	16.8	16.8	12.1	8.6	19.3	14.3	17.5	11.2	8.3	35.0	10.2	15.9	22.8	11.0	41.9	10.8	17.5	41.4	12.3	42.3	9.7	13.1	10.1	13.7	16.2	13.0	14.8	15.8	22.6	17.6	9.4	8.4	19.0	16.5	6.2	8.2	13.5	9.2	20.0	23.2	22.1	20.1	26.5	26.1	23.5	24.1	33.2	23.0	26.0	21.8	20.8	20.9	26.0	18.7	22.8	19.3	20.1	30.7	17.2	23.9	23.2	28.6	25.4	22.9	24.1	23.4	25.6	20.6	22.6	35.7	23.2	29.6	35.2	26.7	24.7	68.6	30.6	50.9	37.5	48.8	21.6	50.6	122.7	36.4	20.1	21.0	30.6	23.3	23.9	37.2	35.7	25.7	24.3	21.3	32.4	39.7	29.2	19.6	34.1	10.0	31.4	30.0	45.5	39.7	26.0	60.5	29.6	54.7	33.9	82.6	49.4	58.2	27.8	59.5	48.0	22.3	58.8	35.4	29.2	26.8
MLC1	"KIAA0027, LVM, MLC, VL"	ENSG00000100427	"Megalencephalic leukoencephalopathy with subcortical cysts 1"	Q15049	22	50059391-50085902	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.0;brain: 95.3"	"Cell type enhanced"	"Detected in some"	23	"Hofbauer cells: 2.6;Muller glia cells: 12.6;T-cells: 4.5"	"Cancer enriched"	"Detected in some"	69	"glioma: 122.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cell: 15.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 46.8;NB-4: 43.3;THP-1: 82.0;U-266/70: 28.7;U-266/84: 24.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003040	Enhanced		Supported	Cytosol		NA	NA			Cytosol		"HPA003040: AB_1079387"	"unprognostic (2.68e-2)"	"unprognostic (5.46e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.54e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-3)"	"unprognostic (8.39e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.92e-1)"	1.6	1.4	42.3	1.9	45.4	27.0	1.4	17.6	95.3	2.5	1.5	25.9	0.0	1.8	1.5	2.3	1.4	2.8	2.1	1.6	30.9	19.6	1.4	1.6	2.3	1.6	22.5	28.9	1.4	1.4	1.4	0.1	3.2	18.4	2.9	1.4	0.0	1.5	2.6	1.4	2.2	1.5	1.6	18.9	2.8	1.5	2.8	17.3	0.0	1.4	0.0	1.8	1.8	2.6	0.1	0.7	0.1	7.1	15.8	3.3	2.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	46.8	15.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	43.3	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	82.0	0.0	0.0	0.0	0.0	0.0	28.7	24.5	0.0	0.0	7.2	0.4	0.0	0.7	0.0	3.3	5.7	0.1	0.1	0.2	1.4	0.7	0.0	0.1	1.6	0.1	15.8	7.1	0.1	0.1	2.7	42.3	45.4	17.6	29.8	30.9	19.6	22.5	28.9	18.4	17.3	0.0	0.3	0.0	0.0	0.2	0.2	0.4	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	2.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.2	4.5	0.0	0.0
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"vagina: 50.4"	"Cell type enhanced"	"Detected in many"	6	"granulocytes: 27.8;Macrophages: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	18.5	4.7	5.2	15.1	8.9	21.6	13.2	2.9	7.9	6.4	8.0	3.2	5.3	8.5	7.5	3.8	11.5	5.2	9.1	6.8	6.4	3.5	7.4	6.7	17.3	14.8	10.5	1.8	2.8	8.2	1.6	3.0	7.1	8.1	6.3	9.2	6.5	12.6	4.3	2.3	3.6	10.0	6.0	11.2	26.2	8.2	1.9	8.4	4.3	6.5	4.9	10.4	9.2	50.4	4.2	9.2	25.2	17.7	1.7	8.1	7.1	6.5	12.2	0.1	0.1	3.2	6.7	0.1	8.5	7.4	8.0	11.9	7.0	13.2	0.1	9.8	7.2	6.9	10.5	2.2	12.2	3.0	4.1	0.3	9.2	9.1	8.0	2.3	6.0	9.6	4.5	1.2	8.5	3.0	4.7	19.3	10.7	1.3	1.3	6.2	10.9	3.4	12.0	1.1	14.3	15.0	6.7	0.9	11.7	11.4	4.8	0.5	0.4	6.7	4.5	3.7	0.0	3.2	6.3	21.0	4.0	2.4	3.6	5.8	5.7	19.2	1.6	7.3	21.2	1.9	8.3	17.7	21.7	5.8	10.6	7.9	4.2	6.5	6.0	9.2	2.8	3.6	5.5	25.2	1.7	10.2	0.5	8.1	7.1	5.2	8.9	2.9	7.9	6.4	3.5	10.5	1.8	8.1	8.4	3.0	15.4	8.1	4.8	3.1	0.0	1.6	2.5	2.7	7.9	1.8	0.0	0.2	1.7	4.0	2.6	17.9	5.8	0.0	4.6	0.5	3.8	2.0	27.8	0.9	14.2	1.6	1.2	14.7	15.5	3.8	0.9	24.1	6.8	1.0	5.6	0.0	4.1	9.1	0.4	0.3	0.4	0.0	3.3	0.0	0.2	2.5	0.2	10.0	6.4	5.1
MMD	"MMA, PAQR11"	ENSG00000108960	"Monocyte to macrophage differentiation associated"	Q15546	17	55392613-55421992	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"adipose tissue: 61.1;brain: 40.5;breast: 46.0"	"Cell type enhanced"	"Detected in many"	6	"monocytes: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 32.8;HSkMC: 59.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026978			Approved	Vesicles		NA	NA			Vesicles		"HPA026978: AB_2672068"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (3.52e-5)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (6.39e-5)"	"unprognostic (8.07e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (3.71e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.12e-2)"	61.1	6.6	33.4	7.1	40.5	5.3	46.0	2.0	23.7	2.6	5.6	4.1	1.7	5.0	3.2	4.9	3.6	1.8	4.7	5.0	26.9	7.5	3.2	6.0	4.7	9.0	11.2	5.1	1.5	1.6	0.9	2.1	13.4	4.6	3.2	6.5	3.2	2.2	4.1	2.5	2.5	4.7	5.4	6.5	8.7	2.4	7.8	5.0	1.4	3.3	1.2	5.6	5.7	4.1	4.1	3.6	9.6	1.6	2.2	4.2	15.9	5.1	13.2	19.5	3.8	32.8	25.9	9.6	3.2	1.5	2.0	3.0	2.0	15.3	7.4	9.4	1.1	5.8	0.3	5.4	4.1	4.3	9.7	1.9	2.7	0.7	23.9	8.8	2.6	0.8	59.3	1.3	2.9	3.3	4.6	2.6	7.2	0.9	5.9	4.3	0.7	7.3	1.9	5.3	0.9	3.4	2.9	12.6	2.7	5.7	1.4	1.8	18.6	1.1	2.0	2.9	12.7	4.3	4.7	2.4	5.4	6.5	4.3	3.6	2.6	1.3	10.4	7.8	2.2	4.3	9.6	1.3	1.5	1.4	1.6	4.2	3.6	1.6	2.9	3.6	4.1	2.7	2.9	3.8	2.2	1.5	1.1	1.7	15.9	33.4	40.5	2.0	16.9	26.9	7.5	11.2	5.1	4.6	5.0	3.0	1.1	10.5	17.0	4.7	24.9	4.3	7.6	0.0	1.2	7.0	3.9	8.1	13.3	22.9	2.1	11.3	2.6	46.7	1.2	13.7	8.0	18.3	0.0	17.0	32.6	15.9	7.5	10.4	35.9	2.5	1.7	28.4	6.8	74.9	5.8	11.5	12.0	0.0	3.2	7.1	9.3	19.4	5.2	15.6	16.0	15.3	16.7	12.5	7.9	4.0
MMD2	PAQR10	ENSG00000136297	"Monocyte to macrophage differentiation associated 2"	Q8IY49	7	4905989-4959213	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"brain: 38.5;testis: 10.1"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 2.0;Muller glia cells: 2.4;Rod photoreceptor cells: 2.3"	"Cancer enriched"	"Detected in single"	59	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.9;SH-SY5Y: 2.0;U-87 MG: 1.0"	"Low region specificity"	"Detected in all"													NA	NA										"unprognostic (2.32e-1)"							"unprognostic (1.53e-2)"		"unprognostic (5.03e-2)"	"unprognostic (2.03e-1)"			0.9	1.2	10.6	0.9	16.2	0.8	0.8	2.4	38.5	0.9	0.9	4.0	0.0	0.9	0.8	0.9	0.9	0.8	0.9	0.8	7.4	6.5	0.9	0.8	0.8	0.9	7.4	6.8	1.0	0.8	0.8	1.9	0.8	7.9	0.9	0.9	1.4	1.0	1.0	0.8	0.8	1.0	0.9	16.7	0.8	0.9	10.1	3.7	0.0	0.9	0.0	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.6	16.2	2.4	9.8	7.4	6.5	7.4	6.8	7.9	3.7	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0
MMGT1	"EMC5, TMEM32"	ENSG00000169446	"Membrane magnesium transporter 1"	Q8N4V1	X	135962070-135974063	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA032037	Approved					NA	NA					"HPA032037: AB_10670705"	"prognostic unfavorable (8.54e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.23e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (1.94e-5)"	"unprognostic (6.08e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.29e-2)"	25.6	13.4	12.2	11.4	21.3	25.6	16.7	13.7	22.7	19.5	18.7	17.0	10.0	12.5	24.8	17.9	18.5	17.0	15.4	18.0	12.1	18.0	19.4	10.7	18.8	19.2	14.4	12.3	18.6	14.8	18.4	20.8	13.5	15.8	17.5	17.1	17.2	16.5	15.6	28.0	14.2	13.9	21.0	18.8	14.5	16.5	7.2	9.8	23.3	23.6	12.9	14.2	24.6	15.3	8.6	11.7	9.7	14.3	10.7	15.3	9.7	13.9	8.4	8.6	13.5	17.9	17.3	11.1	15.7	15.2	13.3	26.5	9.8	21.7	9.2	31.2	17.0	15.6	12.7	21.6	11.7	20.8	10.3	12.4	5.7	10.8	6.2	13.2	12.8	10.1	14.0	21.3	22.3	16.3	13.9	9.9	10.8	7.8	19.3	15.0	14.5	9.5	8.7	6.0	17.3	13.2	8.8	13.7	17.2	12.2	7.6	12.5	11.5	8.4	10.1	21.6	13.2	8.5	7.8	10.1	16.4	9.7	23.7	21.1	11.8	16.6	10.0	14.0	19.2	18.7	9.7	12.3	7.2	9.5	12.5	12.5	8.6	13.1	11.5	11.7	6.2	12.8	12.2	6.2	10.7	14.3	8.0	15.3	9.7	12.2	21.3	13.7	22.7	12.1	18.0	14.4	12.3	15.8	9.8	11.9	10.7	10.0	15.3	19.7	15.1	23.7	15.3	8.1	12.5	14.0	7.9	6.4	6.6	11.2	0.0	11.7	14.8	0.0	10.6	10.3	10.8	19.3	13.9	9.6	13.4	19.1	24.8	14.1	31.7	0.2	12.7	20.8	25.3	7.2	16.7	16.7	11.4	3.5	18.0	12.9	9.9	6.5	21.7	1.4	7.9	21.7	9.6	13.8	14.5	14.8
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 149.8;liver: 129.7"	"Cell type enhanced"	"Detected in all"	12	"Cardiomyocytes: 875.4;Distal tubular cells: 1458.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	13.1	9.4	27.1	7.2	28.5	10.9	12.2	12.3	21.6	12.4	21.1	26.1	8.3	18.8	8.4	10.5	16.0	8.3	9.5	149.8	27.6	21.5	56.1	129.7	10.0	8.7	39.2	18.3	10.5	14.9	12.4	9.4	5.4	23.8	10.3	19.9	11.5	23.0	10.5	63.3	9.2	16.9	11.0	43.3	9.2	19.7	5.0	25.8	9.0	18.6	43.9	9.9	10.6	8.1	12.2	26.5	32.2	43.7	13.9	24.5	17.1	6.5	1.9	8.1	27.9	23.6	13.6	12.0	7.5	12.2	11.8	11.5	9.9	4.6	13.7	13.6	11.6	9.5	6.2	12.1	9.5	8.3	9.3	20.8	6.8	10.1	32.9	9.8	26.2	8.9	10.9	13.4	9.6	6.9	3.6	9.5	21.3	23.6	21.9	7.3	10.4	18.2	48.6	4.1	37.3	9.2	10.0	13.5	34.2	22.0	5.2	25.5	22.6	8.7	38.0	8.6	7.0	9.0	39.4	6.6	6.9	7.1	24.2	7.7	15.0	10.3	11.4	6.3	32.4	10.9	18.6	23.0	32.2	16.4	35.3	15.4	12.2	19.4	17.6	26.5	9.2	18.2	17.4	20.4	13.9	43.7	15.7	24.5	17.1	27.1	28.5	12.3	21.6	27.6	21.5	39.2	18.3	23.8	25.8	110.2	37.1	53.6	36.9	40.5	51.2	875.4	183.4	44.2	47.8	101.2	9.8	19.1	1458.9	78.7	46.1	45.8	147.2	23.3	122.5	67.4	59.4	34.7	70.3	365.8	104.2	46.1	35.7	38.6	74.2	5.6	61.5	76.9	123.2	111.8	87.8	137.3	56.8	120.7	84.5	301.3	55.1	90.5	90.6	126.5	39.4	48.8	20.4	54.3	110.8	45.7
MPC2	"BRP44, DKFZP564B167, SLC54A2"	ENSG00000143158	"Mitochondrial pyruvate carrier 2"	O95563	1	167916729-167937040	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 111.7"	"Cell type enhanced"	"Detected in all"	13	"Early spermatids: 1811.9;Late spermatids: 3927.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPTEC TERT1: 94.3"	"Low region specificity"	"Detected in all"							HPA056091	Uncertain					NA	NA					"HPA056091: AB_2683035"	"unprognostic (3.25e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.79e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.67e-1)"	13.5	22.5	22.6	11.5	21.6	33.5	23.0	15.0	25.3	11.7	26.8	12.1	10.2	27.1	7.8	12.5	12.2	9.9	25.2	46.2	19.0	17.7	46.4	92.9	9.9	11.4	18.8	16.7	9.6	14.7	9.6	18.4	9.9	13.5	34.4	24.8	11.9	20.6	10.8	45.0	9.3	26.3	13.1	16.5	7.4	29.6	111.7	11.4	12.7	11.9	23.5	10.9	11.2	8.1	23.4	28.7	45.3	18.5	27.4	40.2	37.2	18.3	17.6	7.8	17.7	19.5	18.1	1.7	30.1	16.9	14.2	16.6	40.8	10.3	31.9	21.9	17.2	11.6	14.9	10.5	16.3	14.7	40.8	15.7	13.9	18.0	32.4	13.1	15.0	10.3	11.6	14.9	25.5	14.7	12.4	12.4	23.7	17.1	18.7	25.3	8.5	22.2	15.5	12.9	42.3	22.1	11.7	14.2	25.3	94.3	16.1	12.4	12.6	17.3	20.6	16.6	18.9	37.0	19.3	11.4	15.3	11.3	22.2	13.9	24.9	28.3	35.1	39.4	13.6	8.0	41.0	16.6	45.3	23.7	14.6	25.3	23.4	29.3	25.0	28.7	20.6	27.7	26.5	31.8	27.4	18.5	20.7	40.2	37.2	22.6	21.6	15.0	25.3	19.0	17.7	18.8	16.7	13.5	11.4	32.8	46.1	92.5	122.7	112.0	55.3	407.2	440.8	125.8	42.1	123.9	21.6	444.8	868.7	156.5	1811.9	78.2	261.8	93.5	128.1	44.4	116.0	241.3	87.6	688.4	140.6	42.9	318.3	49.7	62.2	3927.7	98.4	101.0	114.7	412.0	246.3	79.1	95.6	240.2	106.1	749.3	55.3	64.7	116.9	623.0	121.0	100.0	287.0	99.6	339.8	130.5
MPEG1	MPG1	ENSG00000197629	"Macrophage expressed 1"	Q2M385	11	59208510-59212951	"Predicted membrane proteins, Transporters"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 47.3;lymphoid tissue: 108.6"	"Cell type enriched"	"Detected in many"	5	"Kupffer cells: 355.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 47.3;intermediate monocyte: 38.9;myeloid DC: 26.6;non-classical monocyte: 41.6;plasmacytoid DC: 38.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 38.3;monocytes: 47.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.8;HMC-1: 1.3;THP-1: 3.8"									HPA046801	Approved					NA	NA					"HPA046801: AB_2679814"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	17.6	6.4	2.2	27.7	2.1	3.6	5.9	1.3	1.8	3.3	9.5	4.9	0.9	9.0	3.2	13.2	3.7	4.9	8.2	7.7	2.2	2.3	7.0	17.3	13.1	51.3	2.6	1.0	4.2	2.7	0.8	2.3	13.4	2.5	5.6	10.0	8.9	7.5	2.4	2.9	2.6	20.6	6.0	3.9	108.6	4.0	3.2	1.7	18.5	3.7	5.5	23.0	11.0	2.7	2.9	38.3	7.0	47.3	0.2	0.1	29.1	0.0	0.0	0.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.3	0.5	0.5	0.1	0.0	0.5	0.4	0.7	0.0	0.5	0.3	0.5	0.2	0.0	0.0	0.0	0.0	3.8	0.5	0.0	0.2	0.4	0.0	0.9	0.1	0.5	0.0	0.2	0.1	0.0	47.3	1.4	0.1	38.9	0.1	2.4	0.0	0.0	26.6	2.9	0.0	0.0	7.0	0.2	41.6	38.3	0.1	29.1	2.2	2.1	1.3	1.8	2.2	2.3	2.6	1.0	2.5	1.7	0.0	12.2	29.3	0.0	1.0	0.0	1.2	2.5	1.4	1.2	0.0	0.0	0.3	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.4	0.9	0.0	2.3	1.7	41.8	0.0	0.0	6.2	355.6	0.0	0.0	71.1	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	6.5	0.3	0.0	0.0	1.4	0.2	0.0	0.0	0.0
MPV17	SYM1	ENSG00000115204	"MPV17, mitochondrial inner membrane protein"	P39210	2	27309492-27325680	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (9.34e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (6.99e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.10e-3)"	"unprognostic (4.62e-2)"	25.2	49.2	25.5	18.3	26.6	13.8	20.9	15.2	41.5	20.0	15.1	29.5	8.4	12.8	20.7	25.3	17.0	20.4	18.7	39.5	24.0	23.6	25.0	16.0	20.2	19.8	24.9	22.9	23.6	17.7	26.3	21.2	17.5	27.7	17.7	18.1	28.8	18.4	19.2	8.8	15.0	13.4	30.1	25.8	20.5	15.1	10.3	22.8	15.2	26.8	12.6	23.8	21.0	14.7	30.7	45.6	18.7	35.8	26.4	30.1	30.7	17.9	17.0	12.6	10.8	53.2	61.5	12.0	17.9	36.0	17.3	15.5	13.6	13.2	10.2	18.7	24.2	31.9	15.4	16.1	33.5	18.0	14.0	13.0	19.0	15.0	25.4	31.8	11.4	12.6	60.2	28.8	30.3	43.6	23.9	25.2	12.2	18.4	19.6	28.1	26.2	11.0	16.1	14.1	26.3	13.6	15.9	17.3	20.8	36.9	14.6	8.4	27.2	9.5	11.1	19.0	13.1	12.4	14.9	22.4	17.4	17.5	21.3	18.8	26.4	25.3	31.0	28.2	24.3	19.2	18.7	35.8	15.7	24.0	29.8	26.1	30.7	25.0	27.0	45.6	26.5	24.2	27.9	3.2	26.4	28.3	33.0	30.1	30.7	25.5	26.6	15.2	41.5	24.0	23.6	24.9	22.9	27.7	22.8	23.8	24.0	31.8	29.7	15.2	21.7	41.5	25.5	25.4	21.6	31.4	7.9	45.3	54.7	33.2	22.9	32.4	9.6	0.0	21.2	50.9	29.8	26.7	41.5	11.9	96.0	7.9	16.1	22.7	26.2	23.7	32.8	30.1	38.8	39.7	14.6	25.8	21.1	11.5	32.9	59.3	12.2	0.0	28.6	14.0	19.5	16.4	49.7	20.8	19.1	25.5
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013409	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Fibroblasts: 34.7;Leydig cells: 61.2;Peritubular cells: 94.7;Sertoli cells: 51.8;Smooth muscle cells: 90.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	4	"cerebellum: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 26.8;ASC TERT1: 12.0;BJ: 15.1;BJ hTERT+: 38.1;BJ hTERT+ SV40 Large T+: 14.3;fHDF/TERT166: 11.6;U-2197: 18.2"	"Region enriched"	"Detected in some"	5	"cerebellum: 16.6"	"Low region specificity"	"Detected in all"			HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	10.8	1.7	0.8	7.6	1.2	0.0	26.6	7.8	1.5	61.9	39.5	1.2	13.9	4.8	49.2	22.3	28.2	28.0	30.6	6.2	0.7	0.4	4.2	2.1	4.8	5.6	1.1	1.3	25.6	0.9	0.4	1.1	5.9	1.8	29.6	4.8	5.8	2.9	25.5	3.1	4.0	10.1	41.1	1.0	8.2	14.2	13.1	0.6	0.1	3.8	6.4	2.7	42.2	19.6	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	26.8	12.0	0.5	15.1	38.1	14.3	9.5	0.0	0.6	0.0	0.3	11.6	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	1.1	0.0	3.3	0.0	0.0	8.8	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	0.6	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	8.8	0.0	18.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.2	7.8	1.5	0.7	0.4	1.1	1.3	1.8	0.6	0.0	0.0	0.0	0.2	4.4	0.0	0.6	2.5	0.0	0.0	10.4	0.0	0.6	0.0	0.0	3.6	0.6	0.0	0.0	0.0	0.6	34.7	0.3	0.0	3.4	0.9	0.0	0.0	5.5	0.0	5.2	61.2	0.0	6.8	0.0	0.0	2.8	0.1	0.0	94.7	0.6	0.2	51.8	90.4	1.0	0.5	3.3	0.9	0.0	0.0	0.2
MRLN	"Linc-RAM, LINC00948, M1, MLN, MUSER1"	ENSG00000227877	Myoregulin	P0DMT0	10	59736692-59756041	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 14.1;skeletal muscle: 59.2;tongue: 22.0"	"Group enriched"	"Detected in some"	5	"Ciliated cells: 65.6;Rod photoreceptor cells: 27.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"					"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	10	"RH-30: 22.7"	"Region enriched"	"Detected in single"	11	"cerebellum: 24.2"	"Low region specificity"	"Detected in some"									NA	NA							"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.54e-1)"	"unprognostic (3.17e-3)"		"unprognostic (9.77e-2)"		"unprognostic (1.09e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	0.8	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.7	2.2	0.0	0.0	0.0		4.5	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	4.4	0.0	0.9	0.4	0.0	1.2	0.1	0.0	59.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.9	22.0	0.7	0.0	0.0	2.5	1.7	4.2	1.4	1.7	2.4	0.4	0.0	0.8	0.4	0.9	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.8	0.6	1.1	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.7	0.2	1.9	0.3	0.1	0.0	1.1	1.9	0.0	0.6	0.0	0.1	0.0	0.1	0.1	1.3	0.0	2.1	0.0	0.9	0.2	0.2	1.6	0.5	22.7	0.0	0.0	0.1	0.6	0.2	0.3	0.1	0.1	0.1	0.4	0.7	0.0	0.3	0.8	0.9	0.6	1.1	0.1	0.1	0.4	0.3	0.0	4.2	1.4	1.6	2.4	1.0	1.7	2.0	1.7	1.5	1.2	2.5	1.2	2.1	4.2	1.7	1.0	1.7	1.5	0.4											0.0	0.3	0.0	0.0	0.0	2.2	0.9	0.0	65.6	3.4	0.0	2.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	4.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	3.3	0.4	0.0	0.4	10.2	27.6	0.0	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0
MRS2	MRS2L	ENSG00000124532	"MRS2, magnesium transporter"	Q9HD23	6	24402908-24426194	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017642	Uncertain					NA	NA					"HPA017642: AB_2669628"	"unprognostic (2.12e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-3)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (7.23e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.89e-3)"	"prognostic favorable (5.14e-11)"	"unprognostic (8.75e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.55e-3)"	14.3	18.6	13.0	16.3	16.1	6.2	18.4	27.4	17.8	11.8	14.5	10.9	15.2	15.7	11.5	15.9	14.5	10.3	12.8	34.1	15.6	13.7	24.4	17.7	11.4	14.0	14.9	15.1	13.8	24.1	16.3	18.9	19.1	14.4	14.1	16.6	16.3	16.9	22.3	47.7	14.0	15.0	12.2	12.1	15.4	15.4	7.9	11.4	11.1	17.4	20.9	14.9	13.9	11.6	11.5	19.4	5.4	15.2	11.2	12.4	9.6	13.2	7.6	9.7	17.2	6.2	5.8	20.8	6.2	7.5	8.0	7.2	30.1	6.2	7.9	25.3	5.4	12.1	8.3	9.6	11.9	8.6	9.6	16.9	12.8	6.6	34.4	9.1	14.1	11.3	9.0	9.6	7.9	6.4	9.2	8.3	10.2	17.7	0.0	8.8	10.3	13.3	13.6	25.3	7.6	7.1	0.1	1.7	17.5	35.0	13.7	14.9	9.1	10.3	32.1	16.9	29.4	16.2	10.1	3.7	3.4	5.3	7.1	11.7	14.4	23.7	10.8	4.3	17.2	14.2	2.3	13.1	5.4	9.5	15.2	12.4	11.5	10.2	10.4	19.4	8.2	11.5	10.6	1.5	11.2	13.5	11.4	8.7	9.6	13.0	16.1	27.4	17.8	15.6	13.7	14.9	15.1	14.4	11.4	32.8	18.3	12.7	11.4	6.4	31.0	50.4	17.8	10.7	11.4	19.2	37.3	38.2	44.7	19.2	0.2	9.5	10.6	0.0	16.5	18.6	12.4	12.6	11.5	12.5	19.8	47.7	9.2	16.5	15.1	0.0	11.2	13.9	6.8	15.4	15.0	21.1	14.0	17.5	15.6	32.6	41.5	19.4	8.9	5.6	10.4	9.8	21.2	12.9	23.3	12.3
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455752-60470760	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 77.7;intestine: 46.1;lymphoid tissue: 134.1"	"Cell type enriched"	"Detected in some"	61	"B-cells: 527.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	105	"memory B-cell: 77.7;naive B-cell: 77.7"	"Lineage enriched"	"Detected in single"	105	"B-cells: 77.7"	"Group enriched"	"Detected in some"	25	"Daudi: 122.9;U-698: 61.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favorable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	1.6	0.3	0.3	79.0	0.3	3.6	0.6	0.3	0.3	0.5	2.0	0.0	0.0	0.2	0.4	0.5	7.0	0.4	1.3	0.7	0.3	0.3	2.0	0.9	2.7	81.2	0.3	0.1	0.3	0.4	0.0	0.4	0.4	0.1	1.1	1.7	0.6	14.5	0.2	0.3	0.3	46.1	0.1	0.4	90.7	2.6	0.6	0.0	15.7	2.5	2.7	134.1	6.4	0.8	77.7	0.0	0.2	0.0	0.7	0.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	122.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	77.7	0.3	0.6	0.0	77.7	0.0	0.2	0.2	0.7	0.0	0.0	0.0	3.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.0	0.0	6.7	527.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.6	1.8	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.7	0.0	0.0
MS4A10	"CD20L7, MS4A9"	ENSG00000172689	"Membrane spanning 4-domains A10"	Q96PG2	11	60785348-60801305	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	33	"intestine: 115.7"	"Cell type enhanced"	"Detected in single"	26	"Enterocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;NB-4: 2.4"					"Low region specificity"	"Detected in all"			HPA014778	Uncertain					NA	NA					"HPA014778: AB_2669089"					"unprognostic (7.67e-3)"						"unprognostic (1.28e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.27e-1)"	"unprognostic (5.21e-2)"			0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	28.3	0.0	0.0	33.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	115.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	3.5	0.5	0.9	0.5	0.1	0.3	0.9	0.4	0.2	0.2	0.0	2.3	0.2	0.1	0.1	0.0	0.8	0.2	0.4	0.3	0.1	0.0	0.7	0.2	0.3	0.2	0.0	0.3	2.1	0.7	0.3	0.1	0.6	1.9	0.0	0.0	0.6	0.3	0.2	0.0	0.3	0.5	1.4	0.7	0.3	0.5	2.4	0.0	0.4	0.3	0.2	0.0	1.7	0.1	0.4	1.0	1.0	0.4	0.6	0.0	0.8	0.4	0.2	1.5	0.7	0.2	1.5	0.3	0.2	0.2	0.4	0.4	0.7	0.2	3.5	0.4	0.7	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.8	0.5	0.5	1.4	0.9	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3
MS4A14	"DKFZp434H092, FLJ32856, MS4A16, NYD-SP21"	ENSG00000166928	"Membrane spanning 4-domains A14"	Q96JA4	11	60378530-60417756	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 79.3;testis: 53.6"	"Group enriched"	"Detected in some"	41	"Early spermatids: 207.0;Late spermatids: 514.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 6.8;non-classical monocyte: 9.2"	"Lineage enriched"	"Detected in many"	5	"monocytes: 9.2"	"Cell line enriched"	"Detected in single"	24	"THP-1: 14.6"									HPA058973			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			Nucleoplasm	"Plasma membrane"	"HPA058973: "	"unprognostic (1.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.50e-6)"	"unprognostic (3.73e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.11e-2)"	14.5	4.4	2.0	4.6	2.3	1.5	5.4	0.8	1.5	2.4	3.9	1.9	1.1	1.5	1.9	6.4	1.8	1.3	2.3	6.4	2.5	2.3	3.5	13.3	18.0	11.3	2.4	0.1	1.3	1.5	1.2	3.2	6.0	2.4	3.0	2.2	4.5	2.1	1.6	1.3	1.3	4.0	2.4	5.5	79.3	1.5	53.6	1.5	3.7	1.7	0.7	3.0	2.4	1.7	0.5	1.8	0.1	9.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	4.3	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.1	0.0	9.2	0.0	0.0	0.9	2.0	2.3	0.8	1.5	2.5	2.3	2.4	0.1	2.4	1.5	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	207.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	7.5	514.6	3.7	8.8	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	6.5	0.0	5.7	2.4	0.3	0.1	0.0	0.0	0.0
MS4A2	"APY, FCER1B, IGER, MS4A1"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098466	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 72.0"	"Cell type enriched"	"Detected in some"	18	"granulocytes: 912.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	720	"basophil: 72.0"	"Lineage enriched"	"Detected in single"	720	"granulocytes: 72.0"	"Cell line enhanced"	"Detected in some"		"HEL: 7.1;NB-4: 2.6;THP-1: 4.2;U-937: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059967	Enhanced					NA	NA					"HPA059967: AB_2684183"	"unprognostic (7.28e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.47e-1)"	"unprognostic (2.40e-6)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.49e-3)"	"unprognostic (9.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.74e-1)"	4.9	0.5	0.4	5.1	0.4	0.2	2.1	0.4	0.4	11.9	4.6	0.1	4.5	4.7	14.3	11.2	5.9	1.1	14.6	2.1	0.4	0.4	1.5	0.9	12.9	0.5	0.4	0.1	1.1	1.2	0.2	0.6	0.6	0.1	17.5	5.6	4.5	3.2	5.4	1.5	4.3	7.4	15.9	0.4	0.6	4.5	2.7	0.2	1.2	0.6	6.7	3.4	5.1	4.1	0.0	0.0	72.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.2	0.0	0.3	0.0	0.0	0.1	0.3	0.2	0.4	0.1	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.0	7.1	0.5	0.2	0.3	0.9	0.4	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.9	0.3	0.0	0.1	0.0	2.6	0.1	0.0	0.1	0.1	0.0	0.2	0.0	1.0	0.2	0.1	0.1	0.2	0.0	0.0	0.3	4.2	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.2	1.9	0.2	72.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.1	0.1	0.2	0.0	51.4	0.0	0.6	0.0	0.4	0.4	0.0	1.4	12.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	912.4	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Deafness, Disease mutation, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 396.5;heart muscle: 345.0;skeletal muscle: 380.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 81405.0;Enterocytes: 59874.1"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 872.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"CAB016241: AB_2229888, HPA069328: AB_2686122"	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	57.6	82.5	184.1	22.2	164.2	26.4	37.4	40.6	117.1	31.5	80.8			78.1	25.7	42.7	43.5	24.8	32.4	345.0	161.8	111.7	151.0	150.5	20.9	22.6	126.3		23.7	42.5	62.3	10.1	29.0		35.8	84.4		65.6	54.2	380.7	68.9	60.0	38.2	61.2	28.1	65.5	27.8			23.8		21.9	31.6	15.3	292.2	232.9	177.4	396.5	182.8	192.4	130.5	114.5	173.2	235.7	256.3	540.3	247.5	249.9	261.4	87.1	66.0	110.6	208.4	373.6	302.7	125.7	198.6	65.0	435.2	26.9	231.6	94.6	143.0	165.0	181.7	872.7	389.9	74.8	104.9	230.2	288.6	241.1	65.3	145.0	306.7	79.4	172.7	115.3	217.3	195.5	277.4	85.7	469.5	59.9	156.0	141.8	112.3	70.4	181.6	334.7	303.0	112.7	150.2	90.6	351.3	163.0	296.6	201.5	352.9	316.5	264.7	180.2	259.8	131.1	103.0	98.6	68.6	130.7	276.7	128.6	177.4	396.5	169.3	156.6	236.0	176.4	255.6	154.9	171.8	163.0	292.2	159.7	192.4	93.5	182.8	260.1	232.9	138.6	130.5											2694.8	3022.9	23660.6	9171.4	8678.3	0.0	81405.0	28094.1	4463.5	5243.5	18590.0	0.0	0.0	3606.0	6482.3	1224.4	4243.1	59874.1	34807.7	4485.9	0.0	3116.3	8181.6	3594.1	45857.2	0.0	0.0	7240.0	18002.1	27410.8	6497.0	10830.0	8032.7	6539.1	13021.9	32338.6	0.0	5722.6	29051.7	7980.9	24852.9	0.0	13394.3	6634.5	9840.4	12887.5	10030.7	0.0	18830.6	25753.2	17251.8
MT-CO2	"CO2, COX2, MTCO2"	ENSG00000198712	"Mitochondrially encoded cytochrome c oxidase II"	P00403	MT	7586-8269	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 489.9;skeletal muscle: 343.4"	"Cell type enriched"	"Detected in many"	10	"Cardiomyocytes: 412590.4"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 1073.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016243, HPA051505, HPA054758"	Enhanced					NA	NA		1300000			"CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.72e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.25e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.72e-3)"	54.6	64.8	149.7	21.7	194.8	30.2	45.5	48.9	99.5	27.0	106.9			73.6	23.8	46.3	35.8	25.1	23.7	252.1	151.9	112.4	158.4	173.8	22.7	22.8	154.6		21.2	46.4	50.4	22.5	41.4		38.2	106.4		61.7	56.0	343.4	56.4	51.1	40.0	77.8	25.9	68.5	28.2			23.3		29.5	29.9	16.2	379.8	278.1	489.9	409.1	220.4	273.9	181.4	111.2	179.1	238.3	230.3	487.6	188.0	175.6	145.1	117.7	82.5	124.6	192.6	251.5	232.6	121.5	213.4	84.9	422.7	31.5	298.5	111.8	180.1	161.5	166.8	1073.7	370.2	106.1	140.2	187.4	275.7	441.7	42.5	152.4	270.3	91.3	232.4	155.7	226.9	226.0	240.8	102.5	404.1	62.3	220.6	114.0	107.2	72.6	194.8	336.5	310.9	89.2	147.6	119.5	294.8	209.6	367.9	205.2	568.6	225.1	200.0	173.5	188.5	102.0	115.3	114.6	131.1	106.4	283.3	131.3	489.9	409.1	476.0	194.9	292.9	236.6	379.8	217.1	218.8	205.5	378.1	227.9	273.9	180.3	220.4	308.7	278.1	170.3	181.4											1343.0	1746.9	18282.0	6995.6	5999.6	0.0	412590.4	19500.5	2813.3	2462.5	17642.7	0.0	0.0	3143.4	3272.8	866.0	2789.7	27604.7	22029.3	4281.1	0.0	1817.5	4991.0	2029.2	43011.4	0.0	0.0	6162.7	12438.4	17929.8	4401.0	7095.7	4687.5	4875.7	4595.3	21499.4	0.0	3881.8	14501.3	4815.7	15512.8	0.0	6946.2	3920.2	6682.3	8100.4	5859.1	0.0	11198.1	21247.6	11593.6
MT-CO3	"CO3, COIII, COX3, MTCO3"	ENSG00000198938	"Mitochondrially encoded cytochrome c oxidase III"	P00414	MT	9207-9990	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase	"Disease mutation, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 319.5"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 76804.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 810.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042788	Approved					NA	NA					"HPA042788: AB_10793985"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.01e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.33e-2)"	56.5	83.7	174.1	20.5	149.4	34.8	55.5	47.4	106.2	30.5	90.9			76.1	27.5	46.0	40.4	26.3	28.7	290.4	159.6	111.4	190.3	143.1	21.0	22.8	120.2		27.9	38.9	60.5	26.7	32.5		37.3	95.5		79.0	64.3	319.5	70.0	55.3	39.0	61.9	21.7	60.5	36.5			31.0		31.0	26.9	18.7	247.1	126.7	244.3	245.3	141.7	181.1	106.8	130.8	155.4	238.8	339.1	475.8	196.3	130.7	170.6	101.1	67.4	104.1	208.0	195.6	292.9	73.9	141.6	73.7	359.5	37.6	204.9	119.5	99.3	164.3	155.7	810.6	345.5	96.2	92.6	205.1	188.5	291.4	74.1	110.5	238.7	124.6	168.0	123.3	296.8	222.5	267.4	94.0	540.0	53.0	208.4	112.2	100.6	75.3	211.0	420.2	231.5	107.0	148.6	79.5	87.1	164.8	347.1	182.0	408.6	199.6	113.0	193.8	211.0	111.3	122.2	78.6	163.5	112.8	302.0	74.2	132.0	245.3	121.5	110.0	128.3	137.4	198.7	119.5	127.0	126.7	247.1	153.2	181.1	244.3	141.7	122.3	107.8	79.5	106.8											1774.7	2343.8	18268.7	8249.8	7411.8	0.0	76804.5	19304.4	3075.6	3885.5	15697.2	0.0	0.0	3702.1	4549.9	1673.9	3293.3	31596.9	21118.2	5876.9	0.0	3002.6	5473.3	1979.3	30765.6	0.0	0.0	6556.1	11050.6	17592.2	7669.6	10722.1	5677.4	5267.0	6541.2	23740.6	0.0	4985.0	16907.1	7340.6	25199.2	0.0	11945.6	6322.1	9983.2	10814.8	7412.6	0.0	11568.9	24590.7	11079.5
MTCH1	"CGI-64, PSAP, SLC25A49"	ENSG00000137409	"Mitochondrial carrier 1"	Q9NZJ7	6	36968141-36986298	"Predicted membrane proteins, Transporters"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 146.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015971	Approved					NA	NA					"HPA015971: AB_1854171"	"unprognostic (3.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.35e-3)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.32e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.68e-2)"	"unprognostic (4.70e-2)"	32.3	50.8	46.3	25.6	57.2	45.2	31.3	28.4	86.3	34.1	26.1	43.1	32.0	25.8	26.7	91.7	25.8	44.0	34.3	47.6	46.9	56.9	31.0	29.6	33.7	23.4	47.1	47.0	38.0	34.7	33.0	52.8	28.9	49.3	34.4	27.5	31.5	34.2	58.8	21.6	37.2	23.2	32.1	45.8	27.7	28.9	21.5	32.4	21.3	98.9	18.3	23.7	23.3	56.3	14.8	17.7	23.9	23.7	10.6	17.6	8.4	28.6	19.4	26.2	32.6	39.7	27.1	15.1	33.7	31.5	47.7	49.8	31.8	17.8	14.4	30.1	56.4	45.9	25.1	28.5	27.1	55.6	15.1	27.6	14.9	33.2	24.2	28.8	9.6	14.0	30.4	21.3	44.0	21.8	41.7	40.7	19.9	26.8	14.8	30.0	32.1	19.2	21.6	25.7	25.8	22.3	17.9	20.4	15.0	26.0	24.0	42.5	18.3	24.5	21.5	29.7	27.5	27.6	26.6	44.9	47.6	38.0	37.2	36.3	13.0	13.1	146.1	17.4	26.5	37.6	6.3	19.0	23.9	8.9	18.9	8.3	10.1	16.7	17.6	17.7	14.8	15.5	9.3	21.7	10.6	23.7	9.8	11.7	8.4	46.3	57.2	28.4	86.3	46.9	56.9	47.1	47.0	49.3	32.4	44.7	85.6	50.2	157.0	101.0	0.0	139.3	96.8	32.1	70.5	66.3	0.0	156.3	142.6	190.2	6.0	114.2	120.7	70.0	149.2	190.3	178.9	169.5	28.8	45.5	161.7	0.0	143.2	73.1	86.8	10.9	128.0	80.4	129.9	242.5	104.4	0.0	154.2	143.8	124.5	103.2	0.0	51.8	128.2	16.3	60.8	107.9	207.7	55.4	120.0	163.4
MTCH2	SLC25A50	ENSG00000109919	"Mitochondrial carrier 2"	Q9Y6C9	11	47617315-47642623	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.8"	"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 432.9;Proximal tubular cells: 398.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA038390	Approved		Approved	Mitochondria		NA	NA		55000	Mitochondria		"HPA038390: AB_10669723"	"unprognostic (4.94e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.12e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	13.6	19.6	15.6	12.8	20.3	8.3	12.5	14.1	21.3	10.4	22.3	19.3	8.7	28.3	12.6	15.1	21.6	9.9	11.6	15.0	14.0	13.8	40.8	74.8	9.1	13.9	15.2	12.2	9.3	14.4	16.8	9.3	9.5	15.4	11.8	24.7	13.6	13.4	10.0	31.4	12.1	33.9	16.1	11.4	11.4	10.1	44.2	10.2	15.1	15.5	24.9	16.4	11.6	10.7	13.7	25.7	7.9	21.3	12.1	13.6	17.5	18.9	20.8	17.8	24.0	21.1	19.6	13.2	20.6	18.9	27.8	26.4	16.5	19.4	26.2	11.2	25.2	30.1	23.9	31.9	27.1	33.9	13.1	29.8	15.0	29.7	32.9	29.1	31.2	15.1	22.1	21.4	18.5	27.7	16.2	25.1	22.6	27.7	15.8	33.9	27.6	23.9	23.5	19.3	37.2	31.6	22.4	27.1	18.8	32.2	24.6	21.2	14.9	28.2	28.5	14.5	17.6	41.0	14.7	20.8	25.7	22.4	42.5	26.4	16.8	19.1	29.6	21.2	27.2	22.9	5.9	19.8	7.9	12.7	21.3	12.0	13.7	11.1	11.7	25.7	10.9	9.7	11.2	1.9	12.1	17.0	16.9	13.6	17.5	15.6	20.3	14.1	21.3	14.0	13.8	15.2	12.2	15.4	10.2	20.8	33.9	37.2	43.0	41.8	0.0	61.0	81.5	46.8	37.5	50.6	0.0	75.5	154.2	136.5	432.9	25.1	133.4	0.0	95.3	101.6	32.1	64.6	35.9	265.9	146.4	0.0	76.7	35.0	64.2	110.8	26.7	50.7	77.6	112.8	82.5	0.0	85.1	63.1	54.8	398.6	0.0	32.3	38.1	327.5	81.0	47.3	106.9	37.6	134.8	50.4
MTNR1A	MEL-1A-R	ENSG00000168412	"Melatonin receptor 1A"	P48039	4	186533655-186555567	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.8;intestine: 3.1;kidney: 5.7;testis: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.8;EFO-21: 2.0;HEK 293: 2.1;NTERA-2: 1.8;SCLC-21H: 1.6;SH-SY5Y: 3.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA								"unprognostic (7.99e-2)"			"unprognostic (2.27e-1)"		"unprognostic (2.16e-1)"		"unprognostic (3.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.20e-2)"	"unprognostic (8.81e-2)"				0.0	0.0	0.1	1.2	0.1	0.0	0.0	3.8	0.2	0.0	3.1			0.3	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	5.7	0.0	0.0	0.0	0.0		0.0	1.6	0.0	0.0	0.0		0.0	2.4		0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5			0.0		0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.5	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MVP	"LRP, VAULT1"	ENSG00000013364	"Major vault protein"	Q14764	16	29820394-29848039	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	Ribonucleoprotein	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Enterocytes: 450.3;monocytes: 338.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 69.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002321, CAB002752, CAB022717, HPA064740"	Enhanced		Supported	Cytosol		NA	NA		38000	Cytosol		"CAB002752: , CAB022717: , HPA002321: AB_1079277, HPA064740: AB_2685342"	"prognostic favorable (4.51e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.86e-1)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.65e-2)"	32.4	55.4	6.8	37.8	17.9	13.9	20.7	5.4	11.4	20.5	49.5	12.0	11.7	48.7	29.5	29.0	28.6	21.0	46.6	27.8	6.6	6.0	58.9	43.6	57.9	59.4	20.4	4.9	42.7	37.2	8.9	14.6	22.8	13.2	18.3	32.6	14.5	23.3	14.8	16.9	17.6	81.5	24.4	14.6	38.8	34.2	27.4	13.5	17.4	27.1	23.5	23.3	25.4	21.6	10.1	28.7	41.1	53.1	17.6	22.4	33.3	10.6	31.5	0.9	1.0	37.5	49.2	4.6	27.0	44.5	16.5	21.4	4.7	36.1	2.0	22.0	39.5	19.2	13.7	1.5	23.6	8.0	25.7	1.6	0.6	13.6	14.1	33.9	1.0	11.5	64.2	18.6	36.6	10.8	30.6	47.8	2.6	0.7	15.4	29.1	5.3	0.5	2.7	1.0	15.8	3.9	2.4	1.6	6.7	39.7	18.2	3.7	2.1	7.7	10.0	5.6	2.0	2.3	3.8	69.8	21.5	10.7	20.6	10.8	12.1	8.6	1.1	50.1	1.9	4.5	9.7	33.8	13.4	19.3	53.1	15.1	10.1	21.8	19.8	28.7	7.1	16.8	14.9	41.1	17.6	47.5	17.5	22.4	33.3	6.8	17.9	5.4	11.4	6.6	6.0	20.4	4.9	13.2	13.5	44.7	98.7	34.8	31.6	17.4	4.2	10.1	86.6	40.2	47.8	66.3	2.0	102.0	38.1	233.0	4.4	35.9	450.3	23.3	272.7	63.2	42.2	19.8	33.4	21.2	72.1	7.9	54.3	39.9	45.7	14.1	53.2	49.6	30.4	338.2	134.2	3.3	221.7	280.5	44.9	146.5	4.3	19.4	32.8	1.7	1.3	19.2	221.2	37.1	139.8	52.1
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361943-41409390	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.2;lymphoid tissue: 35.9"	"Cell type enhanced"	"Detected in many"	5	"Kupffer cells: 26.3;Macrophages: 27.1;Sertoli cells: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 61.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 43.1;BJ hTERT+ SV40 Large T+ RasG12V: 42.1;MOLT-4: 26.9;U-266/84: 44.7;U-937: 46.2"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain					NA	NA					"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	21.6	1.4	1.6	14.3	7.6	12.5	11.5	0.7	2.3	9.2	4.7	3.0	2.5	5.5	9.2	7.4	5.7	5.6	12.4	7.1	2.3	2.2	4.9	3.0	6.1	34.7	2.2	2.8	3.9	2.8	0.2	1.7	5.7	6.1	4.4	2.8	5.7	6.7	1.8	4.5	4.8	8.9	4.9	5.5	24.3	11.2	3.9	2.1	35.9	4.6	2.4	14.9	12.3	6.7	5.2	7.4	61.2	11.7	2.5	8.3	6.3	0.2	0.0	0.0	0.0	1.0	2.3	0.0	0.0	5.9	43.1	42.1	0.0	14.7	0.0	0.0	0.7	8.4	0.0	0.0	0.0	1.4	0.5	0.0	17.7	0.0	7.7	0.3	0.3	0.0	3.5	0.0	0.8	0.0	0.0	0.0	0.4	0.7	9.1	0.0	0.0	26.9	10.7	16.8	2.3	0.2	3.8	0.0	1.4	0.0	1.1	0.0	0.0	0.9	0.0	1.2	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	44.7	0.6	1.3	46.2	4.6	2.3	10.5	9.0	4.4	11.7	5.7	5.2	7.1	5.2	7.4	4.7	8.3	5.4	61.2	2.5	10.3	4.2	4.8	6.3	1.6	7.6	0.7	2.3	2.3	2.2	2.2	2.8	6.1	2.1	6.0	10.3	18.5	2.2	3.7	0.0	2.8	0.0	10.7	15.9	1.8	0.0	0.3	1.7	0.9	0.3	9.7	2.6	0.0	2.6	0.9	8.0	2.7	11.6	0.0	15.0	0.0	2.9	4.3	26.3	1.2	6.4	27.1	10.1	0.0	1.0	0.3	3.9	0.0	3.9	0.1	0.2	25.8	9.5	1.4	6.4	1.3	0.2	13.1	0.0	4.9
MYADM		ENSG00000179820	"Myeloid associated differentiation marker"	Q96S97	19	53866223-53876437	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"granulocytes: 336.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 52.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA056301			Approved	"Nuclear speckles"		NA	NA		34000	"Nuclear speckles"		"HPA056301: "	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.21e-3)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (7.71e-7)"	"unprognostic (2.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.14e-3)"	58.2	9.5	9.2	26.4	13.9	53.5	39.2	7.4	17.1	67.9	58.9	18.8	25.1	15.8	105.6	33.0	44.6	66.1	40.8	39.9	9.3	11.7	13.0	15.6	42.4	22.3	8.2	11.4	51.7	31.8	8.7	8.9	46.5	13.3	41.9	13.4	22.2	21.1	45.4	13.2	19.5	26.8	76.8	9.6	22.6	37.6	28.7	9.4	20.3	20.5	32.6	15.3	81.6	30.5	2.0	14.3	52.2	11.6	4.1	5.4	3.9	6.5	55.1	7.0	5.7	24.1	16.6	11.3	35.1	25.2	13.9	14.2	22.6	20.4	0.6	12.5	44.6	15.1	13.5	3.5	13.3	12.1	8.2	8.3	9.0	9.1	17.2	55.1	18.4	32.5	18.1	3.1	17.8	2.5	23.0	12.5	3.5	9.4	16.9	8.8	7.9	4.9	14.4	6.7	24.7	15.7	19.4	7.6	3.3	15.6	0.7	0.1	10.9	0.3	11.0	3.4	15.0	10.7	15.8	25.5	31.3	11.2	4.1	15.7	11.0	6.9	0.1	19.2	9.0	0.5	14.1	11.6	38.3	5.4	6.7	5.1	1.4	3.5	3.9	14.3	2.0	3.4	2.8	52.2	4.1	5.4	5.5	1.3	3.9	9.2	13.9	7.4	17.1	9.3	11.7	8.2	11.4	13.3	9.4	151.8	58.6	29.9	149.5	91.5	3.9	57.6	43.3	57.6	119.4	19.2	3.9	32.7	0.0	107.8	2.1	93.1	5.4	0.0	45.1	208.7	179.0	42.1	336.4	16.3	69.9	9.5	194.1	115.4	66.4	2.0	83.4	144.1	57.3	15.4	91.5	1.7	54.2	52.6	109.6	0.3	0.9	148.8	157.7	22.0	7.7	52.2	41.4	54.3	65.7	78.1
MYMK	"TMEM226, TMEM8C"	ENSG00000187616	"Myomaker, myoblast fusion factor"	A6NI61	9	133514586-133528612	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Myogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.3;epididymis: 3.1;skeletal muscle: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	34	"HSkMC: 18.4;RH-30: 8.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA051846, HPA055785"	Uncertain					NA	NA					"HPA051846: AB_2681636, HPA055785: AB_2682920"						"unprognostic (9.17e-3)"	"unprognostic (8.63e-2)"	"unprognostic (3.76e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.37e-1)"	"unprognostic (9.32e-2)"			"unprognostic (1.91e-1)"		0.6	0.2	0.5	0.0	3.3	0.2	0.0	0.7	2.6	0.0	0.0	0.8	0.0	0.0	0.0	3.1	0.6	0.1	0.0	0.3	1.0	0.4	1.7	0.2	0.3	0.0	0.9	2.1	0.0	0.0	0.0	0.1	2.0	1.6	0.6	0.0	0.0	0.2	0.0	8.0	0.2	0.0	0.0	0.4	0.1	0.0	1.5	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	3.3	0.7	2.6	1.0	0.4	0.9	2.1	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MYO1C	myr2	ENSG00000197879	"Myosin IC"	O00159	17	1464186-1492812	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001768, HPA005924, CAB037023"	Enhanced		Enhanced	"Nuclear bodies,Plasma membrane"		NA	NA		30000	"Nuclear bodies, Plasma membrane"		"CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: AB_2667469"	"unprognostic (3.60e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.47e-2)"	61.5	8.6	3.3	20.1	4.1	0.9	45.7	4.4	4.3	33.8	35.5	5.3	17.2	14.0	36.0	20.5	34.3	20.3	38.2	29.3	3.3	2.5	24.8	24.8	30.3	13.4	3.3	3.8	23.7	44.8	8.6	7.6	32.2	6.1	27.4	12.7	20.0	44.5	19.0	20.0	17.1	29.9	40.8	3.6	12.3	24.2	12.6	2.9	9.4	23.0	21.3	18.6	32.0	32.4	7.9	1.7	0.8	3.1	0.0	3.5	2.2	36.1	39.7	4.3	17.6	20.3	20.2	16.6	36.9	30.7	24.4	20.6	26.4	19.9	3.6	26.7	56.8	16.3	30.7	6.4	25.7	12.8	16.0	16.2	3.4	21.6	9.7	30.1	0.3	18.3	15.7	12.8	22.4	12.9	22.4	31.3	2.3	2.7	3.0	20.6	27.6	0.4	0.2	2.7	22.7	7.4	1.4	5.9	6.5	22.4	18.9	1.7	9.6	23.2	33.9	14.8	11.1	27.8	1.8	41.0	35.4	27.2	17.3	31.8	2.4	1.9	1.5	28.2	0.8	30.6	0.2	1.3	0.0	1.5	3.1	0.8	7.9	3.5	1.6	1.7	6.7	1.3	0.7	0.8	0.0	2.6	1.6	3.0	2.2	3.3	4.1	4.4	4.3	3.3	2.5	3.3	3.8	6.1	2.9	116.1	28.1	21.6	34.2	35.3	2.0	63.8	53.5	6.7	40.9	82.0	0.0	49.1	18.3	52.4	13.7	49.6	118.0	23.3	44.8	23.7	45.2	47.9	11.5	36.3	17.3	4.8	37.9	89.0	11.3	8.0	39.1	20.0	60.8	33.3	90.6	4.0	74.6	84.6	45.6	11.3	2.2	116.4	76.0	2.1	8.1	37.3	39.8	6.4	57.2	33.6
NALCN	"bA430M15.1, CanIon, VGCNL1"	ENSG00000102452	"Sodium leak channel, non-selective"	Q8IZF0	13	101053776-101416492	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 29.4"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 14.4;Cone photoreceptor cells: 5.9;Horizontal cells: 25.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 5.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.8;HaCaT: 11.8;HHSteC: 12.7;hTERT-RPE1: 9.4;TIME: 15.3;U-87 MG: 9.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031889, HPA031890, HPA031958"	Approved					NA	NA					"HPA031889: AB_10669638, HPA031890: AB_10696056, HPA031958: AB_10601039"	"unprognostic (4.66e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.58e-5)"	"unprognostic (1.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	1.5	8.3	9.8	1.4	18.3	1.6	5.2	13.4	29.4	3.6	1.3	18.6	0.0	1.1	1.5	3.4	1.1	2.6	4.6	6.0	10.8	11.4	1.2	2.3	2.7	1.0	11.0	13.1	5.6	2.1	4.2	13.0	5.6	17.0	1.3	1.7	4.3	1.6	2.5	1.0	1.6	1.4	1.3	12.7	1.3	1.8	2.0	14.1	0.0	4.8	0.0	0.8	1.6	0.6	1.4	0.8	5.4	0.5	0.9	0.9	0.3	0.1	6.6	1.3	0.2	0.6	0.3	0.1	0.7	0.6	1.6	0.4	0.1	7.8	0.0	0.4	3.1	0.8	11.8	0.0	1.8	4.2	0.0	0.8	0.4	3.8	0.1	12.7	0.2	0.2	0.2	0.5	1.4	3.9	9.4	6.9	0.0	0.1	0.4	5.0	0.0	0.1	0.0	0.3	1.1	1.4	0.0	0.0	0.0	3.9	1.6	1.0	0.2	0.1	0.1	0.6	0.7	0.2	0.1	15.3	0.4	0.1	0.3	1.6	0.0	0.1	0.0	9.7	0.0	0.3	5.4	0.5	0.8	0.9	0.3	0.4	0.7	0.5	0.5	0.1	1.4	0.6	0.5	1.8	0.9	0.2	0.8	0.4	0.3	9.8	18.3	13.4	18.2	10.8	11.4	11.0	13.1	17.0	14.1	0.0	0.0	0.0	0.0	0.2	14.4	4.5	0.0	0.0	0.0	0.0	5.9	0.9	0.0	0.5	3.5	0.3	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.1	25.4	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	1.5	0.2	0.0	1.8	0.0	2.4	0.0	0.3	0.2	0.7	0.1	0.5	0.0	0.0	0.0
NCBP1	"CBP80, NCBP, Sto1"	ENSG00000136937	"Nuclear cap binding protein subunit 1"	Q09161	9	97633626-97673748	"Predicted intracellular proteins, Transporters"	"mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042411, HPA049031"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			Cytosol	Nucleoplasm	"HPA042411: AB_2677985, HPA049031: AB_2680606"	"unprognostic (4.76e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (4.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-2)"	18.5	17.2	19.8	27.4	26.2	37.2	23.6	25.5	27.1	17.0	21.9	18.7	19.8	18.0	19.2	15.3	21.7	15.9	16.3	20.4	23.7	17.8	17.9	22.7	17.3	25.9	16.6	23.8	22.8	22.0	17.1	26.9	20.3	22.6	18.4	25.7	18.1	18.3	17.7	25.5	22.4	19.3	16.3	18.7	20.5	19.4	26.8	17.8	36.1	22.5	15.1	25.0	18.5	19.4	7.6	13.7	12.9	14.6	14.9	10.0	7.7	24.3	16.8	18.9	17.6	13.3	13.4	18.4	18.7	10.9	17.1	16.1	22.4	12.8	21.0	8.1	16.8	16.3	27.6	30.0	21.3	24.6	14.0	9.7	19.4	25.3	14.0	13.0	25.8	20.2	10.1	10.7	19.9	15.4	12.3	17.7	16.1	28.6	11.8	28.6	17.6	18.7	13.7	20.4	34.8	18.2	18.0	43.8	8.4	13.9	18.2	24.1	16.2	18.7	16.4	9.7	16.8	10.2	15.8	14.8	13.4	12.5	26.6	19.2	11.5	14.0	10.9	12.3	20.1	17.6	12.9	11.4	11.0	8.7	14.6	9.9	6.5	9.9	9.1	13.7	7.6	8.7	10.0	3.5	14.9	14.3	5.9	8.6	7.7	19.8	26.2	25.5	27.1	23.7	17.8	16.6	23.8	22.6	17.8	6.0	12.0	5.8	5.1	12.0	20.2	21.7	2.5	14.7	14.8	8.7	19.6	11.5	3.3	7.8	12.7	8.7	10.7	0.0	6.0	12.8	9.3	6.9	8.1	14.8	10.5	20.6	8.7	8.0	13.7	6.8	6.1	9.5	5.0	14.4	11.4	10.1	8.6	8.6	7.1	4.5	23.7	6.5	9.2	16.8	15.2	6.5	12.0	8.5	8.9	7.4
NCBP2	"Cbc2, CBP20, NIP1"	ENSG00000114503	"Nuclear cap binding protein subunit 2"	P52298	3	196935402-196942597	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044850, HPA062483"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044850: AB_10961012, HPA062483: AB_2684779"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.12e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.13e-3)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (2.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.04e-3)"	27.6	34.5	39.4	26.8	42.1	11.4	35.6	33.4	37.8	28.0	25.4	17.9	25.2	21.8	26.6	32.1	23.1	24.9	22.5	22.6	37.5	33.3	31.9	21.6	20.3	37.6	33.5	28.9	30.8	27.8	28.3	30.4	25.4	31.4	28.3	26.1	18.7	19.8	27.8	41.8	20.1	19.9	33.7	39.0	24.3	21.3	20.4	31.3	24.9	29.8	19.3	30.5	27.5	23.7	26.1	19.1	9.7	20.8	19.6	28.9	17.6	35.7	11.6	26.9	34.0	30.8	27.0	19.3	27.0	20.1	17.1	17.8	25.4	13.0	23.9	60.4	18.8	22.1	21.8	34.5	29.3	26.7	12.6	22.7	31.2	13.5	21.1	27.3	36.4	21.8	21.6	25.3	12.4	35.0	25.6	26.2	26.3	17.6	25.5	28.6	41.6	27.0	22.4	34.3	33.9	37.6	21.3	20.6	22.6	24.8	25.0	15.2	40.3	16.9	32.5	47.1	22.4	72.1	29.0	24.8	17.7	18.8	21.8	48.5	39.3	36.3	41.1	24.1	41.2	26.9	3.8	18.1	9.7	19.2	20.8	28.9	26.1	23.5	22.5	19.1	20.5	27.3	24.4	2.3	19.6	20.1	15.5	20.8	17.6	39.4	42.1	33.4	35.7	37.5	33.3	33.5	28.9	31.4	31.3	23.8	35.0	86.4	59.4	46.6	55.7	35.2	20.4	37.5	50.0	40.1	55.0	50.6	82.9	57.9	91.7	48.0	33.3	0.0	43.2	65.3	43.0	45.0	51.9	29.2	58.3	42.9	43.3	31.9	50.5	46.4	34.8	49.6	30.4	71.3	40.2	72.8	56.6	43.0	48.4	59.3	55.3	25.8	53.0	32.3	58.0	39.1	44.5	49.8	42.2	83.5
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765460-53838860	"Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"		NA	NA			"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: AB_2686189, HPA070882: AB_2686320"	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	8.8	6.7	3.3	8.6	5.7	4.9	12.9	10.9	7.7	4.8	8.4	5.1	1.9	6.2	6.0	5.4	11.0	5.3	2.9	5.5	4.3	2.8	4.9	11.7	4.4	10.6	8.0	1.5	4.6	6.0	7.6	5.5	5.5	6.6	4.0	10.7	5.5	6.4	3.7	7.1	6.8	6.5	5.0	7.5	7.1	5.8	17.4	7.5	9.1	5.8	6.7	13.0	6.4	5.8	5.5	3.8	2.0	7.2	4.0	8.2	3.4	20.0	10.6	14.4	14.7	5.3	5.4	17.0	13.8	10.3	21.6	17.5	15.6	13.5	39.6	9.0	6.1	17.5	24.2	24.3	14.3	30.6	9.8	17.5	19.3	15.5	13.2	5.0	30.9	11.0	3.2	5.7	21.3	12.7	6.3	13.0	14.8	22.0	5.7	11.8	7.2	15.1	12.3	34.3	17.0	16.9	17.1	23.3	21.6	10.1	13.8	8.7	11.1	12.3	24.0	11.8	16.0	18.6	16.4	7.6	11.3	11.3	15.5	24.7	6.3	15.6	28.2	9.4	23.5	14.1	0.0	3.2	2.0	4.5	7.2	6.9	5.5	4.3	4.0	3.8	4.1	8.2	6.3	0.2	4.0	4.5	3.3	4.7	3.4	3.3	5.7	10.9	7.7	4.3	2.8	8.0	1.5	6.6	7.5	6.0	4.6	3.7	6.1	9.0	4.1	7.6	2.5	2.7	2.3	5.2	2.0	8.2	0.0	5.9	1.7	4.8	3.3	0.0	7.7	16.4	5.9	5.0	7.0	5.9	10.3	3.2	0.0	4.3	9.1	1.7	2.6	6.7	6.8	2.8	8.4	4.1	6.1	2.9	3.2	4.5	3.2	6.5	4.7	9.3	13.1	7.4	5.7	4.1	15.1	5.4
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase"	P46934	15	55826922-55993746	"Enzymes, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 57.7"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 86.4;Alveolar cells type 2: 87.7;Ciliated cells: 135.1;Club cells: 79.6;granulocytes: 67.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol		NA	NA			Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	14.1	4.1	2.5	3.1	3.3	4.5	8.7	1.5	2.7	9.9	9.4	2.8	3.4	3.4	10.1	4.1	8.2	3.8	4.5	4.1	2.9	2.4	8.6	21.5	7.2	2.1	3.5	1.3	6.6	2.8	6.5	6.7	20.1	3.5	8.4	3.4	5.4	4.0	6.4	57.7	7.1	15.2	10.9	6.0	5.9	4.4	2.6	3.1	9.4	5.7	9.0	3.3	11.9	8.9	0.1	1.6	1.2	2.8	1.2	2.9	0.9	7.3	11.5	3.1	3.0	4.1	6.8	5.1	14.1	22.3	10.5	10.5	5.1	2.2	1.8	3.7	5.4	25.5	12.2	3.4	9.3	17.2	4.1	2.1	9.1	2.7	2.6	21.9	4.0	0.9	11.6	23.1	12.5	21.1	5.1	8.6	5.4	3.9	0.0	30.6	3.8	5.3	0.0	0.8	3.9	1.7	3.9	24.8	1.0	4.3	14.6	0.3	2.0	6.3	4.5	5.6	5.9	5.6	3.0	29.6	23.3	7.7	4.9	22.9	1.2	2.7	4.8	15.7	8.6	5.5	0.6	1.0	0.0	1.3	2.8	2.9	0.1	1.5	1.2	0.8	0.0	1.4	1.6	1.2	1.2	1.9	1.6	1.3	0.9	2.5	3.3	1.5	2.7	2.9	2.4	3.5	1.3	3.5	3.1	86.4	87.7	2.0	3.3	10.8	0.3	4.8	7.6	135.1	79.6	0.0	21.6	16.5	1.7	3.2	1.3	16.8	6.9	0.0	4.8	6.4	6.3	3.4	67.4	17.9	4.0	0.0	0.0	15.4	1.8	1.0	5.2	3.8	1.7	0.0	4.2	8.4	3.3	0.0	6.7	10.8	6.0	0.0	8.2	1.2	5.9	9.2	11.6	2.2	2.9	1.6
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 103.8;Hofbauer cells: 99.7;monocytes: 90.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 62.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Centriolar satellite"	"CAB045993: AB_2150651, HPA056828: AB_2683250"	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	14.8	5.3	26.1	22.2	29.1	12.8	18.8	7.2	21.2	20.5	15.6	13.4	4.3	12.5	9.2	7.5	6.8	8.5	18.4	7.0	17.1	16.6	12.9	51.9	17.0	18.1	19.4	13.3	11.2	20.5	1.6	6.4	21.4	14.7	14.8	16.6	18.5	16.9	13.2	5.5	5.1	18.2	23.4	13.0	11.3	19.0	5.8	12.9	4.0	6.3	1.9	22.0	17.7	10.1	21.9	11.5	29.0	18.8	8.3	3.8	7.6	7.4	12.3	11.9	4.6	22.5	29.4	14.8	9.4	15.1	14.6	12.2	11.6	14.0	9.1	15.1	18.1	33.4	1.4	6.1	27.3	9.9	10.0	5.4	24.9	10.4	20.4	26.9	4.5	62.6	39.1	4.4	13.8	14.3	38.4	15.9	4.3	4.4	0.4	26.0	7.8	0.2	4.9	3.0	39.4	11.2	9.6	8.9	4.6	15.6	2.7	5.3	1.8	3.0	5.8	13.3	12.6	12.7	18.4	31.0	10.7	10.8	7.3	6.4	2.0	2.5	5.2	13.4	10.2	14.1	10.2	18.8	29.0	3.8	12.3	2.4	21.9	2.3	3.2	11.5	9.0	0.4	1.6	23.4	8.3	14.7	10.6	2.8	7.6	26.1	29.1	7.2	21.2	17.1	16.6	19.4	13.3	14.7	12.9	8.9	6.6	9.8	11.0	2.2	0.7	2.5	17.8	1.4	4.5	3.5	0.0	33.9	1.7	35.3	14.7	5.5	12.9	23.3	20.0	103.8	9.9	17.8	21.9	33.3	99.7	0.0	5.8	4.3	10.7	12.3	4.6	30.4	6.8	90.2	15.5	28.1	24.3	15.2	3.5	29.9	1.8	0.0	5.3	1.2	10.6	1.0	30.2	0.0	18.6	8.9
NEK7		ENSG00000151414	"NIMA related kinase 7"	Q8TDX7	1	198156963-198322420	"Enzymes, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 150.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 85.5;fHDF/TERT166: 115.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm		Yes	No			Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	"unprognostic (2.08e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.56e-1)"	31.7	31.4	24.9	15.2	23.0	5.6	23.7	7.8	15.6	19.3	20.6	25.5	13.7	11.3	24.5	11.4	18.7	12.8	15.1	74.7	23.9	20.4	16.1	16.0	22.3	14.9	26.8	13.4	17.2	11.1	14.6	17.6	40.5	18.0	20.0	13.2	11.8	13.5	21.3	29.9	10.6	15.8	30.9	34.9	16.4	11.7	9.5	22.6	18.0	14.9	12.8	12.5	27.4	20.7	1.6	2.1	6.1	2.2	3.8	14.7	1.4	7.1	1.9	2.3	0.9	6.0	6.9	2.7	85.5	35.8	34.8	16.5	3.5	7.1	2.6	6.2	115.4	2.0	4.4	3.5	4.6	35.2	8.1	5.0	3.5	8.2	1.4	7.2	5.9	7.3	4.3	4.0	22.9	6.9	13.0	6.6	21.6	2.7	6.4	15.9	2.2	5.1	3.5	1.2	5.7	1.4	2.7	5.7	4.5	5.9	3.7	1.4	2.7	14.2	8.2	9.5	3.4	6.0	5.4	14.5	9.8	8.3	28.0	8.9	4.5	4.1	1.7	4.2	5.4	7.5	1.9	2.2	3.0	3.2	1.9	14.7	1.3	3.6	4.6	2.1	1.6	2.9	3.6	6.1	3.8	1.7	1.4	6.0	1.4	24.9	23.0	7.8	15.6	23.9	20.4	26.8	13.4	18.0	22.6	26.8	24.2	12.3	15.3	45.6	9.4	150.0	10.2	25.4	21.6	17.4	13.7	11.6	10.0	8.8	2.1	26.3	19.8	46.7	16.9	13.3	24.9	20.4	8.1	19.2	15.2	3.2	19.0	35.0	42.5	1.7	27.0	23.7	28.7	16.2	19.6	10.0	34.6	17.3	36.0	11.6	25.0	19.4	44.2	7.5	5.7	43.0	53.8	20.1	14.9	22.4
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved		Approved	Mitochondria		NA	NA		190000	Mitochondria		"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	17.0	20.4	12.7	17.7	17.4	7.3	15.1	15.4	13.3	18.6	18.7	18.3	23.5	14.0	25.0	13.8	15.6	20.0	15.9	23.5	11.4	8.7	14.0	13.3	12.9	16.2	20.2	10.6	25.6	15.7	24.7	23.6	14.3	13.0	15.3	8.1	15.4	12.4	18.9	36.2	10.6	15.3	24.7	14.5	14.7	14.8	16.6	18.2	21.5	17.0	14.1	14.4	23.6	18.7	6.0	6.4	7.5	5.4	5.5	6.2	3.1	10.1	12.0	15.2	17.0	19.6	26.9	17.4	16.5	11.7	8.1	7.9	10.1	8.9	17.5	0.1	11.3	6.7	14.0	11.6	6.4	9.0	14.2	6.7	8.5	12.0	7.3	12.8	5.1	11.4	18.3	7.6	8.4	6.4	21.5	10.1	12.1	9.6	11.3	9.7	1.1	10.8	5.2	9.0	12.9	6.1	17.5	19.4	9.0	6.1	12.5	7.4	18.7	13.3	6.4	12.8	16.7	15.9	14.8	15.3	12.3	5.2	14.3	6.4	18.3	19.5	17.6	9.0	8.7	8.3	7.5	5.4	5.8	4.2	5.0	5.9	2.8	4.8	3.9	6.4	6.0	6.2	5.9	5.5	5.5	3.5	1.8	2.6	3.1	12.7	17.4	15.4	13.3	11.4	8.7	20.2	10.6	13.0	18.2	11.9	33.3	10.4	7.4	7.8	16.5	47.6	5.1	14.7	19.4	10.4	33.4	13.4	6.6	5.0	9.2	14.3	10.6	0.0	4.3	13.7	11.8	6.1	15.1	28.4	12.0	12.7	5.2	17.8	18.7	6.4	23.0	12.6	3.3	6.4	10.5	12.1	5.0	9.0	24.8	7.8	22.6	0.0	12.3	23.8	12.8	8.9	11.7	10.0	10.6	4.8
NETO1	"BCTL1, BTCL1"	ENSG00000166342	"Neuropilin and tolloid like 1"	Q8TDF5	18	72742314-72868146	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 47.9"	"Cell type enriched"	"Detected in some"	38	"Bipolar cells: 163.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	27	"memory B-cell: 1.6;naive B-cell: 3.7"	"Lineage enriched"	"Detected in single"	38	"B-cells: 3.7"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 15.1;NTERA-2: 6.9;REH: 14.9;RPMI-8226: 23.7;RT4: 15.7;SCLC-21H: 20.9;U-2 OS: 7.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064630			Approved	"Golgi apparatus"	"Intracellular and membrane"	NA	NA			"Golgi apparatus"		"HPA064630: AB_2685305"	"unprognostic (4.02e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.35e-5)"	"unprognostic (4.05e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.13e-3)"	2.0	0.8	9.1	1.3	18.3	1.0	1.7	0.4	47.9	0.9	0.9	0.7	0.0	0.8	0.9	0.9	1.0	0.8	0.9	1.4	15.9	3.9	1.0	0.8	0.9	3.8	3.0	15.1	0.8	0.8	1.0	0.3	0.8	5.0	0.9	1.1	3.9	1.1	0.8	0.8	1.2	0.8	0.8	1.1	4.0	0.9	2.0	2.8	0.8	2.3	0.0	2.7	1.2	0.2	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	6.9	0.0	0.0	14.9	0.0	23.7	3.7	15.7	20.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	18.3	0.4	22.8	15.9	3.9	3.0	15.1	5.0	2.8	0.0	0.0	0.0	0.0	0.0	163.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
NETO2	"FLJ10430, NEOT2"	ENSG00000171208	"Neuropilin and tolloid like 2"	Q8NC67	16	47077703-47143997	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.6;lymphoid tissue: 23.8"	"Cell type enhanced"	"Detected in many"	11	"Muller glia cells: 40.0;Spermatogonia: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013180	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA013180: AB_1854383"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.98e-1)"	"prognostic unfavorable (5.53e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.32e-1)"	3.3	6.7	6.9	6.9	23.6	2.4	3.4	11.8	15.8	1.8	9.5	2.1	0.6	1.9	2.8	0.9	5.6	1.1	5.5	2.4	8.3	5.9	2.5	0.9	5.3	6.6	4.9	7.1	2.0	9.8	11.6	1.4	3.8	13.5	1.4	2.8	10.1	2.6	1.6	4.5	1.7	2.7	1.9	2.5	23.8	1.9	8.6	4.7	1.9	10.0	3.1	6.8	4.2	2.5	1.0	2.1	0.9	3.3	0.3	2.2	0.7	25.0	28.0	40.6	0.1	6.0	35.0	6.7	25.0	4.0	22.2	12.1	5.8	16.1	6.2	15.4	5.3	21.4	11.3	25.9	24.8	27.3	0.1	16.7	5.0	10.0	6.2	7.4	16.0	13.3	21.0	16.6	8.9	12.6	21.6	14.7	15.0	7.4	7.7	14.2	6.8	9.1	8.8	19.5	7.5	20.6	0.0	7.9	12.6	15.6	5.4	26.7	19.4	33.0	2.6	3.7	6.9	0.5	11.8	7.1	0.0	0.0	0.0	0.1	8.3	6.8	13.8	18.1	11.4	17.8	0.9	3.3	0.1	0.1	1.6	1.3	1.0	1.3	0.1	2.1	0.4	0.0	0.1	0.9	0.3	1.5	0.2	2.2	0.7	6.9	23.6	11.8	15.8	8.3	5.9	4.9	7.1	13.5	4.7	0.0	5.0	0.0	0.6	6.9	0.7	1.2	0.0	2.7	3.4	0.0	0.0	0.7	0.0	0.4	2.5	4.4	3.5	0.0	2.6	0.4	2.6	2.0	2.3	0.0	6.3	0.0	10.4	0.6	9.4	4.2	0.6	11.3	3.3	6.4	1.3	40.0	1.1	1.1	0.0	0.0	0.8	6.5	2.5	7.7	22.0	2.9	0.7	1.9	1.6	0.9
NGB		ENSG00000165553	Neuroglobin	Q9NPG2	14	77265483-77271312	"Predicted intracellular proteins, Transporters"	"Apoptosis, Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 15.6;brain: 34.5;pancreas: 9.9"	"Cell type enhanced"	"Detected in single"	23	"Spermatogonia: 1.5"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 34.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"RPMI-8226: 7.7;SCLC-21H: 16.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA042615, HPA058596"	Enhanced					NA	NA					"HPA042615: AB_2678079, HPA058596: AB_2683769"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-2)"		"unprognostic (8.86e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-2)"		"unprognostic (3.14e-1)"		"unprognostic (4.08e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.58e-2)"		"unprognostic (3.37e-4)"	"unprognostic (1.80e-1)"		"unprognostic (3.12e-1)"	0.4	15.6	4.2	0.7	4.8	0.3	0.3	1.2	14.2	0.3	2.1	0.5	0.9	0.7	0.3	0.5	0.6	2.9	0.3	0.3	1.7	34.5	0.3	0.3	0.3	0.3	2.0	6.4	0.3	9.9	0.3	7.0	0.3	8.0	0.3	1.3	0.0	0.3	0.3	0.3	0.3	0.9	0.5	1.4	0.3	0.3	0.7	0.9	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.7	0.0	0.0	16.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.8	1.2	14.2	1.7	34.5	2.0	6.4	8.0	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.5
NIPA1	"MGC35570, SLC57A1, SPG6"	ENSG00000170113	"Non imprinted in Prader-Willi/Angelman syndrome 1"	Q7RTP0	15	22773063-22829791	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 9.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 9.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA023269	Uncertain					NA	NA					"HPA023269: AB_1854485"	"unprognostic (1.64e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.32e-2)"	"unprognostic (6.95e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.66e-2)"	3.4	4.9	15.2	4.1	18.1	1.3	3.4	8.3	27.0	4.6	4.6	20.7	1.3	7.3	2.7	2.6	4.5	3.1	5.5	2.9	18.7	15.7	7.3	4.7	5.3	5.4	26.9	11.8	1.6	7.6	12.3	2.9	4.0	24.8	7.9	5.0	2.2	3.9	4.2	2.4	5.6	7.2	2.9	36.7	4.5	7.4	4.9	15.1	2.6	8.5	0.4	6.0	3.6	2.6	2.0	9.1	0.6	0.2	0.6	1.7	0.8	9.8	11.6	3.6	8.3	4.7	3.8	2.9	11.5	8.4	5.8	4.7	8.8	4.9	4.5	9.7	4.8	12.3	6.7	10.8	3.2	6.8	26.5	7.0	6.9	7.1	7.4	5.6	0.1	14.0	1.4	10.4	3.7	6.5	9.2	5.5	10.2	5.5	7.8	3.2	3.7	3.8	6.2	4.1	10.4	13.2	8.4	5.1	3.6	9.0	9.8	10.2	10.5	9.2	1.0	10.9	5.0	7.9	9.0	9.9	16.3	9.5	6.7	18.1	8.8	8.8	8.5	8.5	0.0	10.8	0.6	0.2	0.3	1.1	0.1	1.2	1.8	1.7	1.2	1.4	2.0	0.8	0.6	0.5	0.6	0.1	9.1	1.3	0.8	15.2	18.1	8.3	19.7	18.7	15.7	26.9	11.8	24.8	15.1	11.9	5.1	1.5	3.5	7.8	4.1	3.5	10.2	2.7	4.5	5.2	5.9	2.0	3.3	5.1	2.8	6.0	8.0	0.0	10.3	1.9	4.7	6.9	0.0	5.8	3.4	4.8	2.9	4.9	4.5	3.2	2.0	2.6	5.0	5.4	6.0	5.2	12.8	5.9	2.8	4.8	5.8	19.4	4.4	3.7	9.8	13.0	1.3	5.0	6.0	4.6
NIPA2	SLC57A2	ENSG00000140157	"Non imprinted in Prader-Willi/Angelman syndrome 2"	Q8N8Q9	15	22838641-22868384	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067160, HPA071342"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA067160: AB_2685794, HPA071342: AB_2686391"	"unprognostic (2.88e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.93e-2)"	19.3	26.9	18.6	26.1	22.2	22.1	19.9	17.7	28.2	16.8	30.0	16.6	23.9	28.4	21.7	18.3	26.5	16.1	21.3	17.4	16.7	21.3	26.3	27.8	22.5	35.0	17.9	13.8	19.0	30.8	21.1	24.7	31.3	18.5	20.6	30.1	20.0	26.9	14.0	18.8	16.4	37.1	18.2	13.5	43.9	21.4	19.5	13.1	27.9	21.1	19.2	31.5	22.2	17.2	38.1	40.3	27.2	26.5	22.1	24.6	21.5	30.1	30.8	15.8	18.6	15.2	17.3	17.9	33.9	30.0	23.3	27.3	22.8	19.2	29.8	21.6	19.5	24.0	24.2	29.1	17.1	23.7	31.6	18.8	26.7	20.6	18.4	22.6	37.8	25.3	16.9	19.3	19.2	20.1	15.1	27.2	24.6	40.0	35.8	29.8	12.0	12.0	17.7	18.5	32.4	28.5	26.2	26.8	22.6	22.3	37.1	21.3	22.5	25.9	25.7	28.5	15.3	23.3	35.6	28.2	30.9	20.1	22.3	68.6	28.4	41.1	32.3	23.6	38.3	26.5	27.2	21.4	18.0	21.4	26.5	24.4	38.1	19.3	23.5	26.2	32.7	18.4	18.7	15.8	22.1	24.9	40.3	24.6	21.5	18.6	22.2	17.7	28.2	16.7	21.3	17.9	13.8	18.5	13.1	14.9	20.2	64.8	29.3	40.1	8.8	2.0	15.3	16.0	14.8	12.2	11.8	35.4	18.3	36.8	4.8	28.5	29.6	0.0	38.2	54.4	23.4	34.7	9.3	19.4	43.1	20.6	23.4	24.5	25.4	2.2	12.4	28.7	21.9	27.9	26.1	23.6	43.8	31.3	19.8	18.6	11.6	12.9	29.9	21.5	32.4	50.6	70.6	34.6	32.2	91.1
NIPAL3	"DJ462O23.2, NPAL3"	ENSG00000001461	"NIPA like domain containing 3"	Q6P499	1	24415794-24472976	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.4"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 104.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039978	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA039978: AB_10697712"	"unprognostic (9.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (3.03e-7)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.85e-1)"	5.3	5.1	21.4	5.2	21.8	4.9	8.3	41.2	29.4	6.9	8.9	42.4	5.6	7.1	4.2	7.4	10.3	10.4	6.3	9.2	25.5	21.3	9.4	2.3	9.2	7.1	32.9	14.7	5.5	11.3	14.0	6.5	2.8	31.5	38.4	9.3	7.1	9.9	5.7	3.5	7.7	8.5	8.1	34.8	4.8	9.6	3.1	22.5	5.8	20.7	2.3	7.9	7.8	5.4	12.9	8.4	8.9	3.6	9.2	26.0	9.7	12.8	5.2	0.5	1.7	7.9	8.8	1.9	41.7	29.9	15.3	11.3	1.8	14.7	6.0	13.4	23.0	3.1	12.6	5.1	15.5	15.0	12.2	15.9	6.6	8.7	2.1	7.3	5.8	6.0	8.8	14.4	10.1	30.9	13.9	5.2	11.8	3.8	3.8	9.2	2.8	4.7	2.4	3.2	6.2	14.7	2.2	0.0	6.8	16.2	4.1	19.4	1.8	5.6	7.9	11.2	3.6	10.8	4.4	7.5	13.7	2.9	4.5	9.1	11.9	9.7	2.1	9.2	10.6	12.2	8.9	3.6	4.7	10.8	3.4	10.7	12.9	18.2	14.0	6.5	10.9	26.0	16.1	1.6	9.2	2.3	8.4	17.6	9.7	21.4	21.8	41.2	24.6	25.5	21.3	32.9	14.7	31.5	22.5	44.7	28.0	14.5	11.0	8.1	52.0	21.5	17.8	9.4	19.4	38.4	104.1	3.0	3.3	11.5	2.8	8.5	24.1	46.7	13.4	4.0	8.5	26.1	12.7	3.2	4.2	12.7	18.0	7.4	3.8	5.6	3.7	7.1	13.5	6.4	14.9	15.3	17.2	14.4	4.9	3.6	53.0	0.0	6.2	2.4	5.5	14.3	3.5	20.8	16.3	16.1
NIPAL4	ICHYN	ENSG00000172548	"NIPA like domain containing 4"	Q0D2K0	5	157460019-157474717	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	Receptor	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.9;skin 1: 38.1"	"Group enriched"	"Detected in some"	6	"Basal glandular cells: 9.4;Basal keratinocytes: 26.4;Suprabasal keratinocytes: 36.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	33	"memory B-cell: 2.6;naive B-cell: 8.7"	"Lineage enriched"	"Detected in single"	51	"B-cells: 8.7"	"Group enriched"	"Detected in some"	8	"hTCEpi: 14.1;RT4: 46.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038259	Approved					NA	NA					"HPA038259: AB_10672510"	"unprognostic (6.74e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.28e-9)"	"unprognostic (3.12e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.82e-4)"	0.6	0.5	1.5	2.5	7.1	3.3	3.0	0.4	7.7	3.6	2.1	25.9	0.0	0.8	1.7	0.6	10.6	0.5	1.0	1.0	3.1	1.7	0.5	0.5	0.5	0.9	8.0	2.5	0.5	0.5	0.5	0.4	1.1	10.9	2.6	1.1	0.0	1.2	1.9	0.6	38.1	0.7	5.8	11.9	0.7	1.9	0.6	6.9	0.0	0.8	15.8	6.0	10.7	7.7	8.7	0.0	0.1	0.0	0.0	0.1	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.2	0.0	2.7	0.1	1.2	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.1	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	46.8	0.0	0.1	0.0	0.0	0.0	4.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.1	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	7.1	0.4	7.7	3.1	1.7	8.0	2.5	10.9	6.9	0.0	0.3	0.8	9.4	26.4	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	36.8	0.0	0.0	0.0	3.9
NKAIN1	"FAM77C, FLJ12650"	ENSG00000084628	"Sodium/potassium transporting ATPase interacting 1"	Q4KMZ8	1	31179745-31239554	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 15.5;brain: 23.2;skeletal muscle: 26.2"	"Cell type enhanced"	"Detected in some"	12	"Distal tubular cells: 1.7;Suprabasal keratinocytes: 1.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 10.4;AN3-CA: 17.2;NTERA-2: 44.3;SCLC-21H: 13.2;SH-SY5Y: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006873	Uncertain					NA	NA					"HPA006873: AB_1848410"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.11e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.31e-9)"	"unprognostic (1.00e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.62e-4)"	"unprognostic (5.50e-2)"	0.7	15.5	4.2	0.8	13.3	0.5	1.2	23.2	11.8	0.6	0.7	10.7	0.0	0.7	1.5	5.8	1.4	0.8	0.6	0.6	6.3	4.3	0.6	0.5	0.5	0.5	4.7	7.2	0.6	0.7	0.7	0.3	0.9	18.2	2.2	0.7	0.0	0.7	1.1	26.2	1.9	0.7	0.8	3.3	0.5	0.6	0.9	9.0	0.0	0.5	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.4	17.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.2	0.0	2.3	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.3	44.3	0.0	0.4	0.0	0.1	0.0	0.0	1.5	13.2	21.0	0.4	0.1	1.1	1.2	4.6	0.2	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	13.3	23.2	9.5	6.3	4.3	4.7	7.2	18.2	9.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.6	1.3	0.3	0.0	0.0	0.1
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123804141-124825657	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	9	"brain: 43.2"	"Group enriched"	"Detected in some"	16	"Horizontal cells: 44.5;Muller glia cells: 20.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 4.3"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 4.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Daudi: 3.9;HEK 293: 6.5;HEL: 8.2;Karpas-707: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol		NA	NA			Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	2.2	1.6	12.9	1.1	12.1	1.9	1.3	17.3	43.2	1.4	1.7	24.9	0.0	1.1	1.2	1.6	1.4	1.4	1.3	2.6	17.5	8.8	1.3	1.2	1.3	1.3	18.1	10.9	1.2	1.0	1.0	1.1	1.2	18.0	1.4	1.3	0.5	1.1	1.3	4.8	1.1	1.5	1.5	42.9	1.1	1.0	1.6	16.1	0.0	1.2	0.5	1.3	1.5	0.2	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	8.2	0.1	0.0	0.6	0.0	0.0	1.6	0.2	0.0	0.5	0.1	0.0	0.0	0.0	13.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	12.1	17.3	15.3	17.5	8.8	18.1	10.9	18.0	16.1	0.0	0.0	0.0	0.0	0.1	2.0	0.6	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	44.5	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	20.4	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
NKAIN3	"FAM77D, FLJ39630"	ENSG00000185942	"Sodium/potassium transporting ATPase interacting 3"	Q8N8D7	8	62248591-62999652	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 15.5"	"Cell type enhanced"	"Detected in some"	12	"Bipolar cells: 1.4;Early spermatids: 1.9;Late spermatids: 2.9;Melanocytes: 1.7;Proximal tubular cells: 1.0"	"Cancer enhanced"	"Detected in single"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.5;HeLa: 2.0;OE19: 1.0;PC-3: 2.5;REH: 2.6;RT4: 1.6;SCLC-21H: 5.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018833	Enhanced					NA	NA					"HPA018833: AB_2669943"	"unprognostic (1.28e-1)"		"unprognostic (2.92e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"			"unprognostic (3.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"		"unprognostic (3.22e-2)"	"unprognostic (3.15e-2)"		"unprognostic (1.58e-1)"	0.8	3.4	13.7	1.2	15.5	0.8	1.0	0.6	9.7	1.3	1.4	6.9	0.0	0.7	1.7	0.7	0.8	1.1	0.8	1.1	15.1	1.6	0.8	0.9	0.7	0.8	2.3	7.5	0.9	0.7	0.7	0.8	1.0	7.3	1.0	0.8	0.3	5.9	1.4	2.2	0.7	2.3	0.7	7.3	0.9	0.9	1.9	7.1	0.0	0.8	0.0	0.7	2.2	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	2.5	2.6	0.0	0.0	0.0	1.6	5.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	15.5	0.6	9.7	15.1	1.6	2.3	7.5	7.3	7.1	0.0	0.0	0.0	0.1	0.3	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.6	0.1	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.3	0.0	1.7	0.0	0.0	0.0	0.5	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
NMUR1	"FM-3, GPC-R, GPR66, NMU1R"	ENSG00000171596	"Neuromedin U receptor 1"	Q9HB89	2	231523160-231530495	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	12	"Ito cells: 8.0;Peritubular cells: 7.1;Rod photoreceptor cells: 15.5;T-cells: 10.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	6	"gdT-cell: 15.2;MAIT T-cell: 3.9;memory CD8 T-cell: 7.3;naive CD8 T-cell: 4.6;NK-cell: 8.1"	"Group enriched"	"Detected in many"	18	"NK-cells: 8.1;T-cells: 15.2"	"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA027895	Uncertain					NA	NA					"HPA027895: AB_10602713"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.74e-3)"	"unprognostic (9.44e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-4)"	"unprognostic (3.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.61e-1)"	"unprognostic (5.25e-2)"	13.6	2.2	0.6	1.2	0.9	3.5	3.2	2.1	0.8	2.5	3.5	0.4	4.4	4.4	1.8	3.8	3.3	3.0	4.6	12.6	0.3	0.3	2.1	2.0	6.4	0.5	0.3	0.1	2.8	7.7	0.2	0.6	4.8	0.6	4.0	1.2	8.4	4.6	3.6	0.3	0.8	7.3	8.4	0.6	7.3	1.7	3.0	0.7	0.2	1.8	0.6	0.8	4.4	1.4	0.0	0.3	0.6	0.1	8.1	15.2	3.6	0.3	1.2	1.5	1.5	0.1	0.4	1.3	0.5	0.0	0.0	0.1	0.4	0.5	0.8	0.4	0.4	0.7	0.7	2.6	0.5	0.1	0.5	0.9	0.8	1.1	0.4	0.1	0.8	1.3	0.7	0.3	0.4	0.0	1.2	0.6	0.6	2.5	1.4	0.1	0.8	0.6	1.1	0.7	0.6	0.3	0.4	0.8	0.7	0.1	0.9	0.6	0.7	1.0	0.6	0.3	1.1	1.3	1.6	1.6	1.7	1.3	0.8	0.4	2.0	0.1	0.6	0.5	0.8	0.6	0.4	0.1	0.0	15.2	0.0	3.9	0.0	1.2	7.3	0.0	0.0	0.1	4.6	0.6	8.1	0.1	0.3	0.5	3.6	0.6	0.9	2.1	0.8	0.3	0.3	0.3	0.1	0.6	0.7	0.0	0.0	0.0	0.1	0.9	1.4	2.0	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.0	0.8	0.4	0.0	0.0	0.2	0.1	1.4	0.0	1.1	0.0	0.2	1.6	0.0	8.0	1.9	0.2	2.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	7.1	0.0	15.5	0.0	0.3	1.5	3.2	0.4	0.6	10.9	0.0	0.1
NOTCH1	TAN1	ENSG00000148400	"Notch 1"	P46531	9	136494433-136545786	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Endothelial cells: 41.3;Ito cells: 68.2;Muller glia cells: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 8.8"	"Group enriched"	"Detected in many"	4	"granulocytes: 8.8;NK-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 25.0;HMC-1: 21.7;hTCEpi: 24.0;MOLT-4: 38.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008112, CAB022466, HPA067168"	Supported		Approved	Nucleoplasm		NA	NA		8100000	Nucleoplasm		"CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795"	"unprognostic (1.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.50e-3)"	"unprognostic (8.78e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.84e-2)"	20.0	4.0	10.0	14.5	10.4	14.6	12.8	3.8	18.8	12.8	14.2	19.9	8.2	9.8	11.2	5.1	13.3	9.6	13.1	9.6	10.7	5.8	9.4	7.2	17.4	13.7	11.6	7.5	9.2	17.8	3.7	5.6	8.5	9.3	12.1	5.7	10.4	14.2	11.8	8.2	32.3	10.8	7.7	6.6	20.7	8.6	4.1	9.9	34.8	9.4	10.2	10.9	12.3	22.2	0.6	1.1	8.8	1.0	2.7	1.3	0.9	4.4	7.5	6.2	3.1	0.2	0.5	7.8	2.2	0.6	1.3	0.4	1.1	0.5	6.1	4.7	1.7	1.6	25.0	2.0	10.3	0.2	13.8	1.1	3.4	3.0	0.4	3.4	3.6	21.7	0.4	24.0	1.8	3.8	1.5	8.0	2.7	1.5	1.1	0.9	8.1	38.1	5.8	5.2	3.2	3.4	7.9	5.0	11.2	0.9	3.8	0.0	0.4	3.3	3.5	1.4	1.9	2.1	5.8	11.8	3.3	4.8	3.2	2.4	1.3	1.1	2.4	2.2	2.5	16.9	0.7	1.0	2.8	1.3	0.4	0.8	0.4	0.6	1.0	0.6	0.6	0.4	1.1	8.8	2.7	0.4	1.1	0.4	0.9	10.0	10.4	3.8	11.7	10.7	5.8	11.6	7.5	9.3	9.9	8.9	28.2	13.8	10.6	22.0	0.3	7.3	7.6	0.0	6.8	1.8	2.0	0.7	0.0	4.8	0.3	41.3	4.9	0.0	3.4	1.8	4.8	6.6	34.6	6.8	8.0	1.6	2.4	68.2	10.5	0.0	1.1	17.1	6.8	1.0	11.0	50.6	2.2	7.0	0.7	4.1	1.7	6.5	11.5	0.2	3.2	26.1	0.9	12.9	24.7	14.1
NOV	"CCN3, IGFBP9"	ENSG00000136999	"Nephroblastoma overexpressed"	P48745	8	119416306-119424353	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"adrenal gland: 236.7"	"Cell type enhanced"	"Detected in many"	14	"Collecting duct cells: 36.6;granulocytes: 23.1;Melanocytes: 74.2"	"Cancer enhanced"	"Detected in all"		"melanoma: 62.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	113	"eosinophil: 28.1;neutrophil: 14.0"	"Lineage enriched"	"Detected in single"	151	"granulocytes: 28.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 43.7;hTERT-RPE1: 13.6;U-2197: 45.2"	"Group enriched"	"Detected in many"	7	"amygdala: 134.6;basal ganglia: 51.6;cerebral cortex: 101.0;hippocampal formation: 166.1"	"Low region specificity"	"Detected in many"			"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	269000000	2900000	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	6.3	236.7	2.2	1.4	7.9	1.0	5.6	3.1	12.3	5.0	2.0	3.6	3.6	1.5	5.8	2.9	1.9	3.0	2.0	5.7	3.5	1.9	4.9	0.9	2.9	1.1	2.1	15.1	1.8	2.7	2.1	13.4	0.8	7.4	5.6	2.2	1.2	1.2	5.0	1.6	3.6	1.5	2.5	2.5	1.0	1.6	2.6	0.0	0.0	6.9	4.8	1.1	3.3	2.5	0.0	0.1	28.1	0.1	0.0	0.0	0.0	0.0	1.0	0.6	0.0	4.0	1.0	0.0	5.8	43.7	5.3	3.0	0.0	0.1	0.0	4.6	7.3	4.1	3.6	0.2	0.0	1.8	0.0	0.1	0.0	3.4	0.0	0.1	0.0	0.0	0.2	0.0	2.0	0.2	13.6	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.4	8.7	0.0	0.0	0.0	5.6	0.0	1.3	0.0	2.1	0.0	8.1	0.0	0.0	0.0	0.0	3.8	5.8	45.2	1.2	0.0	0.0	0.0	6.0	1.8	4.3	0.0	0.1	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	2.2	7.9	3.1	12.3	3.5	1.9	2.1	15.1	7.4	0.0	0.0	1.1	0.0	0.6	16.7	0.0	1.2	0.0	2.7	2.3	36.6	0.0	0.0	0.0	7.2	0.0	12.6	0.3	0.0	1.0	0.0	15.4	14.0	23.1	0.0	1.4	3.2	9.2	0.6	1.2	0.0	2.8	0.4	74.2	0.0	1.3	0.0	0.6	2.9	0.7	0.0	0.2	0.0	20.8	0.0	0.0	14.8	0.1	0.0	9.8	0.9
NOX1	"GP91-2, MOX1, NOH-1, NOH1"	ENSG00000007952	"NADPH oxidase 1"	Q9Y5S8	X	100843324-100874345	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 15.0;intestine: 36.3;seminal vesicle: 18.0"	"Cell type enriched"	"Detected in some"	5	"Undifferentiated cells: 70.7"	"Cancer enriched"	"Detected in many"	18	"colorectal cancer: 82.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	14	"CACO-2: 25.8;OE19: 9.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA						"unprognostic (8.31e-2)"	"unprognostic (2.07e-3)"	"prognostic favorable (9.71e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.55e-3)"	"unprognostic (5.48e-3)"	"unprognostic (8.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-3)"	0.1	0.1	0.2	8.8	0.2	0.0	0.1	0.2	0.2	0.2	28.3	0.0	15.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	36.3	0.0	0.1	18.0	0.1	0.8	1.7	0.7	0.1	0.1	0.1	0.4	0.0	0.4	0.1	0.0	0.1	0.6	0.1	0.2	0.7	0.9	0.6	0.8	1.5	0.2	0.3	0.9	0.4	0.3	0.2	0.0	0.3	0.3	0.0	0.0	0.0	25.8	0.3	0.3	0.6	0.0	0.2	0.6	0.0	0.0	0.0	0.3	1.2	0.4	0.6	0.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.2	0.0	0.2	1.1	1.0	0.7	9.7	0.9	0.6	0.6	0.4	0.0	0.9	0.4	0.5	0.6	0.3	0.6	0.2	0.2	0.8	0.2	0.3	0.2	0.5	0.6	0.3	0.6	0.3	0.7	1.1	0.2	0.9	0.3	0.3	0.5	0.3	0.3	0.2	1.1	0.2	0.1	0.1	1.5	0.6	0.1	0.8	0.6	0.7	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	70.7	0.5
NOX3	GP91-3	ENSG00000074771	"NADPH oxidase 3"	Q9HBY0	6	155395370-155455903	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"adrenal gland: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"MCF7: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073837			Uncertain	Vesicles		NA	NA			Vesicles		"HPA073837: "					"unprognostic (3.42e-1)"													0.0	1.8	0.4	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOX4	"KOX, KOX-1"	ENSG00000086991	"NADPH oxidase 4"	Q9NPH5	11	89324356-89498187	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"kidney: 65.2"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 119.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 8.5;HUVEC TERT2: 15.6;TIME: 34.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA015475			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA015475: AB_1854574"	"unprognostic (2.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.83e-3)"	"unprognostic (8.95e-3)"	"unprognostic (3.80e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.99e-4)"	"unprognostic (9.71e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.03e-3)"	7.5	0.6	0.2	0.6	0.6	0.3	6.5	0.3	0.5	1.2	0.9	1.1	0.4	0.3	7.3	2.5	1.5	0.8	1.3	6.9	0.6	0.2	65.2	0.3	1.2	0.3	0.3	0.2	0.7	1.1	3.8	0.8	1.7	1.0	2.6	0.4	0.8	2.6	0.9	5.1	1.1	0.5	3.5	1.2	0.4	0.4	1.0	0.0	0.0	1.7	1.7	0.4	2.1	1.1	0.4	0.3	1.7	0.3	0.8	0.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.8	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	8.5	15.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.2	4.3	0.3	0.0	34.8	0.1	2.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.4	0.3	0.3	1.7	0.8	0.2	0.3	0.2	0.0	0.2	0.6	0.3	0.5	0.6	0.2	0.3	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	4.1	1.1	0.0	0.0	0.0	10.4	5.9	1.2	13.3	0.0	0.8	1.1	0.0	0.0	0.0	0.6	1.1	0.1	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.4	0.3	0.0	0.0	0.0	0.0	3.7	0.1	0.0	1.1	119.8	19.3	0.0	0.3	0.5	0.1	0.3	2.1	0.0	0.0	0.0
NOX5	"NOX5A, NOX5B"	ENSG00000255346	"NADPH oxidase 5"	Q96PH1	15	68930525-69062743	"Predicted membrane proteins, Transporters"	"Angiogenesis, Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 19.1;placenta: 11.1;testis: 43.7"	"Group enriched"	"Detected in some"	4	"Early spermatids: 14.7;Late spermatids: 9.0;Spermatocytes: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.5;EFO-21: 3.2"					"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (2.33e-1)"	"unprognostic (1.63e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.21e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.71e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	1.5	1.0	0.8	0.4	2.3	0.4	1.5	0.8	1.2	3.0	0.9	0.9	5.3	0.4	1.5	2.5	1.1	1.1	1.1	1.6	0.8	0.9	1.4	0.5	0.6	1.1	1.3	0.1	1.2	0.6	0.5	1.9	11.1	2.7	2.1	0.9	1.1	0.6	2.3	0.9	0.8	1.0	2.3	1.3	19.1	0.9	43.7	0.5	0.2	1.4	0.2	0.6	1.5	1.0	0.4	0.1	0.4	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	2.4	0.6	2.0	2.5	1.3	1.5	0.0	3.2	0.4	0.1	0.0	0.0	0.1	1.6	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.5	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.7	1.1	0.0	0.0	0.7	0.6	1.5	0.0	0.1	0.3	1.3	0.0	1.7	0.0	0.1	0.6	2.0	0.2	0.9	0.3	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.1	0.3	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	2.3	0.8	1.2	0.8	0.9	1.3	0.1	2.7	0.5	0.0	0.0	0.0	0.1	0.0	1.4	1.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	14.7	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.0	0.0	4.3	1.3	0.0	1.5	0.0	0.0	0.0
NPAP1	C15orf2	ENSG00000185823	"Nuclear pore associated protein 1"	Q9NZP6	15	24675868-24683393	"Predicted intracellular proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"testis: 17.7"	"Group enriched"	"Detected in some"	5	"Spermatocytes: 16.7;Spermatogonia: 10.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-266/70: 3.4"									"HPA018828, HPA019562"	Uncertain					NA	NA					"HPA018828: AB_2669941, HPA019562: AB_2670190"										"unprognostic (4.40e-2)"	"unprognostic (1.85e-2)"		"unprognostic (6.98e-3)"	"unprognostic (7.45e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.11e-3)"	0.2	0.2	0.2	0.2	1.2	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.8	0.6	0.2	0.2	0.2	0.2	0.2	1.4	0.9	0.0	1.1	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.8	0.2	0.2	0.4	0.3	0.2	17.7	0.2	0.2	1.2	0.2	0.2	0.6	0.2	0.4	0.3	1.6	0.1	0.9	1.2	0.0	0.4	0.2	0.6	0.7	0.1	0.0	0.8	0.4	0.0	0.1	0.0	0.5	0.5	0.5	0.2	0.1	0.3	0.4	0.2	0.4	0.1	0.2	0.5	0.4	1.0	0.5	0.0	0.5	0.2	0.2	0.4	0.3	0.2	0.4	0.0	0.5	0.6	0.5	0.0	0.5	0.2	0.6	0.9	0.2	0.6	0.1	0.1	0.1	0.1	1.4	0.5	0.2	0.3	0.8	0.2	0.4	0.9	0.2	0.9	0.5	1.6	0.2	0.2	3.4	0.2	0.7	0.5	0.3	0.2	1.6	0.1	0.2	1.1	0.1	0.5	0.2	0.2	1.0	0.1	0.4	0.2	1.2	0.9	0.9	0.1	0.3	0.2	0.0	0.2	1.2	0.2	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.7	10.4	0.0	0.0	0.0	0.0	0.1
NPBWR2	GPR8	ENSG00000125522	"Neuropeptides B and W receptor 2"	P48146	20	64105820-64107171	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"brain: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"cerebral cortex: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"basal ganglia: 0.6;hypothalamus: 0.4;olfactory region: 1.5"							NA	NA															"unprognostic (1.44e-1)"								0.2	2.4	0.3	0.3	1.8	0.3	0.2	0.4	14.8	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	2.3	0.2	0.2	0.2	1.6	0.2	0.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.4	14.8	0.2	0.5	0.2	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586898	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.6"	"Cell type enhanced"	"Detected in many"	4	"Urothelial cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 32.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 32.7;T-cells: 14.5"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 70.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		27000	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	13.4	38.8	17.4	11.2	30.9	26.4	15.8	7.1	25.1	10.1	8.7	65.6	3.4	10.2	11.1	11.7	12.8	8.2	11.2	7.1	23.4	14.3	9.9	10.3	17.8	13.0	46.0	15.4	12.0	7.9	51.8	9.9	18.9	27.7	9.7	8.9	12.0	25.4	10.1	13.7	17.0	12.2	10.9	41.4	11.5	12.0	9.5	38.4	7.0	8.3	5.3	10.7	10.8	10.8	3.6	32.7	3.8	5.8	4.6	14.5	4.1	5.3	10.7	4.6	7.4	15.0	11.6	10.5	9.3	20.2	9.9	21.5	7.1	7.8	4.5	7.2	13.4	33.8	15.0	5.8	16.0	8.8	3.5	4.6	1.6	9.7	16.0	21.4	6.1	7.4	11.1	15.9	20.9	70.4	19.6	9.7	5.2	4.8	12.1	11.1	8.1	2.5	3.6	3.2	6.1	9.6	3.6	7.2	11.2	23.0	13.3	1.9	3.7	11.1	16.2	13.7	7.4	4.0	4.8	12.5	21.0	4.1	8.3	8.0	7.5	23.1	3.1	46.3	5.4	9.4	1.8	4.1	3.8	14.5	3.8	9.8	2.4	5.9	9.9	1.7	3.6	2.7	7.3	3.7	4.6	5.8	32.7	7.7	4.1	17.4	30.9	7.1	25.1	23.4	14.3	46.0	15.4	27.7	38.4	23.8	44.3	6.2	23.3	8.2	5.0	4.4	10.2	0.0	15.9	8.7	17.7	11.6	0.0	9.3	1.1	11.4	11.3	0.0	12.8	6.2	6.5	30.4	10.4	7.9	25.1	3.2	3.5	7.4	9.2	1.4	8.3	17.9	11.8	2.8	4.8	16.2	23.5	14.0	9.9	4.7	12.4	0.0	9.0	12.6	20.4	12.7	19.9	20.3	4.5	51.4
NPC2	"EDDM1, HE1, NP-C2"	ENSG00000119655	"NPC intracellular cholesterol transporter 2"	P61916	14	74476192-74494177	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease mutation, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"epididymis: 982.9"	"Cell type enhanced"	"Detected in all"	7	"Alveolar cells type 2: 1546.9;Hofbauer cells: 2619.0;Kupffer cells: 1574.1"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 769.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 139.0;granulocytes: 44.2;monocytes: 112.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 145.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA000835, CAB032888"	Enhanced				"Secreted to blood"	NA	NA		63000000			"CAB032888: AB_2157036, HPA000835: AB_1079499"	"unprognostic (1.27e-3)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-3)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.42e-1)"	34.8	23.7	9.0	14.7	12.2	13.9	27.2	2.4	7.6	21.1	16.0	12.5	92.3	11.9	16.8	982.9	17.1	14.9	17.5	34.1	9.1	9.9	29.2	13.6	65.0	48.8	15.1	6.7	25.3	14.6	4.5	21.3	22.1	25.5	17.8	14.4	39.8	21.8	54.0	9.4	16.6	19.1	12.1	26.5	30.0	13.6	26.6	10.6	7.6	49.8	15.9	15.4	16.4	18.1	18.7	139.0	44.2	112.5	6.3	12.2	67.2	29.9	18.9	12.6	16.0	145.7	42.9	39.8	21.7	73.0	19.2	42.8	32.4	37.9	7.3	15.9	16.9	34.9	59.6	16.3	40.2	16.8	11.7	12.7	2.9	9.8	24.8	32.5	4.7	56.1	43.5	34.1	17.3	33.3	86.9	24.7	8.1	3.0	56.6	18.4	12.6	7.3	7.3	6.5	43.5	30.5	3.5	22.6	24.8	43.6	65.7	0.5	8.8	31.1	11.5	27.1	33.9	19.7	20.5	26.7	27.1	37.1	39.3	19.0	26.3	45.0	2.6	28.9	15.1	15.2	34.1	83.8	17.9	6.6	112.5	6.2	18.7	9.2	6.6	39.1	17.0	9.0	7.5	44.2	6.3	76.2	139.0	12.2	67.2	9.0	12.2	2.4	7.6	9.1	9.9	15.1	6.7	25.5	10.6	354.4	1546.9	199.4	441.4	332.9	6.2	41.4	180.9	202.1	410.6	314.0	21.6	204.0	258.6	495.5	43.7	268.3	275.4	46.7	246.5	603.6	321.0	334.4	324.3	159.5	2619.0	7.9	115.0	406.4	1574.1	41.8	524.7	1241.8	571.9	500.5	250.2	141.9	373.8	381.4	274.4	754.1	22.6	129.4	139.6	230.6	151.8	280.3	176.0	111.8	255.9	447.4
NPHS2	"PDCN, SRN1"	ENSG00000116218	"NPHS2, podocin"	Q9NP85	1	179550539-179575952	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	143	"kidney: 66.5"	"Group enriched"	"Detected in some"	12	"Collecting duct cells: 19.2;Early spermatids: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	24	"NTERA-2: 5.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"CAB037267, HPA049486"	Enhanced					NA	NA					"CAB037267: AB_261982, HPA049486: AB_2680788"													"unprognostic (6.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0
NPIPA1	"morpheus, NPIP"	ENSG00000183426	"Nuclear pore complex interacting protein family member A1"	Q9UND3	16	14922802-14952060	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 33.1"	"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 54.9;Early spermatids: 43.7"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in some"			"Group enriched"	"Detected in many"	16	"B-cells: 2.3;granulocytes: 1.7;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 34.1"									HPA053611	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.82e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.74e-7)"	"unprognostic (2.28e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-5)"	5.1	6.0	5.9	3.8	4.9	4.2	4.8	33.1	8.3	5.0	5.8			1.8	15.6	0.0	3.0	16.3	2.7	4.6	7.0	6.2	6.6	3.0	4.3	5.4	3.7		25.2	4.7	1.1	13.6	3.0		7.8	3.3		2.5	11.7	7.9	16.3	3.0	12.4	3.8	5.0	3.2	6.5			6.1		4.1	5.0	4.0	2.3	0.0	1.7	0.1	0.1	1.3	0.7	0.1	5.3	24.6	9.5	0.0	0.4	4.2	9.3	6.5	8.6	7.7	3.7	5.8	1.5	13.4	12.9	10.3	4.3	11.3	1.3	8.9	4.8	4.3	0.0	8.3	19.6	34.1	11.7	2.8	18.9	18.5	7.2	13.1	5.1	4.1	8.1	1.3	6.5	9.7	11.3	0.0	6.3	0.2	0.0	0.2	4.6	0.1	2.1	13.8	11.3	1.0	9.3	5.0	0.6	10.6	3.1	1.9	10.3	0.8	11.5	0.5	0.2	2.9	3.9	2.8	3.1	0.4	0.7	5.8	1.7	0.0	0.0	0.8	0.0	1.3	2.3	0.3	1.2	0.0	1.3	0.6	0.4	0.0	0.1	0.1	0.0	0.7	0.7											6.0	18.3	0.0	1.1	8.2	7.4	2.0	0.0	54.9	29.6	8.7	5.9	1.8	0.0	5.2	43.7	3.6	2.6	0.0	1.7	1.2	6.2	1.3	20.9	2.9	2.0	6.4	4.7	6.7	5.2	17.6	19.8	4.0	0.0	6.4	4.5	3.0	4.9	3.5	18.0	1.0	4.8	19.4	3.9	12.2	10.4	3.4	1.0	5.0	7.5	0.9
NPLOC4	"FLJ20657, KIAA1499, NPL4"	ENSG00000182446	"NPL4 homolog, ubiquitin recognition factor"	Q8TAT6	17	81556887-81648465	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021560, HPA023295"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA021560: AB_1854586, HPA023295: AB_1854587"	"unprognostic (3.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.95e-7)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.72e-1)"	21.7	23.0	15.3	18.7	16.1	22.0	15.4	14.7	24.1	13.2	15.9	18.6	14.2	14.7	18.9	16.3	25.1	14.7	14.4	35.4	16.2	13.5	20.2	28.2	18.4	18.3	16.4	15.5	13.9	18.2	17.8	17.1	25.6	17.2	16.7	13.3	21.0	16.4	14.9	89.8	24.2	16.4	19.4	14.9	22.0	17.6	31.0	13.4	19.7	14.7	17.1	20.6	15.7	16.6	4.6	5.9	5.7	18.1	2.5	4.6	7.8	29.0	38.3	15.3	23.8	18.9	15.7	19.0	24.1	26.9	40.1	37.2	29.0	26.3	21.6	19.4	28.1	29.4	23.6	15.0	20.2	34.9	13.5	19.8	25.0	31.0	25.7	18.1	26.3	31.9	15.5	19.6	37.4	13.4	19.4	40.9	20.2	26.3	32.9	24.2	18.8	35.4	14.3	17.9	14.5	24.2	23.4	24.6	17.6	14.4	28.1	20.5	23.7	30.3	42.3	27.3	30.5	33.1	19.4	29.2	52.7	36.6	28.6	38.6	25.1	17.7	26.6	42.0	17.7	33.8	3.0	18.1	3.9	4.6	4.6	2.8	4.6	3.2	3.6	5.9	3.7	2.9	3.8	5.7	2.5	2.8	4.6	3.0	7.8	15.3	16.1	14.7	24.1	16.2	13.5	16.4	15.5	17.2	13.4	11.9	17.8	16.0	14.4	15.7	22.7	39.6	12.7	8.1	18.2	19.2	27.5	16.5	1.7	17.6	91.1	20.1	26.2	46.7	32.2	17.3	15.5	19.7	3.5	46.4	16.9	19.1	29.2	29.4	24.0	71.7	16.4	19.3	11.8	19.8	15.0	18.4	36.6	20.1	12.0	20.4	35.3	19.4	16.4	22.3	23.3	21.1	31.0	15.0	15.3	23.7
NPPC	CNP	ENSG00000163273	"Natriuretic peptide C"	P23582	2	231921820-231926403	"Predicted secreted proteins, Transporters"	Osteogenesis	"Hormone, Vasoactive"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 34.2;retina: 24.7"	"Cell type enhanced"	"Detected in many"	16	"Basal glandular cells: 28.5;Collecting duct cells: 10.4;Cone photoreceptor cells: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 7.9;NTERA-2: 3.7;SCLC-21H: 5.2;SK-MEL-30: 22.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 33.4"	HPA035362	Uncertain				"Secreted to blood"	NA	NA	6140				"HPA035362: AB_10671103"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.22e-3)"	"unprognostic (9.81e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.91e-1)"	1.4	0.9	4.1	6.3	4.4	4.5	1.4	5.4	12.0	3.0	5.0	2.9	0.7	0.9	1.6	34.2	7.3	1.8	0.6	3.9	6.9	6.3	0.9	0.5	0.8	4.5	2.8	2.2	1.8	0.5	0.5	3.8	1.1	12.4	13.1	1.3	24.7	4.4	2.0	2.4	0.8	1.6	2.2	13.3	1.7	4.3	1.0	0.9	13.7	2.1	9.3	6.0	0.5	0.6	0.0	1.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.9	0.0	3.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	5.2	0.3	0.2	0.2	22.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.1	4.4	5.4	12.0	6.9	6.3	2.8	2.2	12.4	0.9	0.0	0.0	0.0	28.5	3.1	1.1	1.6	0.0	0.0	0.0	10.4	9.8	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.3	6.7	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.3	0.3	1.7	0.0	1.3	5.8	0.6	2.5	0.0	0.0	3.7	0.0	0.9	0.3	3.4	1.0	0.2	0.0	0.6	2.6
NPR2	"AMDM, ANPb, ANPRB, GUCY2B, NPRB"	ENSG00000159899	"Natriuretic peptide receptor 2"	P20594	9	35792154-35809732	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Osteogenesis"	"Lyase, Receptor"	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7"	"Cell type enhanced"	"Detected in many"	5	"Leydig cells: 8.6;Muller glia cells: 8.2;Peritubular cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 3.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.1;T-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 27.6;ASC TERT1: 20.6;BJ hTERT+: 16.8;HSkMC: 20.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.93e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.59e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.99e-3)"	"unprognostic (7.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.86e-2)"	9.0	4.8	3.8	1.9	6.4	0.0	7.2	32.7	11.2	29.2	7.8	1.8	4.4	1.8	22.6	9.8	5.3	7.6	5.7	7.6	3.7	4.2	3.7	8.4	4.7	2.3	2.5	5.1	8.0	1.3	2.7	7.9	7.1	11.8	8.3	4.0	8.3	3.3	9.5	7.7	6.2	3.7	17.1	3.9	2.6	4.5	5.5	4.0	0.9	3.2	2.4	2.0	6.2	8.9	0.4	3.1	0.0	0.0	0.1	2.1	0.1	0.0	1.6	1.9	0.0	27.6	20.6	1.2	7.7	16.8	6.2	6.7	4.0	2.7	1.1	2.0	15.0	11.6	0.7	2.3	0.2	5.6	1.3	0.7	1.0	1.8	2.0	15.0	0.1	0.0	20.4	1.1	6.9	0.5	6.1	10.1	1.7	0.5	0.1	11.6	0.5	0.3	0.4	2.6	0.8	2.8	1.3	0.1	0.5	1.0	0.8	0.5	0.6	0.2	0.0	0.3	3.1	0.1	0.0	6.5	6.6	5.1	2.1	0.7	0.2	0.3	3.0	8.4	0.3	3.7	0.0	0.0	0.0	1.1	0.0	0.0	0.4	1.2	0.6	0.0	0.0	0.5	0.4	0.0	0.1	0.0	3.1	2.1	0.1	3.8	6.4	32.7	11.2	3.7	4.2	2.5	5.1	11.8	4.0	3.0	4.3	0.0	0.6	1.0	4.0	0.6	0.0	1.4	0.0	0.0	2.0	0.3	0.0	0.4	0.1	2.3	0.1	0.0	0.7	0.1	5.7	1.7	1.1	5.7	0.3	3.2	0.0	2.5	0.3	0.0	8.6	0.0	0.0	0.0	0.9	8.2	0.5	3.1	7.4	0.6	2.1	0.0	1.9	2.8	2.0	1.4	0.2	0.0	1.0	0.3
NPTN	"GP55, GP65, np55, np65, SDFR1, SDR1"	ENSG00000156642	Neuroplastin	Q9Y639	15	73560014-73634134	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051497, HPA072453"	Approved		Approved	"Plasma membrane"		NA	No		21000	"Plasma membrane"		"HPA051497: AB_2681507, HPA072453: AB_2686523"	"unprognostic (9.30e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.42e-3)"	"unprognostic (9.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	20.8	24.9	49.0	17.8	72.9	6.9	22.5	55.3	84.5	30.3	36.2	11.9	28.1	33.2	52.3	39.9	34.2	35.2	30.5	48.4	43.6	38.3	32.7	18.2	27.2	15.9	30.3	47.8	21.0	23.8	35.9	18.3	30.3	40.0	45.3	36.6	22.7	25.9	54.9	12.1	19.5	39.8	75.3	16.8	16.7	27.1	18.8	20.4	6.3	28.7	18.5	16.6	32.7	25.9	3.0	3.9	19.7	13.3	2.5	4.9	7.3	17.5	31.5	18.2	13.3	37.2	33.6	25.5	40.5	66.5	46.8	41.7	21.4	56.4	10.2	24.2	58.1	58.0	72.9	29.2	33.7	27.0	18.2	19.4	8.1	16.1	19.0	26.4	12.4	22.6	27.4	29.9	30.2	18.3	46.4	24.8	9.2	4.5	11.7	33.4	14.0	5.5	7.6	16.7	22.2	11.3	8.9	20.8	8.6	63.7	26.0	11.1	3.4	39.2	21.9	26.0	47.4	19.8	16.9	27.9	36.4	24.5	20.8	23.5	10.2	19.0	8.8	33.8	19.3	24.8	3.6	10.0	9.5	4.9	13.3	4.0	3.0	2.8	4.4	3.7	2.3	2.9	3.3	19.7	2.5	9.6	3.9	3.0	7.3	49.0	72.9	55.3	84.5	43.6	38.3	30.3	47.8	40.0	20.4	71.5	54.8	7.7	22.7	57.8	76.4	87.0	58.6	87.0	66.0	78.5	47.1	5.7	1.7	17.0	2.8	30.7	78.3	0.0	20.5	7.9	45.4	26.3	26.7	38.2	22.1	36.5	98.8	47.9	71.6	6.6	14.1	37.1	40.5	12.6	77.6	35.4	30.5	49.9	36.0	16.8	47.1	19.4	36.0	8.2	10.4	47.7	5.7	12.5	39.9	25.1
NPTX1		ENSG00000171246	"Neuronal pentraxin 1"	Q15818	17	80467148-80477843	"Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 68.9"	"Cell type enriched"	"Detected in some"	6	"Cone photoreceptor cells: 164.9"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 12.4;HeLa: 9.7;SiHa: 15.8;U-138 MG: 33.8;WM-115: 46.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 74.8;cerebellum: 228.3;cerebral cortex: 119.6;hippocampal formation: 173.6"	HPA077062	Enhanced	Approved			"Secreted in brain"	NA	NA		1000000			"HPA077062: AB_2732329"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.05e-6)"	"unprognostic (1.41e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.86e-6)"	"unprognostic (2.71e-3)"	1.0	3.4	28.8	1.4	14.7	0.8	1.1	68.9	62.5	0.8	9.1	0.2	0.0	1.3	1.3	2.5	1.4	1.4	1.7	0.7	15.5	3.0	0.8	0.7	1.0	1.4	1.0	18.2	0.7	0.7	0.7	0.8	1.6	4.6	1.3	2.5	0.6	0.7	2.9	1.0	3.2	1.5	1.4	1.9	2.3	1.5	1.3	0.0	0.9	0.7	0.0	0.7	0.9	0.2	0.0	0.0	0.0	0.0	1.5	0.3	0.1	0.0	0.7	0.2	0.0	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	1.3	0.0	12.4	0.0	0.0	0.0	7.7	0.0	9.7	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	3.2	0.0	0.0	8.4	0.0	15.8	0.0	0.0	0.1	0.0	0.2	0.1	33.8	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	28.8	14.7	68.9	29.9	15.5	3.0	1.0	18.2	4.6	0.0	0.0	0.0	0.0	0.1	1.3	8.7	2.8	0.0	0.0	1.2	0.0	164.9	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.9	0.0	0.0	0.0	0.0	0.8	0.3	0.0	2.1	0.0	2.6	0.0	0.9	1.1	0.5	2.6	0.1	0.0	0.0	0.0
NR1H4	"FXR, HRR-1, HRR1, RIP14"	ENSG00000012504	"Nuclear receptor subfamily 1 group H member 4"	Q96RI1	12	100473708-100564413	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease mutation, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"liver: 109.4"	"Cell type enhanced"	"Detected in some"	15	"Cholangiocytes: 79.0;Distal tubular cells: 36.5;Hepatocytes: 90.4;Proximal tubular cells: 116.5"	"Group enriched"	"Detected in some"	11	"liver cancer: 18.7;renal cancer: 12.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"Hep G2: 18.4;HHSteC: 11.1;RPTEC TERT1: 29.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047699			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047699: AB_10965320"			"unprognostic (1.78e-1)"		"unprognostic (1.81e-1)"		"unprognostic (6.68e-2)"	"unprognostic (2.49e-1)"		"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"		"unprognostic (3.77e-3)"	0.1	11.3	0.1	1.4	0.4	0.0	0.2	0.1	0.2	0.2	5.8	0.4	0.1	11.3	0.1	0.4	0.1	0.1	7.0	0.1	0.1	0.0	25.0	109.4	0.6	2.4	0.1	0.1	7.7	2.7	0.0	2.9	0.2	0.3	0.5	0.4	0.6	0.1	0.1	0.1	0.0	19.5	0.3	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.3	0.3	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.4	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	79.0	0.0	0.0	21.0	0.0	0.0	36.5	6.3	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	90.4	0.0	0.0	0.0	14.7	1.9	1.3	0.9	0.0	0.0	0.0	0.1	0.0	0.6	2.9	0.0	116.5	0.0	0.0	0.1	0.5	0.7	0.0	0.0	0.0	0.3	0.9
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126122-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	5	"brain: 67.2"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 114.4"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 14.6;SH-SY5Y: 11.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: AB_2684413"	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		1.3	6.9	21.5	1.7	27.7	1.7	1.3	5.3	67.2	1.3	1.7	2.1	0.0	1.7	1.5	1.4	1.4	1.3	1.5	1.4	15.3	25.0	1.5	1.4	1.4	1.5	12.4	25.4	1.3	2.6	1.4	12.9	1.3	27.4	1.4	1.7	0.3	1.5	1.3	3.3	1.5	1.6	1.6	6.7	1.5	1.9	1.6	5.0	0.0	1.4	0.0	1.3	1.3	0.1	0.5	0.2	1.8	0.2	0.1	0.3	0.0	0.7	0.0	0.3	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.7	0.1	1.7	0.0	0.0	0.3	0.1	0.0	0.1	1.7	0.6	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.3	2.0	1.3	0.1	0.2	0.3	0.9	0.7	0.2	2.5	0.5	0.2	0.5	0.0	0.0	14.6	11.7	0.0	0.1	0.9	0.2	1.7	3.5	0.2	0.5	0.6	0.1	0.4	0.8	2.3	0.9	0.7	0.0	1.3	1.8	0.1	0.3	0.2	0.2	0.1	0.2	0.1	0.1	0.0	0.5	0.1	0.3	1.0	0.1	0.2	0.2	0.0	0.0	21.5	27.7	5.3	34.1	15.3	25.0	12.4	25.4	27.4	5.0	0.0	0.0	0.0	0.0	0.0	24.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NRSN2	"C20orf98, dJ1103G7.6"	ENSG00000125841	"Neurensin 2"	Q9GZP1	20	346782-359660	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.9"	"Cell type enhanced"	"Detected in many"	5	"Intestinal endocrine cells: 28.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015967	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA015967: AB_1854647"	"unprognostic (5.67e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (1.73e-3)"	8.4	18.6	34.3	6.0	39.3	0.9	7.2	22.7	70.9	12.8	6.6	11.0	4.9	3.5	12.5	16.0	6.1	13.4	9.3	13.5	31.1	24.9	10.1	1.8	8.7	4.1	17.1	28.5	18.3	10.5	26.5	16.3	10.1	27.8	12.2	6.1	12.8	13.3	16.5	1.4	5.0	3.8	16.3	8.7	5.7	5.3	12.8	6.8	1.3	14.9	2.5	4.2	9.4	4.8	9.4	4.8	1.5	1.1	3.4	3.9	1.5	18.9	23.0	13.9	13.1	18.4	20.6	5.4	12.6	24.3	22.9	23.0	12.6	0.4	0.0	4.4	23.3	16.8	8.3	11.2	1.9	14.6	0.1	11.3	6.8	11.0	24.0	18.6	0.2	1.1	23.3	1.5	16.3	2.7	18.7	15.7	0.1	13.5	12.3	20.0	3.3	0.3	5.8	10.7	0.2	11.9	10.8	7.8	0.9	22.8	0.1	28.4	20.4	15.0	4.4	21.5	9.5	18.4	7.1	10.4	24.5	13.0	0.9	15.3	2.3	0.4	5.1	3.2	0.2	12.9	0.0	1.1	1.5	3.8	0.3	1.1	7.2	1.1	3.9	2.1	9.4	1.6	2.7	0.0	3.4	0.4	4.8	0.9	1.5	34.3	39.3	22.7	70.9	31.1	24.9	17.1	28.5	27.8	6.8	0.0	1.9	0.0	3.1	2.9	24.5	4.0	0.0	2.7	7.9	12.2	2.0	6.1	1.7	11.0	5.5	4.5	1.3	0.0	1.4	5.3	10.8	2.5	4.7	0.4	2.7	15.9	28.3	4.3	1.2	10.0	12.0	1.2	3.3	3.6	2.7	12.3	3.8	1.9	9.9	5.7	12.7	19.4	9.2	21.3	6.6	1.9	3.7	1.0	2.0	2.7
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918505-51225575	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 81.9"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 70.6;Early spermatids: 130.0;Horizontal cells: 73.1;Late spermatids: 79.3"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	10	"neutrophil: 4.4"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 4.4"	"Cell line enriched"	"Detected in some"	8	"SCLC-21H: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		620000	"Plasma membrane"		"HPA071400: AB_2732180"	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	2.1	3.2	22.4	2.1	20.3	1.4	1.7	56.5	81.9	2.8	5.1	3.0	0.5	2.1	2.1	3.7	3.0	1.4	2.2	3.8	16.9	13.8	1.5	1.6	1.5	1.4	8.3	25.9	2.1	2.3	1.3	4.8	1.1	12.6	2.5	3.8	2.0	3.5	9.3	1.3	2.0	3.1	2.1	6.5	1.3	2.3	6.5	4.7	0.0	1.4	0.0	1.4	2.0	1.6	0.0	0.0	4.4	0.1	0.3	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	29.0	1.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	2.4	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.4	0.3	0.0	0.0	0.0	0.0	22.4	20.3	56.5	33.2	16.9	13.8	8.3	25.9	12.6	4.7	0.0	0.0	0.0	0.4	0.0	70.6	15.4	0.0	0.0	0.0	0.0	2.0	0.0	1.7	0.0	130.0	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	73.1	1.7	5.5	0.0	79.3	2.3	0.2	1.7	0.0	0.0	20.9	0.3	0.0	0.7	0.0	8.0	0.0	0.3	9.9	3.8	0.1	0.2	0.0	0.0	0.0
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.4"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 95.1;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 82.9"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		6900	Cytosol	"Golgi apparatus"	"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	1.9	3.6	11.2	2.7	19.1	1.6	2.6	14.1	35.4	2.5	4.0			1.4	1.9	2.7	3.9	2.2	2.8	1.5	13.9	14.4	3.4	2.5	2.2	3.1	12.6		1.3	3.5	6.5	5.5	2.6		2.8	5.5		2.4	2.1	4.3	2.4	3.2	2.2	3.1	1.6	3.0	3.1			3.6		3.4	3.3	1.0	7.2	15.5	10.4	13.3	6.7	11.1	8.8	6.1	13.6	9.1	0.6	5.4	7.6	7.4	8.4	9.9	8.1	7.9	9.3	0.0	15.0	15.1	18.6	8.4	1.1	10.2	3.1	13.3	5.3	13.4	0.5	9.8	12.8	8.0	0.4	3.3	6.9	4.3	16.4	6.9	4.3	12.7	3.8	10.0	8.2	17.9	12.0	10.0	3.9	5.1	19.1	16.2	7.2	8.8	14.0	9.3	12.8	8.4	9.5	12.4	0.0	5.9	10.1	15.6	18.7	10.3	22.9	8.1	12.1	12.6	17.7	10.1	8.9	6.4	8.1	16.1	10.4	13.3	7.8	8.2	12.1	8.9	6.8	8.2	10.5	15.5	7.2	6.9	8.1	6.0	6.7	12.1	6.2	11.1	8.8											8.9	9.9	12.6	3.2	3.5	95.1	6.2	10.2	4.0	7.9	21.0	82.5	10.9	10.0	10.3	26.6	10.6	25.1	0.0	14.0	12.0	9.3	10.6	9.2	18.7	16.9	41.3	29.3	11.6	27.2	34.0	5.5	15.5	10.1	28.9	27.8	21.3	11.7	14.4	8.1	12.2	82.9	0.0	11.7	28.9	31.3	5.0	15.4	10.9	16.1	7.8
NTSR1	NTR	ENSG00000101188	"Neurotensin receptor 1"	P30989	20	62708837-62762771	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.0;intestine: 15.1"	"Cell type enhanced"	"Detected in single"	29	"Kupffer cells: 3.2"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"PC-3: 35.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050299			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA050299: "	"unprognostic (4.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.87e-4)"	"unprognostic (9.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.16e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	0.3	0.1	3.7	2.5	3.6	3.8	0.1	0.1	7.0	0.1	15.1	0.0	0.0	0.4	0.2	0.1	0.1	0.1	1.4	0.1	2.0	1.1	0.6	0.2	0.3	0.3	3.3	1.0	0.4	0.1	0.2	0.3	0.2	1.4	0.2	0.5	1.2	0.3	0.1	0.2	0.2	1.5	0.8	0.8	0.6	0.5	0.5	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	6.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	1.7	0.1	1.6	0.2	0.7	35.8	1.1	0.0	5.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.7	3.6	0.1	7.0	2.0	1.1	3.3	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686734-68745809	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: AB_2673992"	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	18.3	12.6	10.2	16.5	13.2	18.7	17.4	20.7	15.2	19.0	12.2	12.1	12.2	9.2	18.6	18.0	14.0	16.6	8.5	12.1	12.2	6.6	12.1	11.1	12.5	21.4	13.2	10.2	19.8	12.5	14.2	16.2	23.5	12.2	12.6	15.3	11.3	13.0	11.8	13.9	14.8	15.8	13.7	12.5	19.7	12.0	20.5	15.9	40.6	12.5	13.1	22.5	17.8	13.1	13.6	7.0	9.5	14.2	20.6	17.0	8.0	17.1	22.1	26.4	19.1	7.8	10.0	28.6	18.8	10.9	28.3	23.7	22.2	14.6	31.5	18.4	9.0	12.6	19.8	29.6	13.9	37.9	29.5	22.0	35.9	15.9	18.7	4.9	31.6	12.2	5.3	6.6	22.6	14.8	9.9	16.9	18.3	42.8	22.7	17.7	20.8	26.0	27.6	29.0	6.6	21.7	26.6	31.8	18.9	12.2	18.3	15.6	16.0	20.8	15.7	11.3	21.5	23.5	15.3	10.3	15.5	15.8	18.0	22.9	9.9	19.8	38.2	11.9	23.1	18.2	6.3	6.5	9.5	13.1	8.5	17.0	13.5	13.0	14.0	7.0	13.6	16.2	14.5	1.7	20.6	14.2	5.5	13.4	8.0	10.2	13.2	20.7	15.2	12.2	6.6	13.2	10.2	12.2	15.9	11.9	15.3	27.4	14.6	15.3	20.5	11.3	12.7	20.1	14.8	8.7	17.7	24.8	10.0	15.4	26.7	16.1	8.4	0.0	15.4	25.3	16.3	13.0	15.1	6.7	15.5	12.7	8.2	17.8	11.1	7.1	35.9	19.8	18.6	27.9	11.3	22.6	17.1	7.0	20.5	5.8	31.5	12.9	14.6	52.6	42.8	15.4	11.8	25.9	13.0	10.0
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440260-229508341	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA059767: AB_2684123"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	20.6	20.0	17.4	16.3	21.6	16.2	25.4	29.8	24.0	19.6	17.7	27.2	15.5	13.2	23.0	18.4	18.5	22.2	13.5	22.7	17.6	17.0	19.5	15.6	19.8	27.8	20.9	20.3	27.3	17.8	33.3	23.3	23.0	20.6	19.1	18.3	15.5	17.8	21.2	28.6	21.8	16.2	20.9	19.4	19.1	17.1	19.4	20.9	38.0	21.7	18.0	22.8	20.2	17.9	9.0	10.5	7.5	13.6	7.6	10.9	7.3	14.3	11.6	18.2	9.4	13.1	14.1	35.5	11.9	12.2	17.8	16.2	13.7	14.2	20.9	10.4	11.8	7.9	19.1	25.1	12.6	19.1	12.6	31.2	12.6	12.0	10.3	10.5	25.5	10.3	11.0	9.5	12.8	15.3	12.4	14.8	18.0	28.4	10.1	13.9	6.5	18.8	10.9	27.2	20.2	10.6	18.4	18.9	20.5	10.1	12.7	15.6	19.4	17.8	11.2	13.0	9.3	17.4	20.3	12.9	8.1	9.9	14.0	17.7	9.7	12.0	22.5	9.2	14.9	16.8	7.5	8.2	6.1	8.8	8.2	10.9	9.0	9.3	9.7	10.5	7.1	9.6	10.0	2.9	7.6	13.6	6.0	8.6	7.3	17.4	21.6	29.8	23.4	17.6	17.0	20.9	20.3	20.6	20.9	8.9	17.6	3.7	5.2	8.0	16.0	17.3	7.6	9.4	10.3	14.0	7.9	18.2	5.0	7.2	1.1	8.7	2.9	0.0	7.4	11.1	10.6	5.8	7.0	9.5	8.5	15.9	9.8	12.3	12.3	1.9	11.5	7.1	6.8	9.0	7.1	11.6	6.2	6.5	11.3	6.8	11.9	0.0	9.9	12.3	16.7	9.4	15.3	7.0	9.5	5.5
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706834	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898, HPA027899"	Supported		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: "	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	20.2	14.0	13.8	22.2	15.3	37.5	19.0	24.7	14.9	17.8	15.2	14.4	18.9	9.8	19.7	16.0	21.6	17.8	15.6	15.1	12.3	10.2	13.4	22.9	17.7	21.6	12.2	10.5	21.0	15.1	23.3	17.3	29.2	12.6	15.1	13.4	12.4	16.3	19.9	30.7	19.9	16.3	16.0	11.0	18.7	15.0	26.8	13.8	34.4	15.9	18.9	26.4	18.4	21.1	3.9	3.5	6.5	3.3	5.5	7.6	2.2	19.2	9.7	21.4	18.6	9.5	11.2	20.8	15.1	14.4	23.1	24.8	16.1	9.0	36.6	25.3	13.7	19.2	14.1	25.0	14.9	37.5	19.2	18.6	19.6	10.7	16.6	7.1	28.3	18.3	11.8	12.1	24.1	17.5	8.8	13.6	12.4	45.4	11.8	15.5	10.4	20.9	17.2	16.6	7.4	10.5	27.7	27.4	34.4	10.2	19.1	23.7	13.7	12.9	21.4	12.9	35.4	13.8	10.3	12.4	23.5	13.3	11.0	23.5	15.0	21.5	37.0	5.8	13.1	27.6	2.4	2.5	5.5	5.9	2.4	7.6	3.6	7.1	6.8	3.5	3.9	4.4	4.3	6.5	5.5	3.3	2.0	3.1	2.2	13.8	15.3	24.7	14.9	12.3	10.2	12.2	10.5	12.6	13.8	17.9	21.0	16.6	35.4	67.9	13.1	10.9	10.2	17.4	11.4	15.7	15.7	17.8	1.7	7.7	20.7	23.4	10.7	0.0	5.2	18.0	24.9	29.7	3.5	24.5	15.1	15.9	20.1	12.9	17.1	16.4	16.1	16.8	20.3	6.4	12.1	8.0	12.4	3.5	13.8	9.1	12.5	12.9	23.6	29.1	20.3	69.4	20.0	20.2	14.6	28.0
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371181	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"lymphoid tissue: 20.4;testis: 70.1"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 50.6;Late spermatids: 71.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"	NA	NA			"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	6.8	5.3	3.9	6.5	5.9	11.2	7.3	6.9	7.5	6.4	5.1	5.9	3.4	4.4	9.7	3.7	6.9	5.0	3.7	4.7	3.9	4.1	4.4	5.3	5.1	8.1	3.8	4.2	7.9	5.5	8.1	7.0	8.4	5.2	5.5	6.3	5.9	6.0	5.9	6.1	8.1	5.0	5.9	3.9	7.2	4.9	70.1	2.5	20.4	5.4	4.8	9.8	5.8	6.0	7.3	4.9	7.1	7.1	7.7	10.0	4.4	13.8	11.0	12.0	17.7	3.7	5.5	43.1	11.2	5.9	15.4	11.3	16.2	11.4	15.7	5.2	7.2	16.7	11.3	20.2	11.0	24.2	10.3	11.4	12.2	40.1	7.5	4.7	20.3	8.6	4.0	4.6	23.7	12.0	4.2	8.1	7.1	22.1	8.4	10.2	6.8	10.8	5.5	11.3	8.5	10.0	13.1	37.8	12.5	3.5	13.3	14.5	10.0	25.8	11.1	6.5	8.9	13.7	8.1	7.0	18.6	15.6	14.0	17.0	9.6	16.0	21.1	8.7	18.4	14.0	7.1	3.4	5.8	6.1	7.1	10.0	7.3	5.7	5.3	4.9	5.8	5.8	6.5	1.3	7.7	5.0	3.4	4.1	4.4	3.9	5.9	6.9	7.5	3.9	4.1	3.8	4.2	5.2	2.5	3.0	5.0	11.5	5.6	9.3	6.5	7.3	2.5	12.0	11.4	3.5	5.9	11.9	0.0	5.9	50.6	7.4	3.8	0.0	5.2	17.5	5.8	6.6	4.7	7.9	6.8	4.8	1.2	13.5	8.8	71.9	10.3	7.4	0.0	4.6	9.7	3.5	5.5	3.5	9.6	3.1	13.1	0.0	6.1	27.7	19.6	10.2	6.3	8.7	10.3	4.4
NUP160	"FLJ22583, KIAA0197"	ENSG00000030066	"Nucleoporin 160"	Q12769	11	47778087-47848555	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (8.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	14.3	11.0	9.6	16.2	13.3	13.3	14.2	23.0	11.3	13.5	10.5	12.9	11.2	9.2	16.6	10.6	12.8	14.5	8.8	9.9	10.7	6.2	11.6	11.3	13.0	15.1	12.2	6.4	21.4	15.9	20.4	14.6	22.4	11.3	11.4	12.1	12.2	13.3	10.1	11.7	12.4	12.3	13.2	13.9	14.4	11.8	13.7	14.1	34.6	16.8	6.6	16.9	12.0	15.2	10.8	11.0	8.5	6.2	6.0	11.2	4.7	5.7	7.6	12.8	8.9	7.6	8.8	16.6	7.4	5.5	10.0	11.7	9.6	8.7	7.8	5.0	6.7	10.1	12.6	23.4	7.3	11.3	6.8	16.2	8.6	33.0	10.4	5.1	25.2	5.9	6.9	4.6	7.1	14.0	4.1	7.9	12.8	24.0	11.1	5.3	9.8	16.8	11.1	19.2	12.7	8.0	20.3	19.3	7.0	5.1	10.1	10.6	12.1	17.5	8.7	6.6	11.8	10.9	9.7	5.3	11.1	9.6	18.5	9.9	4.8	4.6	20.3	5.5	10.8	10.9	5.7	5.1	8.5	7.2	6.2	9.7	10.3	8.4	7.6	8.2	10.8	11.2	8.3	2.8	6.0	4.3	11.0	6.4	4.7	9.6	13.3	23.0	11.3	10.7	6.2	12.2	6.4	11.3	14.1	20.8	16.8	21.7	27.2	20.4	24.6	7.2	12.7	10.7	17.0	19.2	41.2	27.3	13.3	12.7	21.7	16.9	9.7	23.3	14.3	24.6	19.8	25.3	19.6	11.5	13.4	6.4	18.4	14.7	6.6	10.0	22.5	14.9	10.1	9.0	12.8	21.7	12.9	5.8	20.5	9.6	48.5	19.4	14.4	13.5	18.5	24.2	25.7	24.5	11.8	28.2
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 60.3"	"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 43.2;Spermatocytes: 41.6;Spermatogonia: 37.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol		No	No			Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: AB_2684602, HPA063942: AB_2685156"	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	10.2	11.1	7.6	12.6	9.2	14.3	14.0	13.3	8.7	9.2	9.3	10.1	9.6	5.8	9.8	6.7	16.6	8.3	7.6	9.2	5.6	6.3	8.1	9.6	13.1	16.6	6.5	6.7	10.8	13.3	12.6	13.6	9.1	7.3	9.5	9.3	11.2	9.9	8.3	10.9	16.4	9.0	11.0	7.7	12.2	9.5	60.3	7.3	26.5	9.2	11.3	17.3	8.5	10.5	6.1	7.9	6.3	10.7	6.0	12.0	7.0	10.9	21.0	17.4	23.7	13.2	13.1	15.6	15.4	12.2	28.3	18.9	25.3	8.8	19.2	5.8	16.9	18.3	32.6	39.0	19.1	21.2	15.4	18.8	17.1	39.2	19.9	8.4	29.2	17.3	9.1	9.0	29.7	15.2	8.3	16.2	25.0	37.5	13.7	19.9	27.8	24.9	11.9	23.3	21.1	20.2	22.9	37.7	19.6	8.7	12.4	24.5	11.8	39.9	15.2	5.9	13.4	16.7	10.8	13.1	23.5	16.7	23.6	27.5	11.7	21.6	26.0	13.7	18.7	17.3	6.3	5.3	1.9	9.3	10.7	12.0	6.1	7.9	9.0	7.9	5.9	8.1	8.6	0.8	6.0	5.9	3.3	9.5	7.0	7.6	9.2	13.3	8.7	5.6	6.3	6.5	6.7	7.3	7.3	0.0	13.0	7.5	5.2	5.8	14.9	2.7	7.6	4.0	2.3	5.2	43.2	6.4	1.7	5.5	10.1	6.8	3.2	0.0	5.6	5.9	6.9	7.5	5.8	3.8	7.4	19.1	8.7	12.9	4.9	3.1	8.9	7.2	1.7	4.6	6.7	7.5	7.5	0.0	11.0	1.9	25.0	25.8	4.2	41.6	37.7	9.8	7.2	7.0	6.0	7.2
NUP205	"C7orf14, KIAA0225"	ENSG00000155561	"Nucleoporin 205"	Q92621	7	135557919-135648757	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-2)"	13.7	12.6	11.4	14.2	11.9	10.8	13.1	23.3	10.5	12.5	11.9	13.4	11.4	9.0	17.6	9.7	19.3	16.1	7.4	9.5	8.6	6.1	10.3	8.3	12.2	16.1	11.7	6.9	17.4	10.3	23.0	20.9	13.1	10.6	10.6	14.7	14.6	18.4	11.3	16.6	15.1	13.8	14.7	10.8	16.7	12.7	17.4	11.4	31.6	12.4	13.4	22.1	15.6	14.4	4.9	5.7	2.2	6.1	5.3	6.0	2.7	22.1	18.1	24.4	23.8	5.8	9.6	15.9	14.1	10.9	22.0	24.6	18.7	16.2	28.4	11.2	8.4	22.2	17.3	30.6	15.8	28.5	14.0	21.9	16.5	18.7	8.5	4.4	32.1	13.0	5.2	7.2	21.5	14.5	7.7	16.3	20.3	38.2	13.6	16.5	15.1	34.6	9.8	37.4	17.4	16.1	26.0	22.7	22.5	6.7	17.9	24.4	24.9	23.3	19.1	11.4	19.3	11.0	12.3	13.2	18.1	9.0	21.9	26.9	10.1	18.8	38.6	18.4	25.3	24.3	2.2	2.5	0.8	4.9	6.1	6.0	4.9	6.0	5.2	5.7	4.3	5.1	5.6	1.1	5.3	3.3	3.8	5.6	2.7	11.4	11.9	23.3	10.5	8.6	6.1	11.7	6.9	10.6	11.4	11.9	12.0	10.7	5.4	11.6	6.6	3.7	10.2	8.1	7.9	15.7	11.8	10.4	3.3	7.6	0.7	7.4	3.6	0.0	8.3	8.0	7.5	7.6	8.1	8.1	8.9	4.8	8.7	9.2	12.1	1.9	7.5	7.8	10.1	9.0	9.8	4.5	9.1	7.0	7.1	3.7	9.2	0.0	7.6	16.3	12.1	13.6	6.4	6.4	8.6	8.2
NUP210	"FLJ22389, GP210, KIAA0906, POM210"	ENSG00000132182	"Nucleoporin 210"	Q8TEM1	3	13316235-13420309	"Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 31.0;lymphoid tissue: 44.2"	"Cell type enhanced"	"Detected in many"	5	"Horizontal cells: 33.4;T-cells: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 47.0;U-266/84: 52.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066888	Approved					NA	NA		28000			"HPA066888: AB_2685741"	"unprognostic (3.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.63e-2)"	1.6	4.1	4.0	25.6	5.2	31.0	3.7	12.6	6.7	1.7	4.2	8.0	3.3	4.9	1.8	7.0	5.6	2.9	4.0	2.0	4.1	5.3	6.8	13.8	5.3	25.6	4.9	3.5	1.4	11.4	7.2	10.9	4.3	4.5	4.2	3.9	6.3	6.8	4.4	7.2	3.8	16.4	1.6	3.6	25.3	5.6	6.6	6.1	44.2	6.5	3.1	23.1	5.6	1.8	6.7	6.8	1.0	3.9	6.2	9.3	3.6	8.4	14.9	7.4	19.1	0.0	0.0	29.4	0.1	0.0	1.8	0.0	7.6	13.8	34.4	11.9	0.0	0.8	4.9	16.3	0.0	0.7	27.6	12.1	13.3	16.9	8.0	0.0	42.5	4.8	0.0	0.0	0.0	0.0	1.3	0.0	26.0	20.5	37.0	0.0	21.1	22.5	16.9	8.5	2.6	3.1	0.0	0.0	47.0	3.6	7.9	8.5	8.5	10.7	14.3	4.5	3.4	13.6	35.4	0.1	0.0	2.5	0.0	6.5	37.6	52.0	30.0	0.0	23.8	0.0	0.0	2.9	1.0	9.3	3.9	7.4	6.7	6.7	9.0	6.4	4.5	5.6	7.3	0.1	6.2	2.4	6.8	5.6	3.6	4.0	5.2	12.6	6.7	4.1	5.3	4.9	3.5	4.5	6.1	14.9	4.8	32.0	1.2	1.4	16.7	9.6	10.2	2.7	6.8	5.2	13.7	13.4	3.3	5.0	18.8	0.7	1.1	23.3	3.8	3.8	0.5	3.1	4.7	11.6	14.7	33.4	7.9	4.3	12.8	16.6	0.6	8.0	1.7	2.8	4.6	3.2	3.5	0.0	0.4	3.4	20.9	0.0	0.3	3.8	10.0	2.0	4.1	37.3	3.8	1.6
NUP214	"CAIN, CAN, D9S46E, N214"	ENSG00000126883	"Nucleoporin 214"	P35658	9	131125561-131234670	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease mutation, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 131.5"	"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 225.7;Kupffer cells: 255.0;Late spermatids: 282.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 43.7;neutrophil: 131.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 131.5;monocytes: 43.7"	"Cell line enhanced"	"Detected in all"		"K-562: 73.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048789			Approved	"Nucleoplasm,Vesicles,Focal adhesion sites"		NA	NA		100000	Nucleoplasm	"Vesicles, Focal adhesion sites"	"HPA048789: AB_2680521"	"unprognostic (1.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.95e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (5.49e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	16.9	10.3	11.5	13.8	13.9	29.4	12.9	13.0	14.4	10.2	11.4	19.8	10.4	9.0	15.0	13.7	16.1	12.1	10.2	9.7	9.5	8.1	19.0	15.1	11.7	13.3	13.2	8.8	14.2	17.0	16.7	16.9	13.0	11.3	11.1	10.8	15.3	13.0	11.1	15.5	17.5	11.7	11.1	14.3	35.8	12.3	63.7	13.3	27.4	11.8	7.6	16.8	10.7	11.2	1.2	16.8	131.5	43.7	1.2	0.8	17.9	6.8	9.8	8.4	5.0	6.8	6.6	8.8	6.1	6.3	8.0	6.5	8.0	5.0	11.1	4.9	8.4	8.3	15.7	11.3	8.0	7.8	8.0	5.5	6.9	14.0	15.6	6.0	10.8	7.5	7.1	7.4	10.2	8.3	5.1	8.1	7.4	73.0	6.4	8.2	12.8	14.2	16.4	9.1	9.9	8.6	5.0	10.6	11.1	9.2	6.3	7.1	7.4	10.2	9.4	5.3	6.3	12.4	27.0	7.0	14.1	7.9	9.2	9.9	5.6	10.9	10.8	6.9	6.5	8.5	3.5	43.7	17.3	0.7	18.4	0.8	1.2	0.7	0.6	16.8	1.1	0.7	0.7	131.5	1.2	15.0	1.5	0.4	17.9	11.5	13.9	13.0	14.4	9.5	8.1	13.2	8.8	11.3	13.3	17.9	19.9	15.2	9.5	7.7	29.6	24.0	15.3	16.0	15.9	22.7	43.2	10.9	8.3	9.1	225.7	14.6	13.6	0.0	13.1	9.3	11.4	11.4	8.1	11.9	75.5	15.9	19.5	18.4	255.0	282.5	21.6	77.0	10.1	15.4	14.3	14.8	12.0	5.8	19.1	6.7	31.6	6.5	8.1	90.1	44.5	9.5	9.2	11.8	16.3	9.3
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"Early spermatids: 131.7;Late spermatids: 308.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	8.8	10.9	9.1	13.7	21.4	4.1	15.3	18.9	12.6	9.2	8.6	5.6	5.8	7.3	9.6	9.0	11.7	10.6	9.1	7.9	11.1	6.8	11.9	16.4	9.5	9.3	11.5	5.1	13.1	17.2	8.9	13.1	9.0	8.8	9.3	10.7	7.3	9.7	9.6	9.1	10.9	7.1	10.5	7.6	7.8	9.3	25.8	9.7	19.1	10.3	12.6	12.7	8.0	10.2	8.9	3.8	1.7	6.8	5.9	10.5	5.0	10.0	10.8	16.8	9.9	6.1	5.9	12.2	12.1	9.8	18.3	17.6	19.8	12.2	17.1	11.4	6.4	21.7	8.7	23.1	13.4	29.7	15.3	15.3	16.1	9.0	21.0	4.6	11.6	10.9	4.3	7.1	15.6	14.9	4.1	10.7	10.3	14.5	12.7	13.9	11.7	13.4	13.9	28.6	15.8	33.4	16.5	13.3	12.1	16.9	12.3	14.9	10.4	11.2	13.1	12.7	13.0	8.5	8.1	5.7	14.4	10.2	11.6	13.5	8.5	18.4	18.2	9.8	8.5	19.3	0.0	4.8	1.7	6.1	6.3	10.5	8.9	7.8	7.5	3.8	7.9	9.6	8.4	0.1	5.9	6.8	3.6	7.7	5.0	9.1	21.4	18.9	12.6	11.1	6.8	11.5	5.1	8.8	9.7	8.9	5.0	11.1	14.4	23.1	10.8	4.1	10.2	8.1	14.8	15.7	17.7	18.4	10.0	10.8	131.7	9.3	3.1	23.3	11.1	17.4	12.4	7.0	8.1	11.9	7.4	6.4	3.5	11.6	6.2	308.3	8.9	3.7	20.3	4.6	6.6	10.8	9.6	7.0	7.8	10.1	17.1	12.9	13.2	34.7	19.4	24.0	7.9	8.9	7.4	9.7
NUP37	"FLJ22618, MGC5585"	ENSG00000075188	"Nucleoporin 37"	Q8NFH4	12	102073103-102120124	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Extravillous trophoblasts: 79.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056300, HPA073708"	Supported		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA056300: AB_2683092, HPA073708: AB_2686629"	"unprognostic (1.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.72e-4)"	"prognostic unfavorable (7.70e-6)"	"unprognostic (2.48e-3)"	"unprognostic (2.37e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.67e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-1)"	11.1	18.4	6.0	17.5	7.7	12.6	12.8	8.1	7.4	12.4	12.8	8.7	14.9	8.1	13.0	14.7	22.0	12.6	7.8	12.3	5.7	5.4	11.4	8.6	9.0	16.4	6.0	5.1	12.6	11.7	12.6	15.2	17.6	10.6	13.7	16.0	11.2	11.7	9.6	18.0	11.3	14.5	11.4	9.3	16.5	11.5	17.8	6.2	28.4	16.4	18.5	20.8	13.6	11.0	19.4	18.1	30.6	17.2	13.2	26.7	13.0	32.0	23.7	20.9	9.5	17.3	23.0	46.3	20.7	19.5	32.7	22.4	30.2	17.5	21.8	14.8	16.0	22.6	23.8	36.5	32.0	41.1	30.7	20.8	23.4	12.8	27.0	22.1	33.0	7.4	17.7	14.1	25.4	18.9	21.9	26.6	29.1	41.4	8.3	30.2	22.3	24.5	27.4	20.6	30.2	37.9	16.2	29.6	16.5	25.7	24.2	10.9	7.8	15.6	16.8	14.8	24.6	29.4	19.2	8.6	11.8	12.9	16.5	28.3	12.6	23.8	37.4	13.5	27.0	19.7	30.6	14.7	16.4	13.8	17.2	15.0	19.4	16.9	14.0	18.1	17.7	15.3	17.3	4.3	13.2	14.2	15.3	26.7	13.0	6.0	7.7	8.1	7.4	5.7	5.4	6.0	5.1	10.6	6.2	6.0	11.0	22.6	21.0	10.1	7.4	7.9	22.9	28.1	11.4	15.7	7.9	61.2	21.6	20.4	2.3	14.2	9.2	23.3	17.3	79.0	11.7	10.2	7.0	8.6	31.3	3.2	5.8	10.4	14.3	4.0	18.1	16.9	6.8	19.8	15.7	17.6	16.1	10.5	17.7	18.0	17.2	19.4	10.3	50.2	37.0	8.3	33.6	17.3	20.7	10.6
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	16.9	14.2	12.7	15.2	13.8	7.6	19.6	15.6	13.5	20.1	13.1	17.9	18.3	12.4	18.4	11.5	17.4	13.1	9.1	14.7	10.9	10.0	15.7	13.7	12.6	20.3	15.2	9.2	15.7	22.6	14.1	13.2	18.8	12.9	16.6	14.1	17.7	14.2	14.2	20.0	18.7	16.6	16.2	12.1	22.7	14.4	13.8	16.4	28.6	18.9	12.1	24.2	18.4	14.2	10.6	8.1	5.1	8.6	6.1	9.7	3.3	9.0	15.8	13.9	21.8	8.9	11.2	21.8	15.7	9.0	15.4	19.5	22.6	8.5	26.1	16.8	8.6	14.4	14.5	23.8	13.8	26.2	12.2	16.7	29.9	16.8	21.0	6.1	30.6	19.5	6.8	7.3	22.4	14.3	5.8	12.1	15.1	30.5	14.6	12.8	9.7	22.0	12.7	12.2	10.3	9.4	21.6	19.2	8.7	10.1	12.6	5.7	9.6	18.7	11.9	6.1	12.0	12.7	13.0	9.4	12.6	13.7	17.9	23.9	9.0	18.3	28.0	11.2	21.3	17.6	4.4	8.3	5.1	6.3	8.6	6.6	7.3	7.4	6.2	4.2	10.6	7.8	9.7	3.3	6.1	7.2	8.1	7.9	3.3	12.7	13.8	15.6	13.5	10.9	10.0	15.2	9.2	12.9	16.4	3.0	5.6	6.2	4.5	7.0	11.7	12.6	10.2	2.7	4.5	3.5	5.9	9.5	3.3	7.6	27.2	5.3	3.4	0.0	6.7	10.5	4.7	5.3	0.0	3.2	6.7	6.4	9.8	6.2	10.3	58.0	9.5	6.0	8.5	10.0	5.8	11.1	5.5	0.0	9.9	3.8	9.5	12.9	8.2	4.9	10.0	7.4	5.5	6.9	7.6	5.6
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163841-45188015	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA047162	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			Nucleoplasm	"Nuclear membrane"	"HPA047162: AB_2679963"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	9.0	12.0	8.0	12.3	9.3	26.4	12.8	11.3	11.4	8.7	13.2	6.6	15.8	9.0	9.1	11.0	18.1	10.4	8.0	5.3	7.4	8.6	10.8	13.6	10.4	17.6	7.1	8.4	9.9	11.7	8.2	16.1	12.9	16.8	11.9	9.6	8.2	11.3	15.0	6.5	10.8	18.1	6.2	6.3	19.3	13.4	20.0	7.5	41.3	12.2	5.5	19.5	10.7	15.3	8.2	10.3	37.6	16.2	11.8	12.5	12.3	24.3	11.7	22.4	14.5	10.5	11.0	23.9	20.4	13.6	15.8	16.1	25.3	10.9	26.7	9.6	13.4	11.8	17.2	27.5	16.6	22.9	14.2	29.2	23.4	18.3	15.4	11.0	61.7	24.9	13.3	11.5	20.2	15.4	7.6	17.4	23.6	24.2	28.2	16.2	16.3	27.9	16.0	16.8	16.2	12.1	29.7	13.6	18.7	12.3	23.7	14.0	13.6	20.3	12.6	24.0	17.9	7.8	16.4	15.8	33.6	30.2	17.3	17.1	19.7	15.9	39.3	12.6	16.0	23.3	19.7	15.7	31.0	8.8	16.2	12.0	8.2	10.6	10.0	10.3	7.4	12.5	8.5	37.6	11.8	9.2	5.7	10.1	12.3	8.0	9.3	11.3	11.4	7.4	8.6	7.1	8.4	16.8	7.5	8.9	24.7	25.2	40.1	76.0	14.5	9.0	22.9	33.5	18.2	31.4	11.8	20.7	11.6	16.5	34.0	19.0	21.4	70.0	18.1	32.1	18.9	47.3	32.5	32.4	24.1	12.7	16.7	35.0	41.1	58.5	13.6	24.9	23.6	23.4	22.0	9.7	22.7	31.6	13.1	17.4	16.3	25.8	14.7	31.2	39.5	78.2	47.4	37.1	22.2	77.6
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148515	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA035929: AB_10671236, HPA058122: AB_2683613"	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	23.7	14.5	13.5	18.2	15.2	28.4	25.7	26.0	17.2	23.1	20.0	14.6	17.9	15.3	22.9	18.2	21.4	22.5	15.1	17.0	12.2	10.8	16.4	20.3	17.8	22.8	20.5	13.1	25.3	19.3	13.3	16.8	22.8	14.9	19.8	19.7	12.2	20.0	24.1	17.8	21.2	18.4	24.7	14.7	23.6	19.2	19.6	20.0	36.1	19.8	18.1	22.1	24.1	21.8	10.0	11.4	7.7	10.0	21.6	16.5	7.5	17.1	6.8	21.8	15.7	18.6	17.8	19.2	17.4	25.1	25.8	26.6	16.0	24.6	26.0	14.7	17.3	14.0	11.6	23.4	19.4	32.4	17.1	13.7	15.7	8.5	15.2	17.6	30.4	19.0	16.2	14.0	20.4	21.7	11.4	22.1	17.1	26.9	16.4	18.6	15.0	32.0	14.3	34.9	20.9	6.1	25.1	34.4	9.9	15.3	16.5	13.2	11.0	16.1	19.1	14.0	17.8	8.1	18.7	14.7	20.8	18.6	24.7	21.1	10.7	3.9	24.8	14.8	17.9	18.2	6.5	7.5	7.7	12.2	9.0	16.5	9.0	12.9	11.7	11.4	10.0	13.8	13.0	3.5	21.6	10.0	8.4	12.5	7.5	13.5	15.2	26.0	17.2	12.2	10.8	20.5	13.1	14.9	20.0	20.8	11.8	23.1	37.0	31.3	13.7	9.9	7.6	18.7	12.5	10.4	19.6	36.3	24.9	18.9	7.9	20.4	11.5	0.0	24.2	38.9	30.9	23.1	23.1	11.9	19.3	7.9	13.8	18.4	18.3	5.6	25.3	17.0	16.9	30.7	18.4	11.8	15.9	21.0	24.4	17.2	19.1	32.3	26.8	38.4	40.1	25.5	32.7	27.7	21.7	29.4
NUP58	"KIAA0410, NUP45, NUPL1"	ENSG00000139496	"Nucleoporin 58"	Q9BVL2	13	25301524-25349800	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 182.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA039360	Approved					NA	NA					"HPA039360: AB_2676463"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.02e-3)"	"unprognostic (3.03e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.06e-1)"	14.6	15.5	14.8	18.9	19.0	31.2	19.9	23.8	20.6	15.0	12.8	16.4	13.1	12.3	17.3	13.4	15.2	15.0	15.0	16.4	16.5	18.0	17.6	17.2	24.3	20.5	14.1	14.6	24.9	13.3	9.8	30.6	32.3	19.2	17.0	15.9	14.3	14.0	14.3	23.2	14.8	12.4	17.4	15.2	17.9	13.7	47.1	13.5	34.1	20.8	14.0	19.1	22.9	18.5	3.4	5.1	11.9	8.1	2.8	5.7	4.2	13.3	8.1	19.6	14.7	6.6	9.5	14.9	20.1	15.0	21.3	17.5	13.5	14.5	23.0	9.8	11.3	18.3	14.9	22.3	16.4	34.1	21.3	11.0	32.2	7.6	9.3	12.3	23.3	38.3	6.4	22.5	17.6	39.4	10.5	13.0	20.0	17.1	10.0	23.8	5.3	29.8	16.3	11.7	21.5	7.1	20.8	26.0	10.4	11.6	10.5	23.4	11.7	12.9	9.8	16.1	16.7	6.7	21.1	10.6	13.8	13.8	13.2	23.4	12.4	10.3	31.5	10.2	13.7	23.5	1.7	8.1	2.3	3.5	7.2	4.6	3.4	4.5	4.1	5.1	2.9	5.1	4.4	11.9	2.8	7.6	2.7	5.7	4.2	14.8	19.0	23.8	20.6	16.5	18.0	14.1	14.6	19.2	13.5	38.7	79.9	8.9	22.3	0.0	32.9	0.0	12.7	10.7	25.0	24.4	51.1	21.7	10.0	12.6	104.3	17.9	8.1	0.0	9.4	32.8	11.6	29.3	22.1	23.7	20.6	23.8	9.4	22.1	39.4	182.1	17.8	32.1	0.0	15.4	18.5	28.7	14.7	3.5	23.3	22.7	44.0	19.4	0.0	77.6	80.2	0.0	33.1	14.9	18.3	23.8
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	8	"Late spermatids: 254.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.1	25.7	15.8	29.1	18.5	19.8	16.1	28.3	21.7	18.2	17.1	21.0	13.4	20.0	24.1	13.7	21.5	22.1	20.9	16.9	14.3	15.1	16.8	27.5	16.2	29.0	15.2	14.2	26.6	18.6	14.0	21.3	24.1	17.4	19.8	17.7	16.2	18.8	20.2	27.1	18.8	20.2	23.3	14.2	26.0	16.4	70.9	17.6	45.5	16.8	17.3	29.6	18.9	19.4	10.7	21.1	6.2	22.3	13.7	16.9	12.5	32.0	30.5	22.6	19.2	7.1	8.1	21.1	24.3	16.7	25.6	25.6	20.6	18.9	36.1	13.4	15.5	17.2	19.1	27.5	16.8	24.8	52.2	29.3	29.0	15.3	19.0	8.6	26.6	28.9	8.3	11.6	16.9	14.1	11.4	18.8	21.7	35.4	35.3	17.5	15.5	48.0	20.3	21.4	29.0	27.2	43.4	26.4	30.7	12.3	24.9	25.3	18.0	23.2	26.5	12.1	16.9	21.5	13.6	14.6	40.3	23.7	13.0	39.4	25.6	69.7	33.2	16.6	23.2	30.0	6.2	20.7	4.2	12.0	22.3	16.9	10.6	12.0	13.2	21.1	10.7	8.2	10.5	3.3	13.7	11.8	18.3	10.7	12.5	15.8	18.5	28.3	21.7	14.3	15.1	15.2	14.2	17.4	17.6	23.8	21.9	40.6	17.0	30.3	10.8	12.6	20.4	24.1	19.4	8.7	5.9	23.7	8.3	21.3	98.8	27.0	16.6	23.3	14.1	38.8	21.5	15.3	22.0	11.0	44.5	60.4	20.7	30.1	34.9	254.9	23.0	47.7	20.3	90.2	22.7	18.3	20.1	23.4	21.5	13.6	15.4	19.4	12.2	71.6	37.3	28.0	18.2	26.6	27.6	12.9
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA061910: AB_2684634, HPA062595: AB_2684801"	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	21.6	12.9	13.7	22.1	14.2	17.9	19.1	43.0	17.9	17.1	17.2	17.2	12.5	16.1	24.1	16.9	19.6	19.0	15.8	14.7	12.7	8.8	14.9	19.8	17.5	25.4	17.5	12.7	21.4	18.5	12.0	13.5	18.8	13.9	17.3	21.8	15.3	16.8	16.3	17.0	23.5	18.4	20.1	15.6	24.6	16.1	24.5	14.1	28.5	17.8	14.0	26.2	15.8	18.2	17.1	19.0	17.6	20.8	12.6	20.5	13.5	22.5	25.7	18.9	13.0	7.3	11.4	26.3	16.4	13.0	38.6	36.3	22.0	21.7	20.8	9.5	14.0	25.1	19.5	30.9	17.3	34.4	6.5	25.0	17.3	29.6	19.2	6.0	17.8	14.5	10.9	10.8	26.9	11.7	8.9	29.5	17.1	21.3	13.4	18.7	24.9	33.4	21.9	14.1	28.1	23.7	23.4	40.9	18.9	14.7	16.5	14.4	13.8	20.2	26.0	14.4	22.0	29.3	20.3	10.8	28.9	26.8	18.5	26.0	8.3	6.8	26.6	14.9	16.3	17.7	5.2	20.8	17.6	14.6	18.1	20.5	14.2	15.7	14.0	17.1	17.1	15.5	11.8	6.7	12.6	12.9	19.0	13.3	13.5	13.7	14.2	43.0	17.9	12.7	8.8	17.5	12.7	13.9	14.1	6.0	12.2	15.0	7.2	5.5	7.8	7.5	10.2	9.4	11.4	7.0	9.8	17.8	6.6	14.0	2.0	14.2	7.3	46.7	16.9	18.4	14.3	6.5	10.5	19.5	19.7	6.4	7.5	20.9	11.1	2.5	13.3	16.2	8.5	13.6	9.7	4.5	15.0	7.0	9.2	7.9	7.4	32.3	6.1	17.4	30.4	6.1	10.6	12.9	10.7	6.7
NUP88	MGC8530	ENSG00000108559	"Nucleoporin 88"	Q99567	17	5360963-5420160	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 103.0;Spermatocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002209, HPA021816"	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"CAB002209: AB_564128, HPA021816: AB_1854725"	"unprognostic (3.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	10.8	12.4	8.1	17.2	8.8	13.2	14.1	15.0	9.2	9.0	12.5	6.6	8.1	7.4	10.1	12.2	13.1	10.5	7.7	15.3	8.0	5.6	11.3	25.7	9.1	17.8	6.9	6.9	9.9	11.1	11.9	12.4	10.0	7.5	9.6	14.3	6.9	11.7	12.5	33.4	11.8	12.4	10.2	7.7	20.0	11.4	34.4	8.4	28.9	15.8	10.3	23.1	10.9	10.5	24.2	7.4	3.5	8.6	12.2	10.5	7.4	20.6	22.8	18.4	15.5	8.8	9.0	19.9	15.8	14.2	29.2	26.7	19.5	8.7	37.6	6.5	15.4	16.8	20.9	31.7	18.7	32.5	10.4	21.8	16.4	20.4	14.2	12.4	13.4	17.3	6.7	13.6	21.6	33.3	10.4	19.9	15.1	18.7	9.9	20.3	10.0	20.5	9.2	19.4	19.6	11.5	20.2	20.8	18.0	13.4	9.5	8.0	15.5	19.4	9.4	11.8	15.2	10.5	15.6	12.2	12.4	14.1	13.0	28.8	6.4	8.4	18.6	14.7	15.1	19.1	3.5	4.9	2.2	8.2	7.3	8.1	24.2	9.1	9.8	6.9	23.2	9.5	10.1	0.5	12.2	8.6	7.4	10.5	7.4	8.1	8.8	15.0	9.2	8.0	5.6	6.9	6.9	7.5	8.4	11.9	16.2	36.6	23.6	19.7	12.9	8.9	12.7	13.4	19.4	15.7	15.7	27.0	10.0	20.2	103.0	8.5	8.8	0.0	22.2	20.9	10.1	18.0	7.0	15.8	10.5	9.5	13.2	8.0	4.1	21.6	14.1	11.5	3.3	18.0	9.1	8.9	19.4	14.0	10.3	7.0	10.4	12.9	13.2	115.8	53.5	14.9	30.1	18.1	16.8	38.1
NUP93	KIAA0095	ENSG00000102900	"Nucleoporin 93"	Q8N1F7	16	56730105-56850286	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatogonia: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017937	Uncertain					NA	NA					"HPA017937: AB_1854726"	"unprognostic (6.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.18e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.22e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.74e-2)"	14.2	12.2	14.8	15.6	29.7	33.7	12.6	16.8	29.1	12.7	12.4	14.4	4.4	7.2	15.0	9.8	16.8	12.0	8.6	11.5	26.1	11.2	9.9	6.9	12.6	19.1	13.1	16.7	13.4	9.8	16.5	9.6	14.1	23.8	13.9	14.5	23.0	10.4	10.2	15.5	16.3	11.2	14.5	20.7	17.8	11.1	29.3	13.9	28.0	27.4	10.4	22.5	11.5	13.2	12.0	16.9	54.1	21.3	15.1	14.6	11.9	19.3	24.1	21.8	23.8	8.4	9.2	24.2	17.0	13.8	42.3	29.1	33.1	19.5	30.4	17.1	16.0	16.1	34.8	41.3	24.2	41.8	9.3	22.6	20.3	17.4	27.0	10.4	26.9	24.4	9.2	10.6	28.7	18.1	8.8	24.3	27.8	24.6	6.0	20.8	13.9	36.2	23.1	27.7	13.3	27.0	43.9	36.8	30.7	16.4	13.0	19.4	12.8	44.3	15.6	13.9	24.3	11.8	16.8	16.2	20.1	22.6	16.8	19.2	10.5	14.4	50.8	14.1	25.5	19.6	5.1	14.3	54.1	11.9	21.3	14.6	12.0	9.1	12.9	16.9	11.6	9.5	13.2	3.6	15.1	20.9	8.8	11.0	11.9	14.8	29.7	16.8	29.1	26.1	11.2	13.1	16.7	23.8	13.9	6.0	10.5	14.1	9.6	10.6	26.7	10.1	2.5	5.3	14.8	8.7	9.8	17.9	10.0	18.6	8.9	11.3	5.1	0.0	22.2	27.0	13.1	10.3	17.3	5.5	23.6	36.5	4.7	10.4	19.1	6.2	21.6	21.3	15.1	33.3	10.3	11.2	18.4	7.0	12.7	9.2	18.1	12.9	17.6	53.7	64.0	14.1	8.6	19.2	12.9	15.3
NUPL2	"CG1, H_RG271G13.9, hCG1, NLP_1"	ENSG00000136243	"Nucleoporin like 2"	O15504	7	23181827-23201011	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Early spermatids: 230.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049036, HPA057251"			Supported	Nucleoplasm		No	No			Nucleoplasm		"HPA049036: , HPA057251: "	"unprognostic (3.81e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-2)"	13.3	21.1	19.4	27.0	17.1	23.3	14.4	25.9	30.4	15.4	16.4	12.3	26.8	15.4	19.5	26.5	17.9	17.7	18.7	24.3	16.1	16.1	17.8	16.2	14.7	23.2	14.9	19.9	16.7	14.6	22.3	19.7	10.8	15.2	16.5	16.9	12.5	20.3	20.8	16.9	21.6	14.9	19.1	14.6	20.1	15.2	32.2	16.9	19.7	20.8	16.8	19.6	17.7	16.7	16.4	13.8	22.9	8.7	13.9	12.3	9.8	12.1	7.0	9.0	17.0	8.9	11.4	6.6	10.1	7.6	10.8	11.4	9.0	13.6	20.4	9.0	7.0	24.3	14.7	15.5	8.8	13.5	5.9	16.4	14.1	14.9	8.9	11.1	28.7	17.2	5.5	10.7	10.3	6.6	8.3	11.3	11.5	23.7	14.4	10.7	3.5	13.7	16.7	17.1	14.9	10.0	12.6	8.1	15.3	11.9	9.3	11.9	11.4	10.6	5.6	15.6	15.1	7.1	31.4	11.5	7.8	9.8	13.4	16.2	19.0	28.6	22.5	7.3	21.5	17.8	22.9	8.7	7.6	11.4	8.4	10.2	16.4	12.2	11.3	11.5	14.0	11.5	12.3	8.5	13.9	7.1	13.8	12.3	9.8	19.4	17.1	25.9	30.4	16.1	16.1	14.9	19.9	15.2	16.9	14.9	8.6	15.3	14.1	11.9	20.9	15.4	5.1	17.4	12.5	22.7	19.6	14.9	33.2	19.5	230.4	12.2	7.4	0.0	11.6	11.0	12.2	10.0	13.9	5.0	23.6	22.3	15.0	14.1	16.5	25.9	23.3	16.2	8.5	24.4	10.9	16.0	15.1	14.4	19.4	22.3	23.0	12.9	19.8	24.4	11.8	11.8	5.5	20.2	16.8	11.9
NXF1	"DKFZp667O0311, Mex67, TAP"	ENSG00000162231	"Nuclear RNA export factor 1"	Q9UBU9	11	62792123-62806302	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016327, HPA061593"	Supported		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB016327: AB_627608, HPA061593: AB_2684565"	"unprognostic (2.45e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (4.33e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.25e-2)"	24.8	28.6	23.6	38.3	23.5	85.9	24.5	27.7	25.8	25.9	28.9	29.2	44.2	18.8	45.7	28.9	24.7	26.0	25.6	22.4	23.8	18.3	29.9	37.3	23.9	30.2	27.0	18.6	31.4	28.6	47.3	55.0	44.3	22.7	33.4	22.7	30.3	33.2	32.6	28.1	40.1	26.4	33.2	25.5	42.4	27.5	23.0	29.6	35.9	34.6	26.9	35.7	22.7	30.8	14.4	20.6	19.7	22.5	17.1	20.6	12.8	19.6	21.9	38.4	25.9	32.9	24.0	23.2	30.6	27.5	41.2	24.5	29.8	15.9	31.1	18.3	24.5	16.5	24.5	40.8	19.1	37.4	24.6	27.9	23.5	35.3	25.1	25.0	29.0	34.2	35.4	27.8	30.2	14.6	31.0	26.8	27.7	30.1	23.4	29.3	26.9	35.1	37.8	23.1	24.4	19.0	34.2	21.2	33.0	28.5	23.5	20.2	17.0	30.0	24.2	21.8	29.0	27.6	26.0	27.3	24.0	19.4	29.9	27.2	28.4	24.4	31.5	18.5	24.6	24.0	6.0	17.4	19.7	17.9	22.5	19.2	14.4	17.2	17.2	20.6	12.9	18.8	17.2	14.7	17.1	19.2	16.0	20.6	12.8	23.6	23.5	27.7	25.8	23.8	18.3	27.0	18.6	22.7	29.6	35.7	44.2	24.1	23.4	74.0	12.3	19.4	17.8	14.7	18.2	21.0	29.5	40.9	8.3	14.4	17.8	29.2	26.6	0.0	10.6	21.6	30.5	19.0	47.5	18.4	25.3	4.8	30.3	22.7	38.2	10.4	33.9	42.4	30.4	11.8	21.5	11.6	13.1	16.7	24.4	9.6	16.2	25.8	35.9	20.6	19.6	61.2	83.0	29.4	19.6	12.9
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099358	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 37.9;skin 1: 12.3"	"Cell type enhanced"	"Detected in some"	24	"Leydig cells: 8.6;Melanocytes: 40.5;Peritubular cells: 13.8"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SH-SY5Y: 5.9;SK-MEL-30: 22.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA036402			Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.4	0.1	0.9	1.3	4.8	0.0	0.3	0.2	2.9	2.4	0.3	3.6	0.2	0.0	0.4	1.7	2.9	1.6	0.5	0.2	1.3	3.6	0.4	0.4	1.2	3.1	0.3	0.4	0.4	0.2	0.0	1.0	2.9	9.5	0.9	0.2	37.9	1.9	2.7	0.4	12.3	0.2	0.2	0.2	2.0	0.1	2.6	0.2	0.3	7.0	0.5	1.5	0.8	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.1	5.9	0.0	0.0	22.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	4.8	0.2	2.9	1.3	3.6	0.3	0.4	9.5	0.2	0.0	0.0	0.0	0.1	1.8	0.0	0.3	0.0	2.7	1.2	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	8.6	0.0	40.5	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	1.7	2.9	3.9	0.6	0.1	0.0	0.0	0.1
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 58.1"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 1: 101.3;Urothelial cells: 183.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 21.3;CAPAN-2: 28.4;HaCaT: 22.9;MCF7: 22.6;RPTEC TERT1: 17.7;RT4: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Plasma membrane, Cell Junctions"		"CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.8	3.4	3.8	3.7	0.5	7.6	3.9	2.9	4.3	15.5	3.2	21.9	10.2	1.7	7.4	10.6	7.9	17.1	1.1	4.0	2.9	15.3	31.7	29.2	0.4	4.0	1.7	2.3	33.2	12.0	3.2	9.0	6.7	5.7	10.9	7.7	7.1	25.0	0.5	8.7	24.5	1.2	3.8	2.1	15.1	2.0	1.5	0.4	58.1	9.8	8.6	5.0	6.5	1.2	1.2	1.8	0.3	2.0	0.9	0.1	15.4	6.2	0.1	0.5	0.2	0.4	12.5	0.0	1.5	2.1	3.1	21.3	28.4	0.1	5.4	0.3	7.8	22.9	6.3	3.0	5.8	0.1	11.1	1.2	0.2	6.5	0.1	0.5	1.6	0.0	3.2	4.8	0.2	1.1	1.2	2.1	0.0	0.1	0.0	22.6	0.6	0.4	2.4	6.8	2.6	0.0	4.7	0.5	17.7	19.3	2.1	1.0	0.1	16.9	0.2	4.4	9.5	1.9	0.2	0.1	6.4	1.3	1.5	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.7	0.8	0.2	0.2	0.8	0.9	0.3	0.1	1.2	0.7	0.9	1.8	2.0	0.2	1.2	0.4	0.1	3.4	3.7	3.9	2.9	4.0	2.9	4.0	1.7	6.7	1.5	101.3	47.6	3.2	51.5	3.3	6.0	1.3	56.0	48.2	55.7	24.4	13.7	26.5	8.3	49.2	2.0	5.3	55.1	0.0	52.8	1.2	3.2	76.5	2.3	42.9	2.6	6.4	25.2	16.0	25.3	1.1	2.8	2.6	1.7	5.4	35.4	3.5	63.1	47.2	1.4	11.3	6.2	12.9	2.7	4.2	7.8	13.6	13.7	4.9	33.9	183.7
OCSTAMP	"C20orf123, dJ257E24.3"	ENSG00000149635	"Osteoclast stimulatory transmembrane protein"	Q9BR26	20	46540946-46550574	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 6.9;blood: 2.6"	"Cell type enriched"	"Detected in single"	5	"Melanocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	26	"plasmacytoid DC: 2.6"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 2.6"	"Cell line enhanced"	"Detected in some"		"AF22: 2.7;HMC-1: 5.2;Karpas-707: 3.0;NB-4: 5.7;RPMI-8226: 2.4;U-266/70: 1.9;U-266/84: 5.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA031116	Uncertain					NA	NA					"HPA031116: AB_10600758"	"unprognostic (2.77e-1)"		"unprognostic (3.04e-1)"		"unprognostic (8.80e-2)"	"unprognostic (5.02e-2)"		"unprognostic (2.42e-1)"	"unprognostic (2.71e-1)"					"unprognostic (2.65e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.08e-1)"		6.9	0.0	0.1	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.1	0.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.2	0.1	0.2	0.6	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	5.7	0.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.9	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	0.4	0.0	0.1	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1, mitochondrial dynamin like GTPase"	O60313	3	193593144-193697823	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease mutation, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Cardiomyocytes: 130.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		13000	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	17.0	19.7	18.2	13.5	31.7	25.9	15.9	20.2	30.9	13.9	21.8	11.1	12.6	20.0	15.2	11.8	18.8	11.8	12.8	43.9	23.0	19.4	21.8	24.1	10.7	15.3	19.0	22.4	13.2	13.4	20.9	15.6	13.8	28.0	15.5	20.5	9.1	15.7	20.8	38.4	14.6	17.3	16.5	17.0	13.1	16.7	7.6	10.8	18.0	16.8	18.4	14.2	16.5	13.6	8.3	8.8	8.2	17.6	5.0	7.5	5.9	26.0	8.4	8.5	9.3	7.5	11.9	9.0	12.7	11.7	13.9	13.6	20.3	8.8	17.3	27.4	11.9	12.7	17.0	14.8	14.3	24.7	20.8	12.0	29.9	7.5	10.2	11.7	24.6	13.8	13.3	12.8	13.4	19.1	8.6	11.7	7.3	12.7	17.0	13.8	20.6	9.5	13.7	11.9	15.0	28.0	12.5	18.7	18.5	10.4	16.3	18.5	11.3	18.9	21.2	13.4	6.8	27.8	19.5	11.7	12.9	9.8	13.8	26.6	15.4	17.8	33.9	14.3	19.7	12.9	8.2	8.1	7.7	7.2	9.3	6.6	8.3	6.8	6.8	8.8	6.3	6.9	7.3	3.2	5.0	17.6	4.6	7.5	5.9	18.2	31.7	20.2	30.9	23.0	19.4	19.0	22.4	28.0	10.8	14.9	20.0	20.6	13.8	14.2	17.0	130.0	15.3	16.0	20.5	17.4	29.5	16.2	14.9	14.8	7.2	13.5	20.6	70.0	20.7	12.2	15.9	15.5	18.5	30.2	15.9	20.6	22.4	16.0	23.5	10.2	14.7	21.2	20.3	11.8	20.6	15.7	22.7	7.0	13.8	26.9	21.6	6.5	17.5	11.3	15.0	19.6	15.0	12.8	25.8	19.6
OPN1LW	"CBBM, CBP, COD5, RCP"	ENSG00000102076	"Opsin 1, long wave sensitive"	P04000	X	154144224-154159032	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	11	"retina: 14.0"	"Cell type enriched"	"Detected in some"	29	"Cone photoreceptor cells: 683.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA															"unprognostic (6.05e-2)"								0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.1	0.0	1.2	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	683.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
OPN4	"melanopsin, MOP"	ENSG00000122375	"Opsin 4"	Q9UHM6	10	86654557-86666848	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Biological rhythms, Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 21.2;skeletal muscle: 14.6"	"Cell type enriched"	"Detected in single"	34	"Cardiomyocytes: 3.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 21.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"PC-3: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039147	Approved					NA	NA					"HPA039147: AB_10673304"	"unprognostic (3.67e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.89e-2)"		"unprognostic (3.26e-1)"	"unprognostic (9.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.88e-3)"		"unprognostic (1.93e-6)"	"unprognostic (4.10e-2)"		"unprognostic (5.58e-2)"	"unprognostic (6.76e-2)"	3.5	0.3	5.4	0.4	21.2	0.2	1.1	0.0	5.1	0.6	0.9	0.0	0.0	0.5	0.4	0.4	0.6	0.4	0.5	3.1	3.0	0.1	0.3	0.2	0.3	0.2	0.2	3.3	0.3	0.4	3.6	0.6	0.5	0.0	0.2	0.7	1.2	1.6	0.2	14.6	1.2	1.1	0.5	0.0	0.3	0.5	0.5	2.0	0.0	1.4	2.7	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	21.2	0.0	3.5	3.0	0.1	0.2	3.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPRM1	MOR1	ENSG00000112038	"Opioid receptor mu 1"	P35372	6	154010496-154246867	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"brain: 37.9"	"Group enriched"	"Detected in some"	33	"Early spermatids: 24.0;Late spermatids: 23.1"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 37.9"	"Cell type enhanced"	"Detected in single"		"neutrophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	24	"SH-SY5Y: 13.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014509, HPA067435"	Enhanced	Supported				NA	NA					"HPA014509: AB_1854801, HPA067435: "											"unprognostic (7.34e-2)"			"unprognostic (6.91e-2)"				0.5	3.4	7.0	0.6	17.5	1.8	0.9	37.9	7.6	0.5	0.6	0.8	0.0	0.6	0.7	1.4	3.7	0.5	1.0	0.5	2.6	2.3	0.5	0.5	0.5	0.9	0.6	9.3	0.8	0.7	0.4	0.6	0.5	5.2	0.7	0.4	0.0	0.6	0.2	0.9	1.8	0.5	0.3	1.9	0.6	1.0	8.0	0.5	0.0	1.0	0.0	0.3	0.5	0.5	0.5	0.2	2.1	0.1	0.1	0.7	0.0	0.1	0.0	0.2	0.4	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.2	0.4	0.4	0.1	0.0	0.5	0.3	0.3	0.2	0.1	0.3	0.1	0.1	0.4	0.1	0.0	0.3	0.5	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.1	0.3	13.1	0.0	0.1	0.3	0.4	0.3	0.1	0.3	0.4	0.1	0.3	0.1	0.4	0.2	0.1	0.3	0.1	0.0	0.2	0.1	0.6	0.6	0.0	0.7	0.2	0.3	0.5	0.1	0.5	0.4	0.1	2.1	0.1	0.0	0.2	0.3	0.0	7.0	17.5	37.9	7.6	2.6	2.3	0.6	9.3	5.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.5	0.0	0.1
OR1E1	"HGM071, OR13-66, OR17-2, OR17-32, OR1E5, OR1E6, OR1E9P"	ENSG00000180016	"Olfactory receptor family 1 subfamily E member 1"	P30953	17	3397104-3398410	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 1.7;placenta: 1.5;testis: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.7"	"Not detected"	"Not detected"																	NA	NA										"unprognostic (1.12e-1)"										"unprognostic (1.33e-1)"			0.4	0.1	0.2	0.0	0.4	0.0	0.6	0.0	0.1	0.2	0.1			0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.1	0.0	0.3	0.3	0.3		0.0	0.0	0.0	0.0	1.5		0.0	0.0		0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.9	0.0	1.4			0.0		0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2AG1	OR2AG3	ENSG00000279486	"Olfactory receptor family 2 subfamily AG member 1 (gene/pseudogene)"	Q9H205	11	6783020-6791558	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"blood: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"TIME: 2.0"															NA	NA																							0.0	0.0		0.2		0.9	0.1		0.1	0.1	0.0			0.0	0.0	0.2	0.2	0.0	0.3	0.0			0.0	0.0	0.0	0.4			0.1	0.0	0.0		0.1		0.0	0.0		0.2	0.0	0.1	0.6	0.0	0.0		0.3	0.0	0.4			0.2		0.0	0.0		0.6	0.5	1.5	0.2	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.2	0.0	0.2	0.0	0.2	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.3	2.0	0.1	0.1	0.5	0.2	0.0	0.2	0.1	0.0	0.3	0.2	1.2	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.6	0.1	0.2	1.5	0.3	0.2	0.5	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ORAI1	"CRACM1, FLJ14466, TMEM142A"	ENSG00000276045	"ORAI calcium release-activated calcium modulator 1"	Q96D31	12	121626550-121642677	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 26.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 35.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016583, HPA061823"	Approved		Enhanced	Cytosol		NA	NA			Cytosol		"HPA016583: AB_1848720, HPA061823: AB_2684619"	"unprognostic (2.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (7.82e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.00e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	4.3	1.3	0.0	6.2	1.1	3.7	7.1	0.0	1.3	2.1	9.8	1.7	5.0	10.6	2.3	2.2	3.4	1.7	4.8	3.5	0.4		4.9	9.6	7.5	14.1	2.5	0.6	4.8	5.9	1.4	0.0	4.6	5.6	3.3	0.1	10.6	6.8	3.0	26.0	17.0	14.0	4.4	0.9	11.4	3.9	6.8	0.9	8.1	6.5	7.0	9.1	3.8	2.3	6.9	5.6	6.3	4.3	4.9	14.4	5.1	6.1	13.1	1.4	6.0	1.5	2.0	6.7	7.4	1.2	3.4	2.2	11.3	5.0	4.4	12.3	1.4	5.1	11.3	1.1	5.1	0.0	14.8	3.1	8.0	2.2	4.9	4.2	5.0	15.0	0.6	2.1	5.1	0.2	1.9	5.5	13.3	6.4	1.0	1.0	13.6	14.3	35.2	6.2	4.5	15.6	6.5	2.3	7.1	2.5	3.4	5.4	0.8	2.8	3.8	5.5	0.1	8.7	1.9	6.5	7.8	3.5	9.2	5.6	3.8	2.5	1.8	5.2	8.8	5.8	6.3	4.2	5.7	14.1	4.3	10.9	4.4	11.5	14.4	5.6	6.9	11.2	9.8	5.2	4.9	3.7	1.4	10.0	5.1											26.8	16.0	20.4	7.7	20.0	1.9	3.7	22.9	8.1	15.9	1.8	3.9	2.0	1.7	10.9	2.7	38.3	8.6	23.3	17.0	12.5	10.4	5.4	6.9	14.3	32.8	0.0	2.4	32.5	19.7	9.7	12.4	33.8	20.3	19.8	7.1	4.5	23.1	7.0	8.9	9.0	6.5	0.0	8.2	1.2	3.2	32.6	6.5	41.5	16.4	7.5
ORAI3	"MGC13024, TMEM142C"	ENSG00000175938	"ORAI calcium release-activated calcium modulator 3"	Q9BRQ5	16	30949066-30956461	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 36.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA015022: AB_1854807"	"unprognostic (1.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.60e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (2.30e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.43e-3)"	"unprognostic (9.17e-3)"	13.4	22.9	5.5	13.0	5.6	12.4	14.8	6.0	8.1	17.0	12.8	9.1	13.3	7.5	12.4	16.9	19.9	13.6	16.5	10.8	4.9	5.1	16.5	39.6	15.4	20.7	5.9	3.6	16.9	14.5	13.5	12.1	14.8	5.8	26.2	7.3	13.3	10.3	15.3	9.4	10.2	9.9	16.4	5.1	20.0	10.4	19.7	5.2	14.2	25.6	6.3	13.7	29.1	15.2	5.1	6.8	17.9	8.5	8.1	2.8	2.2	1.0	5.8	3.0	4.0	26.1	23.5	0.2	3.3	23.0	2.5	6.5	0.5	9.6	1.4	7.8	6.5	10.3	4.7	0.5	6.4	1.7	4.4	1.9	3.7	1.8	5.7	36.5	4.0	11.5	25.2	17.2	4.9	9.7	24.2	4.3	0.8	4.1	7.7	8.2	3.8	0.2	15.0	2.4	3.2	1.6	3.1	2.3	10.8	9.7	2.5	0.7	5.0	3.1	0.9	5.2	7.7	7.3	16.5	3.1	1.9	1.3	4.2	0.7	18.9	1.3	1.1	9.6	9.4	2.9	14.1	6.5	17.9	2.5	6.3	2.8	5.1	1.4	2.0	6.1	4.8	1.7	2.3	10.9	8.1	8.5	6.8	1.9	2.2	5.5	5.6	6.0	8.1	4.9	5.1	5.9	3.6	5.8	5.2	6.0	9.6	31.2	20.7	7.0	1.7	5.6	5.1	8.1	3.4	15.7	2.0	19.6	11.6	14.8	48.3	11.6	5.1	0.0	10.1	2.1	16.0	14.7	6.9	65.7	77.4	33.4	14.5	17.2	29.5	24.4	49.2	21.5	20.3	28.9	12.9	22.3	8.7	16.9	40.7	47.0	3.4	25.8	6.6	24.5	1.5	4.0	3.7	15.0	6.2	19.2
OS9	"ERLEC2, OS-9"	ENSG00000135506	"OS9, endoplasmic reticulum lectin"	Q13438	12	57693955-57721557	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 291.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011518, HPA013694"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Endoplasmic reticulum"		"CAB011518: AB_776918, HPA013694: AB_1854812"	"unprognostic (1.67e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.21e-2)"	39.3	32.9	24.4	28.1	27.6	32.2	38.0	27.0	34.9	37.4	39.1	27.6	34.5	37.2	36.2	37.7	35.2	32.0	33.0	39.2	23.2	23.1	42.9	94.4	40.2	34.2	27.7	22.0	44.2	110.7	49.5	29.2	47.0	28.2	34.7	34.1	42.0	53.2	28.5	19.0	36.9	47.4	28.1	18.6	37.5	35.7	21.4	24.0	23.8	47.6	23.2	34.4	33.3	35.1	11.5	35.8	54.1	48.7	11.4	16.1	36.7	6.7	13.8	7.0	17.4	36.7	24.9	15.6	17.0	21.7	12.6	12.8	14.3	22.1	8.7	28.4	20.3	9.7	12.3	6.5	11.0	10.0	11.1	7.9	9.8	9.8	12.9	24.0	15.3	25.2	22.8	17.7	12.3	12.6	43.4	20.9	5.8	7.4	34.7	13.1	11.7	4.1	18.6	7.9	13.5	9.8	5.4	291.6	21.8	9.6	16.8	7.2	9.6	24.2	16.7	13.7	13.4	19.9	30.2	19.1	17.0	10.2	11.5	10.7	20.7	17.8	9.0	14.4	11.2	23.4	30.6	48.7	54.1	16.1	44.4	15.2	10.9	13.7	14.2	35.8	11.5	10.7	12.3	52.0	11.4	35.0	31.1	15.0	36.7	24.4	27.6	27.0	34.9	23.2	23.1	27.7	22.0	28.2	24.0	80.4	110.4	55.1	75.1	51.3	42.6	12.6	91.7	93.7	103.5	69.8	72.6	122.4	8.3	114.5	4.8	76.5	142.5	46.7	96.4	106.6	99.6	64.6	86.8	139.4	128.9	47.7	99.5	76.7	105.2	9.1	105.0	115.3	113.1	158.7	107.2	85.8	84.7	129.8	74.3	44.0	34.1	90.5	57.7	33.4	54.8	45.0	165.3	69.2	78.8	57.0
OSBPL5	"KIAA1534, ORP5"	ENSG00000021762	"Oxysterol binding protein like 5"	Q9H0X9	11	3087116-3166739	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"Horizontal cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.1;gdT-cell: 9.3;intermediate monocyte: 4.4;memory CD8 T-cell: 3.4;myeloid DC: 2.7;naive CD8 T-cell: 3.6;NK-cell: 10.0;non-classical monocyte: 10.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 36.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038335, HPA038712, HPA058727"	Approved		Enhanced	Vesicles		NA	NA			Vesicles		"HPA038335: AB_2675963, HPA038712: AB_10675949, HPA058727: AB_2683799"	"unprognostic (6.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.16e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	17.6	7.0	4.2	10.3	6.2	17.8	20.7	4.4	8.8	24.7	15.6	7.5	24.0	9.0	17.1	15.9	8.1	12.6	13.8	10.0	4.6	6.5	8.1	2.7	12.9	10.5	6.9	6.4	9.6	8.4	2.4	6.5	7.8	9.8	15.9	5.2	9.0	17.1	17.5	28.0	17.8	9.6	20.1	11.9	20.3	10.2	4.4	6.3	36.5	9.3	9.6	3.8	14.3	17.7	0.0	2.7	1.0	10.1	10.0	9.3	3.9	1.7	2.7	3.3	3.8	9.9	4.6	0.0	8.9	4.3	3.6	2.5	0.0	5.1	0.0	2.7	5.0	2.5	6.6	0.6	2.5	0.5	1.7	2.5	7.4	8.8	0.0	8.0	6.6	1.1	7.1	2.9	1.3	1.3	2.7	2.4	13.4	2.6	0.0	1.8	4.9	14.4	36.7	2.4	1.1	5.8	7.5	4.5	1.0	1.4	1.6	5.5	0.6	3.6	13.1	3.4	2.0	5.4	17.5	8.1	4.5	6.2	10.7	1.5	1.8	0.0	0.2	4.8	12.4	5.7	0.2	3.1	1.0	9.3	4.4	1.2	0.0	1.0	3.4	2.7	0.0	0.6	3.6	0.4	10.0	10.1	1.2	0.1	3.9	4.2	6.2	4.4	8.8	4.6	6.5	6.9	6.4	9.8	6.3	0.0	5.6	0.5	2.3	4.2	12.7	2.8	2.5	5.3	3.4	3.5	7.9	0.3	1.7	2.9	0.0	7.5	7.7	0.0	1.7	0.4	7.8	2.9	1.1	0.0	1.7	58.8	0.0	3.7	5.9	1.0	8.3	2.5	3.3	0.0	5.4	3.5	2.4	7.0	15.9	1.7	0.6	12.9	8.5	0.0	0.6	5.9	0.0	7.7	6.8	2.2
OSBPL8	"MST120, MSTP120, ORP8, OSBP10"	ENSG00000091039	"Oxysterol binding protein like 8"	Q9BZF1	12	76351797-76559809	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"granulocytes: 242.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001309	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA001309: AB_1079530"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-3)"	29.3	11.4	13.9	18.4	41.9	23.1	17.2	13.7	20.2	20.0	11.5	6.8	8.4	7.5	18.5	10.7	20.1	10.4	15.0	19.3	13.4	12.9	30.2	15.2	20.5	22.7	12.1	13.2	14.9	11.2	12.4	16.5	14.4	13.9	16.2	9.7	9.2	15.8	11.1	21.5	22.9	12.6	15.5	14.8	24.9	12.4	12.8	14.7	41.0	11.7	10.6	24.8	18.0	24.5	11.7	15.8	57.2	15.0	9.9	10.9	8.1	12.4	8.0	17.8	12.6	24.8	35.1	11.3	19.2	27.0	12.4	11.3	11.5	5.2	17.5	11.0	22.8	7.7	5.2	13.2	11.1	18.7	14.9	11.7	46.9	7.9	6.8	15.3	29.7	19.1	18.5	21.2	18.4	23.0	22.3	10.6	10.2	32.1	8.1	20.3	8.6	19.8	14.1	8.7	4.5	7.9	10.4	24.3	10.0	9.5	10.6	9.7	10.2	16.4	6.0	11.9	14.6	4.6	18.1	24.8	20.0	10.0	20.6	10.3	8.1	12.7	19.3	7.6	16.7	11.6	27.5	15.0	20.1	9.0	10.8	8.5	11.7	9.6	7.3	13.2	11.6	8.7	7.1	57.2	9.9	11.7	15.8	10.9	8.1	13.9	41.9	13.7	19.9	13.4	12.9	12.1	13.2	13.9	14.7	53.6	69.1	48.0	37.5	103.3	37.1	37.6	20.4	40.2	34.2	48.8	84.4	28.5	51.4	49.5	35.1	65.2	13.0	23.3	47.9	23.5	68.6	48.2	242.1	32.5	69.5	39.7	9.1	50.3	88.2	15.3	60.9	125.5	33.7	85.6	23.5	51.8	73.4	24.6	77.8	126.3	27.5	45.3	89.0	45.6	131.8	108.8	40.3	78.4	14.9	59.7
OSCP1	"C1orf102, NOR1"	ENSG00000116885	"Organic solute carrier partner 1"	Q8WVF1	1	36415827-36450451	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 35.8;testis: 49.9"	"Group enriched"	"Detected in many"	5	"Ciliated cells: 144.6;Early spermatids: 336.5;Spermatocytes: 91.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028436, HPA052655"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA028436: AB_10600885, HPA052655: "	"unprognostic (3.46e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (1.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-2)"	3.9	5.3	6.2	1.5	14.0	1.2	6.0	3.6	12.7	6.2	3.6	6.5	7.5	1.8	6.3	14.1	3.2	35.8	5.5	4.7	6.5	8.9	11.9	1.8	6.7	1.3	4.9	5.3	5.9	6.2	15.7	15.7	8.9	7.8	6.4	2.5	6.7	5.3	6.8	2.4	3.4	1.3	5.0	3.2	0.9	3.5	49.9	3.2	1.3	11.1	3.5	2.4	3.2	2.6	0.8	3.8	0.3	1.7	0.3	3.1	0.8	5.2	5.0	6.2	7.1	7.4	7.2	1.1	3.2	7.8	7.9	5.4	0.1	4.6	1.1	6.0	5.7	5.8	4.1	0.2	6.0	5.1	0.9	4.7	0.0	3.3	0.5	9.1	0.6	0.9	8.1	9.8	11.1	4.9	11.5	5.4	5.0	0.1	1.3	6.2	3.7	2.7	1.9	6.3	2.0	2.1	2.9	2.5	0.9	12.9	1.8	16.6	7.3	5.9	2.8	4.1	6.1	6.1	0.9	4.6	5.7	2.1	10.3	5.3	2.3	2.3	0.5	11.0	0.1	3.8	0.0	0.7	0.0	0.9	1.7	0.0	0.4	0.9	0.7	1.8	0.8	2.2	3.1	0.3	0.3	0.2	3.8	2.2	0.8	6.2	14.0	3.6	12.7	6.5	8.9	4.9	5.3	7.8	3.2	8.9	7.5	0.5	6.7	1.3	5.3	4.7	5.1	144.6	19.4	12.2	15.7	9.8	19.9	11.2	336.5	2.4	0.7	0.0	8.1	2.6	4.1	4.3	0.0	1.9	3.8	4.8	4.7	2.5	0.6	35.1	11.5	1.2	3.3	0.0	2.6	12.3	7.9	4.0	8.5	18.1	18.9	0.0	3.3	91.2	18.9	2.8	16.8	0.7	2.6	3.3
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteopetrosis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Melanocytes: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		130000	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.3	21.9	9.0	18.1	13.5	5.5	16.7	13.7	17.2	14.4	17.8	12.8	9.9	8.4	21.8	10.3	14.1	15.0	13.5	23.2	10.4	16.5	22.0	15.9	17.0	17.2	11.0	10.5	15.6	9.7	11.8	26.0	24.7	20.0	15.4	12.4	29.7	10.8	19.0	18.0	10.4	12.9	24.7	13.1	21.7	14.3	11.1	10.7	13.6	12.4	8.1	13.9	21.0	19.4	10.8	12.4	20.9	28.1	14.5	16.4	16.9	2.1	6.4	7.6	11.1	23.0	7.5	10.9	16.0	16.1	11.7	19.5	3.8	3.6	5.0	13.2	11.1	31.6	4.1	7.5	5.4	18.1	11.5	5.9	10.6	4.1	4.7	17.8	11.6	24.7	10.9	13.6	14.4	11.5	10.8	5.9	5.7	8.3	18.5	18.9	3.0	2.5	2.6	3.0	2.6	4.9	4.1	11.1	2.7	8.4	5.8	0.8	4.5	12.9	3.3	28.5	10.6	3.7	16.9	7.2	10.3	3.8	22.7	22.6	7.1	12.1	4.4	30.4	7.9	22.6	16.8	13.9	15.2	15.0	19.9	16.0	10.8	12.8	16.4	12.4	6.2	12.0	15.0	20.9	14.5	28.1	8.9	15.4	16.9	9.0	13.5	13.7	17.2	10.4	16.5	11.0	10.5	20.0	10.7	8.9	21.3	25.4	14.7	41.4	29.2	18.5	12.7	5.3	6.8	12.2	9.8	18.7	1.7	10.8	3.4	18.0	10.3	0.0	19.8	29.3	16.9	16.3	24.2	12.4	46.3	27.0	4.1	28.8	46.6	2.7	13.3	33.0	143.4	10.8	4.2	24.0	15.6	12.9	26.9	21.0	15.7	25.8	33.9	19.8	19.5	27.1	51.1	27.7	2.9	14.0
OTOP1		ENSG00000163982	"Otopetrin 1"	Q7RTM1	4	4188803-4226889	"Predicted membrane proteins, Transporters"	"Biomineralization, Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 1.1;skin 1: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035599	Uncertain					NA	NA					"HPA035599: AB_10600924"										"unprognostic (1.83e-1)"					"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.0			0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.1	0.8			0.0		0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTOP2		ENSG00000183034	"Otopetrin 2"	Q7RTS6	17	74924275-74933912	"Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 20.4;testis: 5.1"	"Cell type enriched"	"Detected in some"	48	"Paneth cells: 508.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.4"	"Cell line enriched"	"Detected in single"	47	"HDLM-2: 15.2"	"Region enriched"	"Detected in single"	13	"olfactory region: 15.6"	"Low region specificity"	"Detected in all"			"HPA024524, HPA053090"	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA024524: AB_2671592, HPA053090: AB_2682041"		"unprognostic (1.62e-2)"	"unprognostic (1.45e-1)"			"unprognostic (7.25e-2)"		"unprognostic (3.21e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.30e-1)"			"unprognostic (2.85e-2)"	"unprognostic (3.81e-1)"	"unprognostic (9.04e-2)"		"unprognostic (2.04e-2)"	0.1	0.0	0.1	2.9	0.1	0.0	0.1	0.1	0.1	0.1	20.4	0.1	0.1	0.2	0.5	0.1	1.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.9	0.1	0.1	0.1	0.1	0.2	11.3	0.2	0.1	0.1	0.0	5.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	10.6	0.0	0.0	0.0	0.0	2.7	0.0	0.0	508.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.5	0.0
OTOP3		ENSG00000182938	"Otopetrin 3"	Q7RTS5	17	74935719-74949992	"Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"esophagus: 17.5;intestine: 42.9"	"Cell type enriched"	"Detected in some"	11	"Paneth cells: 71.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;HDLM-2: 2.4;RPMI-8226: 2.3;SH-SY5Y: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA							"unprognostic (9.28e-3)"				"prognostic favorable (3.86e-4)"			"unprognostic (2.77e-1)"		"unprognostic (8.60e-2)"	"unprognostic (3.42e-1)"		"unprognostic (1.03e-1)"	"unprognostic (8.36e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	34.1	0.0	0.0	42.9	0.0	0.0	17.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	2.5	29.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	1.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	71.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
OXA1L	"MGC133129, OXA1"	ENSG00000155463	"OXA1L, mitochondrial inner membrane protein"	Q15070	14	22766522-22773041	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003531	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA003531: AB_1079539"	"unprognostic (4.04e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.15e-3)"	27.8	36.0	11.9	21.2	15.5	25.1	28.4	13.5	23.0	25.4	30.9	18.5	24.3	27.2	22.7	23.9	30.2	21.5	30.6	48.3	12.9	13.0	31.9	58.4	25.8	45.0	15.2	10.9	31.4	59.6	30.0	12.3	18.3	17.9	25.3	24.2	28.1	24.9	27.5	76.3	24.9	32.8	23.9	13.5	32.9	29.9	17.0	10.3	32.7	37.3	49.0	38.3	31.3	22.3	22.1	39.9	7.2	29.4	16.3	22.6	19.9	21.3	29.5	13.3	22.3	37.8	56.3	24.5	16.3	34.4	23.7	27.5	22.1	24.5	40.2	21.9	18.9	18.4	30.6	25.6	31.7	23.9	16.7	16.5	19.9	20.4	80.9	42.3	37.1	24.8	55.1	35.3	19.6	30.4	30.4	68.2	23.6	14.7	32.9	26.0	31.4	21.9	14.4	13.5	28.4	37.2	22.5	22.0	30.5	30.3	26.8	9.1	17.6	23.7	52.8	31.2	16.5	22.5	30.1	21.8	14.2	16.5	25.8	18.6	24.8	19.7	18.8	11.1	21.4	15.2	4.8	27.9	7.2	13.4	29.4	16.3	22.1	19.2	16.9	39.9	21.9	21.9	16.3	6.3	16.3	22.9	11.3	22.6	19.9	11.9	15.5	13.5	23.0	12.9	13.0	15.2	10.9	17.9	10.3	44.7	38.2	84.8	43.0	61.7	27.2	99.9	84.1	38.8	36.4	27.9	9.8	61.8	63.0	75.1	6.3	57.3	51.9	23.3	140.4	103.7	55.7	38.4	77.5	82.5	125.3	17.5	39.0	57.7	124.8	10.2	52.9	86.1	49.0	93.8	66.6	20.9	92.6	80.7	34.6	95.3	30.4	38.8	51.5	34.7	25.8	58.8	47.8	70.4	100.6	68.0
OXTR		ENSG00000180914	"Oxytocin receptor"	P30559	3	8750408-8769628	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"breast: 42.5"	"Cell type enriched"	"Detected in some"	8	"Ciliated cells: 93.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"BJ: 81.2;BJ hTERT+: 24.9;BJ hTERT+ SV40 Large T+: 23.6;fHDF/TERT166: 81.3;HBF TERT88: 18.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.18e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.24e-4)"	"unprognostic (8.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-1)"	0.5	0.4	1.8	0.3	6.5	0.6	42.5	0.9	2.2	0.5	0.3	0.1	0.0	0.3	2.8	0.5	1.1	2.7	1.0	0.6	1.8	4.0	0.6	0.4	1.0	0.4	8.6	0.8	2.8	0.3	0.3	0.3	1.3	3.7	0.9	0.3	1.6	0.4	0.9	0.3	0.4	0.4	0.6	2.5	0.5	0.3	0.5	1.2	0.1	0.4	0.0	0.4	0.4	0.0	0.0	0.2	1.6	0.1	0.1	0.3	1.0	0.2	0.8	0.4	0.1	0.1	0.2	0.1	81.2	24.9	23.6	12.6	0.1	2.1	0.0	0.1	81.3	0.3	0.1	0.3	0.1	18.4	0.7	0.4	0.2	0.3	0.1	0.4	0.1	0.2	0.1	0.1	0.3	0.1	7.1	0.0	0.2	0.0	0.1	13.1	0.0	0.1	0.6	0.5	0.2	3.6	0.1	0.3	4.8	0.9	0.0	0.1	0.1	0.1	0.1	0.0	1.6	0.0	0.1	0.1	1.1	0.3	0.2	0.2	0.1	0.2	0.0	0.1	0.2	0.2	0.5	0.0	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.3	1.6	0.1	0.0	0.1	0.1	1.0	1.8	6.5	0.9	2.2	1.8	4.0	8.6	0.8	3.7	1.2	8.9	1.4	0.0	0.4	0.3	0.2	1.2	0.0	93.7	11.4	0.0	0.0	0.0	0.0	2.6	0.9	0.0	0.0	0.0	0.0	0.1	0.5	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.0	5.8	1.0	0.0	0.4	0.0	0.0	0.0	0.5	0.7	1.3	0.1	0.0	0.0	0.0	0.1
P2RX3	P2X3	ENSG00000109991	"Purinergic receptor P2X 3"	P56373	11	57338374-57370600	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 7.9;testis: 16.3"	"Group enriched"	"Detected in some"	40	"Early spermatids: 34.4;Late spermatids: 10.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.8;hTEC/SVTERT24-B: 1.4;NTERA-2: 1.2;U-87 MG: 1.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA057776	Uncertain					NA	NA					"HPA057776: AB_2683526"	"unprognostic (5.44e-2)"		"unprognostic (9.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-3)"		"unprognostic (2.24e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-7)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.29e-1)"	0.1	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	0.1	0.6	7.9	0.1	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.4	0.4	0.0	2.3	0.0	0.0	1.8	0.0	0.7	0.0	0.4	0.0	1.2	16.3	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	1.4	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.2	1.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
P2RX4	P2X4	ENSG00000135124	"Purinergic receptor P2X 4"	Q99571	12	121209857-121234106	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 110.0;Hofbauer cells: 116.1;Syncytiotrophoblasts: 130.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA039494	Enhanced					NA	NA					"HPA039494: AB_10969132"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (6.30e-10)"	"unprognostic (2.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.76e-3)"	14.1	7.8	4.9	6.5	4.7	4.8	13.8	24.0	8.1	11.3	16.3	8.8	5.5	13.4	6.3	5.5	5.6	8.4	8.6	6.1	3.9	3.4	10.2	13.2	11.6	16.1	6.0	3.5	9.9	22.7	15.7	8.4	25.9	5.8	7.7	13.9	7.0	15.7	9.5	2.3	4.1	17.6	8.4	6.8	11.5	11.2	4.2	5.0	4.2	7.1	2.8	7.1	7.8	5.8	2.7	6.1	17.1	14.2	5.6	6.1	7.2	2.2	6.2	0.1	7.7	4.0	3.7	19.3	2.3	12.4	3.2	5.6	3.6	9.1	1.6	7.0	7.5	20.0	0.9	2.1	1.2	1.5	7.7	4.5	1.0	0.1	3.2	9.7	2.8	16.7	4.6	2.5	3.2	4.2	7.8	11.1	2.5	2.8	5.8	2.4	11.6	1.5	1.9	2.0	11.3	5.0	1.6	11.2	11.9	1.1	3.8	1.9	3.7	5.4	3.2	20.9	2.2	15.6	5.2	0.6	4.5	3.7	0.4	1.3	8.3	9.4	1.5	9.0	3.4	4.3	17.1	13.0	2.1	4.2	14.2	4.2	2.7	6.1	3.4	6.1	1.5	4.5	2.2	0.1	5.6	12.2	1.4	3.9	7.2	4.9	4.7	24.0	8.1	3.9	3.4	6.0	3.5	5.8	5.0	6.0	19.2	9.8	7.8	3.4	11.5	2.7	17.8	9.4	14.8	19.2	2.0	110.0	0.0	52.0	12.4	8.8	73.4	0.0	31.1	62.5	11.8	13.0	12.8	8.5	116.1	14.3	20.6	27.0	43.8	19.4	8.1	37.9	10.1	84.8	75.8	6.3	36.8	55.1	9.2	18.9	7.4	19.4	9.2	5.1	4.9	3.4	130.2	15.2	22.5	8.0
P2RX7	"MGC20089, P2X7"	ENSG00000089041	"Purinergic receptor P2X 7"	Q99572	12	121132819-121188032	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.5"	"Cell type enhanced"	"Detected in many"	8	"Hofbauer cells: 22.5;Kupffer cells: 18.7;Macrophages: 34.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 19.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 4.2;monocytes: 7.5;T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 23.5;RPMI-8226: 13.8;SK-MEL-30: 23.3;U-266/70: 12.9;U-266/84: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034968, HPA042013, HPA044141"	Approved					NA	NA					"HPA034968: AB_10673105, HPA042013: AB_2677797, HPA044141: AB_2678830"	"unprognostic (1.05e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.54e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.65e-1)"	2.4	3.1	13.7	5.7	25.2	2.9	2.4	7.8	23.3	4.6	3.0	26.5	0.1	1.7	4.8	1.8	1.7	2.9	4.1	1.5	14.8	5.9	1.2	5.3	7.4	6.0	30.5	9.4	10.2	1.2	2.4	2.0	3.4	14.5	2.3	2.8	3.1	2.8	2.2	0.8	15.1	1.7	5.1	16.3	6.5	1.8	1.6	26.1	0.4	1.4	0.5	4.0	3.1	3.3	0.6	4.2	0.5	7.5	1.0	2.3	1.3	0.0	0.0	0.0	0.6	0.7	0.3	0.5	0.0	1.1	0.4	1.0	0.0	0.0	0.0	0.0	0.4	2.5	0.1	0.0	0.0	0.3	1.0	0.1	0.4	0.0	0.0	0.5	0.9	6.9	0.6	0.0	1.1	0.0	0.0	1.1	0.2	0.0	23.5	0.0	0.0	0.1	2.5	0.0	0.0	0.2	2.1	5.2	13.8	0.0	0.0	0.3	1.4	0.1	0.0	23.3	0.0	0.3	4.5	0.0	0.4	0.1	0.0	0.1	12.9	11.2	0.1	1.4	6.7	3.6	0.4	4.8	0.0	2.3	7.5	0.8	0.6	1.1	1.0	4.2	0.4	1.0	1.0	0.5	1.0	5.1	0.8	2.3	1.3	13.7	25.2	7.8	23.3	14.8	5.9	30.5	9.4	14.5	26.1	3.0	4.5	2.0	3.1	6.2	2.0	2.2	7.6	6.7	6.8	0.0	2.0	2.5	0.0	0.8	0.6	3.4	0.0	0.0	0.0	0.8	2.3	0.9	5.8	2.9	22.5	1.6	0.0	5.5	18.7	0.4	10.3	34.0	15.1	3.6	0.0	1.4	0.3	0.0	9.9	0.0	0.7	6.5	2.3	1.1	0.7	3.1	3.3	4.6	0.0	0.7
P2RY1	"P2Y1, SARCC"	ENSG00000169860	"Purinergic receptor P2Y1"	P47900	3	152834693-152841439	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.1;placenta: 24.7"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 22.9;Kupffer cells: 17.8;Muller glia cells: 16.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 29.1"	"Group enriched"	"Detected in some"	5	"basophil: 7.0;non-classical monocyte: 4.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 7.0;monocytes: 4.1"	"Cell line enriched"	"Detected in some"	5	"HEL: 30.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015577	Enhanced					NA	NA					"HPA015577: AB_1854882"	"unprognostic (3.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (1.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	2.9	1.7	4.7	5.9	29.1	4.8	2.0	3.1	6.3	6.7	8.7	4.9	0.6	3.3	8.5	0.8	19.4	2.3	2.2	2.9	8.4	2.3	1.1	1.6	10.4	2.1	1.8	6.1	9.6	3.6	0.5	2.3	24.7	2.4	8.0	6.9	2.6	5.6	2.6	7.1	8.8	6.1	4.8	3.8	2.4	1.7	1.3	3.3	3.0	1.5	9.9	3.5	3.0	9.5	0.0	0.9	7.0	4.1	0.0	0.0	0.2	0.0	0.5	4.8	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.4	6.0	0.0	0.0	0.5	0.0	0.7	1.0	2.6	0.8	0.2	0.0	2.3	30.3	0.0	0.0	0.0	3.5	2.8	0.4	6.0	0.0	0.3	2.4	0.0	1.0	0.9	0.0	0.0	0.0	0.5	0.1	4.4	0.0	3.7	0.0	0.1	0.8	0.0	2.0	0.8	0.0	0.0	0.0	0.6	1.1	0.0	1.6	0.0	0.5	1.2	0.0	2.5	0.0	0.0	0.0	3.1	0.0	3.5	7.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	4.1	0.9	0.0	0.2	4.7	29.1	3.1	6.3	8.4	2.3	1.8	6.1	2.4	3.3	0.0	0.3	0.8	6.8	1.6	8.2	6.3	22.9	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.6	10.5	0.0	0.0	0.2	2.7	6.6	9.3	0.2	6.2	0.0	0.0	12.9	17.8	0.0	13.8	6.3	0.0	0.0	8.4	16.6	1.1	10.5	5.6	0.0	1.0	0.0	0.5	0.5	0.4	1.8	0.1	0.0	6.6	4.2
P2RY2	P2U	ENSG00000175591	"Purinergic receptor P2Y2"	P41231	11	73218298-73236352	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 28.1;skeletal muscle: 29.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 14.0;Enterocytes: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"eosinophil: 28.1"	"Group enriched"	"Detected in many"	12	"granulocytes: 28.1;monocytes: 10.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 16.4;HL-60: 15.5;MCF7: 12.4;NB-4: 12.6;PC-3: 12.9;SK-BR-3: 14.3;THP-1: 36.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB022642	Uncertain		Uncertain	Cytosol		NA	NA			Cytosol		"CAB022642: "	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (6.50e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (9.69e-2)"	"unprognostic (4.92e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.57e-3)"	0.4	2.3	0.9	1.4	1.2	10.8	1.3	0.3	1.1	5.5	3.1	1.1	0.3	2.2	1.3	2.3	20.0	1.2	2.8	11.7	0.6	0.3	0.9	2.6	2.9	1.5	1.2	0.6	1.7	1.7	6.1	1.1	10.3	1.0	1.7	2.4	3.3	4.0	1.6	29.5	3.4	10.8	0.4	0.4	6.6	0.6	0.7	0.6	0.6	20.2	20.6	12.8	2.1	10.9	0.0	1.6	28.1	10.4	0.0	0.0	1.2	3.6	3.4	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	8.4	2.8	0.0	5.6	0.2	0.0	16.4	0.4	7.7	0.0	0.0	0.3	1.2	0.2	1.5	0.0	15.5	0.0	0.0	3.6	1.2	0.2	0.0	0.7	0.0	0.7	0.0	0.0	12.4	0.0	12.6	0.2	3.3	12.9	0.0	0.0	0.5	1.2	8.8	0.0	0.0	0.2	14.3	0.0	0.1	6.6	36.3	5.3	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	2.8	0.0	0.2	3.4	28.1	0.0	10.4	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	6.2	0.0	0.0	1.2	0.9	1.2	0.3	1.1	0.6	0.3	1.2	0.6	1.0	0.6	3.0	0.3	0.0	6.8	3.3	0.5	5.3	7.6	0.0	4.5	0.0	0.0	14.0	1.7	5.0	5.3	0.5	12.9	0.0	5.6	0.5	0.4	1.1	0.0	4.5	2.3	0.0	0.0	0.0	2.7	6.7	0.0	0.9	0.0	0.0	2.9	5.2	11.6	10.5	0.0	0.3	0.2	0.0	0.2	0.0	0.0	6.4	9.2	0.0	2.3	11.1
PACS2	"KIAA0602, PACS1L"	ENSG00000179364	"Phosphofurin acidic cluster sorting protein 2"	Q86VP3	14	105300563-105398147	"Predicted intracellular proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 65.7;skeletal muscle: 63.8"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 92.2;Late spermatids: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077892			Approved	Mitochondria		NA	NA			Mitochondria		"HPA077892: AB_2686865"	"unprognostic (4.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.18e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.56e-4)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.30e-1)"	15.3	10.8	18.8	7.7	25.5	6.1	13.3	20.5	29.8	8.0	7.7	41.7	6.5	8.4	10.0	8.1	8.9	9.6	8.7	15.1	23.9	18.0	6.8	3.7	9.3	6.1	36.8	13.9	11.8	21.3	10.3	8.1	6.9	26.3	7.6	5.5	6.7	11.8	9.8	63.8	7.2	9.1	8.1	65.7	10.9	7.4	13.4	26.8	2.7	7.1	7.0	4.4	8.3	7.3	0.6	5.4	0.3	4.0	2.1	2.0	0.9	9.3	12.9	12.2	11.5	12.2	11.9	14.5	7.1	8.3	6.1	5.4	5.6	17.8	10.2	12.1	10.8	7.9	10.8	7.4	10.2	4.4	12.7	6.1	4.6	5.1	8.3	16.1	3.8	8.5	13.8	9.8	4.3	10.0	7.8	11.1	10.4	2.9	9.6	5.3	29.3	6.4	5.1	4.7	11.9	10.7	14.4	7.4	6.5	5.2	21.6	27.5	14.6	6.8	6.2	10.6	8.0	15.6	7.1	16.8	9.1	4.2	14.3	7.1	12.7	8.2	3.8	13.9	6.9	8.8	0.0	1.6	0.2	0.9	2.7	1.7	0.2	0.8	1.0	2.7	0.6	0.3	1.0	0.3	2.1	4.0	5.4	2.0	0.9	18.8	25.5	20.5	18.9	23.9	18.0	36.8	13.9	26.3	26.8	8.9	14.3	0.8	6.5	8.0	30.2	17.8	7.6	1.4	13.6	5.2	11.8	3.8	11.6	11.7	47.3	15.8	19.0	0.0	19.9	2.8	11.2	8.4	1.1	7.8	15.0	92.2	12.5	19.6	14.3	63.1	16.1	13.3	25.3	8.2	13.4	14.7	14.0	10.5	15.6	10.5	22.4	6.5	12.7	12.9	11.3	7.3	2.9	5.3	16.6	7.1
PANX1	"MRS1, PX1, UNQ2529"	ENSG00000110218	"Pannexin 1"	Q96RD7	11	94128928-94181972	"Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Oogenesis, Transport"	"Calcium channel, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	10	"Basal keratinocytes: 90.6;Suprabasal keratinocytes: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016930	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA016930: AB_1854954"	"unprognostic (1.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.09e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-3)"	13.5	9.4	7.9	13.5	14.3	3.8	18.0	7.8	14.8	10.1	11.8	5.6	4.3	6.1	10.8	6.6	9.4	8.7	13.7	13.4	5.6	10.2	8.7	19.4	14.7	6.7	7.4	9.2	9.0	8.5	10.1	7.8	11.0	8.7	9.4	8.6	3.9	9.7	8.6	29.8	11.5	7.4	14.7	5.0	9.6	10.7	12.3	7.4	12.7	10.2	13.9	8.7	13.6	14.1	2.6	5.0	3.6	7.4	4.2	5.1	6.1	11.7	5.0	13.2	8.0	12.3	16.8	8.6	14.7	31.3	12.7	15.6	12.7	18.6	3.7	13.8	14.9	23.3	24.9	10.4	24.3	12.8	16.1	5.4	17.4	5.3	6.5	11.9	8.9	15.6	13.2	17.1	16.5	14.9	8.2	10.5	9.9	11.2	13.7	14.1	3.7	14.8	2.1	10.5	9.5	9.1	17.7	17.6	4.7	8.2	11.7	5.5	16.1	10.3	5.9	7.0	7.0	12.6	4.6	7.6	25.2	13.0	8.2	14.5	2.2	8.5	6.2	10.5	9.3	16.0	3.6	7.4	0.5	4.3	4.2	5.0	2.6	3.5	4.4	5.0	2.4	3.2	3.6	0.5	4.2	2.6	0.8	5.1	6.1	7.9	14.3	7.8	14.8	5.6	10.2	7.4	9.2	8.7	7.4	0.0	8.3	1.9	8.9	90.6	1.2	3.1	0.0	6.7	2.3	1.8	0.0	10.6	0.0	12.9	4.7	3.1	3.3	0.0	15.8	28.0	12.4	6.8	9.2	6.4	16.9	0.0	2.4	2.5	4.4	2.2	4.0	10.1	16.9	3.6	3.3	0.9	18.5	3.4	3.5	1.9	1.3	0.0	14.4	1.0	6.8	63.1	19.9	3.2	2.8	13.1
PANX2	"hPANX2, PX2"	ENSG00000073150	"Pannexin 2"	Q96RD6	22	50170731-50180294	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 10.2;Hepatocytes: 6.8;Muller glia cells: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 1.8;granulocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 9.1;HDLM-2: 13.9;Hep G2: 16.3;MCF7: 9.0;SCLC-21H: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004624, HPA039117"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA004624: , HPA039117: AB_10805354"	"unprognostic (1.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-9)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.08e-1)"	1.6	2.6	10.3	2.6	9.2	5.3	1.4	22.4	31.4	1.8	1.1	1.2	10.5	1.1	2.4	2.7	3.8	4.9	2.3	1.1	14.2	8.8	3.4	7.8	2.4	1.2	15.9	7.9	3.5	3.0	1.0	4.1	1.6	23.9	3.8	1.0	1.5	5.5	6.2	1.5	2.6	1.2	1.2	4.5	2.7	1.4	2.6	2.4	0.0	3.8	0.2	1.5	1.8	0.9	0.0	1.8	5.2	0.0	0.0	0.0	0.0	0.8	1.8	0.3	2.0	0.0	0.2	4.3	2.2	2.2	0.5	0.4	0.4	6.9	0.0	9.1	0.2	1.3	0.4	1.1	0.9	0.1	13.9	1.2	0.3	2.9	16.3	0.7	0.1	1.1	0.2	0.9	0.6	0.0	1.0	0.5	0.0	1.1	0.0	0.2	9.0	0.0	0.8	3.4	0.0	3.7	0.8	0.0	3.3	0.0	1.4	8.6	0.8	1.4	0.1	5.2	0.4	0.6	0.6	3.8	0.4	3.7	5.9	4.1	1.6	0.1	0.5	0.2	0.0	6.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	1.8	0.0	0.0	10.3	9.2	22.4	31.4	14.2	8.8	15.9	7.9	23.9	2.4	0.0	1.4	0.0	2.3	0.5	10.2	0.6	2.5	4.0	4.5	0.0	0.0	0.0	5.0	1.7	0.2	0.0	0.0	0.0	2.4	0.1	0.5	4.0	0.0	6.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.8	0.0	21.1	2.2	0.0	1.1	1.2	3.6	0.0	0.4	0.0	0.4	0.3	0.0	0.0	0.0	2.8
PANX3	Px3	ENSG00000154143	"Pannexin 3"	Q96QZ0	11	124611490-124620356	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.8;testis: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;MCF7: 2.6;U-266/70: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																	"unprognostic (5.80e-2)"			"unprognostic (3.10e-1)"			0.1	0.4	0.1	0.1	1.8	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.2	0.0	0.1	1.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	2.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	2.6	0.2	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	0.0	2.8	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.1	0.5	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PARL	"PRO2207, PSARL, PSARL1, RHBDS1"	ENSG00000175193	"Presenilin associated rhomboid like"	Q9H300	3	183829271-183884933	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019545	Approved		Approved	Mitochondria		NA	NA			Mitochondria		"HPA019545: AB_1855796"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.11e-5)"	24.2	20.6	26.2	19.2	30.1	21.2	30.4	22.1	29.6	22.7	29.0	24.4	19.4	21.5	20.2	43.8	21.4	19.6	21.2	30.9	23.1	23.4	27.0	26.7	20.3	26.5	28.4	20.3	20.3	47.5	22.0	20.6	18.5	19.5	22.1	31.3	25.9	35.1	33.4	41.2	22.3	27.0	38.1	19.4	22.3	24.5	22.2	18.9	22.1	20.7	25.4	24.3	23.2	18.2	21.5	45.4	44.3	50.0	21.5	25.9	35.4	32.6	15.5	11.5	9.8	11.2	12.9	23.9	12.3	16.7	23.7	18.6	47.7	17.1	14.6	27.4	15.6	21.3	14.6	18.3	18.9	26.7	20.7	22.5	22.0	10.4	26.1	16.8	21.8	18.6	17.5	24.3	16.6	20.3	11.2	16.8	23.2	12.5	13.6	19.4	35.4	41.6	53.4	30.9	27.4	15.9	18.4	22.5	26.5	22.1	27.3	11.6	16.5	14.6	47.2	30.0	14.7	48.5	41.4	9.8	8.8	19.2	18.2	31.2	27.4	18.5	33.6	16.9	22.2	10.5	27.6	50.0	44.3	19.0	35.4	21.7	21.5	21.6	22.1	45.4	19.9	25.9	21.1	14.5	21.5	26.2	27.0	24.4	35.4	26.2	30.1	22.1	29.6	23.1	23.4	28.4	20.3	19.5	18.9	20.8	26.1	28.3	47.3	27.0	33.9	33.9	20.4	18.7	15.9	29.6	29.5	49.5	99.5	41.8	15.3	30.4	28.2	0.0	73.6	40.6	37.9	39.4	69.2	28.2	68.8	31.8	32.4	30.1	52.8	7.4	26.7	58.0	40.5	60.5	36.5	35.7	49.3	35.1	25.5	71.7	38.7	6.5	49.1	43.3	46.0	26.2	35.2	38.5	49.1	46.1
PDCD6	"ALG-2, PEF1B"	ENSG00000249915	"Programmed cell death 6"	O75340	5	271621-353856	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047221			Supported	Nucleoplasm,Cytosol		No	No		2100000	Cytosol	Nucleoplasm	"HPA047221: "	"unprognostic (1.32e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.47e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (2.19e-4)"	28.3	48.5	44.6	36.3	42.1	21.0	44.6	42.1	52.0	37.1	47.3	33.7	35.7	41.4	31.5	59.7	58.0	38.9	46.5	23.5	44.4	39.7	35.5	37.1	39.8	48.1	39.2	38.6	36.9	46.2	28.8	36.2	35.4	39.3	32.9	51.0	26.8	40.3	40.4	19.2	31.1	44.3	31.4	38.4	36.6	32.0	31.7	35.1	31.0	42.3	31.9	41.2	31.3	37.7	69.8	67.2	79.9	62.3	70.6	69.9	89.4	27.3	38.5	16.9	25.2	30.7	27.8	34.7	21.3	28.4	27.4	25.8	27.1	34.7	21.5	53.2	28.7	35.6	20.8	25.5	53.6	22.3	72.7	31.6	19.1	99.1	35.0	37.6	27.6	24.5	24.8	33.1	22.2	40.0	28.5	25.7	15.2	24.0	17.0	24.5	42.8	22.4	48.3	17.9	33.5	54.4	18.4	15.7	30.7	64.8	35.3	16.3	22.0	54.2	58.1	39.7	18.3	40.4	38.5	19.8	18.2	14.7	15.7	18.2	22.6	28.0	25.5	26.6	36.2	24.1	40.8	62.3	79.9	49.6	58.7	61.7	69.8	62.2	55.8	67.2	60.9	69.9	56.2	69.0	70.6	56.1	53.8	66.7	89.4	44.6	42.1	42.1	52.0	44.4	39.7	39.2	38.6	39.3	35.1	59.6	50.2	74.3	103.0	72.9	44.2	43.4	84.1	89.7	69.4	97.7	35.3	208.9	213.9	147.4	51.9	103.4	116.6	23.3	113.2	262.6	88.0	103.4	81.8	70.0	126.3	60.4	76.5	63.8	70.9	40.4	108.7	80.4	118.1	180.3	159.6	116.3	131.1	136.8	109.6	163.7	39.4	84.1	82.4	81.7	129.8	80.8	298.3	82.9	170.4	145.4
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"brain: 55.9"	"Group enriched"	"Detected in some"	102	"Early spermatids: 39.7;Late spermatids: 87.7"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Region enriched"	"Detected in many"	4	"basal ganglia: 55.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.6;NTERA-2: 2.8;THP-1: 2.7"	"Group enriched"	"Detected in many"	4	"basal ganglia: 150.7;hypothalamus: 70.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 131.1"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"	NA	NA					"CAB079777: , HPA053342: AB_2682121"					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"			0.4	0.4	13.2	0.4	55.9	0.4	0.4	0.0	40.3	0.4	0.4	1.2	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	5.0	3.9	0.4	0.4	0.4	0.4	0.7	3.7	0.4	0.4	0.4	0.0	0.4	0.2	0.4	0.4	0.0	0.4	0.4	0.4	0.6	0.4	0.4	2.2	0.4	0.4	3.2	1.1	0.0	0.5	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	55.9	0.0	3.8	5.0	3.9	0.7	3.7	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0
PENK		ENSG00000181195	Proenkephalin	P01210	8	56436674-56446734	"Plasma proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 124.3;brain: 171.5"	"Cell type enhanced"	"Detected in some"	32	"Leydig cells: 1053.7;Peritubular cells: 212.2;Spermatocytes: 309.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.5"	"Region enriched"	"Detected in many"	12	"basal ganglia: 171.5"	"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.1"	"Group enriched"	"Detected in many"	19	"B-cells: 3.1;dendritic cells: 1.2;monocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"ASC diff: 16.6;ASC TERT1: 9.9;BJ: 9.2;THP-1: 8.6"	"Region enriched"	"Detected in all"	7	"basal ganglia: 3244.3"	"Region enriched"	"Detected in all"	7	"basal ganglia: 1049.6"	"HPA013138, CAB016390"	Enhanced				"Secreted in other tissues"	NA	NA		35000			"CAB016390: AB_2161515, HPA013138: AB_1855191"	"unprognostic (6.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.58e-3)"		"unprognostic (1.31e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.98e-3)"	2.5	124.3	2.8	1.7	171.5	0.3	0.9	3.9	7.8	14.3	2.2	0.9	0.1	0.6	3.0	0.9	0.9	2.6	4.0	9.1	1.2	9.1	0.3	0.2	1.0	0.3	2.5	0.4	8.2	0.6	0.2	1.5	1.1	8.4	11.7	0.9	2.2	0.9	8.1	1.1	0.5	0.9	1.7	7.0	0.3	1.1	29.9	14.7	0.0	0.6	0.3	0.3	0.5	0.6	3.1	1.2	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	16.6	9.9	0.0	9.2	2.9	1.7	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.2	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.5	2.8	171.5	3.9	7.8	1.2	9.1	2.5	0.4	8.4	14.7	0.0	1.0	0.0	0.0	0.1	0.0	0.6	0.0	1.4	4.5	0.0	0.0	0.0	0.0	0.0	56.7	0.5	0.0	0.0	0.0	0.0	3.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	37.9	1053.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	212.2	0.0	0.0	6.5	0.4	309.0	17.5	0.4	0.0	0.0	0.0	0.0
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528531	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes		NA	NA			Peroxisomes		"HPA020235: AB_1855224"	"unprognostic (4.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.35e-3)"	"unprognostic (4.90e-2)"	11.3	13.8	8.9	13.1	19.1	5.8	14.0	14.3	14.7	12.7	13.2	15.8	19.0	10.2	12.2	18.7	13.0	9.5	10.6	13.4	9.5	9.3	22.4	20.3	8.4	9.9	15.4	9.3	14.3	17.5	23.3	22.5	8.0	18.5	12.9	15.4	13.7	13.6	20.6	16.1	15.0	12.7	12.2	15.0	10.2	12.9	10.2	13.6	15.2	13.8	14.6	11.1	11.5	11.6	5.5	2.1	3.1	3.6	7.9	6.2	1.9	5.7	6.3	10.4	17.6	6.6	5.6	9.4	3.8	5.0	4.6	6.6	3.8	6.1	8.5	8.7	4.4	7.0	5.9	7.9	6.9	7.3	8.8	7.0	4.1	6.8	4.8	4.6	7.3	4.6	6.1	6.3	6.8	9.3	5.7	7.1	8.9	15.0	12.2	7.1	10.8	14.5	7.1	7.2	8.4	5.9	10.3	11.6	10.6	6.4	8.5	7.7	12.4	8.8	24.6	7.5	15.1	5.0	3.1	5.8	4.4	6.0	16.6	4.0	13.7	10.8	11.8	4.1	4.3	7.0	1.1	2.0	3.1	4.7	3.2	4.6	5.5	4.9	5.1	2.1	4.7	5.7	6.2	1.6	7.9	3.6	1.3	4.6	1.9	8.9	19.1	14.3	14.7	9.5	9.3	15.4	9.3	18.5	13.6	26.8	13.6	5.7	7.2	5.3	42.4	25.0	2.5	41.5	12.5	5.2	33.4	7.5	8.3	5.6	4.8	8.7	15.1	23.3	6.5	3.1	5.2	8.0	8.1	11.6	4.7	38.1	13.4	8.6	9.4	3.8	13.3	5.6	6.8	13.6	12.9	16.6	5.7	13.6	14.2	15.3	45.7	6.5	6.1	28.4	10.4	6.8	7.0	8.7	13.3	7.0
PEX10	RNF69	ENSG00000157911	"Peroxisomal biogenesis factor 10"	O60683	1	2403964-2413797	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 144.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049458, HPA049755"	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA049458: AB_2680775, HPA049755: AB_2680867"	"prognostic favorable (4.50e-6)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.16e-6)"	"unprognostic (4.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	14.6	18.7	20.5	6.2	19.9	5.6	16.3	7.6	24.6	9.8	9.2	23.1	6.6	10.1	7.6	13.6	10.6	11.4	8.3	12.9	17.8	15.5	12.0	12.1	8.3	7.6	19.2	13.5	13.0	19.4	12.5	12.2	10.2	16.0	15.4	7.0	11.4	17.4	12.3	22.1	10.8	9.0	6.6	21.3	8.9	10.1	17.3	12.6	6.0	10.5	11.8	9.0	8.1	6.8	7.4	11.5	2.2	10.7	4.5	6.4	4.8	12.2	10.2	8.0	8.9	5.8	6.7	7.4	6.5	7.5	10.8	7.8	16.3	18.5	6.4	17.2	8.5	7.1	9.5	7.3	12.0	5.0	10.3	14.1	4.8	10.5	32.4	11.2	8.6	2.6	6.6	6.3	7.9	10.9	6.8	9.1	7.7	5.9	8.0	9.5	16.0	8.0	4.1	6.8	6.7	20.5	6.6	8.2	13.3	11.6	4.2	12.5	9.6	7.7	11.6	21.1	4.9	10.1	3.4	8.8	9.9	4.4	15.1	8.6	11.7	4.8	5.8	11.4	6.7	7.8	1.9	6.9	2.2	5.2	10.7	6.0	7.4	4.5	6.4	11.5	6.9	5.2	3.9	1.6	4.5	8.7	9.8	2.5	4.8	20.5	19.9	7.6	24.6	17.8	15.5	19.2	13.5	16.0	12.6	3.0	4.1	5.4	10.8	7.8	15.7	0.7	10.2	8.1	4.5	14.0	0.0	22.0	29.9	19.3	42.4	9.2	9.3	0.0	26.3	21.1	10.8	12.5	0.0	8.2	20.4	12.7	12.7	4.9	10.5	144.2	9.8	10.3	21.9	26.2	9.1	39.6	17.3	3.5	12.7	20.2	9.7	0.0	8.5	24.9	16.2	5.4	23.0	4.4	14.9	9.1
PEX11A	"MGC119947, MGC138534, PEX11-ALPHA"	ENSG00000166821	"Peroxisomal biogenesis factor 11 alpha"	O75192	15	89677764-89690783	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 32.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.32e-2)"	20.0	10.0	13.1	5.4	11.7	0.8	18.0	6.1	10.9	6.6	14.4	7.7	27.1	13.9	5.8	9.6	5.8	8.8	8.1	8.8	13.0	6.9	10.4	32.8	5.4	2.1	6.5	7.7	11.9	10.8	8.8	8.5	3.2	8.4	16.3	10.7	8.1	9.2	21.9	18.6	4.4	15.7	7.0	5.6	3.4	9.6	12.5	10.6	1.4	11.0	3.7	3.7	11.2	12.5	3.2	3.5	4.4	1.8	5.6	7.3	3.1	5.9	3.6	2.8	0.2	14.6	5.3	2.3	3.0	5.1	4.5	7.4	2.5	7.2	2.7	3.3	3.4	6.4	8.0	0.0	4.5	5.2	4.3	10.1	4.1	4.0	3.5	10.5	2.7	1.4	6.5	5.6	2.6	4.4	3.5	3.1	2.7	0.0	1.1	3.3	6.0	0.0	0.3	1.6	12.1	6.7	0.0	0.0	2.4	3.7	4.0	2.0	5.3	9.5	32.9	8.7	5.3	8.7	2.6	2.8	2.9	3.0	8.0	2.3	3.2	5.4	0.1	7.3	0.3	2.6	2.3	1.4	4.4	7.3	1.8	4.2	3.2	3.7	4.1	3.5	2.0	4.6	5.3	1.6	5.6	1.3	0.8	3.3	3.1	13.1	11.7	6.1	10.9	13.0	6.9	6.5	7.7	8.4	10.6	6.0	5.9	0.0	8.0	1.5	7.9	6.9	10.2	17.4	7.9	5.2	2.0	8.0	5.0	5.2	18.7	2.7	18.0	0.0	4.0	6.0	4.3	12.1	1.1	32.6	3.4	17.5	3.5	4.3	1.8	27.5	4.9	0.9	3.3	1.0	9.6	13.7	6.5	11.5	2.5	9.0	8.5	0.0	3.1	15.4	7.0	1.8	2.3	1.3	10.9	9.5
PEX12		ENSG00000108733	"Peroxisomal biogenesis factor 12"	O00623	17	35574795-35578863	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 13.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069386	Enhanced					NA	NA					"HPA069386: AB_2686135"	"unprognostic (1.45e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	6.5	12.6	11.4	5.1	13.4	2.1	8.7	9.6	12.2	8.6	6.6	9.9	6.0	5.7	7.3	17.2	6.4	8.7	8.0	13.0	9.9	10.2	12.8	13.2	5.3	6.4	13.9	8.6	13.1	6.7	17.8	20.8	8.6	9.2	11.9	4.6	8.0	7.9	13.4	13.8	6.5	5.3	5.9	10.8	5.6	6.3	9.8	9.9	6.2	12.3	5.4	6.6	8.5	9.1	4.9	3.2	5.3	2.9	3.5	8.0	2.5	2.7	3.6	5.4	4.4	11.3	10.4	3.9	7.2	8.2	6.0	6.4	3.1	2.9	6.0	11.7	4.0	4.9	7.1	6.5	4.8	5.3	2.2	8.5	4.5	4.0	5.7	13.4	6.3	1.1	9.4	9.1	3.7	11.0	7.7	4.5	5.1	7.0	6.6	7.2	2.7	7.5	3.8	2.2	6.3	5.7	3.6	9.4	6.0	7.4	4.2	4.0	4.1	4.5	3.0	9.1	6.8	7.3	3.6	3.5	5.7	3.6	6.3	4.7	13.4	9.3	7.3	6.0	5.0	5.1	4.1	2.9	5.3	3.7	2.2	6.3	4.7	5.9	3.6	3.2	4.9	8.0	6.8	2.0	3.5	2.2	3.0	4.2	2.5	11.4	13.4	9.6	10.7	9.9	10.2	13.9	8.6	9.2	9.9	3.0	0.3	1.3	1.6	0.6	1.8	5.6	0.0	1.4	3.4	3.5	0.0	5.8	3.3	2.6	10.5	3.1	1.3	0.0	1.0	3.8	2.1	2.0	2.3	6.4	2.6	1.6	1.2	1.3	2.7	1.9	2.8	1.2	1.7	1.0	1.9	7.3	2.0	0.0	1.4	3.1	2.2	0.0	2.0	13.2	6.1	1.1	4.3	2.2	2.0	1.0
PEX13		ENSG00000162928	"Peroxisomal biogenesis factor 13"	Q92968	2	61017225-61051990	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032141, HPA032142, CAB032689"	Enhanced		Supported	Peroxisomes		NA	NA			Peroxisomes		"CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676"	"unprognostic (2.44e-3)"	"unprognostic (4.10e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (5.42e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.63e-2)"	11.7	11.5	14.2	9.1	14.7	8.4	29.2	21.4	14.9	14.3	13.1	10.3	6.0	13.0	12.3	10.3	15.7	8.9	11.6	16.3	14.1	11.7	17.7	31.8	16.8	13.1	11.7	11.7	16.5	19.5	10.9	18.7	11.9	10.8	19.6	14.1	11.6	13.7	8.7	20.7	11.5	15.3	17.4	12.2	8.2	12.7	18.2	12.3	11.7	18.0	9.7	11.0	13.7	13.3	8.3	7.9	15.1	7.0	8.0	10.5	6.2	10.4	7.7	11.1	14.2	10.6	8.4	17.1	10.9	8.6	7.5	7.7	11.5	15.9	6.8	11.9	10.7	14.1	15.8	9.8	13.2	14.2	6.6	6.8	6.3	10.4	19.0	12.6	9.3	7.7	10.2	20.4	10.2	15.8	11.5	13.5	7.8	15.1	6.1	11.3	9.5	6.9	11.2	12.0	19.4	7.8	7.4	12.2	8.6	14.2	26.2	12.5	8.6	12.2	16.7	9.8	13.7	11.1	4.9	10.5	14.4	19.2	8.3	9.3	10.0	7.7	17.2	9.1	9.6	10.1	15.1	6.1	8.8	8.3	5.8	7.9	8.3	9.7	9.2	7.9	6.7	10.5	7.9	6.0	8.0	7.0	7.0	8.2	6.2	14.2	14.7	21.4	14.9	14.1	11.7	11.7	11.7	10.8	12.3	17.9	15.5	20.1	29.3	45.4	11.5	17.5	22.9	22.7	21.6	21.0	7.9	33.0	21.6	24.5	86.1	14.6	23.6	0.0	24.5	33.0	13.4	37.4	8.1	40.0	18.9	15.9	2.4	12.3	12.1	19.4	8.9	19.0	15.1	24.4	13.1	11.4	23.4	15.8	11.0	25.0	13.8	6.5	16.7	40.9	19.0	44.0	57.4	17.3	16.3	77.9
PEX14		ENSG00000142655	"Peroxisomal biogenesis factor 14"	O75381	1	10472288-10630758	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 60.6;Syncytiotrophoblasts: 54.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046104, HPA049231"	Supported		Supported	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			Peroxisomes	"Nucleoli fibrillar center"	"HPA046104: AB_2679539, HPA049231: AB_2680683"	"unprognostic (7.23e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-3)"	"unprognostic (9.67e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.75e-2)"	14.9	11.6	14.3	12.2	22.3	8.3	13.1	15.7	35.0	11.8	14.8	18.6	8.3	18.0	14.4	10.4	22.6	14.8	12.2	17.8	14.4	16.2	13.3	25.9	13.6	11.6	13.0	16.1	15.7	15.3	13.6	14.2	17.7	22.4	21.9	10.5	14.8	20.0	31.0	22.1	14.6	20.9	10.7	11.1	11.2	12.8	18.7	11.4	11.4	13.5	11.6	17.3	38.7	13.6	4.2	5.0	7.3	3.8	4.2	8.4	3.6	15.6	14.8	12.6	13.8	9.3	8.8	8.2	18.1	15.3	20.2	19.3	15.6	29.1	11.4	18.1	13.8	12.0	18.7	13.1	17.4	9.7	16.0	21.4	14.0	16.1	21.3	14.0	15.8	20.2	10.6	14.1	15.3	14.1	12.1	12.9	15.1	21.9	11.8	9.1	12.9	15.1	20.8	12.9	12.3	17.4	16.4	10.5	16.3	15.9	10.4	15.0	17.2	17.5	14.7	16.3	10.2	13.5	11.4	12.4	14.8	15.6	14.3	15.3	17.0	13.8	22.3	16.2	21.9	15.7	1.9	3.8	7.3	8.4	2.8	5.3	4.2	4.4	6.2	4.7	3.9	5.8	5.2	0.6	4.2	2.5	5.0	5.2	3.6	14.3	22.3	15.7	35.0	14.4	16.2	13.0	16.1	22.4	11.4	8.9	1.3	7.5	12.5	6.4	14.7	6.1	5.1	21.4	2.3	8.7	25.5	40.0	6.6	15.0	2.2	6.0	18.7	0.0	12.7	15.4	7.1	9.7	5.8	48.3	20.4	17.5	8.6	9.8	7.9	2.4	7.5	5.9	11.8	32.5	8.4	13.8	14.7	10.5	5.3	14.8	60.6	6.5	7.2	5.9	12.1	7.0	54.1	8.5	10.5	11.2
PEX16		ENSG00000121680	"Peroxisomal biogenesis factor 16"	Q9Y5Y5	11	45909669-45918812	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043286	Approved					NA	NA					"HPA043286: AB_10794179"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.06e-3)"	"unprognostic (9.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.75e-3)"	"unprognostic (5.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (9.06e-4)"	14.6	17.6	23.7	13.0	23.5	24.3	12.0	10.6	29.2	9.7	19.6	21.3	13.4	24.8	11.0	13.0	13.8	15.1	14.0	15.4	22.9	17.0	14.8	28.9	11.9	19.9	21.2	14.3	12.7	31.6	12.8	18.6	10.9	17.4	11.9	7.3	13.3	24.1	18.8	9.2	16.5	22.2	8.3	19.9	16.8	15.2	16.7	11.5	18.3	16.0	12.5	18.4	13.8	10.3	36.9	32.4	24.4	31.5	27.4	38.9	29.6	8.3	12.5	3.8	10.4	7.0	8.7	11.4	6.9	9.5	9.7	8.1	13.5	6.4	14.4	9.0	6.7	9.4	17.0	3.9	14.2	2.0	13.0	15.4	9.1	15.9	11.3	21.8	14.2	23.3	13.8	12.6	6.0	9.2	5.5	10.3	14.1	7.5	17.5	6.1	24.1	10.7	19.2	9.3	16.7	13.7	10.8	9.4	16.5	6.2	14.2	10.0	13.4	8.0	16.0	13.4	2.5	24.0	12.2	9.2	10.5	12.2	22.7	12.2	27.9	18.4	9.7	10.6	9.2	10.2	19.7	30.7	24.4	35.5	31.5	32.4	36.9	34.6	34.5	32.4	32.7	31.5	32.6	22.5	27.4	24.2	29.7	38.9	29.6	23.7	23.5	10.6	29.2	22.9	17.0	21.2	14.3	17.4	11.5	3.0	4.8	33.4	19.4	14.7	16.0	2.7	22.9	6.7	2.3	14.0	9.8	29.0	43.1	28.4	18.5	24.8	55.4	23.3	76.7	18.1	15.1	22.5	20.7	69.1	30.5	14.3	27.0	15.4	32.7	23.2	17.8	19.8	20.3	46.9	21.5	26.2	47.0	42.1	13.4	57.5	12.9	32.3	21.5	25.0	12.4	18.3	53.5	34.5	23.9	25.3
PEX19	"D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1"	ENSG00000162735	"Peroxisomal biogenesis factor 19"	P40855	1	160276812-160286348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044837, HPA051966"	Supported		Supported	Peroxisomes		NA	NA			Peroxisomes		"HPA044837: AB_10962496, HPA051966: AB_2681677"	"unprognostic (1.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.92e-5)"	"unprognostic (3.46e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.24e-2)"	41.9	20.4	21.5	8.0	27.8	6.2	24.4	10.0	30.6	12.5	12.9	23.8	8.9	11.0	13.0	15.0	14.6	13.6	11.3	21.7	18.5	21.0	19.5	61.6	12.2	8.7	20.3	17.2	14.5	12.6	17.5	14.3	15.0	25.0	16.8	13.8	17.8	16.2	16.3	32.9	14.1	12.7	10.0	17.4	11.8	12.7	11.4	12.9	9.1	22.2	12.1	11.3	13.4	8.7	9.7	13.0	11.8	15.6	6.9	10.2	7.5	12.4	7.6	29.5	9.1	25.2	24.9	22.2	10.2	21.1	19.0	15.1	14.0	15.3	15.4	17.5	15.5	11.1	12.2	14.1	18.4	15.0	13.3	7.0	10.7	10.8	14.3	20.6	19.4	13.6	37.3	21.3	25.7	16.5	15.3	13.3	21.3	16.1	11.9	21.3	6.9	14.5	6.3	21.0	15.9	20.1	18.4	14.5	18.3	19.2	25.3	9.6	16.0	40.8	20.7	15.4	31.6	20.2	19.1	10.1	11.0	13.2	12.5	12.1	17.7	22.7	28.0	18.2	8.4	16.2	9.2	12.2	11.8	10.2	15.6	8.3	9.7	5.9	7.2	13.0	5.6	7.5	6.8	4.8	6.9	10.2	6.3	8.7	7.5	21.5	27.8	10.0	30.6	18.5	21.0	20.3	17.2	25.0	12.9	8.9	19.4	9.8	17.0	8.9	18.7	41.6	20.4	10.7	5.7	15.7	9.8	24.5	41.4	18.8	4.2	13.2	23.3	0.0	12.9	43.8	15.3	16.7	16.1	52.9	26.1	23.8	10.9	20.3	12.7	2.2	20.1	13.5	20.3	31.5	14.5	30.7	16.8	19.0	27.6	34.2	9.6	32.3	17.8	13.9	25.9	8.7	32.4	14.4	15.5	19.0
PEX2	"PAF-1, PMP35, PXMP3, RNF72, ZWS3"	ENSG00000164751	"Peroxisomal biogenesis factor 2"	P28328	8	76980258-77001044	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 112.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010983, HPA011410, HPA027729"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416"	"unprognostic (6.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.09e-3)"	21.3	30.9	25.4	17.9	23.8	17.3	30.7	20.7	24.6	24.3	23.8	24.1	65.7	22.5	25.7	24.3	21.6	24.1	18.0	22.1	26.9	20.7	31.3	25.3	20.4	27.8	29.8	18.3	20.5	26.4	21.2	32.6	17.4	25.9	25.8	22.9	24.9	28.7	63.6	32.4	17.4	27.2	25.7	30.5	23.1	27.0	14.7	30.9	32.2	34.4	19.0	23.4	24.2	23.5	17.3	17.1	52.4	22.9	28.3	22.3	24.2	27.3	9.3	15.1	15.2	16.1	20.3	7.9	20.6	23.5	15.9	17.6	5.8	24.6	15.6	30.7	18.4	13.0	10.6	10.3	15.6	19.4	28.8	8.5	19.0	8.6	8.9	10.9	15.7	15.1	22.8	13.3	12.0	14.4	25.0	17.3	25.3	10.4	15.0	16.6	8.2	27.6	9.4	8.9	39.2	8.4	5.1	12.0	12.9	18.4	19.4	5.3	14.0	13.2	60.2	11.2	13.5	18.8	11.4	17.2	14.6	19.2	18.8	10.2	27.9	16.1	27.2	18.6	8.4	16.1	52.4	20.3	35.8	22.3	20.8	19.9	17.3	15.6	17.9	16.9	17.2	20.6	19.6	14.1	28.3	22.9	17.1	17.4	24.2	25.4	23.8	20.7	24.6	26.9	20.7	29.8	18.3	25.9	30.9	44.7	18.5	25.9	28.0	16.1	26.4	23.8	28.1	24.1	19.4	26.2	11.8	35.4	112.7	45.9	2.4	15.7	28.0	0.0	43.3	19.6	25.8	30.4	17.4	29.7	24.1	12.7	27.7	17.2	35.1	5.9	27.3	21.5	27.0	32.5	33.2	49.5	36.5	29.1	33.6	53.7	29.7	6.5	24.8	13.5	17.6	18.3	29.1	41.1	26.4	33.0
PEX26	FLJ20695	ENSG00000215193	"Peroxisomal biogenesis factor 26"	Q7Z412	22	18077920-18131138	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070429	Approved					NA	NA					"CAB070429: AB_11154363"	"unprognostic (2.25e-1)"	"unprognostic (5.75e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.77e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (1.59e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (3.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	13.2	16.2	16.7	11.8	18.2	16.5	11.1	14.7	22.0	10.1	28.9	13.6	11.5	28.6	12.3	9.3	14.4	12.0	14.7	11.5	17.1	16.5	14.8	17.8	10.1	11.8	14.7	20.0	10.8	21.8	18.6	14.5	8.3	16.3	10.3	24.3	13.1	12.3	11.1	11.7	11.4	29.0	12.0	10.2	11.9	14.4	5.8	11.1	15.1	13.8	9.6	11.7	11.0	11.3	4.8	7.3	3.8	6.0	4.4	7.0	2.8	16.8	9.2	11.1	10.2	15.1	7.8	18.1	11.3	12.3	11.5	11.0	13.4	14.3	11.8	12.3	19.3	12.4	17.3	17.3	17.8	9.9	18.6	14.9	21.8	12.4	13.2	11.3	26.2	20.1	11.0	11.0	18.6	17.5	8.5	17.0	11.2	22.5	8.9	15.9	27.6	19.5	10.0	13.0	26.7	16.5	17.2	13.1	3.6	16.8	20.4	20.3	14.9	19.3	12.4	15.0	9.1	18.8	9.2	21.1	23.3	10.4	12.3	13.3	19.5	14.3	15.5	10.3	13.8	16.7	2.2	4.0	3.8	5.8	2.5	4.6	3.4	4.8	7.0	3.7	4.8	5.5	3.8	3.0	4.4	6.0	7.3	1.8	2.8	16.7	18.2	14.7	22.0	17.1	16.5	14.7	20.0	16.3	11.1	6.0	9.3	14.6	13.8	11.9	21.7	25.4	35.7	9.4	15.9	7.0	41.2	9.9	5.0	21.6	0.8	14.3	88.1	0.0	20.3	8.4	10.4	15.9	11.5	30.2	13.0	28.6	23.5	16.0	13.7	1.5	11.5	13.2	0.0	9.0	23.8	8.8	28.0	38.6	11.0	19.4	27.6	12.9	9.5	10.6	9.8	15.4	7.8	12.1	26.0	16.2
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450807-143490010	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatocytes: 65.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Approved	Nucleoplasm,Peroxisomes		NA	NA			"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	10.1	47.5	13.7	14.0	15.5	3.3	14.5	17.3	17.7	13.6	8.5	12.1	14.0	7.0	12.5	16.4	21.1	12.5	9.0	15.8	14.3	11.4	22.7	29.2	9.6	10.3	13.7	15.9	14.4	8.6	16.2	14.8	22.2	17.4	15.0	8.1	10.4	12.8	15.7	12.6	14.6	8.8	12.7	14.6	8.7	11.3	14.4	12.7	10.1	19.3	13.5	11.6	11.9	15.1	18.2	8.7	7.8	9.6	12.0	18.7	8.1	14.6	3.6	7.7	16.1	12.8	12.6	9.6	13.1	10.7	18.2	22.2	23.6	9.5	25.6	15.6	14.0	19.6	12.4	10.6	18.6	22.5	14.8	13.0	18.1	7.4	15.2	11.8	29.1	7.3	15.3	12.7	17.4	13.1	8.6	9.9	13.3	15.4	11.8	17.3	10.2	14.7	11.8	4.9	8.9	13.1	11.3	17.3	11.0	22.3	6.3	11.9	4.3	17.4	15.1	11.6	7.8	7.6	9.7	9.1	13.0	11.1	22.2	15.5	8.5	10.7	25.6	17.0	20.1	10.2	7.8	5.1	4.9	13.2	8.0	15.1	18.2	14.1	13.1	7.9	15.4	18.7	17.9	0.8	12.0	9.6	8.7	16.5	8.1	13.7	15.5	17.3	17.7	14.3	11.4	13.7	15.9	17.4	12.7	14.9	11.8	10.0	10.4	23.7	12.3	11.3	5.1	25.4	14.8	8.7	3.9	32.3	16.6	11.5	3.2	11.7	5.5	0.0	8.3	9.5	12.0	7.4	24.3	18.1	9.9	15.9	5.8	12.9	7.5	3.2	12.7	6.4	8.5	9.0	5.0	14.1	7.5	2.9	10.6	19.9	11.9	6.5	14.1	65.4	17.0	30.5	49.1	8.7	7.0	5.9
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963870-42979220	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease mutation, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 73.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 36.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	13.0	14.9	12.1	11.5	18.9	9.0	11.5	21.7	19.0	14.7	16.9	14.6	15.3	9.8	11.9	8.8	18.2	23.4	13.0	10.4	12.9	12.1	11.3	18.8	7.4	17.6	17.3	9.1	20.0	73.2	21.3	18.2	10.6	16.0	17.8	8.5	10.8	15.0	12.8	15.2	14.2	24.6	10.5	9.9	12.8	10.6	10.6	17.2	22.3	21.5	6.9	10.9	11.2	12.4	4.3	4.3	4.8	3.2	4.0	6.1	2.5	15.9	7.7	3.9	14.5	14.5	14.0	4.0	2.8	4.4	2.3	4.8	4.8	4.7	6.5	3.9	6.7	9.8	15.1	13.5	14.6	2.4	12.6	7.2	2.1	10.9	2.8	9.8	2.2	4.5	17.4	16.9	9.5	2.6	18.8	11.7	8.9	11.3	6.7	5.0	1.8	5.7	7.2	4.8	36.3	6.7	12.3	6.8	2.6	5.9	4.6	12.2	5.3	2.6	10.4	14.7	6.6	20.5	9.8	6.5	7.4	1.4	3.6	6.4	10.1	8.8	8.9	2.5	11.3	5.9	2.1	3.2	4.8	3.0	2.4	5.4	2.6	4.4	6.1	4.3	4.3	5.5	5.1	2.0	4.0	1.5	2.5	2.1	2.5	12.1	18.9	21.7	19.0	12.9	12.1	17.3	9.1	16.0	17.2	6.0	1.6	2.7	8.8	4.4	14.5	4.5	5.1	5.3	3.4	7.0	2.0	7.7	11.6	2.4	2.2	4.0	12.4	0.0	1.3	5.7	6.4	6.2	0.0	10.5	4.9	20.6	5.2	9.8	6.7	2.2	13.6	2.8	8.5	1.0	7.4	10.6	1.7	7.0	8.9	9.8	6.4	0.0	5.2	7.7	2.8	4.8	6.2	4.4	8.0	5.5
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913937	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease mutation, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Distal tubular cells: 51.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.5	17.8	8.1	7.0	8.9	4.0	13.5	7.0	10.7	8.7	8.5	7.9	14.0	6.1	5.5	18.9	9.1	8.9	17.0	14.5	7.2	6.7	16.3	10.0	9.2	4.7	8.9	9.5	6.1	43.6	15.5	10.2	6.7	6.9	11.7	9.2	13.6	15.4	18.9	11.7	12.0	6.6	7.5	9.6	4.7	14.5	19.4	5.4	5.9	11.5	7.5	6.8	6.9	7.0	4.6	5.4	4.3	5.3	2.9	6.9	1.8	4.7	4.6	4.6	6.5	6.0	8.9	2.5	6.6	8.3	7.1	7.5	5.7	5.6	1.7	12.6	7.1	8.6	6.1	3.3	12.3	8.8	4.9	8.0	6.4	4.6	0.8	14.4	8.0	3.7	8.5	13.1	5.1	10.2	8.1	5.3	11.7	11.9	5.1	9.7	11.3	3.5	9.9	4.7	12.6	7.9	4.7	4.7	5.0	15.4	6.4	8.8	12.6	6.1	8.8	8.5	5.4	5.7	10.1	4.0	4.7	2.2	7.3	5.1	7.2	4.7	0.0	3.7	7.3	5.6	0.2	3.0	4.3	2.6	2.5	2.0	4.6	3.4	4.2	5.3	2.9	6.9	4.1	0.5	2.9	5.3	5.4	6.4	1.8	8.1	8.9	7.0	10.7	7.2	6.7	8.9	9.5	6.9	5.4	3.0	6.5	1.5	10.9	10.8	8.2	14.1	5.1	8.1	7.9	10.4	7.9	16.2	51.4	13.6	8.7	5.3	10.7	0.0	19.9	17.5	7.5	13.8	13.9	5.7	10.8	0.0	9.9	6.2	5.4	7.3	8.3	7.2	13.5	15.4	17.9	14.0	15.4	14.0	9.2	27.9	8.5	6.5	9.4	34.9	17.6	15.8	14.3	4.3	17.8	15.3
PGAP2	"CWH43-N, FRAG1, MRT21"	ENSG00000148985	"Post-GPI attachment to proteins 2"	Q9UHJ9	11	3797724-3826371	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"GPI-anchor biosynthesis"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 117.3"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 62.9;Early spermatids: 124.4;Late spermatids: 246.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063099	Approved		Approved	Microtubules		NA	NA			Microtubules		"HPA063099: AB_2684940"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.67e-2)"	4.9	9.5	7.6	7.3	8.2	5.2	6.9	5.0	10.6	7.3	12.3	12.4	18.3	10.2	7.4	117.3	20.0	11.1	8.1	9.3	8.0	6.3	8.6	17.1	9.5	8.6	6.9	8.8	7.1	30.8	12.6	9.1	10.7	5.6	10.1	7.9	12.5	14.5	19.6	6.4	25.0	16.7	4.9	8.9	6.6	7.5	17.7	8.4	15.0	14.1	14.6	15.3	7.7	10.4	11.2	8.7	15.9	8.0	8.7	17.0	7.5	12.5	17.2	8.4	7.6	7.5	14.5	13.3	5.2	4.5	7.8	7.0	14.6	22.2	13.6	6.0	3.8	4.6	21.2	13.3	14.5	7.6	16.5	14.5	8.3	7.5	17.9	5.3	10.5	10.9	11.5	20.4	5.6	19.3	5.0	8.7	18.4	17.5	20.3	8.0	18.8	12.9	9.0	15.7	26.7	10.4	20.2	1.0	13.1	14.6	15.2	11.1	11.0	9.4	25.2	5.6	10.3	20.9	4.6	8.2	4.8	4.6	11.4	3.2	12.7	13.9	10.1	6.3	7.2	9.2	1.9	5.8	5.0	8.8	8.0	10.8	11.0	12.6	10.7	8.7	11.2	17.0	11.3	15.9	8.7	8.0	5.9	11.5	7.5	7.6	8.2	5.0	10.6	8.0	6.3	6.9	8.8	5.6	8.4	11.9	8.8	5.1	11.3	28.2	13.3	11.1	10.2	17.4	6.8	12.2	21.6	62.9	1.7	10.5	124.4	10.0	13.1	0.0	18.5	14.0	7.4	10.2	8.1	11.6	13.9	3.2	2.9	3.7	7.0	246.9	8.1	6.1	5.0	11.8	8.5	7.8	12.8	5.8	6.3	7.8	9.1	6.5	7.6	17.7	19.2	25.0	24.5	6.4	20.8	12.4
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"ductus deferens: 249.6;pancreas: 798.6;stomach 1: 963.7"	"Cell type enhanced"	"Detected in some"	28	"Alveolar cells type 2: 270.0;Cholangiocytes: 150.3;Pancreatic endocrine cells: 843.0"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	7	"monocytes: 1.9"	"Group enriched"	"Detected in some"	11	"Hep G2: 69.6;OE19: 42.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.1	3.0	249.6	41.7	0.1	0.0	3.3	0.3	16.8	0.1	0.1	0.1	0.1	0.3	139.4	0.0	0.1	0.0	0.1	798.6	0.0	0.1	0.0	0.1	2.3	0.0	0.0	0.1	35.9	0.1	0.1	0.1	0.0	0.1	0.1	963.7	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.6	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	1.6	42.3	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	23.8	270.0	0.0	3.1	0.3	0.0	0.2	150.3	5.3	9.1	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	117.5	1.0	0.1	95.4	9.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.6	0.0	0.0	843.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.4	0.0	0.0	2.6
PHAX	"FLJ13193, RNUXA"	ENSG00000164902	"Phosphorylated adaptor for RNA export"	Q9H814	5	126600268-126627252	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059630, HPA070326"	Supported		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"HPA059630: AB_2684088, HPA070326: AB_2686253"	"unprognostic (1.06e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.91e-3)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.07e-2)"	3.9	4.9	7.9	3.2	7.6	1.5	4.2	8.9	8.2	3.7	3.2			2.1	4.9	3.9	4.8	4.2	3.6	5.0	7.2	6.5	3.8	4.0	3.1	5.2	6.9		6.6	3.5	4.6	3.0	3.5		4.5	3.0		3.5	3.2	5.7	5.7	2.3	4.3	6.6	3.2	2.9	2.5			4.6		5.3	3.8	3.0	10.4	8.2	8.8	7.2	13.1	11.2	6.6	9.6	9.7	8.6	16.9	12.6	12.5	12.3	13.8	10.2	11.3	10.7	13.7	9.8	9.7	12.6	17.5	13.9	7.9	12.2	18.9	16.6	15.8	13.3	8.1	11.4	5.5	7.5	6.6	9.0	12.3	10.6	11.2	10.1	10.6	9.6	5.5	6.5	11.4	17.3	8.3	9.3	8.4	11.0	6.5	8.1	7.6	12.2	8.0	10.5	11.4	11.5	13.1	12.2	10.9	14.1	8.8	14.3	9.4	15.0	19.2	10.8	10.6	20.8	8.9	8.4	11.0	13.7	11.2	13.8	8.8	6.3	8.1	9.6	7.2	10.9	10.4	9.5	9.9	6.2	9.5	10.8	11.2	5.3	13.1	7.2	8.2	8.0	6.6											23.8	31.5	43.5	29.2	25.3	57.1	47.0	15.3	76.3	38.7	33.2	37.3	44.7	63.0	45.9	31.1	34.6	15.3	0.0	29.2	41.6	31.9	25.6	45.1	25.4	26.2	71.5	26.4	21.5	16.8	8.7	38.9	26.7	20.3	55.1	22.5	88.5	34.5	22.8	38.9	39.8	65.9	45.3	24.7	51.1	80.1	22.6	43.0	27.7	23.4	25.1
PIEZO1	"FAM38A, KIAA0233"	ENSG00000103335	"Piezo type mechanosensitive ion channel component 1"	Q92508	16	88715338-88785220	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 1: 68.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 68.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047185	Uncertain					NA	NA					"HPA047185: AB_2679973"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (3.51e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (8.89e-7)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.74e-1)"	34.6	7.3	5.7	19.2	9.8	24.2	59.0	5.7	6.5	13.8	25.2	7.4	20.3	7.5	13.6	8.2	16.5	12.4	15.4	7.2	6.7	4.3	15.8	18.1	21.2	14.7	10.3	2.5	9.1	6.9	7.0	2.1	17.8	9.1	15.9	4.9	11.9	15.7	16.7	4.2	15.4	12.9	29.2	8.9	18.6	13.2	3.0	7.5	6.7	10.5	9.9	13.3	17.8	39.3	2.5	9.4	3.1	11.6	0.9	8.5	3.6	10.5	10.8	1.7	8.2	7.4	8.1	41.0	25.8	11.5	9.5	3.7	15.6	17.7	8.7	18.1	12.4	4.7	22.8	3.6	9.3	1.9	8.5	14.5	14.7	18.8	12.3	11.2	6.6	2.4	6.6	5.1	7.4	6.2	5.6	11.5	14.6	19.9	11.2	5.5	68.2	8.1	23.0	3.8	5.0	6.7	19.6	2.4	21.8	4.3	15.6	3.3	0.9	33.7	17.8	4.5	1.8	24.3	19.4	30.9	22.9	13.2	15.3	13.0	2.3	5.1	5.3	18.1	11.9	13.5	1.7	5.1	3.1	8.5	9.3	7.9	2.5	6.1	5.5	9.4	2.5	1.0	2.7	0.1	0.9	11.6	1.7	4.7	3.6	5.7	9.8	5.7	6.5	6.7	4.3	10.3	2.5	9.1	7.5	68.5	20.3	5.2	12.3	16.9	0.8	4.5	15.3	4.0	11.4	55.8	15.7	4.4	0.0	30.6	1.3	34.8	7.4	0.0	18.7	24.2	14.2	35.0	8.1	17.8	20.8	3.2	20.2	47.9	19.0	1.0	5.2	15.0	15.1	10.0	23.0	1.1	57.8	14.8	2.5	3.7	3.3	0.0	8.9	0.4	2.7	13.9	4.2	10.2	8.0	13.9
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11148762	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3"	"Cell type enhanced"	"Detected in some"	10	"Cholangiocytes: 10.2;Ciliated cells: 13.4;Early spermatids: 23.3;Ito cells: 22.1"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.6;BJ hTERT+ SV40 Large T+: 10.7;BJ hTERT+ SV40 Large T+ RasG12V: 14.9;HeLa: 23.8;U-266/70: 15.2;U-698: 9.9"	"Low region specificity"	"Detected in single"							"HPA015986, HPA031974, HPA040616"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043"	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	0.9	0.3	3.1	0.9	2.3	0.0	1.9	0.1	3.6	0.9	3.3			0.0	0.3	1.6	5.8	0.8	5.9	0.0	5.2	2.1	0.9	4.5	7.4	0.5	5.8		0.6	1.7	0.0	0.6	0.0		3.4	1.3		0.0	3.3	0.0	0.8	0.9	1.9	10.3	2.7	1.4	0.9			1.3		0.2	4.6	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	1.2	9.6	0.0	0.0	0.0	0.0	0.5	2.8	10.7	14.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	6.9	0.0	0.3	0.0	23.8	5.6	3.4	0.0	0.0	0.0	0.2	2.7	0.7	0.1	3.3	0.3	0.0	0.2	1.7	0.0	0.1	0.0	3.0	4.1	0.0	0.0	0.0	4.2	0.0	3.3	8.3	0.0	0.1	0.0	0.5	4.5	0.0	2.7	0.0	0.0	3.8	0.2	0.5	15.2	0.1	9.9	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	7.7	0.0	0.4	0.7	0.0	1.4	10.2	13.4	1.2	0.0	0.0	0.0	0.0	0.1	23.3	0.9	0.0	0.0	0.2	0.0	3.1	0.1	4.7	4.5	0.7	0.0	0.0	22.1	4.0	8.6	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.5	0.4	0.0	0.4	0.6	0.3	0.0	0.0	0.0
PIRT		ENSG00000233670	"Phosphoinositide interacting regulator of transient receptor potential channels"	P0C851	17	10822475-10838445	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 7.3;brain: 24.8;intestine: 7.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	40	"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HMC-1: 1.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA042337			Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA042337: AB_10794795"	"unprognostic (2.95e-1)"		"unprognostic (2.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.58e-3)"						"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"		"unprognostic (2.85e-3)"				0.4	7.3	9.9	3.2	14.0	0.3	0.3	5.6	5.2	0.4	6.3	10.8	0.0	2.9	0.4	0.4	0.8	0.9	0.7	0.3	13.1	11.6	0.3	0.3	0.4	0.3	12.5	2.3	0.4	0.3	0.3	0.1	0.3	24.8	0.4	7.5	0.0	0.4	0.4	0.4	0.4	5.2	2.5	19.9	0.3	4.9	0.5	12.8	0.0	0.3	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	14.0	5.6	5.2	13.1	11.6	12.5	2.3	24.8	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PJVK	DFNB59	ENSG00000204311	Pejvakin	Q0ZLH3	2	178451346-178461409	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 35.2"	"Cell type enhanced"	"Detected in some"	17	"Alveolar cells type 1: 6.0;Alveolar cells type 2: 10.8;Club cells: 3.4;Distal tubular cells: 3.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"plasmacytoid DC: 6.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 6.5"	"Cell line enhanced"	"Detected in many"		"SuSa: 11.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042621			Approved	Mitochondria		No	No			Mitochondria		"HPA042621: AB_10797503"	"unprognostic (4.01e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.06e-3)"	2.2	1.4	2.5	1.0	3.5	0.7	4.4	1.3	3.7	2.1	1.5	1.2	3.5	0.7	3.5	7.2	2.2	2.6	2.6	1.0	2.7	2.2	2.1	2.2	1.0	1.3	2.8	4.4	7.0	1.0	1.4	3.9	1.0	2.0	2.3	0.9	2.4	2.1	2.7	2.7	3.5	1.3	1.7	2.7	1.0	0.9	35.2	1.3	1.0	2.3	1.7	1.2	1.6	1.2	1.5	6.5	0.6	0.3	0.4	1.3	0.1	0.4	2.7	3.5	2.8	4.7	5.2	1.8	2.2	2.2	2.0	3.1	1.0	4.5	3.1	2.3	1.3	1.6	1.4	2.5	1.4	1.3	1.0	0.9	1.0	3.7	0.6	4.5	0.8	0.2	4.9	3.4	2.2	4.9	5.8	2.3	6.1	0.5	2.0	2.3	0.4	2.9	1.9	4.2	0.3	1.1	3.9	2.6	1.9	3.1	1.4	2.5	2.1	1.0	0.5	0.8	11.0	1.0	0.9	1.5	2.3	0.9	0.7	0.2	6.4	4.0	1.0	1.1	1.7	0.9	0.0	0.3	0.0	0.3	0.2	0.4	0.8	0.4	0.2	0.1	1.5	1.3	0.7	0.6	0.4	0.0	6.5	0.0	0.1	2.5	3.5	1.3	3.7	2.7	2.2	2.8	4.4	2.0	1.3	6.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.8	0.0	0.9	3.3	1.1	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PKD1	"PBP, Pc-1, TRPP1"	ENSG00000008710	"Polycystin 1, transient receptor potential channel interacting"	P98161	16	2088710-2135898	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.3"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 112.8"	"Low cancer specificity"	"Detected in all"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046448	Approved					NA	NA		120000			"CAB046448: AB_2163360"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (3.38e-5)"	"unprognostic (7.86e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	4.5	4.6	2.6	2.3	3.6	1.5	1.4	45.3	7.9	2.8	5.1			1.8	5.4	0.7	2.6	3.4	1.8	7.1	3.5	4.2	0.7	0.6	2.2	1.3	1.9		6.8	3.3	1.2	11.3	1.7		3.7	0.4		4.3	5.4	18.0	7.8	2.8	3.3	1.5	2.7	2.6	2.2			1.0		0.3	3.1	1.8	0.1	0.1	0.0	0.1	0.0	0.4	0.7	3.0	6.5	3.6	8.2	6.3	6.9	7.1	10.6	4.4	3.1	3.1	5.9	2.3	4.6	6.8	5.4	3.3	7.7	1.0	1.6	1.2	5.4	5.3	2.8	16.7	2.3	12.6	3.9	5.9	6.4	5.3	5.7	3.5	4.3	2.4	4.9	4.1	4.7	2.0	5.0	5.5	11.9	3.3	1.2	5.0	15.7	5.9	6.8	1.6	2.1	15.2	17.0	9.6	6.4	6.6	1.4	5.2	13.4	5.4	9.8	8.0	7.3	7.7	6.9	3.1	5.1	5.5	3.7	6.1	0.0	0.1	0.0	0.4	0.0	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.7											11.9	13.5	4.6	8.8	21.6	62.9	21.4	5.1	18.7	7.9	8.7	39.3	5.1	8.3	4.7	53.2	15.2	8.6	0.0	2.7	2.9	19.8	8.0	8.1	21.3	4.5	112.8	29.3	14.1	7.3	8.2	25.6	7.4	21.9	3.6	11.8	30.3	3.7	2.9	43.2	7.3	34.4	32.3	21.7	11.4	15.3	17.6	2.6	6.9	13.4	5.4
PKD1L1	PRO19563	ENSG00000158683	"Polycystin 1 like 1, transient receptor potential channel interacting"	Q8TDX9	7	47774652-47948491	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lung: 13.4;tongue: 16.7"	"Cell type enhanced"	"Detected in some"	21	"Bipolar cells: 3.1;Early spermatids: 11.4;Ito cells: 2.5;Late spermatids: 2.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"T-47d: 6.5;U-266/70: 17.1;U-266/84: 6.1"	"Not detected"	"Not detected"							"HPA020422, HPA022424"	Uncertain					NA	NA					"HPA020422: AB_1855434, HPA022424: AB_1855435"	"unprognostic (5.47e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-1)"	5.4	0.2	1.0	2.3	1.8	0.2	1.6	1.3	1.1	1.2	0.8	0.7	0.1	2.0	2.5	1.6	0.9	0.6	1.0	7.4	0.8	1.5	0.5	1.1	13.4	1.2	0.9	0.1	0.6	0.3	0.1	1.2	2.0	1.0	0.3	0.9	10.0	2.6	0.1	6.4	0.7	0.7	1.7	1.0	0.8	0.4	3.8	0.1	0.9	1.2	16.7	1.4	2.2	1.4	0.0	0.2	0.0	0.8	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.4	0.2	0.0	0.1	0.3	0.1	6.5	0.0	0.0	0.0	0.9	0.0	0.0	17.1	6.1	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.8	1.3	1.1	0.8	1.5	0.9	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.1	3.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	1.0	1.6	0.0	2.5	0.0	2.5	0.3	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.0	0.0
PKD1L3		ENSG00000277481	"Polycystin 1 like 3, transient receptor potential channel interacting"	Q7Z443	16	71929538-71999978	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 2.9;smooth muscle: 2.9;testis: 2.1"	"Cell type enhanced"	"Detected in single"	18	"Cardiomyocytes: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.90e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-6)"	"unprognostic (6.71e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.93e-3)"	0.6	0.5	0.1	2.9	0.1	0.3	0.1	0.1	0.1	0.1	1.0	0.1	0.1	0.7	0.1	0.1	0.1	0.5	0.1	0.2	0.1		0.1	1.2	0.2	0.3	0.1	0.1	0.1	0.1	0.0	0.1	0.8	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	1.9	2.9	0.1	0.4	0.2	2.1	0.1	0.1	0.1	0.1	0.1	1.2	0.1	0.7	0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.6	0.2	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.4	0.0	0.5	0.0	0.8	0.0	0.3	0.4	0.0	0.0	0.9	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.2	0.6	0.0	0.0	0.1	0.0											0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007668-88077777	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 66.3;Peritubular cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 36.9;BJ hTERT+: 56.1;fHDF/TERT166: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB004544: AB_672377, HPA015794: AB_1855437"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	18.4	13.6	8.2	7.7	10.9	5.0	15.1	15.1	10.7	31.4	19.4	15.5	18.5	5.6	42.7	9.8	13.9	25.7	15.3	12.8	9.0	5.2	27.5	7.9	13.4	5.5	12.6	6.4	27.0	9.8	21.9	8.1	12.8	9.2	15.6	7.3	14.1	7.4	22.3	5.4	6.2	9.6	29.3	7.2	5.4	14.8	9.9	12.0	5.5	10.2	3.3	4.9	13.9	21.4	0.5	1.3	4.8	0.8	1.0	1.4	0.4	1.9	10.9	12.3	6.3	28.6	19.1	3.6	36.9	56.1	17.3	17.3	0.5	3.4	1.0	8.1	44.4	6.6	2.4	2.2	5.5	15.2	5.5	1.9	1.7	5.6	1.1	15.9	4.2	3.5	15.8	2.5	13.5	7.3	23.7	7.8	2.0	0.2	2.9	15.0	3.7	2.9	2.0	6.4	1.4	1.8	5.6	7.3	1.5	15.4	4.6	2.5	5.5	6.8	0.3	8.7	13.0	2.6	3.2	12.0	16.4	3.6	4.6	4.9	2.4	0.7	1.2	9.7	0.6	15.0	4.8	0.5	0.9	0.8	0.8	1.4	0.5	0.8	0.6	0.3	0.5	0.9	0.6	0.9	1.0	0.3	1.3	0.4	0.4	8.2	10.9	15.1	10.7	9.0	5.2	12.6	6.4	9.2	12.0	3.0	4.6	1.4	4.2	6.5	14.6	6.3	20.4	16.0	10.3	66.3	9.8	8.7	0.0	10.3	0.3	11.2	0.7	0.0	3.3	3.5	23.9	4.3	1.1	6.8	10.3	25.4	6.4	20.9	4.9	0.7	21.3	8.3	21.9	9.0	2.7	20.1	3.0	5.7	47.7	14.7	1.5	25.8	20.6	0.7	0.9	5.8	2.3	0.7	2.6	2.5
PKD2L1	"PCL, PKD2L, PKDL, TRPP3"	ENSG00000107593	"Polycystin 2 like 1, transient receptor potential cation channel"	Q9P0L9	10	100288154-100330486	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.2;lymphoid tissue: 12.0"	"Cell type enhanced"	"Detected in some"	26	"Early spermatids: 15.0;Hofbauer cells: 12.4;Horizontal cells: 57.2;Late spermatids: 15.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 3.0;non-classical monocyte: 2.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.6;NB-4: 1.8;PC-3: 2.0;RT4: 1.1;SK-MEL-30: 1.6;U-266/70: 1.0;U-266/84: 2.8;U-937: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB022621	Uncertain					NA	NA					"CAB022621: "	"unprognostic (2.67e-1)"	"unprognostic (3.66e-7)"	"unprognostic (8.07e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.49e-4)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	0.3	0.3	0.4	0.6	3.7	1.3	1.4	0.1	6.2	0.1	1.5	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	2.0	0.3	0.5	2.7	4.0	2.3	0.5	4.0	0.2	0.2	0.0	0.2	0.7	1.3	0.4	2.2	1.0	0.3	0.0	0.1	0.1	0.8	0.0	1.5	12.0	0.1	2.3	0.0	0.3	0.1	0.0	2.9	0.4	0.1	0.2	0.3	0.6	3.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	1.6	0.0	0.0	0.0	1.8	0.0	1.0	2.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	0.0	0.0	1.4	0.0	0.0	2.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.6	0.0	2.3	0.0	0.0	0.4	0.4	3.7	0.1	6.2	2.0	0.3	0.5	4.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	12.4	57.2	0.0	0.6	6.6	15.9	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548298-118560730	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"heart muscle: 337.5"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 2230.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.3;naive CD4 T-cell: 1.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.3;Karpas-707: 1.6;NB-4: 1.8;SuSa: 1.7;U-2197: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB005597, HPA026900"	Enhanced					NA	NA					"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (5.59e-4)"	9.0	1.8	0.4	2.7	0.5	0.0	5.4	0.4	0.6	22.3	22.2	0.0	9.8	2.0	21.1	22.3	27.3	11.6	29.8	337.5	0.4	0.5	6.4	0.4	5.3	0.8	0.7	1.4	18.6	0.5	0.1	0.4	0.1	1.4	14.4	3.9	0.0	1.6	6.0	68.4	1.5	14.0	30.8	1.2	0.6	6.5	12.3	0.0	0.0	2.8	23.7	0.8	32.2	6.6	0.3	0.0	1.3	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.2	0.0	0.0	0.3	0.6	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.0	0.3	0.5	0.2	0.1	0.0	0.2	0.2	1.6	0.1	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.7	0.2	0.8	0.4	0.1	0.0	1.7	0.4	0.0	0.5	0.3	0.2	1.3	0.3	0.2	0.3	0.4	0.0	1.0	0.1	0.0	0.4	1.3	0.1	0.0	0.3	0.1	0.4	0.0	0.0	0.3	1.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.4	0.6	0.4	0.5	0.7	1.4	1.4	0.0	0.0	0.0	0.0	0.0	3.8	1.6	2230.5	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	71.2	0.4	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.7	0.9	0.3	3.3	0.0	0.0	0.0	0.1	0.0	11.0	0.0	0.2	271.7	280.1	1.1	0.4	1.4	0.0	0.0	0.0	0.4
PLP2	"A4, A4-LSB, MGC126187"	ENSG00000102007	"Proteolipid protein 2"	Q04941	X	49171926-49175239	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA042415	Approved					NA	NA		710000			"HPA042415: AB_10796907"	"unprognostic (1.40e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.58e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.55e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	32.2	39.3	2.6	24.8	3.5	61.7	29.1	4.4	2.9	64.3	40.1	5.9	20.7	13.4	50.7	31.0	123.4	22.2	24.4	26.7	3.0	4.1	30.8	33.0	42.5	40.3	4.9	3.1	44.8	116.5	5.8	28.3	22.8	8.1	46.7	25.7	13.1	24.2	25.1	46.2	74.9	36.4	65.9	6.8	26.3	23.5	17.8	3.2	34.9	12.6	121.1	93.8	59.2	48.5	34.6	102.5	55.6	40.5	9.7	37.3	27.1	69.0	43.4	0.0	0.1	18.1	54.0	0.4	37.3	29.7	45.9	34.8	16.0	32.9	25.3	9.2	27.3	46.0	58.7	34.6	68.6	29.1	63.7	14.0	9.3	62.9	0.4	29.0	17.4	41.7	24.1	68.0	59.6	70.1	43.0	34.7	8.4	7.1	32.1	33.0	45.6	1.9	44.5	0.4	34.1	61.2	6.3	40.4	72.1	61.5	50.0	9.4	16.3	52.1	20.7	31.6	0.6	45.4	10.0	38.9	26.4	25.4	46.2	61.0	13.8	12.7	6.6	62.6	46.8	61.3	55.6	40.5	20.9	9.3	14.7	15.8	34.6	33.4	17.5	43.6	21.1	17.2	14.4	47.8	9.7	9.0	102.5	37.3	27.1	2.6	3.5	4.4	2.9	3.0	4.1	4.9	3.1	8.1	3.2	68.5	33.9	132.7	253.0	390.6	0.2	24.6	48.4	75.0	60.3	76.8	0.0	2.3	18.3	339.7	12.6	40.9	116.8	0.0	439.0	21.4	160.3	68.4	86.6	6.8	151.3	0.0	107.1	41.7	184.6	13.5	157.3	170.4	212.6	50.5	174.7	15.2	432.9	168.9	57.3	4.3	1.1	122.9	178.8	1.4	1.1	441.3	5.4	137.1	292.0	292.5
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544864	"Predicted intracellular proteins, Transporters"	"Antiviral defense"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 55.1;BJ hTERT+ SV40 Large T+ RasG12V: 73.3;HHSteC: 50.5;SK-MEL-30: 91.2"									"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	Yes			"Nucleoplasm, Golgi apparatus, Plasma membrane"		"CAB070421: AB_11153452, HPA068923: AB_2686059"	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.9	14.9	11.9	39.7	21.4	27.0	31.1	5.7	19.0	20.9	29.6	7.2	22.1	18.4	19.6	25.7	25.4	19.5	30.8	22.7	16.1	12.7	32.0	36.5	33.8	38.6	17.6	4.9	40.0	26.1	10.3	18.4	25.7	22.1	25.0	28.0	12.6	32.3	34.2	16.4	9.9	24.6	19.4	29.8	46.0	20.5	15.4	14.8	16.4	27.5	14.9	19.5	27.5	48.0	6.5	27.5	26.2	41.2	14.3	8.1	17.6	17.2	6.9	4.4	2.0	6.6	11.2	6.8	5.4	14.8	55.1	73.3	5.5	14.4	1.3	12.9	3.4	43.1	14.2	3.5	5.1	9.3	5.3	3.5	11.1	2.2	4.1	50.5	6.3	5.8	17.8	8.7	6.1	31.1	8.8	8.0	3.2	7.1	17.2	11.2	6.7	4.9	2.4	4.2	11.7	6.2	4.4	4.9	0.4	15.5	4.7	2.7	0.0	6.9	3.4	91.2	6.3	3.4	7.7	4.8	4.4	3.8	9.9	9.0	13.2	2.4	0.0	4.5	4.6	3.8	8.2	41.2	11.0	5.6	40.4	8.1	6.5	3.7	5.0	27.5	4.9	2.6	3.8	26.2	14.3	22.7	7.3	2.1	17.6	11.9	21.4	5.7	19.0	16.1	12.7	17.6	4.9	22.1	14.8	32.8	47.9	22.6	70.0	32.7	0.4	4.0	86.6	81.7	60.3	90.7	0.0	46.8	63.0	225.1	1.5	110.1	67.7	0.0	192.6	100.1	54.5	74.2	26.7	25.9	121.5	0.0	31.9	91.4	84.8	2.2	106.4	157.8	45.5	24.4	60.9	52.6	150.7	102.1	43.2	33.8	1.3	38.8	58.7	0.3	2.2	25.0	37.2	21.3	51.4	160.1
PLSCR2		ENSG00000163746	"Phospholipid scramblase 2"	Q9NRY7	3	146391421-146495991	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 8.1;testis: 16.8"	"Group enriched"	"Detected in some"	25	"Early spermatids: 161.5;Late spermatids: 194.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.9;EFO-21: 2.3;GAMG: 3.7;Karpas-707: 2.5;U-266/70: 2.1"									HPA051352			Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA051352: "	"unprognostic (1.11e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.94e-3)"	"unprognostic (7.53e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.23e-2)"	0.3	0.3	0.3	1.7	0.3	1.3	0.4	1.0	0.4	0.4	1.5	0.0	1.3	0.2	0.3	8.1	0.6	0.9	1.4	0.3	1.1	0.3	1.4	0.3	1.0	1.8	0.3	0.4	1.0	1.2	0.3	3.2	0.5	1.6	0.4	0.5	0.6	1.4	3.0	0.3	0.3	0.4	0.2	0.8	0.3	0.5	16.8	0.0	0.1	2.5	0.7	0.1	0.3	2.2	0.6	0.5	1.7	1.1	1.3	1.6	0.6	0.0	0.3	0.0	0.0	0.0	1.4	0.2	0.0	0.4	0.6	0.8	0.2	1.9	0.0	2.3	0.0	3.7	0.2	0.3	0.0	0.4	0.1	0.4	0.6	0.8	0.2	0.8	0.0	0.7	0.5	0.5	0.2	0.9	0.6	0.0	0.2	0.3	2.5	0.1	0.0	0.0	0.0	0.5	0.0	1.5	0.2	0.0	0.0	1.5	0.0	0.6	0.0	0.1	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.4	0.6	0.6	1.3	0.6	0.9	1.4	0.5	0.3	1.4	1.6	1.7	1.3	0.0	0.4	0.0	0.6	0.3	0.3	1.0	0.4	1.1	0.3	0.3	0.4	1.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	2.5	1.4	0.0	7.0	0.0	0.1	1.7	0.8	161.5	0.0	0.0	0.0	0.5	0.1	0.3	0.3	0.0	0.0	0.1	0.0	1.7	0.6	0.0	194.1	1.7	0.3	0.0	0.0	0.0	1.0	0.7	0.0	1.4	1.1	0.3	0.0	0.1	4.8	2.3	0.1	0.0	0.0	0.6	0.1
PLSCR3		ENSG00000187838	"Phospholipid scramblase 3"	Q9NRY6	17	7389727-7394843	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	12	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.0;Ductal cells: 5.1;Exocrine glandular cells: 3.2;monocytes: 3.6;Pancreatic endocrine cells: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048387, HPA068609"	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA048387: AB_2680381, HPA068609: AB_2686011"	"unprognostic (1.86e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.11e-5)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.55e-2)"	21.9	11.5	6.2	17.8	6.1	5.2	31.0	4.4	7.9	24.0	12.7	7.4	16.3	5.6	29.2	22.0	21.6	15.6	17.7	25.3	5.6	5.7	15.3	12.9	25.0	67.2	5.8	7.6	19.9	10.0	10.1	9.0	17.3	8.4	15.4	6.3	10.2	12.5	17.8	16.1	17.8	10.5	21.4	13.1	29.0	11.6	8.6	6.4	12.1	12.2	26.0	21.0	21.5	20.1	12.9	9.5	1.9	13.3	6.6	30.8	12.1	14.3	3.2	2.7	8.4	10.4	18.3	3.7	13.0	12.0	11.1	10.5	4.9	3.3	3.6	10.7	18.8	4.8	19.6	3.5	21.3	5.7	9.8	1.9	3.4	4.4	3.4	14.0	1.2	4.5	13.2	14.5	11.2	16.8	17.8	17.3	7.7	2.0	2.8	14.5	7.3	3.8	1.0	2.5	4.0	9.2	7.9	2.3	3.8	10.5	9.3	2.4	8.1	6.6	4.8	3.1	2.7	8.3	0.6	28.0	7.7	7.8	8.8	5.4	3.2	3.6	1.4	12.0	4.3	8.9	1.9	10.0	1.1	16.8	13.3	17.1	12.9	30.5	17.1	9.5	12.0	25.2	15.0	1.0	6.6	10.9	1.1	30.8	12.1	6.2	6.1	4.4	7.9	5.6	5.7	5.8	7.6	8.4	6.4	3.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.1	0.0	0.0	0.0	0.0	3.2	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
PLSCR4		ENSG00000114698	"Phospholipid scramblase 4"	Q9NRQ2	3	146192339-146251179	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Endothelial cells: 48.7;Fibroblasts: 48.9;Ito cells: 88.4;Muller glia cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 24.5;ASC TERT1: 19.3;hTERT-RPE1: 24.1;HUVEC TERT2: 19.8;TIME: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002276	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Nucleoplasm, Nuclear bodies"		"HPA002276: AB_1855479"	"unprognostic (3.73e-3)"	"unprognostic (4.03e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.97e-3)"	40.5	29.6	19.4	5.9	20.4	1.7	53.3	19.1	23.4	25.1	17.7	14.8	10.8	4.6	21.9	13.9	15.8	28.0	29.4	20.3	23.1	13.8	16.9	43.4	24.2	16.7	13.7	14.6	25.2	13.0	3.8	11.7	35.9	21.8	17.9	16.9	15.9	14.8	18.2	8.7	11.1	9.3	25.0	28.7	18.4	11.0	16.8	16.6	0.9	25.1	8.9	4.5	23.3	28.7	0.0	0.2	0.0	0.2	1.3	0.0	0.5	0.0	3.6	0.6	0.0	24.5	19.3	0.1	4.3	5.9	1.9	4.3	0.4	4.8	0.0	4.8	8.1	1.9	0.5	0.9	0.4	1.1	0.0	0.0	1.9	2.9	0.4	11.2	0.0	0.5	11.7	0.6	4.0	1.2	24.1	19.8	0.0	0.0	0.3	2.9	0.1	0.0	0.0	0.8	1.9	1.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	7.4	0.0	1.4	1.0	0.3	0.2	40.8	4.1	1.0	9.1	0.8	0.1	0.0	0.0	1.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.5	19.4	20.4	19.1	23.4	23.1	13.8	13.7	14.6	21.8	16.6	3.0	10.1	0.0	4.4	9.6	0.3	3.2	17.8	6.7	10.3	3.5	0.0	0.7	0.0	5.0	0.9	48.7	9.1	23.3	10.2	0.2	48.9	3.1	1.1	39.0	0.7	0.0	9.9	88.4	8.6	1.3	39.7	2.5	3.3	0.0	13.5	48.4	5.7	8.6	30.4	16.5	1.3	0.0	25.0	0.7	0.4	7.5	0.7	1.0	6.6	2.2
PLTP	BPIFE	ENSG00000100979	"Phospholipid transfer protein"	P55058	20	45898621-45912155	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 1270.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 19.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 44.9;BEWO: 38.7;HHSteC: 47.5;HSkMC: 61.9;U-87 MG: 65.7"	"Low region specificity"	"Detected in all"							CAB032873	Approved				"Secreted to blood"	NA	NA	9720000000	200000000			"CAB032873: AB_2283977"	"unprognostic (1.27e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (9.52e-8)"	"unprognostic (3.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.68e-2)"	126.5	44.6	20.2	21.8	20.1	5.4	27.0	10.3	21.1	41.5	35.4	30.9	6.9	11.8	28.0	74.6	23.9	41.5	49.9	37.8	18.1	15.9	32.2	13.9	22.6	96.5	15.1	12.2	38.6	83.6	7.4	9.0	117.5	19.5	28.7	12.5	36.4	36.8	22.5	19.8	17.7	14.4	50.1	11.1	25.7	18.7	30.9	11.5	74.7	13.7	11.4	9.5	40.5	26.7	4.7	10.4	19.6	6.7	2.5	1.0	1.6	2.6	0.3	18.6	0.0	44.9	13.7	38.7	1.0	3.2	3.7	2.2	15.2	3.0	0.6	31.2	4.5	0.0	30.7	5.7	0.1	1.7	0.3	0.0	5.5	0.6	7.0	47.5	0.0	6.9	61.9	1.5	9.6	0.1	14.7	8.1	0.6	1.7	8.7	1.2	0.7	0.5	22.9	3.3	2.3	15.2	0.2	0.0	0.3	0.0	0.0	2.0	7.0	0.7	21.6	31.1	3.2	0.2	21.6	1.7	9.2	0.2	4.7	0.1	3.8	0.9	0.9	65.7	6.3	1.5	19.6	1.6	16.1	1.0	3.8	0.8	4.7	0.2	1.0	1.4	2.1	0.0	0.6	0.7	2.5	6.7	10.4	0.4	1.6	20.2	20.1	10.3	18.2	18.1	15.9	15.1	12.2	19.5	11.5	0.0	2.9	0.0	24.8	36.1	0.4	0.8	5.1	41.5	7.9	26.2	0.0	13.0	1.7	2.5	12.9	11.7	0.0	0.0	90.6	73.4	153.4	2.1	0.0	1.9	1270.7	3.2	0.0	117.9	171.6	15.0	285.1	24.8	33.7	6.4	0.8	12.7	13.7	0.0	187.0	8.2	0.5	32.3	27.1	4.9	6.6	31.2	26.5	4.3	0.6	11.3
PMP22	"GAS3, HNPP, Sp110"	ENSG00000109099	"Peripheral myelin protein 22"	Q01453	17	15229777-15265357	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes, Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Fibroblasts: 386.3;Hofbauer cells: 428.7;Leydig cells: 300.3;Melanocytes: 325.6;Peritubular cells: 231.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 14.1;eosinophil: 22.9;plasmacytoid DC: 12.8"	"Group enriched"	"Detected in many"	20	"dendritic cells: 12.8;granulocytes: 22.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 67.7;HMC-1: 53.5;SuSa: 64.1;WM-115: 81.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.33e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.83e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.08e-2)"	66.8	20.9	27.1	22.4	31.4	2.4	43.5	5.7	34.2	69.1	46.0	96.5	11.7	16.7	43.7	28.4	31.3	37.9	40.8	47.5	33.0	17.9	9.0	5.3	47.7	14.0	72.6	22.7	34.9	8.3	3.5	6.7	77.5	42.9	28.0	32.4	39.4	19.2	35.0	91.3	27.0	95.2	48.6	63.9	10.0	25.1	16.5	44.9	1.6	26.4	25.8	8.6	51.6	39.0	0.0	12.8	22.9	0.9	0.0	0.0	0.4	1.3	8.0	11.3	12.2	67.7	28.6	2.5	11.5	11.8	10.2	7.2	8.3	0.2	0.0	1.4	31.1	4.1	0.1	13.4	0.1	3.2	0.0	2.9	0.6	15.6	2.9	36.3	0.0	53.5	24.8	0.2	6.2	0.3	13.1	11.5	0.7	4.3	0.2	6.3	0.9	0.1	0.4	0.7	0.7	12.2	3.7	7.3	0.0	10.6	0.8	0.0	7.2	3.0	0.0	28.8	64.1	0.0	0.1	14.2	2.7	9.2	39.8	11.1	0.0	0.0	0.0	15.1	0.0	81.6	14.1	0.9	22.9	0.0	0.5	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.0	0.4	27.1	31.4	5.7	33.4	33.0	17.9	72.6	22.7	42.9	44.9	26.8	17.3	0.0	7.0	80.0	1.3	61.8	2.5	5.3	12.5	0.0	0.0	7.8	3.3	3.3	9.8	106.8	13.8	0.0	3.0	21.5	386.3	3.8	115.6	0.8	428.7	0.0	4.6	67.5	17.7	6.2	300.3	63.3	325.6	19.8	11.0	57.5	1.6	5.8	231.6	0.8	1.1	226.4	152.7	2.8	4.1	90.1	15.9	1.0	6.6	1.8
PNN	memA	ENSG00000100941	"Pinin, desmosome associated protein"	Q9H307	14	39175183-39183218	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001378	Supported		Supported	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA001378: AB_1079648"	"unprognostic (9.28e-3)"	"unprognostic (5.07e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.38e-3)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.30e-2)"	21.7	25.3	38.9	38.4	50.8	57.5	26.1	54.3	39.3	31.0	30.0	26.4	34.6	27.9	40.4	66.6	29.5	29.6	21.6	19.1	40.1	18.4	27.3	45.7	24.2	40.7	43.9	31.2	36.6	31.3	31.3	61.3	26.7	44.8	33.9	32.0	18.7	26.7	24.5	37.7	27.0	36.0	34.7	49.1	42.6	26.9	21.7	50.4	32.7	37.1	25.9	32.8	28.4	39.9	20.8	15.8	20.4	10.5	10.6	13.5	3.9	32.7	15.7	42.9	21.1	10.0	8.8	31.6	26.2	7.3	18.1	17.4	25.0	51.5	50.6	16.7	11.4	14.3	34.5	32.5	17.8	31.4	22.8	23.1	33.6	47.4	55.1	8.3	43.5	24.6	12.0	15.6	16.4	13.7	24.9	11.5	23.7	31.8	28.5	14.8	26.9	30.7	37.2	28.5	15.5	23.1	40.8	32.1	13.6	14.8	50.0	21.4	12.0	27.0	20.7	15.1	30.6	25.5	25.1	21.2	26.4	20.9	12.2	30.7	23.4	18.6	43.6	13.2	36.1	15.6	5.1	10.2	15.1	13.2	8.0	12.2	14.8	9.0	8.0	8.3	20.8	13.5	12.3	20.4	10.6	10.5	15.8	9.7	3.9	38.9	50.8	54.3	39.3	40.1	18.4	43.9	31.2	44.8	50.4	178.6	96.5	96.3	183.3	112.1	191.9	51.8	48.4	160.6	229.7	57.6	53.0	93.2	29.9	72.1	36.1	84.5	90.7	23.3	50.2	81.5	78.0	127.1	138.6	57.2	54.3	144.6	130.6	65.1	58.9	40.6	144.7	95.9	47.2	56.9	56.4	137.8	66.8	81.6	142.5	18.8	174.1	148.8	92.4	180.7	144.8	97.9	83.3	132.0	84.8	194.6
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Cone photoreceptor cells: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	19.4	15.2	14.5	16.0	17.7	35.0	14.4	25.9	22.0	13.1	16.6	16.0	14.2	19.5	17.9	14.8	15.8	15.8	14.9	11.8	11.7	10.0	14.0	16.6	13.3	18.7	10.8	12.7	18.6	23.3	14.9	20.6	15.4	13.4	18.6	11.4	20.2	17.4	11.7	18.4	17.0	19.1	12.1	12.7	19.0	16.3	17.3	13.5	24.5	19.5	15.2	22.3	15.8	14.5	3.7	4.3	3.7	3.6	4.5	5.2	2.6	17.1	12.6	15.7	35.3	8.5	7.0	13.1	12.3	10.5	12.3	10.7	22.2	10.9	23.7	4.0	10.6	13.7	13.2	15.6	11.9	13.8	20.5	31.1	17.7	12.6	14.7	8.7	36.6	22.6	9.2	8.5	16.3	15.0	8.0	9.1	13.8	48.4	17.8	12.0	13.2	21.8	23.3	16.5	9.6	15.3	20.0	12.3	20.0	6.2	15.1	22.5	19.8	10.8	20.8	11.0	11.0	17.3	19.3	12.8	22.1	13.6	17.4	24.6	21.4	19.8	34.4	12.9	23.5	21.8	0.1	2.3	3.7	5.2	1.4	3.0	3.0	3.3	3.8	2.6	3.7	3.0	4.3	2.6	4.5	3.6	4.3	1.7	2.6	14.5	17.7	25.9	22.0	11.7	10.0	10.8	12.7	13.4	13.5	35.7	28.2	12.7	8.8	22.3	31.1	4.4	25.5	17.4	20.5	17.4	92.3	14.5	5.0	10.8	6.8	14.2	16.9	23.3	14.7	10.9	16.5	15.7	16.1	20.3	13.8	38.1	17.2	17.8	15.8	4.2	13.8	18.3	18.6	7.2	19.6	18.3	17.2	10.5	16.6	5.4	23.8	12.9	15.9	14.2	11.8	27.0	16.2	18.1	19.0	18.4
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324707	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"liver: 144.1"	"Cell type enriched"	"Detected in some"	47	"Hepatocytes: 399.2"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;HeLa: 1.0;RH-30: 1.0;U-266/70: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	24000000000			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	1.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	144.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.0	1.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.6	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.4	0.0	0.2	0.0	1.0	0.0	0.0	0.3	0.6	0.1	0.0	0.3	0.0	0.2	0.4	0.0	0.5	0.0	0.1	0.0	0.2	1.0	0.3	0.0	0.0	0.2	0.3	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.0	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.6	0.0	399.2	0.0	0.0	2.9	8.0	8.6	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0
PORCN	"DHOF, MG61, por, PORC, PPN"	ENSG00000102312	"Porcupine O-acyltransferase"	Q9H237	X	48508962-48520814	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Acyltransferase, Transferase"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Pancreatic endocrine cells: 22.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.3;LHCN-M2: 21.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049215, HPA058413"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA049215: , HPA058413: AB_2683711"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.35e-1)"	4.6	31.4	9.1	4.4	14.1	3.6	4.4	20.0	15.4	12.6	4.6	7.2	12.2	3.4	10.1	3.2	13.9	7.0	6.2	13.4	10.9	9.2	3.3	1.7	5.0	6.6	7.1	8.8	4.9	4.6	6.9	4.1	4.0	8.4	5.0	2.5	7.6	5.8	16.4	5.9	6.8	2.9	6.3	5.5	4.8	5.4	5.4	5.9	2.6	8.5	4.7	5.9	6.5	5.4	4.1	7.2	13.7	5.8	7.8	12.0	4.7	4.4	5.3	1.3	9.3	5.7	3.4	0.5	1.3	2.7	2.0	1.4	0.6	6.8	0.3	5.6	2.8	2.3	6.0	1.9	61.3	0.6	2.8	0.6	0.7	3.2	1.3	8.5	0.7	8.0	4.4	7.2	5.9	12.8	4.8	1.8	2.2	0.3	4.2	21.3	1.2	0.7	0.9	1.7	1.3	3.6	1.3	1.6	6.9	3.4	1.7	1.5	2.3	10.7	2.0	2.0	0.9	2.3	0.3	1.1	5.3	2.8	12.8	2.3	3.7	2.0	0.5	15.3	1.6	3.0	13.7	5.8	7.1	12.0	5.2	9.4	3.7	8.0	10.0	7.2	4.1	5.4	8.1	1.2	7.8	4.2	3.9	5.2	4.7	9.1	14.1	20.0	14.4	10.9	9.2	7.1	8.8	8.4	5.9	6.0	3.2	3.0	4.4	3.5	12.7	2.7	2.5	4.0	4.5	15.7	17.7	0.0	1.7	5.2	0.2	3.5	0.0	0.0	8.6	1.1	4.1	2.3	5.7	1.0	3.1	7.9	5.8	4.9	2.8	0.0	5.2	2.9	3.3	2.8	2.0	9.3	22.6	1.5	3.9	0.7	15.7	6.5	4.7	1.0	3.4	3.3	6.9	6.5	1.2	5.6
PQLC2	FLJ20320	ENSG00000040487	"PQ loop repeat containing 2"	Q6ZP29	1	19312326-19329300	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Hofbauer cells: 31.3;Syncytiotrophoblasts: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057810	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA057810: AB_2683535"	"unprognostic (7.84e-3)"	"unprognostic (6.56e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (3.77e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (2.61e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.46e-2)"	10.9	19.9	11.7	8.5	12.3	18.4	9.4	28.8	16.2	12.2	13.1	16.8	8.6	16.9	11.5	15.5	9.2	8.8	11.1	9.3	10.6	11.2	11.9	20.3	12.1	11.1	14.3	9.1	10.9	19.4	10.0	19.4	24.8	14.4	11.7	7.7	18.9	12.1	11.0	10.9	15.3	16.2	9.3	12.2	12.2	13.3	13.8	10.9	6.2	14.0	9.2	10.5	8.0	9.0	5.1	16.7	7.8	10.1	2.9	3.4	3.5	8.1	8.6	8.1	12.9	7.9	7.5	10.3	10.3	14.2	14.4	12.3	12.5	10.4	2.6	13.5	7.5	20.1	6.2	7.9	9.2	6.5	5.5	9.6	2.0	7.4	13.4	22.7	1.7	3.6	12.3	9.7	20.4	6.5	8.1	5.5	4.7	14.7	6.1	13.8	7.3	1.1	5.7	7.8	2.9	7.7	4.5	10.2	4.6	10.9	5.4	10.0	8.4	7.7	5.2	19.7	7.6	8.8	20.3	7.3	12.1	7.0	20.4	9.1	10.7	7.4	1.4	14.8	10.2	9.8	0.9	8.7	7.8	3.2	7.1	2.4	5.1	3.4	2.7	11.1	5.0	1.0	2.1	5.4	2.9	10.1	16.7	3.1	3.5	11.7	12.3	28.8	16.2	10.6	11.2	14.3	9.1	14.4	10.9	3.0	6.5	6.0	2.9	1.6	11.6	2.2	5.1	2.7	5.7	5.2	5.9	23.5	5.0	14.8	0.4	3.7	9.1	0.0	10.2	15.3	6.1	4.3	3.5	9.8	31.3	6.4	9.9	1.8	6.9	2.3	5.8	7.5	3.3	9.0	5.9	9.8	13.8	5.8	3.2	4.3	8.6	0.0	3.6	7.2	4.1	2.6	50.6	4.3	6.6	2.0
PRAF2	"JM4, Yip6a"	ENSG00000243279	"PRA1 domain family member 2"	O60831	X	49071156-49074071	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 125.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA002859, HPA005504, CAB011655"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum"	Vesicles	"CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340"	"unprognostic (1.50e-1)"	"prognostic favorable (7.42e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.67e-1)"	"prognostic unfavorable (1.66e-6)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"prognostic favorable (4.88e-6)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (5.83e-6)"	"unprognostic (4.96e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	13.5	17.5	25.0	12.3	26.9	6.7	9.0	18.0	39.7	28.1	11.8	26.3	12.6	6.0	22.1	125.1	7.3	15.6	12.3	12.9	25.3	29.9	12.4	6.9	11.5	11.3	26.1	18.9	20.1	6.2	19.7	31.0	9.8	25.5	12.2	10.0	13.0	7.5	29.4	6.8	7.6	6.6	33.2	23.1	10.9	9.2	17.7	17.0	14.4	13.3	3.8	11.9	12.6	10.7	14.6	6.7	16.4	6.4	16.8	29.4	11.1	4.5	9.6	11.3	14.4	40.6	24.7	1.5	16.4	17.1	11.1	12.3	0.5	1.5	0.4	3.9	35.4	9.2	4.3	0.4	8.9	12.4	8.4	12.8	3.6	12.5	0.4	41.6	2.3	7.1	31.3	7.6	21.1	15.4	23.0	17.0	11.5	0.5	1.3	19.4	8.4	15.1	2.9	6.3	2.2	0.6	8.3	6.2	1.0	16.5	1.3	7.5	18.8	13.7	7.1	9.3	10.3	6.9	1.6	10.3	8.6	11.4	18.4	4.7	20.4	5.1	3.7	20.7	4.2	13.3	16.4	5.9	7.9	18.3	6.4	20.7	14.6	20.1	16.1	6.7	13.6	18.1	19.4	15.4	16.8	4.8	2.6	29.4	11.1	25.0	26.9	18.0	39.7	25.3	29.9	26.1	18.9	25.5	17.0	11.9	7.7	10.0	12.1	6.8	21.7	5.1	12.7	10.7	9.1	10.4	11.8	2.9	10.0	14.9	2.9	30.3	1.3	0.0	5.0	10.4	36.2	8.7	16.1	2.5	5.8	15.9	9.8	23.9	4.6	3.5	35.4	7.7	13.5	3.6	3.4	26.4	4.6	0.0	38.9	15.8	6.7	19.4	40.1	10.7	3.9	6.5	8.1	25.3	1.3	8.1
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602775	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease mutation, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 100.3;lymphoid tissue: 38.7"	"Cell type enriched"	"Detected in some"	9	"T-cells: 203.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"gdT-cell: 100.3;MAIT T-cell: 70.9;memory CD8 T-cell: 54.9;naive CD8 T-cell: 36.1;NK-cell: 65.1"	"Group enriched"	"Detected in many"	48	"NK-cells: 65.1;T-cells: 100.3"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 72.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		960000	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	8.8	1.3	0.9	5.5	1.1	15.3	2.4	0.5	0.7	1.7	3.8	0.4	0.2	1.4	4.4	2.9	2.7	1.7	5.3	4.1	0.8	0.9	1.8	6.5	19.6	11.3	2.5	0.3	2.1	1.6	0.0	1.1	3.1	1.2	3.3	0.8	3.9	2.5	3.3	2.6	0.9	5.1	1.2	1.4	38.7	3.1	1.6	0.2	12.7	2.8	1.0	10.3	3.2	1.7	0.4	0.3	1.7	0.2	65.1	100.3	46.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	72.7	0.0	0.4	0.0	2.2	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.2	0.0	100.3	0.1	70.9	0.4	14.6	54.9	0.2	0.2	6.2	36.1	1.7	65.1	0.2	0.3	11.1	46.7	0.9	1.1	0.5	0.7	0.8	0.9	2.5	0.3	1.2	0.2	3.0	22.3	6.5	0.0	0.3	0.0	0.8	0.0	2.7	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.4	0.1	8.1	2.1	0.1	0.0	0.0	8.6	5.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.8	0.0	0.0	0.6	0.6	203.1	0.0	0.0
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645322-56715335	"Enzymes, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 39.1;skeletal muscle: 40.2"	"Cell type enhanced"	"Detected in many"	16	"Cardiomyocytes: 309.5;Rod photoreceptor cells: 106.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"		NA	NA			"Nuclear speckles"	"Golgi apparatus"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	2.4	2.1	3.7	1.2	6.3	0.7	4.1	7.2	8.1	2.2	5.5	1.2	2.4	1.2	3.0	3.2	6.3	3.5	2.6	39.1	4.2	2.9	14.5	1.4	2.0	0.8	2.4	6.2	2.5	2.6	10.4	2.6	1.2	5.0	4.6	2.2	6.0	4.5	3.5	40.2	1.4	2.1	7.2	1.9	1.9	3.2	1.7	0.8	0.0	4.0	12.3	0.8	4.4	2.1	0.2	0.0	1.0	0.1	0.1	0.1	0.0	0.0	3.7	2.0	0.0	0.7	0.5	2.3	1.8	1.4	2.4	4.2	3.7	4.7	0.0	0.6	0.6	7.4	0.0	7.7	0.0	7.1	0.0	8.5	0.0	6.9	5.2	0.0	0.0	0.1	0.6	0.0	3.5	0.3	5.7	0.8	1.9	0.0	0.0	1.0	0.1	0.0	0.0	5.5	0.0	5.4	0.0	0.0	0.0	13.9	1.2	2.0	5.4	5.7	0.1	0.0	6.2	3.2	0.0	0.0	1.5	2.3	2.7	6.2	0.0	0.0	0.0	4.5	0.0	1.1	0.5	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	3.7	6.3	7.2	8.1	4.2	2.9	2.4	6.2	5.0	0.8	8.9	3.7	0.0	5.9	0.8	39.3	309.5	22.9	10.7	15.9	47.1	47.1	0.8	46.4	9.1	2.3	11.7	1.0	0.0	4.1	0.3	3.5	15.6	2.3	6.4	0.1	25.4	13.8	3.7	0.0	1.9	6.4	0.9	5.0	0.0	7.7	16.8	6.7	0.0	27.6	74.2	106.6	6.5	21.2	7.2	2.8	0.4	0.3	0.0	5.2	11.2
PRND	"dJ1068H6.4, DOPPEL, DPL, PrPLP"	ENSG00000171864	"Prion like protein doppel"	Q9UKY0	20	4721910-4728460	"Predicted membrane proteins, Transporters"	Fertilization	Prion		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 80.2"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 1.7;Late spermatids: 7.4;Leydig cells: 2.0;Spermatogonia: 1.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Region enriched"	"Detected in single"	28	"pons and medulla: 6.0"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 2.2;NTERA-2: 3.2;U-698: 1.3"					"Not detected"	"Not detected"			HPA043373	Enhanced					NA	NA					"HPA043373: AB_2678450"	"unprognostic (1.69e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.02e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.63e-3)"	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	1.1	0.7	0.2	0.0	2.5	0.1	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.1	0.0	6.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.7	0.0	0.0	0.1	80.2	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.9	0.5	2.2	0.5	0.6	0.4	0.1	0.2	0.4	0.1	0.3	0.0	0.3	0.4	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.3	0.1	0.3	0.0	0.1	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.2	0.3	0.0	0.0	0.6	0.1	0.3	2.2	0.5	0.0	1.1	0.2	0.2	0.1	0.3	3.2	0.0	0.0	0.2	0.0	0.0	0.3	0.4	0.3	0.4	0.0	0.1	0.1	0.2	0.3	0.1	0.4	0.3	0.7	0.4	0.1	0.3	0.1	1.3	0.2	0.2	0.0	2.2	0.5	0.5	0.3	0.3	0.2	0.6	0.4	0.2	0.2	0.9	0.3	0.3	1.4	0.6	0.5	0.5	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	2.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.2	1.5	0.0	0.0	0.0	0.0	0.1
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686236-4701590	"CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 366.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"basophil: 108.1"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 108.1"	"Cell line enhanced"	"Detected in many"		"WM-115: 116.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"	"Intracellular and membrane"	NA	NA		2200000	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: AB_2678461"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.96e-4)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	24.6	27.3	63.4	14.2	73.1	19.8	30.5	87.5	116.1	42.0	43.4	61.6	8.5	10.6	36.3	17.7	23.0	24.1	31.4	54.1	64.6	48.9	38.5	22.2	22.2	14.7	47.2	65.6	49.6	11.8	20.7	24.9	18.7	71.6	43.8	20.9	34.1	17.1	45.0	21.8	26.7	13.5	40.8	53.1	20.3	18.1	19.1	51.4	2.9	25.6	11.8	16.4	27.0	22.3	4.6	10.5	108.1	11.7	3.6	16.7	10.0	24.6	20.3	4.6	7.2	37.9	23.2	4.1	40.8	58.9	19.8	20.2	6.7	19.1	4.5	9.5	79.5	44.9	57.4	5.1	55.6	37.2	3.7	4.4	0.0	2.3	21.0	46.6	8.0	1.8	21.0	80.2	84.7	66.2	29.2	17.0	3.3	2.4	16.0	22.8	5.5	3.1	4.9	3.8	10.8	30.2	3.8	12.4	4.1	9.9	4.4	5.5	0.8	11.6	16.2	58.0	6.7	3.3	4.2	25.5	32.3	14.8	18.0	33.2	7.4	14.9	15.0	26.0	5.9	116.2	108.1	11.7	0.8	11.9	9.7	16.7	4.2	9.8	9.4	10.5	4.6	5.8	6.8	0.7	3.6	7.6	3.7	11.4	10.0	63.4	73.1	87.5	90.4	64.6	48.9	47.2	65.6	71.6	51.4	74.5	42.1	34.0	181.6	366.5	230.5	189.4	33.1	26.8	70.5	31.4	110.0	6.3	10.0	50.5	4.7	46.7	2.0	0.0	12.7	5.7	171.5	79.9	168.6	29.7	58.0	42.9	28.7	42.4	184.5	8.0	132.6	109.3	160.3	13.6	4.9	133.0	16.9	2.9	159.8	69.9	78.9	12.9	124.6	28.3	4.3	248.5	12.0	52.2	6.9	105.0
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696600-42722574	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 117.8"	"Group enriched"	"Detected in some"	13	"Cone photoreceptor cells: 245.4;Rod photoreceptor cells: 471.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.4"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"ASC diff: 4.3;ASC TERT1: 4.9;fHDF/TERT166: 7.1;HHSteC: 11.0;HSkMC: 8.5;LHCN-M2: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029458	Enhanced					NA	NA					"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.0	0.8	1.5	1.0	1.0	0.0	1.0	1.0	4.8	1.7	2.0	1.0	1.0	0.3	2.3	2.3	1.0	0.9	1.2	1.4	1.1	3.0	1.0	1.0	1.2	1.0	1.1	1.0	3.4	2.0	6.9	2.7	1.0	1.0	1.4	0.8	117.8	1.0	1.3	14.4	0.0	1.1	2.3	1.0	1.0	1.0	3.5	1.0	1.0	5.2	1.0	1.0	1.0	1.0	0.6	0.3	3.4	0.6	0.2	0.8	0.0	0.0	0.0	0.0	0.0	4.3	4.9	1.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	11.0	0.0	0.0	8.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.3	0.0	0.4	0.2	0.8	0.2	0.3	0.0	0.3	0.6	0.4	0.2	2.5	0.2	0.6	0.0	0.3	0.0	1.5	1.0	1.0	3.0	1.1	3.0	1.1	1.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	23.7	0.6	0.0	0.0	0.0	0.0	245.4	0.0	3.3	0.1	0.0	0.2	0.0	0.0	0.2	0.0	1.4	0.2	0.0	0.0	0.0	11.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	28.3	0.7	0.0	1.8	0.0	471.5	0.0	1.5	2.5	0.1	0.3	0.1	0.0	0.0	0.0
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 86.7"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 79.8;Cone photoreceptor cells: 29.5;Leydig cells: 33.4;Peritubular cells: 37.8;Rod photoreceptor cells: 40.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	11	"NK-cell: 7.3"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 7.3"	"Cell line enhanced"	"Detected in many"		"AF22: 19.8;hTERT-RPE1: 12.2;REH: 15.1;U-138 MG: 13.7"									"HPA014447, HPA019203, HPA048045"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	3.7	7.2	27.2	2.8	40.5	0.8	2.1	86.7	53.6	10.1	6.0	6.0	3.1	6.2	20.7	8.3	4.4	10.2	10.3	5.3	18.9	13.0	2.1	0.9	5.7	3.5	5.5	33.2	35.7	2.4	8.6	17.6	7.1	18.0	16.2	2.6	5.2	4.6	14.4	4.3	3.1	6.8	10.3	7.4	1.8	7.3	9.9	10.2	0.0	2.8	0.3	1.6	5.1	10.7	0.2	0.0	0.5	0.2	7.3	0.6	0.3	0.3	1.2	19.8	7.4	1.0	3.7	0.5	2.4	4.0	0.8	0.9	1.1	2.3	0.2	0.4	3.2	0.6	2.0	2.7	0.4	0.3	5.2	1.6	1.3	8.8	0.8	0.2	0.0	0.3	3.4	0.1	1.4	0.1	12.2	1.0	0.6	0.2	1.6	0.6	3.3	0.5	0.6	5.7	0.0	1.0	15.1	1.1	0.4	0.1	0.7	4.3	4.5	0.2	2.9	0.4	3.2	7.3	0.1	1.1	13.7	4.8	0.8	1.3	3.4	0.4	0.1	5.4	0.1	0.5	0.5	0.0	0.1	0.2	0.1	0.3	0.1	0.6	0.4	0.0	0.2	0.4	0.2	0.2	7.3	0.2	0.0	0.1	0.3	27.2	40.5	86.7	53.6	18.9	13.0	5.5	33.2	18.0	10.2	3.0	0.0	0.0	1.3	1.0	79.8	0.8	0.0	6.7	1.2	0.0	29.5	1.5	1.7	1.1	1.7	2.0	9.6	0.0	1.4	0.6	9.3	1.4	0.0	0.0	0.3	19.1	5.8	2.5	0.0	6.3	33.4	0.0	0.0	1.0	2.0	6.5	2.3	10.5	37.8	0.2	40.1	6.5	13.2	2.4	3.2	0.4	2.2	0.0	1.7	1.0
PSAP	"GLBA, SAP1"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851375	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease mutation, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Hofbauer cells: 2783.3;Kupffer cells: 2077.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 252.0;intermediate monocyte: 322.1;myeloid DC: 97.2;neutrophil: 80.8;non-classical monocyte: 263.2"	"Group enriched"	"Detected in all"	12	"dendritic cells: 97.2;granulocytes: 80.8;monocytes: 322.1"	"Cell line enhanced"	"Detected in all"		"ASC diff: 260.8;hTERT-RPE1: 353.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		86000000	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	151.5	178.6	106.6	95.1	137.9	79.7	93.3	93.2	143.4	136.7	74.4	134.2	89.5	53.7	116.0	118.2	71.7	88.1	129.7	164.0	99.5	93.7	108.5	119.6	125.5	136.8	135.4	128.0	137.1	93.7	134.8	76.0	165.5	106.7	94.1	73.4	118.2	88.1	117.0	151.6	67.6	63.3	133.5	109.3	159.8	87.4	60.5	126.1	84.4	103.1	54.1	61.4	102.8	76.3	13.4	97.2	80.8	322.1	9.5	12.5	306.2	21.6	40.9	26.6	55.6	260.8	150.1	94.1	39.4	117.3	31.0	37.1	37.8	55.3	11.8	81.4	64.3	52.0	47.5	10.0	32.0	21.9	23.0	18.9	13.8	18.6	21.3	100.5	8.9	79.4	95.4	73.9	31.0	59.5	353.1	55.0	16.7	19.6	57.1	38.4	13.8	39.5	13.4	12.2	27.5	19.9	8.2	15.2	32.8	36.1	37.3	29.6	26.2	36.8	111.8	148.5	36.6	22.7	20.6	71.5	43.9	31.2	29.2	32.1	63.8	48.5	20.9	69.7	17.9	32.1	19.4	252.0	30.1	12.5	322.1	10.3	13.4	10.3	10.8	97.2	11.8	11.3	10.6	80.8	9.5	263.2	48.5	11.3	306.2	106.6	137.9	93.2	143.4	99.5	93.7	135.4	128.0	106.7	126.1	235.2	379.3	166.5	219.5	202.9	179.8	542.8	254.8	219.5	234.3	451.9	119.8	794.0	59.7	786.8	15.8	344.2	354.0	46.7	402.9	741.7	528.5	293.5	382.9	394.5	2783.3	314.6	251.7	411.3	2077.6	30.6	424.6	1465.0	629.3	1297.6	227.4	506.4	336.4	285.1	518.7	243.0	122.0	271.7	278.1	42.5	119.8	173.1	897.4	139.5	183.5	185.3
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	16.3	15.3	21.0	13.4	34.9	19.2	15.7	15.5	24.7	16.5	26.2	66.1	9.5	26.6	14.2	15.4	19.0	12.6	17.1	9.9	28.6	18.2	19.7	16.9	16.9	10.8	42.1	20.7	13.5	15.0	21.8	9.2	22.7	31.8	13.6	25.6	15.0	16.8	13.4	13.0	24.7	27.9	14.6	61.9	14.6	16.3	16.8	39.7	15.4	19.7	8.7	15.9	17.2	13.5	9.0	24.4	38.1	34.0	11.7	10.5	17.1	14.4	22.2	20.8	8.3	29.1	20.8	18.9	21.3	24.5	21.9	27.6	27.6	36.2	9.4	14.1	20.2	17.9	38.5	17.5	16.1	23.9	21.5	10.8	10.8	15.1	13.4	26.9	10.8	21.1	21.3	29.4	18.1	22.4	20.0	17.5	10.6	12.0	19.2	20.4	28.7	8.2	14.1	9.0	25.7	16.5	10.5	17.7	12.0	30.4	30.7	11.6	15.5	23.2	21.8	18.9	19.7	27.0	24.3	18.5	22.3	18.4	18.1	10.0	12.6	18.4	9.6	18.7	13.2	13.5	29.2	27.1	27.1	7.2	30.8	7.0	7.2	7.0	5.9	24.4	9.0	6.6	6.4	38.1	11.7	34.0	12.8	10.5	17.1	21.0	34.9	15.5	24.7	28.6	18.2	42.1	20.7	31.8	39.7	26.8	35.7	14.6	21.9	25.3	16.5	10.1	20.4	22.7	26.1	22.7	37.3	22.8	5.0	24.3	8.6	20.3	63.6	0.0	23.2	24.7	22.1	24.7	17.4	18.6	27.3	12.7	15.5	13.5	47.8	10.0	15.3	43.2	15.1	33.3	34.1	13.6	29.5	51.8	14.5	13.3	27.4	25.8	18.4	21.6	13.7	28.9	41.8	20.3	36.6	44.4
PSEN2	"AD3L, AD4, PS2, STM2"	ENSG00000143801	"Presenilin 2"	P49810	1	226870184-226896105	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 38.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013634, HPA038005"			Supported	Nucleoplasm		NA	NA			Nucleoplasm		"CAB013634: , HPA038005: "	"unprognostic (3.40e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.53e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	8.9	13.2	9.5	5.9	7.9	1.2	8.1	16.6	10.7	9.2	9.2	5.9	7.3	9.4	16.4	9.0	9.4	8.7	12.0	9.7	6.5	10.8	7.8	7.7	9.0	11.6	8.1	9.3	13.1	31.6	14.0	15.2	7.6	14.8	12.8	6.9	15.9	9.6	13.4	22.1	6.8	12.2	17.0	4.9	10.6	7.1	21.8	5.3	1.4	6.0	7.2	7.0	9.0	7.2	5.1	7.7	19.4	18.7	12.3	3.4	3.1	9.0	13.6	4.0	12.6	5.5	1.8	6.7	7.7	15.1	9.6	7.4	10.6	11.7	0.1	10.4	9.8	6.6	4.6	7.1	7.3	3.9	9.7	13.1	6.1	9.6	6.9	9.3	4.8	10.1	5.4	8.2	11.5	6.3	6.8	4.4	0.0	10.5	4.1	5.6	7.6	0.1	5.5	12.4	11.3	11.2	0.1	14.8	14.5	8.5	7.7	7.1	11.8	6.2	17.1	30.5	11.8	14.7	6.1	4.8	6.8	5.8	6.2	9.6	16.6	24.4	0.4	12.2	1.5	9.0	19.4	5.7	12.1	3.2	6.5	3.4	5.1	1.1	2.9	7.7	2.6	0.6	1.7	1.2	12.3	18.7	0.6	1.4	3.1	9.5	7.9	16.6	10.7	6.5	10.8	8.1	9.3	14.8	5.3	14.9	13.3	3.0	4.2	1.4	6.0	7.5	12.7	2.7	3.4	5.2	0.0	12.2	1.7	11.0	1.9	7.7	6.7	0.0	15.7	4.3	7.6	4.8	13.9	6.8	16.3	15.9	5.8	23.4	5.3	0.9	6.6	8.3	32.1	30.7	4.3	20.0	11.9	5.8	12.4	6.0	5.4	6.5	4.7	0.7	4.5	1.6	38.3	2.5	4.1	3.9
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 98.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 73.9;Hofbauer cells: 62.8;Kupffer cells: 70.6;Macrophages: 55.7;Pancreatic endocrine cells: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 28.2;eosinophil: 98.3;neutrophil: 85.7"	"Group enriched"	"Detected in many"	5	"granulocytes: 98.3;monocytes: 28.2"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 14.7;HMC-1: 53.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	5.6	2.3	2.4	16.2	1.9	20.3	2.4	0.6	2.0	6.9	3.4	1.6	3.5	1.8	2.8	1.4	16.8	2.8	7.5	3.5	2.1	2.3	6.4	1.8	9.2	6.1	4.1	1.0	1.5	2.7	0.9	0.7	3.5	1.8	2.6	3.4	0.6	3.4	2.6	1.1	2.8	5.0	3.8	5.1	15.4	2.3	2.2	1.1	2.3	1.4	22.2	21.7	5.9	3.6	1.5	13.2	98.3	28.2	0.0	0.1	10.1	7.7	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.1	2.2	0.5	0.0	0.0	0.1	5.3	0.2	14.7	0.3	0.1	0.2	2.9	0.0	0.3	0.0	0.7	53.6	0.0	2.4	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.5	0.0	7.2	0.2	0.2	0.1	0.1	0.0	0.0	3.6	0.8	0.1	0.0	0.0	7.3	0.0	0.2	0.1	2.0	0.0	0.1	0.3	0.0	0.0	0.5	0.4	2.1	0.0	0.9	0.2	5.9	28.2	98.3	0.0	8.9	0.1	1.5	0.0	0.0	13.2	0.7	0.0	0.0	85.7	0.0	3.5	0.1	0.1	10.1	2.4	1.9	0.6	2.0	2.1	2.3	4.1	1.0	1.8	1.1	6.0	7.9	4.3	1.5	5.8	1.2	2.0	2.5	6.7	2.3	1.8	2.0	0.5	0.0	8.8	0.0	5.9	0.2	0.0	4.6	0.4	2.2	0.4	73.9	0.8	62.8	0.0	0.0	1.8	70.6	0.0	0.6	55.7	0.0	4.6	0.0	0.2	55.1	0.0	0.0	0.0	0.8	0.0	0.9	2.1	0.5	2.5	1.3	1.0	0.0	8.6
PTCH1	"BCNS, NBCCS, PTCH"	ENSG00000185920	"Patched 1"	Q13635	9	95442980-95517057	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease mutation, Holoprosencephaly, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	17	"Late spermatids: 165.3;Leydig cells: 176.9;Peritubular cells: 417.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 8.9"	"Lineage enriched"	"Detected in many"	8	"T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 15.8;WM-115: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013717, HPA075072"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB013717: , HPA075072: AB_2686733"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-6)"	"unprognostic (8.63e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.82e-1)"	4.1	3.8	6.7	6.0	9.5	0.7	7.9	21.0	6.4	28.5	12.5	6.1	8.0	7.8	16.2	4.2	3.0	7.4	13.2	2.8	7.0	6.6	4.9	2.2	7.1	4.5	9.5	3.2	5.2	10.8	3.4	4.0	3.7	6.9	6.9	12.3	11.2	6.9	9.5	2.7	4.3	10.9	8.5	5.1	3.8	12.1	14.3	7.9	1.0	6.3	1.9	3.2	11.3	6.9	1.0	0.0	0.0	0.0	0.3	8.9	1.8	5.1	2.5	10.9	6.8	1.6	2.7	6.2	1.0	0.9	1.2	0.7	2.5	2.5	4.1	1.8	1.9	2.3	11.8	6.2	0.8	0.7	4.0	4.1	0.0	2.5	1.1	1.5	0.1	2.3	2.5	1.3	1.1	0.8	2.3	2.2	1.8	3.6	4.8	0.5	1.0	0.0	1.6	15.8	3.7	1.0	0.0	8.3	2.1	0.8	0.7	7.5	3.7	3.7	3.6	1.6	10.6	0.9	1.1	0.5	1.4	7.2	7.3	0.7	9.7	8.4	2.7	2.0	2.0	37.6	0.0	0.0	0.0	8.9	0.0	5.3	1.0	1.7	3.8	0.0	0.3	2.8	3.2	0.0	0.3	0.0	0.0	1.4	1.8	6.7	9.5	21.0	6.4	7.0	6.6	9.5	3.2	6.9	7.9	0.0	5.4	0.9	2.8	3.5	17.4	5.1	10.2	1.4	2.3	0.0	39.3	2.0	5.0	2.5	80.9	3.7	1.3	0.0	3.5	1.6	6.9	5.8	1.1	1.0	0.7	19.1	20.8	3.1	0.8	165.3	176.9	0.8	11.8	0.0	11.2	71.0	2.6	3.5	417.9	1.1	13.5	38.8	4.2	3.3	33.2	3.9	1.1	4.3	5.0	1.1
PTGER1	EP1	ENSG00000160951	"Prostaglandin E receptor 1"	P34995	19	14472466-14475362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"kidney: 13.6;lymphoid tissue: 14.2"	"Cell type enriched"	"Detected in some"	75	"Collecting duct cells: 188.5"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.5;NK-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 5.4;NB-4: 2.9;PC-3: 7.2;SH-SY5Y: 4.2"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.50e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.74e-8)"	"unprognostic (1.19e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.88e-2)"	0.7	1.4	1.1	2.7	1.3	0.2	1.5	0.6	1.2	1.3	1.5	0.1	0.0	1.2	0.4	0.3	1.7	1.0	0.4	3.1	0.4	0.4	13.6	0.5	4.9	6.7	1.8	0.0	1.6	1.8	0.2	1.4	0.3	1.0	0.5	0.3	0.3	0.3	0.4	0.7	0.2	1.9	1.4	0.1	14.2	3.2	0.4	0.6	0.0	0.7	0.0	0.3	0.6	1.3	0.0	0.4	0.0	1.5	2.6	1.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.3	0.6	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.0	0.0	2.9	0.3	0.0	7.2	0.8	0.0	0.2	0.0	0.1	0.5	4.2	0.1	0.1	0.2	0.0	0.2	0.4	1.3	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	1.5	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.2	1.1	1.3	0.6	1.2	0.4	0.4	1.8	0.0	1.0	0.6	0.0	0.0	0.0	0.2	0.0	0.4	0.8	2.5	0.0	0.0	188.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.5	0.3	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.7	0.0	0.0	0.0	0.0	0.2
PTH1R	"PTHR, PTHR1"	ENSG00000160801	"Parathyroid hormone 1 receptor"	Q03431	3	46877746-46903799	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease mutation, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 90.4"	"Cell type enhanced"	"Detected in many"	20	"Distal tubular cells: 81.2;Proximal tubular cells: 259.5;Sertoli cells: 135.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 18.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 51.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075879	Enhanced					NA	NA					"HPA075879: "	"unprognostic (1.26e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.24e-5)"	"unprognostic (7.46e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (6.79e-6)"	"unprognostic (4.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-4)"	"unprognostic (6.62e-3)"	8.5	17.9	4.2	1.4	5.9	0.8	5.0	3.7	5.0	6.2	2.3	5.2	1.1	1.5	4.5	2.5	2.3	3.8	2.8	4.3	5.5	3.9	90.4	13.4	4.1	6.9	6.0	5.0	5.4	1.6	1.0	0.9	10.1	4.7	3.2	1.2	3.4	1.5	3.0	4.0	2.6	1.8	4.6	4.1	9.6	1.5	2.2	5.7	0.0	1.2	0.6	1.0	2.8	5.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	7.2	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	2.3	0.0	51.7	0.0	0.0	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.2	5.9	3.7	5.0	5.5	3.9	6.0	5.0	4.7	5.7	0.0	0.0	0.5	0.0	1.1	0.7	2.2	0.0	0.0	0.0	31.4	0.0	0.5	81.2	0.0	8.7	1.5	0.0	0.0	0.5	48.7	10.8	0.0	0.0	0.4	1.8	1.6	0.0	22.1	1.5	22.5	5.5	0.0	0.0	0.0	0.0	3.0	0.2	0.0	2.1	259.5	0.6	135.8	3.1	0.7	1.3	0.6	0.7	0.0	0.0	0.1
PXMP2	PMP22	ENSG00000176894	"Peroxisomal membrane protein 2"	Q9NR77	12	132687606-132704991	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.9"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 191.4;Hepatocytes: 515.6;Proximal tubular cells: 287.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.12e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.84e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.04e-1)"	5.7	4.1	6.5	6.5	5.3	6.7	10.3	3.4	7.6	3.4	18.1	3.8	7.4	17.4	4.3	7.9	5.3	5.0	14.1	16.3	5.3	3.7	18.4	78.9	3.6	5.0	4.4	6.1	6.8	32.3	2.5	2.4	2.7	4.4	5.4	13.3	4.6	9.0	3.6	12.8	4.3	25.9	3.9	3.2	3.5	22.9	4.2	4.6	13.8	7.9	5.8	4.4	4.6	4.1	3.3	9.9	4.3	1.9	2.2	4.4	1.9	24.0	10.1	15.2	14.1	9.2	7.1	8.9	8.6	8.0	18.8	16.7	12.2	9.3	15.0	10.5	12.3	6.6	17.2	20.2	10.9	10.3	8.5	32.1	13.3	18.2	13.4	18.0	9.8	6.0	9.3	9.1	7.7	6.2	13.1	5.0	23.1	22.9	11.8	9.8	21.8	31.0	15.5	14.9	28.4	14.0	32.0	16.4	12.3	13.8	10.2	29.0	9.4	18.6	9.8	11.8	12.3	26.3	22.7	5.8	9.3	21.7	8.0	14.3	10.7	10.3	24.0	10.3	14.1	7.3	0.0	1.9	4.3	3.8	0.8	3.7	3.3	3.1	3.9	3.3	3.3	3.0	2.5	0.9	2.2	0.9	9.9	4.4	1.9	6.5	5.3	3.4	7.6	5.3	3.7	4.4	6.1	4.4	4.6	3.0	4.5	6.7	18.1	7.4	5.1	33.1	147.7	0.0	3.4	24.4	3.9	37.1	140.9	15.6	15.2	9.0	191.4	0.0	9.0	32.9	16.1	31.2	4.6	515.6	27.8	0.0	18.0	36.8	18.3	24.3	28.7	8.0	11.8	1.0	64.3	21.8	13.0	122.2	32.9	287.1	5.0	19.4	10.5	15.3	20.7	9.4	23.8	7.5	155.8	17.5
PXMP4	PMP24	ENSG00000101417	"Peroxisomal membrane protein 4"	Q9Y6I8	20	33702754-33720319	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 2: 61.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.6;SK-BR-3: 35.9;T-47d: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050077	Approved		Approved	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			Peroxisomes	"Nucleoli fibrillar center"	"HPA050077: AB_2681006"	"unprognostic (3.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.53e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.03e-10)"	"unprognostic (3.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.20e-1)"	6.2	20.0	6.4	5.4	10.0	3.9	15.6	4.7	12.6	7.8	7.8	12.5	16.9	10.1	7.1	7.1	10.0	8.0	9.1	7.9	6.7	5.3	6.7	13.4	27.5	9.3	6.1	9.2	9.2	9.5	24.4	5.3	5.0	6.5	11.5	7.5	10.8	27.6	13.2	9.9	14.4	11.8	7.1	7.6	6.4	9.0	4.2	5.9	8.4	19.0	6.9	5.9	10.6	9.0	6.2	6.2	12.0	21.9	5.8	8.5	5.5	1.2	5.6	1.6	5.6	2.8	4.1	4.0	4.0	2.2	3.1	1.4	19.6	6.2	0.0	7.8	3.4	7.7	5.9	4.2	4.7	2.2	1.6	1.6	6.4	4.8	0.1	2.6	0.3	4.9	3.1	5.1	4.3	1.4	1.6	2.0	2.0	3.5	4.1	2.2	12.0	5.8	4.5	0.2	9.9	0.0	3.1	7.7	0.7	2.0	4.1	5.1	2.6	11.3	35.9	3.6	0.9	30.3	2.1	4.0	2.3	2.6	5.7	3.7	2.6	5.8	0.1	4.4	2.1	3.8	1.4	8.0	12.0	8.1	14.9	8.5	5.5	8.3	8.1	6.2	6.2	6.3	8.5	2.1	5.8	21.9	3.8	5.7	5.5	6.4	10.0	4.7	12.6	6.7	5.3	6.1	9.2	6.5	5.9	17.9	61.7	5.2	4.0	1.4	9.9	11.3	12.7	6.7	21.6	17.4	13.7	10.3	8.3	7.1	24.5	6.6	15.1	0.0	8.6	20.0	6.1	4.1	3.5	27.9	13.0	4.8	4.1	8.6	6.7	30.4	9.8	5.0	3.3	4.6	10.9	15.3	6.3	10.5	10.6	7.7	10.2	6.5	4.2	2.3	8.9	2.0	3.7	3.5	12.4	3.5
RABAC1	"PRA1, PRAF1, YIP3"	ENSG00000105404	"Rab acceptor 1"	Q9UI14	19	41956681-41959390	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019320, HPA029171"	Supported		Approved	"Nuclear membrane,Nucleoli fibrillar center"		NA	NA			"Nuclear membrane"	"Nucleoli fibrillar center"	"CAB019320: , HPA029171: AB_10602121"	"unprognostic (7.70e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.45e-2)"	44.2	45.4	42.3	36.7	42.5	29.6	43.5	30.9	53.1	43.6	40.5	32.0	45.3	47.8	46.8	32.4	36.2	30.4	39.8	32.2	39.5	45.9	46.0	92.3	35.7	53.0	44.7	33.4	37.5	88.1	18.5	48.6	51.0	39.9	33.8	19.1	23.3	68.8	40.5	52.2	31.6	43.4	32.0	38.4	32.2	60.6	28.3	31.9	38.8	56.1	28.7	32.4	31.4	47.5	54.5	59.6	114.0	58.1	33.2	57.2	64.1	17.3	47.7	6.9	17.9	47.0	27.0	9.1	51.7	27.4	12.7	17.9	8.4	11.4	50.2	26.8	30.6	7.3	13.0	4.2	16.2	5.3	18.5	28.0	7.3	14.0	14.5	25.2	6.4	20.3	26.2	16.2	8.6	6.3	16.6	17.7	14.2	3.2	65.4	11.7	26.7	11.2	5.8	8.4	24.9	31.0	15.3	14.8	9.7	12.1	13.0	12.7	18.5	13.6	29.6	12.5	5.6	11.1	5.4	34.3	22.8	15.1	22.1	7.4	58.2	19.4	17.4	33.0	12.0	24.5	86.2	58.1	76.4	57.2	30.5	48.1	54.5	52.0	49.8	33.8	49.9	35.3	47.6	114.0	33.2	29.6	59.6	55.8	64.1	42.3	42.5	30.9	53.1	39.5	45.9	44.7	33.4	39.9	31.9	119.1	107.6	134.8	132.5	110.7	54.7	56.9	175.8	84.3	81.9	172.7	15.7	168.6	116.0	298.8	157.9	238.6	301.1	23.3	264.4	410.9	312.7	240.5	140.7	234.8	161.0	54.0	187.1	255.9	127.0	499.8	284.2	161.6	384.6	285.9	338.7	137.5	343.3	280.5	236.2	262.8	46.9	226.4	277.1	222.3	127.0	119.2	227.2	151.3	250.8	152.9
RABGEF1	"rabex-5, RABEX5"	ENSG00000154710	"RAB guanine nucleotide exchange factor 1"	Q9UJ41	7	66682164-66811464	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA001407			Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA001407: AB_1856024"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (3.77e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.64e-4)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.55e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	18.4	15.2	13.0	14.7	14.4	59.2	12.0	22.4	16.8	16.9	14.1	12.6	9.4	9.1	16.4	9.5	20.6	12.0	13.5	10.8	13.5	15.6	14.9	17.2	10.5	10.6	12.8	12.1	14.7	13.2	13.3	10.2	18.8	13.5	13.1	11.0	13.8	10.6	16.1	12.1	21.9	15.5	15.3	11.9	15.3	11.9	21.5	9.8	13.1	22.3	20.7	18.2	19.1	16.3	15.7	10.4	18.1	13.5	15.4	10.9	7.6	20.6	6.2	5.4	9.1	14.7	20.6	5.4	18.2	23.3	19.2	18.3	5.8	13.4	10.1	7.1	26.3	14.1	8.7	7.4	9.8	26.8	6.9	5.9	5.4	7.3	5.7	11.7	9.2	7.7	10.2	12.7	24.7	27.4	15.9	5.0	6.9	9.9	7.4	19.0	10.4	6.2	12.9	7.1	9.6	9.0	5.5	9.4	7.6	16.8	9.5	6.2	9.7	8.4	18.6	9.8	9.4	10.7	5.8	6.5	31.2	6.5	19.1	14.2	9.6	12.5	12.0	14.4	10.3	9.9	18.1	7.8	9.4	8.6	6.9	9.3	11.2	8.1	10.9	7.3	15.7	8.8	8.2	15.1	15.4	13.5	10.4	6.7	7.6	13.0	14.4	22.4	16.8	13.5	15.6	12.8	12.1	13.5	9.8	11.9	13.8	5.2	6.5	3.7	9.7	4.2	0.0	20.1	18.2	5.2	15.7	3.2	10.0	4.5	4.1	5.8	5.9	0.0	4.8	3.0	5.1	10.1	13.9	5.9	4.2	7.9	17.2	4.9	12.3	1.8	5.5	9.3	1.7	5.4	5.1	4.8	12.5	14.0	8.9	4.0	16.7	0.0	7.3	6.6	6.4	5.8	11.3	2.5	4.7	11.1
RAE1	Mnrp41	ENSG00000101146	"Ribonucleic acid export 1"	P78406	20	57351010-57379211	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 64.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048795			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Nucleoplasm, Nucleoli fibrillar center"		"HPA048795: AB_2680523"	"unprognostic (1.20e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.55e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.01e-1)"	9.2	10.0	9.4	11.1	15.2	28.6	12.0	18.1	18.3	9.5	9.7	11.5	9.3	8.0	13.0	13.9	14.0	12.2	7.9	8.1	9.8	11.0	9.2	10.7	7.1	12.5	8.1	12.6	12.1	9.1	12.3	13.7	13.5	10.4	9.2	11.4	9.4	8.9	11.0	9.6	14.8	8.8	11.3	7.3	12.1	8.6	64.8	8.3	19.4	11.7	11.5	17.3	10.0	11.5	17.0	16.6	39.1	21.5	11.8	20.2	17.8	12.8	15.9	15.8	9.0	9.6	8.8	14.4	10.4	14.7	51.4	19.9	50.4	10.3	20.6	14.6	15.0	19.6	17.1	29.7	25.6	42.4	6.2	13.4	14.1	14.2	22.3	18.0	16.9	12.7	12.9	23.1	22.1	24.8	8.6	15.5	14.1	24.7	10.0	16.1	34.7	25.2	14.8	10.0	24.5	28.0	14.1	15.4	13.7	12.0	13.5	17.3	14.3	17.7	40.4	18.2	12.9	22.0	14.8	9.0	21.9	19.7	12.9	17.3	10.9	23.3	23.5	15.3	10.5	10.9	9.1	21.5	39.1	15.6	18.1	18.9	17.0	15.2	15.5	16.6	16.3	20.2	18.4	19.4	11.8	17.9	12.6	12.9	17.8	9.4	15.2	18.1	18.3	9.8	11.0	8.1	12.6	10.4	8.3	17.9	14.7	22.4	14.7	15.2	14.6	8.5	12.7	21.4	12.5	17.4	13.7	44.8	23.2	28.2	84.3	14.2	7.9	23.3	12.5	32.5	15.6	10.5	36.9	11.3	33.3	3.2	6.3	10.4	63.2	48.9	20.1	28.8	10.1	27.1	13.0	17.6	17.6	20.4	21.2	16.6	15.0	19.4	15.0	94.3	78.1	18.3	58.9	21.5	18.0	14.9
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538116	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	Transport	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Collecting duct cells: 455.4;Extravillous trophoblasts: 356.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	10	"neutrophil: 55.1"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 55.1"	"Cell line enhanced"	"Detected in all"		"OE19: 74.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	NA			Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: AB_2679738"	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	19.7	14.6	23.2	14.8	24.3	17.9	19.1	27.1	27.2	17.1	20.7	14.0	54.7	12.5	15.9	16.7	33.7	17.5	13.7	21.4	24.7	19.6	30.6	14.2	15.1	14.6	23.1	13.7	18.8	10.4	19.8	15.3	28.8	19.6	24.3	17.4	9.8	17.6	44.8	24.3	47.5	13.4	22.7	20.6	19.3	17.4	8.5	23.1	15.4	15.7	23.4	16.4	24.3	26.3	2.5	5.5	55.1	4.5	4.3	3.2	1.2	18.4	12.4	11.1	12.5	12.8	20.1	14.7	22.3	12.1	11.4	12.3	13.8	18.3	23.5	16.3	20.4	16.3	10.6	15.3	16.7	14.4	23.3	14.8	12.4	11.5	10.2	10.4	36.4	14.4	14.0	16.8	16.0	16.0	15.4	19.3	20.7	17.7	21.7	18.1	14.6	21.8	16.0	8.6	74.7	12.7	29.5	19.8	17.2	15.8	25.7	14.9	12.2	19.3	16.9	9.9	17.8	10.5	16.9	23.0	34.1	26.2	23.6	26.5	13.4	13.3	25.4	14.8	17.3	12.8	3.1	2.8	4.3	3.2	2.9	2.7	2.5	2.7	2.6	2.4	2.4	2.3	2.9	55.1	4.3	4.5	5.5	1.7	1.2	23.2	24.3	27.1	27.2	24.7	19.6	23.1	13.7	19.6	23.1	53.6	33.1	41.7	69.2	138.9	39.0	58.4	94.3	28.1	45.5	455.4	27.5	88.3	104.5	97.1	10.8	89.6	83.8	93.5	79.0	356.6	77.0	126.4	39.3	76.9	61.7	49.3	71.2	62.0	61.6	4.2	67.3	70.3	55.6	119.0	76.9	41.2	124.5	79.5	82.0	81.7	31.3	64.7	79.6	48.8	70.5	212.0	37.3	67.5	84.5	98.4
RAN	"ARA24, Gsp1, TC4"	ENSG00000132341	"RAN, member RAS oncogene family"	P62826	12	130871879-130877678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063353			Enhanced	Nucleoplasm		No	No		2100000	Nucleoplasm		"HPA063353: "	"unprognostic (2.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (9.99e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (7.86e-5)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (6.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.16e-2)"	52.3	68.3	46.9	75.7	62.7	80.6	53.4	42.1	62.6	38.1	61.9	32.5	41.4	41.7	47.9	59.9	96.4	44.0	36.1	55.2	53.9	59.7	52.6	65.9	50.1	90.3	48.9	61.0	46.9	51.3	31.8	43.8	57.0	50.8	37.0	65.6	28.6	43.7	40.2	84.2	45.5	45.1	59.6	42.1	60.1	47.8	87.2	31.0	84.8	51.7	89.6	108.3	44.7	49.5	94.1	69.3	34.3	62.3	60.5	96.5	110.2	97.8	134.7	116.7	67.5	53.7	66.3	90.1	129.3	67.8	126.1	87.2	144.7	104.3	161.8	87.4	92.9	79.3	63.5	169.6	134.3	137.0	54.2	133.5	95.0	102.8	146.3	65.7	164.3	81.9	62.1	84.0	108.7	158.0	84.2	121.8	116.3	140.0	48.2	123.7	120.3	160.2	198.5	136.9	101.7	215.5	125.3	100.2	90.7	117.6	171.0	107.1	65.5	74.8	67.6	90.7	100.9	133.2	119.1	84.2	72.9	111.4	73.9	120.3	67.4	109.7	227.3	74.9	101.7	101.2	29.6	51.5	34.3	69.6	62.3	84.7	94.1	95.5	79.9	69.3	78.5	87.0	82.5	10.7	60.5	58.0	65.7	96.5	110.2	46.9	62.7	42.1	62.6	53.9	59.7	48.9	61.0	50.8	31.0	169.7	129.5	266.6	518.3	564.3	160.2	103.4	160.5	183.4	197.9	160.5	35.3	577.4	328.3	654.2	67.6	212.9	137.7	233.6	391.9	1042.2	424.8	302.9	190.4	172.1	550.1	131.9	193.7	150.4	155.0	125.0	197.6	285.4	315.5	519.4	219.7	197.5	494.0	152.6	217.1	304.7	106.2	161.7	425.8	567.1	580.4	478.1	512.7	322.1	399.9	542.5
RANBP17		ENSG00000204764	"RAN binding protein 17"	Q9H2T7	5	170861870-171300015	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 16.3"	"Cell type enhanced"	"Detected in many"	12	"Early spermatids: 76.6;Late spermatids: 31.1;Spermatocytes: 27.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBF TERT88: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029568, HPA029569"	Uncertain		Approved	"Nuclear membrane,Nuclear bodies,Cytosol"		Yes	No			"Nuclear bodies"	"Nuclear membrane, Cytosol"	"HPA029568: AB_10599825, HPA029569: AB_10601571"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.56e-3)"	1.6	4.9	1.3	1.8	2.1	0.8	1.8	10.4	3.6	1.8	2.0	2.9	1.1	1.5	5.3	2.8	1.0	2.2	2.7	1.5	1.4	2.2	2.4	1.8	4.1	2.4	1.5	1.7	1.8	7.2	3.6	9.4	5.0	5.3	2.4	2.3	5.4	5.1	2.7	1.0	1.1	2.6	2.4	3.1	1.0	2.5	16.3	0.4	0.1	4.7	0.1	1.4	1.5	1.1	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.1	5.5	4.5	1.5	0.5	3.4	4.0	1.8	2.9	1.7	2.3	0.0	0.1	3.3	3.8	0.0	0.0	0.0	1.7	5.8	0.0	4.3	1.1	2.2	0.0	1.6	0.0	0.0	4.5	0.3	0.3	0.0	0.3	2.6	0.0	0.4	0.0	1.6	2.8	0.0	0.0	0.4	0.8	0.5	0.0	3.6	0.0	0.9	1.4	0.3	2.0	0.0	5.5	2.8	2.5	0.9	1.5	3.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	2.1	10.4	3.6	1.4	2.2	1.5	1.7	5.3	0.4	8.9	1.3	0.0	5.2	0.2	20.8	1.4	5.1	0.0	2.3	0.0	13.7	8.7	0.0	6.3	76.6	2.8	2.8	0.0	1.2	2.7	2.6	5.1	0.0	1.3	1.6	0.0	5.2	3.1	1.2	31.1	2.6	0.0	1.7	1.8	3.3	5.6	3.6	3.5	2.8	0.7	24.1	0.0	2.2	27.1	24.0	0.0	2.1	0.0	4.5	6.1
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719481-108785811	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA			"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.5	24.3	14.4	17.0	18.6	35.5	24.4	23.1	22.2	19.8	17.1	12.8	25.5	13.3	19.9	21.5	17.0	19.1	14.8	20.2	12.9	12.5	18.9	19.5	17.7	19.2	15.1	17.0	32.4	24.1	48.5	37.5	18.8	16.5	21.8	15.8	14.3	20.0	31.6	37.5	17.3	17.4	23.2	17.8	16.3	20.9	20.6	15.9	26.6	28.7	18.0	17.5	20.5	19.7	5.6	5.1	8.3	6.3	4.2	8.7	2.3	18.4	11.3	16.3	14.7	19.0	17.0	15.8	16.6	13.2	13.8	12.1	28.1	8.9	29.1	12.9	17.3	17.0	15.6	27.8	17.3	20.1	17.7	13.5	30.3	14.0	19.8	11.1	35.3	10.2	14.3	13.2	21.5	16.8	13.6	21.0	12.7	32.4	16.1	18.2	10.2	15.6	14.4	20.5	9.3	13.6	14.8	25.0	14.0	12.2	23.1	23.7	10.9	14.7	12.7	16.1	10.2	8.1	16.3	25.0	14.4	19.1	10.1	18.5	13.4	19.8	26.4	11.2	16.0	11.1	8.3	5.3	5.1	7.6	3.4	8.7	5.5	6.3	6.9	4.2	5.6	6.2	6.7	8.3	4.2	6.3	5.1	5.1	2.3	14.4	18.6	23.1	22.2	12.9	12.5	15.1	17.0	16.5	15.9	71.5	71.1	34.9	25.8	49.5	43.3	85.9	33.1	57.6	70.5	55.8	68.7	22.7	1.7	31.3	59.8	43.8	25.7	0.0	44.1	15.0	32.3	38.2	83.1	49.9	41.1	30.2	102.2	27.0	44.0	22.0	35.6	64.2	45.5	49.5	50.9	18.7	36.5	25.9	52.6	15.4	37.7	45.3	62.9	74.1	59.2	59.2	34.0	44.5	31.5	31.5
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41245611-41286251	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 1320.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"		Yes	Yes			"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favorable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	12.2	30.7	23.5	16.9	28.4	28.5	16.1	17.6	41.1	8.5	11.8	23.1	7.3	12.7	9.5	9.4	26.1	11.5	13.7	11.5	26.9	30.4	12.0	25.1	11.5	19.5	31.7	28.6	10.6	20.2	11.0	17.7	16.1	28.1	11.4	9.6	7.1	16.3	13.3	12.5	51.6	12.8	12.3	22.0	14.2	16.0	64.3	28.3	22.1	12.7	14.4	21.7	13.3	29.2	8.7	7.6	8.2	14.8	7.1	13.1	9.7	58.2	30.6	20.0	20.9	10.8	8.9	24.3	50.5	27.6	51.0	26.7	37.1	19.2	31.4	40.8	37.0	24.6	54.3	36.3	39.8	30.8	25.4	56.3	26.6	29.9	28.9	13.5	42.9	20.0	8.6	19.0	36.3	32.2	16.8	26.7	11.8	34.1	22.4	29.0	49.9	25.0	34.9	21.8	53.1	36.4	30.7	19.7	33.1	19.9	33.4	18.2	12.1	35.9	31.8	18.5	19.2	18.7	17.3	41.2	39.1	37.5	21.5	41.5	16.7	22.2	29.9	27.3	30.5	22.5	2.8	9.5	8.2	11.2	11.2	13.1	7.9	11.3	10.3	7.1	8.7	10.5	8.0	2.7	7.1	14.8	7.6	11.6	9.7	23.5	28.4	17.6	41.1	26.9	30.4	31.7	28.6	28.1	28.3	3.0	24.7	28.1	17.5	20.5	15.2	17.4	22.9	9.4	9.1	8.7	13.7	15.1	3.3	34.2	259.8	12.7	10.1	0.0	17.4	28.1	9.3	32.2	5.8	17.9	14.0	14.3	24.0	11.6	13.4	1320.8	13.8	17.1	11.8	10.0	13.9	7.8	29.0	6.5	11.3	11.2	24.4	0.0	9.0	18.0	19.2	27.0	19.8	23.8	10.9	19.2
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 120.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"		NA	NA		120000	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	6.2	6.5	9.1	9.5	9.8	18.7	6.1	6.3	9.8	8.3	6.2	9.6	9.8	6.2	7.4	5.0	15.1	5.7	5.0	6.4	7.3		6.4	6.5	5.5	11.2	7.0	7.1	7.6	5.1	6.9	5.5	7.9	13.5	5.7	5.0	5.7	6.2	6.3	24.6	7.2	6.0	6.8	13.2	6.5	5.8	8.5	9.5	6.8	6.3	4.8	11.7	7.1	3.5	101.9	120.1	118.0	85.5	85.3	89.3	115.9	51.9	42.6	38.9	31.0	14.0	13.8	47.9	31.8	21.6	45.9	33.8	56.2	39.6	47.8	50.4	21.9	24.2	35.8	41.4	34.8	37.7	42.3	39.4	36.8	32.3	41.5	19.8	61.4	32.3	15.1	26.3	41.0	44.0	20.1	34.0	41.6	55.3	45.3	35.2	143.7	61.7	48.7	66.9	45.3	74.3	54.7	34.0	47.5	29.3	50.2	40.0	49.0	47.5	24.4	43.2	35.2	45.7	74.8	35.0	37.0	47.2	36.3	87.0	51.2	80.8	70.1	33.2	37.0	31.9	89.7	77.6	118.0	86.5	85.5	82.1	101.9	82.5	87.8	76.5	90.1	77.7	86.3	89.3	85.3	79.9	120.1	89.3	115.9											65.5	127.4	197.4	354.6	295.8	63.8	60.9	81.5	131.2	154.7	83.7	51.1	325.5	159.2	190.8	135.1	157.7	103.0	116.8	192.9	427.5	170.0	170.0	239.0	101.1	184.0	33.4	152.5	103.2	99.7	35.5	94.6	186.8	197.4	240.7	91.6	97.7	203.4	129.8	80.2	155.5	75.0	97.0	213.9	194.7	163.6	277.9	615.1	199.5	104.0	335.7
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	198	"intestine: 333.2"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 8.9;Collecting duct cells: 12.2;Cone photoreceptor cells: 7.9;Enterocytes: 17.1;Pancreatic endocrine cells: 9.4;Paneth cells: 14.4"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 41.9"	"Region enriched"	"Detected in single"	4	"basal ganglia: 4.6"	"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		96000	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	130.1	0.0	0.0	221.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	1.6	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	333.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	41.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.1	0.0	0.1	0.0	0.0	0.0	5.9	0.0	0.0	2.2	5.5	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	8.9	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	12.2	7.9	0.0	0.0	0.5	0.0	0.0	17.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	9.4	14.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"intestine: 354.2;pancreas: 502.4"	"Cell type enriched"	"Detected in some"	5	"Pancreatic endocrine cells: 8841.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 12.4;EFO-21: 11.8;HDLM-2: 10.9;NB-4: 12.2;RPMI-8226: 15.7;SH-SY5Y: 10.2;U-2 OS: 19.4;U-251 MG: 7.2;U-266/84: 10.2"									"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA		22000000	Cytosol		"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				0.2	0.4	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	73.1	0.2	0.2	276.3	0.2	0.2	0.2	0.0	1.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	502.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	354.2	0.2	0.2	0.2	6.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.1	0.2	0.0	0.0	0.0	15.7	0.0	0.0	1.2	10.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	19.4	3.8	7.2	0.0	10.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.8	4.3	0.0	5.2	0.0	1666.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	97.4	19.1	0.0	8841.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
RER1		ENSG00000157916	"Retention in endoplasmic reticulum sorting receptor 1"	O15258	1	2391775-2405444	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037240, HPA051400"	Supported		Supported	"Golgi apparatus"		No	No			"Golgi apparatus"		"CAB037240: AB_2179604, HPA051400: AB_2681469"	"unprognostic (2.90e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.23e-8)"	"unprognostic (1.01e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.27e-2)"	31.2	59.8	21.6	26.6	24.8	21.2	40.5	22.6	31.1	30.6	40.2	34.6	34.6	34.1	34.0	39.4	63.0	27.0	44.2	31.3	21.0	18.0	44.9	125.8	28.3	39.6	26.8	24.8	31.3	55.8	29.8	31.8	44.8	23.5	30.0	47.5	29.7	57.7	36.9	36.7	35.5	51.5	32.3	24.6	38.6	34.3	35.7	25.3	26.9	36.6	38.5	41.7	28.3	37.3	40.6	62.3	86.1	63.0	36.3	57.3	65.4	38.6	22.0	26.5	29.7	48.9	58.2	19.7	57.5	52.7	52.1	52.4	31.0	60.2	27.3	48.7	59.1	42.0	41.9	30.6	35.4	66.6	34.1	28.2	30.4	46.6	29.7	52.9	33.6	38.2	47.0	36.1	54.1	48.2	35.9	47.6	31.7	36.3	47.2	60.6	27.5	23.8	24.7	17.3	61.8	53.5	28.0	25.9	35.3	46.6	18.7	21.9	25.2	32.2	76.5	45.3	30.8	30.3	25.1	32.7	40.8	23.0	71.8	42.3	44.9	50.1	49.2	43.0	49.5	20.6	46.5	58.5	66.4	50.3	63.0	46.1	40.6	44.7	53.7	53.9	35.1	33.9	41.6	86.1	36.3	61.8	62.3	57.3	65.4	21.6	24.8	22.6	31.1	21.0	18.0	26.8	24.8	23.5	25.3	59.6	41.3	58.1	71.7	47.3	32.8	32.7	132.5	52.2	29.6	99.5	31.4	203.2	56.3	181.2	360.0	58.9	205.6	23.3	226.7	261.7	88.8	117.1	42.8	225.6	195.4	35.0	35.1	84.1	102.8	329.3	76.5	85.4	59.1	129.8	124.7	70.9	203.8	136.3	71.5	98.0	50.2	109.9	61.4	191.9	119.0	58.6	391.3	76.7	138.8	108.5
RFT1	CDG1N	ENSG00000163933	"RFT1 homolog"	Q96AA3	3	53088483-53130462	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA060327, HPA069022"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA060327: AB_2684253, HPA069022: AB_2732126"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.54e-2)"	12.9	19.1	10.8	13.8	14.7	7.2	13.2	11.0	19.2	11.9	11.7	17.0	9.6	10.2	16.2	14.0	16.9	13.0	11.0	12.4	10.2	7.4	10.1	17.7	11.6	15.3	10.5	10.5	15.5	43.7	15.4	9.4	13.8	10.6	11.0	13.8	13.4	18.6	11.3	7.0	13.4	10.5	11.6	11.5	14.5	12.8	23.8	11.1	16.8	15.2	9.1	16.3	12.5	12.1	16.5	27.5	25.9	23.1	11.7	14.5	13.6	16.2	15.4	10.6	16.9	12.5	13.3	22.1	14.8	13.9	25.9	23.7	15.2	32.1	21.5	9.3	14.2	24.4	17.5	23.9	24.2	23.0	20.2	10.5	21.2	11.2	15.0	21.9	19.3	12.5	14.0	20.5	34.8	25.2	11.5	16.4	22.6	11.1	19.7	17.0	16.5	18.1	11.4	21.2	28.4	20.3	7.5	10.2	32.6	14.3	11.0	6.0	8.2	18.3	13.5	13.3	12.0	10.1	27.6	10.8	24.1	15.6	16.4	29.0	12.5	15.0	16.3	17.2	24.8	25.1	25.9	23.1	9.9	13.3	22.4	13.4	12.2	12.5	13.6	24.1	16.5	14.5	14.5	7.7	11.7	15.5	27.5	10.9	13.6	10.8	14.7	11.0	19.2	10.2	7.4	10.5	10.5	10.6	11.1	3.0	3.0	0.8	9.0	4.4	3.9	5.9	10.2	5.3	4.5	8.7	3.9	35.2	1.7	14.2	1.0	5.8	4.3	0.0	18.4	27.2	7.5	7.0	2.3	9.5	19.8	4.8	2.4	10.4	8.7	1.4	8.1	4.7	6.8	10.8	6.7	4.9	11.3	10.2	5.6	4.8	6.1	0.0	2.8	9.3	9.6	3.8	20.3	6.4	10.0	6.4
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605158-49636884	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease mutation, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 54.1"	"Cell type enriched"	"Detected in some"	50	"Erythroid cells: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	190	"HEL: 87.8;K-562: 86.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				1.2	0.2	0.0	1.1	0.5	54.1	3.2	0.0	0.1	2.3	1.0	0.5	1.7	0.2	0.4	0.1	2.6	0.5	0.8	5.3	0.0	0.0	0.1	0.7	3.3	0.1	0.0	0.0	0.1	0.2	0.1	0.1	5.8	0.1	1.3	0.2	0.0	0.2	0.5	0.4	0.1	0.9	0.1	0.0	4.5	0.6	0.2	0.0	1.7	1.8	0.0	0.1	0.8	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	116.8	0.2	0.3	0.0	0.0	2.3	0.0	0.4	0.0	0.0	1.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
RHBDD1	DKFZp547E052	ENSG00000144468	"Rhomboid domain containing 1"	Q8TEB9	2	226835581-226999215	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 35.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013972, HPA057125"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA013972: AB_2178629, HPA057125: AB_2683343"	"unprognostic (1.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.04e-2)"	12.7	14.8	10.8	16.7	16.0	11.0	13.6	8.3	13.0	13.8	14.3	21.2	9.4	11.0	20.6	16.3	13.6	15.4	12.4	14.5	11.4	9.0	13.6	16.9	12.6	17.7	17.6	11.0	18.8	20.4	18.6	17.1	10.5	13.0	15.7	12.4	13.1	14.3	15.5	13.9	13.0	17.5	15.6	16.5	17.3	13.2	25.6	14.7	56.6	17.3	8.8	18.9	18.7	15.4	19.9	16.6	9.8	15.5	8.8	12.5	8.5	5.2	4.5	4.8	7.4	14.6	14.6	0.0	12.5	10.0	6.2	7.1	3.9	9.1	4.9	10.4	12.6	9.0	6.1	0.0	13.0	11.8	12.5	5.0	7.2	2.9	3.4	15.7	7.6	4.2	13.6	19.0	11.8	25.7	7.2	4.7	13.0	19.3	12.9	6.4	10.0	12.9	3.9	0.0	6.1	4.8	5.6	0.0	7.1	5.0	6.3	4.7	3.6	6.8	2.4	9.2	9.5	6.9	8.8	6.2	2.8	6.3	10.7	3.5	14.4	6.7	35.4	9.1	9.3	8.2	8.1	11.1	9.8	6.1	15.5	9.7	17.3	9.6	7.5	13.7	19.9	10.8	8.9	2.5	8.8	10.3	16.6	12.5	8.5	10.8	16.0	8.3	13.0	11.4	9.0	17.6	11.0	13.0	14.7	11.9	5.4	22.9	7.2	4.6	6.3	14.0	2.5	4.0	7.9	10.4	15.7	6.0	3.3	6.1	12.7	5.8	5.0	0.0	8.0	3.3	5.2	9.4	8.1	11.3	4.6	11.1	1.7	3.1	9.2	13.7	5.2	5.0	11.8	1.8	7.1	9.3	7.2	0.0	6.3	2.9	5.9	0.0	7.2	12.9	7.1	4.8	4.7	6.5	3.7	7.7
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein (gene/pseudogene)"	Q9H310	1	156369212-156385219	"Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 23.2;kidney: 16.9;ovary: 5.9"	"Cell type enhanced"	"Detected in some"	15	"Collecting duct cells: 21.0;Distal tubular cells: 16.6;Early spermatids: 10.7;Late spermatids: 8.6"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in some"	15	"cerebellum: 23.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	65	"CACO-2: 4.8;Hep G2: 5.7;RT4: 10.0"					"Low region specificity"	"Detected in all"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	23.2	0.1	0.3	0.3	0.0	1.0	0.0	0.1	0.0	2.2	0.0	0.0	0.1	0.1	0.1	16.9	3.3	0.1	0.0	0.1	0.1	5.9	0.2	0.0	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.4	0.1	1.0	0.3	0.0	0.1	0.1	0.1	1.2	0.0	0.0	0.1	1.1	1.2	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	23.2	0.1	0.1	0.1	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	21.0	0.0	0.0	16.6	0.3	10.7	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.0	4.3	0.1	0.0	0.0	0.0	0.0	8.6	0.3	0.0	0.0	1.0	0.0	1.1	0.1	0.0	0.4	0.9	0.0	0.0	0.0	2.2	0.4	0.4	0.0	0.0	0.0	0.0
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"bone marrow: 40.5"	"Cell type enriched"	"Detected in some"	33	"Erythroid cells: 210.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.4"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.4"	"Cell line enriched"	"Detected in some"	5	"HEL: 44.7"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (1.37e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-5)"	"unprognostic (1.38e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.63e-1)"	0.6	0.8	2.0	0.6	5.1	40.5	0.9	3.3	4.7	0.8	0.7	3.5	1.0	0.7	0.7	5.2	1.4	1.6	0.8	2.1	2.6	1.5	0.8	2.2	0.7	1.0	2.1	2.5	0.9	9.6	0.5	4.0	1.6	5.9	1.6	0.8	2.2	8.4	0.8	1.9	1.1	0.6	0.5	2.9	2.1	0.8	2.6	1.4	1.2	1.1	1.2	0.8	0.5	0.6	0.1	0.2	2.4	0.2	0.1	0.3	0.9	0.1	0.0	0.1	0.2	0.4	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.7	0.3	0.5	0.5	0.0	0.1	0.0	0.1	0.1	0.2	0.0	44.7	0.0	0.0	0.6	0.0	0.3	1.0	0.7	0.3	0.2	0.0	0.0	0.3	8.7	0.2	0.2	0.4	0.0	0.3	0.9	0.3	0.2	0.1	0.1	1.2	0.0	0.0	0.3	0.4	0.1	0.1	0.5	0.4	0.2	0.0	0.0	0.1	0.0	0.4	0.0	2.6	0.6	0.5	1.5	0.4	0.2	2.4	0.2	0.6	0.3	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.2	0.0	1.0	0.1	0.0	0.1	0.3	0.9	2.0	5.1	3.3	4.7	2.6	1.5	2.1	2.5	5.9	1.4	0.0	0.0	0.0	0.5	0.5	3.3	0.4	2.5	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.8	0.0	0.0	210.2	0.2	0.4	0.2	0.4	4.6	0.4	0.2	6.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.1	0.4	0.0	0.7	0.0	2.5	6.5	0.0	2.8	5.1	1.3	0.7	0.0	0.1	0.7
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496613	"Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 304.0;lymphoid tissue: 185.9;tongue: 115.4;vagina: 91.8"	"Group enriched"	"Detected in some"	4	"Muller glia cells: 63.6;Urothelial cells: 75.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 8.0;hTCEpi: 4.5;RT4: 4.5;SK-MEL-30: 2.7"	"Region enriched"	"Detected in some"	5	"olfactory region: 10.4"	"Low region specificity"	"Detected in many"			"HPA041874, HPA043317"	Enhanced					NA	NA					"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.0	0.5	60.6	0.2	0.0	0.0	0.2	4.4	0.2	304.0	0.3	0.3	0.3	0.2	0.0	8.6	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.0	0.2	0.1	0.3	0.2	0.1	37.3	0.3	0.2	0.7	0.2	0.3	0.2	0.2	0.2	0.3	0.0	0.0	0.2	115.4	185.9	0.5	91.8	0.6	0.3	0.0	0.2	0.0	0.6	0.0	0.0	8.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.6	1.6	0.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	4.5	0.3	0.3	0.8	0.0	2.7	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.6	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.2	0.6	0.1	0.1	0.6	0.4	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.2	0.0	0.3	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	8.8	1.1	0.8	0.4	0.0	0.0	0.0	14.0	0.0	0.0	13.3	1.1	1.6	0.0	0.0	0.0	0.3	0.0	0.1	7.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	63.6	1.2	4.0	0.0	0.0	2.4	0.0	0.4	0.1	0.1	15.6	0.0	0.0	0.0	75.2
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 10.0;bone marrow: 16.5;salivary gland: 7.1"	"Cell type enriched"	"Detected in some"	20	"Erythroid cells: 23.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.0"	"Group enriched"	"Detected in some"	6	"HEL: 28.2;K-562: 8.7"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.3	0.3	0.3	0.5	0.5	16.5	0.3	1.5	1.4	0.6	0.3	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.4	0.9	0.3	0.2	0.3	0.3	2.5	0.8	0.3	0.3	0.9	0.3	0.1	0.4	0.3	1.1	0.5	0.0	0.3	7.1	0.3	4.1	2.5	0.4	0.3	0.4	1.8	0.3	0.5	0.3	0.3	0.4	2.3	0.3	0.3	0.3	2.0	0.6	10.0	1.4	1.4	1.4	1.2	0.1	0.0	0.2	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.3	0.4	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.5	0.1	28.2	0.7	0.2	0.0	0.3	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	8.7	0.7	0.0	0.1	0.2	0.2	3.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.5	0.3	0.1	0.2	0.1	0.1	0.2	0.5	0.4	0.5	0.2	0.4	0.1	0.3	0.1	0.1	0.5	0.2	0.1	4.9	1.4	2.8	1.0	0.6	1.1	1.3	1.3	0.8	0.2	2.0	1.4	1.3	10.0	1.4	0.8	0.6	0.9	1.2	0.3	0.5	1.5	1.4	0.3	0.2	0.3	0.3	1.1	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.8	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	23.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0
RHO	"CSNBAD1, OPN2, RP4"	ENSG00000163914	Rhodopsin	P08100	3	129528640-129535169	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Congenital stationary night blindness, Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	151	"retina: 415.0"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 2822.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"cerebellum: 1.6;cerebral cortex: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA013440, CAB022486, CAB034887, CAB034888"	Enhanced					NA	NA					"CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844"	"unprognostic (4.32e-2)"			"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.87e-1)"		"unprognostic (1.94e-1)"			"unprognostic (9.19e-11)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.91e-1)"		0.2	0.0	0.0	0.0	0.3	0.0	0.1	1.6	2.7	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.5	0.0	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.4	0.2	0.0	0.0	0.1	415.0	0.3	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	2.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	290.1	0.6	0.0	0.0	0.0	0.0	428.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	206.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	393.2	0.0	0.0	0.0	0.0	2822.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RIC3	"AYST720, FLJ11608, PRO1385"	ENSG00000166405	"RIC3 acetylcholine receptor chaperone"	Q7Z5B4	11	8106093-8169055	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 168.2;Cone photoreceptor cells: 135.5;Rod photoreceptor cells: 208.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.2;HMC-1: 3.7;NTERA-2: 6.8;SCLC-21H: 11.6;SH-SY5Y: 8.0;SuSa: 6.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065016	Approved				"Intracellular and membrane"	NA	NA					"HPA065016: AB_2685404"	"unprognostic (2.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.45e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-9)"	"unprognostic (4.37e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.52e-2)"	2.1	14.5	14.6	8.2	18.5	2.6	8.6	25.3	20.8	4.7	7.0	8.4	11.3	2.9	11.6	28.0	5.0	8.1	4.9	8.2	9.8	10.5	6.6	2.2	4.7	9.3	9.8	17.0	17.4	12.0	22.7	23.2	1.0	16.4	15.3	3.3	9.8	13.1	14.7	6.7	17.4	5.7	9.3	10.1	6.9	6.2	7.7	9.9	0.4	17.1	1.9	8.8	7.7	4.0	12.8	1.5	2.9	1.5	1.8	6.9	0.8	0.0	1.2	2.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	3.2	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.6	0.0	0.0	0.0	3.7	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.2	0.0	0.2	6.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	11.6	8.0	0.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	1.2	0.2	1.6	0.7	0.0	0.0	0.1	0.0	0.1	2.9	0.6	1.2	2.2	0.8	1.5	11.0	4.6	2.4	0.6	12.8	6.9	5.9	1.8	1.8	1.5	1.5	2.5	0.8	14.6	18.5	25.3	19.1	9.8	10.5	9.8	17.0	16.4	9.9	6.0	13.3	79.3	48.3	32.3	168.2	11.8	20.4	25.4	30.7	22.7	135.5	0.3	0.0	27.5	1.8	3.3	0.0	23.3	24.9	0.3	3.8	35.3	23.2	4.9	0.2	90.6	7.5	1.3	0.6	1.5	31.1	2.8	11.8	2.8	1.3	61.0	15.9	0.3	43.9	1.5	208.7	0.0	2.7	51.4	36.1	34.6	0.5	12.2	0.0	34.1
RNASEK	MGC71993	ENSG00000219200	"Ribonuclease K"	Q6P5S7	17	7012417-7014532	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 97.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044708	Uncertain					NA	NA					"HPA044708: AB_10962051"	"unprognostic (7.59e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.73e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.50e-3)"	"prognostic favorable (1.92e-4)"	"unprognostic (2.93e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-3)"	61.6	116.2	79.8	55.0	81.4	86.1	114.0	49.9	121.1	56.4	50.2	41.5	64.3	54.0	50.7	51.3	60.4	67.0	65.9	90.9	79.4	95.6	92.6	85.2	111.9	141.9	76.7	69.2	57.2	72.7	61.5	98.7	56.3	76.3	53.3	41.6	51.0	69.4	64.6	74.0	60.1	50.2	50.5	82.8	80.7	51.0	61.3	34.7	62.8	64.6	56.6	55.5	63.2	47.0	52.7	92.8	191.8	97.9	34.9	39.2	73.7	33.2	55.9	25.3	43.1	66.0	59.9	22.6	34.6	62.2	45.9	52.1	23.5	31.6	23.9	35.1	67.3	54.2	50.1	31.0	42.6	24.8	48.0	81.5	23.6	45.6	38.0	75.8	14.7	117.7	74.6	51.8	53.9	30.9	50.5	54.3	26.2	20.5	51.4	54.7	31.5	20.2	49.2	17.4	27.1	48.9	24.0	14.5	27.3	59.2	29.9	13.0	46.5	29.4	21.1	61.2	25.9	27.3	26.9	49.2	48.5	21.0	59.7	43.3	42.0	41.0	10.2	75.4	34.4	39.3	67.6	97.9	114.1	35.0	86.6	34.7	52.7	39.2	35.4	73.9	49.1	31.9	30.5	191.8	34.9	81.4	92.8	38.4	73.7	79.8	81.4	49.9	121.1	79.4	95.6	76.7	69.2	76.3	34.7	53.6	59.1	23.1	6.8	18.2	14.5	0.4	10.2	97.7	78.5	5.2	39.3	4.5	3.3	14.4	4.5	17.3	18.2	0.0	4.8	2.6	14.5	9.2	50.0	14.0	12.8	11.1	12.7	25.8	72.0	4.1	8.3	36.6	20.3	38.7	7.7	8.9	12.8	12.7	6.0	3.0	32.2	25.8	10.3	3.7	0.7	19.1	9.8	32.4	9.3	10.5
RNPS1		ENSG00000205937	"RNA binding protein with serine rich domain 1"	Q15287	16	2253116-2268412	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044014	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA044014: AB_10966286"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.27e-1)"	15.5	17.7	25.2	17.4	22.9	42.6	17.1	36.0	34.1	16.4	19.2	19.2	11.5	16.2	20.7	17.0	22.1	21.4	18.3	20.0	23.1	26.7	15.5	18.5	14.8	23.7	20.7	27.4	22.2	17.1	18.3	20.9	26.8	21.7	18.6	14.4	16.7	15.7	20.0	50.9	23.0	15.6	17.8	16.2	19.5	16.6	73.5	13.7	19.5	17.6	29.9	22.8	17.2	15.9	52.4	40.0	30.2	44.3	43.9	48.7	62.1	18.3	28.3	28.2	32.0	16.2	15.4	34.7	20.0	17.2	34.5	30.0	55.0	26.7	37.1	22.9	19.0	19.2	28.5	38.2	27.4	23.1	29.1	50.0	24.5	23.4	35.8	27.6	26.4	29.3	18.5	31.4	27.5	37.5	14.4	26.2	25.2	48.2	38.4	27.0	46.7	64.7	61.7	63.9	22.8	22.8	82.0	28.9	58.8	22.3	12.9	66.6	38.4	25.4	30.6	29.2	14.2	31.0	33.3	16.9	29.8	28.3	26.3	30.9	35.0	47.7	92.6	12.7	29.2	34.9	10.0	37.1	30.2	46.7	42.9	46.1	48.1	45.5	47.6	40.0	52.4	43.5	45.9	11.4	43.9	44.3	33.9	48.7	62.1	25.2	22.9	36.0	34.1	23.1	26.7	20.7	27.4	21.7	13.7	41.7	60.8	131.7	157.1	183.5	110.7	32.3	50.9	40.2	63.7	48.8	131.6	149.8	59.7	107.8	13.7	82.0	69.1	46.7	81.2	199.4	93.8	114.0	102.6	30.8	92.9	92.2	117.0	57.1	53.6	19.1	87.2	74.7	92.8	124.4	85.6	85.3	94.1	70.2	64.7	48.4	116.7	84.1	124.8	116.4	243.4	185.7	135.5	138.5	109.0	172.1
ROMO1	"bA353C18.2, C20orf52, MTGMP"	ENSG00000125995	"Reactive oxygen species modulator 1"	P60602	20	35699272-35700984	"Predicted intracellular proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012782	Uncertain					NA	NA					"HPA012782: AB_1845685"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.84e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-2)"	28.1	38.7	32.0	31.8	27.5	32.4	27.6	10.8	25.2	26.3	36.8	17.5	30.3	35.1	23.4	42.7	38.6	26.2	34.1	86.4	24.8	25.5	43.8	58.6	21.4	24.0	28.7	20.6	23.0	46.8	12.2	34.7	24.1	26.4	24.5	21.9	29.3	46.9	45.2	137.9	23.5	31.0	26.4	24.7	23.7	31.8	30.1	17.4	24.1	33.5	45.2	27.6	31.8	29.3	74.8	140.1	65.4	82.1	47.8	68.2	88.1	31.7	48.2	16.7	20.9	12.1	16.5	29.9	16.9	18.8	25.4	24.9	116.4	27.2	15.3	41.3	11.8	38.8	33.1	8.9	41.6	6.0	8.9	62.3	27.3	55.7	126.6	26.0	16.4	14.5	21.3	19.8	17.9	12.7	12.1	20.3	29.1	21.3	31.7	11.8	91.8	37.1	47.2	27.3	31.6	87.1	24.6	33.6	34.4	23.5	49.7	24.4	25.8	30.6	56.6	30.6	15.7	51.7	37.5	17.7	44.6	25.7	30.0	29.1	53.9	45.6	38.3	39.4	13.5	25.7	65.4	82.1	58.5	56.2	65.2	52.8	74.8	58.5	55.1	76.0	65.5	50.1	56.1	44.5	47.8	60.6	140.1	68.2	88.1	32.0	27.5	10.8	25.2	24.8	25.5	28.7	20.6	26.4	17.4	95.3	176.1	118.3	71.0	105.0	23.0	570.3	318.5	346.6	219.5	244.3	7.9	242.8	341.5	328.0	18.5	164.1	543.2	46.7	496.0	214.3	201.3	104.8	187.2	536.3	194.2	19.1	315.2	192.1	176.3	40.5	120.8	197.3	224.4	348.9	291.8	87.1	470.1	340.1	120.6	547.9	29.4	116.4	195.7	287.5	185.5	133.9	273.3	110.7	265.9	104.0
RTBDN	FLJ36353	ENSG00000132026	Retbindin	Q9BSG5	19	12825478-12835428	"Predicted membrane proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 17.3;pituitary gland: 25.8;retina: 57.0"	"Group enriched"	"Detected in some"	7	"Cone photoreceptor cells: 329.9;Rod photoreceptor cells: 289.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 1.7;neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.2;SH-SY5Y: 5.4;U-266/84: 21.1;U-87 MG: 4.8"					"Not detected"	"Not detected"			HPA052511			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Endoplasmic reticulum"		"HPA052511: AB_2797243"	"unprognostic (4.55e-4)"	"unprognostic (3.94e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.66e-9)"	"unprognostic (3.55e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.24e-2)"	0.3	6.9	10.2	0.5	3.4	0.9	0.3	2.7	17.3	0.2	0.9	0.4	0.0	1.0	0.3	1.5	0.3	0.3	0.4	0.3	7.3	5.1	0.2	0.4	0.5	0.4	2.8	2.8	0.3	2.5	0.2	25.8	0.3	4.0	0.4	0.9	57.0	0.3	0.3	0.3	0.5	1.0	0.6	1.0	0.4	2.5	3.5	0.0	7.0	0.4	0.0	0.4	0.3	0.0	0.3	0.2	1.8	0.2	0.4	0.2	0.0	0.9	0.1	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.1	0.9	0.9	0.0	0.6	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.4	0.9	0.0	0.1	2.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	1.2	2.7	0.0	0.1	0.0	0.0	0.9	0.7	1.1	0.7	0.1	1.0	0.0	0.0	8.2	5.4	0.1	0.1	0.4	0.4	2.7	0.7	0.0	0.8	1.0	0.7	0.1	1.2	21.1	4.0	4.8	0.0	0.0	1.7	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.2	1.8	0.4	0.2	0.2	0.1	0.0	10.2	3.4	2.7	8.6	7.3	5.1	2.8	2.8	4.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	1.4	0.0	0.0	0.0	0.0	329.9	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	27.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.5	45.9	0.1	0.0	0.0	0.0	289.4	0.0	0.0	11.5	5.1	0.0	0.0	0.0	0.0	0.0
RXFP3	"GPCR135, RLN3R1, RXFPR3, SALPR"	ENSG00000182631	"Relaxin/insulin like family peptide receptor 3"	Q9NSD7	5	33936386-33938237	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"adrenal gland: 3.1;brain: 1.1;pancreas: 1.7;pituitary gland: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA027833	Uncertain					NA	NA					"HPA027833: AB_1849247"	"unprognostic (1.93e-2)"					"unprognostic (3.66e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.86e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.72e-1)"		"unprognostic (8.67e-3)"				0.0	3.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3		0.0	1.7	0.0	1.1	0.0		0.0	0.0		0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433699-38587564	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 231.0"	"Cell type enriched"	"Detected in many"	5	"Muller glia cells: 46.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 3.2;myeloid DC: 5.3;non-classical monocyte: 6.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 5.3;monocytes: 6.3"	"Cell line enhanced"	"Detected in some"		"A549: 5.7;HaCaT: 14.0;hTCEpi: 5.7;RH-30: 11.5;SiHa: 22.8;U-2 OS: 9.6"	"Low region specificity"	"Detected in some"							HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Golgi apparatus, Vesicles"	Cytosol	"HPA056416: AB_2683121"	"unprognostic (2.22e-3)"	"unprognostic (1.91e-3)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.07e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.34e-1)"	5.3	0.7	3.0	0.6	1.9	0.4	0.6	2.7	1.7	0.6	0.4	2.7	0.0	0.4	0.4	6.7	3.0	0.6	0.5	0.4	1.8	4.0	0.5	0.4	0.7	0.6	1.5	1.3	0.4	0.4	0.3	0.3	0.6	1.9	0.9	0.4	0.4	2.2	0.6	231.0	2.4	0.5	0.4	1.1	0.6	0.5	1.6	1.9	0.0	1.6	55.1	3.2	0.6	0.5	0.7	5.3	0.1	6.3	0.0	0.6	0.6	0.0	5.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.0	0.3	0.3	4.8	0.0	0.0	14.0	0.2	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.4	1.3	5.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.7	0.0	0.0	11.5	1.1	0.6	0.0	0.0	1.1	22.8	0.0	0.0	0.4	0.5	4.3	0.0	0.0	9.6	0.2	0.0	0.3	1.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.4	3.2	0.5	0.4	0.3	0.6	5.3	0.7	0.0	0.0	0.1	0.0	6.3	0.0	0.6	0.6	3.0	1.9	2.7	1.7	1.8	4.0	1.5	1.3	1.9	1.9	0.0	0.6	0.0	3.4	10.1	4.1	3.4	0.0	0.0	0.0	0.0	2.0	0.1	5.0	0.1	5.2	0.0	0.0	0.0	0.0	0.2	0.3	0.6	0.0	0.0	7.1	1.6	0.0	0.6	1.9	4.7	2.8	4.5	0.0	0.0	0.0	46.0	0.0	0.0	1.8	0.0	1.5	0.0	0.3	5.5	6.9	4.1	0.2	0.0	0.0	0.1
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042205-237833988	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 106.6"	"Cell type enriched"	"Detected in many"	30	"Cardiomyocytes: 1960.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.8;HEK 293: 10.7;K-562: 3.3;NB-4: 2.7;NTERA-2: 4.0;U-937: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Plasma membrane, Cytosol"		"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	1.1	0.9	6.2	0.9	18.7	0.5	1.1	14.8	10.5	1.3	1.2	0.0	1.2	0.7	1.1	0.7	1.8	1.0	1.8	106.6	5.7	1.1	0.9	0.9	1.4	0.6	1.0	7.3	2.2	4.2	0.5	2.0	1.1	1.6	2.0	0.8	0.2	0.9	1.4	0.9	1.0	1.0	4.6	1.0	1.0	1.2	1.1	3.0	0.0	2.7	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.3	0.0	0.0	0.3	0.6	0.0	0.0	7.8	10.7	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	2.7	4.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.2	18.7	14.8	10.5	5.7	1.1	1.0	7.3	1.6	3.0	0.0	0.3	0.0	0.0	0.3	65.2	1960.0	0.0	1.4	2.3	1.8	9.8	0.0	0.0	0.0	15.8	1.5	0.0	0.0	2.5	0.0	2.1	0.0	0.0	0.0	0.1	1.6	3.4	1.3	0.0	10.2	1.1	0.0	8.5	0.0	0.0	1.5	0.3	0.0	0.0	0.0	4.7	0.0	18.6	3.2	0.9	0.0	0.0	0.0	0.0	0.0
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 465.5;skeletal muscle: 423.5"	"Cell type enhanced"	"Detected in many"	22	"Collecting duct cells: 146.5;Distal tubular cells: 137.6;Hofbauer cells: 149.3;Melanocytes: 323.9;Proximal tubular cells: 712.0"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"Hep G2: 43.7;SK-MEL-30: 149.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		240000	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	27.7	3.2	70.0	2.8	67.3	2.2	14.3	4.1	42.5	2.0	2.4	47.3	0.0	3.5	2.6	8.5	14.1	8.8	2.6	465.5	44.9	42.9	20.0	2.6	2.4	2.5	85.0	30.7	2.2	4.5	2.0	4.3	4.5	31.4	6.3	2.1	4.3	99.3	3.7	423.5	4.0	2.9	2.1	87.7	2.4	3.3	2.8	31.8	0.0	29.0	57.6	4.7	2.9	0.1	0.6	0.6	2.1	1.0	0.3	0.5	0.5	0.7	0.3	0.5	4.6	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.9	0.4	0.5	19.6	0.0	0.2	1.1	0.0	0.0	0.0	0.5	0.4	1.0	0.6	43.7	0.0	0.3	0.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	3.5	0.5	0.0	1.2	0.1	0.5	0.2	0.5	0.4	3.1	0.4	1.1	0.8	1.7	0.7	0.2	0.3	1.4	149.9	1.4	4.5	2.3	0.4	0.4	0.3	0.3	0.4	0.7	0.7	0.7	0.3	0.8	0.2	2.1	0.3	0.0	0.1	0.3	0.1	0.0	0.2	0.5	0.0	0.6	0.3	0.0	0.0	0.3	1.0	0.6	0.0	0.5	70.0	67.3	4.1	42.5	44.9	42.9	85.0	30.7	31.4	31.8	0.0	0.0	0.0	1.1	8.7	0.6	57.3	5.1	0.0	0.0	146.5	2.0	0.9	137.6	0.7	0.5	2.1	0.9	0.0	3.4	0.8	2.3	1.2	0.0	3.2	149.3	0.0	1.7	13.5	0.6	1.5	6.1	1.3	323.9	0.0	2.2	60.1	1.1	0.0	8.5	712.0	2.2	0.0	2.1	0.9	0.7	1.9	2.9	0.0	1.5	0.6
S100A10	"42C, ANX2LG, CAL1L, CLP11, P11"	ENSG00000197747	"S100 calcium binding protein A10"	P60903	1	151982915-151994390	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 148.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 148.1;monocytes: 89.2;T-cells: 85.4"	"Cell line enhanced"	"Detected in many"		"OE19: 273.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003340, CAB025484"	Enhanced		Approved	Mitochondria		Yes	No		230000	Mitochondria		"CAB025484: , HPA003340: AB_1856531"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.33e-4)"	"prognostic unfavorable (1.00e-4)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.84e-4)"	36.7	19.9	7.3	12.1	9.4	4.5	30.7	7.3	10.7	19.0	42.3	8.4	7.3	23.4	7.3	10.1	87.1	8.5	10.7	16.7	7.3	4.4	19.1	10.2	33.5	7.3	7.3	7.3	11.5	7.3	1.6	7.3	18.7	11.1	8.5	49.8	9.5	21.1	7.3	7.3	21.8	21.7	14.0	9.6	7.3	8.6	61.4	7.3	7.3	7.3	22.1	13.6	8.1	37.7	17.8	148.1	21.4	89.2	25.9	85.4	74.8	63.5	65.2	0.2	13.5	73.8	98.4	48.6	36.0	48.7	32.3	32.8	117.1	88.5	0.0	35.0	62.8	38.3	111.1	18.5	140.1	30.1	11.4	5.3	7.7	29.7	27.4	26.4	2.9	6.7	25.5	118.1	35.2	40.5	29.0	71.4	4.2	0.1	0.1	42.9	55.1	0.5	18.6	8.8	273.2	72.5	0.0	12.6	1.2	136.1	18.9	0.5	0.5	58.8	21.1	27.4	77.4	46.6	7.4	75.8	15.5	38.8	73.4	25.1	1.7	0.3	10.9	91.1	2.6	54.2	21.4	89.2	21.0	33.3	54.4	35.2	17.8	52.6	42.3	148.1	8.6	19.6	29.5	3.2	25.9	46.5	24.2	85.4	74.8	7.3	9.4	7.3	10.7	7.3	4.4	7.3	7.3	11.1	7.3	2373.2	509.0	165.5	824.9	1416.6	10.1	91.6	634.4	507.3	913.4	902.0	3.9	1028.8	1291.5	1817.5	320.0	1052.4	1898.6	46.7	1882.2	473.9	2108.7	1493.1	280.8	168.1	1060.4	15.9	1037.0	742.7	952.8	225.8	599.2	1623.9	1548.8	1432.9	1679.7	14.1	2865.9	3115.1	60.8	287.0	25.8	142.3	345.1	12.6	80.7	1085.7	314.3	441.6	1750.5	1802.8
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 223.9;tongue: 102.1"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 744.7;Glandular cells: 697.0;Pancreatic endocrine cells: 790.1;Suprabasal keratinocytes: 794.3;Urothelial cells: 1359.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	7	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 2.0"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 117.9;SK-BR-3: 142.9"	"Low region specificity"	"Detected in all"							HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		92000	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (3.18e-4)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	20.1	5.5	9.3	8.0	7.2	0.0	11.9	3.4	8.3	37.2	21.1	8.3	3.2	16.2	8.7	7.2	223.9	7.6	18.2	9.5	6.7	5.4	14.3	27.0	18.3	7.5	7.1	5.7	15.3	4.1	6.5	3.3	14.9	7.2	9.3	14.5	5.1	35.5	5.4	9.8	43.1	31.2	10.6	5.9	13.4	10.6	12.3	4.6	3.2	11.3	102.1	87.5	11.3	51.3	0.0	2.0	0.0	0.0	0.0	0.0	0.0	56.4	27.2	1.4	3.2	9.4	35.7	3.7	32.3	29.7	26.6	23.6	25.5	31.6	0.0	51.9	48.3	6.0	41.5	0.0	72.5	15.6	0.1	0.0	0.0	23.7	7.5	10.8	0.0	0.0	16.9	69.7	64.4	50.7	34.8	117.9	0.0	0.6	0.0	58.5	75.0	0.0	0.1	6.0	100.1	73.6	0.0	16.4	0.1	100.2	20.3	0.0	0.1	23.8	142.9	4.7	12.9	44.4	0.3	63.2	16.0	25.6	15.4	73.0	0.0	0.2	0.1	47.6	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	9.3	7.2	3.4	8.3	6.7	5.4	7.1	5.7	7.2	4.6	35.7	18.0	15.1	744.7	563.0	0.4	29.7	119.8	26.8	103.5	102.9	2.0	12.3	61.3	584.7	3.2	283.5	336.2	0.0	172.2	7.2	105.8	697.0	19.5	109.5	4.7	0.0	133.3	333.3	22.5	10.0	62.2	11.1	106.3	12.6	178.6	38.3	790.1	294.7	57.7	126.7	1.8	6.5	41.5	1.7	1.2	794.3	6.9	12.8	201.3	1359.9
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598962-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 342.0"	"Cell type enhanced"	"Detected in some"	16	"Kupffer cells: 25.7;Macrophages: 53.7;Melanocytes: 94.5;monocytes: 55.9"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 78.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 78.0"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 82.9;WM-115: 163.0"	"Low region specificity"	"Detected in all"							"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		120000	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	67.7	14.0	60.9	5.6	51.0	2.0	13.2	39.4	151.2	5.2	9.1	101.0	3.0	4.7	1.5	7.6	8.6	2.1	8.3	6.6	74.6	65.4	1.5	1.6	2.9	9.8	152.0	36.5	2.4	3.0	1.1	3.1	1.4	90.3	3.0	8.3	7.4	10.1	15.3	1.3	5.7	7.5	4.3	342.0	5.7	4.3	1.5	46.4	0.0	1.3	1.8	10.8	8.2	1.6	0.1	3.4	0.7	1.9	11.0	78.0	10.6	0.1	0.0	18.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	82.9	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.2	1.0	163.0	0.0	0.1	0.0	78.0	1.8	22.4	0.0	0.2	14.5	3.4	0.1	0.6	33.3	0.7	11.0	1.9	0.8	0.0	10.6	60.9	51.0	39.4	37.6	74.6	65.4	152.0	36.5	90.3	46.4	3.0	7.4	0.9	0.2	14.9	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.2	7.6	0.0	0.0	4.9	25.7	0.4	5.2	53.7	94.5	55.9	0.0	9.7	0.1	0.0	0.0	0.0	4.0	0.0	2.1	0.0	0.1	11.0	0.1	0.5	0.0	0.1
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236888-101241518	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 88.9"	"Group enriched"	"Detected in many"	5	"Endothelial cells: 89.9;Ito cells: 114.2;Muller glia cells: 38.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 19.4;HUVEC TERT2: 54.9;TIME: 30.5;U-251 MG: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles		No	NA			Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.41e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.78e-4)"	72.3	8.4	24.7	16.6	26.2	9.7	46.3	21.6	21.8	13.3	10.5	9.5	2.5	5.7	12.1	5.0	14.7	11.5	17.6	43.5	22.9	15.4	8.9	20.5	35.7	24.5	23.2	14.0	7.9	11.0	13.4	4.7	29.6	21.2	8.9	7.0	9.3	7.5	5.6	21.7	8.2	9.8	19.0	11.0	35.2	8.0	5.8	13.9	4.4	17.0	8.7	15.7	15.2	18.5	27.4	0.2	88.9	0.2	33.4	49.8	30.8	3.6	0.0	3.9	0.0	0.4	9.3	0.0	19.4	3.5	11.8	4.2	0.0	0.1	0.0	4.8	6.7	0.0	0.0	0.5	0.2	7.9	1.3	0.4	1.3	0.1	0.0	1.8	0.0	0.8	12.5	0.0	0.0	0.9	0.5	54.9	1.1	0.0	4.0	3.7	0.0	4.6	0.0	1.0	0.1	1.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	30.5	2.0	0.7	0.4	37.6	0.3	0.0	0.2	0.2	0.0	0.1	88.9	0.1	4.9	49.8	0.1	40.2	25.1	45.3	44.1	0.2	27.4	35.7	36.2	1.4	33.4	0.2	0.2	26.8	30.8	24.7	26.2	21.6	16.8	22.9	15.4	23.2	14.0	21.2	13.9	0.0	12.8	17.1	0.1	6.8	0.0	16.9	2.5	0.0	2.3	0.0	0.0	5.5	0.0	0.0	0.0	89.9	0.0	0.0	0.0	0.3	8.4	0.5	7.0	6.0	7.6	0.0	0.0	114.2	6.9	0.0	0.9	1.5	5.0	14.4	0.0	38.0	0.0	0.0	0.0	0.0	1.0	0.0	1.4	0.4	0.7	4.4	2.2	9.2	0.0	0.4
SAMM50	"CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W"	ENSG00000100347	"SAMM50 sorting and assembly machinery component"	Q9Y512	22	43955421-44010531	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034537	Enhanced		Supported	Mitochondria		NA	NA		3700000	Mitochondria		"HPA034537: AB_10602794"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.52e-1)"	"prognostic favorable (4.43e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.60e-1)"	21.7	25.1	12.4	13.9	13.6	10.2	16.0	10.5	20.1	17.4	15.6	11.2	17.2	18.9	12.6	13.5	14.6	16.3	18.2	34.3	11.3	11.9	18.5	18.8	8.9	18.6	12.7	14.7	16.0	16.7	60.6	12.2	7.6	16.4	10.4	13.7	14.3	19.3	13.6	79.5	15.8	21.2	14.2	12.3	12.2	18.5	11.5	8.6	17.4	10.8	34.6	15.1	11.5	11.0	27.7	34.0	22.4	19.6	18.2	29.3	18.5	22.3	21.2	20.7	25.1	26.8	28.5	29.0	22.0	23.6	32.5	28.1	30.3	16.5	37.1	16.2	25.0	18.8	27.0	30.6	29.4	29.3	10.2	37.8	20.1	27.9	35.7	18.8	63.6	30.3	32.8	23.6	28.0	13.0	22.9	33.4	17.8	17.1	12.3	29.1	31.9	24.8	25.0	20.2	27.1	25.5	29.2	22.4	30.0	27.1	28.7	12.4	20.2	24.3	26.1	35.9	23.1	24.4	21.0	20.5	21.1	25.4	19.4	17.9	18.3	25.2	28.6	26.4	23.2	21.0	19.2	19.6	22.4	21.2	19.2	29.3	27.7	19.8	21.5	34.0	24.5	20.8	19.5	3.2	18.2	14.7	13.4	22.7	18.5	12.4	13.6	10.5	20.1	11.3	11.9	12.7	14.7	16.4	8.6	32.8	17.6	39.3	18.4	18.3	20.2	60.5	22.9	37.5	22.7	8.7	7.9	36.5	51.4	35.6	27.0	31.5	56.1	23.3	48.0	43.0	24.4	14.5	26.5	35.8	45.7	30.2	17.9	21.5	29.2	33.7	24.2	25.7	15.1	39.7	29.6	27.1	37.2	38.6	28.7	78.9	23.3	19.4	21.1	41.3	20.6	19.7	17.2	32.0	51.0	12.9
SAP18	"2HOR0202, MGC27131, SAP18p"	ENSG00000150459	"Sin3A associated protein 18"	O00422	13	21140514-21149084	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA011352, CAB012273"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB012273: , HPA011352: AB_1856563"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.78e-2)"	35.3	67.0	55.2	45.3	57.4	81.0	38.0	35.2	49.1	30.0	44.8	43.9	37.6	53.1	37.5	40.3	59.5	32.4	33.0	66.3	68.4	61.3	63.2	47.5	34.8	41.7	64.9	50.2	37.3	52.3	16.2	38.8	43.1	54.9	34.4	23.8	26.4	50.1	34.5	121.6	31.4	48.6	48.1	73.5	31.6	41.6	79.2	49.3	34.0	34.9	51.0	24.4	37.3	48.6	90.1	107.4	97.9	96.4	70.0	94.1	143.8	29.7	16.8	27.3	29.4	29.6	24.9	42.3	38.1	28.4	35.4	26.2	30.3	57.8	30.9	47.1	31.5	38.5	31.3	33.5	23.9	40.0	47.1	17.0	44.0	22.2	50.2	33.7	59.7	35.7	25.0	27.3	27.0	32.4	27.4	26.5	37.6	20.8	17.7	31.9	38.1	67.4	98.2	34.2	83.3	18.5	42.8	43.1	30.7	49.6	26.8	31.8	27.8	24.5	36.5	47.1	31.8	35.2	87.7	32.2	21.8	24.3	39.4	44.3	27.5	38.1	85.1	21.2	35.6	39.9	69.6	82.9	97.9	70.0	89.0	70.6	90.1	86.2	82.4	81.2	77.6	84.2	83.2	83.4	70.0	96.4	107.4	94.1	143.8	55.2	57.4	35.2	49.1	68.4	61.3	64.9	50.2	54.9	49.3	125.0	120.4	256.8	291.2	407.4	98.9	565.8	201.2	230.2	162.7	221.6	39.3	478.6	643.2	319.3	984.2	273.5	352.1	93.5	320.2	439.3	341.9	285.9	252.8	227.3	346.1	112.8	225.1	143.1	173.7	111.6	316.9	273.6	386.3	458.1	262.9	223.0	331.8	354.2	285.3	790.7	102.1	200.5	388.3	329.4	303.0	369.1	759.6	214.2	268.2	375.5
SCAMP1	SCAMP37	ENSG00000085365	"Secretory carrier membrane protein 1"	O15126	5	78360583-78479071	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044753, CAB079009"		Supported	Approved	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Nucleoplasm, Vesicles, Cell Junctions"		"CAB079009: , HPA044753: "	"unprognostic (8.25e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.34e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (8.44e-3)"	"unprognostic (7.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.99e-2)"	7.5	8.3	9.2	4.0	19.3	2.4	10.0	12.8	19.5	8.4	6.4	5.4	9.9	5.3	8.7	9.3	8.6	10.7	6.4	8.0	15.8		10.4	6.2	5.9	3.9	6.5	15.8	8.8	8.8	17.5	14.6	7.6	14.6	12.2	7.3	7.6	10.6	11.0	4.7	5.8	5.3	9.1	9.0	3.9	9.6	4.5	7.1	4.1	14.2	3.8	3.7	8.8	6.3	7.9	14.9	15.3	15.8	10.0	9.9	7.4	12.5	9.9	9.9	30.6	13.7	17.7	15.6	11.6	16.9	9.6	21.9	3.7	23.5	18.5	13.1	16.9	27.5	10.2	14.0	21.8	17.2	6.5	13.3	8.5	7.9	7.6	8.8	5.4	6.6	11.6	20.2	10.9	17.3	24.2	14.6	10.4	3.2	13.3	18.2	14.7	9.3	11.5	8.0	5.4	10.2	11.4	16.3	21.1	17.5	14.9	28.1	17.1	10.7	15.2	10.9	10.5	21.1	9.8	14.9	10.6	7.9	11.7	9.7	9.3	11.2	11.5	20.7	20.3	8.8	15.3	11.4	12.8	8.2	12.6	9.9	7.9	9.4	9.8	14.9	6.6	7.8	6.8	7.0	10.0	15.8	4.6	9.1	7.4											23.8	19.0	6.7	28.6	34.8	72.3	33.0	20.4	71.0	26.1	38.4	66.8	10.4	11.6	22.7	31.3	27.8	11.7	23.3	26.3	21.3	31.0	36.1	11.5	13.9	16.8	30.2	34.0	22.1	30.5	12.1	18.7	22.7	28.7	6.4	33.6	43.2	26.4	11.5	26.9	20.5	63.0	12.9	25.0	17.0	20.4	39.5	8.8	13.8	17.0	25.0
SCAMP2		ENSG00000140497	"Secretory carrier membrane protein 2"	O15127	15	74843730-74873365	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014699, HPA019194"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		110000	"Golgi apparatus, Vesicles"		"HPA014699: AB_1856605, HPA019194: AB_1856604"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.23e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.73e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.10e-2)"	28.8	27.9	15.7	32.2	21.9	22.6	38.7	7.6	16.5	20.9	37.8	27.6	24.6	37.7	22.5	27.9	54.7	24.7	27.0	18.8	14.8	10.1	34.2	37.8	28.8	42.1	24.2	11.6	20.5	32.1	42.7	17.6	47.8	17.4	20.3	37.1	17.5	56.4	31.9	18.5	36.1	47.5	17.1	20.1	39.4	33.2	29.2	20.1	25.8	29.2	28.3	38.4	21.4	25.8	37.8	59.5	46.9	51.3	36.6	47.0	47.4	12.8	16.8	7.2	11.2	22.1	11.5	21.7	13.2	16.8	14.1	15.2	24.1	30.4	10.6	17.5	19.9	20.4	46.8	21.5	16.5	5.9	41.8	21.1	26.8	9.8	16.5	16.7	13.7	51.7	14.8	29.4	13.3	9.7	11.2	13.7	12.4	8.8	20.1	9.8	19.6	6.9	15.8	7.2	32.2	10.9	12.2	6.7	36.4	16.3	18.5	7.5	7.5	10.8	19.2	12.1	11.1	26.4	22.1	12.7	12.2	7.3	13.1	15.3	13.9	20.4	10.8	11.4	32.5	8.9	46.9	51.3	39.4	46.6	48.3	37.6	37.8	42.7	46.9	37.8	32.5	35.6	38.2	34.6	36.6	50.3	59.5	47.0	47.4	15.7	21.9	7.6	16.5	14.8	10.1	24.2	11.6	17.4	20.1	68.5	27.7	38.8	31.5	15.5	6.0	13.3	12.7	37.5	34.2	38.4	2.0	132.9	13.3	51.4	106.8	33.7	86.4	0.0	81.6	53.9	35.5	43.7	77.3	25.6	142.9	6.4	35.8	25.2	59.2	43.9	29.7	61.4	30.4	45.9	66.5	37.9	72.2	69.1	21.5	40.9	7.7	25.8	22.5	46.6	23.8	19.4	114.1	37.3	57.4	47.7
SCAMP3	C1orf3	ENSG00000116521	"Secretory carrier membrane protein 3"	O14828	1	155255979-155262430	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071167			Supported	Vesicles		NA	NA			Vesicles		"HPA071167: AB_2686352"	"unprognostic (4.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.18e-2)"	23.6	41.8	21.0	20.8	25.6	16.8	28.8	22.5	35.5	21.9	19.0	36.1	26.8	24.1	20.7	17.8	27.1	21.9	21.5	37.8	19.8	20.2	33.3	40.8	23.4	25.5	27.1	26.3	22.6	41.5	41.5	20.0	37.0	26.2	23.0	17.3	26.0	33.0	28.1	45.3	30.0	20.9	18.9	30.4	27.0	24.4	14.5	26.4	21.6	27.3	23.6	27.3	23.9	20.8	32.2	32.5	25.6	35.0	29.9	28.7	30.0	13.9	30.0	9.1	18.1	22.2	17.4	9.3	16.8	19.9	19.0	17.9	16.4	19.9	12.9	25.1	19.5	18.6	21.8	13.1	12.7	7.0	17.7	24.0	9.1	19.6	13.3	22.2	17.1	15.5	15.3	16.3	23.8	10.9	12.6	15.8	13.3	16.2	31.4	20.5	27.9	15.8	15.9	17.5	24.0	32.9	13.6	7.4	39.8	11.3	12.5	11.8	23.8	11.7	27.4	19.4	9.0	29.6	26.8	12.9	21.4	12.1	22.0	24.8	41.8	38.8	16.1	21.0	18.4	24.6	25.6	29.0	23.2	28.7	31.1	25.6	32.2	26.6	26.8	31.6	30.5	24.6	26.3	2.6	29.9	35.0	32.5	26.6	30.0	21.0	25.6	22.5	35.5	19.8	20.2	27.1	26.3	26.2	26.4	14.9	36.2	29.6	20.5	34.0	17.4	31.9	28.1	20.1	28.4	31.4	3.9	72.8	8.3	46.2	1.4	29.2	26.9	0.0	60.3	45.7	27.2	20.1	24.3	33.4	50.8	17.5	28.9	28.8	21.0	4.3	15.8	24.5	23.6	54.1	21.9	20.0	40.9	24.3	17.7	21.2	10.5	12.9	21.7	10.7	3.4	35.0	59.6	32.4	24.2	19.7
SCAMP4	FLJ33847	ENSG00000227500	"Secretory carrier membrane protein 4"	Q969E2	19	1905214-1926013	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043284	Approved		Approved	"Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles"	"Lipid droplets, Plasma membrane"	"HPA043284: AB_10806501"	"unprognostic (1.60e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (2.58e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.92e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.03e-1)"	17.3	16.5	17.1	16.0	21.7	10.2	18.4	16.5	28.2	19.5	13.2	46.3	21.1	19.3	16.3	20.4	22.0	37.2	19.4	8.5	19.3	19.5	19.9	21.5	19.3	13.9	22.1	14.6	23.7	28.0	12.7	23.2	24.2	27.6	19.5	9.8	21.4	41.1	21.4	9.1	19.2	18.9	12.1	42.1	17.2	21.8	15.9	20.3	10.3	23.8	10.6	18.2	15.7	13.9	6.4	14.2	2.5	5.9	7.1	5.0	3.7	23.1	23.1	10.6	25.7	21.3	13.3	12.6	15.0	14.0	16.5	20.1	18.8	22.3	9.5	14.7	12.0	9.4	27.7	10.0	15.3	6.1	15.0	9.0	6.6	8.2	18.0	27.3	6.6	10.2	20.3	9.7	14.3	8.7	13.5	11.2	10.6	15.0	10.8	9.5	27.8	8.8	12.8	17.3	12.0	7.8	11.0	7.7	14.4	20.3	20.6	15.0	19.8	9.5	22.9	12.6	7.7	22.4	17.3	11.9	20.3	14.1	36.3	15.8	26.3	25.9	8.5	26.9	11.1	13.0	1.9	5.2	2.0	5.0	5.9	2.7	6.4	3.5	3.2	5.7	4.6	2.1	3.7	2.5	7.1	5.0	14.2	2.7	3.7	17.1	21.7	16.5	28.2	19.3	19.5	22.1	14.6	27.6	20.3	8.9	8.2	23.1	21.9	15.1	18.6	2.2	17.8	10.7	5.7	47.1	70.7	33.6	6.6	18.8	0.6	14.4	42.4	23.3	11.0	30.8	21.6	30.1	17.3	10.4	33.3	20.6	18.0	14.7	18.8	0.4	20.1	12.3	20.3	15.4	27.2	30.6	13.6	20.1	16.3	9.0	49.3	0.0	10.8	16.3	29.8	17.7	49.3	13.3	21.0	23.3
SCAMP5	MGC24969	ENSG00000198794	"Secretory carrier membrane protein 5"	Q8TAC9	15	74957219-75021496	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 87.0"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 110.4;Cone photoreceptor cells: 117.8;Horizontal cells: 66.7;Intestinal endocrine cells: 60.0;Rod photoreceptor cells: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	24	"plasmacytoid DC: 20.0"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 20.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 40.3;SH-SY5Y: 22.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046645	Enhanced					NA	NA					"HPA046645: AB_2679734"	"unprognostic (1.37e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (5.67e-5)"	"unprognostic (9.82e-2)"	"prognostic favorable (1.34e-6)"	"unprognostic (7.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-2)"	2.1	11.1	29.2	2.5	35.7	1.7	2.1	57.5	87.0	1.5	3.3	7.5	0.0	20.6	3.3	2.4	1.3	3.1	3.3	2.8	32.4	32.1	8.9	2.6	1.9	4.0	23.9	27.8	3.6	16.7	27.0	7.4	3.8	31.1	2.6	3.1	10.7	4.1	1.9	0.8	1.6	14.7	2.1	11.9	3.6	8.2	5.6	5.6	0.0	3.8	0.0	5.3	5.5	0.7	0.2	20.0	0.8	0.1	0.3	0.2	0.2	0.6	8.1	1.7	5.7	0.1	0.1	0.2	0.2	0.2	1.8	0.6	2.1	4.0	12.2	3.9	0.4	1.5	0.5	6.9	0.5	0.6	1.9	0.8	1.5	0.8	11.2	1.2	0.3	5.2	0.6	0.9	0.4	0.1	1.2	0.7	4.5	0.1	10.0	0.4	6.6	0.5	4.4	6.0	0.9	3.2	0.2	1.4	2.9	0.4	3.8	40.3	22.5	8.8	6.1	12.2	1.3	3.4	14.8	0.5	0.5	3.9	0.8	0.5	0.9	1.0	1.1	1.4	9.4	2.1	0.3	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.2	0.2	0.0	0.8	0.3	0.1	20.0	0.0	0.2	29.2	35.7	57.5	64.8	32.4	32.1	23.9	27.8	31.1	5.6	0.0	0.6	2.2	0.6	0.2	110.4	2.4	10.2	2.7	0.0	5.2	117.8	0.1	1.7	4.0	0.4	0.7	4.2	0.0	36.9	0.1	0.8	0.9	0.0	0.6	10.4	66.7	60.0	9.2	4.7	0.6	2.0	0.5	1.7	0.0	2.0	20.0	9.3	5.8	6.0	10.7	156.4	0.0	1.0	1.7	3.4	0.1	0.1	0.0	1.9	0.4
SCARB1	"CD36L1, CLA-1, CLA1, SR-BI, SRB1"	ENSG00000073060	"Scavenger receptor class B member 1"	Q8WTV0	12	124776856-124882668	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 173.1;liver: 93.7;placenta: 65.9"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 105.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 24.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 24.9;monocytes: 6.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066285, CAB070124, HPA072449"	Enhanced		Approved	"Vesicles,Lysosomes,Rods & Rings"		NA	NA			Vesicles	"Lysosomes, Rods & Rings"	"CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: AB_2732201"	"unprognostic (9.70e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.21e-3)"	"prognostic unfavorable (1.83e-5)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.49e-5)"	"unprognostic (3.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"	21.2	173.1	7.9	3.5	21.4	1.8	25.0	4.3	10.1	4.7	28.6	13.4	1.1	8.8	4.3	3.5	2.8	4.7	8.0	3.2	7.4	5.1	2.2	93.7	5.8	5.3	6.3	5.1	14.3	2.9	3.3	4.4	65.9	9.4	4.3	4.9	10.7	8.6	2.3	3.0	6.3	21.3	4.4	5.7	5.0	2.7	7.7	11.4	0.5	4.0	1.1	5.6	3.6	10.0	3.1	24.9	1.2	6.5	0.2	0.4	2.5	9.3	22.6	7.4	29.1	4.9	10.5	0.0	6.6	7.5	8.2	5.2	27.0	29.9	27.0	19.0	4.4	13.4	14.2	18.8	44.3	3.9	12.9	18.9	7.6	22.4	43.5	16.6	13.0	6.6	17.9	9.0	15.6	11.1	14.0	22.3	4.9	14.3	11.6	1.5	18.5	4.0	17.4	6.7	11.6	23.4	16.9	5.9	53.9	0.7	13.1	13.9	5.4	35.8	48.4	33.5	4.5	27.1	14.7	2.1	1.3	8.8	6.6	10.1	2.7	1.1	4.4	5.3	15.8	12.8	0.0	6.5	0.0	0.2	3.7	0.2	3.1	0.1	0.4	8.2	1.7	0.1	0.1	1.2	0.2	0.5	24.9	0.0	2.5	7.9	21.4	4.3	10.1	7.4	5.1	6.3	5.1	9.4	11.4	3.0	2.4	18.5	3.1	4.9	5.0	4.8	12.7	4.0	1.2	3.5	27.5	8.8	3.3	5.1	13.9	11.2	9.2	23.3	6.6	9.3	5.9	10.5	1.1	105.2	42.5	15.9	10.3	15.4	14.0	10.8	8.3	10.1	45.5	5.4	14.0	52.5	5.9	14.2	4.9	2.4	7.4	0.0	2.1	27.8	1.7	2.8	36.3	2.5	8.8	3.8
SCN11A	"NaN, Nav1.9, SCN12A, SNS-2"	ENSG00000168356	"Sodium voltage-gated channel alpha subunit 11"	Q9UI33	3	38845769-38950561	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.5;placenta: 5.2"	"Cell type enhanced"	"Detected in some"	8	"Ciliated cells: 4.0;Early spermatids: 5.4;Sertoli cells: 6.5;Spermatocytes: 3.9;Spermatogonia: 6.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.8;HDLM-2: 5.0;SCLC-21H: 1.1;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA036746, HPA036747"	Uncertain					NA	NA					"HPA036746: AB_10696785, HPA036747: AB_2675287"	"unprognostic (6.11e-2)"	"unprognostic (5.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.79e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.30e-4)"	0.9	0.2	0.8	0.5	0.8	0.0	0.6	0.1	0.3	0.0	1.1			0.4	0.0	1.4	0.0	0.1	0.1	0.0	0.4	0.5	0.4	0.3	0.0	0.2	0.4		0.0	0.1	0.0	0.4	5.2		0.1	1.3		0.0	0.0	0.1	0.8	1.0	0.5	0.6	7.5	0.0	2.6			0.1		0.1	3.4	0.1	0.2	0.4	0.9	0.1	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.1	5.0	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.1	0.6	0.0	0.0	0.0	1.3	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.1	0.7	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.9	0.1	0.1	0.4	0.0	0.0											0.0	0.0	0.0	0.8	0.7	0.1	0.8	0.0	4.0	1.2	0.0	0.0	0.2	0.0	0.0	5.4	0.6	0.0	0.0	0.2	0.0	0.6	0.3	0.0	0.2	0.3	0.0	0.0	2.5	0.0	1.0	0.0	0.0	1.7	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.4	6.5	0.9	3.9	6.0	0.6	0.2	0.0	0.0	0.9
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 33.9"	"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 26.9;Bipolar cells: 33.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 11.6;Hep G2: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	1.1	1.3	5.2	1.1	13.6	1.0	1.1	10.3	26.6	1.1	1.1	2.3	0.0	1.0	1.1	1.1	1.0	6.8	1.0	1.1	6.9	8.3	1.1	1.1	5.6	1.0	5.7	9.7	1.0	1.0	1.1	2.9	1.2	33.9	1.1	1.1	0.3	1.0	1.0	1.2	1.1	1.1	1.1	3.6	1.1	1.1	1.4	4.2	0.0	1.1	0.0	1.0	1.1	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	11.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	6.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.2	13.6	10.3	26.6	6.9	8.3	5.7	9.7	33.9	4.2	6.0	26.9	0.0	0.0	0.0	33.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SCN2A	"HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2"	ENSG00000136531	"Sodium voltage-gated channel alpha subunit 2"	Q99250	2	165194993-165392310	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 68.0"	"Cell type enhanced"	"Detected in some"	17	"Bipolar cells: 48.0;Cone photoreceptor cells: 45.2;Horizontal cells: 14.3"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HSkMC: 3.4;SH-SY5Y: 3.1;U-138 MG: 5.8;U-266/84: 12.0;U-87 MG: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022567	Enhanced					NA	NA					"CAB022567: "	"unprognostic (1.16e-1)"	"unprognostic (3.56e-4)"	"unprognostic (5.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.97e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.14e-1)"	1.3	3.0	19.1	1.3	36.4	1.1	2.2	68.0	50.3	1.5	1.3	1.1	0.0	1.5	1.9	2.6	1.2	1.3	2.3	1.3	30.3	8.2	4.0	1.4	1.5	1.2	3.8	23.5	1.5	1.3	1.1	8.2	1.3	9.9	1.3	1.3	0.0	1.5	1.8	1.1	1.2	1.5	2.0	3.7	1.3	1.5	1.5	4.1	0.0	1.1	0.0	1.2	1.3	0.5	1.4	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.8	0.0	0.0	2.8	0.0	2.7	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.5	0.1	1.0	0.7	0.0	0.4	0.0	0.4	0.0	0.2	3.4	0.1	0.3	0.0	2.4	0.0	0.0	0.0	0.3	1.5	0.0	0.2	0.0	2.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	2.9	3.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	5.8	0.4	0.3	0.0	0.5	12.0	0.0	3.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	19.1	36.4	68.0	43.7	30.3	8.2	3.8	23.5	9.9	4.1	0.0	1.7	0.0	0.1	0.2	48.0	0.6	0.0	0.0	0.0	10.4	45.2	0.1	5.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	1.3	1.1	0.0	0.0	0.0	0.0	3.7	0.5	0.0	5.6	0.0	3.4	0.0	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0
SCN2B		ENSG00000149575	"Sodium voltage-gated channel beta subunit 2"	O60939	11	118161951-118176673	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.0;heart muscle: 17.5;skeletal muscle: 9.7"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 7.9;Cardiomyocytes: 14.0;Horizontal cells: 12.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.1"	"Group enriched"	"Detected in some"	5	"HBEC3-KT: 1.5;U-2 OS: 2.6;U-2197: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (9.01e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.71e-4)"	"unprognostic (5.17e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.88e-3)"	1.8	3.0	14.7	1.4	31.5	1.0	1.9	31.1	37.0	2.9	2.0	3.1	0.0	1.7	3.2	2.9	3.6	2.9	2.7	17.5	22.5	11.6	1.6	1.0	2.5	1.0	8.7	30.6	2.8	1.1	1.0	0.8	1.0	12.8	2.4	1.9	0.4	1.8	2.7	9.7	1.4	2.5	3.5	13.9	1.1	1.3	1.3	6.9	0.0	1.9	0.7	1.0	1.5	0.6	0.3	0.2	2.1	0.3	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.7	0.1	0.0	0.0	0.1	2.6	6.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	2.1	0.3	0.9	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.3	0.2	0.2	1.3	0.2	0.0	0.2	0.1	0.0	14.7	31.5	31.1	37.0	22.5	11.6	8.7	30.6	12.8	6.9	0.0	0.0	0.0	0.5	0.3	7.9	14.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	12.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.1	0.0	1.4	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.0	0.2
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 53.7"	"Cell type enhanced"	"Detected in some"	15	"Early spermatids: 3.4;Ito cells: 3.1;Late spermatids: 2.9"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.2"					"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.9"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.9"	"Group enriched"	"Detected in some"	11	"REH: 10.1;RH-30: 31.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053992			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA			Nucleoplasm	"Centriolar satellite"	"HPA053992: AB_2797249"	"unprognostic (2.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.38e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.45e-2)"	5.9	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.2			0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0		0.0	0.0	0.3	0.3	0.0		0.1	0.0		0.5	0.0	53.7	0.0	0.0	0.0	0.0	0.1	0.0	0.4			1.6		0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	10.1	31.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0
SCN4B	LQT10	ENSG00000177098	"Sodium voltage-gated channel beta subunit 4"	Q8IWT1	11	118133377-118152888	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;skeletal muscle: 25.6"	"Cell type enriched"	"Detected in some"	4	"Sertoli cells: 45.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.9;HBEC3-KT: 3.0;NTERA-2: 4.4;SH-SY5Y: 1.7;U-2 OS: 4.0"	"Region enriched"	"Detected in many"	11	"basal ganglia: 731.2"	"Region enhanced"	"Detected in many"		"basal ganglia: 122.8"	HPA017293	Approved					NA	NA					"HPA017293: AB_2184174"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.31e-4)"	20.5	5.4	1.9	1.2	36.4	0.1	6.1	11.7	21.7	2.4	2.6	2.0	0.5	2.4	3.7	1.8	5.4	5.5	3.2	11.0	3.1	2.9	1.4	0.6	8.7	2.0	5.3	2.1	0.7	5.0	6.4	2.4	1.9	28.7	2.1	2.2	4.3	2.8	2.6	25.6	3.8	4.6	7.0	5.5	0.5	3.0	0.8	8.7	1.5	10.4	9.5	1.1	3.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.9	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.6	0.3	3.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	36.4	11.7	21.7	3.1	2.9	5.3	2.1	28.7	8.7	0.0	0.0	0.0	0.3	1.1	1.1	2.8	0.0	6.7	1.2	0.0	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	3.3	2.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.3	45.3	10.8	0.0	0.6	1.0	0.0	0.0	0.0	0.1
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649673	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease mutation, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"heart muscle: 67.3"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 66.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 22.0;RH-30: 18.3"	"Group enriched"	"Detected in some"	5	"amygdala: 3.2;basal ganglia: 10.5;hypothalamus: 7.0"	"Low region specificity"	"Detected in many"			HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.3	0.2	1.3	0.2	0.3	0.4	0.6	0.1	2.3	2.0	0.4	0.0	0.4	0.3	0.9	0.8	0.2	0.4	0.3	67.3	0.5	0.7	0.1	0.1	0.2	0.1	0.1	0.3	0.6	0.2	0.1	0.8	0.3	0.0	1.3	0.2	1.2	0.3	1.6	5.5	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.1	0.1	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.1	0.8	0.4	0.0	0.1	0.3	2.7	0.0	0.0	0.0	0.9	0.9	2.7	0.0	0.4	0.0	1.2	0.7	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.5	0.0	1.7	3.6	0.4	0.0	0.0	22.0	1.1	0.0	0.0	2.0	0.0	0.0	0.0	18.3	0.0	0.0	2.4	0.3	2.4	0.0	0.0	0.0	0.7	0.0	0.0	4.4	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.1	2.3	0.5	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	3.1	66.1	0.0	0.0	0.0	0.0	13.7	0.1	0.0	0.1	1.0	0.4	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.7	0.0	0.4	0.3	0.9	0.0	0.0	0.0	0.0	1.0
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 27.6;pituitary gland: 9.7"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 13.7;Cone photoreceptor cells: 9.8;Intestinal endocrine cells: 10.9;Rod photoreceptor cells: 10.5;Spermatogonia: 10.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AF22: 12.0;ASC TERT1: 12.7;BJ hTERT+: 11.2;WM-115: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	1.1	3.0	9.1	1.5	18.1	1.9	1.9	16.7	27.6	1.0	2.0	1.6	0.0	1.1	1.5	2.0	0.9	1.1	2.5	0.9	12.6	4.5	1.9	4.3	1.0	1.3	3.2	13.7	1.8	3.2	1.5	9.7	0.9	14.8	1.8	2.5	0.9	1.7	1.2	1.0	1.1	1.2	1.0	2.2	1.7	2.7	3.8	1.6	0.0	1.7	0.0	1.2	1.0	0.6	0.4	0.2	0.0	0.0	0.0	1.0	0.0	1.4	1.0	12.0	0.1	1.6	12.7	0.2	6.8	11.2	7.9	7.3	2.0	1.4	0.3	1.6	8.9	3.5	0.0	1.9	0.0	9.3	1.2	0.6	0.1	0.1	0.2	0.1	0.2	0.9	1.7	0.0	5.2	1.1	3.1	8.4	2.8	0.1	0.1	4.9	0.8	2.0	0.1	4.1	0.7	3.8	0.0	0.6	0.0	0.0	0.4	4.8	2.0	3.5	1.8	0.2	1.8	0.3	0.1	2.2	7.7	5.1	2.8	4.3	0.1	0.1	0.0	1.5	1.6	11.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	1.0	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	9.1	18.1	16.7	25.0	12.6	4.5	3.2	13.7	14.8	1.6	0.0	0.0	0.0	0.4	0.0	13.7	1.2	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.2	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.2	0.0	3.4	0.0	4.8	10.9	1.3	0.0	0.2	0.0	0.0	0.0	0.0	1.3	5.3	0.5	0.0	0.7	0.5	10.5	0.0	0.3	1.9	10.0	0.0	0.0	0.0	0.6	0.1
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Exocrine glandular cells: 27.7;Hofbauer cells: 50.6;Intestinal endocrine cells: 31.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	17	"plasmacytoid DC: 18.6"	"Lineage enriched"	"Detected in single"	24	"dendritic cells: 18.6"	"Cell line enhanced"	"Detected in many"		"BJ: 17.2;BJ hTERT+: 12.8;HHSteC: 14.8;hTERT-RPE1: 12.0"	"Region enriched"	"Detected in some"	5	"hypothalamus: 10.9"	"Low region specificity"	"Detected in all"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"	6.6	4.2	3.8	2.8	9.1	4.2	2.7	0.9	4.4	1.8	10.2	0.5	0.1	1.4	0.9	3.8	2.6	1.2	5.8	2.9	2.8	15.9	4.8	8.3	4.5	3.5	4.1	2.3	2.1	4.8	0.6	11.3	9.2	7.3	2.0	7.0	1.7	1.8	1.9	0.9	1.8	4.2	5.2	2.5	12.4	1.7	16.2	0.4	10.3	1.4	1.9	1.2	3.6	1.8	0.0	18.6	0.7	0.1	0.4	0.0	0.0	0.0	1.9	0.1	0.0	7.4	6.5	0.0	17.2	12.8	4.0	1.3	0.5	0.0	0.0	0.0	2.1	0.2	0.0	4.9	0.6	6.6	0.0	1.6	1.3	1.5	1.4	14.8	0.0	0.0	0.4	0.2	6.8	1.3	12.0	0.8	0.9	4.3	5.0	0.6	0.0	2.6	0.0	1.5	0.0	0.5	0.7	2.5	6.5	1.8	7.2	0.8	7.2	0.0	0.0	0.3	3.8	0.2	0.0	0.0	0.0	1.1	0.1	0.3	0.1	0.0	0.0	2.5	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.7	0.4	0.1	18.6	0.0	0.0	3.8	9.1	0.9	4.4	2.8	15.9	4.1	2.3	7.3	0.4	11.9	18.4	0.9	0.2	0.9	0.2	1.6	5.1	4.0	7.9	5.2	0.0	0.2	3.3	14.9	1.7	2.2	11.3	0.0	27.7	0.4	1.2	0.2	3.5	6.0	50.6	0.0	31.7	20.3	1.5	1.9	1.1	4.3	3.3	0.0	14.6	1.3	18.8	8.6	0.0	12.2	0.0	0.0	1.0	0.0	0.4	0.4	0.9	0.0	10.7	0.1
SCNN1A	"ENaCalpha, SCNN1"	ENSG00000111319	"Sodium channel epithelial 1 alpha subunit"	P37088	12	6346843-6377730	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 100.4"	"Cell type enhanced"	"Detected in many"	9	"Collecting duct cells: 108.2;Mucus-secreting cells: 167.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	8	"pons and medulla: 9.4"	"Group enriched"	"Detected in some"	4	"naive CD4 T-cell: 1.7;neutrophil: 4.4;plasmacytoid DC: 3.0;T-reg: 1.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.0;granulocytes: 4.4;T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 71.8;HBEC3-KT: 48.2;hTCEpi: 20.7;RPTEC TERT1: 25.2;RT4: 27.0;SK-BR-3: 23.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012743	Enhanced					NA	NA					"HPA012743: AB_1856627"	"unprognostic (1.68e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.86e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (5.56e-2)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	0.9	3.7	0.4	7.5	0.4	0.0	10.1	0.4	0.9	22.0	20.6	2.2	60.9	5.6	8.1	15.7	47.3	19.3	7.0	0.4	1.1	0.1	100.4	2.2	53.6	0.4	0.5	0.4	5.9	14.2	0.0	10.2	1.6	9.4	15.0	21.5	6.2	53.1	55.5	0.6	14.4	11.8	1.0	0.4	0.4	20.3	2.8	0.4	0.9	74.7	21.1	41.3	10.3	13.8	0.0	3.0	4.4	0.5	0.0	1.7	0.3	5.0	0.9	0.0	0.4	0.0	0.1	4.3	0.0	0.0	0.0	0.0	1.4	71.8	0.0	0.1	0.0	0.0	3.3	0.0	48.2	0.0	0.0	0.0	0.0	4.0	0.7	5.2	0.0	0.0	1.2	20.7	0.0	15.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	4.2	9.1	0.1	0.0	0.0	0.1	25.2	27.0	0.3	0.0	0.5	23.3	0.0	4.3	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.0	0.0	0.2	0.6	0.5	0.0	1.7	0.3	4.4	0.0	0.1	3.0	1.3	0.3	0.4	0.4	0.4	0.9	1.1	0.1	0.5	0.4	9.4	0.4	68.5	63.0	0.0	21.9	1.6	0.8	0.8	68.8	26.8	47.8	108.2	3.9	1.2	5.0	41.1	0.4	1.4	57.4	0.0	30.8	0.2	2.4	31.3	2.3	2.4	0.3	1.6	26.0	0.6	1.9	0.2	1.7	2.1	0.0	1.8	167.5	0.3	24.0	47.5	1.4	4.2	1.6	0.0	1.0	1.4	2.1	7.8	1.4	1.9	31.6	33.3
SCNN1B	ENaCbeta	ENSG00000168447	"Sodium channel epithelial 1 beta subunit"	P51168	16	23278231-23381299	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 42.4"	"Cell type enhanced"	"Detected in many"	12	"Alveolar cells type 1: 92.3;Club cells: 66.0;Collecting duct cells: 54.1;Enterocytes: 54.8"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 26.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 19.4;RT4: 10.4;U-266/70: 32.0;U-266/84: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA015612	Uncertain					NA	NA					"HPA015612: AB_1856629"	"unprognostic (7.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.74e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.32e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-2)"	35.1	0.2	0.1	4.0	0.2	0.0	21.2	1.1	0.1	28.3	27.2	0.0	1.3	1.3	2.9	2.5	42.4	1.3	3.3	0.6	0.0	0.0	13.0	0.0	31.1	1.3	0.0	0.0	2.0	0.8	0.3	1.6	25.2	0.3	5.7	19.7	0.5	29.7	2.4	3.9	13.2	1.7	4.2	0.1	1.9	8.9	1.6	0.0	0.6	16.2	17.8	15.5	5.6	19.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	4.9	0.0	10.4	0.1	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	32.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	92.3	27.0	2.2	14.0	2.7	0.0	0.8	0.0	10.7	66.0	54.1	0.0	0.7	0.0	0.0	0.0	0.7	54.8	0.0	0.4	0.2	0.2	4.3	8.1	0.0	0.1	0.0	7.5	0.0	0.0	0.0	0.0	0.0	10.1	0.0	7.9	0.0	0.2	9.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	4.6	1.8	0.0	7.6	17.0
SCNN1D	"dNaCh, ENaCdelta"	ENSG00000162572	"Sodium channel epithelial 1 delta subunit"	P51172	1	1280436-1292029	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 9.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 11.4"									HPA026884	Enhanced		Supported	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA026884: AB_10601501"	"unprognostic (2.08e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.27e-2)"	"prognostic unfavorable (6.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.06e-2)"	3.2	3.8	4.0	1.9	5.1	3.6	1.2	12.8	6.3	1.7	2.0			7.0	3.2	1.1	1.1	3.9	1.5	1.5	4.1	3.3	1.4	3.2	1.5	2.5	3.1		4.6	3.0	0.8	5.9	1.3		2.3	0.2		8.6	2.4	3.9	4.6	5.1	1.0	3.2	3.8	2.4	10.2			1.3		0.7	0.7	1.8	0.5	0.9	0.0	0.2	0.0	0.8	0.2	0.6	5.0	2.0	5.2	1.4	0.8	0.9	3.3	1.0	1.7	1.9	0.9	2.8	3.6	1.8	1.5	2.5	0.8	0.9	0.8	0.3	6.7	3.1	0.4	6.0	1.3	1.4	0.1	3.6	2.3	1.1	2.6	0.0	2.2	0.5	6.5	2.4	8.5	0.4	1.8	1.4	2.4	1.0	0.6	3.7	9.3	0.4	0.8	0.8	0.2	2.7	3.8	1.4	1.5	2.2	0.8	6.6	1.8	1.4	3.2	2.7	5.0	1.1	11.4	0.7	2.9	2.9	6.1	3.6	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.2											3.0	2.9	0.0	0.2	0.7	3.2	4.0	0.0	2.7	2.3	0.0	3.9	0.1	0.0	0.4	9.6	0.0	1.7	0.0	0.4	0.2	1.0	0.1	2.3	2.1	0.3	4.8	1.2	0.6	0.6	3.2	0.9	0.9	0.0	0.0	0.2	2.0	1.2	3.5	1.8	0.6	2.5	0.0	0.9	1.8	2.1	1.4	0.0	0.0	0.6	0.3
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 gamma subunit"	P51170	16	23182715-23216883	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.9;salivary gland: 26.8"	"Cell type enhanced"	"Detected in some"	29	"Alveolar cells type 1: 17.9;Club cells: 21.6;Collecting duct cells: 85.5"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in some"	6	"cerebellum: 9.7"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	7	"hTCEpi: 31.4;RT4: 14.2"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.8"	"Low region specificity"	"Detected in all"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	1.1	0.3	0.6	0.2	0.0	0.4	2.5	9.7	0.4	14.0	5.5	0.0	4.8	0.2	3.2	1.7	10.3	0.5	0.2	0.2	1.5	0.0	42.9	0.2	15.6	0.2	0.0	0.3	0.2	3.8	0.2	6.5	0.7	0.7	10.2	1.1	0.0	26.8	12.8	2.2	6.6	0.2	0.3	0.3	0.2	6.9	0.3	0.0	1.5	25.5	3.3	3.9	1.7	11.3	0.3	0.3	1.8	0.2	0.2	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	14.2	1.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.3	0.2	0.1	1.8	0.2	0.1	0.3	0.1	0.0	0.6	0.0	9.7	0.4	1.5	0.0	0.0	0.3	0.7	0.0	17.9	3.4	0.0	4.0	0.3	0.0	0.8	0.0	2.7	21.6	85.5	0.0	0.1	0.0	1.3	0.0	0.0	0.3	0.0	1.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.4
SCTR		ENSG00000080293	"Secretin receptor"	P47872	2	119439843-119525301	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"intestine: 13.5;pancreas: 35.3"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 64.4;Ductal cells: 72.3;Exocrine glandular cells: 84.2;Pancreatic endocrine cells: 51.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 15.3"					"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 8.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"midbrain: 1.2;pons and medulla: 1.3;thalamus: 1.5"	HPA007269	Uncertain					NA	NA					"HPA007269: AB_1856640"	"unprognostic (1.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.38e-2)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			13.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.2	4.1	0.0	0.0		0.0	35.3	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.2			0.2		0.0	0.0	0.0	0.5	0.1	3.8	0.3	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	8.2	0.7	0.5	0.1	0.0	0.9	0.3	0.0	0.1	0.0	1.5	0.3	0.5	0.0	0.3	0.0	0.3	0.0	0.3	0.0	1.1	0.0	0.0	0.4	0.6	0.0	0.9	0.3	0.1	0.0	0.0	0.1	3.8	0.3	0.9	0.3	0.2	0.4	0.3	0.3	0.0	0.0	0.5	0.3	0.2	1.2	0.3	0.3	0.1	0.4	0.0											0.0	64.4	0.0	0.2	0.0	0.0	3.1	0.0	0.0	3.4	5.2	0.0	0.0	10.0	72.3	0.4	0.0	0.0	0.0	84.2	0.0	0.0	0.0	2.3	0.0	0.5	4.8	2.4	0.0	0.0	1.1	0.0	0.0	0.0	2.8	0.0	0.2	51.5	0.0	0.0	0.2	1.1	0.0	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.2;placenta: 228.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 298.1;Hepatocytes: 520.4;Urothelial cells: 356.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	17	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	40	"B-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 62.1;hTCEpi: 57.5;U-251 MG: 59.2;U-266/70: 61.4;U-266/84: 129.2"	"Group enriched"	"Detected in some"	4	"cerebellum: 10.7;olfactory region: 5.9"	"Not detected"	"Not detected"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	NA	NA	63100000	1600000	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	0.8	3.4	0.5	5.4	0.6	0.0	4.5	0.8	0.7	21.4	18.3	0.5	3.5	14.3	2.3	8.7	103.7	1.6	55.3	0.3	0.4	0.5	68.5	113.2	15.8	6.3	1.9	0.4	1.6	7.0	0.6	0.6	228.8	0.7	13.3	6.2	1.5	16.0	5.2	0.5	69.5	21.9	4.3	0.4	3.7	16.3	2.6	0.4	1.5	3.5	62.3	48.4	30.0	37.7	3.9	0.0	0.0	0.0	0.0	0.0	0.5	31.4	17.6	5.6	14.0	1.5	0.2	17.7	8.8	8.5	8.2	7.0	3.7	19.2	0.0	3.2	6.2	4.5	31.1	2.4	62.1	5.5	0.1	1.6	0.0	1.6	18.8	1.3	1.3	0.1	0.8	57.5	7.4	17.6	11.5	0.9	0.0	0.7	12.3	4.4	18.8	0.0	0.3	5.0	24.0	34.2	0.6	2.0	23.8	10.6	47.2	1.6	13.1	6.6	44.8	2.0	2.3	4.4	0.3	1.3	32.7	10.5	1.2	59.2	61.4	129.2	0.1	9.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.7	0.4	0.5	1.9	0.4	0.7	0.4	86.4	91.4	3.0	135.6	101.2	0.1	0.8	298.1	2.7	63.7	40.1	0.0	2.4	26.6	54.9	0.0	1.1	102.7	23.3	19.0	43.0	9.7	42.4	5.8	520.4	2.2	20.6	10.4	6.7	9.6	0.0	0.6	5.4	20.3	1.0	72.0	0.0	67.3	73.7	1.1	68.3	0.0	0.0	7.1	0.7	12.8	200.1	209.7	4.4	66.5	356.0
SDC4	"amphiglycan, ryudocan, SYND4"	ENSG00000124145	"Syndecan 4"	P31431	20	45325288-45348424	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 141.1"	"Cell type enhanced"	"Detected in many"	4	"Exocrine glandular cells: 450.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 75.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005716, CAB013240"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA			"Golgi apparatus"	"Plasma membrane"	"CAB013240: AB_2533250, HPA005716: AB_1080160"	"unprognostic (1.34e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.44e-7)"	"unprognostic (3.00e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (7.42e-2)"	15.9	26.2	19.9	15.7	24.3	3.5	40.5	6.9	20.1	20.4	24.8	19.2	9.0	13.3	17.6	14.7	42.4	27.4	26.2	19.5	19.8	12.1	56.6	141.1	56.7	4.8	23.5	20.5	14.7	36.6	6.2	12.5	23.0	30.9	19.5	22.3	21.8	47.6	17.5	25.5	45.5	13.8	38.7	23.0	9.0	46.9	33.7	15.7	2.0	26.5	25.2	23.5	34.4	16.4	0.7	2.8	2.0	3.1	1.4	8.1	1.2	23.0	3.0	1.6	0.1	41.2	25.4	71.1	29.5	40.3	33.5	24.0	35.1	58.9	0.0	13.2	37.1	33.8	30.0	1.2	75.0	40.8	6.6	1.1	0.7	2.4	13.7	44.9	0.1	1.2	34.1	50.4	13.8	33.8	18.6	4.4	0.5	1.1	0.0	19.2	22.9	0.0	2.0	3.0	20.1	9.3	0.0	14.9	0.0	55.0	30.8	0.6	2.3	40.6	25.2	7.2	19.6	18.2	1.4	8.2	25.6	21.3	2.5	19.0	1.2	0.9	0.1	40.2	2.3	15.2	2.0	3.1	0.7	1.3	1.1	4.1	0.6	4.1	1.6	2.8	0.7	0.9	1.1	1.6	1.4	1.1	2.5	8.1	1.2	19.9	24.3	6.9	20.1	19.8	12.1	23.5	20.5	30.9	15.7	271.0	364.7	7.8	299.2	332.0	10.3	49.5	201.2	113.8	195.7	179.7	11.8	27.4	54.7	239.6	0.5	9.0	87.8	0.0	450.4	202.4	50.9	254.2	12.8	232.3	18.5	0.0	52.9	14.7	15.1	2.9	3.7	36.5	72.6	56.9	103.4	8.5	443.3	93.4	4.9	128.2	23.3	0.0	42.6	0.9	2.8	413.3	56.3	18.8	79.5	364.0
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582860	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Melanocytes: 843.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 166.5"	"Group enriched"	"Detected in all"	5	"granulocytes: 166.5;monocytes: 44.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 100.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1500000	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	106.2	32.0	28.5	37.6	45.2	51.5	67.4	20.9	29.0	42.7	28.4	18.8	22.2	19.7	38.4	28.2	37.8	28.0	47.9	36.9	32.1	25.8	41.4	41.7	73.1	49.7	33.4	16.9	35.5	20.1	36.4	16.4	68.5	47.6	35.5	33.6	53.0	41.5	20.7	22.5	24.7	34.3	37.9	39.0	70.1	31.0	25.4	22.2	34.3	44.4	23.4	21.4	50.0	44.2	5.9	21.7	166.5	44.8	3.4	9.8	29.7	14.5	22.6	24.1	12.5	90.5	78.0	10.6	15.0	53.8	21.9	28.8	9.0	30.7	0.0	24.2	20.1	40.3	6.1	13.0	17.3	27.1	2.6	11.1	22.0	20.1	7.2	100.5	5.6	35.8	53.2	23.4	22.0	66.1	34.2	52.4	15.3	10.8	12.9	49.6	3.8	12.3	6.6	15.1	57.5	6.5	6.0	7.3	2.8	34.8	15.3	10.6	19.1	16.0	6.9	73.8	27.9	6.3	15.3	45.0	21.1	9.1	24.9	9.6	3.9	5.2	8.8	53.8	0.0	18.9	52.9	44.8	43.7	5.7	30.0	7.1	5.9	7.6	6.0	21.7	5.4	9.8	7.4	166.5	3.4	26.4	6.0	8.5	29.7	28.5	45.2	20.9	29.0	32.1	25.8	33.4	16.9	47.6	22.2	196.5	114.3	99.6	291.9	300.9	9.9	48.4	58.6	61.6	77.3	195.4	15.7	224.5	190.6	334.0	5.9	318.0	108.1	46.7	256.7	631.9	182.6	258.8	390.0	80.9	683.1	14.3	107.7	330.8	517.6	7.7	216.6	535.9	843.5	212.0	105.0	74.6	227.0	96.2	150.3	153.5	9.7	97.0	282.9	12.5	6.5	151.4	403.9	126.8	84.4	372.9
SDF4	Cab45	ENSG00000078808	"Stromal cell derived factor 4"	Q9BRK5	1	1216908-1232031	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011249, HPA011895, CAB015227"	Supported	Supported	Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		720000	"Golgi apparatus"		"CAB015227: , HPA011249: AB_2668468, HPA011895: "	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.01e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.04e-2)"	34.7	36.0	17.9	37.3	22.7	19.7	56.3	20.6	33.2	30.3	49.9	21.3	46.6	48.5	35.5	53.4	26.2	26.9	57.5	50.8	18.7	18.5	36.3	73.8	55.8	46.2	19.7	21.3	33.1	56.4	25.9	31.1	47.9	18.2	30.3	25.6	26.5	46.7	52.1	30.7	25.5	56.2	27.6	18.0	33.8	32.9	30.0	18.1	20.5	35.1	28.5	19.6	28.5	44.8	11.5	16.0	20.6	15.9	19.6	22.0	7.0	28.5	26.0	14.3	45.5	70.3	35.5	17.2	56.0	51.3	41.2	34.6	30.6	49.9	18.1	43.5	53.9	29.6	29.4	16.4	24.5	12.6	30.3	27.8	31.6	40.0	42.7	32.3	31.9	42.9	43.6	12.7	31.0	17.6	40.4	32.9	12.1	26.0	48.0	20.2	20.6	15.7	32.2	13.1	32.7	34.9	17.5	18.5	47.9	27.3	13.8	52.2	18.5	37.2	44.4	36.8	13.3	23.0	36.6	41.7	42.6	23.1	32.0	31.8	29.6	28.0	29.7	48.4	60.1	18.4	10.4	14.9	20.6	15.0	9.9	11.6	9.4	21.5	22.0	16.0	11.5	12.4	10.7	12.7	19.6	15.9	10.0	16.5	7.0	17.9	22.7	20.6	33.2	18.7	18.5	19.7	21.3	18.2	18.1	20.8	19.2	50.4	64.0	106.5	33.8	30.8	56.0	16.0	25.0	47.1	17.7	104.0	10.0	70.2	29.0	70.3	256.4	46.7	61.6	264.7	99.3	86.2	35.7	97.8	110.9	36.5	63.0	72.4	62.0	26.3	88.3	73.0	158.6	49.5	146.7	55.9	64.2	189.4	71.5	48.8	31.8	58.2	99.4	77.0	64.5	99.9	140.5	71.0	158.0	55.0
SEC13	"D3S1231E, npp-20, SEC13L1, SEC13R"	ENSG00000157020	"SEC13 homolog, nuclear pore and COPII coat complex component"	P55735	3	10293131-10321178	"Predicted intracellular proteins, Transporters"	"ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035292, HPA057943"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		15000	"Nucleoplasm, Vesicles"		"HPA035292: AB_10959451, HPA057943: AB_2683560"	"unprognostic (3.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	25.2	30.7	19.0	24.2	24.7	20.6	25.5	16.2	24.9	37.9	47.0	22.6	38.1	47.7	29.6	30.8	30.1	24.7	41.6	30.6	19.5	20.7	33.2	58.3	27.0	19.9	24.7	17.5	24.7	66.8	22.3	48.1	44.1	20.2	23.2	27.9	22.3	63.5	33.4	42.6	25.5	57.1	32.0	21.9	25.9	27.2	26.4	20.5	29.0	38.2	32.8	28.6	25.8	24.2	26.9	60.8	29.1	44.6	23.2	27.7	41.2	21.2	32.3	26.0	10.0	42.3	47.0	86.4	43.6	53.3	51.0	58.9	26.7	17.5	19.5	20.0	69.0	28.7	8.7	33.4	38.8	26.2	16.9	34.7	23.8	26.2	64.4	58.1	27.1	21.1	41.6	31.4	53.3	33.2	37.6	60.4	26.2	25.4	28.9	39.3	43.9	26.4	29.8	29.5	27.7	39.2	25.7	18.6	34.6	31.0	16.0	14.6	18.2	19.1	17.8	17.0	22.8	22.9	26.4	45.1	21.0	24.0	31.3	37.3	24.0	33.3	45.1	39.7	38.1	34.6	28.0	44.6	28.1	24.5	38.4	27.2	26.9	24.6	23.7	60.8	22.2	20.3	21.2	29.1	23.2	29.5	54.2	27.7	41.2	19.0	24.7	16.2	24.9	19.5	20.7	24.7	17.5	20.2	20.5	44.7	52.3	27.4	45.1	34.9	14.7	37.0	17.8	72.3	47.8	26.2	9.8	98.1	56.3	69.8	20.2	33.5	63.9	0.0	95.6	135.9	66.7	49.4	41.6	54.2	93.9	11.1	39.7	36.8	34.0	6.8	49.5	49.1	25.3	67.7	75.6	30.7	74.0	53.4	49.5	72.3	20.1	12.9	43.2	42.4	36.5	35.1	141.0	40.1	67.8	50.4
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818661-82901166	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		NA	NA		22000	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.69e-4)"	41.3	40.6	22.5	28.0	29.2	30.6	34.5	27.4	30.6	46.4	36.0	26.4	39.2	35.7	53.6	50.2	37.7	34.8	36.1	42.8	23.7	23.8	47.3	57.8	33.9	26.6	25.3	25.3	67.1	79.1	42.7	62.7	54.1	36.0	37.2	38.1	32.6	47.8	46.0	38.7	34.1	51.4	46.2	24.5	28.4	35.9	23.3	23.3	35.7	50.0	31.0	39.5	47.1	37.6	29.4	34.6	34.8	36.0	40.5	40.0	30.5	25.1	11.4	33.1	23.3	59.0	73.6	24.1	46.9	52.7	26.5	32.8	19.8	32.4	32.7	20.7	93.6	15.3	12.1	32.6	31.0	36.6	33.3	13.0	19.9	19.7	51.7	58.7	21.3	25.4	70.4	39.5	40.3	46.4	45.7	42.8	14.8	30.3	32.5	47.0	22.0	28.0	17.2	22.6	26.9	10.5	20.9	17.9	24.2	42.6	14.5	21.4	23.8	18.7	32.5	30.3	35.2	25.3	24.1	43.7	34.8	18.1	30.5	29.4	24.4	10.4	44.9	34.8	25.7	39.9	34.8	31.1	23.3	32.6	34.8	40.0	29.4	29.2	31.8	34.6	24.4	29.3	28.0	9.5	40.5	36.0	28.9	24.0	30.5	22.5	29.2	27.4	30.6	23.7	23.8	25.3	25.3	36.0	23.3	98.3	74.0	44.9	45.0	53.8	48.4	69.9	50.9	80.3	120.6	45.4	51.1	47.9	23.2	54.7	22.3	50.3	62.5	23.3	61.8	70.7	94.4	74.7	70.7	86.8	41.3	39.7	36.8	58.3	42.7	13.0	128.9	48.4	49.0	43.3	90.1	43.6	63.6	38.6	118.5	55.5	61.5	51.8	81.2	28.3	33.4	64.7	68.2	34.8	46.5	74.0
SEC61A1		ENSG00000058262	"Sec61 translocon alpha 1 subunit"	P61619	3	128051641-128071683	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 178.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022076			Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB022076: "	"unprognostic (1.84e-1)"	"unprognostic (8.00e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (2.84e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.84e-9)"	"unprognostic (2.73e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.51e-2)"	28.6	38.2	15.2	23.2	16.2	18.5	38.4	12.8	16.2	45.0	24.2	15.9	77.9	22.1	32.6	52.8	31.1	28.3	34.4	27.6	14.3	13.5	37.6	132.2	33.2	44.9	17.4	10.3	28.5	178.4	31.5	36.5	51.6	15.2	26.2	26.0	19.0	87.1	81.7	22.7	22.7	32.5	31.3	15.4	28.8	33.8	21.2	15.4	22.9	35.5	28.8	36.6	24.2	26.4	13.8	35.6	40.0	25.1	18.7	39.3	29.0	40.1	21.1	21.2	37.7	60.3	52.1	39.1	64.8	75.2	56.5	61.0	40.0	29.3	26.8	39.1	83.6	42.3	35.7	33.2	45.8	54.8	24.2	18.2	30.5	23.6	42.1	88.9	38.7	34.8	57.1	55.4	53.2	68.8	42.8	49.6	18.7	20.0	65.7	65.5	36.6	19.9	12.8	28.6	35.6	29.6	21.0	19.0	52.5	29.4	35.2	24.2	23.7	32.0	30.5	40.8	25.6	28.4	33.1	48.7	44.6	25.3	51.7	30.2	60.1	28.6	38.6	72.9	25.2	57.5	40.0	25.1	19.1	28.3	23.0	39.3	13.8	20.5	24.8	24.7	8.5	13.0	15.0	6.6	18.7	22.4	35.6	13.1	29.0	15.2	16.2	12.8	16.2	14.3	13.5	17.4	10.3	15.2	15.4	29.8	34.5	23.1	22.5	32.7	16.8	12.9	35.7	10.7	20.5	47.1	33.4	56.4	3.3	77.1	35.8	35.6	73.5	23.3	133.3	103.4	63.4	59.6	25.4	101.3	67.9	25.4	70.7	53.4	26.8	17.6	38.0	27.4	32.1	25.2	85.2	24.5	95.2	53.4	41.1	22.6	14.1	32.3	34.0	9.3	15.8	25.7	107.0	25.4	63.1	30.3
SEC61A2	FLJ10578	ENSG00000065665	"Sec61 translocon alpha 2 subunit"	Q9H9S3	10	12129637-12169961	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 33.5"	"Cell type enhanced"	"Detected in many"	6	"Horizontal cells: 33.4;Late spermatids: 23.8;Spermatocytes: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.83e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.95e-2)"	"prognostic favorable (1.08e-5)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (6.41e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.18e-2)"	"prognostic favorable (8.75e-4)"	4.0	5.6	14.3	5.1	19.7	14.1	5.3	16.5	33.5	3.8	3.8	20.3	3.2	3.7	7.8	9.2	3.9	4.1	5.2	11.3	16.8	22.1	3.1	7.8	3.8	5.8	15.6	14.6	5.8	3.3	5.5	9.4	4.5	22.7	6.0	5.9	5.7	2.7	6.3	6.9	8.6	3.3	5.9	21.1	4.8	3.6	17.3	9.9	5.0	5.2	1.3	6.1	4.1	3.6	1.3	5.8	4.1	0.5	2.0	2.7	0.4	5.9	10.8	14.1	8.7	6.0	3.7	4.7	6.0	3.3	11.8	12.5	10.2	4.0	2.2	3.3	9.4	15.9	4.9	19.5	7.8	10.2	6.6	7.4	2.7	12.6	7.2	5.9	1.6	6.5	5.5	4.7	21.5	3.4	5.2	3.0	13.3	3.2	6.5	10.0	5.2	5.4	2.7	13.9	5.3	3.3	5.8	5.8	1.4	7.3	6.2	6.7	9.9	8.8	4.7	4.3	11.5	9.0	2.7	5.4	10.3	12.0	13.1	4.1	6.0	8.5	3.5	8.0	2.2	3.1	0.0	0.4	0.3	2.1	0.1	1.9	0.7	1.3	1.3	1.0	1.3	2.7	1.7	4.1	2.0	0.5	5.8	1.9	0.4	14.3	19.7	16.5	26.4	16.8	22.1	15.6	14.6	22.7	9.9	3.0	3.2	7.5	2.3	1.5	13.1	6.5	2.5	1.4	3.4	8.7	7.9	2.8	0.0	2.4	15.5	2.7	1.1	0.0	2.0	2.1	4.1	2.8	2.3	13.2	2.3	33.4	1.2	3.7	1.9	23.8	6.4	2.5	5.0	1.8	1.6	6.9	1.7	2.9	4.2	1.3	13.8	0.0	3.8	28.9	13.9	1.3	2.9	1.9	1.0	1.4
SEC61B		ENSG00000106803	"Sec61 translocon beta subunit"	P60468	9	99222064-99230615	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"monocytes: 2395.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA049407	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA049407: AB_2680750"	"unprognostic (1.11e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.96e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.75e-1)"	26.2	39.8	20.3	27.1	20.7	41.1	37.2	12.6	20.2	36.5	26.2	15.8	47.9	28.5	32.1	52.7	29.3	26.8	26.4	19.8	19.3	17.7	42.0	153.0	31.9	49.3	19.9	14.8	31.6	175.5	13.6	38.5	36.3	17.7	28.9	19.8	21.3	116.6	50.8	16.9	20.5	31.2	21.0	20.1	41.4	29.7	19.9	16.8	43.8	49.3	29.2	35.9	24.5	24.0	36.9	173.3	71.5	48.5	31.0	52.5	47.1	37.7	37.1	42.9	42.5	42.5	54.5	51.9	56.4	59.3	53.5	46.7	53.0	29.9	51.9	43.2	51.5	58.1	46.8	30.0	45.0	25.8	54.6	41.8	27.1	36.1	74.8	92.7	46.5	34.9	48.6	69.6	42.0	37.6	47.7	65.1	42.6	42.4	101.6	50.3	69.6	42.2	68.1	34.3	90.6	87.3	41.0	36.5	66.9	57.8	27.3	44.7	31.7	31.6	73.6	72.2	35.4	28.5	64.4	45.5	38.3	45.7	63.9	46.8	54.8	36.8	33.2	63.9	30.1	25.2	71.5	48.5	44.5	39.1	38.4	52.5	36.9	43.3	39.3	49.4	25.0	27.5	30.1	40.6	31.0	33.2	173.3	38.3	47.1	20.3	20.7	12.6	20.2	19.3	17.7	19.9	14.8	17.7	16.8	95.3	187.1	256.1	245.3	351.6	50.7	48.6	280.2	210.1	184.2	190.1	29.5	281.8	537.2	460.0	124.8	278.2	231.9	23.3	685.9	442.0	377.2	528.8	210.1	851.3	458.0	50.9	289.9	218.5	275.4	31.8	303.8	326.5	470.7	2395.0	308.0	128.3	615.7	260.3	286.0	654.7	66.5	135.8	230.8	200.9	174.6	387.6	463.2	262.1	249.2	374.6
SEC61G	SSS1	ENSG00000132432	"Sec61 translocon gamma subunit"	P60059	7	54752250-54759974	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"glioma: 333.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053196	Uncertain					NA	NA					"HPA053196: AB_2682077"	"unprognostic (1.39e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.64e-7)"	"prognostic unfavorable (3.85e-6)"	"unprognostic (2.09e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (6.60e-8)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.95e-3)"	"unprognostic (8.43e-2)"	32.5	38.0	31.5	33.4	27.2	35.3	44.2	21.6	27.1	48.0	45.9	18.7	52.6	28.2	35.0	90.5	41.3	29.3	34.4	49.7	26.4	29.0	48.9	99.1	33.3	33.6	27.5	22.4	33.3	114.9	15.9	65.6	45.8	24.5	33.2	45.1	24.0	70.6	55.9	35.1	25.0	42.2	37.3	25.0	40.9	33.8	33.5	23.4	37.9	54.8	56.0	39.1	48.4	30.9	24.2	108.6	37.1	24.1	18.9	34.4	20.7	50.7	29.2	40.8	42.6	41.5	52.3	25.6	80.0	51.0	43.0	77.1	41.0	32.5	43.5	43.0	61.1	89.8	37.6	34.4	57.3	89.9	39.4	30.4	28.5	58.9	46.5	59.2	50.4	28.9	39.3	49.8	43.6	75.1	57.6	56.2	29.1	42.1	105.4	90.8	25.6	25.8	88.8	56.6	64.0	52.3	19.9	24.7	71.4	52.3	30.5	37.5	47.5	33.8	75.9	34.7	73.2	38.8	51.5	46.3	36.3	49.9	148.7	60.9	45.0	41.6	81.6	76.0	30.3	70.5	37.1	23.3	19.4	25.7	22.2	34.4	24.2	29.4	27.2	25.5	17.6	21.0	24.8	7.6	18.9	24.1	108.6	26.8	20.7	31.5	27.2	21.6	27.1	26.4	29.0	27.5	22.4	24.5	23.4	92.3	137.4	198.0	222.1	336.5	44.8	213.4	323.6	111.1	86.4	239.0	7.9	237.6	510.6	588.3	29.8	265.2	458.5	163.5	870.7	578.0	399.6	460.8	145.3	669.9	422.5	22.3	294.3	277.5	340.3	28.5	232.4	327.4	472.3	600.5	452.6	85.0	779.0	403.3	209.3	500.1	30.7	109.9	292.0	299.4	247.4	405.5	424.3	249.0	332.7	285.3
SEC63	"DNAJC23, ERdj2, PRO2507, SEC63L"	ENSG00000025796	"SEC63 homolog, protein translocation regulator"	Q9UGP8	6	107867756-107958189	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Chaperone	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053295, HPA060535"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053295: AB_2682105, HPA060535: AB_2684312"	"prognostic unfavorable (3.32e-4)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.51e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (6.16e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.41e-2)"	19.9	26.0	22.2	14.4	20.0	20.2	17.4	17.3	19.2	22.8	17.6	13.9	21.9	11.5	22.4	21.5	16.3	18.6	15.4	19.5	18.4	14.5	14.2	35.2	17.6	10.6	19.2	17.9	30.5	45.8	24.9	32.3	27.9	16.8	20.0	13.3	14.0	46.6	27.2	15.3	14.6	12.6	20.2	20.0	13.7	18.5	21.6	21.5	16.7	36.2	9.3	11.7	24.2	21.4	6.1	9.6	6.3	12.0	9.2	11.1	4.9	11.3	6.9	19.2	23.8	20.1	23.8	17.3	24.3	26.9	11.6	16.6	12.4	14.2	21.2	20.8	21.8	14.4	16.7	13.3	15.6	17.9	25.4	14.7	22.9	11.0	12.7	31.4	26.1	13.6	18.6	25.9	18.6	41.2	21.1	16.2	13.0	19.1	34.3	23.8	9.0	8.1	11.8	15.1	12.1	7.5	26.0	22.7	17.3	14.1	15.1	16.9	19.2	13.4	20.3	24.3	13.7	14.4	38.7	17.4	17.6	10.9	17.5	18.8	13.1	9.6	21.2	19.4	22.9	20.0	6.3	7.3	6.3	7.0	6.3	11.1	6.1	5.9	5.7	7.4	6.1	6.6	5.1	2.5	9.2	12.0	9.6	3.1	4.9	22.2	20.0	17.3	19.2	18.4	14.5	19.2	17.9	16.8	21.5	110.2	115.9	47.7	57.1	75.6	58.2	69.4	73.9	135.1	136.5	50.6	37.3	67.2	10.0	69.3	20.3	58.5	30.2	0.0	109.1	79.1	85.4	76.0	66.0	118.1	56.0	44.5	51.5	63.3	51.7	13.6	98.4	64.0	75.9	27.1	61.3	52.4	75.9	58.8	111.7	36.6	44.0	45.3	91.8	139.3	53.4	69.9	76.1	46.5	54.2	62.9
SEH1L	"SEC13L, Seh1, SEH1A, SEH1B"	ENSG00000085415	"SEH1 like nucleoporin"	Q96EE3	18	12947133-12987536	"Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039964	Uncertain					NA	NA					"HPA039964: AB_10795241"	"unprognostic (5.14e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.81e-3)"	"unprognostic (5.91e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.05e-2)"	20.1	13.0	21.9	17.7	20.5	12.4	16.8	23.8	31.3	12.6	16.6	16.7	8.6	13.0	16.9	14.7	18.8	12.1	11.3	14.3	26.3	20.0	17.5	28.3	12.1	25.5	16.9	13.5	20.8	26.6	12.6	19.7	14.2	16.7	11.7	16.4	10.3	16.7	11.2	33.6	16.6	13.5	15.5	15.2	17.7	12.3	16.4	13.5	32.2	15.1	18.9	23.6	17.3	12.4	15.4	23.1	3.2	19.0	13.3	14.0	12.2	14.7	11.4	8.9	14.1	6.3	9.4	13.0	12.8	13.2	15.2	17.5	29.3	7.8	31.9	15.7	14.9	13.6	7.5	20.7	14.7	19.8	8.8	13.3	19.8	11.2	17.3	14.3	53.9	13.2	6.7	11.6	17.5	26.0	6.3	7.9	14.7	26.6	11.9	12.2	16.0	28.9	23.4	11.2	60.1	11.9	19.5	20.7	20.7	11.7	15.0	17.3	10.4	16.4	12.5	12.9	6.7	7.8	18.0	6.3	15.6	36.1	23.4	22.4	8.8	12.8	34.3	10.2	19.6	10.0	2.5	14.5	3.2	8.9	19.0	12.1	14.7	10.7	11.1	23.1	15.4	14.0	11.7	1.6	13.3	15.0	12.6	7.2	12.2	21.9	20.5	23.8	31.3	26.3	20.0	16.9	13.5	16.7	13.5	6.0	19.8	14.5	32.5	48.5	7.6	11.8	17.8	8.1	19.4	12.2	11.8	19.9	8.3	11.8	6.9	14.6	10.1	0.0	11.4	26.7	21.0	21.0	7.0	20.5	19.7	3.2	18.4	15.4	11.9	8.5	8.6	18.0	15.1	14.4	17.9	5.1	13.4	14.0	10.3	13.8	9.3	12.9	17.6	10.7	12.6	52.2	19.8	10.1	23.0	33.3
SENP2	"AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2"	ENSG00000163904	"SUMO1/sentrin/SMT3 specific peptidase 2"	Q9HC62	3	185582496-185633551	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 190.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029247, HPA029248"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA029247: AB_10599305, HPA029248: AB_10601855"	"unprognostic (4.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (7.98e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.41e-3)"	"unprognostic (5.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-1)"	10.3	10.1	16.0	7.6	19.8	13.8	11.6	18.8	20.2	8.7	8.8	13.8	7.8	9.2	9.5	15.4	9.3	9.7	7.0	10.9	15.2	15.1	11.3	14.2	9.5	8.6	14.6	12.0	16.0	9.1	15.6	16.7	13.4	13.9	9.7	9.6	9.1	11.0	10.3	24.6	13.9	8.5	9.2	12.9	9.2	9.4	34.9	17.1	11.0	11.2	7.3	8.9	8.5	9.3	4.2	4.4	7.8	3.2	5.1	3.8	1.9	15.3	3.1	7.6	8.7	13.7	9.3	9.9	7.2	8.1	9.0	9.6	11.6	4.9	8.3	13.6	6.4	15.6	8.2	15.9	5.8	13.4	6.1	7.5	5.6	6.4	6.9	7.3	8.2	3.7	5.8	8.8	5.1	6.3	6.6	6.2	8.0	6.6	11.8	7.7	7.6	6.9	9.2	28.1	7.8	5.3	8.2	10.4	13.8	5.0	5.1	7.9	8.9	6.0	13.3	11.1	16.1	18.2	11.1	3.9	6.0	6.5	10.9	11.2	13.7	16.3	15.2	9.8	8.8	8.1	7.2	3.0	5.4	3.7	2.8	3.8	3.0	3.1	3.0	2.2	4.2	3.7	3.6	7.8	5.1	3.2	4.4	2.7	1.9	16.0	19.8	18.8	20.2	15.2	15.1	14.6	12.0	13.9	17.1	26.8	21.4	9.0	19.8	9.6	23.0	20.5	10.2	32.1	35.2	8.7	29.5	21.4	5.0	11.3	190.6	11.3	16.0	0.0	13.3	16.4	13.4	15.3	10.4	15.8	11.1	11.1	5.2	16.5	9.1	24.4	21.0	9.5	16.9	8.2	13.7	15.6	13.8	3.5	16.6	14.7	34.4	19.4	13.4	83.9	30.9	10.9	33.2	16.7	14.4	18.2
SERINC3	"AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1"	ENSG00000132824	"Serine incorporator 3"	Q13530	20	44496221-44522109	"Predicted membrane proteins, Transporters"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Late spermatids: 455.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048116	Uncertain					NA	NA					"HPA048116: AB_2680269"	"unprognostic (3.16e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.64e-2)"	42.5	47.1	35.5	22.8	63.0	21.0	38.9	28.9	80.6	39.0	27.4	52.8	14.8	22.9	31.8	25.4	32.8	28.3	34.2	34.9	40.8	35.2	25.0	45.1	33.0	20.6	40.5	33.9	35.4	24.7	55.9	33.6	55.8	60.9	29.6	31.8	29.4	30.2	33.4	45.3	35.9	25.6	35.2	42.6	26.3	26.2	51.2	33.3	29.2	40.6	20.5	23.8	32.8	28.8	19.6	31.4	58.9	34.5	34.4	34.4	38.7	14.6	15.7	7.5	9.6	66.4	47.8	11.7	30.2	52.5	24.4	22.4	35.4	36.5	10.7	41.2	35.8	27.9	26.5	9.0	30.9	26.0	12.4	10.1	12.5	16.3	17.9	36.0	15.4	27.4	33.8	45.3	24.0	36.0	29.4	23.7	17.5	13.9	31.8	25.5	18.4	15.7	12.2	4.4	19.2	23.9	7.9	11.3	16.3	19.5	16.9	9.5	7.2	28.9	28.3	19.1	11.0	20.2	17.3	30.2	58.1	9.6	25.5	20.9	18.9	20.7	8.2	43.3	10.9	18.1	57.9	30.2	37.9	33.8	31.5	34.4	19.3	29.5	32.8	31.4	19.6	30.6	30.4	58.9	34.4	34.5	28.9	33.1	38.7	35.5	63.0	28.9	80.6	40.8	35.2	40.5	33.9	60.9	33.3	68.5	57.7	38.9	69.7	48.7	35.4	62.4	84.1	45.5	55.7	45.4	33.4	80.2	13.3	67.0	180.5	98.3	50.9	70.0	61.0	74.0	82.1	72.9	98.4	97.2	51.5	42.9	63.8	98.8	68.4	455.0	97.2	53.4	37.1	19.8	58.5	49.9	82.3	52.6	107.1	21.9	28.9	97.0	84.6	177.2	84.8	73.5	138.3	59.8	49.3	65.0
SFXN4	SLC56A4	ENSG00000183605	"Sideroflexin 4"	Q6P4A7	10	119140767-119165667	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020872	Approved					NA	NA					"HPA020872: AB_1856793"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.70e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.07e-3)"	8.7	26.8	10.7	15.8	21.4	11.8	12.9	16.3	18.6	9.2	17.1	15.6	18.2	15.7	8.9	15.1	13.5	11.7	13.5	25.4	11.5	12.0	21.2	25.7	9.3	10.8	17.0	14.4	12.8	30.2	13.4	14.7	7.5	14.2	12.6	20.7	12.8	22.6	11.1	34.2	7.9	14.0	17.8	12.8	14.6	12.0	10.0	13.7	5.1	20.0	16.7	14.8	11.8	9.8	11.1	17.3	2.0	15.7	5.4	10.8	9.0	11.2	13.1	4.1	21.6	4.9	9.0	16.1	7.2	8.3	9.2	9.5	19.0	19.0	25.0	7.2	6.5	11.9	20.8	25.7	15.3	11.2	13.5	27.8	11.6	8.2	24.9	17.0	20.9	12.2	9.5	14.8	9.9	28.7	9.2	10.7	19.4	17.8	9.0	6.4	13.1	22.1	32.7	5.6	25.1	14.0	22.9	12.7	20.3	13.6	8.5	11.1	8.1	4.9	19.1	27.1	5.4	11.7	13.7	5.2	4.4	10.0	8.5	15.7	21.0	23.8	22.9	7.0	31.0	4.0	2.0	14.6	1.4	5.7	15.7	9.4	11.1	6.9	6.1	17.3	5.9	10.8	8.5	1.7	5.4	12.6	8.7	4.9	9.0	10.7	21.4	16.3	18.6	11.5	12.0	17.0	14.4	14.2	13.7	6.0	3.5	13.7	21.7	10.6	7.4	30.1	17.8	9.4	9.1	14.0	2.0	32.9	49.7	22.5	19.5	8.3	19.6	0.0	20.5	19.0	11.2	14.2	5.7	27.1	25.6	6.4	17.2	6.2	14.2	51.4	8.1	9.8	11.8	6.4	21.4	5.5	17.4	3.5	12.7	46.0	9.5	6.5	9.2	12.2	14.9	8.0	18.3	7.5	43.3	16.9
SGSM3	"DJ1042K10.2, RabGAP-5, RABGAP5, RUSC3, RUTBC3"	ENSG00000100359	"Small G protein signaling modulator 3"	Q96HU1	22	40370591-40410289	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048980	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA048980: AB_2680585"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (4.47e-5)"	"unprognostic (1.81e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.70e-3)"	"unprognostic (7.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.98e-3)"	10.5	17.2	18.2	15.9	19.4	11.4	12.0	27.2	29.9	18.7	21.5	13.7	27.2	21.5	13.6	14.9	19.7	17.0	34.5	14.1	17.7	17.3	14.6	14.4	13.3	20.0	16.1	26.3	13.2	51.6	16.4	22.3	14.5	18.5	24.2	16.4	14.4	43.9	22.9	20.5	17.7	20.6	11.7	11.9	19.8	51.5	20.6	14.2	13.3	19.8	11.1	20.9	15.3	13.9	15.7	21.0	10.2	10.1	20.9	13.0	9.9	16.4	9.3	13.9	15.3	15.4	8.6	19.7	15.6	10.2	11.8	15.5	5.3	13.8	10.2	10.9	16.8	7.2	13.4	13.1	19.0	4.7	25.3	31.1	6.9	23.3	4.8	14.8	10.0	15.2	14.0	13.4	13.2	8.0	13.5	20.6	22.0	8.4	14.2	8.6	26.3	13.8	10.2	9.3	33.2	6.3	25.8	8.8	22.2	12.1	14.6	8.5	11.0	17.2	25.0	11.8	11.6	20.9	17.1	17.9	4.1	14.9	10.6	9.0	21.5	9.8	13.3	17.1	8.4	10.2	0.7	9.4	10.2	13.0	10.1	10.9	12.1	8.1	10.4	12.3	15.7	10.0	8.0	2.2	20.9	7.2	21.0	7.5	9.9	18.2	19.4	27.2	29.9	17.7	17.3	16.1	26.3	18.5	14.2	3.0	10.1	25.0	26.4	10.2	54.2	7.7	22.9	4.0	6.8	7.0	17.7	36.5	1.7	16.2	13.9	14.8	34.9	0.0	40.1	44.3	14.3	57.7	16.1	18.3	21.1	25.4	30.1	18.4	17.6	24.3	21.0	8.3	15.1	23.4	123.5	12.0	22.2	46.9	18.0	3.6	31.3	38.8	17.6	46.0	26.0	9.2	38.1	20.0	41.0	54.8
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Early spermatids: 468.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 69.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 69.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol		NA	NA		18000	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	42.3	19.9	15.0	22.1	18.8	23.7	50.5	13.7	16.9	20.1	24.1	17.8	25.7	20.0	19.9	25.6	42.4	15.2	20.0	48.1	15.4	12.6	22.4	24.0	27.6	40.2	18.2	14.8	18.0	28.5	18.2	18.4	23.7	20.3	19.7	24.8	11.7	30.2	24.5	89.7	19.4	24.4	26.6	24.5	33.6	16.1	45.4	16.2	19.0	20.0	29.7	20.8	28.5	35.6	8.9	10.4	69.7	16.3	13.9	14.5	10.0	19.3	7.1	11.4	10.4	47.9	41.6	18.8	29.3	29.4	27.9	29.6	20.5	16.2	9.9	18.9	36.3	34.8	11.3	10.1	19.1	26.6	21.4	7.2	23.6	10.9	21.7	29.0	12.7	24.1	29.7	22.2	30.7	33.8	30.0	43.9	10.6	8.8	28.0	37.3	5.7	11.4	8.1	11.1	14.2	12.2	13.2	48.0	7.3	24.0	33.4	12.5	9.1	16.5	21.3	34.9	17.8	8.4	13.0	38.4	26.9	16.3	33.5	24.1	14.8	13.6	14.6	13.3	13.1	16.2	29.4	13.7	14.7	10.6	14.5	10.4	8.9	9.9	10.6	10.4	8.1	4.8	8.5	69.7	13.9	16.3	10.2	14.5	10.0	15.0	18.8	13.7	16.9	15.4	12.6	18.2	14.8	20.3	16.2	77.4	64.0	67.1	96.1	79.6	31.2	138.8	43.3	80.3	58.0	52.4	49.1	72.5	72.9	127.2	468.5	101.4	103.4	46.7	149.1	181.7	92.1	83.8	111.9	70.0	131.7	15.9	83.1	143.6	150.6	144.3	65.0	116.4	77.6	140.7	120.2	67.6	162.6	110.1	79.9	93.5	53.0	77.6	110.4	217.9	73.1	103.3	85.2	73.9	68.5	158.5
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241263-11564063	"Predicted membrane proteins, Transporters"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6;cervix, uterine: 22.4"	"Group enriched"	"Detected in some"	4	"Late spermatids: 9.9;Peritubular cells: 27.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 34.1"	"Low region specificity"	"Detected in many"							HPA023440	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	2.2	0.7	5.8	0.6	5.5	0.2	1.2	9.8	7.5	22.4	0.9	2.5	1.9	0.4	4.2	2.4	0.9	1.7	0.5	1.1	12.1	9.9	2.5	0.2	1.5	0.2	11.8	2.9	0.6	1.4	6.0	0.0	0.3	13.6	5.9	0.8	0.8	0.2	10.1	1.0	0.5	0.4	1.2	9.6	0.2	6.0	2.9	2.1	0.0	0.7	0.0	0.2	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	34.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.5	9.8	4.9	12.1	9.9	11.8	2.9	13.6	2.1	0.0	0.0	0.0	0.0	0.1	2.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.0	0.1	0.0	1.2	0.0	0.0	9.9	4.6	0.0	1.7	0.0	0.0	0.4	0.0	0.0	27.3	0.0	0.1	0.0	0.1	0.5	1.9	0.1	0.0	0.0	0.0	0.1
SHISA8	"C22orf17, Orf26"	ENSG00000234965	"Shisa family member 8"	B8ZZ34	22	41909554-41914667	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 42.2"	"Cell type enriched"	"Detected in some"	114	"Horizontal cells: 451.3"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	15	"cerebellum: 42.2"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.7"	"Cell line enriched"	"Detected in some"	7	"HEK 293: 20.9"	"Group enriched"	"Detected in some"	5	"cerebellum: 8.7;olfactory region: 19.4"	"Group enriched"	"Detected in all"	4	"cerebellum: 61.4;olfactory region: 45.2"	HPA059173	Uncertain					NA	NA					"HPA059173: AB_2683938"	"unprognostic (8.76e-2)"	"unprognostic (2.98e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.22e-4)"	"unprognostic (7.84e-2)"	0.1	9.4	0.5	1.6	0.5	0.2	0.1	42.2	2.7	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.4	0.2	0.3	0.3	0.5	0.2	0.2	0.1	0.1	3.0	0.3	1.7	0.1	0.1	0.1	0.8	0.0	2.2	0.2	0.0	1.5	1.8	0.2	0.8	0.5	0.8	0.0	0.3	2.7	0.7	0.2	0.0	0.0	0.1	0.0	3.8	0.4	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	42.2	2.7	0.5	0.2	0.3	1.7	2.2	0.0	0.0	0.0	2.7	0.0	0.0	4.0	3.6	0.0	0.0	0.0	0.0	3.9	0.0	1.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	451.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.9	1.9	0.0	0.0	0.0	0.0	0.0
SHISA9		ENSG00000237515	"Shisa family member 9"	B4DS77	16	12901620-13240413	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.5"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 23.8;Alveolar cells type 2: 15.3;Ciliated cells: 21.4;Club cells: 12.5;granulocytes: 10.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"EFO-21: 29.8;LHCN-M2: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072399			Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA072399: AB_2686517"	"unprognostic (1.88e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.69e-5)"	"unprognostic (2.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.90e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	1.2	4.8	17.2	1.6	23.5	2.7	1.3	0.9	21.3	0.9	3.4	3.6	0.4	1.6	1.1	2.3	1.2	0.7	0.9	1.3	10.2	6.7	3.4	1.4	0.7	1.0	3.3	12.6	1.1	1.3	0.6	1.9	1.0	10.2	6.9	1.8	0.6	1.7	1.4	4.2	1.9	1.7	1.2	2.1	1.0	1.3	1.6	4.0	0.0	3.5	0.0	0.8	0.8	0.9	2.0	1.2	3.9	0.9	1.2	0.9	0.0	0.6	0.3	0.5	0.5	0.1	0.2	0.5	0.3	0.0	0.0	0.0	0.3	0.5	0.5	29.8	0.1	0.6	0.5	0.1	0.1	0.1	0.5	0.2	0.7	0.6	0.3	0.0	0.5	0.8	0.9	0.0	0.1	2.1	0.3	0.1	0.5	0.4	1.2	24.2	3.3	0.4	0.7	6.4	0.5	0.3	0.6	0.4	0.3	6.6	1.1	6.4	0.5	0.3	1.0	0.4	3.1	0.8	0.4	0.4	0.6	3.9	0.6	0.4	1.2	1.2	0.6	0.4	0.2	0.8	3.9	0.9	0.4	0.8	0.5	0.6	1.1	0.7	0.8	0.3	2.0	0.9	0.8	3.2	1.2	0.7	1.2	0.7	0.0	17.2	23.5	0.9	18.8	10.2	6.7	3.3	12.6	10.2	4.0	23.8	15.3	0.0	0.5	0.1	0.6	0.8	0.0	21.4	12.5	1.8	0.0	0.0	1.7	0.7	3.8	0.3	0.0	0.0	0.0	0.0	0.2	1.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.2	0.0	0.0	0.0	0.5	0.1	2.9	0.0	0.9	0.3	0.0	0.0	0.2	0.9	0.1	0.1	0.0	0.3	0.5
SIDT1	"FLJ20174, SID-1"	ENSG00000072858	"SID1 transmembrane family member 1"	Q9NXL6	3	113532296-113629578	"Predicted membrane proteins, Transporters"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 21.6"	"Cell type enhanced"	"Detected in many"	8	"B-cells: 13.7;Mucus-secreting cells: 20.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 21.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 11.6;OE19: 12.3;PC-3: 16.4;RT4: 11.4;T-47d: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035862	Approved					NA	NA					"HPA035862: AB_10671110"	"unprognostic (4.23e-1)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.43e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.64e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.50e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.32e-2)"	"prognostic favorable (4.09e-5)"	1.8	4.1	7.5	13.6	5.9	4.1	7.8	17.3	11.7	4.7	8.4	5.5	3.7	2.8	1.2	0.7	2.7	2.8	5.1	1.1	7.9	9.2	1.6	1.1	2.7	17.6	4.7	8.5	0.9	1.7	1.5	12.8	1.6	4.7	7.2	14.0	0.4	13.2	9.7	0.8	1.3	8.4	1.3	4.5	11.6	4.9	1.8	1.2	13.2	1.3	0.7	13.3	6.8	1.9	4.9	21.6	0.2	0.4	5.9	4.9	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.1	0.0	1.1	0.0	0.4	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.4	0.0	11.6	3.1	0.1	0.0	12.3	16.4	4.7	0.0	0.4	0.0	11.4	0.1	0.1	0.0	3.3	0.1	0.0	10.8	0.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	4.9	0.1	4.9	4.9	3.2	3.9	0.9	4.3	4.2	3.5	0.1	5.9	0.0	21.6	2.5	2.1	7.5	5.9	17.3	11.7	7.9	9.2	4.7	8.5	4.7	1.2	6.0	3.5	13.7	1.6	0.3	0.0	0.8	2.5	9.4	3.4	1.8	0.0	0.0	0.0	0.3	2.8	0.7	4.3	0.0	1.0	0.1	0.3	6.3	3.5	0.0	8.7	0.0	9.8	0.6	3.5	1.3	0.0	2.5	5.0	2.8	20.6	0.0	0.7	2.9	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	0.1	8.9	6.3	1.4
SIDT2	CGI-40	ENSG00000149577	"SID1 transmembrane family member 2"	Q8NBJ9	11	117178733-117197445	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 83.9"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 25.6;non-classical monocyte: 41.6"	"Lineage enriched"	"Detected in many"	6	"monocytes: 41.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052352	Approved					NA	NA					"HPA052352: AB_2681797"	"unprognostic (3.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (4.18e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.22e-3)"	23.9	12.1	9.6	12.5	15.9	7.0	23.5	16.2	18.0	12.7	19.2	28.0	19.4	27.1	16.6	14.3	8.7	13.0	15.6	14.9	11.2	10.0	10.0	21.2	29.7	21.3	15.0	14.5	30.6	83.9	12.0	17.4	13.8	17.4	24.5	14.9	14.1	25.5	16.7	11.1	19.5	31.7	18.2	25.4	17.3	35.4	13.8	13.0	6.2	15.4	8.4	12.5	16.1	9.7	7.3	3.5	0.5	41.6	0.4	0.6	2.8	4.2	4.5	5.5	7.8	18.7	16.8	18.4	7.7	10.2	5.0	4.6	12.0	17.2	4.5	12.4	20.3	6.2	4.7	5.3	6.0	4.1	6.7	6.5	3.0	7.9	8.8	9.7	2.7	8.2	20.7	6.7	6.4	6.9	15.3	10.0	5.9	5.9	10.1	11.6	9.3	3.7	3.1	2.6	23.4	3.4	2.8	3.8	12.8	6.5	4.7	1.7	4.1	8.2	20.1	1.3	6.5	16.2	3.2	6.2	6.6	4.3	4.4	1.7	7.1	2.6	4.7	3.7	5.6	4.8	0.1	4.2	0.1	0.6	25.6	0.5	5.7	0.3	0.4	3.5	7.3	0.5	0.4	0.5	0.4	41.6	1.9	0.4	2.8	9.6	15.9	16.2	18.0	11.2	10.0	15.0	14.5	17.4	13.0	6.0	10.5	12.3	19.3	60.1	10.5	6.3	2.5	2.7	4.5	10.4	5.9	7.7	0.0	4.2	5.7	9.5	22.0	0.0	8.4	30.1	16.8	21.1	2.3	17.3	15.7	17.5	10.9	14.7	39.4	8.5	12.4	23.2	18.6	4.6	24.8	7.1	6.8	10.5	12.7	1.5	11.3	19.4	18.9	3.6	4.2	37.5	27.0	7.9	10.2	13.2
SIGMAR1	"OPRS1, SR-BP1"	ENSG00000147955	"Sigma non-opioid intracellular receptor 1"	Q99720	9	34634722-34637809	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Receptor	"Amyotrophic lateral sclerosis, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.1"	"Cell type enhanced"	"Detected in many"	5	"Extravillous trophoblasts: 82.3;Hepatocytes: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013470, HPA018002, HPA024071"	Enhanced					NA	NA					"CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803"	"unprognostic (1.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.42e-4)"	15.3	19.7	9.2	9.8	14.5	8.5	13.0	9.4	16.1	17.0	18.2	13.4	13.3	23.0	18.6	13.4	18.6	17.4	17.1	12.1	9.4	12.0	14.2	89.1	9.6	14.5	10.7	10.7	20.1	22.9	15.0	8.3	17.8	14.0	18.9	13.2	15.7	12.0	19.6	7.7	16.8	24.9	15.1	9.2	9.8	14.6	9.4	9.3	9.6	11.8	15.0	15.8	16.4	15.2	14.0	23.8	12.4	19.3	13.1	32.6	20.1	41.1	36.5	12.7	41.4	47.0	32.6	16.4	30.0	20.3	26.5	24.5	22.9	18.0	20.2	17.8	32.5	16.8	25.8	16.2	34.0	5.8	35.1	43.7	19.3	54.4	25.0	30.9	33.1	16.8	32.9	36.4	29.1	36.2	14.0	20.0	26.7	7.2	37.4	28.3	0.2	20.1	48.0	15.9	21.8	47.5	23.5	14.2	56.8	24.1	8.2	14.9	16.8	29.8	21.3	15.7	5.2	25.2	22.6	16.8	22.0	17.6	23.2	4.4	10.4	16.4	0.5	22.8	28.8	45.5	10.5	19.1	12.4	22.2	18.4	24.2	14.0	32.6	26.7	23.8	10.8	27.8	22.6	5.4	13.1	19.3	17.5	29.9	20.1	9.2	14.5	9.4	16.1	9.4	12.0	10.7	10.7	14.0	9.3	3.0	9.9	15.9	14.7	16.4	7.7	7.3	15.3	8.1	6.8	7.0	0.0	35.2	0.0	30.9	0.6	12.4	34.1	23.3	29.3	82.3	26.6	19.8	6.9	84.9	34.7	4.8	9.9	14.7	11.0	1.1	25.3	7.9	18.6	11.8	22.5	12.7	25.2	28.5	24.1	11.0	6.2	19.4	20.6	5.7	10.0	18.7	30.6	11.7	37.5	11.6
SLC10A1	NTCP	ENSG00000100652	"Solute carrier family 10 member 1"	Q14973	14	69775417-69797289	"Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"liver: 121.2"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 130.2"	"Cancer enriched"	"Detected in some"	79	"liver cancer: 65.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042727	Approved					NA	NA					"HPA042727: AB_10960691"	"unprognostic (3.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.51e-3)"	"prognostic favorable (9.53e-6)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	2.7	0.5	0.1	0.6	0.0	0.2	0.0	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	4.3	0.1	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.5	0.6	0.3	0.6	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.9	0.1	0.1	0.8	0.5	0.0	0.1	0.4	0.5	1.1	0.1	0.6	0.0	0.3	0.0	0.1	0.9	0.1	0.6	0.1	0.0	0.3	1.7	0.5	0.3	0.4	0.8	0.5	0.2	0.3	1.0	0.6	0.4	2.7	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.4	10.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	130.2	0.1	0.0	0.0	1.8	2.7	3.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SLC10A2	"ASBT, ISBT"	ENSG00000125255	"Solute carrier family 10 member 2"	Q12908	13	103043998-103066846	"Disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"intestine: 40.9"	"Group enriched"	"Detected in some"	29	"Enterocytes: 5.1;Proximal tubular cells: 6.4"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.2;HAP1: 2.5;NB-4: 1.2;U-2197: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004795	Approved					NA	NA					"HPA004795: AB_1856953"											"unprognostic (2.82e-2)"		"prognostic favorable (5.78e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	2.5	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC10A3	"DXS253E, P3"	ENSG00000126903	"Solute carrier family 10 member 3"	P09131	X	154487306-154490690	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 86.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	9	"basophil: 51.2"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 51.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021656	Approved		Approved	"Intermediate filaments"		NA	NA			"Intermediate filaments"		"HPA021656: AB_1856955"	"unprognostic (1.60e-1)"	"prognostic favorable (4.53e-4)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.28e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.42e-1)"	"unprognostic (2.52e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-2)"	14.5	14.6	3.6	11.6	5.1	22.5	13.4	5.0	8.1	21.5	15.3	8.1	16.3	10.6	25.0	36.1	22.8	15.4	21.1	19.5	6.0	4.6	17.7	6.7	16.3	14.0	5.8	6.2	32.3	25.7	6.1	12.7	40.1	7.6	23.7	6.4	12.4	11.7	13.3	13.7	26.2	13.6	20.1	5.3	13.1	12.6	11.6	4.7	12.6	15.7	23.3	18.6	23.3	18.3	1.6	2.7	51.2	1.7	2.2	3.8	1.8	24.9	10.7	2.9	14.6	10.1	11.0	19.0	18.6	11.4	12.6	12.7	9.5	12.1	19.0	35.4	17.8	16.8	21.5	9.4	9.5	3.4	12.3	4.4	5.9	14.1	7.5	18.6	7.0	9.6	13.7	10.9	11.7	6.3	11.3	8.6	3.3	6.6	18.7	8.2	33.1	3.8	6.3	2.2	12.2	20.8	6.1	7.7	14.4	9.5	9.3	2.6	4.7	11.7	21.3	4.9	3.5	6.8	5.6	11.3	15.0	9.4	34.8	23.5	13.4	12.9	19.6	16.0	14.7	7.7	51.2	1.3	5.6	3.8	1.7	2.9	1.6	2.6	2.8	1.1	1.6	1.9	1.8	1.7	2.2	1.5	2.7	1.8	1.8	3.6	5.1	5.0	8.1	6.0	4.6	5.8	6.2	7.6	4.7	3.0	6.5	11.7	23.8	20.0	2.0	3.6	7.6	4.0	3.4	17.4	5.9	42.9	6.6	15.3	2.4	14.3	14.4	0.0	17.0	52.6	23.3	12.1	12.7	1.6	17.2	3.2	9.8	18.4	7.8	1.0	25.0	10.5	3.3	16.2	14.0	2.3	15.9	15.3	12.4	7.7	1.6	6.5	22.6	1.2	2.7	24.3	86.2	17.5	10.6	24.7
SLC10A4	MGC29802	ENSG00000145248	"Solute carrier family 10 member 4"	Q96EP9	4	48483343-48489196	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 12.3;brain: 19.0"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 2.7;Cone photoreceptor cells: 2.0;Early spermatids: 1.4"	"Cancer enhanced"	"Detected in many"		"glioma: 5.9"	"Group enriched"	"Detected in many"	7	"basal ganglia: 7.3;cerebral cortex: 6.3;hypothalamus: 6.3;midbrain: 19.0;pons and medulla: 15.3"	"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.6;HEL: 4.6;K-562: 10.6;SH-SY5Y: 28.2;THP-1: 4.6"					"Group enriched"	"Detected in many"	5	"basal ganglia: 19.0;midbrain: 63.0;pons and medulla: 27.5"	HPA028835	Uncertain	Supported				NA	NA					"HPA028835: AB_10603025"	"unprognostic (4.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.73e-2)"	0.4	12.3	1.4	2.7	7.3	3.4	0.5	0.5	6.4	2.9	1.6	0.7	0.0	0.8	0.4	0.2	0.4	0.4	0.6	0.6	1.2	6.3	0.3	0.2	1.1	0.3	19.0	0.8	0.3	0.3	0.4	7.5	0.4	15.3	0.4	1.5	4.0	4.9	0.9	0.9	0.4	1.3	0.6	1.1	0.4	0.8	1.2	0.7	0.0	1.5	0.0	0.3	0.4	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	2.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	2.1	0.0	10.6	0.0	0.1	0.0	2.3	4.6	0.1	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.2	3.1	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.7	28.2	0.5	0.0	0.1	0.6	0.0	4.6	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	7.3	0.5	6.3	1.2	6.3	19.0	0.8	15.3	0.7	0.0	2.7	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0
SLC10A5		ENSG00000253598	"Solute carrier family 10 member 5"	Q5PT55	8	81693607-81696174	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 5.1;liver: 10.3"	"Cell type enhanced"	"Detected in some"	11	"Ciliated cells: 6.7;Enterocytes: 5.2;Intestinal endocrine cells: 3.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 6.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA025966	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA025966: AB_1856959"	"unprognostic (6.42e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.71e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.82e-7)"	0.0	0.3	0.9	0.1	2.3	0.0	0.2	5.1	1.8	0.3	2.5			2.9	0.3	0.9	0.2	0.3	1.4	0.1	0.9	2.1	1.8	10.3	0.3	0.0	0.8		0.4	1.0	0.3	1.9	0.0		0.5	3.5		0.3	0.2	0.1	0.4	3.5	0.2	0.3	0.3	3.4	0.0			0.8		0.0	0.3	0.1	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.7	0.3	0.9	0.9	0.7	1.4	0.7	0.9	0.4	0.3	0.5	0.4	0.5	0.9	1.3	0.2	0.2	0.9	1.1	0.8	1.3	0.7	2.4	1.8	2.6	1.4	0.4	0.1	0.3	0.4	2.2	0.7	1.7	1.5	0.4	0.6	1.6	1.2	1.3	0.7	0.5	1.2	0.4	6.5	0.5	0.3	0.3	0.6	1.2	3.1	2.1	0.9	0.7	0.6	0.3	0.5	1.6	0.6	0.9	1.1	1.5	1.4	1.4	1.5	2.2	0.1	1.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	6.7	0.0	0.0	0.0	0.0	1.7	0.3	0.0	0.0	5.2	0.0	1.0	0.1	0.0	0.2	0.0	2.1	0.0	0.0	3.5	0.6	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.5	1.7	0.0	1.8	0.3	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.0	0.4
SLC10A7	"C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043"	ENSG00000120519	"Solute carrier family 10 member 7"	Q0GE19	4	146253975-146521964	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 23.3;granulocytes: 23.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039996	Uncertain					NA	NA					"HPA039996: AB_10673266"	"unprognostic (9.44e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.69e-2)"	"unprognostic (9.57e-2)"	12.0	10.7	8.0	8.1	14.3	8.8	11.3	17.0	10.5	13.5	11.8	10.0	17.4	7.8	13.2	21.4	14.9	9.2	9.7	8.3	8.6	6.4	8.6	17.2	16.0	13.9	10.9	6.9	12.0	14.5	7.9	22.2	15.0	11.2	11.1	16.2	7.8	15.5	16.0	8.8	9.4	10.3	10.3	19.3	11.0	16.3	6.6	11.7	16.8	12.3	9.2	12.8	10.2	12.7	6.7	6.4	11.5	7.7	7.5	7.8	3.7	3.8	1.3	9.5	4.0	7.1	8.5	4.7	4.9	6.4	4.5	4.6	3.6	16.7	7.4	3.4	5.3	2.8	4.0	5.5	6.7	5.4	8.4	2.6	8.9	3.2	6.4	4.5	15.5	14.2	4.1	5.6	5.3	6.8	2.7	8.0	7.7	9.9	19.5	3.2	2.7	11.6	3.7	1.8	8.8	6.4	6.4	6.9	10.1	3.2	2.9	2.9	2.6	3.3	10.0	4.0	5.3	5.9	6.2	4.4	4.0	4.2	6.1	3.3	16.4	17.9	10.1	5.5	6.5	5.7	11.5	5.1	6.8	6.4	7.7	6.6	6.7	6.5	5.8	6.4	4.5	6.0	5.9	0.5	7.5	5.9	4.4	7.8	3.7	8.0	14.3	17.0	10.5	8.6	6.4	10.9	6.9	11.2	11.7	3.0	3.8	3.7	2.8	3.0	5.6	1.6	12.7	9.4	2.3	1.8	3.9	5.7	1.7	3.3	1.4	3.6	4.9	23.3	4.4	11.7	4.9	5.4	23.0	9.0	5.2	7.9	4.6	8.6	6.3	0.7	6.9	3.6	0.0	2.8	11.3	4.3	3.0	2.9	4.6	1.7	11.3	0.0	5.1	5.4	4.1	4.3	5.1	4.8	5.6	3.5
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 37.6;lymphoid tissue: 23.8"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 2: 52.4;Hofbauer cells: 110.2;Kupffer cells: 163.4;Macrophages: 201.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 7.9;intermediate monocyte: 5.8;myeloid DC: 2.4;neutrophil: 6.0;non-classical monocyte: 7.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 2.4;granulocytes: 6.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"HEL: 3.8;HMC-1: 3.7;NB-4: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA029590, HPA050378, HPA068540"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"HPA029590: AB_10794613, HPA050378: , HPA068540: "	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	13.5	4.7	4.3	14.9	13.3	11.6	2.6	0.6	9.3	1.7	1.8	4.6	0.0	1.3	1.3	2.1	1.4	4.1	3.0	6.5	15.0	2.6	2.1	3.2	37.6	19.9	17.1	0.7	2.4	3.3	1.2	1.9	6.2	11.3	1.7	1.0	1.7	2.0	1.2	2.0	1.0	1.2	4.6	18.1	23.8	1.7	2.4	10.3	0.0	1.8	0.2	1.0	7.1	1.3	0.4	2.4	6.0	7.9	0.2	0.4	2.6	0.3	0.7	0.0	0.4	0.1	0.1	0.9	0.0	0.0	0.1	0.2	1.0	2.1	0.2	0.2	0.0	0.3	0.8	0.0	0.0	0.0	0.7	0.1	3.8	0.6	0.7	0.1	0.0	3.7	0.3	0.1	0.0	0.2	0.3	0.0	1.2	1.0	0.7	0.1	1.3	0.2	3.1	0.0	0.6	0.2	0.2	0.6	0.4	0.1	0.3	0.8	0.2	0.5	0.4	0.4	0.2	0.3	1.1	0.3	0.7	0.4	0.2	0.0	0.3	0.3	0.7	0.2	0.4	0.4	0.3	7.9	0.6	0.4	5.8	0.3	0.1	0.2	0.2	2.4	0.4	0.4	0.3	6.0	0.2	7.0	0.2	0.2	2.6	4.3	13.3	0.6	9.3	15.0	2.6	17.1	0.7	11.3	10.3	20.8	52.4	3.0	3.9	0.8	3.6	6.3	5.1	17.4	22.7	8.7	0.0	1.6	8.3	0.8	1.2	4.7	1.2	0.0	1.8	7.2	2.4	5.7	24.3	4.7	110.2	1.6	1.2	8.6	163.4	0.4	2.0	201.4	1.7	1.0	4.0	7.6	0.6	0.9	0.7	6.8	3.0	19.4	5.0	0.5	1.7	0.9	6.8	1.7	2.2	2.7
SLC11A2	"DCT1, DMT1, NRAMP2"	ENSG00000110911	"Solute carrier family 11 member 2"	P49281	12	50979401-51028566	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032139, HPA032140"	Uncertain		Supported	Mitochondria		No	No			Mitochondria		"HPA032139: AB_10964213, HPA032140: AB_10962932"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.07e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.24e-1)"	11.3	15.1	12.8	9.6	26.2	9.6	20.8	14.7	22.1	20.8	11.3	38.2	8.4	35.3	12.3	12.7	17.3	15.4	12.1	12.9	14.5	14.2	16.1	18.0	18.6	7.9	40.0	15.4	10.4	20.6	29.8	21.7	16.4	29.7	18.0	11.8	18.7	26.9	14.8	17.6	15.6	11.6	11.0	33.1	9.5	12.5	8.7	31.0	15.8	29.9	8.7	16.5	12.9	13.9	4.1	9.8	3.0	9.5	8.3	7.1	4.6	7.7	10.0	13.2	12.1	14.7	12.5	44.4	8.4	30.5	8.0	9.4	12.6	14.6	4.8	16.6	9.4	15.3	10.7	11.9	7.9	9.4	6.9	7.2	11.4	12.1	14.3	15.6	7.7	23.0	13.7	9.9	14.9	15.2	19.6	9.5	9.8	9.8	2.4	9.3	8.9	9.1	5.2	19.6	8.2	6.9	5.9	12.1	8.5	9.7	11.6	9.1	8.1	6.4	19.5	8.5	16.0	21.9	5.1	11.4	8.2	6.9	9.2	4.4	6.0	8.1	2.0	23.1	4.2	3.4	0.7	6.6	2.4	6.4	9.5	5.8	3.6	5.0	6.3	9.8	4.1	7.1	6.6	3.0	8.3	6.0	4.1	3.8	4.6	12.8	26.2	14.7	22.1	14.5	14.2	40.0	15.4	29.7	31.0	35.7	40.3	11.5	22.2	13.7	23.8	12.0	28.1	45.5	43.3	54.1	17.7	20.6	3.3	25.3	0.8	14.3	8.6	70.0	24.8	18.3	17.5	32.8	67.2	38.4	29.8	27.0	15.7	9.8	13.3	1.5	8.9	25.8	25.3	9.0	13.5	27.5	20.6	14.7	8.1	8.8	16.5	6.5	12.4	5.5	12.8	11.7	16.2	7.9	16.1	19.0
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	75	"kidney: 143.2"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 177.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.0"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"basophil: 1.9;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.9"	"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.0	0.0	0.3	0.0	1.0	0.0	0.0	1.4	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	143.2	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.9	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	1.5	0.1	0.0	0.1	0.0	0.0	0.3	1.0	1.4	1.5	0.1	0.3	0.3	0.4	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	36.6	0.0	0.0	177.4	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
SLC12A2	"BSC, BSC2, NKCC1, PPP1R141"	ENSG00000064651	"Solute carrier family 12 member 2"	P55011	5	128083766-128189688	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 50.7;salivary gland: 61.2"	"Cell type enhanced"	"Detected in many"	8	"Glandular cells: 203.2;Mucus-secreting cells: 402.7;Undifferentiated cells: 269.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 54.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 9.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"OE19: 55.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020130, HPA063697"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			Vesicles	"Plasma membrane"	"HPA020130: AB_1854502, HPA063697: AB_2685094"	"unprognostic (4.61e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (8.60e-4)"	"unprognostic (3.99e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.95e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.88e-3)"	5.5	11.0	10.8	9.4	24.1	2.7	26.2	11.4	18.1	5.1	28.5	37.2	0.0	24.6	5.7	1.9	3.8	4.1	50.7	4.1	15.5	9.9	4.5	2.9	6.5	3.5	36.1	13.5	5.6	5.3	11.2	5.5	3.3	30.0	14.8	36.3	8.5	61.2	2.1	8.5	23.0	28.8	6.6	27.7	2.9	36.3	5.5	26.7	2.0	5.6	6.8	18.3	4.2	3.6	3.6	9.8	0.5	1.2	3.6	3.0	0.4	4.8	24.1	24.8	9.6	6.2	4.0	5.1	4.5	3.4	3.2	3.4	9.6	7.7	7.2	6.1	3.9	2.9	14.7	4.7	5.2	5.0	7.2	5.9	2.0	4.3	1.4	1.9	2.6	3.6	4.2	1.9	7.2	4.3	2.4	5.3	3.1	3.3	4.9	5.0	5.1	4.6	2.2	2.9	55.9	7.9	2.5	7.0	2.9	3.8	16.5	4.4	2.8	9.1	4.0	3.5	2.8	2.2	1.3	8.8	8.1	5.4	6.1	5.7	4.1	3.7	8.0	4.2	1.5	6.5	0.5	0.7	0.2	1.9	1.2	3.0	2.7	1.8	2.3	0.9	3.6	2.0	2.7	0.3	3.6	0.8	9.8	1.6	0.4	10.8	24.1	11.4	18.1	15.5	9.9	36.1	13.5	30.0	26.7	14.9	37.4	13.4	18.3	20.4	45.1	14.0	99.3	10.7	38.7	31.4	119.8	0.9	1.7	45.3	45.7	23.6	29.9	0.0	41.4	2.1	14.8	203.2	18.4	7.4	3.6	76.3	71.5	6.7	7.3	70.8	79.1	10.2	194.0	0.0	402.7	27.8	49.2	77.2	27.3	9.6	76.9	71.1	24.5	27.0	21.5	26.2	1.1	12.1	269.5	16.9
SLC12A3	NCCT	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 88.6"	"Group enriched"	"Detected in some"	9	"Collecting duct cells: 3.5;Distal tubular cells: 5.0;monocytes: 7.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 14.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 14.6"	"Group enriched"	"Detected in some"	10	"BEWO: 10.2;HAP1: 5.6;HeLa: 11.4;SuSa: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028748	Enhanced					NA	NA					"HPA028748: AB_10603886"	"unprognostic (1.54e-3)"	"unprognostic (7.09e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.70e-1)"	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	88.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	14.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	14.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.5	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC12A4	KCC1	ENSG00000124067	"Solute carrier family 12 member 4"	Q9UP95	16	67943474-67969601	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 53.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041138	Approved		Approved	Endosomes		NA	NA			Endosomes		"HPA041138: AB_10794544"	"unprognostic (5.07e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (2.25e-6)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.26e-1)"	16.6	18.3	9.2	8.0	8.8	3.1	26.5	7.0	12.7	19.4	16.5	20.1	12.0	5.1	20.7	9.7	11.8	13.8	15.5	24.4	12.2	5.2	10.7	17.1	19.5	6.6	11.4	8.2	14.2	11.9	30.1	8.1	32.6	18.1	17.8	4.3	23.0	10.5	20.7	14.6	16.9	8.6	27.4	10.0	10.2	10.9	17.6	9.8	8.8	21.0	9.1	8.4	16.5	16.6	1.0	2.4	8.3	5.4	2.7	1.6	1.6	5.0	6.8	5.3	10.0	17.6	15.5	28.6	15.6	16.2	13.5	11.8	13.6	8.2	1.8	7.7	21.5	7.5	9.3	2.5	19.3	10.2	1.8	2.0	1.3	8.9	14.9	20.0	0.1	6.4	17.1	12.7	18.1	6.6	15.8	8.3	3.4	4.1	1.5	18.5	0.8	1.9	5.1	4.0	1.5	3.6	2.0	10.0	1.6	7.4	4.4	0.0	3.2	29.7	1.8	2.6	13.8	14.2	2.0	11.2	19.3	13.7	8.5	6.7	9.3	2.3	3.0	11.2	1.4	16.6	8.3	3.9	2.0	1.5	5.4	1.0	0.4	0.9	0.9	2.4	1.0	0.8	0.7	1.4	2.7	3.8	1.1	1.6	1.6	9.2	8.8	7.0	8.6	12.2	5.2	11.4	8.2	18.1	9.8	14.9	7.8	2.2	12.2	9.0	1.0	25.6	2.5	6.7	10.3	14.0	0.0	24.6	0.0	10.9	2.1	14.3	0.0	0.0	7.1	13.5	13.6	12.7	1.1	7.5	6.9	0.0	0.0	14.1	4.6	1.3	18.4	4.4	10.1	16.2	0.0	21.0	12.7	0.0	34.3	3.4	0.8	38.8	27.6	9.7	6.6	4.5	53.1	1.5	0.0	8.6
SLC12A5	"KCC2, KIAA1176"	ENSG00000124140	"Solute carrier family 12 member 5"	Q9H2X9	20	46021690-46060152	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 64.6"	"Group enriched"	"Detected in many"	13	"Bipolar cells: 205.2;Cone photoreceptor cells: 361.3;Rod photoreceptor cells: 172.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 5.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 13.7;NB-4: 28.3;SK-BR-3: 14.3;U-2 OS: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072058	Enhanced					NA	NA					"HPA072058: AB_2686485"	"unprognostic (2.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.44e-4)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.16e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.61e-4)"	"unprognostic (8.78e-4)"	"unprognostic (3.25e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-2)"	1.4	11.2	21.1	2.0	28.8	1.5	1.7	52.1	64.6	2.3	2.1	2.7	0.0	2.2	1.6	2.2	1.3	1.7	1.9	2.1	20.5	19.2	1.4	2.2	2.7	3.1	9.5	32.1	2.0	3.6	1.5	4.8	3.3	15.3	1.5	2.1	4.9	1.9	1.8	1.5	1.5	2.1	1.6	6.3	2.8	3.1	3.4	5.8	0.0	1.3	0.0	2.6	1.2	0.5	1.3	0.2	0.1	1.5	0.7	5.7	1.3	0.0	8.6	3.8	2.8	0.3	0.0	0.8	0.3	0.0	0.0	0.3	1.1	0.0	3.2	13.1	0.2	3.4	0.8	2.5	1.3	0.2	2.0	3.3	2.7	1.6	13.7	1.5	0.0	3.8	0.5	0.0	0.0	0.2	5.9	0.8	3.1	5.1	0.0	0.0	13.0	1.9	28.3	1.4	1.2	4.4	3.2	2.4	0.7	1.3	0.0	4.7	6.7	1.7	14.3	4.1	3.7	5.2	8.1	1.3	1.5	16.3	0.1	0.6	0.0	2.1	4.5	3.5	3.3	0.1	0.0	1.5	0.0	2.6	0.8	1.0	1.0	0.3	0.4	0.2	1.3	5.7	3.2	0.1	0.7	0.2	0.0	3.5	1.3	21.1	28.8	52.1	36.4	20.5	19.2	9.5	32.1	15.3	5.8	0.0	0.0	0.0	0.0	0.5	205.2	0.8	0.0	0.0	0.0	0.0	361.3	1.1	1.7	0.0	1.6	1.6	0.0	0.0	0.2	2.6	0.4	0.4	0.0	0.5	15.2	12.7	19.1	3.7	0.6	3.4	0.0	3.2	5.0	1.0	0.4	12.9	0.5	0.0	0.0	0.2	172.9	0.0	0.4	1.4	2.5	0.5	1.4	0.0	0.4	0.0
SLC12A6	"ACCPN, KCC3"	ENSG00000140199	"Solute carrier family 12 member 6"	Q9UHW9	15	34229996-34338060	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		Neuropathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 80.5;Rod photoreceptor cells: 54.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 9.4;neutrophil: 18.5"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 18.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 27.2"					"Low region specificity"	"Detected in all"			HPA034563	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA034563: AB_10603887"	"unprognostic (3.53e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.33e-6)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.41e-1)"	8.7	5.8	7.4	12.4	11.1	27.5	7.0	10.2	14.1	14.7	8.0	12.7	3.6	8.3	6.3	8.7	24.9	4.7	6.3	6.9	6.8	6.9	18.6	4.9	11.5	10.9	9.9	8.4	5.8	5.1	5.4	10.9	5.2	12.5	5.0	7.4	9.7	9.3	4.9	10.5	8.6	10.2	6.0	9.2	11.1	8.0	38.5	10.9	18.2	10.6	8.2	13.6	8.2	21.2	2.0	1.0	18.5	1.4	0.6	2.3	0.7	2.6	3.2	2.0	2.9	6.5	7.6	1.4	4.0	9.3	3.1	4.5	1.8	4.4	1.9	3.7	4.2	2.8	27.2	4.8	3.3	3.7	0.7	3.2	14.6	8.2	4.2	4.0	8.7	16.0	4.4	5.8	9.1	18.4	7.0	9.4	5.2	3.2	4.3	4.2	0.9	0.9	6.9	1.5	2.3	3.5	4.4	3.5	1.8	3.5	6.8	4.4	3.2	4.4	0.1	0.9	4.7	1.9	3.0	5.8	3.6	2.6	12.4	0.9	3.8	4.1	1.2	4.3	6.5	1.5	9.4	1.1	2.3	0.5	1.4	0.3	1.2	0.8	0.7	0.7	2.0	1.3	1.1	18.5	0.6	0.6	1.0	2.3	0.7	7.4	11.1	10.2	14.1	6.8	6.9	9.9	8.4	12.5	10.9	20.8	18.9	18.2	3.9	1.0	12.8	7.4	5.1	5.3	5.7	5.2	80.5	2.5	0.0	4.2	9.2	16.3	10.3	0.0	4.1	1.3	2.0	4.8	4.7	6.7	11.9	7.9	6.4	14.1	38.6	5.3	7.5	14.4	0.0	1.0	7.3	8.0	8.7	12.7	8.1	17.8	54.2	19.4	2.0	38.5	20.4	0.6	0.9	12.8	6.0	20.5
SLC12A7	"DKFZP434F076, KCC4"	ENSG00000113504	"Solute carrier family 12 member 7"	Q9Y666	5	1050376-1112035	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"Horizontal cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 25.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041652	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA041652: AB_10793971"	"unprognostic (2.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.72e-2)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.16e-5)"	10.1	6.4	5.7	14.1	7.3	4.3	13.0	2.4	8.3	6.5	11.5	5.6	6.6	28.0	7.2	7.6	4.7	8.9	29.4	27.9	6.1	3.8	20.4	31.3	10.0	10.3	5.8	3.2	8.5	12.4	8.2	11.5	3.8	7.9	10.2	7.0	15.5	10.9	8.7	3.2	7.9	20.3	8.2	4.9	17.9	15.2	14.5	7.4	12.2	13.3	5.5	6.9	7.1	34.5	1.4	4.2	0.5	6.9	2.5	2.7	2.2	2.1	6.0	3.3	10.4	0.5	0.5	5.2	0.1	0.7	0.5	0.0	14.3	3.8	0.0	11.8	0.2	4.1	4.4	2.7	3.6	0.0	13.0	3.6	2.8	7.5	4.9	7.6	0.0	6.3	1.1	0.5	0.0	1.1	0.2	3.3	1.3	4.0	0.1	0.0	6.9	8.4	0.0	7.2	8.4	9.6	25.3	14.4	11.8	4.0	8.7	1.8	2.3	3.2	0.0	3.6	2.1	5.8	1.6	2.8	0.0	3.4	0.0	0.0	0.2	0.0	1.4	0.0	0.4	1.7	0.5	3.4	0.0	2.5	5.4	2.6	1.1	2.4	2.7	4.2	1.4	2.5	2.5	0.0	2.5	6.9	1.8	2.4	2.2	5.7	7.3	2.4	8.3	6.1	3.8	5.8	3.2	7.9	7.4	8.9	17.5	5.4	5.2	6.3	17.7	32.1	40.8	10.7	14.8	27.9	2.0	0.2	1.7	23.0	0.3	14.9	28.8	0.0	15.7	0.3	7.3	14.6	8.1	29.2	15.8	265.4	12.7	9.2	20.4	1.3	3.4	12.2	15.1	1.8	16.5	6.6	28.0	17.5	5.3	26.1	2.9	19.4	7.2	0.7	4.5	5.9	0.2	3.3	14.2	13.2
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;thyroid gland: 20.5"	"Cell type enhanced"	"Detected in many"	11	"Collecting duct cells: 22.7;granulocytes: 18.4;Mucus-secreting cells: 28.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HHSteC: 18.2;OE19: 17.3;U-2197: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031123	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.1	1.1	11.1	0.7	19.4	0.0	2.0	0.8	7.0	1.2	3.0	1.7	0.4	4.9	0.4	2.9	3.5	1.7	8.1	0.5	3.8	1.2	2.1	5.7	1.9	0.4	1.0	3.6	0.5	9.0	8.2	1.9	2.2	8.6	2.5	4.1	6.2	10.0	0.4	1.8	1.0	3.4	0.4	1.3	0.4	3.8	4.6	2.0	0.4	20.5	0.4	0.7	1.9	1.7	0.2	0.2	1.8	0.5	0.0	0.2	0.0	8.2	0.0	1.4	0.0	1.7	2.4	4.1	0.4	1.0	0.4	0.9	10.7	3.9	0.0	1.0	3.7	1.4	5.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.0	18.2	0.0	0.6	4.7	5.0	1.4	0.5	9.7	0.0	0.0	0.0	0.3	0.6	2.2	0.0	0.0	5.7	17.3	0.4	0.0	0.1	0.0	4.2	0.6	2.4	0.0	4.8	5.1	0.1	0.6	9.1	0.2	0.1	0.1	0.7	35.3	0.0	0.1	1.0	2.7	1.7	0.0	0.7	1.8	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.1	19.4	0.8	7.0	3.8	1.2	1.0	3.6	8.6	2.0	0.0	0.3	0.0	1.1	0.9	0.0	1.0	0.0	0.0	1.2	22.7	0.0	0.3	0.0	3.9	0.2	0.0	2.0	0.0	2.9	6.2	1.3	5.0	18.4	6.4	0.8	0.0	5.2	0.0	0.0	0.0	0.0	0.6	0.0	3.6	28.6	0.0	4.3	2.9	0.0	1.1	0.0	0.0	0.3	0.7	0.4	0.3	2.5	0.0	5.0	0.9
SLC12A9	CIP1	ENSG00000146828	"Solute carrier family 12 member 9"	Q9BXP2	7	100826820-100867009	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 72.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067536	Approved					NA	NA					"HPA067536: AB_2732768"	"unprognostic (6.53e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.38e-3)"	"prognostic favorable (5.97e-4)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.52e-2)"	"unprognostic (6.00e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.38e-2)"	11.3	12.1	10.6	13.4	12.7	10.5	9.0	7.3	14.2	11.0	12.8	26.8	12.7	12.4	11.9	7.5	11.8	10.2	18.2	6.3	11.7	9.8	12.0	9.2	12.7	16.3	18.3	9.6	10.2	16.7	12.5	6.2	21.8	13.8	11.1	9.2	7.6	11.8	11.5	3.7	11.9	13.2	10.3	19.8	19.5	10.8	4.8	13.9	8.8	9.5	6.5	14.5	13.6	8.5	1.3	5.1	2.9	4.0	0.3	0.8	1.6	8.1	6.4	2.1	17.6	6.5	4.0	22.5	4.2	7.8	6.2	8.7	9.0	13.8	5.7	13.5	7.6	9.9	8.7	3.7	8.9	1.6	6.2	6.2	2.1	5.9	6.4	8.1	2.6	9.2	9.6	5.2	4.9	4.9	4.9	11.9	4.6	5.1	3.1	8.6	25.5	2.8	12.6	4.2	16.7	12.9	6.6	2.2	9.0	6.1	7.2	3.6	8.4	4.5	32.2	8.5	3.7	4.0	9.8	7.2	7.6	7.6	12.5	7.3	1.6	6.6	1.9	5.3	8.9	9.1	0.0	2.9	0.0	0.5	3.8	0.8	1.3	0.2	0.3	5.1	1.3	0.5	0.3	2.9	0.3	4.0	2.5	0.6	1.6	10.6	12.7	7.3	14.2	11.7	9.8	18.3	9.6	13.8	13.9	3.0	17.3	13.7	10.7	9.7	4.9	2.0	5.1	2.7	11.4	17.4	2.0	72.5	0.0	11.9	0.4	10.5	12.3	0.0	11.6	19.9	8.9	8.6	1.1	5.5	27.7	6.4	10.9	11.6	16.2	0.6	8.3	23.4	8.5	10.0	11.1	20.0	11.7	23.0	6.0	11.2	6.0	12.9	7.5	1.4	8.2	9.9	42.0	11.5	16.2	10.2
SLC13A1	"NAS1, NaSi-1"	ENSG00000081800	"Solute carrier family 13 member 1"	Q9BZW2	7	123113531-123199986	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sulfate transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"kidney: 67.5"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 400.4"	"Cancer enriched"	"Detected in single"	219	"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"BEWO: 1.0"	"Region enriched"	"Detected in single"	5	"cerebellum: 0.9"	"Low region specificity"	"Detected in all"			"HPA053615, HPA062714"	Enhanced					NA	NA					"HPA053615: AB_2682207, HPA062714: AB_2684846"											"unprognostic (1.86e-1)"		"prognostic favorable (8.95e-5)"	"unprognostic (1.71e-1)"	"unprognostic (3.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	67.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	1.0	0.9	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.8	0.1	0.6	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.0	0.0	0.0	23.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	400.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC13A2	NaDC-1	ENSG00000007216	"Solute carrier family 13 member 2"	Q13183	17	28473293-28497781	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 181.4"	"Cell type enhanced"	"Detected in some"	18	"Cholangiocytes: 28.1;Enterocytes: 37.5;Mucus-secreting cells: 25.2;Proximal tubular cells: 82.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;RPMI-8226: 2.4;SH-SY5Y: 1.2;SK-BR-3: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014963	Enhanced					NA	NA					"HPA014963: AB_1857096"	"unprognostic (8.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.36e-3)"	"unprognostic (2.06e-1)"		"unprognostic (2.36e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.28e-4)"		"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-1)"		"unprognostic (1.50e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	1.4	0.1	0.1	0.1	142.8	0.0	10.7	34.6	0.1	0.5	0.1	0.1	3.4	0.1	0.1	0.1	12.5	0.3	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	1.8	0.0	14.9	17.1	0.1	2.1	181.4	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.7	0.1	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	28.1	0.0	0.0	3.5	11.8	0.0	8.3	0.0	0.0	0.0	37.5	0.0	6.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	25.2	0.0	0.2	8.6	0.0	82.9	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	13.9	0.3
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 128.6"	"Cell type enhanced"	"Detected in many"	25	"Cytotrophoblasts: 97.7;Proximal tubular cells: 272.5;Syncytiotrophoblasts: 66.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 10.0;EFO-21: 11.4;Hep G2: 32.6;HHSteC: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	0.7	0.9	2.6	0.5	6.2	0.4	0.9	2.5	3.6	0.9	0.5	15.1	0.0	0.4	0.9	0.7	0.6	1.1	0.9	0.6	3.4	3.1	128.6	7.0	0.8	0.5	9.3	2.1	1.8	3.0	0.4	0.6	12.9	6.5	2.3	0.5	8.1	1.7	0.6	0.6	1.0	0.4	0.9	7.8	0.5	1.7	2.7	5.6	0.0	0.8	0.0	0.6	1.0	0.4	0.6	2.4	2.7	0.4	0.7	0.9	0.0	0.0	0.0	0.9	3.3	5.1	4.8	10.0	2.1	1.2	1.1	0.9	0.0	0.0	0.1	11.4	0.1	0.0	1.2	0.0	1.5	2.7	0.0	0.3	3.9	0.2	32.6	11.4	0.0	2.9	6.5	4.5	6.6	3.3	3.2	0.0	0.0	8.7	0.2	0.0	0.3	0.0	0.4	6.1	0.2	0.0	0.1	0.0	0.0	0.7	0.2	0.4	0.1	0.0	2.4	0.5	0.6	1.7	0.1	0.1	0.1	2.4	5.2	0.0	0.3	0.6	0.0	0.4	0.0	0.2	2.7	0.4	0.3	0.9	0.2	0.2	0.4	0.3	0.3	0.1	0.6	0.6	0.6	1.3	0.7	0.3	2.4	0.3	0.0	2.6	6.2	2.5	3.6	3.4	3.1	9.3	2.1	6.5	5.6	0.0	2.1	0.0	1.1	1.1	0.7	0.5	0.0	5.3	0.0	7.0	0.0	97.7	13.3	0.1	17.2	0.2	0.0	0.0	0.8	4.5	1.1	3.2	0.0	11.6	8.1	0.0	0.0	0.0	0.8	22.8	2.8	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	272.5	0.2	0.0	0.3	1.1	0.9	0.5	66.4	0.0	0.0	0.5
SLC13A4	"SUT-1, SUT1"	ENSG00000164707	"Solute carrier family 13 member 4"	Q9UKG4	7	135681237-135729258	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"brain: 85.4;placenta: 44.8;retina: 23.5"	"Cell type enriched"	"Detected in some"	7	"Syncytiotrophoblasts: 657.3"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in many"	7	"pons and medulla: 85.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048582	Enhanced					NA	NA					"HPA048582: AB_2680450"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.78e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.96e-6)"	"unprognostic (3.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.30e-6)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	0.3	0.4	0.7	0.3	1.4	0.3	0.4	4.0	8.9	1.2	0.3	34.0	0.0	0.3	0.4	0.3	4.1	0.8	0.4	0.4	12.3	0.8	0.3	0.4	0.4	0.3	1.4	5.4	0.4	0.5	0.4	1.4	44.8	85.4	0.3	0.3	23.5	1.0	0.4	0.3	0.4	0.3	0.4	5.1	0.3	0.3	5.4	0.5	0.0	0.3	0.0	1.9	0.3	1.8	0.0	0.2	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	25.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.1	0.0	2.1	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	1.4	4.0	8.9	12.3	0.8	1.4	5.4	85.4	0.5	0.0	0.0	0.0	0.5	0.0	2.6	1.6	0.0	6.7	0.0	0.0	3.9	99.4	0.0	0.1	0.4	0.3	0.0	0.0	0.0	5.3	1.1	0.4	0.0	0.0	13.1	3.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.2	0.1	657.3	0.0	0.0	0.3
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684713-6713567	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	65	"liver: 150.4;salivary gland: 153.9"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 374.3"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	61	"Hep G2: 35.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.2	0.8	1.0	0.1	1.9	0.1	0.2	0.6	2.3	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.3	0.9	0.1	0.1	0.9	0.7	0.4	150.4	0.1	0.2	0.8	1.2	0.3	0.2	0.1	0.2	0.1	0.6	0.1	0.1	0.0	153.9	0.1	0.1	0.1	0.1	0.1	0.2	0.9	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	1.9	0.6	2.3	0.9	0.7	0.8	1.2	0.6	0.0	0.0	0.0	7.0	0.6	0.5	0.2	0.6	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	23.3	0.4	0.1	0.0	0.3	0.0	374.3	0.0	0.0	0.0	15.4	21.0	0.0	0.6	0.3	0.0	0.0	0.0	7.4	9.8	0.0	0.0	0.0	1.4	0.0	0.0	0.9	1.5	0.4	0.1	0.0	0.0	0.2
SLC14A1	"HsT1341, JK, RACH1, RACH2"	ENSG00000141469	"Solute carrier family 14 member 1 (Kidd blood group)"	Q13336	18	45687025-45752520	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 44.5;prostate: 64.7;urinary bladder: 29.6"	"Group enriched"	"Detected in some"	10	"Basal glandular cells: 246.2;Erythroid cells: 93.5;Glandular cells: 129.8;Urothelial cells: 212.7"	"Group enriched"	"Detected in many"	5	"glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2"	"Group enriched"	"Detected in many"	5	"granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2"	"Group enriched"	"Detected in some"	5	"GAMG: 79.4;RT4: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059570, HPA077233"	Supported		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA059570: AB_2684066, HPA077233: "	"unprognostic (2.04e-1)"	"unprognostic (2.56e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.93e-2)"	2.2	2.1	15.6	1.5	21.5	10.3	2.4	4.6	24.2	2.9	1.6	33.7	0.0	1.9	1.1	1.4	1.1	1.0	8.7	8.2	33.7	11.7	10.1	1.5	4.1	2.4	28.0	23.4	1.0	1.5	1.2	0.4	2.0	44.5	64.7	1.8	0.0	2.6	3.2	3.4	1.7	2.1	3.9	34.9	2.6	2.0	1.0	44.0	0.0	3.6	0.0	2.6	29.6	3.0	0.7	0.3	2.4	0.1	1.8	7.2	1.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	79.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.0	1.1	0.0	0.0	0.7	0.3	0.3	0.1	0.1	2.4	2.0	0.0	0.1	0.6	2.0	2.4	0.0	0.7	0.5	3.4	0.4	1.8	0.0	0.3	7.2	1.1	15.6	21.5	4.6	24.2	33.7	11.7	28.0	23.4	44.5	44.0	0.0	1.1	1.3	246.2	0.2	0.3	6.7	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	0.0	93.5	0.2	0.0	0.1	129.8	0.0	0.0	0.1	0.0	0.0	17.8	1.2	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	5.7	0.0	212.7
SLC14A2	"HUT2, UT2"	ENSG00000132874	"Solute carrier family 14 member 2"	Q15849	18	45212995-45683686	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 3.3;kidney: 5.7"	"Cell type enriched"	"Detected in some"	5	"Collecting duct cells: 73.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"					"Cell type enhanced"	"Detected in some"		"eosinophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	6	"U-266/70: 7.2"	"Region enriched"	"Detected in some"	4	"basal ganglia: 17.9"	"Not detected"	"Not detected"									NA	NA						"unprognostic (2.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.62e-2)"	1.8	1.0	0.0	0.1	0.4	0.6	0.9	0.0	0.7	0.1	0.0			0.3	0.1	0.3	0.0	0.0	0.1	0.3	0.1	0.1	5.7	0.0	0.2	0.1	0.0		0.1	0.0	0.3	0.1	0.0		0.2	0.0		0.2	0.0	0.3	0.4	1.2	0.0	0.0	0.2	0.1	1.3			1.0		0.0	0.1	0.1	0.4	0.4	3.3	0.3	0.4	0.8	0.1	0.2	0.4	0.4	0.2	0.1	0.1	0.4	0.2	0.1	0.1	0.0	0.4	0.4	0.8	0.2	0.1	0.4	0.3	0.0	0.0	0.1	0.4	0.2	0.4	0.7	0.0	0.1	1.1	0.4	0.1	0.1	0.1	0.1	0.4	0.2	0.4	0.3	0.6	0.0	0.3	0.4	0.5	0.3	0.2	0.4	0.3	0.1	0.7	0.1	0.4	0.6	0.1	0.2	0.1	0.1	0.2	0.1	0.3	0.3	0.4	0.3	1.0	0.4	7.2	0.4	0.3	0.4	1.1	0.3	1.4	0.3	3.3	0.3	0.2	0.2	0.4	0.2	0.3	0.1	0.4	0.2	0.3	0.8	0.4	0.2	0.4	0.8	0.1											6.0	14.8	0.0	0.5	0.6	1.2	0.5	0.0	2.7	3.4	73.3	2.0	0.3	0.0	0.0	0.9	0.7	1.1	0.0	0.0	0.2	1.1	0.3	3.5	0.0	0.3	1.6	0.0	1.8	0.3	1.0	0.6	0.8	1.7	0.0	0.3	0.8	0.1	0.0	0.7	0.0	1.7	0.0	0.0	0.5	0.4	0.1	0.7	0.0	0.0	0.4
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752654	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"intestine: 134.9"	"Cell type enhanced"	"Detected in many"	16	"Cholangiocytes: 30.6;Enterocytes: 51.2;Hepatocytes: 29.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 30.1;SK-BR-3: 29.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.1	51.7	0.2	0.3	42.7	1.9	2.2	0.9	0.1	16.6	0.1	0.1	0.1	6.3	8.2	0.2	0.1	0.1	0.1	0.2	7.1	4.3	0.3	1.0	0.3	0.9	0.5	0.2	0.3	0.3	0.1	9.9	134.9	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.7	0.4	0.5	1.9	1.1	1.1	2.3	0.7	1.2	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.9	30.1	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	6.8	0.0	0.0	0.0	1.7	1.7	0.6	0.1	0.3	0.0	29.9	0.0	1.5	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.7	0.9	0.3	0.8	0.8	0.7	0.7	0.2	1.1	0.9	0.8	2.2	1.2	0.4	1.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	3.0	0.0	0.0	0.1	0.1	0.0	0.4	30.6	1.4	2.3	1.8	0.0	0.0	1.7	9.1	0.0	0.0	51.2	0.0	0.7	0.0	0.0	0.8	0.0	29.9	0.1	0.0	3.5	0.6	0.3	0.0	0.0	0.0	1.7	0.0	1.7	0.0	2.9	5.8	0.0	9.8	0.0	0.0	0.2	0.0	0.2	0.6	0.1	0.0	1.7	0.3
SLC15A2	PEPT2	ENSG00000163406	"Solute carrier family 15 member 2"	Q16348	3	121894089-121944102	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 35.2;ductus deferens: 35.8"	"Cell type enhanced"	"Detected in many"	14	"Alveolar cells type 1: 92.3;Club cells: 31.8;Muller glia cells: 64.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 8.4;U-937: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.72e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.74e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.60e-2)"	1.0	1.2	13.8	1.9	15.0	3.3	3.2	4.0	15.3	35.2	1.8	7.6	35.8	1.5	1.5	26.2	3.6	7.4	4.2	2.0	14.6	5.3	7.4	1.1	12.9	3.6	5.3	12.9	1.0	3.6	2.4	3.6	1.6	6.8	26.5	2.1	15.1	14.6	25.1	0.8	0.7	2.2	0.9	4.0	6.1	1.1	3.9	6.7	0.0	4.6	0.5	3.8	3.6	2.6	4.2	1.6	2.4	2.5	0.3	0.3	0.3	1.9	0.9	1.1	0.4	1.3	0.7	1.4	0.2	0.1	0.5	0.6	1.8	3.2	3.5	0.2	0.1	0.6	2.1	0.8	1.9	0.6	2.8	0.6	5.0	1.3	0.8	0.2	5.3	5.0	1.1	5.5	0.6	0.4	0.6	0.3	1.0	0.8	1.5	0.6	1.4	1.0	8.4	5.8	2.1	0.5	1.2	0.5	1.0	1.3	1.2	0.4	0.4	0.5	0.3	0.1	1.7	0.3	4.7	0.1	0.4	0.3	0.4	0.4	1.9	0.5	5.0	0.6	7.1	0.5	2.4	1.1	0.4	0.3	0.4	0.3	3.3	0.3	0.2	0.3	4.2	0.3	0.3	0.6	0.3	2.5	1.6	0.2	0.3	13.8	15.0	4.0	11.0	14.6	5.3	5.3	12.9	6.8	6.7	92.3	21.4	4.4	2.1	0.5	1.0	1.9	7.6	12.0	31.8	10.4	0.0	2.1	3.3	0.3	0.3	0.8	0.2	0.0	7.5	0.6	0.6	22.7	3.5	0.0	2.1	0.0	0.0	1.3	10.0	0.6	6.1	3.8	0.0	1.0	1.0	64.9	2.6	0.0	4.9	1.1	2.4	0.0	0.1	0.5	0.1	0.5	1.1	0.0	0.6	8.2
SLC15A3	"hPTR3, PHT2"	ENSG00000110446	"Solute carrier family 15 member 3"	Q8IY34	11	60937084-60952530	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	16	"Hofbauer cells: 82.1;monocytes: 92.8;Muller glia cells: 202.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 36.4;BJ hTERT+ SV40 Large T+ RasG12V: 44.2;HHSteC: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047880, HPA057642"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA047880: AB_10959455, HPA057642: AB_2683487"	"unprognostic (5.61e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (8.79e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.78e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	27.2	7.5	7.7	23.5	8.3	36.8	9.3	2.0	7.0	11.0	16.3	10.6	8.1	9.0	10.3	7.4	12.0	8.6	15.4	11.1	8.2	5.4	8.9	9.1	30.1	24.2	12.2	5.9	16.1	6.6	1.9	5.0	26.6	9.8	10.2	6.7	13.2	5.8	5.5	4.0	4.2	14.0	9.7	12.6	40.0	9.8	5.0	8.3	8.6	5.6	6.5	19.3	11.4	9.3	5.0	10.8	15.0	12.5	0.1	1.4	2.2	3.4	0.1	1.3	0.0	7.7	5.5	13.4	0.8	13.5	36.4	44.2	0.0	1.7	5.6	0.1	5.9	9.3	1.1	0.0	0.4	1.3	5.6	0.0	0.1	0.1	0.2	21.4	0.2	0.5	3.9	0.1	9.8	0.0	0.1	2.1	0.0	0.0	1.1	2.3	0.2	0.0	0.8	6.4	0.0	0.2	2.4	0.1	1.7	0.0	0.8	0.0	0.0	1.7	6.8	0.6	0.3	2.8	4.3	0.0	0.2	1.1	0.8	0.1	0.0	0.0	3.5	2.3	0.1	9.7	0.0	9.5	0.9	0.1	12.5	0.1	5.0	0.0	0.0	6.0	2.4	1.3	1.4	15.0	0.1	6.4	10.8	0.0	2.2	7.7	8.3	2.0	7.0	8.2	5.4	12.2	5.9	9.8	8.3	8.9	19.9	9.3	0.2	1.4	1.3	1.7	0.0	0.0	2.3	0.0	0.0	3.1	0.0	0.3	5.5	10.1	0.0	0.0	1.9	10.4	4.1	0.2	15.0	2.4	82.1	4.8	0.0	16.0	47.0	2.9	7.5	37.0	1.7	92.8	0.9	202.1	1.2	0.9	4.6	0.0	4.2	12.9	3.5	0.5	0.7	1.3	2.2	0.0	0.9	0.3
SLC15A4	"PHT1, PTR4"	ENSG00000139370	"Solute carrier family 15 member 4"	Q8N697	12	128793191-128823983	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 67.3;Late spermatids: 84.4;Muller glia cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 20.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016713	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA016713: AB_1856978"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (5.14e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.56e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.57e-1)"	12.7	7.0	6.6	11.4	7.3	17.6	10.7	8.7	10.2	11.6	8.8	16.0	4.2	5.4	17.2	5.7	9.1	12.3	10.0	9.8	8.4	5.0	8.1	20.4	10.9	14.8	13.8	6.6	10.4	8.2	8.4	6.2	8.8	9.7	7.4	5.4	16.1	8.4	8.8	35.1	9.7	8.2	12.2	10.2	12.2	7.9	27.8	10.1	29.7	9.1	7.3	17.8	11.9	10.5	2.0	20.1	12.1	2.4	4.2	5.0	1.7	6.2	10.3	2.6	5.7	23.4	15.2	9.7	10.9	9.2	7.9	9.0	4.6	9.1	22.8	5.7	9.5	7.9	7.1	7.2	6.7	8.6	11.1	6.6	3.1	6.2	8.2	24.4	10.5	3.3	9.8	12.4	6.5	17.2	23.5	5.4	4.6	5.1	14.4	16.0	4.3	5.4	2.7	9.3	6.8	6.0	4.6	5.7	8.8	15.2	8.0	4.7	3.9	4.4	8.4	11.6	7.4	11.3	2.9	8.1	8.7	4.9	4.3	6.6	4.8	10.6	10.5	11.7	7.4	0.1	0.0	1.8	4.4	5.0	2.4	2.5	1.9	0.9	2.9	1.1	2.0	1.0	2.5	12.1	4.2	1.0	20.1	0.4	1.7	6.6	7.3	8.7	10.2	8.4	5.0	13.8	6.6	9.7	10.1	17.9	10.1	9.7	6.1	9.2	10.3	8.3	5.1	0.0	6.8	21.0	11.8	4.5	1.7	21.0	67.3	4.8	5.5	0.0	9.4	4.8	9.8	7.2	11.5	16.3	18.7	14.3	10.4	13.5	21.5	84.4	11.5	18.6	23.6	19.0	4.3	87.4	19.6	4.9	12.7	3.7	15.6	6.5	9.2	8.0	10.6	8.0	3.3	19.2	6.1	6.0
SLC15A5		ENSG00000188991	"Solute carrier family 15 member 5"	A6NIM6	12	16188485-16277685	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in some"	12	"adipose tissue: 1.9;brain: 1.6;breast: 1.2;testis: 1.4"	"Cell type enhanced"	"Detected in single"	35	"Early spermatids: 2.2"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041638	Uncertain					NA	NA					"HPA041638: AB_2677590"	"unprognostic (3.68e-3)"				"unprognostic (1.64e-1)"								"unprognostic (4.89e-6)"		"unprognostic (1.34e-1)"	"unprognostic (1.72e-3)"		1.9	0.0	1.1	0.0	0.7	0.0	1.2	0.3	1.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	1.6		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957013	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Cone photoreceptor cells: 149.2;Muller glia cells: 221.8;Rod photoreceptor cells: 246.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	11.6	7.2	17.4	8.7	19.5	3.1	4.4	10.0	24.0	4.6	23.4	12.7	3.3	18.4	19.3	15.1	10.4	8.7	8.3	39.0	19.5	12.3	6.5	26.9	3.2	5.8	19.2	6.5	6.0	1.9	5.6	3.7	18.8	16.6	8.3	18.1	22.8	2.5	6.5	31.4	7.5	9.5	20.0	16.1	4.8	14.5	17.9	22.5	4.9	5.4	17.7	6.2	9.6	6.2	3.0	5.9	0.6	3.2	2.0	11.4	2.4	20.2	4.7	14.6	12.4	10.1	8.6	48.0	10.9	8.3	8.6	13.9	16.0	11.8	22.2	15.3	9.9	6.4	19.4	20.4	20.3	16.3	13.9	20.7	18.2	12.9	18.6	17.9	23.2	1.9	12.0	24.9	12.7	25.0	13.9	20.8	11.6	23.0	14.8	9.6	3.9	13.6	11.7	47.2	5.6	15.2	12.2	23.0	15.3	10.6	0.4	16.2	8.5	21.2	0.6	16.2	21.9	0.9	8.8	14.0	8.3	14.6	16.3	16.1	7.8	6.8	22.4	24.1	14.7	10.2	0.6	3.2	0.0	4.1	2.6	6.3	3.0	4.1	4.4	5.9	2.1	4.4	3.8	0.3	2.0	0.7	1.0	11.4	2.4	17.4	19.5	10.0	24.0	19.5	12.3	19.2	6.5	16.6	22.5	0.0	1.6	15.2	6.7	79.3	17.1	109.7	5.1	0.0	1.2	0.0	149.2	57.9	0.0	2.0	102.1	20.4	27.6	0.0	2.9	62.5	30.5	13.5	9.2	34.7	13.7	19.1	3.4	8.0	9.1	75.6	10.9	4.8	37.1	1.8	14.9	221.8	5.1	5.7	7.1	10.2	246.9	0.0	20.6	35.1	10.2	34.5	38.4	6.9	13.6	0.9
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 25.1;skeletal muscle: 33.4"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 26.2;Melanocytes: 42.2"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 4.7"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 29.4;HEK 293: 12.7;RPMI-8226: 24.2"	"Low region specificity"	"Detected in many"							HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	7.6	4.9	1.8	2.4	5.4	0.4	1.1	9.5	2.0	0.8	4.8	1.7	1.7	7.6	0.7	1.6	0.7	1.1	1.0	2.8	1.8	1.0	8.1	9.8	6.1	1.8	0.8	0.5	1.2	25.1	8.9	1.5	17.4	5.6	1.2	1.3	3.6	3.5	6.0	33.4	12.1	6.0	0.8	1.0	2.7	3.9	3.5	0.8	19.6	2.2	1.5	0.9	4.4	1.4	0.5	0.3	0.8	0.2	0.3	4.7	0.3	0.6	0.6	0.2	1.3	0.0	0.0	2.4	0.0	0.1	0.5	0.8	5.1	0.2	4.1	0.9	0.1	1.4	0.0	29.4	0.0	0.5	0.1	12.7	4.7	0.3	4.8	0.0	5.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.8	0.1	0.0	2.0	6.2	0.7	9.0	0.1	1.9	3.5	4.3	24.2	0.0	0.4	6.8	2.1	0.1	0.6	1.1	2.3	1.2	0.8	0.0	0.1	1.1	0.3	1.6	2.0	0.0	1.1	0.2	3.8	0.5	0.8	0.2	0.1	0.2	0.2	0.2	0.2	1.1	0.3	0.0	0.5	4.7	4.0	0.8	0.3	0.1	0.3	4.0	0.3	1.8	5.4	9.5	2.0	1.8	1.0	0.8	0.5	5.6	0.8	8.9	26.2	0.9	10.0	8.7	6.2	7.7	0.0	1.4	5.7	5.2	2.0	1.1	1.7	0.1	7.2	0.7	3.9	0.0	11.1	1.7	2.5	2.8	1.1	19.7	20.5	1.6	6.3	5.5	13.5	5.2	0.0	14.3	42.2	1.0	2.8	1.7	3.1	0.0	0.0	15.2	0.6	0.0	1.0	9.8	9.8	12.9	1.0	0.5	5.0	0.9
SLC16A11	"FLJ90193, MCT11"	ENSG00000174326	"Solute carrier family 16 member 11"	Q8NCK7	17	7041630-7043923	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid metabolism, Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 1: 11.9;Muller glia cells: 29.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 12.0"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"B-cells: 2.9;T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.7;NB-4: 1.6;U-266/84: 1.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.65e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.10e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.97e-5)"	"unprognostic (5.22e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.30e-2)"	"prognostic favorable (3.19e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.83e-2)"	2.0	1.3	2.1	1.0	2.8	0.5	3.2	2.0	2.8	2.4	2.3	2.4	18.8	1.3	1.8	7.2	1.9	13.5	2.4	2.4	2.0	1.4	3.3	13.4	4.8	2.4	1.4	1.8	6.2	6.1	14.7	4.4	1.3	4.1	3.7	0.6	4.7	14.2	10.7	2.6	5.8	2.1	0.7	1.3	1.9	2.0	3.4	0.7	1.1	11.9	1.8	3.4	2.5	1.4	2.9	0.1	0.0	0.0	0.4	3.8	0.5	0.6	1.4	0.4	1.1	0.3	0.2	0.1	0.4	0.0	0.0	0.0	1.7	0.0	0.5	0.0	0.5	1.1	0.5	0.0	0.0	0.0	1.1	1.0	0.0	0.1	0.4	0.9	0.3	1.2	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.5	0.0	0.2	0.9	0.3	1.6	0.6	0.1	0.2	0.0	0.1	0.1	0.0	0.3	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.1	1.6	0.1	0.2	0.2	0.0	0.0	0.0	0.0	3.8	0.0	2.0	1.7	0.9	3.5	0.1	2.9	1.7	3.1	0.0	0.4	0.0	0.0	0.0	0.5	2.1	2.8	2.0	2.8	2.0	1.4	1.4	1.8	4.1	0.7	11.9	6.7	3.0	4.4	1.5	0.2	1.7	7.6	6.7	7.9	7.0	0.0	0.0	1.7	2.1	0.1	3.2	0.0	0.0	1.2	0.0	0.9	2.0	0.0	4.0	0.0	0.0	9.2	1.3	0.0	0.0	6.4	0.2	3.3	0.0	0.4	29.4	0.1	0.0	4.6	1.1	1.8	0.0	0.4	1.2	0.6	2.8	0.1	2.9	1.0	7.1
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036075-7040121	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 55.9"	"Cell type enhanced"	"Detected in some"	7	"Collecting duct cells: 5.2;Hepatocytes: 6.8;T-cells: 4.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A549: 16.9;GAMG: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	2.5	1.3	1.4	3.5	0.8	0.2	1.6	1.5	1.0	1.8	4.9	0.7	1.2	8.0	1.1	1.4	5.0	1.5	3.2	1.3	1.2	0.7	12.0	55.9	2.9	7.6	0.8	0.5	1.7	2.8	2.7	1.0	3.3	0.7	1.5	1.3	1.8	3.5	1.5	0.5	4.5	10.2	0.7	0.6	4.8	1.6	0.7	0.3	3.6	3.0	2.4	5.8	1.8	2.4	6.8	2.8	2.4	2.2	2.7	3.9	1.3	9.5	16.9	4.0	2.4	2.5	1.4	1.7	1.0	2.5	2.2	5.0	5.4	10.7	6.1	1.6	1.5	20.0	15.0	3.1	5.2	0.9	7.5	2.1	2.5	1.3	13.0	2.8	0.8	5.8	1.6	6.0	3.3	2.7	2.9	8.9	5.5	2.8	1.7	2.3	4.7	3.6	1.5	1.6	4.9	1.3	1.7	1.4	1.0	2.1	2.7	0.1	1.1	3.0	1.7	1.3	6.2	4.6	1.3	3.3	1.4	3.3	2.3	1.4	3.0	6.3	0.3	4.1	2.2	0.6	0.0	2.0	2.2	3.2	1.9	2.3	2.3	2.9	3.9	2.1	6.8	3.1	2.9	2.4	2.7	2.2	2.8	3.0	1.3	1.4	0.8	1.5	1.0	1.2	0.7	0.8	0.5	0.7	0.3	0.0	1.0	2.2	0.7	0.5	0.1	0.3	0.0	1.4	0.0	5.2	0.0	1.6	0.0	0.8	0.0	1.8	1.5	0.0	0.2	0.4	0.4	0.7	3.5	6.8	0.4	3.2	0.0	2.5	0.3	0.0	0.9	1.7	0.0	1.0	0.3	0.9	0.5	0.0	0.0	1.0	0.4	0.0	0.4	0.0	0.0	1.4	2.1	4.3	0.4	0.9
SLC16A14	"FLJ30794, MCT14"	ENSG00000163053	"Solute carrier family 16 member 14"	Q7RTX9	2	230034974-230068999	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Endothelial cells: 4.5;Suprabasal keratinocytes: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	22	"eosinophil: 12.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 12.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 16.7;Karpas-707: 11.5;REH: 14.3;RPMI-8226: 12.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040518	Uncertain		Approved	"Endoplasmic reticulum"		No	No			"Endoplasmic reticulum"		"HPA040518: AB_10794877"	"unprognostic (2.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	5.4	5.2	7.0	2.2	11.1	6.6	4.0	14.4	16.2	6.5	4.6	3.2	1.1	1.3	4.9	3.2	5.3	4.1	3.6	3.0	6.9	8.2	1.7	2.5	2.5	1.6	6.2	8.2	10.2	1.1	12.4	1.9	1.6	6.7	5.9	5.0	12.0	20.5	4.7	1.3	13.4	1.6	4.9	4.4	10.1	1.8	2.0	1.3	1.1	2.0	3.4	3.3	3.8	4.8	0.4	0.5	12.0	0.0	0.1	0.4	0.1	2.1	1.3	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.5	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.4	3.7	1.1	0.1	0.0	6.3	0.1	2.5	0.0	0.2	16.7	0.0	0.4	2.9	0.0	0.0	3.1	0.1	3.4	0.0	11.5	0.2	0.0	1.6	2.1	0.8	0.2	2.0	14.3	0.0	12.9	4.4	1.9	4.8	1.5	3.5	0.0	0.1	0.0	5.7	1.5	0.0	0.0	0.9	2.4	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.0	0.4	0.0	0.3	0.4	0.2	0.0	0.5	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	7.0	11.1	14.4	16.2	6.9	8.2	6.2	8.2	6.7	1.3	0.0	0.0	0.0	0.6	2.3	2.9	3.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	4.5	0.0	0.0	0.5	0.0	0.8	0.8	0.0	1.0	0.1	3.2	3.5	3.1	0.3	0.0	1.1	0.0	1.7	0.0	0.0	1.8	0.7	0.0	2.8	0.5	1.1	0.0	1.0	0.2	0.2	4.1	0.2	0.0	1.6	0.2
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421461-74533917	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.6"	"Cell type enhanced"	"Detected in many"	13	"Hepatocytes: 50.8;Peritubular cells: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.0"	"Lineage enriched"	"Detected in single"	11	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BJ: 34.4;GAMG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA072719: AB_2686552"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (3.16e-4)"	13.5	24.4	10.9	5.4	12.2	0.7	4.9	5.9	14.3	9.9	5.5	8.4	1.8	4.1	9.4	2.7	5.2	6.7	10.5	10.7	8.0	5.9	9.4	43.6	6.0	1.6	4.2	8.0	14.7	6.6	12.7	12.6	10.0	8.2	9.2	2.6	11.1	5.8	7.0	3.5	2.2	3.0	7.6	4.1	1.9	4.2	1.8	5.1	6.4	13.6	4.3	3.0	5.0	5.8	0.0	0.0	0.0	0.0	0.0	1.0	0.0	3.2	4.0	2.9	16.6	7.9	4.2	0.0	34.4	10.6	14.0	8.0	0.0	0.3	0.0	0.5	13.3	27.0	0.6	0.4	14.6	8.2	2.3	1.3	0.0	0.0	0.0	0.6	0.0	0.0	6.2	3.5	7.2	8.5	5.3	0.0	0.0	0.0	0.0	3.2	0.0	0.2	1.0	11.0	0.0	3.0	6.6	7.9	0.0	6.9	0.0	0.7	5.1	3.8	19.3	0.1	1.0	0.2	0.4	0.0	13.6	3.6	14.9	17.1	0.0	0.0	0.0	15.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	10.9	12.2	5.9	14.3	8.0	5.9	4.2	8.0	8.2	5.1	0.0	1.1	0.0	3.2	0.7	4.5	3.5	5.1	4.0	3.4	3.5	0.0	4.2	3.3	3.7	0.0	2.7	0.0	0.0	2.1	2.7	4.8	3.2	2.3	50.8	0.8	3.2	8.1	2.5	1.5	0.0	14.1	0.0	3.3	1.0	0.0	6.1	3.1	0.0	19.4	5.4	1.1	12.9	5.6	0.1	0.0	1.1	1.7	0.0	0.0	4.8
SLC16A3	"MCT3, MCT4"	ENSG00000141526	"Solute carrier family 16 member 3"	O15427	17	82228397-82261129	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.2"	"Cell type enhanced"	"Detected in many"	18	"Extravillous trophoblasts: 1393.3;Syncytiotrophoblasts: 626.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB017490, HPA021451"	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear membrane"	"CAB017490: AB_2189333, HPA021451: AB_1853663"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-3)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (1.19e-7)"	"prognostic unfavorable (2.02e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.71e-7)"	"unprognostic (2.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.36e-2)"	10.4	4.8	3.9	16.9	5.2	11.2	8.8	1.0	5.2	8.0	10.5	3.8	1.7	8.0	4.8	4.7	12.4	5.0	10.4	7.4	4.1	3.8	10.9	3.7	19.0	14.2	9.6	0.6	8.3	3.9	1.4	3.6	36.7	8.4	6.9	4.3	42.9	8.1	4.8	81.2	2.1	8.0	4.5	8.0	17.3	13.9	12.7	6.9	3.9	8.7	7.3	11.0	13.0	7.4	3.7	10.3	40.4	12.4	9.9	6.2	5.4	11.5	5.8	0.1	0.1	2.6	8.3	11.5	48.2	29.7	34.3	38.9	2.7	30.2	0.1	38.0	34.0	29.7	4.1	4.1	69.9	14.4	20.7	0.2	22.0	42.9	50.4	44.2	32.3	27.2	17.1	10.3	23.0	10.6	45.1	18.6	0.4	0.1	6.8	29.7	3.1	0.3	31.8	0.4	4.8	47.0	0.1	0.5	7.6	18.1	0.5	0.7	0.3	46.4	41.3	0.6	4.8	6.0	27.2	32.2	68.4	1.1	1.0	50.3	22.1	0.3	1.0	33.5	20.4	0.6	17.5	12.4	34.6	4.1	11.7	6.2	3.7	3.5	4.6	10.3	2.8	1.8	2.2	40.4	9.9	11.8	6.1	3.0	5.4	3.9	5.2	1.0	5.2	4.1	3.8	9.6	0.6	8.4	6.9	8.9	12.7	14.3	34.8	5.8	9.7	4.8	7.6	14.7	14.8	54.1	3.9	56.0	0.0	116.4	3.0	22.8	93.3	0.0	16.0	1393.3	24.4	12.4	75.9	0.8	262.7	120.8	20.1	17.2	103.7	2.7	2.8	101.0	13.5	232.6	23.8	21.4	199.4	84.2	3.5	3.8	7.4	0.0	14.7	1.6	7.1	5.8	626.2	40.6	16.6	118.3
SLC16A5	"MCT5, MCT6"	ENSG00000170190	"Solute carrier family 16 member 5"	O15375	17	75087727-75106162	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 45.5;Collecting duct cells: 83.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"classical monocyte: 8.4;neutrophil: 22.1"	"Group enriched"	"Detected in many"	6	"granulocytes: 22.1;monocytes: 8.4"	"Cell line enhanced"	"Detected in many"		"A549: 23.1;OE19: 24.8;RPTEC TERT1: 24.7;RT4: 49.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (8.43e-3)"	"unprognostic (8.07e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.53e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	6.0	1.0	0.9	6.3	1.0	4.1	4.9	2.0	1.1	8.9	18.7	1.5	7.5	19.4	6.6	14.6	6.9	9.4	15.3	8.6	1.2	0.9	35.0	2.3	16.9	7.5	1.7	1.2	8.3	4.1	3.6	2.0	30.8	2.3	13.0	5.7	9.5	5.2	15.2	7.9	8.8	30.5	4.7	1.5	6.8	14.6	4.9	1.0	1.8	13.3	9.5	8.8	15.3	11.0	0.7	2.5	22.1	8.4	0.6	1.0	2.4	4.8	23.1	0.4	0.0	1.2	1.5	7.9	2.7	7.0	2.7	1.9	6.0	14.0	0.0	3.3	8.4	0.3	14.0	1.1	3.8	1.0	0.0	0.0	1.7	10.7	3.0	5.5	0.0	0.0	3.7	4.6	2.8	0.0	0.0	5.6	0.2	0.3	0.0	0.2	0.8	0.1	2.4	1.8	24.8	0.0	0.5	0.0	0.1	24.7	49.0	0.0	0.1	6.8	1.6	3.4	4.1	11.4	2.4	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	1.5	2.4	8.4	2.1	0.3	3.1	0.2	0.7	0.4	0.1	2.5	0.2	1.0	0.3	22.1	0.6	1.6	0.0	0.4	2.4	0.9	1.0	2.0	1.1	1.2	0.9	1.7	1.2	2.3	1.0	35.7	30.9	0.0	6.8	2.3	0.0	4.8	7.6	45.5	30.7	83.7	0.0	16.4	5.0	5.3	41.8	2.9	30.7	0.0	1.2	3.2	3.3	9.6	6.9	0.0	6.1	0.0	6.4	17.2	8.4	26.5	0.6	5.4	6.8	4.6	11.9	0.0	0.7	19.8	0.0	1.8	0.0	0.0	1.9	0.3	1.7	1.1	16.4	0.5	10.1	13.3
SLC16A6	"MCT6, MCT7"	ENSG00000108932	"Solute carrier family 16 member 6"	O15403	17	68267026-68291267	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 32.5"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 21.6;Kupffer cells: 17.4;Rod photoreceptor cells: 39.6"	"Group enriched"	"Detected in many"	6	"breast cancer: 10.9;melanoma: 11.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	13	"SK-MEL-30: 107.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA054459, HPA066328"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA054459: AB_2682494, HPA066328: AB_2685660"	"unprognostic (2.53e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.08e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (9.46e-2)"	7.8	3.4	3.0	6.6	6.3	8.1	6.2	3.7	6.2	2.2	0.8	3.1	9.8	0.9	2.8	32.5	12.4	1.5	1.6	1.4	3.2	4.2	0.9	1.4	9.7	4.6	4.7	1.4	1.8	1.2	0.4	2.4	2.4	6.9	0.8	1.0	13.0	3.5	11.0	10.3	4.2	1.2	0.9	2.7	6.3	1.1	2.2	0.9	1.5	3.3	6.6	7.9	3.7	3.3	0.6	2.7	8.5	4.7	1.1	2.9	1.2	0.4	0.3	0.1	0.1	0.1	0.1	3.1	0.1	3.9	0.3	0.2	0.1	0.5	3.5	0.3	0.0	0.0	0.1	0.6	0.0	0.1	1.0	0.2	0.2	0.4	4.5	0.7	1.2	0.2	0.1	0.0	0.2	0.2	0.3	0.1	0.5	0.2	0.8	0.0	3.9	1.6	0.7	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.3	0.8	0.0	0.1	2.1	107.0	0.8	3.1	0.7	0.5	1.2	0.2	0.1	0.3	0.8	3.1	3.2	8.1	0.9	0.5	1.1	4.7	0.3	2.9	4.4	1.5	0.6	1.2	2.3	2.7	0.3	0.8	1.6	8.5	1.1	2.2	0.6	2.6	1.2	3.0	6.3	3.7	6.2	3.2	4.2	4.7	1.4	6.9	0.9	0.0	4.5	0.8	0.1	0.2	4.8	0.6	0.0	2.7	6.8	8.7	21.6	0.1	0.0	0.0	0.5	0.9	0.0	0.0	0.0	8.6	0.9	0.2	1.1	0.0	5.5	0.0	0.0	1.3	17.4	0.0	0.0	12.8	10.1	1.0	0.0	5.8	0.0	0.0	1.8	0.2	39.6	0.0	0.1	1.6	0.4	0.4	0.3	5.7	0.0	0.0
SLC16A7	MCT2	ENSG00000118596	"Solute carrier family 16 member 7"	O60669	12	59596067-59789855	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 34.7"	"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 116.7;Cholangiocytes: 104.4;Early spermatids: 85.1;Late spermatids: 90.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 64.5"	HPA005911	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA005911: AB_1853659"	"unprognostic (1.52e-2)"	"unprognostic (9.47e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.39e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (8.85e-5)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-2)"	20.1	10.0	2.2	9.2	4.3	4.5	9.2	6.4	8.3	5.4	4.8	1.1	1.1	2.2	8.6	2.7	12.3	4.4	8.9	34.7	2.0	1.9	16.4	5.7	9.4	12.1	3.2	3.3	4.7	13.7	2.2	9.5	2.1	5.5	3.8	3.7	2.7	6.2	2.6	4.2	9.4	4.6	10.5	3.7	16.8	12.8	6.2	2.3	12.8	4.0	8.6	9.4	9.7	8.5	5.8	2.8	0.3	9.1	3.0	7.2	2.4	0.1	2.3	0.5	0.3	10.7	16.3	0.1	9.9	6.4	3.4	3.1	0.2	5.9	5.1	2.3	16.7	3.2	0.5	0.6	1.2	5.2	1.4	0.3	9.2	10.4	0.3	5.6	14.9	0.1	8.4	3.2	0.9	9.8	6.1	1.2	6.2	0.1	11.2	5.5	2.1	4.3	2.2	0.6	1.0	3.1	0.3	0.0	2.4	7.6	14.4	2.6	0.6	0.0	0.2	4.7	0.6	0.3	1.8	0.0	8.1	2.7	14.8	0.3	10.8	0.1	8.6	9.3	0.0	1.3	0.3	2.0	0.0	5.4	3.7	7.2	2.4	4.3	4.8	2.1	5.8	4.9	6.9	0.2	3.0	9.1	2.8	4.8	2.4	2.2	4.3	6.4	8.3	2.0	1.9	3.2	3.3	5.5	2.3	26.8	21.3	14.7	5.7	9.0	23.7	116.7	104.4	24.1	15.9	43.6	9.8	0.2	19.9	46.2	85.1	7.1	0.7	0.0	57.0	0.2	12.5	1.9	9.3	10.5	3.0	7.9	0.0	11.1	27.7	90.6	6.4	8.4	3.3	1.8	24.4	1.3	30.7	0.0	9.6	1.0	5.3	6.5	16.0	4.1	3.0	11.0	0.6	20.8	0.9	2.8
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 70.9"	"Cell type enhanced"	"Detected in some"	9	"Leydig cells: 4.0;Melanocytes: 5.0;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.1;RT4: 4.5;SiHa: 6.5;T-47d: 7.8;U-266/70: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA075017	Enhanced		Approved	"Intermediate filaments,Focal adhesion sites"		No	NA			"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	1.6	2.6	1.9	0.8	5.1	1.2	0.8	0.8	3.3	0.8	0.8	0.8	0.8	0.5	1.3	0.8	1.1	1.2	2.7	2.9	2.7	2.9	0.8	0.8	0.8	0.9	2.8	0.8	0.8	2.1	0.0	2.6	0.8	1.3	4.0	0.0	70.9	10.0	0.8	1.9	4.2	0.8	0.8	3.7	1.8	2.3	2.0	0.8	0.8	0.9	0.8	0.8	1.6	0.8	0.0	0.0	0.0	0.0	0.5	0.6	0.0	1.4	0.7	1.2	0.2	0.0	0.0	6.1	0.5	0.0	0.0	0.0	1.3	3.5	0.4	1.7	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.9	0.3	1.0	0.1	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	1.6	0.0	4.0	0.0	0.0	1.4	0.1	0.1	2.0	0.0	0.0	0.0	4.5	2.0	0.3	6.5	0.3	1.0	0.6	7.8	0.2	0.0	0.0	3.6	0.3	0.0	11.5	1.6	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	5.1	0.8	1.2	2.7	2.9	2.8	0.8	1.3	0.8	0.0	0.0	0.0	0.5	1.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.8	0.0	0.0	1.3	0.3	1.6	4.0	0.0	5.0	0.0	0.0	0.9	0.2	0.0	2.1	0.0	0.5	0.0	0.9	0.9	4.1	0.6	0.0	0.0	0.0	0.1
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650761-59736002	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 58.0;kidney: 70.9"	"Cell type enriched"	"Detected in many"	7	"Proximal tubular cells: 218.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 8.7;NTERA-2: 16.4;SH-SY5Y: 7.9;SuSa: 8.8;U-251 MG: 8.3;U-937: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	0.7	58.0	5.7	2.0	4.6	0.7	0.9	9.9	4.4	8.2	4.6	9.6	1.6	0.3	12.6	2.2	5.3	8.6	3.3	1.4	10.0	2.6	70.9	1.1	0.6	0.8	6.7	5.5	13.4	1.3	11.8	6.4	0.2	8.2	3.2	6.4	5.2	1.6	4.2	9.2	0.5	0.8	3.0	6.0	14.3	2.4	3.4	6.5	0.0	11.2	4.4	3.1	0.9	4.8	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	4.2	5.6	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.0	0.6	0.0	0.0	0.7	8.7	0.0	0.0	0.0	1.4	0.1	0.2	0.0	0.1	1.8	0.0	0.4	0.1	0.0	2.3	0.1	0.3	4.4	6.1	0.1	0.4	3.3	2.3	0.0	16.4	1.6	7.5	2.7	0.2	5.7	0.0	0.2	2.8	7.9	0.1	0.3	0.0	8.8	2.8	3.6	2.6	0.4	0.9	0.1	8.3	0.0	0.0	0.0	0.0	14.8	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.7	4.6	9.9	4.3	10.0	2.6	6.7	5.5	8.2	6.5	0.0	0.0	0.0	1.1	0.1	4.7	2.8	0.0	4.0	9.1	7.0	0.0	0.0	21.6	0.7	0.1	0.0	17.7	0.0	0.0	0.8	1.2	12.7	0.0	0.0	0.1	3.2	19.3	0.0	10.5	0.4	12.7	0.0	3.3	1.0	15.5	11.2	0.2	30.3	11.3	218.2	0.8	0.0	2.8	0.3	0.1	0.1	0.0	0.0	12.8	5.7
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782897-25832059	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	56	"kidney: 67.6;liver: 17.9"	"Cell type enriched"	"Detected in some"	4	"Proximal tubular cells: 44.6"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	389	"RPTEC TERT1: 38.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050513			Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	67.6	17.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	1.8	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	44.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930726	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	333	"liver: 80.2"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 29.7"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 9.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA038270	Uncertain					NA	NA					"HPA038270: AB_10672511"							"prognostic favorable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	80.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
SLC17A3	NPT4	ENSG00000124564	"Solute carrier family 17 member 3"	O00476	6	25833066-25882286	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 62.3"	"Cell type enriched"	"Detected in some"	10	"Proximal tubular cells: 127.1"	"Cancer enriched"	"Detected in some"	17	"renal cancer: 57.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdT-cell: 1.1;MAIT T-cell: 1.9;memory CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Cell line enriched"	"Detected in single"	217	"RPTEC TERT1: 51.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (5.31e-3)"				"unprognostic (1.56e-2)"		"unprognostic (2.51e-1)"	"unprognostic (4.65e-2)"			"unprognostic (5.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"		0.1	0.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.0	62.3	13.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.9	0.0	1.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	6.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	12.4	0.0	0.0	0.0	1.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781191	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"gallbladder: 14.9;intestine: 24.6;liver: 27.2;pancreas: 14.2"	"Group enriched"	"Detected in some"	4	"Cholangiocytes: 86.6;Enterocytes: 45.7;Hepatocytes: 37.5;Paneth cells: 43.2"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 5.8"	"Not detected"	"Not detected"							HPA055564	Approved					NA	NA					"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.2	0.0	0.2	1.8	0.2	0.0	0.2	0.2	0.2	0.2	12.8	0.2	0.2	14.8	0.2	0.4	0.2	0.1	14.9	0.2	0.2	0.1	2.2	27.2	0.2	0.2	0.2	0.2	0.2	14.2	0.0	0.2	0.2	0.2	0.2	14.2	0.2	0.2	0.2	0.2	0.0	24.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	1.3	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.8	0.1	0.0	0.2	0.0	0.3	0.0	0.2	0.4	0.0	0.1	0.8	5.8	0.0	0.2	0.4	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.1	0.1	0.2	0.0	0.3	0.0	0.1	1.3	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	86.6	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.8	0.0	45.7	0.0	0.0	0.0	0.0	0.0	0.0	37.5	0.1	0.0	12.6	0.6	1.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.2	43.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0
SLC17A6	"DNPI, VGLUT2"	ENSG00000091664	"Solute carrier family 17 member 6"	Q9P2U8	11	22338097-22379503	"Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 75.2"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 1.3;Horizontal cells: 1.6;Muller glia cells: 1.3;Rod photoreceptor cells: 2.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"hypothalamus: 20.2;pons and medulla: 75.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	222	"SCLC-21H: 26.6"	"Group enriched"	"Detected in many"	5	"basal ganglia: 54.1;hypothalamus: 163.2;midbrain: 206.4;pons and medulla: 90.5;thalamus: 180.7"	"Low region specificity"	"Detected in all"			"CAB037130, HPA039226, CAB078204"	Supported	Supported				NA	NA					"CAB037130: AB_477611, CAB078204: AB_2665794, HPA039226: AB_2676400"					"unprognostic (1.39e-1)"						"unprognostic (1.93e-1)"							0.5	0.5	7.6	0.5	1.1	0.5	0.5	0.2	13.8	0.5	0.5	1.3	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	1.1	20.2	0.5	0.5	0.5	0.5	7.1	2.1	0.5	1.5	0.5	5.3	0.5	75.2	0.5	0.5	1.4	0.5	0.5	0.5	0.5	0.5	0.5	5.9	0.5	0.5	0.5	0.0	0.0	0.5	0.0	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	1.1	0.2	8.4	1.1	20.2	7.1	2.1	75.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A7	"BNPI, VGLUT1"	ENSG00000104888	"Solute carrier family 17 member 7"	Q9P2U7	19	49429401-49442360	"Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"brain: 150.0"	"Group enriched"	"Detected in some"	27	"Bipolar cells: 377.4;Cone photoreceptor cells: 347.5;Rod photoreceptor cells: 343.9"	"Cancer enriched"	"Detected in some"	6	"glioma: 7.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 21.2;K-562: 6.7;REH: 3.9;SCLC-21H: 4.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"amygdala: 281.0;cerebellum: 378.0;cerebral cortex: 391.3;hippocampal formation: 626.6"	"CAB037183, HPA050458, HPA063679"	Enhanced	Supported				NA	NA					"CAB037183: AB_261840, HPA050458: AB_2681134, HPA063679: AB_2685086"	"unprognostic (1.79e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.32e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.26e-12)"	"unprognostic (8.36e-4)"	"unprognostic (4.27e-1)"	"unprognostic (1.35e-2)"	"unprognostic (6.17e-3)"	2.1	1.2	58.3	1.0	27.6	1.0	1.7	52.7	150.0	1.3	1.3	1.5	0.0	1.1	1.2	1.2	1.4	1.3	1.3	1.4	74.3	1.7	1.1	1.0	1.1	1.3	6.0	36.4	1.0	1.0	1.0	0.1	1.0	20.0	1.0	1.2	9.1	1.1	1.1	1.4	1.6	1.3	1.2	0.9	1.0	1.1	1.5	0.0	0.0	1.2	0.0	1.2	1.2	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	1.7	0.3	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.3	0.5	1.3	0.1	1.9	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.1	0.3	0.0	0.4	0.0	0.3	6.7	1.0	0.0	0.2	0.0	0.1	0.0	0.2	0.3	3.9	0.1	0.1	0.0	0.0	4.9	0.4	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	2.4	0.9	0.0	0.4	0.3	0.3	0.6	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.3	27.6	52.7	76.0	74.3	1.7	6.0	36.4	20.0	0.0	0.0	0.0	0.0	0.1	1.1	377.4	2.4	0.0	0.0	0.0	0.0	347.5	0.1	0.0	0.0	4.0	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	11.1	0.0	0.0	0.0	0.0	6.1	0.3	1.7	0.0	0.0	13.3	0.1	0.0	0.4	0.0	343.9	6.5	2.8	1.0	2.3	0.5	0.0	0.0	0.0	0.0
SLC17A8	"DFNA25, VGLUT3"	ENSG00000179520	"Solute carrier family 17 member 8"	Q8NDX2	12	100357079-100422059	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 10.7;intestine: 12.4;lymphoid tissue: 3.9"	"Group enriched"	"Detected in some"	4	"Enterocytes: 4.1;Extravillous trophoblasts: 1.7;Kupffer cells: 3.5;Paneth cells: 1.4"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 2.1;RPTEC TERT1: 1.1;SuSa: 2.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB079058		Supported				NA	NA					"CAB079058: "	"unprognostic (4.52e-3)"			"unprognostic (2.18e-1)"	"unprognostic (8.56e-2)"		"unprognostic (1.32e-3)"	"unprognostic (3.65e-1)"		"unprognostic (7.67e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.71e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.55e-1)"			0.1	0.3	2.0	0.1	3.7	0.1	0.1	0.0	10.7	0.1	1.1	0.0	0.0	1.8	0.4	0.2	0.1	1.0	0.1	0.1	6.9	2.2	0.3	1.2	0.2	0.1	0.8	1.0	0.2	0.2	0.1	0.4	1.0	3.6	0.1	1.0	1.7	0.1	0.1	0.1	0.1	12.4	0.1	0.5	0.1	0.2	0.4	0.1	3.9	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.4	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	2.0	3.7	0.0	10.7	6.9	2.2	0.8	1.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
SLC17A9	"C20orf59, FLJ23412, VNUT"	ENSG00000101194	"Solute carrier family 17 member 9"	Q9BYT1	20	62952647-62969585	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Exocytosis, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 42.7"	"Cell type enhanced"	"Detected in many"	11	"B-cells: 28.5;Hepatocytes: 35.4;Hofbauer cells: 16.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 7.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 16.0;CACO-2: 14.8;Hep G2: 30.7;NB-4: 16.5;RPMI-8226: 15.9;U-937: 19.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047470			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA047470: AB_2680060"	"unprognostic (2.65e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-3)"	"unprognostic (5.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (2.78e-15)"	"unprognostic (6.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	4.2	1.3	1.6	11.4	3.4	11.9	2.2	0.4	1.4	1.9	4.8	0.6	0.1	6.4	1.7	1.2	1.5	2.1	7.3	1.5	1.5	0.7	1.5	42.7	5.7	6.6	4.8	0.0	1.9	3.4	0.0	2.5	1.9	3.4	1.6	3.8	1.1	3.6	1.2	3.4	0.9	3.9	1.4	3.9	10.5	10.7	0.8	2.9	0.5	1.4	0.5	11.8	5.6	2.4	4.0	4.2	0.0	2.7	7.3	1.3	1.2	0.0	0.0	0.0	0.1	0.1	1.3	0.0	16.0	4.6	5.3	8.4	14.8	0.0	11.5	0.0	12.8	0.0	0.0	2.3	0.0	1.2	0.0	0.0	5.0	0.4	30.7	3.6	9.0	0.0	1.2	0.0	6.3	0.0	0.0	3.4	0.0	0.0	6.7	0.0	0.0	0.3	16.5	0.0	5.7	0.0	11.9	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	1.1	0.0	0.0	0.5	0.0	2.3	0.1	6.2	0.0	19.4	0.0	0.0	1.6	0.0	1.3	2.7	0.9	4.0	0.0	0.6	4.2	3.2	0.0	0.6	0.0	7.3	0.6	0.0	0.1	1.2	1.6	3.4	0.4	1.4	1.5	0.7	4.8	0.0	3.4	2.9	0.0	0.6	28.5	0.0	0.8	0.2	1.2	12.7	0.0	1.2	0.0	0.0	0.3	0.0	0.2	0.6	0.7	1.6	0.0	0.3	0.6	5.8	0.5	4.7	35.4	16.2	0.0	2.9	2.5	4.0	0.0	1.1	9.1	5.0	1.0	7.7	0.0	1.1	0.0	0.7	0.0	0.0	0.0	3.1	0.3	0.9	1.0	0.7	4.1	9.1	0.4
SLC18A1	"CGAT, VAT1, VMAT1"	ENSG00000036565	"Solute carrier family 18 member A1"	P54219	8	20144855-20183206	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 25.4;intestine: 10.8"	"Cell type enriched"	"Detected in some"	37	"Intestinal endocrine cells: 133.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.8"	"Region enriched"	"Detected in single"	4	"midbrain: 2.0"	"Group enriched"	"Detected in some"	12	"intermediate monocyte: 2.3;non-classical monocyte: 6.0"	"Lineage enriched"	"Detected in single"	18	"monocytes: 6.0"	"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA006877, HPA063797"	Enhanced					NA	NA					"HPA006877: AB_2667690, HPA063797: AB_2685125"	"unprognostic (8.03e-4)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.25e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	0.0	25.4	0.2	0.8	0.1	0.0	0.0	0.0	0.2	0.2	8.8	1.3	1.3	1.4	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.0	2.7	0.0	0.0	2.8	0.0	0.0	10.8	0.0	0.1	0.3	1.1	0.2	0.0	0.2	0.2	0.0	0.1	1.3	0.4	0.0	0.3	0.2	6.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.2	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.3	0.2	0.1	0.0	0.2	0.1	0.4	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	133.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241073-117279430	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 26.3;brain: 28.3;cervix, uterine: 31.2"	"Cell type enriched"	"Detected in some"	22	"granulocytes: 603.6"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	10	"hypothalamus: 9.0;midbrain: 28.3;pons and medulla: 26.5"	"Cell type enriched"	"Detected in some"	13	"basophil: 26.3"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 26.3"	"Cell line enriched"	"Detected in some"	20	"HMC-1: 91.2"	"Region enhanced"	"Detected in many"		"midbrain: 75.4"	"Group enriched"	"Detected in all"	5	"midbrain: 143.8;pons and medulla: 34.7"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.7	13.9	1.7	3.1	2.0	2.0	2.0	1.7	1.6	31.2	2.3	0.5	2.2	1.5	11.2	4.9	3.0	1.1	15.9	1.0	1.9	9.0	1.1	3.3	7.6	1.5	28.3	0.2	9.7	3.7	0.5	1.6	2.1	26.5	10.8	3.4	3.1	1.0	4.0	1.1	5.8	2.5	5.4	2.9	0.5	3.5	1.5	0.3	14.1	0.6	3.4	2.9	3.1	5.4	0.0	2.0	26.3	0.0	0.0	0.3	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	4.6	0.0	0.0	0.0	0.2	91.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.1	0.0	0.1	0.4	0.0	26.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	2.0	0.0	1.1	1.7	2.0	1.7	1.6	1.9	9.0	28.3	0.2	26.5	0.3	8.9	27.6	0.0	0.0	1.6	0.6	0.2	0.0	1.4	4.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	4.4	603.6	0.0	0.7	0.0	8.5	11.6	1.8	0.0	0.6	0.6	1.7	0.0	0.0	0.3	0.1	0.0	4.6	0.0	0.7	0.0	0.2	0.2	0.1	2.4	0.0	0.0	0.0	0.0
SLC18A3	VACHT	ENSG00000187714	"Solute carrier family 18 member A3"	Q16572	10	49610301-49612720	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 11.9"	"Cell type enhanced"	"Detected in some"	18	"Cardiomyocytes: 1.1;Syncytiotrophoblasts: 1.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"basal ganglia: 8.8;hypothalamus: 3.4;pons and medulla: 11.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 12.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	14	"basal ganglia: 17.7;pons and medulla: 20.9"	CAB079011		Supported				NA	NA					"CAB079011: "				"unprognostic (2.14e-4)"	"unprognostic (1.55e-1)"			"unprognostic (1.01e-1)"		"unprognostic (9.39e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-1)"		"unprognostic (5.85e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.16e-1)"		0.1	0.3	0.0	2.2	8.8	0.1	0.1	0.0	0.5	0.1	1.5	0.0	1.1	1.3	0.3	0.1	0.1	0.1	0.2	0.1	0.0	3.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.7	3.4	11.9	0.4	0.3	1.4	0.4	0.6	0.2	0.1	1.9	1.5	3.1	0.1	1.2	0.2	1.2	0.2	0.1	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	12.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.8	0.0	0.5	0.0	3.4	0.1	0.0	11.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0
SLC18B1	"C6orf192, dJ55C23.6"	ENSG00000146409	"Solute carrier family 18 member B1"	Q6NT16	6	132769370-132798553	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cholangiocytes: 48.4;Hofbauer cells: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029747, HPA049659"	Approved		Supported	"Golgi apparatus,Cytosol"		NA	NA			Cytosol	"Golgi apparatus"	"HPA029747: AB_10600797, HPA049659: AB_2680843"	"unprognostic (1.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.41e-2)"	"prognostic favorable (3.55e-4)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.88e-2)"	9.3	7.3	26.2	6.0	21.9	4.5	11.0	13.1	20.6	9.4	9.5	18.8	3.1	14.4	7.0	7.8	10.7	10.1	11.5	4.2	21.6	15.8	11.8	6.0	5.7	7.2	19.5	10.8	7.4	7.8	13.0	6.9	15.5	17.0	5.0	11.4	7.4	11.7	4.9	4.8	10.5	10.4	5.8	21.7	7.0	14.9	2.3	16.3	8.3	10.1	5.9	8.6	10.6	5.5	7.5	15.6	0.6	11.3	2.8	9.4	6.5	4.0	3.8	6.5	0.0	0.8	2.4	4.0	1.4	4.5	2.9	9.3	8.4	8.3	0.1	5.8	0.9	5.1	11.3	8.8	9.9	2.3	5.9	16.6	2.1	7.0	10.2	5.0	1.9	0.2	6.5	9.5	4.6	10.0	5.9	9.3	13.2	23.7	1.6	2.4	5.7	6.1	0.2	8.6	9.0	5.4	9.8	7.1	6.6	24.1	7.1	13.1	0.0	7.8	15.5	12.4	3.9	5.3	0.0	4.3	1.3	3.4	1.3	3.8	5.1	0.4	0.2	7.1	0.2	1.0	0.0	11.3	0.5	3.7	2.5	6.7	5.5	5.7	5.2	15.6	7.5	8.2	5.6	0.6	2.8	0.2	12.1	9.4	6.5	26.2	21.9	13.1	20.6	21.6	15.8	19.5	10.8	17.0	16.3	0.0	6.2	5.9	8.2	9.0	4.1	2.6	48.4	12.0	10.3	26.2	2.0	41.0	8.3	26.3	0.1	5.1	3.9	0.0	13.2	16.4	5.1	7.2	0.0	11.9	51.1	0.0	15.6	22.1	19.4	0.0	6.4	7.8	13.5	2.8	11.9	8.5	15.1	3.5	4.2	5.0	3.3	0.0	3.3	0.2	0.4	9.5	23.8	4.9	16.6	11.5
SLC19A1	"FOLT, RFC1"	ENSG00000173638	"Solute carrier family 19 member 1"	P41440	21	45493572-45544411	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 133.1;Syncytiotrophoblasts: 303.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 37.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 37.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024802	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA024802: AB_10602892"	"unprognostic (4.31e-3)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.87e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.07e-10)"	"unprognostic (1.44e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.97e-5)"	"unprognostic (3.10e-1)"	9.0	7.8	7.1	8.2	13.5	10.5	12.5	9.6	8.9	5.0	9.7	6.0	9.4	31.2	4.3	4.6	2.3	4.6	3.5	3.2	7.1	6.1	4.7	14.1	13.9	14.1	8.7	4.4	8.1	5.4	1.8	3.5	32.9	11.5	4.7	2.0	17.8	6.0	3.5	3.5	6.1	16.5	2.3	5.9	11.7	5.7	3.4	3.4	11.8	9.6	2.8	4.1	3.1	3.1	0.9	4.9	37.6	6.4	0.4	1.1	2.4	10.6	9.7	1.9	7.9	0.6	0.8	15.9	5.0	0.8	4.6	2.9	22.4	9.9	9.9	9.9	1.2	3.9	5.5	3.9	3.6	1.1	9.1	19.3	20.8	5.2	15.5	2.7	13.5	3.2	1.0	2.8	4.9	1.6	1.3	3.8	10.6	24.8	4.3	1.6	11.9	18.3	12.6	11.4	4.7	11.3	25.0	2.2	28.7	2.1	6.4	11.8	10.4	5.6	9.3	4.3	2.7	7.0	16.0	4.6	6.0	7.5	1.6	8.1	1.8	6.6	9.0	2.7	22.1	4.8	0.6	6.4	8.5	0.3	6.0	1.1	0.9	0.5	0.7	4.9	0.3	0.8	0.5	37.6	0.4	3.7	1.5	1.0	2.4	7.1	13.5	9.6	8.9	7.1	6.1	8.7	4.4	11.5	3.4	44.7	4.6	0.8	1.7	2.2	18.0	2.4	2.5	1.4	10.3	0.0	0.0	133.1	0.0	7.8	3.3	2.8	9.3	0.0	4.2	16.2	2.9	3.6	1.1	10.9	24.0	7.9	0.0	1.8	11.6	3.2	6.1	5.9	3.3	0.0	3.1	8.6	6.8	5.3	10.6	1.9	3.6	0.0	3.8	1.2	4.1	1.4	303.1	2.2	7.6	0.9
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169486003	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.7"	"Cell type enhanced"	"Detected in many"	12	"Suprabasal keratinocytes: 44.2;Syncytiotrophoblasts: 130.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favorable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	23.1	11.1	1.9	5.3	4.4	4.8	14.2	7.4	6.1	5.9	5.4	2.8	2.7	2.1	5.0	9.0	7.5	10.0	17.5	14.8	2.7	2.1	8.6	23.4	9.2	3.1	2.8	1.7	10.3	14.4	6.8	16.3	22.1	4.7	9.4	2.8	16.4	10.4	4.6	75.7	7.5	6.6	11.3	3.7	1.8	9.4	7.3	1.8	3.6	7.9	21.6	3.9	10.4	9.8	1.4	1.9	3.0	4.6	2.6	3.3	0.7	4.5	3.2	7.3	5.7	22.8	8.4	16.2	3.6	2.7	3.0	4.2	13.1	4.8	4.0	4.2	2.4	5.5	4.9	8.8	5.4	3.3	11.5	8.2	3.8	10.4	11.9	12.4	9.6	3.8	9.9	7.9	4.8	12.3	4.2	4.4	7.1	15.4	2.6	5.0	3.0	4.9	4.3	16.6	8.8	4.9	0.0	15.8	4.6	7.9	9.7	6.4	8.6	5.0	8.7	17.8	8.7	5.5	6.3	3.7	3.6	5.0	4.4	7.1	3.6	3.3	1.3	5.3	3.7	4.7	0.0	1.7	3.0	0.9	0.7	3.3	1.4	1.1	2.1	1.9	1.2	3.1	3.0	1.1	2.6	4.6	0.7	1.0	0.7	1.9	4.4	7.4	6.1	2.7	2.1	2.8	1.7	4.7	1.8	8.9	17.1	0.9	13.6	26.3	4.7	24.0	7.6	13.4	11.4	5.2	2.0	19.6	0.0	7.1	4.4	2.3	6.3	0.0	4.6	3.0	20.6	10.4	10.3	23.1	6.2	6.4	8.6	0.6	3.7	0.4	6.4	5.7	20.3	0.0	4.4	2.6	8.2	5.7	4.6	1.8	4.7	0.0	9.4	3.4	3.4	44.2	130.8	1.5	4.7	21.3
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718031	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 48.2;breast: 78.2;placenta: 27.5"	"Group enriched"	"Detected in many"	8	"Cytotrophoblasts: 45.5;Syncytiotrophoblasts: 134.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 8.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.3;BEWO: 7.4;CACO-2: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	48.2	0.6	2.2	1.8	2.4	1.2	78.2	1.5	1.9	0.5	6.1	1.0	0.5	7.7	0.6	0.4	0.6	0.6	8.9	1.9	2.3	2.4	2.1	16.0	5.6	1.3	3.0	0.7	0.9	1.3	0.2	0.3	27.5	2.6	0.5	1.6	0.7	0.9	0.2	0.7	1.6	4.5	0.5	2.6	0.5	0.5	0.6	1.5	0.0	0.5	0.4	0.4	1.0	2.3	2.6	1.8	8.6	1.8	4.3	1.1	0.4	0.3	1.6	0.3	1.0	14.3	0.4	7.4	0.1	0.2	0.3	0.6	18.7	0.5	0.4	0.2	0.1	4.6	0.5	0.5	0.5	0.8	0.1	1.2	0.1	1.0	0.8	1.7	0.2	0.2	3.3	0.4	0.1	0.9	0.3	0.0	0.3	0.2	0.9	0.0	1.8	0.1	0.7	3.2	0.6	0.3	0.3	0.2	0.2	0.2	0.3	1.1	0.1	0.6	2.1	0.5	2.7	0.3	0.2	0.5	0.5	0.5	4.2	0.4	0.2	0.1	0.7	1.4	0.3	0.5	8.6	1.8	1.7	1.0	1.2	0.6	1.6	0.8	0.9	0.4	2.6	1.0	1.1	6.1	4.3	1.1	1.8	0.4	0.4	2.2	2.4	1.5	1.9	2.3	2.4	3.0	0.7	2.6	1.5	8.9	3.2	0.0	0.4	0.0	2.9	0.3	0.0	0.0	0.0	1.8	0.0	45.5	1.7	1.7	0.3	0.5	6.4	0.0	0.0	7.0	0.9	0.3	0.0	11.4	4.6	0.0	1.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.8	0.6	0.0	0.0	2.2	0.1	0.0	1.0	0.0	0.1	0.0	134.3	0.0	5.6	0.3
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490444-4587469	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease mutation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;kidney: 31.2"	"Cell type enhanced"	"Detected in many"	19	"Alveolar cells type 1: 151.8;Cholangiocytes: 35.7;Enterocytes: 37.3;Hepatocytes: 62.7;Proximal tubular cells: 37.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	30	"T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.9;HDLM-2: 31.6;HUVEC TERT2: 14.9;RPTEC TERT1: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062356	Enhanced					NA	NA					"HPA062356: "	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	3.3	1.4	8.6	3.4	10.2	0.3	2.9	4.7	12.4	4.0	17.9	2.7	0.5	21.0	4.0	28.8	1.7	1.9	16.3	2.0	10.0	10.2	31.2	29.1	12.8	1.8	8.6	5.8	0.7	1.8	0.4	5.2	5.1	6.7	4.3	6.6	1.9	3.1	2.4	2.2	1.2	40.4	5.6	5.3	0.5	3.4	0.8	4.4	0.0	25.0	1.8	5.0	3.5	1.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.9	0.7	4.4	11.5	13.9	3.9	4.7	9.8	1.5	1.4	7.8	0.2	6.1	0.3	2.4	1.8	0.0	1.6	2.6	1.3	31.6	2.1	0.0	6.6	0.0	0.4	0.4	0.0	0.9	0.1	5.6	0.0	0.7	14.9	0.1	0.0	0.0	1.0	0.1	0.0	0.1	1.9	4.7	0.8	0.0	0.0	0.0	31.0	2.7	1.0	0.9	0.3	1.7	0.0	3.7	0.6	0.2	8.0	2.3	0.1	4.4	1.3	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	8.6	10.2	4.7	11.7	10.0	10.2	8.6	5.8	6.7	4.4	151.8	2.7	0.8	1.0	0.0	0.7	0.8	35.7	4.0	9.1	0.0	0.0	0.0	3.3	5.5	3.5	7.0	37.3	0.0	0.7	0.0	0.9	1.7	0.0	62.7	0.1	0.0	0.0	3.1	2.1	6.1	0.3	0.1	0.0	0.0	6.5	0.8	5.8	8.6	0.0	37.2	0.9	0.0	1.1	0.0	0.2	0.5	0.1	0.8	4.8	0.2
SLC1A2	"EAAT2, GLT-1"	ENSG00000110436	"Solute carrier family 1 member 2"	P43004	11	35251205-35420063	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 160.9"	"Cell type enhanced"	"Detected in many"	14	"Cone photoreceptor cells: 139.4;Early spermatids: 85.3;Rod photoreceptor cells: 160.3;Syncytiotrophoblasts: 225.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 28.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 3.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.5;BJ hTERT+: 4.9;fHDF/TERT166: 3.4;Hep G2: 5.7;NTERA-2: 6.4;SCLC-21H: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002574, HPA009172, HPA067499"	Enhanced					NA	NA					"CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: "	"unprognostic (8.00e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.33e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.49e-2)"	1.7	4.1	65.1	1.9	79.4	1.8	3.7	7.2	160.9	2.0	1.7	9.8	0.0	1.8	2.1	1.8	1.7	1.7	1.7	2.1	47.6	11.7	1.7	20.5	1.9	2.5	15.2	43.1	1.6	4.2	1.6	0.4	2.1	27.6	1.7	1.7	0.0	3.9	1.7	1.7	2.3	1.6	1.8	17.2	1.8	2.6	2.4	16.3	0.0	1.7	0.0	2.4	1.7	0.3	1.1	0.7	3.9	0.7	1.2	0.9	0.4	0.0	0.2	1.1	0.1	0.5	4.5	0.0	1.1	4.9	0.2	0.3	0.2	0.0	0.1	0.1	3.4	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.4	0.5	5.7	0.2	0.6	0.2	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.1	2.2	0.0	0.0	6.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	3.3	0.5	0.0	2.3	0.0	0.3	1.1	0.0	0.6	0.2	0.2	0.5	0.1	0.6	0.0	0.0	1.1	0.0	0.3	3.9	0.7	0.8	0.5	0.3	0.3	0.4	0.5	0.4	0.7	1.1	0.9	0.7	2.1	1.2	0.4	0.6	0.4	0.4	65.1	79.4	7.2	64.9	47.6	11.7	15.2	43.1	27.6	16.3	3.0	3.7	0.0	0.0	2.6	48.2	2.8	0.0	1.4	0.0	0.0	139.4	14.9	0.0	0.1	85.3	0.3	0.0	0.0	2.9	0.8	2.6	0.4	0.0	5.4	3.1	6.4	0.0	0.0	0.0	59.1	0.0	0.5	1.7	55.1	0.0	10.6	0.7	0.0	0.0	0.0	160.3	0.0	1.0	0.2	1.2	1.0	225.3	0.0	0.0	0.1
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36606355-36688334	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 188.6"	"Cell type enriched"	"Detected in many"	9	"Muller glia cells: 579.8"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	12	"classical monocyte: 4.3;intermediate monocyte: 2.1;myeloid DC: 3.4"	"Group enriched"	"Detected in many"	39	"dendritic cells: 3.4;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 21.5;CACO-2: 34.7;HaCaT: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Mitochondria		NA	NA			Mitochondria	Nucleoli	"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	17.3	10.3	76.1	5.9	70.6	3.1	6.3	45.8	188.6	6.9	3.2	26.3	0.0	2.1	2.8	2.3	7.2	5.4	5.9	12.0	57.9	27.3	3.1	3.6	4.7	8.6	32.7	39.6	8.6	4.0	2.6	3.7	12.7	28.5	3.3	2.6	1.9	3.0	4.4	7.6	5.5	2.3	4.1	29.4	5.8	2.9	2.7	33.6	0.0	2.6	0.7	4.5	4.8	1.2	0.0	3.4	0.0	4.3	0.0	0.0	0.8	0.4	0.1	21.5	1.9	2.2	6.0	13.8	0.0	0.0	0.8	1.9	34.7	1.7	0.0	10.5	0.3	0.3	26.3	6.3	2.8	0.9	0.3	12.9	0.0	0.1	0.0	0.4	0.4	0.1	11.1	13.0	5.3	2.2	0.4	0.0	0.4	0.0	0.1	3.6	0.0	0.0	0.1	2.5	0.0	2.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	2.1	6.3	0.3	10.5	0.0	1.0	0.0	1.9	3.2	0.0	7.6	0.0	0.0	0.0	8.8	14.5	4.9	0.0	4.3	0.0	0.0	2.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.8	76.1	70.6	45.8	57.8	57.9	27.3	32.7	39.6	28.5	33.6	3.0	0.3	0.5	10.4	9.5	7.7	33.9	0.0	5.3	1.2	0.0	2.0	25.3	0.0	0.4	0.6	1.1	0.0	0.0	0.0	13.5	11.8	3.2	0.0	0.2	38.2	3.2	0.0	1.3	63.4	1.9	4.0	11.0	6.8	3.6	0.0	579.8	0.3	0.0	0.0	0.0	11.3	6.5	4.7	0.2	0.1	6.1	7.7	0.0	0.0	3.3
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Melanocytes: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 72.7;U-266/70: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome		NA	NA			Centrosome		"HPA034963: AB_2797223, HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	6.0	20.3	31.4	7.6	34.4	10.3	12.7	8.8	43.1	13.5	8.3	8.1	6.1	5.6	11.7	7.8	6.5	4.7	3.8	5.1	20.6	23.5	1.9	11.1	4.5	8.7	17.1	21.2	12.2	28.4	6.1	10.3	6.0	15.4	9.1	7.8	12.1	5.7	6.9	29.6	15.9	5.1	11.3	5.8	6.3	7.0	7.8	8.5	15.7	5.3	11.5	15.8	5.4	7.8	1.1	8.4	2.0	10.1	5.5	3.9	1.4	3.7	2.9	1.7	8.8	3.8	2.5	2.4	7.1	3.5	3.0	5.1	0.8	0.5	12.2	1.6	11.1	3.7	10.8	3.4	0.9	3.1	4.9	1.3	6.3	3.5	7.5	8.1	10.6	5.9	1.1	18.8	4.0	6.2	1.0	1.8	12.3	4.9	30.9	2.1	3.3	9.0	7.0	1.2	4.9	3.5	3.3	0.4	30.3	1.2	1.9	7.5	3.6	4.4	4.0	72.7	0.8	4.8	11.7	0.4	4.1	4.9	7.9	4.3	34.0	16.8	29.6	6.0	21.4	21.7	0.0	2.3	2.0	1.0	5.3	1.4	1.1	1.1	1.8	4.4	0.3	0.0	1.0	0.0	5.5	10.1	8.4	3.9	1.4	31.4	34.4	8.8	25.9	20.6	23.5	17.1	21.2	15.4	8.5	0.0	2.4	14.5	2.0	17.7	5.4	4.4	2.5	4.0	1.2	1.8	31.4	0.9	0.0	1.4	23.4	4.5	0.7	0.0	8.1	1.1	5.6	2.5	6.9	10.9	17.4	6.4	8.1	9.2	4.5	34.0	10.3	9.5	81.0	5.4	6.2	14.7	8.6	0.0	28.0	1.2	16.5	0.0	9.0	1.1	0.6	5.4	2.1	2.5	4.4	0.9
SLC1A5	"AAAT, ASCT2, M7V1, RDRC"	ENSG00000105281	"Solute carrier family 1 member 5"	Q15758	19	46774883-46788594	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Host-virus interaction, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 134.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 34.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 34.6;monocytes: 22.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA035239, HPA035240"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA035239: AB_10670587, HPA035240: AB_10604092"	"unprognostic (8.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.66e-8)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.82e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (1.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.83e-2)"	39.3	5.7	3.4	16.0	5.4	16.2	45.0	0.9	3.0	20.7	15.8	5.0	50.4	4.9	14.3	33.7	33.9	18.1	31.2	10.0	4.5	2.2	23.7	4.1	23.4	17.7	8.2	0.9	33.3	24.6	0.2	9.1	25.8	4.9	35.2	13.8	5.2	99.0	55.7	6.9	18.6	12.1	23.1	5.3	19.8	17.9	21.7	6.1	14.9	6.5	28.4	25.9	48.3	44.9	7.0	34.6	0.9	22.4	6.9	5.6	7.4	23.8	44.1	10.6	16.0	27.7	23.6	25.1	34.1	39.0	25.6	37.2	40.0	27.0	26.2	16.7	84.6	14.7	38.5	30.9	40.5	19.1	17.3	28.0	43.4	16.9	37.5	71.7	30.2	25.6	38.3	101.3	30.0	76.2	8.6	13.6	35.0	45.8	69.4	13.6	40.6	13.8	81.3	18.5	85.5	19.4	15.7	12.0	37.2	14.3	52.2	16.4	12.0	16.8	46.0	36.5	8.6	26.5	39.9	10.1	15.4	24.7	12.0	27.7	43.1	41.6	21.8	29.0	37.7	37.7	0.0	11.5	0.9	5.3	19.9	4.4	7.0	3.1	3.7	17.8	2.5	0.7	2.3	0.3	6.9	22.4	34.6	5.6	7.4	3.4	5.4	0.9	3.0	4.5	2.2	8.2	0.9	4.9	6.1	0.0	15.9	11.9	134.3	51.3	0.1	19.9	20.4	4.0	7.9	0.0	0.0	80.4	3.3	26.8	14.6	17.1	22.0	93.5	55.3	97.4	44.3	44.4	28.8	0.5	33.9	0.0	10.3	26.4	16.8	10.3	17.5	27.3	18.6	10.8	88.4	0.6	35.9	74.6	18.4	23.9	0.8	6.5	22.6	4.4	4.3	24.7	20.4	20.8	50.3	96.8
SLC1A6	EAAT4	ENSG00000105143	"Solute carrier family 1 member 6"	P48664	19	14950034-15022990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.1;testis: 23.3"	"Cell type enhanced"	"Detected in some"	11	"Bipolar cells: 12.3;Early spermatids: 29.3;Horizontal cells: 22.3;Late spermatids: 27.3;Syncytiotrophoblasts: 33.4"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 5.2"	"Region enriched"	"Detected in many"	5	"cerebellum: 52.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.6;NTERA-2: 5.4;U-698: 24.6"	"Region enriched"	"Detected in many"	6	"cerebellum: 152.9"	"Low region specificity"	"Detected in all"			"HPA041505, HPA044066"	Enhanced	Supported	Supported	"Plasma membrane,Intermediate filaments"		NA	NA			"Plasma membrane"	"Intermediate filaments"	"HPA041505: AB_2677520, HPA044066: AB_2678796"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"		"unprognostic (4.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.94e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (6.88e-6)"	0.4	0.5	3.2	0.5	9.6	1.2	0.8	52.1	12.8	0.4	0.5	0.6	0.0	0.6	0.8	4.2	0.4	0.5	0.5	0.4	4.8	4.0	0.4	0.5	0.5	0.5	1.6	3.4	0.6	0.9	0.6	0.0	4.3	3.0	0.9	0.6	0.1	0.7	0.9	0.5	9.2	0.5	0.5	1.4	0.7	0.5	23.3	0.9	0.0	0.6	0.0	0.6	0.4	0.0	2.0	0.7	2.2	0.7	0.5	0.6	0.1	0.1	0.1	0.3	0.3	0.2	0.2	0.8	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.2	6.6	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.6	0.1	0.5	0.0	0.3	5.4	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.2	0.2	2.6	0.0	1.1	0.3	0.1	0.0	0.3	1.0	0.2	0.1	0.4	0.1	24.6	0.1	0.3	0.1	1.6	0.7	0.5	0.6	0.4	0.4	1.0	0.5	0.3	0.3	2.0	0.6	0.6	2.2	0.5	0.4	0.7	0.3	0.1	3.2	9.6	52.1	6.5	4.8	4.0	1.6	3.4	3.0	0.9	0.0	0.0	0.0	0.6	2.9	12.3	1.6	0.0	0.0	0.0	1.8	0.0	0.5	0.0	0.0	29.3	0.0	0.0	0.0	0.3	8.5	1.0	0.2	0.0	0.0	0.4	22.3	0.0	0.0	0.0	27.3	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.7	0.0	0.3	1.7	1.5	5.9	33.4	0.0	0.0	0.1
SLC1A7	EAAT5	ENSG00000162383	"Solute carrier family 1 member 7"	O00341	1	53087179-53142632	"Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	7	"retina: 70.1"	"Group enriched"	"Detected in some"	17	"Bipolar cells: 228.0;Cone photoreceptor cells: 66.8;Rod photoreceptor cells: 66.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"gdT-cell: 5.7;memory CD8 T-cell: 2.2;naive CD8 T-cell: 2.6"	"Lineage enriched"	"Detected in single"	58	"T-cells: 5.7"	"Cell line enriched"	"Detected in some"	9	"HHSteC: 24.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049124	Enhanced					NA	NA					"HPA049124: AB_2680643"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.48e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.26e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.70e-3)"	2.0	0.2	1.1	0.6	0.6	0.0	1.2	0.6	0.7	0.9	1.0	0.7	0.6	4.1	1.3	1.2	2.1	2.2	9.6	2.9	1.7	1.1	0.7	2.8	0.9	0.6	1.2	0.6	3.8	0.6	0.0	0.6	0.6	1.1	0.9	0.0	70.1	0.6	0.6	2.1	1.2	5.3	0.6	1.3	0.6	1.1	0.9	0.6	0.6	0.6	0.6	0.6	2.5	0.9	0.0	0.0	0.0	0.0	0.0	5.7	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.2	2.6	0.0	0.0	0.0	0.0	0.1	0.8	1.1	0.6	0.6	0.7	1.7	1.1	1.2	0.6	1.1	0.6	0.0	0.6	0.0	0.0	0.0	228.0	0.4	0.0	0.0	0.0	0.0	66.8	0.1	0.0	0.0	0.0	0.0	7.0	0.0	1.3	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.7	5.2	0.0	2.9	1.1	0.2	66.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC20A1	"Glvr-1, GLVR1, PiT-1"	ENSG00000144136	"Solute carrier family 20 member 1"	Q8WUM9	2	112645857-112663827	"Predicted membrane proteins, Transporters"	"Host-virus interaction, Phosphate transport, Symport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Cone photoreceptor cells: 198.3;Enterocytes: 165.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 87.9;U-87 MG: 85.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019279, HPA035834"	Approved		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB019279: , HPA035834: AB_2674809"	"unprognostic (1.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (6.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-3)"	23.4	9.9	11.9	38.8	16.0	51.3	18.9	25.6	29.1	9.4	42.7	10.6	4.7	12.3	11.7	8.6	11.0	12.2	22.7	17.0	12.0	12.3	16.3	40.2	23.1	27.6	13.5	16.8	7.7	25.7	7.4	13.3	59.8	20.6	15.3	19.1	17.8	10.4	12.2	25.6	10.2	21.8	13.1	15.5	23.8	13.8	13.3	9.1	19.0	12.8	9.5	22.4	21.6	14.4	3.8	17.9	12.3	25.2	19.9	27.1	13.0	10.9	9.0	11.8	9.5	9.0	22.1	9.1	29.6	35.5	13.2	17.2	13.7	27.1	19.9	16.4	11.0	51.3	11.5	12.9	22.5	19.4	10.9	13.2	16.9	9.2	13.0	13.4	9.6	30.0	11.2	8.9	46.6	32.7	87.9	16.8	8.6	31.3	20.9	57.2	4.3	13.1	37.4	19.8	5.1	24.4	12.4	10.6	5.6	19.1	50.8	10.8	10.2	14.9	9.1	20.4	5.5	9.3	6.9	36.4	24.3	16.0	8.4	22.9	8.7	22.4	16.7	85.5	9.3	29.3	3.8	14.5	12.3	24.2	25.2	27.1	3.8	10.4	17.4	10.9	2.1	8.3	13.1	6.1	19.9	14.7	17.9	6.0	13.0	11.9	16.0	25.6	29.1	12.0	12.3	13.5	16.8	20.6	9.1	11.9	32.9	31.8	53.3	100.2	60.0	31.1	22.9	36.1	31.8	8.7	198.3	36.6	11.6	14.7	0.9	44.4	165.9	23.3	12.2	11.8	33.2	30.0	24.3	49.9	25.2	19.1	34.2	46.1	48.3	2.0	3.4	60.3	25.3	8.2	39.4	21.5	21.0	83.4	4.6	3.8	74.9	0.0	22.1	4.8	17.4	54.1	62.1	52.4	51.1	43.9
SLC20A2	"Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1"	ENSG00000168575	"Solute carrier family 20 member 2"	Q08357	8	42416475-42541926	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 90.6"	"Cell type enhanced"	"Detected in many"	7	"Basal glandular cells: 151.7;Urothelial cells: 128.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 48.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026540	Approved					NA	NA					"HPA026540: AB_1855408"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.43e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.95e-2)"	7.3	5.2	12.2	6.3	17.8	2.3	8.0	24.2	22.2	8.5	14.2	28.6	4.9	28.0	10.9	6.8	19.4	15.4	9.4	37.3	16.7	17.3	11.3	23.1	9.3	4.1	22.4	14.4	5.7	30.2	15.1	8.1	8.3	32.8	8.4	11.8	19.0	90.6	11.6	69.9	12.6	18.2	12.1	21.6	4.7	8.8	11.1	18.3	5.6	48.6	19.8	10.5	14.6	11.5	3.2	5.2	3.1	3.0	9.6	7.5	4.1	18.0	5.0	6.9	5.7	3.9	3.3	15.3	16.6	28.9	8.6	21.5	13.4	48.3	6.1	19.6	14.9	4.9	29.7	3.8	16.9	15.3	1.5	3.1	9.7	1.8	7.6	5.6	3.4	4.4	3.6	15.4	8.9	8.8	6.1	4.2	4.9	9.3	5.0	16.3	5.0	6.1	5.6	6.8	17.6	3.2	5.2	7.5	6.4	7.9	17.8	1.8	7.1	4.5	7.8	4.5	5.7	6.3	6.0	13.1	18.7	6.4	4.4	9.0	3.3	7.4	4.4	5.8	6.8	10.1	3.1	3.0	0.3	5.6	2.2	6.3	3.1	6.0	5.2	5.2	3.2	7.5	5.6	1.2	9.6	1.9	3.0	5.8	4.1	12.2	17.8	24.2	19.9	16.7	17.3	22.4	14.4	32.8	18.3	26.8	15.2	6.4	151.7	87.8	13.6	54.5	15.3	64.3	14.8	15.7	15.7	19.5	11.6	26.9	7.6	15.8	30.9	0.0	26.9	19.4	12.7	56.3	3.5	28.4	9.1	6.4	11.5	6.2	7.6	7.5	6.6	6.9	10.1	9.0	10.7	16.4	37.9	12.9	11.0	5.0	10.0	6.5	16.0	3.6	4.3	65.0	21.3	8.5	10.0	128.7
SLC22A1	OCT1	ENSG00000175003	"Solute carrier family 22 member 1"	O15245	6	160121789-160158718	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"liver: 175.8"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 709.2"	"Cancer enriched"	"Detected in some"	81	"liver cancer: 83.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"neutrophil: 7.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 7.3"	"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.7"	"Not detected"	"Not detected"			HPA029846	Approved					NA	NA					"HPA029846: AB_10603026"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.72e-2)"	"unprognostic (8.07e-4)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	175.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	7.3	0.3	0.0	0.5	0.0	0.0	0.9	0.9	1.8	1.6	0.6	0.7	0.4	0.2	0.5	0.5	1.4	0.4	0.5	1.0	0.1	3.1	0.3	0.0	1.8	0.7	1.5	0.9	0.6	0.6	2.4	0.0	1.5	1.1	0.0	2.0	0.0	1.0	0.3	0.1	0.9	0.5	0.3	0.3	0.2	0.0	1.1	0.0	0.3	0.7	0.0	1.8	1.5	0.2	0.9	0.6	0.0	2.5	0.0	1.6	1.5	0.3	0.1	0.0	0.6	0.7	1.7	1.2	1.4	2.8	0.9	0.2	1.0	0.3	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.3	0.0	0.1	7.3	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.3	43.3	0.0	0.0	0.0	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	709.2	0.1	0.0	0.0	14.1	12.6	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.7	1.1	0.0	0.0	0.2	0.0	0.0	0.3	0.1	2.9	0.0	0.1
SLC22A10	"hOAT5, OAT5"	ENSG00000184999	"Solute carrier family 22 member 10"	Q63ZE4	11	63137867-63369718	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	32	"liver: 41.7"	"Cell type enriched"	"Detected in some"	13	"Hepatocytes: 15.5"	"Cancer enriched"	"Detected in single"	14	"liver cancer: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"unprognostic (1.17e-2)"				"unprognostic (9.77e-2)"		"unprognostic (7.07e-3)"	"unprognostic (7.46e-4)"			"unprognostic (7.62e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.25e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555626-64572875	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"epididymis: 22.2;kidney: 47.6;placenta: 64.7"	"Group enriched"	"Detected in some"	17	"Cytotrophoblasts: 554.5;Syncytiotrophoblasts: 1271.5"	"Group enriched"	"Detected in some"	14	"liver cancer: 3.7;renal cancer: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;CACO-2: 1.1;Hep G2: 3.4;SuSa: 1.9"					"Not detected"	"Not detected"			HPA026076	Enhanced					NA	NA					"HPA026076: AB_1854756"	"unprognostic (8.21e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (4.62e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-3)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	4.4	0.0	0.1	22.2	0.1	0.1	0.0	0.1	0.1	0.1	47.6	0.4	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.1	64.7	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	554.5	5.0	0.0	1.0	0.0	0.0	0.0	0.3	13.6	0.6	0.0	0.0	0.0	44.6	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	54.2	0.0	0.0	0.0	0.0	0.1	0.0	1271.5	0.0	0.0	0.0
SLC22A12	"OAT4L, RST, URAT1"	ENSG00000197891	"Solute carrier family 22 member 12"	Q96S37	11	64590641-64602353	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	349	"kidney: 70.1"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 149.1"	"Group enriched"	"Detected in some"	207	"liver cancer: 4.0;renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA024575	Enhanced					NA	NA					"HPA024575: AB_1858650"					"unprognostic (5.88e-2)"		"unprognostic (2.33e-1)"						"prognostic favorable (2.63e-4)"	"unprognostic (6.19e-2)"	"unprognostic (3.91e-2)"			0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	149.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A13	"OAT10, OCTL1, OCTL3, ORCTL3"	ENSG00000172940	"Solute carrier family 22 member 13"	Q9Y226	3	38265812-38278315	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 16.4"	"Cell type enriched"	"Detected in single"	23	"Proximal tubular cells: 6.5"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 0.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"T-reg: 2.3"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.3"	"Cell line enhanced"	"Detected in some"		"HeLa: 2.2"					"Low region specificity"	"Detected in all"			"HPA035603, HPA035962"	Enhanced					NA	NA					"HPA035603: AB_10672869, HPA035962: AB_2674890"	"unprognostic (2.73e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.50e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.74e-1)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	16.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.1	0.3	0.0	2.3	0.0	0.2	0.5	0.1	0.7	0.4	0.5	0.1	0.3	0.0	0.2	0.3	0.0	0.5	0.9	0.2	0.1	0.6	0.8	0.5	0.7	0.1	0.4	0.1	0.0	2.2	0.0	0.1	0.0	0.8	0.0	0.5	0.1	1.5	0.8	0.0	0.9	0.0	0.1	1.1	0.1	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.2	0.0	1.2	0.1	0.1	0.0	0.5	0.0	0.4	0.1	0.1	0.0	0.3	0.7	1.2	0.3	0.3	0.4	0.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.4	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A14	"OCTL2, ORCTL4"	ENSG00000144671	"Solute carrier family 22 member 14"	Q9Y267	3	38282294-38318575	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	8	"testis: 13.2"	"Group enriched"	"Detected in some"	44	"Early spermatids: 57.6;Late spermatids: 81.6"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	13	"neutrophil: 1.4;plasmacytoid DC: 1.2"	"Group enriched"	"Detected in many"	13	"dendritic cells: 1.2;granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"hTCEpi: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (6.26e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-4)"	"unprognostic (2.19e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.35e-1)"	0.1	0.0	0.2	0.0	0.3	0.5	0.0	1.6	0.9	0.0	0.0			0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.2	0.3	1.1	0.0	0.0	0.1	0.2		0.0	0.1	0.0	0.2	0.0		0.1	0.1		0.2	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.2	13.2			0.0		0.0	0.0	0.0	0.0	1.2	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.5	1.7	0.7	1.3	0.2	0.1	0.6	0.4	1.0	1.6	0.1	0.0	0.4	0.9	0.5	0.8	0.0	0.0	0.1	1.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	1.9	2.9	0.0	0.8	1.1	0.1	1.1	0.0	0.0	0.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.4	0.7	0.1	1.4	0.0	0.0	1.9	0.0	1.1	0.6	0.3	0.3	0.3	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	1.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	1.6	0.0	0.0	0.0	81.6	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.1
SLC22A15	FLIPT1	ENSG00000163393	"Solute carrier family 22 member 15"	Q8IZD6	1	115976498-116070054	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 34.6;brain: 27.8"	"Cell type enhanced"	"Detected in many"	5	"Alveolar cells type 2: 10.7;Cone photoreceptor cells: 9.8;Kupffer cells: 8.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.9"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.9;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 21.1;hTERT-HME1: 27.9;NB-4: 15.2;THP-1: 16.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019785	Uncertain					NA	NA					"HPA019785: AB_1857011"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.85e-5)"	"unprognostic (8.91e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.29e-3)"	"unprognostic (8.78e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.97e-4)"	"unprognostic (1.30e-1)"	2.9	4.5	7.0	3.2	14.1	34.6	2.3	8.6	11.1	2.6	2.1	27.8	0.7	1.7	1.9	2.2	5.5	2.4	2.9	6.1	9.9	8.0	4.9	1.3	6.3	1.7	20.0	8.1	2.0	4.2	7.5	4.5	2.9	15.1	2.8	2.7	2.5	4.6	2.7	0.8	11.8	1.7	1.7	14.1	3.5	4.8	1.8	17.6	0.0	4.0	0.8	1.9	2.5	4.6	0.5	0.3	3.9	2.9	0.2	0.0	0.3	1.6	0.1	1.2	0.0	2.2	2.7	0.8	2.7	3.9	1.6	2.9	0.0	0.3	1.8	2.9	1.3	1.4	2.5	2.0	5.5	1.6	0.0	1.3	1.8	1.9	0.2	7.3	2.7	2.5	2.7	21.1	0.0	27.9	0.1	0.0	0.0	0.1	0.0	2.7	1.5	0.0	15.2	1.7	1.5	1.3	0.0	0.0	0.0	2.3	0.9	1.3	1.1	4.6	0.9	7.8	1.9	0.2	16.5	0.0	2.9	1.6	0.5	0.6	2.8	2.6	0.2	3.1	4.5	4.6	1.0	2.5	0.9	0.0	0.7	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	3.9	0.2	2.9	0.0	0.0	0.3	7.0	14.1	8.6	11.1	9.9	8.0	20.0	8.1	15.1	17.6	0.0	10.7	0.8	2.9	2.5	2.1	7.5	0.0	4.0	2.3	5.2	9.8	0.5	1.7	1.1	0.6	0.0	0.0	0.0	0.3	0.3	1.3	0.8	1.1	0.0	2.9	7.9	8.1	1.3	8.6	0.0	0.9	5.9	1.7	1.0	0.2	0.8	1.7	0.2	0.4	0.1	2.0	0.0	1.0	0.2	0.2	2.6	0.0	0.5	0.4	0.9
SLC22A17	"BOCT, BOIT, NGALR"	ENSG00000092096	"Solute carrier family 22 member 17"	Q8WUG5	14	23346306-23352912	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 112.4"	"Cell type enhanced"	"Detected in many"	13	"Horizontal cells: 190.7;Muller glia cells: 81.5;Rod photoreceptor cells: 64.5"	"Cancer enhanced"	"Detected in all"		"glioma: 51.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 1.1;naive CD4 T-cell: 3.6;naive CD8 T-cell: 1.8"	"Lineage enriched"	"Detected in single"	26	"T-cells: 3.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.8;ASC diff: 17.3;SH-SY5Y: 24.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002728	Uncertain					NA	NA					"HPA002728: AB_1079998"	"unprognostic (9.34e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.87e-2)"	6.0	24.2	32.9	4.0	63.4	1.6	7.0	40.7	112.4	12.1	5.6	27.4	2.4	4.5	8.0	10.1	4.7	10.2	7.6	9.1	35.6	69.4	8.6	2.0	5.0	3.8	28.5	27.3	11.0	14.5	13.3	39.4	5.3	33.1	21.9	3.5	13.2	20.5	24.4	2.1	6.6	6.6	7.7	21.8	3.6	6.1	6.6	22.1	0.0	10.8	0.1	2.6	4.2	4.8	0.1	0.0	0.0	0.0	0.0	3.6	0.2	0.0	1.2	13.0	20.8	17.3	9.1	2.0	4.5	8.9	1.7	1.3	0.1	1.2	0.0	1.7	8.4	4.0	0.2	0.6	0.5	0.1	0.0	0.7	2.9	0.0	0.1	9.3	0.0	2.9	11.8	0.8	2.0	0.0	7.5	0.5	5.6	0.0	0.1	2.7	1.9	0.1	0.1	7.1	0.0	0.0	0.0	0.5	0.1	0.0	1.2	12.3	24.2	3.7	0.0	0.0	2.8	2.4	0.4	0.0	1.9	5.6	10.4	0.0	0.0	2.0	0.0	1.2	0.0	7.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.1	3.6	1.8	0.0	0.0	0.0	0.0	0.0	0.2	32.9	63.4	40.7	64.3	35.6	69.4	28.5	27.3	33.1	22.1	0.0	2.4	0.0	18.6	11.2	49.9	9.0	5.1	5.3	9.1	19.2	41.2	1.8	1.7	0.6	0.3	6.8	0.0	0.0	1.2	4.1	14.9	27.1	4.6	0.8	0.8	190.7	20.0	17.8	0.8	1.3	19.5	2.2	6.8	1.0	0.0	81.5	2.4	0.0	40.3	13.5	64.5	0.0	20.0	0.9	2.1	9.5	4.0	0.0	0.0	4.6
SLC22A18	"BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5"	ENSG00000110628	"Solute carrier family 22 member 18"	Q96BI1	11	2899721-2925246	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 71.4;liver: 44.3"	"Cell type enhanced"	"Detected in many"	11	"Enterocytes: 511.8;Late spermatids: 354.1;Paneth cells: 245.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.6;Karpas-707: 20.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA067812, HPA071461"	Enhanced					NA	NA					"HPA067812: AB_2685902, HPA071461: AB_2686401"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.80e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.35e-2)"	"unprognostic (8.60e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.51e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.82e-1)"	3.5	1.6	0.5	11.4	1.2	1.4	3.2	0.1	2.0	2.6	36.6	0.8	2.9	36.7	3.1	15.2	6.1	4.7	21.9	8.5	0.9	1.1	18.2	44.3	8.7	8.3	1.0	1.7	2.9	3.0	4.1	1.5	4.9	1.3	4.0	3.7	4.2	8.6	4.3	1.0	6.5	71.4	3.7	1.2	4.7	8.1	2.8	0.8	3.1	8.1	7.6	5.4	4.5	4.4	2.1	8.9	21.7	15.0	2.7	4.6	6.0	1.4	8.7	0.0	4.9	0.9	1.4	3.6	2.9	5.2	1.7	3.0	5.1	21.6	0.6	9.2	3.9	3.7	4.7	0.2	0.4	0.4	4.3	0.7	0.1	2.1	4.6	9.6	0.0	4.0	4.0	0.9	1.4	0.3	1.5	0.0	3.0	0.1	20.1	0.9	4.4	0.1	0.6	0.5	7.0	1.9	1.5	0.0	2.7	0.8	3.0	0.1	1.6	1.1	12.6	10.4	0.1	2.4	2.5	0.2	1.3	2.8	4.0	0.2	3.6	0.8	0.2	5.3	2.7	5.0	15.3	15.0	12.6	3.5	14.3	2.0	2.1	2.8	2.5	8.9	1.3	1.5	2.2	21.7	2.7	10.8	6.4	4.6	6.0	0.5	1.2	0.1	2.0	0.9	1.1	1.0	1.7	1.3	0.8	6.0	8.1	3.9	17.1	6.5	1.2	8.6	71.4	16.0	9.1	26.2	0.0	70.1	6.6	24.6	135.4	3.2	511.8	0.0	7.7	17.5	12.2	13.4	16.1	138.4	40.5	0.0	19.0	6.2	27.6	354.1	9.8	18.7	18.6	14.4	72.1	5.0	15.7	245.4	7.1	76.4	1.0	0.0	11.3	1.9	2.4	7.8	151.6	15.3	106.9	17.1
SLC22A2	OCT2	ENSG00000112499	"Solute carrier family 22 member 2"	O15244	6	160171061-160277638	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 61.8"	"Group enriched"	"Detected in some"	13	"Distal tubular cells: 77.9;Proximal tubular cells: 187.0"	"Cancer enriched"	"Detected in single"	493	"renal cancer: 30.8"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.8;SuSa: 1.0;U-2197: 3.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA008549, CAB068236, CAB068237"	Enhanced					NA	NA					"CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549: "	"unprognostic (1.01e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.24e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (1.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.45e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.3	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.2	0.1	61.8	0.0	0.0	0.0	0.8	0.8	0.0	0.0	0.0	0.3	0.2	1.9	0.1	0.0	2.7	0.0	0.6	0.3	0.0	0.1	0.1	6.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	1.0	0.0	0.5	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.3	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.2	1.0	0.2	0.1	0.0	0.2	0.0	3.8	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.5	0.0	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.5	0.0	0.3	0.1	0.0	0.0	0.2	0.6	0.3	0.2	0.1	0.8	0.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	10.4	0.0	0.0	77.9	0.6	4.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	187.0	0.0	0.0	0.3	0.0	0.1	0.3	0.1	0.0	0.0	0.0
SLC22A23	"C6orf85, FLJ22174"	ENSG00000137266	"Solute carrier family 22 member 23"	A1A5C7	6	3268962-3457022	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 73.9;Late spermatids: 171.9;Mucus-secreting cells: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014697	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Nucleoplasm, Vesicles"	Cytosol	"HPA014697: AB_1844371"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (5.16e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.53e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (8.91e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	7.4	2.2	9.0	4.6	16.2	8.1	9.3	8.4	14.8	5.6	17.4	30.8	3.4	19.6	3.6	11.8	16.8	11.3	7.5	2.2	11.0	8.1	6.9	12.6	8.0	3.9	28.6	8.7	3.0	14.9	14.8	6.5	8.3	17.8	14.2	14.4	5.7	10.0	2.8	5.9	14.9	20.3	3.0	17.5	4.6	26.0	7.2	21.0	5.2	4.1	9.8	9.9	3.8	9.9	0.1	0.7	0.8	0.3	0.3	1.4	1.9	2.4	5.6	12.5	13.9	4.4	5.0	16.0	0.4	0.1	0.7	0.3	12.5	0.4	0.6	1.4	2.7	11.1	3.6	2.5	6.6	0.2	2.0	7.7	5.8	2.1	11.0	0.6	0.3	0.4	1.2	13.0	12.1	0.6	2.6	0.4	3.2	5.2	3.3	0.4	2.9	0.5	1.4	4.3	13.7	2.3	1.3	0.8	9.9	0.0	15.3	1.4	0.2	3.3	4.8	4.1	13.3	18.5	0.1	3.1	7.3	2.3	9.4	1.5	7.5	0.1	0.2	12.8	0.4	4.4	0.0	0.3	0.0	0.4	0.0	0.2	0.0	1.0	0.4	0.2	0.1	1.4	0.9	0.8	0.3	0.2	0.7	0.0	1.9	9.0	16.2	8.4	14.8	11.0	8.1	28.6	8.7	17.8	21.0	6.0	13.7	0.5	4.2	10.3	7.9	2.4	10.2	33.5	17.0	5.2	7.9	12.2	0.0	2.5	73.9	8.4	29.0	23.3	7.0	0.9	1.4	19.2	0.0	10.0	9.8	0.0	4.1	6.7	8.0	171.9	1.7	2.0	3.3	10.8	52.1	9.1	5.7	14.4	0.7	2.4	3.4	0.0	0.9	2.1	1.1	11.0	7.7	1.0	22.6	3.9
SLC22A24	"MGC34821, NET46"	ENSG00000197658	"Solute carrier family 22 member 24"	Q8N4F4	11	63079940-63144221	"Predicted membrane proteins, Transporters"	"Ion transport, Lipid metabolism, Steroid metabolism, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"kidney: 10.5"	"Cell type enriched"	"Detected in single"	30	"Proximal tubular cells: 8.4"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045015	Uncertain					NA	NA					"HPA045015: AB_2679183"							"unprognostic (5.72e-3)"						"unprognostic (1.80e-7)"					0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	2.1	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A25	"HIMTP, MGC120420, UST6"	ENSG00000196600	"Solute carrier family 22 member 25"	Q6T423	11	63163776-63229652	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	165	"liver: 16.5"	"Cell type enriched"	"Detected in single"	9	"Hepatocytes: 5.8"	"Cancer enriched"	"Detected in single"	66	"liver cancer: 3.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA039390	Uncertain					NA	NA					"HPA039390: AB_10671996"	"unprognostic (3.19e-2)"				"unprognostic (2.38e-1)"	"unprognostic (4.51e-1)"	"prognostic favorable (7.04e-4)"							"unprognostic (1.01e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348268-160452581	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 98.6"	"Cell type enhanced"	"Detected in many"	10	"Alveolar cells type 2: 62.8;Hepatocytes: 56.3;Leydig cells: 31.4;Pancreatic endocrine cells: 33.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A549: 17.6;HeLa: 23.6;Hep G2: 14.7;hTERT-RPE1: 6.2;OE19: 7.5;RPTEC TERT1: 9.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029750	Approved		Approved	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavorable (7.26e-4)"	4.1	6.9	1.0	2.1	1.3	0.0	5.2	1.8	0.9	7.6	4.1	0.9	4.1	0.2	14.2	11.8	4.1	9.0	9.0	1.1	1.2	1.3	2.4	15.2	12.7	9.7	2.2	0.9	10.3	1.3	0.0	0.9	17.8	1.9	18.9	0.6	0.9	34.5	23.0	98.6	5.1	2.7	10.8	4.4	0.3	2.9	3.4	0.6	0.4	3.4	5.7	2.1	3.2	7.3	0.0	0.0	0.8	0.0	0.1	1.5	0.0	0.0	17.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.2	0.0	0.0	0.0	23.6	14.7	0.8	0.0	0.0	0.5	4.5	2.2	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	7.5	4.9	0.0	0.0	0.0	9.0	0.0	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.8	0.1	0.0	0.0	0.0	0.0	1.0	1.3	1.8	0.9	1.2	1.3	2.2	0.9	1.9	0.6	14.9	62.8	0.0	0.3	4.1	0.0	1.6	5.1	1.4	10.3	0.0	0.0	0.4	5.0	9.1	0.4	0.3	0.7	0.0	2.5	0.2	11.0	3.4	2.3	56.3	0.6	0.0	0.0	0.0	0.6	0.9	31.4	1.5	3.3	0.0	0.4	0.0	33.9	0.0	23.0	2.1	0.0	0.0	11.4	0.2	0.1	5.8	0.3	0.0	0.4	0.7
SLC22A5	"CDSP, OCTN2, SCD"	ENSG00000197375	"Solute carrier family 22 member 5"	O76082	5	132369752-132395614	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.3;skeletal muscle: 93.6"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 22.3;SiHa: 23.0"									HPA063062			Approved	Mitochondria		NA	NA			Mitochondria		"HPA063062: AB_2684934"	"unprognostic (3.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (2.87e-5)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.53e-2)"	"prognostic favorable (8.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-2)"	3.0	4.7	4.0	1.9	4.9	0.6	4.4	9.0	4.2	4.4	10.6	3.6	15.0	11.8	3.6	12.6	2.5	7.4	5.2	7.2	3.8	3.8	42.3	4.5	2.3	1.5	3.5	3.2	3.9	5.2	17.9	8.5	8.1	3.9	8.2	8.3	5.9	4.2	21.8	93.6	3.5	19.6	2.9	3.8	1.7	4.4	2.5	2.7	1.0	5.0	3.2	2.4	3.9	3.2	1.4	6.4	0.4	4.1	1.5	4.0	2.1	3.6	8.7	0.5	7.0	2.8	1.3	12.1	1.6	1.8	2.8	3.9	6.4	7.5	1.7	3.8	1.6	8.1	8.7	5.8	4.3	3.3	2.2	7.1	0.9	22.3	2.9	4.7	1.4	1.5	1.3	8.1	1.9	9.9	4.8	0.7	3.2	4.0	1.1	2.6	6.2	2.1	1.4	0.6	6.3	3.8	0.8	0.0	9.4	8.4	9.1	3.0	2.1	23.0	18.0	4.4	1.9	8.3	1.8	0.4	0.5	2.5	5.9	2.0	3.8	7.4	0.1	1.8	3.6	1.6	0.0	4.1	0.0	2.6	2.2	2.8	1.4	2.4	3.1	6.4	1.4	2.6	3.0	0.4	1.5	0.7	0.6	4.0	2.1	4.0	4.9	9.0	4.2	3.8	3.8	3.5	3.2	3.9	2.7	8.9	5.1	2.7	5.9	6.8	6.5	5.2	20.4	6.7	3.4	15.7	11.8	16.6	1.7	8.8	1.4	3.0	46.4	0.0	4.5	4.8	4.0	12.8	0.0	5.9	4.0	9.5	6.9	1.3	8.7	2.3	6.1	2.6	5.0	0.0	12.6	8.7	5.4	25.9	3.9	23.2	7.4	0.0	1.9	7.2	2.5	5.5	6.9	2.9	16.1	7.8
SLC22A6	"OAT1, PAHT, ROAT1"	ENSG00000197901	"Solute carrier family 22 member 6"	Q4U2R8	11	62936385-62984983	"FDA approved drug targets, Predicted membrane proteins, Transporters"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"kidney: 94.2"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 213.4"	"Cancer enriched"	"Detected in single"	102	"renal cancer: 18.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA074559, CAB075704"	Enhanced					NA	NA					"CAB075704: , HPA074559: AB_2732260"					"unprognostic (2.42e-2)"								"unprognostic (2.25e-3)"	"unprognostic (4.43e-1)"				0.2	0.2	0.8	0.2	1.3	0.2	0.2	0.4	1.4	0.2	0.2	0.7	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	1.8	94.2	0.2	0.2	0.2	2.4	0.6	0.2	0.2	0.2	0.1	0.2	4.1	0.2	0.2	9.4	0.2	0.2	0.2	0.2	0.2	0.2	2.4	0.2	0.2	0.2	0.5	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.4	1.4	0.8	1.8	2.4	0.6	4.1	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	213.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A7	"NLT, OAT2"	ENSG00000137204	"Solute carrier family 22 member 7"	Q9Y694	6	43295694-43305538	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 88.9"	"Group enriched"	"Detected in some"	16	"Hepatocytes: 185.6;Proximal tubular cells: 86.1"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 81.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Cell line enriched"	"Detected in single"	19	"Hep G2: 14.9"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA030220	Approved					NA	NA					"HPA030220: AB_10603027"	"unprognostic (9.17e-2)"			"unprognostic (9.73e-4)"	"unprognostic (2.13e-1)"		"prognostic favorable (5.48e-6)"			"unprognostic (1.45e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	13.8	88.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.2	0.0	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	1.2	0.3	2.5	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	185.6	0.0	0.0	0.0	1.8	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A8	OAT3	ENSG00000149452	"Solute carrier family 22 member 8"	Q8TCC7	11	62989154-63015839	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Detoxification, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	341	"brain: 33.7;kidney: 127.3;retina: 93.5"	"Cell type enriched"	"Detected in some"	30	"Proximal tubular cells: 197.4"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Region enriched"	"Detected in some"	25	"pons and medulla: 33.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"EFO-21: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044174	Enhanced					NA	NA					"HPA044174: AB_10963058"							"unprognostic (5.35e-4)"					"unprognostic (4.66e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"			0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	1.0	0.1	0.1	3.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.7	0.1	127.3	0.1	0.1	0.1	0.1	1.3	0.1	0.1	0.1	0.2	0.1	33.7	0.1	0.1	93.5	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	1.0	0.7	0.1	0.1	1.3	33.7	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	0.0	0.0	5.2	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A9	"FLJ23666, OAT4, OAT7, UST3"	ENSG00000149742	"Solute carrier family 22 member 9"	Q8IVM8	11	63369789-63410294	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 32.2"	"Cell type enhanced"	"Detected in some"	30	"Cholangiocytes: 2.5;granulocytes: 4.6;Hepatocytes: 12.7"	"Cancer enriched"	"Detected in single"	166	"liver cancer: 19.3"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.1;Karpas-707: 1.9;U-266/70: 2.4"															NA	NA											"unprognostic (2.45e-1)"	"unprognostic (7.24e-2)"	"unprognostic (8.86e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.08e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.09e-2)"	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.2	32.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.6	2.8	0.8	0.9	0.5	0.3	0.4	0.5	0.0	0.6	0.2	0.0	0.9	0.0	0.3	0.1	0.2	0.2	0.4	0.5	0.2	0.1	0.1	0.4	0.0	0.5	0.1	1.3	0.3	0.3	0.5	2.1	0.0	0.1	0.5	0.0	0.0	0.5	0.0	0.1	0.2	0.0	0.3	1.9	0.1	0.6	0.3	0.9	0.7	0.1	0.2	0.1	1.1	0.1	0.0	0.5	0.1	0.2	0.0	0.3	0.2	0.0	0.4	0.5	0.0	0.5	0.3	0.6	0.3	2.4	0.5	1.0	0.3	0.6	0.3	2.8	0.8	0.7	0.4	0.5	0.2	0.5	0.2	0.3	0.2	1.0	0.4	0.5	2.2	0.9	0.2	0.6	0.3	0.3	0.4	0.1	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	4.6	12.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0
SLC23A1	"SLC23A2, SVCT1, YSPL3"	ENSG00000170482	"Solute carrier family 23 member 1"	Q9UHI7	5	139367196-139384553	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 24.8;intestine: 94.3;liver: 25.4"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 18.7;Hepatocytes: 17.5;Proximal tubular cells: 25.1"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.8;Hep G2: 11.1;JURKAT: 13.0;Karpas-707: 9.2;RPMI-8226: 9.0;U-266/70: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047612	Enhanced					NA	NA					"HPA047612: AB_2680102"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.36e-6)"	"unprognostic (7.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.65e-3)"	0.3	0.0	0.3	0.5	0.5	0.8	0.3	0.3	0.3	2.3	22.1	0.3	0.8	11.6	0.3	1.6	0.3	24.8	1.8	0.3	0.3	0.3	18.0	25.4	0.6	0.4	0.3	0.3	0.4	0.9	0.0	0.3	0.3	0.4	2.7	0.3	0.3	1.0	0.6	0.3	1.0	94.3	0.3	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.2	4.4	0.7	0.1	0.0	0.3	0.0	0.2	1.8	0.3	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.8	1.0	4.7	2.5	0.0	0.1	0.2	0.0	0.0	0.1	6.7	0.1	0.1	0.6	11.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	13.0	0.1	9.2	0.0	0.1	4.6	0.8	0.1	0.7	0.1	5.6	0.2	9.0	0.4	0.3	0.2	0.3	0.2	1.6	0.0	0.6	4.3	0.1	0.3	0.3	0.2	0.1	0.0	14.3	1.7	6.2	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.0	1.2	0.2	0.0	0.7	0.0	0.1	4.4	0.3	0.0	0.3	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	18.7	3.4	0.0	3.9	0.4	5.0	0.1	0.0	0.0	5.1	0.0	0.2	0.0	0.0	1.3	0.0	17.5	0.1	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.5	0.0	25.1	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.1
SLC23A2	"KIAA0238, SLC23A1, SVCT2, YSPL2"	ENSG00000089057	"Solute carrier family 23 member 2"	Q9UGH3	20	4852356-5010293	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 55.6"	"Cell type enhanced"	"Detected in many"	12	"Bipolar cells: 215.7;Cone photoreceptor cells: 108.0;Horizontal cells: 81.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052825, HPA059314"	Approved		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA052825: AB_2681965, HPA059314: AB_2683975"	"unprognostic (3.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (6.22e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.36e-3)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.08e-5)"	6.6	55.6	14.7	6.1	17.5	5.4	6.3	15.9	27.2	8.6	4.6	19.3	4.0	5.0	9.5	7.1	4.6	12.4	7.8	5.4	14.4	14.5	6.0	27.7	7.4	7.2	14.9	16.6	29.4	7.5	15.1	12.5	25.1	16.4	9.0	5.0	22.1	4.2	8.4	2.6	8.5	6.3	7.8	17.5	11.7	7.1	8.5	11.4	5.3	18.6	2.2	7.4	18.7	6.4	4.2	6.0	3.1	2.5	0.8	2.8	2.0	10.7	12.7	17.0	6.4	12.0	6.8	21.7	4.6	6.3	5.4	5.1	6.5	12.3	4.9	5.0	6.4	15.5	10.4	4.7	12.6	10.3	3.0	8.5	6.8	2.2	24.4	6.8	9.5	4.0	5.7	7.3	13.7	8.2	11.5	7.9	8.1	4.6	4.2	7.2	4.0	10.3	5.3	6.0	8.6	7.8	9.6	11.2	7.3	3.0	17.6	5.7	6.4	8.8	9.3	32.7	6.3	5.1	5.6	6.8	12.3	5.7	14.7	8.8	5.9	10.9	13.2	4.3	5.7	19.3	0.0	2.5	0.2	2.8	1.8	2.6	4.2	2.2	2.0	3.6	2.9	2.1	2.1	3.1	0.8	2.1	6.0	1.3	2.0	14.7	17.5	15.9	25.3	14.4	14.5	14.9	16.6	16.4	11.4	6.0	7.4	9.5	4.0	6.5	215.7	5.5	20.4	4.0	13.6	14.0	108.0	3.6	0.0	4.0	3.5	7.7	0.5	0.0	4.7	4.8	8.9	5.5	8.1	58.7	9.5	81.0	6.9	22.1	27.3	7.0	18.7	8.3	15.1	7.2	1.5	26.4	2.9	5.1	27.6	1.3	64.3	12.9	5.6	0.5	9.6	5.4	3.3	7.1	3.1	10.1
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"intestine: 36.5;kidney: 32.4"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 6.7;Proximal tubular cells: 8.9"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 9.0;U-266/70: 6.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 1.3"	"Not detected"	"Not detected"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"		NA	NA			Nucleoplasm	"Cell Junctions"	"HPA019059: AB_1857017"	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	0.4	0.0	0.3	2.3	0.3	0.0	0.5	0.3	0.5	0.8	14.9	0.3	0.3	5.3	1.1	0.3	0.9	0.5	0.3	0.3	0.3	0.0	32.4	3.1	0.7	0.3	0.3	0.3	1.0	0.4	0.5	0.3	0.5	0.3	1.4	0.8	0.3	0.4	0.3	0.3	1.1	36.5	0.3	0.3	0.4	0.5	0.3	0.3	0.3	1.3	0.3	0.4	0.6	1.3	0.8	0.0	0.0	0.8	0.0	0.5	0.0	0.9	0.4	0.2	1.1	4.0	2.2	0.8	2.2	0.6	0.4	1.3	2.4	1.6	0.5	0.8	1.5	0.1	3.2	0.7	0.3	0.6	1.9	1.8	2.1	1.9	0.2	0.7	0.2	0.9	0.7	9.0	0.9	2.9	3.6	1.2	1.2	0.3	0.9	0.6	0.3	0.1	1.0	0.0	0.8	0.2	0.5	0.6	0.8	3.1	3.7	0.5	1.0	0.2	0.0	2.4	1.1	0.9	1.1	2.6	2.1	1.4	2.2	0.7	6.6	0.3	2.9	0.6	0.7	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.3	0.3	0.5	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	2.0	1.1	1.3	0.8	0.3	2.5	0.0	0.0	1.8	0.0	0.2	1.7	0.2	0.0	0.7	6.7	0.0	0.0	0.1	0.6	1.4	0.0	0.5	0.2	0.0	1.7	0.6	0.3	0.0	1.4	0.4	1.7	1.0	2.8	1.9	0.2	3.1	1.1	8.9	0.1	0.0	0.8	0.0	0.1	1.4	0.3	0.0	1.6	0.7
SLC24A1	"CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX"	ENSG00000074621	"Solute carrier family 24 member 1"	O60721	15	65611366-65660995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision"		"Congenital stationary night blindness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"retina: 91.1"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 301.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA039370	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA039370: AB_10960279"	"unprognostic (9.47e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.39e-3)"	"unprognostic (4.64e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (8.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.96e-2)"	6.2	5.3	4.5	7.7	5.0	2.6	9.3	7.0	3.4	8.9	5.0	5.6	7.5	3.7	10.6	12.2	4.2	9.0	6.2	4.1	4.7	4.1	7.9	4.7	12.0	6.0	5.3	2.6	9.7	6.6	6.5	6.1	8.9	4.0	6.0	4.1	91.1	6.4	8.3	3.8	8.5	4.5	5.0	6.8	7.8	4.2	10.8	3.2	6.9	9.0	4.6	4.8	6.0	5.3	3.8	2.6	4.7	1.5	2.3	1.8	0.4	1.5	3.1	3.3	3.0	5.0	8.4	4.1	3.9	4.2	3.8	2.5	1.4	6.6	2.1	12.9	3.7	1.3	4.2	3.9	4.2	2.3	2.1	2.9	4.6	2.3	6.8	7.2	3.0	6.3	7.1	6.2	2.1	12.8	5.4	6.6	4.9	4.8	7.2	6.2	6.4	1.9	2.8	4.3	13.5	1.2	2.0	1.0	1.4	5.8	6.0	1.6	2.3	1.0	2.9	8.0	4.8	6.2	4.2	9.4	3.9	3.9	1.5	2.6	2.9	5.2	2.5	4.1	6.5	3.3	4.7	1.5	2.1	1.4	1.3	1.8	1.4	1.5	1.2	1.1	3.8	1.1	1.5	1.7	2.3	0.6	2.6	0.3	0.4	4.5	5.0	7.0	3.4	4.7	4.1	5.3	2.6	4.0	3.2	6.0	3.2	1.4	1.2	1.3	26.9	1.9	0.0	4.0	5.7	0.0	25.5	3.3	0.0	1.1	1.1	7.0	2.8	0.0	1.1	2.0	1.5	1.1	2.3	1.5	1.7	19.1	1.7	4.3	2.2	1.8	2.8	1.5	1.7	0.0	2.2	23.4	1.7	0.0	2.1	0.5	301.7	0.0	1.4	10.4	6.4	0.9	2.1	0.8	2.1	0.8
SLC24A2	NCKX2	ENSG00000155886	"Solute carrier family 24 member 2"	Q9UI40	9	19507452-19786928	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 31.8"	"Group enriched"	"Detected in some"	18	"Bipolar cells: 68.2;Cone photoreceptor cells: 257.2;Horizontal cells: 92.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"K-562: 5.7;NTERA-2: 2.0;SCLC-21H: 5.2;U-87 MG: 6.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.30e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.48e-2)"		"unprognostic (8.46e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.08e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.51e-2)"	0.2	6.1	4.0	0.2	11.2	0.3	0.1	2.4	31.8	0.2	0.2			0.2	0.5	0.2	0.2	0.2	0.3	0.2	8.9	4.0	0.3	0.2	0.1	0.2	8.2		0.2	0.2	0.2	0.0	0.3		0.2	0.2		0.2	0.2	0.2	0.3	0.2	0.2	10.7	0.2	0.2	0.4			0.2		0.1	0.2	0.0	1.2	1.0	2.6	1.3	1.7	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	5.7	0.2	0.1	0.3	0.0	0.1	2.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	5.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.2	0.0	0.0	6.8	0.0	0.1	2.6	0.8	0.9	0.7	0.8	1.0	0.9	0.8	0.6	0.5	1.2	1.1	1.0	2.0	1.7	1.3	1.0	0.8	0.4											0.0	0.0	0.0	0.0	0.0	68.2	1.7	0.0	0.0	0.0	0.0	257.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	92.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.4	0.0	7.7	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.0
SLC24A3		ENSG00000185052	"Solute carrier family 24 member 3"	Q9HC58	20	19212646-19722937	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	11	"Early spermatids: 18.2;granulocytes: 26.5;Late spermatids: 14.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	53	"basophil: 7.1;eosinophil: 3.3"	"Lineage enriched"	"Detected in single"	72	"granulocytes: 7.1"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043400, HPA045497"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus"	Cytosol	"HPA043400: AB_2678462, HPA045497: AB_2679349"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (7.36e-3)"	7.0	2.5	10.9	4.6	11.0	1.0	3.6	7.4	9.2	17.6	8.9	5.5	7.0	2.9	26.3	19.0	15.3	17.2	14.5	1.7	27.1	12.0	1.2	0.6	6.2	1.5	4.5	3.4	14.8	1.2	7.9	1.6	3.0	5.3	8.5	4.1	5.5	6.1	13.8	26.4	5.2	4.4	21.7	2.9	1.7	2.7	1.7	3.1	0.9	2.5	11.0	4.9	8.1	20.7	0.0	0.0	7.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	6.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	9.2	0.0	0.0	0.4	0.0	41.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	4.8	0.0	0.3	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	10.9	11.0	7.4	6.5	27.1	12.0	4.5	3.4	5.3	3.1	3.0	0.6	0.0	1.0	1.0	9.4	0.4	0.0	0.0	2.3	1.8	0.0	5.4	0.0	0.0	18.2	0.1	0.0	0.0	0.0	0.3	1.5	0.7	26.5	0.0	0.6	1.6	7.5	0.6	0.0	14.9	3.4	0.0	0.0	0.0	2.6	2.9	0.1	0.9	3.9	0.0	1.4	0.0	3.1	0.5	0.4	3.6	2.9	0.0	0.6	2.7
SLC24A4	NCKX4	ENSG00000140090	"Solute carrier family 24 member 4"	Q8NFF2	14	92322581-92501483	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 11.6;brain: 28.1"	"Group enriched"	"Detected in some"	8	"Bipolar cells: 223.9;Cone photoreceptor cells: 188.5"	"Group enriched"	"Detected in some"	5	"glioma: 0.5;melanoma: 0.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 7.9;intermediate monocyte: 11.6;non-classical monocyte: 9.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 11.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.7;SCLC-21H: 5.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA063206			Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA063206: "	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.58e-2)"	1.8	1.0	4.9	3.8	6.0	8.6	0.6	1.1	11.7	0.8	0.9	9.6	6.3	0.9	0.6	0.7	0.8	0.8	1.9	0.9	4.7	3.2	0.5	0.7	2.3	2.7	10.8	4.7	1.0	0.6	0.5	1.8	1.2	28.1	0.7	1.0	4.6	0.7	1.2	2.4	0.8	1.2	1.4	14.2	5.0	0.9	2.9	5.7	0.0	0.6	0.0	1.4	1.5	0.8	0.1	2.3	1.3	11.6	0.2	0.2	2.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.6	2.7	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.7	0.4	0.4	0.2	0.0	0.2	0.3	0.0	0.2	0.3	0.0	0.2	0.0	0.2	0.1	0.6	0.0	0.4	0.0	0.3	1.1	0.0	0.3	0.1	0.1	0.3	0.0	0.3	5.2	0.0	0.2	0.2	0.5	0.1	0.3	1.2	0.6	0.2	1.5	0.3	0.1	0.4	0.1	0.1	0.2	0.3	0.3	0.2	7.9	0.0	0.0	11.6	0.2	0.0	0.0	0.0	2.3	0.1	0.0	0.0	1.3	0.2	9.4	0.4	0.0	2.0	4.9	6.0	1.1	7.3	4.7	3.2	10.8	4.7	28.1	5.7	0.0	3.4	0.0	0.1	0.0	223.9	1.2	0.0	1.4	0.0	0.0	188.5	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	3.5	0.0	0.0	1.8	26.6	4.6	0.3	4.0	0.0	0.0	0.0	2.1	0.1	0.0	0.4	0.0	8.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1
SLC24A5	"JSX, OCA6"	ENSG00000188467	"Solute carrier family 24 member 5"	Q71RS6	15	48120972-48142672	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		Albinism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 71.9"	"Cell type enriched"	"Detected in some"	4	"Melanocytes: 72.6"	"Cancer enriched"	"Detected in single"	162	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	751	"SK-MEL-30: 75.0"	"Group enriched"	"Detected in some"	5	"hippocampal formation: 3.3;pons and medulla: 4.4;thalamus: 1.7"	"Low region specificity"	"Detected in all"									NA	NA										"unprognostic (3.47e-2)"				"unprognostic (1.80e-1)"	"unprognostic (1.35e-1)"			"unprognostic (1.92e-3)"					0.1	0.1	0.5	0.1	0.6	0.1	0.6	1.5	0.5	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.2	0.1	0.4	0.1	0.5	1.0	0.3	0.1	0.2	0.1	1.7	0.1	0.1	0.1	0.1	1.5	0.1	0.4	0.1	0.1	71.9	0.2	0.1	0.1	15.4	0.7	0.1	0.6	0.1	0.1	3.0	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.6	1.5	0.5	0.5	1.0	1.7	0.1	0.4	0.4	0.0	0.3	0.0	0.0	2.2	6.1	0.3	0.0	1.4	0.0	0.0	2.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	4.8	0.0	0.0	0.0	3.8	0.0	0.0	72.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0
SLC25A1	"CTP, SLC20A3"	ENSG00000100075	"Solute carrier family 25 member 1"	P53007	22	19175575-19178830	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Congenital myasthenic syndrome, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 221.7;Hepatocytes: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		19000				"unprognostic (2.12e-1)"	"unprognostic (3.98e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.03e-2)"	42.5	23.6	11.6	16.1	12.8	5.5	59.1	9.1	12.2	14.9	33.8	14.6	17.6	50.1	12.9	16.4	20.2	12.4	25.1	9.2	14.0	17.6	26.2	60.2	12.2	18.8	15.6	9.1	20.7	25.1	14.8	12.7	15.1	18.0	19.1	15.4	13.6	19.3	16.3	4.8	14.0	53.9	13.8	16.6	12.0	16.1	14.5	13.8	9.9	20.1	13.0	13.7	14.7	15.2	14.2	5.6	38.5	9.2	4.9	8.4	4.0	24.8	25.5	20.2	16.8	50.0	24.9	20.7	19.6	22.4	15.4	21.0	30.6	17.4	15.1	9.3	25.1	16.4	20.8	19.0	31.3	8.8	15.1	37.4	7.7	21.7	60.5	35.3	14.6	24.4	34.6	19.2	17.6	13.8	17.2	14.4	12.2	41.1	14.1	17.1	63.0	9.0	17.4	13.4	39.2	15.5	16.0	10.1	6.6	45.6	30.4	12.5	15.9	18.9	36.7	10.5	12.9	27.9	37.9	14.0	18.7	16.7	14.3	12.0	18.4	8.9	7.7	19.3	7.0	9.4	3.6	6.2	38.5	7.3	7.2	4.7	13.4	8.4	7.9	5.6	14.2	7.5	6.3	3.3	4.9	9.2	4.4	7.7	4.0	11.6	12.8	9.1	12.2	14.0	17.6	15.6	9.1	18.0	13.8	8.9	13.9	19.3	22.4	19.6	8.1	6.4	30.6	8.1	9.1	31.4	2.0	120.4	43.1	27.7	24.4	9.2	221.7	0.0	39.5	122.5	22.9	31.5	2.3	166.9	41.0	12.7	39.4	22.1	23.7	72.6	26.7	19.7	27.0	29.7	90.6	20.4	33.4	101.7	27.6	99.7	3.8	12.9	19.1	17.3	24.7	26.6	106.8	17.5	86.4	25.2
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 51.8"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 37.7;Late spermatids: 65.6;Proximal tubular cells: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 3.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 50.4;SK-BR-3: 38.8"									HPA023048	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.31e-4)"	10.2	4.9	2.7	5.9	3.2	5.2	6.3	3.3	5.2	4.2	9.5	3.9	7.5	13.9	1.3	3.8	12.2	5.4	8.2	4.3	2.1	2.5	21.0	51.8	3.3	4.6	3.7	4.6	2.4	17.4	10.7	2.1	2.1	3.5	5.6	4.4	4.7	16.8	6.6	2.0	5.9	11.2	1.8	4.7	1.6	7.4	21.8	2.5	7.8	3.3	7.7	8.7	4.3	3.4	0.9	0.7	0.0	1.2	3.6	1.9	0.7	14.2	26.4	2.5	12.6	0.9	0.7	5.0	6.0	2.0	7.8	5.9	16.0	6.1	6.4	4.7	1.4	3.8	9.2	3.6	6.3	1.4	4.7	20.4	5.2	16.1	50.4	1.1	11.7	6.4	0.5	3.3	5.5	1.1	1.5	4.5	9.1	8.7	8.1	2.6	26.8	17.1	12.4	2.6	6.0	19.9	13.0	5.4	20.2	6.9	12.9	16.7	11.3	5.7	38.8	1.3	0.7	16.6	6.5	1.9	6.0	19.8	8.7	11.0	5.0	2.5	3.7	2.6	12.4	5.2	0.0	0.9	0.0	0.8	1.2	1.5	0.1	0.5	1.9	0.7	0.9	0.5	0.4	0.0	3.6	0.2	0.4	1.0	0.7	2.7	3.2	3.3	5.2	2.1	2.5	3.7	4.6	3.5	2.5	0.0	2.1	0.0	5.5	0.0	2.9	3.3	17.8	13.4	5.7	14.0	0.0	11.3	21.6	15.4	23.8	0.5	9.3	0.0	20.3	4.7	0.9	3.9	0.0	37.7	6.8	0.0	4.7	3.1	0.3	65.6	2.0	0.3	0.0	1.0	15.4	1.5	9.6	24.6	1.8	75.1	3.8	0.0	0.2	8.4	2.3	0.0	3.5	1.5	28.8	4.3
SLC25A11	"OGC, SLC20A4"	ENSG00000108528	"Solute carrier family 25 member 11"	Q02978	17	4937130-4940251	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 100.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021167	Approved					NA	NA		17000			"HPA021167: AB_1857021"	"unprognostic (8.58e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-1)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.41e-6)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.84e-9)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	11.8	17.5	17.8	11.9	20.8	10.3	11.7	18.2	34.3	11.1	15.7	16.3	10.3	17.3	12.4	10.1	18.9	16.1	14.3	82.1	19.8	17.7	24.2	22.6	10.6	13.3	19.5	16.3	12.1	15.3	16.0	12.3	13.3	18.7	12.0	13.7	22.2	16.8	15.6	100.8	16.9	14.6	13.0	13.8	12.8	12.3	5.2	9.6	17.4	14.6	42.4	14.0	15.1	10.5	26.9	50.1	39.3	53.9	42.7	32.4	51.4	16.5	44.9	22.9	22.4	22.6	14.0	16.2	18.8	19.3	33.0	27.4	28.1	8.3	25.8	25.6	18.3	16.1	33.2	29.7	34.0	13.1	32.5	37.7	28.3	24.9	24.3	23.1	12.1	34.5	20.1	22.2	29.1	24.7	16.0	22.8	27.9	12.4	25.1	27.8	29.9	39.0	12.0	12.0	18.4	30.1	35.5	14.1	23.3	25.4	17.4	20.5	21.3	23.7	26.8	21.5	12.0	24.8	19.3	15.3	14.8	9.7	20.0	35.9	13.4	8.1	9.7	29.2	20.6	36.4	32.7	53.9	39.3	32.4	53.0	30.0	26.9	25.1	28.9	50.1	23.0	25.3	27.5	35.1	42.7	47.8	33.3	29.1	51.4	17.8	20.8	18.2	34.3	19.8	17.7	19.5	16.3	18.7	9.6	23.8	21.8	25.3	43.8	33.9	56.9	133.9	56.0	21.4	10.3	62.8	15.7	118.0	157.5	53.9	10.7	38.3	80.6	23.3	47.0	120.4	39.9	34.3	39.2	56.3	97.1	44.5	26.5	28.3	40.3	16.2	28.1	40.6	49.0	141.5	43.6	45.0	38.7	50.7	36.0	151.2	45.3	51.8	41.5	14.1	30.9	38.8	85.7	41.5	73.0	33.1
SLC25A12	Aralar	ENSG00000115840	"Solute carrier family 25 member 12"	O75746	2	171784370-171999859	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.7"	"Cell type enhanced"	"Detected in many"	8	"Cardiomyocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035333, HPA035334"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA			"Nuclear speckles"	Cytosol	"HPA035333: AB_10603028, HPA035334: AB_2674577"	"unprognostic (3.24e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (2.65e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.21e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.91e-8)"	"unprognostic (8.64e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	6.4	6.7	8.8	6.2	18.2	2.9	9.2	17.9	25.0	10.6	12.2	5.7	5.2	4.2	10.4	7.1	11.5	6.9	5.9	42.4	9.9	13.4	10.7	1.9	5.2	6.5	10.4	12.4	10.0	3.5	16.4	14.7	4.7	15.2	10.6	10.0	11.0	21.7	14.8	84.7	7.6	5.7	14.3	7.1	5.6	9.0	4.3	6.2	5.8	10.1	23.8	8.4	10.0	6.7	6.4	3.6	5.1	4.6	6.6	8.1	2.9	7.2	5.3	5.6	13.0	16.7	18.9	0.1	9.2	15.7	12.6	12.1	2.8	6.8	22.9	6.1	10.8	9.8	9.1	11.8	11.6	15.8	14.0	11.1	10.0	7.7	6.7	6.4	20.0	10.0	16.5	11.5	14.6	4.2	6.8	13.0	9.1	6.9	10.5	8.0	4.4	14.1	8.4	4.5	6.1	7.5	14.7	8.1	11.9	13.2	6.3	7.9	2.5	5.8	13.7	7.3	3.8	5.0	5.9	8.9	10.5	4.6	11.6	6.3	14.2	9.1	23.2	14.5	10.6	7.1	5.1	3.0	1.6	6.5	3.9	7.3	6.4	4.5	6.8	3.6	3.9	6.3	8.1	0.2	6.6	4.6	0.6	4.5	2.9	8.8	18.2	17.9	25.0	9.9	13.4	10.4	12.4	15.2	6.2	0.0	6.0	1.5	11.2	6.2	25.4	94.4	0.0	13.4	22.7	17.4	23.6	6.0	16.6	1.5	2.5	7.0	5.6	23.3	2.9	1.2	7.0	4.3	10.4	0.2	4.0	35.0	13.8	8.6	7.3	1.7	11.5	5.4	15.1	6.4	7.0	18.3	1.3	3.5	23.0	10.9	22.1	12.9	11.8	3.2	9.0	6.8	1.0	8.7	7.4	4.6
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 79.1"	"Cell type enhanced"	"Detected in many"	6	"Hepatocytes: 124.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018997	Enhanced		Supported	Mitochondria		NA	NA			Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	7.7	10.3	4.2	4.9	11.8	4.1	6.7	3.0	7.5	5.4	12.5	21.1	15.6	8.9	5.1	8.0	6.9	5.9	6.7	4.5	5.6	5.3	17.7	79.1	5.5	4.9	14.5	4.8	5.9	7.3	8.2	8.8	8.9	12.4	5.9	10.2	12.6	5.7	17.3	4.6	8.2	9.7	5.0	13.1	7.2	7.9	4.3	12.6	1.8	7.9	3.0	4.8	5.0	5.3	3.7	8.9	3.1	6.7	2.8	2.4	2.1	16.1	14.3	16.5	5.7	2.8	2.3	23.2	4.1	3.1	10.0	10.1	25.6	15.2	7.3	19.6	2.6	21.8	9.7	18.5	5.9	11.8	2.8	12.2	8.3	13.5	19.9	6.7	10.5	6.5	6.1	6.3	8.5	7.7	3.8	11.4	1.1	23.3	2.8	4.8	17.8	0.0	9.8	29.1	17.3	8.9	4.1	9.8	16.8	23.8	15.3	7.9	26.0	14.2	30.2	24.3	28.7	9.0	8.1	6.6	7.4	16.6	17.5	12.4	5.7	14.3	4.6	9.1	10.1	12.2	0.6	4.6	3.1	2.2	6.3	2.4	3.7	1.8	2.0	8.9	2.0	1.2	1.5	0.8	2.8	6.7	4.7	1.8	2.1	4.2	11.8	3.0	7.5	5.6	5.3	14.5	4.8	12.4	12.6	8.9	9.3	10.5	6.9	6.5	34.3	7.1	38.2	14.7	6.8	17.4	51.1	25.9	23.2	17.3	9.5	16.9	23.5	0.0	16.5	20.5	14.8	9.8	13.9	124.1	20.1	9.5	36.2	12.3	22.7	6.7	12.0	19.6	20.3	2.8	19.4	22.1	18.9	24.6	14.9	50.8	47.6	12.9	8.3	5.4	9.1	6.9	16.7	5.7	23.3	12.2
SLC25A14	"BMCP1, UCP5"	ENSG00000102078	"Solute carrier family 25 member 14"	O95258	X	130339888-130373361	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Spermatogonia: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060316			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			Mitochondria		"HPA060316: AB_2684251"	"unprognostic (1.65e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.36e-3)"	"unprognostic (8.92e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.95e-3)"	"prognostic favorable (1.78e-4)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (5.52e-6)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (1.39e-5)"	3.1	9.3	9.2	3.4	18.3	3.7	5.5	13.6	20.6	4.8	3.8	6.1	4.2	2.2	6.7	11.0	4.3	9.7	4.6	7.7	8.7	15.8	5.2	4.1	4.6	4.1	7.3	11.4	6.8	4.5	5.6	15.0	3.6	11.2	5.1	4.1	5.7	5.1	6.7	3.4	4.7	3.6	7.7	5.3	3.5	4.8	10.2	4.2	4.2	5.7	4.6	5.3	3.1	3.8	7.5	9.3	8.7	7.2	8.1	9.5	4.9	6.9	9.1	6.5	4.8	4.4	4.2	3.5	5.2	7.0	10.2	10.2	3.6	4.2	4.7	18.2	7.0	12.5	3.9	9.4	3.9	10.1	6.0	11.9	1.5	8.4	8.5	6.2	5.9	2.8	3.9	4.7	12.8	3.9	6.0	5.6	6.6	4.1	6.7	16.1	10.6	6.2	8.3	5.5	7.5	15.0	5.3	8.5	9.4	5.9	3.0	8.2	7.3	5.5	5.6	8.8	4.5	3.6	3.3	3.7	5.5	3.6	12.5	10.5	6.3	16.1	4.1	10.0	7.3	4.9	5.8	7.2	5.2	6.4	5.8	7.8	7.5	5.4	6.1	7.5	4.6	4.2	7.0	8.7	8.1	5.2	9.3	9.5	4.9	9.2	18.3	13.6	15.6	8.7	15.8	7.3	11.4	11.2	4.2	6.0	2.1	8.3	6.8	8.9	8.8	3.2	7.6	26.8	1.2	3.5	2.0	8.0	14.9	9.4	9.0	4.4	3.8	0.0	7.9	7.3	6.0	4.1	3.5	3.8	4.6	6.4	8.6	4.9	3.3	5.1	4.6	5.1	8.5	2.8	4.0	8.5	7.5	4.5	7.8	8.3	12.7	6.5	6.2	21.6	39.2	7.3	4.5	7.0	5.2	4.7
SLC25A15	"D13S327, HHH, ORC1, ORNT1"	ENSG00000102743	"Solute carrier family 25 member 15"	Q9Y619	13	40789412-40810111	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 26.0;liver: 66.4;pancreas: 24.9"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 37.5;Hepatocytes: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042146	Approved					NA	NA					"HPA042146: AB_2677874"	"unprognostic (4.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (1.74e-4)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (5.46e-4)"	1.0	1.1	1.4	4.7	1.7	1.6	2.6	1.0	2.0	1.3	13.2	1.0	0.2	16.3	1.6	1.5	1.8	1.2	3.1	1.9	1.3	1.6	4.0	66.4	1.6	2.0	1.6	0.9	1.8	24.9	0.8	1.0	1.8	1.5	1.0	2.6	0.9	1.4	1.6	2.5	1.3	26.0	1.5	1.4	1.5	2.0	3.8	1.0	2.7	8.0	2.9	3.8	1.2	1.1	1.7	3.4	0.0	3.1	2.4	5.0	1.6	5.0	9.9	9.9	13.5	3.6	4.8	12.5	3.8	1.9	4.2	2.7	10.5	9.7	32.1	4.3	6.2	8.3	8.3	15.4	10.3	3.7	7.6	7.7	24.2	4.9	13.6	6.9	8.6	3.1	5.2	4.5	5.3	13.0	2.6	6.5	14.7	12.4	5.1	6.5	16.4	6.4	3.8	21.2	18.8	5.1	15.9	8.1	6.9	5.1	4.6	5.5	13.6	6.9	10.9	5.9	6.9	9.1	12.8	6.2	5.3	8.5	8.1	10.7	5.8	5.5	18.8	5.6	7.0	10.6	0.0	1.3	0.0	4.3	3.1	2.7	1.6	2.9	2.8	3.4	1.7	3.0	5.0	0.0	2.4	1.0	0.7	1.8	1.6	1.4	1.7	1.0	2.0	1.3	1.6	1.6	0.9	1.5	1.0	3.0	0.3	0.0	1.0	0.2	1.1	1.2	2.5	0.0	0.0	0.0	0.0	2.0	6.6	1.7	3.6	0.4	1.3	0.0	3.8	37.5	0.5	1.5	0.0	30.8	1.6	0.0	1.2	0.6	1.9	5.4	0.6	0.6	1.7	0.0	0.2	0.3	2.2	0.6	0.0	3.1	1.8	0.0	0.8	4.1	7.7	0.1	1.3	0.0	3.0	0.8
SLC25A16	"D10S105E, GDA, HGT.1, ML7"	ENSG00000122912	"Solute carrier family 25 member 16"	P16260	10	68477999-68527474	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 50.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036243, HPA044580"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA036243: AB_2675019, HPA044580: AB_10962723"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.44e-3)"	18.7	8.0	6.4	5.5	8.9	7.0	15.5	9.6	13.5	5.1	6.9	8.1	4.8	8.1	7.7	7.8	5.9	5.4	8.8	5.9	8.4	7.3	12.0	22.6	10.2	9.2	7.8	8.6	6.3	21.1	6.9	7.3	7.1	9.2	17.3	6.4	8.5	15.0	6.6	9.4	6.5	11.0	8.4	6.3	6.4	9.4	3.5	6.6	6.4	7.8	4.8	7.7	6.4	5.4	3.2	2.9	5.0	2.7	2.4	2.5	1.2	3.0	1.2	3.5	4.8	4.7	5.7	3.8	4.1	4.5	2.7	2.9	7.1	2.0	3.2	3.0	8.1	1.4	1.8	11.0	2.1	6.8	2.4	6.8	1.7	3.2	3.1	5.8	5.4	3.8	4.9	5.4	5.0	7.1	4.0	2.2	2.9	1.9	5.4	5.6	2.8	3.1	3.9	0.8	0.8	15.9	1.7	2.5	1.0	7.3	9.8	2.5	2.0	5.9	5.8	4.6	2.5	3.2	2.2	9.5	4.1	5.3	6.6	4.7	5.5	2.9	5.2	3.9	4.5	1.8	4.0	2.7	2.7	1.7	1.9	1.6	1.7	1.6	1.4	1.8	3.2	1.6	2.5	5.0	2.4	1.5	2.9	1.7	1.2	6.4	8.9	9.6	13.5	8.4	7.3	7.8	8.6	9.2	6.6	41.7	20.2	6.9	5.6	5.7	16.9	8.0	15.3	13.4	7.9	12.2	37.3	14.4	10.0	6.6	7.7	5.8	13.8	0.0	16.7	23.1	7.2	16.0	8.1	35.0	9.4	19.1	14.5	14.7	7.2	9.2	2.8	5.8	1.7	3.6	7.8	8.5	12.2	7.0	7.4	19.2	31.5	0.0	8.9	4.1	2.5	5.9	50.0	4.3	7.4	8.6
SLC25A17	PMP34	ENSG00000100372	"Solute carrier family 25 member 17"	O43808	22	40769630-40819399	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052708, HPA060972"	Approved		Supported	Peroxisomes		NA	NA			Peroxisomes		"HPA052708: AB_2681924, HPA060972: AB_2684400"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	9.7	15.0	10.2	10.2	10.9	3.3	16.8	12.9	14.1	11.8	7.2	12.2	7.5	6.4	22.4	22.6	8.7	13.7	7.4	5.5	10.4	13.4	18.6	19.7	9.0	11.8	10.3	7.7	26.5	12.4	14.3	13.0	14.9	11.9	12.6	8.7	9.5	11.4	10.3	4.6	10.9	7.1	12.1	11.4	8.8	8.9	12.1	9.5	12.6	14.7	10.4	11.2	7.1	8.7	10.2	6.8	5.9	4.9	10.3	11.7	6.4	13.4	7.4	12.6	11.0	8.0	9.7	10.3	12.2	13.4	19.5	21.5	10.8	5.1	15.9	7.5	12.0	11.1	10.8	18.3	10.1	20.0	16.3	24.5	17.8	11.5	11.1	11.3	20.5	9.5	9.6	13.5	17.2	11.1	9.0	11.8	13.3	25.7	7.6	15.8	11.5	12.3	13.2	10.6	19.1	12.3	13.5	19.6	23.2	16.1	11.4	8.7	7.9	25.2	15.5	15.0	12.8	12.9	6.1	6.9	11.0	15.1	9.7	11.0	8.4	16.3	15.1	12.0	10.4	11.9	5.9	4.4	5.1	7.0	4.9	9.2	10.2	8.1	7.5	5.7	9.5	11.7	9.3	1.8	10.3	3.9	6.8	10.8	6.4	10.2	10.9	12.9	14.1	10.4	13.4	10.3	7.7	11.9	9.5	17.9	7.4	10.7	13.0	14.7	11.7	3.1	7.6	12.0	17.0	12.2	7.9	34.1	18.3	16.2	6.5	9.3	6.3	0.0	15.3	27.0	16.0	15.6	4.7	21.2	11.5	11.1	5.8	5.5	7.3	8.5	25.0	7.6	15.1	25.2	3.3	10.6	14.6	5.8	25.1	15.9	7.0	32.3	10.8	37.1	36.6	15.1	23.9	10.0	7.7	13.3
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563439-17590994	"Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 13.1;brain: 49.0;liver: 50.0"	"Cell type enhanced"	"Detected in many"	18	"Alveolar cells type 1: 26.8;Alveolar cells type 2: 15.9;Ciliated cells: 28.1;Hepatocytes: 67.6"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"eosinophil: 2.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.7;BEWO: 12.9"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	13.1	2.2	33.2	1.5	28.0	1.2	2.7	7.5	49.0	1.4	1.4	13.3	0.0	1.5	1.7	1.4	1.5	1.7	2.1	2.3	33.3	15.7	1.8	50.0	1.5	1.5	25.6	19.1	1.9	1.8	1.7	0.0	1.3	17.8	4.8	1.3	0.0	1.6	1.6	2.5	1.4	1.4	1.8	14.9	1.9	1.5	3.4	21.6	0.0	1.5	0.0	1.3	1.4	0.0	0.4	0.4	2.1	0.6	0.0	0.5	0.1	0.5	0.9	3.4	0.6	5.7	0.0	12.9	0.4	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.0	3.7	1.1	0.1	0.0	0.0	0.4	1.4	0.5	0.4	0.8	2.3	0.5	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.3	0.6	0.4	0.0	0.6	0.1	0.8	2.9	1.3	2.1	4.2	1.2	0.0	0.1	0.6	1.2	0.5	0.4	0.6	1.0	2.6	3.7	1.4	0.2	0.2	0.5	0.3	0.4	1.4	1.7	0.0	2.7	0.3	0.5	0.0	0.4	2.1	0.4	0.6	0.0	0.4	0.5	0.1	0.3	0.2	0.1	0.3	0.5	0.0	0.2	0.4	0.1	0.1	33.2	28.0	7.5	25.7	33.3	15.7	25.6	19.1	17.8	21.6	26.8	15.9	0.0	0.2	0.0	0.5	1.4	0.0	28.1	12.5	0.0	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.5	4.6	5.8	67.6	0.2	0.0	0.0	2.5	4.6	0.6	0.9	0.7	0.0	0.0	0.0	1.4	0.0	0.0	2.5	0.6	3.2	0.0	0.0	2.7	4.8	0.1	1.5	0.0	0.0	0.1
SLC25A19	"DNC, MCPHA, MUP1, TPC"	ENSG00000125454	"Solute carrier family 25 member 19"	Q9HC21	17	75272981-75289510	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 35.5"	"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 59.5;monocytes: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.28e-1)"	"unprognostic (7.05e-3)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.13e-1)"	8.1	18.5	9.9	14.0	15.7	6.7	5.7	9.0	10.9	6.5	7.9	4.3	2.6	8.5	5.8	3.1	6.8	6.0	5.8	7.9	7.1	6.0	9.1	9.2	10.7	19.3	9.6	5.7	5.4	10.6	4.5	4.1	10.8	9.2	5.1	8.5	3.2	5.4	3.8	10.6	4.5	6.8	6.6	12.3	12.2	8.0	35.5	8.7	9.3	7.7	3.9	16.8	7.8	5.8	19.4	18.2	1.2	14.7	5.3	10.4	8.3	9.4	11.7	2.1	6.3	4.8	2.5	6.9	6.2	2.4	7.1	7.3	20.2	6.0	30.3	4.5	2.2	6.2	8.4	15.0	7.1	8.9	8.8	24.1	13.8	14.0	19.3	4.1	19.6	15.7	2.1	4.0	11.1	9.0	1.6	11.7	15.4	16.8	14.5	2.2	19.7	20.2	19.7	4.6	18.6	23.1	15.8	6.9	28.7	4.9	6.6	21.3	5.3	6.6	17.7	7.6	3.7	11.1	15.9	4.1	4.3	8.5	8.2	16.5	36.0	17.3	31.8	3.3	22.6	5.3	0.2	12.7	1.2	10.4	14.7	10.4	19.4	8.1	9.6	14.8	16.3	9.3	9.6	1.1	5.3	8.4	18.2	9.8	8.3	9.9	15.7	9.0	10.9	7.1	6.0	9.6	5.7	9.2	8.7	6.0	7.9	29.8	9.4	13.5	1.3	0.6	2.5	2.7	7.9	7.0	2.0	5.7	19.9	5.9	12.0	7.1	5.1	0.0	4.6	59.5	8.6	6.2	11.5	2.8	41.1	3.2	2.9	3.1	11.0	18.8	2.8	30.8	23.6	62.3	4.8	1.5	4.6	5.5	3.2	4.7	5.8	6.5	7.2	33.0	10.5	11.3	7.4	13.1	9.7	6.4
SLC25A2	ORNT2	ENSG00000120329	"Solute carrier family 25 member 2"	Q9BXI2	5	141302629-141304045	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	27	"testis: 12.6"	"Group enriched"	"Detected in some"	9	"Early spermatids: 8.6;Late spermatids: 8.3;Spermatocytes: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Daudi: 1.4"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA042146	Uncertain					NA	NA					"HPA042146: AB_2677874"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.81e-1)"		"unprognostic (2.62e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.82e-10)"	"unprognostic (2.56e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.14e-1)"	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	12.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	1.4	0.0	0.5	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	2.2	0.7	0.0	0.0	0.0	0.0	0.0
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856931-48898993	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.8;liver: 58.3"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 38.0;Hepatocytes: 55.2;monocytes: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 35.4;RPMI-8226: 48.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Approved	Mitochondria,Cytosol		NA	NA		13000	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	11.9	13.7	6.7	5.6	7.3	3.4	10.2	3.0	5.6	3.3	19.7	4.7	5.2	25.0	4.7	3.1	3.3	5.0	9.9	37.1	7.3	4.6	16.8	58.3	6.6	4.9	8.5	5.1	2.7	16.8	5.9	5.1	3.3	5.8	5.0	9.1	5.4	7.4	3.7	27.4	4.0	32.2	5.7	5.5	8.8	7.5	4.4	6.6	9.1	5.5	5.5	5.9	4.5	9.8	9.4	33.3	57.8	29.0	17.3	28.4	24.7	1.4	4.5	3.6	5.0	11.5	4.4	0.7	8.0	4.3	5.6	5.8	5.6	6.9	6.6	5.7	12.6	6.8	1.4	8.8	3.5	4.2	16.8	4.2	9.2	7.0	7.1	5.2	9.6	17.8	5.6	4.0	7.5	1.2	2.2	7.2	10.1	8.2	35.4	7.3	3.7	10.5	4.8	1.8	8.1	10.2	3.8	2.1	48.7	6.0	3.5	1.4	5.1	7.4	0.0	4.0	5.2	11.3	4.5	5.8	6.4	1.1	9.3	5.8	13.1	9.1	7.7	9.1	6.8	8.4	13.8	29.0	57.8	28.4	21.0	18.1	9.4	16.1	20.8	27.0	7.8	12.7	21.3	13.5	17.3	21.4	33.3	16.1	24.7	6.7	7.3	3.0	5.6	7.3	4.6	8.5	5.1	5.8	6.6	6.0	2.4	7.5	2.3	1.5	1.1	31.1	7.6	5.3	2.3	0.0	5.9	1.7	3.3	3.2	1.1	3.1	38.0	0.0	3.7	1.9	4.1	2.4	1.1	55.2	15.8	0.0	7.0	9.2	13.2	1.0	9.8	7.5	1.7	40.5	10.8	2.8	4.0	13.5	11.7	12.5	1.1	0.0	2.2	7.1	7.0	1.1	1.0	13.8	12.8	2.0
SLC25A21	"ODC, ODC1"	ENSG00000183032	"Solute carrier family 25 member 21"	Q9BQT8	14	36678431-37172866	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 25.6"	"Cell type enriched"	"Detected in many"	11	"Erythroid cells: 93.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"K-562: 15.5;Karpas-707: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000662	Uncertain					NA	NA					"HPA000662: AB_1080000"	"unprognostic (6.81e-3)"	"unprognostic (6.98e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.07e-1)"	1.3	2.1	1.1	1.0	2.0	8.8	1.4	0.4	2.5	3.0	1.9	0.7	0.1	1.1	4.0	1.4	2.9	1.8	1.2	2.2	1.1	1.4	2.8	1.1	1.9	0.1	1.4	0.7	4.6	5.2	0.9	1.8	0.4	1.7	3.1	0.4	3.6	2.9	0.9	9.6	0.9	2.4	3.0	1.2	0.9	2.6	25.6	1.0	0.2	3.3	2.2	1.3	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.8	0.7	0.2	2.0	0.0	0.6	0.0	0.3	0.5	1.0	0.4	0.1	0.7	0.0	0.9	0.2	0.0	0.7	0.0	0.4	0.4	0.5	5.9	0.6	0.6	0.6	0.6	0.0	0.0	0.5	0.8	0.0	0.3	0.6	2.4	0.0	15.5	34.0	0.5	1.8	0.0	0.0	1.3	0.0	2.5	0.0	0.0	0.0	0.5	2.4	1.5	0.0	1.6	0.1	0.8	0.3	2.2	0.0	1.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	1.1	2.0	0.4	2.5	1.1	1.4	1.4	0.7	1.7	1.0	0.0	0.0	0.0	1.7	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.7	1.0	0.4	0.0	93.5	8.3	0.0	0.8	2.3	0.0	0.0	0.2	1.6	1.7	1.3	0.0	0.0	1.4	0.0	0.0	0.0	0.2	3.4	5.4	0.0	0.7	3.1	1.5	0.0	1.0	3.0	2.1	0.6	0.0	0.0	0.8	0.6
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798333	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.0;pancreas: 43.0"	"Cell type enhanced"	"Detected in many"	13	"Bipolar cells: 147.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 44.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	4.9	5.2	23.3	8.3	19.0	5.7	2.7	32.2	45.0	3.5	4.1	3.4	2.5	10.3	3.2	2.3	4.4	5.0	3.8	3.2	27.8	13.2	4.1	14.2	4.6	7.5	9.6	22.8	4.8	43.0	4.0	13.4	4.4	13.5	5.2	2.9	4.6	11.4	4.2	1.1	5.8	8.5	3.3	2.8	5.3	6.8	6.6	2.6	3.5	3.1	3.0	5.1	4.5	2.4	2.5	3.1	4.0	5.7	3.6	7.2	2.3	23.4	15.2	8.9	8.0	3.8	6.8	8.4	11.2	9.4	12.5	7.9	15.0	16.1	7.0	8.4	9.3	14.2	20.8	9.8	13.5	2.8	13.2	18.1	6.4	7.5	9.2	16.2	10.4	10.9	6.8	8.2	9.5	10.2	3.9	5.7	8.3	13.1	11.1	5.5	14.2	10.8	9.8	19.3	14.5	23.4	12.8	4.9	16.6	7.4	3.9	44.3	19.9	6.4	15.5	8.0	1.4	7.5	5.3	5.6	14.0	9.4	6.4	10.5	9.7	5.7	9.0	16.8	9.3	8.3	0.0	2.4	4.0	6.6	5.6	4.2	2.5	4.1	7.2	3.1	2.1	2.5	4.2	1.5	3.6	5.7	0.9	2.2	2.3	23.3	19.0	32.2	37.4	27.8	13.2	9.6	22.8	13.5	2.6	6.0	10.4	2.2	6.3	11.2	147.0	1.8	5.1	2.7	4.5	8.7	31.4	5.9	3.3	22.2	11.5	4.9	7.0	0.0	17.0	8.9	7.4	13.6	2.3	15.3	4.0	41.3	12.5	1.8	1.8	5.6	4.4	2.6	3.3	6.4	7.3	13.4	14.1	7.0	4.6	5.6	29.9	0.0	6.1	1.4	6.3	11.7	2.6	5.2	5.0	8.1
SLC25A23	"APC2, FLJ30339, MGC2615"	ENSG00000125648	"Solute carrier family 25 member 23"	Q9BV35	19	6436079-6465203	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 97.6"	"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009675, HPA050883"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA009675: AB_2668252, HPA050883: AB_2681260"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.10e-12)"	"unprognostic (8.95e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.22e-1)"	12.1	13.0	68.2	5.2	97.6	0.4	6.3	21.5	51.7	12.5	22.3	17.6	10.3	18.2	13.0	11.9	31.2	16.1	10.1	36.2	66.2	25.1	17.9	13.0	11.3	4.0	25.6	33.1	15.8	10.0	24.5	5.5	2.2	28.0	14.3	23.5	12.2	32.1	20.3	37.0	11.9	18.6	30.7	16.9	4.3	9.9	3.7	25.9	1.2	29.2	9.7	14.1	16.8	9.3	2.5	0.9	0.8	0.0	0.7	4.5	0.9	20.0	8.1	11.8	37.1	15.9	7.0	5.4	5.8	9.6	11.4	13.8	20.4	13.4	11.2	14.3	14.7	12.5	17.1	24.0	14.0	9.1	0.0	20.2	8.1	17.2	16.2	14.8	0.5	19.2	20.0	12.3	10.1	4.4	23.3	11.9	12.5	23.3	14.3	2.2	14.6	7.0	11.5	8.5	21.6	25.0	3.4	3.2	17.2	30.5	3.6	0.8	11.6	4.2	25.8	10.7	13.4	13.5	17.8	4.1	3.6	15.4	0.9	3.8	2.6	3.5	9.9	1.6	19.1	5.6	0.8	0.0	0.0	4.5	0.0	1.1	2.5	2.7	2.3	0.4	1.0	4.0	3.4	0.0	0.7	0.0	0.9	2.6	0.9	68.2	97.6	21.5	51.7	66.2	25.1	25.6	33.1	28.0	25.9	8.9	18.1	7.0	8.3	9.3	9.8	34.8	48.4	1.4	4.5	43.6	7.9	1.2	16.6	52.9	16.5	5.5	100.4	0.0	24.8	1.5	5.8	13.9	6.9	27.0	2.1	7.9	13.3	12.9	2.1	45.5	17.5	2.2	16.9	1.8	35.6	14.6	40.3	35.4	27.6	22.6	16.4	12.9	6.2	0.3	3.2	20.5	0.7	4.3	23.9	24.3
SLC25A24	"APC1, DKFZp586G0123"	ENSG00000085491	"Solute carrier family 25 member 24"	Q6NUK1	1	108134036-108200849	"Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA028519, HPA063636"	Enhanced		Enhanced	Mitochondria		NA	NA		8900	Mitochondria		"HPA028519: AB_10603890, HPA063636: AB_2685068"	"unprognostic (1.94e-2)"	"unprognostic (7.30e-3)"	"prognostic favorable (1.01e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.54e-4)"	"unprognostic (1.51e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	19.8	10.8	3.0	13.1	3.3	3.8	25.2	2.3	4.5	15.9	26.6	3.9	9.6	13.6	12.4	11.8	11.4	9.0	16.1	12.4	2.8	3.3	15.3	2.9	17.8	10.8	3.0	2.7	13.5	7.2	13.2	7.7	10.4	5.3	12.4	18.2	9.8	11.2	9.7	7.4	6.9	42.4	9.7	4.0	17.0	9.0	5.1	1.5	10.3	13.7	10.8	9.4	10.8	18.2	2.9	4.8	4.4	7.1	1.7	4.3	2.1	24.2	5.4	16.6	5.1	11.4	15.1	8.3	8.5	10.0	15.1	16.7	6.6	8.1	0.0	7.8	15.6	6.7	9.5	4.9	13.7	20.5	6.0	2.5	1.5	8.1	3.2	9.5	3.9	3.2	11.2	9.7	8.8	11.3	9.8	11.5	3.5	4.1	8.2	19.1	15.9	2.2	0.8	9.8	10.0	6.2	4.1	21.7	7.2	10.2	12.5	3.2	5.5	12.0	8.6	11.2	16.4	8.3	6.9	7.8	8.6	4.4	15.3	9.1	2.3	1.3	0.0	2.9	7.1	5.1	2.8	4.9	4.4	2.3	5.7	2.9	2.9	2.7	2.3	4.8	2.3	1.3	2.3	0.6	1.7	7.1	1.4	4.3	2.1	3.0	3.3	2.3	4.5	2.8	3.3	3.0	2.7	5.3	1.5	50.6	26.7	15.9	17.7	13.9	14.1	12.9	20.4	57.6	36.4	17.4	7.9	5.8	18.3	29.1	2.2	20.4	70.3	0.0	32.1	55.2	18.8	10.7	21.9	0.4	48.5	9.5	17.4	36.8	51.2	2.1	18.1	43.2	21.9	26.2	43.1	8.9	48.3	51.2	17.0	19.3	31.4	51.8	17.9	4.3	1.3	13.0	5.1	13.1	47.4	29.8
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria		NA	NA			Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favorable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	11.8	12.9	20.2	8.5	14.8	13.3	16.5	7.9	27.2	10.3	12.6	15.8	9.2	9.7	11.1	12.9	14.3	13.1	10.1	19.5	16.9	12.8	15.7	22.7	10.0	15.2	17.6	11.8	20.0	21.2	16.2	11.6	11.9	14.6	10.8	13.4	12.6	16.1	12.6	29.8	16.5	11.0	16.8	14.3	11.4	12.7	18.3	12.6	12.0	19.0	14.2	12.9	13.4	10.8	12.0	12.2	3.6	7.1	10.5	14.4	9.1	6.3	6.2	3.8	7.7	8.5	8.8	8.0	5.3	10.2	7.2	6.8	8.1	8.5	6.5	3.2	9.7	8.8	4.7	4.4	9.9	7.4	6.8	10.3	9.9	4.9	11.7	10.2	13.8	8.4	12.0	19.7	5.7	13.8	6.9	5.3	13.2	4.4	8.7	8.6	7.9	5.8	15.9	11.1	14.4	3.6	6.0	6.9	11.0	5.9	4.7	2.9	8.9	7.7	6.7	12.6	7.0	5.6	10.9	6.0	7.6	7.2	9.5	9.3	12.9	16.8	8.4	10.5	13.2	8.2	1.3	6.8	3.6	10.9	7.1	9.9	12.0	12.1	11.1	12.2	10.2	14.4	12.3	0.4	10.5	4.1	11.6	11.1	9.1	20.2	14.8	7.9	27.2	16.9	12.8	17.6	11.8	14.6	12.6	29.8	20.3	23.3	31.4	31.8	17.7	96.8	20.4	13.4	12.5	17.4	11.8	29.9	29.9	25.2	20.6	19.7	19.1	0.0	38.7	36.6	33.9	31.6	18.5	34.2	26.5	11.1	17.9	9.2	19.0	19.2	15.0	17.8	35.4	20.8	25.5	22.4	26.4	14.0	20.5	46.3	21.5	19.4	29.5	21.4	30.2	32.1	27.3	46.5	33.0	33.6
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678193	"Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 20.5;Cone photoreceptor cells: 27.5;Early spermatids: 23.2;Horizontal cells: 19.1;Rod photoreceptor cells: 38.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 26.3;hTCEpi: 14.8;U-698: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria		NA	NA			Mitochondria		"HPA069732: AB_2686185"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	13.3	15.0	18.5	6.6	28.8	1.5	18.7	63.8	30.2	11.8	13.2	20.2	11.3	5.0	28.4	50.9	7.6	13.9	14.2	11.9	17.6	10.5	12.6	12.2	10.1	4.2	24.7	28.9	39.4	9.7	25.8	37.8	2.6	19.6	31.0	11.5	23.6	14.3	17.9	11.2	28.1	6.8	17.0	18.0	6.3	9.1	12.6	26.9	0.4	21.7	7.7	3.8	11.4	17.6	0.0	0.4	0.3	0.0	0.0	0.3	0.0	2.0	1.4	2.4	8.0	9.1	6.3	0.1	1.1	3.7	1.1	0.2	0.0	2.9	0.8	5.5	2.0	2.6	4.1	1.1	3.5	0.7	0.0	11.8	0.0	26.3	2.9	4.8	0.1	0.3	9.8	14.8	0.0	9.4	5.8	0.2	8.0	0.1	0.0	0.9	0.8	0.0	0.1	1.2	2.0	3.1	0.0	3.1	0.1	6.0	7.5	7.3	0.8	5.5	0.3	2.9	3.6	5.9	0.0	0.8	5.0	3.3	0.5	1.0	3.2	0.0	16.2	0.8	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	18.5	28.8	63.8	30.2	17.6	10.5	24.7	28.9	19.6	26.9	3.0	2.9	0.0	3.6	0.8	20.5	7.0	0.0	6.7	2.3	5.2	27.5	0.0	0.0	0.6	23.2	3.1	0.3	0.0	0.6	0.0	2.5	5.8	1.1	1.7	0.2	19.1	5.8	2.5	0.3	16.0	2.8	0.1	1.7	0.0	1.3	8.3	0.3	0.0	4.9	0.5	38.2	0.0	2.3	0.5	0.7	2.0	0.0	0.0	1.5	2.1
SLC25A28	"MRS3/4, MRS4L"	ENSG00000155287	"Solute carrier family 25 member 28"	Q96A46	10	99610522-99620609	"Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Early spermatids: 121.1;Late spermatids: 296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.87e-3)"	"prognostic favorable (2.18e-6)"	"unprognostic (8.59e-3)"	"unprognostic (6.86e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.80e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.62e-3)"	26.2	29.8	30.6	22.1	37.5	52.2	23.7	34.8	31.7	21.7	28.5	29.1	33.9	16.5	21.1	34.7	28.0	22.3	25.8	27.2	26.7	25.2	19.2	31.8	25.3	26.5	31.9	24.6	29.0	28.9	25.6	21.4	19.9	28.8	29.1	24.9	21.8	29.3	35.0	35.1	32.9	19.7	37.3	21.5	30.1	21.2	34.1	34.6	13.5	24.1	18.1	25.8	29.6	36.5	3.0	9.5	6.2	2.5	2.3	4.6	1.0	13.8	13.8	8.7	21.1	16.4	20.4	9.0	16.3	19.8	22.5	18.6	10.8	17.2	17.7	10.1	14.7	10.3	23.4	10.7	15.3	13.8	13.1	13.8	7.7	20.0	11.2	16.4	13.8	10.9	17.2	22.7	14.5	28.8	29.3	15.9	15.8	5.6	13.7	11.4	18.6	11.9	31.2	2.0	11.1	10.8	15.0	10.5	9.9	14.6	14.9	5.9	7.4	9.3	10.2	12.1	11.9	18.4	13.9	9.5	13.9	9.5	18.5	19.8	11.3	7.2	8.7	13.3	26.8	5.7	0.0	2.5	6.2	4.6	2.2	2.1	3.0	3.3	2.8	3.5	3.0	2.5	2.3	2.2	2.3	2.1	9.5	3.6	1.0	30.6	37.5	34.8	31.7	26.7	25.2	31.9	24.6	28.8	34.6	11.9	8.3	4.3	14.5	22.6	30.1	17.3	17.8	0.0	5.7	5.2	19.6	15.5	6.6	3.7	121.1	16.5	6.7	0.0	6.9	7.9	13.6	20.8	5.8	17.9	8.6	41.3	4.1	7.4	8.7	296.1	11.8	12.0	18.6	9.0	10.5	23.8	5.0	9.9	17.0	7.3	29.6	12.9	15.3	22.1	7.2	24.0	12.1	7.4	9.0	17.8
SLC25A29	"C14orf69, FLJ38975"	ENSG00000197119	"Solute carrier family 25 member 29"	Q8N8R3	14	100291111-100306547	"Predicted intracellular proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 83.5"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 116.9;Cone photoreceptor cells: 70.7;Rod photoreceptor cells: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030781	Uncertain					NA	NA					"HPA030781: AB_10603029"	"unprognostic (8.64e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.00e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.26e-4)"	6.3	11.1	9.0	4.3	15.2	8.3	10.5	7.0	14.0	13.5	4.4	29.7	9.5	5.9	9.8	32.0	6.8	22.7	8.7	7.8	10.3	9.7	19.5	6.3	10.5	5.2	29.7	10.3	10.9	5.9	5.7	13.1	4.9	25.4	12.9	4.3	22.1	20.9	9.8	6.2	14.1	5.2	6.3	30.9	6.5	8.3	9.6	23.1	2.4	83.5	3.9	5.4	5.1	5.1	1.2	2.8	4.9	2.8	0.3	2.4	0.7	4.6	10.2	13.6	17.9	3.2	1.2	8.1	3.6	4.1	7.8	4.7	2.3	3.0	0.0	9.4	1.2	3.9	5.2	5.8	1.9	2.6	1.8	2.7	4.7	14.1	4.4	7.6	2.7	6.1	3.6	6.0	3.5	3.3	11.9	10.7	16.3	1.5	0.5	2.2	15.0	16.5	14.8	6.9	4.3	10.9	21.0	5.7	0.3	25.8	3.4	19.9	24.8	8.6	6.2	6.7	6.1	15.0	4.6	11.0	2.8	5.5	3.9	5.7	1.4	0.6	0.6	3.2	6.7	3.4	3.6	2.8	4.9	2.3	0.4	0.0	0.4	1.1	2.4	2.8	1.2	0.3	1.6	3.2	0.3	0.1	1.3	1.6	0.7	9.0	15.2	7.0	14.0	10.3	9.7	29.7	10.3	25.4	23.1	8.9	27.4	0.5	16.0	5.8	18.5	1.2	12.7	34.8	25.0	116.9	70.7	3.9	14.9	25.9	15.8	14.7	4.0	0.0	10.3	0.8	5.3	29.3	13.9	7.4	6.6	20.6	20.1	21.5	3.4	34.1	2.3	9.0	10.1	8.2	7.4	18.3	13.9	14.4	5.6	10.5	82.2	12.9	6.6	2.6	4.1	5.6	15.6	1.5	12.7	10.3
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 233.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria		NA	NA		5500000	Mitochondria		"HPA045709: AB_10965843"	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	35.7	71.2	23.6	38.3	27.2	24.6	48.9	25.1	50.2	29.8	69.6	22.4	33.8	53.9	38.5	35.9	54.6	30.1	55.1	233.5	22.9	25.3	60.2	72.6	47.0	75.5	27.8	26.0	39.6	59.7	55.5	29.1	34.2	31.6	33.8	53.3	30.9	53.5	33.5	190.6	33.8	76.0	46.7	19.6	35.6	51.4	16.9	15.1	42.0	41.5	125.8	44.4	38.5	31.9	46.8	82.3	33.4	78.5	43.3	56.6	76.3	74.7	58.4	77.5	64.2	70.6	117.4	99.9	65.6	87.5	85.1	71.2	104.8	39.3	102.2	39.0	79.5	38.5	64.4	78.6	88.7	89.8	38.4	62.7	60.9	43.1	69.5	86.9	71.3	48.4	111.0	79.4	61.8	88.9	128.1	120.1	53.0	65.6	30.3	101.4	55.8	66.1	79.6	71.7	64.7	96.0	75.6	80.8	113.4	110.0	75.1	39.8	53.4	78.5	70.7	108.3	68.5	95.5	78.0	80.7	47.4	44.8	52.0	65.6	51.4	60.4	71.5	37.4	42.1	61.0	24.4	59.5	33.4	40.1	77.2	47.4	46.8	45.7	44.3	82.3	33.3	47.9	45.3	26.4	43.3	78.5	50.3	56.6	76.3	23.6	27.2	25.1	50.2	22.9	25.3	27.8	26.0	31.6	15.1	199.5	265.4	295.0	454.5	334.1	211.9	1401.5	384.7	145.9	192.2	204.1	74.6	677.0	741.1	434.4	31.9	273.0	744.3	163.5	762.2	755.9	400.5	371.4	205.5	373.5	527.3	276.5	300.1	249.2	430.8	19.5	236.2	288.2	415.0	543.8	392.0	226.4	536.4	501.2	241.1	802.3	176.2	297.5	387.5	94.1	178.4	316.8	681.4	269.7	620.6	559.0
SLC25A30		ENSG00000174032	"Solute carrier family 25 member 30"	Q5SVS4	13	45393316-45418455	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 38.0;skeletal muscle: 43.1"	"Cell type enhanced"	"Detected in many"	7	"Cardiomyocytes: 39.7;Hepatocytes: 38.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045260			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045260: AB_10962505"	"unprognostic (9.23e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (9.91e-8)"	"unprognostic (2.24e-1)"	"unprognostic (5.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.19e-3)"	7.7	6.3	6.2	4.7	5.7	5.3	7.1	3.6	6.3	6.5	4.2	2.1	9.7	2.5	7.7	7.2	5.3	3.9	4.5	38.0	5.8	3.8	24.6	19.5	5.9	9.3	5.4	4.3	10.8	7.5	2.4	5.7	3.4	8.1	8.0	3.5	9.5	6.8	9.1	43.1	4.4	3.5	9.4	7.6	6.1	4.0	5.0	4.9	1.2	6.5	6.7	4.4	6.6	9.0	1.6	5.3	4.3	3.4	1.7	2.7	1.1	2.3	5.1	3.0	13.1	15.4	9.8	1.0	10.9	6.4	9.5	5.7	5.3	6.3	0.0	9.6	11.1	7.0	4.5	7.0	11.0	11.3	7.6	5.7	8.6	3.3	14.1	9.1	12.3	11.7	6.4	7.5	13.9	10.4	11.2	16.4	8.7	5.2	0.0	19.1	2.7	4.5	8.5	4.5	2.7	6.5	11.2	5.1	4.5	20.5	1.9	0.6	3.1	6.1	9.4	8.7	5.5	7.3	16.6	6.0	8.9	5.1	9.8	7.5	2.3	4.5	0.1	9.7	11.7	13.6	0.0	2.8	4.3	2.2	3.4	1.5	1.6	2.2	2.2	4.0	1.5	2.7	1.2	0.0	1.7	1.5	5.3	0.8	1.1	6.2	5.7	3.6	6.3	5.8	3.8	5.4	4.3	8.1	4.9	6.0	2.1	1.5	1.9	11.4	1.7	39.7	10.2	0.0	1.2	14.0	3.9	0.7	19.9	2.2	7.6	4.1	1.4	0.0	1.2	0.8	2.2	2.8	4.7	38.9	3.7	0.0	2.4	7.4	10.0	2.3	4.6	5.9	5.0	6.4	3.9	0.8	2.4	0.0	6.0	22.1	1.1	6.5	2.2	0.0	1.4	5.4	0.5	4.4	3.3	1.1
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730378-127774299	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	687	"testis: 68.6"	"Cell type enriched"	"Detected in some"	9	"Spermatocytes: 113.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria		NA	NA			Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431"					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	113.2	11.9	0.0	0.0	0.0	0.0	0.0
SLC25A32	MFTC	ENSG00000164933	"Solute carrier family 25 member 32"	Q9H2D1	8	103398635-103415189	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024763, HPA047402"	Uncertain		Supported	Mitochondria		NA	NA			Mitochondria		"HPA024763: , HPA047402: AB_2680032"	"unprognostic (2.45e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.47e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (7.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.49e-2)"	24.1	14.9	11.1	19.6	17.0	21.6	21.6	22.1	21.9	16.3	14.7	15.4	8.8	11.0	19.4	13.0	13.1	18.8	19.6	16.4	12.6	16.5	15.2	29.6	16.1	23.9	16.4	11.6	21.0	13.4	17.3	30.1	16.5	24.2	14.9	14.2	15.7	13.0	13.1	17.8	13.9	14.1	18.5	14.1	25.1	14.4	15.3	13.6	17.2	14.9	11.7	19.8	18.3	14.2	8.9	5.0	1.8	4.6	5.7	9.3	6.5	15.0	5.4	7.4	9.0	10.1	11.8	4.9	12.8	18.1	14.4	15.0	6.6	9.3	32.8	12.2	13.8	8.6	9.7	10.6	10.8	22.4	20.0	7.5	24.2	4.6	8.4	17.6	11.8	11.0	11.6	9.0	16.2	24.2	5.8	14.9	9.6	14.9	12.9	14.3	6.0	20.1	9.7	8.9	17.7	10.9	15.1	7.9	22.6	9.8	6.9	20.7	9.0	6.2	10.3	21.4	6.2	9.1	8.5	10.3	17.9	11.9	20.6	16.5	9.2	8.6	34.2	15.2	17.3	13.2	0.7	3.9	1.8	7.7	4.4	9.3	8.9	8.3	8.8	5.0	6.5	8.6	8.7	1.1	5.7	4.6	4.3	6.5	6.5	11.1	17.0	22.1	21.9	12.6	16.5	16.4	11.6	24.2	13.6	3.0	3.5	26.5	13.0	20.5	8.9	9.9	10.2	1.4	3.4	5.2	5.9	10.3	6.6	7.8	3.0	19.4	3.2	0.0	8.2	11.5	13.8	8.2	9.2	13.0	9.3	7.9	10.9	16.5	5.0	2.8	8.6	7.4	10.1	10.0	6.3	7.1	8.1	3.5	8.1	7.4	7.4	19.4	12.6	20.0	17.9	22.6	11.7	13.1	6.2	14.0
SLC25A33	"BMSC-MCP, MGC4399, PNC1"	ENSG00000171612	"Solute carrier family 25 member 33"	Q9BSK2	1	9539482-9585179	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 318.7;Late spermatids: 434.0;Spermatocytes: 229.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 6.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049982	Uncertain					NA	NA					"HPA049982: AB_2680981"	"unprognostic (1.61e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.02e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.55e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.77e-2)"	14.6	5.3	11.3	3.8	15.3	11.0	13.0	8.4	20.6	4.1	6.6	6.5	3.5	3.4	4.6	18.9	4.5	3.5	5.6	6.1	9.4	12.2	13.9	15.1	6.1	4.6	15.1	8.7	3.3	8.5	4.5	6.4	2.3	12.6	6.3	5.6	10.5	7.0	3.8	16.8	2.6	3.4	4.1	10.4	3.3	4.7	16.0	7.0	4.2	7.6	2.8	5.1	4.1	2.5	2.0	1.6	6.1	1.1	1.3	1.9	0.4	4.4	2.1	5.9	9.1	4.8	2.8	3.8	4.3	4.1	7.3	6.5	4.6	3.5	12.9	5.3	3.5	7.7	1.9	14.8	2.9	9.1	9.9	9.3	12.7	3.0	17.9	10.5	12.6	10.1	3.3	5.1	7.3	3.5	1.8	4.3	9.7	12.3	6.8	4.1	4.6	7.9	8.7	7.3	8.2	4.9	10.8	6.2	8.3	4.6	2.5	10.3	6.7	4.9	15.0	12.7	5.4	5.5	9.3	1.9	4.7	6.1	6.2	5.5	8.1	14.9	21.9	3.4	14.1	5.6	6.1	0.9	0.3	1.5	1.1	1.0	2.0	1.1	0.9	1.6	1.0	1.9	1.9	1.3	1.3	1.0	1.5	0.2	0.4	11.3	15.3	8.4	20.6	9.4	12.2	15.1	8.7	12.6	7.0	3.0	12.5	21.1	88.7	45.7	12.9	6.9	28.1	6.7	6.8	8.7	49.1	10.2	169.1	11.4	318.7	15.5	10.2	0.0	13.0	34.4	13.9	74.4	24.1	53.3	18.4	9.5	63.7	9.8	7.2	434.0	9.2	21.8	30.4	10.0	22.0	142.8	9.5	8.6	9.6	19.9	46.4	6.5	36.0	229.6	117.3	31.2	32.8	12.1	24.7	85.3
SLC25A34	DKFZp781A10161	ENSG00000162461	"Solute carrier family 25 member 34"	Q6PIV7	1	15736405-15741396	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 38.8;skeletal muscle: 22.2"	"Cell type enhanced"	"Detected in many"	13	"Enterocytes: 16.0;Paneth cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 10.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069806			Approved	Mitochondria		NA	NA			Mitochondria		"HPA069806: AB_2686202"	"unprognostic (2.06e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-4)"	"unprognostic (5.74e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.40e-4)"	2.5	2.4	1.2	0.9	1.9	2.8	0.7	10.4	1.8	1.1	25.9	0.8	0.5	13.5	1.7	1.4	1.6	1.3	3.6	13.3	1.5	1.2	7.3	3.9	1.1	1.1	0.7	1.8	2.4	18.6	0.6	2.1	1.2	1.5	1.1	1.9	3.7	11.1	0.8	22.2	0.8	38.8	1.0	1.1	1.9	1.4	2.3	1.2	0.5	1.9	11.0	1.9	0.7	1.1	0.7	0.5	2.0	0.5	2.2	4.1	1.1	0.7	0.5	3.5	1.6	1.7	0.7	1.5	0.5	0.3	0.8	0.6	1.4	1.9	0.9	0.8	0.7	1.8	0.7	0.6	0.6	0.8	1.2	0.7	1.5	1.1	0.5	0.6	0.4	2.2	0.8	2.7	1.0	0.5	2.2	0.4	4.6	0.6	3.2	0.6	1.8	3.7	2.0	2.9	0.4	1.0	1.9	3.1	1.0	0.3	0.1	0.7	2.8	0.8	1.0	7.4	3.4	1.9	2.5	1.7	1.7	2.2	2.3	0.6	3.8	3.5	0.7	0.6	2.2	1.4	1.2	0.5	0.4	1.4	0.2	3.1	0.5	3.0	2.0	0.2	0.7	4.1	2.3	2.0	2.2	0.2	0.5	1.3	1.1	1.2	1.9	10.4	1.8	1.5	1.2	0.7	1.8	1.5	1.2	0.0	0.0	0.0	0.3	0.2	2.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.7	16.0	0.0	0.2	0.2	0.7	0.3	0.0	2.1	1.2	3.2	3.4	2.5	2.6	0.4	0.9	0.1	0.0	1.8	2.4	1.7	0.2	5.3	0.4	3.0	1.4	0.0	0.9	0.5	0.6	0.1	1.1	0.0	4.1	0.4
SLC25A35	FLJ40217	ENSG00000125434	"Solute carrier family 25 member 35"	Q3KQZ1	17	8287763-8295343	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 44.4"	"Cell type enhanced"	"Detected in many"	7	"Spermatocytes: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051720	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			"Vesicles, Mitochondria"		"HPA051720: AB_2681584"	"unprognostic (4.73e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.37e-7)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (5.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.91e-5)"	6.8	8.2	4.0	10.2	8.3	7.4	8.1	2.6	6.0	13.0	7.2	11.1	18.2	8.3	14.1	11.6	5.3	8.6	7.5	4.4	8.2	3.7	14.4	4.4	7.2	8.2	8.9	5.2	3.4	9.6	6.6	12.9	44.4	9.2	8.2	7.9	11.3	6.2	24.9	3.4	4.2	7.2	6.0	9.7	9.4	9.8	20.2	7.2	9.0	9.1	4.1	7.1	7.2	4.6	3.8	7.2	9.0	11.1	3.2	5.6	2.9	4.5	12.5	2.1	9.4	7.2	2.8	5.2	2.9	2.7	3.3	3.6	1.5	11.7	5.2	3.1	3.4	6.7	10.1	2.7	3.6	1.8	2.8	3.3	4.4	9.2	1.8	2.7	0.5	11.9	5.9	2.1	6.2	1.1	2.3	5.1	6.1	1.2	1.8	2.7	2.5	4.7	2.4	0.7	3.1	4.2	5.1	1.5	2.3	2.5	11.6	1.1	2.8	8.6	5.2	3.7	2.3	11.6	3.3	6.7	2.2	1.7	5.3	2.5	4.0	2.4	1.8	5.7	7.8	5.6	4.5	7.3	9.0	5.5	11.1	4.3	2.6	4.8	5.6	7.2	3.8	1.7	3.5	1.4	3.2	7.8	3.6	4.9	2.9	4.0	8.3	2.6	6.0	8.2	3.7	8.9	5.2	9.2	7.2	0.0	4.8	5.4	1.5	0.7	3.7	1.2	2.5	0.0	1.2	10.4	7.9	7.3	10.0	2.4	2.4	2.2	2.5	0.0	6.2	2.0	1.3	1.8	4.7	2.4	5.9	1.6	8.6	2.5	3.7	3.6	1.4	2.7	0.0	8.2	2.7	6.8	2.6	3.1	1.1	5.7	8.9	0.0	0.7	27.9	0.7	0.3	14.5	3.8	3.0	1.1
SLC25A36	"FLJ10618, PNC2"	ENSG00000114120	"Solute carrier family 25 member 36"	Q96CQ1	3	140941830-140979933	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027036	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Mitochondria, Cytosol"	Nucleoplasm	"HPA027036: AB_1857048"	"unprognostic (4.12e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (1.55e-4)"	20.2	16.9	14.9	13.4	20.5	36.5	25.2	18.7	31.3	23.5	19.4	18.3	17.3	22.3	25.6	37.3	12.2	25.1	13.7	29.5	15.9	19.0	29.0	3.1	22.4	18.6	15.6	16.7	32.6	33.9	29.7	26.3	19.1	21.6	20.6	14.8	21.1	17.5	17.7	60.6	16.2	17.2	20.4	18.5	14.1	23.6	24.4	12.2	15.4	23.7	15.1	12.7	20.7	18.5	17.0	14.9	15.7	13.1	18.1	16.6	10.9	23.8	5.4	17.5	14.3	16.1	20.6	22.1	9.0	11.5	10.1	14.3	14.9	11.4	19.9	22.4	7.6	14.5	16.0	21.2	8.8	20.7	15.2	17.2	16.4	13.0	9.4	24.2	23.4	10.2	23.2	29.6	7.4	22.7	22.7	10.6	14.7	8.7	12.9	14.7	10.3	13.9	16.1	17.4	5.9	10.1	15.1	15.6	28.2	11.9	8.2	11.3	18.5	12.2	22.2	39.1	16.0	15.4	13.3	10.7	14.1	7.9	24.9	8.6	26.2	17.0	23.2	18.2	9.8	6.9	10.5	10.4	15.7	11.4	13.1	13.3	17.0	11.7	12.5	14.9	16.0	16.6	15.7	1.8	18.1	13.1	10.9	10.2	10.9	14.9	20.5	18.7	31.3	15.9	19.0	15.6	16.7	21.6	12.2	92.3	107.7	22.2	58.2	60.7	96.5	82.2	38.2	133.8	62.6	68.0	125.7	48.2	54.7	22.9	5.0	40.0	22.6	0.0	33.6	33.4	49.8	72.0	63.6	0.4	22.8	87.4	57.0	29.4	35.2	11.5	55.3	36.5	54.0	29.7	27.0	70.1	26.8	17.5	55.9	52.8	122.5	58.2	54.2	29.3	61.1	47.6	41.3	41.1	40.3	64.7
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528805-23575463	"Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 88.8"	"Cell type enriched"	"Detected in all"	5	"Erythroid cells: 3550.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 28.9"	"Lineage enriched"	"Detected in many"	18	"granulocytes: 28.9"	"Cell line enhanced"	"Detected in many"		"HEL: 47.7;hTERT-RPE1: 27.9"	"Low region specificity"	"Detected in all"							HPA045680	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	8.2	18.3	5.8	13.7	8.3	88.8	13.1	4.2	8.2	13.4	16.4	6.5	11.7	39.7	10.3	6.8	8.2	9.5	8.5	16.8	6.2	5.2	9.4	11.8	25.7	18.5	12.2	5.1	17.2	14.8	15.6	8.8	23.9	10.3	17.1	5.8	7.9	21.1	17.4	13.8	7.6	17.6	7.9	10.2	28.7	8.0	15.0	8.6	1.9	9.0	5.9	5.7	13.9	33.0	1.2	1.4	28.9	1.6	0.7	1.2	0.8	3.8	4.2	4.5	4.1	5.9	7.3	6.6	3.0	3.9	2.2	2.5	4.1	8.2	6.2	3.7	2.5	14.5	4.9	4.1	8.2	3.0	1.0	2.2	47.7	7.0	1.4	4.9	2.7	1.9	6.2	8.0	4.8	4.8	27.9	3.4	5.0	10.5	3.1	3.5	1.6	3.2	11.3	2.3	4.7	3.3	3.3	2.2	2.4	6.8	2.1	1.4	1.9	4.1	6.4	3.0	4.4	1.8	4.1	5.5	10.9	1.6	6.4	5.8	2.5	0.9	3.9	10.2	6.5	6.8	0.6	1.6	1.4	0.6	0.6	0.6	1.2	0.4	0.3	1.4	0.8	1.2	0.7	28.9	0.7	0.8	0.4	0.7	0.8	5.8	8.3	4.2	8.2	6.2	5.2	12.2	5.1	10.3	8.6	35.7	79.2	39.5	104.8	82.9	35.3	31.5	48.4	21.4	84.2	73.3	64.8	32.1	13.3	81.9	645.6	82.4	66.7	3550.9	197.4	63.8	90.2	258.9	35.8	34.3	36.1	6.4	19.5	100.7	50.6	772.4	48.6	101.8	65.8	8.2	33.2	41.6	177.5	34.5	35.0	24.5	60.7	19.4	95.7	12.5	47.1	47.0	15.3	22.7	43.1	139.3
SLC25A38	FLJ20551	ENSG00000144659	"Solute carrier family 25 member 38"	Q96DW6	3	39383324-39397351	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041027	Approved					NA	NA					"HPA041027: AB_10794403"	"unprognostic (3.82e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (7.29e-4)"	14.0	24.6	12.2	18.2	17.1	38.1	20.9	16.7	21.9	17.2	17.8	11.9	22.2	16.0	21.3	18.2	13.3	17.8	18.2	12.9	12.0	15.3	18.0	35.9	14.7	22.5	12.8	16.2	29.1	41.3	27.2	21.7	12.8	13.4	21.3	24.1	15.1	15.5	18.4	30.0	10.6	16.4	17.0	11.3	18.9	21.3	17.7	13.0	24.7	39.8	12.5	21.5	20.5	22.7	21.6	8.1	12.4	4.2	23.2	22.7	11.9	9.7	15.6	10.3	17.3	24.2	20.1	12.9	14.0	19.1	20.3	18.5	10.7	2.3	27.4	8.3	12.9	17.3	7.6	22.9	16.4	15.3	17.5	18.4	21.2	13.8	15.7	32.5	14.9	14.5	25.2	19.4	19.5	39.6	19.0	13.1	21.9	18.9	17.3	15.1	14.0	17.8	26.5	27.6	14.6	18.1	6.5	11.0	18.9	15.9	18.6	10.3	13.1	4.8	27.6	13.5	19.8	14.0	14.1	11.2	16.3	11.1	23.5	19.8	23.2	36.5	16.7	12.4	19.6	10.3	12.4	4.2	7.7	17.7	2.5	20.4	21.6	18.3	19.4	6.4	19.0	19.6	19.0	0.6	23.2	3.4	8.1	22.7	11.9	12.2	17.1	16.7	21.9	12.0	15.3	12.8	16.2	13.4	13.0	20.8	27.2	29.7	11.4	10.2	13.9	15.3	17.8	13.4	6.8	26.2	5.9	28.2	18.3	13.7	5.2	9.0	18.2	0.0	14.6	27.5	14.4	13.3	21.9	24.1	13.2	4.8	12.1	10.4	9.8	6.3	14.4	8.3	11.8	13.6	25.4	16.3	12.3	21.0	12.7	15.4	10.3	6.5	15.6	10.4	4.7	8.9	16.2	36.2	26.0	7.2
SLC25A39	"CGI-69, FLJ22407"	ENSG00000013306	"Solute carrier family 25 member 39"	Q9BZJ4	17	44319625-44324870	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Heme biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	6	"Distal tubular cells: 416.1;Erythroid cells: 584.0;Late spermatids: 585.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026785	Approved					NA	NA					"HPA026785: AB_10601715"	"unprognostic (8.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-3)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.58e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.21e-2)"	14.6	36.5	17.8	19.0	19.4	101.0	21.9	15.4	18.1	18.8	29.8	17.4	22.9	30.2	16.0	20.5	43.2	19.1	24.5	19.3	16.4	18.5	58.8	69.8	25.0	29.8	18.6	15.6	25.1	63.3	27.2	24.6	33.5	17.1	23.4	19.9	20.6	39.9	26.5	13.7	25.6	28.7	13.5	17.6	28.8	23.8	39.7	16.2	18.0	46.4	36.4	29.3	16.8	18.6	34.0	35.2	11.2	27.4	43.9	30.2	31.0	44.3	28.2	8.8	37.0	17.2	13.4	30.9	14.8	13.4	19.3	14.9	27.8	21.5	23.9	26.2	20.9	34.3	22.9	27.5	44.9	6.8	27.9	44.1	12.5	25.5	50.6	18.8	21.7	27.5	20.2	40.0	18.0	23.3	17.5	19.7	36.3	36.7	38.2	16.2	83.9	27.3	21.2	17.3	34.1	78.2	33.0	24.4	68.4	33.2	23.7	60.0	22.4	17.1	27.4	30.0	17.0	52.6	18.6	14.0	25.3	35.6	43.2	28.9	24.0	28.8	21.9	22.8	17.0	15.3	11.2	19.5	9.4	26.6	27.3	30.2	34.0	28.9	28.6	30.5	25.3	29.9	27.4	2.9	43.9	27.4	35.2	26.6	31.0	17.8	19.4	15.4	18.1	16.4	18.5	18.6	15.6	17.1	16.2	8.9	23.1	46.2	55.8	47.4	17.1	21.2	45.9	18.7	26.1	66.3	9.8	75.3	416.1	140.7	181.7	45.0	106.3	584.0	271.0	134.5	37.6	112.5	31.3	61.9	122.6	12.7	62.7	26.4	47.0	585.1	36.8	47.7	87.7	148.7	86.5	37.5	164.8	80.6	36.4	185.1	14.0	19.4	41.2	103.7	99.4	56.6	98.2	55.8	137.6	83.2
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143241-185150382	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Transport"		"Cardiomyopathy, Disease mutation, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"heart muscle: 163.7;skeletal muscle: 92.5;tongue: 62.4"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 4236.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.5;dendritic cells: 3.0;T-cells: 4.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	3.0	4.2	6.9	2.0	10.8	1.4	3.1	19.4	14.4	2.6	6.6	3.7	2.9	2.8	3.0	3.4	6.7	3.7	3.5	163.7	7.4	7.3	8.3	4.3	3.0	2.0	6.3	6.1	3.6	3.0	4.6	4.6	2.2	12.8	6.2	3.4	7.9	4.4	8.5	92.5	2.3	4.1	5.5	4.5	2.1	5.3	3.1	2.3	0.0	4.6	62.4	3.4	4.4	2.1	3.5	3.0	0.4	0.0	0.7	4.1	1.5	0.7	3.3	2.7	5.5	3.0	0.3	5.0	2.7	0.9	3.3	3.3	7.1	1.8	2.4	2.0	3.3	2.6	2.6	10.4	2.9	2.2	4.0	8.9	1.6	4.9	8.3	6.1	1.4	1.6	2.2	7.1	5.1	1.4	7.8	2.4	4.2	3.8	1.9	2.0	5.1	1.6	3.2	4.4	2.3	7.1	2.6	1.4	3.3	7.5	5.1	8.8	6.7	3.2	1.4	12.6	5.1	2.6	1.2	1.8	0.2	1.5	1.7	3.5	7.9	3.6	3.1	2.4	0.3	3.0	0.0	0.0	0.0	4.1	0.0	3.1	3.5	1.4	3.5	0.1	2.2	1.2	3.0	0.4	0.7	0.0	3.0	1.2	1.5	6.9	10.8	19.4	14.1	7.4	7.3	6.3	6.1	12.8	2.3	80.4	55.4	33.5	125.8	39.2	174.4	4236.1	140.1	112.4	42.1	68.0	98.2	59.7	837.3	68.4	15.8	25.9	41.2	0.0	65.1	47.9	24.6	55.0	11.5	83.9	50.1	151.0	51.6	24.5	7.6	7.7	43.1	7.9	180.5	15.4	35.7	473.2	51.1	24.6	106.1	140.9	178.4	103.5	194.8	24.0	35.3	15.8	33.9	10.7	48.8	46.9
SLC25A40	MCFP	ENSG00000075303	"Solute carrier family 25 member 40"	Q8TBP6	7	87833568-87876357	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Kupffer cells: 32.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055197	Uncertain					NA	NA					"HPA055197: AB_2682735"	"unprognostic (4.19e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.80e-2)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.73e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.78e-2)"	"prognostic favorable (1.52e-5)"	"unprognostic (8.42e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.85e-2)"	8.2	12.1	13.8	12.5	20.5	10.8	13.1	19.8	26.3	10.0	12.3	12.4	5.9	10.2	11.1	10.2	10.4	10.2	8.7	14.7	13.3	17.0	13.4	10.4	12.6	15.3	17.1	15.4	14.4	9.3	13.0	15.9	5.8	28.2	14.4	15.7	10.0	11.1	8.9	9.0	12.7	11.1	8.5	13.5	14.8	11.0	9.2	11.3	20.0	11.4	6.6	15.1	9.8	9.7	2.6	5.9	9.3	5.8	6.3	3.0	2.4	11.4	3.0	9.6	3.7	3.9	6.3	2.8	8.3	7.3	6.0	8.8	2.6	16.4	13.5	5.4	4.1	9.6	5.0	4.6	4.7	8.7	8.5	2.3	7.1	6.9	3.2	3.8	17.2	9.6	3.8	3.4	5.4	4.3	5.0	6.4	10.9	7.7	20.0	10.2	4.9	19.9	14.5	4.4	9.5	3.5	9.9	12.2	11.8	8.7	6.2	4.7	11.3	10.6	10.5	7.9	8.1	5.1	13.6	4.4	10.3	7.7	16.0	7.8	11.0	12.0	17.5	7.2	21.2	21.0	9.3	5.4	7.1	1.9	5.8	3.0	2.6	2.7	2.6	5.9	2.6	3.0	2.7	3.0	6.3	5.8	1.5	3.0	2.4	13.8	20.5	19.8	26.3	13.3	17.0	17.1	15.4	28.2	11.3	3.0	4.0	12.3	4.7	6.6	4.5	12.6	17.8	2.7	7.9	7.0	9.8	7.0	13.3	3.2	8.4	4.5	5.1	0.0	3.5	6.6	4.7	5.3	4.7	6.0	10.2	3.2	2.9	7.4	32.8	2.9	7.2	14.5	20.3	1.8	10.0	3.3	5.6	10.8	10.3	6.8	4.2	12.9	2.6	6.5	4.9	6.9	3.1	6.9	9.0	4.2
SLC25A41	"APC4, FLJ40442, MGC34725"	ENSG00000181240	"Solute carrier family 25 member 41"	Q8N5S1	19	6426037-6433779	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 8.1;testis: 26.5"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 91.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 2.3;HMC-1: 7.1;K-562: 2.1;U-937: 4.2"	"Low region specificity"	"Detected in single"							HPA043591	Uncertain					NA	NA					"HPA043591: AB_10964585"	"unprognostic (1.87e-3)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.29e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	0.3	0.2	2.4	0.3	6.3	0.0	0.5	8.1	3.2	0.3	0.5	0.3	0.3	0.4	0.3	0.8	1.7	0.4	0.3	1.6	2.6	1.3	0.3	0.3	0.3	0.3	0.6	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	0.0	0.3	0.5	0.9	1.3	1.2	0.3	0.5	0.6	0.3	0.0	26.5	0.3	0.3	0.4	0.3	0.3	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	1.1	0.4	0.0	0.0	0.7	0.0	0.0	0.4	0.2	0.0	0.0	0.3	0.4	0.0	0.0	2.3	1.6	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	7.1	0.7	1.7	0.0	0.0	0.4	0.0	0.4	2.1	0.0	0.0	0.9	0.0	1.7	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.6	0.0	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	6.3	8.1	2.7	2.6	1.3	0.6	0.3	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.2	91.3	0.0	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	3.2	0.0	0.0	0.0	11.5	0.9	0.0	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.1	1.2	0.0	0.0	0.2	0.2	0.3	0.5	0.0	0.2	0.1
SLC25A42	MGC26694	ENSG00000181035	"Solute carrier family 25 member 42"	Q86VD7	19	19063999-19112888	"Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 42.3"	"Cell type enhanced"	"Detected in many"	9	"Bipolar cells: 68.0;Hepatocytes: 44.5;Rod photoreceptor cells: 42.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.1;MAIT T-cell: 2.8;memory B-cell: 6.2;memory CD4 T-cell: 2.9;memory CD8 T-cell: 4.3;naive B-cell: 5.1;naive CD4 T-cell: 1.9;naive CD8 T-cell: 2.8;NK-cell: 2.8;T-reg: 2.9"	"Group enriched"	"Detected in many"	6	"B-cells: 6.2;NK-cells: 2.8;T-cells: 5.1"	"Cell line enhanced"	"Detected in many"		"K-562: 17.5"	"Low region specificity"	"Detected in all"							HPA049449	Approved		Supported	Mitochondria		Yes	No			Mitochondria		"HPA049449: AB_2680772"	"unprognostic (2.27e-1)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.79e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.03e-2)"	4.8	5.7	13.8	4.5	12.2	7.5	4.9	22.5	15.4	7.0	4.8	5.9	4.5	5.7	6.8	4.4	4.5	7.4	4.7	8.9	9.7	7.8	26.7	42.3	5.4	8.5	5.9	7.8	13.8	7.4	6.5	9.6	3.2	7.9	7.6	3.0	12.2	11.0	6.3	26.7	5.2	5.6	5.7	6.1	7.3	4.6	4.5	8.1	6.6	17.1	7.3	12.2	5.5	5.4	6.2	0.7	0.2	0.6	2.8	5.1	1.5	6.2	0.8	1.6	2.8	6.1	5.1	2.5	3.0	4.6	4.7	5.4	1.2	12.5	4.5	7.1	2.8	4.7	1.1	3.2	2.5	2.7	1.1	6.2	1.5	1.7	10.0	4.9	0.7	3.2	5.1	1.8	3.6	2.2	3.8	2.1	14.7	17.5	8.1	2.5	5.6	7.5	7.1	0.9	1.7	6.5	5.8	2.8	8.6	1.8	1.1	1.8	1.3	3.2	0.1	1.3	2.2	5.7	3.5	1.9	3.5	2.0	7.3	2.9	9.4	5.1	3.5	3.7	9.6	1.8	0.0	0.2	0.2	5.1	0.5	2.8	6.2	2.9	4.3	0.3	5.1	1.9	2.8	0.0	2.8	0.6	0.7	2.9	1.5	13.8	12.2	22.5	15.4	9.7	7.8	5.9	7.8	7.9	8.1	0.0	9.6	8.9	2.4	2.9	68.0	8.9	2.5	1.4	3.4	8.7	17.7	5.7	11.6	1.4	1.2	3.5	5.4	0.0	2.7	2.7	3.6	2.6	3.5	44.5	1.5	3.2	8.1	4.3	0.3	0.6	4.6	1.1	3.3	0.0	4.0	11.9	1.9	2.9	6.0	27.0	42.5	6.5	5.7	7.9	6.4	2.5	3.9	11.4	2.9	1.3
SLC25A43		ENSG00000077713	"Solute carrier family 25 member 43"	Q8WUT9	X	119399060-119454478	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035188, HPA078530"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA035188: AB_10602400, HPA078530: "	"unprognostic (6.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (4.99e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.06e-8)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.92e-2)"	12.7	3.0	4.4	11.1	3.7	1.3	11.8	5.9	3.8	8.9	12.3	4.3	5.6	12.8	8.0	7.3	23.5	5.8	6.3	6.0	5.1	3.4	11.4	11.3	10.4	9.5	3.8	2.7	7.8	15.6	4.0	3.0	7.3	5.8	8.5	14.2	7.4	12.8	4.4	6.3	14.0	13.3	7.7	8.2	9.0	7.9	4.3	4.3	1.9	5.7	9.6	16.2	8.9	12.9	4.3	6.3	0.2	10.7	6.6	3.2	1.4	13.6	10.1	0.7	4.0	14.0	21.2	5.4	7.5	9.6	6.1	5.9	5.2	6.9	1.5	4.6	21.0	18.4	10.1	7.9	7.1	5.5	11.8	2.4	4.9	3.3	7.0	8.7	4.6	5.2	8.7	12.6	10.1	8.5	8.7	7.5	2.7	0.9	7.3	7.0	24.4	0.0	6.5	4.6	7.2	15.9	1.2	0.0	2.0	10.1	4.7	0.6	0.0	10.2	21.6	12.0	3.4	3.8	4.6	10.4	10.0	2.9	10.8	11.6	0.1	5.7	3.3	10.0	7.7	8.8	0.0	3.4	0.2	1.0	5.1	1.8	4.3	2.0	3.2	6.3	3.6	1.1	1.9	0.0	6.6	10.7	1.6	1.6	1.4	4.4	3.7	5.9	3.8	5.1	3.4	3.8	2.7	5.8	4.3	6.0	8.9	6.0	5.9	6.9	0.1	1.4	0.0	1.4	6.8	3.5	0.0	8.9	8.3	3.6	0.0	7.3	16.9	0.0	7.9	6.7	9.3	3.1	8.1	4.9	9.7	0.0	7.0	6.2	6.5	0.0	7.5	9.9	10.1	11.8	10.3	0.0	12.1	8.6	5.3	7.0	0.1	0.0	13.3	0.4	2.2	12.2	5.7	7.2	10.3	5.1
SLC25A44	"FLJ90431, KIAA0446"	ENSG00000160785	"Solute carrier family 25 member 44"	Q96H78	1	156193932-156212796	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 115.9;Late spermatids: 71.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 33.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065411			Approved	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA065411: AB_2685486"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (2.49e-4)"	"unprognostic (3.37e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.37e-1)"	14.3	9.0	15.9	9.3	23.1	10.2	8.9	18.6	31.9	9.1	10.4	19.7	6.6	16.8	8.1	11.1	9.0	7.8	10.7	10.6	16.1	16.7	25.9	31.2	10.6	8.7	14.4	18.1	7.1	8.3	17.7	10.9	7.8	22.5	8.7	11.1	9.3	7.0	9.5	12.8	9.1	13.9	10.8	13.5	13.3	8.4	8.9	12.1	10.6	9.7	6.0	11.2	9.7	7.9	3.7	6.3	33.8	9.1	4.2	4.9	5.6	10.3	17.7	8.7	11.5	19.0	10.3	6.8	11.1	16.4	20.3	16.6	17.3	9.4	8.2	9.8	16.6	11.0	15.5	31.7	13.1	18.0	9.4	10.6	7.5	11.3	10.4	14.5	9.7	13.8	14.4	11.5	20.5	12.4	9.8	16.4	10.2	7.8	13.6	13.9	18.6	10.1	6.9	20.5	19.8	18.4	6.5	8.8	14.0	26.5	12.3	13.6	18.3	13.0	23.6	14.8	16.0	17.8	15.9	13.2	11.7	9.9	13.1	13.2	14.0	10.6	12.5	12.9	10.2	11.5	6.5	8.4	8.7	4.7	9.1	4.9	3.7	3.8	4.4	6.3	2.4	3.1	3.7	33.8	4.2	7.1	2.8	3.3	5.6	15.9	23.1	18.6	31.9	16.1	16.7	14.4	18.1	22.5	12.1	11.9	24.8	12.3	4.8	24.6	12.6	30.7	7.6	4.0	14.8	8.7	19.6	4.3	5.0	5.4	115.9	11.7	9.2	0.0	4.9	3.3	17.9	6.1	4.7	29.8	6.5	19.1	5.8	10.4	8.6	71.2	6.6	12.2	11.8	1.8	8.5	7.2	4.9	5.8	5.3	13.9	8.8	19.4	12.2	9.1	7.7	29.7	6.9	7.5	7.5	6.3
SLC25A45		ENSG00000162241	"Solute carrier family 25 member 45"	Q8N413	11	65375192-65383701	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 60.5"	"Cell type enhanced"	"Detected in many"	5	"B-cells: 32.2;T-cells: 35.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 13.8;Karpas-707: 18.7;RPMI-8226: 13.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA050821	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA050821: AB_2681249"	"unprognostic (3.73e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.44e-4)"	"unprognostic (6.17e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.84e-7)"	"unprognostic (7.57e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.06e-2)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.43e-1)"	2.2	1.8	2.1	4.0	2.3	3.1	3.2	1.0	2.6	1.7	4.5	4.0	4.7	4.1	1.0	5.4	1.5	1.3	1.3	2.8	2.5	1.1	3.9	7.7	5.3	9.4	1.8	2.3	1.3	60.5	4.2	4.7	1.2	2.3	2.5	1.2	3.5	5.0	1.3	4.1	2.0	11.0	1.5	2.3	9.6	1.9	2.4	2.0	5.8	9.0	2.8	8.2	1.9	1.7	10.8	19.2	6.0	10.1	13.5	11.4	2.5	0.3	4.7	0.2	6.9	1.3	0.6	3.5	0.8	2.1	0.4	0.4	1.0	2.2	4.1	3.9	1.9	1.8	0.6	0.5	0.3	0.0	13.8	1.0	4.5	2.5	0.3	0.8	1.4	4.8	1.6	0.1	0.5	0.4	0.4	0.7	8.0	0.6	18.7	0.7	1.5	3.3	0.1	0.3	0.2	2.2	6.1	0.9	13.6	0.7	0.0	2.3	3.1	1.4	3.7	0.7	0.4	1.9	0.7	1.3	0.5	1.8	4.5	0.3	7.8	4.9	1.2	1.4	1.0	2.7	6.0	5.5	3.9	7.9	9.0	8.4	8.9	7.0	7.5	5.7	10.8	11.4	8.5	3.3	13.5	10.1	19.2	6.3	2.5	2.1	2.3	1.0	2.6	2.5	1.1	1.8	2.3	2.3	2.0	0.0	3.5	32.2	5.2	2.5	9.0	5.5	10.2	17.4	4.5	12.2	0.0	1.4	0.0	4.9	5.2	2.9	23.9	0.0	4.7	1.0	3.3	7.8	4.6	12.1	6.3	6.4	6.4	7.4	7.0	3.3	6.4	13.8	5.0	18.0	12.9	7.7	4.3	8.6	3.5	6.2	0.3	6.5	2.5	2.3	0.2	1.8	1.3	35.9	7.4	3.5
SLC25A46		ENSG00000164209	"Solute carrier family 25 member 46"	Q96AG3	5	110738136-110765161	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 176.3;Late spermatids: 325.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039601, HPA071582"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"HPA039601: AB_2676592, HPA071582: AB_2686422"	"unprognostic (1.86e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.98e-1)"	16.9	15.6	11.9	12.7	19.3	11.3	13.6	17.6	25.7	12.5	14.0	12.2	8.5	15.7	13.4	9.5	16.4	9.5	10.0	20.8	10.4	10.0	18.7	22.0	11.4	13.7	14.5	14.8	10.2	12.4	12.7	20.2	11.5	27.7	10.2	14.7	8.3	14.2	10.7	55.6	13.0	15.4	13.9	15.0	12.1	12.9	15.8	12.3	20.4	12.5	14.3	17.5	13.1	10.9	14.6	15.1	20.2	17.3	17.7	16.3	14.9	12.5	9.7	9.2	7.4	21.3	20.2	3.7	15.7	20.4	18.0	22.5	13.2	10.7	33.8	16.1	18.3	23.9	10.4	14.5	26.0	20.4	21.7	8.3	14.5	14.1	9.5	19.0	12.6	14.6	17.0	7.7	21.2	15.0	9.4	11.2	12.9	10.9	21.3	18.6	10.0	18.4	5.4	6.9	8.2	9.7	9.0	20.6	25.1	11.4	14.7	16.2	12.0	13.6	10.5	16.5	9.1	11.4	10.5	14.7	15.9	8.0	14.4	18.8	40.9	25.6	25.4	16.5	14.8	8.5	20.2	14.7	11.5	12.3	17.3	12.4	14.1	13.7	12.6	15.1	14.6	14.8	14.8	6.2	17.7	15.2	10.6	16.3	14.9	11.9	19.3	17.6	25.7	10.4	10.0	14.5	14.8	27.7	12.3	20.8	22.7	11.9	7.5	20.4	16.0	56.7	5.1	12.0	7.9	19.2	21.6	18.8	16.6	15.0	176.3	20.2	27.2	23.3	22.2	16.5	20.2	7.3	18.5	39.4	23.8	17.5	22.5	30.1	24.3	325.8	19.5	18.9	28.7	22.6	25.4	21.5	14.4	25.7	20.8	30.4	13.6	19.4	20.6	20.0	10.2	23.5	17.2	25.4	19.0	5.5
SLC25A47	C14orf68	ENSG00000140107	"Solute carrier family 25 member 47"	Q6Q0C1	14	100323337-100330378	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	88	"liver: 127.2"	"Cell type enriched"	"Detected in some"	21	"Hepatocytes: 185.9"	"Cancer enriched"	"Detected in single"	273	"liver cancer: 56.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 5.7;HL-60: 1.4;RH-30: 1.4;SCLC-21H: 2.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"									NA	NA						"unprognostic (2.54e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	127.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.0	5.7	0.0	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	2.0	0.2	0.6	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	185.9	0.0	0.0	0.0	4.3	8.8	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.0
SLC25A48	"FLJ44862, HDMCP"	ENSG00000145832	"Solute carrier family 25 member 48"	Q6ZT89	5	135579202-135889770	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 22.4;kidney: 11.7;skeletal muscle: 12.8"	"Cell type enhanced"	"Detected in some"	26	"Distal tubular cells: 8.3;Enterocytes: 4.5;Proximal tubular cells: 27.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.0;HEK 293: 4.2;HEL: 4.1;RPMI-8226: 3.7;SCLC-21H: 3.9;U-2 OS: 5.1"									HPA014674	Uncertain		Approved	"Intermediate filaments,Actin filaments"		NA	NA			"Intermediate filaments"	"Actin filaments"	"HPA014674: AB_1859512"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	1.0	0.8	10.8	1.0	13.0	0.9	1.6	1.3	18.8	0.9	2.0	10.3	0.0	2.0	1.0	0.7	1.3	0.7	0.9	0.9	11.9	8.1	11.7	1.3	0.7	1.0	22.4	4.1	0.7	3.3	0.8	0.4	1.1	5.6	1.3	1.8	0.0	3.5	0.6	12.8	3.2	4.1	0.7	5.4	0.9	0.8	1.2	15.2	0.0	1.0	0.5	0.7	0.8	0.3	0.6	1.0	2.1	1.0	0.8	0.7	0.2	0.4	0.3	0.1	0.3	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.4	0.7	0.1	0.4	0.0	0.1	0.5	5.0	0.0	0.0	0.7	4.2	4.1	0.6	0.8	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.1	0.0	0.0	1.7	0.8	0.0	0.1	0.1	0.0	3.7	0.3	0.6	3.9	0.4	0.7	0.5	1.0	1.3	1.8	0.6	0.5	0.4	5.1	0.3	0.2	1.7	0.5	0.2	0.4	0.4	0.3	2.1	0.3	0.7	0.5	0.5	0.6	0.5	0.5	0.4	0.3	0.6	0.6	0.7	1.5	0.8	1.0	1.0	0.5	0.2	10.8	13.0	1.3	9.9	11.9	8.1	22.4	4.1	5.6	15.2	0.0	0.0	0.0	0.0	2.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.8	0.3	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.2	0.1	2.9	0.0	27.1	0.1	0.0	0.0	0.1	0.5	0.6	0.1	0.0	1.6	0.1
SLC25A5	"2F1, ANT2, T2, T3"	ENSG00000005022	"Solute carrier family 25 member 5"	P05141	X	119468400-119471319	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Chromosome partition, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Distal tubular cells: 2147.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		7800000	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.25e-2)"	"prognostic favorable (7.35e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.41e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-1)"	26.0	28.9	26.8	32.2	29.5	36.5	36.6	21.8	39.0	23.0	74.1	16.3	26.0	120.7	22.5	18.3	64.1	17.5	39.5	31.4	22.5	18.8	80.7	71.0	38.3	53.8	27.2	23.8	18.1	128.2	22.5	14.6	30.7	24.2	18.9	84.9	20.1	58.3	21.5	16.6	42.1	157.5	33.6	20.5	34.3	68.2	16.8	17.1	87.0	31.1	59.9	47.0	30.8	33.8	51.6	97.8	18.5	113.2	33.4	48.0	84.9	82.0	78.9	30.9	53.1	19.8	29.2	57.4	30.7	33.5	64.8	58.0	65.5	52.1	104.2	41.3	29.4	46.8	57.8	75.8	64.1	59.2	27.5	73.1	35.1	47.7	46.6	25.1	95.3	58.0	31.7	72.1	66.7	42.6	24.7	67.2	53.7	28.1	43.2	35.3	182.7	84.3	96.8	65.0	112.7	127.2	46.3	39.1	80.8	49.3	66.0	37.4	35.4	52.7	80.3	62.1	32.9	33.1	48.3	27.9	30.7	44.4	68.3	110.0	50.7	62.9	83.4	33.9	97.5	49.5	10.1	68.1	18.5	20.7	113.2	23.9	51.6	30.1	26.9	97.8	39.7	30.1	28.3	11.3	33.4	84.9	53.9	48.0	84.9	26.8	29.5	21.8	39.0	22.5	18.8	27.2	23.8	24.2	17.1	151.8	244.7	335.6	401.9	724.7	105.3	125.5	328.6	187.4	221.8	177.9	56.9	945.1	2147.0	467.3	2.7	209.6	1628.0	163.5	919.2	321.7	246.2	228.4	191.3	343.1	785.8	25.4	385.2	119.1	477.4	13.9	134.6	447.5	519.6	300.2	755.1	85.2	524.3	956.2	104.0	1138.1	131.4	129.4	460.4	8.9	116.7	839.4	1329.0	292.0	958.7	657.9
SLC25A51	"CG7943, MCART1, MGC14836"	ENSG00000122696	"Solute carrier family 25 member 51"	Q9H1U9	9	37879400-37904353	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"Early spermatids: 74.4;Late spermatids: 125.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 13.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA046388: AB_2679649, HPA058261: AB_2683657"	"unprognostic (5.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (6.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (8.27e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (2.08e-2)"	17.6	9.1	11.7	9.9	12.9	21.2	27.6	11.3	14.2	12.0	10.7	12.0	10.8	15.3	10.3	10.2	12.6	8.1	10.7	11.5	12.9	9.3	13.3	9.7	14.6	10.8	11.9	14.9	11.0	16.7	20.6	12.8	9.7	11.9	10.5	9.0	8.2	13.3	8.4	15.9	11.7	13.4	12.2	11.4	12.6	9.7	18.8	12.4	14.4	9.8	7.6	12.9	9.1	10.2	3.1	1.4	13.4	3.9	2.1	3.6	1.1	8.2	6.6	5.1	8.0	24.5	10.7	5.2	7.0	7.3	6.1	8.9	8.6	3.6	17.4	4.1	16.6	8.6	4.1	13.6	9.9	11.8	11.9	4.2	5.3	18.2	12.0	13.8	8.3	7.8	10.7	11.6	9.1	11.7	9.7	11.0	16.7	11.6	13.9	13.0	4.7	10.0	1.9	6.3	8.5	4.8	7.0	6.8	10.7	6.1	6.0	10.7	6.9	5.6	6.8	4.0	9.0	3.7	9.1	11.9	10.3	12.1	4.8	8.7	5.3	11.2	12.2	13.5	6.1	8.5	13.4	1.9	3.2	2.1	3.9	3.6	3.1	2.3	3.0	1.4	2.2	2.2	2.5	1.5	2.1	1.6	0.6	3.4	1.1	11.7	12.9	11.3	14.2	12.9	9.3	11.9	14.9	11.9	12.4	8.9	0.6	4.2	5.0	4.1	4.3	5.7	2.5	1.4	2.3	1.8	3.9	3.2	14.9	8.3	74.4	3.4	5.1	0.0	6.3	11.8	4.2	3.9	3.5	3.2	10.5	1.6	3.5	0.6	5.9	125.5	3.4	5.0	1.7	9.0	4.2	3.4	7.2	7.0	3.9	13.4	3.4	0.0	3.1	10.2	10.3	5.1	3.3	3.2	3.5	3.4
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392724	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 85.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		7200000	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.57e-3)"	18.5	19.7	12.1	12.2	14.0	23.7	14.4	8.2	12.2	9.8	16.5			28.9	14.3	4.8	16.4	10.4	7.0	9.4	10.3	8.2	18.4	5.4	11.1	14.4	9.4		25.6	38.7	10.1	14.0	8.6		12.4	8.8		45.0	12.5	6.1	14.9	23.3	7.7	5.8	15.4	19.2	2.4			16.3		9.5	14.2	11.2	62.2	85.7	3.7	69.0	30.1	43.6	71.2	22.2	48.7	34.6	35.3	24.0	46.8	37.5	34.1	32.7	25.2	25.1	64.4	27.2	82.8	27.6	22.4	38.0	14.5	23.2	40.7	7.9	20.7	73.8	45.2	33.4	73.5	56.3	32.5	55.2	77.2	75.0	19.7	29.0	32.7	37.3	26.1	31.5	19.5	24.6	47.4	60.1	62.3	43.9	8.8	65.7	30.4	28.6	64.2	30.7	56.0	56.6	88.9	23.1	70.1	97.0	21.0	38.9	67.0	42.7	25.7	14.4	50.2	34.0	50.6	8.1	55.8	3.8	31.4	13.9	2.4	58.1	3.7	29.4	69.0	43.6	62.2	40.4	34.8	85.7	47.5	38.1	37.2	3.0	30.1	67.9	41.0	38.7	71.2											137.0	195.3	871.5	1042.4	1022.6	282.9	87.0	257.4	128.5	280.9	300.1	92.3	1322.2	1405.9	633.0	8.9	418.0	863.0	303.7	1275.3	963.9	807.0	855.9	337.0	132.8	1090.5	228.8	892.0	411.9	1235.3	26.5	618.4	976.3	715.3	1354.4	1107.0	100.8	835.0	866.6	344.4	1021.3	199.6	336.3	860.1	13.3	52.8	1155.2	1458.6	553.5	1380.0	1328.6
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.1;liver: 45.4"	"Group enriched"	"Detected in some"	4	"Extravillous trophoblasts: 3.3;Hepatocytes: 9.0;Proximal tubular cells: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 7.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 13.3;HMC-1: 9.1;T-47d: 9.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.1	6.5	1.4	1.7	1.7	1.5	1.6	4.6	2.7	1.3	7.4	1.1	1.1	6.5	1.4	1.9	1.1	1.1	2.6	1.1	1.4	1.5	17.1	45.4	1.1	1.7	1.1	1.1	1.6	4.0	0.0	2.1	1.1	1.1	1.8	0.0	1.1	4.2	1.1	1.5	3.1	10.5	1.1	1.1	2.4	4.0	1.1	1.1	1.1	2.0	1.1	1.1	1.1	1.1	0.4	0.3	7.0	0.6	1.1	1.8	0.7	1.3	2.3	0.0	1.8	0.2	0.4	4.2	1.9	0.1	0.0	0.0	4.5	2.6	0.7	2.3	0.0	1.8	1.3	0.1	0.0	0.0	2.6	0.9	3.4	3.1	13.3	0.2	2.1	9.1	0.6	0.2	0.1	0.0	1.0	0.3	2.9	3.5	0.0	0.4	2.9	1.3	3.6	1.0	1.7	7.2	7.3	0.0	0.3	0.7	5.1	0.2	1.4	0.5	0.2	1.2	0.4	9.2	1.4	2.1	4.8	1.0	4.8	1.3	7.0	3.2	1.2	1.7	4.4	2.1	7.0	0.6	0.4	0.4	0.3	0.8	0.4	1.2	0.9	0.2	0.1	0.8	1.8	0.0	1.1	0.3	0.3	1.6	0.7	1.4	1.7	4.6	1.6	1.4	1.5	1.1	1.1	1.1	1.1	0.0	0.6	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	1.3	0.0	0.3	3.3	0.2	0.1	1.1	9.0	0.6	0.0	0.0	1.3	0.3	0.0	0.9	0.0	1.7	0.0	0.6	0.2	0.6	0.2	0.4	8.5	0.1	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.6	0.1
SLC26A10		ENSG00000135502	"Solute carrier family 26 member 10"	Q8NG04	12	57619527-57626151	"Predicted membrane proteins, Transporters"	"Antiport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 8.5"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 9.1;Peritubular cells: 4.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.0;HEK 293: 3.5;NTERA-2: 5.6;RH-30: 4.4;SH-SY5Y: 7.9;U-266/70: 5.4"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA044719	Uncertain					NA	NA					"HPA044719: AB_10962362"	"unprognostic (1.16e-1)"	"unprognostic (1.21e-2)"	"unprognostic (8.57e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.12e-5)"	"unprognostic (3.22e-3)"	"unprognostic (2.65e-12)"	"unprognostic (1.28e-2)"	"unprognostic (3.80e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.40e-1)"	2.0	0.7	0.4	0.5	0.9	0.0	0.4	3.8	0.9	0.4	0.8	0.4	0.4	0.0	2.9	1.2	0.4	1.9	1.8	8.5	0.4	0.2	0.4	0.4	0.4	0.5	0.4	0.4	0.9	0.4	0.0	0.4	0.4	0.4	2.1	0.5	0.4	0.8	1.6	2.6	0.1	1.1	1.9	0.4	0.7	0.6	0.4	0.4	0.4	0.4	0.4	0.4	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	3.0	0.0	0.0	0.5	1.1	0.2	0.7	0.3	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.7	0.0	0.2	0.0	3.5	0.4	0.2	0.7	0.7	0.0	0.1	0.0	0.0	0.5	0.0	0.4	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	4.4	0.0	0.0	0.0	2.3	7.9	0.0	0.0	0.5	0.4	0.1	0.6	0.0	0.6	1.3	0.7	0.0	5.4	0.5	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	3.8	0.9	0.4	0.2	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.3	9.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	4.9	0.0	0.8	0.0	1.7	0.5	0.2	0.4	0.1	0.0	0.0	0.0
SLC26A11		ENSG00000181045	"Solute carrier family 26 member 11"	Q86WA9	17	80219699-80253500	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 37.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"dendritic cells: 1.3;monocytes: 2.3;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029893	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA029893: AB_10600809"	"unprognostic (5.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (3.80e-2)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (2.86e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.40e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.32e-2)"	9.9	30.9	10.2	10.2	19.3	16.3	8.4	9.1	18.0	11.6	8.2	12.6	14.1	8.7	11.6	14.6	6.9	9.2	10.0	5.1	9.4	30.5	12.4	6.9	12.8	14.3	10.5	17.4	18.3	7.9	14.9	25.6	21.1	17.2	11.8	5.1	15.6	12.2	14.8	6.5	13.1	11.9	11.6	9.3	17.3	7.3	4.8	7.3	1.8	18.1	4.9	6.7	9.8	14.1	0.4	1.3	0.1	2.3	0.1	4.9	1.9	0.5	8.2	9.7	7.5	4.9	3.6	11.2	4.7	5.9	10.6	6.6	9.4	1.7	0.1	9.6	4.9	7.7	3.1	5.4	3.5	4.2	11.2	9.7	0.0	10.4	8.7	12.9	0.0	1.5	6.6	5.7	5.1	2.3	1.0	8.9	1.9	4.0	11.9	6.2	7.7	0.4	0.2	4.3	2.3	8.0	0.4	1.0	4.3	9.6	9.0	3.8	11.9	4.7	11.8	12.2	15.8	14.1	0.2	6.6	8.6	5.0	7.3	0.5	13.5	5.1	1.3	4.4	0.0	6.8	0.0	2.3	0.0	1.8	0.9	2.6	0.4	3.2	2.6	1.3	0.2	4.9	2.0	0.1	0.1	0.3	0.0	4.0	1.9	10.2	19.3	9.1	18.0	9.4	30.5	10.5	17.4	17.2	7.3	6.0	12.0	0.9	9.3	4.0	28.0	2.0	0.0	2.7	5.7	12.2	55.0	12.2	1.7	6.3	0.4	14.1	3.9	0.0	5.3	7.0	8.2	9.4	1.1	2.0	14.0	3.2	9.8	6.2	5.9	0.2	15.8	8.3	3.3	2.8	2.5	21.0	3.9	3.5	11.7	4.8	37.6	32.3	4.7	0.2	1.5	4.1	21.7	5.7	2.8	5.2
SLC26A2	"DTD, DTDST"	ENSG00000155850	"Solute carrier family 26 member 2"	P50443	5	149960737-149993455	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease mutation, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 81.9"	"Cell type enriched"	"Detected in many"	4	"Syncytiotrophoblasts: 676.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 24.2;RPTEC TERT1: 55.5;TIME: 28.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041957, HPA058090"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA041957: AB_10795646, HPA058090: AB_2683602"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.06e-1)"	8.5	15.6	2.6	23.2	3.7	1.3	4.7	6.3	2.3	3.8	81.9	3.0	29.4	5.4	4.8	14.2	8.3	3.1	2.6	3.1	2.5	2.6	3.8	1.6	6.8	5.3	3.7	2.3	5.1	2.9	21.4	11.1	16.9	7.6	6.1	75.0	4.9	27.9	36.7	11.2	6.0	13.4	4.3	5.5	3.0	2.4	2.8	3.0	5.2	2.7	4.4	13.0	4.1	2.8	1.6	1.7	7.0	3.3	2.5	3.0	1.1	3.3	3.0	3.8	6.2	4.6	3.3	0.9	3.1	2.8	2.5	3.1	15.7	1.8	2.5	24.2	3.3	6.1	2.4	3.6	7.3	4.6	2.0	2.3	3.2	2.4	1.8	3.5	5.9	5.5	3.6	4.3	4.2	5.5	6.3	6.0	3.2	0.8	2.6	10.6	1.0	2.2	3.1	1.2	1.1	4.8	3.3	5.9	1.3	55.5	14.7	1.1	2.9	5.5	1.3	9.4	3.1	2.6	3.5	28.5	5.9	4.4	5.1	3.7	1.8	2.4	1.5	5.4	7.2	8.4	7.0	1.1	0.8	2.5	0.8	3.0	1.3	1.5	2.1	1.7	1.6	2.1	2.2	1.0	2.5	3.3	1.7	2.6	1.1	2.6	3.7	6.3	2.3	2.5	2.6	3.7	2.3	7.6	3.0	41.7	13.7	7.5	12.5	4.0	16.1	6.7	7.6	6.7	14.8	31.4	15.7	160.9	1.7	5.2	17.7	15.3	151.8	0.0	8.6	5.2	16.0	21.5	87.8	2.4	26.4	6.4	20.3	16.5	13.8	9.9	16.1	12.2	86.0	16.2	37.7	15.0	9.4	147.9	11.7	4.4	80.3	0.0	10.2	9.2	10.2	4.4	676.5	9.6	53.2	4.9
SLC26A3	"CLD, DRA"	ENSG00000091138	"Solute carrier family 26 member 3"	P40879	7	107765467-107803225	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 53.5;intestine: 110.1;lymphoid tissue: 42.8"	"Cell type enriched"	"Detected in some"	11	"Enterocytes: 543.6"	"Cancer enriched"	"Detected in many"	14	"colorectal cancer: 52.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;CACO-2: 1.9;NB-4: 1.5;RPMI-8226: 7.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA036055	Approved					NA	NA					"HPA036055: AB_10602401"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.58e-3)"	0.3	0.3	0.3	42.8	0.3	0.0	6.1	0.3	0.3	0.4	110.1	0.2	0.3	58.4	0.3	1.2	0.3	0.6	53.5	0.3	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.3	0.0	0.3	0.2	0.2	0.5	92.7	0.2	0.3	14.4	0.3	0.3	106.5	1.2	0.3	0.3	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	48.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	543.6	0.0	0.0	0.0	0.0	0.2	27.5	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	26.7	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.4	0.0
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660635-107717809	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"thyroid gland: 79.2"	"Cell type enhanced"	"Detected in many"	7	"Alveolar cells type 2: 11.4;Glandular cells: 8.7;Intestinal endocrine cells: 7.0;Melanocytes: 6.8"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	5	"B-cells: 3.1"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.5;hTERT-RPE1: 8.3;LHCN-M2: 4.6"	"Region enriched"	"Detected in some"	4	"hippocampal formation: 10.6"	"Low region specificity"	"Detected in all"			HPA042860	Approved					NA	NA					"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.1	0.0	0.8	0.2	0.5	0.0	0.2	0.0	2.9	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.2	3.3	0.0	0.2	0.0	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.0	1.8	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	79.2	0.0	0.1	0.8	0.1	3.1	0.1	0.1	0.2	0.1	0.5	0.3	0.7	0.3	0.5	0.0	0.7	1.5	0.4	0.3	0.2	0.3	0.1	0.0	0.1	0.1	2.5	0.3	0.0	0.2	0.5	0.2	0.1	3.5	0.9	0.0	0.3	0.2	0.4	0.4	1.1	0.0	0.9	0.4	0.0	8.3	0.1	0.8	0.0	0.4	4.6	0.7	0.0	0.4	0.0	0.0	0.8	0.2	1.3	0.0	0.0	0.1	2.5	0.1	0.0	0.0	1.7	0.2	0.0	0.4	0.7	0.7	0.5	0.2	2.8	0.7	0.7	0.3	0.8	0.4	1.7	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	3.1	0.0	0.1	0.1	0.1	0.2	0.1	0.5	0.3	0.8	0.5	0.0	1.4	0.5	0.2	0.1	0.6	0.0	0.0	3.0	11.4	0.0	0.6	1.4	5.6	0.7	0.0	1.4	4.5	0.0	2.0	0.2	0.0	0.1	2.6	0.7	0.0	0.0	0.0	0.1	1.1	8.7	4.7	0.0	0.2	1.6	7.0	0.6	0.3	2.0	0.9	1.4	6.8	1.0	0.0	0.4	0.1	0.0	1.1	0.0	1.1	0.0	0.9	1.7	0.3	1.3	0.0	1.0	0.0	1.2
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446177	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	4	"brain: 20.4"	"Cell type enhanced"	"Detected in some"	14	"Alveolar cells type 1: 6.0;Ciliated cells: 4.0;Ito cells: 3.7"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"cerebellum: 20.4"	"Cell type enriched"	"Detected in single"	8	"basophil: 2.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.9;PC-3: 2.6;U-2197: 1.8"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in some"	8	"basal ganglia: 9.5"							NA	NA						"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	1.3	1.0	0.6	0.3	0.7	2.3	3.1	20.4	0.8	0.6	0.3	0.5	0.0	0.9	0.5	0.0	0.2	0.4	0.2	0.4	0.8	0.4	0.7	0.9	2.2	1.2	1.3	0.4	0.4	0.7	2.5	4.6	0.1	2.6	3.1	0.1	0.9	1.4	1.0	0.6	2.2	0.5	1.2	2.9	0.9	3.2	0.9	0.2	0.0	1.8	0.0	0.2	3.2	0.4	0.2	0.0	2.7	0.1	0.3	0.1	0.0	0.2	0.0	0.3	0.7	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	1.1	0.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.2	0.9	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	2.9	0.0	1.2	0.8	0.3	0.1	0.5	2.6	0.3	0.1	0.4	0.0	0.8	0.9	1.5	0.3	0.3	0.0	0.6	0.7	0.0	0.0	0.6	0.6	1.8	0.4	0.8	0.4	0.4	0.2	0.2	0.3	2.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.7	20.4	0.8	0.8	0.4	1.3	0.4	2.6	0.2	6.0	1.6	0.0	0.0	0.2	0.1	0.8	0.0	4.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.6
SLC26A6	DKFZp586E1422	ENSG00000225697	"Solute carrier family 26 member 6"	Q9BXS9	3	48625723-48635493	"Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 43.3;Mucus-secreting cells: 32.0;Paneth cells: 36.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048363	Approved		Uncertain	Cytosol		NA	NA			Cytosol		"HPA048363: AB_2680371"	"unprognostic (1.54e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.66e-3)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.58e-2)"	5.3	5.7	6.4	12.3	9.8	18.8	5.7	6.8	6.9	6.3	24.8	6.0	7.3	9.7	6.8	7.4	6.5	4.7	6.3	6.7	4.9	3.1	13.6	6.2	7.8	7.4	9.4	3.1	6.7	14.9	6.8	5.8	6.5	9.3	10.2	25.4	7.7	9.6	7.4	8.8	6.7	19.5	6.8	4.8	10.6	19.7	7.7	9.9	7.7	5.5	5.4	6.3	5.1	6.6	0.9	8.8	5.2	10.7	0.5	3.3	4.5	4.5	5.1	7.3	8.2	23.1	11.6	6.2	7.5	9.9	14.6	15.7	9.7	4.2	6.5	2.6	6.4	16.2	6.1	6.8	6.9	4.2	4.8	6.8	5.9	14.5	18.7	16.8	2.8	9.2	15.8	24.8	9.9	7.2	12.6	4.5	6.7	4.5	7.4	3.5	5.4	5.4	14.8	10.4	12.5	9.9	2.8	2.7	7.9	10.7	4.5	1.8	3.5	9.8	12.1	14.1	10.6	6.3	10.5	3.6	6.3	5.3	8.5	17.1	8.8	9.2	2.9	5.3	11.1	15.9	5.2	10.7	2.1	3.1	10.0	2.8	0.9	1.9	2.0	8.8	0.2	1.1	1.6	1.5	0.5	8.9	5.0	3.3	4.5	6.4	9.8	6.8	6.9	4.9	3.1	9.4	3.1	9.3	9.9	3.0	5.1	0.8	2.4	2.9	1.5	6.4	2.5	2.7	1.2	1.8	13.7	7.5	0.0	2.5	1.2	2.9	43.3	0.0	5.6	13.1	4.3	1.9	0.0	4.2	6.2	4.8	19.5	5.5	5.2	0.7	3.4	7.0	5.0	4.6	32.0	2.0	5.2	36.6	8.9	5.1	6.4	0.0	5.7	2.5	5.7	3.0	8.8	3.8	23.5	0.8
SLC26A8		ENSG00000112053	"Solute carrier family 26 member 8"	Q96RN1	6	35943514-36024868	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 65.2"	"Cell type enhanced"	"Detected in some"	24	"Early spermatids: 26.1;Late spermatids: 8.8;Spermatocytes: 42.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;RT4: 2.9;T-47d: 1.0;THP-1: 2.3;TIME: 1.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038081	Enhanced					NA	NA					"HPA038081: AB_10670653"	"unprognostic (8.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.63e-6)"	"unprognostic (7.14e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.24e-8)"	0.3	0.2	1.3	0.5	2.2	3.7	0.3	4.2	1.8	0.2	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	2.1	0.2	0.2	0.2	1.1	0.7	1.7	0.2	0.3	0.2	0.1	0.2	1.9	0.2	0.2	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.6	0.9	0.2	65.2	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.2	5.4	0.4	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.4	0.0	0.0	0.8	2.9	0.8	0.0	0.0	0.0	0.1	0.2	1.0	2.3	1.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.2	1.3	2.2	4.2	1.8	0.8	2.1	0.7	1.7	1.9	0.1	3.0	1.4	0.0	0.3	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.8	0.1	0.0	0.0	0.6	1.2	8.8	0.9	0.4	1.7	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	42.9	0.3	0.1	0.2	0.0	0.0	0.1
SLC26A9		ENSG00000174502	"Solute carrier family 26 member 9"	Q7LBE3	1	205913048-205943460	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"salivary gland: 108.4"	"Cell type enhanced"	"Detected in some"	23	"Alveolar cells type 2: 51.6;Cardiomyocytes: 25.8;Proximal tubular cells: 10.5"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.6;Hep G2: 4.7;OE19: 20.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051485	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA051485: AB_2681503"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.01e-1)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	1.3	0.1	6.4	0.1	0.1	0.0	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.5	0.0	0.3	0.1	0.1	0.1	0.0	0.1	108.4	0.1	0.1	1.9	0.1	0.1	0.1	0.1	17.8	0.1	0.1	0.2	0.4	1.1	2.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.0	51.6	0.0	0.0	0.0	0.0	25.8	0.0	4.0	4.5	1.8	0.0	0.0	1.7	2.9	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6
SLC27A1	"ACSVL5, FATP, FATP1, FLJ00336, MGC71751"	ENSG00000130304	"Solute carrier family 27 member 1"	Q6PCB7	19	17468769-17506168	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 17.6;SK-MEL-30: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076520			Approved	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Plasma membrane"	"Mitochondria, Cytosol"	"HPA076520: AB_2732311"	"unprognostic (1.48e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	14.5	14.3	13.1	5.2	13.9	2.0	9.3	20.1	19.3	11.8	6.4	44.1	10.1	4.6	8.9	6.4	5.9	14.7	11.0	18.3	12.9	10.0	5.2	5.2	8.5	6.7	22.0	17.2	23.2	14.5	26.1	9.8	7.5	16.1	11.0	2.6	9.6	26.7	13.0	24.2	13.7	3.7	5.5	13.4	7.1	10.9	9.6	19.3	1.3	9.9	4.7	5.3	6.9	8.8	0.5	7.4	0.3	9.9	1.7	3.2	4.6	3.6	1.8	2.5	6.1	17.6	9.8	2.1	2.6	7.0	3.0	4.5	0.2	11.3	1.2	5.0	4.4	2.8	4.4	0.2	4.1	0.7	1.4	0.8	0.7	0.2	1.3	3.4	0.3	4.0	9.0	2.9	3.0	1.2	12.5	2.0	2.4	0.4	0.7	1.9	1.5	2.0	2.9	0.7	3.6	3.2	2.8	2.0	0.8	1.9	1.1	0.8	1.8	1.8	0.9	29.1	1.6	3.2	0.9	1.2	5.9	3.9	4.7	1.8	2.5	1.8	0.4	6.1	3.2	4.1	0.0	9.9	0.3	1.7	4.7	3.2	0.5	1.2	2.1	7.2	0.3	1.6	2.1	0.0	1.7	1.8	7.4	0.7	4.6	13.1	13.9	20.1	19.3	12.9	10.0	22.0	17.2	16.1	19.3	3.0	14.0	1.5	14.9	6.0	8.2	16.7	10.2	4.0	9.1	8.7	25.5	3.7	1.7	9.3	0.7	4.7	0.1	0.0	4.1	14.7	9.7	10.3	2.3	5.8	24.7	6.4	5.2	9.2	20.6	1.7	19.8	9.1	8.5	5.4	2.6	9.7	4.9	0.0	11.0	2.7	17.6	6.5	5.2	8.1	4.3	4.0	1.9	6.1	1.3	7.0
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236395	"Enzymes, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 168.1"	"Cell type enhanced"	"Detected in many"	15	"Cytotrophoblasts: 236.8;Hepatocytes: 188.9;Proximal tubular cells: 112.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	27	"basophil: 27.3"	"Lineage enriched"	"Detected in many"	27	"granulocytes: 27.3"	"Cell line enhanced"	"Detected in many"		"A549: 17.9;HaCaT: 32.2;HL-60: 23.1;OE19: 36.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"hippocampal formation: 2.5"	HPA026089	Enhanced					NA	NA					"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.40e-4)"	1.1	8.1	0.7	4.1	0.8	1.2	3.4	1.5	1.0	0.5	4.2	0.4	1.3	2.5	0.2	17.5	1.2	2.6	1.3	0.2	1.1	1.1	39.4	168.1	1.7	0.8	0.3	1.0	0.7	6.3	2.0	10.4	7.4	3.0	1.2	4.0	3.2	0.6	0.3	0.2	0.6	5.3	0.1	0.3	0.4	0.4	0.7	0.1	0.1	1.0	0.2	1.3	1.4	0.8	0.1	0.0	27.3	0.0	1.0	0.5	0.2	0.0	17.9	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.5	9.3	2.5	0.0	0.2	0.4	0.2	32.2	8.2	0.2	0.8	12.6	10.1	13.2	16.6	8.3	0.1	23.1	9.5	0.0	0.7	0.0	0.0	0.0	0.0	6.1	4.0	0.0	0.0	2.9	0.6	15.6	0.6	36.0	0.6	0.0	0.0	0.6	1.7	16.3	14.9	0.9	3.1	0.4	0.0	0.4	1.7	8.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	27.3	0.0	0.4	0.4	0.0	0.4	0.1	0.4	0.4	0.0	0.1	0.1	0.1	0.2	1.0	0.0	0.0	0.5	0.2	0.7	0.8	1.5	1.0	1.1	1.1	0.3	1.0	3.0	0.1	0.0	0.6	0.9	0.8	0.9	0.7	0.3	0.0	54.9	6.8	8.7	0.0	236.8	10.0	0.3	0.4	0.1	20.6	0.0	1.7	2.6	0.0	1.8	5.8	188.9	14.3	1.6	4.1	3.7	2.5	0.0	0.3	0.1	0.0	0.0	18.6	0.5	1.6	28.1	0.0	112.0	1.5	0.0	0.1	1.8	2.5	0.3	45.9	4.3	21.1	4.4
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Ito cells: 131.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.9;granulocytes: 13.7;monocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 35.6;HaCaT: 12.5;MCF7: 18.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"		Yes	No			"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: AB_2685857"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	20.7	3.7	4.9	6.4	4.3	3.7	15.0	7.5	6.6	11.1	11.6	3.6	7.9	3.5	10.1	39.1	9.4	9.5	9.2	7.0	3.5	2.4	12.2	19.5	21.1	7.0	3.5	4.7	13.6	5.7	4.5	6.7	9.7	3.3	11.6	6.1	4.6	7.7	9.7	3.6	11.0	6.8	10.5	1.8	6.9	14.4	15.4	3.4	3.5	8.6	10.3	5.5	9.7	9.4	0.6	5.9	13.7	8.7	2.2	2.2	2.5	4.0	0.2	1.7	0.8	35.6	6.9	3.1	1.5	3.0	0.6	0.8	2.3	1.8	0.5	4.2	1.7	0.3	12.5	1.7	1.4	0.4	0.3	2.3	0.8	2.2	1.0	4.3	1.4	2.9	4.6	4.7	0.2	0.9	0.6	4.8	0.2	0.4	0.7	0.2	18.8	0.1	4.1	4.1	8.6	1.9	7.1	0.3	0.4	1.0	0.5	3.5	3.9	0.8	8.3	1.5	2.4	2.2	4.1	1.1	0.8	1.7	4.4	0.0	1.3	1.2	0.1	2.0	4.8	0.6	7.2	8.7	13.7	2.1	7.3	1.5	0.5	1.0	2.2	5.9	0.6	0.5	1.1	1.7	2.2	7.2	1.0	0.3	2.5	4.9	4.3	7.5	6.6	3.5	2.4	3.5	4.7	3.3	3.4	17.9	43.8	4.5	9.1	10.4	0.8	2.5	38.2	0.0	7.9	3.5	0.0	24.4	0.0	3.1	0.4	20.2	2.5	0.0	6.4	10.1	17.3	4.2	25.3	25.9	29.3	1.6	4.1	131.3	31.9	2.4	17.5	32.9	21.9	45.1	16.0	1.5	3.7	33.6	13.4	3.4	1.0	6.5	12.8	1.1	3.4	6.8	7.3	15.9	9.1	2.6
SLC27A4	"ACSVL4, FATP4"	ENSG00000167114	"Solute carrier family 27 member 4"	Q6P1M0	9	128340646-128361470	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase	"Disease mutation, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 56.1"	"Cell type enhanced"	"Detected in many"	9	"Enterocytes: 75.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007293, CAB009771"	Approved		Approved	Vesicles		NA	NA			Vesicles		"CAB009771: AB_2270540, HPA007293: AB_1857062"	"unprognostic (7.25e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (2.61e-5)"	"unprognostic (7.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.45e-2)"	"unprognostic (8.01e-3)"	7.7	7.1	9.9	7.0	13.6	2.5	4.9	9.4	26.5	6.5	25.7	15.8	5.2	54.0	6.6	5.6	26.1	4.4	9.8	7.7	11.6	15.9	17.7	20.8	5.8	5.0	14.8	9.6	5.6	11.3	9.8	5.4	5.8	21.9	5.7	8.3	6.7	7.5	7.3	6.7	24.3	56.1	8.1	11.6	5.1	8.6	13.2	7.9	6.8	12.7	15.2	14.9	8.5	9.5	3.7	7.2	2.6	6.2	1.9	8.1	3.3	10.2	20.1	10.3	13.2	15.7	4.8	11.8	8.7	5.5	10.1	7.3	14.4	10.1	9.6	7.0	9.3	12.1	35.2	12.4	10.0	3.1	9.6	19.1	5.7	17.7	12.5	8.5	10.5	9.2	6.3	13.7	10.4	8.3	4.5	11.4	13.0	13.5	6.7	9.2	25.2	12.4	10.1	4.6	23.2	32.0	15.2	10.1	17.8	17.2	15.5	17.9	9.8	14.5	26.7	9.5	5.4	13.3	4.0	16.7	12.1	11.8	13.2	10.7	6.0	8.5	3.1	12.3	6.3	13.6	0.0	4.1	2.6	8.1	5.6	6.1	3.7	5.2	6.4	7.2	1.7	4.1	4.3	1.6	1.9	6.2	6.4	3.6	3.3	9.9	13.6	9.4	26.5	11.6	15.9	14.8	9.6	21.9	7.9	0.0	1.4	3.0	1.2	2.5	9.3	2.8	7.6	1.4	0.0	8.7	11.8	4.9	1.7	12.4	2.2	3.3	75.1	0.0	13.8	5.7	3.8	2.4	9.2	15.5	9.9	7.9	12.6	4.9	7.1	3.6	1.1	2.9	1.7	12.6	14.0	4.8	20.8	31.7	3.9	8.1	6.2	6.5	2.7	8.8	6.9	5.4	4.3	1.7	12.4	2.6
SLC27A5	"ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2"	ENSG00000083807	"Solute carrier family 27 member 5"	Q9Y2P5	19	58479512-58512413	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Ligase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 157.6"	"Group enriched"	"Detected in many"	6	"Early spermatids: 114.0;Hepatocytes: 338.0;Late spermatids: 303.5"	"Cancer enriched"	"Detected in all"	26	"liver cancer: 49.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA007292, CAB056160, CAB068239"	Enhanced					NA	NA					"CAB056160: AB_2665590, CAB068239: AB_2665592, HPA007292: AB_1857064"	"unprognostic (5.97e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-2)"	"prognostic favorable (1.57e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.16e-1)"	1.3	2.0	5.4	1.4	5.3	1.1	2.0	1.9	3.9	1.7	1.0	1.7	1.2	1.0	1.1	1.1	1.4	2.6	1.1	1.3	3.7	3.8	1.9	157.6	0.9	1.4	4.3	2.5	1.4	2.6	1.1	1.3	0.8	3.4	1.4	0.8	1.3	2.7	2.1	1.4	1.1	0.9	1.5	2.7	1.1	1.1	2.3	3.0	1.4	1.8	0.6	1.4	1.1	1.6	13.3	10.8	2.2	3.0	9.6	18.7	8.9	16.0	22.0	3.9	4.1	3.7	3.9	2.4	0.9	2.1	3.1	4.3	1.7	3.5	20.9	2.7	1.1	0.6	3.4	4.5	14.1	1.3	9.7	14.9	14.0	22.9	18.3	5.6	7.3	5.0	4.5	2.4	0.4	8.5	5.3	1.5	15.9	12.9	0.0	3.7	13.1	18.1	15.5	2.4	13.5	12.9	9.1	0.1	28.4	10.1	7.6	5.4	7.3	0.0	21.7	4.7	1.1	6.4	6.4	1.2	0.0	2.8	0.0	1.8	13.8	15.4	8.5	4.5	13.7	0.8	0.0	2.4	2.2	8.7	3.0	18.7	13.3	11.2	11.4	6.5	8.9	13.9	14.3	0.3	9.6	2.1	10.8	13.3	8.9	5.4	5.3	1.9	3.9	3.7	3.8	4.3	2.5	3.4	3.0	0.0	8.2	11.5	13.1	8.0	11.5	5.6	22.9	9.4	5.7	5.2	0.0	6.4	33.2	10.3	114.0	11.9	1.3	0.0	13.3	2.3	7.6	17.0	4.7	338.0	9.1	9.5	9.7	15.4	11.3	303.5	10.0	8.9	15.1	1.8	3.5	6.1	7.4	0.0	8.9	39.7	7.6	6.5	15.5	8.8	13.2	12.3	2.9	10.2	4.7	12.1
SLC27A6	"ACSVL2, FACVL2, FATP6, VLCS-H1"	ENSG00000113396	"Solute carrier family 27 member 6"	Q9Y2P4	5	128538013-129033642	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 23.2"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 22.4;Cytotrophoblasts: 39.8;Extravillous trophoblasts: 30.2;Muller glia cells: 39.4;Syncytiotrophoblasts: 23.0"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 19.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"BEWO: 31.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008987	Approved		Approved	"Nuclear bodies"		NA	NA			"Nuclear bodies"		"HPA008987: AB_1857065"	"unprognostic (5.39e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.53e-1)"		"unprognostic (2.64e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.66e-4)"	0.5	23.2	6.3	0.5	6.8	0.3	2.9	0.6	2.8	4.1	0.9	8.2	0.0	0.6	4.2	0.5	7.2	19.5	2.7	20.6	3.2	3.3	0.2	0.3	0.9	0.4	10.4	0.0	9.7	0.3	0.2	7.7	19.6	13.3	3.7	1.8	1.7	3.9	0.4	0.5	2.2	1.1	1.0	12.7	0.3	0.6	11.3	15.1	5.4	3.9	8.7	5.5	1.5	3.2	0.2	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	31.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.6	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	2.4	0.0	2.2	1.5	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.2	3.1	0.0	3.7	0.0	2.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.3	6.8	0.6	2.8	3.2	3.3	10.4	0.0	13.3	15.1	0.0	0.0	0.0	1.0	2.9	0.0	22.4	0.0	0.0	0.0	0.0	0.0	39.8	0.0	0.0	6.2	0.0	0.0	0.0	0.0	30.2	0.9	0.1	0.0	0.0	3.4	3.2	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.9	1.0	0.6	23.0	0.0	0.0	0.0
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945796	"Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"intestine: 32.7;kidney: 35.6;liver: 43.8"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 34.1;Hofbauer cells: 40.6;Proximal tubular cells: 88.5"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.6;SK-BR-3: 1.8;SuSa: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.1	0.1	17.3	0.1	1.5	0.1	0.1	0.1	0.5	0.1	0.1	35.6	43.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	32.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.5	0.3	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.1	0.4	0.1	1.8	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	7.6	1.4	0.0	7.0	0.0	0.4	10.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	34.1	40.6	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	88.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1
SLC28A2	"CNT2, HCNT2, HsT17153, SPNT1"	ENSG00000137860	"Solute carrier family 28 member 2"	O43868	15	45252230-45277845	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"gallbladder: 28.7;intestine: 49.3"	"Cell type enhanced"	"Detected in many"	15	"Enterocytes: 26.0;Paneth cells: 17.3;Undifferentiated cells: 59.6"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.3;NB-4: 2.3"					"Low region specificity"	"Detected in all"			"HPA046068, HPA055623"	Enhanced					NA	NA					"HPA046068: AB_2679523, HPA055623: AB_2682866"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.95e-2)"	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.2	0.8	18.5	0.2	0.1	25.7	0.4	0.1	0.3	0.2	28.7	0.1	0.2	0.2	1.0	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.2	1.6	0.1	0.2	13.8	0.1	0.1	0.1	0.1	0.2	49.3	0.1	0.2	0.1	8.5	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.6	0.2	1.3	0.5	0.6	0.7	0.0	0.1	0.3	0.1	0.1	0.0	0.1	4.3	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.5	0.6	0.2	0.0	0.0	0.7	0.0	0.1	0.2	0.6	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.2	1.5	0.0	0.1	0.3	2.3	0.2	0.9	0.3	0.2	0.4	1.3	0.0	0.2	1.1	1.6	0.0	0.1	0.3	0.6	0.2	0.6	0.3	0.4	0.5	1.2	0.2	0.8	0.2	0.3	0.4	0.6	0.3	1.3	0.2	0.1	0.4	0.1	0.2	0.5	0.3	0.1	0.2	0.6	0.4	0.7	0.2	0.6	0.5	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1	0.0	7.2	0.9	0.2	0.1	2.7	0.4	12.7	8.1	7.9	0.0	2.0	11.0	0.0	0.0	0.4	0.4	26.0	0.0	0.0	1.6	0.4	0.2	8.1	0.0	0.8	1.6	13.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.6	0.5	0.0	17.3	0.7	0.3	4.6	0.0	0.0	1.9	1.7	0.3	3.9	0.9	59.6	0.1
SLC28A3	CNT3	ENSG00000197506	"Solute carrier family 28 member 3"	Q9HAS3	9	84275457-84340683	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 34.8;pancreas: 24.6;seminal vesicle: 29.1"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 7.6;Ductal cells: 17.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	16	"pons and medulla: 6.0"	"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 2.7"	"Lineage enriched"	"Detected in single"	6	"monocytes: 2.7"	"Cell line enriched"	"Detected in some"	7	"HMC-1: 36.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023311, HPA024729"	Approved					NA	NA					"HPA023311: AB_1857067, HPA024729: AB_1857069"	"prognostic favorable (3.37e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-7)"	"unprognostic (1.03e-1)"	"unprognostic (9.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.03e-2)"	5.1	0.0	0.1	0.8	0.3	9.9	10.2	0.1	0.1	1.2	1.3	0.7	34.8	1.0	0.8	2.8	4.5	2.6	12.2	0.6	0.3	0.2	0.2	0.4	1.1	0.1	0.1	0.1	2.0	24.6	0.0	2.5	0.1	6.0	1.0	2.9	0.6	12.5	29.1	0.1	9.8	2.0	0.1	0.1	0.4	0.8	0.5	0.1	0.9	0.2	6.4	3.3	0.3	1.4	0.2	0.0	0.0	2.7	0.4	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	3.9	0.4	0.9	0.5	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	36.9	0.0	0.3	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.0	0.0	0.3	0.0	5.5	0.0	0.1	3.7	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.2	0.1	0.3	0.1	0.1	0.3	0.2	0.1	0.1	6.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.7	7.6	4.0	1.2	1.8	0.0	0.1	0.0	17.3	1.0	0.0	0.3	0.0	2.6	0.1	0.1	0.1	1.1	0.0	1.9	0.0	2.9	0.0	2.4	1.3	0.0	0.7	0.0	1.8	3.4	0.6	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.1	0.0	2.4	0.1
SLC29A1	ENT1	ENSG00000112759	"Solute carrier family 29 member 1 (Augustine blood group)"	Q99808	6	44219505-44234151	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 117.2"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 192.2;Extravillous trophoblasts: 188.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	25	"eosinophil: 117.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 117.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012384	Approved					NA	NA					"HPA012384: AB_1857073"	"unprognostic (1.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.76e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.34e-1)"	42.9	40.9	5.8	9.4	9.6	17.9	57.2	10.4	15.2	21.2	35.8	5.9	6.9	5.2	19.8	11.7	22.8	14.9	24.4	46.8	5.4	6.4	14.7	23.2	15.3	14.4	5.5	8.4	12.5	35.8	8.7	15.2	23.2	9.8	21.4	7.4	18.0	15.7	8.4	53.0	23.8	12.4	39.0	5.3	11.4	33.0	8.8	4.8	53.9	18.8	17.2	11.1	28.7	20.7	0.5	4.7	117.2	4.5	0.3	0.9	0.7	16.5	16.5	11.8	19.0	18.2	1.7	70.5	12.2	4.8	17.1	11.7	18.0	6.8	33.7	12.3	3.6	10.6	20.6	21.1	14.7	10.4	19.1	19.4	29.1	11.4	23.3	2.9	32.7	28.1	2.2	3.8	25.1	8.8	34.8	42.9	27.6	39.3	19.9	9.3	18.2	26.9	21.9	17.9	42.9	11.1	18.0	23.8	40.8	10.0	9.7	15.2	19.6	3.5	11.9	8.6	12.7	16.1	20.7	64.9	9.4	15.4	12.7	23.1	13.6	17.7	43.0	5.7	26.7	11.3	1.8	1.4	117.2	0.6	4.5	0.4	0.5	0.3	0.4	0.8	0.3	0.1	0.3	0.2	0.3	3.6	4.7	0.9	0.7	5.8	9.6	10.4	15.2	5.4	6.4	5.5	8.4	9.8	4.8	0.0	10.9	0.8	7.7	9.5	9.0	38.3	20.4	8.1	6.8	7.0	13.7	192.2	3.3	21.3	0.4	24.6	0.5	0.0	50.3	188.6	38.1	6.0	8.1	12.1	53.2	4.8	30.0	19.6	23.3	1.5	30.5	11.7	33.7	11.8	2.4	4.7	45.0	3.1	50.5	0.9	10.8	90.5	16.5	0.3	10.0	13.7	35.1	3.5	5.3	6.8
SLC29A2	"DER12, ENT2, HNP36"	ENSG00000174669	"Solute carrier family 29 member 2"	Q14542	11	66362521-66372214	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 68.9"	"Cell type enhanced"	"Detected in many"	10	"Cytotrophoblasts: 40.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"B-cells: 1.6;dendritic cells: 1.6;T-cells: 4.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 16.7;CAPAN-2: 21.4;K-562: 16.1;T-47d: 26.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018168	Approved		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA018168: AB_1857077"	"unprognostic (3.20e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.37e-1)"	"unprognostic (5.08e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.38e-3)"	5.4	1.3	2.5	2.8	3.2	1.2	13.2	10.3	5.1	1.9	4.0	3.1	4.8	5.6	1.2	5.2	2.7	3.0	3.2	9.0	2.9	3.3	6.4	1.5	3.4	2.5	3.3	3.5	1.0	7.8	11.3	5.9	3.3	7.0	4.2	2.3	2.2	6.0	6.3	68.9	1.9	4.3	0.9	1.7	2.0	6.6	0.9	2.0	1.6	4.2	18.0	2.5	1.5	2.2	1.6	1.6	0.2	0.1	0.1	4.1	1.2	5.8	4.4	3.5	0.7	0.3	0.0	16.7	0.2	0.0	0.2	0.3	7.0	21.4	2.6	5.5	0.0	1.1	5.9	3.3	4.2	0.0	0.1	9.6	5.7	5.4	0.5	0.7	9.5	0.1	0.3	1.7	0.6	1.9	1.7	0.3	2.0	16.1	0.0	0.0	12.1	0.7	13.4	10.1	7.3	4.6	0.7	0.0	12.1	8.9	4.4	7.1	3.2	0.3	9.2	0.6	0.4	26.0	2.1	0.0	0.1	5.8	0.1	0.0	0.1	0.3	0.2	0.4	0.2	0.2	0.0	0.1	0.0	3.5	0.0	1.1	0.6	2.2	4.1	0.8	1.6	4.1	4.1	0.2	0.1	0.1	1.6	0.4	1.2	2.5	3.2	10.3	5.1	2.9	3.3	3.3	3.5	7.0	2.0	3.0	4.6	1.4	4.4	0.6	2.5	9.7	5.1	5.3	7.9	14.0	11.8	40.5	3.3	4.3	0.0	0.7	2.1	0.0	5.8	12.3	1.0	2.8	4.6	0.5	3.8	4.8	2.4	0.0	0.6	0.0	0.0	0.0	0.0	1.0	8.5	2.3	3.2	3.5	0.4	0.6	3.3	0.0	2.3	0.1	0.2	0.0	11.3	1.3	10.7	2.5
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319258-71381423	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Cytotrophoblasts: 36.0;Extravillous trophoblasts: 36.5;Hofbauer cells: 32.2;Syncytiotrophoblasts: 26.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 19.8;Hep G2: 22.0;RT4: 17.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.43e-3)"	11.3	4.0	6.4	6.6	8.3	1.9	6.8	3.2	12.6	8.3	6.1	11.3	2.4	4.1	12.1	4.6	3.5	9.4	7.4	3.6	8.0	5.5	3.9	12.5	11.1	10.5	9.8	6.5	15.8	7.4	7.1	2.8	24.6	6.7	8.3	6.0	4.6	7.5	5.4	2.1	3.7	4.9	8.9	8.0	9.4	8.9	4.9	7.7	9.3	6.7	1.3	6.2	18.4	10.0	3.6	19.3	2.8	12.9	5.7	4.0	5.6	1.2	7.4	1.1	4.7	4.2	3.3	19.8	1.4	1.4	0.4	0.2	8.1	5.2	4.3	4.0	2.8	2.0	11.7	3.4	1.9	0.0	3.4	3.3	1.3	0.6	22.0	2.0	1.0	2.8	3.2	8.1	0.2	0.3	0.9	1.9	5.3	3.9	4.1	0.5	11.4	2.7	2.1	2.5	11.4	2.7	3.4	0.4	3.4	1.7	17.5	5.6	5.9	3.9	12.8	1.0	3.5	1.9	2.3	3.1	0.1	2.4	1.3	0.0	1.1	1.8	2.4	5.1	14.5	0.8	2.8	12.9	1.4	4.0	10.1	3.4	3.6	3.2	3.6	19.3	1.5	2.6	3.6	1.0	5.7	6.3	13.6	3.4	5.6	6.4	8.3	3.2	12.6	8.0	5.5	9.8	6.5	6.7	7.7	3.0	0.6	0.5	1.7	0.2	1.1	0.6	2.5	2.7	3.4	0.0	0.0	36.0	0.0	4.3	3.3	1.1	1.3	0.0	7.9	36.5	2.6	2.8	2.3	4.9	32.2	0.0	1.7	3.7	7.8	10.5	2.6	9.5	1.7	10.0	2.7	2.4	6.6	11.5	1.4	1.4	0.2	0.0	0.3	0.5	4.7	0.0	26.5	1.0	2.7	1.2
SLC29A4	"ENT4, FLJ34923"	ENSG00000164638	"Solute carrier family 29 member 4"	Q7RTT9	7	5274369-5306870	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 35.7"	"Group enriched"	"Detected in many"	8	"Horizontal cells: 158.9;Intestinal endocrine cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 24.5;SH-SY5Y: 35.6;U-2 OS: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052829			Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Microtubules, Cytokinetic bridge"		"HPA052829: AB_2681967"	"unprognostic (6.04e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.49e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.60e-2)"	35.7	8.3	7.6	2.5	6.4	0.8	6.5	4.2	9.7	2.0	2.5	2.0	0.3	4.5	2.4	5.3	1.3	4.2	1.8	1.7	9.4	15.7	3.4	3.8	1.2	1.8	12.2	5.4	3.2	13.0	0.5	1.6	0.8	7.0	3.0	2.0	11.5	1.1	1.0	2.1	1.4	5.4	2.0	3.1	1.1	7.1	1.3	1.1	0.3	4.3	0.3	0.7	2.3	0.5	1.3	1.1	4.3	1.1	4.3	1.3	0.3	0.0	10.6	6.3	24.5	0.3	0.1	1.2	0.9	0.0	0.8	0.4	6.0	0.2	0.0	1.2	0.9	4.1	0.1	2.4	0.2	0.2	0.0	1.3	0.1	0.3	8.7	1.9	0.1	1.5	0.8	8.2	0.1	0.4	1.5	0.7	2.2	1.7	0.1	0.6	5.2	0.9	0.4	8.0	0.7	0.6	4.0	1.0	0.9	1.6	0.2	4.2	35.6	0.6	2.2	0.4	5.7	2.7	2.8	0.3	8.8	12.3	0.8	0.2	0.5	0.0	0.0	1.1	0.3	3.9	2.0	1.1	0.6	0.8	0.5	1.3	0.7	0.5	0.7	0.4	1.3	0.7	0.9	4.3	4.3	0.5	1.1	0.3	0.3	7.6	6.4	4.2	9.7	9.4	15.7	12.2	5.4	7.0	1.1	3.0	0.3	0.0	0.2	0.1	1.8	2.3	0.0	1.4	0.0	0.0	15.7	0.2	0.0	4.3	0.0	0.0	1.3	0.0	0.2	0.2	1.1	2.2	0.0	0.6	0.4	158.9	98.9	0.0	0.0	0.4	0.3	0.0	0.0	0.0	2.2	4.4	1.9	0.0	0.4	0.0	1.3	0.0	0.9	0.3	6.0	0.3	0.2	0.0	0.6	0.0
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925375-42959176	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"placenta: 194.0"	"Cell type enhanced"	"Detected in many"	20	"Cytotrophoblasts: 686.5;Extravillous trophoblasts: 412.9;Syncytiotrophoblasts: 2076.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.8;CACO-2: 72.7;Hep G2: 49.6"	"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		No	No		36000000	"Plasma membrane"		"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734"	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (3.65e-8)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.05e-4)"	4.2	3.7	12.4	3.9	16.9	45.2	4.1	6.7	15.5	15.2	4.8	15.1	4.3	2.4	7.6	3.4	28.8	8.5	8.6	5.0	15.4	13.7	7.6	2.1	2.4	5.3	18.2	5.0	3.4	3.7	7.3	2.9	194.0	15.5	5.2	3.3	44.2	8.4	7.9	1.8	42.1	2.9	2.5	17.8	3.4	5.5	2.5	12.5	1.8	4.0	11.5	12.0	22.2	24.5	8.4	14.7	1.3	0.2	3.0	7.5	2.7	10.7	15.6	12.8	3.2	1.5	0.5	44.8	7.1	15.4	8.8	12.9	72.7	30.1	4.1	21.2	2.1	6.2	10.1	2.8	16.5	3.9	2.4	2.6	6.7	9.0	49.6	4.5	3.6	1.9	1.9	12.7	5.5	5.9	26.0	1.4	3.5	15.0	0.9	3.9	19.2	1.7	2.5	8.2	5.3	3.9	1.6	4.1	5.7	8.0	5.2	6.8	4.8	8.3	26.3	3.1	19.2	1.1	4.6	3.2	8.0	5.8	1.4	16.0	0.7	1.5	2.5	15.8	2.6	6.5	0.3	0.2	1.3	7.5	0.2	6.9	8.4	4.1	5.1	2.9	7.3	3.2	4.7	1.0	3.0	0.1	14.7	4.7	2.7	12.4	16.9	6.7	15.5	15.4	13.7	18.2	5.0	15.5	12.5	0.0	2.6	23.8	35.5	254.3	8.1	23.0	25.5	28.1	9.1	26.2	62.8	686.5	5.0	47.8	4.0	9.9	16.8	303.7	10.3	412.9	42.1	25.5	5.8	1.3	74.8	4.8	17.6	0.6	1.3	0.0	7.2	3.2	20.3	61.3	13.7	394.9	72.4	18.7	13.8	1.6	31.1	0.0	20.2	0.0	1.7	208.3	2076.2	17.3	9.0	98.7
SLC2A10	GLUT10	ENSG00000197496	"Solute carrier family 2 member 10"	O95528	20	46709487-46736347	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 51.5"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 33.5;Hepatocytes: 41.2;Mucus-secreting cells: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	44	"basophil: 13.8"	"Lineage enriched"	"Detected in single"	44	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"ASC diff: 19.5;HSkMC: 24.2;OE19: 20.0;SK-MEL-30: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041015	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA041015: AB_2677252"	"unprognostic (8.94e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.96e-2)"	4.7	4.6	2.6	4.3	3.3	0.1	8.7	2.1	3.1	11.4	6.7	2.7	6.7	2.6	5.4	6.6	4.8	5.6	10.2	6.7	3.3	1.4	2.6	51.5	4.8	3.4	2.2	2.0	7.1	22.9	15.0	4.2	8.3	3.8	18.0	8.8	9.8	11.5	11.0	2.1	2.4	3.0	9.7	2.3	1.9	12.4	3.4	1.0	0.8	18.1	4.5	4.6	7.1	5.7	0.0	0.0	13.8	0.0	0.3	0.0	0.0	0.0	0.0	4.7	4.8	19.5	16.7	14.3	9.1	12.4	4.2	5.1	0.3	16.0	0.0	6.9	16.5	0.0	0.1	0.0	0.4	2.0	0.0	0.1	1.3	0.0	7.6	13.8	0.0	0.0	24.2	0.4	2.6	0.0	4.9	1.7	0.0	0.1	0.0	7.2	16.6	0.0	0.4	1.7	20.0	1.2	0.0	0.7	0.0	0.0	4.3	0.0	0.7	1.8	3.0	24.8	3.5	2.3	3.7	1.0	9.1	4.0	7.2	1.1	0.1	0.0	0.0	0.0	0.0	1.9	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	2.6	3.3	2.1	3.1	3.3	1.4	2.2	2.0	3.8	1.0	6.0	4.6	0.0	6.8	0.6	0.0	2.2	10.2	33.5	11.4	1.8	0.0	1.9	0.0	5.2	0.1	4.1	2.2	0.0	4.9	12.8	11.7	28.1	5.8	41.2	0.9	0.0	3.5	9.2	2.8	0.9	24.5	0.3	1.7	0.0	60.1	5.6	5.1	2.9	16.3	0.7	0.5	12.9	3.9	0.4	0.2	0.9	1.7	0.0	6.6	10.2
SLC2A11	"GLUT10, GLUT11"	ENSG00000133460	"Solute carrier family 2 member 11"	Q9BYW1	22	23856703-23886309	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 280.8;Rod photoreceptor cells: 194.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 12.0"									"HPA042960, HPA071184"	Uncertain		Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			"Cell Junctions"	Nucleoplasm	"HPA042960: AB_2678241, HPA071184: AB_2686355"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.77e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.29e-2)"	4.3	7.8	8.5	6.1	15.3	3.5	6.2	22.9	17.0	4.1	4.9	6.4	17.2	3.9	7.7	9.0	2.8	5.0	5.2	8.5	11.0	13.4	19.5	4.9	4.5	7.1	9.5	10.9	6.6	28.8	18.6	14.0	21.0	9.7	7.6	6.0	10.4	6.1	11.4	13.6	4.2	4.8	10.4	9.6	5.3	6.1	4.5	6.2	1.6	9.2	2.4	6.4	4.5	5.3	2.2	4.6	1.5	1.1	1.2	1.6	0.3	2.6	1.3	1.7	7.6	1.6	3.4	0.7	1.6	2.0	1.8	1.3	1.8	1.8	3.4	0.9	2.2	1.6	2.2	3.2	0.9	0.9	2.3	2.9	1.7	2.8	2.6	2.5	1.6	1.8	1.3	3.2	2.7	2.3	8.4	0.7	2.7	0.7	7.6	1.0	2.8	0.3	0.7	2.5	1.7	2.1	4.6	0.2	3.8	5.6	0.7	4.1	2.3	0.8	12.0	2.7	2.1	6.2	0.8	0.5	0.7	1.2	0.7	0.8	7.1	1.9	3.3	1.5	1.2	1.8	1.5	0.4	0.9	0.9	1.1	0.7	2.1	0.8	0.8	0.2	2.2	1.6	1.1	1.2	1.2	0.7	4.6	0.2	0.3	8.5	15.3	22.9	17.0	11.0	13.4	9.5	10.9	9.7	6.2	17.9	12.9	16.6	8.2	2.9	57.0	29.0	7.6	8.1	4.5	24.4	280.8	7.0	11.6	4.7	5.9	3.3	3.4	0.0	4.9	7.6	4.5	8.0	2.3	5.8	5.2	35.0	10.4	4.9	3.1	8.5	8.6	4.2	3.3	2.8	4.9	15.4	3.5	2.9	9.2	20.7	194.1	0.0	6.2	3.9	5.1	2.8	16.7	7.5	7.3	5.4
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133988697-134052636	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 46.6"	"Cell type enhanced"	"Detected in many"	15	"Ciliated cells: 9.4;Glandular cells: 11.7;Muller glia cells: 11.4;Syncytiotrophoblasts: 30.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.3;myeloid DC: 1.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.0;monocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 7.4;hTERT-RPE1: 13.5;SuSa: 22.1;U-2 OS: 8.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.9	1.2	5.2	0.4	6.7	0.1	1.5	14.6	5.5	4.8	3.0	7.1	4.9	8.1	9.7	2.6	7.0	3.4	3.0	11.4	6.5	2.8	6.7	7.9	3.4	0.2	3.4	5.2	1.5	1.3	1.2	2.5	1.9	19.7	27.0	1.4	46.6	5.2	11.2	4.2	3.9	11.9	14.8	1.6	0.3	14.4	0.5	3.3	0.6	0.6	1.9	2.7	6.7	2.0	0.0	1.0	0.0	1.3	0.0	0.1	0.1	2.1	0.7	1.8	0.0	1.4	0.7	0.1	1.3	5.4	0.7	3.0	0.0	7.4	0.2	1.1	0.1	5.5	5.6	0.0	0.5	1.0	0.0	4.7	0.0	0.6	0.1	0.2	0.0	0.0	1.0	0.5	0.6	0.1	13.5	0.4	0.3	0.4	0.6	0.1	0.6	0.1	0.1	1.6	0.0	0.5	0.0	0.9	2.0	1.6	0.7	0.2	0.5	0.0	1.7	0.0	22.1	0.0	0.0	0.0	0.2	8.0	0.2	0.7	2.8	2.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.1	0.1	5.2	6.7	14.6	5.5	6.5	2.8	3.4	5.2	19.7	3.3	0.0	4.8	0.0	0.8	1.8	0.1	5.7	0.0	9.4	2.3	0.0	0.0	1.9	3.3	1.2	0.0	0.4	0.0	0.0	0.2	0.5	0.3	11.7	0.0	0.9	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	0.8	2.9	1.4	0.3	0.5	0.0	0.1	0.0	0.0	1.6	30.7	0.0	0.3	1.4
SLC2A13	HMIT	ENSG00000151229	"Solute carrier family 2 member 13"	Q96QE2	12	39755021-40106089	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.7;parathyroid gland: 43.0"	"Cell type enhanced"	"Detected in many"	10	"Horizontal cells: 87.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006584, HPA061679"	Enhanced		Approved	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA006584: AB_1849755, HPA061679: "	"unprognostic (1.66e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.12e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.16e-2)"	3.8	7.2	9.8	3.3	18.0	1.2	3.0	4.0	27.7	13.0	7.4	2.8	0.3	6.0	5.9	5.3	3.7	2.9	4.0	4.9	8.2	14.1	10.7	6.2	3.7	1.9	14.9	11.0	3.1	5.0	43.0	11.1	4.6	4.8	3.0	6.8	2.4	4.2	2.6	1.2	2.1	8.3	4.7	2.7	2.3	5.6	2.0	4.1	0.6	2.2	0.9	1.4	3.9	3.9	2.0	0.1	1.5	0.5	0.6	0.9	0.0	0.6	3.6	2.6	1.2	18.5	7.7	5.3	5.8	4.1	2.6	3.4	0.0	1.7	2.2	4.3	4.6	3.6	0.3	1.8	1.8	2.2	1.9	5.4	1.7	9.1	1.3	2.9	4.9	2.9	3.8	1.7	1.2	2.2	1.5	1.2	2.2	0.7	5.7	5.9	0.6	0.7	4.1	2.9	0.0	2.5	0.0	4.0	1.2	4.8	2.2	3.3	3.4	2.3	4.5	1.5	4.1	2.5	4.3	1.1	3.5	1.3	12.4	3.4	4.5	0.1	1.4	6.4	2.8	2.2	0.0	0.5	1.5	0.4	0.2	0.3	0.1	0.4	0.9	0.0	2.0	0.2	0.5	0.8	0.6	0.1	0.1	0.1	0.0	9.8	18.0	4.0	19.8	8.2	14.1	14.9	11.0	4.8	4.1	8.9	17.1	4.7	1.7	3.7	4.3	3.5	10.2	5.3	2.3	8.7	0.0	5.0	0.0	4.3	2.5	5.2	35.1	0.0	10.9	2.1	7.1	2.7	10.3	8.5	7.2	87.4	19.5	8.0	7.9	2.1	21.3	7.4	15.1	6.4	21.3	2.0	8.7	29.4	7.1	6.4	1.3	6.5	6.1	0.9	1.9	4.5	3.1	4.4	11.1	1.4
SLC2A14	"GLUT14, SLC2A3P3"	ENSG00000173262	"Solute carrier family 2 member 14"	Q8TDB8	12	7812512-7891148	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis, Sugar transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 52.4"	"Cell type enriched"	"Detected in many"	7	"Spermatocytes: 60.6"	"Cancer enriched"	"Detected in single"	35	"testis cancer: 7.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.6;CACO-2: 20.4;Hep G2: 5.3;SuSa: 25.2"									HPA006539	Supported		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA006539: AB_1078984"	"unprognostic (2.52e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.46e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-2)"	0.4	3.1	0.1	0.1	0.6	3.0	0.4	0.1	0.2	0.4	0.4	0.3	0.1	0.0	0.3	0.8	0.8	0.1	0.3	0.1	0.2	0.3	0.1	2.0	0.2	0.2	0.1	0.1	2.7	7.4	0.0	0.6	0.5	0.3	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.7	0.2	0.1	0.1	0.0	52.4	0.2	0.1	0.1	0.1	0.1	0.6	0.1	0.6	0.4	6.9	0.7	1.3	1.7	0.2	0.0	0.3	0.3	0.2	0.2	0.6	12.6	0.0	0.0	0.0	0.2	20.4	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	2.1	0.5	5.3	0.0	0.0	3.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.9	0.1	0.0	0.1	0.1	0.1	2.3	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.4	0.0	25.2	0.0	1.3	0.3	0.1	0.5	0.3	0.1	0.1	0.1	0.2	0.3	0.0	0.3	5.5	0.7	1.8	1.0	0.2	1.2	0.5	1.0	0.8	0.4	0.6	0.7	0.9	6.9	1.3	0.2	0.3	1.7	0.2	0.1	0.6	0.1	0.2	0.2	0.3	0.1	0.1	0.3	0.2	0.0	0.6	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	3.9	0.2	0.0	0.0	3.7	2.3	0.0	0.0	1.3	0.9	1.9	0.0	9.2	0.4	0.2	0.0	0.0	8.0	4.4	0.9	0.3	3.1	1.7	0.0	0.0	0.0	0.5	5.8	2.5	0.0	0.4	0.0	4.2	60.6	2.7	0.1	0.3	3.2	0.0	0.0
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996348-171026750	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 77.4;liver: 172.8"	"Cell type enriched"	"Detected in some"	5	"Hepatocytes: 433.3"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	68	"CACO-2: 7.3;Hep G2: 24.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	27.9	0.0	0.0	10.8	0.1	0.2	0.1	0.1	3.8	0.1	0.1	0.1	15.3	172.8	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	77.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.6	0.0	0.0	0.0	0.0	0.0	1.7	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	433.3	0.0	0.0	0.0	6.7	8.9	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	49.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0
SLC2A3	GLUT3	ENSG00000059804	"Solute carrier family 2 member 3"	P11169	12	7919230-7936275	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 166.3"	"Cell type enhanced"	"Detected in many"	7	"granulocytes: 462.0"	"Cancer enriched"	"Detected in all"	7	"testis cancer: 107.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 30.2;neutrophil: 55.6"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 55.6"	"Group enriched"	"Detected in many"	5	"BEWO: 143.6;CACO-2: 154.0;SuSa: 113.9"									"CAB002763, HPA006539"	Approved		Approved	"Plasma membrane"		NA	NA		33000000	"Plasma membrane"		"CAB002763: , HPA006539: AB_1078984"	"unprognostic (9.20e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.36e-8)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.91e-3)"	48.8	10.0	9.5	25.2	10.5	166.3	26.4	13.1	24.3	9.4	10.0	6.8	1.8	4.2	10.3	8.2	13.2	8.0	25.6	22.8	10.8	13.6	10.3	14.1	32.4	12.8	13.3	3.3	18.8	6.1	6.9	10.9	43.9	13.7	15.0	6.9	14.8	3.8	3.9	13.6	7.4	5.8	18.7	15.4	16.4	7.0	10.6	12.5	3.3	15.7	7.0	13.6	51.8	10.5	1.8	2.4	55.6	4.6	3.6	6.4	3.5	0.0	0.7	6.6	2.5	2.4	8.5	143.6	2.3	2.5	2.3	5.4	154.0	1.0	0.1	0.0	1.6	3.2	0.0	0.2	0.3	4.2	4.5	0.1	8.9	0.6	20.2	6.7	3.2	13.0	3.5	0.2	6.1	2.8	5.4	2.1	0.7	4.1	2.1	2.1	0.0	0.2	3.4	29.1	0.1	0.0	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.2	3.0	113.9	0.0	0.4	2.1	2.9	1.5	5.6	0.2	0.0	6.2	0.4	8.5	1.5	1.5	30.2	4.6	7.0	6.4	0.5	5.3	1.8	4.4	4.9	2.4	1.7	2.8	3.8	55.6	3.6	0.2	0.1	5.8	3.5	9.5	10.5	13.1	13.3	10.8	13.6	13.3	3.3	13.7	12.5	134.0	147.7	116.7	2.9	115.1	27.9	8.4	7.6	18.7	48.9	3.5	58.9	41.5	0.0	0.2	2.4	227.7	0.0	0.0	0.0	218.4	149.1	3.8	462.0	1.0	97.9	4.8	1.2	85.3	85.8	1.9	9.5	229.2	173.7	1.0	0.0	19.2	0.8	0.2	7.4	1.2	68.8	116.4	236.4	1.4	0.6	71.6	93.1	133.8	0.0	2.8
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281667-7288257	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Diabetes mellitus, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 37.2;skeletal muscle: 76.8;tongue: 33.5"	"Cell type enhanced"	"Detected in many"	26	"Cardiomyocytes: 120.2;Sertoli cells: 32.3;Smooth muscle cells: 25.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.7"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.7"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 10.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB016544	Enhanced					NA	NA					"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	9.9	1.4	0.6	1.8	0.7	1.1	6.4	0.0	0.6	4.7	13.9	0.2	4.0	1.0	4.2	7.0	11.8	3.2	2.9	37.2	0.3	0.1	0.7	1.2	0.5	0.7	0.8	0.1	1.9	0.4	2.9	1.2	0.8	0.5	6.3	1.4	6.4	4.6	3.8	76.8	0.9	3.3	23.5	0.2	0.2	3.8	1.5	0.0	0.0	1.2	33.5	1.6	18.6	1.6	0.0	1.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.8	1.5	0.7	0.0	0.4	0.0	0.1	0.0	0.0	0.6	0.1	1.2	0.2	0.0	0.8	0.8	0.3	0.2	0.1	0.0	1.8	0.0	0.3	10.8	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	1.1	0.6	0.2	0.0	0.4	0.0	0.2	0.8	0.2	0.1	2.4	0.6	0.8	0.0	0.1	0.0	1.0	0.0	1.3	0.0	1.8	0.8	0.1	0.0	0.0	1.5	0.0	0.2	0.6	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.7	0.0	0.6	0.3	0.1	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.7	1.5	0.0	120.2	0.0	0.0	0.0	0.0	0.0	0.3	6.6	0.1	5.7	1.5	0.8	0.0	0.0	0.0	0.4	0.5	0.0	2.0	0.1	0.0	0.0	1.8	0.0	3.6	0.0	0.0	6.8	0.0	0.5	5.6	0.1	0.2	8.1	0.2	0.0	32.3	25.1	2.1	2.7	1.0	0.8	0.0	1.0	0.3
SLC2A6	"GLUT6, GLUT9, HSA011372"	ENSG00000160326	"Solute carrier family 2 member 6"	Q9UGQ3	9	133471095-133479137	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 27.7;brain: 17.3"	"Cell type enhanced"	"Detected in many"	7	"Cone photoreceptor cells: 49.1;granulocytes: 45.2;monocytes: 68.5;Rod photoreceptor cells: 45.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 27.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 7.0;granulocytes: 15.6;monocytes: 27.7"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.7;HMC-1: 37.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042272, CAB046014"	Uncertain					NA	NA					"CAB046014: AB_2270444, HPA042272: AB_2677924"	"unprognostic (2.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.71e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.36e-2)"	"unprognostic (6.28e-3)"	3.8	3.1	7.2	12.7	8.3	10.5	2.1	8.1	16.3	1.4	2.5	4.3	0.0	3.3	2.3	3.1	1.8	1.4	3.6	3.0	9.1	12.1	2.3	2.7	7.4	10.8	12.4	9.1	1.7	3.2	1.1	1.8	2.5	17.3	1.6	2.1	2.9	2.2	2.2	2.1	1.9	4.9	3.3	7.3	10.6	4.0	2.2	2.4	1.7	1.6	0.0	7.1	4.9	1.1	4.0	7.0	15.6	27.7	0.4	0.6	3.1	2.5	4.7	1.7	5.1	1.0	1.5	1.3	2.6	4.5	2.7	2.7	2.3	3.7	2.1	6.6	2.6	12.6	4.1	1.1	3.2	0.6	15.7	0.8	2.6	3.5	2.7	3.4	0.0	37.0	2.1	0.5	4.0	0.5	0.2	2.7	2.5	0.4	2.2	1.9	6.1	1.5	2.7	2.5	1.2	5.6	1.0	2.8	11.7	3.8	7.5	2.0	2.7	3.9	2.1	1.3	1.0	8.0	1.1	6.9	6.5	2.5	6.8	2.1	1.1	0.8	3.0	1.6	0.6	1.4	15.6	7.2	0.7	0.6	14.6	0.4	4.0	0.1	0.4	6.4	3.9	0.2	0.5	0.4	0.4	27.7	7.0	0.1	3.1	7.2	8.3	8.1	16.3	9.1	12.1	12.4	9.1	17.3	2.4	3.0	5.5	19.9	1.3	0.3	24.3	2.0	5.1	2.7	0.0	3.5	49.1	0.3	0.0	32.4	6.3	4.7	1.8	0.0	7.9	0.5	1.9	1.1	45.2	0.0	4.6	22.3	3.5	2.5	19.2	1.3	0.9	31.5	3.3	68.5	1.5	3.9	16.6	31.7	0.0	0.0	45.6	32.3	7.2	2.2	6.6	0.4	0.2	3.8	1.2	0.5
SLC2A7	GLUT7	ENSG00000197241	"Solute carrier family 2 member 7"	Q6PXP3	1	9003300-9026345	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 19.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039931	Uncertain					NA	NA					"HPA039931: AB_10671046"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-1)"				"unprognostic (1.96e-2)"		"unprognostic (2.20e-1)"		"unprognostic (1.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.69e-4)"	"unprognostic (5.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.35e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	7.2	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	19.3	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.4	0.5	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC2A8	"GLUT8, GLUTX1"	ENSG00000136856	"Solute carrier family 2 member 8"	Q9NY64	9	127397138-127408424	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	11	"Early spermatids: 119.6;Late spermatids: 229.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"plasmacytoid DC: 33.8"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 33.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 46.6;Hep G2: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011935	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA011935: AB_1849760"	"unprognostic (6.49e-2)"	"prognostic favorable (2.57e-6)"	"unprognostic (9.13e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (9.86e-6)"	"unprognostic (1.70e-1)"	"prognostic favorable (6.55e-6)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.04e-3)"	10.9	24.5	11.4	13.3	11.3	3.5	10.4	15.0	15.2	9.0	19.8	11.7	37.0	17.7	9.5	17.4	8.7	6.0	9.4	9.8	10.4	9.3	8.7	25.7	8.1	7.3	12.5	10.2	6.7	12.1	5.7	5.5	13.2	8.7	18.5	6.5	12.5	9.4	28.3	22.6	11.6	17.0	44.1	10.3	11.3	13.1	30.6	9.3	1.2	9.1	6.9	4.3	42.4	9.1	2.4	33.8	6.9	5.6	1.2	6.3	2.0	1.8	7.2	3.2	7.2	0.0	0.0	10.2	2.8	1.9	4.5	2.7	46.6	1.7	2.8	6.4	1.5	7.2	9.7	3.9	4.5	1.1	2.6	6.2	0.4	5.7	27.5	4.2	0.0	3.0	0.1	4.2	0.4	1.8	2.2	3.5	3.9	2.9	6.3	1.8	13.1	0.0	0.0	5.2	10.2	11.3	1.0	4.5	7.8	4.2	19.3	5.4	3.7	6.7	11.5	2.5	4.3	7.4	1.6	3.0	0.0	4.7	0.3	6.2	19.5	18.2	4.2	3.1	0.0	3.4	0.0	3.0	6.9	4.9	5.6	3.5	2.3	1.6	3.3	4.6	2.4	0.3	1.2	0.2	1.2	5.1	33.8	6.3	2.0	11.4	11.3	15.0	15.2	10.4	9.3	12.5	10.2	8.7	9.3	8.9	9.6	5.4	6.1	9.8	11.1	6.1	7.6	5.3	4.5	5.2	9.8	66.2	13.3	12.0	119.6	7.4	15.1	23.3	14.7	10.8	11.6	11.0	6.9	23.6	59.6	6.4	11.6	12.9	12.4	229.4	10.0	8.2	25.3	8.2	13.3	14.9	15.9	21.5	11.0	12.2	7.7	12.9	8.1	38.0	10.9	9.3	56.3	6.9	15.6	5.5
SLC2A9	"Glut9, GLUTX, URATv1"	ENSG00000109667	"Solute carrier family 2 member 9"	Q9NRM0	4	9771153-10054936	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 43.4"	"Cell type enhanced"	"Detected in many"	14	"Cytotrophoblasts: 16.4;Proximal tubular cells: 47.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 20.6;myeloid DC: 16.7"	"Group enriched"	"Detected in many"	31	"dendritic cells: 16.7;monocytes: 20.6"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 29.6;Hep G2: 14.2;hTCEpi: 12.5;THP-1: 12.5;U-937: 8.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA066229, HPA075669"	Enhanced					NA	NA					"HPA066229: AB_2685639, HPA075669: "	"unprognostic (3.21e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.94e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.32e-11)"	"unprognostic (1.01e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.20e-1)"	5.6	2.8	1.0	1.3	2.0	1.2	3.2	0.6	1.2	2.6	10.4	2.3	5.7	7.8	1.7	12.0	5.8	2.6	1.7	2.7	1.0	0.9	43.4	17.7	4.7	2.8	1.9	0.7	1.5	1.3	1.5	1.8	8.8	2.1	4.6	1.1	4.1	10.8	15.6	1.1	2.4	12.0	1.4	4.1	3.0	1.2	1.3	2.3	3.0	2.9	3.4	3.9	7.1	3.9	0.2	16.7	0.6	20.6	0.1	0.2	4.9	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.2	1.5	0.0	2.2	0.4	0.0	4.5	0.0	29.6	0.0	4.8	0.1	0.0	0.0	14.2	1.0	0.1	4.0	2.2	12.5	0.0	3.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.2	1.4	0.0	0.2	0.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	20.6	0.4	0.1	4.1	0.2	0.2	0.2	0.0	16.7	0.1	0.1	0.0	0.6	0.1	0.4	6.6	0.1	4.9	1.0	2.0	0.6	1.2	1.0	0.9	1.9	0.7	2.1	2.3	0.0	0.0	1.4	11.1	0.8	0.0	2.1	0.0	4.0	3.4	3.5	2.0	16.4	3.3	0.4	3.9	1.4	2.9	0.0	0.9	1.3	1.1	1.0	1.1	4.9	9.3	0.0	0.0	2.5	6.5	2.8	0.0	10.2	0.0	1.0	0.8	0.8	0.4	0.0	0.4	47.2	0.4	0.0	1.0	0.7	1.2	0.5	7.1	0.5	1.0	8.8
SLC30A1	"ZNT1, ZRC1"	ENSG00000170385	"Solute carrier family 30 member 1"	Q9Y6M5	1	211571568-211578742	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 53.3"	"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 83.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015275, HPA049000"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA015275: AB_1857083, HPA049000: AB_2680593"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.82e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.42e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.53e-2)"	11.4	16.6	9.3	7.5	11.4	15.5	17.3	5.2	13.6	13.0	15.3	6.9	4.9	17.2	7.1	7.6	9.0	9.2	12.9	6.1	9.7	7.9	13.4	53.3	12.0	3.5	9.5	8.0	9.5	8.9	8.8	4.8	9.3	8.7	7.3	8.9	7.7	5.9	9.2	3.6	13.9	28.1	7.5	8.3	10.7	6.4	12.5	5.5	3.1	11.0	5.2	4.4	7.7	8.4	0.5	2.5	3.9	4.2	1.3	1.7	1.0	4.7	6.9	3.8	4.9	16.6	7.7	33.7	13.0	9.6	6.9	6.9	3.0	22.6	2.6	11.4	11.9	9.6	8.1	5.7	7.5	8.3	6.7	4.3	2.1	14.1	6.9	9.3	7.4	4.8	11.5	19.0	8.8	14.4	10.4	4.2	1.6	8.4	12.5	8.5	4.3	1.4	4.6	11.7	5.1	5.5	4.5	1.8	9.6	21.5	12.7	3.8	6.7	12.7	6.7	29.0	7.5	3.4	9.7	6.8	5.2	12.1	17.3	10.3	5.5	8.4	2.2	4.8	7.5	4.5	3.9	3.9	1.3	1.2	4.2	1.7	0.5	0.9	0.8	2.5	0.3	0.9	1.2	0.4	1.3	3.2	1.7	0.8	1.0	9.3	11.4	5.2	13.6	9.7	7.9	9.5	8.0	8.7	5.5	8.9	9.8	5.1	7.2	25.3	10.9	17.9	17.8	6.7	2.3	34.9	5.9	9.8	1.7	5.4	21.7	18.0	37.9	46.7	10.7	27.0	15.0	12.6	4.7	83.9	29.4	6.4	9.1	15.4	33.3	2.8	9.2	15.1	20.3	5.4	23.6	26.5	7.9	31.7	7.1	29.5	8.5	6.5	11.6	33.0	9.4	40.4	20.5	10.2	20.5	11.4
SLC30A10	"DKFZp547M236, ZnT-10, ZNT8, ZRC1"	ENSG00000196660	"Solute carrier family 30 member 10"	Q6XR72	1	219685427-219958647	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 33.4"	"Group enriched"	"Detected in some"	6	"Early spermatids: 23.4;Enterocytes: 12.9;Hepatocytes: 19.8;Late spermatids: 27.7"	"Cancer enriched"	"Detected in some"	14	"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 4.4;HEL: 2.2;Hep G2: 4.3;K-562: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064547	Enhanced					NA	NA					"HPA064547: AB_2732715"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.47e-7)"	"unprognostic (3.16e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.19e-3)"	"unprognostic (5.72e-2)"	0.3	0.3	2.9	0.7	3.5	0.4	0.3	1.8	3.9	0.3	7.1	1.9	0.0	5.9	0.3	0.3	0.3	0.3	0.5	0.3	3.5	1.6	0.3	33.4	0.3	0.3	1.7	1.7	0.6	0.3	0.3	0.4	0.4	2.5	0.3	1.7	0.6	0.3	0.3	0.3	0.3	6.8	0.3	0.8	0.3	0.3	1.9	1.9	0.0	0.3	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.4	2.2	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.5	1.8	3.9	3.5	1.6	1.7	1.7	2.5	1.9	0.0	0.0	0.0	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.4	0.0	12.9	0.0	0.0	0.2	0.0	0.0	0.0	19.8	0.1	0.0	0.0	0.6	0.6	27.7	1.1	0.0	1.7	0.0	0.1	3.4	0.0	3.2	1.4	0.0	0.0	0.0	0.0	0.5	0.9	0.1	0.2	0.0	0.6	0.0
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046133	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 78.0;placenta: 20.0"	"Cell type enhanced"	"Detected in many"	16	"Cytotrophoblasts: 23.2;Exocrine glandular cells: 18.5;Proximal tubular cells: 27.2;Syncytiotrophoblasts: 71.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"BEWO: 4.7;RPTEC TERT1: 10.6;WM-115: 6.5"	"Region enriched"	"Detected in single"	5	"olfactory region: 1.5"	"Not detected"	"Not detected"			HPA017979			Approved	Vesicles		NA	NA			Vesicles		"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	0.7	0.1	0.1	0.1	0.2	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.0	1.3	1.1	0.1	0.1	4.0	2.2	0.1	0.1	10.4	0.1	0.2	0.1	0.1	0.1	0.1	78.0	0.1	0.1	20.0	0.1	0.3	0.0	2.0	1.0	1.4	1.7	0.4	0.6	0.1	0.1	0.1	0.1	0.4	0.1	0.1	12.8	0.2	0.1	0.5	0.1	1.5	1.1	3.1	1.0	1.5	0.9	0.4	0.2	0.2	0.2	1.0	0.3	0.1	4.7	0.4	0.2	0.1	0.1	0.9	1.0	0.2	0.9	0.1	0.2	0.9	0.2	0.3	0.1	0.6	0.3	0.6	0.7	0.1	0.1	0.6	0.7	0.0	0.2	0.1	0.1	0.3	0.0	0.3	0.6	1.5	0.1	0.8	0.5	0.9	0.8	0.4	0.2	0.3	0.7	0.7	10.6	0.4	0.9	0.5	0.6	1.1	0.4	1.6	0.7	0.5	0.6	0.7	1.2	0.6	0.3	1.1	0.6	0.8	0.5	0.6	6.5	3.1	1.0	0.4	0.9	0.4	0.5	0.7	0.6	0.8	0.2	1.5	0.6	0.8	3.1	1.5	0.5	1.1	0.5	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.0	4.0	0.0	0.7	0.3	2.4	5.1	15.3	0.0	0.0	8.7	0.0	23.2	5.0	6.8	0.0	0.5	0.4	0.0	18.5	2.4	0.6	0.6	4.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.3	1.8	0.1	0.5	5.4	0.0	0.0	27.2	1.8	6.5	0.9	0.2	0.4	0.6	71.2	0.0	0.6	0.7
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 28.7;epididymis: 41.0;testis: 19.5"	"Group enriched"	"Detected in some"	18	"Cardiomyocytes: 8.1;Early spermatids: 13.1;Late spermatids: 29.1;Peritubular cells: 14.2;Spermatocytes: 18.7;Spermatogonia: 9.4"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	9	"amygdala: 15.8;basal ganglia: 11.4;cerebral cortex: 28.7;hippocampal formation: 10.2;olfactory region: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.0;HAP1: 8.8;Hep G2: 11.7;REH: 19.0;RH-30: 9.9"	"Group enriched"	"Detected in many"	5	"amygdala: 135.1;basal ganglia: 48.1;cerebral cortex: 108.9;hippocampal formation: 75.6"	"Group enriched"	"Detected in many"	7	"amygdala: 43.9;cerebral cortex: 117.8;hippocampal formation: 91.9"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875"	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.5	1.9	15.8	0.5	11.4	0.5	0.4	0.4	28.7	0.5	0.5	0.0	1.9	0.4	0.5	41.0	0.4	0.7	0.4	5.0	10.2	0.8	0.4	0.5	0.5	0.8	1.1	12.1	0.5	0.4	0.6	0.4	0.4	1.6	0.6	0.5	0.7	0.4	0.9	0.4	0.4	0.5	0.5	0.7	0.5	0.4	19.5	0.0	0.0	0.4	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.0	1.5	0.0	0.2	0.1	0.0	0.0	1.0	1.0	0.3	0.4	0.0	0.0	0.0	8.0	0.2	8.8	0.0	0.2	0.0	1.0	5.0	0.2	11.7	0.2	0.1	2.0	0.0	0.0	0.5	0.0	0.1	0.7	2.4	1.4	0.0	0.1	3.8	0.0	0.3	1.5	0.2	0.0	19.0	9.9	1.0	0.0	0.0	0.0	0.6	2.3	0.0	0.0	0.0	0.0	0.7	0.0	0.2	4.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	15.8	11.4	0.4	28.7	10.2	0.8	1.1	12.1	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	29.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.3	18.7	9.4	0.1	0.1	0.0	0.0	0.0
SLC30A4	ZNT4	ENSG00000104154	"Solute carrier family 30 member 4"	O14863	15	45479611-45522807	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 47.7"	"Cell type enhanced"	"Detected in many"	8	"Early spermatids: 59.6;Late spermatids: 60.4"	"Cancer enriched"	"Detected in all"	20	"prostate cancer: 34.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018178	Uncertain					NA	NA					"HPA018178: AB_1857087"	"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.66e-2)"	"unprognostic (4.72e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.28e-3)"	"unprognostic (2.01e-3)"	3.7	2.9	6.2	4.5	11.3	1.6	4.1	6.7	8.1	3.7	8.8	7.0	2.3	8.5	4.3	4.1	5.6	3.4	3.1	3.0	5.2	3.8	5.5	3.6	2.9	3.6	6.9	4.9	3.9	2.8	6.8	3.0	4.6	5.1	47.7	4.4	3.1	2.7	3.5	2.4	3.6	19.9	4.7	4.5	4.0	3.0	15.8	9.0	1.0	6.2	1.8	4.5	3.1	4.4	7.1	0.5	2.6	0.3	2.4	4.3	1.0	2.0	2.6	0.7	5.6	10.2	7.2	0.5	5.4	4.9	3.3	4.7	0.3	1.8	8.0	1.8	5.5	1.3	1.5	2.4	2.5	3.0	1.9	2.2	0.2	2.6	0.2	6.6	0.2	4.2	6.0	4.1	4.3	1.1	5.1	3.8	3.8	1.2	4.6	6.1	0.9	2.7	0.4	0.2	0.4	0.5	4.2	4.8	1.2	2.7	0.5	1.9	2.8	3.5	4.0	0.9	0.9	3.5	0.3	7.1	4.9	2.8	5.9	1.8	8.6	6.2	2.0	2.1	0.3	3.7	2.6	0.3	0.3	4.3	0.2	3.9	3.8	2.9	2.4	0.3	7.1	2.9	4.2	1.1	2.4	0.3	0.5	0.4	1.0	6.2	11.3	6.7	8.1	5.2	3.8	6.9	4.9	5.1	9.0	3.0	3.8	3.2	2.0	6.1	2.6	2.3	0.0	1.4	0.0	1.8	15.7	0.7	0.0	1.0	59.6	5.0	13.6	0.0	1.0	0.2	7.2	30.7	1.1	2.4	2.5	12.7	1.2	7.4	1.8	60.4	5.8	5.8	6.8	9.0	5.1	4.9	0.6	14.4	7.8	8.4	2.2	6.5	5.9	29.4	16.8	5.6	0.2	4.4	2.9	1.4
SLC30A5	"FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1"	ENSG00000145740	"Solute carrier family 30 member 5"	Q8TAD4	5	69093646-69131069	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035373	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA035373: AB_10794630"	"unprognostic (9.81e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	19.4	22.1	14.4	19.4	15.7	13.3	29.7	14.9	18.5	25.0	20.9	13.2	33.7	19.7	24.3	32.4	20.5	20.3	23.5	25.4	14.5	15.4	28.6	39.2	24.3	23.7	15.5	13.1	25.4	50.5	29.6	38.1	34.3	13.9	24.5	19.8	17.6	36.8	35.3	17.1	21.2	25.0	18.1	13.2	20.1	20.3	18.1	12.7	22.1	33.5	18.8	19.6	18.2	28.9	8.3	13.2	12.4	6.9	5.6	9.1	3.3	15.7	12.2	11.4	20.0	30.1	23.2	36.2	25.0	22.7	15.8	24.2	11.2	19.8	20.9	31.9	17.0	27.7	17.0	15.8	18.9	26.8	24.9	18.2	23.3	15.4	18.3	24.2	14.6	26.0	15.6	25.1	16.2	19.4	22.2	15.3	14.5	14.0	25.0	20.1	19.9	19.2	30.4	12.9	10.7	14.0	15.4	14.5	37.7	23.6	14.8	20.4	16.2	19.8	19.9	33.9	16.6	19.2	32.5	13.9	10.3	13.4	25.7	24.7	22.7	27.9	16.3	20.3	26.6	25.4	12.4	6.7	10.7	6.1	6.8	6.5	8.3	9.1	8.9	8.4	6.3	8.4	7.1	5.9	5.6	6.9	13.2	6.1	3.3	14.4	15.7	14.9	18.5	14.5	15.4	15.5	13.1	13.9	12.7	17.9	15.5	9.0	22.6	16.7	13.9	26.2	12.7	14.7	14.8	24.4	21.6	35.4	24.9	18.8	5.2	16.6	12.3	23.3	23.5	60.9	24.0	28.7	41.4	17.4	19.6	7.9	12.7	19.0	17.3	6.7	22.5	16.4	13.5	12.6	24.9	13.4	17.8	21.0	20.8	16.1	22.6	25.8	20.9	9.9	14.9	18.7	43.1	20.3	21.7	24.2
SLC30A6	"FLJ31101, ZNT6"	ENSG00000152683	"Solute carrier family 30 member 6"	Q6NXT4	2	32165841-32224379	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055032, HPA057328"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA055032: AB_2682677, HPA057328: AB_2683411"	"unprognostic (5.61e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (2.98e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.30e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	15.9	17.9	10.3	11.9	13.1	5.4	15.3	21.1	13.7	16.6	14.4	14.2	10.6	12.6	22.5	12.1	16.8	13.8	13.5	13.5	10.6	8.7	17.9	18.4	14.3	17.9	17.3	8.1	17.8	23.7	15.7	19.8	18.1	13.2	13.7	15.3	14.8	17.2	12.4	18.8	15.2	14.3	14.1	20.1	16.2	14.9	12.8	15.9	21.3	17.8	9.9	18.8	15.0	14.2	4.3	3.9	12.5	3.1	9.2	6.1	2.6	18.3	13.8	14.2	12.4	18.1	16.3	15.8	17.3	17.1	14.2	13.0	10.7	17.4	8.8	11.5	13.7	16.4	11.6	16.9	11.9	18.2	17.7	9.4	19.1	7.9	13.6	11.6	20.0	11.9	12.1	18.7	19.1	15.4	14.5	11.4	6.3	16.1	11.8	16.2	6.8	10.5	9.2	21.4	20.7	7.3	9.4	17.2	12.9	15.7	16.2	10.7	16.3	13.6	14.7	13.6	13.9	8.1	9.2	9.7	18.2	10.1	11.9	20.3	16.1	27.9	13.1	16.2	15.7	18.3	12.5	3.1	2.6	3.6	2.7	4.9	4.3	3.3	4.0	3.9	3.8	5.0	4.6	3.5	9.2	3.0	3.2	6.1	2.6	10.3	13.1	21.1	13.7	10.6	8.7	17.3	8.1	13.2	15.9	8.9	6.9	8.8	4.1	8.0	4.9	3.5	10.2	4.0	1.2	7.0	5.9	17.2	5.0	6.6	1.6	9.8	7.2	0.0	7.4	12.5	9.8	7.6	3.5	15.5	9.4	1.6	3.5	9.2	6.3	0.4	6.1	6.4	8.5	4.6	8.5	6.3	8.0	7.0	7.4	7.9	6.1	12.9	5.1	11.1	8.9	5.5	23.0	5.0	9.8	4.3
SLC30A7	"ZNT7, ZnTL2"	ENSG00000162695	"Solute carrier family 30 member 7"	Q8NEW0	1	100896076-100981753	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018034	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA018034: AB_1857089"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.37e-1)"	15.6	14.2	5.0	13.1	6.4	10.3	12.7	7.4	7.6	13.3	10.8	6.2	17.2	10.8	13.3	13.7	10.8	9.4	13.2	9.3	5.9	5.6	13.0	43.1	18.1	25.6	7.7	4.6	10.5	19.1	17.1	17.7	25.2	9.2	11.9	14.7	10.8	17.5	18.1	5.7	12.6	15.8	9.0	8.1	16.2	13.3	7.5	6.4	24.7	13.2	10.9	17.4	10.5	11.1	5.5	8.2	13.9	14.9	8.4	10.7	5.9	10.9	5.7	6.2	13.6	13.2	13.5	15.7	7.2	19.3	8.8	11.6	5.8	7.9	4.4	15.7	14.7	7.0	10.9	7.2	10.7	13.5	6.9	4.5	8.6	9.7	10.4	14.8	11.3	9.2	15.4	6.9	14.8	18.1	8.5	14.2	8.4	5.2	19.3	11.9	4.9	8.2	5.7	6.6	5.5	7.1	4.1	11.1	5.7	7.8	12.8	3.4	6.7	12.9	14.5	9.3	4.9	7.2	6.3	15.3	20.8	8.0	19.2	11.5	13.1	6.9	4.9	21.2	9.3	5.5	13.9	10.7	7.4	10.7	10.4	9.2	5.3	9.9	8.4	8.2	5.5	8.9	9.6	5.3	8.4	14.9	7.7	7.2	5.9	5.0	6.4	7.4	7.6	5.9	5.6	7.7	4.6	9.2	6.4	29.8	16.3	25.1	16.5	50.9	8.9	3.2	15.3	10.7	12.5	22.7	5.9	26.3	1.7	20.8	0.6	24.6	16.0	0.0	23.0	19.6	25.5	36.1	36.9	38.5	19.8	4.8	21.9	35.0	29.4	0.9	15.8	29.5	30.4	14.4	32.0	7.8	29.1	24.6	15.6	16.2	12.4	6.5	22.3	6.2	7.6	55.8	34.9	29.8	20.1	24.8
SLC30A8	"ZnT-8, ZNT8"	ENSG00000164756	"Solute carrier family 30 member 8"	Q8IWU4	8	116950273-117176714	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"pancreas: 37.1"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 3.0;Late spermatids: 5.4;Pancreatic endocrine cells: 8.2;Spermatogonia: 3.0"	"Group enriched"	"Detected in some"	28	"breast cancer: 10.6;pancreatic cancer: 15.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	34	"U-266/70: 30.5;U-266/84: 21.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA076165	Enhanced					NA	NA					"HPA076165: AB_2732304"	"unprognostic (2.14e-2)"		"unprognostic (1.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"		"unprognostic (5.57e-2)"	"unprognostic (4.38e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.66e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.16e-3)"	0.1	0.0	0.1	0.1	0.4	0.0	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.4	0.1	0.1	0.1	0.1	0.1	0.1	37.1	0.0	0.3	0.1	0.1	0.1	0.0	5.0	6.4	0.1	0.1	0.3	0.4	0.1	0.1	0.1	0.6	2.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.5	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	30.5	21.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	1.5	0.0	0.0	0.0	1.4	3.0	0.0	0.0	0.0	0.0	0.0
SLC30A9	"C4orf1, GAC63, HUEL, ZNT9"	ENSG00000014824	"Solute carrier family 30 member 9"	Q6PML9	4	41990472-42090457	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transcription, Transcription regulation, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA004014	Approved					NA	NA					"HPA004014: AB_1080005"	"unprognostic (4.26e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (2.86e-14)"	"unprognostic (4.67e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.39e-2)"	11.0	20.4	23.6	11.2	28.8	7.0	18.1	24.2	32.4	16.5	17.0	12.8	15.3	16.1	13.8	21.8	12.5	13.3	11.5	33.4	22.7	24.4	38.2	17.9	11.6	9.0	22.7	23.7	15.1	16.6	30.4	32.6	12.2	27.7	18.3	18.4	11.5	15.0	16.4	17.1	12.6	15.5	11.5	19.2	11.9	16.1	8.8	15.4	12.0	22.5	15.8	10.0	11.8	11.6	4.0	7.1	6.2	6.5	5.9	5.5	3.9	8.5	4.3	14.2	16.1	11.0	15.4	8.1	11.9	14.4	10.5	12.5	4.4	11.2	8.8	8.7	13.6	13.5	4.4	11.9	9.8	15.0	3.0	7.2	10.1	7.6	7.3	19.5	13.8	7.3	12.2	10.1	8.9	11.7	16.9	11.3	9.0	13.5	4.2	18.2	4.1	7.9	13.2	10.9	13.3	6.0	4.0	12.9	7.2	21.2	7.2	15.9	17.9	8.4	9.4	10.5	10.6	12.0	10.5	12.1	12.3	7.2	12.3	13.7	8.3	6.3	8.4	16.8	11.8	10.7	6.2	5.3	3.0	3.6	6.5	4.2	4.0	4.2	4.6	7.1	3.8	5.5	4.3	2.6	5.9	5.0	5.1	4.7	3.9	23.6	28.8	24.2	32.4	22.7	24.4	22.7	23.7	27.7	15.4	44.7	38.5	16.7	19.2	13.5	33.9	83.2	25.5	49.5	34.2	36.6	23.6	37.0	87.9	31.8	3.9	18.8	23.6	0.0	31.7	28.0	22.1	27.9	33.5	23.6	21.4	47.7	32.1	22.7	21.0	6.9	19.2	20.3	23.6	28.9	35.3	24.3	29.0	10.5	21.2	80.0	36.5	6.5	23.1	11.7	14.9	19.8	41.3	14.9	36.5	19.2
SLC31A1	"COPT1, CTR1, hCTR1"	ENSG00000136868	"Solute carrier family 31 member 1"	O15431	9	113221562-113264492	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 55.7;salivary gland: 57.9"	"Cell type enhanced"	"Detected in many"	5	"Hepatocytes: 81.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.0;intermediate monocyte: 16.2;myeloid DC: 9.9;neutrophil: 5.0;non-classical monocyte: 17.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 9.9;granulocytes: 5.0;monocytes: 17.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA013810	Approved					NA	NA					"HPA013810: AB_1857095"	"unprognostic (1.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.29e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (1.22e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.51e-2)"	7.8	12.1	5.0	4.9	6.1	4.6	6.0	3.7	6.7	10.6	16.2	6.7	21.2	20.7	4.9	7.8	9.8	4.8	5.7	5.8	5.0	4.9	15.4	55.7	8.8	3.5	5.6	4.0	6.3	11.4	5.8	9.4	7.9	7.4	10.3	8.1	8.5	57.9	21.7	3.0	14.3	41.8	4.6	5.8	8.6	9.3	4.7	5.0	2.6	6.3	6.8	9.8	5.8	5.2	1.0	9.9	5.0	17.0	2.5	2.0	4.3	8.2	8.9	7.3	16.0	16.7	12.0	26.9	14.6	22.3	10.1	11.9	12.6	7.2	6.4	5.9	12.5	12.9	20.4	13.7	8.3	11.4	5.6	7.7	5.3	7.9	14.1	40.9	9.6	8.1	14.4	18.9	13.1	21.5	6.8	9.2	7.5	12.0	12.0	9.6	8.7	6.5	4.9	11.8	31.6	10.0	6.8	19.1	6.4	9.3	10.3	6.9	9.0	14.1	28.3	38.2	10.7	14.4	8.3	8.4	7.6	4.7	15.2	8.7	7.2	14.7	9.0	12.6	9.1	8.9	1.3	13.0	1.5	1.5	16.2	2.0	1.0	1.0	1.5	9.9	0.9	1.2	1.1	5.0	2.5	17.0	1.4	1.1	4.3	5.0	6.1	3.7	6.7	5.0	4.9	5.6	4.0	7.4	5.0	32.8	31.0	8.2	8.3	13.5	12.2	7.0	17.8	25.4	40.9	5.2	31.4	14.3	8.3	15.5	0.2	8.4	47.6	0.0	23.5	21.7	15.1	32.7	4.7	81.5	41.2	6.4	8.6	12.3	27.6	0.5	5.8	27.2	11.8	11.8	14.4	11.3	18.9	11.8	6.7	23.2	11.2	6.5	12.2	11.9	34.9	13.8	18.8	2.5	16.6	16.2
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150942-113164137	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"blood: 60.2;salivary gland: 125.5"	"Cell type enhanced"	"Detected in many"	5	"Cytotrophoblasts: 80.2;Kupffer cells: 82.1;Macrophages: 93.6;monocytes: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"classical monocyte: 36.6;intermediate monocyte: 50.5;myeloid DC: 21.2;neutrophil: 54.5;non-classical monocyte: 60.2"	"Group enriched"	"Detected in many"	36	"dendritic cells: 21.2;granulocytes: 54.5;monocytes: 60.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 22.2;hTCEpi: 33.7;hTERT-HME1: 23.1;LHCN-M2: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"		NA	NA			"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	15.7	8.0	10.0	8.1	20.5	7.0	8.5	3.2	15.0	3.0	8.4	45.1	27.1	5.2	2.0	6.0	4.6	3.0	4.5	3.4	18.2	9.4	9.8	11.2	10.0	6.2	34.3	10.5	2.8	7.8	17.9	1.2	10.2	22.3	2.1	4.4	1.0	125.5	21.8	6.7	18.5	9.9	3.8	48.5	14.1	4.5	5.4	26.2	1.2	2.8	2.9	5.8	3.9	4.1	0.3	21.2	54.5	60.2	0.2	1.2	13.4	5.5	2.5	1.4	2.0	22.2	9.1	4.8	4.2	5.4	5.1	4.9	1.8	1.7	0.3	0.8	3.5	8.3	20.6	2.0	12.0	4.8	2.8	0.8	0.3	1.2	2.9	8.5	2.2	1.2	10.2	33.7	11.9	23.1	2.7	2.7	2.7	1.6	3.0	26.6	5.3	2.1	1.3	0.7	2.8	2.3	0.4	20.1	0.4	1.7	3.4	1.3	2.2	5.8	17.8	1.7	1.2	6.4	2.0	2.5	2.8	1.9	9.2	3.6	1.9	3.9	0.2	8.8	2.9	2.8	0.8	36.6	3.6	0.9	50.5	1.2	0.2	1.0	1.0	21.2	0.3	0.8	0.8	54.5	0.2	60.2	0.5	0.6	13.4	10.0	20.5	3.2	15.0	18.2	9.4	34.3	10.5	22.3	26.2	8.9	8.6	18.0	5.3	33.0	6.9	0.4	2.5	10.7	5.7	1.8	33.4	80.2	3.3	10.7	2.3	6.7	17.4	0.0	6.6	5.8	13.3	7.9	0.0	18.7	55.9	6.4	3.4	17.2	82.1	2.0	14.7	93.6	0.0	89.2	3.2	8.2	13.8	7.0	8.9	17.4	9.1	19.4	8.9	30.6	5.1	33.5	36.0	8.3	3.5	4.2
SLC32A1	"bA122O1.1, VGAT, VIAAT"	ENSG00000101438	"Solute carrier family 32 member 1"	Q9H598	20	38724462-38729372	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 38.3"	"Cell type enriched"	"Detected in some"	14	"Horizontal cells: 55.6"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	20	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 1.9"	"Group enriched"	"Detected in some"	12	"MOLT-4: 5.5;SH-SY5Y: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037156, HPA058859, HPA059985"	Enhanced	Supported				NA	NA					"CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187"					"unprognostic (1.13e-2)"					"unprognostic (2.09e-1)"				"unprognostic (1.17e-1)"	"unprognostic (6.57e-2)"			1.0	1.1	4.6	1.0	38.3	1.5	1.0	4.9	25.8	1.0	1.0	0.8	0.0	1.0	1.0	1.0	1.0	1.1	1.0	1.0	3.9	9.7	1.0	1.0	1.0	1.0	4.4	6.8	1.0	1.1	1.0	4.1	1.0	10.4	1.0	1.0	0.7	1.0	1.0	1.0	1.0	1.1	1.0	4.4	1.0	1.0	1.6	7.9	0.0	1.0	0.0	1.0	1.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	4.6	38.3	4.9	11.9	3.9	9.7	4.4	6.8	10.4	7.9	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0
SLC33A1	"ACATN, AT-1, AT1, SPG42"	ENSG00000169359	"Solute carrier family 33 member 1"	O00400	3	155821024-155854456	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Cataract, Deafness, Disease mutation, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA042430, HPA060345"	Uncertain		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA042430: AB_10806238, HPA060345: AB_2732647"	"unprognostic (5.12e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.74e-2)"	11.3	17.3	6.5	9.9	8.6	3.1	12.1	9.4	9.4	18.8	13.1	10.5	29.9	11.3	14.0	22.9	11.8	12.3	11.5	12.9	7.8	6.7	19.4	38.3	12.8	13.6	9.4	5.6	13.6	42.4	18.8	24.6	13.9	8.9	15.0	10.5	9.2	26.6	33.9	7.0	9.4	15.2	10.4	8.2	11.9	12.4	8.9	8.8	14.9	26.1	5.8	10.7	10.2	11.6	6.0	16.7	12.1	8.3	6.9	10.8	6.0	14.9	10.4	5.4	6.7	20.0	17.3	10.2	11.2	15.0	13.6	13.4	5.9	16.0	7.7	18.1	9.1	14.2	12.7	9.3	11.0	15.4	10.9	9.6	8.0	5.0	11.6	29.0	8.8	7.1	13.8	22.1	7.2	28.1	15.2	14.9	7.3	6.4	18.6	12.2	9.5	3.5	5.2	5.2	12.6	10.0	4.0	6.0	23.1	13.9	9.5	6.3	5.2	9.4	21.9	19.9	8.0	6.9	11.2	15.4	8.0	4.0	14.7	11.7	21.9	7.7	8.1	11.5	7.2	11.4	12.1	8.3	6.0	9.4	6.5	10.8	6.0	6.8	7.4	10.7	4.1	6.5	6.3	1.8	6.9	6.3	16.7	6.1	6.0	6.5	8.6	9.4	9.4	7.8	6.7	9.4	5.6	8.9	8.8	20.8	20.6	11.9	10.4	7.9	16.4	21.8	22.9	21.4	18.2	10.4	25.5	15.7	5.0	13.3	10.1	11.3	14.8	0.0	13.5	23.4	14.7	16.8	11.5	43.1	17.3	17.5	12.0	18.4	16.2	9.1	17.3	15.9	11.8	14.4	14.7	17.2	15.0	3.5	20.1	15.5	19.9	12.9	17.2	17.2	7.2	8.3	31.5	15.8	12.1	9.1
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	79	"kidney: 94.5"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 128.7"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.1"	"Group enriched"	"Detected in some"	12	"HEL: 6.7;U-937: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA			"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	7.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	128.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lung: 259.9;seminal vesicle: 69.1"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 443.7;Alveolar cells type 2: 1050.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 585.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	81	"BEWO: 12.6;EFO-21: 47.7;RPTEC TERT1: 34.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	3.2	0.2	0.1	13.0	0.1	0.0	24.7	2.9	6.9	2.1	0.5	13.0	3.4	0.1	0.1	0.1	10.8	0.5	259.9	0.0	0.1	0.0	2.9	4.4	0.0	0.6	2.6	0.8	0.3	0.0	1.6	27.4	69.1	0.1	0.7	2.1	0.0	0.1	0.1	0.4	0.5	0.0	0.4	27.9	0.1	1.9	0.0	0.1	0.4	0.2	1.9	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	1.9	0.5	0.2	0.3	0.3	0.1	0.2	0.1	0.1	0.0	0.4	0.3	0.2	1.5	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.8	0.0	443.7	1050.6	0.0	0.1	0.0	0.0	0.6	40.8	125.8	178.6	19.2	0.0	1.6	5.0	57.7	3.5	0.0	0.0	0.0	7.1	0.0	0.0	3.5	26.7	0.0	0.2	0.0	0.0	0.0	0.0	14.0	1.1	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	2.9	0.0	0.0	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.1
SLC34A3	"FLJ38680, NPTIIc"	ENSG00000198569	"Solute carrier family 34 member 3"	Q8N130	9	137230757-137236554	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 10.4;kidney: 14.8"	"Cell type enriched"	"Detected in some"	12	"Proximal tubular cells: 20.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HDLM-2: 3.7;HeLa: 4.0;MCF7: 9.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			HPA023776	Enhanced					NA	NA					"HPA023776: AB_1857102"	"unprognostic (2.69e-1)"	"unprognostic (4.16e-1)"	"unprognostic (9.08e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.20e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.5	0.2	0.2	0.2	0.0	14.8	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	1.6	0.2	0.2	0.2	0.0	0.2	1.2	0.2	0.2	0.3	10.4	0.2	0.2	0.2	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.7	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	6.0	0.4	0.2	0.0	0.1	3.0	0.0	0.0	0.0	3.7	0.2	0.0	4.0	2.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.7	0.0	9.7	0.1	0.1	0.6	1.1	1.2	1.3	0.5	0.0	0.0	0.5	0.0	1.5	0.6	1.4	0.3	0.7	3.4	0.1	0.4	0.5	0.4	1.9	0.1	1.1	0.5	0.4	0.8	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC35A1	"CMPST, hCST"	ENSG00000164414	"Solute carrier family 35 member A1"	P78382	6	87470623-87512336	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Mucus-secreting cells: 73.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.04e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (2.85e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.04e-1)"	11.0	18.0	14.0	9.2	19.8	6.3	20.5	24.1	22.9	19.2	25.3	10.0	8.0	12.0	20.1	15.1	10.0	13.6	12.7	10.6	15.2	13.8	15.7	20.8	24.2	10.3	16.3	11.6	15.8	11.6	13.0	24.4	12.6	21.4	24.9	31.6	13.1	19.4	11.4	9.1	15.9	14.5	18.9	12.2	14.0	18.8	8.1	14.5	18.6	14.2	8.2	11.8	17.4	12.0	9.4	24.6	21.6	28.4	8.7	15.1	17.2	2.0	5.0	9.1	10.7	24.9	22.8	7.3	6.1	5.4	5.1	7.1	4.3	37.8	7.6	7.5	7.5	14.2	8.1	10.9	4.9	6.6	10.8	8.1	8.6	6.8	7.6	16.4	11.1	6.0	11.6	12.0	6.0	11.8	12.1	12.2	11.2	11.0	12.6	7.5	19.0	3.0	16.9	4.9	26.0	8.2	9.6	8.9	8.1	15.8	8.8	6.0	6.6	11.2	21.1	9.7	10.9	18.7	22.9	11.3	7.4	5.0	8.1	4.9	9.4	13.6	2.8	6.2	19.9	10.5	21.6	28.4	11.6	9.8	22.1	15.1	9.4	10.6	11.9	24.6	8.7	13.6	12.6	7.0	8.7	21.5	9.1	13.6	17.2	14.0	19.8	24.1	22.9	15.2	13.8	16.3	11.6	21.4	14.5	41.7	25.2	6.9	15.8	13.2	6.9	5.2	17.8	16.0	10.3	15.7	11.8	20.9	6.6	8.2	5.8	14.3	15.8	0.0	7.9	15.9	17.7	17.6	21.8	17.4	14.5	11.1	14.5	47.3	30.6	4.9	15.3	13.6	20.3	10.8	73.6	18.1	8.5	14.0	18.0	9.3	6.4	19.4	16.5	7.5	9.7	12.9	23.0	13.8	25.5	7.4
SLC35A2	"UGALT, UGAT, UGT, UGT1, UGT2, UGTL"	ENSG00000102100	"Solute carrier family 35 member A2"	P78381	X	48903180-48911958	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036087	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA036087: AB_10604093"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.34e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	11.4	17.2	10.5	9.7	12.2	10.9	21.9	5.9	18.4	16.2	22.7	20.5	13.4	13.5	11.5	24.2	17.2	23.1	14.3	12.8	10.3	10.9	18.8	43.6	14.5	18.9	12.0	9.7	10.6	30.6	18.8	16.2	29.8	12.7	14.1	23.1	10.3	16.9	14.7	12.9	15.9	13.0	9.0	13.8	12.1	19.8	8.8	10.3	8.8	13.3	12.5	13.0	11.3	11.4	7.5	18.5	24.2	15.7	7.8	10.9	6.9	20.5	23.7	8.1	11.5	17.4	14.1	11.9	21.2	20.7	21.2	25.6	25.5	36.3	7.7	10.1	23.2	29.0	29.6	21.8	16.3	17.6	10.2	14.7	8.5	14.9	19.9	20.3	16.2	18.4	15.0	27.6	18.7	17.7	12.1	12.4	11.1	16.1	12.8	15.7	19.5	7.9	13.4	16.8	23.1	28.9	8.5	14.5	23.6	19.2	16.8	9.4	15.2	22.1	24.0	12.1	15.9	35.2	12.7	8.9	12.8	13.1	23.0	11.9	20.0	13.6	8.5	15.5	13.3	15.8	11.4	14.4	24.2	10.2	15.7	10.9	7.5	9.2	9.6	17.5	7.3	5.8	10.6	15.9	7.8	10.6	18.5	8.8	6.9	10.5	12.2	5.9	18.4	10.3	10.9	12.0	9.7	12.7	10.3	8.9	17.1	6.7	10.5	12.6	4.5	4.2	10.2	20.1	6.8	15.7	0.0	27.3	3.3	23.0	2.5	11.9	18.8	23.3	28.6	22.7	14.8	16.6	2.3	14.9	21.4	6.4	12.2	12.3	10.1	1.0	9.2	11.9	10.1	30.7	30.3	9.4	20.7	17.5	10.3	10.5	4.6	6.5	7.3	5.6	4.1	15.3	40.2	9.6	17.4	22.6
SLC35A3		ENSG00000117620	"Solute carrier family 35 member A3"	Q9Y2D2	1	99969351-100035637	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Enterocytes: 139.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015253	Uncertain					NA	NA					"HPA015253: AB_1857106"	"unprognostic (1.05e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.34e-2)"	10.7	9.4	6.5	16.7	6.8	5.9	16.2	7.4	8.9	12.4	31.4	5.5	16.2	29.1	10.5	10.8	14.9	9.5	12.5	7.1	5.4	4.8	13.2	21.9	18.0	10.9	7.0	6.3	7.9	13.8	12.8	8.6	12.2	9.6	14.4	32.7	6.0	22.3	21.9	7.5	10.0	41.0	15.3	7.6	6.3	19.9	5.1	5.6	24.7	15.3	7.9	8.1	13.9	13.0	4.3	9.0	6.4	3.7	7.7	5.2	3.2	17.4	4.7	4.3	4.5	9.8	8.6	17.3	15.6	9.5	6.2	9.0	3.1	9.5	9.4	19.6	9.0	8.7	10.1	8.1	7.0	14.2	11.5	5.9	8.5	6.7	7.4	6.2	13.5	1.0	4.6	7.9	7.4	14.6	7.4	7.1	7.5	14.0	14.1	12.5	4.3	8.9	7.1	5.3	10.0	15.9	2.8	13.2	5.9	11.3	10.1	5.6	3.1	10.8	20.9	8.2	4.2	12.7	10.3	8.2	9.4	8.5	20.7	8.3	8.4	9.8	7.0	15.0	8.5	3.9	6.4	3.6	2.0	4.2	3.7	4.7	4.3	4.2	4.9	3.1	3.4	5.2	4.4	1.2	7.7	2.9	9.0	4.8	3.2	6.5	6.8	7.4	8.9	5.4	4.8	7.0	6.3	9.6	5.6	74.5	25.8	14.7	19.1	22.1	16.3	7.4	22.9	64.3	35.2	52.4	19.6	15.3	6.6	14.1	3.5	17.5	139.9	0.0	13.4	24.2	13.2	46.0	16.2	42.7	12.4	9.5	19.0	23.9	17.4	0.0	12.4	12.9	8.5	9.0	96.8	16.0	18.6	71.9	12.4	28.5	22.5	6.5	15.1	11.9	5.7	26.0	19.5	21.8	78.5	31.8
SLC35A4		ENSG00000176087	"Solute carrier family 35 member A4"	"L0R6Q1, Q96G79"	5	140564456-140569103	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062210			Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA062210: AB_2684712"	"unprognostic (3.01e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (4.56e-5)"	"unprognostic (2.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.55e-1)"	22.0	30.4	12.3	18.6	17.1	8.4	19.6	14.0	21.8	18.2	25.5	24.9	22.6	19.2	18.2	19.8	30.3	20.6	26.0	25.7	13.1	10.3	35.1	39.2	23.1	22.5	16.0	11.1	19.0	28.3	28.2	14.9	24.6	19.4	20.4	26.5	20.5	32.6	15.9	54.3	28.3	30.6	19.8	13.0	28.5	21.7	30.5	15.3	26.0	29.2	28.0	27.5	18.3	18.0	15.4	32.8	15.8	36.9	26.9	27.6	32.4	15.5	46.7	18.7	35.2	25.7	16.1	27.9	22.7	15.3	27.7	29.2	56.5	18.0	46.0	28.1	21.3	32.3	17.2	0.0	33.1	23.8	55.9	25.6	34.4	45.6	0.2	18.3	33.6	26.0	21.3	25.9	27.5	24.7	13.0	23.7	22.8	26.6	46.5	27.4	28.8	35.0	14.6	12.7	22.4	23.9	26.1	37.9	39.9	20.7	30.8	20.9	27.9	28.7	47.8	22.3	19.2	39.7	14.4	27.7	24.9	17.4	24.7	25.4	19.3	45.3	19.3	18.4	38.0	28.9	7.5	26.9	15.8	27.6	36.9	26.3	14.3	22.1	24.7	32.8	15.4	25.9	23.0	9.9	26.9	33.3	12.0	14.7	32.4	12.3	17.1	14.0	21.8	13.1	10.3	16.0	11.1	19.4	15.3	11.9	24.8	21.9	20.2	9.3	12.2	23.8	43.3	6.7	17.0	15.7	3.9	26.8	38.1	28.1	58.7	14.7	37.1	0.0	30.4	42.8	19.5	22.2	20.7	19.5	28.5	12.7	24.2	27.6	21.1	94.4	11.5	15.8	16.9	31.5	27.2	20.3	31.1	21.0	11.7	31.1	8.5	32.3	12.6	5.4	16.4	10.2	25.5	20.3	28.7	29.1
SLC35A5	FLJ20730	ENSG00000138459	"Solute carrier family 35 member A5"	Q9BS91	3	112561709-112585577	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035519, HPA057964"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA035519: AB_10601487, HPA057964: AB_2683566"	"unprognostic (7.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.60e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.51e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.05e-2)"	"unprognostic (3.42e-1)"	13.4	17.7	19.4	11.2	22.1	4.4	13.0	14.2	24.1	15.0	13.6	32.7	9.7	14.9	15.2	15.0	13.0	13.3	13.8	9.6	22.9	22.0	18.2	18.0	12.8	12.4	37.8	19.5	16.9	12.6	17.9	17.6	17.2	27.5	14.8	14.8	14.4	11.7	13.4	5.5	8.0	15.5	14.1	42.9	12.7	12.5	15.4	26.6	11.6	23.8	6.4	13.1	13.2	10.4	12.0	15.2	15.7	20.1	5.2	11.5	7.8	11.3	10.3	17.6	10.7	23.1	22.0	10.2	18.5	13.5	16.0	18.3	7.6	13.0	10.3	15.9	16.2	18.1	14.3	12.8	8.9	20.1	7.7	6.3	12.9	9.9	6.7	19.1	11.5	12.4	19.1	17.8	14.1	8.7	20.1	14.2	7.9	7.4	12.7	21.9	4.0	8.7	7.3	11.9	13.0	11.0	7.7	6.6	10.6	19.7	8.5	10.3	14.0	12.0	5.9	21.0	12.7	7.9	8.1	15.9	23.3	12.8	5.0	8.5	8.9	12.8	17.9	17.3	9.6	17.0	8.4	12.6	15.7	8.9	19.8	8.3	12.0	8.5	7.0	15.2	11.5	11.5	9.4	11.2	5.2	20.1	7.2	8.4	7.8	19.4	22.1	14.2	24.1	22.9	22.0	37.8	19.5	27.5	26.6	3.0	8.5	10.0	7.0	5.7	12.3	4.7	10.2	5.3	6.8	14.0	0.0	30.6	8.3	6.8	94.9	12.4	12.4	0.0	6.7	20.1	15.1	7.4	13.9	10.2	15.8	35.0	7.5	12.9	19.1	17.6	15.8	9.1	25.3	11.8	10.7	18.5	6.5	12.9	16.3	12.3	14.0	25.8	9.9	15.4	10.0	5.8	24.9	10.9	8.5	2.7
SLC35B1	UGTREL1	ENSG00000121073	"Solute carrier family 35 member B1"	P78383	17	49700943-49709014	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048655, HPA057418"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"HPA048655: AB_2680481, HPA057418: AB_2683432"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.36e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.17e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (5.69e-7)"	"unprognostic (6.28e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-2)"	8.5	8.3	8.4	7.4	11.8	8.0	10.7	8.2	14.0	9.3	13.0	9.3	9.2	13.7	7.6	26.5	9.4	9.9	7.3	15.8	8.6	9.2	16.0	46.7	10.1	16.0	9.8	7.9	7.5	22.3	13.5	13.2	12.4	9.9	7.4	13.1	8.4	22.4	12.7	33.7	9.2	27.3	8.0	8.1	10.2	9.3	9.1	7.1	6.5	19.7	13.8	10.8	9.9	6.7	6.6	25.0	8.1	15.1	7.0	9.5	7.9	13.6	22.9	17.2	27.0	15.8	9.9	19.5	14.5	23.6	30.9	24.8	47.3	16.0	9.5	34.0	20.1	18.6	10.2	27.1	17.3	33.9	11.6	19.8	12.0	15.1	27.7	27.6	22.5	11.4	10.1	19.0	22.2	27.8	7.9	19.0	15.6	11.7	27.4	21.2	27.8	16.5	14.6	7.6	25.6	25.9	11.1	18.6	25.7	15.1	14.5	14.9	19.1	8.5	6.8	9.9	19.3	21.8	15.4	8.1	23.6	10.5	25.2	19.0	14.5	23.8	14.2	15.4	17.1	20.6	8.1	15.1	5.0	9.5	13.5	6.9	6.6	6.5	8.9	16.7	3.6	6.6	6.0	6.7	7.0	9.1	25.0	7.4	7.9	8.4	11.8	8.2	14.0	8.6	9.2	9.8	7.9	9.9	7.1	14.9	27.2	30.7	36.3	19.8	25.8	35.5	20.4	30.8	31.8	26.2	33.4	49.1	29.9	55.6	40.4	35.0	41.9	0.0	89.2	91.8	36.1	53.6	41.5	49.5	66.9	20.6	48.6	22.7	21.3	11.3	27.9	37.0	35.4	45.9	30.5	41.4	64.2	27.5	19.4	37.9	30.4	12.9	15.3	44.2	33.8	22.0	67.3	35.2	36.0	37.4
SLC35B2	UGTrel4	ENSG00000157593	"Solute carrier family 35 member B2"	Q8TB61	6	44254096-44257890	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029638	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA029638: AB_10602402"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	18.0	28.2	14.8	12.6	15.0	10.7	17.7	16.2	24.8	18.3	18.9	35.8	19.0	13.0	22.6	23.4	14.3	18.6	27.1	17.7	15.2	10.9	32.3	35.5	16.1	12.9	17.1	14.6	16.7	38.1	27.4	11.1	26.1	19.8	19.0	20.2	23.8	49.6	20.4	17.5	15.6	16.4	20.5	24.7	18.4	20.6	16.3	18.7	12.2	19.3	17.8	17.6	19.6	14.3	12.9	14.4	21.8	8.6	10.8	21.1	10.2	23.1	13.3	16.7	32.0	27.5	29.1	12.2	25.4	42.1	25.0	30.8	11.7	21.6	5.2	22.9	31.4	26.9	22.1	11.4	28.6	17.6	15.3	14.7	10.4	10.5	13.9	25.7	22.2	17.0	29.8	30.1	23.0	11.3	34.6	18.3	11.9	14.9	22.4	29.9	27.2	8.2	18.6	7.4	69.9	15.5	8.2	10.8	26.4	27.0	17.2	20.8	20.0	12.5	13.9	28.6	10.9	25.8	20.4	18.1	19.7	13.1	19.6	22.1	17.3	19.7	12.1	26.3	17.7	40.0	21.8	8.6	13.2	21.1	6.5	17.8	12.9	11.9	16.1	7.7	7.7	11.0	14.2	0.7	10.8	2.3	14.4	9.6	10.2	14.8	15.0	16.2	24.8	15.2	10.9	17.1	14.6	19.8	18.7	6.0	11.5	22.3	25.5	11.9	9.7	6.7	43.3	5.3	11.4	26.2	2.0	50.8	11.6	69.2	0.4	9.8	13.7	0.0	64.7	44.1	30.6	27.0	34.6	15.3	32.9	9.5	18.9	16.0	9.9	1.2	21.6	10.0	50.6	32.5	20.3	42.2	56.9	27.4	18.7	11.5	12.5	0.0	16.7	15.2	67.3	12.2	29.4	13.1	29.9	18.4
SLC35B3	"C6orf196, CGI-19, dJ453H5.1, PAPST2"	ENSG00000124786	"Solute carrier family 35 member B3"	Q9H1N7	6	8413068-8435611	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054661, HPA057801"	Approved					NA	NA					"HPA054661: AB_2682561, HPA057801: AB_2683532"	"unprognostic (2.84e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.88e-3)"	12.2	12.1	12.1	11.3	22.6	4.0	13.7	11.4	15.8	14.2	23.5	12.5	27.0	16.0	11.9	43.2	12.4	10.9	16.3	12.3	13.5	10.2	18.5	22.2	12.6	12.5	20.0	11.9	10.2	22.0	17.6	16.0	18.7	15.9	14.6	24.7	8.5	19.0	35.4	6.4	13.0	27.1	10.8	20.5	16.4	18.3	9.6	17.5	13.1	20.1	10.0	13.3	15.9	14.9	10.4	9.7	10.2	13.7	19.7	13.0	8.8	11.3	7.5	8.4	12.9	19.3	24.9	6.2	26.0	21.4	9.7	12.9	23.0	10.0	8.8	16.9	19.5	14.2	7.9	8.0	7.2	15.6	13.6	8.6	4.3	5.4	11.5	19.5	7.6	10.4	18.5	11.1	11.0	11.7	13.7	12.9	6.3	9.7	3.6	19.7	9.0	4.9	9.1	5.6	13.0	8.1	4.8	7.2	10.0	23.3	11.4	8.0	6.5	7.8	5.6	12.6	22.5	4.8	13.3	13.0	17.0	4.8	10.9	12.3	9.7	17.3	6.0	8.8	7.2	20.2	10.2	10.1	9.1	10.6	8.9	13.0	8.2	11.1	11.4	9.7	10.4	12.9	10.8	9.5	19.7	13.7	4.6	12.0	8.8	12.1	22.6	11.4	15.8	13.5	10.2	20.0	11.9	15.9	17.5	6.0	11.7	8.1	11.9	11.9	4.2	8.8	15.3	26.8	10.3	27.9	3.9	18.1	6.6	17.9	5.2	15.8	24.7	0.0	21.6	24.2	23.9	20.6	5.8	22.4	17.4	9.5	14.3	19.0	15.5	5.9	14.4	10.1	20.3	17.2	40.9	5.1	15.7	35.3	11.3	22.6	2.7	12.9	18.6	32.1	17.7	15.4	13.7	8.7	28.3	18.2
SLC35C1	"FLJ11320, FUCT1"	ENSG00000181830	"Solute carrier family 35 member C1"	Q96A29	11	45804072-45813015	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.7"	"Cell type enhanced"	"Detected in many"	4	"Cardiomyocytes: 49.8;Enterocytes: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064001	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA064001: AB_2685171"	"unprognostic (2.62e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (8.22e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.30e-2)"	14.9	4.8	5.1	7.2	4.5	1.5	14.3	4.4	7.3	7.0	13.8	4.4	4.9	17.4	7.1	3.2	22.5	6.1	8.8	5.3	5.4	3.9	6.0	74.7	7.1	7.1	3.9	3.6	4.9	11.4	4.9	7.8	10.5	5.6	6.0	9.8	3.6	15.5	7.0	8.5	3.4	17.4	6.8	5.0	6.5	13.4	7.4	4.8	5.6	5.2	7.0	10.9	9.4	8.6	4.7	8.3	9.9	10.5	4.3	16.7	8.6	5.2	13.7	3.1	8.0	10.2	10.3	10.5	11.6	10.0	6.7	7.5	6.2	8.7	5.0	5.5	13.1	10.0	14.0	6.5	6.8	3.2	13.0	7.8	2.8	11.0	11.2	22.4	5.5	8.7	12.3	8.2	5.1	5.6	8.1	8.8	5.1	6.3	7.5	7.1	11.5	2.8	4.2	13.9	19.4	19.4	3.8	5.2	11.8	7.5	13.3	3.1	4.5	8.6	8.3	4.7	3.4	7.4	2.9	13.3	14.1	8.2	24.8	8.2	5.5	12.9	2.5	10.1	7.2	7.7	5.0	10.2	9.9	10.2	10.5	11.1	4.7	16.7	13.4	8.3	3.6	8.5	7.4	1.6	4.3	6.9	7.2	10.8	8.6	5.1	4.5	4.4	7.3	5.4	3.9	3.9	3.6	5.6	4.8	0.0	9.1	3.0	8.5	3.2	1.7	49.8	25.5	8.1	4.5	5.2	2.0	12.0	0.0	18.1	3.4	7.6	46.6	0.0	37.1	12.3	11.0	8.0	2.3	37.2	13.3	3.2	9.2	6.7	7.1	4.1	6.1	5.3	1.7	9.0	30.4	2.5	36.3	43.2	5.3	3.5	1.0	0.0	5.2	4.3	3.3	2.0	12.8	5.2	19.9	16.9
SLC35C2	"bA394O2.1, C20orf5, CGI-15, OVCOV1"	ENSG00000080189	"Solute carrier family 35 member C2"	Q9NQQ7	20	46345980-46364458	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027011	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA027011: AB_2672082"	"unprognostic (7.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (9.31e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.88e-1)"	16.8	25.9	19.4	26.7	24.0	25.6	17.5	30.3	25.0	19.1	19.3	22.8	21.3	22.0	19.2	20.9	23.4	24.3	20.2	13.5	19.0	12.9	20.7	26.7	17.4	22.9	19.9	13.6	21.0	30.5	18.0	23.7	29.8	17.7	23.6	12.2	28.9	30.9	17.3	13.4	25.6	20.7	15.8	19.3	26.1	21.6	19.6	23.3	19.7	23.0	13.5	23.4	19.1	19.3	17.4	42.9	26.8	21.9	18.3	28.3	23.5	14.3	17.4	8.1	6.4	11.3	10.9	15.0	7.8	14.9	8.8	10.5	24.3	22.9	9.6	26.8	9.3	11.9	20.3	4.6	17.7	3.3	7.8	13.6	8.5	10.6	19.4	21.5	11.0	10.1	15.7	22.7	12.5	14.6	9.7	7.3	10.6	13.3	17.7	6.5	34.8	7.8	16.5	10.5	15.4	16.9	7.3	8.7	18.6	11.1	14.2	12.0	16.6	7.3	38.1	24.4	5.2	22.5	19.3	7.0	22.7	14.5	11.4	12.4	23.7	19.4	9.9	25.7	12.6	10.1	19.0	21.9	26.8	23.8	21.5	22.2	17.4	24.4	24.0	23.9	16.9	28.3	25.5	19.5	18.3	16.7	42.9	22.1	23.5	19.4	24.0	30.3	25.0	19.0	12.9	19.9	13.6	17.7	23.3	14.9	15.5	28.6	25.7	12.8	31.2	5.9	17.8	12.0	18.2	26.2	39.3	80.2	11.6	34.0	4.6	13.5	26.5	0.0	53.8	43.9	23.9	32.4	14.9	23.7	33.9	17.5	20.2	28.3	19.1	4.3	17.8	17.0	20.3	45.1	31.2	21.9	31.3	30.6	18.0	15.4	29.4	19.4	14.4	15.6	21.0	14.4	66.2	25.9	27.7	28.5
SLC35D1	"KIAA0260, UGTREL7"	ENSG00000116704	"Solute carrier family 35 member D1"	Q9NTN3	1	66999332-67054099	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 50.4"	"Cell type enhanced"	"Detected in many"	8	"Hepatocytes: 84.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.91e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.63e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (2.12e-3)"	"unprognostic (6.39e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.20e-1)"	4.0	6.3	5.1	7.5	7.0	4.7	4.7	6.6	5.5	6.2	16.2	7.5	4.8	9.9	5.4	3.8	5.3	4.4	4.4	3.8	4.7	3.8	8.1	50.4	3.8	5.7	7.4	4.0	6.4	7.2	6.4	8.7	6.0	5.4	5.6	17.3	7.1	3.9	4.0	6.9	6.2	14.3	5.4	4.0	4.0	8.0	4.1	5.6	11.1	5.1	4.0	6.4	5.8	6.5	2.3	1.8	9.7	2.4	5.1	4.3	1.4	5.0	2.9	8.9	7.5	9.3	10.8	10.6	11.3	15.0	8.2	5.8	6.2	1.2	15.6	5.0	8.9	9.7	7.7	6.1	7.2	10.4	15.5	2.8	11.6	6.1	12.2	7.8	13.1	7.7	10.5	16.1	9.7	6.9	13.3	3.1	6.6	7.0	8.3	19.9	1.7	8.0	4.1	3.7	13.6	4.0	6.2	18.4	1.7	3.8	9.6	1.1	4.0	17.1	5.3	7.2	5.2	4.4	9.8	3.4	15.4	3.6	9.4	10.8	17.4	9.0	8.7	11.0	2.0	6.5	9.7	1.5	4.0	3.4	1.1	4.2	2.3	2.6	2.7	1.8	1.7	3.7	3.3	0.3	5.1	2.4	1.0	4.3	1.4	5.1	7.0	6.6	5.5	4.7	3.8	7.4	4.0	5.4	5.6	6.0	2.1	4.3	4.7	4.8	6.9	2.6	33.1	6.7	2.3	5.2	11.8	30.4	0.0	2.8	37.3	4.2	36.7	23.3	8.6	4.0	7.2	5.6	4.6	84.4	6.2	6.4	14.5	6.7	9.2	6.6	5.8	3.8	1.7	1.0	14.9	21.0	7.2	14.4	4.2	8.4	8.7	0.0	3.9	7.6	6.7	6.8	13.6	6.9	13.4	7.4
SLC35D2	"SQV7L, UGTrel8"	ENSG00000130958	"Solute carrier family 35 member D2"	Q76EJ3	9	96320706-96383710	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.6"									HPA064047	Approved		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA064047: AB_2685182"	"unprognostic (3.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.44e-1)"	8.7	6.1	5.9	7.8	13.6	4.6	8.8	1.6	10.8	7.9	23.8	21.2	4.2	30.7	8.3	8.7	8.7	7.8	16.2	7.3	7.8	5.2	20.1	27.9	13.2	17.6	13.7	4.7	10.5	26.0	8.0	5.1	10.5	9.2	8.0	22.6	13.1	8.5	5.3	2.8	5.7	39.6	11.2	14.3	6.5	18.7	5.1	9.8	2.7	14.3	5.0	7.5	10.0	8.0	1.5	2.4	1.6	1.4	1.9	5.3	1.0	11.3	8.9	5.6	11.5	7.1	14.7	10.6	5.1	10.8	7.9	6.7	18.2	37.6	0.2	8.5	4.5	18.6	16.5	7.7	8.0	7.0	5.3	6.3	4.1	3.7	31.2	10.5	0.0	0.0	12.0	9.5	6.1	17.4	15.6	17.2	0.0	7.6	0.1	8.7	7.7	0.0	0.0	4.9	21.2	10.3	0.0	0.0	0.0	18.8	6.9	2.1	13.1	4.4	8.9	22.6	19.4	5.6	8.2	15.3	5.5	5.9	7.9	4.9	0.0	0.3	0.0	11.3	0.0	7.5	1.6	1.4	1.0	1.8	1.0	2.4	1.5	2.2	3.5	2.4	0.3	0.7	1.7	0.1	1.9	0.8	0.1	5.3	1.0	5.9	13.6	1.6	10.8	7.8	5.2	13.7	4.7	9.2	9.8	8.9	8.3	0.9	7.2	4.6	0.5	6.9	30.6	6.7	5.7	12.2	2.0	23.1	10.0	6.1	0.1	11.3	52.6	0.0	21.1	37.7	5.0	13.5	4.6	41.4	17.3	1.6	9.2	10.4	16.1	0.2	10.0	9.4	16.9	7.2	45.1	7.7	22.3	38.6	5.6	18.0	3.5	12.9	7.6	1.5	1.9	4.6	22.2	8.4	27.7	13.9
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922264-136925639	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.9;retina: 16.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Group enriched"	"Detected in some"	4	"basal ganglia: 9.9;hypothalamus: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 18.7"	"Group enriched"	"Detected in many"	5	"basal ganglia: 26.6;olfactory region: 10.4"	"Region enriched"	"Detected in many"	6	"basal ganglia: 24.4"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA			"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.1	4.9	0.0	0.4	9.9	1.2	0.1	0.0	0.4	2.0	0.4	0.4	0.0	0.7	0.1	0.0	0.6	0.1	0.1	0.4	0.0	4.8	4.0	0.0	2.1	0.0	1.7	0.0	0.8	1.2	0.0	0.0	0.1	0.5	4.3	0.6	16.4	0.2	0.1	0.0	0.2	1.3	0.3	0.0	0.2	3.2	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	18.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	9.9	0.0	0.4	0.0	4.8	1.7	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1
SLC35E1	FLJ14251	ENSG00000127526	"Solute carrier family 35 member E1"	Q96K37	19	16549831-16572382	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016570, HPA062214"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA016570: AB_2190214, HPA062214: AB_2684713"	"unprognostic (1.76e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.75e-2)"	15.2	12.7	11.9	9.3	12.3	10.3	13.5	11.7	19.2	15.1	12.4	8.7	22.4	9.7	11.3	10.3	14.2	11.2	13.7	12.6	9.3	9.7	11.6	20.1	13.5	9.5	8.3	7.9	11.9	34.5	25.8	14.4	23.9	10.7	17.9	9.4	11.4	23.7	21.4	23.1	14.3	13.4	10.0	5.9	9.7	17.0	6.4	7.2	14.0	13.8	12.3	13.9	15.2	14.1	5.9	3.2	7.9	5.0	4.5	5.2	2.9	17.9	7.1	5.1	11.3	19.0	14.8	12.0	13.1	14.0	10.7	12.7	8.3	12.9	9.4	21.1	20.3	10.6	12.0	13.8	14.6	12.3	10.7	20.0	8.5	8.2	9.8	15.2	14.0	10.3	11.8	17.3	11.9	17.8	14.0	10.3	10.9	13.1	12.7	14.2	17.0	10.2	6.5	5.9	16.7	24.1	9.9	7.8	11.0	11.0	11.6	8.6	8.5	9.0	14.5	8.0	6.6	10.1	6.9	11.3	14.3	7.1	19.3	15.0	16.5	17.5	10.6	21.2	14.9	8.8	5.0	3.9	7.9	4.1	2.5	5.2	5.9	4.3	3.6	2.7	2.8	3.2	2.5	4.8	4.5	5.0	3.2	4.8	2.9	11.9	12.3	11.7	19.2	9.3	9.7	8.3	7.9	10.7	7.2	35.7	43.9	15.8	12.5	19.5	27.6	13.7	33.1	14.7	33.0	27.9	33.4	10.8	0.0	17.8	2.8	14.6	18.1	0.0	31.7	22.5	12.7	25.9	8.1	24.2	15.2	28.6	17.7	23.4	21.8	2.7	15.8	19.4	8.5	8.2	25.5	20.8	33.5	14.0	19.8	8.6	25.4	6.5	12.3	10.9	15.4	22.6	27.2	20.2	15.5	26.8
SLC35E2B		ENSG00000189339	"Solute carrier family 35 member E2B"	P0CK96	1	1659529-1692728	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 72.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045641, HPA062711"	Uncertain		Uncertain	Nucleoplasm		NA	NA			Nucleoplasm		"HPA045641: AB_2679402, HPA062711: AB_2684844"	"unprognostic (9.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.64e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.54e-2)"	"prognostic favorable (5.15e-4)"	7.4	9.7	11.3	5.8	9.3	6.4	14.2	15.5	14.5	8.1	15.4	9.7	15.4	12.5	10.2	10.5	6.8	9.0	9.8	5.0	11.7	7.5	7.7	14.2	8.6	18.8	10.0	8.5	15.0	16.6	6.5	14.4	11.0	9.2	9.7	7.3	8.7	12.1	10.2	10.4	10.5	12.1	13.6	7.1	12.8	8.2	3.9	12.6	8.5	9.8	7.2	10.2	7.3	13.0	4.8	8.7	6.8	3.9	4.5	9.5	5.0	6.1	7.7	27.5	19.4	15.4	14.7	6.9	3.4	8.0	4.0	4.1	3.5	8.4	8.3	12.4	16.4	9.9	4.5	10.9	5.9	3.5	11.7	10.3	12.3	13.7	9.9	15.3	11.6	10.0	13.7	13.8	10.7	12.0	21.4	16.8	16.0	14.6	14.9	9.3	3.8	15.2	13.2	9.5	5.1	9.1	12.7	5.8	14.4	9.9	3.4	18.6	23.8	12.7	11.2	20.1	12.5	9.0	15.8	12.4	11.5	6.1	4.9	4.1	12.5	9.6	17.5	9.1	21.1	8.1	1.7	3.9	3.3	8.3	3.5	8.9	4.3	6.8	9.5	2.8	4.8	8.1	6.7	6.8	4.5	2.5	8.7	6.4	5.0	11.3	9.3	15.5	14.5	11.7	7.5	10.0	8.5	9.2	12.6	11.9	27.0	23.5	6.5	6.5	33.6	15.3	35.7	13.4	27.3	3.5	72.6	11.2	0.0	5.0	0.8	18.6	25.2	0.0	5.3	7.3	19.3	8.4	22.0	18.1	8.9	28.6	24.5	30.1	33.0	1.3	28.1	8.0	11.8	6.4	23.6	12.3	4.8	17.5	25.1	2.2	66.3	6.5	9.5	6.1	15.5	8.4	7.3	30.6	26.7	6.7
SLC35E3	BLOV1	ENSG00000175782	"Solute carrier family 35 member E3"	Q7Z769	12	68746106-68793964	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 19.2;U-698: 19.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049403	Uncertain					NA	NA					"HPA049403: AB_2680747"	"unprognostic (1.49e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.26e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.80e-1)"	8.1	12.3	7.9	7.2	11.9	12.0	12.4	14.1	13.7	8.2	6.2	18.9	3.5	5.7	7.4	9.6	8.7	5.5	5.8	6.2	8.9	7.4	8.0	12.7	7.6	9.2	13.9	10.6	8.7	9.8	7.7	6.7	5.8	14.4	10.2	5.9	9.7	11.8	5.8	7.3	14.5	5.5	7.4	15.7	8.2	9.2	5.7	11.0	18.8	6.9	5.3	9.0	8.0	6.6	4.4	3.7	9.5	3.8	3.6	4.6	1.5	2.2	2.4	3.7	2.3	4.8	2.2	3.4	2.0	4.1	4.6	2.0	4.9	2.8	10.5	1.3	4.1	3.0	3.2	2.1	4.2	2.8	2.3	3.7	4.5	3.0	8.1	3.5	2.3	2.3	4.8	3.2	5.7	2.9	3.3	3.7	3.6	2.3	3.9	4.6	3.4	2.9	7.3	3.7	1.5	3.5	19.2	5.9	2.6	3.4	5.5	2.9	5.0	4.0	3.2	2.6	3.8	5.7	1.1	2.7	5.6	2.3	3.2	2.1	8.6	4.2	19.5	6.7	2.0	2.9	4.7	3.3	4.2	4.0	3.1	4.6	3.1	3.2	3.2	2.4	4.4	3.6	2.9	9.5	3.6	3.8	3.7	2.7	1.5	7.9	11.9	14.1	13.7	8.9	7.4	13.9	10.6	14.4	11.0	11.9	24.8	17.1	19.2	7.0	61.6	12.9	10.2	26.8	21.6	17.4	37.3	21.6	5.0	16.2	3.2	12.8	7.1	0.0	19.5	20.0	16.0	14.6	17.4	20.2	13.6	41.3	12.6	14.7	21.1	1.7	14.1	26.5	6.8	19.0	8.4	28.1	16.8	5.8	21.5	11.3	61.9	25.8	12.0	9.6	13.5	6.6	10.4	29.9	12.3	14.9
SLC35E4		ENSG00000100036	"Solute carrier family 35 member E4"	Q6ICL7	22	30635652-30669016	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 20.2;testis: 22.5"	"Cell type enhanced"	"Detected in many"	13	"Early spermatids: 93.5;Late spermatids: 68.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.0;U-2197: 14.5;U-87 MG: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049558	Approved		Approved	Cytosol		NA	NA			Cytosol		"HPA049558: AB_2680817"	"unprognostic (2.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-4)"	"unprognostic (5.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-7)"	"unprognostic (2.77e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.05e-3)"	4.0	2.5	5.6	3.3	11.8	3.4	2.6	4.0	11.4	2.7	5.9	8.1	2.1	2.7	4.2	3.5	4.5	3.1	2.9	5.6	5.2	4.7	2.0	1.1	2.4	2.1	13.0	6.3	2.8	4.1	3.1	2.8	1.6	6.6	2.9	4.2	2.4	2.6	3.5	20.2	7.3	2.5	3.5	2.6	2.4	3.8	22.5	10.1	0.0	2.0	6.6	2.1	3.6	7.6	0.7	3.6	1.6	2.8	2.1	3.2	0.9	6.5	2.9	1.1	2.2	3.0	7.7	0.6	4.3	3.8	3.0	2.8	0.2	1.8	0.4	2.3	4.4	4.2	4.2	1.9	2.5	1.5	15.0	2.1	0.1	2.1	0.2	4.3	0.3	1.8	2.4	1.1	11.9	3.7	4.7	10.1	0.5	0.6	2.0	4.6	1.9	0.2	1.3	1.3	1.9	10.9	1.2	2.2	0.2	1.4	0.5	6.0	2.3	4.4	1.9	2.1	0.5	1.3	0.5	13.4	12.7	4.0	14.5	4.1	0.6	0.5	0.2	15.5	0.2	3.3	1.6	2.1	0.3	0.9	2.8	1.4	0.3	2.1	3.2	3.6	0.7	2.1	1.7	0.8	2.1	2.2	1.0	2.3	0.9	5.6	11.8	4.0	11.4	5.2	4.7	13.0	6.3	6.6	10.1	0.0	1.0	0.9	2.0	12.9	8.8	1.6	0.0	8.1	1.2	1.8	21.6	0.0	0.0	3.2	93.5	4.9	2.6	0.0	2.1	0.4	3.7	1.5	1.1	0.0	1.7	11.1	2.4	4.9	0.3	68.4	3.1	4.5	3.3	2.8	2.6	17.3	1.9	5.7	3.5	0.3	9.3	0.0	4.1	21.8	3.4	16.7	0.1	2.5	4.4	1.4
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907526-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 41.9"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 11.0;Early spermatids: 10.7;Horizontal cells: 15.9;Late spermatids: 17.4;Melanocytes: 13.5;Muller glia cells: 27.9"	"Group enriched"	"Detected in some"	16	"glioma: 15.1;melanoma: 3.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	9	"AF22: 23.9;WM-115: 40.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	2.8	2.7	13.8	2.1	14.5	0.9	1.2	3.6	41.9	1.7	3.5	4.3	0.0	1.6	2.7	5.5	1.8	1.5	1.8	5.3	10.4	10.2	1.7	1.0	1.1	1.0	9.3	15.3	1.4	1.4	1.0	0.6	1.0	5.6	2.3	2.3	2.6	1.7	2.9	1.2	1.6	1.8	2.6	4.1	1.6	1.4	1.8	5.6	0.0	1.8	0.0	1.0	1.4	2.6	0.2	0.6	1.0	0.1	0.3	0.9	0.1	0.0	0.0	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.2	0.0	2.9	3.4	0.0	0.0	0.1	0.0	40.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.9	1.0	0.3	0.0	0.6	0.0	0.1	13.8	14.5	3.6	17.4	10.4	10.2	9.3	15.3	5.6	5.6	0.0	0.0	0.0	0.0	0.3	11.0	4.3	0.0	0.0	2.3	0.0	2.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.0	0.1	15.9	0.0	0.0	0.0	17.4	0.6	0.0	13.5	0.0	0.0	27.9	0.0	0.0	1.1	0.0	1.8	0.0	0.7	0.9	1.2	0.0	0.0	0.0	0.0	0.0
SLC35F2	FLJ13018	ENSG00000110660	"Solute carrier family 35 member F2"	Q8IXU6	11	107790991-107928293	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 43.2"	"Cell type enhanced"	"Detected in many"	5	"Basal keratinocytes: 40.9;Suprabasal keratinocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 54.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048185, HPA050695, HPA060150"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA048185: AB_2680304, HPA050695: AB_2681217, HPA060150: "	"unprognostic (7.73e-2)"	"unprognostic (3.28e-3)"	"unprognostic (8.37e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (6.22e-2)"	"unprognostic (8.20e-2)"	"prognostic unfavorable (5.92e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	3.0	2.5	2.4	7.4	2.2	1.3	2.7	2.1	2.4	7.4	8.1	1.8	3.8	8.4	2.6	4.8	5.0	6.2	5.9	2.4	3.7	2.6	5.6	2.0	4.0	7.7	2.4	2.2	3.4	3.4	0.3	2.6	9.7	1.9	10.6	9.8	5.2	43.2	2.7	2.3	8.5	7.4	1.8	4.2	2.7	2.8	3.7	2.3	1.8	3.2	6.7	6.9	3.4	3.7	9.3	5.9	0.5	0.2	2.9	11.2	1.6	8.5	5.6	0.6	7.9	4.7	7.0	8.1	2.0	1.1	5.3	6.8	24.2	9.0	14.2	20.3	5.9	28.6	17.9	11.3	18.1	10.5	11.8	10.4	7.9	5.5	10.0	7.7	18.5	4.0	4.8	10.5	17.5	37.9	15.9	27.6	11.3	20.7	5.9	3.7	5.1	7.6	17.8	6.0	18.9	54.7	15.5	7.2	18.6	28.3	7.8	13.8	5.8	6.4	14.9	3.9	7.9	11.0	3.9	20.5	9.7	16.1	0.2	20.4	15.4	17.4	15.6	6.2	5.9	6.3	0.1	0.2	0.0	2.8	0.1	7.3	9.3	4.8	4.9	5.9	6.1	1.8	2.5	0.5	2.9	0.0	0.3	11.2	1.6	2.4	2.2	2.1	2.4	3.7	2.6	2.4	2.2	1.9	2.3	8.9	1.0	11.1	30.1	40.9	1.1	0.5	0.0	0.0	15.9	3.5	11.8	0.7	3.3	10.1	0.3	5.8	14.0	0.0	7.2	13.5	5.1	19.0	2.3	0.0	5.0	0.0	5.8	0.0	0.8	0.9	0.9	3.9	21.9	6.4	10.2	1.3	17.0	10.5	2.5	5.5	7.5	6.5	4.1	0.3	4.9	44.0	3.8	2.5	22.6	15.2
SLC35F3	FLJ37712	ENSG00000183780	"Solute carrier family 35 member F3"	Q8IY50	1	233904933-234324516	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.0"	"Cell type enhanced"	"Detected in some"	9	"Basal glandular cells: 2.4;Distal tubular cells: 3.3;Exocrine glandular cells: 3.0;Glandular cells: 1.7;Intestinal endocrine cells: 1.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	49	"plasmacytoid DC: 7.1"	"Lineage enriched"	"Detected in single"	69	"dendritic cells: 7.1"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051327, HPA061582"	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoli	"HPA051327: AB_2681443, HPA061582: AB_2684563"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.69e-5)"	"unprognostic (3.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.58e-1)"	0.8	3.5	4.6	1.3	26.0	0.7	6.8	25.1	16.7	1.4	0.8	0.5	0.0	0.8	1.0	2.5	1.6	1.7	0.8	0.6	5.4	4.6	1.6	0.6	1.2	2.4	4.8	6.6	0.6	3.6	4.6	2.8	0.7	4.1	2.0	0.8	0.0	6.6	1.1	1.1	0.8	0.9	1.1	4.8	1.0	2.5	1.1	4.3	0.5	1.9	0.3	1.9	0.8	0.6	0.0	7.1	0.0	0.1	0.0	0.0	0.0	1.4	3.9	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.1	0.3	0.0	3.6	0.0	49.4	0.1	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.8	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	4.4	0.0	0.0	0.0	3.6	0.0	2.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	7.1	0.0	0.0	4.6	26.0	25.1	11.6	5.4	4.6	4.8	6.6	4.1	4.3	0.0	0.0	0.0	2.4	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.6	0.0	0.0	0.0	3.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.7	1.3	0.1	0.0	0.0	0.0	0.0
SLC35F4	"C14orf36, FLJ37712"	ENSG00000151812	"Solute carrier family 35 member F4"	A4IF30	14	57563922-57982194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"brain: 29.5;seminal vesicle: 10.5"	"Cell type enhanced"	"Detected in some"	24	"Cone photoreceptor cells: 3.9;Early spermatids: 5.9;Peritubular cells: 2.8;Rod photoreceptor cells: 14.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	6	"cerebellum: 29.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 4.5;U-87 MG: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA043853	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"HPA043853: AB_10963083"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-4)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-2)"		"unprognostic (1.38e-1)"		"unprognostic (1.76e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.03e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (9.23e-2)"	0.1	0.1	1.2	0.1	4.9	0.1	0.1	29.5	1.1	1.0	0.2	0.1	0.5	0.2	1.5	0.2	0.1	0.2	0.5	0.1	0.9	2.2	0.4	0.1	0.1	0.1	0.8	1.2	0.3	0.1	0.1	0.2	0.1	2.9	3.5	0.1	2.4	0.1	10.5	0.1	0.1	0.4	1.1	1.3	0.1	0.1	2.7	0.7	0.0	2.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.0	4.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.2	4.9	29.5	1.1	0.9	2.2	0.8	1.2	2.9	0.7	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	2.8	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC35F5	FLJ22004	ENSG00000115084	"Solute carrier family 35 member F5"	Q8WV83	2	113705011-113756823	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034828, HPA049229"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA034828: AB_2674350, HPA049229: AB_2680682"	"unprognostic (1.59e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.83e-2)"	20.0	46.8	7.9	11.7	9.2	3.6	13.8	10.6	9.0	16.9	18.1	15.0	18.9	14.5	14.2	12.6	20.4	10.7	14.9	20.0	8.2	7.9	44.7	29.5	15.0	12.7	10.4	5.0	19.1	23.6	21.6	20.6	24.6	11.7	16.1	16.5	14.1	23.4	16.9	20.0	15.1	32.4	13.1	9.6	12.6	13.7	12.6	10.3	9.2	33.1	14.6	16.7	14.1	16.7	3.4	6.8	5.8	9.1	6.2	4.3	3.2	9.9	9.4	5.1	2.8	47.8	33.3	15.2	16.5	17.4	10.6	15.8	18.7	18.4	9.3	21.3	21.2	27.1	9.2	9.1	8.6	14.7	3.7	3.7	6.5	6.5	16.5	16.4	9.4	17.7	28.8	11.5	13.5	19.2	16.9	11.2	2.5	8.3	9.1	22.5	6.9	2.8	4.8	5.0	11.7	7.7	3.9	10.3	5.9	37.4	13.5	1.6	3.8	12.2	13.2	9.2	10.2	10.4	5.4	10.0	16.8	8.9	8.7	5.2	6.1	8.1	6.3	13.0	5.3	10.9	5.8	5.4	3.7	2.9	8.0	3.8	3.3	2.6	3.1	6.8	3.4	2.9	2.1	4.3	6.2	9.1	3.0	4.3	3.2	7.9	9.2	10.6	9.0	8.2	7.9	10.4	5.0	11.7	10.3	20.8	16.6	2.4	27.7	22.6	10.8	21.0	22.9	20.1	28.4	69.8	21.6	39.1	10.0	25.8	21.3	12.6	39.7	0.0	25.0	60.1	22.6	31.6	24.2	22.1	24.5	4.8	13.9	10.4	14.3	11.0	11.5	11.2	8.5	19.0	23.1	20.9	21.3	26.6	13.1	35.7	17.6	0.0	12.2	42.6	11.7	29.6	55.5	10.4	21.3	29.8
SLC35F6	"ANT2BP, C2orf18, FLJ20555, TANGO9"	ENSG00000213699	"Solute carrier family 35 member F6"	Q8N357	2	26764284-26781231	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 48.6;Karpas-707: 42.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034655	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			Vesicles	"Nucleoplasm, Cytosol"	"HPA034655: AB_10696359"	"unprognostic (2.26e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.11e-4)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-2)"	37.3	24.1	9.7	10.5	11.7	6.5	42.2	8.3	15.6	17.9	14.5	16.0	12.4	10.4	14.1	14.0	25.2	12.5	14.4	15.0	10.4	11.6	37.4	25.4	15.3	22.0	12.3	9.3	20.4	12.6	13.1	12.2	26.6	11.9	15.3	9.0	13.8	16.7	14.2	16.7	30.9	14.7	15.4	11.4	14.8	16.3	11.7	9.1	10.5	24.1	20.4	15.5	13.8	18.2	3.1	7.1	7.8	19.0	8.6	8.8	5.9	8.3	14.7	4.5	11.4	15.5	7.0	6.9	4.7	7.3	6.1	5.6	9.2	16.0	2.2	8.0	6.6	15.1	10.4	6.4	9.5	4.3	3.8	3.1	2.5	5.6	7.7	48.6	2.7	12.8	11.1	9.8	6.9	23.2	2.8	7.1	3.4	4.7	42.8	6.1	13.5	3.4	2.4	2.5	6.0	3.9	3.0	12.9	3.5	16.2	6.7	3.4	4.5	8.0	13.1	8.5	3.9	4.9	2.8	6.4	8.0	8.5	10.9	5.2	8.3	10.4	4.3	8.6	4.6	7.2	7.0	12.0	5.3	8.8	16.5	5.0	3.1	6.1	8.0	7.1	2.5	4.2	6.0	7.8	8.6	19.0	5.5	3.8	5.9	9.7	11.7	8.3	15.6	10.4	11.6	12.3	9.3	11.9	9.1	11.9	8.0	6.7	11.8	15.0	17.3	11.2	25.5	5.3	7.9	31.4	5.9	22.1	6.6	29.6	1.5	19.2	18.8	0.0	33.5	20.1	22.4	12.8	1.1	19.2	46.2	14.3	8.7	28.8	43.7	1.1	17.0	26.4	27.0	10.8	8.7	18.9	38.9	9.1	11.3	49.9	9.7	25.8	29.9	3.7	6.5	22.5	31.8	13.8	9.7	10.6
SLC35G1	"C10orf60, FLJ33990, TMEM20"	ENSG00000176273	"Solute carrier family 35 member G1"	Q2M3R5	10	93893973-93956062	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 73.5;retina: 24.6"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 34.2;Peritubular cells: 34.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.6;T-cells: 3.8"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.94e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.90e-4)"	"unprognostic (8.89e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.47e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.30e-1)"	1.4	1.7	0.7	2.7	1.9	0.5	1.1	1.2	1.4	1.0	29.0	0.8	0.7	52.2	1.9	0.9	2.2	1.1	1.1	2.4	0.8	0.6	0.8	5.1	1.1	1.5	0.6	1.0	1.9	11.6	1.0	3.7	0.9	4.5	1.1	4.7	24.6	2.1	0.9	1.3	2.2	73.5	1.9	0.7	1.4	3.3	4.4	0.4	1.5	2.1	1.6	1.0	1.4	1.5	0.6	0.3	2.6	0.4	0.0	3.8	1.0	7.9	7.7	3.6	4.4	1.1	3.3	5.3	7.3	8.4	6.3	8.5	6.0	5.9	5.1	3.1	4.5	4.7	14.0	8.0	2.6	10.5	6.6	9.2	4.1	4.7	4.7	1.9	7.9	8.2	3.2	2.6	5.4	3.1	2.2	2.8	4.4	3.8	3.1	4.3	2.6	3.9	1.4	4.8	2.7	9.8	0.0	6.1	2.0	3.2	7.1	4.5	4.2	9.7	4.6	5.7	3.3	5.0	2.3	3.8	5.4	9.1	9.3	7.1	3.6	3.4	1.8	3.4	0.0	3.8	0.0	0.4	2.6	0.4	0.4	1.6	0.4	3.0	1.8	0.3	0.6	3.2	2.0	0.2	0.0	0.0	0.3	3.8	1.0	0.7	1.9	1.2	1.4	0.8	0.6	0.6	1.0	4.5	0.4	3.0	3.8	0.5	1.9	2.7	3.9	2.8	5.1	1.4	1.2	7.0	3.9	2.7	3.3	2.4	15.6	3.5	34.2	0.0	8.3	5.0	3.5	1.0	0.0	5.5	1.9	1.6	4.1	4.9	3.7	6.8	15.8	0.7	5.0	3.6	3.6	5.0	3.0	10.2	34.3	1.3	2.4	0.0	1.7	7.7	8.3	1.6	0.7	2.2	4.3	1.6
SLC35G2	"DKFZp564K2464, MGC3295, TMEM22"	ENSG00000168917	"Solute carrier family 35 member G2"	Q8TBE7	3	136818647-136855892	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Early spermatids: 36.2;Endothelial cells: 26.0;Ito cells: 26.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 1.6;memory CD8 T-cell: 3.5;naive CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052054, HPA064728"	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA052054: AB_2681709, HPA064728: AB_2685336"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.91e-4)"	"unprognostic (2.56e-4)"	"unprognostic (5.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.30e-2)"	20.2	24.6	10.6	3.7	12.0	1.3	18.3	16.6	17.4	8.1	3.6	6.4	6.6	2.2	6.7	8.1	4.1	5.0	8.7	7.6	11.6	15.2	4.3	7.1	6.0	3.3	10.9	10.5	5.3	13.3	6.7	15.9	11.7	11.3	4.8	3.8	3.2	2.7	4.8	2.8	3.0	2.4	8.5	12.4	3.1	3.1	17.2	4.9	0.9	8.8	2.1	2.5	8.2	9.3	0.2	0.0	0.0	0.1	0.0	3.5	0.3	1.7	4.9	5.0	2.2	10.1	8.2	0.0	7.8	34.1	11.7	17.7	4.6	2.6	0.0	6.0	8.0	18.7	0.6	5.9	0.3	10.9	0.0	1.6	1.4	6.0	2.8	12.9	0.0	0.0	11.6	0.9	10.2	2.8	8.6	8.7	3.1	0.8	0.0	14.9	0.0	2.1	1.5	1.1	0.0	3.7	1.8	3.3	0.0	10.0	0.4	8.3	5.5	6.3	0.0	10.7	1.8	0.0	0.8	5.9	8.7	2.2	3.8	8.4	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.5	0.0	0.1	3.5	0.0	0.2	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.3	10.6	12.0	16.6	17.0	11.6	15.2	10.9	10.5	11.3	4.9	11.9	6.5	2.7	3.7	3.0	5.4	2.0	0.0	1.4	10.3	1.8	11.8	1.0	1.7	2.7	36.2	26.0	0.5	0.0	9.3	1.1	11.0	3.3	2.3	1.8	0.6	6.4	4.1	26.4	1.0	19.8	9.2	3.5	3.3	3.6	0.6	6.8	9.1	0.0	2.8	0.4	4.7	6.5	7.2	22.7	9.4	2.6	1.8	4.8	0.6	1.8
SLC35G3	"AMAC1, FLJ40154, TMEM21A"	ENSG00000164729	"Solute carrier family 35 member G3"	Q8N808	17	35192520-35194523	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.1;skeletal muscle: 1.4;testis: 6.5"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 16.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"naive CD8 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	31	"T-cells: 3.1"	"Not detected"	"Not detected"																	NA	NA							"unprognostic (1.88e-1)"		"unprognostic (2.67e-1)"		"unprognostic (6.17e-3)"				"unprognostic (3.83e-1)"				"unprognostic (6.24e-2)"	"unprognostic (3.06e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	6.5			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.9	3.1	0.0	0.0	0.0	0.0	1.1	0.2											0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0
SLC35G4	"AMAC1L1, SLC35G4P"	ENSG00000236396	"Solute carrier family 35 member G4"	P0C7Q5	18	11609596-11610612	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	14	"testis: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	1.3			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC35G5	"AMAC, AMAC1L2"	ENSG00000177710	"Solute carrier family 35 member G5"	Q96KT7	8	11330888-11332208	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 5.5"	"Cell type enhanced"	"Detected in some"	18	"Early spermatids: 8.2;Rod photoreceptor cells: 3.2"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"TIME: 2.4"															NA	NA						"unprognostic (7.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.60e-4)"	"unprognostic (6.48e-3)"	"unprognostic (4.09e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.06e-6)"	"unprognostic (7.88e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.04e-3)"	0.0	0.2	0.4	0.7	0.5	1.3	0.0	0.5	0.4	0.3	0.6			0.1	0.2	0.2	0.4	0.2	0.5	1.1	0.5	0.6	0.5	0.3	0.5	0.8	0.6		0.2	0.9	0.0	0.8	0.1		1.1	0.2		0.3	0.0	1.9	1.2	0.6	0.1	0.5	1.4	0.5	5.5			0.6		0.5	0.3	0.4	0.4	1.7	0.1	0.8	0.0	2.1	0.0	0.3	0.0	0.2	0.8	0.7	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.3	0.2	0.8	0.8	0.3	0.6	0.1	0.2	0.2	0.4	0.1	0.5	1.5	0.1	0.0	0.1	0.8	1.1	0.4	0.0	0.0	0.3	0.1	0.7	0.8	0.7	1.1	0.8	0.3	0.3	0.5	0.4	0.7	0.6	0.5	0.6	0.1	0.7	0.9	1.4	1.6	0.1	0.2	0.5	0.5	0.0	2.4	0.5	0.8	0.7	0.3	0.5	0.6	1.0	0.3	0.4	0.7	0.1	0.3	0.0	2.1	0.1	0.2	0.0	0.8	0.0	0.6	0.4	0.4	0.1	0.1	0.0	0.8	1.7	0.0	0.0											0.0	0.0	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.2	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	0.4	1.6	0.0	1.8	0.0	1.3	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.4	0.0	3.2	0.0	0.0	1.1	0.4	0.1	0.0	0.0	0.4	0.3
SLC35G6	"AMAC1L3, TMEM21B"	ENSG00000259224	"Solute carrier family 35 member G6"	P0C7Q6	17	7481332-7483496	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"testis: 8.5"	"Cell type enriched"	"Detected in some"	6	"Early spermatids: 26.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.1;HeLa: 3.7;U-138 MG: 1.2"															NA	NA						"unprognostic (3.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-3)"		"unprognostic (1.37e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.01e-2)"	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.2	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	8.5			0.2		0.0	0.0	0.0	1.1	0.9	1.1	0.3	0.0	0.3	0.0	0.0	0.7	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.1	3.7	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.2	1.2	0.1	0.6	0.4	0.1	0.2	0.1	0.4	0.2	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.1	1.1	0.3	0.1	1.1	0.0	0.0	0.9	0.0	0.0											0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.8	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0
SLC36A1	"LYAAT-1, PAT1, TRAMD3"	ENSG00000123643	"Solute carrier family 36 member 1"	Q7Z2H8	5	151437046-151492381	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 43.3"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 49.3;Enterocytes: 37.0;Kupffer cells: 22.4;Late spermatids: 21.6;Paneth cells: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 15.9;classical monocyte: 6.6;neutrophil: 14.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.9;monocytes: 6.6"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035937	Approved					NA	NA					"HPA035937: AB_10672995"	"unprognostic (5.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (6.30e-5)"	"unprognostic (1.86e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-1)"	5.6	4.7	5.1	6.0	11.1	19.3	4.4	43.3	15.3	3.8	11.1	5.0	11.6	32.5	4.6	3.8	5.4	3.8	8.3	3.7	4.2	4.1	7.3	3.5	6.0	4.5	6.0	6.8	4.0	6.5	32.1	6.3	4.4	13.9	9.9	17.5	4.1	5.1	7.6	7.6	3.9	28.7	5.2	4.1	9.2	4.8	11.2	5.0	7.1	3.7	3.6	4.2	7.2	4.5	1.7	2.1	15.9	6.6	0.3	1.9	0.8	3.9	6.8	3.6	2.4	9.0	6.6	19.3	11.5	6.4	8.0	9.0	15.6	5.8	9.1	6.8	13.7	8.5	9.7	11.3	7.1	7.9	2.5	9.8	2.8	11.1	5.2	11.6	6.7	15.5	4.8	8.3	6.7	4.4	2.2	7.0	5.0	6.4	8.0	6.7	4.3	1.9	3.4	3.5	4.9	6.4	0.0	8.6	3.6	2.1	5.9	3.2	6.2	7.1	8.6	4.1	7.6	6.5	9.8	7.0	10.7	6.0	17.3	6.4	3.8	5.3	5.9	6.8	11.8	7.0	15.9	6.6	2.5	1.2	2.8	0.8	1.6	1.1	1.9	2.1	1.7	0.9	0.8	14.5	0.3	2.8	0.4	1.1	0.8	5.1	11.1	43.3	15.3	4.2	4.1	6.0	6.8	13.9	5.0	0.0	1.7	0.0	1.0	1.3	1.2	2.2	7.6	0.0	1.2	1.8	2.0	0.5	0.0	1.6	49.3	1.0	37.0	0.0	1.7	7.2	2.3	2.8	1.1	1.7	12.1	1.6	0.0	4.9	22.4	21.6	4.6	3.8	1.7	1.0	6.1	0.8	1.6	21.0	11.0	3.9	0.8	0.0	1.9	0.5	1.9	1.1	0.2	2.1	6.9	1.8
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314978-151347590	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"kidney: 60.3;skeletal muscle: 36.8;tongue: 16.1"	"Cell type enriched"	"Detected in some"	9	"Proximal tubular cells: 44.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Region enhanced"	"Detected in single"		"midbrain: 1.2"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.9;NB-4: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA044002, HPA062229"	Enhanced					NA	NA					"HPA044002: AB_10964214, HPA062229: AB_2684717"	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	2.6	0.5	0.1	0.0	0.2	0.1	0.1	60.3	0.1	0.1	0.0	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.0	1.1	2.0	0.0	36.8	0.1	0.1	0.0	0.2	0.1	0.1	0.7	0.0	0.0	0.1	16.1	1.4	0.1	0.1	2.1	1.5	4.3	0.8	1.5	0.9	0.3	0.1	0.3	0.4	0.7	0.3	0.1	1.0	0.4	0.0	0.1	0.0	0.6	0.3	0.8	0.3	0.2	0.3	0.4	0.0	0.7	0.0	1.5	1.5	0.3	0.8	0.3	0.0	1.9	0.5	0.1	0.1	0.0	0.0	0.0	0.5	0.5	0.1	1.4	0.2	0.3	0.4	2.0	1.2	0.0	0.2	0.5	0.4	0.2	0.2	0.1	0.4	0.4	0.1	1.2	0.0	0.2	0.3	0.3	0.5	0.2	0.2	1.2	0.2	0.5	0.2	0.4	0.3	0.3	0.1	3.2	0.8	0.9	0.7	0.6	0.6	1.1	0.6	0.6	0.2	2.1	0.7	0.9	4.3	1.5	0.6	1.5	0.5	0.3	0.1	0.1	0.1	0.1	0.1	0.1	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.8	0.0	0.0	5.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC36A3	"PAT3, TRAMD2, tramdorin2"	ENSG00000186334	"Solute carrier family 36 member 3"	Q495N2	5	151276762-151303766	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	17	"testis: 14.5"	"Group enriched"	"Detected in some"	57	"Early spermatids: 47.0;Late spermatids: 85.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA							"unprognostic (5.41e-1)"				"unprognostic (5.38e-1)"		"unprognostic (7.01e-2)"	"unprognostic (2.13e-1)"				"unprognostic (2.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.57e-2)"		"unprognostic (2.18e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.2	0.3	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	85.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0
SLC36A4	"FLJ38932, PAT4"	ENSG00000180773	"Solute carrier family 36 member 4"	Q6YBV0	11	93144171-93197964	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017887	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017887: AB_2190238"	"unprognostic (1.23e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.04e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.45e-3)"	"unprognostic (4.20e-2)"	8.0	11.0	16.0	12.6	19.3	24.1	6.5	20.7	20.2	8.0	7.3	8.7	2.1	3.0	10.4	3.6	7.8	6.2	8.4	9.2	14.2	14.8	13.7	11.0	8.2	7.0	16.8	10.3	8.6	8.0	8.0	17.2	8.7	17.6	7.5	9.4	5.4	5.4	9.1	3.4	5.9	4.2	11.5	20.0	5.7	6.4	6.0	13.4	5.6	12.7	2.3	9.2	8.6	7.7	1.6	2.9	8.1	7.7	0.8	2.6	1.8	5.1	9.3	19.0	3.8	6.7	13.7	10.7	9.0	15.0	13.4	16.3	7.4	17.0	6.3	5.2	8.3	7.0	6.4	5.8	3.3	12.3	10.5	6.8	7.2	19.5	4.9	5.3	18.1	10.8	6.6	10.4	7.7	4.9	6.3	7.1	9.0	0.6	0.1	13.6	1.3	7.9	13.7	7.6	2.0	9.4	3.6	11.3	2.6	4.5	7.7	17.6	22.9	13.1	5.1	3.2	14.5	9.3	5.3	7.9	25.3	7.8	14.9	13.0	2.6	5.2	0.0	5.7	7.6	13.0	0.2	7.7	8.1	1.3	3.9	1.8	1.3	1.0	1.6	2.9	1.6	2.6	1.7	2.5	0.8	2.5	1.1	0.8	1.8	16.0	19.3	20.7	20.2	14.2	14.8	16.8	10.3	17.6	13.4	11.9	8.6	18.2	35.2	27.2	21.1	7.7	12.7	21.4	6.8	19.2	21.6	9.5	29.9	19.1	1.7	18.0	0.7	0.0	37.9	21.2	11.6	37.1	4.6	6.4	13.1	25.4	26.5	10.4	59.0	3.1	16.7	44.6	20.3	10.0	17.4	13.3	27.9	5.8	14.5	12.3	23.0	6.5	17.6	6.2	2.7	28.0	13.6	10.7	4.3	23.7
SLC37A1		ENSG00000160190	"Solute carrier family 37 member 1"	P57057	21	42496008-42581440	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 254.9;Late spermatids: 218.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 48.5;MCF7: 19.3;OE19: 20.9;SK-BR-3: 16.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030418, CAB034154"	Approved					NA	NA					"CAB034154: AB_2190373, HPA030418: AB_10601602"	"unprognostic (1.44e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.22e-5)"	"unprognostic (1.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.61e-2)"	4.7	6.6	7.2	15.8	5.3	7.5	7.3	8.0	6.1	6.3	28.6	2.7	5.1	31.0	2.4	10.6	9.8	6.9	18.4	2.3	3.4	4.9	4.7	4.0	8.0	6.1	3.5	4.6	3.9	4.8	2.2	14.0	9.7	3.9	10.8	13.7	5.5	14.5	9.0	6.4	4.6	45.9	3.0	7.1	7.0	16.7	16.8	3.3	9.3	9.3	4.4	16.2	7.1	5.9	7.8	13.1	23.0	10.5	4.1	6.7	4.0	5.2	2.1	0.5	1.0	0.0	0.1	4.6	0.2	0.0	0.2	0.1	1.2	10.7	3.7	5.5	0.0	3.3	2.1	1.0	2.7	0.0	1.7	2.6	48.5	1.8	0.1	1.3	1.0	4.8	0.2	1.6	0.0	0.1	0.0	1.6	4.2	0.9	5.2	0.0	19.3	3.6	2.6	3.7	20.9	1.2	3.7	0.0	0.1	4.5	10.0	5.7	0.7	3.1	16.9	1.2	0.5	6.3	5.4	2.8	0.0	1.0	0.0	0.0	10.0	6.1	3.6	0.0	8.0	0.5	2.1	3.2	23.0	5.2	8.6	6.7	7.8	3.6	4.6	4.6	5.4	3.1	4.3	3.8	4.1	10.5	13.1	1.8	4.0	7.2	5.3	8.0	6.1	3.4	4.9	3.5	4.6	3.9	3.3	17.9	23.0	14.6	7.2	1.9	2.7	3.2	20.4	22.7	10.3	12.2	5.9	5.4	0.0	21.7	254.9	4.6	47.1	0.0	27.2	4.9	3.2	22.1	1.1	4.9	7.7	3.2	28.9	4.9	6.4	218.7	6.6	5.1	6.8	21.6	37.8	37.2	27.4	56.0	2.5	1.1	4.1	0.0	3.3	25.0	4.6	1.4	7.2	7.5	35.5	16.1
SLC37A2	FLJ00171	ENSG00000134955	"Solute carrier family 37 member 2"	Q8TED4	11	125063067-125090312	"Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 47.2;salivary gland: 85.6"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 32.3;Kupffer cells: 15.9;Macrophages: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	13	"classical monocyte: 8.0;intermediate monocyte: 9.9;myeloid DC: 3.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	12	"dendritic cells: 3.7;monocytes: 11.9"	"Cell line enhanced"	"Detected in some"		"A-431: 12.7;CAPAN-2: 27.2;hTCEpi: 12.2;hTERT-HME1: 29.3;U-138 MG: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014948	Uncertain					NA	NA					"HPA014948: AB_2190374"	"unprognostic (8.47e-2)"	"unprognostic (4.85e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.66e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.24e-2)"	7.1	26.4	1.0	47.2	1.4	0.0	3.4	0.4	1.0	2.5	3.6	3.5	0.5	3.7	0.7	2.0	7.2	1.0	2.4	2.3	1.3	0.7	1.0	2.7	7.2	6.4	1.5	0.3	1.8	0.7	0.0	0.6	3.2	1.5	2.0	4.6	2.4	85.6	0.6	0.4	16.3	4.6	1.3	1.7	10.2	0.8	0.7	1.2	1.4	0.6	3.3	3.1	6.6	6.5	0.1	3.7	0.6	11.9	0.0	0.0	3.1	12.7	0.0	0.2	0.0	0.3	0.4	0.0	0.4	1.2	0.4	1.2	0.1	27.2	0.0	3.9	0.1	1.0	6.7	0.2	7.2	1.8	0.3	0.2	2.9	0.2	0.6	0.0	0.0	0.1	0.3	12.2	1.2	29.3	0.7	0.7	0.2	0.1	0.1	1.3	0.0	0.0	0.6	0.3	0.0	0.2	0.0	0.9	0.2	0.3	6.6	0.0	0.1	2.3	0.0	0.8	0.2	0.0	0.6	1.5	20.9	0.0	0.2	0.5	0.3	0.4	0.0	0.7	0.7	1.6	0.0	8.0	0.0	0.0	9.9	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.0	0.6	0.0	11.9	0.0	0.0	3.1	1.0	1.4	0.4	1.0	1.3	0.7	1.5	0.3	1.5	1.2	0.0	1.1	1.4	1.2	0.2	1.4	0.8	0.0	0.0	2.3	0.0	2.0	0.5	0.0	0.1	1.3	0.8	0.0	0.0	0.0	0.6	0.3	0.8	2.3	0.0	32.3	0.0	0.0	1.8	15.9	1.7	0.9	9.3	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.0	0.7	0.0	0.4	2.2	1.0	0.6	2.9	0.7	0.0	2.6
SLC37A3	DKFZp761N0624	ENSG00000157800	"Solute carrier family 37 member 3"	Q8NCC5	7	140293693-140404433	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.39e-1)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (4.78e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.50e-2)"	11.7	6.9	8.4	6.2	13.6	6.6	14.1	14.0	15.0	18.7	16.3	9.1	5.1	8.7	31.5	16.1	7.7	15.6	12.3	8.5	10.1	7.9	10.2	8.2	10.5	5.0	8.4	12.3	14.6	20.4	20.0	17.4	13.9	10.6	9.8	16.1	10.4	26.6	8.6	5.0	8.7	10.4	21.6	9.6	10.6	11.6	6.8	8.6	10.0	13.8	6.8	9.2	13.5	12.0	2.5	3.2	12.8	3.9	5.6	8.6	4.0	7.8	13.2	13.8	24.2	20.0	22.0	16.5	11.8	13.9	8.2	12.3	10.5	17.1	1.1	15.0	10.6	21.1	6.5	8.4	14.3	12.6	17.7	12.2	1.3	3.4	10.6	16.8	0.0	4.5	16.9	14.8	8.6	10.2	14.4	12.5	7.0	7.8	3.3	12.6	15.1	7.5	0.7	20.4	19.0	8.3	4.0	3.7	3.6	15.7	16.1	13.5	16.9	3.3	13.4	12.9	15.5	7.2	0.7	14.3	9.4	6.9	23.6	12.0	6.4	11.8	3.0	9.9	0.1	21.5	6.3	3.9	3.7	7.4	2.2	4.1	2.5	8.0	5.6	3.2	2.0	8.6	6.4	12.8	5.6	1.3	1.0	8.6	4.0	8.4	13.6	14.0	15.0	10.1	7.9	8.4	12.3	10.6	8.6	8.9	11.3	4.7	35.2	13.5	9.3	4.3	12.7	10.7	15.9	12.2	9.8	15.5	1.7	19.3	0.9	11.2	12.4	0.0	23.4	22.0	24.6	26.5	8.1	6.6	3.4	12.7	20.7	16.0	5.9	1.1	18.7	4.1	18.6	3.6	21.2	3.1	24.0	10.5	12.7	4.6	9.2	6.5	12.2	3.6	6.5	10.8	11.0	9.6	13.6	33.9
SLC38A1	"ATA1, NAT2, SAT1"	ENSG00000111371	"Solute carrier family 38 member 1"	Q9H2H9	12	46183063-46270017	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 374.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 77.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039460, HPA052272"	Uncertain	Supported				NA	NA					"HPA039460: , HPA052272: AB_2681781"	"unprognostic (8.92e-3)"	"unprognostic (3.23e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (1.00e-1)"	"unprognostic (3.74e-1)"	"prognostic unfavorable (6.95e-8)"	"unprognostic (2.01e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.19e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.55e-2)"	5.3	3.1	9.2	18.4	14.9	11.7	44.8	28.7	24.1	7.8	23.1	15.2	26.0	8.7	13.4	5.4	14.3	10.9	9.0	23.7	11.9	16.5	11.5	5.8	7.7	30.5	12.6	13.3	9.9	21.0	51.9	22.5	45.0	24.7	16.2	20.5	7.1	14.1	29.9	62.9	15.8	16.8	14.6	22.4	15.6	17.9	1.3	8.7	26.5	22.5	16.6	27.1	14.5	8.5	21.2	15.4	8.8	0.3	22.2	26.5	14.4	15.2	15.9	5.7	21.4	2.6	0.9	29.3	12.2	19.9	5.5	8.8	27.2	15.1	34.9	23.3	14.8	17.2	23.4	19.1	25.0	10.4	21.5	10.1	2.4	26.4	10.1	22.7	24.5	0.9	4.5	38.5	1.7	67.3	13.9	12.4	22.6	12.6	29.3	17.5	19.0	21.7	4.3	21.2	0.0	24.9	19.6	1.4	24.3	21.7	21.9	23.0	15.9	25.3	31.1	14.3	23.2	18.1	18.1	26.0	4.3	4.1	0.1	12.4	28.0	24.0	77.9	14.0	48.3	3.7	0.3	0.3	8.8	19.4	0.0	26.5	17.9	20.3	22.3	12.0	21.2	23.8	21.2	0.8	22.2	0.1	15.4	21.4	14.4	9.2	14.9	28.7	21.1	11.9	16.5	12.6	13.3	24.7	8.7	32.8	36.5	89.1	59.0	86.8	374.0	184.5	40.8	29.4	33.0	202.4	133.5	88.8	3.3	51.7	0.1	21.5	54.6	0.0	40.0	70.3	12.8	33.7	3.5	5.9	10.4	7.9	38.9	4.9	9.7	0.0	2.0	19.2	25.3	7.2	68.9	47.9	44.6	40.3	0.7	1.0	55.9	0.0	40.3	0.0	0.4	107.3	155.3	109.7	62.4	59.6
SLC38A10	"MGC15523, PP1744"	ENSG00000157637	"Solute carrier family 38 member 10"	Q9HBR0	17	81245000-81295547	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021374, HPA023161, HPA024631"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		44000000	"Golgi apparatus"		"HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860"	"unprognostic (2.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.92e-4)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (6.55e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	22.8	18.6	8.1	17.0	11.3	18.5	43.0	9.9	10.2	15.8	23.8	13.8	22.0	21.8	17.4	30.7	13.2	15.2	28.4	17.3	7.4	9.2	18.0	59.2	24.6	23.7	11.6	6.7	23.7	55.1	6.8	30.2	23.2	10.0	16.0	6.5	15.1	33.3	26.1	8.7	11.2	26.2	10.9	10.4	21.0	19.1	25.0	12.3	20.2	25.9	10.3	15.8	18.4	13.0	6.6	10.0	17.2	15.4	4.6	9.8	7.9	17.3	30.5	5.3	28.1	20.6	9.7	31.9	21.4	19.3	13.1	15.5	14.1	29.2	13.3	24.5	14.7	14.5	21.0	5.4	10.7	4.9	13.3	16.0	13.4	10.9	23.9	18.4	13.1	32.1	16.8	8.0	11.8	7.7	10.7	25.1	9.7	9.9	20.6	9.8	22.1	8.0	22.5	5.3	16.1	15.1	13.0	11.2	13.4	9.2	16.4	10.3	26.7	17.2	10.8	23.3	7.8	15.4	27.5	24.6	21.2	12.4	15.8	11.4	18.1	7.9	7.6	12.6	20.4	21.7	11.0	10.2	17.2	8.1	12.0	9.8	6.6	7.8	9.8	6.3	6.6	5.4	5.8	8.2	4.6	15.4	10.0	5.5	7.9	8.1	11.3	9.9	10.2	7.4	9.2	11.6	6.7	10.0	12.3	23.8	35.2	11.2	10.8	7.3	11.5	14.7	40.8	6.7	18.2	10.4	17.7	47.8	5.0	33.0	17.9	21.0	56.4	0.0	23.2	52.2	22.1	16.5	15.0	66.3	42.5	23.8	43.3	27.6	39.2	46.8	30.5	26.6	13.5	19.0	55.6	28.3	24.6	42.1	25.8	20.3	9.1	32.3	15.3	16.7	21.5	6.4	52.3	17.5	40.8	10.0
SLC38A11	"AVT2, FLJ39822"	ENSG00000169507	"Solute carrier family 38 member 11"	Q08AI6	2	164896186-164955525	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"epididymis: 35.6"	"Cell type enhanced"	"Detected in some"	27	"Intestinal endocrine cells: 167.1;Sertoli cells: 71.1;Smooth muscle cells: 32.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 7.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	54	"memory B-cell: 2.7;naive B-cell: 7.9"	"Lineage enriched"	"Detected in single"	79	"B-cells: 7.9"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 75.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043432	Uncertain					NA	NA					"HPA043432: AB_10793948"	"unprognostic (1.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.36e-2)"	1.8	3.9	5.1	1.4	8.0	0.4	1.1	1.4	9.7	2.7	1.5	2.7	6.5	5.4	2.1	35.6	1.3	1.2	19.1	1.1	5.6	4.0	7.2	2.5	0.6	2.8	5.8	2.6	0.6	2.7	2.1	11.7	0.5	22.1	9.9	2.7	15.6	1.0	15.9	1.8	0.8	2.6	2.1	2.4	11.2	10.2	1.1	3.2	0.0	2.1	2.9	1.4	2.1	1.5	7.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	8.7	75.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	8.0	1.4	9.7	5.6	4.0	5.8	2.6	22.1	3.2	0.0	0.0	2.0	0.2	0.0	0.0	0.7	20.4	0.0	0.0	3.5	0.0	0.4	0.0	1.6	1.4	0.0	0.5	0.0	0.5	0.4	0.2	4.0	0.0	3.0	0.0	0.0	167.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	1.2	2.9	0.0	1.9	0.0	71.1	32.0	0.0	0.0	0.3	1.3	0.0	0.4	0.1
SLC38A3	"G17, SN1"	ENSG00000188338	"Solute carrier family 38 member 3"	Q99624	3	50205246-50221486	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 107.8"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 86.1;Cone photoreceptor cells: 176.7;Hepatocytes: 93.4;Muller glia cells: 75.9;Rod photoreceptor cells: 112.3"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 140.0"					"Cell type enhanced"	"Detected in some"		"basophil: 5.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"Hep G2: 32.4;SCLC-21H: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031871			Approved	Microtubules,Cytosol		NA	NA			Cytosol	Microtubules	"HPA031871: AB_2674080"	"unprognostic (2.14e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.19e-4)"	"unprognostic (7.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.96e-1)"	0.7	0.3	3.4	0.3	5.2	0.5	0.7	2.4	10.5	0.3	0.3	10.3	0.0	0.7	0.4	0.4	0.6	0.4	0.4	2.0	4.1		1.5	107.8	0.3	0.4	3.4	4.0	2.4	11.6	1.8	0.7	0.6	7.8	0.4	0.3	22.2	0.9	0.3	10.4	0.5	0.4	0.3	4.7	0.3	0.9	0.7	5.2	0.0	0.6	1.9	0.4	0.3	0.0	1.1	1.0	5.6	0.8	1.5	0.8	0.2	0.0	0.0	0.8	4.9	0.0	0.0	1.3	0.0	0.0	0.9	0.4	2.9	0.1	0.1	0.8	0.0	0.2	0.0	1.3	0.0	0.6	0.1	0.4	0.0	0.6	32.4	0.1	0.3	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.3	0.1	0.3	0.0	0.0	0.1	0.4	0.5	0.1	0.0	0.4	0.3	0.0	0.1	0.2	10.8	0.9	0.5	0.1	0.0	1.5	1.3	0.2	0.0	0.2	0.9	0.0	0.7	0.3	0.0	0.1	0.1	0.2	0.1	5.6	0.8	0.9	0.6	0.2	0.4	0.7	0.5	0.4	0.2	1.1	0.6	0.8	3.3	1.5	0.2	1.0	0.4	0.2											0.0	0.0	1.9	0.1	0.0	86.1	2.8	15.3	0.0	0.0	0.0	176.7	0.2	0.0	0.7	0.1	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.0	93.4	0.1	7.9	3.4	0.0	3.3	0.0	2.0	0.0	0.0	1.0	0.0	75.9	0.8	0.0	0.4	1.4	112.3	0.0	0.0	1.0	1.8	0.0	1.1	0.0	0.0	0.0
SLC38A4	"ATA3, NAT3, PAAT"	ENSG00000139209	"Solute carrier family 38 member 4"	Q969I6	12	46764761-46832408	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"liver: 128.2"	"Cell type enriched"	"Detected in some"	16	"Hepatocytes: 251.9"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 61.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basophil: 3.0;NK-cell: 1.9"	"Group enriched"	"Detected in many"	8	"granulocytes: 3.0;NK-cells: 1.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 8.8;LHCN-M2: 21.7;RH-30: 7.2;RT4: 42.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.81e-2)"	"unprognostic (7.46e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.37e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.21e-2)"	0.2	0.1	0.1	1.4	0.0	0.0	0.1	0.1	0.2	0.1	0.9	0.0	0.3	0.0	1.7	0.1	0.6	0.1	0.3	1.1	0.0	0.0	5.9	128.2	0.1	0.0	0.0	0.0	0.1	2.1	0.0	0.0	1.0	0.1	0.4	0.2	0.1	0.3	0.0	2.9	0.4	0.1	1.4	0.0	0.3	0.0	0.2	0.0	0.2	0.2	0.4	0.2	0.7	0.0	0.1	0.3	3.0	0.0	1.9	0.1	0.0	0.0	0.0	0.0	0.0	8.8	1.1	1.7	1.0	2.8	0.9	0.9	0.5	2.0	0.0	1.7	3.7	0.0	0.5	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	2.1	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	21.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.2	0.0	0.0	42.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.3	15.3	0.0	0.0	1.8	0.0	2.0	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.4	1.9	0.4	0.0	251.9	0.4	0.0	0.0	3.1	3.9	0.2	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.6	0.0
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470256	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 87.7"	"Cell type enhanced"	"Detected in many"	14	"Exocrine glandular cells: 67.4;Pancreatic endocrine cells: 93.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 35.6;HBEC3-KT: 54.3;HeLa: 53.5;hTCEpi: 40.4;Karpas-707: 47.8;RPMI-8226: 87.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	1.5	0.9	5.3	4.7	7.1	17.3	0.9	3.5	11.6	4.0	4.9	7.7	0.1	5.1	1.8	1.3	3.7	2.0	1.5	2.4	6.9	5.7	0.7	0.4	9.4	3.3	7.0	2.7	3.7	87.7	0.4	0.4	2.8	14.6	5.1	6.4	1.5	4.4	3.7	0.4	8.0	3.5	2.8	7.3	4.8	4.5	0.5	4.6	2.4	7.9	3.6	3.4	4.8	3.1	7.4	8.3	0.3	0.4	5.4	16.2	5.7	23.0	0.0	0.0	0.2	0.4	2.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	24.2	0.0	10.2	0.0	35.6	27.6	54.3	0.0	7.7	0.0	13.1	53.5	16.6	4.0	26.8	0.0	3.8	40.4	0.5	0.1	0.0	0.4	5.9	24.1	47.8	5.4	0.0	5.8	9.3	12.5	0.0	0.1	21.3	0.1	87.9	0.0	0.0	2.2	0.1	0.0	0.1	0.0	0.1	0.0	1.1	0.7	0.1	0.0	0.0	0.0	0.0	0.1	8.7	0.2	0.1	0.1	0.0	0.2	0.2	11.5	0.4	16.2	7.4	12.6	10.8	1.5	4.7	6.0	7.7	0.3	5.4	0.0	8.3	13.0	5.7	5.3	7.1	3.5	11.6	6.9	5.7	7.0	2.7	14.6	4.6	0.0	1.1	0.8	1.6	23.7	0.6	0.4	0.0	1.4	0.0	5.2	17.7	0.1	0.0	4.9	0.4	3.1	2.3	23.3	67.4	0.4	5.6	0.9	4.6	0.4	2.5	0.0	0.0	0.0	0.0	0.7	2.3	1.1	8.5	2.8	12.3	0.0	93.7	3.5	1.1	0.0	0.2	0.0	1.0	0.0	0.0	7.4	0.0	8.5	19.1	0.9
SLC38A6	NAT-1	ENSG00000139974	"Solute carrier family 38 member 6"	Q8IZM9	14	60981114-61083733	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Early spermatids: 130.6;Hofbauer cells: 89.9;Late spermatids: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018508	Approved		Approved	"Plasma membrane,Cell Junctions,Microtubules"		NA	NA			"Cell Junctions"	"Plasma membrane, Microtubules"	"HPA018508: AB_2190518"	"unprognostic (7.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (9.47e-6)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-1)"	26.1	16.9	8.3	6.7	16.6	4.0	11.4	9.7	14.0	8.1	7.1	5.2	5.5	4.5	10.0	20.5	5.0	8.4	14.4	5.4	8.8	8.6	16.9	9.2	12.2	9.6	8.6	10.9	9.9	6.1	23.8	21.5	13.7	14.3	8.1	10.1	10.9	11.7	6.4	4.1	4.6	5.6	8.0	7.6	10.8	6.4	10.9	6.5	8.8	9.7	7.1	7.2	11.6	8.1	2.4	5.2	0.2	8.6	0.7	5.2	3.4	7.1	10.0	3.2	5.9	33.9	12.3	2.2	5.4	16.2	5.1	4.8	2.5	19.6	1.7	9.3	4.9	10.8	6.3	3.1	5.5	4.8	2.4	1.4	3.0	4.1	6.5	11.1	1.5	5.8	9.7	2.3	5.0	5.9	21.1	6.8	2.7	4.1	3.7	17.9	4.0	2.7	3.9	2.0	4.3	6.6	0.5	9.5	5.5	15.0	4.0	1.5	1.2	4.5	3.3	8.7	4.7	4.7	2.6	7.2	8.0	3.4	9.3	3.0	0.7	2.1	0.6	16.4	1.3	6.3	0.0	8.4	0.1	2.2	8.6	2.6	2.4	4.0	2.9	4.4	2.2	3.3	4.3	0.2	0.7	5.4	5.2	5.2	3.4	8.3	16.6	9.7	14.0	8.8	8.6	8.6	10.9	14.3	6.5	20.8	4.1	2.7	10.8	4.6	18.5	2.8	5.1	34.8	5.7	5.2	21.6	5.0	1.7	4.1	130.6	6.7	2.2	0.0	2.5	7.9	8.5	6.5	5.8	4.0	89.9	4.8	4.1	3.7	20.7	97.9	10.0	19.2	5.0	1.8	2.3	14.2	6.0	2.0	5.6	16.8	25.0	0.0	6.6	15.1	10.6	2.5	5.6	4.4	2.8	5.9
SLC38A7	FLJ10815	ENSG00000103042	"Solute carrier family 38 member 7"	Q9NVC3	16	58665109-58685104	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	14	"Early spermatids: 273.8;Late spermatids: 600.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041777	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041777: AB_10796782"	"unprognostic (2.16e-3)"	"unprognostic (2.30e-2)"	"unprognostic (6.23e-3)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.49e-1)"	"unprognostic (8.08e-3)"	"unprognostic (9.76e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.93e-3)"	7.0	11.1	10.6	6.7	10.0	2.7	7.2	7.7	13.7	6.2	5.3	10.6	6.8	4.8	6.0	7.4	6.0	4.2	6.5	13.8	7.2	7.2	7.4	12.1	5.2	4.3	6.1	11.0	4.7	5.0	16.9	10.2	8.4	8.3	5.2	6.9	8.9	6.1	5.6	9.6	5.3	4.9	8.5	5.8	10.3	5.4	27.1	6.6	4.2	8.0	8.1	5.1	6.5	6.3	2.8	6.1	2.5	8.6	2.3	5.2	6.6	4.4	7.0	6.9	10.6	14.4	8.7	13.0	10.5	12.2	14.8	10.3	6.5	6.9	2.8	6.0	14.6	11.9	10.8	6.6	7.3	8.8	1.8	6.0	3.2	5.8	10.5	21.9	6.6	9.2	17.4	15.4	10.3	6.8	8.0	15.1	6.7	9.4	4.3	10.7	5.3	2.6	3.9	7.5	4.7	10.4	9.6	7.5	7.6	6.5	10.2	5.1	7.7	15.8	10.8	4.6	9.7	5.1	2.8	11.8	8.1	6.2	14.0	3.1	6.3	4.1	3.2	11.0	4.0	6.0	0.2	8.6	2.5	5.2	8.4	3.1	1.9	3.3	3.8	6.1	2.8	2.7	2.9	0.8	2.3	7.5	2.1	2.2	6.6	10.6	10.0	7.7	13.7	7.2	7.2	6.1	11.0	8.3	6.6	3.0	4.1	0.5	3.9	3.4	9.7	11.2	2.5	4.0	3.4	10.4	11.8	7.3	3.3	12.6	273.8	4.7	3.9	0.0	7.4	7.9	5.7	3.0	1.1	8.5	31.3	15.9	12.6	8.6	8.6	600.3	8.9	7.1	8.5	2.8	3.6	8.0	10.5	3.5	8.1	4.6	7.1	6.5	5.1	6.2	6.1	3.8	12.8	1.8	5.1	2.7
SLC38A8		ENSG00000166558	"Solute carrier family 38 member 8"	A6NNN8	16	84009667-84042636	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.1;liver: 4.5"	"Group enriched"	"Detected in some"	8	"Early spermatids: 2.8;Late spermatids: 9.5"	"Cancer enriched"	"Detected in single"	14	"melanoma: 6.5"	"Group enriched"	"Detected in some"	5	"amygdala: 6.1;cerebral cortex: 2.6;hypothalamus: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 1.5;HMC-1: 2.2;SCLC-21H: 8.7;SK-MEL-30: 1.3;SuSa: 1.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (9.69e-2)"	"unprognostic (6.16e-2)"		"unprognostic (8.00e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.16e-2)"		"unprognostic (3.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"			0.2	0.1	6.1	0.2	0.6	0.0	0.2	0.2	2.9	0.2	0.2	0.2	0.2	0.3	0.2	2.2	0.2	0.0	0.2	1.4	0.6	2.5	0.2	4.5	0.2	0.2	0.7	0.2	0.2	1.3	0.5	1.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	2.3	2.4	0.2	2.1	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.0	0.0	1.3	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.6	0.2	2.6	0.6	2.5	0.7	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	9.5	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0
SLC38A9	FLJ90709	ENSG00000177058	"Solute carrier family 38 member 9"	Q8NBW4	5	55625845-55773194	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 44.2"	"Cell type enhanced"	"Detected in many"	20	"Cytotrophoblasts: 168.8;Early spermatids: 189.6;Syncytiotrophoblasts: 518.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 49.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043785, HPA061702"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA043785: AB_10961859, HPA061702: "	"unprognostic (4.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (2.49e-1)"	"unprognostic (8.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.87e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.12e-1)"	7.2	6.3	8.2	6.9	8.0	5.2	6.8	9.9	9.7	6.4	7.5	9.2	6.7	6.6	7.5	5.9	9.0	5.8	7.1	3.9	6.2	6.4	6.7	13.5	6.4	8.4	9.4	6.4	6.9	18.2	10.1	11.8	44.2	8.6	5.9	8.5	6.7	7.6	5.3	5.2	6.2	7.1	7.2	8.8	8.9	7.7	15.8	8.5	13.3	7.1	5.7	11.4	8.7	6.9	10.8	10.8	7.4	11.8	8.9	10.0	6.4	8.1	8.3	6.9	9.3	9.6	9.9	49.9	6.8	9.6	8.3	13.7	13.3	11.2	13.3	11.6	5.6	13.6	10.1	9.3	8.0	10.9	7.1	8.7	4.2	8.9	8.9	15.4	7.5	5.1	12.0	9.7	9.2	10.8	6.0	9.3	8.7	9.1	8.9	7.7	6.9	9.4	7.2	12.8	3.1	7.5	7.2	11.6	13.4	11.2	6.5	3.8	6.1	7.0	4.3	11.6	10.1	9.4	15.3	12.6	1.7	5.6	12.2	7.1	9.6	19.6	8.0	4.3	7.7	4.7	4.8	11.8	7.4	7.8	10.2	10.0	10.8	6.3	9.0	10.8	6.2	9.2	7.7	2.9	8.9	7.5	10.8	8.1	6.4	8.2	8.0	9.9	9.7	6.2	6.4	9.4	6.4	8.6	8.5	6.0	1.9	9.5	3.9	2.9	5.4	2.0	15.3	4.0	7.9	8.7	7.9	168.8	1.7	7.8	189.6	6.8	4.0	0.0	9.9	52.8	5.4	4.1	2.3	18.4	23.0	1.6	4.1	9.8	10.6	73.4	6.9	8.2	5.0	8.2	5.0	5.1	9.5	7.0	4.6	5.7	7.9	6.5	4.5	14.0	4.3	3.0	518.4	8.7	5.2	4.2
SLC39A1	"ZIP1, ZIRTL"	ENSG00000143570	"Solute carrier family 39 member 1"	Q9NY26	1	153959099-153968184	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 292.9;Extravillous trophoblasts: 244.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (6.27e-2)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (5.26e-5)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (2.36e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-2)"	32.5	31.8	12.5	20.6	19.3	3.8	28.0	11.1	14.0	21.8	24.1	16.6	18.2	15.9	28.7	20.8	25.6	20.8	31.9	25.5	13.2	9.3	39.0	53.7	34.7	19.5	20.7	10.1	28.1	27.8	20.7	13.0	65.5	16.2	29.5	17.2	20.1	21.9	22.3	18.6	25.6	22.4	22.2	18.6	28.1	23.6	14.9	17.4	15.2	46.9	24.5	18.5	23.7	28.5	17.4	22.3	26.9	34.7	11.1	14.1	20.4	24.1	27.9	22.8	19.2	21.6	22.2	50.1	15.7	38.1	26.2	29.0	41.1	62.4	9.4	50.3	21.5	21.9	54.4	23.1	23.8	15.0	29.4	18.7	12.8	29.7	18.1	24.7	9.7	14.9	26.8	22.2	20.6	20.6	24.5	18.7	10.9	12.0	11.0	21.0	49.2	9.8	12.5	32.3	49.8	22.1	11.1	19.8	11.4	41.0	17.5	10.2	23.9	29.6	76.1	27.1	30.6	40.8	20.8	16.9	24.3	22.1	17.2	22.5	13.3	17.0	12.1	17.3	7.7	32.1	5.9	27.3	7.8	14.1	30.6	8.8	13.9	10.7	10.6	22.3	17.4	11.7	10.6	26.9	11.1	34.7	20.2	10.1	20.4	12.5	19.3	11.1	14.0	13.2	9.3	20.7	10.1	16.2	17.4	8.9	3.5	16.6	81.5	50.3	7.0	11.8	50.9	5.3	3.4	50.6	2.0	292.9	11.6	174.0	0.7	65.7	26.4	0.0	99.6	244.0	77.9	82.7	36.8	23.7	103.7	17.5	18.5	31.3	47.4	2.0	44.8	38.9	45.5	117.2	28.0	38.0	101.5	25.9	58.4	35.1	5.8	45.3	63.7	14.4	23.2	46.7	128.0	19.2	32.9	64.0
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 41.0;thyroid gland: 39.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		49000	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	6.6	10.9	16.0	6.0	24.8	3.7	6.2	10.8	41.0	9.8	3.8	4.2	4.9	3.6	9.4	3.3	3.5	8.5	7.6	4.7	15.0	11.2	7.8	2.1	6.3	6.5	8.5	24.4	7.4	5.7	5.8	5.7	10.7	15.7	16.7	4.0	1.4	4.8	6.5	3.3	5.7	5.7	6.7	10.2	14.4	4.3	7.9	6.2	10.6	39.9	1.7	6.4	6.1	4.9	9.4	18.4	19.3	2.7	11.0	4.6	1.5	2.9	9.9	18.9	5.2	3.7	8.8	9.8	13.7	6.7	6.6	3.3	14.8	10.6	4.1	20.9	7.8	5.1	4.2	11.5	12.6	8.4	2.1	8.6	4.6	15.4	12.1	4.1	16.8	1.9	5.2	1.8	7.3	8.4	23.4	14.8	4.2	13.3	5.8	10.6	2.8	4.8	5.2	22.0	17.2	7.8	11.3	6.6	10.2	28.8	4.9	7.3	10.0	13.7	28.0	7.2	34.5	4.5	10.5	14.5	12.1	14.0	7.9	7.1	2.0	1.2	2.4	9.7	7.9	12.2	19.3	2.7	1.9	4.5	2.5	3.5	6.8	4.0	3.7	3.3	9.4	3.5	4.6	0.5	11.0	1.8	18.4	3.9	1.5	16.0	24.8	10.8	39.7	15.0	11.2	8.5	24.4	15.7	6.2	3.0	10.9	18.2	9.3	22.8	21.9	7.3	7.6	6.7	29.6	34.9	7.9	41.3	1.7	17.6	23.2	27.0	2.9	23.3	9.5	54.8	20.3	18.5	12.7	2.5	21.6	7.9	15.0	24.5	18.1	11.5	17.5	29.7	6.8	8.2	5.1	15.6	17.5	2.9	17.7	14.9	19.9	12.9	13.8	47.8	27.0	17.9	19.6	21.5	4.5	6.4
SLC39A11	C17orf26	ENSG00000133195	"Solute carrier family 39 member 11"	Q8N1S5	17	72645949-73092712	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Late spermatids: 49.0;Mucus-secreting cells: 73.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 48.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021455			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA021455: AB_2670710"	"unprognostic (2.29e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.85e-2)"	10.4	7.4	12.4	7.8	17.9	10.7	10.8	5.3	14.4	9.3	13.3	19.8	6.6	11.5	4.8	9.6	13.0	5.6	8.6	4.2	13.3	6.3	7.9	21.9	8.2	4.8	27.8	6.6	2.8	23.8	3.1	3.8	7.0	15.3	5.3	13.8	6.7	16.6	5.2	3.7	11.2	12.7	5.7	15.7	6.5	27.6	4.1	22.5	6.0	20.6	3.6	8.6	8.3	7.6	6.0	14.9	9.8	16.2	8.7	6.9	6.3	4.3	7.9	0.9	3.8	6.9	5.6	5.4	4.6	4.1	2.1	2.9	2.9	19.7	5.4	4.8	4.7	3.4	3.7	1.3	2.3	3.3	5.8	2.8	5.0	2.1	3.4	4.1	5.3	48.4	4.8	4.5	4.4	2.6	2.3	2.2	2.8	2.6	6.8	2.7	6.1	3.4	11.6	0.7	13.3	3.4	2.3	3.6	4.5	3.5	4.5	2.2	3.1	2.5	18.7	2.8	3.9	12.8	7.4	1.8	4.2	4.0	3.6	2.8	5.5	2.5	3.8	6.9	10.8	2.4	5.5	16.2	9.8	6.9	15.4	4.6	6.0	5.3	5.2	14.9	3.9	3.8	5.2	2.5	8.7	11.9	10.5	6.5	6.3	12.4	17.9	5.3	14.4	13.3	6.3	27.8	6.6	15.3	22.5	0.0	4.6	3.7	4.4	3.9	2.3	2.0	7.6	6.7	7.9	3.5	0.0	4.7	0.0	6.8	19.2	3.6	19.9	23.3	12.3	14.7	3.6	5.1	29.9	25.0	25.0	4.8	8.1	4.3	15.5	49.0	3.7	7.6	10.1	15.4	73.3	3.9	8.3	20.4	3.2	9.8	1.5	12.9	6.1	1.9	2.5	3.9	4.1	3.2	14.7	6.3
SLC39A12	FLJ30499	ENSG00000148482	"Solute carrier family 39 member 12"	Q504Y0	10	17951839-18043292	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"brain: 42.3;retina: 19.2"	"Cell type enriched"	"Detected in some"	30	"Muller glia cells: 85.4"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-2 OS: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.43e-2)"				"unprognostic (2.67e-1)"	"unprognostic (3.30e-1)"		"unprognostic (8.70e-2)"	"unprognostic (1.02e-1)"		"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.40e-6)"	"unprognostic (1.94e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.76e-2)"		1.2	1.0	13.7	1.0	14.6	0.9	2.3	2.2	31.2	0.9	1.0	14.8	0.0	0.9	0.9	0.9	0.9	0.9	0.9	1.0	21.4	5.5	0.9	0.9	1.0	0.9	9.9	5.6	0.9	1.2	0.9	1.5	1.1	42.3	1.0	1.1	19.2	1.0	0.9	0.9	0.9	0.9	1.0	1.5	1.0	0.9	1.4	8.7	0.0	0.9	0.0	0.9	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.3	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	14.6	2.2	17.5	21.4	5.5	9.9	5.6	42.3	8.7	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.3	0.0	0.0	0.0	0.0	85.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0
SLC39A13	FLJ25785	ENSG00000165915	"Solute carrier family 39 member 13"	Q96H72	11	47407132-47416501	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	11	"Early spermatids: 250.1;Late spermatids: 701.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043971	Approved					NA	NA					"HPA043971: AB_10959744"	"unprognostic (7.84e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-3)"	"unprognostic (3.81e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.12e-1)"	17.0	19.2	14.1	19.7	17.0	6.3	15.1	25.6	21.8	17.8	18.6	18.8	12.4	12.1	32.1	20.2	17.1	18.5	19.0	35.5	16.1	10.3	39.9	17.6	23.2	14.8	18.5	15.0	21.3	20.7	19.0	21.0	34.5	15.5	20.5	6.3	23.8	20.0	24.9	19.8	27.1	12.0	22.8	10.6	15.3	16.1	25.9	16.4	9.8	18.7	9.3	10.4	19.5	15.7	5.8	5.0	6.5	14.4	6.7	13.2	5.2	7.4	6.6	7.8	8.7	19.1	26.8	2.2	30.0	22.2	16.8	19.2	2.6	5.1	2.9	8.2	22.5	16.6	12.6	2.3	20.1	4.7	8.4	8.8	1.5	15.7	5.3	28.7	2.5	3.7	22.3	14.5	10.6	8.7	21.1	17.9	5.6	1.4	6.4	18.0	6.6	5.4	3.7	3.7	6.3	9.9	6.6	11.4	2.9	28.4	3.6	6.9	12.5	9.0	16.1	8.4	3.0	10.7	3.8	24.9	25.7	11.9	29.3	13.6	5.0	1.6	1.2	28.4	3.6	18.6	2.0	3.6	3.0	13.2	13.7	8.8	4.5	8.7	9.3	4.6	5.8	8.3	6.8	6.5	6.7	14.4	5.0	4.5	5.2	14.1	17.0	25.6	21.8	16.1	10.3	18.5	15.0	15.5	16.4	8.9	5.4	2.2	16.0	16.3	23.6	15.5	10.2	1.4	5.7	27.9	11.8	8.4	8.3	29.6	250.1	17.6	4.0	0.0	18.1	14.1	34.0	9.3	5.7	5.0	17.2	30.2	9.2	19.0	4.8	701.9	30.5	10.7	18.6	44.1	7.3	15.8	25.0	6.2	37.8	7.3	15.8	45.3	20.3	12.5	5.7	3.6	16.4	8.6	5.5	6.7
SLC39A3	ZIP3	ENSG00000141873	"Solute carrier family 39 member 3"	Q9BRY0	19	2732204-2740152	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	10	"Early spermatids: 234.7;Late spermatids: 338.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042139, HPA058526"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA042139: AB_10793875, HPA058526: AB_2683743"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.75e-3)"	"unprognostic (9.22e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.80e-2)"	11.1	15.5	13.3	8.3	18.0	23.9	13.3	10.6	28.0	12.7	10.8	14.0	8.3	10.2	14.3	19.5	10.5	14.6	10.5	11.7	14.4	13.0	11.0	23.6	9.0	11.7	11.5	12.9	11.0	11.9	17.8	15.5	10.6	14.9	10.8	8.8	10.7	12.4	11.7	11.2	8.1	9.4	14.0	11.1	12.9	9.3	50.1	8.8	13.0	12.5	6.8	9.4	14.2	7.8	24.4	38.0	29.6	17.5	13.1	17.5	15.4	11.9	9.7	7.3	18.0	15.2	10.4	7.4	8.7	10.3	16.1	16.5	10.5	7.8	7.4	5.6	14.9	12.8	9.7	11.2	11.6	10.1	0.0	8.0	32.5	7.2	10.5	16.8	26.9	47.6	9.3	18.8	11.9	9.8	5.8	8.2	13.9	35.6	33.1	10.8	7.7	13.2	20.2	7.8	10.6	12.9	17.5	4.8	22.0	7.6	9.3	10.1	9.2	7.6	5.4	18.1	4.9	9.5	35.3	5.0	11.3	6.2	17.5	12.6	9.0	14.1	7.0	8.5	90.6	13.4	16.4	17.5	29.6	17.5	16.1	15.4	24.4	15.4	14.9	23.4	24.4	12.9	14.5	7.8	13.1	15.5	38.0	9.7	15.4	13.3	18.0	10.6	28.0	14.4	13.0	11.5	12.9	14.9	8.8	3.0	3.2	33.4	14.3	9.2	19.5	6.7	28.1	5.3	5.7	7.0	7.9	32.9	14.9	40.6	234.7	14.4	18.4	70.0	53.8	46.9	22.6	24.4	25.3	27.7	57.4	46.1	23.1	17.2	18.1	338.5	19.8	24.6	23.6	28.9	16.6	28.8	36.0	20.3	26.2	18.0	15.4	25.8	15.1	118.7	27.5	8.5	22.1	20.0	23.4	14.6
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 77.8;liver: 38.2;pancreas: 101.1"	"Group enriched"	"Detected in many"	6	"Cone photoreceptor cells: 110.0;Enterocytes: 260.0;Hepatocytes: 140.6;Mucus-secreting cells: 92.0;Paneth cells: 142.5;Proximal tubular cells: 149.4;Undifferentiated cells: 142.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	51	"CACO-2: 22.8;Hep G2: 32.9"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.2	0.1	0.2	4.1	0.2	0.0	0.2	0.2	0.2	0.2	40.5	0.2	0.2	48.6	0.2	2.3	0.2	0.1	5.9	0.2	0.2	0.1	22.5	38.2	0.2	0.2	0.2	0.2	0.2	101.1	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.2	0.2	0.2	0.1	77.8	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.0	22.8	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	32.9	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.5	0.0	0.1	0.1	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	2.2	0.0	0.6	0.6	0.2	12.7	0.0	0.0	3.5	110.0	0.0	16.6	0.3	0.4	0.1	260.0	0.0	17.7	0.0	0.1	0.1	0.0	140.6	0.1	0.0	24.3	2.5	1.3	0.0	0.0	0.0	0.0	1.0	92.0	0.5	12.1	142.5	0.0	149.4	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	142.6	0.0
SLC39A6	LIV-1	ENSG00000141424	"Solute carrier family 39 member 6"	Q13433	18	36108532-36129385	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Glandular cells: 212.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 361.9"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042377	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			Cytosol	"Nucleoplasm, Plasma membrane"	"HPA042377: AB_2677968"	"unprognostic (7.60e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.50e-2)"	"unprognostic (7.63e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	11.1	12.6	14.3	8.6	13.4	4.3	63.5	19.4	14.7	15.7	8.7	16.0	68.7	4.1	24.7	24.5	9.8	27.7	10.3	8.2	14.2	17.5	12.3	7.7	7.9	8.2	18.3	8.7	30.5	15.5	32.1	23.9	52.5	16.0	55.2	5.9	25.1	15.5	51.5	7.7	22.6	5.7	12.7	21.7	11.2	8.1	9.9	13.5	8.0	15.7	10.7	11.3	23.8	20.2	12.6	25.2	22.2	14.6	12.9	15.6	9.7	10.4	13.2	31.7	18.6	33.5	24.8	8.3	28.5	33.8	19.1	22.5	7.3	11.6	11.3	14.4	27.4	13.3	25.5	27.6	26.7	29.1	25.1	10.0	4.9	18.6	10.6	21.3	16.5	12.4	22.6	59.1	29.0	25.3	17.6	2.8	9.4	2.5	22.8	26.8	16.0	16.2	3.7	7.6	5.7	7.5	16.8	18.1	14.8	21.3	35.2	33.4	29.4	35.1	10.3	48.1	13.6	14.0	7.8	4.6	46.7	7.8	8.8	14.3	21.5	20.8	8.6	16.1	11.7	24.5	19.5	9.8	22.2	13.0	14.6	15.6	12.6	11.1	11.5	12.2	12.3	9.8	14.2	7.5	12.9	13.7	25.2	12.2	9.7	14.3	13.4	19.4	12.4	14.2	17.5	18.3	8.7	16.0	13.5	35.7	16.0	13.7	44.4	40.8	40.2	16.6	10.2	42.8	60.3	40.1	31.4	5.4	1.7	46.8	16.8	10.8	2.8	0.0	32.7	50.5	40.3	212.3	23.1	7.9	18.4	22.3	24.5	7.4	15.6	14.6	34.5	25.1	64.1	24.4	6.7	35.8	34.0	0.0	44.9	13.9	25.8	38.8	37.6	43.4	22.9	65.1	19.9	16.0	4.1	55.4
SLC39A7	"D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7"	ENSG00000112473	"Solute carrier family 39 member 7"	Q92504	6	33200445-33204439	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053999	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA053999: AB_2682338"	"unprognostic (3.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (4.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	14.7	25.1	9.0	12.1	9.5	6.1	15.8	11.9	11.9	24.7	19.8	12.2	43.3	17.3	20.1	24.6	14.4	13.6	25.6	20.7	8.7	8.9	24.6	55.1	20.2	11.6	12.6	9.6	14.4	49.2	37.1	24.2	43.8	18.8	22.8	22.9	16.8	48.0	41.7	10.4	11.3	18.8	20.1	10.6	15.2	21.1	9.5	10.7	9.9	28.2	14.4	17.0	16.6	13.9	2.6	3.4	6.2	2.8	4.2	5.1	2.1	8.5	9.9	15.2	14.1	22.9	15.7	13.3	22.9	30.1	17.8	21.0	16.2	8.3	6.4	11.2	25.5	13.8	9.7	11.5	13.5	15.9	8.1	10.2	10.9	11.6	20.8	16.6	10.8	13.2	14.8	11.4	15.7	17.0	17.6	14.2	6.8	11.9	10.5	12.2	9.7	5.9	6.3	6.5	12.5	9.1	6.4	8.9	10.6	11.9	10.7	9.9	8.0	9.3	22.0	12.5	9.6	21.3	10.1	14.0	16.4	10.0	12.2	15.2	16.5	14.5	5.7	9.9	10.3	18.1	6.2	2.4	2.3	5.1	2.8	4.8	1.8	3.2	3.9	2.3	2.6	2.9	3.3	2.4	4.2	1.6	3.4	3.0	2.1	9.0	9.5	11.9	11.9	8.7	8.9	12.6	9.6	18.8	10.7	23.8	33.3	14.5	25.7	32.1	27.2	29.7	28.1	22.7	33.0	24.4	27.5	88.4	5.0	60.8	0.6	33.7	62.8	23.3	75.1	113.6	62.0	56.4	19.7	31.1	38.7	11.1	24.3	29.4	17.0	1.9	42.6	23.9	38.8	27.9	109.3	41.2	56.0	56.2	40.3	20.1	22.2	19.4	33.9	7.9	10.6	35.8	141.1	27.4	54.4	33.5
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 67.3;salivary gland: 54.6"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 723.6;Alveolar cells type 2: 227.4;Extravillous trophoblasts: 184.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 45.5;HL-60: 33.1;Karpas-707: 49.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038832, HPA038833"	Approved					NA	NA					"HPA038832: AB_2676226, HPA038833: AB_10670910"	"prognostic favorable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	22.0	2.0	3.7	11.4	5.5	10.3	6.1	2.8	4.3	31.4	18.1	2.2	1.1	2.1	3.9	7.3	1.7	7.2	2.6	17.8	4.3	3.5	6.2	18.4	67.3	8.6	5.1	1.6	5.4	42.1	25.7	6.7	44.8	5.9	5.7	14.9	4.3	54.6	2.3	1.8	5.1	3.4	3.0	8.8	6.5	2.5	2.3	3.2	7.5	4.9	2.3	5.6	5.8	6.0	3.1	2.7	1.0	1.5	11.5	10.5	3.4	5.5	5.5	1.2	0.0	4.6	10.6	2.9	0.6	45.5	1.7	2.7	0.2	20.6	5.4	6.0	0.1	5.7	0.4	3.8	1.2	1.0	9.3	11.3	14.1	11.6	0.1	1.8	33.1	4.8	5.6	1.4	0.8	2.6	4.5	0.6	13.4	14.1	49.4	8.8	3.7	11.9	15.5	3.7	7.5	5.4	3.0	0.0	17.6	9.6	2.1	1.6	4.0	15.5	0.2	1.5	1.1	3.8	12.4	3.1	5.5	2.1	11.2	8.7	22.1	9.2	25.6	9.1	21.7	5.0	0.0	1.5	1.0	5.6	1.0	9.8	1.3	10.5	9.0	2.7	3.1	7.9	5.4	0.1	11.5	0.3	1.0	3.9	3.4	3.7	5.5	2.8	4.3	4.3	3.5	5.1	1.6	5.9	3.2	723.6	227.4	10.4	9.5	10.4	0.8	22.6	7.6	1.4	27.3	5.2	3.9	12.1	10.0	1.9	0.3	8.0	3.3	23.3	28.2	184.5	25.7	10.8	3.5	22.1	43.3	3.2	23.1	6.7	29.8	0.4	1.1	25.3	27.0	16.2	72.2	4.5	16.3	7.0	1.1	8.1	1.2	6.5	14.6	2.7	5.9	6.0	50.7	13.8	56.9	6.8
SLC39A9	FLJ11274	ENSG00000029364	"Solute carrier family 39 member 9"	Q9NUM3	14	69398015-69462388	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007921, HPA075390"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA007921: AB_1080007, HPA075390: AB_2686748"	"unprognostic (2.37e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	15.8	22.2	19.5	11.3	19.2	8.8	24.8	15.0	26.3	19.5	25.5	22.4	20.6	20.8	19.1	25.6	22.3	16.5	16.7	14.5	18.9	19.1	31.2	52.9	15.7	13.0	17.8	13.7	16.3	28.0	24.5	24.6	29.7	17.1	19.4	22.7	17.0	65.2	24.2	7.7	16.7	27.8	16.3	19.3	16.3	19.8	17.4	14.1	18.3	22.4	13.7	19.2	14.5	14.6	9.9	17.2	12.5	14.8	9.2	12.5	9.2	29.4	23.2	14.9	15.0	25.6	19.9	13.4	18.1	21.0	15.5	17.9	17.4	27.9	24.0	13.2	20.9	7.9	24.3	16.2	17.0	19.6	16.2	8.7	15.2	13.2	13.2	19.2	11.2	21.6	16.0	27.2	14.2	21.4	16.6	16.2	20.4	11.6	24.0	18.0	16.4	16.7	12.1	11.9	24.7	16.5	16.9	21.0	15.6	20.9	32.2	15.3	25.1	17.5	30.6	10.5	12.0	43.0	18.3	17.2	28.4	20.3	11.8	12.3	26.4	14.7	18.5	26.8	12.8	23.1	11.9	14.8	12.5	11.7	14.1	12.5	9.9	10.2	11.5	17.2	7.7	10.3	11.2	12.0	9.2	13.0	8.3	7.4	9.2	19.5	19.2	15.0	26.3	18.9	19.1	17.8	13.7	17.1	14.1	17.9	13.0	13.7	6.6	10.8	7.2	7.0	20.4	12.0	10.3	15.7	5.9	12.4	5.0	12.6	13.3	14.6	36.8	0.0	21.6	13.5	14.1	18.8	11.5	62.5	14.0	9.5	28.3	23.4	21.5	15.1	12.0	9.3	6.8	10.0	31.8	10.4	22.1	20.1	12.0	14.6	11.0	6.5	12.9	11.8	6.4	10.9	14.9	8.2	22.3	12.4
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 66.0;kidney: 191.5;pancreas: 36.8"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 256.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	17	"RPTEC TERT1: 49.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.2	0.1	0.2	0.7	0.2	0.0	0.2	0.7	0.2	0.3	28.4	0.1	0.1	18.8	1.3	4.6	0.2	0.2	17.9	0.1	0.2	0.2	191.5	5.3	0.2	0.1	0.2	0.1	0.2	36.8	0.0	0.2	0.5	0.1	0.3	3.7	0.2	0.1	0.1	0.2	0.2	66.0	0.1	0.2	0.2	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	4.0	1.3	2.0	1.3	1.6	2.7	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.9	0.2	0.0	0.1	0.2	49.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.1	1.3	1.3	1.0	2.6	1.3	1.9	1.9	2.5	1.4	0.4	4.0	2.5	2.7	2.0	1.6	0.6	1.3	0.9	0.3	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.1	0.1	3.0	1.0	1.5	0.2	0.0	12.5	0.3	63.7	0.0	0.0	40.1	9.8	0.0	53.0	18.3	10.9	0.0	32.7	0.0	12.6	0.0	0.2	1.4	0.0	2.8	0.1	20.6	0.0	0.6	0.0	3.3	1.1	0.0	0.0	2.8	3.8	1.6	3.4	7.2	0.4	256.0	11.9	0.0	0.1	0.7	0.3	0.1	0.1	0.0	8.0	0.5
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856102-62888875	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Syncytiotrophoblasts: 652.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 132.2;SiHa: 134.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		210000000	"Plasma membrane"	Nucleoplasm	"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	28.5	30.8	34.6	23.0	36.8	62.4	30.8	18.7	34.8	26.0	26.8	25.3	30.4	34.3	29.2	41.2	31.2	23.8	19.9	14.7	31.3	27.1	71.4	31.8	33.5	17.8	37.8	24.1	29.9	39.2	138.6	19.3	75.5	32.9	28.3	13.9	52.5	39.0	27.5	32.5	32.1	33.8	19.6	38.0	21.9	28.2	33.4	30.8	13.6	33.7	33.4	22.2	20.6	56.6	16.6	73.9	11.6	36.2	20.3	39.8	37.3	16.4	69.3	7.1	22.0	8.6	6.9	65.6	28.6	11.0	15.0	13.3	66.2	31.2	18.1	31.8	16.8	28.7	57.0	12.9	56.2	8.0	32.9	12.2	13.0	50.5	29.2	79.9	15.2	19.0	15.1	132.2	18.3	56.1	5.5	8.7	39.4	25.0	40.1	9.2	79.2	15.6	19.4	11.8	20.5	23.5	16.2	10.7	35.4	10.5	9.2	12.1	5.8	134.7	50.5	97.2	12.0	18.1	19.9	16.0	15.3	22.8	22.4	20.1	49.9	55.3	57.4	15.0	23.9	43.6	8.5	36.2	11.6	30.1	34.8	39.8	14.4	27.7	30.8	22.1	16.6	23.5	25.2	7.5	20.3	27.6	73.9	26.2	37.3	34.6	36.8	18.7	34.7	31.3	27.1	37.8	24.1	32.9	30.8	44.7	40.7	54.9	229.6	193.7	59.3	10.9	20.4	36.1	40.9	47.1	62.8	187.9	28.2	148.4	23.7	94.0	85.3	93.5	129.2	134.7	88.4	145.6	82.0	22.5	178.6	50.9	80.9	70.6	47.5	19.5	28.1	97.7	212.6	153.3	33.1	212.1	128.6	31.6	28.7	161.8	52.2	6.5	137.2	12.6	29.8	131.6	652.9	75.6	40.7	193.5
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560579-189583758	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 126.4;lymphoid tissue: 170.2"	"Group enriched"	"Detected in many"	5	"Kupffer cells: 1044.2;Syncytiotrophoblasts: 2060.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 64.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.2;CACO-2: 21.3;HEL: 75.5;HMC-1: 19.9;T-47d: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Nucleoplasm	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	18.2	126.4	3.9	10.1	5.5	3.9	47.4	1.8	3.5	20.0	25.7	3.7	13.9	34.4	24.7	24.3	6.3	25.9	25.2	37.1	4.1	4.3	14.4	42.1	45.9	170.2	5.1	1.9	50.9	24.0	4.6	9.8	51.3	6.4	18.4	15.8	11.6	10.2	16.6	12.3	4.9	44.7	13.6	5.8	76.4	11.3	16.2	3.5	17.0	20.8	6.4	8.8	11.1	20.4	0.1	22.7	64.7	20.8	0.8	17.3	20.1	0.0	1.3	0.1	0.0	93.2	0.6	4.5	0.0	1.1	0.3	0.5	21.3	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.0	0.3	75.5	0.3	7.8	0.3	0.2	19.9	6.5	0.0	0.2	0.0	2.1	2.2	2.9	7.7	0.2	1.1	0.0	3.1	4.9	0.2	16.0	0.3	0.0	0.8	0.4	0.9	3.1	0.1	0.9	0.1	6.2	0.0	7.4	36.8	1.1	0.0	0.1	2.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.3	20.8	32.9	0.4	4.7	0.6	0.0	11.3	1.0	22.7	0.1	17.3	3.7	64.7	0.8	0.4	3.7	1.0	20.1	3.9	5.5	1.8	3.5	4.1	4.3	5.1	1.9	6.4	3.5	116.1	32.3	28.1	45.3	8.1	3.7	37.5	142.7	53.5	39.8	31.4	3.9	335.3	41.4	23.9	6.9	30.8	119.4	70.0	64.9	10.7	46.3	32.2	9.2	223.5	72.3	6.4	17.9	211.8	1044.2	4.7	112.2	26.2	8.5	1.8	50.3	9.6	51.2	77.2	55.2	100.1	43.2	64.7	18.1	5.0	0.9	7.0	2060.1	8.4	30.8	19.7
SLC41A1	MgtE	ENSG00000133065	"Solute carrier family 41 member 1"	Q8IVJ1	1	205789093-205813748	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 78.1;pancreas: 36.8"	"Group enriched"	"Detected in many"	5	"Cardiomyocytes: 157.4;Cone photoreceptor cells: 47.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014721, HPA015138"	Uncertain		Approved	Mitochondria		NA	NA			Mitochondria		"HPA014721: , HPA015138: AB_1857160"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.65e-1)"	6.0	7.2	6.2	4.0	7.3	3.3	3.4	9.0	8.3	3.6	3.9	10.8	4.0	1.6	5.0	5.9	3.8	7.3	4.7	78.1	7.2	3.8	6.1	1.2	5.3	4.5	7.8	4.9	7.5	36.8	5.8	3.6	2.6	6.9	5.1	1.5	5.8	2.8	4.8	26.5	2.6	2.7	4.0	8.5	3.3	6.6	11.6	7.3	2.1	11.2	11.9	4.5	5.2	5.0	1.8	0.0	0.1	0.3	1.0	4.6	2.0	10.8	9.6	6.1	9.7	7.6	7.5	8.3	11.2	11.0	11.4	10.1	4.8	6.2	15.7	7.1	10.2	9.5	11.3	5.9	8.2	3.9	28.8	9.0	3.8	9.5	0.7	7.3	0.0	11.0	9.5	6.9	13.0	9.3	9.5	7.0	12.8	7.0	6.6	9.1	6.7	7.0	1.1	7.2	2.9	4.4	8.3	18.3	3.8	2.6	13.5	5.1	6.5	8.6	7.7	7.0	5.3	5.5	4.0	8.7	13.6	8.8	12.4	11.6	22.0	14.6	5.2	10.6	5.0	8.4	0.0	0.1	0.1	3.6	0.3	4.6	1.5	3.4	3.4	0.0	1.8	3.2	3.3	0.0	1.0	0.0	0.0	3.3	2.0	6.2	7.3	9.0	8.3	7.2	3.8	7.8	4.9	6.9	7.3	3.0	16.5	12.6	19.3	18.4	12.9	157.4	10.2	9.4	12.5	0.0	47.1	1.7	1.7	8.2	1.5	20.4	0.0	0.0	9.4	12.7	8.0	15.4	6.9	1.8	2.7	17.5	5.8	4.3	2.2	1.7	9.2	3.2	8.5	0.0	0.8	18.0	8.8	0.6	8.9	13.7	21.3	0.0	19.4	6.8	15.0	15.8	2.6	8.5	1.0	20.0
SLC41A2	DKFZP434K0427	ENSG00000136052	"Solute carrier family 41 member 2"	Q96JW4	12	104802553-104958744	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.1;liver: 54.1"	"Cell type enhanced"	"Detected in many"	6	"Exocrine glandular cells: 33.6;Hepatocytes: 45.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 4.4;plasmacytoid DC: 13.0"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 13.0"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.6;SK-BR-3: 24.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038658	Approved					NA	NA					"HPA038658: AB_10671747"	"unprognostic (7.19e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.06e-3)"	"unprognostic (3.05e-2)"	"prognostic favorable (9.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.30e-2)"	6.1	7.0	3.8	5.2	3.9	0.5	7.1	9.2	5.4	4.9	19.9	2.3	15.9	14.5	3.0	7.9	1.6	2.1	6.8	3.0	2.9	5.5	4.6	54.1	4.5	2.0	2.8	4.0	4.2	12.0	5.7	21.5	16.1	3.4	2.2	7.2	2.0	5.9	14.9	0.9	1.6	37.1	4.0	2.4	1.9	16.8	4.3	2.1	1.0	5.8	0.3	2.7	2.2	2.7	0.6	13.0	0.3	0.2	0.3	0.9	0.3	6.0	13.8	0.5	2.9	11.8	8.6	5.5	4.3	7.0	3.0	5.1	8.6	5.9	2.5	4.7	8.4	11.0	0.6	3.1	1.4	5.6	29.6	7.8	0.2	5.5	3.8	2.6	0.9	3.4	2.9	1.2	3.2	0.9	6.5	3.8	1.6	0.2	6.5	0.5	2.8	1.2	0.0	1.3	10.9	4.4	0.5	6.0	5.9	11.9	0.2	5.5	1.4	7.3	24.4	1.2	2.2	9.5	0.0	1.1	4.5	3.2	4.8	4.8	7.8	9.6	3.2	7.2	0.5	3.1	0.2	0.2	0.0	0.2	0.1	0.9	0.6	0.2	0.1	4.4	0.3	0.4	0.2	0.3	0.3	0.1	13.0	0.1	0.3	3.8	3.9	9.2	5.4	2.9	5.5	2.8	4.0	3.4	2.1	17.9	8.1	6.0	2.6	2.2	2.8	0.8	20.4	1.4	4.5	7.0	0.0	1.4	0.0	23.5	21.0	1.4	29.0	0.0	33.6	15.7	9.3	3.9	0.0	45.9	5.4	4.8	1.2	1.3	2.2	3.4	2.0	9.7	0.0	31.5	8.3	2.6	26.2	8.7	6.0	6.2	0.0	0.0	5.0	2.9	1.9	1.9	7.6	1.0	9.7	4.7
SLC41A3	FLJ20473	ENSG00000114544	"Solute carrier family 41 member 3"	Q96GZ6	3	126006355-126101561	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045847	Approved		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA045847: AB_2679472"	"unprognostic (1.77e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.36e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (6.04e-7)"	"unprognostic (1.26e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.54e-2)"	11.2	20.2	21.3	10.7	20.7	5.3	22.2	29.8	43.4	18.6	10.6	12.6	12.1	10.1	21.1	32.9	10.8	24.0	16.3	17.1	17.9	20.6	14.0	8.5	9.5	14.3	17.1	16.5	31.2	17.6	19.7	16.9	10.9	21.4	12.5	10.9	18.6	16.7	14.5	25.5	10.7	8.9	17.1	11.7	8.8	10.7	30.5	6.0	27.7	18.0	11.5	10.4	12.3	11.9	9.0	8.6	9.3	8.2	13.0	18.8	5.6	17.7	7.3	12.1	10.2	34.5	20.3	18.3	10.2	17.7	14.2	16.8	9.7	16.2	13.0	19.3	20.1	15.4	14.0	4.4	17.7	12.4	12.6	13.9	7.1	13.8	14.0	28.6	12.8	7.9	19.7	21.7	8.5	17.6	20.9	19.5	16.1	5.9	10.9	18.6	9.5	14.1	10.5	9.2	23.6	11.5	7.5	12.5	17.6	16.9	13.2	9.4	10.2	15.7	5.1	43.1	11.9	5.1	17.3	13.4	13.2	10.2	20.1	11.4	8.3	6.7	6.3	12.0	5.7	12.1	9.3	5.7	3.9	11.2	8.2	9.1	9.0	10.6	11.5	8.6	8.4	9.2	8.7	1.2	13.0	5.1	8.4	18.8	5.6	21.3	20.7	29.8	43.4	17.9	20.6	17.1	16.5	21.4	6.0	14.9	10.4	8.0	20.1	12.2	12.9	12.9	25.5	6.7	14.8	21.0	3.9	30.6	3.3	30.8	27.0	24.2	6.8	0.0	21.8	27.8	22.2	13.0	5.7	5.8	14.0	27.0	20.3	27.0	8.9	12.0	34.8	9.4	13.5	14.4	12.7	23.0	21.6	3.5	51.6	10.9	10.8	25.8	19.6	12.6	38.4	13.4	21.2	17.5	16.6	16.8
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515786	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 27.0;liver: 91.8;pancreas: 100.5"	"Cell type enhanced"	"Detected in many"	14	"Cholangiocytes: 40.8;Hepatocytes: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 23.8;NB-4: 28.3;U-937: 27.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Golgi apparatus, Vesicles, Plasma membrane"		"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (7.30e-2)"	4.7	3.3	0.8	2.2	0.8	9.3	7.4	0.7	1.3	6.0	4.8	0.9	3.9	2.5	5.0	6.8	4.1	3.3	27.0	3.2	0.7	0.6	3.4	91.8	2.9	3.3	0.8	1.1	6.5	100.5	0.1	1.3	1.8	0.7	6.2	2.8	11.4	14.9	2.1	7.5	5.6	2.6	7.0	0.9	2.5	7.6	3.1	0.7	0.8	7.4	2.9	3.1	7.6	3.5	3.1	8.2	8.1	6.0	6.9	11.1	5.2	0.4	0.6	0.7	8.0	10.5	7.7	0.1	4.2	5.4	1.2	3.1	2.5	1.1	23.0	1.1	3.1	1.5	0.3	7.1	0.4	1.5	1.1	1.8	11.8	0.2	23.8	13.8	20.7	2.9	9.7	1.7	2.0	9.3	2.9	5.3	13.8	16.5	4.3	1.5	0.8	0.1	28.3	2.6	10.4	5.4	19.7	3.9	10.2	0.2	0.0	9.4	1.4	0.7	0.1	9.2	0.2	0.6	10.5	2.1	1.2	2.9	10.6	0.6	4.8	1.5	13.5	0.6	27.3	1.6	8.1	6.0	0.7	11.1	2.4	9.5	3.1	5.2	8.0	8.2	1.7	5.1	7.2	0.5	6.9	0.1	1.9	9.1	5.2	0.8	0.8	0.7	1.3	0.7	0.6	0.8	1.1	0.7	0.7	0.0	8.2	0.8	1.6	6.3	5.0	4.9	40.8	1.4	1.2	0.0	0.0	0.1	3.3	2.5	22.9	4.6	0.9	23.3	30.5	0.4	5.4	1.9	3.5	109.6	6.1	0.0	5.8	14.7	7.6	11.8	14.4	1.8	5.0	0.0	6.1	0.0	18.0	0.0	7.4	0.0	0.3	6.5	6.2	0.5	0.4	3.1	0.1	6.4	9.8	0.9
SLC43A2	MGC34680	ENSG00000167703	"Solute carrier family 43 member 2"	Q8N370	17	1569267-1628886	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 92.7"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 312.2;Syncytiotrophoblasts: 788.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021564	Enhanced					NA	NA					"HPA021564: AB_1857169"	"unprognostic (5.95e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.40e-5)"	"unprognostic (1.84e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-1)"	5.5	2.7	5.4	13.7	5.7	12.2	3.6	14.8	11.9	2.6	2.6	5.0	2.1	7.0	2.1	4.1	1.4	5.9	3.9	1.6	5.6	7.2	15.8	3.0	6.8	8.3	5.1	3.8	2.3	1.6	1.5	6.2	92.7	5.8	2.8	2.4	4.9	4.0	3.5	23.2	1.3	11.6	4.7	3.5	8.9	2.8	1.5	1.3	5.0	5.8	2.2	3.5	5.0	1.3	1.3	3.1	15.0	5.4	0.5	0.3	2.0	0.9	2.6	0.8	7.6	1.6	1.3	10.4	0.5	0.3	1.8	0.8	15.5	1.7	4.5	5.2	0.8	0.7	1.8	4.6	0.9	0.3	0.0	0.4	0.8	2.3	3.9	1.9	0.1	1.4	1.6	1.4	1.1	0.5	0.2	7.3	0.5	1.9	0.0	0.3	3.6	9.2	0.9	0.8	2.4	0.3	2.6	0.0	5.3	3.5	8.9	3.1	1.6	2.3	6.3	0.2	3.4	6.3	5.4	9.5	0.2	1.1	2.0	0.6	0.5	9.4	2.2	0.4	0.9	0.2	2.5	5.4	5.3	0.3	4.6	0.1	1.3	0.2	0.2	3.1	1.2	0.2	0.2	15.0	0.5	4.5	1.7	0.2	2.0	5.4	5.7	14.8	11.9	5.6	7.2	5.1	3.8	5.8	1.3	14.9	40.5	18.3	5.4	4.2	22.8	2.7	15.3	21.4	22.7	34.9	23.6	312.2	16.6	21.0	2.9	4.5	16.2	0.0	6.3	29.6	10.2	7.2	11.5	1.3	81.4	19.1	10.9	16.5	88.0	1.9	10.0	84.8	0.0	73.9	12.2	23.6	6.4	21.6	8.5	19.3	35.8	0.0	5.7	3.1	3.2	3.8	788.9	3.8	10.0	4.2
SLC43A3	"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1"	ENSG00000134802	"Solute carrier family 43 member 3"	Q8NBI5	11	57406954-57427580	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 149.9;thyroid gland: 69.0"	"Cell type enhanced"	"Detected in many"	5	"granulocytes: 63.7;Hofbauer cells: 71.5;Sertoli cells: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 71.0;HMC-1: 62.7;RPMI-8226: 80.1;WM-115: 76.4"	"Region enriched"	"Detected in many"	4	"olfactory region: 12.7"	"Low region specificity"	"Detected in all"			"HPA030551, HPA077244"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Vesicles	"Nucleoplasm, Plasma membrane"	"HPA030551: AB_10604094, HPA077244: AB_2732335"	"unprognostic (2.64e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.67e-3)"	"unprognostic (7.41e-3)"	"unprognostic (6.59e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (3.97e-13)"	"unprognostic (8.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-1)"	32.3	6.3	2.5	12.4	4.3	18.8	16.8	2.2	3.0	11.9	9.6	3.6	2.4	2.7	10.1	6.5	12.6	8.9	11.4	12.5	3.1	1.5	4.2	149.9	16.5	8.8	4.0	1.8	16.0	7.2	1.2	1.8	5.1	3.4	11.6	4.2	9.4	12.2	3.1	15.4	11.0	6.2	10.3	4.7	11.6	6.9	6.8	2.3	10.4	69.0	11.5	13.8	20.3	15.4	2.7	23.6	6.1	36.8	1.1	7.8	14.0	40.0	0.0	2.3	0.0	7.8	11.5	0.1	3.1	13.3	4.6	7.9	0.0	8.8	23.1	1.4	7.3	2.4	23.1	6.7	4.1	9.3	0.1	0.0	36.0	13.7	0.0	15.9	71.0	62.7	34.5	0.1	44.6	0.5	3.3	12.9	10.7	41.1	22.4	17.8	0.0	14.9	45.6	3.5	0.0	0.7	30.9	0.4	80.1	11.0	0.0	5.5	0.0	8.8	0.2	37.4	0.2	3.4	10.8	6.8	0.2	12.0	30.4	8.7	0.0	0.1	5.8	27.5	25.8	76.4	3.2	28.8	6.1	5.7	34.5	6.5	2.7	4.0	7.8	23.6	2.0	3.1	3.2	2.5	1.1	36.8	23.6	6.9	14.0	2.5	4.3	2.2	3.0	3.1	1.5	4.0	1.8	3.4	2.3	14.9	41.4	4.5	6.7	41.6	0.5	2.8	30.6	5.3	34.2	1.8	0.0	0.5	0.0	47.0	1.0	23.3	0.0	0.0	5.5	2.2	20.2	3.4	63.7	53.8	71.5	0.0	0.0	11.6	17.3	1.4	9.2	55.1	28.7	0.0	0.5	0.9	10.9	0.0	11.7	0.0	0.0	64.7	18.4	1.0	0.2	15.4	0.7	15.0	0.6	2.5
SLC44A1	"CD92, CDw92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"brain: 111.6"	"Cell type enhanced"	"Detected in many"	4	"Cone photoreceptor cells: 221.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 73.5;ASC TERT1: 58.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		270000	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	8.7	7.4	40.0	6.4	48.8	5.3	14.6	7.2	37.0	9.9	26.7	69.5	10.2	12.0	8.8	18.4	10.1	8.5	11.0	6.9	50.0	29.6	12.0	20.3	9.8	4.6	64.3	21.3	8.0	8.0	20.5	3.9	12.3	38.2	6.6	26.9	4.6	6.0	14.8	4.8	11.4	14.0	9.5	111.6	4.8	18.9	2.3	59.4	2.3	24.0	5.1	7.9	12.4	7.9	2.4	3.7	2.5	5.4	8.7	1.8	1.6	6.9	5.8	1.6	1.9	73.5	58.1	5.0	5.8	15.3	3.8	5.1	6.2	18.5	9.2	3.0	22.0	4.3	13.8	4.7	8.4	6.5	8.0	3.8	11.5	4.1	7.7	4.9	2.2	5.9	32.2	6.9	7.3	6.6	9.8	12.0	4.8	0.3	19.2	4.3	9.8	9.1	2.6	8.9	12.3	5.6	1.9	6.1	6.9	5.2	16.3	7.7	3.0	8.2	9.1	8.2	9.9	9.0	6.9	10.2	3.8	3.4	4.1	4.2	14.8	9.8	6.9	7.4	5.0	5.0	2.5	5.4	1.1	1.1	2.1	0.8	2.0	1.2	0.8	3.7	2.4	1.8	0.6	1.0	8.7	1.2	1.3	1.1	1.6	40.0	48.8	7.2	29.8	50.0	29.6	64.3	21.3	38.2	59.4	32.8	21.6	15.9	31.4	62.7	7.6	9.3	56.0	14.7	9.1	101.2	221.9	44.4	3.3	16.4	2.4	38.4	140.4	0.0	31.4	7.9	49.9	25.3	98.1	132.6	20.0	6.4	151.0	54.0	50.8	2.9	101.8	39.6	70.9	122.6	158.5	6.7	33.4	123.8	75.0	23.3	44.8	38.8	27.0	1.4	1.7	65.0	59.0	15.3	134.8	29.5
SLC44A2	CTL2	ENSG00000129353	"Solute carrier family 44 member 2"	Q8IWA5	19	10602457-10644559	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Extravillous trophoblasts: 210.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 62.3;SK-BR-3: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003228, HPA070799"	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA		78000	"Vesicles, Cell Junctions"		"HPA003228: AB_1080009, HPA070799: AB_2686314"	"unprognostic (6.35e-3)"	"unprognostic (5.75e-2)"	"unprognostic (4.34e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.21e-3)"	"unprognostic (3.61e-2)"	29.3	14.2	25.1	21.4	28.3	23.4	31.6	24.2	33.9	24.7	23.0	40.7	21.7	10.5	21.0	17.3	31.8	24.8	24.9	29.1	21.2	17.9	29.4	9.1	39.4	46.7	26.1	18.4	14.2	16.5	21.6	8.6	114.9	31.8	19.9	20.3	36.6	22.1	28.8	51.6	29.0	19.1	19.3	37.5	49.4	44.0	51.6	21.2	30.4	26.9	26.4	39.2	29.0	26.3	19.0	17.8	86.0	45.9	13.1	21.8	22.8	62.3	1.5	14.0	8.3	21.2	13.1	39.9	13.6	33.4	22.4	26.5	14.0	29.9	12.6	18.2	37.6	2.7	48.3	2.1	10.4	14.5	0.3	1.8	8.0	7.9	0.5	23.5	0.1	6.8	14.1	13.9	8.4	7.4	18.3	17.1	5.9	3.8	2.1	34.0	45.9	6.6	6.1	4.9	18.5	5.6	14.2	19.9	0.5	7.3	33.2	1.3	8.4	10.7	60.1	1.5	15.2	23.4	0.6	15.6	10.1	3.6	12.0	3.4	0.8	1.4	12.4	2.5	5.6	11.2	22.9	7.2	39.3	21.8	19.6	17.2	17.7	15.1	16.5	3.7	19.0	16.5	16.8	86.0	13.1	45.9	17.8	16.5	22.8	25.1	28.3	24.2	33.9	21.2	17.9	26.1	18.4	31.8	21.2	50.6	29.0	40.2	16.9	8.7	11.9	32.2	20.4	16.0	39.8	87.2	13.7	107.9	1.7	38.7	130.7	26.0	27.4	46.7	39.5	210.6	15.5	11.6	19.7	0.9	32.0	3.2	9.2	66.9	28.0	20.6	35.9	7.7	5.0	4.6	17.2	33.6	29.3	37.4	53.0	3.8	2.9	58.2	18.6	3.0	2.7	7.4	78.1	41.7	20.9	16.5
SLC44A3	"CTL3, MGC45474"	ENSG00000143036	"Solute carrier family 44 member 3"	Q8N4M1	1	94820342-94895246	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	52	"T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"OE19: 14.8;RPTEC TERT1: 43.5;RT4: 29.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047433	Enhanced					NA	NA					"HPA047433: AB_2680046"	"unprognostic (8.06e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.63e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (9.09e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.31e-3)"	1.8	7.3	9.1	6.1	8.3	0.0	5.3	6.6	5.6	5.9	19.8	3.9	4.5	16.5	4.8	5.1	6.6	5.1	16.3	4.5	6.3	5.0	21.4	3.9	6.7	0.4	6.1	3.6	2.7	22.2	5.3	22.2	3.9	5.8	7.2	22.9	9.5	16.0	8.5	1.6	3.7	17.2	2.9	5.4	0.5	17.9	1.6	4.2	2.6	5.4	0.9	4.1	11.0	6.3	0.0	0.0	0.0	0.0	0.0	5.2	0.1	9.5	1.3	0.3	0.0	1.1	1.4	6.7	0.1	1.4	0.3	1.6	8.9	2.4	0.0	6.6	0.1	3.0	3.2	1.4	2.3	0.6	0.0	1.7	0.0	0.5	0.7	0.4	0.0	0.0	4.3	2.1	0.7	0.0	2.7	0.1	0.0	0.0	0.0	0.6	1.4	0.0	0.1	0.4	14.8	0.3	0.7	0.3	0.5	43.5	29.0	4.5	7.3	0.4	4.6	3.2	3.3	2.6	0.3	0.0	0.2	1.5	0.6	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.1	8.3	6.6	5.6	6.3	5.0	6.1	3.6	5.8	4.2	23.8	7.9	0.0	27.4	2.7	0.5	6.5	33.1	4.0	3.4	12.2	0.0	13.2	13.3	27.9	20.6	1.0	14.8	0.0	24.6	0.5	5.2	16.6	1.1	1.6	1.1	0.0	15.6	0.6	0.3	2.5	4.6	0.7	5.0	1.8	32.8	14.5	30.4	31.6	10.3	28.4	0.2	0.0	2.1	0.1	0.2	3.3	5.6	0.0	40.5	25.0
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 34.6;intestine: 65.7"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 245.0;Enterocytes: 364.2;Exocrine glandular cells: 194.5;Glandular cells: 195.5;Mucus-secreting cells: 268.8;Paneth cells: 234.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.0"	"Cell line enriched"	"Detected in some"	5	"OE19: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA046977, HPA054176"	Enhanced					NA	NA					"HPA046977: AB_2679887, HPA054176: AB_2682404"	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (6.06e-4)"	0.3	2.4	0.2	11.2	0.3	0.2	2.1	0.2	0.3	5.9	43.6	0.3	7.6	23.7	2.9	3.0	0.6	10.9	34.6	0.2	0.2	0.0	20.4	0.3	9.1	0.6	0.2	0.2	4.9	7.3	0.0	5.0	5.1	0.5	25.7	8.6	0.3	12.0	4.4	0.2	0.1	65.7	1.2	0.2	0.6	23.7	0.8	0.2	0.4	0.5	0.7	4.2	6.3	1.9	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	13.2	0.0	0.1	0.0	0.4	0.0	2.0	0.0	0.2	0.0	1.1	0.0	0.1	0.4	0.3	2.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.2	0.2	0.5	0.2	20.8	29.0	6.7	17.5	0.5	0.0	0.3	30.6	245.0	54.6	62.8	0.0	0.2	3.3	91.8	2.2	0.5	364.2	0.0	194.5	0.3	1.8	195.5	2.3	0.0	0.5	0.0	44.9	0.0	0.0	2.9	1.4	2.0	0.0	2.8	268.8	0.4	123.2	234.4	0.4	56.6	0.6	0.0	0.4	0.2	0.2	0.4	0.6	0.0	158.0	88.5
SLC44A5	"CTL5, MGC34032"	ENSG00000137968	"Solute carrier family 44 member 5"	Q8NCS7	1	75202131-75611116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 63.4;Late spermatids: 27.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 7.2;RPTEC TERT1: 7.1;SH-SY5Y: 11.1;SuSa: 11.8;TIME: 13.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047455, HPA051011"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA047455: AB_2680054, HPA051011: AB_2681309"	"unprognostic (9.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (1.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.30e-1)"	1.0	0.4	2.4	1.0	1.5	0.0	6.3	1.0	3.6	1.0	1.8	1.0	1.0	0.9	1.0	1.0	7.7	3.7	1.0	2.2	2.8	2.8	2.0	1.0	1.0	1.0	2.3	1.0	1.0	1.8	5.6	3.7	3.8	1.0	1.0	2.9	1.0	1.6	1.0	1.5	11.3	1.0	1.0	1.0	1.0	1.3	32.6	1.0	1.0	1.0	1.0	1.8	2.2	1.9	3.2	0.3	0.6	0.3	0.5	1.1	0.3	0.2	0.2	4.5	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	2.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.5	0.6	1.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.8	0.4	2.4	2.6	0.0	0.0	1.7	0.0	4.5	2.9	0.6	0.0	0.0	2.1	7.1	4.8	1.0	11.1	0.0	4.6	0.0	11.8	0.2	0.0	13.7	0.4	1.2	0.0	1.4	2.0	1.9	3.0	0.2	0.0	0.7	0.4	0.3	0.2	0.4	0.1	0.9	3.2	0.8	1.1	0.1	2.4	0.6	0.4	0.6	0.5	0.2	0.3	0.6	0.3	2.4	1.5	1.0	3.4	2.8	2.8	2.3	1.0	1.0	1.0	0.0	0.6	0.0	0.6	1.6	3.7	0.6	0.0	2.7	1.2	0.0	0.0	6.8	0.0	0.1	63.4	0.4	0.4	0.0	0.8	3.2	0.2	0.8	0.0	0.0	1.0	0.0	2.4	3.1	0.0	27.3	0.9	0.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.2	5.8	3.2	0.0	0.2	3.1
SLC45A1	DNB5	ENSG00000162426	"Solute carrier family 45 member 1"	Q9Y2W3	1	8317826-8344167	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Symport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.0"	"Cell type enhanced"	"Detected in some"	7	"Bipolar cells: 6.7;Horizontal cells: 9.5;Muller glia cells: 5.7;Peritubular cells: 5.3;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 7.1"	"Group enriched"	"Detected in many"	7	"monocytes: 7.1;T-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.9;GAMG: 4.2;HHSteC: 7.8;U-87 MG: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078818	Enhanced					NA	NA					"HPA078818: "	"unprognostic (1.77e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.32e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-3)"	5.0	6.6	8.5	2.4	15.3	1.1	2.6	13.8	24.0	6.0	4.4	5.4	2.1	2.5	6.8	3.6	3.9	5.2	4.3	3.1	6.0	7.9	4.3	1.1	2.0	2.1	6.1	12.4	4.4	4.1	4.1	8.1	1.9	13.1	4.9	2.2	3.2	1.5	7.7	4.0	1.7	2.8	4.3	4.6	4.4	2.6	3.8	4.6	0.0	2.4	0.8	1.5	3.6	3.3	0.6	0.2	0.0	7.1	0.0	1.8	0.7	0.0	2.7	0.5	1.1	5.9	3.9	0.1	0.2	1.2	0.4	0.8	0.0	0.4	0.0	0.2	0.8	4.2	0.0	0.1	0.3	0.1	2.3	0.0	0.0	0.2	0.0	7.8	0.0	2.2	2.0	0.2	0.9	0.0	1.4	0.6	0.6	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.0	1.7	0.0	1.2	0.0	0.0	0.0	2.0	2.8	0.0	0.0	0.0	0.2	0.2	0.0	2.5	0.1	0.5	2.3	0.4	0.0	0.0	0.0	10.1	0.0	0.1	0.0	0.2	0.0	1.3	1.3	1.8	0.6	0.9	0.9	0.2	0.1	0.6	0.6	0.0	0.0	7.1	0.0	0.6	0.7	8.5	15.3	13.8	24.0	6.0	7.9	6.1	12.4	13.1	4.6	0.0	0.0	0.5	1.2	0.3	6.7	0.8	0.0	0.0	0.0	1.8	3.9	0.0	0.0	0.5	1.9	0.9	0.0	0.0	0.2	0.0	0.9	1.0	0.0	0.0	0.1	9.5	0.0	1.3	0.0	4.0	3.1	0.0	0.0	0.0	0.0	5.7	0.1	0.0	5.3	0.6	4.4	6.5	2.9	0.2	0.0	0.3	0.0	0.0	0.0	0.3
SLC45A2	"AIM-1, MATP, OCA4"	ENSG00000164175	"Solute carrier family 45 member 2"	Q9UMX9	5	33944616-33984730	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Sensory transduction, Vision"		"Albinism, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 39.9"	"Cell type enhanced"	"Detected in some"	31	"Early spermatids: 2.4;Late spermatids: 3.1;Melanocytes: 11.8"	"Cancer enriched"	"Detected in some"	18	"melanoma: 47.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	27	"SK-MEL-30: 37.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.97e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.39e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.39e-1)"	0.2	0.0	0.3	0.2	0.4	0.0	0.2	0.7	0.4	0.2	1.1	0.2	0.2	0.0	0.5	0.2	0.2	0.4	0.3	1.5	0.4	0.6	0.8	3.1	0.2	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.8	1.2	39.9	0.2	0.2	0.4	4.5	0.2	0.3	0.4	0.2	0.6	2.8	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	37.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.7	0.4	0.4	0.6	0.3	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.6	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	11.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0
SLC45A3	"IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein"	ENSG00000158715	"Solute carrier family 45 member 3"	Q96JT2	1	205657851-205680459	"Cancer-related genes, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"prostate: 115.0"	"Group enriched"	"Detected in many"	11	"Glandular cells: 50.8;granulocytes: 117.6"	"Cancer enriched"	"Detected in all"	49	"prostate cancer: 539.9"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	226	"basophil: 22.6"	"Lineage enriched"	"Detected in single"	226	"granulocytes: 22.6"	"Cell line enriched"	"Detected in some"	30	"HMC-1: 141.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019073, HPA019075"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA019073: AB_1857177, HPA019075: AB_1857179"	"unprognostic (1.80e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.33e-5)"	0.8	1.5	2.5	1.5	6.2	0.7	0.8	0.4	5.8	1.9	2.1	19.0	0.0	2.1	0.9	0.6	0.9	1.1	1.8	0.7	4.2	2.0	1.1	4.0	1.7	1.6	13.2	1.6	1.0	0.7	0.5	1.9	0.6	7.2	115.0	1.6	0.2	0.9	0.7	2.2	0.9	2.1	0.8	12.4	5.0	6.4	1.4	11.1	0.0	0.5	0.7	0.7	1.5	0.4	0.0	0.0	22.6	0.0	0.0	0.0	0.2	1.5	0.5	0.4	0.4	0.0	0.0	0.3	0.2	0.0	0.5	0.4	1.1	2.9	0.4	0.7	0.0	0.5	0.5	0.2	0.5	0.0	0.6	0.4	4.7	0.1	0.3	0.3	0.8	141.5	0.0	0.1	0.3	0.0	0.3	1.6	0.7	0.7	0.2	0.2	0.3	0.1	1.3	2.0	2.7	1.7	0.1	0.7	0.2	0.6	2.2	0.2	0.5	0.2	3.5	0.6	0.4	0.8	0.2	1.5	0.2	1.6	0.5	1.1	0.0	0.1	0.0	0.3	0.2	1.1	22.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	6.2	0.4	5.8	4.2	2.0	13.2	1.6	7.2	11.1	0.0	5.6	1.3	1.1	0.0	0.2	1.7	5.1	2.7	1.2	1.8	0.0	0.4	0.0	1.8	0.1	0.6	3.4	0.0	0.5	0.1	0.6	50.8	117.6	4.9	2.0	0.0	0.0	0.0	0.6	0.0	1.7	0.9	0.0	1.0	7.4	0.2	2.4	7.0	1.4	1.8	0.0	6.5	1.0	0.0	1.5	0.1	0.0	0.0	4.4	0.8
SLC45A4	KIAA1126	ENSG00000022567	"Solute carrier family 45 member 4"	Q5BKX6	8	141207166-141308305	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Bipolar cells: 32.9;Collecting duct cells: 47.1;Cone photoreceptor cells: 51.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"eosinophil: 9.4;neutrophil: 8.6"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.6;OE19: 23.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023154	Uncertain		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA023154: AB_2191204"	"unprognostic (7.79e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.73e-6)"	"unprognostic (8.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.40e-2)"	5.6	3.9	6.9	7.6	7.0	10.2	4.3	10.0	19.1	14.2	6.6	2.7	8.5	5.4	6.7	8.9	5.0	11.6	6.9	9.3	8.2	5.9	12.2	1.6	10.1	7.6	5.1	8.4	5.0	14.2	5.4	20.6	17.8	11.5	9.5	3.9	11.4	15.6	16.3	6.4	7.4	6.0	4.3	3.0	6.8	24.4	28.5	2.9	6.6	8.7	1.8	6.4	7.8	4.4	0.0	0.4	9.4	0.1	0.2	0.5	0.1	3.7	8.6	3.1	4.9	0.2	0.2	13.8	2.1	1.3	1.9	1.5	5.4	10.0	0.8	9.4	0.8	2.7	3.1	1.7	1.0	0.9	5.9	2.5	2.4	2.5	0.0	1.5	0.9	15.6	0.7	1.4	1.5	0.8	0.4	1.3	4.0	4.6	0.6	0.5	9.2	8.4	1.9	4.1	23.2	3.5	2.6	0.2	2.4	6.8	6.8	4.9	3.9	2.3	0.8	3.6	2.2	1.6	5.6	0.7	0.0	2.1	3.3	4.1	3.1	9.9	1.0	1.9	3.7	3.6	1.3	0.1	9.4	0.2	0.1	0.2	0.0	0.2	0.5	0.1	0.0	0.2	0.2	8.6	0.2	0.1	0.4	0.2	0.1	6.9	7.0	10.0	19.1	8.2	5.9	5.1	8.4	11.5	2.9	8.9	10.1	0.0	5.7	2.4	32.9	11.1	10.2	17.4	6.8	47.1	51.1	7.1	0.0	6.2	9.5	1.4	9.5	0.0	2.4	0.6	2.0	6.0	1.1	0.0	5.6	3.2	2.4	0.6	2.7	4.1	2.0	2.7	3.3	0.0	6.3	2.8	5.6	5.8	2.1	3.3	9.3	0.0	2.1	4.2	1.9	2.0	13.6	1.5	3.3	9.5
SLC46A1	"HCP1, MGC9564, PCFT"	ENSG00000076351	"Solute carrier family 46 member 1"	Q96NT5	17	28394756-28407197	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.7"	"Cell type enhanced"	"Detected in many"	5	"Bipolar cells: 25.6;Hepatocytes: 24.9;Hofbauer cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	5	"CACO-2: 67.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011614	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"CAB011614: AB_2270597"	"unprognostic (1.10e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-1)"	3.1	17.8	4.6	2.5	7.0	1.3	5.1	13.2	5.2	2.9	43.8	5.2	9.4	45.4	2.2	4.5	1.8	6.7	3.0	2.2	4.4	6.0	3.8	17.9	3.2	4.9	4.0	4.0	4.4	5.0	8.1	7.8	5.0	5.0	3.7	2.7	6.1	5.7	5.8	2.0	2.0	52.7	2.6	4.6	4.9	2.3	2.2	4.2	2.2	4.0	0.4	1.2	2.4	2.4	2.7	2.6	7.1	5.9	2.9	1.7	0.8	1.7	7.4	2.5	4.1	2.0	0.4	7.8	2.1	1.5	1.7	2.0	67.6	2.1	0.2	1.2	1.1	5.0	5.8	2.8	4.7	1.5	4.3	6.6	0.0	4.6	5.7	0.7	0.0	3.4	1.0	8.7	1.8	5.4	2.4	0.1	0.6	2.8	0.4	0.3	2.3	0.0	0.2	1.5	1.7	1.0	0.1	2.0	0.8	1.3	3.9	6.6	3.5	14.5	6.8	0.9	3.6	5.3	1.1	0.2	0.2	3.0	0.4	2.2	3.1	3.5	0.1	0.4	0.4	1.6	7.1	1.6	1.1	0.8	5.9	1.4	2.7	0.9	0.7	2.6	1.7	1.0	1.7	2.3	2.9	4.3	1.1	1.6	0.8	4.6	7.0	13.2	5.2	4.4	6.0	4.0	4.0	5.0	4.2	11.9	4.0	3.2	1.9	0.3	25.6	1.8	15.3	4.0	1.2	7.0	3.9	16.6	0.0	2.8	3.4	1.0	1.3	0.0	3.9	7.3	3.1	2.2	1.1	24.9	21.1	19.1	1.2	2.5	13.0	13.5	3.7	3.9	0.0	1.0	2.1	1.6	3.5	0.9	3.2	4.1	5.6	6.5	1.0	0.0	0.2	0.3	3.7	0.0	1.2	1.4
SLC46A2	"Ly110, TSCOT"	ENSG00000119457	"Solute carrier family 46 member 2"	Q9BY10	9	112878920-112890913	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"ductus deferens: 21.1;lymphoid tissue: 31.8;skin 1: 22.3"	"Group enriched"	"Detected in some"	7	"Alveolar cells type 2: 35.7;Kupffer cells: 13.2"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 17.0;intermediate monocyte: 8.7"	"Lineage enriched"	"Detected in many"	4	"monocytes: 17.0"	"Cell line enhanced"	"Detected in some"		"U-138 MG: 1.1;U-2197: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA020098	Approved					NA	NA					"HPA020098: AB_2670363"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.82e-2)"	0.2	0.1	0.1	0.5	0.1	0.0	1.0	1.1	0.5	17.7	0.1	0.0	21.1	0.0	3.6	10.4	1.4	0.1	0.3	0.1	0.1	0.3	0.2	0.2	17.1	1.9	0.1	0.2	0.1	0.2	0.0	0.1	0.2	0.0	0.8	0.0	0.1	0.4	9.9	0.1	22.3	0.2	0.6	0.2	1.0	0.1	1.5	0.0	31.8	0.1	0.0	0.3	5.4	0.7	0.0	3.8	0.2	17.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.2	0.1	0.2	0.0	0.0	1.1	0.0	1.1	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.2	0.0	6.5	0.1	0.0	4.1	0.1	0.1	1.1	0.5	0.1	0.3	0.1	0.2	0.0	0.0	0.0	35.7	0.0	0.0	0.0	0.0	0.4	2.5	1.4	2.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.6	13.2	1.6	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 62.9;liver: 50.0"	"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 58.8;Hepatocytes: 50.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 20.5;T-47d: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favorable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	6.9	14.2	3.8	5.9	5.7	1.4	6.4	7.6	6.5	8.3	19.6	6.9	2.8	24.0	5.2	7.4	3.1	4.1	12.7	8.1	4.2	4.2	10.4	50.0	6.0	11.4	4.7	3.9	5.0	5.5	4.2	18.2	5.0	6.6	5.3	10.1	17.4	10.3	5.6	8.2	4.0	62.9	4.5	5.1	11.6	4.8	9.3	3.7	11.8	6.8	3.0	6.9	6.1	4.7	9.1	10.4	22.6	15.9	5.6	11.2	7.4	0.0	2.0	0.0	5.5	4.5	1.8	0.1	2.0	11.1	2.2	3.2	0.1	4.7	3.8	3.7	2.8	8.4	0.4	2.5	1.0	3.3	2.8	4.9	2.5	0.0	0.0	8.4	0.0	3.3	7.2	2.1	3.3	5.4	2.2	4.0	11.3	2.7	0.0	10.5	2.0	6.2	0.4	0.2	5.6	1.7	2.6	9.9	0.1	20.5	0.6	0.9	0.3	0.0	10.2	4.0	2.4	15.0	3.3	1.5	1.1	2.1	0.3	11.7	3.1	1.5	0.5	0.6	0.0	2.0	22.6	8.0	3.0	9.8	11.5	8.4	6.6	7.9	9.6	10.4	9.1	11.2	10.6	8.2	5.6	15.9	9.7	9.2	7.4	3.8	5.7	7.6	6.5	4.2	4.2	4.7	3.9	6.6	3.7	0.0	4.8	5.1	0.0	1.6	22.0	7.7	17.8	10.7	1.2	8.7	7.9	0.5	1.7	11.8	3.0	8.9	58.8	0.0	4.9	0.2	5.4	0.6	24.4	50.6	9.7	20.6	3.5	19.6	25.4	1.7	1.4	14.5	6.8	4.6	7.0	14.1	3.8	5.8	2.1	8.4	9.5	0.0	2.8	2.3	0.5	1.5	0.6	10.0	10.0	0.1
SLC47A1	"FLJ10847, MATE1"	ENSG00000142494	"Solute carrier family 47 member 1"	Q96FL8	17	19495385-19579034	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 45.6;kidney: 51.1;liver: 44.9"	"Group enriched"	"Detected in many"	4	"Hepatocytes: 40.8;Proximal tubular cells: 54.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 37.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 11.4"	"Group enriched"	"Detected in some"	7	"eosinophil: 12.2;plasmacytoid DC: 6.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 6.9;granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"A549: 13.2;AN3-CA: 10.6;Hep G2: 25.4;U-266/70: 19.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021987	Enhanced					NA	NA					"HPA021987: AB_1857185"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.54e-8)"	"unprognostic (7.87e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.88e-5)"	"unprognostic (4.84e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.91e-2)"	"unprognostic (9.40e-2)"	2.2	45.6	0.8	0.4	2.2	1.1	0.6	1.0	3.1	13.2	1.2	3.7	1.3	0.7	7.6	12.2	0.9	2.4	1.7	3.5	4.7	0.5	51.1	44.9	3.0	3.5	0.9	2.5	5.0	0.2	0.2	7.2	0.3	11.4	2.6	0.5	4.3	1.1	5.5	12.1	10.4	0.6	3.5	2.3	1.9	0.5	15.5	0.6	0.9	4.7	5.7	1.2	0.6	4.5	0.1	6.9	12.2	1.3	0.0	0.7	0.4	0.0	13.2	0.4	10.6	0.3	0.0	0.0	0.4	0.3	1.6	1.5	0.0	0.4	0.1	2.5	1.9	5.3	0.0	4.7	0.3	0.4	0.0	6.2	0.1	7.0	25.4	0.1	0.1	0.3	0.2	2.4	1.2	0.2	1.8	3.7	0.0	0.0	0.0	0.0	1.8	0.0	0.2	1.4	0.1	0.5	0.1	0.1	0.1	0.0	0.8	2.5	2.2	4.3	0.0	1.1	3.7	4.5	1.2	0.0	0.1	0.5	0.2	1.2	19.8	7.8	0.0	0.5	0.1	2.3	0.2	1.3	12.2	0.3	1.0	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.7	0.3	0.0	0.2	6.9	0.0	0.4	0.8	2.2	1.0	3.1	4.7	0.5	0.9	2.5	11.4	0.6	6.0	3.0	0.0	2.2	4.1	0.3	3.8	5.1	1.4	0.0	1.8	0.0	0.0	3.3	0.1	11.3	0.7	0.0	0.0	0.0	0.0	2.3	1.3	5.7	40.8	1.5	0.0	0.0	0.0	1.6	2.7	3.4	0.6	1.7	0.0	0.0	1.2	0.0	0.0	1.4	54.2	0.7	6.5	1.0	0.2	0.7	5.8	0.0	0.0	0.0	1.3
SLC47A2	"FLJ31196, MATE2, MATE2-K"	ENSG00000180638	"Solute carrier family 47 member 2"	Q86VL8	17	19678288-19718979	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 55.5"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 69.0"	"Cancer enhanced"	"Detected in some"		"renal cancer: 4.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.9;HeLa: 1.5;hTCEpi: 6.7"					"Not detected"	"Not detected"									NA	NA						"unprognostic (4.52e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (5.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.71e-2)"	0.2	0.3	3.0	0.1	4.4	0.1	0.3	0.2	0.4	0.1	0.2	10.3	0.6	0.2	0.2	6.5	0.2	8.6	0.1	0.3	6.2	5.5	55.5	0.1	0.1	0.1	1.1	0.1	0.6	0.1	0.1	0.0	0.1	12.8	0.1	0.1	0.7	0.1	0.3	0.7	1.8	0.4	0.2	2.0	0.1	0.1	0.2	2.8	0.0	0.3	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	1.2	0.0	0.2	1.9	0.0	0.1	0.0	0.0	0.0	0.0	1.5	1.0	0.0	0.0	0.0	0.0	6.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.8	0.0	0.3	0.0	0.1	0.3	0.5	0.2	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	3.0	4.4	0.2	0.4	6.2	5.5	1.1	0.1	12.8	2.8	0.0	0.0	0.0	0.2	0.2	0.0	0.6	0.0	0.0	0.0	5.2	0.0	0.1	5.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	69.0	0.2	0.0	0.3	0.5	0.2	0.3	0.0	0.0	0.0	0.1
SLC48A1	"FLJ20489, hHRG-1, HRG1"	ENSG00000211584	"Solute carrier family 48 member 1"	Q6P1K1	12	47753916-47782753	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 90.7"	"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 42.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065396, HPA073994"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA065396: , HPA073994: "	"unprognostic (9.60e-2)"	"prognostic favorable (4.27e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.63e-3)"	"prognostic favorable (1.34e-6)"	"unprognostic (1.45e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-2)"	16.2	13.5	27.8	5.0	33.5	7.7	10.7	12.5	39.5	13.1	8.3	90.7	6.7	5.6	11.9	12.7	13.9	21.9	11.5	12.8	32.7	20.8	18.5	6.3	11.7	4.9	44.1	27.9	35.6	10.6	24.3	6.4	13.2	38.6	9.3	8.2	7.4	13.2	18.1	16.7	14.7	5.3	12.7	44.5	11.3	7.7	5.1	39.7	4.9	35.6	6.1	6.0	9.9	7.6	7.1	8.5	23.7	11.9	1.2	5.4	4.0	4.5	14.2	2.2	17.0	14.9	6.4	5.0	3.3	7.3	3.1	3.2	4.5	12.4	2.8	42.7	9.1	6.3	18.2	2.9	3.8	2.4	23.1	2.8	19.3	11.9	6.1	8.5	5.1	11.5	3.8	7.7	4.5	5.5	16.4	8.8	7.9	5.0	11.3	2.0	9.5	2.4	5.2	1.5	8.5	7.0	2.4	0.6	15.1	12.6	12.2	2.9	1.3	4.4	5.5	3.1	4.3	18.4	4.8	4.8	4.5	6.0	8.4	2.3	9.1	5.6	0.8	5.8	24.5	2.6	0.0	11.9	7.8	3.6	8.5	3.2	7.1	4.4	3.7	8.5	6.3	5.4	4.4	23.7	1.2	4.8	1.6	3.4	4.0	27.8	33.5	12.5	39.5	32.7	20.8	44.1	27.9	38.6	39.7	8.9	9.1	3.7	8.4	6.0	10.5	14.3	10.2	1.4	5.7	48.8	2.0	8.0	19.9	8.5	7.7	21.5	6.7	0.0	8.5	1.7	9.9	11.0	1.1	10.4	20.5	14.3	8.1	12.9	14.9	10.4	30.2	9.3	5.0	40.5	12.9	19.3	6.7	7.0	21.5	27.0	10.3	6.5	8.5	4.3	9.6	10.5	3.0	2.5	7.6	10.1
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248385-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease mutation, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 95.7;placenta: 32.7"	"Cell type enriched"	"Detected in some"	66	"Erythroid cells: 1261.4"	"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebellum: 0.4"	"Low region specificity"	"Detected in all"			"HPA015584, CAB034438, HPA063911"	Enhanced					NA	NA		160000000			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.9	0.1	0.3	0.2	0.4	95.7	0.2	0.8	0.2	0.1	0.1	0.6	0.0	0.2	0.1	0.4	0.6	0.2	0.2	2.6	0.2	0.3	18.6	1.3	12.9	0.8	0.6	0.1	2.8	0.1	0.0	0.6	32.7	0.9	0.6	0.1	1.2	0.1	0.1	1.2	0.2	0.1	0.0	1.0	8.4	0.1	0.3	0.0	0.7	1.9	0.0	0.2	3.9	11.8	1.8	1.4	6.3	1.2	2.9	1.5	0.7	1.3	0.5	1.4	1.7	0.6	0.7	1.0	0.3	0.4	0.3	0.8	1.4	3.2	0.7	0.6	0.3	0.4	1.4	0.5	0.5	1.1	1.3	1.3	1.7	1.6	2.2	0.0	0.8	2.3	0.8	0.5	0.8	0.8	0.5	0.2	0.6	4.8	3.5	0.4	0.6	1.0	3.5	0.9	0.7	0.5	2.5	0.7	1.9	0.3	0.8	2.2	1.0	1.3	1.4	0.5	0.7	2.5	1.8	1.0	2.4	2.1	1.4	1.4	1.0	2.3	1.1	1.6	2.2	1.1	6.1	1.0	2.0	1.1	0.9	1.0	1.1	1.0	0.9	0.5	1.8	1.5	1.2	6.3	2.9	1.2	1.4	0.7	0.7	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.1	0.9	0.0	6.0	1.1	0.0	0.9	0.0	0.4	0.7	0.0	0.0	1.2	19.2	0.0	0.3	3.3	0.0	0.5	0.0	0.0	1261.4	0.0	0.9	0.3	0.4	0.0	0.0	1.3	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.2	0.0	0.0	0.2	0.9	0.4	0.0	0.7	0.0	0.0	0.5
SLC4A10	"NBCn2, NCBE"	ENSG00000144290	"Solute carrier family 4 member 10"	Q6U841	2	161424332-161985282	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"blood: 31.2;brain: 48.1"	"Cell type enriched"	"Detected in some"	12	"Bipolar cells: 116.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"MAIT T-cell: 31.2"	"Lineage enriched"	"Detected in single"	78	"T-cells: 31.2"	"Cell line enriched"	"Detected in some"	11	"Karpas-707: 14.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034755, HPA076725"	Enhanced					NA	NA					"HPA034755: AB_10670296, HPA076725: "	"unprognostic (4.64e-4)"	"unprognostic (3.88e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.89e-3)"	"unprognostic (5.99e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.26e-1)"	1.0	3.7	21.6	1.9	24.1	1.2	1.3	14.9	48.1	1.1	3.3	2.1	0.0	1.4	1.0	2.8	1.0	1.8	1.5	1.0	20.4	10.8	1.0	1.3	1.1	1.1	4.3	29.6	1.0	2.9	1.0	4.4	1.0	17.7	1.3	2.7	1.7	1.0	1.1	1.0	1.0	1.5	1.1	1.9	3.0	1.3	1.4	3.5	0.0	1.0	0.0	1.5	1.3	0.3	0.0	0.0	0.0	0.0	0.4	31.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	1.2	0.0	31.2	0.0	0.6	3.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	21.6	24.1	14.9	37.9	20.4	10.8	4.3	29.6	17.7	3.5	0.0	0.0	0.0	0.0	0.0	116.7	0.4	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	1.8	1.2	8.4	0.0	0.0	0.0	0.0	2.2	2.4	0.1	0.0	0.0	0.0	6.7	0.0	0.0	0.9	0.2	0.0	0.0	4.4	0.0	0.0
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 34.4;thyroid gland: 42.7"	"Cell type enriched"	"Detected in some"	4	"Collecting duct cells: 106.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 1.4;T-reg: 1.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 36.0;Hep G2: 21.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	0.8	3.1	3.3	0.8	4.9	0.3	2.4	2.1	2.8	8.6	0.2	1.3	0.8	0.1	0.9	2.0	7.5	1.1	2.2	0.5	3.0	0.6	11.4	0.1	1.3	0.9	1.4	1.1	0.6	0.1	0.4	2.4	0.3	1.8	2.2	0.3	1.1	34.4	5.8	3.5	5.3	0.3	0.2	1.4	0.3	1.9	3.2	1.2	0.2	42.7	3.3	5.1	2.6	2.1	0.0	0.7	0.0	1.4	0.0	1.1	0.4	5.4	7.8	0.9	4.1	2.7	0.7	11.1	2.7	1.7	1.4	0.8	0.5	7.2	0.0	3.2	0.9	3.4	36.0	4.2	8.5	0.2	0.0	1.7	0.3	3.4	21.0	1.7	1.9	7.0	0.3	3.5	1.7	1.6	1.2	3.6	5.0	0.7	5.0	1.4	3.5	0.2	0.2	6.2	6.7	10.6	1.2	5.3	1.7	8.7	15.3	0.4	2.5	1.4	9.0	0.2	2.9	3.4	3.4	6.1	1.1	3.7	0.2	1.3	0.2	0.3	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.0	0.3	0.0	0.0	0.0	1.4	0.0	1.1	0.4	3.3	4.9	2.1	2.8	3.0	0.6	1.4	1.1	1.8	1.2	0.0	0.0	0.0	1.7	0.7	0.1	1.2	0.0	5.3	2.3	106.4	0.0	0.0	0.0	0.7	3.5	0.3	0.0	0.0	0.4	0.1	0.3	2.0	0.0	0.0	0.3	0.0	0.0	1.8	0.3	1.5	0.0	0.0	0.0	1.0	0.1	0.0	2.2	0.6	0.4	0.3	0.0	25.8	0.5	0.6	5.2	0.4	0.0	0.0	0.0	2.6
SLC4A1AP	"HLC3, kanadaptin"	ENSG00000163798	"Solute carrier family 4 member 1 adaptor protein"	Q9BWU0	2	27663471-27694976	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Spermatocytes: 127.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036679	Approved		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			Nucleoplasm	"Vesicles, Plasma membrane"	"HPA036679: AB_2675244"	"unprognostic (5.63e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.62e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (2.21e-1)"	"unprognostic (7.89e-3)"	"prognostic unfavorable (3.76e-7)"	"unprognostic (1.32e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.66e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.40e-2)"	"prognostic unfavorable (1.79e-4)"	12.3	16.1	18.8	14.2	27.0	12.7	13.9	27.4	29.0	11.5	11.3	15.8	8.7	11.6	12.8	12.2	14.2	12.3	9.8	18.6	17.9	19.6	15.3	15.0	12.8	14.6	17.0	20.5	15.2	13.3	23.8	16.0	14.5	29.1	12.6	12.3	9.0	12.4	12.1	26.0	15.1	12.0	12.5	15.4	13.1	12.5	29.9	16.8	16.1	14.6	14.9	15.1	11.1	11.0	16.7	13.3	40.8	17.9	22.5	19.5	14.1	22.0	12.9	13.0	12.1	13.4	12.4	19.1	18.4	12.7	19.4	15.9	18.8	16.2	14.0	17.1	14.7	20.5	15.8	20.8	14.2	17.4	19.4	17.0	16.1	13.5	20.6	16.4	22.9	15.4	11.1	18.1	19.3	18.3	16.3	19.7	13.8	23.2	15.3	17.8	13.4	15.4	22.5	13.1	14.6	12.7	12.8	28.5	16.1	19.9	10.3	14.2	14.0	14.3	19.6	17.6	13.8	11.8	15.1	19.9	18.1	16.4	12.5	21.4	25.3	35.7	44.8	19.6	18.5	14.4	40.8	17.7	24.2	17.6	16.9	17.4	13.5	16.1	15.3	13.3	16.7	19.5	16.5	16.5	22.5	17.9	10.7	17.1	14.1	18.8	27.0	27.4	29.0	17.9	19.6	17.0	20.5	29.1	16.8	29.8	21.6	5.2	11.5	10.5	20.1	26.0	12.7	22.7	29.6	17.4	17.7	21.1	5.0	23.4	23.8	18.3	9.7	0.0	31.5	17.0	12.3	7.8	37.0	14.0	21.3	23.8	15.6	12.9	15.8	3.1	16.1	13.3	16.9	27.1	10.6	21.0	27.1	8.6	18.0	12.6	20.2	32.3	10.0	127.5	65.0	10.5	20.4	15.0	8.5	7.6
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076527	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 94.2;retina: 100.7"	"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 76.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	7	"pons and medulla: 73.3"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA019339	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	9.9	13.5	4.7	10.4	7.4	6.7	10.5	3.0	8.6	12.4	18.6	29.0	6.0	12.1	16.2	6.3	7.7	10.8	14.1	11.9	10.1	3.8	35.5	94.2	12.3	7.2	10.4	4.8	12.6	34.1	30.6	5.3	31.4	73.3	10.5	4.0	100.7	11.9	8.3	8.7	9.5	26.0	10.7	10.4	10.1	27.1	6.5	8.5	8.8	9.7	7.0	5.9	11.7	10.6	2.5	5.6	2.1	4.2	0.5	2.7	1.9	15.9	52.8	10.4	21.4	10.4	6.1	23.8	19.4	10.5	15.9	13.8	30.0	25.6	9.6	42.6	9.2	23.4	15.7	10.6	9.4	2.9	27.6	15.8	12.6	25.7	15.2	17.0	6.5	40.6	8.9	8.3	18.0	4.6	17.1	8.8	13.6	38.9	8.1	12.3	30.6	18.6	11.2	24.7	21.5	19.6	14.7	5.7	11.2	13.0	12.1	8.6	31.2	17.7	33.5	16.5	8.2	13.8	12.8	19.0	21.4	10.9	21.0	28.5	8.8	11.8	5.4	32.7	16.3	42.9	0.0	4.2	2.1	2.7	3.9	1.9	2.5	2.1	1.8	2.4	1.0	2.4	2.4	1.0	0.5	2.5	5.6	1.0	1.9	4.7	7.4	3.0	8.6	10.1	3.8	10.4	4.8	73.3	8.5	8.9	10.9	6.7	4.5	9.8	7.9	3.6	17.8	1.4	2.3	19.2	23.6	28.5	14.9	31.0	0.6	9.8	17.3	0.0	30.9	9.0	16.2	5.0	48.3	31.4	23.1	14.3	26.5	14.7	15.1	1.3	12.7	9.9	25.3	9.0	11.1	22.3	39.3	14.0	18.7	18.9	8.8	12.9	15.5	3.2	7.7	6.0	76.5	8.3	18.9	3.1
SLC4A3	"AE3, SLC2C"	ENSG00000114923	"Solute carrier family 4 member 3"	P48751	2	219627327-219641980	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 103.6;ovary: 30.2"	"Group enriched"	"Detected in many"	17	"Cardiomyocytes: 201.0;Horizontal cells: 527.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	36	"myeloid DC: 2.3;plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	58	"dendritic cells: 8.9"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063498			Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA063498: AB_2685025"	"unprognostic (9.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (8.92e-4)"	"unprognostic (1.77e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.12e-4)"	1.8	5.4	11.8	1.6	22.5	1.2	2.0	8.8	22.0	2.8	1.3	3.0	0.4	1.4	3.4	2.6	2.9	2.7	2.3	103.6	10.4	8.2	1.6	1.0	1.3	1.4	6.5	9.0	30.2	2.7	4.5	9.9	2.5	24.1	4.2	1.1	4.9	3.1	4.3	1.2	1.6	1.3	3.1	1.6	2.6	1.4	4.2	3.5	0.0	1.5	0.0	1.3	1.6	0.9	0.0	8.9	0.0	0.1	0.0	0.0	0.0	6.2	0.2	2.2	6.5	0.4	0.4	4.4	3.9	4.1	5.3	3.8	4.5	3.6	0.0	1.5	1.4	9.2	3.6	1.1	7.1	1.6	0.0	1.0	0.0	0.0	0.1	1.1	0.1	0.3	3.1	6.7	0.0	2.1	13.4	0.0	0.0	0.2	0.0	1.5	2.1	0.0	0.0	3.6	0.2	5.3	0.0	0.0	0.0	3.6	1.5	1.3	6.4	2.5	6.8	3.3	7.5	0.6	1.6	0.0	3.3	5.8	0.0	3.1	0.0	0.0	0.0	2.7	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	11.8	22.5	8.8	22.0	10.4	8.2	6.5	9.0	24.1	3.5	0.0	0.0	0.0	0.6	0.2	8.9	201.0	0.0	0.0	1.2	1.8	0.0	10.5	1.7	2.8	2.0	0.1	0.0	0.0	1.5	2.5	2.2	0.3	0.0	0.0	1.6	527.6	0.0	0.0	0.0	11.9	14.1	1.1	0.0	1.0	0.0	7.0	1.3	0.0	21.2	0.3	6.7	6.5	1.4	0.5	1.1	0.6	11.6	0.0	0.0	0.0
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71186757-71572087	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 47.4;pancreas: 113.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 107.0;Ductal cells: 81.5;Enterocytes: 173.4;Proximal tubular cells: 149.5"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.8;memory CD8 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"BJ: 13.9;fHDF/TERT166: 6.3;hTERT-RPE1: 6.0;RPTEC TERT1: 14.9;U-138 MG: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA					"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	2.4	0.9	14.3	4.3	19.9	0.7	1.1	18.1	15.2	5.8	17.2	4.5	0.1	22.4	0.8	0.7	1.1	1.0	24.9	2.9	13.1	8.1	47.4	9.4	5.8	0.6	9.7	11.2	1.0	113.8	10.0	4.1	1.6	18.1	14.6	17.1	11.1	1.5	1.1	1.3	0.7	10.4	1.3	21.6	0.9	8.3	0.7	8.0	0.0	9.5	0.0	0.6	2.6	0.9	0.0	0.1	0.0	0.0	0.5	2.8	0.3	0.0	3.6	1.0	0.0	0.0	0.0	0.1	13.9	1.9	2.3	1.8	0.0	0.1	0.0	0.1	6.3	0.6	0.0	0.2	0.0	5.7	0.0	1.8	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.9	0.0	0.6	1.2	0.0	4.7	0.2	0.1	0.2	0.0	0.0	0.0	0.9	14.9	4.2	1.0	0.1	0.0	0.0	0.2	1.2	0.0	0.0	0.0	7.9	0.7	5.7	0.6	0.0	0.0	0.0	5.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	1.4	0.0	0.8	2.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.3	14.3	19.9	18.1	12.4	13.1	8.1	9.7	11.2	18.1	8.0	3.0	32.5	1.3	4.2	0.0	0.0	20.1	107.0	14.7	31.8	24.4	0.0	0.2	13.3	81.5	6.6	1.9	173.4	0.0	21.6	0.1	1.1	63.3	1.1	31.7	0.2	0.0	8.2	1.8	0.6	1.0	0.0	1.0	1.7	1.8	66.7	3.3	19.9	56.6	0.0	149.5	1.1	6.5	2.5	0.1	0.4	0.0	0.2	6.9	42.6	7.0
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 48.5"	"Group enriched"	"Detected in many"	10	"Cone photoreceptor cells: 691.1;Rod photoreceptor cells: 667.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 38.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	14.5	5.0	3.2	10.5	4.6	3.3	17.0	4.0	4.8	10.8	38.2	5.0	8.8	48.5	8.1	12.6	8.4	6.5	12.5	9.3	5.0	3.8	15.3	3.7	9.3	10.3	4.8	1.9	9.0	3.3	2.4	4.4	5.6	4.5	10.3	6.9	20.0	8.3	8.4	5.6	5.6	43.4	18.2	5.8	9.7	7.8	6.1	5.5	6.8	6.3	14.7	15.5	15.0	14.9	1.8	2.0	0.1	0.9	2.4	3.9	0.7	5.9	11.1	10.0	4.6	4.7	8.4	7.1	20.2	9.4	7.8	6.1	3.0	3.1	13.5	1.7	7.8	7.5	2.6	9.5	9.8	12.4	11.4	3.1	6.2	7.6	3.2	8.1	14.0	5.4	6.7	4.3	11.8	38.2	16.5	12.8	8.9	4.1	4.8	16.0	2.1	13.9	3.2	6.6	0.7	11.0	9.5	7.9	2.7	18.3	4.2	2.5	6.3	9.2	6.8	3.1	8.9	15.5	5.4	8.9	18.4	5.1	12.7	15.6	1.8	1.9	7.7	16.1	9.9	8.4	0.0	0.5	0.0	3.0	0.6	2.0	1.2	3.8	3.9	1.4	1.8	1.5	2.7	0.1	2.4	0.9	2.0	3.2	0.7	3.2	4.6	4.0	4.8	5.0	3.8	4.8	1.9	4.5	5.5	0.0	12.8	13.2	28.2	26.1	65.7	18.7	15.3	5.3	25.0	59.3	691.1	4.5	8.3	13.6	6.7	25.3	5.8	0.0	6.2	23.0	30.2	41.3	23.1	5.9	16.9	6.4	36.7	14.7	33.1	5.9	8.3	36.7	33.7	20.8	50.6	45.2	13.6	12.7	9.2	10.5	667.4	38.8	32.8	32.4	21.7	26.8	6.8	33.0	12.2	33.6
SLC4A9	AE4	ENSG00000113073	"Solute carrier family 4 member 9"	Q96Q91	5	140360202-140375143	"Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"kidney: 26.7"	"Cell type enhanced"	"Detected in single"	21	"Distal tubular cells: 1.7"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 3.8;U-698: 2.0"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.0"	"Low region specificity"	"Detected in all"			HPA051307	Uncertain					NA	NA					"HPA051307: AB_2681434"	"unprognostic (1.68e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.82e-2)"	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	26.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.2	0.2	0.0	0.7	0.6	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	3.8	0.0	0.8	0.0	0.4	0.0	0.2	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.1	0.2	0.1	0.0	1.0	0.5	2.0	0.0	0.1	0.2	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.0	0.0	0.0	0.1
SLC50A1	"HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1"	ENSG00000169241	"Solute carrier family 50 member 1"	Q9BRV3	1	155135344-155138857	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Extravillous trophoblasts: 115.3;Mucus-secreting cells: 113.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 54.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018095	Approved					NA	NA					"HPA018095: AB_1856048"	"unprognostic (4.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (4.36e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.39e-2)"	11.6	23.4	4.9	16.3	5.7	7.2	13.6	4.2	6.7	13.6	19.8	5.6	28.7	17.2	11.5	49.0	20.3	10.0	21.3	7.5	5.1	7.0	23.8	34.5	22.8	24.3	5.3	4.3	13.6	55.3	12.7	10.3	19.5	6.2	14.4	25.0	11.3	37.5	17.2	4.5	15.9	28.6	9.8	6.1	27.0	19.9	9.3	6.7	12.8	23.4	15.9	25.0	12.4	10.2	32.2	15.3	12.0	18.2	24.0	14.7	15.3	15.8	4.9	5.2	9.4	13.7	13.1	10.7	6.2	16.1	10.5	14.1	8.6	54.8	11.2	17.1	9.1	11.1	22.6	7.1	18.8	8.2	19.6	2.4	9.2	4.6	5.4	21.2	6.1	12.5	14.3	42.7	12.4	30.7	13.7	9.3	5.4	10.1	17.3	10.1	15.6	4.5	8.7	7.0	30.1	16.3	8.6	3.0	33.6	21.3	4.6	9.2	6.9	10.4	21.3	16.9	8.0	44.3	8.8	5.3	7.0	6.1	9.1	3.1	19.6	11.6	9.8	11.3	13.9	6.9	11.3	12.9	12.0	10.4	18.2	12.6	27.1	13.6	12.2	15.3	32.2	14.7	12.9	5.8	24.0	16.8	14.9	13.7	15.3	4.9	5.7	4.2	6.7	5.1	7.0	5.3	4.3	6.2	6.7	20.8	28.1	41.2	17.9	14.3	6.6	4.1	10.2	22.7	26.1	22.7	11.8	31.6	11.6	37.2	0.4	30.6	61.6	23.3	42.8	115.3	23.2	36.2	23.1	16.3	41.3	6.4	22.4	22.1	24.0	1.1	12.4	30.6	27.0	43.3	113.0	6.2	34.6	38.6	5.3	20.4	6.7	6.5	21.7	9.3	5.2	16.2	52.5	27.4	43.3	33.3
SLC51A	OSTalpha	ENSG00000163959	"Solute carrier family 51 alpha subunit"	Q86UW1	3	196211487-196243178	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 53.9;liver: 59.5"	"Cell type enhanced"	"Detected in many"	12	"Enterocytes: 130.2;Leydig cells: 57.0;Peritubular cells: 95.5;Sertoli cells: 142.3"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 15.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.7;neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"REH: 8.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA045488	Enhanced					NA	NA					"HPA045488: "	"unprognostic (1.63e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-5)"	0.5	2.3	0.3	3.8	0.3	2.4	0.4	0.3	0.4	0.5	12.3	0.4	0.7	13.6	0.4	2.8	0.5	0.5	0.5	0.5	0.3	0.1	2.2	59.5	0.8	0.3	0.3	0.3	0.6	0.3	1.4	0.5	0.3	0.3	0.5	0.1	0.3	0.6	0.3	0.5	1.0	53.9	0.3	0.3	0.8	0.2	1.8	0.3	0.6	0.8	0.3	0.5	0.3	0.7	0.2	0.0	1.7	0.6	0.4	0.6	0.1	1.1	1.7	1.4	1.7	0.0	1.1	0.1	0.8	0.0	0.1	0.0	0.7	0.5	0.1	2.0	1.1	0.1	0.9	0.2	0.0	0.0	0.7	2.9	1.0	0.8	1.8	0.2	1.4	1.4	0.3	0.0	0.2	1.3	1.5	0.2	0.3	0.2	3.3	0.0	0.6	0.1	1.2	0.1	0.4	2.0	8.1	0.1	0.5	0.0	0.9	0.3	0.5	0.5	3.3	0.3	0.4	2.4	0.5	0.6	1.7	0.7	1.3	0.9	3.3	4.0	0.6	1.1	0.7	0.6	0.0	0.2	1.7	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.6	1.6	0.4	0.5	0.0	0.1	0.1	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3	0.0	0.3	0.0	1.9	3.0	0.5	3.3	2.5	10.7	4.5	0.0	3.9	0.5	3.3	0.3	16.2	1.8	130.2	23.3	0.2	0.3	3.1	1.4	0.0	38.6	0.5	1.6	0.0	4.3	3.8	10.3	57.0	3.3	3.3	0.0	0.4	0.3	0.1	8.6	95.5	4.9	0.9	142.3	2.0	2.1	1.1	2.3	0.8	2.6	0.5	2.6
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 beta subunit"	Q86UW2	15	65045370-65053396	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 85.0"	"Cell type enriched"	"Detected in many"	6	"Enterocytes: 518.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"CACO-2: 16.9;EFO-21: 11.3;Hep G2: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria		No	NA			Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.4	0.5	0.4	3.8	0.6	0.0	0.4	0.4	0.8	14.0	34.9	0.4	0.4	28.1	0.9	3.3	0.4	1.0	0.5	0.4	0.5	0.6	7.5	2.4	1.6	0.4	0.6	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.8	9.5	0.4	0.4	0.8	0.4	0.1	85.0	0.4	0.4	0.4	0.2	4.1	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.7	0.1	0.0	0.5	0.3	0.0	1.4	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.2	0.0	16.9	0.0	0.1	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	14.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.4	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.8	0.4	0.0	0.6	0.5	0.0	0.0	0.0	2.2	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.3	0.7	0.0	0.1	0.0	0.0	0.3	0.4	0.6	0.4	0.4	0.5	0.6	0.6	0.4	0.4	0.4	0.0	0.6	1.5	0.1	0.0	0.0	0.0	2.5	10.7	0.0	0.0	0.0	0.0	11.6	0.0	48.8	0.0	518.3	0.0	0.0	0.0	0.0	0.0	4.6	1.5	0.1	0.0	1.7	0.6	0.0	9.7	0.3	0.0	0.0	0.0	7.7	0.0	0.0	84.2	0.0	54.0	0.0	6.5	0.0	1.5	0.4	0.0	0.1	0.0	19.7	0.0
SLC52A2	"D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2"	ENSG00000185803	"Solute carrier family 52 member 2"	Q9HAB3	8	144354135-144361286	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Host cell receptor for virus entry, Receptor"	"Deafness, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 51.0"	"Low region specificity"	"Detected in all"							HPA063036	Approved					NA	NA					"HPA063036: AB_2684928"	"unprognostic (7.80e-3)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (7.74e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	16.0	12.8	7.3	13.2	8.8	9.9	23.7	19.2	10.5	10.9	18.1	7.5	19.3	19.6	10.7	19.9	14.6	7.4	16.3	8.0	7.7	9.0	14.7	12.4	10.7	10.7	13.0	5.9	10.6	22.4	7.9	10.9	19.5	9.5	10.8	9.3	7.2	21.3	14.1	7.0	12.6	17.8	8.5	7.9	15.2	16.8	17.0	7.4	11.5	12.4	11.6	14.6	8.6	13.1	7.7	9.0	9.2	7.4	5.7	6.3	1.9	12.8	18.5	2.6	6.9	4.9	3.7	13.4	9.9	7.0	9.0	7.2	14.7	15.5	6.1	16.3	7.1	6.6	15.3	4.4	7.6	1.9	7.5	10.5	10.6	10.6	13.3	16.0	3.9	9.1	5.1	9.2	8.2	6.8	4.4	5.2	5.8	14.5	7.8	4.7	37.4	6.0	10.3	5.6	16.0	51.0	11.2	3.1	13.8	7.3	9.5	8.2	9.8	12.2	12.7	11.4	2.5	10.0	5.1	7.4	7.4	16.8	18.4	14.2	3.9	5.4	4.6	12.2	9.7	8.5	1.2	4.2	9.2	5.9	6.1	3.7	4.2	4.7	6.3	5.2	7.7	4.6	3.1	1.4	5.7	7.4	9.0	5.7	1.9	7.3	8.8	19.2	10.5	7.7	9.0	13.0	5.9	9.5	7.4	6.0	5.4	19.3	19.4	27.7	10.9	2.5	12.7	4.0	14.8	12.2	2.0	74.0	0.0	60.6	2.5	20.6	60.0	0.0	58.0	74.5	27.7	31.3	10.3	4.0	47.5	11.1	16.7	17.8	14.8	4.2	11.8	20.9	28.7	55.1	32.0	13.5	64.4	42.1	18.7	12.9	8.9	19.4	26.4	31.7	39.6	31.6	43.9	20.8	38.1	32.6
SLC52A3	"bA371L19.1, C20orf54, hRFT2, RFVT3"	ENSG00000101276	"Solute carrier family 52 member 3"	Q9NQ40	20	760080-776015	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 32.5"	"Cell type enhanced"	"Detected in many"	11	"Collecting duct cells: 22.7;Cytotrophoblasts: 15.8;Enterocytes: 25.3;Syncytiotrophoblasts: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 25.9;OE19: 17.9;RT4: 6.0;SK-BR-3: 9.5;T-47d: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049391, HPA059078"	Approved					NA	NA					"HPA049391: AB_2680743, HPA059078: AB_2732630"	"unprognostic (4.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.36e-2)"	"unprognostic (4.39e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (5.51e-6)"	"unprognostic (3.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	2.0	0.4	7.3	1.4	5.9	0.5	2.8	3.5	9.0	2.6	9.6	2.1	12.0	13.1	1.8	1.9	4.6	2.0	3.0	3.3	6.6	4.2	10.0	0.4	1.4	0.7	5.6	1.3	1.2	2.2	0.6	0.5	6.7	7.3	7.9	6.3	0.5	5.5	15.8	1.0	1.7	16.3	1.5	4.7	0.4	5.2	32.5	6.0	0.0	0.7	1.2	0.9	4.7	2.2	1.1	0.7	2.4	0.6	1.1	0.8	0.4	3.3	0.9	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	2.3	25.9	0.0	3.8	0.0	0.2	3.8	0.0	2.8	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	17.9	2.3	0.0	0.0	0.3	0.0	6.0	0.0	0.1	3.8	9.5	0.0	0.4	11.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.5	0.4	0.2	0.4	0.5	0.4	0.4	0.1	1.1	0.4	0.8	2.2	1.1	0.4	0.7	0.3	0.4	7.3	5.9	3.5	9.0	6.6	4.2	5.6	1.3	7.3	6.0	8.9	1.9	0.0	2.2	0.6	0.4	0.4	0.0	0.0	3.4	22.7	2.0	15.8	1.7	5.6	0.7	2.9	25.3	0.0	1.6	0.7	0.2	5.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	2.0	0.9	0.3	1.7	0.0	4.9	0.0	4.1	14.4	0.4	0.0	0.0	0.0	0.2	0.5	0.7	1.0	43.6	0.0	9.3	6.2
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043032-32113029	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 274.9"	"Cell type enhanced"	"Detected in many"	13	"Cardiomyocytes: 111.5;Cholangiocytes: 117.2;Early spermatids: 40.8;Late spermatids: 54.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"OE19: 27.0"	"Region enriched"	"Detected in single"	26	"cerebellum: 8.6"	"Not detected"	"Not detected"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.2	0.0	0.2	1.3	0.2	0.0	1.5	0.2	0.2	2.2	181.5	0.2	2.9	95.5	0.3	0.8	1.9	0.0	14.1	24.5	0.2	0.0	1.0	0.9	0.3	0.2	0.2	0.2	0.2	0.4	0.0	1.0	0.2	0.2	0.8	1.6	0.2	5.7	3.5	0.2	4.6	274.9	0.2	0.2	0.7	1.2	0.8	0.2	0.2	0.2	3.5	1.5	0.2	2.0	0.3	0.1	0.6	0.8	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.1	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	27.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.8	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	1.8	0.6	0.0	111.5	117.2	0.0	4.5	0.0	0.0	0.0	0.0	2.4	40.8	0.0	26.1	0.0	1.2	0.0	0.2	19.7	0.0	0.0	0.0	0.0	24.5	0.0	0.0	54.9	1.1	0.0	0.0	0.0	8.7	0.0	0.6	14.7	1.4	1.9	0.0	0.0	0.0	4.2	0.5	4.8	0.0	0.0	19.6	4.8
SLC5A10	SGLT5	ENSG00000154025	"Solute carrier family 5 member 10"	A0PJK1	17	18950345-19022595	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 70.6"	"Group enriched"	"Detected in some"	4	"Late spermatids: 20.1;Proximal tubular cells: 51.2"	"Cancer enriched"	"Detected in some"	11	"renal cancer: 6.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 3.0;non-classical monocyte: 7.9"	"Lineage enriched"	"Detected in many"	7	"monocytes: 7.9"	"Cell line enriched"	"Detected in some"	5	"U-937: 11.0"	"Not detected"	"Not detected"							HPA052014	Uncertain					NA	NA					"HPA052014: AB_2681694"	"unprognostic (3.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.36e-4)"	"unprognostic (7.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.11e-1)"	0.1	0.1	0.1	0.5	0.1	1.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.1	0.7	0.1	0.0	70.6	0.4	0.3	0.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	15.1	0.1	0.1	0.1	0.7	1.1	0.1	0.2	3.1	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	1.2	0.1	7.9	0.0	0.6	0.5	0.0	0.0	0.1	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.1	1.8	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.5	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.7	0.0	0.1	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	11.0	0.0	0.1	0.0	0.0	0.1	3.0	0.0	0.4	0.3	0.0	1.2	0.3	0.6	0.2	0.0	0.0	7.9	0.0	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.3	8.7	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.0	20.1	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	51.2	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.0	0.0	0.0
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667019-26723427	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 60.8;kidney: 90.3"	"Cell type enriched"	"Detected in some"	18	"Proximal tubular cells: 145.9"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	0.0	11.3	0.0	0.2	1.7	0.0	18.5	0.0	0.0	0.0	3.4	0.1	0.1	90.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.8	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.8	1.0	0.7	0.9	0.7	0.1	0.4	0.1	0.2	0.6	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.2	0.6	0.8	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.1	0.7	0.1	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.4	5.2	0.1	0.3	0.2	0.5	3.8	0.7	0.1	0.1	0.0	0.6	0.1	1.1	2.0	0.3	1.7	0.2	0.0	7.8	2.8	0.5	0.6	0.4	0.2	0.4	0.2	2.3	0.7	0.2	0.2	0.0	0.0	1.0	0.5	0.1	0.6	0.7	0.4	1.1	0.4	0.4	0.5	1.5	0.7	0.6	0.4	0.9	0.6	0.8	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	3.5	0.0	0.1	8.3	0.0	0.7	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.3	0.0	145.9	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.4	0.0
SLC5A2	SGLT2	ENSG00000140675	"Solute carrier family 5 member 2"	P31639	16	31483002-31490860	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"kidney: 33.7"	"Group enriched"	"Detected in some"	11	"Early spermatids: 46.9;Late spermatids: 103.8;Proximal tubular cells: 139.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 1.6"	"Group enriched"	"Detected in many"	16	"NK-cells: 1.4;T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;EFO-21: 2.0;Hep G2: 2.6;NB-4: 1.3;U-2 OS: 1.2;U-266/84: 1.8;U-937: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041603	Enhanced					NA	NA					"HPA041603: AB_10960540"	"unprognostic (1.61e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.22e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.6	0.6	0.1	0.4	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	1.2	0.1	0.0	0.0	1.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	1.6	0.5	0.0	0.0	0.5	0.1	0.0	1.4	0.0	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	0.3	0.0	1.4	0.0	8.7	0.0	0.2	6.6	0.7	46.9	0.0	0.3	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	103.8	2.0	0.4	0.0	0.0	0.2	0.0	0.7	0.0	1.4	139.8	0.0	0.0	0.0	3.2	0.9	0.3	0.1	0.0	0.6	0.0
SLC5A3	"SMIT, SMIT1"	ENSG00000198743	"Solute carrier family 5 member 3"	P53794	21	34073570-34106262	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 46.0"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 130.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029791			Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA029791: AB_10601892"	"unprognostic (9.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.60e-2)"	10.1	9.5	10.5	7.3	11.0	3.6	26.6	8.0	10.1	6.5	7.6	4.6	9.4	5.0	11.3	9.1	7.5	8.5	4.9	6.8	11.6	6.8	46.0	9.5	8.5	7.6	11.7	4.7	9.0	5.8	6.3	6.6	15.8	13.6	7.0	8.8	11.3	6.4	6.9	7.8	10.1	7.4	5.9	14.7	4.9	7.8	10.6	9.0	5.9	42.7	4.4	8.0	6.5	22.1	0.8	2.3	0.7	1.0	1.0	2.6	0.7	6.3	5.7	11.9	8.4	10.0	8.2	5.7	7.2	22.1	4.5	6.9	9.4	13.9	10.2	5.9	14.6	8.5	3.3	14.4	4.1	7.7	10.6	3.7	10.6	5.3	3.1	2.6	4.5	4.5	3.9	10.7	12.3	4.9	13.9	2.7	8.5	10.4	2.4	11.6	4.3	4.8	3.7	6.0	2.4	5.6	4.9	2.1	4.6	17.8	8.9	6.2	2.9	15.0	4.0	3.4	7.4	2.4	4.8	2.6	8.9	6.9	16.9	2.9	12.7	10.9	7.7	17.9	6.6	5.9	0.0	1.0	0.2	2.6	0.9	2.1	0.8	1.4	1.7	0.9	0.8	1.9	2.6	0.7	1.0	0.4	2.3	0.4	0.7	10.5	11.0	8.0	10.1	11.6	6.8	11.7	4.7	13.6	9.0	14.9	12.2	8.0	40.9	0.0	28.5	7.6	12.7	16.0	23.9	130.9	19.6	21.2	18.3	3.4	8.6	4.5	28.0	0.0	4.5	15.7	10.7	71.1	41.4	15.3	12.8	35.0	47.1	6.7	12.1	5.2	6.1	9.8	0.0	24.4	48.3	6.0	5.8	46.0	19.4	6.5	20.8	12.9	2.2	12.1	18.9	0.0	23.6	17.3	26.6	32.3
SLC5A4	"DJ90G24.4, SAAT1, SGLT3"	ENSG00000100191	"Solute carrier family 5 member 4"	Q9NY91	22	32218476-32255341	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	29	"intestine: 73.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	10	"melanoma: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SK-MEL-30: 25.2"					"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.93e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.50e-1)"	"unprognostic (1.99e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.69e-1)"	1.2	0.1	0.4	0.4	0.4	0.1	1.6	0.4	0.5	1.2	41.7	0.4	0.4	18.0	1.8	0.4	0.4	1.2	0.6	0.9	0.5	0.6	1.0	0.4	2.5	0.4	0.6	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.9	0.1	0.4	0.4	0.4	0.4	0.3	73.6	1.5	0.6	0.6	0.2	0.7	0.4	0.4	2.4	0.4	0.4	0.4	1.3	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	25.2	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.5	0.5	0.6	0.6	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871973-17895174	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Congenital hypothyroidism, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 31.5;salivary gland: 66.8;stomach 1: 32.7"	"Group enriched"	"Detected in some"	6	"Ciliated cells: 5.3;Club cells: 7.9;Spermatogonia: 7.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"pons and medulla: 31.5"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"BEWO: 16.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022364, HPA049055"	Enhanced					NA	NA					"CAB022364: , HPA049055: AB_2680614"	"unprognostic (2.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.51e-8)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-1)"	0.0	0.0	0.1	0.1	0.4	0.1	0.1	2.4	2.3	5.1	0.1	9.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.0	1.7	0.1	0.1	0.0	0.2	0.2	0.3	2.7	0.0	0.1	0.0	0.2	0.0	31.5	0.1	0.0	5.5	66.8	0.0	0.2	0.2	0.3	0.0	1.9	0.2	32.7	0.4	0.1	0.0	7.1	0.0	0.1	0.0	0.1	1.3	0.8	2.5	1.4	1.0	4.3	0.9	0.0	0.0	0.1	0.1	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.5	0.0	0.2	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.1	0.5	0.0	0.2	1.2	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.1	0.0	3.7	0.0	2.5	0.6	0.4	1.1	1.4	1.3	1.0	3.2	0.6	0.8	1.3	4.3	3.2	2.2	1.0	0.4	0.4	2.0	0.9	0.1	0.4	2.4	2.3	1.7	0.1	0.3	2.7	31.5	0.1	0.0	1.1	0.0	0.0	0.3	0.0	0.6	0.0	5.3	7.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	7.9	0.3	0.0	0.5	0.0	0.0
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 64.0;placenta: 51.7"	"Cell type enhanced"	"Detected in many"	12	"Cytotrophoblasts: 98.8;Extravillous trophoblasts: 89.2;monocytes: 78.5;Syncytiotrophoblasts: 190.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 69.3;SK-BR-3: 74.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	20.9	4.6	5.0	7.6	8.5	8.5	15.9	7.9	8.1	4.0	6.4	5.6	6.4	10.9	7.4	36.7	5.5	5.9	6.3	3.5	5.3	5.7	5.9	64.0	6.0	6.4	7.0	8.1	5.6	6.0	4.5	4.2	51.7	7.1	4.8	6.6	5.6	6.7	10.6	7.9	4.6	7.6	4.9	4.4	4.8	4.8	17.5	6.1	5.8	5.1	4.3	13.0	4.6	10.1	6.8	10.0	2.0	9.0	6.3	10.4	5.8	16.7	17.4	11.1	14.6	10.3	3.7	69.3	6.1	4.1	9.3	6.4	25.6	6.0	11.6	9.3	3.3	10.1	9.4	23.7	7.0	6.5	9.0	13.9	20.6	7.4	39.2	12.2	26.4	10.8	12.9	6.0	11.4	8.9	2.6	8.3	9.5	30.1	4.8	5.9	34.4	8.9	12.9	32.0	19.4	6.4	15.1	13.1	16.8	5.3	16.1	9.4	13.9	6.6	74.6	8.8	11.3	16.6	5.7	3.8	10.3	14.1	6.2	16.3	8.0	18.3	18.5	5.6	18.6	14.4	0.1	6.5	2.0	8.5	7.3	10.4	6.8	8.3	8.2	9.7	6.7	8.5	10.1	0.3	6.3	9.0	10.0	8.2	5.8	5.0	8.5	7.9	8.1	5.3	5.7	7.0	8.1	7.1	6.1	0.0	4.1	13.4	6.8	7.1	4.5	5.9	7.6	4.0	2.3	7.0	3.9	98.8	1.7	9.6	11.6	3.8	6.0	0.0	7.0	89.2	5.4	7.1	0.0	36.0	19.5	11.1	5.2	7.4	10.0	25.3	6.6	6.5	0.0	78.5	6.8	3.9	6.2	2.9	13.1	3.6	3.4	12.9	5.9	31.1	18.5	5.5	190.6	7.5	13.3	6.4
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	9	"brain: 45.1"	"Group enriched"	"Detected in some"	13	"Alveolar cells type 1: 3.0;Ciliated cells: 2.7;Club cells: 5.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Group enriched"	"Detected in some"	13	"basal ganglia: 13.8;pons and medulla: 45.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"RT4: 8.9;SCLC-21H: 2.6"	"Group enriched"	"Detected in many"	4	"basal ganglia: 21.3;hypothalamus: 10.1;midbrain: 12.2;pons and medulla: 16.6;thalamus: 7.1"	"Region enhanced"	"Detected in some"		"pons and medulla: 26.3"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA			"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.3	2.4	0.1	1.6	13.8	0.0	0.3	0.1	0.4	3.3	5.2	0.1	0.3	2.3	1.6	0.7	1.0	0.2	0.5	1.2	0.2	2.2	0.9	0.2	0.9	0.0	0.3	0.5	0.8	0.5	0.0	0.1	0.0	45.1	0.8	2.5	1.0	0.9	4.2	0.1	0.1	2.5	3.1	10.0	0.1	1.7	0.3	0.8	0.0	4.0	0.3	0.1	4.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	2.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.8	0.1	0.4	0.2	2.2	0.3	0.5	45.1	0.8	3.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.7	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 77.3"	"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 20.8;Early spermatids: 5.8;granulocytes: 4.6;Late spermatids: 7.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 18.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"		NA	NA			"Actin filaments"	Cytosol	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	33.0	0.1	0.8	26.0	0.1	7.2	0.1	0.2	2.2	0.1	0.0	0.0	3.1	4.9	2.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	1.0	77.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	1.0	0.0	0.0	0.1	0.0	0.4	2.5	0.0	0.0	0.0	0.0	0.0	1.7	0.4	5.8	0.0	0.7	0.0	0.2	0.0	0.0	0.1	4.6	4.5	0.1	0.0	0.0	0.0	1.2	7.9	0.3	0.0	0.0	0.0	0.6	0.0	0.1	1.1	0.4	3.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0
SLC6A1	"GABATHG, GABATR, GAT1"	ENSG00000157103	"Solute carrier family 6 member 1"	P30531	3	10992186-11039249	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 56.2;liver: 75.6"	"Cell type enhanced"	"Detected in some"	16	"Cholangiocytes: 17.8;Hepatocytes: 24.5;Muller glia cells: 41.9;Sertoli cells: 12.9"	"Group enriched"	"Detected in some"	16	"glioma: 16.1;liver cancer: 24.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013341, CAB022293"	Enhanced		Uncertain	Mitochondria		No	NA			Mitochondria		"CAB022293: , HPA013341: AB_1849509"	"unprognostic (1.66e-3)"	"unprognostic (1.30e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (5.05e-6)"	"unprognostic (7.32e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.34e-2)"	1.8	2.1	32.2	1.6	31.0	3.0	1.8	15.1	56.2	2.0	1.7	25.4	0.0	1.7	1.9	3.9	4.3	2.4	2.3	3.3	22.2	16.6	2.1	75.6	2.5	1.7	22.7	25.3	2.4	1.4	9.3	1.0	2.0	17.0	2.1	1.8	1.7	1.6	5.0	3.3	1.7	1.7	1.8	13.7	1.9	1.7	4.4	14.3	0.5	1.9	0.0	1.7	1.9	0.9	1.0	0.8	1.2	0.3	0.2	0.8	0.2	0.8	0.6	1.9	1.3	1.5	0.4	1.1	0.7	0.2	0.8	1.1	1.5	1.0	1.6	0.3	0.4	1.8	1.3	2.3	0.9	0.7	0.2	1.8	1.3	4.6	2.8	0.7	2.2	2.3	1.1	0.2	0.2	1.3	0.5	0.3	1.7	1.1	3.7	0.2	1.1	0.7	1.8	0.8	1.2	1.4	1.2	0.2	0.1	0.6	1.8	0.8	0.3	1.0	0.7	0.2	1.1	1.0	1.0	0.3	0.8	0.5	0.7	0.7	1.1	0.3	1.2	0.9	1.7	0.4	0.3	0.3	1.1	0.5	0.1	0.8	0.9	0.6	0.5	0.3	1.0	0.3	0.5	1.2	0.2	0.3	0.8	0.3	0.2	32.2	31.0	15.1	41.5	22.2	16.6	22.7	25.3	17.0	14.3	0.0	0.3	0.0	0.0	0.2	1.8	1.4	17.8	0.0	1.2	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	24.5	0.0	0.0	0.0	0.0	1.0	0.2	5.2	0.0	0.0	0.0	0.0	41.9	0.0	0.0	9.6	0.1	3.3	12.9	2.1	5.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816200-10940733	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 37.0;esophagus: 10.5;skin 1: 11.5"	"Cell type enhanced"	"Detected in some"	19	"Bipolar cells: 7.9;Extravillous trophoblasts: 6.2;Muller glia cells: 21.8;Peritubular cells: 6.3"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 4.7;HaCaT: 12.7;Hep G2: 14.6;hTCEpi: 11.5;NTERA-2: 6.4;SH-SY5Y: 4.4;T-47d: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles		NA	NA			Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.8	0.8	11.5	0.7	14.1	0.8	2.9	3.1	23.0	0.9	0.8	5.0	0.0	0.7	1.7	1.1	10.5	1.8	0.7	0.8	8.4	24.5	0.7	0.9	0.8	0.7	37.0	5.9	0.8	1.0	0.7	0.2	1.6	35.4	2.3	0.8	0.4	1.1	0.7	1.0	11.5	0.8	1.0	10.4	1.5	0.7	3.4	9.2	0.0	0.8	0.2	1.1	1.3	0.7	0.5	0.3	1.2	0.4	0.2	0.3	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	12.7	0.0	2.1	0.0	0.0	0.2	0.2	0.0	14.6	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	2.9	1.8	4.4	3.7	0.1	0.0	0.1	4.8	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.5	0.2	0.2	1.2	0.2	0.4	0.3	0.3	0.0	11.5	14.1	3.1	14.7	8.4	24.5	37.0	5.9	35.4	9.2	0.0	0.0	0.0	0.2	1.1	7.9	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	3.1	0.0	0.0	0.0	0.0	21.8	0.3	0.0	6.3	0.0	1.3	0.0	0.0	0.2	1.5	3.1	0.8	0.0	0.0	1.5
SLC6A12	BGT-1	ENSG00000111181	"Solute carrier family 6 member 12"	P48065	12	190077-214570	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 22.1;liver: 59.3"	"Cell type enhanced"	"Detected in some"	18	"Collecting duct cells: 43.6;Hepatocytes: 17.4;monocytes: 17.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	57	"classical monocyte: 6.6;intermediate monocyte: 6.4;myeloid DC: 2.9;neutrophil: 3.7;non-classical monocyte: 8.6"	"Group enriched"	"Detected in many"	51	"dendritic cells: 2.9;granulocytes: 3.7;monocytes: 8.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.4;RPTEC TERT1: 17.0;SuSa: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034973	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA034973: AB_10610427"	"unprognostic (3.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (2.70e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-4)"	"unprognostic (3.35e-1)"	"unprognostic (4.31e-4)"	0.6	0.8	6.3	1.3	12.9	0.6	0.8	6.6	14.7	0.9	1.0	4.3	0.0	3.7	1.3	5.6	0.5	3.0	1.2	0.7	7.2	4.6	22.1	59.3	2.2	0.8	8.1	4.9	0.7	1.3	0.6	0.3	0.9	9.4	0.6	1.8	0.2	0.6	0.5	0.5	0.7	1.1	1.2	3.1	0.8	2.3	1.6	8.8	0.0	4.5	0.0	0.7	0.9	0.2	0.0	2.9	3.7	8.6	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	1.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	17.0	0.1	0.0	0.5	0.0	0.0	0.1	3.7	0.3	0.5	0.0	0.0	0.6	0.0	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.0	6.6	0.0	0.0	6.4	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	3.7	0.0	8.6	0.0	0.0	1.9	6.3	12.9	6.6	14.7	7.2	4.6	8.1	4.9	9.4	8.8	0.0	0.3	0.9	0.0	0.1	0.0	0.4	0.0	0.0	0.0	43.6	0.0	0.0	1.7	0.0	3.6	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	17.4	2.4	0.0	0.0	1.3	0.3	3.4	0.6	1.8	0.0	17.2	1.2	6.3	0.0	0.0	0.0	6.8	0.2	6.5	0.0	0.5	1.7	0.4	0.7	0.0	0.8	0.0
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"kidney: 77.6;retina: 95.9"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 261.2"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 10.0;SuSa: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA			Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.6	0.5	3.0	0.4	5.8	0.5	0.5	2.1	5.8	0.5	0.5	2.5	0.0	1.8	0.5	0.9	0.4	4.2	0.5	1.0	3.1	2.4	77.6	13.2	0.9	0.5	3.4	4.1	0.5	0.4	0.4	1.0	0.5	4.8	0.5	0.5	95.9	0.5	0.5	0.6	0.6	0.8	0.4	5.7	0.5	0.5	1.1	2.1	0.0	4.9	0.0	0.5	0.5	0.0	0.4	0.0	0.0	0.0	0.6	0.9	0.3	0.0	0.0	0.1	0.3	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.6	0.0	0.0	0.0	1.3	0.2	0.1	0.0	0.0	0.3	0.0	0.5	0.4	0.4	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.1	10.0	0.1	0.1	0.0	0.1	0.0	0.9	3.7	0.0	0.0	0.3	0.2	1.0	0.0	0.4	1.4	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.3	3.0	5.8	2.1	5.8	3.1	2.4	3.4	4.1	4.8	2.1	0.0	1.1	0.5	0.0	0.0	0.2	1.3	0.0	1.4	0.0	17.4	2.0	0.0	41.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	19.7	0.0	0.0	0.0	0.6	0.6	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	261.2	0.8	0.0	0.0	0.5	0.5	0.0	0.2	0.0	0.0	0.0
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436622-116461458	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 17.8;pituitary gland: 14.4;salivary gland: 26.3;tongue: 23.5"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 2: 100.3;Club cells: 33.0;Exocrine glandular cells: 28.5;Pancreatic endocrine cells: 101.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.8;Hep G2: 8.2;OE19: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003193	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	5.9	0.0	0.0	6.3	0.8	0.0	11.8	0.4	0.1	0.0	1.8	0.0	1.0	0.0	0.0		0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.2	0.5	0.3	0.0	26.3	5.8	0.0	1.1	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	23.5	1.2	1.0	1.0	0.4	0.2	1.1	0.4	0.3	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	3.8	8.2	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	3.0	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.2	0.0	1.4	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.5	0.4	0.1	0.3	0.4	0.2	0.2	0.1	0.4	0.3	0.3	0.4	0.3	0.2	0.2	0.1	0.0											20.8	100.3	0.0	0.1	0.1	0.0	0.2	0.0	10.7	33.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.2	0.0	28.5	0.0	0.0	5.2	3.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.1	0.0	101.5	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.0	3.2
SLC6A15	"FLJ10316, hv7-3, NTT73, SBAT1, V7-3"	ENSG00000072041	"Solute carrier family 6 member 15"	Q9H2J7	12	84859488-84913615	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 18.0;Horizontal cells: 11.1;Melanocytes: 30.4;Rod photoreceptor cells: 10.2"	"Cancer enhanced"	"Detected in some"		"melanoma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 31.1;ASC TERT1: 19.2;hTERT-HME1: 43.9;SCLC-21H: 30.0;SK-MEL-30: 22.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008609	Uncertain		Approved	Nucleoli,Vesicles		NA	NA			Nucleoli	Vesicles	"HPA008609: AB_1857190"	"unprognostic (1.01e-4)"	"unprognostic (9.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.65e-6)"	"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"unprognostic (7.65e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.69e-4)"	"unprognostic (2.57e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-3)"	1.4	4.5	18.0	2.2	16.2	1.0	2.3	17.8	31.0	1.7	2.2	5.4	0.0	1.4	2.8	1.1	6.7	1.2	1.3	1.0	10.9	18.2	1.5	1.0	1.3	1.1	10.3	16.9	2.1	1.0	1.0	5.6	8.9	14.7	1.8	1.8	9.2	1.4	1.5	1.0	4.9	2.1	1.6	4.9	1.1	1.3	3.6	12.8	0.0	2.0	1.8	1.8	1.1	1.5	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	3.6	0.0	31.1	19.2	0.0	0.0	6.5	0.5	0.3	0.0	0.0	0.0	0.0	0.2	4.1	0.4	0.0	8.3	0.0	0.0	9.5	0.0	1.5	0.0	11.5	0.0	0.2	10.7	16.0	4.2	43.9	8.5	0.1	0.0	0.0	0.0	7.9	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.0	7.8	0.0	9.9	22.1	0.1	0.0	0.0	0.0	4.7	2.5	0.0	0.0	0.0	0.0	0.0	8.2	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.0	16.2	17.8	18.6	10.9	18.2	10.3	16.9	14.7	12.8	0.0	0.0	0.0	0.0	2.4	18.0	0.4	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.1	11.1	0.0	0.0	0.0	0.2	0.0	0.0	30.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.2	0.0	0.2	0.1	0.4	0.5	0.2	0.0	0.0	0.0
SLC6A16	NTT5	ENSG00000063127	"Solute carrier family 6 member 16"	Q9GZN6	19	49289638-49325225	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"testis: 102.2"	"Cell type enhanced"	"Detected in many"	16	"Early spermatids: 81.2;Late spermatids: 36.5;Spermatocytes: 90.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 17.3;SuSa: 10.0"									HPA076812			Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA076812: AB_2686816"	"unprognostic (1.98e-1)"	"unprognostic (7.15e-3)"	"unprognostic (6.39e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.83e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.18e-2)"	1.5	0.4	0.8	1.1	0.9	1.9	1.0	0.8	0.8	1.3	1.1	0.8	0.8	0.3	1.5	1.0	0.8	2.0	1.0	0.8	0.8	0.3	2.0	3.6	1.6	3.1	0.8	0.8	2.9	2.6	0.7	0.8	1.3	0.8	1.8	0.3	0.9	0.8	1.2	0.8	0.7	1.2	0.8	0.8	1.7	1.0	102.2	0.8	0.8	1.1	0.8	2.4	0.8	1.2	7.8	2.1	4.8	3.7	3.8	3.1	2.2	0.0	6.8	17.3	6.2	0.3	2.8	3.1	0.9	1.4	0.6	1.9	0.4	0.5	8.0	1.1	0.7	0.3	0.2	1.9	0.3	2.1	1.3	2.0	0.7	0.7	1.5	1.3	0.5	2.9	2.7	1.1	1.3	0.9	5.1	1.5	1.4	1.5	1.1	2.2	1.5	0.4	0.5	6.1	0.3	0.9	0.3	4.2	1.5	0.9	0.0	0.2	0.3	2.7	0.1	0.6	10.0	2.8	0.2	8.6	1.4	6.6	4.0	0.0	3.8	4.0	7.2	0.1	1.9	0.4	0.4	0.8	4.8	3.1	2.2	3.0	7.8	1.1	3.1	0.8	4.5	2.7	1.8	4.0	3.8	3.7	2.1	1.7	2.2	0.8	0.9	0.8	0.8	0.8	0.3	0.8	0.8	0.8	0.8	0.0	0.6	3.7	0.8	1.3	6.3	1.2	2.5	17.4	0.0	1.8	2.0	0.0	10.0	0.6	81.2	3.9	0.0	0.0	0.5	0.0	1.6	0.4	1.1	4.9	0.7	0.0	0.0	1.3	0.3	36.5	3.4	0.8	5.0	0.0	0.0	0.5	0.3	0.0	3.2	0.0	1.3	0.0	7.2	90.2	2.1	1.1	0.0	0.5	0.0	0.2
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150486-110202202	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 53.5"	"Cell type enhanced"	"Detected in some"	22	"Bipolar cells: 2.1;Melanocytes: 10.1;Rod photoreceptor cells: 3.6"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 28.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008043, HPA008044"	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA008043: , HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	1.4	7.8	9.3	1.2	18.3	1.1	1.3	21.8	53.5	1.0	1.1	2.3	0.0	1.0	1.0	2.1	1.3	1.0	1.1	1.0	11.2	14.9	2.1	0.9	1.0	0.9	6.0	16.2	1.0	2.6	1.0	12.4	1.8	19.5	1.0	1.0	2.6	1.2	1.0	1.0	7.6	1.1	1.1	1.8	1.0	1.8	2.4	0.7	0.0	1.3	0.0	0.9	1.0	0.1	0.3	0.0	0.8	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	4.3	0.4	1.7	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.3	0.6	4.8	1.5	28.3	0.8	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	5.7	0.0	2.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	9.3	18.3	21.8	37.3	11.2	14.9	6.0	16.2	19.5	0.7	0.0	0.0	0.0	0.0	0.5	2.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	10.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	3.6	0.0	0.4	0.0	1.1	0.4	0.1	0.0	0.0	0.0
SLC6A18	"FLJ31236, Xtrp2"	ENSG00000164363	"Solute carrier family 6 member 18"	Q96N87	5	1225355-1246189	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	32	"kidney: 14.1"	"Group enriched"	"Detected in some"	71	"Distal tubular cells: 6.6;Proximal tubular cells: 21.3"	"Cancer enriched"	"Detected in single"	44	"renal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011885	Enhanced					NA	NA					"HPA011885: AB_1857198"			"unprognostic (2.02e-1)"										"unprognostic (5.69e-3)"	"unprognostic (2.90e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.3	0.0	0.4	0.6	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225117	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 167.3"	"Group enriched"	"Detected in some"	6	"Cholangiocytes: 63.7;Enterocytes: 25.3;Proximal tubular cells: 65.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 14.4;HEL: 17.6;OE19: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced					NA	NA					"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	55.3	0.0	0.0	44.6	0.1	0.0	0.1	0.1	30.0	0.1	0.1	0.1	28.7	0.5	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.5	1.7	0.0	0.1	0.0	0.1	0.1	167.3	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	4.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	63.7	0.0	1.2	1.8	0.0	0.0	1.7	0.0	0.1	0.0	25.3	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	5.8	0.0	65.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 20.4;placenta: 41.8"	"Group enriched"	"Detected in some"	5	"Early spermatids: 3.2;Extravillous trophoblasts: 6.9;Late spermatids: 3.7;Spermatocytes: 10.4;Syncytiotrophoblasts: 4.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in single"	27	"pons and medulla: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	30	"SH-SY5Y: 107.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 8.2"	"Region enriched"	"Detected in single"	32	"pons and medulla: 23.1"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA			Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	2.4	20.4	0.3	0.1	0.1	0.0	1.8	0.1	0.3	3.2	0.3	0.3	0.1	0.0	4.5	7.2	0.8	0.4	0.4	0.1	0.1	0.0	0.4	1.0	0.5	0.1	0.1	0.1	0.2	0.1	0.0	0.1	41.8	9.7	0.5	0.1	0.1	1.6	1.7	0.1	11.4	0.4	1.0	0.2	0.1	0.2	8.3	0.2	0.1	0.2	0.9	0.5	0.5	1.7	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.8	107.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.0	0.1	0.1	9.7	0.2	0.0	0.0	0.0	0.1	1.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	0.0	6.9	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.1	0.4	4.7	0.0	0.0	0.0
SLC6A20	"XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755450-45796535	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 14.3;intestine: 25.5;retina: 51.3"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 5.3;Cholangiocytes: 12.7;Ductal cells: 10.1;Pancreatic endocrine cells: 6.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"HaCaT: 3.1;OE19: 7.1;SuSa: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029873	Uncertain					NA	NA					"HPA029873: AB_10602403"	"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.3	0.1	0.3	0.6	0.8	0.5	0.7	1.5	2.2	2.4	11.2	3.0	0.4	22.3	1.3	1.7	0.1	0.4	14.3	0.1	0.5	0.4	3.3	0.2	1.9	0.2	1.0	1.7	0.1	5.1	0.0	2.0	0.1	6.1	1.0	0.2	51.3	1.3	0.1	0.9	0.6	25.5	0.3	1.5	0.1	4.7	0.4	0.3	0.0	0.1	0.4	0.1	0.2	0.3	0.8	0.7	2.6	0.2	0.5	0.4	0.1	0.2	0.4	0.4	0.4	0.1	0.0	0.5	0.1	0.0	0.0	0.0	1.6	1.4	0.2	1.1	0.0	0.3	3.1	0.1	0.0	0.2	0.1	0.2	1.3	1.2	0.2	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.2	0.0	0.5	0.2	0.5	0.0	0.3	0.5	0.3	1.4	7.1	0.3	0.5	0.1	0.4	0.2	0.3	0.4	0.4	1.5	0.2	0.0	10.3	0.3	0.1	0.1	0.5	0.4	0.4	0.3	0.8	0.3	0.1	0.2	0.3	0.1	1.0	0.2	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.8	0.4	0.3	2.6	0.5	0.1	0.7	0.1	0.1	0.3	0.8	1.5	2.2	0.5	0.4	1.0	1.7	6.1	0.3	0.0	5.3	0.0	0.4	0.5	0.0	0.8	12.7	0.0	2.3	0.0	0.0	0.0	0.0	10.1	0.5	0.0	2.6	0.0	0.2	0.1	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	6.2	0.0	1.1	1.4	0.0	0.0	0.2	0.2	0.1	0.3	0.0	0.0	0.4	0.4
SLC6A3	"DAT, DAT1"	ENSG00000142319	"Solute carrier family 6 member 3"	Q01959	5	1392790-1445430	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 48.4"	"Cell type enriched"	"Detected in single"	5	"Alveolar cells type 2: 2.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 25.7"	"Region enriched"	"Detected in some"	47	"midbrain: 48.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 1.2;RPMI-8226: 2.1;SCLC-21H: 3.8"	"Group enriched"	"Detected in some"	8	"midbrain: 96.4;thalamus: 31.8"	"Region enriched"	"Detected in single"	138	"midbrain: 362.2"	"HPA012763, HPA013602, CAB016249, CAB078172"	Enhanced	Supported	Approved	Vesicles		NA	NA			Vesicles		"CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484"	"unprognostic (2.25e-4)"	"unprognostic (2.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-5)"	"unprognostic (9.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.40e-7)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.74e-2)"	0.2	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.0	0.0	0.0	0.3	1.1	0.8	0.1	0.8	0.6	0.1	0.0	0.6	0.3	0.0	3.4	0.0	48.4	0.0	1.5	0.0	0.0	0.0	0.1	1.0	0.7	0.0	1.7	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.8	0.0	2.4	2.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.0	0.1	3.8	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.6	48.4	0.0	1.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.0;lung: 50.5"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 90.5;Syncytiotrophoblasts: 89.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enriched"	"Detected in single"	36	"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.9;CACO-2: 5.5;Hep G2: 14.7"	"Region enriched"	"Detected in some"	5	"midbrain: 69.9"	"Low region specificity"	"Detected in all"			"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.1	6.3	0.1	0.3	1.6	0.9	0.1	0.7	0.1	0.1	0.3	0.1	50.5	0.1	0.1	0.1	0.1	0.6	0.0	0.1	11.3	11.2	0.1	0.0	0.2	0.7	0.1	0.1	0.4	25.0	0.4	0.1	0.1	0.5	0.3	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.0	0.1	1.0	0.2	0.4	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	5.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	14.7	1.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	1.0	0.0	0.7	0.8	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.0	0.4	0.2	0.1	0.0	2.3	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	11.2	0.1	14.9	5.3	0.0	0.4	0.1	0.2	0.8	0.0	1.4	3.4	1.8	0.0	90.5	0.0	0.0	2.3	0.5	1.0	0.0	0.0	7.0	1.6	0.3	2.3	0.0	8.4	0.0	0.0	2.5	0.6	1.0	0.3	0.4	0.0	0.0	0.0	0.5	0.5	0.0	0.4	0.3	0.9	0.0	1.4	0.0	0.4	0.3	89.0	0.0	0.0	0.3
SLC6A5	"GLYT2, NET1"	ENSG00000165970	"Solute carrier family 6 member 5"	Q9Y345	11	20599400-20659285	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 21.3"	"Group enriched"	"Detected in some"	27	"Early spermatids: 20.8;Late spermatids: 40.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	6	"pons and medulla: 21.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"SCLC-21H: 2.6"	"Region enriched"	"Detected in some"	9	"pons and medulla: 51.6"	"Region enriched"	"Detected in some"	9	"pons and medulla: 33.2"	CAB079052		Supported				NA	NA					"CAB079052: "					"unprognostic (6.94e-2)"	"unprognostic (2.28e-1)"									"unprognostic (4.75e-2)"			0.0	0.1	0.1	0.1	0.0	0.0	0.0	3.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	5.1	0.1	0.1	0.0	0.0	0.0	0.0	2.2	0.0	21.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	6.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.4	0.3	0.1	0.1	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 76.4"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 502.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 33.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 33.2"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.2	25.9	5.7	18.0	16.5	46.4	8.1	11.1	12.2	11.3	9.5	8.7	3.6	8.5	14.5	4.4	7.0	7.0	14.5	23.2	5.6	4.6	16.6	2.3	18.6	12.9	18.0	7.6	31.3	2.8	3.8	9.6	18.0	13.3	5.0	4.1	76.4	15.7	7.7	26.6	16.8	22.2	8.2	11.1	20.3	14.0	4.0	12.6	6.2	10.4	11.3	11.2	8.8	6.1	1.6	1.9	33.2	6.9	0.7	3.9	2.3	4.6	17.3	6.2	4.7	8.1	2.5	12.8	7.0	27.8	8.3	6.1	6.3	8.0	13.5	6.4	11.0	12.0	3.7	4.2	5.7	7.4	1.5	5.2	12.8	22.7	9.4	0.2	3.5	27.8	1.3	1.7	7.6	2.0	7.2	9.0	6.3	7.1	2.7	7.3	4.9	9.8	6.8	9.6	6.5	5.0	7.0	7.4	21.1	45.5	9.7	11.5	4.1	5.2	2.8	1.5	24.4	10.7	1.9	22.7	10.6	5.7	2.6	5.0	3.0	3.4	5.0	24.7	6.9	32.4	2.5	5.1	5.0	1.3	4.2	0.7	1.6	1.4	1.7	1.9	0.9	0.2	0.3	33.2	0.7	6.9	0.7	3.9	2.3	5.7	16.5	11.1	12.2	5.6	4.6	18.0	7.6	13.3	12.6	6.0	22.1	4.7	11.2	43.8	102.1	3.6	2.5	12.0	12.5	19.2	538.0	2.2	0.0	9.6	17.0	16.1	0.7	0.0	7.1	12.8	16.4	5.5	12.7	0.4	26.7	9.5	13.8	11.6	62.5	13.3	16.1	47.4	16.9	129.0	2.9	28.2	21.5	2.9	16.3	26.3	502.9	0.0	8.2	0.5	1.5	20.8	4.2	22.4	1.2	10.6
SLC6A7	PROT	ENSG00000011083	"Solute carrier family 6 member 7"	Q99884	5	150189957-150222788	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 40.2"	"Cell type enhanced"	"Detected in some"	18	"Enterocytes: 2.1;Intestinal endocrine cells: 3.5;Mucus-secreting cells: 4.8;Paneth cells: 8.6;Undifferentiated cells: 3.4"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.6;HeLa: 1.8;SK-BR-3: 1.4;U-87 MG: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028907	Uncertain					NA	NA					"HPA028907: AB_10602404"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.82e-4)"	"unprognostic (6.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.73e-4)"	"unprognostic (8.11e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.70e-3)"	0.5	0.4	3.9	1.0	9.7	0.4	0.5	40.2	22.4	0.6	5.7	0.3	0.0	2.6	0.5	0.6	0.4	0.4	0.5	0.5	6.5	4.5	0.4	0.4	0.5	0.7	1.3	14.5	0.4	0.5	0.4	0.2	0.4	1.6	0.4	7.7	0.0	0.8	0.4	0.5	0.5	4.9	0.7	1.4	0.4	0.4	0.5	0.0	0.0	0.4	0.0	0.7	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.2	0.3	0.0	0.0	0.0	1.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	9.7	40.2	22.4	6.5	4.5	1.3	14.5	1.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	3.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.8	0.0	0.1	8.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	3.4	0.1
SLC6A8	"CRTR, CT1"	ENSG00000130821	"Solute carrier family 6 member 8"	P48029	X	153688099-153696593	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Bipolar cells: 127.1;Enterocytes: 208.5;Horizontal cells: 112.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	4	"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 42.8;SK-BR-3: 44.4"															NA	NA						"unprognostic (5.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (2.87e-1)"	17.6	19.5	26.3	5.8	39.0	19.3	7.3	23.9	31.9	6.1	26.8	36.6	7.6	32.4	11.2	9.1	20.0	10.6	20.2	53.1	29.3	16.1	27.3	1.9	3.1	1.9	55.6	22.0	5.1	8.3	17.0	7.2	22.6	25.8	12.8	20.2	20.9	31.8	24.9	76.4	28.0	48.3	13.5	28.2	5.1	11.0	16.7	38.9	4.6	2.8	11.0	5.0	40.4	10.1	0.5	0.0	2.6	0.2	0.0	0.0	0.1	40.6	1.7	12.5	42.8	4.0	2.8	2.9	6.1	10.1	7.9	9.8	5.2	0.5	0.0	4.7	7.3	9.3	15.1	25.0	21.0	4.9	0.7	23.8	0.1	14.1	15.5	13.9	0.3	2.8	5.9	4.5	7.9	28.7	15.0	3.9	0.2	9.9	0.6	4.4	2.4	0.2	0.9	12.8	8.1	17.9	1.9	1.4	0.5	8.6	7.9	16.1	18.0	8.9	44.4	28.8	3.0	8.6	6.2	3.9	13.1	20.9	16.8	18.0	1.5	0.7	0.4	29.3	1.2	13.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	26.3	39.0	23.9	30.4	29.3	16.1	55.6	22.0	25.8	38.9	0.0	3.4	2.7	10.6	20.6	127.1	89.0	25.5	8.1	0.0	5.2	104.1	11.0	3.3	3.6	0.6	5.6	208.5	23.3	18.9	27.8	11.2	21.2	4.6	0.8	4.3	112.8	24.9	4.9	1.3	2.2	8.3	1.6	23.6	5.4	32.8	17.4	55.3	41.8	7.8	49.9	48.6	32.3	15.3	2.9	2.8	13.7	76.0	0.0	15.7	17.6
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.2;skin 1: 38.2"	"Cell type enhanced"	"Detected in many"	16	"Bipolar cells: 26.6;Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.9;hTCEpi: 41.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	2.9	22.8	8.8	4.6	18.3	8.6	5.4	5.5	14.3	6.0	7.9	38.1	2.6	2.5	6.2	1.5	16.5	9.6	4.9	1.3	9.9	10.0	2.0	4.9	5.6	1.4	29.5	4.5	4.0	7.8	2.1	1.0	1.7	26.8	2.6	6.2	24.0	7.9	6.1	1.3	38.2	5.6	8.9	42.2	1.1	3.5	1.2	26.3	0.0	4.9	7.2	4.3	6.6	10.9	0.2	0.0	0.2	0.1	0.0	1.4	0.2	7.3	5.5	2.7	7.0	4.4	1.5	6.2	5.9	15.9	9.6	11.9	1.8	2.9	0.1	0.6	16.3	0.0	23.9	4.2	4.7	1.9	0.0	0.7	6.5	13.1	2.1	20.2	1.4	0.3	4.5	41.9	4.7	11.2	6.0	0.2	4.7	5.0	18.8	0.4	4.0	1.0	0.0	2.1	2.8	7.4	0.8	0.0	8.4	0.9	0.8	1.7	1.6	3.0	13.7	2.7	0.7	3.6	3.9	0.1	1.1	4.5	0.9	3.0	20.8	14.3	1.6	3.6	0.0	1.4	0.0	0.0	0.2	0.4	0.1	0.2	0.2	0.4	0.0	0.0	0.0	1.4	0.3	0.2	0.0	0.0	0.0	0.0	0.2	8.8	18.3	5.5	9.4	9.9	10.0	29.5	4.5	26.8	26.3	0.0	1.3	0.9	0.7	6.6	26.6	0.6	5.1	8.1	0.0	1.8	15.7	0.4	0.0	3.2	5.8	0.4	9.8	70.0	7.9	0.7	0.9	1.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.4	1.4	0.0	3.3	1.8	2.9	1.2	4.2	2.0	1.4	1.0	10.2	6.5	6.3	0.0	0.4	11.3	0.5	0.0	1.3	2.5
SLC7A1	"ATRC1, CAT-1, ERR, HCAT1, REC1L"	ENSG00000139514	"Solute carrier family 7 member 1"	P30825	13	29509410-29595688	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 42.8"	"Cell type enhanced"	"Detected in many"	4	"Collecting duct cells: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039721, HPA077838"	Approved					NA	NA					"HPA039721: AB_10672893, HPA077838: "	"unprognostic (1.85e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.20e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.37e-3)"	5.7	4.5	8.5	9.0	11.7	8.6	7.0	8.7	19.6	8.1	8.7	10.7	7.5	9.0	7.3	9.6	42.8	6.9	4.8	6.2	12.2	10.4	4.3	2.4	4.4	7.1	11.4	7.7	5.3	26.6	2.9	6.4	12.9	20.0	7.2	6.8	6.1	16.2	12.6	2.1	14.8	12.9	8.1	11.9	5.7	10.0	8.8	6.9	5.3	8.6	27.7	16.2	6.4	8.3	2.0	3.7	0.5	2.8	0.8	3.3	1.7	12.2	9.9	8.7	17.5	4.5	9.0	9.9	26.2	17.5	22.7	16.9	20.0	21.6	24.3	7.1	39.9	25.4	56.3	15.1	18.5	30.0	22.8	9.0	18.2	10.8	10.8	23.4	26.4	12.0	11.4	39.6	25.2	29.9	5.3	11.1	27.8	11.6	11.4	9.5	16.5	19.2	7.1	8.3	21.8	6.6	13.3	18.0	13.9	14.4	8.2	29.7	14.1	14.9	14.6	23.7	5.7	6.4	22.5	10.4	17.9	12.5	15.7	18.7	12.8	9.2	27.7	14.3	10.7	18.0	0.0	1.1	0.5	3.3	1.2	2.7	2.0	2.4	2.7	1.8	1.4	1.9	3.1	0.0	0.8	2.8	3.7	1.9	1.7	8.5	11.7	8.7	15.9	12.2	10.4	11.4	7.7	20.0	6.9	0.0	5.3	14.9	42.8	44.3	15.1	6.7	10.2	5.3	12.5	68.0	15.7	0.4	1.7	19.5	0.2	14.3	16.1	23.3	49.3	31.4	9.3	41.6	6.9	0.8	6.1	23.8	29.9	3.7	4.3	0.4	5.8	5.2	8.5	4.6	28.0	3.4	45.4	24.5	3.5	0.0	17.8	6.5	9.9	0.5	2.1	30.6	3.3	4.9	24.5	38.1
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.9;brain: 13.6;breast: 15.6"	"Group enriched"	"Detected in some"	5	"Muller glia cells: 1.8;Spermatogonia: 1.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 4.3;HHSteC: 2.6;HSkMC: 3.7;THP-1: 8.4;U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA			"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	40.9	1.0	9.8	1.9	13.6	1.0	15.6	2.4	12.1	1.0	2.2	0.8	0.0	1.0	1.0	1.0	1.0	1.0	1.0	1.1	4.7	6.2	1.3	1.0	1.0	1.2	7.6	5.0	1.0	1.2	1.0	0.0	1.2	9.0	1.0	1.0	8.4	2.3	1.0	1.0	1.1	1.0	1.1	0.8	1.0	1.0	1.4	1.8	0.0	1.4	0.0	1.4	1.0	1.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.2	8.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.8	13.6	2.4	12.1	4.7	6.2	7.6	5.0	9.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.1	0.0	0.0	0.0
SLC7A11	xCT	ENSG00000151012	"Solute carrier family 7 member 11"	Q9UPY5	4	138164097-138242349	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.2"	"Cell type enhanced"	"Detected in many"	13	"Glandular cells: 37.7;monocytes: 90.2;Muller glia cells: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 3.8"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 3.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 28.6;TIME: 31.4;WM-115: 46.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064215			Approved	Vesicles		NA	NA			Vesicles		"HPA064215: AB_2685213"	"unprognostic (3.55e-3)"	"unprognostic (4.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.07e-8)"	"unprognostic (1.98e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.22e-8)"	"unprognostic (3.81e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.54e-2)"	1.1	0.9	16.3	4.7	15.8	2.2	1.5	8.2	26.0	2.4	2.0	17.9	0.0	1.5	1.3	13.4	3.3	8.9	3.8	2.5	17.4	6.9	0.9	0.9	2.3	1.5	12.6	16.8	1.7	5.4	1.0	1.2	2.1	17.2	2.0	2.8	0.3	1.6	1.0	0.8	1.9	1.4	1.0	27.2	1.4	9.2	2.2	14.0	0.0	8.9	6.0	2.2	4.0	0.8	0.1	3.8	0.4	0.0	0.1	0.0	0.0	1.6	13.8	6.2	4.8	1.3	1.7	1.7	7.6	5.3	1.7	4.0	1.5	5.8	3.1	10.0	26.5	9.4	2.2	3.3	6.5	7.4	5.9	0.7	2.2	13.1	3.4	20.6	5.8	2.1	4.1	28.6	4.9	22.1	2.6	21.6	3.2	3.0	8.2	9.1	1.2	0.8	0.5	1.2	8.1	3.9	0.9	2.0	3.6	1.0	6.6	2.5	0.5	3.3	0.9	11.7	1.4	1.5	12.4	31.4	2.3	6.5	3.4	6.0	6.9	3.1	3.2	3.9	3.2	46.1	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	3.8	0.0	0.0	16.3	15.8	8.2	15.9	17.4	6.9	12.6	16.8	17.2	14.0	0.0	5.9	3.7	7.0	4.0	4.0	3.6	2.5	1.4	3.4	0.0	2.0	2.2	0.0	3.6	2.1	1.6	1.1	0.0	21.4	0.5	1.0	37.7	4.6	0.4	0.5	1.6	25.9	3.7	0.0	0.4	2.3	9.0	5.0	90.2	5.4	48.4	27.4	1.1	2.1	0.0	1.9	0.0	1.0	0.7	0.7	2.8	0.9	0.0	1.3	11.1
SLC7A13	"AGT-1, XAT2"	ENSG00000164893	"Solute carrier family 7 member 13"	Q8TCU3	8	86214052-86321146	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	12	"kidney: 31.7"	"Cell type enhanced"	"Detected in some"	31	"Collecting duct cells: 1.8;Distal tubular cells: 3.3;Proximal tubular cells: 8.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (3.34e-1)"						"unprognostic (2.62e-1)"					"unprognostic (1.12e-1)"	"unprognostic (2.96e-5)"					0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	31.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.6	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.2	0.1	0.0	1.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459584-170586074	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 33.4;pituitary gland: 14.5"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 31.5;Horizontal cells: 27.0"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 7.2;SCLC-21H: 7.2;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	1.1	5.8	12.1	1.9	17.7	1.4	1.1	14.9	33.4	1.0	1.8	8.0	0.0	1.6	1.1	1.2	1.1	1.1	1.3	1.1	11.5	12.1	1.3	1.2	1.1	1.1	6.7	12.8	1.3	2.4	1.1	14.5	1.1	11.8	1.2	1.9	0.1	1.1	1.1	1.2	1.3	1.7	1.3	9.0	1.1	1.5	1.3	6.3	0.0	1.1	0.0	1.1	1.1	0.3	1.0	0.6	2.1	0.5	0.7	0.6	0.1	0.0	0.0	0.4	0.1	1.3	2.0	0.1	0.6	0.2	0.8	0.8	0.1	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	1.8	0.0	0.1	1.3	0.8	0.2	0.1	0.0	0.2	7.2	0.0	0.0	0.2	1.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	7.2	2.1	0.0	0.1	0.0	0.3	0.1	0.1	1.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	2.1	0.5	0.5	0.4	0.3	0.3	0.8	0.3	0.3	0.1	1.0	0.6	0.5	1.2	0.7	0.3	0.6	0.3	0.1	12.1	17.7	14.9	16.9	11.5	12.1	6.7	12.8	11.8	6.3	3.0	2.1	0.0	0.3	0.3	31.5	0.8	0.0	5.3	4.5	0.0	2.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.5	0.2	2.3	1.0	0.0	27.0	1.7	0.0	0.0	0.4	2.0	0.9	3.3	0.0	0.0	1.8	0.1	0.0	2.5	0.0	3.9	0.0	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8"	"Cell type enhanced"	"Detected in many"	11	"Hepatocytes: 230.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 67.7;RT4: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"		NA	NA			"Plasma membrane"	"Cell Junctions"	"HPA009277: AB_2668229"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.65e-7)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	10.6	3.8	8.6	1.4	3.4	0.1	18.0	2.5	8.3	11.5	2.5	2.4	2.9	0.8	6.4	11.8	3.7	13.6	5.1	9.7	6.8	0.9	3.8	68.1	3.3	2.8	4.4	3.5	35.1	32.2	78.2	3.0	29.0	9.1	4.9	1.5	13.0	2.4	3.3	57.8	3.3	2.0	4.3	10.9	1.8	3.3	7.7	3.5	0.0	14.3	10.4	1.2	3.4	6.4	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.9	0.3	10.4	0.0	0.1	11.3	0.0	7.0	0.5	0.6	3.3	0.0	0.0	2.4	0.0	1.5	0.0	7.5	1.7	2.4	0.0	3.9	0.0	8.1	7.2	67.7	3.1	0.0	9.1	1.4	8.8	8.4	0.0	3.2	0.0	0.0	0.0	7.9	11.0	0.4	3.6	3.8	2.3	0.9	0.0	5.2	5.4	0.8	17.4	0.1	1.4	0.5	0.2	3.1	8.0	0.0	0.3	7.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.6	3.4	2.5	8.3	6.8	0.9	4.4	3.5	9.1	3.5	11.9	63.8	0.0	6.1	7.3	1.8	14.3	33.1	84.3	27.3	7.0	33.4	17.0	0.0	4.5	10.8	5.2	0.1	0.0	79.6	13.8	18.2	28.5	2.3	230.6	4.7	0.0	84.5	6.7	6.9	17.4	35.1	1.5	3.3	1.0	2.2	15.0	29.6	0.0	26.2	1.8	38.5	58.2	52.8	0.4	0.4	3.3	21.7	2.5	2.6	1.8
SLC7A3	"ATRC3, CAT-3, FLJ14541"	ENSG00000165349	"Solute carrier family 7 member 3"	Q8WY07	X	70925582-70931125	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 45.5"	"Group enriched"	"Detected in some"	6	"Early spermatids: 5.3;Late spermatids: 1.9"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 43.0"	"Region enhanced"	"Detected in many"		"hypothalamus: 6.7"	"Cell type enriched"	"Detected in single"	16	"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	16	"T-cells: 1.5"	"Group enriched"	"Detected in some"	4	"HAP1: 20.7;NTERA-2: 42.6;SuSa: 53.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.42e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.45e-2)"			"unprognostic (1.45e-2)"		"unprognostic (3.66e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.89e-1)"		"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (5.42e-4)"	"unprognostic (3.57e-2)"	0.1	0.0	1.0	0.1	1.0	1.3	1.4	0.1	2.1	2.0	0.1	1.1	0.8	0.1	9.1	6.2	0.7	2.7	0.1	0.0	1.2	6.7	0.2	0.0	0.1	0.5	0.5	0.5	1.7	0.0	0.0	0.6	0.0	1.2	10.4	0.0	0.5	0.2	9.4	0.0	0.0	0.3	4.6	0.2	0.1	5.6	2.4	0.4	45.5	0.0	0.2	0.5	4.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.1	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	42.6	0.0	0.0	8.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	1.0	1.0	0.1	2.1	1.2	6.7	0.5	0.5	1.2	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0
SLC7A4	"CAT-4, HCAT3, VH"	ENSG00000099960	"Solute carrier family 7 member 4"	O43246	22	21028718-21032840	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 19.6;testis: 29.1"	"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 6.0;Cytotrophoblasts: 9.1;granulocytes: 4.6;Mucus-secreting cells: 7.9;Syncytiotrophoblasts: 8.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.4;naive CD8 T-cell: 2.4"	"Group enriched"	"Detected in many"	18	"NK-cells: 1.0;T-cells: 2.4"	"Cell line enriched"	"Detected in some"	21	"BEWO: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031023	Enhanced					NA	NA					"HPA031023: AB_10669669"	"unprognostic (1.02e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	2.7	3.5	2.2	0.4	3.8	0.1	2.6	6.0	5.9	2.8	1.8	0.4	1.4	1.7	1.5	0.7	8.5	1.6	4.1	1.2	2.7	7.1	0.2	0.3	1.4	1.2	2.4	4.3	0.3	0.4	0.1	5.1	19.6	2.4	4.1	1.4	3.3	4.3	5.3	0.6	1.9	2.0	0.6	0.6	0.9	2.4	29.1	0.4	0.2	0.1	1.3	2.1	2.4	0.7	0.0	0.0	0.0	0.0	1.0	2.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.4	0.0	0.2	1.2	0.0	0.0	0.1	2.4	0.0	1.0	0.0	0.0	0.0	0.8	2.2	3.8	6.0	5.9	2.7	7.1	2.4	4.3	2.4	0.4	6.0	3.4	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.1	0.0	0.1	0.0	0.4	2.8	0.1	0.4	4.6	0.0	1.2	0.0	1.2	1.8	0.0	1.3	1.7	0.0	0.0	0.0	7.9	1.8	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.2	0.0	8.5	0.0	0.6	0.1
SLC7A5	"CD98, D16S469E, E16, LAT1, MPE16"	ENSG00000103257	"Solute carrier family 7 member 5"	Q01650	16	87830023-87869488	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 71.2"	"Cell type enhanced"	"Detected in many"	5	"Erythroid cells: 70.0;granulocytes: 68.9;Intestinal endocrine cells: 82.6;Smooth muscle cells: 85.8;Syncytiotrophoblasts: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"plasmacytoid DC: 15.9"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 108.7;hTCEpi: 186.8;MCF7: 101.2;SiHa: 153.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052673, HPA056077"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"HPA052673: AB_2681909, HPA056077: AB_2683031"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.93e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.19e-3)"	8.2	3.2	18.3	14.7	24.5	71.2	4.3	15.9	45.8	7.9	4.6	16.7	8.9	6.2	5.3	30.4	38.7	3.3	6.4	8.2	19.8	22.1	3.6	9.7	3.8	11.1	23.9	9.6	5.1	12.1	1.5	9.0	28.4	23.4	4.3	3.4	34.9	11.5	15.4	11.2	10.7	5.7	4.8	17.7	6.4	12.7	34.9	19.8	3.7	4.2	16.7	15.0	11.5	7.7	0.5	15.9	0.6	0.0	0.2	1.4	0.4	14.9	56.6	1.1	15.9	0.4	0.9	40.8	12.0	4.3	7.3	4.7	36.9	21.4	13.7	10.6	15.2	2.5	67.4	11.7	108.7	5.1	14.3	5.9	11.2	53.1	26.4	17.1	10.4	20.7	3.0	186.8	9.0	66.8	2.4	1.4	48.5	16.7	15.3	5.8	101.2	12.5	15.3	5.2	9.4	13.8	12.2	4.3	20.9	8.1	1.2	9.1	3.6	153.4	30.7	32.9	10.8	14.1	13.8	1.1	2.6	17.1	10.6	9.3	20.0	16.3	59.1	10.1	25.9	24.4	0.6	0.0	0.0	1.0	0.0	1.2	0.5	0.5	0.8	0.3	0.0	0.1	0.4	0.1	0.2	0.0	15.9	1.4	0.4	18.3	24.5	15.9	28.1	19.8	22.1	23.9	9.6	23.4	19.8	0.0	1.1	16.4	11.1	65.1	12.7	2.8	2.5	0.0	0.0	1.8	15.7	12.4	0.0	16.8	0.8	4.3	1.7	70.0	8.0	28.4	10.4	13.9	68.9	14.5	8.2	9.5	82.6	2.5	3.5	4.0	1.7	6.6	37.1	2.8	2.8	13.3	19.5	0.2	1.4	0.5	50.1	0.0	85.8	1.7	2.5	32.9	89.8	8.6	1.6	26.1
SLC7A6	"KIAA0245, LAT-2, LAT3, y+LAT-2"	ENSG00000103064	"Solute carrier family 7 member 6"	Q92536	16	68264516-68301823	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 58.8"	"Cell type enhanced"	"Detected in many"	4	"Alveolar cells type 1: 38.7;Syncytiotrophoblasts: 40.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050713	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA050713: AB_2681218"	"unprognostic (6.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.84e-4)"	25.9	7.6	5.4	12.9	6.7	6.9	18.7	9.0	8.0	5.3	7.1	3.4	6.7	3.6	5.5	14.0	4.0	7.1	4.7	13.1	5.3	3.3	5.4	2.3	9.8	16.3	3.3	4.6	3.0	3.2	2.5	11.1	16.3	5.4	6.6	10.8	9.0	5.8	5.1	58.8	8.4	9.4	8.3	3.4	9.4	5.3	5.2	3.7	31.8	15.0	8.0	19.6	5.7	8.0	7.2	16.2	5.9	3.6	6.7	12.6	1.7	9.4	9.7	7.2	7.7	21.4	12.8	20.3	11.1	8.1	16.6	13.9	41.3	7.2	18.8	8.8	14.2	4.8	14.5	14.0	13.9	18.1	3.8	10.0	10.0	19.1	13.1	3.9	11.8	9.1	8.6	12.2	12.9	6.5	5.3	11.1	9.8	14.7	3.4	9.0	5.1	15.3	8.2	5.4	6.4	3.5	19.5	4.5	15.8	5.8	8.3	10.6	5.8	32.1	9.0	3.8	6.3	13.5	6.4	16.3	11.0	8.4	9.2	13.9	7.2	13.5	21.5	7.0	8.7	7.4	2.5	3.6	3.0	4.9	1.7	6.1	6.6	7.3	4.6	3.4	7.2	12.6	7.4	5.9	6.7	1.4	16.2	3.1	1.7	5.4	6.7	9.0	8.0	5.3	3.3	3.3	4.6	5.4	3.7	38.7	16.8	11.1	8.0	17.4	3.7	17.3	0.0	8.1	3.4	17.4	35.3	20.4	0.0	3.0	4.0	9.0	4.2	0.0	3.4	1.6	10.5	3.0	4.6	1.3	12.0	9.5	2.4	7.4	6.7	14.6	5.5	7.5	10.1	3.6	8.9	2.1	4.1	6.2	3.5	0.3	2.6	0.0	7.3	14.2	9.4	19.2	40.0	17.5	6.9	2.3
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 63.8;intestine: 93.5;kidney: 67.3"	"Cell type enhanced"	"Detected in many"	13	"Hofbauer cells: 200.4;Kupffer cells: 312.3;Macrophages: 142.1;Proximal tubular cells: 254.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 59.5;non-classical monocyte: 63.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 63.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 44.5;CACO-2: 72.0;EFO-21: 15.6;OE19: 63.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced					NA	NA					"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	10.4	2.8	1.9	8.3	3.1	3.6	3.2	0.7	2.7	2.6	48.0	4.1	0.2	24.1	2.7	2.3	2.1	4.6	7.6	3.0	2.2	1.6	67.3	6.5	15.3	20.5	3.7	1.0	2.6	2.7	26.3	1.0	6.5	3.2	2.7	3.4	2.1	3.3	0.9	1.6	1.8	93.5	3.5	4.5	32.4	3.0	13.4	2.7	2.1	2.8	0.8	5.7	4.1	3.6	3.0	14.6	5.4	63.8	0.0	0.1	17.8	0.0	2.4	0.2	0.1	0.4	0.8	44.5	0.5	3.6	0.1	0.3	72.0	7.3	3.5	15.6	0.3	0.2	2.7	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.7	2.1	0.3	0.3	1.6	0.2	0.2	0.1	0.3	5.5	0.2	0.0	2.8	0.5	0.1	0.0	0.3	0.7	63.3	0.0	0.6	7.8	2.1	0.1	0.2	0.0	0.1	0.1	0.1	0.5	2.1	0.1	1.7	0.3	0.1	0.3	0.1	0.1	0.6	0.1	1.8	0.2	0.1	0.0	0.0	41.2	0.1	0.0	59.5	0.0	3.0	0.0	0.0	14.6	2.3	0.1	0.0	5.4	0.0	63.8	0.5	0.1	17.8	1.9	3.1	0.7	2.7	2.2	1.6	3.7	1.0	3.2	2.7	11.9	10.3	23.7	0.1	0.9	0.0	0.8	58.6	9.4	4.5	3.5	0.0	1.0	10.0	6.7	40.8	4.5	8.6	0.0	5.8	4.5	4.8	0.2	1.1	1.3	200.4	0.0	1.2	22.1	312.3	7.5	3.4	142.1	5.0	34.3	0.4	0.5	7.3	0.0	0.0	254.4	1.2	6.5	2.8	12.2	1.7	0.4	1.5	5.0	0.3	0.0
SLC7A8	"LAT2, LPI-PC1"	ENSG00000092068	"Solute carrier family 7 member 8"	Q9UHI5	14	23125295-23183674	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 204.0"	"Cell type enhanced"	"Detected in many"	6	"Ito cells: 97.0;Kupffer cells: 71.7;Proximal tubular cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"basophil: 7.6;eosinophil: 13.2;naive CD8 T-cell: 3.5"	"Group enriched"	"Detected in many"	46	"granulocytes: 13.2;T-cells: 3.5"	"Cell line enhanced"	"Detected in many"		"AF22: 21.2;ASC diff: 22.3;BEWO: 38.9;CACO-2: 21.5;K-562: 40.6;NTERA-2: 21.2;SuSa: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046015, HPA051950, HPA060672"	Enhanced					NA	NA					"CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: AB_2684340"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.97e-4)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.39e-3)"	"unprognostic (9.44e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.52e-4)"	10.5	5.9	4.6	3.0	6.6	1.3	11.0	10.9	10.7	12.7	5.9	2.5	28.2	11.7	23.0	7.2	13.2	21.7	6.2	3.1	7.8	3.0	37.6	3.0	6.2	5.8	2.4	5.6	33.7	9.1	204.0	16.7	19.8	6.9	13.0	5.1	31.2	9.5	50.9	23.6	11.2	8.8	7.5	1.9	10.0	19.3	10.5	4.7	0.3	12.8	5.2	4.9	15.2	14.5	0.1	0.0	13.2	0.1	0.0	3.5	1.7	0.4	0.0	21.2	0.0	22.3	2.7	38.9	2.1	8.5	0.0	0.6	21.5	1.1	0.1	0.3	4.6	2.2	3.6	2.8	1.1	0.1	0.0	2.0	0.1	0.0	0.0	8.7	0.0	12.1	19.2	10.7	0.3	0.2	5.0	1.7	1.9	40.6	0.0	0.4	0.3	0.0	0.2	21.2	4.0	15.8	0.0	0.2	4.0	0.2	7.9	2.6	0.1	0.0	3.7	10.0	25.5	13.5	0.1	0.1	0.7	0.5	0.2	0.0	0.1	4.6	0.0	2.4	0.0	0.1	7.6	0.1	13.2	0.0	0.1	1.1	0.1	0.9	0.1	0.0	0.0	0.9	3.5	0.4	0.0	0.0	0.0	0.5	1.7	4.6	6.6	10.9	10.7	7.8	3.0	2.4	5.6	6.9	4.7	14.9	16.7	2.9	22.2	2.7	28.0	5.1	0.0	0.0	13.6	15.7	0.0	14.7	5.0	1.3	1.8	1.3	12.9	0.0	2.1	2.2	8.7	34.8	4.7	0.4	47.4	25.4	31.8	97.0	71.7	1.7	8.9	9.7	18.6	0.0	30.8	48.5	3.9	3.5	7.4	98.9	4.2	0.0	3.1	0.3	0.6	2.6	34.6	1.3	18.9	31.8
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869766	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 63.3;kidney: 26.4"	"Cell type enriched"	"Detected in some"	5	"Proximal tubular cells: 55.5"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"BEWO: 4.9;CACO-2: 11.3;Hep G2: 11.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced					NA	NA					"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.1	0.0	0.1	0.3	0.2	0.0	0.1	0.3	0.2	0.2	20.1	0.1	0.1	30.5	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.1	26.4	11.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	63.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	4.9	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.0	2.7	0.0	5.2	3.9	0.1	1.7	0.0	0.7	0.0	0.0	0.0	6.6	6.5	0.0	0.0	0.0	10.5	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	55.5	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 67.7"	"Cell type enriched"	"Detected in many"	11	"Cardiomyocytes: 601.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 25.2"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 25.2"	"Cell line enhanced"	"Detected in many"		"BJ: 15.4;fHDF/TERT166: 37.3;hTERT-HME1: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	3.9	2.9	7.7	4.4	14.3	1.4	2.0	3.5	15.3	5.5	7.3	1.8	7.1	3.3	12.2	3.9	4.0	3.9	5.3	67.7	7.7	6.6	11.0	2.2	3.7	2.5	5.2	8.2	2.1	1.5	1.1	1.9	6.8	7.6	12.2	3.4	1.0	1.5	17.2	1.5	2.1	3.6	20.5	2.8	4.4	2.5	1.4	2.5	0.1	1.6	0.0	1.3	9.8	2.8	0.0	2.4	25.2	6.0	0.0	0.0	0.5	1.5	1.2	1.1	0.1	1.7	3.6	0.0	15.4	6.0	5.1	3.3	0.0	2.5	0.0	1.2	37.3	5.5	0.6	0.3	2.5	5.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	5.9	10.9	2.3	0.4	0.0	0.0	0.2	6.5	0.0	0.4	0.0	0.8	0.1	2.1	4.1	8.1	0.0	1.8	0.2	1.7	0.3	0.0	0.0	0.0	5.6	0.0	0.3	5.2	4.8	0.1	0.0	1.6	0.8	0.0	0.0	0.8	0.9	0.7	0.0	4.9	0.0	0.0	5.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	25.2	0.0	6.0	0.1	0.0	0.5	7.7	14.3	3.5	15.3	7.7	6.6	5.2	8.2	7.6	2.5	3.0	3.2	2.9	0.0	1.1	50.8	601.5	2.5	0.0	1.2	33.2	3.9	0.4	0.0	0.0	0.8	3.3	0.0	0.0	0.0	1.4	4.8	0.1	0.0	0.0	28.3	0.0	0.0	20.3	56.6	0.7	0.0	46.7	1.7	1.0	0.6	35.9	0.1	0.0	7.8	0.1	6.9	12.9	19.6	0.2	0.4	2.8	0.9	0.0	0.0	0.0
SLC8A2	"KIAA1087, NCX2"	ENSG00000118160	"Solute carrier family 8 member A2"	Q9UPR5	19	47428017-47472168	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 50.9"	"Cell type enriched"	"Detected in some"	8	"Bipolar cells: 16.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 4.4;SCLC-21H: 12.5;SH-SY5Y: 6.7;SiHa: 5.2;U-2 OS: 8.1"	"Group enriched"	"Detected in many"	4	"amygdala: 80.3;basal ganglia: 95.4;cerebral cortex: 125.2;hippocampal formation: 110.1"	"Low region specificity"	"Detected in all"			"HPA050818, HPA054671"	Enhanced					NA	NA					"HPA050818: AB_2681248, HPA054671: AB_2682568"	"unprognostic (3.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-2)"	1.2	4.0	16.6	1.0	18.1	0.9	0.9	50.9	50.7	1.0	2.4	1.8	1.0	1.3	5.4	1.0	2.3	2.2	1.1	0.9	21.4	6.8	1.0	0.9	0.9	0.9	2.1	21.1	0.9	10.3	0.9	3.2	1.0	2.0	1.4	1.4	0.0	1.2	4.4	0.9	1.0	1.2	5.5	2.0	1.0	1.3	1.9	1.2	0.0	1.0	0.0	0.9	1.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	4.4	0.6	0.0	0.0	0.0	0.0	0.4	0.1	12.5	6.7	5.2	0.6	0.4	0.4	0.2	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	18.1	50.9	34.6	21.4	6.8	2.1	21.1	2.0	1.2	0.0	0.0	0.0	0.1	0.0	16.2	1.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.9	0.0	0.3	1.1	1.7	0.0	0.1	0.0	0.0	0.1
SLC8A3	NCX3	ENSG00000100678	"Solute carrier family 8 member A3"	P57103	14	70044217-70189070	"Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 17.0;skeletal muscle: 32.1"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 33.9"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.0;LHCN-M2: 7.3;SH-SY5Y: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.65e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	0.7	2.8	6.1	1.2	6.1	1.0	0.9	3.8	17.0	1.4	1.1	3.1	0.0	1.1	0.9	1.0	1.1	0.7	1.3	1.5	5.8	8.2	0.6	0.6	1.6	1.0	4.7	7.1	0.6	1.0	0.6	1.5	0.7	6.4	1.2	1.1	1.5	0.6	0.8	32.1	0.8	1.2	1.2	2.8	0.7	1.2	0.8	1.9	0.0	0.6	4.9	0.9	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	4.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	23.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.1	6.1	3.8	10.6	5.8	8.2	4.7	7.1	6.4	1.9	0.0	1.1	0.0	0.0	0.1	33.9	1.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	8.1	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC8B1	"FLJ22233, NCKX6, NCLX, SLC24A6"	ENSG00000089060	"Solute carrier family 8 member B1"	Q6J4K2	12	113298759-113359493	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040668	Approved					NA	NA					"HPA040668: AB_10793861"	"prognostic favorable (9.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.54e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (5.02e-4)"	12.6	43.9	7.2	15.0	9.5	12.0	11.0	5.5	7.8	11.8	11.1	9.0	7.9	7.7	9.0	10.9	9.3	7.2	10.4	9.2	6.5	3.7	10.6	18.6	12.2	26.2	8.2	4.5	35.1	13.2	5.5	9.3	15.5	7.0	10.0	7.5	6.2	10.4	9.6	7.1	11.2	14.1	9.3	9.6	20.8	7.6	13.9	8.0	29.5	8.2	8.1	14.4	8.4	10.8	3.1	11.4	18.5	14.7	3.3	18.8	8.4	12.4	2.7	1.6	3.6	8.5	5.9	5.4	4.0	12.6	5.7	5.6	2.9	10.4	3.4	9.4	5.9	4.9	10.1	5.2	3.0	2.7	7.8	1.5	6.4	6.1	3.1	14.1	16.7	14.4	6.0	9.0	6.5	2.8	4.9	13.0	12.6	13.5	1.7	3.2	2.8	5.1	13.5	2.9	4.3	7.1	1.9	2.2	3.9	6.1	17.7	0.1	2.9	11.8	23.8	2.8	2.4	3.7	6.6	26.9	3.9	4.7	11.2	2.5	2.1	5.0	2.5	4.9	9.4	3.1	2.4	9.6	18.5	5.0	14.7	6.4	2.2	9.2	4.9	11.4	3.1	18.8	8.6	6.3	3.3	14.1	8.5	10.9	8.4	7.2	9.5	5.5	7.8	6.5	3.7	8.2	4.5	7.0	8.0	11.9	13.0	4.2	11.4	3.9	1.1	3.3	7.6	4.0	7.9	12.2	9.8	7.1	5.0	11.7	1.3	9.0	25.1	0.0	15.3	7.2	8.7	13.6	20.8	10.2	20.0	0.0	4.7	3.7	16.4	1.3	22.7	20.0	1.7	15.4	12.0	3.2	17.9	13.6	26.5	3.2	0.7	32.3	11.3	0.7	3.8	6.1	8.9	7.5	9.3	15.3
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098815-27166981	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 60.7"	"Cell type enhanced"	"Detected in many"	4	"Enterocytes: 52.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	7.1	11.3	7.5	9.9	10.1	7.3	8.4	11.7	18.9	8.7	14.0	5.0	26.9	20.7	10.6	6.8	10.3	7.1	24.4	13.4	4.6	5.3	7.3	2.4	11.2	5.8	5.0	6.7	6.9	6.4	13.4	8.0	42.5	14.8	8.5	10.2	10.1	60.7	55.4	3.8	9.2	24.7	8.1	3.9	10.5	45.6	8.3	4.9	6.0	8.0	6.5	9.0	18.8	8.4	0.9	0.6	5.5	1.5	0.4	4.2	1.8	13.7	4.7	4.5	4.5	10.2	7.4	27.6	11.3	17.3	9.9	10.8	5.7	9.0	6.2	9.7	14.7	4.8	17.2	4.4	28.0	6.2	7.4	4.1	9.5	3.1	2.4	31.1	5.5	7.2	9.2	13.6	16.7	23.3	7.2	16.4	4.4	2.6	6.1	14.5	8.2	2.8	2.9	6.2	17.0	9.8	5.1	4.0	2.9	5.2	20.8	5.2	1.6	9.5	13.0	5.7	4.8	6.0	3.5	17.6	10.6	4.2	9.8	6.2	5.5	3.5	1.8	11.3	6.2	6.1	0.1	1.5	1.5	1.9	0.9	4.2	0.2	2.2	2.0	0.6	0.9	1.4	1.7	5.5	0.4	1.5	0.1	0.8	1.8	7.5	10.1	11.7	18.9	4.6	5.3	5.0	6.7	14.8	4.9	6.0	17.9	5.2	16.2	27.7	6.3	11.3	10.2	0.0	3.4	10.4	0.0	30.0	0.0	8.5	26.9	7.1	52.0	0.0	10.9	16.2	11.0	8.8	26.5	1.0	11.5	19.1	12.0	8.0	4.9	9.7	8.6	6.6	6.8	1.8	12.3	10.8	19.4	22.0	12.4	1.3	3.6	6.5	8.7	1.4	3.4	22.0	44.3	6.7	14.3	16.3
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619707-102711318	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.8;intestine: 16.1;stomach 1: 19.8"	"Cell type enhanced"	"Detected in some"	10	"Early spermatids: 19.1;Enterocytes: 23.6;Late spermatids: 22.4;Mucus-secreting cells: 26.9;Paneth cells: 40.3;Undifferentiated cells: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.8;OE19: 25.9;RT4: 11.9;SK-BR-3: 10.5;T-47d: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: AB_2674477"	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.2	0.4	0.9	10.8	1.4	0.0	1.0	0.5	1.9	1.0	15.0	0.6	8.4	4.6	0.2	5.8	0.5	0.2	16.8	0.2	1.5	1.0	4.6	0.2	0.2	0.0	0.9	0.7	0.2	0.2	0.1	1.7	0.0	1.8	4.5	16.1	0.9	3.7	11.7	4.4	1.3	9.5	0.4	1.3	0.2	19.8	5.3	0.6	1.0	0.6	1.8	3.1	2.8	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	6.8	4.3	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.1	0.0	2.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	2.3	2.1	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.3	0.0	0.0	0.1	25.9	3.6	0.0	0.0	0.0	0.8	11.9	0.0	0.0	0.0	10.5	0.0	0.0	13.2	0.0	0.0	0.0	0.5	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.9	1.4	0.5	1.9	1.5	1.0	0.9	0.7	1.8	0.6	0.0	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.0	8.7	0.0	0.4	0.0	0.2	19.1	0.0	23.6	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.1	0.0	9.4	0.0	0.0	22.4	0.6	0.0	0.0	0.0	26.9	0.5	4.9	40.3	0.0	1.0	0.0	0.0	0.3	0.7	0.1	0.5	0.2	0.0	31.4	0.7
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470458-524332	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.8;intestine: 85.1;kidney: 43.6"	"Cell type enhanced"	"Detected in some"	15	"Alveolar cells type 1: 14.9;Club cells: 10.3;Collecting duct cells: 15.7;Proximal tubular cells: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 28.2"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.6"	"Not detected"	"Not detected"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	0.6	0.6	0.5	16.2	1.0	0.0	0.6	4.2	0.9	0.9	27.5	0.7	1.1	12.7	0.9	3.4	2.4	0.8	65.8	0.6	0.6	0.6	43.6	0.5	0.5	0.9	0.9	0.7	0.8	1.1	0.6	0.9	0.5	1.2	1.4	2.3	1.2	2.1	0.8	0.7	4.2	85.1	1.1	0.6	0.5	22.7	1.1	0.5	0.6	0.7	2.4	2.7	0.8	2.0	1.9	2.0	0.2	1.2	3.5	6.8	2.9	4.2	3.8	7.0	7.4	1.7	2.0	5.5	4.2	2.5	5.2	3.3	9.3	4.9	10.2	5.5	1.9	3.8	7.0	3.9	2.5	2.5	28.2	7.3	4.6	16.5	3.4	2.6	3.4	5.9	2.7	5.2	2.3	3.5	2.6	1.5	4.2	6.1	5.4	1.8	6.6	3.7	16.7	2.6	12.2	6.3	5.6	6.6	5.3	1.8	3.6	7.9	3.3	12.6	3.5	2.6	3.2	8.0	2.7	1.9	6.0	5.3	4.1	2.7	9.1	3.6	5.8	3.8	15.3	3.8	0.0	1.2	0.1	4.3	0.5	3.8	1.6	5.6	4.1	1.4	1.9	6.8	5.2	0.2	3.5	0.4	2.0	4.2	2.9	0.5	1.0	4.2	0.9	0.6	0.6	0.9	0.7	1.2	0.5	14.9	4.3	0.0	0.0	0.0	0.0	0.6	0.0	5.3	10.3	15.7	0.0	0.0	5.0	7.5	0.0	0.0	1.0	0.0	7.7	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	8.2	0.0	0.0	6.5	0.0	0.0	38.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748652-74769353	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Enterocytes: 372.3;Proximal tubular cells: 352.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 78.7;SK-BR-3: 64.2;T-47d: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	Yes		9600000	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	5.4	33.3	19.8	9.9	23.3	22.6	15.2	21.9	15.1	12.5	30.6	15.2	35.9	57.6	5.4	12.0	74.3	20.5	30.8	5.6	14.2	8.8	36.1	64.9	8.6	13.5	14.3	14.0	5.0	26.5	12.5	4.9	8.3	12.8	10.1	13.4	22.9	41.8	23.3	1.5	11.2	73.3	3.1	12.1	13.8	14.8	5.4	14.1	18.4	5.6	24.3	30.3	7.1	20.3	9.8	14.3	72.7	24.8	45.1	70.4	44.3	13.9	11.5	5.7	5.9	3.5	2.5	25.9	3.3	3.1	8.6	8.4	36.0	8.4	3.0	3.4	7.1	4.6	20.1	9.8	6.5	4.1	3.7	9.4	23.0	31.1	47.9	7.1	15.0	15.6	2.1	3.6	6.8	2.9	18.0	7.1	9.2	7.3	16.5	13.2	78.7	35.3	33.7	5.1	39.5	6.8	3.8	6.5	13.9	11.9	10.0	4.9	6.5	3.5	64.2	7.2	16.6	124.2	12.0	2.3	2.7	7.8	6.3	5.5	28.6	12.9	5.6	4.3	20.0	1.5	72.7	14.1	65.3	70.4	20.6	46.6	9.8	43.2	59.3	13.7	8.6	25.5	45.2	50.3	45.1	24.8	14.3	47.0	44.3	19.8	23.3	21.9	15.1	14.2	8.8	14.3	14.0	12.8	14.1	6.0	18.8	36.3	18.8	41.0	1.9	14.9	206.4	41.5	14.8	29.6	3.9	67.4	56.3	154.8	9.9	11.7	372.3	0.0	86.0	43.0	16.6	31.5	24.3	159.6	66.7	4.8	18.0	4.9	23.7	8.2	8.1	24.4	27.0	7.2	41.8	82.0	78.1	101.7	39.3	352.2	4.7	6.5	14.4	6.0	20.7	50.2	93.3	101.5	27.5	31.5
SLC9A3R2	"E3KARP, NHERF-2, SIP-1, TKA-1"	ENSG00000065054	"SLC9A3 regulator 2"	Q15599	16	2025356-2039026	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 275.4;Hepatocytes: 196.4;Ito cells: 306.3;Pancreatic endocrine cells: 190.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 3.6;intermediate monocyte: 2.7;myeloid DC: 6.8;plasmacytoid DC: 5.0"	"Group enriched"	"Detected in many"	5	"dendritic cells: 6.8;monocytes: 3.6"	"Cell line enhanced"	"Detected in many"		"A549: 38.1;MCF7: 60.8;PC-3: 57.3;SK-BR-3: 38.5;U-251 MG: 38.3;WM-115: 41.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001672, HPA066520"	Enhanced		Supported	"Plasma membrane"		NA	NA		120000	"Plasma membrane"		"HPA001672: AB_1080017, HPA066520: AB_2732748"	"unprognostic (6.99e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.20e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.80e-2)"	51.5	19.4	20.0	10.0	25.4	1.1	41.0	15.5	26.6	29.7	13.1	15.2	13.5	13.5	28.7	10.3	16.1	20.9	30.4	65.1	18.4	15.7	40.7	80.9	51.2	11.1	21.0	15.9	18.3	14.0	5.3	17.4	25.1	17.8	25.5	6.5	37.5	76.3	22.9	60.9	7.1	15.7	9.9	12.2	39.0	35.0	8.8	13.5	2.5	32.7	21.5	12.3	13.3	25.0	0.1	6.8	0.0	3.6	0.1	0.9	1.0	6.3	38.1	1.0	7.9	1.3	1.8	1.1	27.8	16.8	14.0	4.6	5.0	8.5	0.0	13.2	11.9	1.8	6.2	3.0	2.7	1.5	0.0	9.1	0.6	16.4	12.1	9.3	0.1	2.8	1.9	2.8	4.1	1.2	6.6	13.9	2.9	4.6	0.5	0.9	60.8	0.1	7.0	1.5	15.2	57.3	5.4	1.6	10.0	3.1	0.6	7.3	6.8	1.9	38.5	2.5	1.0	31.2	3.3	35.5	4.4	6.4	0.4	38.3	1.0	0.8	0.1	0.5	0.7	41.1	0.0	3.6	0.0	0.9	2.7	0.3	0.0	0.2	0.2	6.8	0.1	0.9	0.9	0.0	0.1	0.9	5.0	0.2	1.0	20.0	25.4	15.5	26.6	18.4	15.7	21.0	15.9	17.8	13.5	3.0	13.8	20.1	19.8	13.5	1.5	21.0	66.2	6.7	5.7	12.2	0.0	0.8	5.0	30.7	12.9	275.4	5.7	0.0	7.5	0.7	37.7	42.0	0.0	196.4	2.2	3.2	20.6	306.3	28.2	22.9	75.9	9.5	32.1	1.8	66.3	11.2	190.9	5.8	41.8	12.2	4.4	25.8	53.1	1.7	7.7	9.9	0.8	6.9	14.3	41.9
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473303-102533972	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	6	"gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9"	"Cell type enriched"	"Detected in some"	8	"Collecting duct cells: 24.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.9;OE19: 11.4;RT4: 7.1"	"Group enriched"	"Detected in some"	18	"hippocampal formation: 11.6;olfactory region: 8.3"	"Not detected"	"Not detected"			HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA036096: AB_2674939"	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.3	0.0	1.1	0.1	0.0	1.3	0.1	23.2	0.2	0.1	0.1	12.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	3.7	2.4	0.7	0.2	0.2	0.0	0.1	0.1	33.9	0.3	0.0	0.2	0.1	0.5	0.4	0.6	0.2	1.5	0.9	1.8	0.8	1.2	1.2	0.1	0.2	0.2	0.2	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.4	0.1	2.4	0.0	0.3	0.3	0.0	0.0	0.0	3.9	0.1	0.2	0.4	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.9	0.0	0.4	0.1	0.1	1.1	11.4	0.4	0.2	0.5	0.3	0.0	7.1	0.2	0.2	0.1	0.4	0.0	0.3	0.2	0.1	0.5	0.4	1.1	0.7	0.2	0.2	0.2	0.0	0.5	0.1	0.1	1.6	0.7	1.1	1.2	0.6	0.8	0.8	0.9	0.9	0.5	1.5	1.0	1.2	1.8	1.2	0.8	0.9	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	3.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	2.7	1.2	24.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3
SLC9A5	NHE5	ENSG00000135740	"Solute carrier family 9 member A5"	Q14940	16	67237683-67272190	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 13.5;lymphoid tissue: 14.5"	"Cell type enriched"	"Detected in some"	5	"Horizontal cells: 15.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 8.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041004, HPA041329"	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA			Cytosol	"Plasma membrane"	"HPA041004: AB_10794433, HPA041329: AB_10794373"	"unprognostic (8.90e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (9.85e-11)"	"unprognostic (9.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.07e-2)"	1.7	1.7	2.9	1.1	8.8	0.5	1.1	13.5	8.6	0.9	1.4	0.5	3.6	1.3	1.1	3.2	0.6	0.6	1.9	2.3	2.9	3.6	1.1	0.6	2.9	2.1	2.1	2.3	1.4	1.5	0.5	0.6	1.7	4.3	1.0	1.1	0.5	1.0	2.5	1.7	4.2	0.9	0.6	2.7	14.5	0.8	3.3	1.2	0.0	1.0	0.0	1.3	1.6	0.4	1.5	0.8	1.0	0.5	0.6	0.9	0.1	0.5	4.1	3.7	1.2	6.8	4.7	0.4	1.3	5.8	3.4	3.1	0.2	2.9	0.0	0.8	1.6	1.7	0.2	1.0	0.7	1.3	1.2	1.2	3.2	0.3	0.9	0.8	1.4	6.7	5.3	1.4	1.9	0.4	6.3	0.7	1.2	0.7	1.9	2.2	2.3	0.1	0.3	2.5	0.2	0.4	0.0	0.8	0.9	0.6	0.7	2.1	0.9	3.5	0.2	1.8	0.9	1.4	0.3	1.0	8.8	1.4	1.6	0.6	3.6	0.9	1.8	6.3	0.7	2.2	0.0	0.4	0.0	0.0	0.0	0.6	1.5	0.4	0.9	0.1	0.0	0.4	0.4	1.0	0.6	0.5	0.8	0.0	0.1	2.9	8.8	13.5	8.6	2.9	3.6	2.1	2.3	4.3	1.2	3.0	3.2	0.0	0.1	0.6	1.9	1.2	2.5	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.6	0.7	0.0	0.0	0.2	0.1	0.6	0.4	0.0	0.0	0.1	15.9	1.2	2.5	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.3	0.4	0.0	2.1	0.0	0.6	0.0	0.7	1.7	1.1	0.6	0.0	0.0	0.2	0.1
SLC9A6	"KIAA0267, NHE6"	ENSG00000198689	"Solute carrier family 9 member A6"	Q92581	X	135973841-136047269	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease mutation, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.1"	"Cell type enhanced"	"Detected in many"	7	"Horizontal cells: 46.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059445, HPA059590"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA059445: AB_2684021, HPA059590: AB_2684075"	"unprognostic (1.35e-1)"	"unprognostic (8.28e-3)"	"unprognostic (4.36e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.06e-2)"	4.3	5.7	16.4	4.7	27.6	4.0	3.1	15.3	35.1	5.2	5.2	7.8	1.6	7.5	5.7	3.2	5.6	5.2	4.8	7.2	19.1	24.3	6.2	3.9	5.7	4.7	15.0	15.6	7.4	3.3	9.3	8.6	4.0	22.3	3.6	5.5	4.6	3.3	4.6	5.5	4.1	6.5	6.5	9.5	4.8	5.2	5.1	4.0	3.6	5.9	1.7	5.8	4.7	3.2	5.3	6.8	3.2	8.4	5.9	13.9	6.0	13.2	7.0	7.4	2.7	10.5	10.2	13.3	10.7	11.5	9.2	19.5	6.1	10.6	9.9	24.4	12.3	13.7	7.9	9.6	9.6	13.4	7.7	8.7	2.7	11.2	3.6	5.5	7.7	9.4	5.6	8.5	15.2	7.5	6.6	7.8	9.7	4.9	14.1	10.1	5.8	10.2	2.2	4.2	4.9	9.5	6.9	11.0	10.0	6.6	6.6	6.6	5.0	7.7	0.8	6.2	6.6	3.2	6.0	11.1	11.5	8.2	17.0	13.7	6.8	15.1	8.7	7.0	13.2	6.4	2.2	6.0	3.2	8.1	8.4	13.9	5.3	9.5	7.9	6.8	4.0	10.6	7.9	2.6	5.9	6.6	4.3	8.0	6.0	16.4	27.6	15.3	25.9	19.1	24.3	15.0	15.6	22.3	4.0	3.0	4.8	4.2	1.3	6.6	13.4	8.1	17.8	0.0	1.2	12.2	7.9	2.2	0.0	4.0	0.6	4.6	8.0	0.0	5.1	2.1	4.7	2.1	1.1	7.8	8.9	46.1	10.3	8.6	12.9	0.9	5.2	8.8	8.5	2.8	3.4	13.2	4.6	5.8	4.2	4.9	7.0	0.0	4.9	5.0	12.3	5.9	2.4	7.7	5.0	2.2
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599252-46759172	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 42.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 42.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA048938: AB_2680565, HPA075385: AB_2686747"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.58e-4)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	1.7	7.2	4.4	3.8	42.0	4.4	7.9	7.0	12.4	1.8	1.2	1.8	1.2	1.7	1.2	3.8	3.2	2.5	2.2	2.3	3.3	7.1	3.3	4.1	1.8	7.8	3.6	4.3	6.3	4.6	11.5	13.6	1.4	12.7	6.5	1.3	2.3	7.3	2.9	10.0	2.9	2.7	1.0	2.7	4.7	8.2	1.3	8.2	2.8	6.9	1.7	8.2	2.3	2.2	4.3	6.0	2.1	0.6	1.4	0.7	0.5	7.0	5.4	0.8	2.4	0.9	5.4	3.1	6.7	8.4	4.0	3.3	5.5	7.7	15.5	2.1	10.7	7.9	3.3	5.2	7.6	7.4	8.1	2.8	1.6	2.1	2.2	3.3	0.7	12.8	3.4	1.0	11.4	7.6	19.2	5.7	5.4	0.1	0.3	5.5	10.6	1.7	0.8	3.7	3.4	6.5	6.9	0.3	0.2	3.1	7.9	5.8	0.7	3.4	5.2	1.5	6.8	6.9	0.3	0.3	8.7	2.9	1.3	3.9	1.6	0.4	7.8	12.3	0.1	2.8	1.0	0.6	0.3	0.6	0.6	0.4	3.4	0.7	0.3	2.4	4.3	0.4	0.5	2.1	1.4	0.6	6.0	0.7	0.5	4.4	42.0	7.0	8.3	3.3	7.1	3.6	4.3	12.7	8.2	3.0	8.0	17.9	7.5	0.6	10.1	4.5	2.5	0.0	3.4	15.7	3.9	5.5	0.0	15.3	0.0	0.5	0.0	0.0	12.2	0.3	0.4	18.2	0.0	4.9	6.6	12.7	2.4	0.6	4.7	0.4	0.9	9.1	1.7	9.0	1.0	6.6	12.5	0.0	0.4	1.7	3.4	6.5	0.8	0.0	0.9	0.9	6.1	0.5	0.8	11.2
SLC9A8	"KIAA0939, NHE8"	ENSG00000197818	"Solute carrier family 9 member A8"	Q9Y2E8	20	49812713-49892242	"Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 27.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033682	Approved					NA	NA					"CAB033682: AB_2270441"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.96e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (5.28e-2)"	9.0	14.0	7.6	11.4	13.9	29.8	8.9	10.3	15.1	8.4	9.1	14.0	7.7	9.7	12.2	10.6	16.0	8.6	9.4	6.8	7.3	7.8	8.4	16.2	9.5	10.6	6.6	8.0	7.2	13.5	11.7	12.4	7.2	11.9	9.1	9.0	15.4	13.7	7.9	19.5	7.3	9.8	9.0	8.1	13.9	12.8	19.6	5.8	13.6	11.9	8.4	18.6	11.4	7.6	2.2	1.4	7.1	1.7	0.8	2.5	1.4	4.3	7.9	3.5	3.5	4.5	2.9	9.0	4.5	6.1	8.6	4.1	5.6	9.8	5.2	5.8	6.4	7.0	9.7	3.7	4.5	4.4	4.5	2.0	2.5	5.0	2.8	6.3	4.5	6.3	5.4	5.2	4.5	9.2	4.5	3.6	6.9	4.9	5.4	5.2	4.7	4.1	3.1	2.9	6.5	3.7	3.1	4.2	3.7	5.1	4.7	3.6	3.1	7.4	27.8	5.6	2.5	9.0	7.5	5.5	11.7	6.5	5.7	4.3	8.3	3.6	3.8	16.0	6.1	4.8	2.8	1.4	3.6	2.3	1.1	2.5	1.6	1.7	2.0	1.4	2.2	1.8	1.1	7.1	0.8	1.7	0.7	1.2	1.4	7.6	13.9	10.3	15.1	7.3	7.8	6.6	8.0	11.9	5.8	11.9	9.1	3.0	3.8	2.3	5.5	4.4	2.5	12.0	11.4	3.5	13.7	4.9	1.7	5.1	2.1	4.3	10.5	0.0	5.5	3.3	3.3	6.3	21.9	13.9	4.4	6.4	6.4	6.2	10.0	5.3	3.4	4.1	1.7	4.6	7.1	5.2	7.7	6.0	4.6	3.5	9.5	0.0	3.4	6.5	6.5	1.6	2.9	6.9	6.6	6.7
SLC9A9	"FLJ35613, NHE9"	ENSG00000181804	"Solute carrier family 9 member A9"	Q8IVB4	3	143265222-143848531	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Erythroid cells: 23.3;Hofbauer cells: 42.3;Ito cells: 25.2;Kupffer cells: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.6;ASC TERT1: 13.8;HSkMC: 9.6;Karpas-707: 33.4;RPMI-8226: 15.5;U-266/70: 15.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058234	Approved					NA	NA		41000			"HPA058234: AB_2683648"	"unprognostic (8.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.35e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (5.57e-7)"	"unprognostic (5.01e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-2)"	17.4	8.4	16.8	11.4	25.9	2.7	7.7	4.5	17.2	10.6	9.6	17.2	2.0	4.5	6.2	5.7	18.0	9.2	13.4	8.2	14.7	11.7	3.7	9.9	8.3	17.5	23.0	7.4	11.8	2.2	1.9	6.5	21.3	18.3	12.9	8.6	4.6	7.1	12.8	3.5	10.3	9.3	12.1	27.5	16.9	7.3	2.9	24.1	10.7	5.7	7.1	17.8	17.3	10.8	4.4	8.7	0.7	10.8	3.9	9.3	4.7	0.3	0.3	0.4	0.5	10.6	13.8	0.1	0.5	3.5	0.2	1.7	0.0	0.1	1.6	0.1	1.6	0.9	0.4	0.5	1.0	0.4	6.8	0.1	0.9	0.2	0.0	1.2	0.4	0.7	9.6	2.8	0.3	0.5	0.6	0.1	1.2	0.0	33.4	2.2	0.0	0.8	0.0	0.1	0.0	0.2	1.3	0.1	15.5	0.0	0.2	0.2	0.0	0.8	0.0	0.0	0.2	0.1	0.3	0.0	1.3	0.3	1.5	0.7	15.6	0.0	0.0	2.3	0.2	0.6	0.1	6.6	0.7	5.2	10.8	4.5	3.7	5.5	8.1	8.7	4.4	3.1	4.6	0.5	3.9	9.2	0.6	9.3	4.7	16.8	25.9	4.5	17.2	14.7	11.7	23.0	7.4	18.3	24.1	0.0	1.4	3.7	9.4	3.3	0.1	1.1	0.0	1.4	2.3	3.5	2.0	0.4	0.0	0.8	3.9	2.8	0.0	23.3	0.2	0.3	9.4	12.5	0.0	0.0	42.3	0.0	0.0	25.2	24.1	2.7	8.6	9.6	6.8	19.8	0.0	3.7	1.0	0.0	6.7	0.4	0.0	0.0	3.1	0.2	0.2	4.4	0.9	10.2	0.0	4.8
SLC9B1	"NHA1, NHEDC1"	ENSG00000164037	"Solute carrier family 9 member B1"	Q4ZJI4	4	102885048-103019739	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Fertilization, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"testis: 43.1"	"Group enriched"	"Detected in many"	7	"Early spermatids: 118.1;Late spermatids: 86.8;Spermatocytes: 121.2"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 2.0;dendritic cells: 1.9;T-cells: 4.9"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA058971, HPA065520"			Supported	"Centriolar satellite,Mitochondria"		NA	NA			Mitochondria	"Centriolar satellite"	"HPA058971: AB_2683865, HPA065520: AB_2685502"	"unprognostic (4.87e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.06e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-5)"	"unprognostic (5.78e-2)"	1.1	1.1	1.1	1.1	3.1	0.9	0.9	1.4	2.0	0.9	0.8	3.7	0.0	0.8	2.6	2.3	0.7	0.9	1.6	0.9	1.6	1.0	0.8	0.7	1.1	2.4	2.4	1.1	1.5	1.3	1.2	2.4	0.9	3.1	1.1	0.8	2.8	0.7	0.9	0.7	1.9	0.8	0.7	4.4	1.0	0.8	43.1	2.3	4.2	1.1	0.0	1.7	1.2	0.9	2.0	1.9	0.6	0.6	0.4	4.9	0.6	0.4	0.0	2.2	3.3	4.4	3.3	0.7	0.8	1.1	0.0	0.2	0.0	0.2	1.7	0.6	1.7	0.7	0.0	1.7	0.9	1.5	3.2	2.3	2.5	2.0	0.0	0.0	0.7	0.5	0.5	1.0	0.0	1.8	0.9	1.3	4.5	1.2	1.7	1.7	1.3	1.0	2.2	0.8	0.5	0.0	2.7	1.8	0.5	0.9	0.5	2.1	5.0	0.6	0.8	2.5	1.5	0.4	1.7	0.7	0.9	0.3	1.0	1.1	5.5	4.0	1.4	1.2	1.0	2.4	0.6	0.6	0.1	1.5	0.4	1.7	1.8	1.2	1.8	0.7	2.0	4.9	2.8	0.3	0.4	0.3	1.9	1.7	0.6	1.1	3.1	1.4	2.0	1.6	1.0	2.4	1.1	3.1	2.3	3.0	1.0	1.9	0.5	1.1	1.9	0.8	0.0	0.0	0.0	0.0	15.7	0.4	1.7	0.3	118.1	0.7	0.0	0.0	0.4	0.2	1.5	0.8	0.0	0.0	1.1	3.2	0.0	0.6	4.1	86.8	4.9	0.8	1.7	1.8	0.0	2.7	0.7	0.0	2.8	0.6	5.0	0.0	1.4	121.2	8.1	0.5	0.5	1.0	0.0	0.5
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 45.6"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 25.5;Exocrine glandular cells: 60.7;Hepatocytes: 33.1;Pancreatic endocrine cells: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 5.6;NK-cells: 12.2;T-cells: 6.3"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Nucleoplasm, Cell Junctions"		"HPA047008: AB_2679901"	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.3	7.9	8.8	6.3	13.3	5.3	5.5	16.5	24.5	5.6	5.0	5.2	0.4	2.0	8.5	4.2	4.7	5.9	9.8	5.5	8.9	12.5	1.9	45.6	3.3	7.2	10.3	13.4	8.0	2.4	1.2	8.8	5.2	20.8	5.6	3.9	8.3	2.1	6.7	4.5	3.7	3.0	9.8	9.8	4.6	5.7	4.8	4.7	2.5	2.6	1.8	6.9	5.5	8.5	5.6	1.7	0.0	0.1	12.2	6.3	1.8	2.6	1.3	3.1	6.5	15.7	13.1	0.0	12.0	4.8	2.0	1.9	1.3	1.7	16.9	2.1	13.9	2.7	0.8	7.1	5.0	2.8	14.8	4.9	16.9	4.2	12.2	8.4	11.8	5.3	11.5	6.8	4.2	14.7	6.7	8.6	4.8	5.7	12.4	6.2	1.0	9.5	7.3	2.4	0.0	3.8	0.0	3.4	7.4	5.8	1.0	10.8	9.7	5.4	1.4	3.5	0.9	1.5	7.9	10.5	4.5	2.7	7.0	4.1	10.6	7.6	12.3	5.3	10.4	1.7	0.0	0.1	0.0	5.1	0.0	6.3	5.6	5.6	4.5	0.9	3.6	3.4	4.2	0.0	12.2	0.1	1.7	2.4	1.8	8.8	13.3	16.5	21.2	8.9	12.5	10.3	13.4	20.8	4.7	0.0	0.3	6.5	2.6	4.2	8.9	2.4	7.6	0.0	1.2	0.0	25.5	0.3	0.0	5.5	10.6	8.7	0.0	0.0	60.7	2.0	8.8	2.0	1.1	33.1	1.3	7.9	2.9	4.3	1.5	5.0	5.2	2.3	10.1	6.4	0.6	0.6	60.5	0.0	4.9	1.0	2.0	6.5	10.5	1.8	4.3	3.3	0.2	4.6	0.0	0.9
SLC9C1	"NHE, SLC9A10"	ENSG00000172139	"Solute carrier family 9 member C1"	Q4G0N8	3	112140887-112294258	"Predicted membrane proteins, Transporters"	"Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 25.5"	"Cell type enriched"	"Detected in some"	6	"Spermatocytes: 12.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"AF22: 1.0;HaCaT: 1.5;Karpas-707: 1.0;REH: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.21e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.32e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.25e-1)"	0.3	0.1	0.1	1.4	0.2	0.1	0.1	0.1	0.1	0.3	0.2	0.0	0.4	0.0	0.2	0.1	0.1	0.3	1.7	0.5	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.3	1.2	0.0	0.8	0.7	0.4	0.1	0.1	0.3	0.2	1.1	0.1	4.0	1.0	0.2	0.3	0.4	0.3	25.5	0.0	1.0	0.5	0.5	0.4	0.3	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.4	0.0	0.3	0.0	0.0	0.0
SLC9C2	"MGC43026, SLC9A11"	ENSG00000162753	"Solute carrier family 9 member C2 (putative)"	Q5TAH2	1	173500464-173603094	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 24.9"	"Cell type enhanced"	"Detected in some"	13	"Club cells: 2.3;Cone photoreceptor cells: 5.9;Early spermatids: 4.2;Late spermatids: 2.3;Spermatocytes: 4.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.7"	"Group enriched"	"Detected in some"	4	"BEWO: 1.8;THP-1: 3.7"					"Low region specificity"	"Detected in all"			"HPA059122, HPA079529"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Plasma membrane"	"Nuclear speckles"	"HPA059122: , HPA079529: "	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"		"unprognostic (8.52e-2)"	"unprognostic (5.88e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-6)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.81e-1)"	0.4	0.1	0.3	0.0	1.3	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.5	0.0	0.1	0.4	0.0	1.7	0.0	0.1	0.5	0.3	0.2	0.0	0.4	0.1	0.0	0.4	0.8	0.3	0.1	0.4	0.5	0.5	0.1	0.0	0.1	0.0	2.7	0.0	0.0	0.0	0.1	0.3	1.0	0.3	24.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.3	1.3	0.0	1.6	0.5	0.3	0.0	0.4	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.3	0.0	5.9	0.1	0.0	0.0	4.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.1	0.0	0.0	0.0
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5"	"Cell type enriched"	"Detected in some"	9	"Alveolar cells type 1: 32.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 13.3;RPMI-8226: 9.2;SuSa: 14.2;U-266/70: 19.8;U-266/84: 8.0"					"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"		No	No			"Plasma membrane"		"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.2	0.1	3.3	0.0	3.4	0.0	3.6	3.4	17.9	0.1	0.1	1.9	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.9	4.1	2.5	1.1	11.2	2.7	0.6	3.0	4.0	0.2	2.3	0.5	0.5	1.2	9.7	0.7	0.0	14.2	14.5	0.0	0.4	0.4	0.2	0.0	2.9	0.4	0.4	1.6	1.4	0.0	0.3	0.0	0.3	0.4	0.1	1.3	0.7	4.3	0.4	1.1	2.3	0.2	2.0	0.5	0.8	0.2	0.0	0.0	2.7	0.0	0.0	0.0	0.0	2.9	1.7	0.1	2.1	0.1	0.0	0.2	0.2	0.1	0.4	0.5	0.7	0.0	0.4	1.1	0.0	0.3	0.2	0.0	1.3	0.1	0.1	1.2	0.1	0.4	3.4	1.4	0.0	2.0	0.3	0.1	13.3	1.5	0.1	0.1	0.2	9.2	0.0	2.0	1.8	2.3	0.0	0.2	0.2	14.2	2.6	0.7	0.0	0.0	1.4	0.6	0.3	19.8	8.0	0.1	0.2	0.2	0.1	0.6	0.4	0.3	1.4	0.3	2.3	1.3	2.2	1.5	0.1	1.0	2.1	1.6	4.3	1.1	0.1	0.7	1.8	0.2	3.3	3.4	3.4	5.0	4.1	2.5	3.0	4.0	9.7	1.4	32.8	1.9	0.0	0.0	0.0	0.0	0.4	0.0	2.7	0.0	1.8	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.1	0.0	0.0	0.0
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131202-21239246	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	618	"liver: 121.0"	"Cell type enriched"	"Detected in some"	39	"Hepatocytes: 71.0"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 2.2;A549: 1.9;HeLa: 2.9;NTERA-2: 2.6;RPMI-8226: 3.5;SuSa: 5.6"									HPA050892	Supported					NA	NA					"HPA050892: AB_2681265"			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	121.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.6	0.0	0.7	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.8	0.0	0.4	0.0	0.8	0.0	0.0	1.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.0	0.0	0.0	0.0	1.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"liver: 88.1"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 91.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 35.8;A549: 9.8;CAPAN-2: 7.1;GAMG: 7.8;HeLa: 8.1;PC-3: 9.8;U-2 OS: 8.5"									"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	4.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	88.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.8	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.1	0.0	2.5	0.0	7.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	8.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	91.8	0.0	0.0	0.0	0.6	1.9	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1
SLCO1B7	"LST3, SLC21A21"	ENSG00000205754	"Solute carrier organic anion transporter family member 1B7 (putative)"	G3V0H7	12	21015696-21092745	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	6	"breast: 28.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 6.0;A549: 4.1;CAPAN-2: 4.4;HeLa: 4.2;U-2 OS: 3.0"									HPA050892	Uncertain					NA	NA					"HPA050892: AB_2681265"							"unprognostic (8.82e-3)"					"unprognostic (2.53e-1)"						0.0	0.0	0.0	0.0	0.0	0.1	28.2	0.0	0.0	1.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0		0.0	0.1	0.0	0.1	0.0		0.0	0.0		0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6			0.2		0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	4.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	1.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.4	0.2	0.7	0.6	0.0	0.0	0.2	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	3.0	0.5	0.3	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLCO1C1	"OATP-F, OATP1, OATP1C1, SLC21A14"	ENSG00000139155	"Solute carrier organic anion transporter family member 1C1"	Q9NYB5	12	20695355-20753386	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"brain: 32.4;retina: 15.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 5.8;Late spermatids: 10.3;Muller glia cells: 4.9"	"Cancer enriched"	"Detected in single"	17	"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	13	"HeLa: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.32e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.37e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.76e-2)"	3.5	1.2	11.6	1.0	16.2	0.9	1.2	1.1	32.4	0.9	1.4	6.2	0.0	1.1	0.9	1.3	1.2	0.9	2.1	1.5	10.4	2.8	1.1	0.9	1.2	1.2	6.5	8.0	0.9	1.0	1.5	5.5	1.0	20.3	1.0	1.3	15.3	1.1	1.0	0.9	1.2	1.6	1.2	4.9	0.9	1.0	3.3	8.1	0.0	1.7	0.2	1.4	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.6	16.2	1.1	11.5	10.4	2.8	6.5	8.0	20.3	8.1	0.0	0.0	0.0	0.0	0.1	1.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	10.3	1.7	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.4	0.0	0.1	0.0	1.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0
SLCO2A1	"MATR1, OATP2A1, PGT, SLC21A2"	ENSG00000174640	"Solute carrier organic anion transporter family member 2A1"	Q92959	3	133932696-134052184	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 112.9;seminal vesicle: 147.1"	"Group enriched"	"Detected in many"	5	"Endothelial cells: 38.0;Ito cells: 74.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	15	"plasmacytoid DC: 1.5"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 1.5"	"Cell line enriched"	"Detected in some"	4	"EFO-21: 45.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA013742	Enhanced					NA	NA					"HPA013742: AB_2668877"	"unprognostic (4.39e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.32e-3)"	"prognostic favorable (9.24e-5)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.63e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.07e-2)"	9.3	14.7	1.0	6.0	1.0	0.0	6.2	0.4	1.6	13.9	8.1	1.5	112.9	3.7	18.4	4.5	7.8	11.5	15.3	10.1	0.7	0.5	32.9	4.2	56.8	10.6	0.7	1.2	7.2	9.2	16.1	6.5	40.3	1.8	13.7	7.2	15.1	8.2	147.1	1.5	4.5	10.1	13.6	3.0	17.7	8.3	3.0	0.6	4.6	33.6	8.6	9.0	10.5	7.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.7	2.0	0.2	0.0	0.0	0.0	0.0	45.0	0.4	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	1.2	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	2.8	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	2.1	0.7	0.0	1.9	0.0	0.0	10.5	0.0	2.2	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.0	1.0	0.4	1.6	0.7	0.5	0.7	1.2	1.8	0.6	0.0	4.5	3.2	8.7	4.5	0.0	2.2	2.5	1.4	2.3	3.5	0.0	0.2	0.0	0.9	0.6	38.0	7.4	0.0	2.9	2.0	1.0	1.5	1.1	0.2	0.2	0.0	1.2	74.3	1.0	0.8	0.3	0.2	0.0	0.0	1.5	0.0	10.3	3.6	0.0	1.7	0.0	0.0	1.0	0.5	0.2	1.5	0.7	0.0	0.4	2.0
SLCO2B1	"OATP-B, OATP2B1, SLC21A9"	ENSG00000137491	"Solute carrier organic anion transporter family member 2B1"	O94956	11	75100563-75206549	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 98.1"	"Group enriched"	"Detected in many"	5	"Hepatocytes: 171.3;Hofbauer cells: 103.0;Kupffer cells: 116.2;Macrophages: 55.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 36.0;GAMG: 8.9;Hep G2: 8.1;HMC-1: 10.9;OE19: 43.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020659	Uncertain					NA	NA					"HPA020659: AB_1857219"	"unprognostic (8.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.75e-3)"	"unprognostic (2.54e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	21.4	15.2	15.0	13.4	23.1	1.4	7.8	4.8	15.8	8.6	12.9	22.8	0.8	18.0	5.8	7.7	8.8	8.3	12.3	7.1	15.6	11.9	9.6	98.1	24.9	21.4	23.9	7.4	4.9	9.6	3.7	4.0	18.3	17.7	4.9	10.4	9.1	6.3	4.7	2.6	3.0	21.2	10.9	24.1	23.6	6.5	4.4	21.3	4.0	6.8	3.6	11.8	12.5	4.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.4	0.0	5.9	0.3	8.1	0.0	0.4	10.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	3.6	0.0	0.0	0.0	0.0	0.0	43.2	0.0	0.0	1.0	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.6	0.6	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	23.1	4.8	15.8	15.6	11.9	23.9	7.4	17.7	21.3	0.0	12.8	1.5	0.0	1.6	1.6	2.0	20.4	1.4	3.4	0.0	0.0	0.6	1.7	0.0	2.4	12.9	20.2	0.0	0.2	2.1	1.8	0.0	23.0	171.3	103.0	0.0	0.0	3.1	116.2	1.1	10.0	55.1	0.0	3.6	4.4	0.3	0.1	14.0	9.9	7.0	0.2	0.0	0.3	0.5	0.2	0.4	2.1	0.7	9.3	0.0
SLCO3A1	"OATP-D, OATP3A1, SLC21A11"	ENSG00000176463	"Solute carrier organic anion transporter family member 3A1"	Q9UIG8	15	91853695-92172435	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 87.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 26.2;HaCaT: 39.7;HMC-1: 23.4;RPMI-8226: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066327	Approved					NA	NA					"HPA066327: AB_2732743"	"unprognostic (1.05e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (1.03e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.62e-2)"	11.1	8.5	12.3	8.6	19.2	10.6	7.9	7.8	18.4	6.8	4.6	32.8	6.6	2.7	4.5	4.8	9.2	7.7	8.3	24.3	19.5	10.9	7.1	4.1	14.7	7.3	27.0	10.0	4.2	3.2	22.6	5.4	1.7	17.2	4.2	4.9	7.7	4.0	8.9	5.4	15.1	3.5	6.7	31.9	11.5	3.9	15.5	25.0	0.8	10.1	3.2	7.9	8.4	9.3	0.2	2.0	9.5	3.2	0.4	3.2	0.7	4.0	5.0	5.9	0.1	9.0	5.5	0.0	1.6	1.4	0.6	0.1	0.0	26.2	4.9	2.2	0.5	3.8	39.7	1.1	2.6	0.0	3.5	0.1	11.2	9.1	0.0	0.4	0.2	23.4	2.4	2.8	1.2	3.1	2.3	0.0	1.5	0.0	0.0	0.0	0.7	0.0	2.0	1.5	0.0	0.7	0.0	0.4	17.7	5.6	4.1	0.8	1.4	4.3	0.4	0.0	0.9	0.0	3.4	0.0	1.4	2.0	0.0	4.2	10.8	6.3	4.8	1.8	6.9	2.5	5.2	3.2	8.2	1.9	2.4	1.4	0.2	2.0	2.2	2.0	0.0	0.7	0.8	9.5	0.4	1.9	0.0	3.2	0.7	12.3	19.2	7.8	18.4	19.5	10.9	27.0	10.0	17.2	25.0	44.7	23.5	1.9	22.8	34.7	25.0	33.9	28.1	14.7	18.2	48.8	3.9	0.0	1.7	24.0	87.8	19.9	1.6	0.0	7.9	0.0	15.0	14.4	22.0	0.5	4.8	0.0	36.2	31.9	17.3	29.6	4.6	28.3	10.1	12.6	4.7	4.5	6.8	8.6	2.8	0.2	2.9	38.8	42.4	22.8	10.2	52.6	0.0	16.6	6.9	34.6
SLCO4A1	"OATP-E, OATP4A1, SLC21A12"	ENSG00000101187	"Solute carrier organic anion transporter family member 4A1"	Q96BD0	20	62642445-62685785	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	17	"Extravillous trophoblasts: 195.5;Melanocytes: 57.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.3"	"Group enriched"	"Detected in many"	5	"B-cells: 2.3;dendritic cells: 2.6;T-cells: 4.3"	"Cell line enhanced"	"Detected in many"		"PC-3: 56.2;RPTEC TERT1: 53.9"	"Region enriched"	"Detected in single"	5	"cerebellum: 7.5"	"Low region specificity"	"Detected in some"			"HPA030669, HPA030670"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cell Junctions"		"HPA030669: AB_10601163, HPA030670: AB_10670033"	"unprognostic (8.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.25e-1)"	25.0	5.2	16.4	5.3	22.4	3.9	27.2	11.3	23.8	5.0	6.4	1.6	4.3	4.2	5.5	2.3	24.1	5.2	5.6	18.1	19.0	9.2	16.6	3.1	29.4	5.7	18.1	2.3	3.1	5.4	13.8	1.2	11.9	24.8	2.8	5.5	7.1	20.1	4.1	19.2	16.5	4.4	3.6	9.8	4.5	14.9	3.3	16.5	0.5	4.5	4.0	8.7	7.4	18.5	2.3	2.6	0.0	0.5	0.0	4.3	0.7	4.1	5.3	0.2	3.1	0.7	0.6	7.6	1.3	4.7	4.1	1.4	8.9	4.2	4.9	12.9	0.1	2.8	6.1	4.7	0.3	1.5	0.5	2.7	5.9	6.0	6.5	0.0	4.5	1.9	0.0	1.8	0.0	1.8	1.2	0.7	3.0	4.6	1.3	0.0	4.1	4.6	17.6	1.4	20.5	56.2	8.4	0.3	7.2	53.9	3.9	5.0	7.2	1.1	1.2	4.5	2.0	0.2	2.1	0.8	0.1	3.0	2.0	7.6	2.6	4.2	3.0	11.2	6.5	0.7	0.0	0.0	0.0	0.2	0.5	0.0	2.3	0.5	0.1	2.6	2.0	0.7	0.3	0.0	0.0	0.1	0.0	4.3	0.7	16.4	22.4	11.3	23.8	19.0	9.2	18.1	2.3	24.8	16.5	3.0	2.2	5.7	0.7	24.3	13.2	3.6	2.5	1.4	1.2	24.4	29.5	1.6	0.0	4.0	0.3	26.3	2.1	0.0	2.2	195.5	4.1	2.1	0.0	0.0	5.0	0.0	0.0	17.8	9.9	0.4	0.3	8.4	57.3	0.0	5.1	4.2	7.7	2.3	0.7	4.2	43.2	0.0	6.6	0.2	4.2	14.1	19.7	3.2	6.8	6.3
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296549	"Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"kidney: 55.9"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 38.8;Proximal tubular cells: 28.3"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"neutrophil: 10.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.0;NK-cells: 2.6;T-cells: 4.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.1;RPTEC TERT1: 45.9;U-937: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.4	0.3	0.7	0.7	5.4	0.3	0.2	1.8	0.3	1.9	0.0	5.2	1.4	0.2	0.6	0.3	0.3	1.6	1.1	0.3	0.4	55.9	5.2	11.0	0.2	0.3	1.0	0.3	0.9	0.0	0.7	0.1	0.2	0.4	0.5	0.0	3.2	11.8	0.3	0.6	2.1	0.0	0.3	1.6	0.4	1.3	0.0	1.5	1.0	0.3	0.1	0.7	1.1	0.1	0.4	10.0	1.1	2.6	4.3	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.5	0.0	0.4	0.1	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.5	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.5	45.9	0.0	0.3	0.2	0.0	0.1	0.0	1.1	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	0.0	11.6	0.0	7.9	1.1	7.5	4.3	0.0	0.4	0.0	0.7	2.3	0.4	0.1	0.2	1.5	10.0	2.6	0.0	0.3	0.0	1.0	0.3	0.7	0.2	1.8	0.3	0.4	0.3	1.0	0.2	0.0	6.0	38.8	0.0	0.1	0.0	0.0	0.3	0.0	4.0	6.8	5.2	0.0	0.0	1.7	0.2	8.3	0.0	1.2	0.0	0.7	0.0	0.0	0.0	5.7	5.5	0.2	0.0	0.0	0.0	0.0	0.4	0.3	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	28.3	0.0	0.0	0.0	1.7	0.7	0.0	0.0	2.2	1.2	0.3
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667047-69835064	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 12.4;Cardiomyocytes: 13.6;Glandular cells: 10.0;Intestinal endocrine cells: 15.0;monocytes: 36.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HAP1: 9.0;NTERA-2: 6.0;RPMI-8226: 5.7;SCLC-21H: 6.5;U-266/70: 3.5"	"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory region: 8.2"					HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.7	0.2	0.5	1.5	0.7	1.5	0.2	0.1	0.8	0.3	0.4	0.1	0.0	0.4	0.5	1.5	1.0	0.5	0.4	21.4	0.7	0.7	0.2	0.4	0.3	4.1	0.3	0.3	0.2	0.7	0.0	4.7	0.0	0.5	4.2	0.7	0.6	0.9	0.0	13.9	0.3	0.7	0.2	0.2	0.8	0.3	0.4	0.0	9.5	0.5	16.2	1.7	0.9	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.0	0.0	0.0	2.4	2.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.1	6.0	0.0	0.9	1.0	0.9	5.7	0.1	0.0	6.5	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.6	0.1	1.2	3.5	0.6	0.0	0.3	0.0	1.7	0.7	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.2	0.0	1.7	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.0	0.5	0.7	0.1	0.7	0.7	0.7	0.3	0.3	0.5	0.0	3.0	0.0	1.9	1.1	0.2	12.4	13.6	0.0	0.0	1.2	0.0	2.0	0.0	0.0	1.5	0.4	0.7	0.0	0.0	1.2	0.0	0.6	10.0	0.0	0.0	0.1	1.6	15.0	0.0	0.0	0.4	0.0	0.3	0.0	36.9	1.6	0.3	2.4	0.0	0.0	0.0	0.2	0.0	1.0	0.9	1.7	0.4	0.0	0.0	0.9	0.7
SLCO6A1	"CT48, MGC26949, OATP6A1, OATPY"	ENSG00000205359	"Solute carrier organic anion transporter family member 6A1"	Q86UG4	5	102371782-102499016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	93	"testis: 39.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 111.3;Spermatocytes: 59.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 1.8;SuSa: 4.2;U-266/84: 1.4"					"Low region specificity"	"Detected in some"			HPA054126	Enhanced					NA	NA					"HPA054126: AB_2682390"		"unprognostic (1.17e-1)"			"unprognostic (2.59e-1)"	"unprognostic (4.37e-2)"		"unprognostic (4.65e-1)"		"unprognostic (1.84e-1)"					"unprognostic (2.60e-2)"		"unprognostic (6.70e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.6	1.8	0.1	0.7	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	111.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	59.8	2.6	0.0	0.0	0.0	0.0	0.0
SLN	"MGC12301, MGC125854, MGC125855"	ENSG00000170290	Sarcolipin	O00631	11	107707378-107719693	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"skeletal muscle: 446.6"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 248.9;Muller glia cells: 330.7"	"Group enriched"	"Detected in many"	13	"glioma: 21.6;head and neck cancer: 22.4;prostate cancer: 4.5"	"Region enhanced"	"Detected in some"		"basal ganglia: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HSkMC: 6.0;Karpas-707: 2.8;PC-3: 2.7;SuSa: 6.2;U-2 OS: 2.7"	"Region enriched"	"Detected in some"	5	"basal ganglia: 19.0"	"Not detected"	"Not detected"			CAB011628			Approved	Microtubules		NA	NA			Microtubules		"CAB011628: AB_2195046"	"unprognostic (6.85e-2)"	"unprognostic (6.18e-8)"	"unprognostic (2.60e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.12e-3)"		"unprognostic (5.28e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.52e-9)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.09e-4)"	"unprognostic (3.77e-2)"	4.8	0.5	0.2	0.0	1.9	0.0	0.1	0.4	1.0	0.0	0.2	0.0	0.0	0.0	0.0	5.3	9.1	0.1	0.0	72.9	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.1	0.1	2.3	0.0	0.4	4.3	0.0	446.6	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	1.9	40.1	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.3	0.4	0.2	0.0	0.1	0.6	1.1	0.1	0.2	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.3	0.3	6.0	0.0	0.8	0.0	0.4	0.0	0.0	0.1	2.8	0.0	0.4	0.3	0.4	0.1	0.1	2.7	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.1	0.0	6.2	0.0	0.0	0.0	0.0	2.7	0.0	0.2	1.1	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	1.9	0.4	1.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	1.7	248.9	0.0	0.0	0.0	0.0	2.0	1.0	0.0	0.0	7.3	0.0	0.0	0.0	0.4	1.7	0.5	0.0	0.0	0.0	0.3	3.2	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	330.7	0.2	0.0	0.4	0.1	14.1	0.0	0.4	0.0	0.0	1.3	4.8	0.0	0.0	0.0
SLURP1	"ANUP, ARS, ArsB, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740944-142742411	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 137.6;lymphoid tissue: 93.7;skin 1: 91.2;tongue: 107.5"	"Cell type enriched"	"Detected in some"	24	"Suprabasal keratinocytes: 57.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 3.4;hTCEpi: 2.3;MCF7: 3.8;RT4: 2.7;T-47d: 6.6"	"Not detected"	"Not detected"							HPA050967	Approved				"Secreted in other tissues"	NA	NA		5400000			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.1	0.1	0.1	0.1	0.1	0.1	2.5	0.1	0.1	17.3	0.1	0.1	0.1	0.1	1.1	0.1	137.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	7.7	0.1	0.4	91.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	107.5	93.7	0.1	19.8	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.8	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	3.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.5	0.0	0.0	0.0	0.7
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: AB_2684257"	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favorable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favorable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	8.7	12.3	20.3	14.6	18.0	15.3	19.9	19.5	17.9	15.2	12.9	10.2	14.7	11.0	13.0	20.2	16.4	15.7	10.7	21.3	15.8	16.2	14.1	18.4	10.1	14.4	16.3	12.4	23.2	21.6	11.3	12.9	9.8	9.9	16.4	12.1	15.5	37.0	15.9	26.4	10.4	18.0	9.8	13.3	10.6	12.9	10.9	7.9	15.2	23.4	18.7	16.1	14.9	16.9	5.4	5.0	2.3	3.5	2.9	5.9	3.0	2.2	1.5	3.1	3.7	5.7	4.1	2.4	0.8	4.1	5.1	4.4	2.9	2.2	5.8	1.0	4.3	1.4	2.6	4.0	4.3	3.3	1.5	6.6	1.9	3.2	4.1	7.1	3.5	2.5	3.2	7.3	2.0	4.3	2.9	5.0	2.1	3.1	5.1	3.5	5.9	4.9	5.3	1.1	5.7	3.3	4.3	2.7	8.4	6.4	2.6	3.8	2.5	2.0	4.6	5.0	1.6	3.9	3.8	2.0	2.2	2.4	1.9	1.5	3.5	3.8	6.9	3.3	3.4	1.6	2.3	3.5	1.6	2.7	1.7	3.7	3.7	5.4	2.8	5.0	5.4	5.9	3.9	0.3	2.9	2.5	3.8	3.0	3.0	20.3	18.0	19.5	17.9	15.8	16.2	16.3	12.4	9.9	7.9	77.4	85.3	270.8	168.6	148.1	59.5	296.6	234.4	179.3	92.1	193.7	19.6	251.6	485.7	138.8	92.3	121.8	346.2	0.0	174.6	167.3	105.2	269.9	91.0	309.5	220.1	52.4	331.5	110.5	164.5	80.6	175.2	186.8	200.8	116.4	276.7	86.2	148.7	295.1	140.0	446.7	82.0	122.9	137.7	196.7	54.5	239.6	258.2	167.5	271.3	230.0
SMIM6	C17orf110	ENSG00000259120	"Small integral membrane protein 6"	P0DI80	17	75646243-75647977	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 22.0;fallopian tube: 19.1;stomach 1: 26.5;testis: 20.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 508.7;Late spermatids: 1038.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	46	"plasmacytoid DC: 22.0"	"Lineage enriched"	"Detected in single"	46	"dendritic cells: 22.0"	"Cell line enhanced"	"Detected in some"		"A549: 12.6;CACO-2: 4.1;EFO-21: 9.8;HEL: 7.1;OE19: 11.6;RPTEC TERT1: 4.5"									HPA065721	Uncertain		Approved	Nucleoplasm		Yes	NA			Nucleoplasm		"HPA065721: AB_2685546"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.06e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (2.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.64e-4)"	0.2	0.1	2.4	0.6	4.1	0.6	0.1	0.6	6.1	1.8	5.3	12.3	3.2	7.9	0.9	2.2	0.2	19.1	15.8	0.1	4.0	2.1	13.5	5.2	1.8	0.3	5.3	4.1	0.4	7.3	1.7	0.1	0.4	5.4	0.3	5.5	0.1	0.2	2.9	0.1	0.2	9.4	0.0	9.1	0.2	26.5	20.6	3.1	0.0	0.1	0.2	0.2	1.1	0.8	0.0	22.0	0.0	0.0	0.4	0.0	0.2	0.7	12.6	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.1	3.9	0.0	9.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	7.1	0.3	3.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.4	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.2	4.5	2.1	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	22.0	0.0	0.2	2.4	4.1	0.6	6.1	4.0	2.1	5.3	4.1	5.4	3.1	3.0	1.9	0.8	3.2	0.1	0.0	0.0	30.6	44.2	6.8	33.2	0.0	0.0	116.0	27.9	508.7	0.1	26.2	0.0	14.7	2.6	0.2	1.8	0.0	5.4	0.6	0.0	189.1	0.0	0.0	1038.8	6.1	1.0	0.0	2.8	36.2	0.0	37.4	84.2	1.8	15.7	0.0	6.5	0.1	4.9	2.1	0.0	3.4	0.0	3.1	8.4
SMO	"FZD11, SMOH"	ENSG00000128602	"Smoothened, frizzled class receptor"	Q99835	7	129188872-129213545	"Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Collecting duct cells: 10.4;Leydig cells: 19.2;Muller glia cells: 15.1;Peritubular cells: 20.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.3;AN3-CA: 37.6;NTERA-2: 28.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011446	Approved					NA	NA					"CAB011446: "	"unprognostic (2.48e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.61e-2)"	4.0	4.1	4.2	3.8	4.8	0.5	7.4	5.3	4.6	18.2	5.8	5.1	9.2	2.5	20.9	18.7	10.3	11.4	10.0	5.2	8.4	3.7	10.6	13.7	2.4	2.0	4.3	4.5	23.0	7.1	14.4	13.5	2.6	9.0	18.4	2.2	17.2	9.4	12.8	3.5	16.6	3.5	9.8	7.0	2.0	4.2	7.9	3.4	5.3	9.2	6.8	4.6	6.3	17.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	8.0	20.3	37.6	0.5	0.1	6.4	2.2	2.9	4.5	2.6	6.1	0.1	0.0	6.2	4.5	10.2	12.4	12.2	0.7	1.7	0.0	9.9	3.9	0.0	9.8	2.5	0.1	0.0	7.4	5.0	1.4	0.0	9.0	2.6	11.2	0.6	0.0	1.4	0.0	10.3	0.0	28.8	0.0	2.3	15.0	8.7	0.0	2.3	0.0	0.6	13.6	0.0	0.0	5.3	8.1	4.9	2.6	0.0	0.3	6.5	7.8	4.3	0.4	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.8	5.3	4.6	8.4	3.7	4.3	4.5	9.0	3.4	0.0	0.0	0.0	2.3	1.6	0.6	1.2	2.5	0.0	4.5	10.4	0.0	0.3	1.7	3.2	0.3	0.4	0.0	0.0	1.0	0.3	4.4	2.8	0.0	5.1	3.3	0.0	0.0	1.3	1.3	0.9	19.2	0.4	0.0	1.0	0.0	15.1	1.9	0.0	20.5	3.7	0.3	6.5	2.1	0.0	0.4	2.5	0.5	0.0	0.0	0.4
SNAP23	"HsT17016, SNAP23A, SNAP23B"	ENSG00000092531	"Synaptosome associated protein 23"	O00161	15	42491233-42545356	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 273.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"eosinophil: 102.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001214, CAB037083, CAB037317"	Approved		Supported	"Plasma membrane"		NA	NA		12000000	"Plasma membrane"		"CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.76e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	29.9	24.0	15.2	28.4	20.5	14.3	28.6	11.1	17.5	20.8	30.8	21.6	27.7	23.0	38.9	18.6	20.3	21.3	18.7	24.6	16.6	11.7	22.8	23.0	28.0	35.4	27.3	10.5	24.6	19.8	10.4	17.7	81.6	18.9	24.1	24.5	16.3	37.0	25.8	32.8	15.3	40.8	22.8	23.4	41.6	22.1	25.1	21.3	20.1	20.3	18.1	35.1	25.5	53.7	17.2	22.9	102.0	36.3	10.3	11.5	23.0	17.5	7.9	15.0	14.6	24.7	19.5	23.1	22.1	16.7	13.1	15.9	25.7	6.9	8.5	29.2	13.6	14.4	15.0	16.6	12.9	18.6	14.4	9.6	40.6	8.6	24.1	17.9	16.3	39.1	15.5	10.2	11.7	20.1	18.7	50.2	19.6	30.4	8.8	17.8	6.0	19.4	16.9	12.7	25.3	6.1	35.7	8.9	14.0	18.4	15.9	2.4	9.6	15.9	14.6	14.0	23.9	21.0	23.5	39.4	13.3	18.1	15.9	21.8	19.1	33.8	45.5	16.0	33.2	17.1	30.2	24.7	102.0	8.4	36.3	9.8	17.2	8.9	8.2	22.9	15.4	11.5	8.8	56.2	10.3	34.4	9.5	9.8	23.0	15.2	20.5	11.1	17.5	16.6	11.7	27.3	10.5	18.9	21.3	104.2	26.2	49.8	68.2	45.1	7.4	14.3	22.9	41.5	19.4	19.2	19.6	58.5	48.0	63.9	163.9	67.1	52.1	0.0	45.9	88.6	49.1	68.2	79.9	24.3	76.0	4.8	14.3	67.5	97.9	273.8	36.2	83.7	42.2	120.8	68.8	14.6	83.4	48.0	57.0	61.4	19.1	51.8	45.7	15.6	6.5	33.6	119.1	47.7	32.9	54.8
SNAP25	"bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25"	ENSG00000132639	"Synaptosome associated protein 25"	P60880	20	10218830-10307418	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"			"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"brain: 356.9"	"Cell type enhanced"	"Detected in many"	23	"Bipolar cells: 497.2;Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 186.3"	"Group enriched"	"Detected in many"	6	"glioma: 28.9;pancreatic cancer: 6.4"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"Karpas-707: 11.0;SCLC-21H: 36.6;SH-SY5Y: 21.8;U-87 MG: 26.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000360, HPA001830, HPA071013"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA			"Plasma membrane"	Vesicles	"CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: "	"unprognostic (1.64e-3)"	"unprognostic (7.26e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-7)"	"unprognostic (6.86e-3)"	"unprognostic (5.87e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-2)"	2.2	16.4	81.0	3.3	60.0	2.1	3.4	202.9	356.9	2.2	2.8	3.4	3.7	3.2	4.6	6.4	2.2	4.0	2.8	2.4	86.5	37.1	2.5	2.3	2.6	2.2	46.7	65.2	3.7	4.1	2.1	5.5	2.3	97.7	3.1	2.8	4.0	2.2	11.9	2.1	2.2	3.3	4.7	13.9	2.1	4.3	3.2	7.4	0.0	2.3	0.0	2.2	2.6	0.1	0.0	1.6	0.7	0.0	0.0	0.6	0.3	0.0	2.1	1.8	0.0	0.2	0.0	0.0	0.9	0.0	2.2	0.6	0.0	0.0	0.0	2.0	0.0	1.6	0.4	0.2	0.0	4.5	0.2	0.1	0.0	3.0	0.3	1.6	0.0	0.2	2.1	0.0	1.8	0.0	5.0	0.0	1.3	0.0	11.0	0.7	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	0.0	0.4	0.0	36.6	21.8	0.3	0.0	0.0	1.1	0.0	2.9	0.0	2.3	3.1	0.0	1.0	0.0	5.6	0.0	26.3	0.0	2.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.6	0.3	81.0	60.0	202.9	163.5	86.5	37.1	46.7	65.2	97.7	7.4	0.0	0.0	0.0	1.7	0.7	497.2	0.4	7.6	0.0	0.0	0.0	100.1	0.0	0.0	0.1	16.5	0.6	0.0	0.0	0.0	0.1	1.0	0.5	0.0	0.0	0.1	62.0	41.6	0.0	0.0	56.7	15.8	0.2	1.7	0.0	0.0	42.9	1.6	0.2	64.7	1.4	186.3	0.0	1.0	0.9	0.3	0.6	0.0	0.0	0.0	0.0
SNAPIN	"BLOC1S7, BORCS3, SNAPAP"	ENSG00000143553	"SNAP associated protein"	O95295	1	153658654-153661830	"Predicted intracellular proteins, Transporters"	"Exocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046974	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA		15000	"Golgi apparatus"	Nucleoli	"HPA046974: AB_10962506"	"unprognostic (3.65e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.31e-3)"	"unprognostic (4.89e-2)"	21.8	32.5	20.2	14.5	25.9	8.4	30.2	12.1	26.3	17.5	19.2	18.5	17.2	9.1	19.7	25.0	20.7	20.4	21.4	38.1	17.4	17.7	21.8	22.1	15.7	26.1	21.6	17.8	17.9	22.9	18.0	10.8	14.5	20.5	17.9	14.7	15.6	14.1	22.6	56.9	16.1	13.2	24.9	22.1	19.4	16.0	16.5	20.8	18.1	19.9	29.8	21.7	19.6	13.9	42.4	50.8	44.6	49.9	35.4	42.8	42.8	20.1	24.8	21.1	12.7	27.0	18.1	13.6	17.1	19.0	24.3	18.5	17.6	16.2	14.5	34.6	17.4	11.9	27.0	17.3	22.3	17.0	19.3	23.9	16.0	19.1	8.4	27.9	15.7	10.2	21.7	16.7	18.1	20.7	24.5	22.7	17.0	13.6	11.2	24.3	32.6	17.9	9.2	11.4	31.7	26.7	17.1	18.4	38.3	26.8	19.4	16.1	28.2	19.7	22.9	22.4	20.7	34.8	16.8	20.0	11.3	17.3	22.4	16.0	27.3	29.8	22.1	21.6	9.9	14.7	27.6	49.9	44.6	30.9	49.1	35.0	42.4	31.4	31.0	50.8	36.9	34.8	31.8	10.4	35.4	39.0	38.1	42.8	42.8	20.2	25.9	12.1	26.3	17.4	17.7	21.6	17.8	20.5	20.8	17.9	17.6	24.3	31.9	18.3	13.6	35.0	22.9	36.1	22.7	27.9	7.9	54.7	63.0	60.4	5.7	30.1	18.8	0.0	57.1	40.8	26.9	29.4	30.0	25.5	77.8	20.6	13.3	31.9	48.5	18.5	28.4	40.8	25.3	91.0	20.8	57.6	41.2	25.7	46.7	60.8	17.2	45.3	38.2	29.6	39.2	20.6	61.7	26.6	25.6	33.4
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89724099-89838315	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Alzheimer disease, Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 31.2;bone marrow: 91.0;brain: 121.3"	"Group enriched"	"Detected in many"	7	"Erythroid cells: 630.8;Melanocytes: 334.0"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"myeloid DC: 25.4;plasmacytoid DC: 31.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 31.2;granulocytes: 10.1;monocytes: 20.5"	"Cell line enhanced"	"Detected in many"		"HEL: 43.9;HUVEC TERT2: 53.5;RT4: 28.3;SK-MEL-30: 52.4;TIME: 61.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"	NA	NA		23000000			"CAB010877: AB_261518, HPA005459: AB_2667324"	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	3.9	5.4	38.9	4.7	26.1	91.0	4.3	41.7	121.3	6.2	4.7	9.0	0.0	2.3	15.5	2.5	4.5	3.2	3.2	9.0	35.2	22.5	4.2	1.9	4.5	1.8	36.2	49.6	13.6	1.6	1.2	5.4	12.1	26.3	4.6	3.9	5.3	4.9	5.3	1.1	7.6	2.9	15.1	21.4	4.0	1.7	2.2	15.1	0.0	5.2	1.2	2.9	4.1	4.4	0.9	31.2	10.1	20.5	4.8	0.6	19.5	0.1	0.1	8.3	0.0	0.1	0.0	0.1	0.0	8.7	0.3	0.6	0.0	0.0	0.0	2.4	0.0	0.0	1.8	10.8	20.0	0.3	0.0	4.8	43.9	24.8	0.0	18.0	0.0	0.3	0.4	7.7	0.0	22.6	24.8	53.5	0.4	0.3	0.1	0.0	0.0	0.3	0.0	2.1	0.0	0.9	0.0	3.2	0.0	0.0	28.3	4.7	3.1	0.0	0.0	52.4	6.3	0.0	0.0	61.2	0.2	1.6	0.0	0.1	0.0	0.0	0.0	1.7	0.0	17.6	10.1	20.5	0.0	0.0	8.1	0.0	0.9	0.6	0.1	25.4	0.5	0.3	0.2	3.7	4.8	2.3	31.2	0.0	19.5	38.9	26.1	41.7	55.1	35.2	22.5	36.2	49.6	26.3	15.1	0.0	1.1	2.7	16.7	68.1	4.0	6.2	0.0	5.3	9.1	10.4	0.0	9.1	1.7	0.0	0.3	16.5	0.0	630.8	0.2	2.7	7.8	6.3	0.0	0.0	54.2	9.5	1.7	1.8	8.8	1.3	2.0	48.8	334.0	15.4	0.0	15.1	0.3	0.0	0.0	1.2	6.1	12.9	3.3	4.2	3.0	19.7	2.9	0.0	0.0	2.7
SNCB		ENSG00000074317	"Synuclein beta"	Q16143	5	176620084-176630556	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	24	"brain: 134.8"	"Cell type enhanced"	"Detected in some"	20	"Bipolar cells: 71.1;Cone photoreceptor cells: 15.7;Horizontal cells: 47.7;Rod photoreceptor cells: 33.9"	"Cancer enriched"	"Detected in some"	8	"glioma: 11.1"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"naive B-cell: 3.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 3.1"	"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 36.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002681, HPA035876"	Enhanced	Supported				NA	NA					"CAB002681: , HPA035876: AB_10670592"	"unprognostic (3.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-2)"		"unprognostic (6.07e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.31e-1)"	"unprognostic (5.41e-5)"	"unprognostic (1.31e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.42e-3)"	1.6	3.9	53.7	1.6	24.9	1.5	1.6	64.1	134.8	1.5	1.7	2.2	0.0	1.6	1.6	1.5	1.5	1.6	1.6	1.8	39.4	31.0	1.6	1.5	1.5	1.7	27.5	30.0	1.5	2.1	1.5	1.9	1.6	31.5	1.6	1.6	5.6	1.5	1.5	2.7	1.6	1.6	1.6	7.4	1.6	1.6	1.7	1.5	0.0	1.5	0.0	1.6	1.6	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.5	0.0	3.8	0.1	1.7	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	1.1	0.6	0.0	0.0	2.8	0.0	1.6	0.0	0.0	0.2	0.0	0.0	36.9	1.3	0.0	0.1	3.5	0.1	1.6	0.1	0.0	0.0	1.5	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	53.7	24.9	64.1	87.6	39.4	31.0	27.5	30.0	31.5	1.5	0.0	0.0	0.0	0.0	0.0	71.1	1.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	47.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.3	0.0	0.0	0.0	33.9	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0
SNCG	"BCSG1, persyn, SR"	ENSG00000173267	"Synuclein gamma"	O76070	10	86958618-86963260	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 74.1;adrenal gland: 78.3;brain: 100.1;urinary bladder: 76.6"	"Cell type enhanced"	"Detected in many"	12	"Smooth muscle cells: 114.4;Urothelial cells: 347.2"	"Group enriched"	"Detected in all"	8	"ovarian cancer: 84.1;urothelial cancer: 301.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.4;naive CD4 T-cell: 1.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 95.9;RT4: 79.0"	"Region enhanced"	"Detected in many"		"pons and medulla: 292.8"	"Low region specificity"	"Detected in many"			"CAB001452, HPA014404, CAB040581"	Enhanced	Supported	Supported	Centrosome		NA	NA			Centrosome		"CAB001452: AB_564020, CAB040581: , HPA014404: AB_1857715"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (2.29e-8)"	"prognostic unfavorable (7.15e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.77e-3)"	74.1	78.3	82.3	5.3	20.8	1.0	28.9	12.3	44.5	9.5	5.8	4.6	6.4	4.8	6.1	12.0	11.0	26.5	6.2	9.0	40.0	92.9	4.1	1.9	4.6	4.9	72.9	35.1	15.0	3.5	1.6	1.7	4.9	100.1	11.9	2.7	10.8	10.9	44.4	6.6	8.5	5.4	5.8	35.2	20.2	2.6	2.9	5.3	0.2	3.4	3.3	9.6	76.6	18.3	0.0	0.7	0.0	2.4	0.0	1.8	0.6	0.2	1.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	95.9	0.0	2.0	0.1	0.0	8.0	0.0	0.3	0.0	0.0	0.0	0.6	18.6	0.3	0.1	0.0	0.1	0.4	7.5	0.0	0.0	0.0	6.8	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	79.0	0.0	0.0	0.7	1.0	0.1	0.0	20.8	0.0	17.4	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	1.8	0.0	0.0	0.0	0.9	0.0	0.0	0.6	82.3	20.8	12.3	44.5	40.0	92.9	72.9	35.1	100.1	5.3	0.0	0.0	0.0	64.9	25.5	30.2	1.4	0.0	1.4	5.7	52.4	5.9	12.2	106.1	3.7	0.4	107.8	0.0	0.0	1.0	0.4	12.1	11.4	0.0	0.2	4.3	82.6	0.0	108.1	1.6	0.6	54.7	2.9	21.9	1.0	0.0	45.4	2.9	0.0	9.2	0.9	69.6	90.5	114.4	0.5	0.5	17.2	5.1	0.0	0.0	347.2
SNX27	"KIAA0488, MGC20471, MY014"	ENSG00000143376	"Sorting nexin family member 27"	Q96L92	1	151612006-151699091	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 9.5;classical monocyte: 18.6;intermediate monocyte: 16.1;myeloid DC: 8.4;neutrophil: 20.3;non-classical monocyte: 16.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 8.4;granulocytes: 20.3;monocytes: 18.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045816			Approved	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA045816: "	"unprognostic (3.35e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.79e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.04e-1)"	10.9	12.5	21.5	12.5	28.6	13.4	12.6	25.0	27.7	14.8	15.9	23.4	13.5	9.1	12.1	16.2	12.1	13.9	11.5	12.1	23.0	21.3	24.2	12.8	13.6	10.4	23.7	19.2	17.2	10.0	26.0	14.8	17.5	20.3	14.8	13.0	13.1	9.7	20.6	25.6	16.0	10.1	21.3	23.1	17.0	11.2	12.8	18.7	8.8	12.8	7.7	10.8	17.4	21.7	2.5	8.4	20.3	18.6	1.7	3.6	7.3	5.9	8.9	9.5	11.9	15.0	11.1	21.1	3.2	6.7	5.7	6.2	7.2	8.0	5.7	7.1	5.2	6.2	7.5	12.1	6.5	7.2	8.1	4.5	9.1	5.2	8.1	10.0	10.8	6.3	8.8	4.9	6.5	7.5	5.8	6.4	9.1	5.5	35.1	7.5	10.7	6.4	7.5	16.7	11.8	5.8	6.7	9.2	7.3	8.9	9.0	9.5	8.1	8.7	16.2	6.2	10.7	10.4	9.2	8.5	8.1	5.5	8.4	6.7	7.4	7.4	11.5	9.7	7.0	9.0	9.5	18.6	2.6	2.6	16.1	3.6	1.8	3.2	2.3	8.4	2.5	3.1	2.5	20.3	1.7	16.9	2.1	2.5	7.3	21.5	28.6	25.0	24.6	23.0	21.3	23.7	19.2	20.3	18.7	11.9	21.9	11.2	13.8	18.8	42.4	25.5	20.4	8.1	15.9	27.9	25.5	40.5	21.6	21.5	23.7	16.1	12.3	23.3	18.3	18.4	17.5	15.0	3.5	17.9	37.8	38.1	18.0	22.7	76.7	6.6	28.1	28.6	28.7	32.5	15.2	22.7	21.5	10.5	37.4	51.8	27.3	32.3	19.4	41.7	29.4	21.7	87.6	12.9	15.8	13.2
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572882-100663415	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 21.4;prostate: 13.8;urinary bladder: 25.4;vagina: 16.0"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 73.9"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in single"	50	"RT4: 42.9"	"Region enriched"	"Detected in single"	5	"thalamus: 2.9"	"Region enhanced"	"Detected in single"		"olfactory region: 3.1"	"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.5	0.0	0.6	0.1	0.7	0.1	0.4	0.6	2.3	1.7	0.3	0.3	0.1	0.2	0.3	0.2	6.2	0.3	0.9	1.8	0.8	0.7	0.3	0.4	0.3	0.3	0.9	0.3	0.3	0.2	0.1	0.2	0.1	0.6	13.8	0.1	0.4	1.4	0.1	1.0	0.5	0.1	7.4	0.8	0.1	0.6	3.3	0.5	0.1	0.4	2.6	21.4	25.4	16.0	1.1	0.3	3.0	0.5	1.6	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.9	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.1	2.5	0.5	0.2	0.3	0.2	0.1	1.1	0.1	0.2	0.2	0.5	0.1	0.3	3.0	1.6	0.0	0.3	0.0	0.0	0.6	0.7	0.6	0.3	0.8	0.7	0.9	0.3	0.6	0.5	0.0	0.0	0.0	3.6	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	73.9	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.0	0.4	0.4	0.4	0.0	0.0	0.0	1.0
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA binding protein"	P18583	21	33542618-33577481	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030"	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	40.0	41.1	33.3	32.7	42.8	87.7	40.8	46.2	42.3	38.7	36.1	41.3	34.1	27.8	51.9	41.6	39.3	44.8	27.7	37.5	32.9	25.6	32.0	38.0	41.3	44.8	40.0	32.6	52.9	40.4	92.1	70.3	42.4	41.2	41.3	37.6	37.6	40.7	36.3	64.1	39.2	41.6	34.6	47.6	47.0	41.2	29.6	41.4	59.0	42.1	27.3	46.4	43.0	47.3	20.1	27.1	26.8	15.5	15.2	17.2	9.0	27.8	14.0	36.4	20.5	32.2	29.1	26.2	19.5	26.1	20.7	19.6	23.3	20.2	45.3	11.4	32.5	23.9	20.7	42.2	32.6	33.0	18.7	20.7	58.7	19.2	30.9	23.9	55.2	27.0	30.8	38.0	24.5	37.6	26.5	31.4	24.7	44.2	45.7	29.7	28.1	29.5	31.1	39.7	30.5	16.3	29.0	38.8	33.4	32.0	24.9	20.9	20.6	32.7	28.0	22.6	31.5	25.5	32.5	31.2	22.2	20.7	16.6	21.2	42.9	35.1	54.1	23.8	47.4	21.6	18.6	14.4	18.7	15.4	12.6	15.3	19.9	17.1	16.0	10.9	20.1	17.2	16.7	26.8	15.2	15.5	27.1	14.5	9.0	33.3	42.8	46.2	42.3	32.9	25.6	40.0	32.6	41.2	41.4	381.2	269.8	245.0	287.1	384.7	382.2	339.3	303.2	329.2	315.1	286.1	208.1	195.6	164.2	182.7	62.5	272.4	180.8	256.9	180.4	138.6	293.6	211.2	400.4	301.9	149.2	430.6	179.2	276.8	201.3	39.3	364.7	259.5	207.5	184.0	159.3	365.4	155.4	161.4	369.9	137.2	353.2	375.1	318.2	436.1	320.9	344.7	273.6	278.4	160.2	183.4
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397951	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Osteogenesis, Transport"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 71.1;epididymis: 75.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 9.0;non-classical monocyte: 10.0"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA	7170000		"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	22.9	6.5	24.0	6.2	35.5	10.1	15.5	6.4	40.6	10.1	15.2	50.3	18.1	11.5	11.9	75.2	22.0	14.8	9.5	31.8	45.2	19.8	21.1	3.7	19.2	3.6	57.9	22.8	3.6	9.3	24.2	5.7	22.9	27.1	10.3	14.4	12.2	11.8	24.8	36.4	8.3	11.3	14.6	71.1	5.4	9.5	21.6	42.2	1.1	22.5	5.1	5.4	8.7	8.2	0.0	4.5	2.3	10.0	0.4	0.0	1.7	11.8	4.7	11.9	14.5	34.8	6.9	34.3	8.8	14.1	8.7	9.3	12.2	4.4	0.1	11.3	3.7	6.4	2.9	14.0	6.9	12.5	0.3	6.6	3.2	7.7	13.1	13.6	0.0	10.7	17.3	1.1	10.6	2.3	23.3	1.3	9.9	24.4	1.2	12.1	12.5	8.3	0.2	4.4	5.3	2.0	9.3	28.1	5.7	16.6	8.6	12.2	7.0	5.2	34.5	37.0	17.7	14.5	2.0	0.3	1.8	7.1	0.3	14.7	11.8	9.6	0.0	3.1	0.0	7.6	0.0	7.1	2.3	0.0	9.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.9	0.4	10.0	1.6	0.0	1.7	24.0	35.5	6.4	33.9	45.2	19.8	57.9	22.8	27.1	42.2	35.7	42.8	0.0	4.2	1.1	14.6	83.1	33.1	22.7	18.2	71.5	33.4	26.8	5.0	23.3	53.4	7.3	49.9	0.0	20.8	26.7	6.1	10.7	7.0	22.5	27.9	12.7	16.1	4.3	36.7	56.4	8.1	24.8	20.3	20.8	30.9	20.4	21.0	17.5	46.7	9.9	42.2	32.3	31.1	51.1	20.4	1.6	30.8	1.8	19.9	10.8
SPNS1	"HSpin1, LAT, nrs, PP2030, SPIN1, SPINL"	ENSG00000169682	"Sphingolipid transporter 1 (putative)"	Q9H2V7	16	28974221-28984548	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041995, HPA042988"	Enhanced		Approved	"Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol"		NA	NA			Vesicles	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA041995: AB_10959609, HPA042988: AB_10964587"	"unprognostic (3.54e-2)"	"unprognostic (4.57e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.66e-1)"	"unprognostic (7.86e-5)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.85e-7)"	"unprognostic (1.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.12e-2)"	23.4	23.9	14.5	22.0	15.9	38.3	24.2	21.0	22.8	18.2	22.1	24.1	20.1	26.9	25.1	21.3	20.9	17.1	26.8	16.1	14.9	12.1	24.1	28.3	33.4	22.6	15.4	17.0	18.3	20.8	29.5	17.2	40.7	15.4	20.1	12.6	19.8	20.8	22.8	21.3	30.9	22.3	26.3	14.5	27.3	20.7	22.3	17.2	31.0	22.0	24.5	17.2	21.2	19.5	3.1	15.6	7.2	23.5	4.2	7.9	10.1	10.3	24.5	9.3	21.6	17.9	9.9	26.5	11.6	12.0	19.4	17.4	22.3	24.9	6.6	28.6	10.4	16.1	22.0	15.0	12.8	7.0	7.6	25.5	9.6	23.9	27.7	30.4	10.6	20.7	16.5	17.2	20.9	8.9	11.4	17.8	12.4	21.5	12.0	9.7	27.7	11.6	30.4	21.9	8.4	16.2	14.7	11.2	29.6	10.5	10.1	16.7	21.6	8.2	24.7	18.0	8.1	24.6	12.9	15.0	15.8	12.0	22.0	8.9	18.2	14.3	6.2	20.2	16.3	12.7	6.4	18.2	7.2	6.0	23.5	5.0	3.1	6.0	7.9	15.6	2.8	6.2	4.1	3.3	4.2	15.7	6.5	6.8	10.1	14.5	15.9	21.0	22.8	14.9	12.1	15.4	17.0	15.4	17.2	6.0	7.4	9.0	18.6	18.9	27.1	0.4	10.2	12.0	3.4	19.2	27.5	55.8	11.6	51.1	1.5	21.6	16.8	0.0	39.5	59.8	27.5	13.4	20.9	12.1	87.9	25.4	11.7	19.6	37.6	1.9	21.0	27.5	32.1	26.2	18.9	29.6	34.8	14.0	15.6	13.5	33.9	6.5	15.3	17.2	28.3	19.8	73.0	22.5	23.8	17.0
SPNS2		ENSG00000183018	"Sphingolipid transporter 2"	Q8IVW8	17	4498838-4539035	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 45.9"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 25.5;Collecting duct cells: 21.0;Endothelial cells: 25.3;Proximal tubular cells: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"eosinophil: 1.2;NK-cell: 1.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.2;NK-cells: 1.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 11.0;RPTEC TERT1: 57.9;SK-BR-3: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068717	Uncertain					NA	NA					"HPA068717: AB_2686021"	"unprognostic (3.03e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.89e-2)"	9.8	2.1	10.3	5.8	13.6	7.9	8.6	5.3	19.5	8.2	4.9	22.6	0.0	13.1	5.4	2.1	45.9	4.6	13.8	7.2	11.0	7.8	31.2	3.3	16.1	5.4	21.3	10.9	1.8	7.3	2.3	1.3	9.0	25.0	3.2	3.2	11.6	11.2	3.2	5.0	13.8	8.5	5.8	12.3	9.1	21.7	2.0	15.7	0.0	5.2	10.9	15.7	8.4	13.1	0.0	0.2	1.2	0.0	1.2	0.2	0.0	3.2	0.4	0.0	0.1	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.1	2.8	0.1	4.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.6	0.0	0.0	0.0	1.3	0.0	5.7	0.0	6.0	0.1	0.2	0.0	0.1	57.9	0.2	1.9	0.0	0.0	26.9	0.0	1.9	0.9	2.5	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.3	1.2	0.0	0.0	0.0	0.0	10.3	13.6	5.3	19.5	11.0	7.8	21.3	10.9	25.0	15.7	6.0	8.8	0.0	0.2	1.5	0.6	0.8	25.5	1.4	12.5	21.0	0.0	0.1	1.7	14.3	0.2	25.3	1.3	0.0	2.7	14.8	1.7	4.6	0.0	5.6	0.9	6.4	0.0	14.7	0.8	0.0	0.6	0.7	1.7	0.0	10.8	0.3	11.9	0.0	0.4	23.7	0.7	0.0	2.3	0.5	0.4	2.0	1.6	0.0	0.4	1.4
SPPL2A	"IMP3, PSL2"	ENSG00000138600	"Signal peptide peptidase like 2A"	Q8TCT8	15	50702266-50765808	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036062, HPA067304"	Enhanced		Supported	Vesicles		NA	NA			Vesicles		"HPA036062: AB_10611670, HPA067304: AB_2685820"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.66e-1)"	20.5	23.5	6.9	18.0	8.6	15.0	23.3	6.2	8.1	16.4	29.3	10.8	15.3	24.9	14.5	17.9	18.7	13.0	14.9	37.6	7.8	5.3	23.3	44.8	19.2	23.9	8.3	6.1	13.2	32.7	61.0	11.8	32.2	14.4	14.7	26.9	14.9	21.7	15.5	63.1	15.8	39.2	20.5	8.5	21.2	18.3	10.2	7.4	21.6	15.6	17.4	17.7	19.7	13.9	9.8	19.4	24.0	27.3	11.9	15.4	22.4	15.4	26.9	10.5	13.8	41.4	24.7	16.5	24.9	41.8	22.9	32.7	31.1	17.9	9.6	18.6	48.7	34.4	23.3	12.6	15.1	25.6	19.6	7.7	18.2	18.4	16.0	34.2	11.3	29.8	21.4	27.8	18.9	30.6	17.0	22.5	10.5	13.7	37.8	30.2	35.6	5.3	4.3	4.5	24.8	6.1	6.5	16.2	21.1	31.4	36.0	8.4	9.5	15.0	29.0	16.8	22.0	20.6	22.4	27.4	37.0	14.9	23.7	29.3	15.4	26.3	10.6	16.7	19.0	25.3	21.2	26.9	24.0	15.4	24.6	9.7	9.8	12.6	13.9	19.4	9.3	7.2	11.5	19.4	11.9	27.3	17.1	15.4	22.4	6.9	8.6	6.2	8.1	7.8	5.3	8.3	6.1	14.4	7.4	44.7	34.7	37.5	70.0	38.2	14.8	64.5	58.6	29.4	37.5	64.6	19.6	118.1	19.9	75.9	11.3	46.7	152.1	0.0	145.2	68.6	45.2	72.3	45.0	111.7	79.3	7.9	36.9	43.0	60.6	5.6	41.4	67.0	30.4	170.5	66.7	31.2	103.1	123.8	34.3	42.8	17.0	25.8	39.1	30.5	14.8	33.9	171.1	48.4	59.7	82.4
SPRN	"bA108K14.1, FLJ41197, Shadoo, Sprn"	ENSG00000203772	"Shadow of prion protein"	Q5BIV9	10	133420666-133424572	"Predicted intracellular proteins, Transporters"		Prion		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 20.7"	"Cell type enhanced"	"Detected in some"	15	"Cardiomyocytes: 1.2;Horizontal cells: 3.2;Ito cells: 2.5;Kupffer cells: 2.2"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in some"		"non-classical monocyte: 4.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA						"unprognostic (2.66e-1)"	"unprognostic (1.64e-3)"	"unprognostic (3.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.17e-2)"	"prognostic favorable (1.58e-7)"	0.5	2.5	4.3	1.5	3.8	0.8	0.1	7.4	20.7	0.4	0.5			3.3	1.1	0.0	1.0	0.2	1.3	0.8	6.1	2.7	1.1	6.9	0.6	1.6	1.7		1.0	1.7	0.0	1.7	0.8		1.2	0.0		2.0	0.1	2.3	2.0	2.2	0.4	0.9	1.7	2.2	1.9			0.9		0.0	0.9	0.1	1.1	1.0	0.4	4.5	0.2	1.2	0.6	2.7	5.2	3.9	7.8	0.0	0.0	6.3	4.2	0.0	1.0	0.1	6.3	1.9	3.9	1.5	2.1	0.9	3.4	0.6	0.0	0.0	2.5	7.3	3.7	6.0	7.1	0.3	3.9	3.2	0.5	0.0	0.0	0.0	2.5	0.0	2.9	4.0	2.7	0.5	2.7	2.2	7.4	3.8	1.4	2.1	5.4	2.5	0.7	0.0	3.2	2.3	3.5	1.4	3.8	4.7	1.5	2.4	2.8	2.8	2.3	3.0	1.7	3.2	3.2	1.6	3.0	1.7	2.6	1.2	0.4	0.3	0.0	0.4	0.9	0.8	0.3	0.9	1.2	0.2	1.1	1.0	0.4	0.0	0.2	4.5	1.0	0.6	0.6											0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.2	0.0	2.5	2.2	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 5.3;non-classical monocyte: 4.4"	"Group enriched"	"Detected in many"	6	"dendritic cells: 3.0;monocytes: 5.3"	"Cell line enhanced"	"Detected in many"		"A549: 35.9;HBEC3-KT: 33.4;RT4: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		20000000	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	6.9	17.5	12.8	11.1	12.0	5.4	9.9	6.4	16.0	16.0	16.4	3.5	15.1	29.5	20.3	9.7	16.2	14.2	42.1	5.8	11.3	6.6	13.4	2.9	10.4	7.0	3.3	9.9	15.8	19.1	6.6	11.3	6.3	5.1	19.9	13.1	13.1	7.5	22.5	3.4	7.7	28.1	27.2	3.6	12.2	29.8	27.3	4.8	4.0	6.6	10.5	10.4	26.4	20.0	0.3	3.0	0.1	5.3	0.6	0.1	1.6	7.7	35.9	8.3	7.4	3.1	5.0	17.2	7.2	6.2	8.8	5.6	13.5	7.0	0.2	4.5	13.0	10.0	14.2	4.9	33.4	3.4	0.0	4.5	2.0	1.3	20.9	7.5	0.1	3.1	5.3	11.4	5.7	7.7	9.8	8.0	4.6	0.2	0.0	1.4	5.3	1.9	0.2	3.9	21.5	32.6	8.4	2.2	0.2	3.7	34.4	7.7	27.9	8.1	11.4	8.9	6.6	10.2	2.8	11.6	10.5	7.1	3.8	6.4	0.1	0.2	0.1	7.4	0.0	7.8	0.0	2.6	0.0	0.0	5.3	0.0	0.3	0.0	0.1	1.1	0.3	0.0	0.0	0.1	0.6	4.4	3.0	0.1	1.6	12.8	12.0	6.4	16.0	11.3	6.6	3.3	9.9	5.1	4.8	3.0	1.7	4.4	10.8	7.2	5.4	1.6	15.3	1.4	0.0	12.2	2.0	1.6	1.7	9.7	1.3	1.4	30.0	0.0	16.2	7.0	8.2	11.2	0.0	0.9	5.8	3.2	16.1	1.3	6.9	1.5	10.0	12.1	1.7	7.2	25.9	4.1	29.0	18.1	16.3	9.5	4.7	12.9	6.4	0.2	0.7	8.0	1.9	0.0	14.9	27.7
SRP14	"ALURBP, MGC14326"	ENSG00000140319	"Signal recognition particle 14"	P37108	15	40035739-40039188	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053738, HPA065118"			Approved	Nucleoplasm,Nucleoli		NA	NA		400000	Nucleoli	Nucleoplasm	"HPA053738: , HPA065118: "	"unprognostic (2.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (2.20e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.41e-3)"	"unprognostic (4.94e-2)"	63.0	81.2	100.0	46.0	102.8	85.9	75.4	65.4	91.3	87.8	62.6	67.9	54.7	50.7	83.0	115.7	75.6	87.8	64.2	114.2	80.7	95.4	107.2	79.6	52.2	60.8	103.5	86.3	99.1	59.1	69.6	82.3	68.8	84.3	84.1	65.0	61.0	71.3	66.4	107.5	44.4	65.7	67.2	86.5	67.5	56.0	43.4	68.9	58.7	98.9	56.6	65.0	80.9	72.7	78.7	151.5	111.2	69.3	63.6	96.4	135.1	24.2	30.4	73.8	55.1	55.3	50.1	36.0	44.7	47.4	38.8	39.9	54.7	20.8	20.4	46.6	54.2	62.1	39.3	58.6	46.5	36.8	48.6	41.9	48.6	97.1	64.0	42.4	43.2	39.7	52.1	53.3	32.1	39.4	73.9	65.2	55.9	50.8	37.4	62.0	36.8	63.8	51.0	40.2	94.1	55.2	43.9	33.7	34.3	83.7	72.4	53.8	48.0	45.1	44.8	29.3	47.6	61.6	80.2	56.1	45.2	30.7	42.6	32.6	30.5	85.1	50.5	43.9	47.2	41.8	76.2	69.3	111.2	68.5	62.5	66.4	78.7	77.7	76.3	74.5	66.1	75.4	72.8	60.7	63.6	56.5	151.5	96.4	135.1	100.0	102.8	65.4	91.3	80.7	95.4	103.5	86.3	84.3	68.9	428.8	342.1	635.3	745.6	592.5	436.3	765.2	639.5	717.4	483.4	943.9	117.8	766.6	2161.9	1141.2	204.6	898.5	667.3	467.2	948.8	912.5	754.8	783.4	543.5	639.1	894.6	328.9	532.2	609.5	565.3	236.1	962.8	751.5	749.0	1439.1	546.1	918.4	1056.2	782.0	927.8	1642.5	369.6	614.4	716.0	645.9	602.6	620.9	634.6	518.4	577.5	829.8
SRP19		ENSG00000153037	"Signal recognition particle 19"	"P09132, Q15695"	5	112861188-112898371	"Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029272	Approved					NA	NA					"HPA029272: AB_10600910"	"unprognostic (4.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (3.72e-10)"	"unprognostic (1.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.69e-3)"	20.3	24.6	21.2	21.3	24.2	52.3	23.0	20.2	27.4	16.9	17.9	18.4	20.1	18.7	20.1	30.7	23.1	17.5	18.3	20.2	20.0	25.2	27.1	53.2	18.8	27.2	19.3	21.6	16.6	36.2	18.2	45.2	24.5	24.9	26.3	21.7	12.7	34.5	19.9	25.6	18.3	20.4	23.5	19.3	23.4	19.4	14.7	19.8	23.5	31.2	20.1	29.3	18.5	16.9	27.3	43.0	26.2	19.3	23.8	35.0	17.5	22.3	15.1	19.2	30.8	18.0	21.0	46.9	31.8	19.6	27.1	32.7	25.8	17.8	23.4	21.9	20.2	43.7	15.0	20.6	32.4	32.8	25.1	33.6	21.0	28.7	30.3	28.5	16.6	23.2	24.4	31.9	25.7	37.8	18.0	25.0	25.8	15.4	28.4	23.1	26.4	26.7	29.7	19.9	22.7	24.0	17.3	17.1	35.1	26.6	28.5	22.0	19.4	25.4	16.7	14.7	23.2	25.2	24.2	20.1	22.8	19.2	22.5	37.2	33.6	40.6	40.8	22.1	28.4	23.4	26.2	17.7	20.9	26.5	18.0	32.4	27.3	29.8	27.9	19.8	23.2	25.6	28.3	24.2	23.8	19.3	43.0	35.0	17.5	21.2	24.2	20.2	27.4	20.0	25.2	19.3	21.6	24.9	19.8	74.5	47.1	73.7	61.1	76.7	15.1	38.0	38.2	71.0	80.8	41.8	19.6	67.2	87.9	85.6	16.7	40.6	28.5	46.7	89.8	103.9	58.3	74.4	71.6	58.2	75.1	12.7	114.2	34.4	53.7	16.7	35.9	72.3	49.0	83.8	43.5	23.4	113.3	35.1	37.1	90.1	21.5	25.8	39.2	85.2	43.5	76.8	123.9	69.2	34.6	107.5
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029567	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Hydrolase, Ribonucleoprotein, RNA-binding"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 276.0;Late spermatids: 646.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Supported	Nucleoli,Cytosol		NA	NA			Cytosol	Nucleoli	"HPA048977: AB_2680583, HPA062044: AB_2684668"	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	18.4	27.5	18.6	21.3	21.0	13.6	22.5	18.2	26.0	24.6	19.2	23.2	31.2	19.3	24.1	25.5	22.6	18.0	17.1	21.8	18.7	22.5	34.4	67.8	19.4	24.0	23.7	17.1	21.1	43.2	30.1	47.1	26.4	29.4	23.2	21.7	19.2	48.1	31.2	28.4	19.6	24.4	20.0	22.3	23.5	22.3	30.8	19.4	32.3	23.6	22.5	27.9	23.9	17.6	20.5	23.4	26.3	30.1	29.5	33.4	19.7	20.7	22.5	21.6	20.2	22.3	23.0	25.9	29.8	27.1	30.8	39.5	27.0	23.3	30.3	30.4	28.4	28.5	21.9	29.5	23.4	44.8	30.1	14.8	24.5	21.4	63.3	34.6	26.2	24.8	19.2	23.1	22.7	40.4	24.0	31.0	24.4	21.7	33.2	32.0	34.5	27.9	14.7	16.5	34.4	21.8	22.3	26.4	24.2	36.7	31.8	20.5	22.0	21.4	27.7	27.1	27.5	36.8	18.2	23.5	18.8	20.2	22.3	20.5	28.8	38.6	37.9	13.4	16.9	22.4	15.9	19.8	26.3	23.6	24.0	29.3	20.5	23.6	26.0	23.4	18.6	22.3	21.7	19.3	29.5	30.1	16.0	33.4	19.7	18.6	21.0	18.2	26.0	18.7	22.5	23.7	17.1	29.4	19.4	11.9	36.4	40.4	46.3	35.5	36.9	37.2	33.1	69.6	51.2	38.4	55.0	59.6	54.7	58.2	276.0	33.1	35.1	0.0	69.6	58.9	47.2	64.3	46.2	104.3	43.9	25.4	43.1	39.9	42.5	646.5	35.6	43.2	27.0	55.1	39.6	44.1	49.6	29.4	35.3	59.6	42.9	25.8	33.7	79.0	57.0	44.0	78.6	47.1	27.0	51.8
SRP68		ENSG00000167881	"Signal recognition particle 68"	Q9UHB9	17	76038775-76072653	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 135.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023303, HPA055617"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA023303: AB_1857477, HPA055617: AB_2682863"	"unprognostic (1.25e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (3.31e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.75e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.02e-3)"	23.2	23.8	39.8	20.3	41.1	17.5	22.9	35.4	44.1	25.4	28.1	16.6	26.3	18.4	25.7	34.4	37.6	26.0	16.4	25.5	32.4	24.9	24.9	28.9	21.8	22.1	23.8	32.2	32.3	43.1	33.4	29.1	32.0	34.5	24.4	25.0	16.6	27.6	25.8	71.7	35.4	19.7	30.8	30.3	22.6	25.2	18.4	32.4	20.6	32.0	20.4	34.5	25.6	27.3	17.5	20.4	20.2	16.4	26.3	24.5	10.5	38.5	34.1	21.1	22.0	30.1	24.3	38.2	28.2	20.7	33.8	26.5	28.7	21.5	30.5	14.5	28.6	28.7	26.2	39.7	29.9	50.5	12.7	44.1	28.3	27.6	42.2	35.6	33.3	22.1	21.4	33.5	29.6	26.0	25.4	39.2	19.3	40.4	28.8	28.3	23.6	32.1	20.7	19.5	38.4	36.1	27.2	56.5	31.2	28.2	34.0	26.0	25.5	25.8	41.9	31.0	37.0	37.3	30.4	25.0	36.9	28.2	17.0	37.5	28.5	12.9	34.4	26.7	24.8	27.4	3.7	16.4	20.2	15.2	15.0	16.5	17.5	21.5	23.3	20.4	14.6	24.5	18.2	2.6	26.3	14.8	15.8	18.8	10.5	39.8	41.1	35.4	44.1	32.4	24.9	23.8	32.2	34.5	32.4	26.8	19.3	22.9	42.7	27.8	22.2	22.7	17.8	24.1	18.2	12.2	35.3	74.5	31.5	33.0	12.5	26.3	16.9	70.0	35.9	53.4	23.6	31.9	16.2	20.2	33.1	35.0	13.8	18.4	16.2	13.7	22.5	16.9	23.6	38.7	16.9	28.4	35.1	14.0	26.5	20.3	21.5	0.0	28.8	30.5	24.8	27.7	135.7	22.4	20.8	41.4
SRP72		ENSG00000174780	"Signal recognition particle 72"	O76094	4	56467336-56503681	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Ribonucleoprotein	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034621	Approved					NA	NA					"HPA034621: AB_10601593"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.35e-1)"	28.7	26.4	18.5	23.1	27.0	37.3	29.8	24.1	33.5	27.0	22.7	17.3	31.3	17.1	30.2	22.7	32.1	24.3	20.2	21.6	17.2	20.9	26.6	52.5	24.9	33.4	20.5	23.6	32.7	43.8	26.7	32.5	40.9	32.1	21.8	25.3	13.0	49.6	30.1	34.4	33.3	23.2	27.1	22.6	34.4	24.1	15.9	18.8	41.8	32.9	34.8	31.9	28.7	25.4	25.7	37.4	16.8	32.4	25.9	31.5	23.9	26.9	20.8	26.4	25.4	16.8	24.2	25.5	40.1	32.1	33.7	27.1	23.0	30.8	41.9	27.6	33.4	17.8	15.6	32.5	34.0	40.1	11.0	18.9	36.5	24.6	21.4	30.8	70.1	30.4	22.8	45.8	35.9	64.0	29.4	30.0	32.3	52.9	40.5	32.1	20.9	41.3	18.2	22.8	33.8	21.9	37.1	21.3	31.5	23.2	25.7	16.4	27.3	25.4	49.9	22.1	22.2	19.8	25.5	36.2	28.1	37.8	28.6	41.4	29.1	13.8	46.0	30.2	37.4	33.9	14.6	30.0	16.8	24.8	32.4	31.5	25.7	25.1	24.5	37.4	22.8	25.0	24.5	3.8	25.9	24.5	28.1	26.8	23.9	18.5	27.0	24.1	33.5	17.2	20.9	20.5	23.6	32.1	18.8	68.5	57.4	61.0	74.3	86.4	58.8	42.5	45.9	68.3	83.0	26.2	17.7	105.5	56.3	84.6	70.7	79.2	35.5	46.7	113.8	163.4	78.3	66.7	98.3	74.0	91.1	54.0	51.0	54.6	79.0	91.4	60.4	87.7	55.6	90.2	73.1	54.0	101.1	35.1	62.6	51.0	31.7	38.8	73.4	41.2	101.8	88.2	139.2	67.1	82.7	104.0
SRP9		ENSG00000143742	"Signal recognition particle 9"	P49458	1	225777813-225790466	"Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA						"unprognostic (1.45e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.84e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	39.3	60.1	77.2	30.7	61.8	34.8	54.8	48.8	63.2	39.6	47.8	49.4	28.7	37.3	39.2	52.4	41.8	38.8	38.1	43.2	62.4	72.0	61.6	78.2	31.8	40.7	75.4	48.3	45.2	32.4	39.8	60.4	32.7	59.9	45.6	48.4	39.7	43.5	34.7	56.7	30.1	42.4	39.1	69.8	36.0	34.5	25.4	38.2	48.3	56.3	40.1	43.0	37.7	27.5	69.1	74.1	76.4	71.4	73.5	93.2	109.8	68.3	40.7	106.5	54.6	43.0	53.7	44.3	47.0	50.5	50.4	59.0	46.4	50.6	64.4	63.4	55.3	49.0	43.9	66.7	55.0	73.4	55.0	93.5	51.3	55.6	57.1	37.6	92.7	45.6	40.0	51.3	45.9	60.5	55.5	78.1	68.4	95.5	46.3	83.3	28.4	86.6	67.5	33.6	123.6	63.9	71.0	99.8	74.5	80.1	62.9	94.0	80.9	54.6	62.0	64.6	58.0	75.6	89.4	52.5	46.5	41.6	61.3	88.3	28.5	74.0	62.6	53.8	64.0	91.5	57.2	67.7	76.4	61.2	71.4	77.0	69.1	76.5	69.7	74.1	59.7	92.6	78.4	38.3	73.5	59.8	54.3	93.2	109.8	77.2	61.8	48.8	63.2	62.4	72.0	75.4	48.3	59.9	38.2	98.3	74.2	161.8	151.2	233.5	67.7	141.3	201.2	155.2	86.4	165.7	29.5	187.5	507.3	221.8	17.5	168.0	120.0	70.0	163.8	213.5	196.0	238.7	82.0	175.1	183.7	60.4	230.3	104.3	130.8	20.0	173.4	138.5	300.3	186.7	182.8	336.7	161.4	174.6	199.8	387.4	81.5	129.4	220.5	242.9	139.9	253.7	166.5	176.9	194.1	220.1
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673267	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"		NA	NA		12000	"Nuclear speckles"		"HPA049941: AB_2680962, HPA058612: AB_2683778"	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	25.0	22.4	16.6	21.8	29.5	44.5	26.9	38.0	30.0	37.1	27.9	39.7	26.3	20.7	35.6	65.6	21.7	31.7	18.6	23.9	19.5	16.6	24.1	27.7	22.8	27.3	27.2	21.1	49.8	20.3	26.7	35.5	35.2	32.6	33.3	20.8	31.8	24.2	25.5	34.4	30.5	28.6	24.2	32.4	29.8	21.5	23.4	29.8	43.4	24.2	20.3	36.4	28.5	29.8	20.3	19.1	23.9	23.7	27.9	26.2	14.8	17.2	13.9	27.6	24.7	15.6	16.1	27.1	20.2	13.4	20.3	23.3	15.3	29.0	38.6	12.8	17.1	13.5	21.7	27.5	19.8	26.7	13.2	19.1	29.6	27.0	18.1	10.9	34.1	19.7	10.9	12.5	16.4	24.2	23.2	17.5	19.0	28.7	21.2	20.8	14.9	30.9	22.9	45.4	14.1	9.5	27.6	22.1	18.8	17.7	18.0	16.8	15.2	21.8	17.7	15.0	21.7	15.9	16.7	19.4	17.8	18.5	24.1	20.2	19.0	14.5	47.7	19.2	40.1	19.7	23.9	17.8	19.2	21.8	21.7	26.2	20.3	20.7	21.2	19.1	19.7	19.2	21.8	23.6	27.9	23.7	16.6	15.4	14.8	16.6	29.5	38.0	30.0	19.5	16.6	27.2	21.1	32.6	29.8	145.9	144.9	171.3	231.9	268.6	176.0	131.8	137.6	180.7	174.0	115.1	111.9	129.0	169.1	144.9	235.5	146.8	116.3	163.5	128.5	137.4	157.1	230.0	229.3	203.4	133.1	117.6	113.6	127.1	162.6	96.6	155.3	180.0	146.8	260.5	126.0	204.1	128.5	135.3	141.8	117.6	174.7	135.8	173.5	224.9	222.2	258.2	201.7	198.3	147.2	308.0
STAC	STAC1	ENSG00000144681	"SH3 and cysteine rich domain"	Q99469	3	36380344-36548007	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	22	"Distal tubular cells: 5.0;Early spermatids: 4.5;granulocytes: 5.8;Muller glia cells: 21.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 21.3"	"Group enriched"	"Detected in some"	5	"eosinophil: 3.2;NK-cell: 2.8;T-reg: 3.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 2.8;T-cells: 3.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 22.0;HaCaT: 16.2;hTERT-RPE1: 13.5;SH-SY5Y: 23.2;U-251 MG: 14.1;U-87 MG: 23.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035143	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA035143: AB_10603892"	"unprognostic (5.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-6)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.73e-4)"	"unprognostic (8.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.94e-3)"	3.7	6.4	1.4	1.1	5.4	0.6	5.7	21.3	0.8	9.2	4.6	1.2	4.7	0.3	9.0	2.2	3.3	4.0	5.1	0.7	0.9	3.9	3.3	1.8	15.0	0.7	1.6	0.2	3.2	0.6	18.8	1.8	0.6	5.2	17.2	1.1	1.9	1.8	5.7	4.0	1.6	0.6	12.5	1.2	0.9	1.5	2.4	0.2	0.7	1.0	4.4	0.5	8.4	15.5	0.0	0.6	3.2	0.4	2.8	3.8	0.2	3.5	1.5	0.8	0.0	3.2	1.0	0.0	9.0	0.2	1.9	2.3	0.0	0.0	0.0	3.7	22.0	6.3	16.2	1.1	3.9	2.0	0.0	2.8	0.5	4.9	0.1	0.0	9.0	0.1	1.2	0.1	0.0	0.3	13.5	0.0	0.9	0.0	0.2	0.2	0.0	1.8	0.1	6.7	0.0	1.4	0.0	0.0	0.0	5.1	0.0	3.0	23.2	3.6	2.5	0.0	7.0	0.0	0.9	4.0	0.2	9.4	0.3	14.1	0.0	0.0	0.0	23.9	3.6	4.0	0.0	0.1	3.2	0.0	0.4	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.1	0.0	3.8	0.2	1.4	5.4	21.3	0.8	0.9	3.9	1.6	0.2	5.2	0.2	0.0	0.3	0.0	0.0	0.0	0.7	1.1	0.0	0.0	2.3	0.0	0.0	0.0	5.0	0.1	4.5	0.1	0.0	0.0	0.0	0.1	0.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	21.3	0.1	0.0	0.0	0.0	0.6	0.0	2.0	0.6	0.0	0.3	0.0	0.0	0.0	0.0
STARD3	"es64, MLN64"	ENSG00000131748	"StAR related lipid transfer domain containing 3"	Q14849	17	39637065-39663484	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	6	"SK-BR-3: 89.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017021, HPA024307, HPA073948"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB017021: , HPA024307: , HPA073948: "	"unprognostic (1.11e-1)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.92e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.25e-3)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.51e-3)"	"unprognostic (3.00e-2)"	22.2	34.8	23.3	27.5	28.0	33.5	22.8	27.7	30.1	17.1	23.7	38.1	21.7	26.6	20.6	20.7	22.4	25.6	27.7	17.8	21.0	16.8	18.2	24.0	27.0	31.5	28.5	25.7	21.5	32.7	21.9	23.7	26.9	25.7	19.0	9.7	17.9	21.4	26.7	20.8	24.5	34.2	15.8	27.8	32.3	25.3	26.7	26.1	33.0	21.1	15.1	24.8	28.8	18.7	15.3	23.2	35.3	21.2	21.4	25.3	17.4	7.9	12.6	5.7	10.1	6.9	8.4	8.5	6.5	8.5	8.5	7.8	7.4	13.1	7.1	14.2	5.9	10.5	15.2	3.4	7.7	1.9	9.6	12.9	4.8	5.5	8.6	9.7	9.7	10.8	9.1	6.3	9.6	4.6	6.5	8.2	9.9	11.1	9.2	7.8	7.0	9.1	9.2	6.3	5.4	6.9	7.2	9.8	10.5	5.8	9.0	7.2	7.7	4.9	89.9	16.1	4.0	10.6	11.6	7.7	12.0	8.3	13.1	12.2	8.8	10.8	5.7	10.7	10.5	12.3	12.5	21.2	29.3	25.3	19.6	18.5	11.9	18.3	19.0	23.2	15.3	18.4	16.9	35.3	21.4	15.6	10.8	20.4	17.4	23.3	28.0	27.7	30.1	21.0	16.8	28.5	25.7	25.7	26.1	3.0	9.8	21.7	11.2	14.7	13.5	3.0	20.4	5.3	3.4	10.4	35.3	24.1	8.3	20.7	2.3	23.3	21.4	0.0	30.9	31.1	16.0	17.5	18.5	10.6	45.2	17.5	26.4	42.4	36.6	4.1	15.8	20.8	5.0	17.2	11.7	17.0	30.5	15.8	12.4	8.7	13.2	12.9	9.5	8.4	13.9	14.8	33.4	34.8	12.4	16.9
STATH	STR	ENSG00000126549	Statherin	P02808	4	69995930-70002570	"Plasma proteins, Predicted secreted proteins, Transporters"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	162	"salivary gland: 5940.6"	"Cell type enriched"	"Detected in single"	7	"Early spermatids: 2.1"	"Group enriched"	"Detected in some"	14	"head and neck cancer: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HHSteC: 1.4"									HPA044569	Enhanced				"Secreted to digestive system"	NA	NA					"HPA044569: AB_10966146"						"unprognostic (2.00e-2)"												0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.3	1.5	0.0	0.1	0.1	0.0	0.5	0.0	0.0	5940.6	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	36.5	5.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306026-76311599	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 16.1;liver: 14.3;skeletal muscle: 34.5"	"Cell type enhanced"	"Detected in some"	14	"Ciliated cells: 12.0;Ductal cells: 5.3;Enterocytes: 4.9;Exocrine glandular cells: 3.5;Pancreatic endocrine cells: 3.5;Paneth cells: 3.5"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 15.0;Karpas-707: 31.5;U-266/70: 20.4"	"Low region specificity"	"Detected in many"							"HPA011952, HPA012849"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	16.1	1.2	0.1	0.7	0.0	1.9	3.7	0.0	0.5	1.2	2.7			1.2	2.3	0.0	1.6	1.2	1.0	7.1	0.0	0.5	0.7	14.3	2.6	0.0	0.3		1.3	1.9	0.4	0.2	1.2		2.1	1.6		1.2	1.1	34.5	0.0	3.9	2.4	0.6	0.0	2.3	0.5			0.1		0.0	3.4	1.4	0.2	3.2	5.9	3.6	3.7	3.6	1.4	3.8	1.8	0.2	2.4	5.3	1.4	3.3	4.2	2.5	1.6	1.9	1.8	4.5	0.0	3.4	2.7	3.7	2.4	0.7	0.9	0.6	15.0	1.0	0.2	2.3	2.2	0.7	2.1	2.8	0.8	2.7	1.3	0.7	4.1	0.0	0.0	0.1	31.5	2.8	2.5	0.2	1.8	0.4	2.7	2.0	0.0	0.9	2.6	0.9	1.9	0.8	4.4	3.3	4.2	0.0	0.4	1.1	0.7	0.7	3.2	2.0	7.5	2.3	20.4	3.7	0.0	4.4	1.4	1.0	0.3	3.6	5.9	2.7	3.3	1.7	0.2	3.6	3.4	3.2	0.0	0.6	1.1	0.7	3.7	1.6	0.2	0.6	1.4											0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	4.9	0.0	3.5	1.1	0.3	0.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.0	0.0	3.5	3.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	1.5	0.6
STEAP1	"PRSS24, STEAP"	ENSG00000164647	"STEAP family member 1"	Q9UHE8	7	90154375-90164829	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 44.7"	"Cell type enhanced"	"Detected in many"	8	"Basal glandular cells: 43.1;Exocrine glandular cells: 33.5;Glandular cells: 64.3;Urothelial cells: 39.0"	"Cancer enriched"	"Detected in all"	6	"prostate cancer: 94.0"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.6;CAPAN-2: 35.5;U-138 MG: 45.1"									HPA030985	Uncertain					NA	NA					"HPA030985: AB_2673686"	"unprognostic (2.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-3)"	"unprognostic (9.20e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.45e-3)"	"unprognostic (8.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.38e-1)"	19.8	1.5	2.9	16.5	1.4	0.0	26.0	0.9	6.3	5.5	10.0	0.1	0.7	2.7	3.0	4.4	10.0	7.3	8.4	7.1	1.4	0.5	5.3	21.2	9.3	2.9	0.5	2.7	12.4	6.5	0.2	5.8	0.5	1.4	44.7	7.3	1.2	9.8	5.3	3.9	3.3	7.4	13.7	1.4	2.8	7.4	2.1	0.7	0.0	4.6	6.5	3.7	12.5	16.1	0.8	1.7	0.0	0.0	0.0	0.0	0.2	6.8	13.9	0.8	2.5	29.6	24.6	0.2	4.7	5.8	0.6	0.8	10.3	35.5	0.0	0.2	7.7	12.6	1.4	6.0	6.6	1.3	0.0	2.2	0.0	0.1	3.4	1.1	0.0	0.0	17.3	1.0	19.6	10.4	4.6	25.4	2.1	0.3	19.8	8.1	0.1	0.0	0.1	4.2	0.3	6.7	0.0	0.0	0.0	5.6	1.4	0.0	0.3	1.8	0.0	3.1	0.5	7.8	0.1	13.0	45.1	2.3	22.7	5.7	3.7	0.1	0.0	22.1	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.9	1.4	0.9	6.3	1.4	0.5	0.5	2.7	1.4	0.7	0.0	0.3	0.0	43.1	3.8	0.0	0.8	0.0	6.7	2.3	1.8	0.0	0.0	0.0	2.1	0.3	2.2	3.5	0.0	33.5	0.1	15.0	64.3	0.0	30.1	0.5	0.0	6.9	1.8	1.0	1.0	0.9	1.8	6.8	0.0	4.1	9.4	29.2	10.5	1.4	13.9	0.2	6.5	5.6	12.6	30.9	1.9	0.2	0.0	13.5	39.0
STEAP2	"IPCA-1, PCANAP1, STAMP1, STMP"	ENSG00000157214	"STEAP2 metalloreductase"	Q8NFT2	7	90167590-90238137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"prostate: 100.2"	"Cell type enriched"	"Detected in many"	4	"Glandular cells: 110.4"	"Cancer enriched"	"Detected in many"	12	"prostate cancer: 88.1"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 13.4;CAPAN-2: 28.9;U-138 MG: 16.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029115, HPA055603"	Uncertain		Supported	Vesicles		NA	NA			Vesicles		"HPA029115: AB_10603894, HPA055603: "	"unprognostic (6.26e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.67e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (9.86e-5)"	"unprognostic (3.69e-2)"	10.7	4.1	6.2	9.7	14.5	1.3	13.6	8.7	18.2	7.0	8.3	2.3	2.2	5.7	5.4	3.6	9.1	7.5	8.8	9.4	5.1	5.2	6.5	3.6	10.8	1.6	3.2	11.1	19.5	6.4	10.3	17.6	1.4	6.0	100.2	7.0	3.8	6.8	6.7	2.3	3.5	5.9	9.0	2.9	3.0	9.2	2.3	1.6	1.6	5.8	1.2	2.5	10.4	19.9	1.1	0.4	1.3	0.4	0.3	0.2	0.0	1.8	13.4	0.3	3.8	7.2	7.0	0.2	1.6	3.5	0.2	0.5	2.5	28.9	0.0	0.2	4.4	5.4	1.1	2.9	2.1	0.5	0.0	2.9	0.0	0.0	0.7	0.6	0.0	0.0	5.1	0.4	7.0	1.4	5.8	3.6	0.0	0.0	0.2	4.0	0.0	0.0	0.4	5.5	0.0	1.5	0.0	0.0	0.1	6.3	3.9	0.3	1.3	2.1	0.0	0.1	0.6	10.2	0.0	3.0	16.8	3.8	2.3	1.4	0.0	0.0	0.0	7.3	0.0	0.7	1.3	0.4	0.5	0.2	0.2	0.1	1.1	0.1	0.1	0.0	0.4	0.2	0.2	1.2	0.3	0.2	0.4	0.0	0.0	6.2	14.5	8.7	18.2	5.1	5.2	3.2	11.1	6.0	1.6	0.0	0.6	0.0	20.8	4.2	5.1	11.6	17.8	16.0	13.6	12.2	2.0	0.0	0.0	0.6	0.4	1.8	11.8	0.0	6.6	0.0	17.5	110.4	0.0	4.9	0.0	1.6	15.1	2.5	0.0	0.4	14.4	1.7	0.0	0.0	12.5	26.2	8.6	25.8	14.5	8.6	1.2	0.0	6.2	1.0	3.4	4.6	0.0	0.0	12.7	19.6
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306891	"Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 122.8"	"Cell type enhanced"	"Detected in many"	15	"Alveolar cells type 2: 320.5;Club cells: 178.6;Sertoli cells: 452.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Group enriched"	"Detected in some"	5	"midbrain: 1.7;pons and medulla: 6.4"	"Cell type enriched"	"Detected in some"	13	"neutrophil: 48.9"	"Lineage enriched"	"Detected in many"	13	"granulocytes: 48.9"	"Group enriched"	"Detected in some"	6	"HSkMC: 39.3;SiHa: 36.9;U-2197: 52.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favorable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	122.8	29.3	0.3	12.7	0.8	2.4	55.6	0.6	0.7	15.9	14.0	1.1	5.3	1.4	10.7	22.3	23.7	17.1	9.3	18.7	0.5	0.3	10.8	71.7	27.5	49.4	1.7	0.2	17.8	13.3	12.0	35.1	45.0	6.4	25.8	3.9	4.9	14.6	4.6	22.1	10.5	5.2	13.9	1.8	5.3	5.7	27.3	0.4	0.4	40.9	8.4	5.2	28.4	26.3	0.0	0.3	48.9	3.8	0.0	0.0	0.7	1.4	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.1	5.8	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	39.3	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	36.9	3.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	52.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.0	0.7	0.3	0.8	0.6	0.7	0.5	0.3	1.7	0.2	6.4	0.4	50.6	320.5	0.0	6.3	8.4	1.1	4.0	0.0	97.7	178.6	0.0	2.0	0.3	0.0	11.7	12.9	8.9	0.0	0.0	8.2	9.0	11.1	62.8	15.1	0.4	2.1	0.0	0.0	19.0	5.1	1.9	106.4	7.7	5.0	0.0	0.0	2.4	16.5	0.0	8.5	0.0	0.2	452.7	115.4	0.9	0.2	16.4	9.2	0.0	0.0	12.2
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		4900000	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	20.8	9.9	15.5	28.9	19.9	23.1	53.1	14.1	16.8	20.5	21.2	8.5	16.5	9.2	20.6	20.3	35.1	19.8	35.6	14.3	10.3	10.5	13.2	29.0	21.6	34.0	7.7	10.3	21.7	21.2	27.7	9.4	18.1	9.0	18.2	13.7	23.5	46.9	17.0	49.4	22.1	16.0	22.5	8.7	23.2	15.6	20.1	6.0	39.7	34.2	26.6	23.4	19.5	21.7	11.1	8.5	17.1	20.6	17.6	18.2	13.3	14.9	19.4	6.1	10.6	29.0	25.2	8.4	13.5	13.7	9.6	11.9	8.7	5.0	15.9	14.0	18.6	20.1	27.4	7.7	7.9	8.0	13.0	11.6	25.6	7.4	13.1	23.6	20.6	14.9	28.6	19.7	14.0	34.4	13.1	12.5	21.7	15.5	30.3	9.9	3.4	19.4	7.5	2.4	8.3	6.9	4.9	8.7	14.9	15.2	8.8	1.2	5.6	19.2	12.3	7.2	10.3	4.6	11.7	12.8	17.7	5.9	17.2	9.2	32.8	24.7	8.1	14.7	8.7	10.1	12.4	9.5	17.1	17.3	13.0	13.9	7.3	12.6	18.2	8.5	11.1	14.3	12.8	15.2	17.6	20.6	7.5	12.8	13.3	15.5	19.9	14.1	16.7	10.3	10.5	7.7	10.3	9.0	6.0	14.9	8.0	10.3	6.0	14.5	4.9	3.9	12.7	9.4	5.7	5.2	13.7	20.7	1.7	12.2	3.6	14.7	8.6	0.0	12.5	11.0	12.4	10.5	28.9	28.0	13.7	15.9	8.7	20.3	19.4	4.9	25.3	12.4	16.9	5.4	12.9	16.9	10.2	3.5	10.6	3.5	3.6	25.8	18.1	20.9	8.1	19.4	14.5	22.0	7.5	10.3
STIM2		ENSG00000109689	"Stromal interaction molecule 2"	Q9P246	4	26857678-27025381	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ciliated cells: 100.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 73.1;U-698: 34.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036933, CAB037196, HPA057511"	Supported					NA	NA					"CAB037196: AB_1841195, HPA036933: AB_2675391, HPA057511: AB_2683453"	"unprognostic (7.09e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (5.01e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.17e-3)"	13.5	11.0	15.2	23.3	19.9	15.1	16.0	12.0	16.8	12.3	11.9	12.6	10.2	18.0	13.4	20.3	7.6	12.7	22.3	9.6	14.9	8.8	16.9	12.2	17.9	25.1	12.5	13.1	20.7	14.3	10.2	17.3	9.4	18.8	14.7	14.4	25.2	14.8	7.1	8.2	16.0	19.7	9.8	10.2	24.0	14.8	8.7	12.6	19.2	14.6	6.5	23.5	15.9	10.3	7.9	7.3	11.0	7.5	2.7	6.8	1.8	4.5	6.0	5.6	9.0	5.2	3.7	5.8	8.5	3.1	5.9	5.8	4.4	12.6	18.6	4.7	3.5	6.1	4.2	4.1	11.1	5.8	4.4	7.1	5.4	9.1	3.9	4.1	9.9	4.7	4.3	5.0	6.8	3.2	6.0	5.8	6.5	4.7	3.7	11.0	4.9	7.7	9.7	6.1	8.3	8.2	73.1	10.7	4.2	4.1	9.9	11.3	3.9	6.8	4.8	2.5	3.9	2.5	7.2	6.3	7.9	4.2	5.2	6.8	8.9	8.4	34.1	7.9	9.7	11.1	11.0	2.5	1.7	6.0	2.0	3.8	6.0	6.5	5.0	1.7	7.9	6.8	5.9	4.0	2.7	7.5	7.3	3.3	1.8	15.2	19.9	12.0	16.8	14.9	8.8	12.5	13.1	18.8	12.6	11.9	24.0	31.8	12.6	14.5	33.9	8.1	28.1	100.4	19.4	31.4	76.6	9.6	11.6	8.4	8.0	32.1	14.4	0.0	17.7	7.3	8.6	10.8	35.8	9.6	6.8	28.6	43.9	33.7	17.0	5.0	14.1	22.7	8.5	7.2	25.9	22.7	10.0	10.1	6.7	3.3	56.8	19.4	7.8	15.6	24.2	13.6	4.1	34.6	11.5	10.5
STIMATE	"MGC52022, TMEM110"	ENSG00000213533	"STIM activating enhancer"	Q86TL2	3	52836219-52897596	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	13	"Ciliated cells: 17.4;Collecting duct cells: 7.0;Hofbauer cells: 8.1;Proximal tubular cells: 11.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA051855	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA051855: AB_2681639"	"unprognostic (1.45e-1)"	"unprognostic (7.93e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.55e-4)"	"unprognostic (3.34e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	12.0	13.0	8.9	12.0	13.9	26.4	12.8	11.6	16.1	12.5	10.7	17.8	8.8	7.8	14.4	7.9	9.2	17.7	9.6	8.3	9.5	6.7	9.9	34.7	15.2	18.1	9.9	8.1	12.2	19.2	7.7	8.9	7.8	13.0	10.2	6.7	13.0	12.8	11.5	17.9	10.5	10.1	16.5	10.2	14.9	11.2	8.4	9.5	18.0	11.8	6.8	13.2	12.5	12.5	1.7	4.0	1.7	5.8	0.7	4.6	1.4	6.8	6.0	9.2	15.9	20.9	13.3	18.5	10.1	11.3	13.7	12.6	7.3	7.2	6.7	2.0	11.5	13.1	6.5	10.8	9.8	9.6	14.9	8.3	10.9	7.6	11.4	14.0	16.4	8.4	10.5	13.6	15.3	6.9	8.6	11.1	10.9	3.8	6.7	11.4	5.6	8.9	9.2	8.3	5.6	12.3	4.9	7.1	4.5	6.4	8.9	2.0	6.8	10.2	7.0	9.5	5.4	5.9	14.3	11.2	10.9	6.4	14.3	12.0	13.1	8.4	6.3	9.5	16.5	8.3	0.0	3.3	1.7	2.2	5.8	1.8	1.7	3.5	2.4	4.0	1.5	1.9	1.4	0.3	0.7	5.5	2.3	4.6	1.4	8.9	13.9	11.6	16.1	9.5	6.7	9.9	8.1	13.0	9.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	17.4	1.2	7.0	0.0	1.5	1.7	2.1	0.0	0.0	0.0	0.0	2.5	5.3	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	2.7	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338988-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Erythroid cells: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.9;HHSteC: 57.5;hTCEpi: 86.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		140000000	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	96.0	27.5	29.3	29.7	41.6	89.2	78.6	15.0	19.4	28.7	46.4	23.2	14.6	14.4	35.7	26.7	34.9	28.2	45.2	46.4	27.2	18.5	35.4	114.4	66.0	40.2	24.2	15.1	31.5	11.8	21.0	11.3	77.0	28.1	36.8	16.7	27.7	23.0	28.3	50.6	25.4	25.0	50.4	37.8	48.3	34.5	17.4	23.3	4.4	29.6	25.1	16.1	56.6	51.8	1.4	8.6	5.2	13.2	33.2	43.4	25.8	1.5	9.8	0.8	4.5	105.9	30.4	0.0	26.3	26.2	7.4	11.7	1.3	1.9	12.0	6.5	32.8	4.4	2.6	5.5	24.4	13.2	7.3	2.3	27.9	21.7	3.8	57.5	10.3	5.9	50.4	86.5	11.6	15.4	2.1	26.5	3.7	6.0	16.1	16.1	7.9	0.3	7.9	12.0	0.6	3.1	1.4	0.0	26.1	5.8	0.3	1.0	0.1	22.0	19.5	11.3	8.2	6.7	8.5	33.6	17.2	5.4	17.1	2.4	6.8	7.5	0.7	6.6	10.4	9.2	3.4	8.5	0.9	43.4	13.2	42.8	1.4	22.0	38.9	8.6	1.1	4.1	22.0	5.2	33.2	9.0	1.5	2.0	25.8	29.3	41.6	15.0	19.4	27.2	18.5	24.2	15.1	28.1	23.3	148.9	81.9	21.1	213.5	93.8	3.6	29.1	119.8	124.5	113.7	33.2	5.9	85.6	3.3	48.0	2.7	299.7	8.4	373.8	19.1	46.5	164.1	41.4	34.7	315.8	77.6	3.2	0.0	270.1	169.6	5.7	61.5	72.7	84.4	33.3	0.2	8.0	31.1	14.4	96.9	74.2	4.6	135.8	215.9	21.4	6.8	104.1	144.5	93.2	0.1	170.5
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38991066	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2"	"Cell type enriched"	"Detected in some"	24	"Ciliated cells: 133.8"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	39	"AF22: 19.0"	"Region enriched"	"Detected in some"	6	"olfactory region: 29.0"	"Low region specificity"	"Detected in all"			"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA012892: AB_1857610, HPA071011: AB_2732169"		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.1	0.1	2.9	0.1	3.8	0.1	0.2	0.0	0.2	1.7	0.2	6.6	0.0	0.2	1.1	8.1	0.1	31.7	0.1	0.1	4.4	4.1	0.1	0.1	9.2	0.1	0.0	0.0	7.6	0.1	0.1	0.0	0.3	9.7	0.2	0.2	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.1	0.6	2.1	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.8	0.0	0.2	4.4	4.1	0.0	0.0	9.7	2.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	133.8	5.7	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0
STRA6	FLJ12541	ENSG00000137868	"Stimulated by retinoic acid 6"	Q9BX79	15	74179466-74212267	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Disease mutation, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"cervix, uterine: 22.7;placenta: 88.6;retina: 42.8"	"Cell type enhanced"	"Detected in some"	16	"Extravillous trophoblasts: 11.0;Leydig cells: 6.4;Syncytiotrophoblasts: 22.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 16.6;CAPAN-2: 47.1;SH-SY5Y: 29.3;WM-115: 70.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040839	Approved					NA	NA					"HPA040839: AB_10794881"	"unprognostic (1.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.89e-1)"	"unprognostic (7.91e-13)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	0.2	1.6	0.2	0.5	0.3	0.0	1.1	0.2	0.5	22.7	0.1	0.3	1.6	0.0	6.9	2.8	1.0	5.0	0.7	0.3	0.4	0.2	7.3	0.0	0.3	1.1	0.1	0.3	0.6	0.2	0.0	5.3	88.6	0.7	5.0	0.0	42.8	0.6	2.6	0.1	0.4	0.2	0.3	1.5	0.3	0.1	2.8	0.1	0.9	0.2	1.4	1.9	1.8	2.3	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.2	16.6	1.0	0.0	0.0	0.0	2.8	0.5	0.1	0.0	0.0	5.7	47.1	0.0	11.4	0.0	0.4	1.6	0.9	0.0	0.0	0.0	0.1	1.4	0.6	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	3.0	0.2	1.5	0.0	0.0	0.2	0.0	0.0	0.0	1.5	8.9	29.3	0.0	1.7	0.0	1.9	0.1	0.0	0.0	0.1	3.9	0.3	0.7	0.1	0.1	0.0	0.3	0.0	70.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.4	0.4	0.2	0.1	0.3	0.7	0.1	0.0	0.0	0.0	1.0	0.3	0.0	1.0	0.0	4.0	3.4	0.0	0.0	2.0	1.7	0.2	1.2	0.4	0.0	0.0	0.0	11.0	0.9	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	6.4	0.0	1.7	0.0	0.0	0.0	2.8	0.0	3.9	4.1	0.0	0.0	0.4	0.5	0.4	0.0	22.1	0.0	0.0	0.9
STX1A	"HPC-1, p35-1, STX1"	ENSG00000106089	"Syntaxin 1A"	Q16623	7	73699206-73719672	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Neurotransmitter transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 73.7;pituitary gland: 26.9"	"Cell type enhanced"	"Detected in many"	13	"Intestinal endocrine cells: 50.6;Pancreatic endocrine cells: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"gdT-cell: 2.5;T-reg: 2.4"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.5"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 50.8;U-87 MG: 33.8"	"Group enriched"	"Detected in many"	5	"amygdala: 253.0;basal ganglia: 94.3;cerebral cortex: 362.2;hippocampal formation: 251.5"	"Group enriched"	"Detected in all"	8	"amygdala: 69.4;cerebral cortex: 158.6;hippocampal formation: 149.3"	"CAB008372, HPA069176"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA			Vesicles	"Nuclear membrane"	"CAB008372: AB_592786, HPA069176: AB_2686098"	"unprognostic (5.12e-3)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.02e-8)"	"unprognostic (1.11e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.70e-3)"	"unprognostic (4.18e-6)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-3)"	"unprognostic (6.20e-2)"	1.4	5.6	27.4	2.4	20.9	7.6	1.4	33.7	73.7	1.7	2.6	1.3	0.8	3.7	2.8	1.8	1.7	2.3	5.5	1.2	22.0	8.3	1.1	1.2	1.8	1.4	4.0	28.0	2.2	5.7	1.5	26.9	2.2	2.6	1.9	2.1	0.1	1.9	1.8	1.1	1.9	3.5	2.6	1.3	1.3	6.2	2.0	0.7	0.0	1.6	0.0	1.1	2.8	1.1	0.4	0.0	0.1	0.2	0.0	2.5	2.7	1.6	7.5	1.2	3.6	1.6	4.2	0.8	5.1	3.4	2.1	1.4	2.6	4.3	1.9	0.7	3.6	11.8	1.3	1.8	3.2	1.6	3.5	1.4	0.6	2.6	1.5	1.8	0.8	1.8	2.5	1.4	14.8	5.2	9.6	3.7	0.3	1.6	2.3	4.0	3.7	0.6	7.3	0.9	2.8	17.0	0.0	0.8	1.9	1.7	1.3	50.8	8.0	1.5	4.2	1.0	1.5	1.4	0.6	13.8	10.5	3.5	8.1	13.5	1.3	0.8	0.9	33.8	0.7	12.3	0.0	0.2	0.0	2.5	0.0	0.9	0.4	0.4	0.6	0.0	0.1	0.8	0.3	0.1	0.0	0.0	0.0	2.4	2.7	27.4	20.9	33.7	49.9	22.0	8.3	4.0	28.0	2.6	0.7	0.0	3.2	0.0	11.2	3.8	4.5	2.2	5.1	2.7	3.4	1.8	3.9	0.4	0.0	3.1	0.0	0.5	1.8	0.0	3.2	1.6	2.4	9.7	15.0	0.2	0.6	7.9	50.6	1.3	0.8	0.0	1.7	1.7	3.3	0.0	2.4	0.8	18.8	0.3	1.4	0.4	1.8	0.0	2.3	1.7	3.3	2.4	0.6	2.2	1.5	12.9
STX4	"p35-2, STX4A"	ENSG00000103496	"Syntaxin 4"	Q12846	16	31032889-31042975	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001330	Approved		Enhanced	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA001330: AB_1080167"	"unprognostic (2.31e-3)"	"prognostic favorable (3.65e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"unprognostic (5.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.88e-9)"	"unprognostic (6.90e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.26e-2)"	26.5	28.2	28.6	23.8	29.6	14.1	23.5	24.2	28.0	21.4	24.0	24.4	16.9	28.3	24.1	19.8	26.4	19.6	23.7	24.6	26.7	18.0	21.7	25.2	25.8	22.5	38.1	22.3	22.7	19.3	33.6	14.9	27.0	32.4	19.8	22.0	14.0	21.3	21.8	30.3	32.7	26.7	27.7	26.1	31.4	22.7	10.7	31.5	19.2	21.3	17.3	26.7	25.4	29.4	11.9	14.8	20.6	18.2	18.2	14.9	8.6	18.4	26.4	6.0	13.4	20.2	20.6	12.8	17.1	30.2	18.3	18.9	8.1	20.1	12.5	22.2	30.2	21.1	13.4	5.6	19.8	17.5	22.4	16.9	9.0	18.4	22.0	22.9	10.4	30.3	19.6	13.9	31.6	23.6	22.7	24.2	8.7	10.5	14.6	32.4	28.9	9.8	16.1	12.4	13.8	14.2	8.4	17.9	16.3	18.1	13.7	4.9	9.4	15.1	15.5	6.2	8.3	12.4	13.8	25.9	18.5	8.2	20.8	9.5	15.7	12.7	5.5	27.9	16.8	11.2	14.6	17.7	20.6	14.9	18.2	12.9	9.7	12.5	14.5	14.8	11.9	9.5	12.2	18.5	18.2	15.8	8.6	6.8	8.6	28.6	29.6	24.2	28.0	26.7	18.0	38.1	22.3	32.4	31.5	41.7	20.7	21.5	31.3	57.9	6.7	21.4	45.9	34.8	23.9	21.0	11.8	27.3	24.9	50.0	6.2	41.3	69.9	0.0	59.4	32.0	50.3	41.0	59.9	17.0	84.0	4.8	24.6	29.4	48.2	10.8	35.6	88.9	28.7	62.3	35.0	20.7	57.7	47.2	33.2	45.6	5.9	38.8	44.3	6.5	7.9	57.0	27.7	40.5	40.8	30.1
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	12.2	10.4	17.6	14.1	18.9	2.9	12.4	21.7	25.5	13.4	10.4	15.5	7.2	9.8	11.3	10.7	22.2	10.3	9.6	8.1	18.6	13.2	11.6	6.5	15.3	12.7	18.5	13.1	11.5	5.5	9.2	6.8	15.0	16.1	10.1	11.1	6.4	10.7	9.6	5.7	16.5	9.9	11.8	15.0	11.6	10.5	7.3	20.0	14.1	15.3	7.3	17.8	16.3	15.6	1.7	5.1	5.9	3.6	0.4	3.2	1.4	9.8	11.1	11.0	14.6	11.6	13.7	18.6	12.7	16.4	10.0	8.6	10.3	9.9	10.0	17.6	13.9	6.3	17.7	9.9	22.4	11.8	7.2	7.3	6.7	8.4	10.0	11.5	9.5	8.7	12.4	20.6	16.9	17.5	18.1	20.2	9.4	12.2	7.1	13.3	14.2	9.1	9.0	17.1	12.4	5.6	8.0	13.4	14.4	11.9	24.8	15.6	16.6	13.3	25.7	13.9	19.7	15.6	8.7	16.6	13.9	7.3	12.9	10.1	12.1	6.7	7.3	6.8	9.4	8.1	5.9	3.6	4.5	1.8	2.9	1.9	1.7	2.6	2.7	5.1	1.7	3.2	2.4	3.4	0.4	2.5	1.7	3.2	1.4	17.6	18.9	21.7	19.1	18.6	13.2	18.5	13.1	16.1	20.0	14.9	15.2	3.7	16.3	43.5	11.7	5.6	0.0	13.4	11.4	17.4	5.9	22.0	10.0	9.1	6.4	22.4	7.8	0.0	8.5	21.8	11.5	17.4	11.5	4.3	24.6	7.9	22.4	11.1	21.9	8.0	7.8	30.2	6.8	19.0	12.7	6.0	11.1	14.0	12.4	6.7	10.1	6.5	13.3	4.7	14.5	33.0	17.2	13.3	9.8	18.7
SUN1	"FLJ12407, KIAA0810, UNC84A"	ENSG00000164828	"Sad1 and UNC84 domain containing 1"	O94901	7	816615-896435	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Meiosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Early spermatids: 286.8;Late spermatids: 435.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008346, HPA008461"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA008346: AB_1080462, HPA008461: AB_1080461"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.33e-2)"	29.8	14.5	18.2	17.2	23.6	4.0	26.0	49.6	28.9	31.1	22.5	23.6	18.9	18.1	47.1	22.6	24.2	28.5	20.0	40.8	16.6	14.9	19.4	13.4	19.6	11.6	15.9	21.3	39.6	22.4	37.5	26.8	25.3	18.0	18.8	16.8	27.6	19.5	19.7	56.7	46.1	17.9	33.6	15.3	17.6	23.9	36.4	15.4	11.8	20.1	31.0	17.8	20.3	25.3	8.0	8.1	7.6	10.2	6.7	13.2	6.5	38.7	10.5	12.7	20.6	14.0	20.1	12.4	9.8	16.5	18.3	18.8	8.9	43.8	9.3	10.2	13.4	36.1	48.9	10.3	17.4	17.9	3.9	10.4	3.0	15.4	8.4	18.0	4.6	7.7	10.0	20.8	14.6	24.4	17.1	13.3	5.9	12.5	7.0	18.3	13.4	3.0	7.6	17.6	13.4	12.2	6.6	7.0	8.7	18.7	12.5	24.5	15.9	12.4	25.5	9.4	21.4	20.2	4.7	10.0	16.9	15.4	17.5	16.1	6.5	7.5	5.7	11.6	3.8	23.2	7.6	10.2	2.6	4.7	8.8	5.0	8.0	9.2	5.3	8.1	6.8	13.2	8.2	0.6	6.7	6.3	1.6	7.7	6.5	18.2	23.6	49.6	28.9	16.6	14.9	15.9	21.3	18.0	15.4	41.7	34.2	14.9	83.2	94.7	70.8	83.7	30.6	73.6	47.8	38.4	82.5	26.8	23.2	36.0	286.8	74.1	41.1	23.3	20.1	19.4	40.9	82.0	16.2	36.5	14.8	106.5	39.1	67.5	19.0	435.0	52.9	19.2	40.5	3.6	39.1	23.8	40.3	52.6	40.0	19.3	66.7	64.7	64.5	30.9	48.0	74.9	32.2	15.0	33.0	105.6
SURF4	"ERV29, FLJ22993, MGC102753"	ENSG00000148248	"Surfeit 4"	O15260	9	133361449-133376166	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 272.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064613	Approved					NA	NA		470000			"HPA064613: AB_2685299"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.47e-5)"	"prognostic unfavorable (8.11e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.29e-3)"	31.1	33.7	11.4	19.0	15.3	29.1	34.4	9.9	23.4	24.0	36.9	19.3	29.5	40.4	26.6	27.2	24.6	23.5	32.4	24.4	10.9	11.0	28.6	120.0	27.1	26.7	12.6	12.1	27.2	60.3	16.8	29.4	48.7	13.2	22.3	20.0	18.9	65.6	30.8	18.0	19.2	61.5	22.5	13.5	19.8	26.2	26.5	11.5	21.3	35.5	21.0	23.2	20.2	20.6	7.7	18.9	18.8	19.0	13.7	29.7	28.0	14.5	24.3	16.8	23.1	35.6	37.3	32.8	45.3	45.5	32.9	32.6	36.4	21.5	10.2	17.6	63.9	31.9	38.5	19.3	23.9	25.4	21.3	11.2	17.9	23.1	38.6	41.4	30.6	24.3	39.8	22.2	28.2	31.4	26.5	30.2	16.0	21.3	28.3	41.9	32.6	14.6	28.4	18.4	40.5	23.3	10.1	23.2	38.6	25.9	14.2	13.8	16.9	34.0	25.8	23.4	16.7	27.3	18.9	31.7	46.9	16.7	35.4	29.5	14.6	20.4	11.6	43.5	16.6	35.0	18.8	19.0	16.6	27.0	15.7	29.7	7.7	19.2	24.7	16.3	6.3	11.8	18.2	13.8	13.7	14.0	18.9	22.3	28.0	11.4	15.3	9.9	23.4	10.9	11.0	12.6	12.1	13.2	11.5	41.7	40.8	25.7	53.2	54.0	19.6	33.9	20.4	8.1	25.0	33.2	37.3	139.2	16.6	91.6	24.8	37.0	108.9	23.3	102.3	209.4	84.5	89.9	24.3	194.5	78.7	31.8	72.2	60.8	48.4	14.2	63.3	37.8	38.8	50.5	87.5	56.5	101.3	60.4	49.8	44.4	23.7	77.6	66.9	54.4	43.9	54.5	272.0	74.0	55.4	60.0
SV2C		ENSG00000122012	"Synaptic vesicle glycoprotein 2C"	Q496J9	5	76083172-76353939	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 52.2"	"Cell type enriched"	"Detected in some"	4	"Intestinal endocrine cells: 19.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"basal ganglia: 52.2;pons and medulla: 26.6"	"Cell type enriched"	"Detected in single"	14	"basophil: 4.2"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 4.2"	"Group enriched"	"Detected in some"	5	"Karpas-707: 12.2;SCLC-21H: 5.0;SH-SY5Y: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040722, HPA040770"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Nucleoplasm, Vesicles"		"HPA040722: AB_10795624, HPA040770: AB_10805828"	"unprognostic (7.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	0.5	5.5	0.8	1.3	52.2	0.7	1.2	1.2	9.5	0.7	0.8	0.5	0.0	1.0	0.7	0.9	0.6	1.8	0.6	0.8	0.6	8.3	0.4	0.4	0.4	0.5	5.6	1.9	2.6	0.8	0.9	0.8	0.4	26.6	1.0	1.1	1.1	1.7	1.2	0.3	0.7	1.3	1.0	5.8	0.6	1.6	1.0	6.7	0.0	0.5	0.0	0.4	0.6	0.4	0.1	0.1	4.2	0.2	0.1	0.2	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	12.2	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	5.0	11.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	4.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.2	0.2	0.8	52.2	1.2	9.5	0.6	8.3	5.6	1.9	26.6	6.7	0.0	0.0	0.0	0.5	0.0	3.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.0	0.0	0.1	0.0	19.0	0.6	0.0	0.7	0.0	0.0	3.3	0.0	0.5	0.8	0.0	0.0	0.0	0.0	4.4	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	1.1
SYNDIG1	"C20orf39, FLJ14220, IFITMD5, SynDIG1, TMEM90B"	ENSG00000101463	"Synapse differentiation inducing 1"	Q9H7V2	20	24469199-24666616	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.3;heart muscle: 28.2"	"Cell type enhanced"	"Detected in some"	14	"Bipolar cells: 5.0;Cardiomyocytes: 12.1;Distal tubular cells: 5.0;Peritubular cells: 6.7;Proximal tubular cells: 5.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.2;RH-30: 23.3;RPMI-8226: 22.1;SCLC-21H: 5.4;U-87 MG: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044271, HPA059267"			Enhanced	Vesicles		NA	NA			Vesicles		"HPA044271: AB_2732515, HPA059267: AB_2683961"	"unprognostic (9.33e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.16e-6)"	"unprognostic (1.40e-3)"	2.6	1.7	12.5	2.1	12.0	0.7	0.8	21.3	22.7	4.5	1.5	23.3	0.3	1.9	2.6	1.5	0.9	5.1	10.0	28.2	12.8	8.8	6.2	0.7	1.1	2.5	14.5	12.9	1.3	1.4	0.9	0.6	0.9	11.5	3.2	1.6	0.5	0.8	14.8	0.6	0.8	2.8	3.1	22.4	1.4	2.2	1.3	16.6	0.1	5.1	0.0	3.1	2.7	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	8.2	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	23.3	22.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	12.0	21.3	19.7	12.8	8.8	14.5	12.9	11.5	16.6	0.0	0.0	0.0	0.0	0.0	5.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	6.7	5.4	0.4	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0
SYNJ2BP	Arip2	ENSG00000213463	"Synaptojanin 2 binding protein"	P57105	14	70366496-70417061	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000866	Approved	Supported	Approved	Mitochondria		NA	NA			Mitochondria		"HPA000866: AB_2276678"	"unprognostic (2.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-2)"	12.0	13.8	10.8	8.2	13.0	1.7	11.2	15.8	13.7	11.8	20.1	14.1	14.1	21.0	12.5	10.4	16.3	9.5	11.7	15.7	10.5	8.9	32.0	25.9	10.4	6.8	11.0	6.4	10.3	11.0	28.9	22.2	12.0	13.4	15.3	16.7	11.6	13.2	15.0	27.4	6.7	32.2	15.2	12.4	11.3	16.8	16.9	9.9	7.0	16.9	14.4	7.9	15.4	9.1	4.6	5.1	0.6	5.3	3.8	7.4	1.9	9.7	6.3	11.1	7.4	8.6	10.0	7.8	7.5	7.9	5.4	6.1	6.1	9.2	0.0	7.3	8.7	5.4	8.4	11.1	8.2	12.8	1.3	5.6	3.6	9.7	7.9	7.6	0.0	1.2	7.7	6.8	6.7	3.8	9.6	11.7	4.2	2.1	2.0	9.6	7.0	5.0	1.5	8.1	9.8	7.7	6.3	16.1	2.7	11.7	14.8	8.1	14.2	10.4	8.7	6.1	7.5	16.3	2.5	12.8	12.9	9.0	4.9	6.1	2.7	10.3	0.0	11.4	1.2	10.6	0.6	5.3	0.1	4.3	5.1	4.9	4.6	5.2	5.0	5.1	3.9	7.4	5.9	0.6	3.8	3.3	3.2	3.9	1.9	10.8	13.0	15.8	13.7	10.5	8.9	11.0	6.4	13.4	9.9	35.7	36.9	17.6	23.9	5.4	40.6	75.0	53.5	22.7	35.2	71.5	76.6	33.0	119.3	39.0	15.9	38.3	52.7	0.0	34.4	27.1	19.9	26.7	9.2	42.3	21.8	28.6	19.0	31.3	22.7	5.4	28.1	19.1	13.5	30.7	45.5	35.5	32.5	35.1	38.9	59.1	83.2	25.8	20.2	26.1	10.2	4.3	9.2	29.8	56.5	28.8
SYP	MRX96	ENSG00000102003	Synaptophysin	P08247	X	49187804-49200259	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 179.2"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 496.0;Cone photoreceptor cells: 514.4;Rod photoreceptor cells: 549.6"	"Group enriched"	"Detected in many"	6	"glioma: 12.8;pancreatic cancer: 5.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 8.7;SCLC-21H: 46.8;SH-SY5Y: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000076, HPA002858, CAB055505, CAB078999"	Enhanced	Supported				NA	NA					"CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153"	"unprognostic (2.08e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.37e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.46e-5)"	"unprognostic (8.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.94e-1)"	2.7	21.4	34.5	3.2	42.5	1.9	1.9	53.8	179.2	2.0	3.6	7.2	0.0	7.4	2.2	2.6	2.2	2.0	2.0	2.3	44.4	45.3	2.7	1.8	2.8	2.0	25.5	39.0	2.1	5.2	1.9	17.4	2.0	46.7	2.1	3.5	11.5	2.0	2.1	2.4	2.3	8.1	2.5	15.5	2.4	3.9	2.0	4.0	0.0	2.1	0.0	1.9	1.8	0.2	1.3	1.6	5.3	0.8	0.5	0.7	0.1	0.4	1.7	1.3	2.6	1.5	0.2	0.2	0.1	0.0	0.3	0.3	1.6	0.9	1.4	0.2	0.0	2.0	1.3	1.4	0.1	0.3	2.8	1.6	2.1	0.5	0.5	0.0	0.2	4.8	0.2	0.0	0.2	0.3	0.2	0.1	1.2	8.7	3.4	0.3	0.5	0.7	0.1	4.3	1.1	0.3	0.3	0.2	0.6	0.1	0.2	46.8	16.9	0.5	0.2	0.6	0.4	0.8	0.8	0.2	0.3	1.4	0.4	0.2	0.2	2.8	0.3	0.7	0.5	1.4	1.7	0.8	0.4	0.2	0.7	0.4	0.7	0.5	0.7	0.4	1.3	0.5	0.5	5.3	0.5	0.4	1.6	0.3	0.1	34.5	42.5	53.8	84.8	44.4	45.3	25.5	39.0	46.7	4.0	0.0	3.8	0.8	2.5	2.3	496.0	1.2	5.1	6.7	4.5	8.7	514.4	0.9	0.0	0.8	8.8	5.4	7.8	0.0	2.1	0.5	2.1	1.2	8.1	0.6	1.0	116.0	111.7	6.7	2.4	9.9	3.7	4.5	3.3	2.8	18.4	54.5	1.6	2.3	3.5	0.4	549.6	6.5	4.4	0.4	2.5	2.3	1.1	3.2	6.3	0.8
SYT1	"P65, SVP65, SYT"	ENSG00000067715	"Synaptotagmin 1"	P21579	12	78863993-79452008	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation		"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 141.7"	"Group enriched"	"Detected in many"	9	"Bipolar cells: 1152.5;Cone photoreceptor cells: 842.3;Muller glia cells: 363.8;Rod photoreceptor cells: 831.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.3;memory B-cell: 3.3;naive B-cell: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 21.8;hTERT-RPE1: 20.4;LHCN-M2: 17.5;SH-SY5Y: 16.9;WM-115: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008394, HPA064788"	Enhanced	Supported				NA	NA					"HPA008394: AB_1857696, HPA064788: AB_2685351"	"unprognostic (1.02e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.68e-5)"	"unprognostic (2.78e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.05e-8)"	"unprognostic (2.89e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	1.3	11.5	23.9	2.1	31.8	1.3	1.4	44.3	141.7	1.8	2.3	1.8	0.0	1.8	5.6	1.4	1.4	1.4	1.7	1.1	32.4	22.9	2.0	2.0	1.5	1.2	23.1	38.6	3.6	1.2	1.1	1.4	2.3	28.9	4.3	2.5	2.7	1.2	3.8	1.1	1.2	2.6	12.9	2.5	2.2	1.8	1.4	3.6	0.0	1.2	0.0	1.2	1.3	0.7	3.4	0.9	0.0	2.3	0.0	0.0	0.1	0.0	10.2	7.7	0.0	0.7	2.3	0.0	0.7	0.9	0.5	0.6	0.5	0.3	0.0	1.5	0.1	2.8	0.3	0.1	1.2	0.9	0.1	0.4	0.6	0.2	0.0	2.0	0.0	0.1	0.6	0.7	2.8	21.8	20.4	7.3	0.3	0.4	1.2	17.5	1.6	0.9	0.0	5.6	1.1	2.9	0.0	8.0	0.0	0.0	2.9	10.3	16.9	0.0	1.3	0.2	5.5	3.8	0.0	2.9	1.1	0.4	0.0	3.2	1.9	4.1	0.0	2.5	0.0	15.8	0.0	2.3	0.0	0.0	0.2	0.0	3.3	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	23.9	31.8	44.3	74.8	32.4	22.9	23.1	38.6	28.9	3.6	0.0	1.1	3.7	0.0	0.8	1152.5	0.4	0.0	0.0	2.3	0.0	842.3	4.4	0.0	0.0	0.9	2.2	0.0	0.0	0.2	2.0	0.7	14.4	0.0	0.0	10.4	58.8	93.0	3.1	4.7	2.0	64.2	1.1	1.7	0.0	0.0	363.8	0.1	0.2	4.2	0.0	831.5	0.0	1.0	1.1	5.2	0.5	4.9	0.0	0.0	0.1
SYTL2	"CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2"	ENSG00000137501	"Synaptotagmin like 2"	Q9HCH5	11	85694224-85811159	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 65.2"	"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 139.2;granulocytes: 122.9;Mucus-secreting cells: 160.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdT-cell: 10.5;MAIT T-cell: 17.9"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.9"	"Cell line enhanced"	"Detected in many"		"MCF7: 25.3;OE19: 41.5;RH-30: 51.1;RPTEC TERT1: 36.5"	"Low region specificity"	"Detected in many"							HPA039651	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Nucleoplasm, Golgi apparatus"	"Plasma membrane"	"HPA039651: AB_10795153"	"unprognostic (8.07e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (9.34e-4)"	"unprognostic (6.60e-3)"	"unprognostic (2.19e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (9.07e-4)"	12.8	5.5	27.6	11.8	13.9	1.8	9.7	6.8	32.0	6.5	26.3	6.8	2.1	11.4	7.6	11.8	9.6	6.3	15.0	5.7	13.8	9.0	14.5	3.9	8.1	5.7	8.4	21.5	3.7	2.5	7.2	5.5	9.8	12.4	9.9	39.8	5.7	8.4	5.8	3.7	4.6	17.7	7.8	12.8	5.4	65.2	3.2	5.1	5.8	4.2	5.0	3.8	17.2	11.3	0.1	0.7	0.0	0.0	3.0	17.9	1.7	0.9	2.2	3.5	0.3	0.8	4.6	0.0	8.6	11.3	7.6	17.4	9.7	1.3	0.2	3.2	6.0	11.1	6.3	0.2	0.7	10.1	0.6	0.0	0.0	0.0	0.1	0.5	0.7	0.1	5.8	1.1	16.5	0.2	1.8	0.0	0.2	0.1	0.1	9.6	25.3	0.0	0.2	5.9	41.5	3.9	0.3	51.1	0.0	36.5	13.2	0.1	0.1	1.9	1.5	0.8	3.1	0.1	0.1	0.0	12.0	4.6	7.5	0.4	0.0	0.0	4.5	12.3	0.1	7.3	0.0	0.0	0.0	10.5	0.0	17.9	0.0	2.1	6.3	0.0	0.1	1.7	3.1	0.0	3.0	0.0	0.7	0.8	1.7	27.6	13.9	6.8	32.0	13.8	9.0	8.4	21.5	12.4	5.1	20.8	30.4	1.4	10.2	3.2	8.3	1.6	10.2	139.2	38.7	64.6	7.9	0.7	0.0	8.4	1.1	3.6	40.7	0.0	14.7	0.2	9.3	37.7	122.9	0.4	0.5	1.6	18.5	7.4	4.7	0.4	1.7	3.9	10.1	1.0	160.5	13.4	13.2	34.8	28.3	7.7	8.1	32.3	29.7	3.3	2.1	5.0	0.3	30.0	35.7	46.4
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853978	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 45.3"	"Cell type enhanced"	"Detected in many"	5	"monocytes: 144.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA		110000	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	10.7	7.9	3.8	20.4	5.2	6.1	8.7	3.1	4.9	6.5	12.6	4.5	1.9	9.1	8.2	3.9	10.5	6.4	9.6	6.5	3.5	3.3	6.5	6.4	17.6	26.9	6.4	3.6	5.0	4.4	3.0	3.6	8.7	6.0	9.0	5.4	6.6	9.4	4.4	7.5	15.3	19.5	5.7	5.2	24.2	12.6	5.8	4.9	20.8	13.1	8.9	20.3	6.6	7.6	22.7	8.8	45.3	10.9	14.4	25.3	21.0	2.8	1.8	0.0	1.7	0.9	1.2	16.8	1.5	3.4	7.0	9.5	0.1	3.0	6.0	4.0	1.1	6.5	5.5	1.2	2.5	0.4	10.2	1.6	6.7	1.4	2.3	4.4	0.0	2.4	1.3	2.1	1.9	1.2	0.0	1.7	2.2	0.4	5.7	0.8	1.7	1.1	13.3	0.0	0.6	2.0	5.9	1.2	4.0	9.0	0.5	0.0	0.3	1.6	4.3	5.8	0.3	3.9	12.0	0.9	2.6	1.0	6.4	0.0	7.6	10.6	1.7	1.7	4.0	1.8	27.7	10.6	44.2	15.5	10.9	16.3	22.7	17.5	16.4	8.8	20.9	25.3	19.4	45.3	14.4	10.5	7.2	21.7	21.0	3.8	5.2	3.1	4.9	3.5	3.3	6.4	3.6	6.0	4.9	23.8	29.5	66.8	38.2	66.3	4.1	5.3	35.7	8.1	17.0	5.2	0.0	3.2	5.0	68.6	0.4	41.7	52.4	0.0	65.7	73.1	29.1	47.1	26.5	9.7	45.6	14.3	16.1	26.4	22.4	0.0	12.0	40.0	21.9	144.3	54.7	32.1	71.9	35.1	9.9	5.0	3.0	6.5	44.0	0.9	0.7	66.9	4.0	91.4	30.7	39.7
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838780	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"monocytes: 92.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 28.6;U-251 MG: 28.3"									HPA001312	Approved		Supported	"Nuclear speckles,Endoplasmic reticulum"		NA	NA		14000	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	12.8	8.4	6.5	22.5	6.9	14.7	9.5	6.3	7.3	8.8	15.0	7.6	3.3	15.3	9.6	5.9	17.4	7.9	11.5	7.7	5.2	6.0	10.8	19.0	18.0	14.0	7.1	6.3	9.7	6.1	2.6	5.8	5.7	7.9	8.2	11.9	7.9	12.1	5.2	5.8	9.6	28.0	7.0	6.1	24.9	7.7	3.3	6.9	25.9	14.7	7.1	20.1	23.6	10.7	0.9	2.8	4.9	5.4	2.9	4.1	1.9	7.9	0.0	0.0	2.3	2.2	3.1	0.0	0.5	1.6	6.2	8.5	2.1	16.3	15.5	3.1	4.0	11.2	8.3	7.1	28.6	2.5	10.5	0.9	1.8	6.1	0.7	1.0	0.0	12.3	0.3	0.4	8.4	13.1	0.0	4.0	0.0	8.6	5.2	0.0	0.6	2.0	1.0	0.3	0.6	4.0	8.4	0.0	5.9	5.2	0.1	0.1	0.0	7.7	16.4	1.6	0.3	0.8	0.0	2.3	8.8	2.0	2.3	28.3	8.1	13.4	14.5	8.1	10.9	1.6	1.7	2.0	1.8	4.1	5.4	2.0	0.9	1.2	2.7	2.0	0.6	1.0	0.6	4.9	2.9	4.1	2.8	1.9	1.9	6.5	6.9	6.3	7.3	5.2	6.0	7.1	6.3	7.9	6.9	0.0	6.9	28.3	12.0	0.0	4.5	2.4	2.5	2.7	6.8	14.0	2.0	1.2	1.7	33.7	0.0	28.7	19.3	0.0	28.6	35.6	4.1	11.3	4.7	5.8	22.4	17.5	3.5	16.0	12.3	0.0	5.2	14.5	0.0	92.8	18.4	18.9	27.4	13.9	5.6	4.7	4.8	0.0	7.5	0.4	1.2	0.0	1.4	24.5	10.3	14.8
TAS1R1	"GPR70, T1R1, TR1"	ENSG00000173662	"Taste 1 receptor member 1"	Q7RTX1	1	6555181-6579757	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	4	"salivary gland: 10.9;testis: 8.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 6.0;Late spermatids: 14.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	15	"neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 2.7;HDLM-2: 4.7;Hep G2: 4.6;LHCN-M2: 3.7;U-698: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034579, HPA034580"	Approved					NA	NA					"HPA034579: AB_2674232, HPA034580: AB_10671504"	"unprognostic (2.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.53e-4)"	"unprognostic (3.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.17e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.22e-2)"	0.4	0.8	0.7	0.1	0.8	1.5	0.4	0.6	1.2	0.7	0.9	0.1	0.1	0.4	0.1	0.1	0.4	0.4	1.0	0.1	1.2	0.2	0.1	0.1	0.6	0.2	0.2	0.1	0.9	0.1	0.0	0.5	0.3	0.5	0.1	0.0	0.7	10.9	2.1	0.6	1.4	0.5	0.1	0.1	1.3	0.5	8.7	0.1	0.1	0.1	2.2	0.5	0.4	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.5	0.1	0.3	0.1	2.7	0.0	0.0	0.3	0.0	0.0	4.7	0.0	0.0	0.1	4.6	0.1	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.2	0.7	0.8	0.6	1.2	1.2	0.2	0.2	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.7	0.1	0.0	0.0	0.0	0.0
TAS1R2	"GPR71, T1R2, TR2"	ENSG00000179002	"Taste 1 receptor member 2"	Q8TE23	1	18839599-18859682	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"skin 1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0			0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.4			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R19	"T2R19, T2R23, TAS2R23, TAS2R48"	ENSG00000212124	"Taste 2 receptor member 19"	P59542	12	11021619-11022620	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 3.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 1.1"					"Cell type enriched"	"Detected in single"	5	"T-reg: 1.0"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.3;HDLM-2: 1.1;hTERT-HME1: 2.9;SuSa: 1.2"															NA	NA						"unprognostic (1.90e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.76e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-8)"	"unprognostic (9.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	0.3	0.5	0.4	0.3	0.4	0.5	0.7	3.4	0.7	0.5	0.4			0.6	1.1	0.1	0.2	0.7	0.6	1.4	0.6	0.5	0.4	0.2	0.4	0.2	0.4		3.0	0.4	1.1	1.9	0.4		0.6	0.3		0.3	0.6	1.1	0.5	0.3	0.5	0.7	0.4	0.3	0.8			1.0		0.3	0.4	0.5	0.0	0.1	0.0	0.2	0.1	1.0	0.0	0.4	0.0	0.3	0.5	0.0	0.0	0.2	0.0	0.4	0.3	0.7	0.2	0.1	1.0	0.0	0.0	0.3	0.0	0.1	0.0	1.3	1.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.2	0.0	0.1	0.4	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	1.0	0.0											0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS2R38	"PTC, T2R61"	ENSG00000257138	"Taste 2 receptor member 38"	P59533	7	141972631-141973773	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"intestine: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.3;NB-4: 1.1;OE19: 1.6;SK-BR-3: 1.1;U-266/70: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043862, HPA054366"	Uncertain					NA	NA					"HPA043862: AB_2678703, HPA054366: AB_2682464"			"unprognostic (5.18e-3)"			"unprognostic (6.87e-2)"		"unprognostic (1.22e-1)"		"unprognostic (3.58e-1)"	"unprognostic (1.25e-1)"			"unprognostic (8.36e-2)"	"unprognostic (5.86e-2)"		"unprognostic (8.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.5		0.1	1.9		0.1	0.0	0.0	0.0	2.2	0.2	0.0	0.2	0.2	0.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D1	"KIAA1108, TBC, TBC1"	ENSG00000065882	"TBC1 domain family member 1"	Q86TI0	4	37891087-38139175	"Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Smooth muscle cells: 93.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041816, HPA058158"	Approved		Approved	Nucleoli		NA	NA			Nucleoli		"HPA041816: AB_10796784, HPA058158: "	"unprognostic (3.77e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"prognostic favorable (1.47e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.21e-1)"	13.6	3.7	9.3	19.8	8.3	19.0	9.8	9.5	8.4	36.0	48.9	7.1	24.5	10.2	63.4	16.5	14.9	22.9	30.6	24.0	7.5	6.0	29.0	8.8	13.3	16.6	7.0	7.6	16.1	9.4	55.9	8.0	32.4	7.4	18.0	9.8	18.2	8.3	28.1	41.9	5.6	15.1	31.6	7.4	21.2	18.1	15.6	5.4	30.4	26.1	23.1	13.3	27.2	26.8	6.0	4.8	14.0	16.7	6.2	4.3	2.2	5.7	6.6	12.1	13.0	4.3	12.2	10.4	15.8	26.5	14.9	15.3	3.8	18.9	29.7	3.9	10.5	18.9	0.3	9.1	11.4	23.1	2.3	5.2	11.4	4.6	7.9	7.0	21.1	13.1	14.7	2.3	9.2	6.4	12.5	22.9	20.9	13.9	5.1	15.5	4.4	29.3	19.9	6.8	0.9	6.0	26.1	19.7	8.6	12.3	10.7	10.6	9.5	5.8	5.4	6.6	28.6	5.3	16.4	15.6	19.8	22.5	4.9	22.8	12.6	15.5	78.1	8.6	19.4	17.4	1.9	5.0	14.0	2.6	15.6	4.3	4.8	2.6	2.2	4.8	6.0	2.4	3.0	13.9	6.2	16.7	4.2	2.1	2.2	9.3	8.3	9.5	8.4	7.5	6.0	7.0	7.6	7.4	5.4	11.9	7.0	34.9	12.1	7.0	10.8	58.5	20.4	2.7	6.8	26.2	0.0	18.0	64.6	13.4	22.1	27.3	14.6	23.3	34.7	22.8	13.9	30.2	2.3	16.1	28.6	9.5	42.5	20.9	50.5	34.2	21.6	33.1	10.1	36.1	9.0	9.3	33.5	11.9	18.7	55.2	0.9	38.8	93.2	10.3	20.6	7.5	24.4	26.2	9.9	26.3
TBC1D4	"AS160, DKFZp779C0666, KIAA0603"	ENSG00000136111	"TBC1 domain family member 4"	O60343	13	75284665-75482114	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"GTPase activation"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"T-reg: 17.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.2;T-cells: 17.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 36.9;HUVEC TERT2: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040145, HPA059885"	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA040145: AB_2676860, HPA059885: AB_2684152"	"unprognostic (5.44e-3)"	"unprognostic (5.23e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.07e-11)"	"unprognostic (6.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.88e-2)"	"unprognostic (3.45e-1)"	12.0	43.9	6.7	6.7	7.0	1.2	17.5	9.3	10.7	6.9	5.7	4.6	4.2	1.9	5.4	10.1	6.1	5.9	8.5	25.5	8.0	4.1	15.6	5.3	8.5	14.9	5.4	7.0	22.5	8.5	9.5	4.2	9.5	11.1	7.4	4.9	2.0	20.8	2.4	40.1	10.8	6.3	4.7	4.8	9.6	6.1	3.3	4.4	1.1	17.7	17.3	14.8	4.7	8.7	0.5	7.2	2.6	0.3	0.3	17.4	1.8	5.5	6.5	4.1	0.2	9.7	10.5	5.3	4.8	2.5	3.9	4.3	36.9	6.8	1.1	1.1	6.8	1.9	5.2	10.4	4.8	4.1	18.3	10.5	18.0	8.8	11.1	2.4	8.5	0.2	11.4	8.9	4.3	10.2	6.8	27.3	20.3	5.0	0.6	4.4	2.6	12.4	1.5	5.8	10.7	3.9	11.2	3.9	6.5	3.8	4.0	7.6	2.3	2.1	6.5	3.5	2.2	2.2	0.2	11.4	4.4	5.5	2.3	5.6	0.3	0.0	0.1	7.9	8.0	6.5	2.6	0.3	0.0	0.5	0.1	0.0	0.5	8.6	1.8	0.4	0.4	8.0	3.7	0.3	0.3	0.1	7.2	17.4	1.8	6.7	7.0	9.3	10.7	8.0	4.1	5.4	7.0	11.1	4.4	6.0	26.1	0.5	7.9	32.2	0.0	70.6	12.7	4.0	9.1	14.0	0.0	9.3	13.3	9.7	13.3	32.1	3.5	0.0	6.5	8.5	8.2	13.9	4.7	16.4	21.4	1.6	20.2	33.7	17.4	3.6	3.4	8.8	20.3	47.7	10.6	0.3	5.3	0.0	6.7	7.4	0.6	6.5	12.3	0.9	6.1	38.6	4.1	13.1	16.2	8.1
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	35	"testis: 52.7"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 13.5;Spermatocytes: 29.0;Spermatogonia: 15.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.1;Karpas-707: 11.9;MCF7: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"	Vesicles	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.2	0.1	0.3	1.5	0.1	0.9	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.5	0.2	0.0	52.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.8	0.2	0.1	0.0	0.2	2.6	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.7	0.2	0.0	0.2	0.0	0.4	0.0	0.2	9.1	1.4	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.5	0.1	11.9	0.0	4.8	0.4	0.1	0.6	0.1	0.1	0.5	0.4	1.8	0.0	0.1	1.4	0.2	0.0	0.1	0.6	0.4	0.4	0.1	0.0	0.1	0.3	0.0	0.0	2.1	0.5	1.1	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.5	0.0	0.8	0.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.9	0.2	0.3	0.2	0.2	0.1	0.4	0.1	0.0	0.0	0.0	1.2	0.8	0.4	1.4	5.1	0.0	2.3	1.8	0.0	0.9	0.0	0.0	13.5	0.2	0.0	0.0	0.0	0.7	0.6	0.6	1.1	0.4	3.1	0.0	0.0	1.8	1.2	3.6	0.3	2.4	3.3	0.0	0.0	0.5	0.1	0.0	0.4	0.0	1.1	0.0	0.9	29.0	15.8	0.1	0.9	0.0	0.0	0.3
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Receptor	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"liver: 112.6"	"Cell type enriched"	"Detected in many"	4	"Hepatocytes: 379.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	46	"basophil: 5.5;eosinophil: 3.9"	"Lineage enriched"	"Detected in single"	54	"granulocytes: 5.5"	"Group enriched"	"Detected in some"	11	"HEL: 28.5;HMC-1: 39.6;K-562: 26.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.1	0.0	0.1	0.1	0.1	5.3	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.3	0.1	0.0	0.1	112.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.5	0.0	2.9	0.0	0.6	39.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	7.8	0.9	0.2	5.3	0.9	12.7	0.0	1.2	0.0	7.9	0.1	0.0	0.4	4.0	0.0	0.0	93.5	0.2	1.1	0.4	0.5	0.0	379.7	0.3	20.6	0.0	7.4	6.9	5.7	0.0	0.5	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	1.8	0.0	0.7	0.7	2.0	0.5	0.1	2.5	0.5	0.6
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082189	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 110.0"	"Cell type enhanced"	"Detected in many"	10	"Erythroid cells: 560.6;Syncytiotrophoblasts: 420.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	14000000	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	24.3	11.9	11.9	20.6	11.3	73.8	7.6	9.6	17.8	11.8	25.0	9.5	3.8	11.9	12.1	7.5	18.5	11.7	11.4	18.7	9.5	8.3	15.3	13.6	28.1	8.1	7.4	9.5	50.0	7.8	18.0	6.9	110.0	26.5	7.2	19.4	8.5	8.3	5.0	25.6	9.9	37.4	10.9	13.2	7.9	10.0	8.3	6.1	14.3	7.0	10.5	12.9	11.2	8.0	5.7	7.5	2.2	12.4	1.8	6.5	2.1	22.2	20.2	9.3	18.9	20.6	12.0	58.3	31.8	24.2	22.4	37.2	49.3	20.5	22.8	60.4	11.8	49.0	34.3	31.9	10.5	27.5	109.0	10.8	86.4	17.3	22.9	16.3	70.8	17.5	13.5	10.4	19.3	17.4	6.4	7.4	12.6	36.0	21.9	17.5	20.6	23.2	15.0	28.4	29.3	41.5	12.3	13.8	27.3	20.1	56.3	21.3	8.8	30.7	80.8	7.2	16.1	78.4	14.8	9.5	26.7	21.7	23.3	47.6	6.2	48.1	35.6	31.2	19.2	16.1	0.0	1.6	2.2	2.5	7.9	1.7	5.7	2.7	1.7	3.7	3.2	2.5	1.9	0.3	1.8	12.4	7.5	6.5	2.1	11.9	11.3	9.6	17.8	9.5	8.3	7.4	9.5	26.5	6.1	41.7	27.2	29.6	33.6	53.5	48.1	81.5	45.9	28.1	26.1	19.2	139.4	104.0	0.0	43.1	2.6	17.8	72.1	560.6	36.6	18.5	33.8	15.8	22.0	94.1	70.3	12.7	53.9	6.7	33.3	3.9	10.6	89.7	16.9	72.1	50.0	17.3	38.9	52.6	8.1	9.1	42.4	25.8	34.8	22.3	19.3	31.2	420.4	21.8	70.2	22.9
TJP1	"DKFZp686M05161, MGC133289, ZO-1"	ENSG00000104067	"Tight junction protein 1"	Q07157	15	29699367-29968865	"Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA001636, HPA001637, CAB010822"	Enhanced		Enhanced	"Cell Junctions"		NA	NA			"Cell Junctions"		"CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760"	"unprognostic (2.11e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.54e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.54e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.85e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-1)"	22.1	11.7	27.5	9.2	32.8	2.2	18.0	12.0	36.3	24.8	16.9	37.5	10.7	10.9	29.5	27.6	45.7	22.9	18.2	26.0	28.3	19.1	20.4	20.8	31.1	7.8	29.3	21.3	23.6	19.4	30.1	17.7	38.3	23.4	17.8	15.5	15.2	18.5	15.4	16.4	17.8	14.4	29.4	31.7	10.1	16.7	25.9	32.6	1.2	23.1	17.9	13.2	18.5	27.3	0.7	0.2	0.3	0.4	1.0	0.2	0.1	26.1	19.3	10.6	8.7	9.4	13.1	12.0	8.1	7.2	6.8	7.7	26.6	10.5	0.1	11.0	10.8	9.0	19.7	6.5	9.1	8.7	0.2	7.2	0.1	10.4	11.2	25.3	0.0	0.3	7.2	6.6	8.4	16.3	10.4	15.1	0.0	9.7	5.4	5.2	14.5	0.1	0.2	9.7	11.9	6.1	0.0	15.0	0.0	13.6	16.1	5.2	7.4	16.7	7.3	6.9	21.9	5.0	0.3	23.6	7.0	10.7	4.8	11.1	1.9	1.8	0.1	7.9	0.1	3.9	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.7	0.2	0.2	0.3	1.0	0.4	0.2	0.2	0.1	27.5	32.8	12.0	26.1	28.3	19.1	29.3	21.3	23.4	32.6	157.8	42.2	2.2	89.8	31.8	36.2	95.8	38.2	29.4	43.3	55.8	9.8	24.8	21.6	107.0	12.1	131.3	49.5	0.0	72.9	11.2	45.0	132.7	5.7	41.4	3.3	119.2	44.1	93.3	8.4	9.4	31.4	5.7	60.8	2.8	31.6	34.9	126.3	31.5	60.1	20.9	49.7	77.6	86.8	53.9	47.9	52.6	28.1	4.4	19.1	142.6
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724730	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Hofbauer cells: 31.7;Ito cells: 59.5;Kupffer cells: 88.0;Macrophages: 33.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 30.1"	"Group enriched"	"Detected in many"	30	"dendritic cells: 7.5;granulocytes: 30.1;monocytes: 21.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 29.6;TIME: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	29.2	12.1	15.5	23.5	12.5	17.8	21.9	9.4	10.3	6.9	6.8	10.6	3.0	4.4	5.8	7.7	5.0	6.8	10.6	10.9	19.9	7.5	9.0	16.5	16.0	30.9	12.4	11.4	6.7	3.0	2.9	3.8	22.8	10.5	5.7	7.4	7.2	9.0	3.6	7.4	5.2	6.6	10.4	11.1	41.4	4.5	2.4	13.0	1.1	8.3	5.6	7.5	12.1	16.1	0.6	7.5	30.1	21.4	0.0	0.0	6.9	0.0	0.0	12.7	0.0	5.9	12.0	0.1	5.0	8.8	1.3	0.7	0.0	1.2	1.7	0.2	13.0	3.9	0.0	0.0	1.1	1.9	0.0	0.0	2.7	2.7	0.1	4.4	9.1	0.0	7.4	0.0	2.8	0.3	11.4	15.5	0.0	0.0	29.6	15.4	0.0	0.0	1.8	1.5	1.2	0.6	0.0	14.3	9.3	0.5	14.8	0.0	0.0	3.2	0.0	0.5	1.2	0.0	5.0	21.4	0.7	9.6	0.0	2.4	0.0	0.0	0.0	0.4	9.6	7.6	17.6	21.4	7.2	0.0	19.6	0.0	0.6	0.0	0.0	7.5	0.2	0.0	0.0	30.1	0.0	20.2	0.3	0.0	6.9	15.5	12.5	9.4	10.3	19.9	7.5	12.4	11.4	10.5	13.0	0.0	5.3	1.5	0.1	0.7	0.2	2.5	5.1	2.7	4.5	0.0	0.0	0.2	0.0	0.0	0.0	19.7	0.3	0.0	0.2	0.2	1.9	0.2	15.1	1.8	31.7	0.0	0.0	59.5	88.0	0.0	0.0	33.1	1.7	0.0	0.6	13.8	0.3	1.7	0.0	0.4	0.8	6.5	0.9	0.0	0.2	0.0	0.7	0.0	0.1	2.2
TM4SF18	L6D	ENSG00000163762	"Transmembrane 4 L six family member 18"	Q96CE8	3	149318498-149334414	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Endothelial cells: 155.8;Ito cells: 174.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 29.6;EFO-21: 62.5;GAMG: 12.4;HUVEC TERT2: 20.7;NTERA-2: 14.9"					"Low region specificity"	"Detected in all"			"HPA053639, HPA069378"	Approved		Supported	Vesicles,Cytosol		NA	NA			Vesicles	Cytosol	"HPA053639: , HPA069378: AB_2686133"	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (2.84e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-1)"	17.9	4.8	7.1	4.0	8.8	0.1	14.4	3.7	7.3	7.9	3.5	1.7	4.7	3.1	7.6	7.2	5.4	5.6	9.0	10.8	8.4	6.2	26.6	9.7	7.4	8.0	9.3	1.5	5.4	8.0	4.2	7.4	14.1	12.3	9.1	2.9	11.9	3.5	5.6	9.3	2.7	3.9	12.3	7.4	34.6	3.5	2.6	8.2	0.6	12.0	5.7	4.0	6.0	5.8	0.9	0.6	1.2	0.4	2.8	0.5	0.0	0.0	29.6	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	62.5	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.9	20.7	0.0	0.0	0.0	1.9	0.2	0.0	0.0	14.9	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	2.6	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.7	1.2	0.4	0.4	0.3	0.2	0.1	0.5	0.4	0.2	0.0	0.9	0.4	0.5	0.5	2.8	0.3	0.6	0.1	0.0	7.1	8.8	3.7	7.3	8.4	6.2	9.3	1.5	12.3	8.2	0.0	4.1	2.2	0.0	2.9	0.1	1.1	7.6	1.4	0.0	1.8	0.0	0.0	8.3	21.2	0.3	155.8	0.0	0.0	0.2	0.0	0.9	1.0	1.1	0.6	0.1	0.0	0.0	174.3	13.0	1.0	2.0	0.2	1.7	1.0	0.0	0.6	1.2	0.0	6.3	25.4	0.0	0.0	2.1	0.0	0.2	2.5	0.0	1.3	0.0	0.4
TM4SF19		ENSG00000145107	"Transmembrane 4 L six family member 19"	Q96DZ7	3	196319342-196338503	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in many"	5	"adipose tissue: 69.9"	"Cell type enriched"	"Detected in some"	9	"Hofbauer cells: 78.9"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"gdT-cell: 14.8;memory CD8 T-cell: 3.8;naive CD8 T-cell: 5.4"	"Lineage enriched"	"Detected in single"	19	"T-cells: 14.8"	"Cell line enriched"	"Detected in some"	12	"GAMG: 100.5"															NA	NA						"unprognostic (9.90e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.90e-5)"	"unprognostic (8.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-3)"	69.9	0.4	0.4	0.7	0.4	0.9	4.5	0.4	0.5	2.1	0.4	0.4	0.4	0.0	0.4	0.6	5.0	0.3	0.8	0.4	0.4	0.1	0.4	0.8	4.9	0.6	0.4	0.4	1.2	0.4	0.0	0.4	1.1	0.4	0.6	0.1	0.4	2.2	0.4	2.1	3.2	0.4	0.4	0.4	0.8	0.6	8.2	0.4	0.5	1.0	2.0	1.3	0.9	2.1	0.3	0.5	0.6	0.4	0.8	14.8	1.4	3.4	1.6	0.1	0.1	0.2	1.1	0.1	0.0	1.0	0.3	0.7	0.0	1.9	0.0	0.6	0.0	100.5	0.5	0.0	0.3	0.2	0.1	0.0	0.1	0.4	0.0	0.2	0.2	0.1	0.1	0.3	4.4	7.4	0.0	0.0	0.2	2.1	0.2	1.1	0.2	0.0	0.1	0.0	0.0	8.4	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.3	4.4	3.6	0.6	2.0	0.1	1.2	0.0	4.7	0.1	0.1	0.6	0.3	0.4	14.8	0.4	0.1	0.1	1.4	3.8	0.1	0.3	0.8	5.4	0.6	0.8	0.1	0.5	0.3	1.4	0.4	0.4	0.4	0.5	0.4	0.1	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	78.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	3.8	0.0	0.3	0.0	0.0	0.0
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362156-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	86	"intestine: 147.8"	"Cell type enhanced"	"Detected in some"	23	"Early spermatids: 33.2;Enterocytes: 27.7;Late spermatids: 61.3;Paneth cells: 11.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 7.2;RPMI-8226: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	46.5	0.0	0.0	73.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.1	0.1	147.8	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	1.2	1.1	0.5	1.7	0.7	0.0	0.1	7.2	0.2	0.1	0.0	0.0	1.3	0.9	0.1	0.0	0.0	1.4	0.5	0.2	0.1	0.4	0.2	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.3	0.2	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.4	0.4	0.8	0.3	0.0	0.1	1.6	0.3	0.1	0.1	0.5	0.1	4.5	0.1	0.3	0.6	1.7	1.1	0.1	0.0	0.1	0.3	0.1	0.3	0.6	0.3	2.0	0.2	0.5	0.3	0.4	0.2	0.2	0.2	0.8	0.5	0.1	0.7	0.3	0.3	0.7	0.4	0.4	0.0	1.1	0.7	0.5	1.1	1.7	0.1	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	27.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.3	0.0	0.0	0.0	0.0	0.6	0.2	0.0	11.5	0.7	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	0.0	1.2	0.0
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149473974-149503281	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 196.0;intestine: 126.4;liver: 81.8"	"Cell type enriched"	"Detected in many"	5	"Cholangiocytes: 2236.9"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.3"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.3"	"Group enriched"	"Detected in some"	6	"A549: 15.4;OE19: 14.2;RPTEC TERT1: 24.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	0.3	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	68.2	0.0	0.0	70.3	0.2	0.1	0.3	0.3	196.0	0.2	0.2	0.2	0.4	81.8	0.3	0.0	0.2	0.0	0.2	24.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.2	126.4	0.0	0.2	0.3	2.3	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.3	0.2	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.6	0.1	14.2	0.0	0.0	0.3	0.9	24.0	0.0	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.1	0.0	3.4	2236.9	0.0	1.2	0.0	0.0	0.0	0.0	20.8	0.8	0.0	2.6	23.3	1.7	0.1	0.0	0.0	0.0	475.7	0.1	0.0	2.9	8.0	11.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	7.6	0.0	0.0	2.1	0.0	0.0	1.1	3.6	0.1	0.0	0.1	0.0	0.1	0.1
TM6SF1		ENSG00000136404	"Transmembrane 6 superfamily member 1"	Q9BZW5	15	83107407-83144854	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.3;skeletal muscle: 37.8"	"Cell type enhanced"	"Detected in many"	9	"granulocytes: 43.8;Hofbauer cells: 47.4;Kupffer cells: 39.6;Macrophages: 43.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"eosinophil: 44.3;neutrophil: 26.4"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 44.3"	"Cell line enhanced"	"Detected in some"		"HEL: 9.3;HHSteC: 22.1;HUVEC TERT2: 11.7;JURKAT: 15.7;TIME: 30.4;U-698: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016051, HPA056857"	Uncertain					NA	NA					"HPA016051: AB_2203924, HPA056857: AB_2683259"	"unprognostic (8.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.15e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	9.6	3.4	4.9	4.9	6.8	4.7	11.2	4.4	13.9	4.0	3.0	6.8	0.9	2.3	3.2	4.1	2.4	3.4	3.9	9.2	7.2	6.7	2.9	2.5	10.6	9.0	8.0	7.1	2.1	1.5	1.8	1.7	7.2	10.0	2.5	2.9	3.4	3.2	1.9	37.8	1.7	2.6	3.8	12.5	5.2	2.1	4.1	3.7	0.6	9.9	3.5	3.0	4.9	2.4	0.2	4.6	44.3	7.8	1.0	1.2	2.8	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.2	9.3	0.0	0.0	22.1	0.5	0.0	0.1	0.0	0.0	0.0	0.1	11.7	15.7	0.4	0.0	0.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.8	0.2	0.0	6.5	30.4	0.3	0.4	0.0	0.1	0.9	0.0	7.0	0.0	1.2	0.0	14.1	7.8	44.3	1.2	3.3	0.0	0.0	0.1	0.1	4.6	0.2	0.0	0.1	26.4	1.0	1.4	0.6	0.0	2.8	4.9	6.8	4.4	13.9	7.2	6.7	8.0	7.1	10.0	3.7	0.0	8.9	0.5	0.0	2.2	1.1	1.2	2.5	1.4	1.2	0.0	0.0	0.2	0.0	0.1	9.8	10.5	0.0	0.0	1.8	0.3	0.7	0.0	43.8	0.0	47.4	0.0	0.0	5.5	39.6	6.3	0.9	43.7	3.3	5.4	0.0	0.4	0.3	0.0	0.0	0.0	1.1	0.0	0.4	14.9	2.2	1.5	0.2	5.0	0.0	0.0
TM9SF1	"HMP70, MP70"	ENSG00000100926	"Transmembrane 9 superfamily member 1"	O15321	14	24189143-24195687	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059249	Supported		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA059249: AB_2683959"	"unprognostic (3.27e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.18e-3)"	13.3	20.4	6.3	10.9	6.6	3.4	14.0	5.4	8.1	18.5	15.6	10.4	33.1	10.7	17.7	21.8	14.1	23.4	18.4	14.6	6.2	6.0	24.5	46.4	17.0	14.6	6.2	7.1	17.6	39.9	27.4	12.3	25.1	6.5	16.9	9.4	15.6	31.8	36.0	10.1	12.0	16.8	13.6	5.9	12.7	14.7	10.3	5.6	9.6	32.3	12.9	12.1	12.8	12.4	10.6	25.8	18.0	13.6	14.5	10.8	8.6	9.5	16.0	7.1	5.5	14.1	11.0	11.1	18.7	21.3	22.5	25.3	8.0	18.6	5.7	12.5	15.9	10.7	21.5	4.4	11.3	12.3	9.5	7.5	4.4	8.3	16.5	9.9	8.1	10.3	12.8	15.9	14.2	8.2	10.9	12.8	3.2	5.2	11.0	13.4	15.0	4.8	5.6	3.3	13.5	18.9	7.2	10.5	9.5	7.8	13.0	7.2	8.3	22.6	10.2	9.1	5.4	9.6	3.6	12.8	19.7	9.0	10.3	11.7	15.5	11.8	4.1	6.6	4.5	13.4	17.2	13.6	15.2	10.0	10.9	10.8	10.2	9.9	8.7	15.0	10.6	9.2	8.7	18.0	14.5	10.4	25.8	9.9	8.6	6.3	6.6	5.4	8.1	6.2	6.0	6.2	7.1	6.5	5.6	14.9	4.0	3.9	5.0	3.0	4.2	1.0	5.1	45.5	7.9	1.8	13.7	8.2	0.0	6.6	9.3	6.0	4.2	0.0	4.3	8.1	5.9	6.7	2.3	4.3	3.7	0.0	1.7	4.9	1.0	3.8	4.9	3.2	1.7	5.4	2.3	6.1	4.6	4.2	4.2	2.3	6.6	6.5	6.2	5.6	5.1	4.1	10.0	4.5	3.7	3.5
TM9SF2	P76	ENSG00000125304	"Transmembrane 9 superfamily member 2"	Q99805	13	99446311-99564006	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005657	Supported					NA	NA					"HPA005657: AB_1080303"	"unprognostic (9.77e-3)"	"unprognostic (3.51e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.21e-7)"	"unprognostic (6.49e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.21e-1)"	28.8	35.4	24.0	23.3	30.0	20.6	34.6	22.0	33.1	40.5	42.6	28.4	44.4	43.8	33.1	46.5	34.5	29.5	30.2	25.7	22.7	26.8	44.9	83.9	42.6	49.6	21.4	24.9	28.0	65.6	42.0	47.4	60.9	26.6	38.2	47.1	31.4	59.2	48.4	22.5	28.3	57.4	24.9	27.9	36.5	38.2	36.3	21.7	29.4	47.6	24.8	33.8	40.8	28.7	22.4	38.9	61.9	43.5	17.5	26.1	35.9	39.2	12.2	16.6	23.5	50.2	30.6	23.9	26.8	33.5	19.1	30.0	19.8	50.7	15.2	22.3	32.1	19.6	39.6	17.6	23.4	26.2	17.0	12.7	18.9	21.4	21.1	26.6	49.1	22.0	23.9	29.2	16.5	17.1	29.7	24.0	15.9	18.8	15.3	22.4	13.2	12.2	19.2	14.5	71.7	15.4	10.3	13.4	16.4	39.5	29.3	15.8	19.4	15.4	62.5	19.4	33.7	38.1	59.4	23.5	15.4	11.4	15.4	16.5	21.3	24.8	6.2	36.3	25.5	22.3	38.1	38.5	41.3	15.1	43.5	18.9	22.4	18.3	16.9	34.2	14.6	17.1	15.6	61.9	17.5	41.3	38.9	26.1	35.9	24.0	30.0	22.0	33.1	22.7	26.8	21.4	24.9	26.6	21.7	77.4	61.2	41.0	47.9	36.4	20.0	34.4	81.5	105.7	86.4	82.0	17.7	82.4	10.0	84.4	109.4	53.7	104.0	46.7	89.6	106.7	61.2	80.2	53.1	153.2	100.7	20.6	79.7	89.0	138.5	30.7	46.3	76.0	69.2	45.1	144.6	47.3	77.9	122.8	49.1	58.9	22.6	19.4	57.7	95.8	54.7	45.7	143.4	35.8	100.6	91.9
TM9SF4	"dJ836N17.2, KIAA0255"	ENSG00000101337	"Transmembrane 9 superfamily member 4"	Q92544	20	32109506-32167258	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064099	Approved					NA	NA					"HPA064099: AB_2685190"	"unprognostic (3.10e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.37e-6)"	"unprognostic (3.85e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.98e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	20.3	26.2	18.1	23.5	27.7	11.6	21.1	29.8	38.5	23.4	25.7	25.4	21.8	23.7	31.4	25.7	34.4	29.3	22.2	24.1	16.0	20.6	22.5	36.9	21.7	17.7	14.7	20.9	26.8	28.2	52.4	26.6	34.6	21.3	23.9	30.8	22.4	39.6	32.2	26.4	29.4	24.7	26.2	14.9	21.4	23.6	27.2	15.7	18.7	21.6	19.0	24.1	25.9	25.0	7.8	19.3	9.9	28.9	8.3	12.1	13.9	19.0	13.6	15.6	17.8	30.7	25.1	20.1	15.8	24.0	22.2	21.8	40.1	23.7	13.4	30.1	25.7	34.9	31.6	17.5	33.8	19.3	7.6	9.8	30.7	11.7	30.0	27.2	14.7	17.7	26.3	25.8	16.8	27.2	27.4	19.7	16.1	19.3	25.0	17.3	20.2	14.8	11.1	13.9	23.2	16.7	14.2	22.0	16.6	19.3	13.5	13.3	15.5	29.4	19.4	16.9	21.6	24.3	17.0	16.0	40.8	12.7	21.5	19.2	25.4	20.8	12.6	32.3	49.1	18.2	9.9	21.7	4.4	9.9	23.3	12.1	7.8	8.8	11.2	19.3	6.8	9.8	8.3	5.6	8.3	28.9	6.3	8.5	13.9	18.1	27.7	29.8	38.5	16.0	20.6	14.7	20.9	21.3	15.7	23.8	25.1	8.2	15.5	6.3	11.8	12.9	10.2	24.1	28.4	8.7	15.7	25.1	1.7	16.5	41.7	16.9	24.2	0.0	15.9	18.5	17.6	16.8	8.1	23.2	20.3	7.9	13.4	15.4	15.1	45.1	15.5	18.8	6.8	10.0	32.5	15.7	17.3	28.1	10.3	13.5	12.0	6.5	13.0	20.0	9.4	9.9	31.5	13.8	23.5	17.9
TMBIM1	"LFG3, PP1201, RECS1"	ENSG00000135926	"Transmembrane BAX inhibitor motif containing 1"	Q969X1	2	218274192-218292586	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RT4: 85.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012093, HPA070824"	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA012093: AB_1858056, HPA070824: AB_2686317"	"unprognostic (4.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.81e-3)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.76e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.50e-1)"	64.3	34.6	26.5	22.1	45.0	23.0	84.3	11.0	38.3	35.7	42.2	43.1	33.7	41.8	35.0	30.0	86.8	25.1	50.3	34.6	21.0	17.2	50.7	69.3	46.7	34.3	37.5	13.7	27.9	87.6	31.3	15.0	92.7	40.9	31.6	40.1	23.9	40.1	43.7	53.2	49.5	70.6	41.2	50.3	22.7	57.8	13.2	32.5	9.4	66.4	42.1	36.3	57.7	54.5	17.0	19.6	60.3	43.5	13.0	24.0	33.6	26.9	9.7	0.5	7.2	63.1	26.6	29.0	26.5	32.7	15.7	18.1	24.8	66.9	6.2	19.3	38.9	29.9	46.1	9.0	59.4	15.5	22.2	3.7	39.0	6.7	29.8	28.6	0.5	38.5	25.2	55.8	32.1	41.0	16.8	16.6	1.0	24.3	11.6	27.3	1.1	0.4	6.7	0.4	55.7	8.8	0.9	4.3	4.8	21.1	85.0	0.5	0.5	8.7	32.5	18.4	6.0	8.7	5.9	25.1	28.2	7.8	13.0	9.6	5.6	6.5	2.7	27.8	6.2	15.9	60.3	27.7	59.9	24.0	36.2	20.5	17.0	22.0	19.5	19.6	14.0	14.7	15.8	35.5	13.0	43.5	5.3	23.5	33.6	26.5	45.0	11.0	38.3	21.0	17.2	37.5	13.7	40.9	32.5	68.5	24.6	28.7	69.9	72.6	1.9	23.1	86.6	8.1	29.6	66.3	0.0	126.2	11.6	144.8	0.6	46.0	183.5	23.3	245.6	121.5	63.2	108.4	48.5	40.1	94.3	0.0	21.8	25.2	35.2	1.9	50.0	57.9	43.9	14.4	54.8	22.4	239.0	105.2	55.9	32.3	1.7	12.9	47.2	0.7	12.3	88.3	235.9	34.8	41.2	229.1
TMBIM4	"CGI-119, GAAP, LFG4, S1R, ZPRO"	ENSG00000155957	"Transmembrane BAX inhibitor motif containing 4"	Q9HC24	12	66135846-66170072	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA077642			Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA077642: AB_2686849"	"unprognostic (5.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.36e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.20e-3)"	47.2	57.3	18.4	31.2	23.8	22.2	40.1	9.2	21.0	34.8	36.5	30.8	39.8	24.1	42.5	40.3	32.2	33.7	31.7	37.2	18.9	19.9	56.2	66.7	46.8	48.6	27.3	14.4	41.6	63.5	30.6	48.2	42.5	27.2	34.5	29.5	44.8	56.4	39.7	29.1	24.9	45.8	37.0	34.2	55.7	39.1	66.7	22.5	39.6	54.3	32.0	38.1	36.8	31.6	30.6	38.9	100.3	60.9	18.8	26.1	61.1	13.1	17.3	11.1	20.3	37.9	35.7	11.7	20.5	35.9	16.0	13.0	8.9	21.9	12.4	24.5	28.8	12.0	21.9	5.6	18.1	10.4	20.0	7.4	23.9	8.9	10.3	19.3	28.8	31.0	25.0	26.3	7.8	8.8	22.5	24.3	14.3	17.5	44.9	26.3	21.6	10.9	10.0	13.3	20.6	17.6	5.8	7.4	13.8	35.7	22.0	5.6	13.5	23.3	43.6	27.3	10.1	40.9	39.9	29.3	19.9	7.4	14.3	12.0	23.3	12.6	8.8	27.2	28.3	23.4	51.4	56.7	53.9	21.9	55.6	21.9	30.6	22.9	22.4	38.9	28.8	26.1	23.0	100.3	18.8	60.9	25.9	23.2	61.1	18.4	23.8	9.2	21.0	18.9	19.9	27.3	14.4	27.2	22.5	140.0	123.5	60.5	48.9	0.0	46.5	31.6	0.0	182.0	121.7	232.1	43.2	122.1	87.9	183.7	222.5	73.0	105.9	0.0	295.0	97.7	70.5	78.3	171.3	0.0	189.1	42.9	71.7	0.0	0.0	105.9	96.7	181.8	0.0	136.1	134.7	96.6	178.8	186.2	85.6	171.1	56.2	58.2	40.1	301.5	37.0	0.0	109.4	0.0	147.8	52.1
TMBIM6	"BAXI1, BI-1, TEGT"	ENSG00000139644	"Transmembrane BAX inhibitor motif containing 6"	P55061	12	49707725-49764934	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hepatocytes: 2191.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017378	Approved					NA	NA					"HPA017378: AB_2669604"	"prognostic unfavorable (3.54e-4)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.80e-1)"	"prognostic favorable (1.00e-5)"	"unprognostic (1.95e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.54e-2)"	73.3	78.3	57.3	33.4	60.1	34.9	54.9	31.5	56.7	57.1	68.5	84.0	73.0	60.2	46.0	86.7	70.5	57.1	57.5	36.7	47.0	46.1	146.2	245.5	62.2	36.1	56.9	38.2	52.8	88.9	54.6	29.3	69.2	55.1	51.6	65.0	55.1	131.6	59.5	41.3	37.0	123.7	38.4	65.4	53.5	68.0	45.2	50.8	52.5	117.0	42.6	55.8	54.7	42.1	47.1	65.7	139.2	80.5	49.1	69.8	158.0	57.5	50.1	40.9	37.4	118.7	66.0	51.0	43.6	83.6	56.9	52.2	80.6	166.4	36.3	74.5	85.1	59.7	63.3	35.5	64.0	62.1	52.2	38.2	57.7	38.4	39.3	72.0	65.9	95.7	66.7	150.1	63.6	92.9	80.8	47.1	45.0	51.9	150.5	64.9	56.1	33.7	40.0	42.5	69.8	38.5	28.7	40.9	61.4	86.3	87.9	31.7	20.8	58.5	77.5	49.1	55.2	97.3	70.1	44.2	52.4	40.0	35.1	37.8	65.0	65.5	31.1	73.2	31.1	25.5	79.0	80.5	85.6	66.5	80.1	69.8	47.1	60.6	65.9	65.4	41.4	54.0	61.2	139.2	49.1	79.7	65.7	59.1	158.0	57.3	60.1	31.5	56.7	47.0	46.1	56.9	38.2	55.1	50.8	443.7	382.6	246.5	431.6	231.8	227.2	183.8	608.9	568.8	390.2	516.5	108.0	351.1	111.0	761.8	1344.0	309.2	1092.3	140.2	713.9	744.7	268.9	579.3	248.6	2191.3	569.6	170.0	283.3	377.5	527.1	1530.3	267.2	425.0	234.5	566.3	551.0	486.2	743.7	520.2	270.1	658.8	131.4	168.1	298.1	317.6	224.2	205.4	745.0	292.8	412.7	569.2
TMC1	"DFNA36, DFNB11, DFNB7"	ENSG00000165091	"Transmembrane channel like 1"	Q8TDI8	9	72521608-72838230	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Transport"	"Ion channel"	"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"cervix, uterine: 3.0"	"Cell type enhanced"	"Detected in some"	8	"Cytotrophoblasts: 3.3;Early spermatids: 3.7;Glandular cells: 3.2;Urothelial cells: 5.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.4;HAP1: 10.5;NTERA-2: 4.3;SuSa: 1.6;U-266/84: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.97e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-1)"	0.2	0.0	0.9	0.0	0.7	0.0	0.2	0.2	1.1	3.0	0.0			0.0	0.2	1.3	0.7	0.7	0.2	0.0	0.7	0.5	1.4	0.0	0.0	0.0	1.0		0.2	0.0	0.0	0.0	1.1		0.7	0.0		0.0	0.3	0.2	0.0	0.0	0.0	1.5	0.0	0.0	1.1			0.0		0.3	1.6	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.3	10.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0											0.0	0.0	0.0	2.2	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	3.3	0.0	0.1	3.7	0.4	0.0	0.0	0.5	2.1	0.4	3.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.9	0.3	0.0	0.0	1.0	0.0	0.9	0.4	0.0	0.0	2.9	0.0	0.0	0.4	1.2	3.0	0.0	2.2	0.0	0.0	5.9
TMC6	"EVER1, EVIN1, LAK-4P"	ENSG00000141524	"Transmembrane channel like 6"	Q7Z403	17	78110458-78132407	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 39.6;brain: 43.1;lymphoid tissue: 41.4"	"Cell type enhanced"	"Detected in many"	4	"monocytes: 77.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 34.4;SK-BR-3: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051430	Uncertain					NA	NA					"HPA051430: AB_2681483"	"unprognostic (6.34e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-2)"	"prognostic favorable (3.20e-4)"	10.5	3.5	7.5	26.1	25.5	39.6	8.3	2.1	12.8	4.1	8.8	33.5	5.6	13.5	3.1	1.7	9.5	5.6	6.5	8.1	12.5	8.1	6.9	3.7	14.4	39.2	43.1	4.6	1.7	6.4	1.8	2.4	6.6	20.3	7.5	4.7	3.6	12.7	7.2	2.3	6.5	17.5	2.7	31.4	41.4	9.1	1.6	31.2	12.1	5.0	2.7	24.8	7.3	6.5	13.5	8.3	9.8	26.7	15.6	27.2	13.2	5.5	4.4	2.4	1.9	0.0	0.0	5.0	0.0	0.0	0.0	0.0	8.0	6.3	6.3	7.8	0.0	2.1	9.9	0.3	1.9	0.0	0.6	3.6	13.1	1.2	9.8	0.6	11.9	22.3	0.3	5.3	0.0	0.4	0.0	4.8	2.9	34.4	23.8	0.0	11.2	5.8	20.4	1.9	10.5	1.6	2.6	0.2	18.4	3.7	20.7	0.6	1.6	1.8	39.2	10.6	3.3	22.3	18.2	1.6	0.0	3.0	0.0	0.1	18.9	8.2	4.0	0.0	19.3	0.3	6.4	4.9	9.8	27.2	16.9	23.7	13.5	20.1	21.9	8.3	10.2	18.1	18.7	6.9	15.6	26.7	2.5	17.0	13.2	7.5	25.5	2.1	12.8	12.5	8.1	43.1	4.6	20.3	31.2	38.7	26.4	66.2	15.9	9.8	3.5	11.8	10.2	5.3	22.7	15.7	0.0	0.9	0.0	38.9	0.3	14.3	19.3	23.3	20.8	23.7	5.3	23.5	39.3	0.9	59.4	1.6	8.7	23.4	44.3	0.4	8.9	34.5	13.5	77.5	10.4	6.3	30.2	43.2	1.1	1.4	1.3	12.9	4.6	0.3	1.9	8.9	3.1	73.4	30.8	33.5
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.6;intestine: 23.2;lymphoid tissue: 52.9"	"Cell type enhanced"	"Detected in many"	7	"B-cells: 29.6;granulocytes: 40.4;Hofbauer cells: 25.4;monocytes: 26.2;T-cells: 39.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 15.7;HL-60: 20.9;HMC-1: 42.3;Karpas-707: 36.0;RPMI-8226: 22.2;U-266/70: 17.4;U-937: 17.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favorable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	3.6	1.6	2.3	30.1	4.6	33.6	1.9	0.7	2.3	1.7	4.4	3.5	0.1	4.2	2.5	2.1	2.5	2.1	6.2	1.5	2.3	1.7	3.4	3.1	10.7	38.7	4.0	0.8	0.9	1.2	0.1	1.3	1.5	2.8	2.4	1.9	2.6	10.2	1.0	0.6	1.7	23.2	1.0	5.1	52.9	4.1	0.7	3.7	49.7	3.1	1.8	36.6	3.9	2.5	5.0	2.1	5.5	6.6	6.7	13.1	4.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	15.7	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.2	0.0	20.9	42.3	0.0	0.0	0.0	0.0	0.0	0.0	7.9	1.3	36.0	0.0	0.4	7.1	0.9	0.0	1.1	0.1	0.4	0.1	22.2	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	2.3	4.3	0.0	0.0	0.0	0.0	0.0	17.4	0.7	1.5	0.0	17.7	0.0	2.3	1.8	5.5	13.1	3.1	9.4	5.0	10.5	12.9	2.1	5.0	9.4	8.4	3.0	6.7	6.6	1.9	5.7	4.2	2.3	4.6	0.7	2.3	2.3	1.7	4.0	0.8	2.8	3.7	3.0	15.1	29.6	9.3	4.7	0.0	1.6	0.0	1.4	7.9	0.0	0.0	0.3	0.0	0.9	0.3	1.4	2.1	0.0	1.1	1.0	1.5	2.2	40.4	0.4	25.4	0.0	1.2	6.2	22.6	0.0	0.0	15.6	6.8	26.2	0.8	0.2	0.4	3.1	0.4	0.3	0.0	0.0	1.7	0.4	0.5	4.0	0.5	39.2	2.2	11.7
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054768, HPA078775"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA054768: AB_2682597, HPA078775: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (5.17e-7)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	28.8	48.5	28.1	18.7	29.8	17.2	34.1	21.5	28.7	30.2	47.4	26.9	37.6	43.0	28.4	43.3	34.3	24.9	30.6	25.9	23.8	26.8	62.6	89.8	24.9	23.6	27.2	21.0	30.6	37.3	32.6	50.1	47.0	31.1	30.7	48.8	29.9	43.5	38.5	20.2	20.9	70.9	23.7	31.4	29.4	29.9	34.4	22.4	36.3	53.7	24.1	31.1	29.4	25.2	46.0	76.6	52.5	57.6	45.1	61.7	78.0	28.0	31.7	24.3	14.6	44.8	21.2	23.7	48.2	34.2	28.4	29.6	45.2	42.5	17.9	50.1	34.9	12.5	40.0	31.5	25.3	31.0	45.4	29.2	22.6	36.9	27.9	36.2	38.4	29.8	28.9	29.5	33.0	26.6	26.2	20.6	22.1	58.6	35.1	39.8	21.7	30.4	29.2	31.0	92.2	36.0	22.4	27.2	45.2	34.4	37.0	25.0	43.8	36.9	39.3	29.3	37.4	51.5	48.9	22.6	26.2	21.8	22.9	44.6	67.2	90.9	63.0	21.0	25.1	34.7	52.5	55.6	51.2	53.0	50.8	55.6	46.0	56.5	56.5	41.8	39.8	46.0	53.2	43.1	45.1	57.6	76.6	61.7	78.0	28.1	29.8	21.5	28.7	23.8	26.8	27.2	21.0	31.1	22.4	89.3	64.3	79.5	78.2	75.3	77.8	52.9	242.0	129.8	92.1	202.4	64.8	116.6	36.5	176.6	62.6	87.0	250.8	46.7	166.4	124.7	115.1	88.8	73.0	298.8	125.0	71.5	85.0	87.8	100.9	101.4	114.5	87.4	94.5	55.9	105.0	214.5	177.4	168.4	121.6	108.8	60.1	122.9	83.4	191.2	73.2	81.2	93.1	105.4	127.3	85.0
TMCO3	"C13orf11, FLJ20623"	ENSG00000150403	"Transmembrane and coiled-coil domains 3"	Q6UWJ1	13	113490995-113554590	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 17.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039561, HPA048126"	Uncertain		Approved	Cytosol		NA	NA			Cytosol		"HPA039561: AB_2676573, HPA048126: AB_2680276"	"unprognostic (7.89e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (6.78e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (2.93e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.47e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (4.10e-4)"	16.1	20.5	15.1	11.1	14.2	40.3	14.5	38.7	14.6	21.3	15.7	18.6	16.7	13.0	23.1	15.5	13.1	17.2	23.2	17.0	14.4	13.0	18.0	15.5	13.8	9.4	17.4	9.6	16.9	46.1	18.6	18.6	23.2	21.2	16.1	14.1	17.1	25.8	14.5	10.2	7.7	17.6	18.9	20.7	14.8	27.8	11.0	11.3	7.2	7.5	13.4	11.3	13.2	23.9	2.6	5.0	17.4	8.5	4.1	1.8	2.0	27.1	9.2	13.4	9.2	27.7	41.0	7.3	29.8	28.5	13.1	13.3	10.1	12.1	6.5	7.6	32.6	17.9	11.0	7.0	10.8	20.5	13.3	7.2	5.8	14.9	10.0	26.1	9.5	12.3	33.2	25.6	9.8	20.4	34.1	21.4	4.2	8.3	9.3	22.9	4.9	4.9	5.7	6.7	13.0	14.6	6.3	8.2	4.6	21.9	3.7	11.8	9.8	9.2	20.4	9.5	19.9	12.0	18.1	33.3	14.9	15.9	10.8	12.5	11.5	6.5	4.2	49.2	5.0	7.1	2.4	6.9	6.8	1.1	4.4	1.4	2.6	1.4	1.8	5.0	1.4	1.5	1.5	17.4	4.1	8.5	1.1	1.2	2.0	15.1	14.2	38.7	14.6	14.4	13.0	17.4	9.6	21.2	11.3	11.9	13.7	13.7	30.6	8.8	15.6	16.5	25.5	33.5	21.6	24.4	13.7	17.6	5.0	37.3	11.6	32.2	18.2	0.0	32.8	48.1	26.7	79.7	26.5	8.9	17.4	20.6	32.8	31.9	30.8	28.3	33.9	20.1	16.9	30.7	58.9	26.1	43.8	28.3	44.9	12.8	17.6	6.5	32.0	17.7	13.2	6.1	10.9	12.7	15.2	27.6
TMED1	"Il1rl1l, IL1RL1LG, MGC1270, p24g1, p24gamma1, ST2L"	ENSG00000099203	"Transmembrane p24 trafficking protein 1"	Q13445	19	10832438-10836318	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Syncytiotrophoblasts: 122.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018507	Uncertain					NA	NA					"HPA018507: AB_1858063"	"unprognostic (6.98e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.27e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.93e-2)"	"prognostic favorable (8.66e-5)"	"unprognostic (9.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.45e-2)"	12.1	15.8	9.5	8.7	9.4	10.5	17.0	5.2	11.5	13.5	10.5	13.6	16.8	11.8	13.1	19.7	12.8	15.4	14.8	23.6	10.7	10.2	20.9	32.2	9.3	12.5	13.1	6.5	22.4	19.4	10.5	18.3	35.3	9.9	12.8	4.2	13.2	15.6	10.4	33.5	8.7	10.1	6.3	11.5	14.8	11.6	11.4	10.0	12.5	22.7	18.2	9.2	12.8	10.0	17.6	27.0	14.2	32.2	37.6	20.8	20.9	13.3	23.3	10.0	15.2	9.7	10.9	10.4	20.6	19.1	22.0	31.5	21.7	19.7	9.9	48.9	14.6	11.5	11.7	6.1	11.0	7.9	14.3	15.2	13.5	17.7	17.1	14.2	10.0	32.2	15.6	12.8	13.0	7.2	9.7	12.9	7.9	11.3	27.7	8.8	23.4	7.5	14.2	14.8	8.5	23.8	9.1	7.6	15.4	12.8	11.4	10.6	10.9	11.8	11.5	11.3	4.3	15.3	13.8	13.0	27.5	11.8	27.3	21.5	17.0	17.2	9.0	19.7	22.0	13.5	4.1	32.2	14.2	20.8	30.7	14.5	17.6	14.4	16.9	27.0	14.3	13.5	14.9	11.7	37.6	31.4	19.5	12.2	20.9	9.5	9.4	5.2	11.5	10.7	10.2	13.1	6.5	9.9	10.0	8.9	11.7	20.5	19.6	16.5	9.6	0.3	35.7	34.8	13.6	50.6	7.9	95.0	34.9	45.3	3.6	26.7	25.4	0.0	38.5	78.9	41.1	29.9	27.6	37.7	46.7	4.8	22.7	22.1	20.0	4.9	20.8	20.2	40.5	27.1	20.5	36.4	37.0	28.8	19.1	50.6	16.4	32.3	25.4	15.1	28.2	15.3	122.3	17.5	25.4	18.4
TMED2	"P24A, p24b1, p24beta1, RNP24"	ENSG00000086598	"Transmembrane p24 trafficking protein 2"	Q15363	12	123584531-123598577	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014060	Approved		Supported	Vesicles		NA	NA			Vesicles		"HPA014060: AB_1856389"	"unprognostic (6.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.57e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.35e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.87e-2)"	31.3	31.9	15.7	21.8	21.2	23.5	32.0	13.2	21.5	38.5	31.6	20.4	41.1	27.6	33.4	49.0	41.3	27.4	28.9	41.7	15.7	17.1	32.6	120.1	28.1	29.4	18.2	16.7	37.4	135.4	18.1	36.3	40.0	18.9	33.3	32.8	23.8	90.2	38.0	46.3	27.4	34.2	30.5	22.5	25.6	32.4	17.8	15.0	24.0	49.2	23.8	30.0	34.0	27.8	32.4	69.3	58.9	40.9	39.5	61.2	36.2	41.9	37.4	24.9	43.0	56.8	50.4	59.3	73.0	59.0	46.5	36.9	37.3	36.6	36.0	39.2	72.7	31.9	42.1	33.6	39.3	48.9	27.0	29.0	38.8	22.7	48.1	107.9	52.8	33.5	42.3	65.7	39.9	54.3	66.7	43.4	24.6	39.1	24.7	47.4	31.1	28.0	43.4	35.9	36.3	33.7	29.1	40.6	41.8	56.7	63.6	31.0	26.8	48.9	49.1	48.3	31.5	83.3	42.9	41.1	39.7	25.1	38.3	40.8	54.7	50.7	30.5	46.9	35.0	46.8	58.9	39.8	39.6	46.8	40.9	61.2	32.4	42.4	44.1	44.2	27.2	34.6	40.3	31.5	39.5	37.8	69.3	38.3	36.2	15.7	21.2	13.2	21.5	15.7	17.1	18.2	16.7	18.9	15.0	44.7	63.4	116.9	242.8	370.8	48.2	119.4	201.2	64.3	75.1	146.5	19.6	243.2	99.5	277.5	9.2	101.5	131.7	0.0	218.6	589.4	362.9	393.4	91.1	470.6	200.1	46.1	163.9	139.3	120.4	10.9	168.0	156.4	359.4	130.8	234.1	92.4	213.4	161.4	144.2	138.8	38.3	161.7	234.9	97.7	158.0	436.1	377.9	163.0	207.2	283.9
TMED3	"C15orf22, p24B, p24g4, p24gamma4"	ENSG00000166557	"Transmembrane p24 trafficking protein 3"	Q9Y3Q3	15	79311062-79427432	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 182.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049314, HPA076949"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA049314: AB_2680708, HPA076949: AB_2686820"	"prognostic unfavorable (7.71e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.85e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.09e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.52e-1)"	6.1	7.0	5.0	6.1	5.8	7.5	16.8	9.6	8.9	15.0	12.0	6.9	32.2	6.0	10.0	34.9	31.2	9.9	18.0	11.4	6.1	10.0	11.0	4.6	7.7	12.2	5.7	7.5	8.1	68.0	6.5	23.5	24.2	8.2	15.0	13.9	7.1	182.4	34.0	2.0	25.0	6.0	9.4	7.1	9.4	16.0	13.9	4.2	7.0	18.8	20.9	23.4	11.2	17.4	28.3	40.9	34.0	33.0	21.7	29.3	32.2	14.2	37.2	7.2	13.6	50.5	38.9	15.5	34.0	46.3	23.2	28.8	31.0	26.2	6.7	26.0	51.9	30.3	27.0	21.3	21.7	12.2	13.3	32.9	22.5	33.6	22.8	29.5	23.9	44.8	28.7	32.1	13.3	19.5	27.8	26.9	23.1	9.9	0.1	22.6	30.0	6.7	21.8	10.0	53.4	20.9	8.2	10.4	33.6	21.1	10.9	22.0	10.9	18.0	34.7	32.1	24.6	30.2	16.9	22.0	18.8	17.0	0.4	23.6	14.1	16.2	9.4	24.1	38.2	21.9	21.7	26.5	34.0	23.3	31.3	24.8	28.3	23.1	25.2	40.1	23.4	29.3	28.1	2.3	21.7	33.0	40.9	26.2	32.2	5.0	5.8	9.6	8.9	6.1	10.0	5.7	7.5	8.2	4.2	26.8	42.4	32.0	84.7	85.2	13.7	13.7	38.2	17.4	33.0	54.1	7.9	144.0	19.9	121.4	36.7	30.9	49.4	0.0	217.2	259.1	80.2	134.4	47.2	6.4	94.4	12.7	80.6	66.3	51.8	91.1	46.1	49.7	81.0	70.3	131.0	35.8	146.0	51.8	25.8	21.4	12.1	19.4	44.5	43.6	58.2	106.4	144.2	35.5	122.8	149.3
TMEM104	"FLJ00021, FLJ20255"	ENSG00000109066	"Transmembrane protein 104"	Q8NE00	17	74776483-74839779	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Cardiomyocytes: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044330	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			Nucleoplasm	"Golgi apparatus"	"HPA044330: AB_10960543"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (7.46e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.75e-1)"	"prognostic favorable (1.97e-5)"	"unprognostic (8.14e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.46e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.00e-2)"	11.5	15.5	10.6	11.6	12.1	15.4	7.7	10.5	13.9	8.1	7.9	19.1	9.5	7.6	7.4	8.9	9.3	6.8	9.6	9.0	11.4	8.2	10.9	19.9	14.7	19.0	17.3	9.1	9.4	18.7	21.0	14.7	12.5	13.1	8.0	6.7	10.0	15.1	9.1	7.5	9.7	7.7	9.4	18.5	10.4	8.3	17.4	14.2	7.5	11.7	6.5	10.2	10.6	6.1	4.9	8.8	5.7	7.7	3.9	7.9	5.0	6.3	15.6	8.4	9.4	11.9	7.4	5.0	11.0	11.1	14.1	15.7	12.8	6.9	3.4	3.5	12.5	14.4	7.2	8.4	6.1	7.5	2.5	11.9	8.4	6.3	8.8	8.7	13.7	7.8	5.9	6.8	14.3	3.1	4.2	10.0	8.3	4.8	5.3	9.6	6.0	8.2	5.6	4.6	8.4	12.5	5.2	13.2	5.6	6.3	5.6	7.1	9.3	6.1	7.9	8.1	6.6	10.1	21.4	7.9	29.8	7.6	11.3	14.2	3.6	3.1	3.8	11.5	14.4	11.3	2.2	7.7	5.7	7.9	6.5	4.0	4.9	7.6	7.2	8.3	1.6	6.3	4.4	3.6	3.9	6.6	8.8	7.5	5.0	10.6	12.1	10.5	13.9	11.4	8.2	17.3	9.1	13.1	14.2	6.0	7.2	0.8	1.0	2.3	2.3	36.1	10.2	0.0	3.4	5.2	2.0	3.3	0.0	3.9	1.6	2.3	3.9	0.0	4.8	3.3	2.7	2.1	1.1	11.5	10.6	0.0	7.9	3.1	6.3	1.7	2.6	5.5	0.0	4.6	4.0	4.0	5.3	3.1	2.1	1.6	3.0	0.0	1.4	4.3	4.1	1.9	3.2	2.9	2.6	1.3
TMEM106B	"FLJ11273, MGC33727"	ENSG00000106460	"Transmembrane protein 106B"	Q9NUM4	7	12211241-12243367	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Amyotrophic lateral sclerosis, Disease mutation, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058342	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Endosomes, Lysosomes"		"HPA058342: AB_2683684"	"unprognostic (5.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-1)"	17.1	48.3	16.2	11.4	23.7	6.2	17.0	18.5	29.0	26.0	20.3	19.4	13.5	16.1	24.9	19.7	18.5	19.9	18.0	20.8	15.7	16.2	30.9	33.0	12.9	11.7	20.5	21.2	22.1	18.3	17.5	31.3	35.3	26.8	27.2	22.6	15.2	23.2	24.3	23.9	15.5	18.1	24.8	24.8	13.5	15.5	12.0	21.3	14.7	30.7	14.9	12.4	21.4	17.9	7.6	2.8	8.8	6.3	14.1	19.4	7.3	9.3	22.3	9.0	24.0	21.2	20.6	9.6	13.9	31.8	9.8	12.7	5.5	37.0	3.7	15.7	18.5	18.8	10.8	7.8	9.1	13.4	5.4	7.1	4.6	10.4	6.4	17.0	12.1	6.5	16.5	11.8	7.2	17.1	44.0	15.1	6.8	11.0	11.2	14.7	4.0	2.7	6.9	14.5	12.3	9.0	6.8	7.8	7.3	24.3	9.4	11.6	16.5	14.8	13.6	12.8	13.6	12.3	8.7	14.8	14.2	17.1	12.2	11.9	10.4	18.8	4.3	17.7	5.0	32.5	8.8	4.2	4.8	9.4	4.9	13.5	6.3	11.6	11.1	2.8	7.6	19.4	13.5	2.5	14.1	6.3	0.9	9.7	7.3	16.2	23.7	18.5	29.0	15.7	16.2	20.5	21.2	26.8	21.3	68.5	32.3	22.3	34.8	32.6	52.4	35.3	40.8	36.1	27.3	62.8	43.2	47.5	14.9	96.5	3.0	30.3	45.9	0.0	50.6	29.6	53.1	59.5	13.9	60.6	29.3	62.0	55.3	36.8	27.3	4.1	45.5	20.5	35.4	11.8	40.5	88.3	60.8	51.5	57.3	53.1	45.1	32.3	32.3	41.6	27.5	37.9	113.4	30.2	41.7	40.1
TMEM109	MGC5508	ENSG00000110108	"Transmembrane protein 109"	Q9BVC6	11	60913874-60923443	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011785	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Nuclear membrane, Cytosol"		"HPA011785: AB_1858075"	"unprognostic (5.23e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (2.68e-4)"	40.2	21.2	7.7	22.4	11.5	10.4	45.4	13.4	17.4	39.7	28.8	17.0	17.7	12.0	43.1	25.9	38.0	30.0	32.0	32.7	9.9	8.3	27.0	31.7	30.0	26.0	16.5	9.5	42.6	28.5	23.2	18.9	36.2	12.4	38.5	11.8	44.1	43.4	27.5	41.9	28.4	19.2	38.0	10.5	28.8	25.1	16.6	12.1	21.5	36.9	35.2	33.0	35.6	44.7	25.5	83.1	9.5	13.7	19.9	36.2	21.9	24.5	21.7	14.0	23.3	35.5	16.4	11.7	23.1	20.8	24.5	21.3	19.3	26.1	28.3	43.0	25.5	14.7	32.2	14.5	9.9	14.9	22.0	19.3	20.0	10.2	4.2	10.5	40.5	17.9	11.1	12.6	19.0	9.5	8.7	29.6	22.9	10.3	74.5	17.4	44.5	29.8	17.4	24.0	12.5	22.2	29.7	27.3	40.6	12.0	12.6	5.7	10.1	18.3	44.4	21.9	9.8	24.9	7.4	30.3	31.6	15.2	39.8	20.9	25.6	18.8	15.2	28.1	17.5	36.5	6.2	13.7	9.5	35.8	12.1	36.2	22.3	20.8	30.3	40.8	25.5	19.0	24.3	1.5	19.9	8.8	83.1	15.5	21.9	7.7	11.5	13.4	17.4	9.9	8.3	16.5	9.5	12.4	12.1	65.5	21.0	47.9	39.3	45.1	12.5	30.7	20.4	22.7	22.7	24.4	0.0	104.3	21.6	63.3	20.4	85.0	6.5	0.0	69.7	95.5	55.6	29.5	49.7	16.6	62.1	28.6	6.9	50.3	19.6	7.5	82.8	53.7	49.0	53.3	10.1	27.1	44.7	19.5	91.6	13.3	33.9	38.8	64.8	6.0	6.8	44.3	44.5	56.6	16.5	34.5
TMEM120A	"NET29, TMPIT"	ENSG00000189077	"Transmembrane protein 120A"	Q9BXJ8	7	75986837-75994659	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 64.3"	"Cell type enhanced"	"Detected in many"	15	"Early spermatids: 217.5;Late spermatids: 771.6"	"Low cancer specificity"	"Detected in all"							"Cell type enhanced"	"Detected in all"		"neutrophil: 64.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.78e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.15e-2)"	8.7	14.0	6.3	2.4	6.2	3.0	11.8	3.5	5.2	5.2	15.2	3.1	11.1	15.5	3.4	5.6	6.4	5.3	7.4	25.0	5.6		8.2	14.9	3.9	5.1	6.0	3.9	12.6	8.9	3.1	1.9	3.8	15.4	5.5	3.7	4.3	7.3	12.7	11.0	2.4	24.0	4.5	3.8	3.9	5.0	10.8	5.0	0.5	4.7	12.5	3.0	4.2	5.0	5.4	8.0	64.3	16.5	7.7	13.6	11.1	4.8	7.7	3.2	27.0	24.7	16.1	8.5	4.6	12.5	6.1	8.4	12.5	6.2	2.6	3.5	13.1	19.4	5.4	3.3	4.8	2.0	4.1	4.1	2.5	5.2	17.3	23.9	0.9	16.3	17.5	4.0	4.7	6.1	6.4	10.3	5.5	4.4	3.4	10.8	8.1	1.4	15.5	1.5	10.7	8.0	1.5	3.9	11.4	12.6	4.4	1.7	9.1	5.0	14.1	8.0	8.2	10.5	5.8	5.3	17.4	6.0	10.3	3.9	4.5	3.2	0.9	10.2	2.5	3.9	24.5	16.5	29.4	7.7	14.6	5.8	4.4	6.4	6.0	8.0	5.4	4.5	4.4	64.3	7.7	14.6	3.0	13.6	11.1											20.8	10.5	14.7	17.4	0.0	5.0	99.7	45.9	8.1	15.9	26.2	5.9	18.4	21.6	38.0	217.5	23.9	179.6	23.3	34.0	12.7	22.1	21.2	23.2	102.6	31.8	11.1	8.1	18.4	36.2	771.6	37.4	28.9	0.0	14.4	31.0	12.6	35.2	112.2	29.0	101.8	5.9	38.8	23.0	80.7	14.5	0.0	9.2	20.8	35.2	23.1
TMEM128	MGC13159	ENSG00000132406	"Transmembrane protein 128"	Q5BJH2	4	4235542-4248212	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044809	Uncertain					NA	NA					"HPA044809: AB_10963539"	"unprognostic (4.97e-2)"	"unprognostic (4.32e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.65e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.94e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.09e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	14.4	19.8	20.7	11.7	22.6	4.8	23.0	16.7	27.6	18.4	15.4	28.0	18.3	13.8	18.9	33.8	14.2	20.6	12.3	17.7	22.1	26.0	23.2	12.9	22.4	26.7	25.6	19.2	26.3	32.7	21.4	14.9	18.0	22.4	19.0	17.3	19.5	15.2	18.9	18.3	15.0	12.8	13.9	36.7	14.2	15.8	27.7	15.8	12.9	25.9	13.5	15.1	12.5	13.9	20.9	33.0	22.4	26.9	23.0	34.8	19.1	7.3	5.8	21.5	16.3	17.5	14.7	15.4	16.0	18.1	17.3	16.4	6.5	29.4	4.3	8.4	14.2	16.3	6.4	10.2	10.9	16.4	11.7	6.4	8.0	4.2	9.0	24.7	19.3	14.8	20.4	19.1	6.6	13.5	15.5	10.1	14.6	11.4	8.8	19.8	8.0	15.7	26.0	17.7	10.8	11.4	6.2	8.7	9.1	25.7	11.7	12.1	19.6	6.6	6.3	18.6	14.8	21.6	19.2	9.9	16.3	6.9	15.2	16.5	24.5	20.1	14.6	17.0	13.6	19.7	12.7	20.7	22.4	21.1	26.9	26.1	20.9	25.6	20.7	20.6	19.3	34.8	29.2	9.5	23.0	22.8	33.0	19.1	19.1	20.7	22.6	16.7	27.6	22.1	26.0	25.6	19.2	22.4	15.8	11.9	20.7	13.7	14.0	15.9	9.5	7.3	17.8	24.1	15.9	29.6	2.0	39.5	24.9	23.1	16.6	21.5	19.1	23.3	20.6	34.3	31.9	18.6	15.1	14.9	27.4	12.7	16.6	23.9	23.5	5.8	37.7	19.4	37.1	24.4	20.8	22.9	17.3	30.3	35.3	30.5	10.7	45.3	14.4	77.0	31.3	22.0	36.6	18.7	18.5	16.7
TMEM134	FLJ21749	ENSG00000172663	"Transmembrane protein 134"	Q9H6X4	11	67461710-67469272	"Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA043744	Approved		Supported	Cytosol		NA	NA			Cytosol		"HPA043744: AB_10794773"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.43e-3)"	7.1	15.3	11.2	11.9	14.9	4.8	7.8	6.5	12.7	10.1	11.2	13.4	16.1	8.8	7.2	16.4	30.2	10.3	14.1	22.7	9.7	7.9	13.1	23.7	8.1	10.9	12.9	7.9	6.9	42.1	6.9	4.7	10.7	10.1	15.6	5.1	7.1	16.9	14.0	46.2	31.8	10.2	6.9	12.5	12.3	14.0	12.0	9.7	11.1	8.3	20.7	21.6	10.4	13.2	51.9	23.9	25.9	44.5	22.7	32.2	19.2	7.1	2.7	3.9	8.4	2.6	4.5	4.3	1.5	2.8	1.8	0.7	3.4	8.5	6.8	16.6	3.6	5.6	6.0	1.7	6.3	1.1	6.5	2.9	1.3	2.4	3.5	4.1	1.3	2.0	4.5	8.2	1.4	4.7	7.7	1.8	4.7	1.7	4.0	3.8	17.0	7.6	4.9	6.6	11.9	9.7	3.7	2.3	22.1	6.7	7.3	3.7	8.1	5.4	8.5	15.6	2.8	20.7	1.3	3.4	6.4	5.6	7.5	1.9	16.9	10.6	4.5	9.5	1.7	5.0	12.5	15.4	25.9	20.9	34.7	22.9	51.9	25.0	23.3	18.2	50.3	25.5	23.9	7.2	22.7	44.5	23.9	32.2	19.2	11.2	14.9	6.5	12.7	9.7	7.9	12.9	7.9	10.1	9.7	14.9	37.4	63.8	71.1	79.9	27.8	45.6	53.5	53.5	48.9	64.6	9.8	58.8	112.7	81.8	42.3	30.4	71.9	0.0	110.6	111.2	35.7	133.5	22.0	66.8	75.8	11.1	68.5	22.1	35.0	27.2	19.2	50.4	104.6	75.7	89.3	29.2	138.9	72.4	23.3	134.2	27.4	6.5	42.2	95.3	76.8	157.5	60.9	50.7	73.6	137.5
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1;kidney: 22.6;placenta: 28.0"	"Cell type enhanced"	"Detected in many"	7	"Collecting duct cells: 48.8;Ductal cells: 42.9;Enterocytes: 54.0;Proximal tubular cells: 67.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A-431: 9.7;CAPAN-2: 18.3;EFO-21: 12.9;RPTEC TERT1: 32.2;SK-BR-3: 11.3;T-47d: 31.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.5	2.2	0.9	2.8	1.9	0.0	2.1	0.6	1.6	6.3	14.7	6.0	1.5	22.7	1.6	3.5	0.4	4.6	4.8	2.3	1.6	1.1	22.6	7.8	5.5	0.1	4.2	0.7	0.9	9.6	6.4	2.0	28.0	4.8	1.6	2.9	1.4	6.1	2.2	0.1	1.1	25.1	0.4	13.4	0.8	2.0	3.0	2.1	0.1	8.8	0.4	0.7	2.1	2.4	0.5	0.3	0.9	3.2	0.0	2.0	0.4	9.7	0.7	0.1	0.0	0.0	0.0	6.5	0.1	0.0	0.0	0.0	2.3	18.3	0.1	12.9	0.0	0.8	8.3	0.0	4.2	0.0	0.1	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.2	0.0	0.6	0.7	0.4	0.0	0.2	0.7	0.1	0.1	0.0	32.2	2.5	0.1	0.0	0.5	11.3	0.0	0.2	31.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	3.2	0.0	0.5	1.3	0.8	0.0	0.0	1.1	0.6	0.0	0.0	2.4	0.3	2.0	0.4	0.9	1.9	0.6	1.6	1.6	1.1	4.2	0.7	4.8	2.1	14.9	5.1	0.0	2.4	0.1	0.0	2.0	35.7	2.7	5.7	48.8	0.0	26.6	29.9	42.9	12.0	0.3	54.0	0.0	4.0	4.7	0.3	0.3	0.0	13.4	1.7	0.0	3.5	1.3	0.6	8.8	0.0	0.1	5.0	1.8	4.3	8.3	23.3	23.0	0.0	67.4	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	7.4	1.2
TMEM163	"DKFZP566N034, SV31"	ENSG00000152128	"Transmembrane protein 163"	Q8TC26	2	134455759-134719000	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.8;pancreas: 19.7"	"Cell type enhanced"	"Detected in many"	13	"Alveolar cells type 2: 28.8;Exocrine glandular cells: 26.7;Pancreatic endocrine cells: 11.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 1.6;NK-cells: 2.0;T-cells: 2.5"	"Cell line enhanced"	"Detected in some"		"HEL: 10.7;RPTEC TERT1: 37.0;SCLC-21H: 16.8;U-937: 6.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007224	Uncertain					NA	NA					"HPA007224: AB_2667780"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.08e-3)"	"prognostic favorable (7.94e-4)"	"unprognostic (9.05e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.75e-3)"	"prognostic favorable (3.15e-4)"	3.8	6.4	8.1	5.4	5.7	0.5	1.5	31.8	13.4	0.5	0.8	5.8	0.0	0.9	0.8	0.7	0.4	3.4	10.4	7.2	9.1	13.7	1.8	1.7	16.4	10.9	6.9	3.8	1.2	19.7	0.4	11.2	4.2	14.8	0.5	0.9	2.6	3.5	0.5	0.6	0.4	0.8	0.7	13.9	1.9	8.3	6.9	5.0	0.0	1.3	0.0	17.4	9.9	0.3	1.6	0.3	0.1	0.0	2.0	2.5	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.9	3.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	2.9	0.5	1.2	0.0	0.0	0.0	37.0	5.4	16.8	0.6	0.0	0.0	0.9	0.0	0.0	0.0	3.7	0.0	0.2	0.0	0.8	0.9	0.0	0.0	0.0	6.7	0.7	0.0	0.0	0.0	1.3	0.0	1.7	1.6	0.5	2.4	0.3	0.6	0.1	0.5	0.1	2.0	0.0	0.0	2.5	0.8	8.1	5.7	31.8	9.7	9.1	13.7	6.9	3.8	14.8	5.0	3.0	28.8	0.0	0.0	0.0	2.0	1.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	6.6	3.5	0.3	0.0	0.0	26.7	0.2	0.3	0.0	0.0	0.0	4.0	1.6	0.0	0.0	1.0	1.8	0.0	1.3	0.0	4.6	0.1	1.0	11.4	0.0	0.4	0.1	4.0	0.0	0.3	1.5	0.2	0.4	0.1	0.0	0.0	0.5
TMEM165	"GDT1, TMPT27, TPARL"	ENSG00000134851	"Transmembrane protein 165"	Q9HC07	4	55395957-55453397	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Urothelial cells: 421.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038299, HPA062424"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA038299: AB_10675793, HPA062424: AB_2732682"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.07e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.18e-8)"	"unprognostic (9.05e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-2)"	28.5	37.6	19.4	25.6	49.0	6.0	27.3	11.3	26.1	31.1	20.0	54.4	17.6	19.8	22.4	20.7	33.0	19.1	29.4	23.9	29.1	20.0	26.7	11.9	30.4	22.3	65.8	16.2	14.0	23.6	22.9	14.9	37.6	33.1	24.9	21.6	15.7	25.5	20.8	9.9	16.2	16.0	25.0	50.5	22.6	23.8	8.4	49.4	14.4	24.3	16.5	25.5	34.0	23.2	11.3	22.8	17.6	24.8	11.3	11.8	17.8	18.8	7.9	12.5	13.2	39.0	28.9	13.3	36.1	55.8	26.1	28.7	8.8	28.3	19.7	26.3	22.2	15.0	14.0	13.1	14.8	26.6	11.1	12.1	16.8	14.1	16.9	24.3	23.1	20.0	29.6	19.3	14.9	10.0	22.1	29.7	6.6	28.3	12.6	30.6	13.8	18.2	19.4	13.6	25.0	18.6	13.2	9.4	10.6	39.2	18.1	12.9	17.3	18.1	68.9	21.5	12.9	10.8	16.7	25.5	22.3	13.3	9.8	26.1	11.8	9.5	12.1	26.5	19.7	17.8	12.7	24.8	15.5	9.9	20.9	11.3	11.3	9.6	11.8	22.8	7.8	8.2	9.8	17.6	11.3	20.5	17.5	10.8	17.8	19.4	49.0	11.3	26.1	29.1	20.0	65.8	16.2	33.1	49.4	50.6	44.9	77.0	225.4	217.7	52.2	28.4	71.4	24.1	36.4	75.0	76.6	95.8	14.9	148.1	29.0	90.3	40.6	46.7	143.8	136.2	133.6	205.0	20.7	16.1	94.9	27.0	48.4	110.5	75.9	17.9	54.4	126.9	84.4	71.3	52.4	71.5	188.4	45.6	59.8	43.2	75.4	97.0	160.3	38.1	23.7	234.9	67.4	84.1	48.5	421.9
TMEM17	FLJ34583	ENSG00000186889	"Transmembrane protein 17"	Q86X19	2	62500221-62511894	"Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Ciliated cells: 29.4;Spermatocytes: 36.9;Spermatogonia: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 5.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018100	Uncertain		Approved	"Actin filaments"		NA	NA			"Actin filaments"		"HPA018100: AB_2240686"	"unprognostic (8.09e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.78e-1)"	"unprognostic (1.87e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.49e-6)"	3.3	8.2	6.1	1.0	10.8	0.9	3.7	2.2	10.1	3.0	1.7	4.3	1.5	1.5	3.5	2.9	4.1	6.7	4.4	3.2	13.5	14.6	6.7	3.4	2.6	1.2	6.0	8.2	5.1	6.8	7.6	10.2	2.5	9.3	3.9	1.2	4.1	3.3	3.3	2.5	3.5	1.1	2.4	4.5	1.0	1.9	7.0	4.4	0.9	7.1	1.3	1.6	2.2	1.7	0.3	5.5	1.5	0.7	0.9	0.9	1.0	3.9	5.2	5.5	2.1	2.9	3.6	3.5	2.9	2.7	2.4	2.4	0.4	7.0	0.0	3.9	3.9	7.9	3.8	2.4	1.6	1.8	3.7	1.7	1.8	2.2	0.4	4.2	2.5	2.5	3.3	4.6	2.0	4.6	3.9	3.1	0.4	1.6	0.2	6.0	1.0	0.4	0.6	2.8	3.3	3.3	0.3	0.7	0.3	4.9	1.1	1.4	4.8	3.0	1.2	10.1	2.0	1.7	3.4	1.9	4.8	2.7	5.7	2.9	0.6	0.1	0.0	6.9	0.4	9.6	0.9	0.7	0.1	0.2	0.2	0.0	0.1	0.1	0.1	1.6	0.3	0.1	0.9	1.5	0.9	0.2	5.5	0.1	1.0	6.1	10.8	2.2	10.1	13.5	14.6	6.0	8.2	9.3	4.4	3.0	2.6	0.0	2.3	4.4	6.6	2.2	7.6	29.4	9.1	5.2	7.9	1.9	0.0	4.3	2.4	1.9	0.0	0.0	7.5	1.7	3.5	0.8	1.1	1.8	2.1	9.5	1.2	5.5	1.2	2.1	4.4	0.3	3.3	1.0	0.6	9.0	6.6	0.0	3.5	2.1	3.7	6.5	0.8	36.9	19.6	2.5	0.3	0.0	0.9	0.9
TMEM170A	"FLJ37611, TMEM170"	ENSG00000166822	"Transmembrane protein 170A"	Q8WVE7	16	75443054-75465497	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA						"unprognostic (3.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.15e-2)"	"prognostic favorable (2.36e-9)"	"unprognostic (4.37e-2)"	"unprognostic (3.41e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.53e-3)"	10.2	12.6	14.8	14.1	18.1	39.9	16.2	11.5	14.7	10.0	16.3	18.9	11.3	20.5	11.3	8.5	10.8	10.5	10.5	8.7	15.1	13.6	10.6	15.2	10.1	15.2	20.5	9.2	13.8	12.5	5.5	11.8	18.8	17.3	9.9	15.0	13.3	8.5	8.5	4.7	9.4	20.4	8.8	23.7	13.2	10.3	20.1	18.7	10.7	14.4	4.2	12.9	9.9	10.0	22.8	20.6	28.5	22.9	18.2	29.6	16.6	7.4	8.9	13.1	11.9	6.4	4.7	22.6	4.8	3.5	5.1	7.3	18.8	15.9	11.7	9.3	2.7	8.8	13.3	12.5	4.9	9.0	6.8	7.3	6.3	7.4	12.3	4.4	15.6	16.6	3.3	3.9	8.0	6.5	4.8	4.5	13.3	12.1	7.4	2.6	15.2	12.9	11.0	16.8	9.6	4.9	24.5	4.8	8.8	2.9	10.0	8.1	7.9	13.0	3.6	6.3	15.2	4.8	6.8	5.3	7.3	10.8	5.3	5.3	6.8	8.1	33.1	5.6	8.7	7.0	9.8	21.0	28.5	22.3	22.9	29.6	22.8	23.7	25.0	18.5	22.2	25.5	22.4	25.7	18.2	20.0	20.6	17.1	16.6	14.8	18.1	11.5	12.1	15.1	13.6	20.5	9.2	17.3	18.7	17.9	12.9	30.3	37.5	17.6	23.1	7.3	35.7	16.0	11.4	19.2	35.3	64.3	21.6	23.8	21.8	31.7	60.4	0.0	16.9	42.8	23.4	49.1	28.8	21.2	33.1	35.0	32.7	31.3	23.8	5.0	22.5	28.6	20.3	39.7	36.9	40.4	19.0	58.5	20.1	23.4	36.2	32.3	20.6	57.5	54.9	17.6	44.6	39.5	49.0	54.2
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Nucleoplasm, Nuclear membrane"		"HPA057160: AB_2683356"	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.2	22.9	20.5	13.5	24.0	17.8	12.2	29.0	27.6	17.4	10.8	23.5	16.8	13.6	13.4	14.9	13.4	12.9	16.0	13.3	18.4	19.8	11.7	24.2	14.1	21.9	16.9	25.4	9.3	26.3	18.7	26.4	11.8	20.4	15.0	6.2	17.1	26.8	16.8	14.5	25.8	12.4	10.4	17.2	18.7	14.8	11.8	17.9	13.0	19.7	9.2	12.0	16.2	9.6	13.8	29.3	16.9	23.4	9.5	13.6	11.8	3.3	6.1	3.5	4.8	17.0	8.9	8.2	8.2	6.0	5.0	7.5	2.8	13.4	2.5	5.1	8.6	8.8	5.5	3.2	6.5	2.2	6.2	7.5	5.2	9.0	2.8	9.8	2.7	9.7	12.6	7.9	4.5	3.0	3.6	3.1	5.4	5.2	20.9	4.4	10.9	6.9	11.2	2.2	3.9	17.2	4.8	2.1	7.2	4.8	3.2	9.6	8.5	5.7	3.6	5.4	1.8	16.0	7.5	4.1	9.3	2.1	10.7	6.3	14.2	3.7	4.9	9.0	6.0	7.5	16.9	19.8	15.5	13.6	23.4	9.1	12.5	11.7	10.1	17.2	13.8	8.4	11.9	16.4	9.5	21.6	29.3	11.0	11.8	20.5	24.0	29.0	27.6	18.4	19.8	16.9	25.4	20.4	17.9	11.9	9.9	12.9	8.5	5.6	24.5	8.7	5.1	4.0	5.7	14.0	3.9	21.7	1.7	7.4	4.4	8.2	12.4	0.0	10.0	9.3	12.7	8.2	6.9	23.8	13.5	44.5	15.5	8.6	15.3	3.2	11.5	11.0	18.6	4.6	8.1	43.7	8.0	14.4	15.2	6.7	25.4	12.9	9.5	22.3	10.2	6.8	15.8	13.1	7.0	5.4
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 87.4"	"Cell type enhanced"	"Detected in some"	11	"Collecting duct cells: 12.2;Cone photoreceptor cells: 5.9;Intestinal endocrine cells: 15.4;Rod photoreceptor cells: 5.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 87.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA052128: AB_2681738"	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	2.9	4.2	13.3	0.9	10.6	0.6	6.8	87.4	35.6	1.6	1.9	6.4	0.0	2.3	3.8	2.0	1.8	3.3	3.1	3.6	16.4	7.4	18.9	2.7	5.8	0.8	10.7	10.9	1.8	2.2	1.3	2.5	3.6	17.0	12.2	2.2	3.7	3.8	2.1	2.3	3.5	2.4	2.9	22.6	1.6	3.5	1.2	5.3	0.0	5.7	0.8	2.2	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	0.0	0.1	1.8	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.1	0.1	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	7.1	0.1	0.0	0.6	0.0	0.0	0.4	0.1	10.4	0.2	0.0	0.2	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.3	10.6	87.4	18.8	16.4	7.4	10.7	10.9	17.0	5.3	0.0	1.3	0.0	0.6	0.3	2.1	3.7	0.0	4.0	1.2	12.2	5.9	0.3	0.0	0.3	0.3	3.1	0.4	0.0	0.2	0.0	0.2	4.1	0.0	0.2	0.2	1.6	15.4	1.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.3	0.3	0.0	0.0	0.7	5.8	0.0	0.4	0.2	0.2	0.5	0.5	0.0	0.4	0.1
TMEM179	"C14orf90, FLJ42486, TMEM179A"	ENSG00000258986	"Transmembrane protein 179"	Q6ZVK1	14	104474678-104605647	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 20.2;brain: 30.4;pituitary gland: 23.0"	"Group enriched"	"Detected in some"	12	"Bipolar cells: 41.7;Horizontal cells: 62.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 6.5;SCLC-21H: 28.3;SH-SY5Y: 8.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002942			Uncertain	Mitochondria		NA	NA			Mitochondria		"HPA002942: AB_1078113"	"unprognostic (8.65e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.71e-6)"	"unprognostic (1.70e-2)"	1.1	20.2	11.8	1.5	18.9	0.9	0.9	10.3	30.4	1.0	1.8	3.4	0.0	1.4	1.0	1.6	1.1	1.1	1.1	1.2	12.4	21.7	1.0	1.1	0.9	0.9	13.7	7.2	1.0	4.8	1.0	23.0	2.3	8.3	1.4	1.4	2.2	1.1	1.3	1.0	1.0	1.8	1.4	6.1	0.9	1.8	3.1	4.5	0.0	1.0	0.0	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.3	8.9	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	18.9	10.3	16.7	12.4	21.7	13.7	7.2	8.3	4.5	0.0	0.0	0.0	0.0	0.0	41.7	1.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	62.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	4.3	0.0	0.1	0.6	3.2	0.0	0.0	0.0	0.0	0.0
TMEM179B		ENSG00000185475	"Transmembrane protein 179B"	Q7Z7N9	11	62787415-62790405	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA016585, HPA062068"			Enhanced	"Nuclear speckles"		NA	NA			"Nuclear speckles"		"HPA016585: AB_1844357, HPA062068: AB_2684676"	"unprognostic (1.18e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.61e-3)"	"unprognostic (2.76e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.60e-2)"	26.1	34.6	13.2	19.5	15.7	13.4	36.0	6.3	15.4	24.9	31.3	23.7	37.7	24.5	27.8	53.6	24.9	28.9	35.0	21.8	12.9	11.1	43.1	55.4	39.0	43.2	17.1	9.8	27.4	47.1	15.5	17.5	39.8	20.9	28.8	29.3	28.0	55.1	54.2	16.7	29.7	44.2	20.4	19.9	30.4	26.5	29.4	14.8	25.5	44.9	21.2	28.2	24.1	24.0	35.5	80.6	70.4	67.6	28.3	35.4	53.5	12.6	25.8	6.4	12.7	50.4	12.8	7.9	13.9	17.1	11.0	12.6	14.7	29.4	5.8	19.9	27.4	15.9	23.2	11.8	12.5	8.5	17.2	16.8	8.4	11.7	13.4	34.0	10.6	11.8	24.6	20.3	20.7	25.6	21.9	11.0	17.3	11.6	16.6	12.4	28.8	13.6	20.6	9.6	26.6	28.5	9.3	10.3	30.2	20.5	15.6	8.8	9.7	17.9	23.2	23.7	13.4	27.1	13.1	14.2	14.4	10.8	26.4	11.4	19.0	11.2	7.5	20.8	6.5	16.7	52.6	67.6	70.4	35.4	64.9	34.8	35.5	32.5	33.9	43.2	31.5	28.9	28.5	49.9	28.3	61.8	80.6	31.3	53.5	13.2	15.7	6.3	15.4	12.9	11.1	17.1	9.8	20.9	14.8	56.6	43.3	42.5	61.1	61.0	12.3	1.1	63.7	73.6	54.6	57.6	0.0	154.6	31.5	119.9	4.5	76.8	91.9	23.3	131.2	131.6	80.8	88.4	54.2	69.2	120.1	7.9	62.6	65.1	70.8	7.8	70.2	79.2	101.3	101.0	82.1	70.3	107.6	133.3	43.2	73.2	12.7	64.7	35.0	93.4	90.3	66.5	154.8	55.4	88.9	75.9
TMEM18	"DKFZp434C1714, lncND"	ENSG00000151353	"Transmembrane protein 18"	Q96B42	2	667335-677439	"Predicted membrane proteins, Transporters"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040233	Approved		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			Mitochondria	"Endoplasmic reticulum"	"HPA040233: AB_10794737"	"unprognostic (9.01e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.98e-3)"	"unprognostic (8.08e-2)"	18.9	22.1	13.7	11.3	14.4	12.9	23.4	10.0	18.7	17.6	17.4	16.0	12.0	13.9	19.3	19.5	16.1	15.6	18.1	12.3	13.4	14.5	17.3	18.1	12.2	12.5	14.8	15.6	43.7	31.7	13.2	13.5	19.6	12.3	19.2	9.5	18.3	19.5	16.5	28.3	14.2	15.5	18.4	21.9	12.5	13.4	19.1	11.4	23.9	23.1	19.7	13.8	15.0	14.1	17.3	19.7	5.8	14.4	16.2	14.8	11.2	9.8	9.4	11.6	13.1	12.9	19.8	12.3	13.6	10.8	12.2	11.6	1.8	16.1	14.0	25.6	16.7	6.3	14.0	4.7	15.7	10.1	21.8	11.3	8.2	5.6	20.2	16.6	8.2	7.4	14.1	16.0	20.7	14.1	10.5	3.7	23.8	8.3	8.7	16.3	33.2	19.1	19.8	8.5	8.6	13.9	11.1	6.2	10.6	11.2	10.7	9.6	15.6	7.9	14.6	14.7	5.3	9.8	15.3	11.6	11.2	15.3	7.4	20.5	11.6	19.0	12.1	13.7	9.1	7.8	3.7	14.4	5.8	11.3	13.8	11.8	17.3	12.5	9.2	14.9	13.6	14.8	13.9	1.2	16.2	14.1	19.7	14.4	11.2	13.7	14.4	10.0	18.7	13.4	14.5	14.8	15.6	12.3	11.4	20.8	26.2	26.8	25.3	31.9	18.7	21.3	28.1	34.8	27.3	26.2	7.9	62.0	26.6	32.1	11.2	32.9	25.7	46.7	39.9	50.7	45.7	34.7	28.9	31.8	43.3	19.1	19.0	31.9	30.8	9.1	58.7	29.1	38.8	26.2	36.8	41.0	36.0	43.2	48.1	36.3	27.2	19.4	40.1	80.7	64.7	37.8	67.9	17.3	41.4	31.5
TMEM184B	"C22orf5, DKFZP586A1024, FM08, HS5O6A"	ENSG00000198792	"Transmembrane protein 184B"	Q9Y519	22	38219291-38273034	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Syncytiotrophoblasts: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 60.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024076	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA024076: AB_1858106"	"unprognostic (1.52e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.94e-6)"	"unprognostic (1.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.96e-1)"	21.8	16.5	23.9	14.7	24.1	6.0	27.5	26.4	40.0	22.4	14.4	31.2	12.2	18.5	12.1	9.5	11.0	14.2	16.1	17.8	25.8	21.5	13.0	7.4	20.5	8.6	26.1	22.2	10.8	18.0	27.3	21.9	41.2	23.8	12.3	12.5	20.1	16.8	17.3	19.0	10.9	16.5	15.7	41.2	14.1	19.3	5.8	20.9	3.9	16.7	10.6	9.2	20.0	15.4	1.6	7.3	12.4	3.1	6.2	5.8	2.6	17.3	15.2	9.0	7.1	17.9	14.4	20.8	18.8	26.8	15.5	13.8	11.1	8.1	3.3	14.8	28.0	14.0	21.6	8.1	18.5	10.5	11.8	14.5	6.6	11.1	9.2	18.9	5.1	9.2	12.0	16.5	18.2	20.4	16.0	19.3	5.1	4.1	11.7	13.4	9.9	3.2	4.3	7.3	13.0	14.0	5.6	8.1	3.3	11.5	19.3	19.5	3.4	14.1	20.7	10.0	10.9	11.4	3.8	28.4	15.8	16.2	13.8	11.4	24.3	60.1	2.7	22.9	3.8	13.5	12.4	3.1	4.6	5.8	2.4	5.3	1.6	3.3	4.3	4.7	1.2	2.3	2.7	11.2	6.2	1.6	7.3	1.0	2.6	23.9	24.1	26.4	35.4	25.8	21.5	26.1	22.2	23.8	20.9	6.0	15.0	1.5	15.0	11.0	17.0	14.6	10.2	4.0	9.1	14.0	2.0	27.6	3.3	15.0	4.9	26.7	7.5	0.0	19.1	38.8	21.0	27.4	2.3	3.4	13.3	14.3	24.9	16.0	7.5	1.7	10.9	10.2	13.5	16.2	16.0	40.7	22.7	7.0	12.7	4.2	8.1	19.4	23.4	2.3	6.6	8.4	65.6	10.1	9.4	30.1
TMEM192	FLJ38482	ENSG00000170088	"Transmembrane protein 192"	Q8IY95	4	165070608-165208549	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014717, HPA024110"	Enhanced		Supported	Nucleoplasm,Endosomes,Lysosomes		NA	NA			"Endosomes, Lysosomes"	Nucleoplasm	"HPA014717: AB_1844373, HPA024110: AB_2204898"	"prognostic unfavorable (9.52e-4)"	"unprognostic (5.38e-3)"	"unprognostic (9.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.33e-14)"	"unprognostic (2.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.30e-2)"	12.6	14.4	11.3	7.4	13.6	5.3	12.1	12.0	11.9	11.6	9.7	10.5	6.2	8.3	9.7	10.0	7.8	10.1	8.9	10.4	9.9	9.4	40.7	37.7	9.1	8.5	13.0	10.6	21.8	21.3	20.3	14.2	9.3	13.1	19.4	11.7	24.7	11.3	7.8	19.0	7.4	8.2	8.6	13.3	10.8	10.5	8.6	11.3	3.1	22.9	5.2	6.6	12.1	7.3	18.2	12.0	3.4	12.5	13.4	12.8	7.7	6.3	9.6	3.5	8.8	9.1	3.2	8.1	9.7	14.3	10.1	11.3	5.6	10.5	14.0	5.8	6.2	16.5	5.7	13.0	9.9	11.7	9.0	6.7	7.8	7.2	6.3	23.3	19.1	10.5	11.7	21.2	9.1	18.6	8.8	8.2	7.6	13.2	23.6	12.4	13.8	3.3	5.6	7.3	13.3	8.3	7.5	3.0	12.7	8.2	9.4	7.5	7.8	15.1	24.1	15.3	5.4	11.7	8.8	6.1	4.5	5.5	14.0	10.9	23.2	30.6	19.5	10.7	10.6	17.8	2.0	12.5	3.4	9.7	10.9	12.8	18.2	7.5	9.9	11.6	15.2	8.3	10.0	1.4	13.4	5.8	12.0	6.0	7.7	11.3	13.6	12.0	11.9	9.9	9.4	13.0	10.6	13.1	11.3	29.8	33.4	17.1	16.9	8.7	34.9	28.7	48.4	12.0	22.7	52.4	15.7	23.8	10.0	18.4	13.5	19.6	13.2	0.0	22.3	16.3	19.5	28.7	38.3	68.1	32.6	35.0	20.8	27.0	24.1	7.5	36.8	24.0	27.0	9.0	15.9	31.7	12.7	14.0	31.5	49.7	25.3	6.5	13.2	13.1	11.9	11.3	28.1	19.8	22.9	12.3
TMEM199	"C17orf32, MGC45714, VMA12, VPH2"	ENSG00000244045	"Transmembrane protein 199"	Q8N511	17	28357581-28363683	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027051	Uncertain					NA	NA					"HPA027051: AB_10600915"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (9.98e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.51e-3)"	"unprognostic (5.95e-2)"	14.5	20.7	16.0	18.3	17.9	21.7	16.7	19.7	23.7	13.2	14.2	19.7	17.9	13.9	17.0	19.1	17.5	13.2	15.7	15.9	16.4	18.2	22.3	23.4	14.5	21.4	17.0	20.1	14.4	15.4	23.9	23.0	23.4	17.1	17.3	15.4	15.9	16.0	15.7	14.3	18.7	14.5	12.1	19.0	23.2	14.4	19.3	13.9	24.8	20.5	15.0	20.2	14.9	14.4	17.1	19.7	22.2	24.0	14.4	17.7	17.0	7.1	12.6	12.0	10.3	5.0	4.2	10.2	8.9	5.7	12.5	11.4	29.1	5.8	10.3	9.2	6.6	16.2	12.4	13.1	8.3	11.0	19.2	11.9	7.6	10.8	14.1	10.0	10.7	13.5	6.2	7.7	11.9	8.0	7.5	6.2	9.7	12.4	13.3	9.2	14.3	12.2	15.0	10.0	12.5	8.5	10.2	14.9	9.6	9.5	12.1	15.3	16.0	10.7	27.7	15.5	12.9	17.4	9.9	8.5	10.8	8.4	9.2	14.9	18.0	22.0	9.7	13.3	6.7	13.4	22.2	24.0	18.8	15.9	23.9	17.3	17.1	14.0	13.9	19.7	16.1	17.7	15.4	18.6	14.4	21.0	13.7	14.1	17.0	16.0	17.9	19.7	23.7	16.4	18.2	17.0	20.1	17.1	13.9	29.8	7.5	21.3	9.8	5.0	12.3	4.3	12.7	9.4	18.2	8.7	7.9	35.1	36.5	35.2	2.9	10.3	16.2	0.0	27.6	30.5	7.4	10.2	7.0	23.1	45.2	11.1	15.0	16.0	26.6	3.3	10.6	17.3	20.3	62.3	15.0	18.4	31.5	15.6	6.0	40.4	12.4	12.9	8.3	19.9	34.3	7.8	40.5	14.9	11.7	9.5
TMEM202	FLJ27523	ENSG00000187806	"Transmembrane protein 202"	A6NGA9	15	72398273-72408029	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	219	"testis: 23.5"	"Group enriched"	"Detected in some"	44	"Early spermatids: 52.5;Late spermatids: 43.7;Spermatocytes: 18.0"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"													NA	NA																				"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	18.0	0.9	0.0	0.0	0.0	0.0	0.0
TMEM203	"HBEBP1, MGC14327"	ENSG00000187713	"Transmembrane protein 203"	Q969S6	9	137204082-137205638	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.31e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.16e-2)"	"prognostic favorable (4.78e-6)"	"unprognostic (2.94e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.19e-1)"	15.3	21.1	20.6	13.5	22.4	7.6	19.2	18.2	34.1	16.8	20.0	19.0	17.6	18.5	20.0	23.5	19.2	20.2	20.0	31.4	19.7	18.2	23.7	35.5	15.6	20.5	20.0	17.0	24.8	17.4	20.9	16.9	16.5	19.1	17.1	15.8	19.7	22.3	20.0	33.2	26.2	22.8	18.8	14.5	20.0	18.0	17.5	16.3	21.4	25.2	15.6	18.4	15.9	16.9	9.9	6.5	6.4	5.8	9.2	12.7	3.5	17.0	18.2	17.2	28.4	25.7	20.1	20.7	22.4	21.8	26.2	19.7	14.9	15.5	17.8	21.8	19.4	25.2	33.7	21.2	22.3	15.3	32.1	20.4	12.3	21.6	16.9	21.5	28.3	12.7	19.1	35.7	17.0	22.7	17.5	16.7	23.5	28.6	20.9	20.2	29.6	22.4	24.6	28.6	33.0	29.6	24.5	24.1	35.4	21.9	12.5	22.9	22.4	17.9	22.9	17.6	12.4	32.3	23.1	14.8	27.0	14.4	30.0	25.0	11.3	35.2	22.4	20.8	21.1	22.1	6.4	5.3	5.3	7.4	5.8	9.2	9.9	8.5	9.2	6.1	7.1	12.7	8.7	2.8	9.2	5.0	6.5	5.2	3.5	20.6	22.4	18.2	34.1	19.7	18.2	20.0	17.0	19.1	16.3	8.9	5.0	14.4	20.3	15.7	35.3	10.8	25.5	1.4	6.8	29.6	3.9	26.3	44.7	45.2	2.9	15.8	14.2	0.0	36.9	22.8	18.1	25.7	5.7	36.1	25.5	30.2	15.6	13.5	20.2	6.8	20.4	13.2	23.6	66.7	14.0	43.3	31.8	7.0	19.4	46.8	19.4	12.9	13.0	16.7	11.5	23.8	16.2	14.0	18.9	16.2
TMEM205	"MBC3205, UNQ501"	ENSG00000105518	"Transmembrane protein 205"	Q6UW68	19	11342776-11346518	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Early spermatids: 396.4;Hepatocytes: 417.5;Late spermatids: 488.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	"Nucleoplasm, Nuclear membrane"	"HPA041504: AB_10795595"	"unprognostic (2.54e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.56e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	15.8	40.5	25.7	10.6	29.4	14.5	19.3	16.2	36.3	30.3	19.2	19.8	34.6	18.7	15.5	29.7	14.6	25.9	27.8	31.7	24.5	23.6	36.1	90.8	19.4	22.9	25.2	21.9	21.7	50.5	52.4	21.7	17.5	20.6	24.3	11.3	31.8	28.6	28.4	30.0	15.0	18.2	16.9	21.4	14.2	17.2	23.1	13.2	11.1	46.6	15.4	13.3	21.3	13.1	21.9	43.1	11.0	71.0	10.4	14.8	32.1	19.3	48.1	5.9	20.1	11.8	14.2	11.2	7.4	17.1	16.2	12.7	14.6	6.2	17.4	44.9	14.9	16.1	19.9	8.5	22.2	10.9	20.4	8.1	4.6	16.7	23.9	29.8	7.8	14.9	13.4	22.7	10.4	17.4	16.3	19.5	16.7	14.0	74.6	10.0	49.0	11.7	21.9	10.6	25.3	36.9	11.1	9.2	46.0	39.4	35.1	10.7	16.3	7.8	32.1	18.0	7.4	27.9	22.8	11.4	20.4	7.8	22.2	16.4	44.5	44.3	10.3	19.7	35.1	15.6	5.2	71.0	7.1	14.6	29.8	14.8	21.9	12.2	12.8	43.1	18.4	9.8	11.8	11.0	10.4	17.5	31.0	14.6	32.1	25.7	29.4	16.2	36.3	24.5	23.6	25.2	21.9	20.6	13.2	62.5	59.8	25.2	116.9	45.7	27.8	62.3	178.3	58.9	89.9	144.8	11.8	101.4	51.4	137.3	396.4	66.1	62.3	0.0	143.8	66.1	80.7	116.5	28.8	417.5	85.9	25.4	113.0	63.3	78.3	488.1	74.8	50.9	91.1	31.5	72.5	72.5	99.5	66.6	64.0	180.1	27.1	45.3	59.3	30.7	14.9	47.2	80.9	37.9	73.4	104.8
TMEM208	HSPC171	ENSG00000168701	"Transmembrane protein 208"	Q9BTX3	16	67227103-67229278	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA041868, HPA041949"	Supported					NA	NA					"HPA041868: AB_10962347, HPA041949: AB_10959903"	"unprognostic (9.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (9.63e-5)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.42e-2)"	14.5	37.0	19.9	15.9	20.5	10.0	22.1	23.3	23.7	19.5	22.0	16.3	26.4	23.7	15.4	32.1	17.3	17.8	19.3	13.2	19.2	21.1	23.0	51.5	25.1	16.7	21.7	20.8	11.8	45.0	31.5	27.9	19.1	21.2	14.8	22.3	17.3	29.6	25.0	10.7	13.6	20.0	14.8	15.8	17.0	19.7	25.4	19.3	9.2	19.4	16.0	16.1	15.6	12.0	23.9	58.6	24.8	39.1	17.2	27.8	31.0	19.1	25.9	12.3	14.6	39.9	18.9	22.7	20.1	25.4	22.5	19.1	31.9	24.1	19.4	24.2	28.6	20.1	26.2	19.7	27.7	14.2	8.5	30.0	10.5	19.2	32.3	40.8	16.8	28.7	25.3	35.0	29.7	26.1	15.9	16.7	17.7	17.9	25.0	26.1	38.7	16.6	24.5	20.9	31.6	18.2	18.1	15.2	55.4	29.9	13.0	20.6	21.1	36.4	15.2	16.2	8.8	20.0	21.0	10.1	17.0	11.1	24.3	22.2	38.5	36.7	39.6	29.8	16.1	24.0	21.7	39.1	20.2	27.8	34.8	25.3	23.9	26.4	24.2	30.2	19.5	21.8	24.0	24.8	17.2	26.8	58.6	25.4	31.0	19.9	20.5	23.3	23.7	19.2	21.1	21.7	20.8	21.2	19.3	23.8	31.7	67.0	60.5	45.9	42.5	27.1	107.0	45.5	40.9	54.1	31.4	84.2	51.4	139.6	9.6	42.4	90.2	46.7	175.0	107.0	67.5	120.5	53.0	175.9	109.8	25.4	73.7	39.9	52.1	3.2	57.5	50.4	84.4	105.6	72.4	84.2	118.6	97.9	39.3	142.5	47.6	25.8	40.1	57.2	61.4	45.4	120.1	34.6	77.4	100.9
TMEM212	FLJ23172	ENSG00000186329	"Transmembrane protein 212"	A6NML5	3	171843349-171938715	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"fallopian tube: 19.2;lung: 10.0;ovary: 12.8"	"Cell type enhanced"	"Detected in some"	30	"Alveolar cells type 1: 32.8;Alveolar cells type 2: 22.8;Ciliated cells: 167.3;Club cells: 46.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045736			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA045736: AB_2679436"	"unprognostic (3.39e-2)"			"unprognostic (1.78e-2)"	"unprognostic (3.05e-1)"			"unprognostic (5.54e-2)"		"unprognostic (3.06e-1)"				"unprognostic (2.87e-1)"				0.4	0.4	0.5	0.6	0.8	2.2	0.4	0.4	0.5	1.6	0.8	0.9	0.4	0.2	1.3	2.5	0.8	19.2	0.4	0.4	0.6	0.7	0.4	3.3	10.0	0.6	0.4	0.4	12.8	0.4	0.0	0.4	0.4	0.7	0.4	0.8	0.4	0.4	2.1	1.1	1.5	0.5	0.4	0.4	0.4	0.4	1.5	0.4	0.4	0.4	0.4	0.4	0.4	0.4	4.1	3.2	6.3	2.1	3.8	2.7	0.5	4.1	2.5	2.8	3.1	0.8	0.4	5.5	3.0	0.9	1.2	1.2	2.0	3.3	5.4	3.6	1.4	3.1	2.9	1.7	1.3	2.6	7.1	2.8	6.4	6.5	2.7	0.5	3.7	5.4	1.1	1.5	1.4	1.2	1.8	1.3	3.4	4.4	8.6	0.9	2.7	3.2	4.1	4.9	2.1	2.7	2.7	4.4	4.5	1.1	3.2	3.4	3.3	4.1	3.1	2.3	3.3	3.6	3.3	6.6	4.6	5.0	7.2	3.2	5.1	4.0	3.6	2.3	3.4	2.4	6.3	2.1	1.8	2.7	1.8	2.1	1.9	2.0	1.8	1.1	4.1	2.3	2.5	5.0	3.8	2.0	3.2	1.3	0.5	0.5	0.8	0.4	0.4	0.6	0.7	0.4	0.4	0.7	0.4	32.8	22.8	0.0	0.0	0.0	0.0	0.0	0.0	167.3	46.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0
TMEM230	"C20orf30, HSPC274"	ENSG00000089063	"Transmembrane protein 230"	Q96A57	20	5068232-5113103	"Predicted membrane proteins, Transporters"			"Disease mutation, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA009078, HPA061421"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA009078: AB_1078345, HPA061421: AB_2684513"	"unprognostic (1.39e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.34e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.55e-2)"	40.0	40.4	34.3	17.1	27.9	15.6	80.9	20.2	44.8	35.7	29.9	23.2	33.3	18.7	30.2	39.0	26.0	27.4	31.4	49.7	32.7	36.1	44.6	81.0	32.9	49.2	41.1	23.1	31.5	53.5	22.4	31.5	21.8	25.8	33.8	27.9	27.4	26.8	31.0	32.4	10.6	29.4	28.1	44.3	20.6	25.8	24.0	16.4	18.8	42.5	24.9	22.2	31.5	18.9	45.6	44.7	30.5	49.2	39.1	48.2	78.3	33.3	23.5	30.9	23.2	70.0	62.5	23.6	27.1	40.8	26.8	29.7	18.5	33.4	16.0	22.3	39.1	30.6	27.8	22.9	40.4	38.9	17.8	26.3	28.3	7.3	56.8	44.8	32.7	11.8	43.1	45.2	20.5	41.3	37.5	35.2	35.8	26.4	44.4	43.8	9.5	32.9	30.6	23.5	64.2	33.6	21.4	20.7	34.3	40.2	17.2	26.1	31.7	16.3	34.3	56.3	34.8	27.4	31.3	29.5	34.9	20.4	33.4	29.0	29.7	58.9	31.3	14.0	28.3	36.5	28.4	48.1	30.5	39.3	49.2	48.2	45.6	43.1	41.9	44.7	37.9	45.0	44.3	15.6	39.1	46.1	43.8	38.6	78.3	34.3	27.9	20.2	44.8	32.7	36.1	41.1	23.1	25.8	16.4	53.6	61.3	129.3	107.8	62.5	93.4	47.8	94.3	64.3	48.9	146.5	60.9	146.0	426.1	129.1	144.0	103.4	53.5	46.7	97.3	172.4	154.3	157.7	111.9	118.4	189.6	58.8	91.9	120.3	153.8	67.6	196.5	153.1	189.0	263.3	96.8	65.8	86.4	119.7	207.2	284.9	89.9	84.1	143.4	110.9	90.6	52.9	123.8	145.1	112.1	128.5
TMEM234	"C1orf91, dJ622L5.7, FLJ90779, RP4-622L5"	ENSG00000160055	"Transmembrane protein 234"	Q8WY98	1	32214472-32222359	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Late spermatids: 41.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015049	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA015049: AB_1856409"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.37e-2)"	7.9	9.2	7.0	9.5	9.2	5.7	8.6	9.5	12.2	9.4	9.4	9.9	21.9	5.0	9.6	22.2	10.4	11.8	12.3	11.0	7.4	8.4	11.5	7.3	9.8	9.9	6.0	7.6	12.6	10.8	14.5	14.9	12.5	6.6	10.2	9.3	14.8	8.8	25.0	6.3	5.3	7.4	9.6	5.8	9.0	9.4	15.9	4.7	8.6	15.3	4.0	9.4	6.8	9.0	5.2	7.5	23.2	8.3	7.0	6.4	4.1	8.2	6.8	3.6	3.9	10.5	8.3	4.0	12.2	9.0	6.3	4.8	4.5	8.8	2.5	14.2	11.6	4.9	6.9	4.6	9.0	5.6	5.3	5.4	5.2	10.0	5.1	8.0	6.1	3.5	10.7	9.6	6.8	5.0	11.7	9.3	2.7	4.7	1.8	11.0	2.4	2.4	4.9	6.9	2.1	5.0	3.3	2.9	2.9	14.3	4.0	4.7	4.8	9.2	5.2	4.0	12.3	2.4	2.0	11.0	2.4	3.8	9.1	8.7	3.1	1.5	1.2	7.2	2.3	8.4	11.7	8.0	11.9	4.1	8.3	6.4	4.5	3.3	4.4	7.5	5.2	2.4	3.0	23.2	7.0	5.9	5.6	1.9	4.1	7.0	9.2	9.5	12.2	7.4	8.4	6.0	7.6	6.6	4.7	8.9	1.0	5.8	6.2	2.4	5.6	2.8	2.5	22.7	6.8	22.7	2.0	22.7	1.7	18.9	18.4	7.7	12.9	0.0	13.5	19.1	7.5	6.4	3.5	5.8	16.7	1.6	5.8	9.2	7.5	41.2	8.6	6.3	13.5	15.4	10.8	8.0	15.1	11.5	7.4	9.8	11.5	6.5	6.9	26.5	15.3	2.8	17.8	5.7	8.4	5.8
TMEM255A	"FAM70A, FLJ20716"	ENSG00000125355	"Transmembrane protein 255A"	Q5JRV8	X	120258650-120311556	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 30.4;ovary: 29.6"	"Cell type enhanced"	"Detected in some"	11	"Alveolar cells type 1: 3.0;Melanocytes: 5.0;monocytes: 5.4"	"Group enriched"	"Detected in many"	10	"glioma: 21.3;melanoma: 8.0;renal cancer: 7.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"gdT-cell: 5.9;MAIT T-cell: 3.3;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	10	"T-cells: 5.9"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.3;NTERA-2: 6.0;RPMI-8226: 11.1;SK-MEL-30: 18.1;U-2 OS: 7.8;U-87 MG: 19.8"	"Low region specificity"	"Detected in all"							HPA048470	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"		No	No			"Nucleoplasm, Nuclear bodies"		"HPA048470: AB_2680406"	"unprognostic (3.41e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.55e-4)"	3.9	5.5	6.8	3.4	14.4	1.5	5.4	6.8	7.8	11.2	3.5	12.4	1.7	1.9	3.2	2.9	4.4	6.3	2.1	2.4	5.3	25.4	2.4	1.5	4.8	5.0	30.4	4.4	29.6	1.1	0.6	6.6	0.8	18.4	3.8	3.9	7.1	1.3	3.3	2.4	4.0	2.8	2.0	13.0	2.8	2.1	0.9	7.8	6.4	0.9	1.8	5.7	1.6	8.0	0.5	0.3	0.0	0.6	0.0	5.9	0.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.3	0.1	0.0	0.1	0.2	0.0	1.8	0.0	1.1	0.4	0.5	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	17.3	0.3	0.0	0.0	0.1	6.0	0.0	0.0	0.0	0.0	11.1	0.0	0.0	3.5	0.2	0.3	0.0	18.1	0.2	0.0	0.2	0.0	0.0	7.8	0.0	2.8	0.0	3.3	2.4	19.8	0.0	0.0	0.0	0.6	0.0	5.9	0.2	3.3	0.5	0.4	2.2	0.3	0.1	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.9	6.8	14.4	6.8	3.9	5.3	25.4	30.4	4.4	18.4	7.8	3.0	0.0	0.0	0.0	0.3	0.6	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.2	0.0	0.0	0.6	0.6	1.1	0.6	0.7	5.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	1.1	0.1	0.0	0.0	0.0
TMEM255B	"FAM70B, MGC20579"	ENSG00000184497	"Transmembrane protein 255B"	Q8WV15	13	113759240-113816995	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	15	"Endothelial cells: 51.3;granulocytes: 39.2;Ito cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 17.0"	"Group enriched"	"Detected in many"	7	"granulocytes: 17.0;monocytes: 4.8"	"Cell line enhanced"	"Detected in many"		"HMC-1: 15.7;HUVEC TERT2: 20.4;PC-3: 20.7;RPMI-8226: 13.2;TIME: 19.1;U-87 MG: 21.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA043334	Approved		Approved	Nucleoplasm		NA	NA			Nucleoplasm		"HPA043334: AB_10795982"	"unprognostic (2.20e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (4.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.83e-1)"	18.5	6.6	3.9	7.1	4.5	1.5	11.8	2.0	4.7	11.1	3.9	2.3	4.3	3.5	10.1	5.3	3.9	6.6	7.5	7.3	6.5	3.7	9.0	6.6	11.7	7.9	5.4	2.1	4.6	4.7	3.1	8.0	2.4	6.1	8.8	3.2	3.3	3.8	5.1	4.6	6.0	4.5	10.4	4.9	9.5	4.4	4.6	4.0	0.1	12.4	2.4	3.7	8.1	29.9	1.5	1.3	17.0	4.8	0.0	0.0	1.0	5.3	0.0	0.3	0.0	1.5	0.0	0.0	2.5	5.7	2.9	1.8	0.2	0.1	0.1	0.0	3.9	6.8	0.8	0.5	0.3	1.2	0.0	0.6	0.1	0.2	0.0	0.9	1.4	15.7	1.1	1.3	6.3	2.4	8.4	20.4	0.3	0.0	0.1	6.3	0.1	0.7	0.4	0.6	0.8	20.7	0.9	0.4	13.2	2.9	0.2	1.2	2.8	0.1	0.7	0.0	0.6	0.3	4.2	19.1	0.8	5.8	0.3	0.9	0.0	0.0	1.0	21.8	1.4	0.1	17.0	4.8	0.6	0.0	4.5	0.0	0.8	0.0	0.0	1.3	1.5	0.0	0.0	2.2	0.0	3.2	0.0	0.0	1.0	3.9	4.5	2.0	4.7	6.5	3.7	5.4	2.1	6.1	4.0	6.0	7.4	0.5	1.1	5.3	0.7	6.7	0.0	0.0	0.0	1.8	0.0	0.0	1.7	8.3	0.6	51.3	0.0	23.3	1.5	0.1	3.7	1.3	39.2	0.4	11.0	0.0	1.2	111.1	17.8	0.4	7.2	14.4	8.5	4.6	0.0	0.5	1.5	0.0	2.8	0.0	0.7	6.5	4.1	1.4	17.0	4.1	0.0	0.0	0.4	0.6
TMEM263	"C12orf23, MGC17943"	ENSG00000151135	"Transmembrane protein 263"	Q8WUH6	12	106955719-106978778	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014453, HPA042339"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA014453: , HPA042339: AB_10795503"	"unprognostic (2.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (7.84e-4)"	"unprognostic (4.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.53e-1)"	14.5	17.6	13.7	15.1	14.7	4.0	25.9	10.6	12.4	29.0	13.9	5.2	26.7	10.8	22.6	27.9	13.2	12.8	19.6	25.3	10.9	16.0	24.4	44.8	12.9	18.2	11.3	10.4	24.0	28.1	12.8	65.3	40.9	11.6	21.1	12.3	10.0	25.2	26.8	10.1	5.6	15.0	18.9	10.4	15.0	18.9	12.4	6.9	32.1	32.8	7.0	12.1	21.2	23.2	11.9	9.1	5.9	0.9	11.5	17.9	8.3	8.9	8.0	15.4	10.3	36.1	40.9	6.4	33.9	31.8	16.8	21.3	8.5	3.9	0.8	10.5	48.3	9.4	4.1	9.6	13.5	23.3	16.0	9.8	12.4	12.6	17.7	18.5	0.6	7.9	28.4	6.4	18.3	15.2	39.0	20.4	9.6	5.8	3.4	22.9	7.3	9.3	5.6	4.9	5.6	15.4	20.7	11.4	2.0	16.7	7.6	7.9	10.7	18.1	8.6	13.4	12.4	10.1	3.6	23.7	14.2	8.7	18.6	8.6	14.2	8.1	8.3	11.2	2.1	22.3	5.9	0.8	0.9	10.2	0.9	12.0	9.2	9.9	8.7	2.6	11.9	17.9	16.0	0.7	11.5	0.3	9.1	10.2	8.3	13.7	14.7	10.6	11.0	10.9	16.0	11.3	10.4	11.6	6.9	8.9	17.6	20.1	43.8	0.0	24.3	46.6	12.7	22.7	20.5	22.7	29.5	34.9	77.9	16.2	24.1	20.3	13.5	0.0	28.5	63.2	46.3	43.7	29.9	42.7	11.8	11.1	27.6	28.8	5.0	29.3	43.7	6.9	0.0	12.6	48.2	31.2	18.5	8.6	41.1	34.0	18.5	25.8	39.5	31.2	23.2	0.0	30.1	14.6	17.4	23.5
TMEM30A	"C6orf67, CDC50A, FLJ10856"	ENSG00000112697	"Transmembrane protein 30A"	Q9NV96	6	75252924-75284968	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014561	Approved					NA	NA					"HPA014561: AB_10601823"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.00e-1)"	29.9	29.6	42.7	28.3	63.3	23.8	27.2	40.3	55.1	33.4	31.3	36.8	22.3	21.2	31.9	25.7	30.1	24.6	30.6	22.9	45.6	48.2	39.6	48.1	45.0	23.9	43.8	41.0	25.2	41.0	57.0	45.5	29.4	50.5	33.6	36.8	20.5	31.9	31.7	18.6	19.4	22.5	39.8	45.3	28.9	28.0	14.1	40.3	21.1	43.1	17.0	29.3	32.8	22.8	9.1	24.3	42.7	26.8	13.1	16.3	16.7	10.5	10.2	18.9	15.8	47.7	44.9	15.6	43.1	33.9	16.8	25.7	10.9	24.8	12.3	29.8	37.9	15.3	12.4	8.4	24.0	44.9	15.8	12.5	11.9	11.2	11.2	27.2	14.2	20.8	41.5	23.9	23.3	13.1	36.2	53.4	11.2	11.6	21.9	32.7	7.0	5.0	10.4	6.7	8.9	8.8	8.3	13.4	15.5	65.1	26.0	13.3	13.0	21.9	10.8	14.5	22.7	11.9	44.6	46.3	21.3	23.8	13.3	30.4	18.0	24.5	5.3	16.9	27.5	33.3	12.3	26.8	17.7	12.7	26.6	15.3	9.1	13.0	12.2	24.3	7.5	12.5	12.6	42.7	13.1	25.6	10.6	16.3	16.7	42.7	63.3	40.3	52.7	45.6	48.2	43.8	41.0	50.5	40.3	151.8	109.2	38.2	28.7	63.3	24.2	34.7	33.1	68.3	76.2	62.8	43.2	31.3	10.0	43.7	7.5	65.2	34.1	0.0	96.0	46.0	58.6	62.3	37.1	70.2	48.7	19.1	34.9	69.3	81.5	5.9	42.0	50.3	45.5	23.4	43.5	37.2	78.7	37.4	58.7	29.3	20.0	32.3	70.7	36.2	18.8	68.4	78.9	28.9	26.2	42.3
TMEM30B	CDC50B	ENSG00000182107	"Transmembrane protein 30B"	Q3MIR4	14	61277370-61281840	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 50.3"	"Cell type enhanced"	"Detected in many"	5	"Basal glandular cells: 101.7;Urothelial cells: 117.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 2.8"	"Lineage enriched"	"Detected in single"	4	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"A-431: 25.0;CAPAN-2: 20.4;HaCaT: 11.9;HBEC3-KT: 14.4;hTCEpi: 11.0;MCF7: 16.1;RT4: 35.0;T-47d: 11.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043162	Uncertain					NA	NA					"HPA043162: AB_10796688"	"unprognostic (4.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.89e-5)"	"unprognostic (2.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.85e-1)"	3.7	1.2	0.8	1.6	1.3	0.0	4.7	0.7	1.0	5.4	11.5	0.5	18.0	14.1	3.9	14.6	8.1	4.8	10.6	1.5	0.8	0.8	6.7	5.5	6.4	0.4	0.8	0.7	4.8	23.3	20.3	27.3	11.6	3.4	9.1	8.4	1.0	18.9	14.4	1.6	3.9	19.5	2.0	1.7	0.9	13.3	6.3	0.2	2.3	50.3	6.2	4.7	9.6	5.7	0.0	0.0	0.0	0.0	0.7	2.8	0.5	25.0	0.0	0.0	0.0	2.9	0.7	0.0	0.0	0.0	0.0	0.0	4.3	20.4	0.0	0.0	0.0	0.0	11.9	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.2	10.3	0.5	0.0	0.5	0.0	0.0	35.0	4.2	0.0	0.3	9.7	0.0	0.7	11.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.6	0.0	1.2	0.6	0.0	0.0	2.8	1.8	0.0	0.7	0.0	0.0	0.0	0.5	0.8	1.3	0.7	1.0	0.8	0.8	0.8	0.7	3.4	0.2	26.8	29.3	0.0	101.7	57.7	0.0	1.1	40.8	10.7	19.4	38.4	0.0	24.7	11.6	21.2	0.9	2.9	81.5	0.0	32.4	9.3	8.9	91.9	2.3	11.5	1.7	0.0	22.4	3.7	1.3	1.0	8.1	1.0	5.0	1.0	67.9	2.7	28.3	56.1	74.3	0.5	0.2	12.9	2.1	4.3	1.5	55.7	30.0	3.2	55.7	117.4
TMEM33	FLJ10525	ENSG00000109133	"Transmembrane protein 33"	P57088	4	41935120-41960572	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075863	Approved					NA	NA					"HPA075863: "	"unprognostic (7.14e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.70e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.36e-2)"	15.8	24.7	14.7	18.1	17.3	12.6	20.4	11.1	22.3	12.6	17.8	16.7	14.5	20.0	12.6	25.4	30.6	12.0	16.6	14.6	15.2	16.0	24.0	59.4	18.6	20.4	16.0	15.0	14.7	18.1	23.9	31.8	22.3	17.4	17.3	20.6	15.9	22.0	17.9	14.0	16.3	22.2	10.8	21.7	19.2	18.4	11.2	14.0	23.6	22.7	16.4	18.4	17.7	16.5	8.8	15.0	27.0	20.8	9.8	12.3	9.8	13.0	15.1	14.0	19.2	17.9	12.2	16.5	17.8	19.6	15.4	17.7	18.6	44.8	23.0	27.7	14.9	31.7	20.9	45.6	23.8	20.8	5.9	9.3	28.4	19.5	16.7	21.7	38.2	25.1	12.7	25.8	19.4	28.6	10.0	12.2	14.2	30.1	9.2	20.9	11.3	33.9	25.7	24.8	20.7	18.1	15.4	21.4	18.3	21.5	19.1	15.3	21.9	14.6	14.4	23.3	13.9	15.7	13.8	18.9	18.2	24.3	18.1	32.1	16.5	26.3	27.8	19.5	31.6	26.3	19.3	20.8	13.4	10.4	19.5	12.3	8.8	10.7	9.7	15.0	7.4	9.6	10.5	27.0	9.8	19.9	11.7	12.1	9.8	14.7	17.3	11.1	22.3	15.2	16.0	16.0	15.0	17.4	14.0	56.6	26.4	27.6	25.8	65.1	19.0	15.9	28.1	16.0	28.4	52.4	15.7	48.9	19.9	39.5	2.0	22.6	49.6	0.0	33.1	41.7	36.6	65.9	38.1	73.1	53.1	27.0	33.7	22.7	58.5	2.2	18.7	54.6	54.0	24.4	38.2	37.6	42.8	41.9	21.9	34.8	18.4	25.8	22.6	27.0	30.0	58.5	111.3	23.5	32.1	57.0
TMEM38B	"bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B"	ENSG00000095209	"Transmembrane protein 38B"	Q9NVV0	9	105694544-105776612	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 43.9"	"Cell type enhanced"	"Detected in many"	10	"Early spermatids: 220.6;Late spermatids: 366.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018465	Uncertain					NA	NA					"HPA018465: AB_1858116"	"unprognostic (3.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.80e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.89e-3)"	"unprognostic (9.98e-2)"	8.8	10.0	6.0	4.0	7.4	10.4	17.4	4.1	5.7	6.8	7.4	10.4	2.8	4.0	5.5	11.0	4.8	4.5	4.2	28.3	6.6	6.1	18.6	11.7	5.7	8.1	12.5	3.4	11.7	4.1	5.3	16.6	2.9	7.9	5.1	7.3	9.2	4.2	4.4	43.9	4.0	6.4	5.2	10.4	3.6	4.3	21.1	9.0	3.3	17.9	15.6	3.0	7.5	8.2	26.3	24.2	24.5	13.3	12.0	20.2	11.3	5.9	9.3	7.2	11.4	42.1	9.3	15.4	8.8	5.6	8.4	8.8	14.4	8.2	13.8	4.4	3.0	13.6	4.3	10.4	4.9	9.2	10.4	14.1	5.6	6.5	8.8	5.9	17.0	12.2	8.7	4.4	5.7	8.3	2.6	3.3	9.7	29.6	12.4	5.1	16.5	11.7	5.1	5.6	17.4	10.2	7.9	22.8	6.6	3.8	5.0	12.7	3.1	8.8	14.5	6.3	5.1	18.1	12.0	1.7	7.7	7.7	29.3	8.8	15.2	37.6	6.8	14.3	18.8	15.3	5.8	9.7	24.5	6.7	13.3	8.7	26.3	9.2	7.9	10.8	24.7	20.2	12.5	1.4	12.0	11.5	24.2	7.8	11.3	6.0	7.4	4.1	5.7	6.6	6.1	12.5	3.4	7.9	9.0	0.0	2.4	10.3	19.8	27.0	12.2	48.5	17.8	4.0	2.3	24.4	27.5	8.2	56.3	6.4	220.6	8.2	11.8	0.0	5.9	14.5	10.8	30.3	15.1	23.1	29.9	11.1	30.6	2.5	7.3	366.7	78.9	26.7	30.4	25.2	11.2	27.6	7.3	14.0	42.1	31.4	11.8	116.4	51.3	129.7	51.9	28.5	17.7	10.0	19.9	10.7
TMEM50A	SMP1	ENSG00000183726	"Transmembrane protein 50A"	O95807	1	25337917-25362361	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065192			Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Plasma membrane"	"Actin filaments, Cytosol"	"HPA065192: AB_2685429"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-3)"	"prognostic favorable (8.64e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (7.39e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.39e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-3)"	"unprognostic (3.44e-2)"	36.2	45.6	29.2	23.2	39.1	19.4	43.4	30.5	29.4	29.7	32.7	21.5	25.6	26.5	29.4	31.5	36.7	23.5	30.9	32.6	30.9	23.6	39.1	31.8	34.2	36.3	29.3	18.5	22.6	29.7	21.7	13.6	40.4	19.9	32.8	38.6	19.1	56.5	33.0	21.5	25.7	39.6	27.8	38.1	39.4	26.5	17.5	20.4	32.7	39.2	29.6	28.1	37.1	31.0	13.0	14.0	56.5	26.8	19.2	25.0	23.1	8.5	9.8	16.5	8.5	31.0	27.9	5.8	17.4	27.9	33.1	37.1	7.9	21.5	9.9	9.8	61.9	12.4	12.5	12.9	14.2	36.2	26.1	18.5	21.2	10.8	12.0	22.9	16.1	17.2	30.4	20.9	24.5	14.2	15.7	23.8	11.2	14.1	15.6	31.2	6.0	10.5	19.7	19.3	14.1	8.1	9.3	18.1	17.5	33.3	6.3	13.8	8.8	18.0	12.7	13.9	15.6	6.5	10.6	35.2	18.5	7.7	30.2	7.2	10.9	11.8	9.1	24.1	24.2	10.2	56.5	19.1	26.3	24.0	23.0	25.0	13.0	21.1	24.4	14.0	10.1	15.5	21.1	39.7	19.2	26.8	13.0	23.4	23.1	29.2	39.1	30.5	29.4	30.9	23.6	29.3	18.5	19.9	20.4	134.0	76.3	88.7	152.8	225.1	40.2	88.4	119.8	104.4	70.5	160.5	25.5	94.3	43.1	257.7	13.8	175.4	107.8	46.7	188.7	283.9	172.6	238.9	122.5	56.8	203.7	23.8	79.6	140.6	162.8	8.4	140.7	195.1	189.0	268.7	149.5	99.5	250.4	140.3	93.0	82.3	29.5	207.0	211.1	93.4	46.0	277.7	151.8	110.7	95.4	208.9
TMEM50B	C21orf4	ENSG00000142188	"Transmembrane protein 50B"	P56557	21	33432485-33480011	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034199, HPA068995"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Nucleoli fibrillar center"		"CAB034199: AB_2205160, HPA068995: AB_2686066"	"unprognostic (3.22e-1)"	"unprognostic (5.93e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (9.58e-3)"	"unprognostic (3.41e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.32e-3)"	12.8	16.1	12.1	12.4	14.6	5.6	20.3	31.1	14.1	16.1	12.0	13.7	25.3	12.9	16.5	32.0	11.8	16.5	16.9	14.0	13.1	13.5	21.0	14.3	14.3	8.9	14.8	11.2	27.8	19.4	14.7	20.3	10.0	16.4	18.1	11.6	19.5	10.5	32.4	16.1	10.9	16.1	22.0	14.1	16.0	15.1	14.9	12.2	6.9	51.0	8.6	8.8	16.5	15.3	9.3	12.4	20.3	10.5	10.9	16.3	11.9	9.3	1.9	3.6	5.1	20.7	15.0	3.0	8.8	9.9	6.1	4.5	2.5	8.0	5.9	8.1	7.2	8.1	3.7	4.9	5.1	4.4	6.3	5.7	10.9	1.6	5.0	9.5	7.1	6.1	7.4	4.9	4.8	3.7	10.2	7.3	5.7	7.5	10.4	8.2	6.0	5.6	7.6	1.5	15.9	4.1	3.0	7.1	9.0	11.0	7.1	3.4	5.3	10.6	11.1	8.8	2.0	12.3	9.5	6.3	4.5	3.3	5.6	2.8	10.7	18.0	7.5	4.2	12.1	7.2	7.9	8.4	20.3	11.3	9.2	9.1	9.3	12.6	11.4	11.3	8.5	13.8	13.5	1.7	10.9	10.5	12.4	16.3	11.9	12.1	14.6	31.1	14.1	13.1	13.5	14.8	11.2	16.4	12.2	26.8	50.7	27.6	88.0	65.8	53.8	42.3	50.9	57.6	30.7	78.5	102.1	30.2	23.2	30.3	32.6	54.4	51.5	0.0	27.5	33.5	55.1	133.9	28.9	51.2	32.7	41.3	20.7	94.5	34.9	29.6	66.2	26.8	79.2	31.5	40.9	66.5	26.7	35.1	112.4	48.1	79.3	97.0	62.6	182.7	78.6	81.9	34.6	41.5	39.2	92.9
TMEM59L	"BSMAP, C19orf4"	ENSG00000105696	"Transmembrane protein 59 like"	Q9UK28	19	18607430-18621039	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 148.3"	"Cell type enhanced"	"Detected in some"	18	"Bipolar cells: 92.0;Horizontal cells: 47.7;Muller glia cells: 72.1;Rod photoreceptor cells: 22.8"	"Cancer enriched"	"Detected in many"	8	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 20.4;ASC diff: 24.8;EFO-21: 14.6;Hep G2: 14.8;HSkMC: 9.1;hTERT-RPE1: 13.4;SH-SY5Y: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010661	Approved					NA	NA					"HPA010661: AB_1078338"	"unprognostic (3.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.24e-4)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-3)"	"prognostic favorable (8.80e-4)"	"unprognostic (4.65e-2)"	"unprognostic (9.17e-7)"	"unprognostic (1.47e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-5)"	2.6	12.8	36.9	2.5	39.4	1.7	1.9	41.9	148.3	2.2	2.9	7.5	0.0	2.0	2.5	2.0	2.5	2.1	2.9	3.5	39.9	49.6	1.9	1.8	1.9	1.8	17.7	32.8	1.8	2.8	4.9	13.2	2.3	24.1	2.2	2.2	1.9	2.3	2.6	2.5	1.8	3.0	3.1	7.3	1.7	2.0	2.4	5.2	0.0	1.8	0.0	1.7	2.0	0.1	0.5	0.7	0.0	0.0	0.0	0.5	0.4	0.0	0.6	0.2	20.4	24.8	1.2	0.0	2.1	0.4	0.8	0.4	0.0	1.0	0.1	14.6	1.3	2.0	0.3	6.0	0.0	0.7	0.1	0.9	0.0	0.3	14.8	3.8	0.0	0.3	9.1	0.0	0.2	0.7	13.4	0.0	0.8	0.0	0.1	0.5	0.9	0.1	0.0	1.8	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.3	12.1	1.4	0.0	0.0	0.2	0.2	0.0	0.2	0.4	4.9	0.1	1.3	3.0	1.1	0.1	0.8	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.4	36.9	39.4	41.9	70.3	39.9	49.6	17.7	32.8	24.1	5.2	0.0	0.0	0.0	0.2	0.0	92.0	0.4	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.2	47.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	1.0	0.0	72.1	0.3	0.0	0.0	0.0	22.8	0.0	2.7	2.6	0.9	0.1	0.1	0.0	0.0	0.0
TMEM60	"C7orf35, DC32"	ENSG00000135211	"Transmembrane protein 60"	Q9H2L4	7	77793728-77798580	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062625	Approved					NA	NA					"HPA062625: AB_2684811"	"prognostic favorable (3.09e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.73e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.43e-3)"	16.4	19.7	14.6	16.2	14.8	6.9	22.8	8.6	21.3	17.4	18.0	10.0	17.1	13.3	16.4	23.1	15.0	14.5	13.6	15.1	14.6	17.8	25.5	25.8	19.3	18.8	15.7	12.2	18.6	24.1	33.9	30.6	20.1	19.7	17.9	18.4	16.0	27.5	21.3	19.2	15.1	19.6	14.7	15.3	22.7	14.2	20.3	9.8	18.8	30.9	17.2	20.5	14.0	14.1	25.9	15.6	48.3	17.2	8.8	23.1	12.2	15.1	10.2	16.2	18.7	21.6	19.2	7.4	14.3	27.0	15.2	24.3	9.4	19.5	11.8	3.5	13.1	52.9	16.1	15.0	8.2	17.2	9.1	14.2	6.3	9.6	13.0	15.3	8.9	11.9	14.0	12.0	11.3	13.8	15.0	10.7	11.0	14.8	23.7	23.7	16.1	6.7	22.8	11.3	18.6	13.3	8.1	12.7	16.8	17.9	11.3	8.1	13.1	10.7	15.1	21.4	17.8	18.3	16.5	7.2	19.7	13.8	17.1	10.5	9.7	14.8	16.8	14.9	18.6	17.3	48.3	16.0	28.6	9.4	17.2	10.1	25.9	16.5	11.6	11.9	20.9	14.0	11.8	15.6	8.8	15.7	15.6	23.1	12.2	14.6	14.8	8.6	21.3	14.6	17.8	15.7	12.2	19.7	9.8	8.9	11.5	29.7	29.5	26.7	6.9	5.6	12.7	21.4	7.9	41.8	7.9	49.2	44.7	24.1	6.5	19.7	20.7	0.0	25.8	34.9	31.9	26.7	24.3	23.5	59.9	12.7	8.7	25.8	36.2	8.4	42.3	34.9	27.0	33.3	30.3	16.2	24.9	24.6	33.2	41.8	9.3	51.8	17.0	43.3	39.5	29.2	36.7	16.6	26.4	33.5
TMEM63B	"C6orf110, dJ421H19.2, DKFZp434P0531"	ENSG00000137216	"Transmembrane protein 63B"	Q5T3F8	6	44126914-44155519	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Late spermatids: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"OE19: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029249, HPA029250, HPA029251"	Uncertain		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Plasma membrane, Actin filaments"		"HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967"	"unprognostic (8.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.15e-1)"	9.7	13.2	24.4	8.7	21.4	14.0	9.4	33.2	34.3	9.1	19.7	14.8	7.5	17.1	8.2	11.7	21.1	8.6	13.2	16.6	21.6	15.2	10.7	28.6	35.0	5.2	13.1	18.2	8.0	10.6	19.6	10.2	12.8	22.8	12.9	18.4	18.6	13.9	8.8	29.4	29.6	17.0	9.7	13.8	6.3	24.5	22.7	16.0	4.7	11.4	14.8	8.9	14.4	13.4	1.3	1.3	1.7	2.1	0.3	2.6	1.2	15.4	8.2	7.8	13.2	12.3	7.3	13.2	6.3	8.6	7.8	7.4	5.8	5.7	2.6	10.5	9.4	11.6	15.3	9.1	23.6	4.5	7.2	7.9	7.6	6.0	17.0	8.7	1.5	8.0	10.0	20.5	10.0	6.3	14.1	7.1	6.0	24.6	4.6	7.8	15.3	1.6	3.7	4.0	58.7	4.1	2.0	4.8	4.9	19.1	14.7	8.5	6.9	5.9	13.6	14.1	9.9	16.0	4.0	8.4	9.3	11.1	7.1	7.7	5.5	4.0	3.0	14.5	2.6	11.5	1.1	2.1	1.3	1.4	1.1	2.5	1.3	0.7	0.7	0.9	0.8	1.0	1.1	1.7	0.3	1.4	1.3	2.6	1.2	24.4	21.4	33.2	34.3	21.6	15.2	13.1	18.2	22.8	16.0	14.9	29.0	1.4	12.3	12.0	16.3	2.8	10.2	0.0	7.9	10.4	15.7	12.5	1.7	13.4	56.9	6.8	47.1	0.0	13.3	14.8	10.8	15.8	0.0	31.6	21.1	15.9	17.9	12.9	8.3	71.4	10.9	7.0	6.8	7.2	26.3	11.1	25.1	40.4	8.5	10.2	26.6	6.5	9.2	1.6	5.8	15.9	16.7	4.3	18.0	22.6
TMEM63C	"C14orf171, CSC1, DKFZp434P0111, hsCSC1"	ENSG00000165548	"Transmembrane protein 63C"	Q9P1W3	14	77116568-77259495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.8;pituitary gland: 21.1"	"Cell type enhanced"	"Detected in some"	17	"Early spermatids: 7.2;Intestinal endocrine cells: 18.4;Late spermatids: 4.8;Paneth cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	5	"cerebellum: 63.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 11.8;Karpas-707: 15.9;RPMI-8226: 8.1;SCLC-21H: 21.7;SK-BR-3: 19.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030657	Uncertain		Approved	Centrosome		NA	NA			Centrosome		"HPA030657: AB_10601699"	"unprognostic (2.74e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-8)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.34e-7)"	"unprognostic (5.90e-3)"	0.4	14.1	3.4	1.0	8.4	1.1	5.2	63.8	16.3	1.5	5.8	1.9	0.0	1.8	0.3	6.8	4.8	0.6	0.5	0.3	3.2	9.7	0.7	0.4	0.9	0.6	4.6	6.0	0.4	6.7	1.2	21.1	1.1	6.6	0.4	4.3	0.9	1.3	0.2	0.8	4.4	2.2	1.1	1.8	3.2	3.1	9.9	1.2	0.0	3.2	0.6	0.6	0.3	2.9	0.1	0.7	2.0	1.7	1.7	1.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	11.8	2.3	0.0	2.0	1.6	2.5	0.9	0.0	0.8	0.9	0.2	1.2	0.0	0.0	2.0	0.1	0.0	5.0	0.0	0.1	0.0	0.0	5.6	0.0	15.9	0.0	5.9	1.6	0.1	0.5	0.0	0.0	0.0	0.8	8.1	0.2	0.0	21.7	3.2	0.2	19.2	0.0	0.4	1.9	1.0	0.0	0.0	4.1	0.0	0.0	1.3	0.0	0.4	0.2	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.0	0.5	1.0	0.7	0.1	0.5	0.4	2.0	1.7	1.7	0.0	0.0	0.4	3.4	8.4	63.8	13.0	3.2	9.7	4.6	6.0	6.6	1.2	0.0	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	0.0	0.0	2.0	0.1	1.7	0.0	7.2	0.0	2.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	2.0	3.2	18.4	0.0	0.0	4.8	0.0	0.0	0.0	0.0	3.1	0.1	0.3	6.6	0.4	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0
TMEM64	DKFZp762C1112	ENSG00000180694	"Transmembrane protein 64"	Q6YI46	8	90621995-90791632	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"epididymis: 84.0"	"Cell type enhanced"	"Detected in many"	4	"Hepatocytes: 42.9;Leydig cells: 43.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034221	Uncertain					NA	NA					"CAB034221: AB_1567653"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.55e-3)"	"unprognostic (4.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.97e-1)"	9.2	12.6	4.3	5.2	5.3	2.1	6.1	2.7	6.1	10.6	10.8	16.2	14.5	5.7	11.9	84.0	7.3	5.7	6.3	5.8	6.2	5.5	11.6	11.7	7.2	6.7	11.2	3.3	10.1	11.3	4.1	5.9	6.1	10.0	10.7	3.7	15.1	12.4	11.0	8.2	6.8	11.3	9.6	12.1	7.2	5.4	9.7	7.5	2.3	20.0	5.2	7.2	11.9	10.9	5.7	0.6	3.2	0.8	5.9	3.7	1.6	12.8	10.0	5.1	2.7	23.7	17.3	2.7	9.5	9.1	7.5	8.4	2.8	8.9	8.4	3.8	5.8	3.2	4.5	13.5	6.5	10.0	16.8	4.9	15.6	4.0	6.3	8.4	0.9	2.6	22.5	7.1	3.1	7.0	8.7	7.5	2.0	7.0	18.6	12.6	17.1	0.0	2.2	0.7	6.6	5.3	1.8	11.2	4.2	14.8	25.0	3.6	10.2	6.2	5.5	11.5	7.1	5.5	0.7	7.4	7.6	6.7	5.5	7.7	12.3	0.2	9.2	6.9	1.9	10.0	3.2	0.2	0.3	3.0	0.6	3.7	5.7	3.2	3.4	0.6	2.9	1.5	2.1	0.1	5.9	0.8	0.4	1.4	1.6	4.3	5.3	2.7	6.1	6.2	5.5	11.2	3.3	10.0	7.5	8.9	12.2	16.1	8.7	21.4	0.6	17.1	10.2	4.0	3.4	21.0	0.0	20.2	1.7	3.8	2.4	7.0	3.4	0.0	8.8	5.2	14.6	15.6	13.9	42.9	3.6	1.6	7.5	5.5	7.5	2.1	43.4	6.5	23.6	0.0	4.3	2.6	8.2	3.1	20.1	22.1	0.0	0.0	10.8	3.4	1.6	20.6	13.2	9.6	5.1	6.2
TMEM67	"JBTS6, MGC26979, MKS3, NPHP11"	ENSG00000164953	"Transmembrane protein 67"	Q5HYA8	8	93754844-93819234	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Deafness, Disease mutation, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Ciliated cells: 57.6;Cone photoreceptor cells: 62.8;Rod photoreceptor cells: 70.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.25e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (8.41e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	4.1	4.9	8.3	2.5	12.3	2.3	6.2	6.8	7.6	6.7	3.7	4.9	10.1	2.7	9.8	11.2	3.3	22.4	5.0	8.4	6.8	8.3	5.6	2.3	9.3	4.0	2.9	6.4	8.6	6.2	9.3	21.3	3.7	19.1	5.2	4.0	7.0	3.8	8.9	2.1	6.2	2.6	8.2	3.3	3.3	3.7	22.5	3.7	3.4	10.3	1.8	3.2	5.1	4.4	3.9	2.9	2.9	1.5	4.8	4.0	1.2	6.3	4.1	5.8	4.4	5.2	8.5	3.6	3.6	6.1	4.3	8.6	2.0	14.4	1.6	7.9	3.9	7.9	6.6	2.1	3.7	6.5	1.3	4.9	3.8	6.0	2.0	4.7	2.9	1.7	4.9	3.4	7.7	3.4	8.1	4.5	6.7	2.6	1.0	4.5	1.5	4.9	2.2	4.7	2.5	3.8	1.8	1.9	0.0	5.4	2.8	3.8	6.5	3.7	1.0	6.2	5.5	7.5	1.6	2.3	4.7	2.0	6.5	3.3	2.1	5.6	1.5	8.4	0.8	4.4	2.9	1.5	0.5	3.6	0.7	3.1	1.8	3.4	3.2	2.3	3.9	4.0	3.9	1.5	4.8	0.5	2.9	0.7	1.2	8.3	12.3	6.8	7.6	6.8	8.3	2.9	6.4	19.1	3.7	11.9	8.3	4.7	4.2	2.5	12.3	29.5	7.6	57.6	14.8	19.2	62.8	2.6	0.0	5.4	15.4	6.2	0.4	0.0	2.5	5.0	8.4	1.9	4.7	1.1	2.0	22.3	8.6	7.4	2.7	6.0	15.0	0.6	1.7	1.8	2.3	14.1	2.1	0.0	9.9	2.1	70.0	6.5	5.0	36.3	14.1	1.3	1.9	3.8	2.1	0.8
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 81.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: AB_2671101"	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	9.5	12.3	7.6	7.4	8.0	7.0	9.4	7.1	12.8	6.0	7.4	3.6	3.9	4.8	6.1	9.0	6.2	9.1	7.4	13.3	9.3	7.9	9.7	38.8	6.2	9.6	6.8	7.3	7.3	17.0	5.1	6.3	8.1	10.0	6.3	8.0	3.8	7.1	5.3	81.1	4.8	6.9	7.7	6.3	9.9	10.6	10.9	5.1	8.5	6.5	13.4	7.9	6.7	5.9	18.4	12.3	7.5	11.0	6.2	12.7	12.7	11.2	9.0	7.2	7.5	8.5	7.3	7.4	9.6	8.7	10.7	8.7	8.4	6.5	15.2	8.3	6.4	9.1	10.2	13.8	9.2	12.1	9.8	9.4	15.2	5.9	11.2	8.5	8.2	8.1	6.8	8.6	6.8	3.6	4.1	9.0	7.7	11.4	7.5	11.4	8.3	18.8	15.6	6.7	14.4	11.2	13.3	7.1	12.9	11.3	10.6	16.4	7.3	5.9	43.0	12.1	6.0	8.9	7.6	5.7	6.3	7.6	11.4	9.0	11.2	9.6	14.9	9.1	6.4	6.9	6.3	10.8	7.0	9.5	11.0	10.9	18.4	10.9	10.8	10.5	10.8	12.7	11.8	7.5	6.2	8.1	12.3	8.6	12.7	7.6	8.0	7.1	12.8	9.3	7.9	6.8	7.3	10.0	5.1	14.9	36.2	37.2	32.5	59.8	24.1	39.1	15.3	42.8	23.9	21.0	7.9	61.6	56.3	28.4	11.2	35.3	22.8	0.0	55.5	44.6	47.0	32.0	38.2	44.2	119.9	9.5	13.3	28.3	89.0	5.6	27.6	68.1	38.8	36.1	27.6	19.7	38.3	37.1	27.3	55.5	15.9	38.8	44.8	32.9	28.3	52.1	58.8	34.8	29.0	23.3
TMEM74	"FLJ30668, NET36"	ENSG00000164841	"Transmembrane protein 74"	Q96NL1	8	108606850-108787615	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 14.1"	"Cell type enhanced"	"Detected in some"	13	"Bipolar cells: 2.7;Cone photoreceptor cells: 5.9;Rod photoreceptor cells: 7.9;Spermatogonia: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	14	"memory B-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"B-cells: 1.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 5.2;NTERA-2: 6.5;SCLC-21H: 14.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015672, HPA076461"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"		"HPA015672: AB_1858132, HPA076461: "	"unprognostic (8.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.75e-4)"	"unprognostic (8.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.46e-3)"	1.3	1.4	4.8	1.1	4.2	0.4	0.9	13.1	12.0	0.7	2.7	10.4	0.0	0.9	0.7	0.7	2.9	1.0	0.9	7.5	5.9	2.8	0.7	2.2	0.8	0.8	3.2	6.1	0.9	2.7	0.4	1.1	0.5	9.3	1.0	1.3	1.0	0.9	1.1	5.5	2.0	1.4	2.9	14.1	0.6	0.9	2.7	6.8	0.7	0.8	0.8	0.9	0.9	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.1	0.3	0.0	1.6	0.0	0.1	0.0	0.1	3.0	0.7	0.0	0.4	5.2	1.9	0.8	0.3	0.1	0.5	0.7	0.0	0.0	0.1	0.1	0.1	0.5	3.6	0.0	0.2	0.0	0.0	0.2	0.0	6.5	0.0	3.7	0.0	3.7	0.0	0.0	0.0	14.2	0.1	0.0	0.5	0.0	1.6	0.2	0.2	0.0	1.7	3.0	0.0	0.3	0.6	0.1	0.0	2.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	4.2	13.1	7.3	5.9	2.8	3.2	6.1	9.3	6.8	0.0	0.0	0.0	0.6	0.8	2.7	0.6	0.0	0.0	0.0	0.0	5.9	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.5	0.2	0.0	0.2	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	7.9	0.0	0.7	0.2	5.1	0.5	0.1	0.0	0.0	0.0
TMEM8A	"M83, PGAP6, TMEM6, TMEM8"	ENSG00000129925	"Transmembrane protein 8A"	Q9HCN3	16	370773-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Enterocytes: 67.7;Syncytiotrophoblasts: 83.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 24.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			Nucleoplasm	"Cytokinetic bridge"	"HPA051281: AB_2681418, HPA064673: AB_2685317"	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	8.4	9.3	6.9	9.5	7.8	15.2	13.5	7.7	7.9	6.8	16.6	7.3	24.1	17.7	7.3	29.6	11.8	6.5	15.2	10.0	5.6	4.3	28.7	33.5	13.0	10.7	7.1	3.2	8.3	44.2	11.5	10.7	45.5	6.7	11.4	6.0	8.8	22.5	8.8	12.8	3.7	25.0	5.0	4.7	13.2	17.5	26.3	6.0	12.6	12.3	5.2	14.6	9.3	8.8	2.0	2.9	24.3	5.5	0.9	7.6	3.3	4.4	11.8	6.8	12.5	9.3	8.4	13.6	12.9	13.5	6.6	9.5	46.4	21.1	4.8	17.5	12.4	10.1	6.4	3.0	14.2	1.8	13.6	11.3	7.9	8.0	26.4	21.6	5.9	15.0	9.7	4.3	10.1	2.9	6.7	15.2	5.4	12.6	7.4	8.2	27.8	8.3	11.7	10.8	7.2	4.7	18.1	7.8	10.9	10.7	11.5	8.1	9.3	7.2	7.3	37.9	3.7	13.1	11.9	22.1	18.8	20.3	13.0	6.8	14.9	7.4	9.5	9.5	6.3	11.9	4.6	5.0	6.3	7.4	5.5	5.9	1.8	5.8	5.8	2.5	2.0	7.6	5.5	24.3	0.9	3.8	2.9	4.3	3.3	6.9	7.8	7.7	7.9	5.6	4.3	7.1	3.2	6.7	6.0	14.9	12.5	10.7	3.2	2.6	5.7	12.5	10.2	1.4	1.2	22.7	9.8	46.7	5.0	27.5	15.5	8.7	67.7	23.3	36.8	5.9	6.6	11.5	1.1	25.5	24.7	17.5	26.6	14.7	14.5	58.4	2.6	10.1	6.8	8.2	26.1	8.2	42.6	38.6	1.8	9.9	7.8	12.9	6.1	1.1	2.5	2.8	83.8	7.5	18.9	6.8
TMEM8B	"C9orf127, NAG-5, NGX6"	ENSG00000137103	"Transmembrane protein 8B"	A6NDV4	9	35814451-35865518	"Predicted membrane proteins, Transporters"	"Cell adhesion, Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 29.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 27.2"	"Lineage enriched"	"Detected in many"	18	"dendritic cells: 27.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052130, HPA062701"	Approved		Approved	Vesicles		NA	NA			Vesicles		"HPA052130: AB_2681740, HPA062701: AB_2684839"	"unprognostic (5.54e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (5.93e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (8.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	9.7	19.5	28.2	5.7	30.4	3.4	9.4	22.9	34.4	15.5	13.0	16.9	14.9	8.7	18.4	11.5	9.3	18.3	12.1	17.8	25.3	14.1	11.3	4.7	10.4	5.9	12.9	21.2	33.3	14.6	28.4	23.6	7.7	18.3	19.3	9.4	17.5	19.9	24.0	19.1	9.2	8.4	18.1	13.0	8.7	13.1	13.6	15.4	5.6	17.3	5.1	4.9	14.2	11.9	0.9	27.2	0.6	1.5	0.5	0.6	1.1	2.9	3.1	11.0	8.6	12.4	10.4	1.3	2.6	5.1	2.9	3.6	1.3	0.8	2.3	6.3	7.1	8.5	1.1	2.9	4.3	2.4	1.8	4.9	0.7	2.2	3.1	8.8	0.2	0.3	9.7	5.6	3.0	3.2	9.4	1.6	10.7	1.0	6.5	5.1	1.1	6.0	1.3	1.6	2.4	4.3	6.7	2.2	5.7	3.0	1.3	2.6	7.7	4.0	1.9	3.9	3.8	3.0	1.1	2.6	6.9	2.2	6.7	1.0	8.7	2.6	2.6	6.3	1.1	4.2	0.4	1.5	0.1	0.6	0.3	0.5	0.9	0.6	0.6	4.7	0.9	0.6	0.5	0.6	0.5	0.3	27.2	0.4	1.1	28.2	30.4	22.9	34.4	25.3	14.1	12.9	21.2	18.3	15.4	11.9	13.5	0.9	7.2	3.9	3.9	10.1	10.2	4.0	7.9	14.0	2.0	29.0	1.7	4.4	20.2	2.9	3.9	0.0	3.4	5.3	7.2	9.2	1.1	2.9	2.9	1.6	6.4	1.3	1.9	9.9	13.6	3.3	10.1	0.0	5.6	8.2	3.2	8.6	18.4	4.1	5.0	6.5	6.1	8.0	4.4	1.4	10.9	3.8	6.3	8.2
TMEM91	"FLJ27310, IFITMD6"	ENSG00000142046	"Transmembrane protein 91"	Q6ZNR0	19	41350911-41384083	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 178.4;Late spermatids: 342.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 51.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 51.9"	"Cell line enhanced"	"Detected in many"		"HEL: 15.2;HSkMC: 16.2;TIME: 15.2"	"Low region specificity"	"Detected in all"							HPA053240	Uncertain					NA	NA					"HPA053240: AB_2682085"	"unprognostic (3.02e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (3.54e-5)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.52e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.06e-2)"	10.5	6.2	12.1	9.2	42.0	35.5	22.0	5.2	13.0	12.1	9.8	9.5	12.9	4.3	17.3	12.8	11.2	15.8	9.7	7.2	11.3	22.9	8.3	4.2	13.9	6.8	9.3	13.7	9.7	12.9	4.3	19.2	10.8	11.6	12.3	5.1	12.3	8.6	13.5	4.0	29.7	5.4	10.9	8.1	15.7	6.0	15.2	14.7	6.0	10.7	3.8	8.6	14.4	12.1	0.4	3.4	51.9	12.5	0.3	2.0	11.0	2.2	5.5	4.2	1.9	5.1	11.0	3.7	1.7	2.5	0.9	1.7	0.4	2.0	1.1	1.7	2.2	1.6	0.7	1.1	1.9	2.3	1.6	2.5	15.2	3.6	8.1	9.3	2.5	4.1	16.2	9.6	3.1	7.0	11.5	6.9	2.9	2.8	4.5	1.6	5.0	1.4	4.6	1.7	0.7	3.3	3.0	1.1	1.0	2.6	1.3	1.2	2.3	3.9	0.8	2.5	2.9	0.8	7.0	15.2	2.6	2.3	2.3	2.1	3.0	0.4	0.9	5.0	3.1	0.9	7.1	12.5	0.9	1.5	2.6	1.8	0.1	0.8	0.7	2.1	0.4	2.0	0.9	51.9	0.3	1.8	3.4	1.0	11.0	12.1	42.0	5.2	13.0	11.3	22.9	9.3	13.7	11.6	14.7	3.0	21.9	3.0	19.5	15.9	9.2	3.0	0.0	5.3	9.1	7.0	5.9	1.6	1.7	3.0	178.4	13.0	1.0	0.0	2.8	59.8	10.3	5.3	33.5	3.0	13.8	7.9	13.8	16.5	57.3	342.9	13.0	14.6	8.5	1.8	1.9	3.8	5.2	14.4	6.7	2.1	6.0	6.5	4.6	2.8	9.6	18.6	7.2	8.7	1.6	9.6
TMEM97	MAC30	ENSG00000109084	"Transmembrane protein 97"	Q5BJF2	17	28319095-28328685	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 228.7"	"Cell type enhanced"	"Detected in many"	7	"Cholangiocytes: 94.3;Exocrine glandular cells: 170.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044795, HPA076689"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"HPA044795: AB_10959306, HPA076689: "	"unprognostic (1.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-2)"	2.0	11.5	3.1	2.8	3.3	1.7	3.4	2.9	4.9	2.6	4.2	2.2	1.2	4.7	2.9	1.9	3.1	4.0	8.1	1.6	2.4	3.0	2.2	33.7	12.5	3.4	2.4	2.7	8.2	228.7	1.7	0.6	2.0	7.7	6.9	3.8	3.2	1.5	2.8	5.7	3.6	3.2	3.4	4.0	1.7	13.2	31.5	1.3	4.6	1.3	3.9	2.5	12.5	6.0	9.0	13.8	1.7	2.3	8.2	10.0	4.6	9.9	25.0	48.1	23.7	6.4	9.2	15.8	9.6	6.2	15.3	20.5	70.9	7.6	27.2	10.5	3.7	31.7	10.7	30.5	16.4	12.1	12.8	21.4	10.2	13.1	30.2	5.8	16.2	8.2	18.7	2.1	14.9	6.2	1.8	4.6	17.6	21.3	20.5	5.1	16.8	25.3	15.3	21.1	40.1	6.5	20.4	52.8	24.6	18.8	45.4	34.7	15.2	15.4	12.2	7.8	28.1	21.6	7.5	3.0	16.5	13.0	14.1	17.6	16.6	32.7	24.9	3.3	11.7	9.7	0.4	2.0	1.7	7.3	2.3	8.5	9.0	6.2	8.8	13.8	5.1	10.0	9.3	0.9	8.2	0.8	8.0	5.8	4.6	3.1	3.3	2.9	4.2	2.4	3.0	2.4	2.7	7.7	1.3	8.9	43.3	13.7	5.6	12.9	11.4	6.8	94.3	16.0	17.0	14.0	15.7	19.3	13.3	16.0	18.3	4.7	3.4	23.3	170.2	63.4	9.1	12.3	1.1	86.2	17.6	3.2	37.2	8.0	6.2	38.1	12.4	8.5	15.1	18.0	13.5	7.8	60.6	0.0	10.6	4.3	8.4	6.5	6.1	87.2	53.0	9.8	8.9	7.1	27.0	7.0
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"adrenal gland: 11.7;brain: 11.4"	"Cell type enhanced"	"Detected in some"	9	"Bipolar cells: 3.5;Distal tubular cells: 1.7;Spermatogonia: 3.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 6.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.3;EFO-21: 3.8;JURKAT: 15.0;SH-SY5Y: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	1.2	11.7	6.7	0.7	2.9	0.0	0.5	2.7	7.0	0.8	0.9	2.3	0.4	0.6	0.8	1.2	2.2	1.0	0.4	1.0	5.9	11.4	1.4	0.9	1.8	1.2	5.8	4.8	2.8	0.4	0.0	8.1	0.7	3.8	0.9	0.6	1.1	0.8	1.8	5.8	1.3	0.6	0.7	5.2	1.2	0.3	1.6	1.0	0.4	0.8	1.7	1.3	0.8	0.4	0.0	0.3	0.0	0.1	0.0	6.1	1.2	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.3	0.0	3.8	0.0	0.7	0.2	0.2	0.3	0.0	0.0	0.0	1.1	0.0	0.0	1.2	0.0	0.0	0.0	2.6	0.0	1.7	0.0	0.7	15.0	0.0	0.4	0.0	0.2	0.1	0.0	0.3	1.0	0.2	1.6	0.0	0.3	0.1	0.1	0.4	3.3	0.4	0.5	0.0	0.2	0.1	0.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.2	0.0	1.8	1.0	0.3	0.0	6.1	0.9	0.0	0.0	0.0	0.0	1.0	1.2	6.7	2.9	2.7	7.0	5.9	11.4	5.8	4.8	3.8	1.0	0.0	0.0	0.0	0.1	0.7	3.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.3	0.2	0.2	0.0	0.0	0.4	0.1	0.5	0.2	0.0	0.0	0.5	0.0	0.0	0.6	0.0	1.0	0.6	0.0	0.0	0.0	0.0	1.3	0.7	0.0	0.4	0.0	0.4	0.0	1.4	1.4	3.1	0.6	0.1	0.0	0.0	0.1
TMTC3	"FLJ90492, SMILE"	ENSG00000139324	"Transmembrane and tetratricopeptide repeat containing 3"	Q6ZXV5	12	88142296-88199887	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Transferase	"Disease mutation, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038550	Approved					NA	NA					"HPA038550: AB_10672715"	"unprognostic (1.05e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	12.4	7.8	9.9	6.3	9.4	2.8	14.0	15.1	12.0	13.8	9.6	5.7	10.7	8.5	12.0	9.2	18.4	8.1	9.8	7.4	8.3	9.5	14.0	18.1	8.8	4.6	8.3	7.9	9.7	6.6	12.6	18.3	18.5	10.1	13.0	8.3	8.3	11.0	11.4	5.1	20.4	10.5	15.3	9.5	6.6	8.2	7.4	7.7	6.1	10.7	10.5	7.4	13.2	12.2	4.1	1.7	9.5	2.7	2.2	4.8	1.4	7.3	7.9	7.3	6.8	17.1	15.2	13.0	15.4	14.9	9.2	9.9	11.4	5.2	2.2	2.9	14.3	5.6	16.4	7.7	12.7	15.5	1.3	5.8	2.2	5.8	5.2	8.9	2.3	1.5	12.9	6.9	17.7	7.0	9.3	14.2	1.9	4.8	0.8	10.2	4.4	1.6	3.0	5.6	2.7	4.2	1.4	15.8	2.2	8.0	12.0	6.2	6.1	12.9	9.1	4.0	8.1	14.8	2.4	14.9	12.8	7.1	11.3	7.6	2.6	3.3	2.7	4.0	2.8	9.4	9.5	2.5	4.0	3.6	2.2	4.4	4.1	4.1	2.8	1.7	3.7	4.8	3.9	2.4	2.2	2.7	1.7	3.0	1.4	9.9	9.4	15.1	12.0	8.3	9.5	8.3	7.9	10.1	7.7	11.9	5.1	6.4	21.6	30.3	12.8	10.2	0.0	26.8	11.4	7.0	25.5	23.6	3.3	12.5	20.6	12.7	5.6	0.0	9.5	15.8	20.8	14.5	9.2	16.3	6.8	12.7	3.5	19.0	4.1	14.6	18.7	3.9	8.5	1.8	6.2	9.7	10.0	5.8	18.4	10.2	23.5	19.4	17.6	10.9	8.4	35.4	14.9	4.4	6.6	9.8
TMUB1	"C7orf21, SB144"	ENSG00000164897	"Transmembrane and ubiquitin like domain containing 1"	Q9BVT8	7	151081080-151083546	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029429	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA029429: AB_10601825"	"unprognostic (8.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	10.6	15.2	10.3	16.1	11.0	13.7	17.8	9.1	16.0	9.7	27.5	9.0	17.0	31.8	10.4	15.4	21.6	9.6	18.0	17.3	10.6	9.6	25.5	35.5	12.9	15.6	10.2	10.0	13.1	51.5	9.5	21.1	18.9	8.3	16.1	6.0	12.7	29.6	12.9	33.8	15.1	39.2	12.8	8.7	16.1	24.0	11.5	8.5	23.9	23.6	12.9	19.1	18.7	11.8	8.0	4.2	18.2	3.6	3.1	9.5	1.8	24.4	22.1	5.2	26.8	3.4	4.2	19.5	10.0	8.5	9.0	10.0	19.0	29.9	16.4	21.6	4.9	11.6	16.7	5.8	8.9	2.0	30.0	20.5	7.0	20.5	28.8	8.8	8.6	24.8	6.5	7.4	7.5	2.0	6.8	6.6	17.0	43.7	22.4	4.0	39.5	28.7	37.2	22.3	14.4	13.4	18.0	6.6	30.3	9.3	19.0	19.1	21.3	8.1	12.5	13.1	3.2	9.8	12.0	8.0	11.4	8.4	14.3	16.5	35.3	19.4	11.2	26.4	16.2	14.4	3.5	2.7	18.2	5.4	3.6	4.7	4.4	8.0	5.8	2.8	8.0	7.8	4.5	4.7	3.1	2.2	4.2	9.5	1.8	10.3	11.0	9.1	16.0	10.6	9.6	10.2	10.0	8.3	8.5	6.0	5.6	49.1	25.7	23.5	14.7	8.1	22.9	0.0	0.0	21.0	13.7	83.6	29.9	61.9	8.5	23.9	135.7	0.0	95.6	50.7	20.3	31.1	16.1	44.1	39.1	19.1	39.6	21.5	20.8	2.5	11.5	25.8	30.4	58.7	75.9	22.0	80.5	108.7	15.6	34.6	14.8	38.8	29.9	25.1	10.6	32.2	79.1	52.4	64.5	33.0
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103123442-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	12	"monocytes: 414.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 25.9"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"RT4: 128.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: AB_2673552"	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favorable (7.17e-5)"	27.3	17.0	3.8	58.2	5.7	20.1	19.3	2.5	3.6	23.5	12.9	2.8	4.7	8.1	16.7	18.7	35.5	14.3	30.9	12.7	2.9	3.6	18.8	13.6	32.0	17.9	4.6	3.0	9.7	9.0	17.4	3.5	33.0	6.1	21.7	6.1	16.3	25.1	7.1	12.5	13.2	11.3	28.0	3.8	35.9	8.3	13.0	2.9	11.0	8.5	31.4	48.6	39.8	16.3	0.1	5.0	25.9	9.8	0.1	0.1	1.9	5.5	27.4	0.2	0.1	1.8	7.9	9.2	1.6	7.0	4.4	1.5	0.3	24.9	0.0	20.5	8.0	23.4	17.7	1.9	0.0	2.1	0.9	0.1	2.5	19.1	0.1	3.4	1.2	3.4	3.0	0.2	1.4	0.0	1.7	2.3	1.3	2.5	6.0	0.6	0.5	0.0	1.9	1.6	3.2	2.2	1.1	3.1	4.0	14.0	128.9	0.2	0.3	25.2	8.8	0.3	1.0	14.2	8.1	4.7	0.9	2.4	5.1	5.0	5.4	0.4	0.1	6.7	5.6	2.6	2.5	8.8	4.6	0.0	9.8	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.1	25.9	0.1	6.9	0.2	0.0	1.9	3.8	5.7	2.5	3.6	2.9	3.6	4.6	3.0	6.1	2.9	0.0	33.8	0.5	27.9	25.1	0.6	12.5	40.8	25.4	30.7	26.2	0.0	0.8	0.0	129.0	29.4	40.9	0.4	0.0	39.8	58.7	62.7	91.7	33.4	6.4	46.3	0.0	16.6	22.1	116.0	36.8	7.8	125.1	28.7	414.8	0.0	8.0	86.0	6.5	2.1	5.5	0.4	19.4	41.0	1.1	2.8	29.2	4.0	2.5	0.2	83.4
TNKS	"PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1"	ENSG00000173273	Tankyrase	O95271	8	9555914-9782346	"Enzymes, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	7	"Early spermatids: 118.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025690	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA025690: AB_10602249"	"unprognostic (2.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.45e-3)"	"unprognostic (8.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.01e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.10e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.36e-2)"	9.1	13.4	17.8	8.7	19.6	14.6	14.0	26.5	22.3	18.1	8.9	17.0	12.5	8.5	14.9	25.3	7.7	11.9	8.9	9.5	18.6	17.9	9.0	9.1	10.3	12.9	28.7	17.2	19.2	10.2	23.9	20.0	11.0	20.1	11.5	10.0	10.9	9.4	11.7	22.1	15.6	9.8	11.0	21.0	8.7	10.1	26.3	21.8	15.6	13.7	4.4	11.7	10.8	13.6	6.8	3.6	7.4	2.8	2.9	4.8	1.2	6.1	8.1	20.8	12.5	13.2	17.7	7.7	9.5	10.8	7.7	8.8	4.8	4.9	13.2	3.9	9.3	10.4	6.5	11.8	8.9	11.2	3.4	6.1	9.2	7.4	10.8	11.9	4.7	5.7	12.5	10.8	8.0	15.8	12.6	10.4	10.3	8.6	14.1	14.2	4.0	11.9	7.2	13.6	6.7	4.7	9.6	12.9	3.8	9.3	12.5	21.2	15.6	7.4	7.1	13.4	13.2	4.7	7.1	13.9	12.7	7.8	8.6	7.0	4.9	7.9	9.4	13.7	6.7	12.2	4.8	2.3	1.8	4.4	2.2	2.4	4.2	3.5	4.2	2.8	6.8	4.2	4.8	7.4	2.9	2.8	3.6	1.7	1.2	17.8	19.6	26.5	22.3	18.6	17.9	28.7	17.2	20.1	21.8	14.9	9.4	11.0	11.2	10.2	32.0	14.3	17.8	26.8	9.1	8.7	13.7	9.0	1.7	9.8	118.1	10.9	9.0	0.0	7.4	7.7	14.9	11.9	9.3	15.8	6.2	39.7	13.3	20.9	9.4	58.4	15.5	7.3	11.8	1.8	13.5	18.4	11.2	13.1	17.0	6.0	36.2	0.0	9.9	30.7	13.5	13.6	10.3	11.5	11.7	10.2
TNPO1	"IPO2, KPNB2, MIP, MIP1, TRN"	ENSG00000083312	"Transportin 1"	Q92973	5	72816312-72916733	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016325	Approved		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		47000	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"CAB016325: AB_675691"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (6.55e-5)"	"unprognostic (8.93e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.49e-2)"	23.9	29.3	20.1	26.2	24.5	20.7	52.3	18.5	21.9	18.5	21.6	15.7	32.3	16.4	25.4	25.4	26.5	17.9	22.8	21.9	22.5	16.5	26.2	20.8	24.2	22.4	22.9	16.4	22.5	28.9	54.1	36.5	34.9	27.0	21.2	24.4	19.4	26.1	35.3	38.0	15.9	19.9	32.0	31.2	21.7	25.3	30.9	20.8	25.2	32.6	18.0	23.6	27.5	30.8	11.1	10.7	8.9	13.3	14.1	18.3	10.6	21.8	28.8	42.0	25.1	31.3	38.9	24.8	25.9	35.4	25.9	26.6	24.5	18.8	25.6	17.8	40.7	30.9	16.0	28.6	23.1	37.4	14.8	15.8	15.8	38.3	12.4	21.2	17.4	11.6	28.1	16.7	34.6	49.2	18.7	62.7	10.8	23.5	13.7	73.4	10.4	15.8	6.6	22.6	8.1	22.1	19.2	37.8	16.0	15.9	29.3	21.8	22.5	41.7	13.4	30.6	24.1	16.5	14.3	59.4	22.0	25.8	33.1	29.0	12.6	19.5	34.2	17.4	17.8	40.2	7.3	8.3	6.9	13.4	11.5	18.3	11.1	12.2	10.0	10.7	11.0	13.4	13.4	8.9	14.1	13.3	5.0	8.1	10.6	20.1	24.5	18.5	21.9	22.5	16.5	22.9	16.4	27.0	20.8	11.9	20.6	52.7	32.3	52.5	99.6	47.6	35.7	16.0	21.6	26.2	92.3	65.2	14.9	34.0	73.5	57.3	27.7	23.3	35.6	40.7	52.1	43.3	20.9	35.0	37.7	84.2	51.1	55.3	37.6	46.9	43.1	33.6	23.6	44.1	45.5	134.9	48.6	21.0	56.6	30.6	174.6	25.8	39.2	47.7	78.6	46.5	109.8	24.9	30.8	51.9
TNPO2	"FLJ12155, IPO3, KPNB2B, TRN2"	ENSG00000105576	"Transportin 2"	O14787	19	12699194-12724011	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 94.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046446, HPA071498"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Nucleoplasm, Nucleoli"		"CAB046446: AB_10603392, HPA071498: AB_2686405"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (2.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.76e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-3)"	"unprognostic (7.63e-2)"	21.7	19.8	37.1	16.0	35.7	17.8	13.5	33.1	44.7	17.9	13.9	23.2	12.7	13.4	20.7	20.9	22.9	22.4	15.9	20.0	31.1	24.9	14.3	10.1	13.7	16.6	24.8	36.6	32.9	16.0	26.6	19.1	16.1	22.2	16.8	15.9	18.2	15.1	20.0	15.2	36.6	12.5	23.3	25.2	15.3	12.9	24.1	20.9	14.9	17.8	9.9	17.8	18.9	14.7	1.6	4.3	2.6	1.2	0.4	3.3	0.7	17.6	13.5	20.8	26.5	12.7	16.8	13.5	20.4	13.5	29.6	20.9	18.4	9.6	12.0	16.0	17.2	8.3	23.6	36.8	20.2	16.5	14.8	29.5	18.5	21.2	22.3	14.3	32.6	17.8	14.9	16.0	19.6	20.9	19.2	13.8	24.4	28.7	11.5	16.3	30.6	27.3	22.5	24.1	13.1	40.8	26.3	16.2	22.0	17.5	12.9	51.0	25.3	16.6	21.1	10.1	14.7	14.7	11.6	13.8	45.5	12.0	24.3	29.9	22.9	22.0	20.5	13.5	29.7	16.1	0.6	0.9	0.3	2.1	0.8	3.0	1.5	1.5	1.7	1.2	1.6	2.7	3.3	2.6	0.4	1.2	4.3	0.5	0.7	37.1	35.7	33.1	42.1	31.1	24.9	24.8	36.6	22.2	20.9	6.0	19.9	11.8	8.5	27.5	38.9	15.9	17.8	6.7	9.1	21.0	94.2	9.1	5.0	8.3	9.5	17.5	10.5	0.0	7.3	5.6	14.7	12.6	3.5	15.3	8.9	54.0	22.0	18.4	11.3	15.4	28.7	9.5	8.5	10.8	17.0	24.7	13.1	5.8	30.4	14.6	32.2	6.5	17.8	24.7	10.0	36.3	12.1	11.5	15.0	8.0
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA			Mitochondria	Cytosol	"HPA036231: AB_2675010, HPA036232: AB_2675011"	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	16.0	25.3	13.6	16.9	15.6	19.7	20.6	17.7	27.0	10.2	20.5	10.9	10.1	20.0	11.8	10.5	22.9	13.5	11.4	21.5	15.3	14.9	16.5	36.9	15.1	22.3	15.6	13.3	18.2	19.2	16.2	11.9	15.3	20.2	11.2	16.7	11.5	11.5	13.5	32.3	14.7	15.1	11.6	11.9	12.7	12.6	12.3	8.8	14.2	11.6	18.6	15.6	10.9	12.5	7.3	7.0	5.1	6.8	4.7	8.7	2.0	30.8	52.3	19.1	26.3	7.1	6.4	24.3	22.2	12.3	42.1	30.2	56.8	21.4	45.6	23.9	14.6	23.9	33.4	49.5	31.9	19.2	17.6	44.9	30.6	20.5	44.7	15.2	39.0	27.5	10.1	18.1	32.6	20.7	7.9	14.5	22.0	48.2	15.9	16.4	38.5	42.3	28.7	33.4	44.1	32.6	43.3	21.7	26.5	19.3	42.9	29.8	19.1	23.6	49.8	15.8	11.1	16.7	39.6	11.9	29.2	29.6	20.3	57.8	17.2	35.6	44.7	21.6	41.5	30.7	0.7	5.5	5.1	4.7	6.8	5.2	7.3	4.5	6.5	7.0	4.2	7.9	8.7	1.1	4.7	5.9	6.9	4.8	2.0	13.6	15.6	17.7	27.0	15.3	14.9	15.6	13.3	20.2	8.8	14.9	5.3	28.9	52.0	77.6	63.2	14.2	30.6	0.0	10.3	29.6	27.5	84.7	33.2	54.9	9.5	29.3	31.6	23.3	33.2	145.9	33.4	37.4	19.5	20.8	91.8	66.7	28.2	11.1	20.4	5.6	24.7	36.1	37.1	39.7	43.5	43.9	41.3	28.8	23.0	28.3	55.9	19.4	40.6	53.5	60.1	78.2	61.0	26.6	93.2	64.9
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687550	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease mutation, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 102.6"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876"	Enhanced		Enhanced	Nucleoplasm		Yes	No			Nucleoplasm		"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, HPA051244: AB_2681403, HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	18.5	11.1	6.0	28.6	6.8	9.0	17.5	2.5	7.3	18.5	14.6	6.8	8.3	9.7	20.3	15.0	25.3	16.7	22.6	8.1	5.0	3.8	10.6	20.8	11.2	26.0	6.6	3.1	33.8	13.8	4.9	6.0	22.8	6.9	16.5	14.5	9.9	15.3	16.1	12.5	24.6	14.0	12.8	6.2	24.2	12.0	14.1	6.9	102.6	13.2	23.5	31.2	16.9	15.0	15.2	19.6	2.2	14.1	11.0	11.3	8.2	19.4	36.0	19.7	14.2	9.2	11.0	20.8	7.0	15.8	19.4	24.6	1.0	10.0	45.8	31.9	13.8	18.9	43.0	28.5	19.3	18.2	10.2	19.1	18.5	20.2	17.1	27.7	0.4	9.6	13.9	22.5	9.4	26.1	11.2	19.0	6.2	0.9	1.8	9.9	34.6	31.1	22.7	19.8	2.5	0.7	60.4	13.9	15.9	14.5	21.6	11.7	20.3	23.1	15.6	5.9	10.2	27.0	1.7	24.6	23.3	7.7	0.3	11.8	12.1	8.8	19.7	6.0	2.4	19.6	0.8	13.3	2.2	9.1	14.1	11.1	15.2	9.4	10.2	19.6	14.5	9.9	10.8	1.7	11.0	11.9	17.9	11.3	8.2	6.0	6.8	2.5	6.4	5.0	3.8	6.6	3.1	6.9	6.9	8.9	10.9	24.4	8.9	25.4	2.3	2.0	22.9	8.1	12.5	19.2	0.0	30.5	8.3	19.1	7.8	19.6	10.2	0.0	15.7	35.3	17.1	11.3	1.1	16.1	21.7	0.0	29.6	20.3	27.8	2.1	21.3	14.4	11.8	15.4	37.2	6.1	19.5	0.0	15.9	6.5	2.2	12.9	20.1	0.5	4.2	28.7	18.8	15.7	50.6	7.4
TPCN1	"FLJ20612, KIAA1169, TPC1"	ENSG00000186815	"Two pore segment channel 1"	Q9ULQ1	12	113221050-113298585	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 49.6;hTERT-RPE1: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039757	Approved					NA	NA					"HPA039757: AB_10795156"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.47e-3)"	18.1	28.6	16.0	15.8	24.8	9.7	17.7	67.8	28.1	19.1	19.1	30.8	23.6	17.0	23.9	19.7	21.8	19.2	25.3	46.5	18.0	11.4	31.2	15.2	18.6	13.6	34.4	17.9	25.6	30.3	28.5	25.0	16.4	28.4	16.3	17.5	26.7	29.9	28.7	28.4	13.2	19.4	16.9	22.1	18.0	11.3	9.7	27.8	5.4	32.5	16.1	24.8	17.4	15.5	5.5	9.3	5.0	13.7	8.6	3.4	3.8	4.8	14.8	1.7	2.1	13.3	15.1	5.0	6.9	49.6	3.7	4.4	10.9	16.9	11.2	10.5	7.1	12.1	6.1	3.9	12.4	5.0	1.3	3.0	4.2	7.5	6.0	17.3	1.4	9.5	14.3	6.3	7.2	12.7	41.5	5.6	3.2	4.7	4.0	4.5	5.9	0.4	22.1	2.8	6.0	7.5	0.8	2.1	21.8	11.9	17.9	2.1	3.3	5.6	14.5	5.8	3.6	4.6	13.5	2.3	5.5	2.7	7.5	4.3	6.7	4.0	9.7	16.2	3.5	4.1	5.0	13.7	1.2	1.7	2.3	2.1	3.5	2.4	2.3	9.3	5.5	3.4	2.1	0.5	8.6	0.3	4.9	1.1	3.8	16.0	24.8	67.8	28.1	18.0	11.4	34.4	17.9	28.4	27.8	8.9	18.7	3.7	4.9	4.0	16.8	28.8	12.7	12.0	9.1	26.2	15.7	5.9	1.7	11.7	10.3	4.4	26.0	0.0	15.9	2.6	8.7	9.8	31.1	17.1	18.6	47.7	27.6	19.6	17.3	8.7	19.8	9.6	6.8	4.6	24.8	20.4	10.4	19.9	20.1	17.5	13.4	0.0	10.3	3.0	2.0	3.4	5.5	6.1	15.8	14.8
TPCN2	TPC2	ENSG00000162341	"Two pore segment channel 2"	Q8NHX9	11	69048897-69162440	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Melanocytes: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 21.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA016561, HPA027080"	Supported		Approved	Nucleoli		NA	NA			Nucleoli		"HPA016561: AB_1858207, HPA027080: AB_10600917"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (7.60e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.88e-2)"	11.0	6.2	6.3	8.7	11.1	9.2	9.4	14.5	14.0	18.0	18.0	9.2	11.3	15.0	22.4	12.4	11.2	13.8	12.1	7.5	6.2	4.9	11.6	15.7	8.7	10.4	6.0	7.7	12.1	6.8	6.4	7.2	7.1	8.8	13.1	7.4	20.7	8.1	17.8	8.1	16.1	13.7	15.6	6.0	10.9	11.4	8.5	4.9	6.4	7.3	7.4	10.1	11.0	11.2	2.0	7.5	7.1	9.9	6.9	3.2	3.6	3.4	8.9	2.7	4.2	2.6	2.1	11.7	3.9	4.7	4.7	2.8	7.6	10.9	4.5	5.6	4.8	3.7	8.0	2.2	4.4	1.4	2.8	2.3	6.1	9.5	2.5	2.5	4.3	8.3	3.3	2.3	2.4	2.5	1.9	3.2	7.4	2.9	21.1	2.9	8.1	3.6	10.3	3.2	10.1	3.2	3.4	2.2	5.5	4.7	5.6	2.4	3.2	4.5	10.2	15.7	4.1	6.6	5.7	2.9	3.2	4.7	5.9	3.6	5.5	2.3	2.3	5.2	4.6	6.7	4.3	9.8	2.9	1.0	9.8	0.9	2.0	2.1	2.1	7.5	1.5	1.7	2.0	7.1	6.9	9.9	3.2	3.2	3.6	6.3	11.1	14.5	14.0	6.2	4.9	6.0	7.7	8.8	4.9	8.9	1.0	7.5	2.1	3.5	1.5	3.2	7.6	0.0	1.2	12.2	2.0	2.3	14.9	6.0	16.2	2.9	6.2	23.3	7.6	3.7	3.5	1.2	2.3	12.9	10.5	0.0	0.0	6.2	15.4	1.7	5.8	7.4	33.7	4.6	2.9	2.5	3.7	3.5	6.3	9.6	4.2	6.5	5.9	1.9	3.8	3.0	1.6	2.6	3.4	1.4
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	7	"Spermatocytes: 640.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	21.5	17.3	14.3	26.7	21.3	21.6	19.0	24.4	17.1	21.7	24.2	7.3	27.1	12.9	20.8	23.5	18.5	16.9	16.8	28.3	13.8	10.5	18.7	20.6	17.9	20.4	14.1	16.6	24.7	17.8	44.2	29.1	29.7	15.1	22.2	17.7	9.1	20.2	30.1	33.1	20.5	21.1	21.2	16.4	26.1	18.8	35.0	17.8	39.5	21.7	19.7	21.4	25.1	19.1	19.1	19.8	50.3	15.2	10.7	16.9	5.2	21.6	18.7	28.1	16.3	22.6	20.2	29.6	24.9	16.7	17.6	16.4	28.2	18.5	25.4	19.3	16.9	12.1	28.4	21.1	17.0	21.8	19.0	23.1	33.8	30.3	19.7	12.1	36.0	22.2	15.4	10.3	26.5	20.6	16.3	20.7	14.6	40.7	22.9	18.7	18.7	17.9	9.6	30.9	19.8	6.5	21.2	22.0	22.0	14.4	26.1	15.3	24.3	29.0	19.3	15.6	40.1	21.4	23.0	29.1	17.6	16.8	19.4	30.1	25.1	29.3	23.2	11.3	18.4	15.7	29.5	12.0	21.9	15.8	10.0	13.3	15.2	13.8	12.7	6.8	19.1	16.9	11.7	50.3	10.7	15.2	19.8	15.3	5.2	14.3	21.3	24.4	17.1	13.8	10.5	14.1	16.6	15.1	17.8	202.5	98.3	78.9	89.1	89.9	87.4	160.6	35.7	133.8	120.6	55.8	74.6	117.3	19.9	88.2	106.7	100.9	41.3	23.3	65.3	89.1	87.0	62.9	77.5	34.3	63.0	93.8	65.1	57.1	60.2	23.6	116.2	74.5	52.3	147.9	49.2	93.4	74.7	52.6	110.3	23.7	104.0	129.4	82.9	640.0	239.5	86.7	126.1	97.0	64.6	75.6
TRDN		ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1"	"Group enriched"	"Detected in some"	21	"Cardiomyocytes: 855.7;Muller glia cells: 805.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 2.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 2.9"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.6;K-562: 1.8;MCF7: 6.1;SCLC-21H: 1.2;SK-BR-3: 2.0"	"Region enriched"	"Detected in single"	10	"olfactory region: 13.6"					"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	3.8	0.4	0.4	0.0	0.5	0.0	0.3	0.2	0.2	0.3	0.1	0.0	0.7	0.1	0.3	9.2	3.0	1.9	0.1	52.8	1.6	1.3	0.1	0.1	0.1	0.1	1.6	0.1	1.5	0.1	0.0	3.2	0.1	1.3	1.9	0.1	1.3	2.0	0.2	215.5	0.1	0.1	0.2	3.4	0.1	0.1	0.7	0.5	0.0	1.2	80.1	1.6	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.2	0.0	6.1	0.0	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	2.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.2	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.2	0.2	1.6	1.3	1.6	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.0	5.8	855.7	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	40.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	22.9	12.0	0.0	1.7	0.0	0.0	805.6	0.0	0.0	10.6	0.0	13.4	0.0	0.8	0.1	0.5	0.0	0.0	0.0	0.0	0.0
TRHR		ENSG00000174417	"Thyrotropin releasing hormone receptor"	P34981	8	109086621-109119584	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Congenital hypothyroidism, Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 1.0;pituitary gland: 3.3;thyroid gland: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 1.6;SH-SY5Y: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA055162	Approved					NA	NA					"HPA055162: AB_2732592"										"unprognostic (1.92e-2)"				"unprognostic (8.58e-2)"		"unprognostic (1.17e-1)"		0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	1.0	0.0	0.2			0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	3.3	0.0		0.0	0.3		0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0			1.6		0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.2	0.3	0.2	0.3	0.6	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIAP1	"HSPC132, MDM35, P53CSV, WF-1"	ENSG00000170855	"TP53 regulated inhibitor of apoptosis 1"	O43715	12	120443961-120446412	"Predicted intracellular proteins, Transporters"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Cytotrophoblasts: 113.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053640	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Nucleoplasm, Mitochondria"		"HPA053640: AB_2682213"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.87e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.97e-2)"	11.7	16.8	10.6	12.5	13.1	14.6	20.6	9.1	12.4	9.4	12.5	8.0	12.0	10.0	9.9	11.6	15.4	9.3	12.7	17.3	13.6	8.3	12.5	34.5	14.2	13.6	15.5	11.9	7.7	36.5	5.7	8.6	17.8	13.5	12.4	17.0	6.8	19.3	8.6	29.1	16.8	12.1	11.1	10.4	12.3	12.3	11.2	11.6	11.7	11.2	21.5	13.9	12.0	10.0	17.4	28.2	9.0	24.8	22.2	25.5	19.6	15.9	21.9	20.1	13.7	17.5	27.1	48.2	21.0	15.0	18.7	15.5	18.2	8.9	31.7	17.9	17.1	7.5	11.0	23.3	34.7	19.8	14.0	26.0	19.2	15.3	47.8	26.1	32.2	14.9	27.9	43.8	18.3	26.3	18.8	38.6	17.6	30.7	8.2	27.2	20.1	24.1	43.5	28.7	19.6	17.8	20.1	19.0	32.8	24.0	17.9	19.8	13.0	24.2	8.3	17.9	33.2	27.8	18.9	21.8	12.1	18.2	12.1	12.7	21.2	33.4	34.0	18.5	25.0	21.0	9.0	22.0	8.0	20.7	24.8	24.9	17.4	20.3	19.7	28.2	15.8	25.5	22.0	1.9	22.2	16.5	25.4	17.6	19.6	10.6	13.1	9.1	12.4	13.6	8.3	15.5	11.9	13.5	11.6	3.0	14.6	36.3	21.1	45.4	8.2	10.2	45.9	17.4	6.8	7.0	5.9	113.6	56.3	43.3	5.9	25.3	16.1	0.0	43.5	66.9	27.2	25.9	17.3	49.7	46.9	3.2	21.2	22.7	22.8	3.9	15.3	20.8	37.1	53.3	21.2	9.4	40.3	14.0	17.3	36.6	9.3	19.4	26.9	34.9	34.6	62.4	63.0	29.9	38.3	23.3
TRIM72	MG53	ENSG00000177238	"Tripartite motif containing 72"	Q6ZMU5	16	31214021-31231537	"Predicted intracellular proteins, Transporters"	"Exocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 71.6;tongue: 37.7"	"Cell type enhanced"	"Detected in some"	10	"Alveolar cells type 1: 3.0;Alveolar cells type 2: 6.7;Club cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	12	"cerebellum: 3.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 4.8;LHCN-M2: 8.9;RH-30: 23.1;U-266/70: 14.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA054909: AB_2682639"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-10)"	"unprognostic (7.70e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.30e-4)"	2.3	0.1	0.1	0.1	0.2	0.3	0.1	3.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	5.5	1.8	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.8	0.0	0.0	1.0	0.0	71.6	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.2	37.7	1.9	0.0	0.0	2.0	1.9	4.9	1.3	2.1	1.3	0.4	0.1	0.2	0.2	0.3	0.1	0.1	0.4	0.2	0.1	0.0	0.0	0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.7	0.3	0.2	4.8	0.2	1.0	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.5	8.9	0.2	0.1	0.4	0.2	0.1	0.3	0.3	23.1	3.0	0.0	0.3	1.9	0.2	0.2	0.3	0.1	0.3	0.2	2.0	0.1	0.2	0.3	0.2	0.1	14.4	1.2	0.2	0.2	0.4	0.2	4.5	1.3	1.5	1.1	1.2	1.0	1.3	1.0	0.9	0.8	2.0	1.3	1.3	4.9	2.1	1.2	1.9	0.8	0.4	0.1	0.2	3.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	6.7	0.0	2.0	0.1	0.8	2.6	0.0	0.0	4.5	0.0	2.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.2	1.4	1.1	0.0	0.2	0.0	0.0	0.6	1.9	0.0	0.0	0.6	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.5	1.6
TRPA1	ANKTM1	ENSG00000104321	"Transient receptor potential cation channel subfamily A member 1"	O75762	8	72019917-72075617	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 20.8;urinary bladder: 20.1;vagina: 12.1"	"Group enriched"	"Detected in some"	10	"Early spermatids: 6.4;Mucus-secreting cells: 5.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"HHSteC: 24.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.14e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.11e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.16e-4)"	"unprognostic (2.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.90e-1)"	0.3	0.2	0.2	9.1	0.2	0.0	0.2	0.2	0.4	0.4	16.8	0.3	0.0	4.8	0.2	0.3	2.2	0.2	5.7	0.3	0.2	0.2	0.2	0.2	0.3	0.8	0.3	0.0	0.4	0.2	0.0	0.2	0.3	0.1	4.7	7.5	0.0	0.2	0.0	0.2	0.2	20.8	3.8	0.2	0.4	7.9	0.4	0.0	0.6	0.2	0.3	1.4	20.1	12.1	0.5	0.6	0.1	1.1	0.3	2.6	0.2	0.0	2.5	0.7	0.0	0.0	0.1	0.0	0.3	2.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.8	0.4	1.4	0.1	0.0	0.5	0.0	24.5	0.0	0.2	1.6	0.0	1.1	0.2	5.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	2.4	0.2	0.0	0.3	0.0	0.1	3.8	1.1	0.0	0.3	0.3	0.0	1.8	0.0	1.7	0.0	0.0	0.0	0.3	0.0	1.1	0.5	0.5	2.6	0.0	0.5	0.0	0.4	0.1	0.3	1.1	0.6	1.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0
TRPC1	HTRP-1	ENSG00000144935	"Transient receptor potential cation channel subfamily C member 1"	P48995	3	142724074-142807888	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 18.1;Cone photoreceptor cells: 15.7;Horizontal cells: 12.7;Rod photoreceptor cells: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009387, HPA021130"	Supported		Approved	Vesicles		NA	NA			Vesicles		"CAB009387: AB_2240941, HPA021130: AB_1858361"	"unprognostic (1.66e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.37e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (1.44e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.49e-2)"	6.8	8.3	8.5	3.5	13.4	1.2	6.8	23.0	15.9	17.7	8.3	11.4	4.3	2.6	20.4	9.2	6.5	10.1	9.1	15.9	10.0	11.4	6.0	2.0	5.4	3.3	9.4	12.2	24.5	3.0	12.2	14.4	6.1	14.7	12.3	4.9	13.0	3.7	13.6	2.4	6.2	4.7	17.6	11.4	5.0	4.4	8.0	7.9	0.4	8.9	3.9	2.3	9.3	8.9	0.6	0.0	0.0	0.0	0.3	1.3	0.3	3.2	4.6	8.4	1.0	7.6	18.7	3.8	5.1	8.1	6.5	9.6	1.4	0.9	0.0	1.7	5.3	11.4	0.3	2.3	2.4	9.4	0.8	3.4	5.1	1.9	2.2	3.1	0.2	0.0	9.0	2.4	6.0	7.3	11.0	3.7	0.0	0.2	0.0	9.1	2.0	0.3	0.4	4.7	0.0	2.4	0.0	4.0	0.0	4.5	0.1	5.4	4.0	6.3	0.0	1.1	8.0	2.6	0.0	3.4	8.2	1.3	11.0	6.9	3.4	1.4	1.6	6.2	0.1	2.4	0.0	0.0	0.0	0.2	0.0	1.2	0.6	1.3	0.6	0.0	0.3	1.2	1.3	0.0	0.3	0.0	0.0	0.0	0.3	8.5	13.4	23.0	15.9	10.0	11.4	9.4	12.2	14.7	7.9	3.0	0.3	0.0	2.2	2.6	18.1	10.1	0.0	2.7	0.0	5.2	15.7	0.1	0.0	0.2	2.1	2.9	0.0	0.0	0.2	0.2	7.2	0.8	0.0	0.0	0.1	12.7	1.7	4.3	0.0	1.7	7.8	0.0	1.7	0.0	0.0	6.8	0.1	0.0	10.3	0.3	15.0	0.0	9.0	10.3	2.1	1.0	0.2	0.0	0.0	0.2
TRPC3		ENSG00000138741	"Transient receptor potential cation channel subfamily C member 3"	Q13507	4	121879027-121951754	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 9.3;pituitary gland: 12.0;smooth muscle: 9.4"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.7;HEL: 5.6;Karpas-707: 5.9;U-2 OS: 3.7;U-251 MG: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.12e-3)"	"unprognostic (9.80e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.42e-3)"	1.4	0.4	1.8	0.7	9.3	0.3	0.5	5.8	7.4	3.3	0.8	1.7	0.8	0.8	1.6	1.2	0.6	1.1	7.3	0.5	1.8	2.3	0.7	0.5	2.9	0.5	2.3	1.9	0.8	0.2	0.6	12.0	4.2	7.3	1.1	0.8	0.3	0.8	2.5	0.6	0.5	1.2	9.4	1.1	1.0	0.9	1.6	3.6	0.0	0.6	0.0	0.4	3.6	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	1.0	1.5	0.6	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.9	0.0	0.1	0.0	3.7	5.6	0.1	0.0	0.2	1.5	0.5	0.6	0.0	0.1	0.0	2.5	0.0	0.2	0.0	5.9	1.3	0.0	1.6	0.0	1.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	3.7	0.0	3.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	9.3	5.8	7.4	1.8	2.3	2.3	1.9	7.3	3.6	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	28.1	0.0	0.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0
TRPC4	"HTRP4, TRP4"	ENSG00000133107	"Transient receptor potential cation channel subfamily C member 4"	Q9UBN4	13	37636636-37870425	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.0;smooth muscle: 17.2"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 2.4;Smooth muscle cells: 1.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.2;BJ: 16.7;BJ hTERT+ SV40 Large T+: 7.2;fHDF/TERT166: 15.9;U-2197: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.52e-4)"	"unprognostic (9.99e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-6)"	"unprognostic (3.73e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-2)"	1.3	0.8	4.6	1.2	4.0	0.2	0.6	2.1	4.0	5.5	4.1	0.6	6.9	0.8	31.0	2.1	0.4	1.9	4.5	1.9	4.8	2.1	3.0	0.5	4.2	0.3	2.5	0.4	3.8	1.8	0.7	0.5	4.6	3.9	9.5	1.1	0.1	0.5	12.6	0.4	0.5	1.6	17.2	2.5	0.5	3.6	0.8	2.5	0.0	1.1	0.0	0.3	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	1.1	2.4	0.0	16.7	2.3	7.2	3.8	0.0	0.2	0.0	0.0	15.9	2.4	0.0	0.1	0.0	3.6	0.0	0.1	0.0	0.3	0.0	2.8	0.0	0.0	1.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	7.6	1.5	4.0	1.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.0	2.1	4.0	4.8	2.1	2.5	0.4	3.9	2.5	0.0	0.0	0.0	0.4	0.0	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TRPC5	PPP1R159	ENSG00000072315	"Transient receptor potential cation channel subfamily C member 5"	Q9UL62	X	111774315-112082776	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"brain: 5.3;liver: 3.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"testis cancer: 0.8;thyroid cancer: 2.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"NTERA-2: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA										"unprognostic (3.29e-2)"		"unprognostic (6.15e-2)"	"unprognostic (7.32e-2)"			"unprognostic (2.60e-3)"		"unprognostic (3.68e-2)"	"unprognostic (5.69e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.78e-2)"		0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.6	5.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.3	0.4	3.2	0.0	0.0	0.9		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 35.3;placenta: 20.6"	"Cell type enhanced"	"Detected in some"	16	"Club cells: 19.4;Leydig cells: 5.8;Smooth muscle cells: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.5"	"Cell line enhanced"	"Detected in some"		"A549: 4.7;ASC diff: 8.8;BJ hTERT+: 4.7;HEL: 4.4;RPTEC TERT1: 21.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6"	HPA045098	Approved					NA	NA		140000			"HPA045098: AB_10959600"	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	6.0	0.5	1.5	0.6	2.4	0.1	9.7	0.8	2.0	7.6	3.9	1.1	7.5	1.1	6.6	7.0	10.8	5.3	3.2	1.1	2.0	1.5	1.6	0.4	35.3	0.9	2.2	3.4	2.2	1.0	1.0	0.6	20.6	2.9	2.3	1.6	0.3	3.3	7.2	0.8	3.0	1.9	3.9	0.7	2.0	1.5	1.0	0.1	0.1	9.6	2.7	1.1	1.6	3.8	0.0	1.0	5.5	0.5	0.0	0.0	0.3	0.0	4.7	0.2	0.0	8.8	2.2	0.0	3.0	4.7	0.7	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.3	1.5	2.4	0.8	2.0	2.0	1.5	2.2	3.4	2.9	0.1	0.0	1.6	0.0	1.7	2.1	0.8	0.4	0.0	1.4	19.4	3.5	0.0	0.9	0.0	0.0	0.6	0.8	0.0	0.0	0.2	0.0	1.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.8	2.6	1.7	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	9.8	0.0	0.0	3.0	0.3	0.0	0.0	1.0
TRPM2	"EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7"	ENSG00000142185	"Transient receptor potential cation channel subfamily M member 2"	O94759	21	44350163-44443081	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Calcium channel, Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.9"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 7.0;Hofbauer cells: 15.8;Kupffer cells: 12.5;Macrophages: 9.0;Sertoli cells: 6.5;T-cells: 4.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.3;plasmacytoid DC: 14.5"	"Group enriched"	"Detected in many"	8	"dendritic cells: 14.5;monocytes: 7.3"	"Cell line enhanced"	"Detected in some"		"HL-60: 16.8;NB-4: 23.8;OE19: 16.9;THP-1: 29.4;U-937: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035260	Enhanced					NA	NA					"HPA035260: AB_2674540"	"unprognostic (3.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.55e-2)"	"prognostic favorable (9.28e-4)"	"unprognostic (6.49e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.40e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.88e-3)"	"prognostic favorable (7.59e-4)"	5.4	4.5	7.4	8.6	7.8	29.9	3.9	14.5	16.3	2.9	4.5	6.9	0.0	4.4	1.9	1.5	2.1	2.6	5.7	1.8	7.8	8.9	2.1	2.0	3.8	8.2	8.5	10.4	1.5	2.4	2.1	2.1	7.1	11.7	1.9	3.0	2.6	2.9	1.3	1.3	2.3	5.1	3.2	9.7	8.1	3.1	1.9	7.3	2.0	1.7	0.0	4.8	4.9	1.7	1.4	14.5	0.4	7.3	0.5	1.1	1.8	8.3	3.1	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.2	0.1	0.0	0.0	0.2	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	16.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	2.6	23.8	0.0	16.9	9.9	0.9	3.0	3.2	0.0	0.0	6.1	0.0	0.0	9.9	0.0	0.0	11.6	29.4	0.0	0.5	8.9	0.0	0.3	0.1	12.5	0.0	0.0	27.7	0.0	0.0	7.3	0.0	1.0	2.6	0.6	0.3	0.3	0.4	2.5	1.4	0.3	0.4	0.4	0.5	2.0	14.5	1.1	1.8	7.4	7.8	14.5	16.3	7.8	8.9	8.5	10.4	11.7	7.3	0.0	0.3	0.0	0.0	0.3	0.5	1.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.0	1.0	0.0	0.0	0.2	7.0	0.2	0.0	1.1	0.0	15.8	0.0	0.0	0.6	12.5	1.2	0.6	9.0	0.0	1.0	0.1	0.5	0.8	0.0	0.0	0.1	0.4	6.5	0.0	0.5	0.0	0.3	1.1	4.8	0.0	0.0
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529063-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 36.6;kidney: 28.0;retina: 105.2"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 278.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.1"	"Cell line enriched"	"Detected in some"	4	"HAP1: 19.4"	"Low region specificity"	"Detected in all"							"HPA072650, HPA074393"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.9	1.7	6.0	0.7	4.5	1.1	0.8	36.6	5.1	0.8	0.7	9.6	2.1	1.8	2.4	3.0	0.7	1.3	1.3	1.4	9.4	6.0	28.0	0.9	0.8	0.7	8.3	3.5	5.3	1.5	0.7	6.8	0.8	34.8	1.4	0.7	105.2	0.8	5.0	1.1	0.8	0.7	1.0	8.1	1.1	1.6	5.3	5.9	0.0	2.1	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.1	0.1	1.3	3.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	19.4	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.2	0.0	0.0	1.2	4.5	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.2	0.0	1.0	0.0	1.3	0.0	0.2	0.0	0.4	0.2	0.0	0.0	3.6	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.0	4.5	36.6	3.8	9.4	6.0	8.3	3.5	34.8	5.9	3.0	4.0	0.0	0.9	0.3	9.5	4.8	2.5	1.4	4.5	15.7	62.8	0.0	5.0	0.0	3.9	1.3	0.0	0.0	0.2	0.0	1.5	0.4	0.0	0.0	0.2	1.6	14.8	0.6	0.0	1.7	5.2	1.1	0.0	0.0	0.0	278.6	0.1	0.0	8.5	25.8	4.7	0.0	1.0	1.5	0.4	0.6	0.2	0.8	0.0	0.3
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 120.1;Mucus-secreting cells: 88.2;Paneth cells: 80.4;Undifferentiated cells: 78.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"OE19: 15.6;RT4: 32.4;SK-BR-3: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		6500	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	6.7	3.8	3.5	13.7	3.7	4.3	8.5	3.0	6.8	8.2	25.2	4.5	8.6	20.6	7.9	9.1	7.7	5.4	24.8	9.3	2.7	2.2	14.2	23.6	9.4	3.5	2.6	5.7	2.7	17.4	3.4	3.3	5.0	6.9	20.2	11.4	10.6	16.2	13.2	16.4	16.1	26.8	9.4	2.5	3.4	18.3	4.2	2.2	0.4	10.1	11.5	6.8	9.9	8.6	1.1	5.4	4.9	6.8	1.0	0.7	2.1	6.0	4.5	1.1	5.0	3.8	3.6	3.6	5.1	3.0	1.4	1.9	3.3	9.5	0.2	1.3	3.4	1.9	7.9	0.7	1.5	0.6	0.1	1.6	1.0	1.9	2.0	3.4	0.1	6.6	4.3	7.0	2.6	1.2	1.7	2.4	0.5	2.4	1.2	3.5	9.0	0.4	0.5	0.6	15.6	6.9	2.2	1.0	0.3	2.4	32.4	0.4	1.1	2.1	21.3	1.1	0.4	11.6	2.0	6.1	7.6	4.2	4.2	0.1	2.2	2.2	0.2	4.3	3.9	2.8	2.7	6.8	1.1	0.6	4.0	0.5	0.8	0.5	0.4	5.4	1.1	0.6	0.7	4.9	1.0	1.5	4.9	0.3	2.1	3.5	3.7	3.0	6.8	2.7	2.2	2.6	5.7	6.9	2.2	29.8	1.6	11.7	13.4	11.1	2.1	14.9	22.9	2.7	3.4	14.0	0.0	5.3	16.6	7.6	2.1	9.2	120.1	0.0	16.1	5.7	6.6	47.1	5.7	64.7	16.1	0.0	20.8	15.4	9.7	3.1	6.4	7.9	37.1	14.4	88.2	6.3	25.2	80.4	6.7	3.8	2.4	32.3	9.1	6.6	11.9	10.0	2.9	0.0	78.1	25.3
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2423045	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0"	"Cell type enhanced"	"Detected in single"	14	"Undifferentiated cells: 1.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 2.6;OE19: 3.6;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.47e-5)"	"unprognostic (6.81e-4)"	"unprognostic (7.90e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.91e-2)"	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			6.1	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0		0.0	4.5	0.0	0.5	0.0		0.2	0.5		0.0	4.0	0.0	0.0	6.3	0.0	0.0	0.0	0.5	0.9			3.1		0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	3.6	0.1	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.1;intestine: 19.5"	"Group enriched"	"Detected in many"	4	"Enterocytes: 28.8;Paneth cells: 10.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 16.1;neutrophil: 6.6"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;HeLa: 4.5;Karpas-707: 2.6;RT4: 7.4;U-266/70: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	2.9	0.0	1.3	0.5	1.2	2.5	1.1	1.3	1.2	0.8	13.3	0.2	1.0	7.2	0.4	0.2	0.6	0.4	1.0	0.5	1.9	1.2	3.1	0.2	1.5	0.2	2.6	0.0	0.4	0.2	3.8	4.9	0.2	1.6	1.7	17.5	0.4	1.1	0.0	1.6	0.8	19.5	0.7	5.0	3.9	0.2	1.7	0.5	1.6	0.3	1.1	2.1	0.5	0.6	0.3	0.3	16.1	0.1	0.5	0.1	0.0	0.1	1.7	0.2	0.2	0.0	0.0	7.7	0.1	0.0	0.0	0.1	2.1	0.2	0.6	0.0	0.1	0.3	0.3	0.5	0.5	0.0	0.1	0.2	0.2	4.5	0.3	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.1	0.2	0.3	0.0	2.6	0.1	0.9	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.3	0.0	7.4	0.3	0.0	0.0	0.1	0.1	0.4	0.3	0.0	0.0	0.2	1.1	0.2	0.0	2.8	0.0	0.2	0.1	0.1	0.3	16.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	6.6	0.5	0.1	0.3	0.0	0.0	1.3	1.2	1.3	1.2	1.9	1.2	2.6	0.0	1.6	0.5	0.0	1.7	0.0	1.7	0.1	0.2	0.6	0.0	1.4	2.3	3.5	0.0	0.2	0.0	0.0	2.5	0.7	28.8	0.0	0.0	0.1	0.3	1.1	0.0	0.0	0.0	0.0	3.5	4.9	0.3	0.4	0.0	0.2	0.0	0.0	3.3	0.1	0.0	10.5	0.4	0.0	2.3	0.0	0.3	1.5	2.3	0.9	0.1	0.0	2.6	0.9
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 91.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	13.3	10.8	6.6	14.7	9.0	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11.0	8.2	19.1	5.5	4.9	16.0	20.0	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10.0	14.5	12.6	6.9	12.6	12.9	12.3	7.0	4.7	4.4	3.4	5.7	7.6	2.0	8.5	8.5	7.1	7.9	20.6	15.5	8.7	10.8	15.0	6.9	9.1	11.7	4.7	18.6	5.3	12.4	17.8	14.4	9.5	7.9	9.9	10.3	5.7	14.8	13.1	6.1	18.8	15.3	11.5	14.4	9.4	7.8	14.7	10.1	5.5	11.8	16.7	14.3	12.5	13.4	9.8	7.5	5.4	11.8	5.3	10.8	9.9	9.1	9.6	20.2	5.9	7.5	7.4	11.9	14.5	13.1	7.4	16.7	8.4	11.0	5.2	50.9	12.4	9.7	21.5	17.9	11.9	31.3	10.2	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7.0	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2.0	6.6	9.0	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10.0	17.9	25.3	18.2	14.9	28.0	22.9	21.4	28.1	24.1	7.9	12.2	11.8	18.5	3.3	9.7	25.2	18.5	16.9	23.3	11.1	8.0	17.0	21.2	16.3	35.0	12.7	20.6	17.7	15.4	18.6	17.9	24.5	17.0	18.6	14.4	17.3	9.1	12.8	12.9	19.1	9.6	21.5	12.9	13.7	13.6	19.4	21.1	13.6	17.5	16.3	9.0
TRPV1	VR1	ENSG00000196689	"Transient receptor potential cation channel subfamily V member 1"	Q8NER1	17	3565444-3609411	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 11.7"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 25.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (3.96e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.21e-4)"	"unprognostic (9.90e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.43e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.97e-4)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.12e-3)"	1.4	1.2	3.5	0.7	2.9	0.3	1.7	2.7	2.1	2.1	1.4			6.5	2.3	1.5	0.8	2.8	1.1	1.9	3.2	3.6	2.5	11.7	0.7	1.3	4.7		5.1	2.5	1.0	2.0	1.2		1.5	1.7		2.1	1.0	2.8	4.7	5.1	0.9	2.3	1.2	2.2	1.2			1.3		0.8	1.2	1.1	1.1	1.4	1.5	0.8	0.5	2.2	0.3	3.0	5.6	4.5	5.0	4.9	4.7	4.1	1.7	2.4	2.6	2.4	1.4	1.7	1.2	2.3	1.8	1.8	13.2	2.8	0.9	1.9	7.3	6.7	0.7	2.9	5.6	2.2	0.4	5.7	5.6	3.0	3.8	1.5	2.5	0.5	2.9	0.3	2.2	1.5	3.8	2.1	1.0	3.0	0.6	2.7	6.2	2.9	0.9	2.2	2.7	1.9	4.2	2.3	4.4	2.2	3.5	8.3	2.3	1.7	1.1	2.7	4.5	2.2	1.9	1.3	0.5	1.9	2.4	2.4	0.9	0.8	1.5	0.7	0.2	0.9	0.4	0.6	0.2	0.1	1.1	0.8	2.2	1.5	0.5	0.3	1.4	0.2	0.3											0.0	1.6	0.0	0.4	0.0	8.6	0.2	2.5	4.0	2.3	5.2	15.7	1.0	0.0	0.4	1.8	0.0	2.6	0.0	0.6	0.3	0.4	0.6	0.0	6.4	0.7	6.4	1.2	2.5	0.6	0.2	4.4	1.2	0.0	0.0	1.5	2.8	0.4	0.0	3.5	1.4	25.1	0.0	0.1	0.7	0.7	0.0	0.7	0.0	2.2	0.3
TRPV2	"VRL, VRL-1, VRL1"	ENSG00000187688	"Transient receptor potential cation channel subfamily V member 2"	Q9Y5S1	17	16415542-16437003	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"granulocytes: 48.5;Hofbauer cells: 48.6;monocytes: 52.3"	"Cancer enriched"	"Detected in all"	8	"melanoma: 59.8"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 27.1;fHDF/TERT166: 35.4;HMC-1: 29.8;SK-MEL-30: 30.7;TIME: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044993	Uncertain		Supported	"Plasma membrane"		NA	NA			"Plasma membrane"		"HPA044993: AB_10960889"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.16e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (8.07e-2)"	"unprognostic (1.23e-1)"	25.4	17.6	5.9	14.3	4.9	15.6	11.3	1.9	7.6	6.7	6.0	4.2	0.5	5.4	8.2	6.1	5.7	6.8	6.7	8.9	5.0	8.1	4.4	4.5	25.8	24.9	6.0	4.2	8.9	8.4	7.7	1.8	15.6	8.1	6.3	5.0	4.9	4.4	2.1	3.8	5.0	8.8	9.2	4.1	23.4	5.3	2.8	2.5	23.4	5.7	4.2	18.0	8.1	6.7	9.0	25.9	20.4	22.3	26.5	29.8	17.4	0.1	0.5	0.0	0.0	8.7	27.1	1.6	2.7	3.1	3.0	3.0	0.1	0.1	3.1	0.7	35.4	2.6	0.0	0.0	0.0	1.7	13.7	0.2	3.4	0.0	8.4	10.4	4.7	29.8	12.0	0.0	18.2	0.2	1.4	1.2	4.2	11.6	8.6	14.4	0.1	6.0	6.5	0.0	0.0	0.0	3.6	0.1	1.3	13.5	0.3	0.4	0.0	0.0	0.0	30.7	14.5	0.0	4.1	27.6	0.0	0.1	0.1	0.3	0.0	0.1	1.6	2.8	6.9	4.1	20.4	12.2	15.2	29.8	22.3	25.9	9.0	21.9	27.6	25.9	8.7	12.5	21.7	3.0	26.5	19.8	22.7	21.2	17.4	5.9	4.9	1.9	7.6	5.0	8.1	6.0	4.2	8.1	2.5	0.0	7.7	9.3	0.1	2.5	0.5	1.0	2.5	1.4	1.2	0.0	0.0	1.9	0.0	0.2	0.3	8.7	0.0	0.0	3.1	1.3	8.9	0.0	48.5	0.5	48.6	0.0	0.0	11.1	17.4	0.0	1.7	26.8	27.0	52.3	0.0	0.0	4.0	0.0	4.2	0.0	0.4	25.8	17.3	0.5	0.9	1.5	13.5	29.9	0.0	0.1
TRPV5	"CaT2, ECAC1"	ENSG00000127412	"Transient receptor potential cation channel subfamily V member 5"	Q9NQA5	7	142908101-142933808	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"kidney: 26.0"	"Cell type enriched"	"Detected in single"	8	"Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in single"		"RT4: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA063175	Uncertain					NA	NA					"HPA063175: AB_2684954"	"unprognostic (7.44e-2)"	"unprognostic (3.93e-2)"		"unprognostic (1.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"		"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.73e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-1)"	"unprognostic (7.76e-3)"	0.1	0.0	0.8	0.4	0.7	0.5	0.5	0.1	0.8	0.1	0.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0.1	0.1	1.1	0.7	26.0	0.1	0.1	0.2	1.6	0.4	0.1	0.3	0.0	0.1	0.1	0.7	0.1	0.0	0.1	0.3	0.1	0.2	0.1	0.1	0.1	3.5	0.2	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.5	1.1	0.7	1.6	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPV6	"CaT1, ECAC2"	ENSG00000165125	"Transient receptor potential cation channel subfamily V member 6"	Q9H1D0	7	142871203-142885762	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 26.1;placenta: 65.1;salivary gland: 34.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 25.5;Collecting duct cells: 26.2;Ductal cells: 63.7;Early spermatids: 26.4;Late spermatids: 28.8"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.7;HaCaT: 10.5;RT4: 18.7;SK-BR-3: 13.8;T-47d: 30.8"	"Low region specificity"	"Detected in some"							HPA062864	Approved					NA	NA					"HPA062864: AB_2684885"	"unprognostic (9.85e-2)"	"unprognostic (1.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.53e-2)"	0.3	0.0	0.3	0.3	0.3	0.0	2.1	0.3	0.3	0.4	1.2	0.3	0.3	4.1	0.3	0.4	1.7	0.1	4.1	0.3	0.3	0.2	2.5	0.6	0.8	0.3	0.8	0.3	0.3	26.1	0.0	0.4	65.1	0.4	12.6	0.0	0.4	34.2	0.7	0.3	3.7	1.0	0.5	2.0	0.3	2.4	0.7	0.3	0.3	0.7	0.6	1.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	1.1	0.0	0.0	13.8	0.3	0.6	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.8	0.3	0.4	0.3	3.0	0.0	0.0	0.9	0.5	0.4	1.6	25.5	1.4	2.3	26.2	0.0	13.3	0.0	63.7	26.4	0.0	0.0	0.0	2.8	0.6	0.4	14.3	0.0	0.0	1.4	3.2	0.0	0.0	0.0	28.8	0.9	0.0	0.0	3.6	0.0	0.8	13.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.6	5.0	0.0	0.0	3.1
TSPAN12	"NET-2, TM4SF12"	ENSG00000106025	"Tetraspanin 12"	O95859	7	120787320-120858402	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Angiogenesis		"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 110.2;Collecting duct cells: 97.7;Distal tubular cells: 160.8;Proximal tubular cells: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 21.2;HUVEC TERT2: 23.7;RH-30: 21.7;RPTEC TERT1: 34.7;RT4: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051570, HPA058244"	Uncertain		Approved	Vesicles,Microtubules		NA	NA			Microtubules	Vesicles	"HPA051570: , HPA058244: AB_2683652"	"unprognostic (2.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.43e-1)"	6.8	40.9	3.1	4.3	3.9	0.0	4.5	2.2	3.3	8.1	19.3	2.1	36.8	13.5	6.1	8.7	3.6	3.7	13.6	22.2	3.2	2.7	40.7	12.6	16.9	1.6	2.7	2.3	2.5	12.8	1.1	10.3	9.9	3.3	7.9	7.1	2.9	33.7	15.1	2.3	1.2	31.0	4.1	1.8	18.4	7.6	3.0	2.2	0.5	18.7	3.5	3.2	10.4	3.3	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	6.2	0.1	1.3	0.4	6.0	0.1	0.2	0.5	2.0	1.0	1.5	0.0	4.3	0.1	0.7	0.1	3.1	0.6	0.8	0.0	21.2	1.1	6.2	0.9	3.4	0.0	1.0	0.1	0.0	0.1	0.1	0.8	23.7	0.0	0.2	0.7	2.7	0.8	0.0	0.1	9.9	4.1	3.8	0.0	21.7	0.7	34.7	26.4	5.1	3.0	0.2	0.5	0.0	8.7	3.2	0.7	1.0	5.1	1.6	0.0	2.6	6.5	0.0	0.0	0.7	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	3.9	2.2	3.3	3.2	2.7	2.7	2.3	3.3	2.2	110.2	36.0	1.7	16.9	2.3	0.0	56.0	43.3	9.4	29.6	97.7	0.0	34.8	160.8	6.2	0.4	28.0	15.4	0.0	6.4	39.5	5.6	12.3	2.3	28.6	3.7	0.0	9.2	8.6	0.3	1.2	3.7	1.5	5.0	0.0	22.1	0.5	4.2	26.2	0.7	93.5	0.0	0.0	13.4	0.1	6.9	1.8	20.3	0.5	26.6	20.7
TSPAN14	"DC-TM4F2, MGC11352, TM4SF14"	ENSG00000108219	"Tetraspanin 14"	Q8NG11	10	80454166-80533123	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Ito cells: 166.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 64.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014773, HPA057174"	Uncertain		Supported	Vesicles		NA	NA		170000	Vesicles		"HPA014773: AB_2208670, HPA057174: "	"unprognostic (7.52e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.55e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.12e-3)"	"prognostic favorable (4.20e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.57e-3)"	56.8	10.3	15.4	17.2	14.1	22.0	45.1	5.2	16.8	30.0	14.1	15.1	28.1	13.3	18.9	22.4	44.6	22.2	15.1	15.2	13.4	7.7	22.9	16.0	32.9	47.4	18.8	10.8	21.7	14.4	12.3	7.4	39.0	13.0	20.0	12.3	22.7	24.8	16.5	11.3	33.3	17.3	15.3	16.5	28.2	12.6	12.9	14.5	16.0	26.2	19.1	26.7	30.5	28.4	4.4	10.1	16.2	47.7	26.1	29.0	21.3	21.9	32.5	30.2	10.4	46.5	14.9	14.2	11.3	21.7	12.3	9.0	31.3	12.8	7.1	21.8	6.1	4.4	22.9	8.4	20.5	10.1	12.5	3.2	20.1	3.8	26.8	15.6	7.5	4.9	14.3	18.2	12.4	22.7	22.4	45.9	7.3	11.1	5.2	3.5	18.8	10.8	5.3	6.9	13.7	0.0	37.5	3.5	1.1	48.3	31.5	6.5	9.9	4.5	31.5	34.8	10.8	12.7	18.0	64.7	3.1	12.9	3.0	7.9	2.5	9.3	2.5	10.2	15.1	13.6	3.8	14.8	16.0	29.0	30.4	13.2	4.4	22.7	25.7	10.1	4.2	27.1	25.2	16.2	26.1	47.7	4.0	17.9	21.3	15.4	14.1	5.2	16.8	13.4	7.7	18.8	10.8	13.0	14.5	14.9	59.8	19.7	37.8	31.0	1.9	11.8	35.7	9.4	17.0	31.4	72.6	5.4	6.6	35.7	1.9	70.2	22.1	0.0	21.7	57.5	18.8	31.3	7.0	17.9	43.6	3.2	61.8	166.3	95.3	1.7	36.2	45.9	13.5	14.4	32.7	26.6	48.5	11.5	38.5	7.2	7.0	97.0	20.8	3.9	20.0	31.9	6.4	40.7	24.8	62.8
TSPAN15	"NET-7, TM4SF15"	ENSG00000099282	"Tetraspanin 15"	O95858	10	69451473-69507669	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"	7	"Ductal cells: 106.8;Exocrine glandular cells: 167.5;Mucus-secreting cells: 103.1;Pancreatic endocrine cells: 141.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"MAIT T-cell: 17.4"	"Lineage enriched"	"Detected in many"	6	"T-cells: 17.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 34.9;EFO-21: 48.7;MCF7: 36.8;OE19: 33.8;PC-3: 60.5;SK-BR-3: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044657, HPA071160"	Approved		Approved	"Nuclear bodies,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Nuclear bodies, Plasma membrane"	"Vesicles, Cytosol"	"HPA044657: AB_10967927, HPA071160: "	"unprognostic (2.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.78e-3)"	34.2	3.1	11.5	9.7	22.7	0.9	24.9	40.4	17.0	8.9	30.4	49.2	12.5	24.0	15.1	8.4	7.1	16.2	17.1	8.3	18.0	9.2	10.2	3.0	20.4	4.9	33.1	11.2	3.0	10.8	1.4	3.3	17.7	16.8	17.6	24.9	5.4	16.8	17.0	9.9	4.6	21.5	23.0	43.0	13.5	46.4	4.0	28.3	0.8	6.7	2.7	4.8	22.6	6.8	0.0	2.7	0.0	0.0	0.1	17.4	0.5	11.1	23.2	0.4	0.0	0.5	0.0	2.7	0.0	0.4	0.6	1.5	10.0	34.9	0.0	48.7	0.5	2.1	22.8	1.6	2.5	0.7	9.2	4.6	0.6	0.7	2.2	0.2	0.0	0.4	0.5	0.7	0.3	0.3	1.7	8.9	4.6	0.2	0.0	0.2	36.8	0.1	0.2	0.6	33.8	60.5	0.8	0.4	0.4	6.8	20.7	7.9	3.0	0.1	30.7	3.8	4.1	13.4	0.5	7.7	0.0	0.1	0.0	3.8	0.2	1.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.0	17.4	0.0	2.7	2.5	2.7	0.0	0.9	0.2	0.0	0.1	0.0	0.2	0.9	0.5	11.5	22.7	40.4	17.0	18.0	9.2	33.1	11.2	16.8	28.3	29.8	5.8	2.7	9.7	3.2	3.0	0.8	25.5	14.7	6.8	27.9	5.9	1.5	3.3	106.8	26.3	18.7	73.5	0.0	167.5	9.1	4.7	50.7	1.1	0.0	20.5	1.6	38.6	11.1	5.6	4.9	0.6	10.5	27.0	27.1	103.1	36.7	141.3	88.3	0.0	1.3	1.4	12.9	7.6	0.9	17.7	2.8	2.5	2.5	61.6	27.1
TSPAN3	"TM4-A, TM4SF8, TSPAN-3"	ENSG00000140391	"Tetraspanin 3"	O60637	15	77041404-77083984	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Muller glia cells: 483.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 69.4;naive B-cell: 69.7;plasmacytoid DC: 46.7"	"Group enriched"	"Detected in all"	5	"B-cells: 69.7;dendritic cells: 46.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015996	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Nucleoplasm, Golgi apparatus"		"HPA015996: AB_1858406"	"unprognostic (5.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.51e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.35e-1)"	64.0	31.4	71.6	16.9	66.5	6.0	43.3	36.8	67.5	31.4	75.3	49.4	74.2	70.6	28.4	95.9	16.8	53.8	39.4	24.6	58.1	63.7	44.9	17.8	41.9	22.9	64.4	45.8	33.0	31.6	53.6	44.0	23.1	54.1	21.3	82.7	44.3	30.8	60.9	79.3	16.3	71.2	27.6	49.2	19.1	46.1	21.3	40.4	14.2	43.0	24.7	25.4	23.2	15.2	69.7	46.7	1.5	10.8	8.3	6.9	12.1	20.8	56.9	47.3	29.8	83.1	51.2	15.6	33.4	36.4	41.2	45.1	34.6	43.6	20.5	49.7	34.5	39.4	47.4	44.8	22.9	31.0	22.9	67.9	14.6	43.6	32.7	40.3	18.8	10.8	48.1	27.7	22.7	20.3	63.0	50.4	13.7	15.4	18.1	40.3	7.9	16.6	17.9	33.4	67.0	25.3	21.0	58.8	21.6	67.8	11.9	42.9	47.5	22.9	19.4	62.1	47.4	20.8	35.7	47.7	38.3	15.0	23.0	46.7	39.9	54.2	10.9	33.9	28.2	21.8	0.8	7.5	1.5	5.1	9.9	5.4	69.4	2.6	3.7	14.8	69.7	6.9	6.3	0.7	8.3	10.8	46.7	0.6	12.1	71.6	66.5	36.8	64.2	58.1	63.7	64.4	45.8	54.1	40.4	104.2	182.8	49.0	53.9	30.8	241.7	81.1	112.1	176.7	158.1	64.6	172.8	77.0	21.6	218.3	24.0	52.8	344.7	0.0	309.7	26.2	81.8	155.9	22.0	27.0	57.7	120.8	87.8	60.2	53.5	44.3	59.5	31.1	69.2	23.4	234.6	483.1	209.9	302.5	48.4	50.7	133.3	25.8	63.7	84.0	50.0	29.9	63.5	26.1	164.4	170.4
TSPAN33	"MGC50844, Penumbra"	ENSG00000158457	"Tetraspanin 33"	Q86UF1	7	129144892-129169697	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 56.8"	"Cell type enhanced"	"Detected in many"	11	"Macrophages: 25.0;monocytes: 64.9;Peritubular cells: 30.8;Proximal tubular cells: 50.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 5.3;naive B-cell: 6.4"	"Group enriched"	"Detected in many"	5	"B-cells: 6.4;dendritic cells: 2.8;monocytes: 3.2"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 20.9;HEL: 32.6;U-266/70: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020357	Enhanced		Approved	Microtubules		NA	NA			Microtubules		"HPA020357: AB_1858410"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.67e-1)"	"prognostic favorable (8.74e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.16e-2)"	2.8	3.5	7.4	13.4	7.7	3.8	3.5	7.5	10.0	1.9	4.3	9.9	8.7	3.8	1.5	15.9	3.4	2.6	3.8	5.4	7.2	12.4	56.8	17.2	3.2	15.9	12.1	6.5	1.8	13.0	9.4	13.0	4.6	7.9	8.0	4.8	5.5	20.5	9.5	7.1	4.5	7.1	2.8	8.0	13.7	4.3	6.8	6.0	10.4	8.5	2.9	19.6	6.2	2.4	6.4	2.8	0.2	3.2	0.4	0.9	2.1	1.2	2.7	0.8	20.9	0.0	0.0	1.0	0.0	0.2	0.5	0.2	0.4	1.9	15.8	1.6	0.5	12.2	1.4	10.8	3.3	0.8	13.4	8.3	32.6	0.8	5.9	0.8	4.5	0.6	0.6	3.3	0.1	1.1	0.0	0.5	9.4	0.3	2.0	0.0	3.6	9.5	0.1	6.0	0.9	2.9	2.9	0.4	0.4	1.7	3.9	4.9	5.9	2.0	0.6	11.0	6.2	4.5	1.9	0.0	0.0	1.5	1.7	0.5	38.6	4.5	6.8	0.3	14.5	2.0	0.0	1.1	0.0	0.1	3.2	0.0	5.3	0.1	0.0	2.8	6.4	0.9	0.1	0.2	0.4	0.2	1.1	0.0	2.1	7.4	7.7	7.5	10.0	7.2	12.4	12.1	6.5	7.9	6.0	0.0	1.1	24.2	0.8	2.3	3.8	5.6	0.0	2.7	0.0	5.2	3.9	0.1	11.6	2.0	2.0	0.4	0.8	0.0	7.4	0.2	1.1	2.5	0.0	12.5	7.1	0.0	3.4	0.6	17.8	3.3	2.6	25.0	1.7	64.9	0.3	4.8	3.0	0.0	30.8	50.8	1.4	0.0	0.0	0.5	0.7	2.6	0.1	1.5	0.2	1.0
TSPAN7	"A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2"	ENSG00000156298	"Tetraspanin 7"	P41732	X	38561370-38688920	"CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 131.1"	"Cell type enhanced"	"Detected in many"	15	"Endothelial cells: 113.7;Ito cells: 372.0"	"Cancer enhanced"	"Detected in all"		"glioma: 71.5"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"JURKAT: 68.6;MOLT-4: 45.1;SCLC-21H: 25.2;U-266/70: 16.7"									"HPA003140, CAB062566, CAB068245"	Enhanced					NA	NA					"CAB062566: AB_2665608, CAB068245: AB_2665609, HPA003140: AB_1078454"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (5.06e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.48e-7)"	"unprognostic (5.65e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-3)"	15.2	28.7	39.6	3.5	83.0	0.8	7.3	83.8	131.1	12.4	18.5	11.5	2.3	7.9	11.6	9.2	7.9	10.5	5.8	17.1	34.5	30.7	15.8	12.0	16.2	8.8	19.4	37.7	5.2	4.4	4.1	11.4	6.6	23.8	5.6	17.3	8.1	3.3	7.4	17.9	4.9	7.8	14.5	11.9	21.3	4.6	1.7	9.5	0.0	11.8	5.4	8.2	8.2	4.2	0.9	0.5	0.3	0.2	0.3	2.9	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.0	10.9	2.0	0.0	0.0	8.6	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.0	0.2	0.1	45.1	0.0	2.3	0.0	0.0	2.2	0.9	0.0	1.1	0.2	25.2	2.6	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.6	0.0	0.2	16.7	4.7	0.0	1.0	0.1	0.3	0.2	0.1	0.0	0.6	0.2	0.7	0.4	1.1	2.9	0.1	0.9	2.1	1.8	0.3	0.3	0.0	0.5	0.0	0.1	39.6	83.0	83.8	86.3	34.5	30.7	19.4	37.7	23.8	9.5	11.9	18.4	0.5	2.3	9.4	87.2	35.4	2.5	1.4	4.5	10.4	41.2	0.3	19.9	0.4	0.0	113.7	34.6	0.0	0.5	0.4	6.8	2.4	9.3	2.9	33.9	92.2	18.0	372.0	20.5	1.1	0.6	1.5	13.5	0.0	25.1	94.7	1.4	17.3	2.8	8.3	66.4	58.2	4.4	0.6	3.2	5.6	0.7	4.3	31.0	0.9
TTYH1		ENSG00000167614	"Tweety family member 1"	Q9H313	19	54415219-54436900	"Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 66.9"	"Group enriched"	"Detected in many"	4	"Muller glia cells: 594.3;Rod photoreceptor cells: 149.3"	"Cancer enriched"	"Detected in many"	15	"glioma: 63.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 6.3;AN3-CA: 19.6;U-2 OS: 7.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023617, HPA050655"	Approved					NA	NA					"HPA023617: AB_10600836, HPA050655: AB_2681204"	"prognostic favorable (3.64e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.60e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.09e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.69e-1)"	2.2	2.7	49.5	2.1	55.4	2.1	2.3	17.9	66.9	2.4	2.3	33.9	0.0	2.4	2.6	2.1	2.2	4.4	2.3	2.3	31.0	23.4	2.1	2.1	2.1	2.1	39.3	24.4	2.2	10.4	2.1	1.9	2.1	19.7	2.5	2.1	1.9	2.8	2.4	3.0	2.2	2.1	2.2	29.7	2.4	2.2	7.4	18.0	0.0	2.1	0.0	2.1	2.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.3	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	49.5	55.4	17.9	42.9	31.0	23.4	39.3	24.4	19.7	18.0	3.0	1.1	0.0	1.0	0.7	84.6	1.1	0.0	1.4	1.2	0.0	19.6	0.4	0.0	25.4	3.1	0.6	0.0	0.0	0.5	0.6	0.5	2.1	0.0	0.0	0.2	9.5	1.2	1.3	0.0	4.0	1.7	0.0	21.9	0.0	0.0	594.3	2.2	0.0	0.7	0.6	149.3	6.5	1.4	2.1	4.4	0.6	3.5	0.0	0.2	1.0
TTYH2	C17orf29	ENSG00000141540	"Tweety family member 2"	Q9BSA4	17	74213514-74262020	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 84.1"	"Cell type enhanced"	"Detected in many"	11	"Bipolar cells: 58.7;granulocytes: 21.8;Melanocytes: 21.9"	"Group enriched"	"Detected in all"	6	"glioma: 16.7;melanoma: 20.3"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 16.6"	"Group enriched"	"Detected in many"	5	"dendritic cells: 11.5;monocytes: 16.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 11.8;SK-MEL-30: 41.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.19e-1)"	"unprognostic (5.08e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.51e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.90e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.74e-5)"	"unprognostic (8.98e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.50e-3)"	"unprognostic (3.51e-3)"	4.6	4.4	20.7	5.8	32.1	2.8	2.9	4.6	63.5	3.8	3.1	84.1	0.0	2.6	4.4	3.4	3.1	4.8	4.5	12.8	31.6	15.9	1.8	1.9	4.3	5.9	59.3	19.0	12.9	4.9	5.4	3.1	8.2	28.7	2.8	2.6	8.5	5.4	3.9	10.5	4.5	3.2	3.6	48.6	8.8	2.3	9.2	45.6	0.7	8.5	2.1	4.8	3.0	2.1	0.2	11.5	0.8	16.6	0.1	3.1	3.8	0.1	1.0	4.7	4.4	0.5	0.6	0.1	0.2	0.0	0.3	0.0	3.0	0.0	2.6	0.7	0.1	0.5	7.4	4.6	0.1	0.1	6.2	2.6	2.8	0.1	0.2	3.3	0.3	1.9	11.8	2.4	0.1	0.8	0.3	0.1	1.9	0.5	1.3	0.1	0.5	1.3	0.2	0.9	4.3	8.1	4.4	8.4	5.0	0.1	0.3	1.6	5.7	0.0	2.8	41.1	2.5	1.5	0.6	0.1	0.0	2.3	0.0	0.1	0.2	0.1	0.0	0.1	0.8	2.5	0.6	8.0	0.7	1.6	13.9	0.2	0.2	3.1	2.6	9.0	0.2	0.5	1.1	0.8	0.1	16.6	11.5	2.7	3.8	20.7	32.1	4.6	29.8	31.6	15.9	59.3	19.0	28.7	45.6	0.0	5.5	2.2	0.7	2.1	58.7	1.4	2.5	0.0	0.0	0.0	5.9	0.3	0.0	0.1	20.0	2.1	0.0	0.0	0.2	0.4	3.1	0.5	21.8	0.4	4.2	3.2	1.7	0.6	13.0	8.7	8.9	10.1	21.9	15.4	0.0	15.3	0.2	0.0	2.5	0.1	9.1	19.4	3.8	1.5	1.6	2.3	0.2	1.3	0.0	0.3
TUSC3	"MGC13453, MRT7, N33, OST3A"	ENSG00000104723	"Tumor suppressor candidate 3"	Q13454	8	15417215-15766649	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 127.8"	"Cell type enhanced"	"Detected in many"	13	"Cytotrophoblasts: 406.6;Extravillous trophoblasts: 249.7;Syncytiotrophoblasts: 655.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	15	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049851, HPA049974"	Approved					NA	NA					"HPA049851: AB_2680913, HPA049974: AB_2680976"	"unprognostic (3.31e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.81e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.86e-4)"	"unprognostic (1.55e-1)"	10.5	35.3	10.5	4.0	23.0	0.1	19.7	21.5	19.8	12.1	6.2	5.4	5.1	4.5	16.0	50.5	6.1	27.0	8.1	16.1	10.4	21.4	11.6	3.2	8.5	3.3	6.0	15.6	35.5	15.8	24.8	50.6	127.8	13.4	23.9	7.1	11.6	5.7	14.1	2.8	3.8	4.1	14.4	4.3	3.6	5.2	10.2	3.3	2.9	4.7	3.6	2.4	15.0	9.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	13.2	9.6	26.5	24.7	30.9	35.8	0.0	18.8	40.4	20.8	34.9	0.0	0.0	0.1	6.6	25.0	23.0	10.1	9.2	18.0	30.3	0.0	12.6	0.0	7.8	1.5	13.4	0.0	1.3	28.4	5.7	29.1	10.9	29.9	1.7	3.9	17.5	4.0	31.6	9.5	4.8	0.1	13.2	0.0	8.3	5.9	22.0	0.1	28.8	33.0	10.5	20.3	0.0	10.7	14.6	20.2	12.6	0.0	8.1	19.2	19.0	8.0	9.3	0.0	2.3	0.0	0.3	0.0	26.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.5	23.0	21.5	19.8	10.4	21.4	6.0	15.6	13.4	3.3	0.0	9.3	0.0	50.9	8.9	49.5	42.5	20.4	75.0	29.6	75.0	7.9	406.6	14.9	137.4	9.6	16.8	0.2	0.0	10.2	249.7	45.2	77.9	1.1	0.0	36.4	30.2	92.1	10.4	0.0	5.7	32.2	2.2	23.6	2.8	20.2	33.8	32.0	0.0	21.5	18.8	20.0	38.8	18.3	50.1	42.8	3.6	655.5	0.5	8.3	40.9
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628433	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favorable (5.09e-5)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	35.6	25.0	41.2	31.5	39.9	44.2	35.9	31.9	49.6	43.9	50.4	35.5	31.5	22.2	35.5	52.2	44.8	47.6	27.1	34.8	39.5	40.5	37.2	39.5	34.8	55.6	40.5	36.1	35.3	41.7	23.8	35.3	33.6	35.9	30.8	46.4	30.7	30.5	37.9	80.6	33.2	37.4	39.3	41.9	41.3	29.1	68.0	29.3	71.0	34.4	31.2	64.5	42.2	36.1	34.3	39.3	40.8	23.0	22.5	41.7	19.5	34.1	22.8	40.0	27.9	27.0	34.7	25.6	36.1	33.8	42.6	49.9	58.6	32.5	48.8	47.6	37.2	52.7	21.7	39.2	60.9	57.1	31.5	22.9	27.7	25.2	33.7	52.9	27.0	24.7	27.2	31.5	42.3	63.3	36.9	45.4	32.3	24.0	41.8	39.5	34.3	41.6	38.5	22.0	12.0	24.8	31.8	41.6	35.3	44.8	40.4	36.5	24.1	31.5	40.6	57.4	89.9	25.4	24.0	29.7	32.6	18.1	27.0	44.1	30.1	48.9	68.5	23.3	44.6	25.9	14.8	20.9	40.8	22.6	18.8	24.7	34.1	32.7	31.7	23.4	34.3	41.7	35.2	34.5	22.5	23.0	39.3	40.0	19.5	41.2	39.9	31.9	49.6	39.5	40.5	40.5	36.1	35.9	29.3	29.8	71.1	173.0	150.9	152.6	68.0	80.9	79.0	36.1	43.3	64.6	76.6	160.4	182.4	173.6	500.3	117.4	113.7	70.0	156.3	191.8	125.8	164.5	136.2	71.0	157.1	89.0	118.5	93.9	121.3	409.1	96.7	157.7	145.1	191.2	112.3	128.4	182.8	103.7	88.1	147.6	99.0	116.4	156.8	337.7	125.2	178.2	208.7	191.8	148.1	221.1
UBE2I	UBC9	ENSG00000103275	"Ubiquitin conjugating enzyme E2 I"	P63279	16	1308880-1327018	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003909, CAB009021"	Approved					NA	NA		120000			"CAB009021: AB_2210610, HPA003909: AB_1858529"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.15e-3)"	34.3	43.1	28.8	36.3	36.9	48.4	45.2	45.6	48.5	38.1	32.0	28.6	28.1	28.9	55.4	32.9	43.4	35.6	30.3	41.8	27.4	28.4	29.4	26.6	29.1	44.2	22.7	32.9	62.5	35.5	33.4	36.2	47.2	21.4	40.7	31.0	34.1	37.8	32.2	31.6	35.8	32.2	40.0	23.2	43.7	29.4	43.6	21.6	78.0	42.5	31.8	53.9	38.7	38.8	82.2	58.0	85.4	67.4	50.9	57.8	60.0	25.5	35.2	59.5	35.0	25.5	30.9	25.7	36.8	26.6	34.3	34.2	41.7	42.0	44.5	30.6	31.7	31.2	31.1	42.5	34.6	44.2	31.9	30.0	27.8	32.6	40.2	40.4	41.2	33.2	28.6	22.4	33.6	40.1	33.3	37.0	37.0	39.8	28.0	32.3	54.4	72.7	41.5	48.4	28.9	26.1	92.4	37.7	50.5	31.9	23.5	33.7	35.6	32.3	36.7	36.6	35.5	37.3	50.0	30.5	34.0	39.0	29.8	33.2	29.6	35.0	90.7	19.1	30.6	36.0	63.9	59.3	85.4	48.0	67.4	57.8	82.2	49.0	48.7	58.0	61.8	44.1	44.2	41.3	50.9	62.3	50.1	50.9	60.0	28.8	36.9	45.6	48.5	27.4	28.4	22.7	32.9	21.4	21.6	47.6	65.0	161.9	150.2	158.7	57.7	79.1	79.0	46.8	86.4	59.3	47.1	272.2	89.5	194.9	43.7	106.6	69.9	46.7	129.2	244.2	135.3	169.8	105.3	33.7	188.2	44.5	98.2	78.5	89.4	24.8	120.3	128.8	121.4	250.7	90.2	79.4	176.3	97.7	101.1	89.7	59.4	77.6	104.9	123.1	163.1	180.8	349.7	134.6	123.3	223.4
UBQLN4	"A1U, C1orf6, UBIN"	ENSG00000160803	"Ubiquilin 4"	Q9NRR5	1	156035301-156053794	"Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 9.7"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061797	Approved		Supported	Nucleoplasm		NA	NA			Nucleoplasm		"HPA061797: AB_2684613"	"unprognostic (3.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.57e-1)"	7.1	6.7	13.8	7.4	19.9	3.9	12.4	23.1	25.2	9.9	7.8	6.5	4.2	7.2	11.9	8.9	11.6	10.2	6.2	9.3	17.7	9.7	7.9	10.2	8.5	7.3	15.0	18.7	15.1	14.1	10.6	3.6	8.4	12.4	8.9	8.8	6.4	12.4	11.8	24.3	11.6	7.4	13.1	8.7	6.8	9.4	6.9	13.7	7.9	6.8	6.6	8.9	8.2	8.4	1.9	2.0	9.7	1.2	1.7	3.2	1.1	16.2	19.6	18.8	18.4	12.9	8.0	18.6	13.7	7.6	13.8	10.4	17.6	14.8	27.7	12.6	12.5	7.5	18.3	19.0	14.8	13.2	23.3	20.1	15.2	11.2	16.9	8.3	16.3	28.8	6.0	19.1	19.0	15.5	12.2	16.4	8.9	28.4	15.5	12.4	20.0	17.9	16.5	25.8	41.9	18.3	23.0	13.9	27.4	11.2	16.5	13.9	40.2	13.8	34.3	14.1	19.1	33.1	18.0	15.8	12.8	17.0	13.0	14.7	34.5	27.4	30.2	7.8	16.5	17.9	9.7	1.1	0.6	2.5	1.2	3.2	1.9	2.0	2.7	0.9	1.5	1.5	2.1	0.0	1.7	0.2	2.0	1.6	1.1	13.8	19.9	23.1	25.2	17.7	9.7	15.0	18.7	12.4	13.7	6.0	4.0	4.5	7.5	11.8	5.9	4.3	15.3	2.7	4.5	22.7	5.9	7.1	3.3	10.9	0.7	6.8	6.6	0.0	9.3	8.1	7.9	16.4	1.1	19.4	8.6	6.4	10.3	9.8	7.2	2.3	6.1	7.4	16.9	17.2	9.7	6.1	11.1	5.8	8.5	9.2	5.2	0.0	8.0	3.6	5.1	12.8	6.9	5.7	13.3	10.5
UCP1	"SLC25A7, UCP"	ENSG00000109424	"Uncoupling protein 1"	P25874	4	140559434-140568805	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 2.4;adrenal gland: 8.4;breast: 2.2;heart muscle: 7.1"	"Cell type enhanced"	"Detected in single"	24	"Syncytiotrophoblasts: 1.9"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 9.8;HAP1: 7.1;JURKAT: 2.5"	"Not detected"	"Not detected"													NA	NA						"unprognostic (5.08e-3)"	"unprognostic (4.44e-1)"		"unprognostic (2.65e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.17e-2)"		"unprognostic (6.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"		"unprognostic (4.45e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.58e-2)"	2.4	8.4	0.1	0.1	0.1	0.0	2.2	0.1	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	7.1	0.1	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.2	0.0	0.1	0.8	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	9.8	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.7	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0
UCP2	"BMIQ4, SLC25A8"	ENSG00000175567	"Uncoupling protein 2"	P55851	11	73974667-73983307	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 219.1;lymphoid tissue: 144.8"	"Cell type enhanced"	"Detected in many"	11	"Erythroid cells: 420.4;Hofbauer cells: 378.7;Intestinal endocrine cells: 285.5;monocytes: 710.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 68.0;SK-BR-3: 87.6;U-698: 56.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025583, HPA075202"	Approved		Supported	Mitochondria		NA	NA			Mitochondria		"CAB025583: , HPA075202: AB_2732284"	"unprognostic (1.13e-1)"	"prognostic favorable (4.65e-5)"	"unprognostic (8.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.80e-6)"	"unprognostic (3.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.88e-3)"	19.8	9.8	5.3	40.4	9.5	24.5	15.9	1.1	4.9	8.1	7.7	10.2	20.3	11.4	4.2	12.0	4.5	37.9	13.1	11.5	4.4	5.5	12.8	10.6	20.2	85.6	7.8	2.4	7.2	4.7	1.2	6.2	8.7	6.5	6.5	8.9	14.2	17.4	17.2	45.3	4.3	24.7	6.4	9.0	91.1	12.3	5.5	5.9	144.8	17.9	19.3	55.7	19.4	2.9	141.6	219.1	101.8	135.3	119.8	180.2	172.1	0.1	14.3	3.3	9.8	1.9	0.0	2.5	2.4	1.6	9.8	2.8	25.1	12.2	68.0	34.0	3.7	0.8	0.6	2.3	0.0	4.6	17.2	0.8	39.7	6.0	5.2	5.9	20.8	16.7	2.2	0.0	9.3	0.0	1.9	1.3	26.2	18.2	27.8	1.9	24.5	21.5	11.2	2.6	1.5	2.9	19.9	22.7	38.5	27.4	40.6	5.0	6.1	12.8	87.6	4.8	9.9	25.8	18.6	1.8	0.0	12.6	2.9	4.7	9.5	4.5	56.6	1.7	8.3	0.1	45.7	81.5	101.8	112.6	135.3	69.9	141.6	92.3	95.0	88.4	134.2	86.9	91.1	11.4	119.8	111.3	219.1	180.2	172.1	5.3	9.5	1.1	4.9	4.4	5.5	7.8	2.4	6.5	5.9	3.0	35.4	250.6	2.3	3.1	0.9	3.6	2.5	93.7	23.9	87.2	7.9	6.6	6.6	1.2	16.1	5.0	4.2	420.4	6.5	10.3	6.7	15.6	84.3	0.6	378.7	0.0	285.5	11.6	244.1	37.5	0.9	160.3	25.3	710.6	23.4	2.9	2.5	37.6	0.4	1.9	6.3	6.5	5.3	14.4	13.4	4.0	9.4	172.7	24.7	21.6
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000281-74009435	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease mutation, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	15	"skeletal muscle: 99.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 14.7;Late spermatids: 10.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"cerebellum: 1.1"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 18.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	0.9	0.2	0.2	0.3	0.2	0.6	0.2	1.1	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.5	0.9	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.2	1.0	0.2	99.6	0.3	0.2	0.2	0.2	0.5	0.1	0.6	0.2	0.2	0.6	6.4	0.8	0.2	0.2	0.8	0.1	0.7	0.3	0.2	2.1	0.4	0.2	2.1	2.1	1.8	0.8	0.4	0.4	0.5	0.5	0.5	0.3	0.5	0.4	1.1	0.3	0.4	0.3	2.2	0.8	0.4	0.8	18.3	0.7	0.4	2.4	0.2	0.6	1.2	1.7	0.5	1.4	1.3	0.1	0.4	0.7	1.0	0.5	1.4	0.7	1.2	0.8	1.6	1.0	1.6	1.4	1.6	4.3	0.6	1.1	0.6	1.2	1.3	0.5	0.9	0.7	0.4	0.2	1.1	0.4	0.3	1.4	0.7	1.3	1.6	1.7	0.8	0.3	1.1	0.7	0.0	0.3	0.7	2.1	0.1	0.9	0.0	1.5	1.8	0.0	0.8	0.6	1.2	0.1	0.2	0.0	0.1	0.4	0.4	0.2	0.2	1.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.5	0.1	0.1	2.2	0.5	0.0	2.7	1.2	0.0	0.0	0.3	0.0	0.3	14.7	0.1	0.0	0.0	0.4	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.8	10.7	0.0	0.0	0.0	0.0	0.6	0.7	0.3	0.0	0.7	0.0	1.6	0.0	0.1	1.2	0.7	0.3	0.2	2.2	0.6	0.0
UFD1	UFD1L	ENSG00000070010	"Ubiquitin recognition factor in ER associated degradation 1"	Q92890	22	19449910-19479215	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cytotrophoblasts: 105.1;Ductal cells: 98.8;Exocrine glandular cells: 123.6;monocytes: 132.6;Pancreatic endocrine cells: 115.9;Syncytiotrophoblasts: 142.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 131.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030286, HPA030287"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Nucleoplasm, Cytosol"	Nucleoli	"HPA030286: , HPA030287: AB_10601830"	"unprognostic (2.52e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.50e-8)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	27.8	28.0	22.7	24.3	38.0	38.7	23.9	25.3	30.4	21.1	28.9	23.3	24.7	21.7	32.8	40.3	31.6	21.3	21.7	35.6	21.9	22.9	28.0	46.6	24.6	34.8	44.3	15.9	22.4	34.7	22.5	22.6	31.6	33.0	21.7	27.7	21.9	26.7	24.4	57.9	27.3	24.7	28.3	39.7	26.7	26.2	31.8	29.9	37.8	27.8	26.9	31.7	23.9	23.7	27.7	35.3	53.5	42.8	31.1	67.6	37.5	31.8	23.2	19.8	30.0	16.3	11.5	15.2	26.4	26.4	36.5	33.8	25.7	13.9	22.3	20.5	22.1	16.8	27.7	23.2	23.1	31.8	41.0	24.5	23.5	16.4	20.3	15.5	37.2	32.1	10.5	23.8	31.1	15.3	10.7	29.2	11.8	131.8	43.0	22.2	46.3	23.9	22.8	14.2	40.2	19.7	29.1	46.9	8.6	22.4	30.1	16.3	18.3	20.7	22.5	20.7	21.6	13.5	17.9	31.7	30.8	41.9	25.6	28.3	18.4	36.6	29.0	25.9	19.0	28.1	39.8	29.0	47.8	36.1	42.8	34.7	27.7	41.6	37.3	25.5	23.9	35.9	35.1	53.5	31.1	41.1	35.3	67.6	37.5	22.7	38.0	25.3	30.4	21.9	22.9	44.3	15.9	33.0	29.9	23.8	34.6	0.0	0.0	0.0	0.0	0.0	0.0	50.9	30.7	26.2	0.0	105.1	71.3	98.8	0.0	0.0	0.0	0.0	123.6	90.9	0.0	0.0	25.6	0.0	79.3	0.0	0.0	0.0	0.0	0.0	0.0	26.0	0.0	132.6	0.0	0.0	115.9	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	142.5	0.0	0.0	0.0
UGCG	GCS	ENSG00000148154	"UDP-glucose ceramide glucosyltransferase"	Q16739	9	111896766-111935369	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	9	"Urothelial cells: 446.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	19	"plasmacytoid DC: 39.7"	"Lineage enriched"	"Detected in many"	19	"dendritic cells: 39.7"	"Cell line enhanced"	"Detected in all"		"LHCN-M2: 50.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024124	Approved					NA	NA					"HPA024124: AB_1858595"	"unprognostic (1.22e-2)"	"prognostic favorable (6.62e-4)"	"unprognostic (5.39e-2)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.53e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.77e-2)"	33.7	37.7	5.9	21.4	7.8	55.2	20.5	9.5	11.2	14.6	19.6	5.0	3.3	13.3	10.6	8.6	34.0	11.1	24.5	17.5	8.6	9.0	23.8	18.4	28.1	35.4	7.1	5.8	15.9	11.4	3.5	11.9	15.3	6.8	12.4	10.5	11.9	10.8	5.4	14.0	21.7	25.5	12.4	12.9	33.1	26.1	11.7	6.2	17.9	8.5	16.9	27.7	34.2	25.9	2.0	39.7	0.4	0.3	0.5	1.2	0.5	23.1	2.4	4.0	2.7	8.8	10.6	2.1	14.5	15.3	17.0	23.1	4.9	17.8	5.5	11.5	9.6	37.3	11.9	4.7	6.3	18.3	2.2	2.7	2.2	3.7	2.4	6.3	2.4	3.6	10.5	4.9	16.2	23.4	39.5	5.2	2.7	12.1	10.7	50.2	3.9	2.6	2.7	4.6	7.8	2.6	3.0	28.9	1.7	39.1	8.8	1.9	3.1	6.4	5.4	15.9	25.1	29.2	2.5	24.4	7.8	4.0	21.9	10.3	2.0	7.3	2.5	9.7	1.5	10.6	0.0	0.1	0.0	0.4	0.2	0.7	1.6	0.8	0.6	0.6	2.0	0.7	0.7	0.4	0.5	0.3	39.7	1.2	0.5	5.9	7.8	9.5	11.2	8.6	9.0	7.1	5.8	6.8	6.2	38.7	48.5	29.9	123.9	67.2	26.0	9.2	30.6	115.1	113.7	27.9	58.9	5.7	14.9	98.3	14.5	72.6	52.6	0.0	43.7	10.2	46.0	156.5	10.4	15.5	19.6	17.5	17.7	92.7	30.2	3.6	45.5	30.8	55.6	69.5	41.5	7.8	67.4	21.0	36.0	56.0	14.2	12.9	60.8	1.6	1.5	106.9	2.9	26.6	12.8	446.9
UNC93B1	UNC93	ENSG00000110057	"Unc-93 homolog B1, TLR signaling regulator"	Q9H1C4	11	67991104-68004982	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in many"	6	"Hofbauer cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 13.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 31.3;RPMI-8226: 87.0;SK-BR-3: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038716, HPA038717, HPA042803"	Approved		Approved	Nucleoplasm		No	No			Nucleoplasm		"HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176"	"unprognostic (3.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-3)"	"unprognostic (5.23e-3)"	8.0	2.7	5.7	9.7	7.4	9.2	5.0	6.2	7.0	4.7	11.9	5.3	6.9	11.8	2.3	5.7	5.5	4.1	13.9	4.6	8.7	6.0	5.9	7.1	13.4	20.8	3.6	0.4	3.0	5.2	0.8	3.3	6.7	2.7	5.3	1.2	5.0	12.3	9.0	6.1	3.7	16.9	2.7	3.5	28.6	10.7	4.1	2.2	2.6	5.3	2.4	13.3	5.9	2.8	2.5	13.6	5.7	6.6	1.8	0.2	0.9	4.5	8.2	0.6	3.3	1.8	0.6	7.1	2.0	1.8	3.2	2.9	0.6	31.3	10.0	7.8	0.9	2.7	10.9	0.2	1.7	0.1	3.5	2.3	1.0	2.6	1.5	2.8	7.1	5.7	1.5	1.8	0.9	0.3	1.2	0.6	1.5	0.7	4.7	0.5	4.3	0.0	5.6	1.5	11.0	4.4	5.9	0.0	87.0	2.8	2.5	0.9	1.4	3.4	23.4	4.5	0.2	8.7	9.3	2.2	2.1	3.1	3.1	0.2	3.3	4.4	1.6	4.0	7.3	2.5	0.1	3.6	5.7	0.1	6.6	0.2	2.4	0.2	0.2	4.7	2.5	0.0	0.0	3.1	1.8	6.6	13.6	0.0	0.9	5.7	7.4	6.2	7.0	8.7	6.0	3.6	0.4	2.7	2.2	8.9	7.8	29.4	21.8	3.5	0.0	1.6	35.7	36.1	6.8	15.7	0.0	9.0	1.7	33.6	0.6	5.8	24.2	0.0	20.5	41.1	8.3	14.1	6.9	4.0	87.3	4.8	4.1	5.5	53.9	0.0	4.0	51.3	21.9	53.3	14.2	4.8	34.0	21.0	3.9	5.7	0.3	0.0	4.2	0.0	0.9	5.6	6.1	9.6	18.7	30.4
UPK1A	TSPAN21	ENSG00000105668	"Uroplakin 1A"	O00322	19	35666516-35678483	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"prostate: 20.3;urinary bladder: 80.6"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 28.0"	"Cancer enriched"	"Detected in many"	41	"urothelial cancer: 148.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"RT4: 29.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA049879	Enhanced					NA	NA					"HPA049879: AB_2680929"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.40e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-9)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.72e-1)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	6.0	0.1	0.1	0.1	0.0	0.4	0.1	12.8	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	20.3	0.0	0.1	0.9	0.1	0.1	6.7	0.1	4.5	0.1	0.1	0.0	0.2	0.1	0.1	0.1	1.1	1.0	80.6	8.6	1.7	0.5	1.8	0.5	1.6	2.0	0.8	0.2	0.9	0.1	0.2	0.3	0.1	0.3	0.2	0.0	0.1	0.4	1.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.8	0.7	0.0	0.3	0.2	0.1	0.1	0.4	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.4	6.1	0.2	0.0	0.1	0.0	0.0	29.6	0.1	0.3	0.4	0.3	0.5	0.2	0.2	0.3	0.9	0.0	1.2	0.1	0.2	0.1	0.4	0.0	0.1	0.1	0.2	1.1	0.5	0.2	0.3	0.4	0.5	0.6	2.0	0.6	0.2	1.7	0.1	0.6	1.8	1.6	0.1	0.5	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.1	0.4	0.1	0.0	0.0	28.0
UPK1B	"TSPAN20, UPK1"	ENSG00000114638	"Uroplakin 1B"	O75841	3	119173517-119205153	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 56.4;urinary bladder: 41.9"	"Cell type enhanced"	"Detected in some"	16	"Cholangiocytes: 35.7;Club cells: 9.1;Ductal cells: 10.8;Proximal tubular cells: 11.2;Urothelial cells: 19.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 147.3"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"CACO-2: 15.4;RPTEC TERT1: 14.4;RT4: 55.5"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA031799, HPA031800"	Enhanced					NA	NA					"HPA031799: AB_10671579, HPA031800: AB_10671580"	"unprognostic (1.20e-2)"	"unprognostic (7.18e-2)"		"prognostic favorable (3.87e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"		"unprognostic (8.77e-3)"	"unprognostic (3.67e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.68e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	6.1	0.2	0.2	0.2	1.2	0.0	0.2	0.2	0.3	3.6	0.7	0.0	0.0	0.0	1.5	0.3	2.4	5.1	12.9	1.8	0.2	0.2	6.6	0.6	1.4	0.0	0.2	0.1	0.8	11.6	0.0	0.4	56.4	1.1	15.4	0.0	0.0	0.4	0.0	0.2	0.6	0.2	4.3	1.8	0.2	22.9	0.7	0.0	1.4	0.2	1.4	12.9	41.9	1.1	0.7	1.1	2.5	0.5	0.6	1.9	0.5	0.0	6.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	15.4	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	14.4	55.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.5	0.3	0.3	0.2	0.4	0.2	0.3	0.5	0.7	1.9	0.3	1.8	0.6	0.4	1.1	0.2	0.5	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.1	1.1	0.0	0.0	1.0	0.0	0.3	0.2	0.4	0.1	35.7	0.0	9.1	0.0	0.0	1.0	0.0	10.8	3.0	0.1	0.0	0.0	0.6	7.7	0.2	0.8	2.3	0.0	0.5	1.6	0.0	0.0	0.0	1.0	0.0	1.4	1.7	1.8	0.0	0.2	0.6	0.0	0.0	11.2	0.6	0.0	0.2	0.2	0.2	0.0	1.3	0.0	0.0	19.0
UPK2	"MGC138598, UP2, UPII"	ENSG00000110375	"Uroplakin 2"	O00526	11	118925164-118958559	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"prostate: 39.0;urinary bladder: 52.4;vagina: 25.9"	"Group enriched"	"Detected in some"	6	"Club cells: 3.4;Cytotrophoblasts: 5.1;Syncytiotrophoblasts: 8.0;Urothelial cells: 6.9"	"Cancer enriched"	"Detected in many"	72	"urothelial cancer: 339.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.0;T-reg: 1.9"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"MCF7: 47.0;RT4: 53.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043312, HPA061106"	Enhanced					NA	NA					"HPA043312: AB_2678420, HPA061106: AB_2684429"	"unprognostic (6.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.12e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (7.30e-7)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.00e-1)"	1.0	0.0	0.2	0.0	0.3	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.1	0.0	0.0	0.2	0.2	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	3.8	0.0	39.0	0.0	0.0	0.2	0.1	0.1	0.1	0.0	6.8	0.1	0.1	0.1	0.2	0.0	0.2	0.0	0.2	1.3	52.4	25.9	0.7	0.6	0.0	0.1	2.0	1.9	0.2	1.2	0.1	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.4	0.0	2.0	0.0	0.6	1.9	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	3.4	0.0	0.0	5.1	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.4	0.2	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	8.0	0.0	0.0	6.9
UPK3A	UPK3	ENSG00000100373	"Uroplakin 3A"	O75631	22	45284982-45295874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.7;skeletal muscle: 24.5;urinary bladder: 45.5"	"Cell type enhanced"	"Detected in some"	20	"Basal glandular cells: 20.5;Glandular cells: 61.9;monocytes: 13.6;Urothelial cells: 21.4"	"Group enriched"	"Detected in many"	6	"prostate cancer: 35.3;urothelial cancer: 78.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	11	"classical monocyte: 8.5;intermediate monocyte: 9.6;myeloid DC: 33.7;non-classical monocyte: 11.3;plasmacytoid DC: 13.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 33.7;monocytes: 11.3"	"Group enriched"	"Detected in some"	5	"Hep G2: 18.7;RT4: 31.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018407, HPA018415"	Enhanced		Uncertain	"Nuclear membrane,Nuclear bodies"		NA	NA			"Nuclear membrane"	"Nuclear bodies"	"HPA018407: AB_1858641, HPA018415: AB_1858640"	"unprognostic (1.27e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.98e-5)"	"unprognostic (1.69e-2)"	"unprognostic (4.82e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.05e-3)"	0.2	0.1	0.3	1.6	0.4	0.9	0.3	0.2	0.5	0.4	0.7	0.0	0.0	0.0	0.2	2.3	0.2	0.2	0.6	0.2	0.3	0.3	0.2	0.2	0.2	1.0	0.4	0.1	0.2	0.2	6.4	0.5	0.0	0.7	17.9	0.5	0.6	12.9	1.8	24.5	0.2	1.8	13.0	0.3	0.7	0.2	0.2	0.0	1.3	4.6	1.7	0.6	45.5	2.7	0.3	33.7	1.4	11.3	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.2	0.0	2.9	0.0	0.0	0.0	0.1	0.0	31.3	0.1	0.0	0.1	0.5	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	9.6	0.0	0.3	0.0	0.0	33.7	0.2	0.0	0.0	1.4	0.1	11.3	13.0	0.0	2.8	0.3	0.4	0.2	0.5	0.3	0.3	0.4	0.1	0.7	0.0	0.0	0.0	0.5	20.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	61.9	0.0	0.0	1.6	0.0	0.0	0.0	6.4	0.9	0.3	6.3	0.0	13.6	3.1	0.7	0.0	7.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.4	0.1	0.0	2.8	21.4
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510428-76516521	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 28.5;esophagus: 40.2;lung: 34.1;lymphoid tissue: 25.0"	"Cell type enriched"	"Detected in some"	10	"Alveolar cells type 1: 113.2"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Region enriched"	"Detected in single"	58	"pons and medulla: 5.8"	"Cell type enriched"	"Detected in single"	6	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in some"		"A549: 7.8;CAPAN-2: 28.5;HaCaT: 5.8;RT4: 19.5;T-47d: 16.2"									HPA010506	Approved					NA	NA					"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	28.5	0.3	0.0	7.1	0.0	0.4	0.3	0.0	0.3	1.5	6.9	0.1	0.0	0.3	0.8	7.9	40.2	2.8	3.0	9.4	0.0	0.0	0.3	0.4	34.1	0.4	0.0	0.0	13.2	0.3	0.3	0.1	0.3	5.8	1.4	0.3	0.8	1.4	0.3	0.4	1.1	0.5	1.5	0.2	0.4	0.6	6.1	0.0	0.2	0.3	6.1	25.0	20.5	2.1	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.6	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	28.5	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.2	2.3	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	113.2	3.5	0.0	0.2	1.4	0.0	0.3	2.5	4.0	9.1	3.5	3.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.2	1.1	0.0	0.1	1.6	0.0	0.6	0.0	0.0	11.2	0.9	3.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	2.5	0.1	0.0	0.1	2.5
VAMP1	"SYB1, VAMP-1"	ENSG00000139190	"Vesicle associated membrane protein 1"	P23763	12	6462237-6470987	"FDA approved drug targets, Predicted membrane proteins, Transporters"			"Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.7;brain: 85.2"	"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 16.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	6	"U-698: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002779, CAB016119, CAB079000"	Approved	Supported				NA	NA					"CAB002779: , CAB016119: AB_628309, CAB079000: "	"unprognostic (2.33e-1)"	"unprognostic (6.72e-3)"	"prognostic unfavorable (6.37e-5)"	"unprognostic (8.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.22e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.04e-11)"	"unprognostic (1.47e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.65e-2)"	3.4	6.8	10.2	13.7	12.8	38.7	4.2	9.8	53.1	5.7	8.0	11.1	1.6	4.7	8.7	5.4	3.9	5.1	5.2	4.0	14.1	25.4	3.2	4.3	5.3	24.3	33.5	10.0	3.8	2.4	1.1	3.1	2.4	85.2	8.6	8.8	4.8	6.3	7.6	4.0	4.2	7.9	7.7	31.3	12.4	5.4	3.7	8.3	3.7	7.9	0.8	23.0	5.0	4.7	5.5	2.5	13.4	1.0	2.1	7.0	2.5	0.9	3.5	1.9	2.6	5.7	6.6	2.2	1.8	3.5	1.9	5.5	1.1	3.2	9.9	0.4	4.4	1.9	3.0	2.3	1.0	2.8	7.8	5.5	1.5	10.4	1.2	2.7	3.8	3.8	4.8	0.4	2.5	1.4	6.5	1.7	4.4	0.5	2.9	4.3	1.0	5.0	4.4	9.4	0.4	1.5	5.5	3.1	1.8	1.2	1.3	0.4	0.8	3.8	2.0	1.4	10.8	0.6	1.5	2.1	0.9	3.0	2.0	1.2	2.6	1.0	67.8	3.6	8.0	0.7	6.9	1.0	13.4	6.7	0.4	5.3	5.5	5.5	6.2	1.1	1.3	5.8	4.8	5.5	2.1	0.5	2.5	7.0	2.5	10.2	12.8	9.8	53.1	14.1	25.4	33.5	10.0	85.2	8.3	6.0	1.3	8.2	2.7	1.0	16.3	1.4	2.5	4.0	2.3	0.0	5.9	0.3	1.7	0.2	0.3	2.2	1.7	0.0	0.4	0.7	2.6	2.4	10.4	3.2	1.4	1.6	4.6	2.5	1.8	0.4	3.4	2.4	0.0	4.6	1.2	6.1	0.5	0.9	4.6	0.3	6.8	6.5	3.6	2.3	2.6	0.6	0.1	9.2	1.5	0.8
VAMP2	"SYB2, VAMP-2"	ENSG00000220205	"Vesicle associated membrane protein 2"	P63027	17	8159149-8163546	"FDA approved drug targets, Predicted membrane proteins, Transporters"			"Disease mutation, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 168.0"	"Cell type enhanced"	"Detected in all"	7	"Bipolar cells: 1189.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB078785		Supported				NA	NA					"CAB078785: "	"unprognostic (8.25e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (3.83e-6)"	"unprognostic (8.27e-2)"	"prognostic favorable (9.76e-8)"	"unprognostic (1.21e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	22.0	38.3	65.1	16.2	111.7	57.4	20.2	72.2	168.0	20.1	16.3	51.6	11.6	15.7	27.4	24.1	11.6	26.8	14.4	22.1	61.7	56.5	23.5	11.4	21.0	23.1	52.7	71.1	48.4	22.6	52.2	40.6	15.4	88.4	25.1	19.3	37.5	19.5	27.0	33.6	25.0	17.9	25.2	30.7	27.2	17.4	15.1	35.1	9.2	22.0	8.8	22.8	11.7	16.0	25.1	15.4	37.8	8.8	25.1	33.4	9.3	13.8	10.4	25.8	13.8	22.7	17.8	11.6	13.0	16.5	13.3	18.3	4.1	9.5	15.8	9.3	20.8	12.5	16.9	16.9	14.0	15.4	18.3	18.5	11.0	26.7	5.6	20.4	7.3	17.1	19.6	21.1	15.3	23.0	27.5	12.9	27.7	8.5	18.4	22.5	7.3	19.1	10.1	5.9	9.3	7.7	24.4	11.8	12.4	17.2	9.3	12.0	19.2	10.2	5.7	12.7	11.8	13.0	9.5	19.7	8.1	11.2	14.8	12.0	20.3	11.5	11.4	20.6	12.8	18.3	13.7	7.4	24.5	28.4	6.9	24.4	25.1	28.2	30.0	5.7	22.1	33.4	30.8	37.8	25.1	8.8	15.4	20.1	9.3	65.1	111.7	72.2	168.0	61.7	56.5	52.7	71.1	88.4	35.1	38.7	21.2	219.6	147.9	101.1	1189.4	24.3	147.7	17.4	34.2	219.8	233.7	157.6	334.9	66.7	5.4	128.8	97.5	23.3	73.0	75.1	142.8	110.4	150.8	68.4	95.0	440.2	310.2	154.7	94.0	5.9	242.4	101.2	183.9	129.8	134.5	437.1	85.1	111.2	202.6	152.5	445.5	291.1	199.4	106.5	119.6	131.7	267.6	252.2	82.9	115.3
VAMP3	CEB	ENSG00000049245	"Vesicle associated membrane protein 3"	Q15836	1	7771269-7781432	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.09e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.15e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.49e-3)"	"unprognostic (2.00e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.30e-2)"	52.6	35.6	36.0	20.3	43.9	42.4	35.9	14.8	37.6	37.1	28.8	92.8	19.3	27.0	45.3	30.1	40.5	29.4	28.2	32.8	38.9	30.4	38.3	27.2	39.3	25.8	63.3	26.1	35.9	17.8	31.7	24.9	45.4	50.2	31.4	32.9	41.3	23.1	37.9	34.8	33.6	41.5	37.7	90.6	34.2	26.3	25.4	48.2	14.7	30.0	37.1	26.8	36.4	29.9	5.1	15.8	31.2	26.0	6.8	7.4	9.5	19.1	13.7	14.8	17.6	40.6	45.9	10.4	34.7	39.4	37.4	35.4	14.9	24.9	2.5	19.6	43.6	19.1	16.8	16.1	23.4	48.1	2.0	20.1	12.4	12.8	20.7	26.4	7.3	12.3	37.3	17.6	26.5	21.7	37.0	45.0	5.7	12.7	11.8	52.0	8.6	5.5	6.5	6.5	21.6	24.1	4.6	21.5	7.8	29.2	11.1	4.0	15.5	30.1	14.9	31.0	18.5	15.0	7.8	39.8	33.7	11.6	34.8	16.6	9.8	13.2	7.5	38.5	29.8	26.4	17.4	22.6	22.3	6.3	26.0	6.4	5.1	6.0	5.5	15.8	4.4	4.9	5.2	31.2	6.8	22.5	5.2	7.4	9.5	36.0	43.9	14.8	37.6	38.9	30.4	63.3	26.1	50.2	48.2	44.7	33.7	17.9	51.0	38.7	12.1	38.3	22.9	33.5	28.4	38.4	3.9	70.0	54.7	60.2	19.5	76.7	51.9	0.0	44.0	93.9	39.8	49.7	55.6	30.6	70.0	7.9	30.0	58.9	66.5	9.8	30.0	70.1	54.0	65.9	37.0	79.1	68.1	40.3	44.2	73.6	8.3	45.3	66.3	48.4	39.6	44.8	95.8	20.8	36.2	80.6
VAMP8	EDB	ENSG00000118640	"Vesicle associated membrane protein 8"	Q9BV40	2	85561562-85582031	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 172.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 82.0;NB-4: 128.2;THP-1: 63.7;U-937: 85.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006882, HPA007215, CAB037132, CAB037147"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		210000	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: "	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (8.07e-9)"	"prognostic favorable (1.59e-6)"	16.5	8.2	7.1	20.7	11.2	27.6	24.2	1.9	6.2	16.3	49.4	5.7	43.5	24.1	6.0	25.5	65.4	17.1	28.8	13.0	4.7	3.8	67.7	46.5	53.1	48.0	10.5	3.2	7.1	58.0	15.4	8.3	108.1	11.9	22.1	31.9	7.7	90.7	40.4	9.0	43.3	87.1	6.8	10.4	53.5	28.7	5.5	8.4	24.5	47.5	35.4	34.9	20.6	30.4	39.2	172.5	37.7	69.7	41.4	51.3	100.9	23.9	3.1	0.2	0.2	0.2	0.1	23.9	0.0	0.0	0.0	0.0	17.8	22.0	5.3	17.4	0.1	1.8	17.0	0.2	42.9	0.0	21.8	16.6	27.6	10.6	20.2	0.3	82.0	28.6	0.2	30.5	0.0	7.1	0.1	5.5	0.1	19.7	1.1	9.8	33.6	0.0	128.2	0.3	30.0	2.5	0.5	0.9	36.0	49.7	36.0	0.8	0.3	11.7	62.1	1.9	13.0	22.8	63.7	11.0	0.0	1.5	0.3	0.2	0.3	13.5	31.4	0.3	85.1	0.1	37.7	69.7	25.2	40.4	57.7	38.8	39.2	46.8	39.5	63.5	37.8	37.3	39.1	4.5	41.4	34.3	172.5	51.3	100.9	7.1	11.2	1.9	6.2	4.7	3.8	10.5	3.2	11.9	8.4	345.4	256.8	171.2	244.0	230.2	1.1	5.5	331.2	341.3	271.8	347.2	0.0	869.6	648.2	536.4	20.3	29.2	900.3	0.0	637.4	386.9	34.1	294.8	263.2	244.8	1050.6	0.0	124.1	155.3	836.3	34.0	8.6	660.7	334.0	762.0	322.8	2.4	674.2	501.5	7.1	797.0	1.6	45.3	25.8	28.4	6.4	288.3	734.1	248.2	230.6	528.7
VAPB	"ALS8, VAP-B, VAP-C"	ENSG00000124164	"VAMP associated protein B and C"	O95292	20	58389122-58451101	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"		"Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013144, CAB013722"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		220000	"Endoplasmic reticulum"		"CAB013722: , HPA013144: AB_1858717"	"unprognostic (3.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (1.08e-8)"	"unprognostic (1.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.99e-2)"	17.4	31.1	21.8	12.6	24.3	4.8	13.2	16.5	31.8	11.7	16.1	17.0	13.3	22.5	13.0	13.1	14.8	13.7	12.7	24.5	21.4	22.1	21.8	23.5	13.6	10.4	23.2	25.1	17.7	15.5	28.5	16.3	11.1	31.6	15.0	12.1	11.4	17.9	15.7	46.8	15.3	20.6	15.2	24.9	11.4	14.7	9.4	15.8	6.7	26.7	18.8	9.4	11.6	18.5	5.6	4.3	6.8	5.2	6.6	9.5	4.6	10.9	11.0	12.4	6.6	11.4	4.8	11.0	9.8	4.1	15.2	7.5	44.3	10.6	9.7	14.1	6.6	12.1	21.0	9.8	14.1	9.1	4.5	7.4	5.8	12.2	13.9	11.5	5.4	7.4	10.9	16.4	8.4	7.0	7.4	7.5	9.7	13.7	5.5	7.3	34.4	8.5	10.8	6.5	21.5	14.6	8.6	11.5	6.3	11.6	14.7	17.5	12.1	16.2	43.2	16.9	7.1	17.7	8.3	10.3	24.6	12.0	12.3	13.1	7.4	7.9	11.1	20.8	6.0	12.4	3.9	4.4	5.2	7.8	4.4	9.1	5.6	9.0	6.2	4.3	4.7	6.7	9.5	6.8	6.6	5.2	4.3	5.0	4.6	21.8	24.3	16.5	31.8	21.4	22.1	23.2	25.1	31.6	15.8	41.7	23.2	11.7	12.1	10.4	26.4	43.1	25.5	18.7	13.6	29.6	27.5	28.5	29.9	29.7	4.2	20.4	30.7	0.0	26.6	42.2	18.8	15.2	9.2	32.1	14.0	33.4	20.8	14.7	14.0	5.1	17.3	13.9	13.5	24.4	22.3	34.0	29.0	19.2	23.7	31.6	29.2	12.9	20.5	20.4	28.3	9.3	37.2	18.7	24.2	13.6
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35056064-35073249	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Syncytiotrophoblasts: 452.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		110000000	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	33.7	43.6	19.6	30.3	21.8	30.8	31.4	19.4	31.0	32.2	25.7	22.7	32.9	22.2	30.5	34.0	40.0	24.7	33.8	69.6	20.0	23.4	30.1	63.4	27.6	42.7	23.1	21.1	25.0	34.9	44.5	29.0	46.3	26.3	33.4	26.5	21.2	30.7	34.1	80.4	29.2	26.3	29.2	23.0	37.8	28.9	25.6	18.2	43.3	32.1	42.2	35.7	31.5	26.5	25.9	29.4	43.4	30.6	23.0	32.1	34.4	36.0	41.2	28.4	15.3	34.3	24.2	21.7	33.6	38.1	50.3	37.2	27.5	14.9	28.6	29.5	41.7	44.2	17.4	42.3	40.1	43.6	30.7	24.5	19.9	39.0	37.6	26.7	22.3	26.6	27.6	27.0	43.6	19.5	21.1	54.4	13.1	20.6	20.8	40.2	25.4	21.8	53.7	37.0	18.7	39.4	19.4	22.1	17.7	39.3	25.8	15.5	19.5	20.3	23.0	10.2	36.9	18.5	15.9	44.5	20.2	26.1	17.9	29.5	10.6	22.4	24.5	33.1	16.1	25.8	43.4	24.5	31.9	24.7	27.2	23.8	25.9	23.6	24.8	29.4	21.1	17.7	18.5	28.4	23.0	30.6	18.9	32.1	34.4	19.6	21.8	19.4	31.0	20.0	23.4	23.1	21.1	26.3	18.2	74.5	72.0	80.5	100.9	68.5	80.1	178.9	43.3	71.0	68.2	52.4	111.9	240.5	63.0	177.8	24.1	121.1	90.3	23.3	162.4	147.5	81.6	98.2	61.1	102.4	116.5	69.9	80.8	122.8	57.9	36.5	77.6	66.7	72.6	234.4	63.9	87.7	195.1	56.3	81.7	89.3	82.6	135.8	82.4	127.7	117.9	79.3	452.1	76.6	57.1	105.3
VDAC2		ENSG00000165637	"Voltage dependent anion channel 2"	P45880	10	75210154-75231448	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA043475	Enhanced		Supported	Mitochondria		NA	NA		4000000	Mitochondria		"HPA043475: AB_10795615"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.47e-2)"	"unprognostic (9.00e-3)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (4.51e-4)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.34e-2)"	26.2	31.9	27.8	18.7	40.5	25.1	59.7	34.2	55.4	29.0	39.1	24.2	19.9	31.8	25.5	20.3	63.7	25.0	18.5	141.7	28.1	24.1	38.2	24.4	23.2	23.0	27.6	37.7	29.6	38.9	37.6	18.4	24.1	36.5	24.2	40.3	23.0	30.5	30.6	99.7	30.7	30.5	43.7	27.9	17.8	31.1	30.4	16.9	15.6	27.5	31.9	30.0	33.7	39.1	44.8	63.2	39.0	62.9	36.0	49.6	54.6	41.9	34.7	42.0	53.2	37.5	51.1	44.1	54.6	61.6	59.9	56.6	52.3	40.2	50.0	30.7	45.6	33.3	56.5	76.9	54.1	58.9	27.1	44.8	29.1	29.4	59.0	37.5	55.2	32.4	45.2	64.2	51.0	109.3	84.4	44.2	31.7	49.1	40.8	62.9	31.0	35.5	45.0	36.1	47.6	134.3	42.6	33.3	31.7	58.9	26.4	26.7	31.5	30.1	101.0	63.8	51.3	58.8	24.8	34.1	29.9	41.0	44.2	58.5	32.9	44.8	51.6	43.4	54.7	25.4	39.0	51.5	38.0	32.5	54.0	39.6	44.8	44.7	36.4	63.2	36.0	45.5	41.7	17.7	36.0	62.9	30.8	49.6	54.6	27.8	40.5	34.2	55.4	28.1	24.1	27.6	37.7	36.5	16.9	89.3	45.7	134.1	325.8	338.7	144.0	304.7	142.7	73.6	99.0	106.4	41.2	263.8	567.0	389.3	129.8	150.9	543.9	46.7	300.7	379.6	156.9	217.1	110.7	72.5	237.9	122.3	143.7	133.8	127.5	75.8	157.3	179.7	212.6	317.4	241.2	222.4	375.0	269.6	156.3	255.3	119.1	174.6	229.6	245.4	142.7	367.4	331.6	102.2	304.0	486.8
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 57.1;parathyroid gland: 45.8"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 101.9;Paneth cells: 43.0;Undifferentiated cells: 54.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 23.0;HDLM-2: 32.4;U-937: 31.8"	"Region enhanced"	"Detected in single"		"olfactory region: 2.5"	"Not detected"	"Not detected"			"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			Nucleoplasm	"Intermediate filaments, Cytosol"	"CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.0	9.2	0.2	10.0	0.3	2.5	7.8	0.3	0.6	3.5	40.9	0.4	4.1	21.2	1.2	7.7	10.2	1.1	10.7	1.5	0.5	0.3	13.0	0.6	8.3	3.8	0.5	0.1	1.3	6.5	45.8	11.7	4.4	0.6	2.1	12.6	0.4	4.9	2.8	5.3	15.2	57.1	1.2	1.5	3.1	2.6	1.5	0.2	2.0	1.9	9.4	8.2	4.0	5.2	0.7	5.7	7.5	7.0	0.2	0.8	1.2	5.5	0.9	0.0	0.0	4.8	7.0	0.1	6.8	3.5	5.8	5.0	4.0	4.7	1.4	7.4	4.6	4.1	10.4	0.2	23.0	2.7	32.4	1.7	2.4	1.3	0.3	3.5	4.9	7.8	9.4	10.8	6.4	10.5	9.2	0.4	0.5	0.7	1.5	2.6	3.7	0.1	2.4	0.0	13.8	7.5	0.1	0.0	3.5	5.2	5.5	2.6	0.1	5.8	16.7	2.1	0.0	18.8	2.7	0.4	11.1	2.9	3.2	3.8	0.9	0.0	1.2	3.4	31.8	2.8	0.2	3.7	2.1	0.0	7.0	0.1	0.7	0.3	0.0	5.7	0.1	0.1	0.0	7.5	0.2	6.9	0.6	0.8	1.2	0.2	0.3	0.3	0.6	0.5	0.3	0.5	0.1	0.6	0.2	11.9	15.3	1.9	8.2	32.1	0.4	1.2	0.0	9.4	11.4	7.0	0.0	0.1	6.6	3.7	0.1	0.8	101.9	0.0	9.4	0.1	7.8	3.9	6.9	0.4	3.6	0.0	20.8	0.0	6.6	0.0	0.0	18.7	8.5	6.4	30.0	0.2	14.7	43.0	0.4	17.5	0.2	0.0	2.8	0.7	0.3	35.5	0.2	3.2	54.4	8.4
VEGFC	VRP	ENSG00000150630	"Vascular endothelial growth factor C"	P49767	4	176683538-176792727	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 20.1"	"Cell type enhanced"	"Detected in many"	9	"Endothelial cells: 10.5;Fibroblasts: 7.4;Ito cells: 5.5;Leydig cells: 12.7"	"Low cancer specificity"	"Detected in all"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"BJ: 41.6;HBF TERT88: 33.9;hTEC/SVTERT24-B: 34.0;LHCN-M2: 37.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	383000	50000				"unprognostic (4.18e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (4.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.89e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	8.9	2.0	0.5	1.9	2.0	0.0	20.1	1.5	1.9	4.8	4.5	0.7	2.9	0.8	6.2	1.5	5.5	5.1	7.7	5.9	0.8		1.5	1.7	16.0	3.5	0.0	0.1	3.9	0.5	0.6	0.0	11.6	1.6	4.8	1.6	3.4	4.3	2.7	6.2	0.2	1.6	3.8	1.7	2.6	0.4	2.4	0.4	0.3	17.7	3.4	2.3	6.8	9.2	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.6	0.8	0.5	0.0	7.6	7.6	0.0	41.6	25.1	23.2	18.5	0.0	0.2	0.0	0.0	23.5	9.7	1.2	0.3	15.7	33.9	0.0	0.8	0.0	1.1	0.0	4.1	0.0	0.0	8.0	0.7	34.0	23.8	23.3	14.3	0.0	0.0	0.0	37.6	0.6	0.0	0.0	0.3	0.0	13.6	0.0	2.4	0.0	0.0	0.9	0.0	0.0	0.6	0.9	0.0	0.2	0.2	0.0	6.9	24.7	2.6	6.0	11.7	0.0	0.0	0.0	10.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1											3.0	0.0	0.0	1.2	2.2	0.6	1.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	2.6	10.5	0.0	0.0	0.0	0.0	7.4	1.9	0.0	0.0	0.3	1.6	0.0	5.5	0.0	1.0	12.7	0.9	3.3	0.0	0.0	4.1	0.1	0.0	0.0	0.0	0.2	0.0	1.7	0.0	1.7	1.8	0.0	0.0	0.0	2.2
VIPR1	"HVR1, RDC1, VPAC1, VPAC1R"	ENSG00000114812	"Vasoactive intestinal peptide receptor 1"	P32241	3	42489299-42537573	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 83.1"	"Cell type enhanced"	"Detected in many"	14	"Enterocytes: 40.7;Mucus-secreting cells: 38.5;Paneth cells: 92.0;Sertoli cells: 32.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 3.2;intermediate monocyte: 2.6;MAIT T-cell: 1.9;memory CD4 T-cell: 4.8;memory CD8 T-cell: 1.9;myeloid DC: 3.9;naive CD4 T-cell: 5.5;naive CD8 T-cell: 1.7;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	32	"dendritic cells: 3.9;monocytes: 3.2;T-cells: 5.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 27.3;OE19: 15.9;RT4: 19.5;SK-BR-3: 11.1;WM-115: 35.4"	"Group enriched"	"Detected in many"	5	"amygdala: 6.5;basal ganglia: 4.1;cerebral cortex: 9.2;hippocampal formation: 8.5"	"Low region specificity"	"Detected in all"			HPA026777	Approved					NA	NA					"HPA026777: AB_10604003"	"unprognostic (9.02e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.89e-4)"	"unprognostic (4.00e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.05e-2)"	8.1	1.8	5.6	6.4	11.8	1.3	7.4	10.2	13.8	2.0	17.7	0.6	27.8	22.0	0.9	4.6	2.7	1.0	10.6	3.1	2.9	1.2	1.4	15.4	83.1	5.1	1.3	8.4	0.5	1.4	2.9	1.2	1.9	1.9	13.0	18.1	2.2	9.7	29.0	0.8	12.2	25.9	1.3	0.9	2.7	3.7	0.9	1.3	0.0	7.2	3.2	3.1	6.0	2.4	0.1	3.9	0.1	3.2	0.0	5.5	1.3	0.0	1.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.9	27.3	0.1	1.3	0.0	0.0	1.1	0.0	0.7	0.0	0.0	2.1	1.6	0.8	0.0	0.1	0.0	0.2	0.0	1.7	0.1	0.5	0.0	0.3	0.2	0.0	0.0	0.0	2.2	0.0	0.1	1.7	15.9	0.1	0.2	0.0	1.2	0.0	19.5	0.6	0.0	0.0	11.1	0.0	3.3	6.8	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.4	0.0	3.2	0.0	0.4	2.6	1.9	0.1	4.8	1.9	3.9	0.0	5.5	1.7	0.1	0.0	2.3	0.0	0.7	1.3	5.6	11.8	10.2	13.8	2.9	1.2	1.3	8.4	1.9	1.3	3.0	5.9	2.0	4.2	6.8	0.1	1.2	5.1	1.4	2.3	1.8	7.9	0.0	0.0	0.4	0.7	1.4	40.7	0.0	0.8	0.3	0.4	9.6	0.0	0.0	0.6	0.0	4.6	14.7	8.9	0.4	0.0	2.4	0.0	0.0	38.5	1.2	0.8	92.0	0.0	0.0	5.1	32.3	2.2	0.0	0.0	6.8	0.2	1.3	22.9	3.2
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 193.2"	"Cell type enhanced"	"Detected in many"	6	"Basal glandular cells: 872.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 193.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 193.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: AB_2685348"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	22.0	37.8	20.4	21.9	24.9	13.0	18.6	20.0	28.7	18.2	32.0	27.8	16.7	40.5	18.3	15.4	22.9	14.4	25.2	19.6	21.7	22.3	22.9	43.0	22.4	20.1	23.1	15.6	16.5	22.9	19.0	20.1	27.9	29.8	17.3	29.3	20.0	17.8	13.9	19.8	19.2	39.7	14.3	26.4	36.6	19.0	17.6	16.2	14.4	18.1	12.5	16.8	19.5	17.6	3.3	10.9	193.2	39.9	3.8	4.1	24.7	20.3	41.0	13.3	20.5	28.5	17.5	21.4	32.4	23.1	20.2	27.2	26.8	29.3	11.7	48.4	21.9	22.1	25.3	15.4	18.6	25.2	30.0	19.3	15.0	23.5	28.2	27.8	17.0	18.4	26.8	15.9	26.0	22.1	16.2	21.4	10.0	19.6	20.7	20.9	56.0	15.8	8.9	15.0	42.3	21.1	8.7	23.4	24.1	25.0	23.8	9.6	21.7	18.5	15.7	21.5	19.1	32.5	14.6	30.2	27.2	26.0	21.6	26.7	32.2	36.9	16.3	30.0	10.4	27.4	7.0	35.1	4.4	3.8	24.4	4.0	3.3	3.7	4.0	10.9	2.8	3.5	3.8	193.2	3.8	39.9	3.6	4.1	24.7	20.4	24.9	20.0	28.7	21.7	22.3	23.1	15.6	29.8	16.2	83.4	125.2	71.3	872.7	143.1	32.8	26.9	112.1	278.4	247.9	261.7	55.0	83.1	19.9	167.6	5.2	128.4	394.9	0.0	118.5	105.1	178.7	606.4	129.6	93.2	107.6	27.0	298.1	52.2	269.6	8.8	33.1	306.0	123.2	55.9	173.1	46.7	132.9	326.1	33.2	57.2	44.2	90.5	178.6	63.8	38.3	113.3	147.0	90.6	149.1	526.3
VN1R1	"V1RL1, VNR19I1, ZVNH1, ZVNR1"	ENSG00000178201	"Vomeronasal 1 receptor 1"	Q9GZP7	19	57454790-57457142	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 9.2"	"Cell type enhanced"	"Detected in some"	15	"Bipolar cells: 4.8;Cone photoreceptor cells: 2.0;Horizontal cells: 6.4;Rod photoreceptor cells: 3.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 6.2;U-266/70: 5.6;U-266/84: 6.7"									HPA062209			Uncertain	Nucleoplasm,Vesicles		NA	NA			Vesicles	Nucleoplasm	"HPA062209: "	"unprognostic (7.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.59e-5)"	0.1	1.4	2.0	0.3	2.9	0.3	1.5	9.2	3.5	0.2	0.7			0.0	0.5	5.3	0.9	0.8	0.6	1.9	1.9	2.0	0.8	0.9	0.9	0.7	1.5		1.6	0.4	3.6	3.5	1.1		2.0	0.4		0.8	1.3	3.6	4.0	0.5	0.5	1.5	1.1	0.9	1.4			2.7		0.4	0.5	0.3	2.3	0.3	0.5	0.3	0.6	0.4	0.1	0.5	0.1	1.8	1.9	0.1	0.5	0.9	0.5	0.7	0.4	1.9	0.0	0.2	0.2	0.9	0.2	0.3	0.0	0.4	0.2	0.7	0.0	6.2	0.9	0.0	0.6	0.3	0.4	1.2	0.7	0.7	0.1	0.4	1.0	0.2	0.6	0.3	0.9	0.9	0.3	0.4	2.1	0.5	0.1	0.6	0.4	1.2	0.9	0.6	1.1	3.4	1.4	0.0	0.5	0.1	1.0	0.9	0.6	0.1	1.5	0.2	0.4	0.6	5.6	6.7	0.5	0.5	0.1	1.1	0.5	0.3	0.3	0.4	0.0	0.2	1.3	0.3	0.3	0.2	2.3	0.4	0.3	0.5	0.6	0.2	0.3	0.0	0.1											0.0	0.6	0.5	0.0	0.0	4.8	0.2	0.0	0.0	1.2	0.0	2.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.7	0.0	3.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3
VTI1B	VTI2	ENSG00000100568	"Vesicle transport through interaction with t-SNAREs 1B"	Q9UEU0	14	67647075-67674831	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 380.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044121, HPA048150, HPA060118"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206"	"unprognostic (2.26e-1)"	"unprognostic (4.83e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.11e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (8.35e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.02e-3)"	37.5	21.4	49.3	14.9	39.3	14.3	32.1	12.6	32.9	11.3	22.8	16.8	16.1	21.3	12.5	42.5	34.1	14.6	22.0	49.6	36.9	30.4	39.0	30.5	14.8	16.3	38.1	20.5	12.7	27.9	20.3	11.3	21.0	24.2	16.2	27.4	15.4	25.7	18.8	31.0	21.8	20.2	22.9	37.1	15.6	20.7	15.4	20.2	8.2	25.9	18.8	19.5	19.4	24.2	18.7	22.4	52.1	29.6	20.1	21.7	18.9	38.5	19.5	11.4	6.6	22.7	13.5	16.4	17.1	10.6	8.3	8.5	9.7	13.9	11.6	14.6	19.0	10.1	10.9	13.0	12.9	13.5	11.8	8.2	11.7	11.8	12.3	9.7	7.2	8.4	13.1	14.1	9.2	9.5	22.0	9.5	8.1	7.6	9.1	12.0	45.8	9.0	26.8	7.4	26.7	31.5	11.0	12.9	4.2	12.3	23.2	6.4	13.1	12.1	16.4	24.2	9.1	15.3	20.4	13.7	23.0	34.4	18.5	15.8	8.5	9.1	17.8	19.4	13.6	10.5	28.6	23.4	52.1	19.8	29.6	16.9	18.7	17.5	20.2	22.4	16.4	16.7	20.4	10.6	20.1	24.7	14.7	21.7	18.9	49.3	39.3	12.6	32.9	36.9	30.4	38.1	20.5	24.2	20.2	23.8	34.1	49.1	46.9	37.5	22.4	26.0	53.5	48.2	38.7	62.8	21.6	89.3	184.1	93.0	115.6	46.6	134.6	116.8	115.1	143.6	54.1	81.6	62.4	79.1	116.8	14.3	44.7	56.4	74.2	380.3	38.6	65.2	67.4	137.1	84.4	35.2	113.0	108.7	37.4	203.8	35.3	19.4	41.0	101.0	65.5	46.2	105.3	34.1	80.0	77.1
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease mutation, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	8	"Alveolar cells type 1: 122.1;Extravillous trophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 39.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved					NA	NA					"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.64e-2)"	28.5	13.3	17.9	7.0	52.5	1.5	16.5	9.4	24.2	22.3	15.5	13.2	21.9	12.0	31.2	15.1	12.1	28.9	24.0	27.8	19.4	12.2	7.1	7.6	30.2	7.4	13.5	16.5	51.0	12.4	8.8	20.7	25.4	13.6	22.6	4.5	16.6	12.1	39.0	10.3	10.0	11.1	28.1	14.2	16.9	12.5	18.3	14.9	1.3	23.4	4.4	3.2	24.2	12.2	4.4	0.6	0.0	1.6	2.5	6.9	2.4	5.2	10.8	3.6	13.0	15.0	3.9	39.4	9.3	12.3	6.4	5.6	9.2	14.4	2.4	13.7	10.1	29.3	2.4	2.6	5.2	2.6	2.1	5.4	0.0	4.8	28.5	13.4	0.0	0.3	13.3	7.3	5.5	5.2	5.3	9.8	0.9	0.1	9.6	3.8	9.7	0.4	0.1	5.1	7.6	15.2	1.2	3.6	2.7	2.5	22.8	2.3	6.1	5.4	6.7	5.1	4.3	11.7	0.1	8.0	7.4	9.5	7.2	5.6	10.6	3.5	0.0	9.3	0.0	7.4	0.0	1.0	0.0	4.9	1.6	6.9	4.4	2.6	3.5	0.3	2.3	2.3	2.8	0.0	2.5	1.6	0.6	1.3	2.4	17.9	52.5	9.4	24.2	19.4	12.2	13.5	16.5	13.6	14.9	122.1	18.0	0.0	1.5	2.2	3.8	37.8	2.5	9.4	5.7	24.4	0.0	18.0	0.0	4.7	9.3	18.4	2.0	0.0	3.8	107.4	6.7	3.8	1.1	11.0	15.1	3.2	32.1	27.0	1.6	16.6	37.2	2.2	11.8	1.0	2.8	37.2	9.3	1.4	54.5	3.7	3.8	12.9	10.8	10.2	15.3	3.0	33.2	0.5	2.8	2.0
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls"	ENSG00000116729	"Wntless Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	5	"Rod photoreceptor cells: 160.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 10.0;neutrophil: 29.1"	"Group enriched"	"Detected in many"	46	"granulocytes: 29.1;monocytes: 10.0"	"Cell line enhanced"	"Detected in many"		"AF22: 70.0;ASC TERT1: 54.2;SuSa: 66.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	13.7	17.2	33.5	14.3	39.0	1.5	14.5	6.8	26.6	20.0	28.3	25.8	51.6	9.1	19.5	55.1	26.7	19.9	37.1	24.1	23.1	25.4	36.8	8.9	20.3	6.9	27.0	18.6	31.4	34.7	12.1	9.8	29.2	44.5	29.0	22.8	37.8	14.5	47.4	5.3	19.3	14.1	46.2	30.5	10.8	24.4	12.2	22.3	1.9	8.9	13.5	8.2	29.6	17.0	0.0	0.4	29.1	10.0	0.0	0.0	1.9	1.9	2.9	70.0	0.0	38.8	54.2	40.6	9.7	23.9	13.5	18.8	4.2	4.6	0.0	9.8	2.7	12.6	20.3	15.7	15.9	11.5	0.1	11.7	0.0	8.4	0.0	33.9	0.0	0.1	38.7	10.7	33.1	10.9	13.7	31.7	3.7	0.0	0.1	19.9	0.3	0.0	0.2	3.1	4.2	4.7	0.0	14.7	0.0	2.3	10.5	3.9	8.2	8.9	0.4	11.6	66.2	1.9	0.2	36.7	13.0	10.4	20.8	13.1	4.7	0.1	0.0	29.9	0.3	23.7	0.0	10.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	29.1	0.0	0.3	0.1	0.0	1.9	33.5	39.0	6.8	23.8	23.1	25.4	27.0	18.6	44.5	22.3	44.7	28.8	2.4	56.2	37.7	7.2	27.1	35.7	115.1	44.3	26.2	131.6	119.4	8.3	69.5	13.0	20.8	38.0	0.0	52.3	3.0	31.4	26.5	5.7	10.2	20.8	12.7	9.2	34.4	10.2	7.0	30.2	10.7	18.6	12.6	24.7	7.3	63.3	28.8	51.9	30.0	160.2	38.8	20.8	0.5	0.7	26.2	46.1	1.8	33.6	39.6
WRB	"CHD5, GET1"	ENSG00000182093	"Tryptophan rich basic protein"	O00258	21	39380244-39428528	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Spermatocytes: 200.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA018527	Approved					NA	NA					"HPA018527: AB_1858860"	"unprognostic (4.34e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.08e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.02e-3)"	"unprognostic (9.48e-2)"	"unprognostic (6.50e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.78e-3)"	"unprognostic (8.13e-2)"	11.8	28.1	41.2	7.0	34.4	4.9	15.9	25.1	35.7	18.2	10.5	32.1	10.3	12.1	18.1	29.4	9.5	42.4	11.5	17.0	35.9	46.2	23.2	20.0	11.4	7.9	35.0	24.3	26.2	9.4	5.6	17.1	13.2	32.1	15.6	9.5	16.6	9.1	13.8	22.4	6.0	11.6	14.0	40.8	8.0	10.6	32.4	23.3	5.8	17.1	6.2	8.7	10.4	8.0	19.2	26.2	31.2	17.6	16.8	19.2	24.6	14.6	13.5	24.2	14.6	31.7	29.8	7.7	21.0	20.9	9.8	9.1	12.4	20.4	24.4	15.0	21.8	12.1	5.5	19.4	12.7	13.9	10.6	12.5	17.3	12.8	19.9	19.0	13.0	6.5	19.0	12.6	15.9	14.7	28.3	24.0	24.8	26.0	15.5	25.8	33.5	14.9	10.0	22.4	26.5	9.8	16.9	14.8	17.6	27.9	7.7	12.2	18.5	17.9	9.4	21.2	13.7	17.8	15.1	14.6	12.7	4.6	17.1	9.2	19.6	27.5	10.8	30.8	22.5	14.2	18.4	17.6	17.1	13.5	12.7	11.9	19.2	16.5	14.2	19.4	12.1	19.2	17.9	31.2	16.8	12.5	26.2	14.6	24.6	41.2	34.4	25.1	33.6	35.9	46.2	35.0	24.3	32.1	23.3	14.9	12.6	16.4	26.4	9.8	61.1	32.9	22.9	132.5	23.9	38.4	51.1	31.4	31.5	41.2	85.9	29.4	12.2	46.7	30.9	28.9	28.9	28.2	15.0	29.7	27.5	38.1	24.2	33.7	23.0	71.4	44.0	10.4	27.0	19.8	14.3	65.1	30.5	17.3	54.1	99.7	109.4	45.3	33.2	200.7	70.7	11.7	11.4	16.0	19.0	11.2
XK	"Kx, NA, NAC, X1k, XKR1"	ENSG00000047597	"X-linked Kx blood group"	P51811	X	37685756-37732130	"Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	"Blood group antigen"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.6"	"Cell type enhanced"	"Detected in many"	10	"Enterocytes: 21.1;Erythroid cells: 23.3;Mucus-secreting cells: 12.1;Undifferentiated cells: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	40	"basophil: 9.4;eosinophil: 6.8"	"Lineage enriched"	"Detected in single"	94	"granulocytes: 9.4"	"Cell line enhanced"	"Detected in many"		"HEL: 25.2;HL-60: 13.0;K-562: 16.2;NB-4: 11.9;RPMI-8226: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019036	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		No	No			Mitochondria	"Nucleoplasm, Vesicles"	"HPA019036: AB_1846286"	"unprognostic (2.37e-2)"	"unprognostic (7.13e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (4.56e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.44e-8)"	"unprognostic (1.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	0.6	2.9	4.9	3.0	5.1	14.0	1.1	10.2	8.3	1.8	16.5	1.2	0.0	12.9	1.2	0.8	2.7	4.8	2.0	8.1	4.7	6.6	1.4	2.1	1.5	0.7	3.0	5.9	1.2	7.9	2.2	3.8	1.4	4.4	2.1	13.8	1.0	8.6	1.5	5.9	1.2	23.6	3.2	1.6	1.2	13.3	3.5	0.2	0.1	1.4	5.9	0.8	2.9	2.5	0.0	0.0	9.4	0.0	0.0	0.0	0.7	9.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	8.4	0.1	0.0	0.4	1.6	8.9	0.0	0.0	0.0	2.4	25.2	1.4	0.0	0.0	13.0	2.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.2	6.4	0.1	0.9	0.1	11.9	3.2	0.4	3.2	0.0	0.0	11.4	0.0	0.6	2.4	0.0	0.4	0.8	0.0	0.5	1.2	3.2	0.0	0.0	0.4	0.0	1.4	5.5	9.1	0.0	0.1	6.9	0.0	9.4	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	4.9	5.1	10.2	8.3	4.7	6.6	3.0	5.9	4.4	0.2	0.0	0.6	0.0	0.2	0.3	0.5	5.9	0.0	1.4	0.0	0.0	5.9	0.1	0.0	0.0	0.9	0.0	21.1	23.3	2.6	0.1	0.0	1.1	0.0	0.8	0.1	3.2	5.8	0.0	0.0	0.2	0.0	0.0	1.7	0.0	12.1	0.0	1.2	8.6	0.7	0.0	0.9	0.0	1.7	4.6	4.3	1.0	0.0	0.0	10.8	0.4
XKR3	"MGC57211, XTES"	ENSG00000172967	"XK related 3"	Q5GH77	22	16783412-16821699	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	44	"blood: 4.7;testis: 13.5"	"Cell type enriched"	"Detected in some"	15	"Early spermatids: 93.9"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	8	"basophil: 1.5;neutrophil: 4.7"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 4.7"	"Cell line enriched"	"Detected in some"	16	"Karpas-707: 73.1"									"HPA003379, HPA035081"	Uncertain					NA	NA					"HPA003379: AB_10602682, HPA035081: AB_2674451"	"unprognostic (4.57e-1)"				"unprognostic (3.37e-1)"								"unprognostic (3.11e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.77e-2)"			0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	13.5			0.0		0.0	0.0	0.0	0.0	0.2	4.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	4.5	73.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	0.0	1.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1											0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	93.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.1	0.0	0.0	0.0
XKR4	KIAA1889	ENSG00000206579	"XK related 4"	Q5GH76	8	55102389-55542054	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.7"	"Cell type enhanced"	"Detected in some"	13	"Alveolar cells type 2: 25.5;Club cells: 17.0;Cone photoreceptor cells: 33.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"REH: 3.7;RPTEC TERT1: 15.0"	"Low region specificity"	"Detected in all"							"HPA025072, HPA028083"	Uncertain		Approved	Vesicles		NA	NA			Vesicles		"HPA025072: AB_1858886, HPA028083: AB_10601025"	"unprognostic (7.15e-4)"	"unprognostic (1.28e-3)"	"unprognostic (6.98e-2)"	"unprognostic (5.63e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.96e-2)"	1.2	1.4	18.7	4.3	5.6	0.8	0.7	4.4	12.1	2.1	5.1	0.6	0.3	1.5	1.0	1.4	2.5	1.1	1.4	2.6	8.6	4.5	0.9	0.7	0.7	2.0	2.0	8.8	0.9	1.1	0.5	5.3	0.6	2.0	1.2	2.2	2.5	2.0	2.9	0.8	1.4	2.0	3.5	1.2	0.9	1.5	0.9	3.4	0.6	0.7	0.6	2.3	1.0	1.6	0.8	0.3	2.2	0.2	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.7	0.0	0.0	15.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.2	0.3	0.2	0.1	0.1	0.6	0.2	0.1	0.0	0.8	0.2	0.3	1.2	0.7	0.1	0.3	0.1	0.1	18.7	5.6	4.4	11.5	8.6	4.5	2.0	8.8	2.0	3.4	8.9	25.5	0.0	0.5	0.3	6.5	1.4	0.0	9.4	17.0	3.5	33.4	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.1	0.7	0.5	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	1.1	8.5	2.8	0.0	0.6	0.7	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.6	0.1	0.0	0.0	0.7
XKR8	FLJ10307	ENSG00000158156	"XK related 8"	Q9H6D3	1	27959462-27968096	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"blood: 47.1"	"Cell type enhanced"	"Detected in many"	8	"Cytotrophoblasts: 47.7;monocytes: 27.9"	"Low cancer specificity"	"Detected in all"							"Group enriched"	"Detected in all"	10	"eosinophil: 47.1;neutrophil: 24.3"	"Lineage enriched"	"Detected in all"	15	"granulocytes: 47.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049984, HPA053529"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Golgi apparatus"		"HPA049984: AB_2680982, HPA053529: AB_2682179"	"prognostic favorable (8.63e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.87e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-2)"	2.6	2.3	2.8	4.2	3.8	10.3	1.8	8.3	1.8	2.3	2.5			4.1	3.3	2.9	2.4	3.2	2.9	3.2	2.8	1.9	3.3	8.6	3.1	3.0	3.0		3.6	8.7	3.5	2.4	7.8		3.5	2.4		5.6	3.7	2.9	2.0	3.1	3.5	4.9	5.6	4.7	1.6			3.5		2.4	2.8	2.4	1.3	2.6	47.1	2.5	2.8	3.0	1.9	4.6	2.5	3.0	2.9	3.3	6.2	7.6	6.9	7.5	8.8	9.0	6.6	3.7	0.0	5.7	7.6	1.9	2.6	5.5	3.3	3.1	7.5	10.0	6.1	2.0	4.5	5.4	0.0	0.0	6.5	5.5	9.5	2.7	9.4	8.6	4.6	0.0	1.8	5.0	2.2	3.3	2.2	13.9	4.4	5.7	5.4	0.0	3.3	5.7	2.4	2.1	0.0	2.0	2.8	0.1	6.6	2.0	4.7	3.6	7.0	0.2	13.1	2.2	7.3	7.0	0.8	17.3	0.0	0.3	3.5	2.5	47.1	3.0	2.4	2.9	1.3	3.0	2.6	2.6	1.3	2.6	2.6	24.3	2.8	1.7	1.2	2.9	1.9											3.0	0.6	8.8	3.3	1.6	3.9	2.4	2.5	0.0	4.5	3.5	0.0	47.7	3.3	6.8	0.4	5.2	4.5	0.0	9.9	12.2	4.8	4.7	1.1	4.3	12.1	3.2	1.7	6.2	6.6	0.5	3.1	5.4	1.7	27.9	5.2	15.4	6.3	0.0	3.5	3.6	0.9	6.5	2.5	0.6	5.9	2.6	18.8	8.7	4.5	3.4
XKR9		ENSG00000221947	"XK related 9"	Q5GH70	8	70669365-70790371	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 17.1"	"Cell type enriched"	"Detected in many"	11	"Spermatocytes: 89.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CACO-2: 5.4;hTCEpi: 11.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044430	Enhanced		Approved	Mitochondria		NA	NA			Mitochondria		"HPA044430: AB_10961283"	"unprognostic (1.79e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.29e-1)"	"unprognostic (6.96e-6)"	"unprognostic (3.65e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.71e-2)"	0.9	3.4	1.9	0.8	4.3	0.9	1.1	0.6	6.4	0.9	1.7	1.9	0.0	4.9	0.7	2.5	1.1	0.7	4.1	1.0	2.3	1.5	1.0	7.5	2.1	1.0	1.3	7.3	1.0	1.3	0.3	2.1	0.8	7.4	1.4	1.0	2.6	2.0	0.2	0.9	1.7	9.6	3.5	1.7	1.0	3.6	17.1	0.7	0.0	1.0	0.0	1.0	2.5	1.2	1.2	0.3	0.9	0.2	0.6	3.1	0.2	3.9	0.3	0.8	0.4	0.0	1.0	0.6	1.6	0.8	0.5	1.7	5.4	0.4	0.5	2.7	0.1	1.9	0.1	0.1	0.9	2.0	0.8	0.5	0.4	0.3	0.6	0.1	1.2	2.2	1.1	11.1	0.3	0.0	0.5	0.0	2.6	0.2	3.9	0.3	0.5	0.7	0.6	2.2	0.1	0.5	0.5	1.1	0.2	0.3	2.9	2.4	0.4	0.9	1.6	0.5	0.3	0.5	0.2	0.4	0.5	1.1	0.8	0.6	3.4	0.9	2.5	0.2	0.5	0.3	0.9	0.1	0.3	0.9	0.1	1.7	0.9	1.7	0.8	0.1	1.2	2.6	1.7	0.6	0.6	0.2	0.3	3.1	0.2	1.9	4.3	0.6	6.4	2.3	1.5	1.3	7.3	7.4	0.7	6.0	2.1	0.0	3.1	2.4	2.3	0.4	2.5	4.0	4.5	0.0	7.9	0.8	0.0	1.0	4.0	0.1	1.2	0.0	3.9	0.3	0.7	1.1	0.0	0.5	0.3	1.6	0.0	0.0	0.0	2.9	0.9	0.2	0.0	0.0	1.0	1.5	5.3	0.2	0.4	0.3	5.4	0.0	0.3	89.2	5.1	0.6	0.8	0.0	0.1	1.8
XKRX	"XKR2, XPLAC"	ENSG00000182489	"XK related, X-linked"	Q6PP77	X	100913445-100929433	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pituitary gland: 12.0;placenta: 12.2;skin 1: 12.9;thyroid gland: 11.0"	"Cell type enhanced"	"Detected in some"	17	"Melanocytes: 1.7;Syncytiotrophoblasts: 2.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"naive B-cell: 5.0;naive CD4 T-cell: 3.7;naive CD8 T-cell: 2.8"	"Group enriched"	"Detected in many"	44	"B-cells: 5.0;T-cells: 3.7"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 13.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (3.35e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.37e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.60e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.18e-1)"	0.1	1.0	0.2	2.1	0.3	0.1	1.1	0.1	0.1	1.2	7.2	0.2	8.3	0.4	0.2	1.9	3.5	1.1	0.5	0.1	0.2	0.4	0.3	0.1	3.3	2.4	0.2	0.0	0.3	0.2	0.0	12.0	12.2	0.2	0.5	1.3	0.0	1.0	1.8	0.2	12.9	6.8	0.0	0.2	0.6	0.5	0.4	0.0	0.8	11.0	1.9	5.4	0.5	2.4	5.0	0.0	0.0	0.0	0.0	3.7	0.6	0.3	1.0	0.1	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	13.2	1.6	1.0	0.1	0.0	1.1	0.2	0.0	0.9	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.3	2.5	1.0	0.0	0.1	0.1	0.6	0.1	0.0	0.4	2.5	0.0	0.0	0.0	2.5	0.1	2.1	0.3	1.1	0.2	1.1	0.0	0.3	0.4	0.0	2.3	0.0	0.3	0.0	0.0	2.0	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.0	0.0	5.0	3.7	2.8	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.1	0.1	0.2	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	2.2	0.0	0.1	0.3
XPO1	"CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61477849-61538626	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA		170000	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	20.7	27.9	36.1	28.1	39.6	21.6	35.1	41.5	36.3	28.2	23.2	19.5	26.0	16.5	35.7	35.3	26.1	36.0	20.3	20.1	33.0	19.2	19.5	22.2	22.0	34.5	42.0	19.5	45.0	34.6	33.4	27.6	30.8	33.6	25.8	24.5	18.0	20.2	29.9	34.9	29.8	25.0	28.4	32.1	24.5	21.9	32.1	39.3	51.1	28.2	16.4	35.7	26.0	57.8	6.1	5.4	12.6	5.1	6.2	5.1	2.5	39.4	35.3	47.9	35.9	21.7	29.2	35.3	43.7	28.2	46.0	39.4	46.9	29.7	57.9	30.6	29.9	46.8	33.5	73.0	30.3	67.7	35.3	26.9	57.0	36.3	29.3	15.7	57.4	39.0	16.4	22.7	36.3	39.6	34.9	37.5	29.2	65.7	33.8	42.3	20.8	47.7	25.2	55.7	47.2	27.1	42.8	54.7	35.2	20.9	30.0	38.3	20.4	42.5	35.9	21.3	50.4	29.4	28.4	25.0	43.2	49.1	35.1	42.9	27.5	45.3	84.0	26.8	49.3	38.9	12.6	5.1	5.8	5.1	5.0	4.7	4.3	3.6	4.5	3.9	6.1	4.3	3.7	12.4	6.2	3.2	5.4	3.2	2.5	36.1	39.6	41.5	36.3	33.0	19.2	42.0	19.5	33.6	39.3	38.7	36.3	31.8	27.6	46.2	69.7	57.0	43.3	46.8	28.4	29.6	90.3	46.3	11.6	24.4	3.2	40.7	19.3	70.0	22.5	42.3	40.9	34.4	40.5	48.0	49.4	68.3	43.4	42.4	46.3	8.0	31.1	53.2	35.4	49.5	31.2	34.0	26.3	17.5	29.0	20.8	102.5	19.4	43.7	64.6	88.2	49.7	25.2	42.9	37.6	38.3
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 47.3"	"Cell type enhanced"	"Detected in many"	6	"Cone photoreceptor cells: 60.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol		NA	NA			"Nucleoplasm, Cytosol"		"HPA053768: AB_2682254"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	8.9	6.6	4.9	6.9	9.6	10.9	7.9	13.6	11.1	7.5	6.7	11.6	7.9	5.0	11.4	5.9	7.5	7.3	4.9	12.8	6.1	5.3	6.9	6.1	7.7	8.6	8.0	5.3	9.0	7.8	8.1	12.9	6.8	10.2	7.3	7.6	10.7	7.4	7.4	47.3	8.2	7.2	8.2	8.3	8.6	6.7	7.9	8.0	14.3	8.4	6.3	12.3	7.8	7.3	3.1	2.7	3.1	6.0	3.1	4.0	1.2	6.7	5.1	8.4	8.0	4.1	7.2	8.7	7.7	5.7	9.1	7.6	10.4	8.5	14.9	4.2	7.4	6.9	11.1	19.4	10.4	17.1	10.1	5.5	23.6	6.4	6.9	6.2	20.6	7.7	7.0	6.6	9.2	17.6	5.3	11.0	8.6	11.1	4.9	8.6	5.5	9.8	9.1	9.5	14.3	4.8	11.0	13.9	6.2	6.3	8.2	9.6	6.6	6.6	9.7	7.9	8.9	5.7	11.3	9.0	6.5	5.1	7.9	10.9	3.3	4.8	12.4	3.2	13.3	9.6	3.1	2.0	2.1	3.4	2.3	4.0	3.1	2.9	2.9	2.7	2.6	3.6	3.5	0.0	3.1	6.0	2.0	2.7	1.2	4.9	9.6	13.6	11.1	6.1	5.3	8.0	5.3	10.2	8.0	11.9	15.1	10.4	7.2	7.3	14.3	19.9	10.2	2.7	0.0	8.7	60.9	6.9	0.0	4.9	8.1	7.1	3.5	0.0	3.6	6.4	7.7	6.1	15.0	9.6	9.1	9.5	1.2	13.5	7.9	6.1	16.1	8.0	11.8	6.4	6.8	6.4	4.3	3.5	7.8	3.4	21.0	32.3	9.3	10.9	17.2	9.8	10.8	11.5	8.5	8.7
XPO5	KIAA1291	ENSG00000124571	"Exportin 5"	Q9HAV4	6	43522330-43576075	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Spermatocytes: 27.2;Spermatogonia: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012357, HPA018402, HPA023959, HPA029909"	Enhanced		Enhanced	Nucleoplasm		NA	NA			Nucleoplasm		"CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245"	"unprognostic (6.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (6.16e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (4.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.48e-2)"	"unprognostic (5.66e-3)"	11.5	12.2	9.5	10.8	14.0	9.0	10.8	14.6	15.4	9.6	8.8	11.5	8.3	7.8	12.0	12.0	16.7	9.8	7.5	8.9	8.0	7.3	10.0	13.1	9.4	10.0	9.5	8.0	11.9	19.7	17.7	16.1	9.5	9.4	10.5	11.5	9.7	12.9	10.6	14.9	15.3	8.6	12.3	8.0	9.9	11.2	42.3	9.7	18.3	16.7	8.5	13.7	10.5	10.4	3.7	5.9	3.6	11.7	8.4	6.8	4.4	15.6	9.4	15.7	31.6	8.2	6.9	14.6	8.2	5.8	16.2	11.8	25.8	5.5	21.3	10.7	7.8	15.3	13.5	26.1	11.9	18.3	15.4	20.7	20.6	11.3	18.7	11.8	22.7	11.0	5.0	12.4	17.0	26.6	5.8	11.5	15.3	44.1	16.8	10.9	19.2	17.1	11.3	16.8	43.1	9.6	18.7	16.7	15.9	9.3	12.3	32.5	13.4	11.4	10.5	14.6	14.4	12.1	18.3	9.6	12.0	14.3	11.4	17.2	10.7	11.7	41.9	4.3	19.9	12.8	0.0	5.0	3.6	6.3	6.4	5.8	3.7	5.6	6.8	5.9	3.4	4.5	5.9	0.5	8.4	11.7	1.8	5.5	4.4	9.5	14.0	14.6	15.4	8.0	7.3	9.5	8.0	9.4	9.7	6.0	3.5	3.0	4.4	7.9	10.8	5.4	2.5	5.3	1.2	10.4	7.9	4.2	1.7	6.5	9.2	4.5	3.3	0.0	6.6	5.6	6.4	6.0	11.5	4.0	5.5	20.6	13.8	1.8	6.5	10.2	3.7	4.0	1.7	2.8	6.6	4.1	6.4	0.0	7.8	4.2	13.7	0.0	4.4	27.2	26.3	6.1	3.7	3.2	6.4	5.2
XPO7	"KIAA0745, RANBP16"	ENSG00000130227	"Exportin 7"	Q9UIA9	8	21919671-22006585	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	4	"Early spermatids: 63.2;Erythroid cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043727, HPA048153"	Uncertain					NA	NA		24000			"HPA043727: AB_2678638, HPA048153: AB_2680289"	"unprognostic (6.30e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (6.61e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	18.5	22.3	24.4	15.8	34.6	40.1	20.5	33.2	37.1	22.0	18.5	28.5	19.4	12.1	24.0	23.0	21.9	24.3	15.8	23.3	26.8	22.9	31.3	17.0	18.2	18.9	19.2	23.6	31.9	20.1	39.3	27.2	24.0	26.5	20.1	22.4	26.8	18.6	23.6	22.6	22.7	16.9	22.5	19.7	22.0	18.3	29.6	20.4	23.2	27.6	11.4	22.9	19.9	25.5	8.6	8.9	7.2	8.2	5.7	9.5	6.7	17.3	30.8	23.0	16.5	19.4	17.0	18.2	17.1	20.3	25.5	23.2	23.4	10.8	28.5	19.7	21.2	23.3	17.0	32.9	24.6	45.2	8.6	16.7	31.9	25.8	17.1	13.2	15.2	24.4	13.2	17.5	25.4	24.6	18.7	24.5	25.8	37.8	23.0	18.7	13.4	37.7	14.3	29.6	29.7	12.4	21.9	29.6	14.9	16.8	36.2	14.0	22.1	16.2	17.1	17.0	24.4	15.5	12.7	15.9	13.4	17.2	19.0	17.2	8.1	9.0	30.8	20.6	18.7	23.6	7.2	6.0	4.4	9.5	8.2	8.2	8.6	8.6	7.3	8.9	5.9	6.6	8.0	3.0	5.7	7.0	3.2	8.3	6.7	24.4	34.6	33.2	37.1	26.8	22.9	19.2	23.6	26.5	20.4	20.8	10.7	13.7	5.1	12.7	34.5	36.0	7.6	4.0	13.6	17.4	13.7	9.9	3.3	8.9	63.2	9.9	6.7	70.0	9.7	11.1	8.5	9.0	7.0	12.3	12.2	47.7	20.1	11.1	21.8	29.3	14.4	10.3	10.1	7.2	9.5	14.7	9.3	5.8	16.6	11.6	23.7	12.9	6.8	15.5	23.0	10.7	4.7	9.5	12.2	6.7
XPOT	XPO3	ENSG00000184575	"Exportin for tRNA"	O43592	12	64404350-64451127	"Predicted intracellular proteins, Transporters"	Transport	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Muller glia cells: 71.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048067, HPA057602"			Enhanced	Nucleoplasm,Cytosol		NA	NA			Nucleoplasm	Cytosol	"HPA048067: AB_2680246, HPA057602: AB_2683481"	"unprognostic (4.53e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (2.41e-12)"	"unprognostic (2.72e-1)"	"unprognostic (3.68e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (5.79e-4)"	19.3	19.4	20.7	19.3	22.8	26.9	29.9	17.9	21.7	16.9	12.4	18.7	13.2	10.5	16.1	19.8	21.3	12.5	12.6	12.7	19.0	19.4	14.7	35.7	18.3	18.9	22.4	15.5	17.3	30.1	21.4	18.5	18.6	23.5	15.3	14.7	15.8	21.3	13.7	15.6	17.3	11.6	16.7	21.7	14.5	14.7	17.9	21.3	18.2	48.7	14.1	21.4	15.8	27.8	7.9	10.2	10.1	7.5	11.1	14.7	6.5	17.8	12.4	12.6	15.8	19.0	20.3	23.1	23.9	20.1	16.1	14.7	12.3	6.1	36.3	17.1	30.1	17.2	13.5	23.9	18.4	23.4	22.6	12.6	20.2	11.6	10.7	33.7	37.1	18.3	14.4	47.5	17.9	55.3	20.9	14.2	27.2	33.5	72.9	17.0	21.9	20.4	14.7	24.0	12.6	22.2	16.3	15.2	27.1	8.8	10.5	14.1	16.5	14.0	16.1	34.6	12.8	28.6	37.0	14.9	12.7	12.8	18.2	18.7	45.9	35.2	28.1	28.1	29.0	20.4	5.8	7.5	10.1	10.9	7.5	14.7	7.9	12.4	11.3	10.2	5.3	11.4	9.6	2.3	11.1	6.7	3.5	10.3	6.5	20.7	22.8	17.9	21.2	19.0	19.4	22.4	15.5	23.5	21.3	11.9	7.8	10.7	12.2	17.4	16.4	9.8	12.7	5.3	11.4	14.0	11.8	21.2	14.9	8.8	3.3	16.7	5.4	23.3	11.0	17.4	18.5	18.0	24.3	28.2	12.9	12.7	10.9	24.5	21.3	4.1	18.7	12.1	20.3	3.6	10.9	71.1	13.5	3.5	19.1	11.3	21.2	12.9	19.6	11.8	12.7	19.6	14.2	15.0	12.7	12.8
YIPF1	"DJ167A19.1, FinGER1"	ENSG00000058799	"Yip1 domain family member 1"	Q9Y548	1	53851719-53889834	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Syncytiotrophoblasts: 108.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014716, HPA073931"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA014716: AB_1847686, HPA073931: "	"unprognostic (4.94e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.96e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.39e-3)"	"unprognostic (6.35e-1)"	10.1	15.6	12.8	9.1	13.9	8.0	18.2	6.9	12.8	11.2	12.1	8.8	11.5	11.0	6.6	12.2	14.0	10.2	10.8	13.4	10.6	12.1	16.1	31.8	11.9	14.1	12.4	9.1	11.8	13.7	7.2	15.5	15.4	14.4	17.8	14.4	10.2	17.1	14.3	18.7	13.9	10.6	9.4	10.6	13.3	13.0	10.8	11.1	10.3	33.5	9.8	15.7	12.9	16.2	8.1	11.4	26.7	14.5	6.9	16.0	10.2	6.9	4.2	6.7	4.7	7.9	8.9	6.0	5.0	7.9	9.3	12.2	4.8	2.1	2.3	8.5	6.0	14.3	8.3	8.8	11.1	9.6	17.6	7.0	5.8	4.7	7.2	10.9	6.4	5.5	8.9	10.5	7.4	9.0	7.9	10.0	8.7	6.0	6.7	9.0	5.9	6.5	9.3	4.9	8.2	7.0	4.1	6.3	9.9	7.9	3.6	3.0	3.8	4.7	9.0	23.0	22.1	13.9	7.2	4.5	3.8	3.9	6.7	4.3	13.5	15.4	4.3	5.8	5.3	3.3	12.5	12.5	13.2	8.5	11.3	8.0	8.1	7.3	8.5	11.4	7.7	7.1	6.7	26.7	6.9	14.5	7.8	16.0	10.2	12.8	13.9	6.9	12.8	10.6	12.1	12.4	9.1	14.4	11.1	6.0	13.0	10.7	15.1	7.6	6.5	8.5	28.1	14.7	15.9	8.7	0.0	65.7	10.0	23.6	22.9	8.7	11.7	0.0	28.3	23.0	8.3	37.4	9.2	17.4	34.5	9.5	9.2	13.5	19.9	41.4	5.5	15.8	10.1	16.2	23.0	16.2	25.6	12.9	8.9	13.5	5.4	0.0	6.2	12.7	18.3	9.5	108.4	13.8	9.5	22.0
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511827-43516990	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	26.8	51.0	26.1	20.3	36.8	19.3	28.1	24.2	48.9	33.5	30.4	38.1	40.3	31.9	31.2	50.5	31.9	34.4	39.9	30.9	26.2	25.5	44.2	62.0	30.0	21.1	26.1	21.4	34.0	73.7	47.0	38.9	59.3	29.7	36.0	29.9	36.8	75.4	31.8	30.6	26.9	38.4	27.4	28.1	28.0	38.8	27.8	22.6	27.9	51.2	31.3	32.9	32.8	26.5	11.7	18.5	74.3	19.7	14.6	18.3	16.0	19.0	13.4	19.8	38.3	44.6	36.1	11.9	23.0	35.7	19.1	24.2	16.0	13.9	7.8	18.4	42.2	16.5	19.2	14.5	22.4	12.1	14.3	20.8	12.2	19.8	30.4	34.6	12.9	18.4	36.0	29.3	16.2	16.1	32.5	28.7	13.3	13.2	18.1	22.7	29.2	9.8	16.5	10.2	99.8	14.9	8.7	9.1	20.6	34.0	20.3	16.0	22.9	10.4	13.9	24.3	15.7	22.9	27.2	27.3	21.7	11.4	11.9	15.8	21.3	17.1	15.5	15.4	11.2	14.6	26.2	19.7	28.3	15.3	18.5	13.3	11.7	13.8	13.5	18.5	11.7	11.3	12.6	74.3	14.6	18.4	17.0	18.3	16.0	26.1	36.8	24.2	48.9	26.2	25.5	26.1	21.4	29.7	22.6	32.8	25.2	38.7	57.7	36.1	56.4	26.7	56.0	32.1	39.8	52.4	35.3	167.5	41.4	124.0	24.9	56.8	99.6	23.3	88.8	180.7	66.2	64.5	40.3	62.3	87.8	55.6	102.8	65.7	41.3	59.8	64.7	40.3	62.4	92.8	108.3	110.5	105.8	94.7	62.9	58.6	49.3	32.3	47.5	38.7	38.1	31.0	220.8	42.4	69.7	72.1
YWHAZ	"14-3-3-zeta, KCIP-1, YWHAD"	ENSG00000164924	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta"	P63104	8	100916525-100953388	"Plasma proteins, Predicted intracellular proteins, Transporters"			"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Late spermatids: 1590.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB005065, HPA061603"	Approved		Approved	"Nucleoplasm,Nucleoli rim,Cytosol"		NA	NA		760000000	Cytosol	"Nucleoplasm, Nucleoli rim"	"CAB005065: AB_2218378, HPA061603: "	"unprognostic (4.70e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (1.83e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.28e-5)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.03e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	54.6	40.9	89.9	51.8	104.6	70.8	39.6	55.8	117.7	52.4	69.6	38.7	25.3	47.4	43.5	37.6	141.8	38.3	51.9	29.1	81.7	67.0	44.1	32.9	40.7	60.0	50.1	66.7	46.4	27.5	37.8	25.2	69.0	78.2	42.5	70.3	31.7	55.2	47.2	19.7	63.0	71.4	53.5	43.8	56.3	51.5	34.1	31.5	89.4	46.0	74.9	83.2	53.6	70.2	58.6	57.2	129.4	77.9	57.0	78.4	104.9	135.5	66.0	125.8	36.1	31.3	39.8	62.4	63.7	82.9	86.3	84.1	45.9	89.0	60.9	69.1	101.2	71.9	59.0	79.1	90.8	131.5	53.9	31.2	57.5	49.9	29.7	41.2	24.0	66.0	36.9	123.8	71.3	113.7	73.1	77.5	43.6	65.4	59.8	73.7	49.2	99.1	42.6	42.5	171.2	69.1	42.2	36.6	41.9	83.0	76.6	70.5	50.3	48.4	48.1	100.9	93.7	69.7	28.4	63.0	43.8	64.3	52.7	57.1	38.1	45.2	74.8	72.4	45.4	179.2	129.4	45.0	81.2	69.1	66.5	70.3	58.6	59.0	66.5	57.2	48.0	44.8	56.4	74.6	57.0	77.9	35.4	78.4	104.9	89.9	104.6	55.8	117.7	81.7	67.0	50.1	66.7	78.2	31.5	232.3	218.0	255.7	330.0	894.5	96.7	77.9	206.4	306.5	335.5	249.5	84.4	219.2	102.8	385.1	1094.8	171.9	335.2	46.7	365.6	441.5	215.1	349.2	432.9	89.1	253.4	127.1	254.5	172.5	286.2	1590.1	116.2	345.3	371.2	266.9	443.9	100.4	544.8	334.6	138.3	122.2	86.4	129.4	256.3	148.6	68.6	1035.6	342.0	343.9	282.9	758.7
ZACN	"L2, LGICZ, LGICZ1, ZAC, ZAC1"	ENSG00000186919	"Zinc activated ion channel"	Q401N2	17	76071961-76083666	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"intestine: 2.1"	"Cell type enhanced"	"Detected in single"	15	"Ciliated cells: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SiHa: 2.1"					"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (8.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.10e-3)"	"unprognostic (5.17e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.16e-5)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-7)"	"unprognostic (6.27e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.1	2.1			1.2	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0		0.0	0.1	0.0	0.1	0.1		0.4	0.0		0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.3	0.3	0.1			0.1		0.0	0.0	0.0	0.2	0.4	0.1	0.7	0.2	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.4	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.6	0.3	0.2	0.2	0.0	0.4	0.2	0.3	0.5	0.1	0.2	0.3	0.1	0.4	0.1											0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type containing 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Early spermatids: 73.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 54.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			Vesicles	"Golgi apparatus"	"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.7	5.2	6.3	9.3	8.0	6.8	7.3	13.2	9.7	8.8	13.2	5.8	7.1	8.7	6.4	5.6	36.4	10.5	6.9	7.7	6.2	7.1	10.8	2.3	4.7	6.9	5.4	5.2	5.8	14.0	10.9	20.1	9.4	9.4	7.1	14.7	6.4	11.2	5.9	2.1	14.9	12.3	4.9	4.7	6.3	14.4	11.2	4.8	15.0	7.7	18.2	27.5	15.3	14.5	6.3	4.3	23.4	5.8	4.3	7.5	3.5	15.9	7.6	7.3	6.2	2.6	3.0	7.0	7.7	7.1	8.6	10.0	4.6	3.8	8.2	5.3	6.4	19.4	24.4	10.4	5.0	9.5	10.1	9.1	4.3	4.8	3.7	6.0	5.8	7.4	3.4	6.0	3.6	5.1	8.1	54.4	11.5	4.1	4.1	8.8	5.2	7.4	4.7	6.0	15.1	7.0	8.2	10.1	1.9	8.9	10.6	12.7	9.3	9.2	11.2	4.1	7.3	5.3	6.7	15.6	7.7	5.4	11.7	6.1	3.5	10.8	7.5	9.2	6.0	13.4	7.4	3.5	23.4	6.8	5.8	6.1	6.3	5.3	7.5	4.3	4.2	5.1	6.5	4.4	4.3	4.6	4.2	6.8	3.5	6.3	8.0	13.2	9.7	6.2	7.1	5.4	5.2	9.4	4.8	8.9	12.5	4.9	19.3	21.5	10.4	32.9	10.2	33.5	21.6	15.7	9.8	7.5	5.0	17.2	73.0	9.3	13.5	0.0	17.0	15.7	10.6	33.7	11.5	0.8	5.5	15.9	15.0	9.2	5.9	36.4	7.2	7.4	3.3	29.7	21.1	61.2	17.7	14.0	2.1	2.2	8.5	0.0	5.6	38.7	22.6	31.7	5.3	8.7	18.7	44.2
ZDHHC17	"HIP14, HYPH, KIAA0946"	ENSG00000186908	"Zinc finger DHHC-type containing 17"	Q8IUH5	12	76763588-76853696	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 16.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA016807, HPA058674"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"		"HPA016807: AB_1858999, HPA058674: AB_2732626"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (1.77e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.71e-2)"	7.9	7.8	10.0	5.8	14.0	11.3	8.8	18.1	18.1	8.0	5.9	9.2	3.8	3.6	12.0	6.8	6.4	7.0	5.5	6.4	8.7	6.5	9.1	13.1	5.4	7.1	11.3	10.7	11.5	5.2	9.5	10.3	8.7	13.2	7.9	5.4	5.9	5.7	7.3	5.4	5.9	6.4	8.0	10.0	7.1	6.1	6.4	11.6	7.5	6.2	4.1	5.7	5.6	6.3	3.8	16.3	5.8	2.2	1.7	3.6	1.4	5.2	6.4	20.1	10.2	12.1	12.8	9.8	10.6	8.8	7.1	6.2	5.0	3.8	7.3	6.4	10.3	7.0	4.9	7.9	6.6	11.0	6.0	8.4	10.5	7.9	7.7	8.2	10.5	9.4	12.0	6.9	6.6	9.9	23.8	8.1	10.0	11.3	3.4	9.2	4.9	7.5	14.1	14.9	2.3	7.4	10.2	7.1	7.8	8.1	8.0	7.9	13.6	11.6	4.3	6.8	18.1	9.5	10.6	11.1	9.7	7.3	5.9	6.0	5.4	5.3	7.9	3.6	5.0	10.0	5.7	2.1	5.2	3.6	2.2	2.9	2.6	2.9	2.7	2.6	3.8	3.1	2.6	5.8	1.7	2.1	16.3	1.2	1.4	10.0	14.0	18.1	13.8	8.7	6.5	11.3	10.7	13.2	11.6	29.8	16.5	7.3	9.8	6.4	45.0	18.5	10.2	18.7	19.4	12.2	37.3	14.4	0.0	7.7	7.3	19.6	4.1	23.3	4.0	8.2	15.1	9.9	40.4	9.8	7.6	27.0	18.4	18.4	13.2	10.6	18.7	14.9	5.0	7.2	5.9	26.4	6.4	5.5	19.8	4.4	32.3	0.0	16.0	17.4	22.1	4.8	4.7	10.9	5.2	4.5
ZDHHC9	"CGI-89, CXorf11, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type containing 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease mutation, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 78.3"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavorable (9.77e-5)"	"prognostic unfavorable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	18.2	7.3	16.7	6.7	24.7	3.2	14.2	7.8	33.9	14.1	14.7	78.3	5.1	21.1	8.4	8.4	9.8	7.9	10.4	7.4	24.1	15.2	25.4	27.0	15.6	3.0	24.9	13.9	8.0	17.4	19.6	7.1	11.5	28.4	13.4	17.3	3.8	13.2	8.3	7.4	19.7	22.2	10.4	32.7	2.4	12.8	2.8	25.3	1.2	9.6	5.7	4.3	10.8	9.4	4.6	7.8	2.6	6.8	3.4	7.6	3.3	15.0	7.9	11.4	23.0	39.4	31.1	9.3	14.9	17.1	7.2	9.0	12.5	19.7	0.5	25.5	15.9	18.6	10.2	12.8	15.0	10.4	0.8	8.0	3.0	8.3	16.4	15.6	2.0	5.4	33.7	24.4	11.7	17.4	12.6	13.5	5.0	3.2	6.1	11.5	13.1	2.8	3.7	6.1	33.8	13.7	2.7	7.3	8.8	10.4	8.4	9.0	7.6	4.2	22.1	6.9	14.0	9.4	3.3	10.9	7.3	2.5	17.1	12.0	5.7	4.0	1.8	13.1	8.3	3.6	0.0	3.3	2.6	4.8	2.9	6.1	4.6	5.8	4.7	3.7	2.7	7.6	4.3	0.0	3.4	6.8	7.8	2.5	3.3	16.7	24.7	7.8	33.9	24.1	15.2	24.9	13.9	28.4	25.3	20.8	28.7	3.0	9.8	16.6	9.1	3.5	28.1	5.3	17.0	43.6	2.0	5.0	3.3	16.9	1.1	10.3	26.8	0.0	17.0	17.3	20.5	23.0	2.3	41.5	4.4	1.6	17.3	6.7	2.1	1.3	11.2	4.6	10.1	0.0	24.9	1.2	26.6	10.5	7.1	24.6	2.4	0.0	13.7	6.1	6.0	16.8	8.6	2.5	25.5	13.6
ZMPSTE24	"FACE-1, HGPS, PRO1, STE24, Ste24p"	ENSG00000084073	"Zinc metallopeptidase STE24"	O75844	1	40258107-40294184	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006988	Approved					NA	NA		13000			"HPA006988: AB_1080659"	"unprognostic (6.32e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.78e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (2.71e-2)"	21.6	24.2	17.6	15.4	19.6	6.5	18.6	10.7	21.3	20.9	20.6	14.9	27.0	17.9	29.7	19.7	21.4	19.9	20.7	20.8	17.1	16.9	34.2	48.7	16.2	23.1	21.9	17.0	16.0	20.4	39.8	17.0	23.0	23.5	21.7	23.3	15.6	18.9	19.0	19.1	14.7	20.9	25.2	19.2	17.7	19.0	10.7	17.9	20.9	20.6	14.7	18.4	19.1	16.7	15.1	25.8	15.1	23.9	24.2	22.5	20.3	20.9	14.0	10.9	8.1	29.0	23.3	21.2	22.0	18.4	24.9	22.8	15.3	36.4	18.1	15.3	26.9	9.7	21.8	22.3	20.3	28.7	17.0	14.3	17.4	15.0	14.0	16.6	28.1	21.9	16.8	20.8	21.2	9.2	14.0	17.4	9.0	18.5	18.2	23.5	9.8	17.0	8.4	21.0	13.9	14.6	14.8	19.4	22.4	22.0	20.3	11.4	13.5	20.3	45.3	27.3	17.6	16.7	77.7	17.3	22.5	16.5	20.9	26.7	11.2	30.0	15.8	24.7	19.8	23.8	15.1	20.0	13.6	17.9	23.9	21.5	15.1	19.1	18.9	25.8	11.6	17.0	22.5	11.8	24.2	22.7	16.9	22.3	20.3	17.6	19.6	10.7	21.3	17.1	16.9	21.9	17.0	23.5	17.9	35.7	23.7	17.1	19.8	28.4	5.7	18.7	50.9	49.5	28.4	69.8	0.0	33.1	26.6	47.9	2.1	31.5	34.1	0.0	31.7	32.0	28.1	33.2	20.7	56.7	30.7	9.5	26.5	20.3	28.9	0.5	26.4	29.6	23.6	31.5	26.3	29.0	37.5	25.9	30.8	33.7	6.3	0.0	21.5	7.0	5.5	23.7	32.6	17.5	28.0	19.9
